0001193125-14-062525.txt : 20140221 0001193125-14-062525.hdr.sgml : 20140221 20140221143910 ACCESSION NUMBER: 0001193125-14-062525 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140221 DATE AS OF CHANGE: 20140221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRYOLIFE INC CENTRAL INDEX KEY: 0000784199 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 592417093 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13165 FILM NUMBER: 14633076 BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193355 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 10-K 1 d644771d10k.htm 10-K 10-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-K

 

 

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2013

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                

Commission file number 1-13165

 

 

CRYOLIFE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Florida   59-2417093

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

1655 Roberts Boulevard N.W., Kennesaw, GA 30144

(Address of principal executive offices) (zip code)

Registrant’s telephone number, including area code (770) 419-3355

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Name of each exchange on which registered

Common Stock, $.01 par value

Preferred Share Purchase Rights

  

New York Stock Exchange

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K Section 229.405 of this chapter is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one).

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of June 30, 2013 the aggregate market value of the voting stock of the Registrant held by non-affiliates of the registrant was $155,031,053 computed using the closing price of $6.26 per share of Common Stock on June 30, 2013, the last trading day of the registrant’s most recently completed second fiscal quarter, as reported by the New York Stock Exchange, based on management’s belief that Registrant has no affiliates other than its directors and executive officers.

As of February 14, 2014 the number of outstanding shares of Common Stock of the registrant was 27,894,710.

Documents Incorporated By Reference

 

Document   Parts Into Which Incorporated
Proxy Statement for the Annual Meeting of Stockholders
to be filed within 120 days after December 31, 2013.		   Part III
 

 

 

 

PART I

Item 1. Business.

Overview

CryoLife, Inc. (“CryoLife,” the “Company,” “we,” or “us”), incorporated in 1984 in Florida, develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation. CryoLife’s surgical sealants and hemostats include BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (“SMI”). CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”), specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina. CryoLife and its subsidiary, Hemosphere, Inc. (“Hemosphere”), market the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”), which is a solution for end-stage renal disease (“ESRD”) in certain hemodialysis patients. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve® SG pulmonary heart valve (“CryoValve SGPV”) and the CryoPatch® SG pulmonary cardiac patch tissue (“CryoPatch SG”), both of which are processed using CryoLife’s proprietary SynerGraft® technology.

Products and Preservation Services

Surgical Sealants and Hemostats. CryoLife’s proprietary product, BioGlue, designed for cardiac, vascular, pulmonary, and general surgical applications, is a polymer based on bovine blood protein and an agent for cross-linking proteins. CryoLife distributes BioGlue throughout the U.S. and in approximately 80 other countries for designated applications. In the U.S., BioGlue is U.S. Food and Drug Administration (“FDA”) approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. CryoLife distributes BioGlue for repair of soft tissues (which include cardiac, vascular, pulmonary, and additional soft tissues) in the European Economic Area (“EEA”) (33 member state countries—28 European Union (“EU”) countries, 4 European Free Trade Association countries, and Turkey) under Conformité Européene Mark product certification (“CE Mark”). CryoLife distributes BioGlue in Japan for use in the repair of aortic dissections. Additional marketing approvals have been granted for specified applications in several other countries throughout the world.

CryoLife has a worldwide distribution agreement (except in China and certain related territories and governing areas) and a license and manufacturing agreement with SMI for PerClot, a polysaccharide hemostatic agent used in surgery. PerClot is an absorbable powdered hemostat that has a CE Mark allowing commercial distribution into the EEA and other markets. It is indicated for use in surgical procedures, including cardiac, vascular, orthopaedic, neurological, gynecological, ENT, and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical. In June 2013 CryoLife received conditional approval of its investigational device exemption (“IDE”) for PerClot from the FDA. IDE approval would allow the Company to begin clinical trials for the purpose of obtaining Premarket Approval (“PMA”) to distribute PerClot in the U.S. As part of the conditional approval for the PerClot IDE, the Company must make certain revisions to the investigational study protocol and clinical product labeling. The Company refiled the IDE submission on September 27, 2013. CryoLife received a second conditional approval on October 30, 2013. The Company has had multiple discussions with the FDA to resolve any remaining issues and expects to obtain FDA approval to begin enrollment into the pivotal trial in the first half of 2014.

CryoLife’s proprietary product, BioFoam, is a protein hydrogel biomaterial with an expansion agent, which generates a mixed-cell foam. The foam creates a mechanical barrier to decrease blood flow and develops pores for the blood to enter, leading to cellular aggregation and enhanced hemostasis. Due to its foaming characteristic, BioFoam has the potential to rapidly seal organs, such as the liver, and may provide hemostasis in penetrating wounds and trauma. CryoLife distributes BioFoam under a CE Mark for use as an adjunct in the sealing of the liver and spleen and as an adjunct to hemostasis in cardiovascular surgery when cessation of bleeding by ligature or conventional methods is ineffective or impractical.

Revascularization Technologies. In May 2011 CryoLife acquired Cardiogenesis, a leading developer of surgical products used in the treatment of patients with severe angina resulting from diffuse coronary artery disease. Cardiogenesis markets the FDA approved Holmium: YAG laser console, single use, fiber-optic handpieces, and the servicing and maintenance of the console for performing a surgical procedure known as transmyocardial revascularization (“TMR”), used for treating patients with severe angina that is not responsive to conventional therapy. Patients undergoing TMR treatment with Cardiogenesis products have been shown to have angina reduction, longer event-free survival, reduction in cardiac related hospitalizations, and increased exercise tolerance.

 

2

HeRO Grafts. In May 2012 CryoLife acquired Hemosphere. Hemosphere developed and markets the HeRO Graft, a proprietary graft-based solution for ESRD hemodialysis patients with limited access options. The HeRO Graft is the only fully subcutaneous arteriovenous (“AV”) access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis. The HeRO Graft is indicated for ESRD patients who are either catheter dependent or approaching catheter dependency, on long-term hemodialysis, and have exhausted all other access options, as well as for patients with failing fistulas and grafts due to central venous stenosis.

Tissue Preservation Services. CryoLife distributes preserved human cardiac and vascular tissues to implanting institutions throughout the U.S., Canada, and Europe. CryoLife processes and preserves cardiac and vascular tissues using proprietary processing and freezing techniques, or cryopreservation. Management believes the human tissues it distributes offer specific advantages over mechanical, synthetic, and animal-derived alternatives. Depending on the alternative, the advantages of the Company’s heart valves include more natural blood flow properties, the ability to use with patients who have endocarditis, the elimination of a need for long-term drug therapy to prevent excessive blood clotting, and a reduced risk of catastrophic failure, thromboembolism (stroke), or calcification. The Company’s cardiac tissues include the CryoValve SGPV and the CryoPatch SG, both processed with the Company’s proprietary SynerGraft decellularization technology. CryoLife uses the SynerGraft technology for a portion of its pulmonary valve and pulmonary cardiac patch tissue processing. The Company’s vascular tissues, including the CryoVein and CryoArtery, have been used to treat a variety of vascular reconstructions such as peripheral bypass, hemodialysis access, and aortic infections which have saved the lives and limbs of patients.

Research and Business Development

Through its continuing research and development activities, CryoLife uses its expertise in chemistry (protein, material, organic, and bio), biomaterials, molecular biology, and engineering, and its understanding of the cardiac and vascular surgery medical specialties to develop useful technologies, products, and services. In addition, CryoLife uses this expertise to acquire and license supplemental and complimentary products and technologies. CryoLife seeks to identify market areas that can benefit from medical devices, preserved tissues, and other related technologies, to develop innovative products and technologies within these areas, to secure their commercial protection, to establish their efficacy, and then to market these products and techniques. In order to expand its product and service offerings, CryoLife is in the process of developing or investigating several products and technologies. Some of the products in development and under investigation have not been subject to completed clinical trials and have not received FDA or other regulatory approval, so CryoLife may not derive any revenues from them. CryoLife performs significant research and development work before offering its products and services, building on either existing proprietary and non-proprietary knowledge or acquired technology and know-how. CryoLife developed its BioGlue and BioFoam products from a technology originally developed by a third-party and acquired by CryoLife. CryoLife purchased the rights to distribute and manufacture PerClot from a third-party and is working towards obtaining FDA approval to distribute PerClot in the U.S. CryoLife acquired Cardiogenesis and is evaluating the use of biologic materials in conjunction with TMR. CryoLife also acquired Hemosphere, and its HeRO Graft, and is working on product enhancements. CryoLife’s current tissue preservation services were developed internally.

Risk Factors

CryoLife’s business is subject to a number of risks. See Part I, Item 1A, “Risk Factors” below for a discussion of these and other risk factors.

Strategy

The key elements of the Company’s strategy relate to growing its business and leveraging its strengths and expertise in its core marketplaces in order to generate revenue and earnings growth. These key elements are described below:

 

  •  

Identify and Evaluate Acquisition and Investment Opportunities of Complementary Product Lines and Companies. Leverage the Company’s current distribution channels and its expertise in the cardiac and vascular medical specialties by selectively pursuing the potential acquisition, licensing, or distribution rights of additional technologies that complement existing products and services. Identify potential investment opportunities in companies that have complementary products that could, in the future, enhance the Company’s current distribution channels and expertise in the cardiac and vascular medical specialties.

 

  •  

Expand Core Business. Expand the Company’s core business in cardiac and vascular medical specialties by expanding the market penetration of BioGlue, BioFoam, PerClot, revascularization technologies, the HeRO Graft, heart valves, cardiac patch tissues, and vascular tissues.

 

3

  •  

Develop the Company’s Pipeline of Products and Services. Develop the Company’s technologies and intellectual property for additional service and product offerings and commercialization of new products and services.

 

  •  

License Company Technology to Third-Parties for Non-Competing Uses. Leverage the Company’s current technology platforms, including its protein hydrogel technology (“PHT”) platform and SynerGraft technology, in medical specialties other than cardiac and vascular surgery through strategic alliances, licenses, or distribution arrangements for additional indications or product line extensions. The Company considers licensing or distribution opportunities for existing products or for products in its research and development pipeline if the Company determines that licensing or distribution opportunities could enhance shareholder value.

 

  •  

Analyze and Identify Underperforming Assets for Potential Sale or Disposal. Continue to analyze and identify underperforming assets not complementary to the strategies identified above for potential sale or disposal.

As a result of the above strategies, the Company has pursued several opportunities in the past few years that resulted in the acquisition of PerClot technologies in September 2010 and 2011, the acquisition of Cardiogenesis and its revascularization technologies in May 2011, and the acquisition of Hemosphere and its HeRO Graft in May 2012, as discussed above. Additionally, in July 2011 the Company purchased approximately 2.4 million shares of Series A Preferred Stock of ValveXchange, Inc. (“ValveXchange”) for approximately $3.5 million and in 2012 advanced $2.0 million to ValveXchange through a revolving credit facility. ValveXchange is a private medical device company that was spun off from the Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets. CryoLife’s investment represents an approximate 19% equity ownership in ValveXchange. See Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Other Than Temporary Investment Impairment,” regarding the impairment of CryoLife’s investment in ValveXchange.

Products and Services

Medical Devices

PHT Platform

Closing internal wounds effectively following surgical procedures is critical to the restoration of the function of tissue and to the ultimate success of the surgical procedure. Failure to effectively seal surgical wounds can result in leakage of blood in cardiac surgeries, air in lung surgeries, cerebral spinal fluid in neurosurgeries, and gastrointestinal contents in abdominal surgeries. Fluid, air, and content leakage resulting from surgical procedures can lead to prolonged hospitalization, higher levels of post-operative pain, higher costs, and a higher mortality rate.

Sutures and staples facilitate healing by joining wound edges to allow the body to heal naturally. However, sutures and staples do not have inherent sealing capabilities, and they cannot consistently eliminate air and fluid leakage at the wound site. This is particularly the case when sutures and staples are used to close tissues containing air or fluids under pressure, such as in blood vessels, the lobes of the lung, the dural membrane surrounding the brain and spinal cord, and the gastrointestinal tract. In some cases, the tissues may be friable, which complicates the ability to achieve closure. In addition, in minimally invasive surgical procedures where the physician must operate through small access devices, it can be difficult and time consuming for the physician to apply sutures and staples. The Company believes that the use of surgical adhesives and sealants with or without sutures and staples could enhance the efficacy of these procedures through more effective and rapid wound closure. In order to address the inherent limitations of sutures and staples, the Company developed and commercialized its PHT platform. The PHT platform is based on a bovine protein that mirrors an array of amino acids that perform complex functions in the human body. Together with a cross-linker, the protein forms a hydrogel, a water-based biomaterial somewhat similar to human tissue. Materials and implantable replacement devices created with PHT may have the potential to provide structure, form, and function similar to certain human tissues.

BioGlue. BioGlue is the first product to be developed from the Company’s PHT platform. BioGlue is a polymeric surgical adhesive based on bovine blood protein and an agent for cross-linking proteins. BioGlue has a tensile strength that is four to five times that of fibrin sealants, and it is stronger than other cardiovascular sealants. BioGlue begins to polymerize within 20 to 30 seconds and reaches its bonding strength within two minutes. BioGlue is pre-filled in 2ml, 5ml, and 10ml volumes. BioGlue is dispensed by a controlled delivery system that consists of either a reusable delivery device and disposable syringe or a disposable syringe alone. Both systems use an assortment of applicator tips (standard size tips, 12mm and 16mm spreader tips, 10cm and 27cm flexible extender tips, and 10cm, 27cm, and 35cm delivery tip extenders).

CryoLife is authorized to distribute BioGlue throughout the U.S. and in approximately 80 other countries for designated applications. In the U.S., BioGlue is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. The Company estimates that the existing U.S. market for internal tissue surgical sealants was

 

4

approximately $200 million in 2013. CryoLife distributes BioGlue under a CE Mark in the EEA for repair of soft tissues (which include cardiac, vascular, pulmonary, dura, and additional soft tissues). CryoLife has also received specified approvals and distributes BioGlue in several other countries throughout the world. Revenues from BioGlue represented 41%, 40%, and 41% of total Company revenues in 2013, 2012, and 2011, respectively.

BioFoam. BioFoam is the second product to be developed from the Company’s PHT platform. BioFoam is a protein hydrogel biomaterial with an expansion agent, which generates a mixed-cell foam. The foam creates a mechanical barrier to decrease blood flow and develops pores for the blood to enter, leading to cellular aggregation and enhanced hemostasis. It is easily applied and could potentially be used intra-operatively to control internal organ hemorrhage, limit blood loss, and reduce the need for future re-operations in liver resections.

BioFoam received a CE Mark in August 2009 for use as an adjunct in the sealing of abdominal parenchymal tissues (liver and spleen) when cessation of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife began a controlled launch of BioFoam at three clinical centers in Europe in 2009 and, in 2010, began distribution of BioFoam in Europe. In November 2012 CryoLife received approval for an additional indication in Europe, allowing it to market BioFoam as an adjunct to hemostasis in cardiovascular surgery when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. Revenues from BioFoam represented less than 1% of total Company revenues in 2013, 2012, and 2011.

Hemostatic Agents

Hemostatic agents are frequently utilized as an adjunct to sutures and staples to control inter-operative bleeding. Hemostatic agents prevent excess blood loss and can help maintain good visibility of the operative site. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic agents are available in various forms including pads, sponges, liquids, and powders.

The Company estimates that the existing U.S. market for hemostatic agents was approximately $780 million in 2013. The Company estimates that the total existing European market for hemostatic agents was approximately $280 million in 2013. Revenues from hemostatic agents represented 3%, 2%, and 4% of total Company revenues in 2013, 2012, and 2011, respectively.

PerClot. PerClot is an absorbable, powdered hemostatic agent used in surgery. The PerClot technology modifies plant starch into ultra-hydrophilic adhesive forming hemostatic polymers. PerClot granules are biocompatible, absorbable polysaccharides containing no animal or human components. Utilizing this purified plant source material aids in minimizing the risks of infection and bleeding-related complications during surgery. PerClot granules have a molecular structure that rapidly absorbs water, forming a gelled adhesive matrix that provides a mechanical barrier to further bleeding and results in the accumulation of platelets, red blood cells, and coagulation proteins (thrombin, fibrinogen, etc.) at the site of application. This gelled adhesive matrix promotes the normal physiological clotting cascade. Easy to apply, PerClot does not require additional operating room preparation or special storage conditions. PerClot is readily dissolved by saline irrigation and is totally absorbed by the body within several days. PerClot is currently available in 1 gram, 3 gram, and 5 gram configurations with a 100mm or 200mm applicator tip for certain sizes. PerClot Laparoscopic is available in a 3 gram configuration with a 380mm applicator tip.

In September 2010 CryoLife entered into a worldwide distribution agreement and a license and manufacturing agreement with SMI for PerClot, which has a CE Mark allowing commercial distribution into the EEA and other markets. PerClot is indicated for use in surgical procedures, including cardiac, vascular, orthopaedic, neurological, gynecological, ENT, and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venular, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical.

CryoLife is currently seeking approval to begin clinical trials for the purpose of obtaining PMA to distribute PerClot in the U.S., as discussed further in “Research and Development and Clinical Research” below. The Company expects to obtain FDA approval to begin enrollment into the pivotal trial in the first half of 2014.

CryoLife distributes PerClot in Europe and other international countries. CryoLife plans to begin distribution of PerClot in additional international markets as required regulatory approvals are obtained. Revenues from PerClot represented approximately 3%, 2%, and 2% of total Company revenues in 2013, 2012 and 2011, respectively.

HemoStase. CryoLife distributed HemoStase under a private label exclusive distribution agreement with Medafor, Inc. (“Medafor”) from May 2008 to March 2011. Medafor fully, finally, and effectively terminated the agreement in 2010. The

 

5

parties litigated the agreement and its termination and settled the litigation in 2012. Revenues from HemoStase represented 0%, 0%, and 2% of total Company revenues in 2013, 2012, and 2011, respectively.

Revascularization Technologies

CryoLife’s subsidiary, Cardiogenesis, markets its Holmium: YAG laser console and single use, fiber-optic handpieces. These products are FDA approved for performing a surgical procedure known as TMR for treating patients with severe angina that is not responsive to conventional therapy. Patients undergoing TMR treatment with Cardiogenesis products have been shown to have angina reduction, longer event-free survival, reduction in cardiac related hospitalizations, and increased exercise tolerance.

During TMR, the surgeon uses one of the flexible, fiber-optic handpieces to deliver precise bursts of Holmium: YAG laser energy directly to an area of heart muscle that is suffering from ischemic heart disease. This condition can manifest itself with severe persistent chest pain, or chronic angina. The surgical procedure is performed through a small incision or small ports with the patient under general anesthesia. The surgeon can position the laser fiber on the surface of the beating heart. It takes approximately 6 to 10 pulses of the laser to transverse the myocardium and create channels one millimeter in diameter. During a typical procedure, approximately 20 to 40 channels are made in the heart muscle.

The outside punctures seal over with little blood loss. Published research shows evidence that these channels promote the growth of new blood vessels or angiogenesis over time. That, in turn, provides the damaged heart tissue a better supply of blood and oxygen. Angina usually subsides with improved oxygen supply to the targeted areas of the damaged heart muscle.

SolarGen 2100s Console. The SolarGen 2100s Console (“Console”) uses the solid state technology of the Holmium:YAG laser system to provide a stable and reliable energy platform that is designed to deliver precise energy output for the desired tissue effect. The Console implements an advanced electronic and cooling system technology to greatly reduce the size and weight of the unit, while providing 115V power capability. The Console was approved by the FDA in 2004 and received a CE Mark in 2005. The Company provides service plan options to ensure that the Console is operating within the critical factory specifications and to protect the customer’s investment.

SoloGrip® III. The SoloGrip III handpiece contains multiple, fine fiber-optic strands in a one millimeter diameter bundle. The flexible fiber-optic delivery system combined with the ergonomic handpiece provides access for treating all regions of the left ventricle. The SoloGrip III handpiece fiber-optic delivery system has an easy to install connector that screws into the laser base unit, and the device is pre-calibrated in the factory so it requires no special preparation. The SoloGrip III handpiece received FDA approval in 1999 and received a CE Mark in 1997.

PEARL 5.0. The minimally invasive Port Enabled Angina Relief with Laser (“PEARL”) 5.0 handpiece is compatible for use with Intuitive Surgical’s da Vinci Surgical System. The PEARL 5.0 handpiece received FDA approval in 2007 and received a CE Mark in 2005.

PEARL 8.0. The PEARL 8.0 handpiece has been designed for use in a minimally invasive thoracoscopic procedure. The PEARL 8.0 received FDA approval in 2012 and a CE Mark in 2005. As a condition of the FDA approval, the Company is currently conducting a post approval study. The Company anticipates the study will be completed in 2014, followed by full market launch of the PEARL 8.0.

CryoLife began distributing, primarily in the U.S., the revascularization technologies product line in May 2011 when it completed the acquisition of Cardiogenesis. Revenues from revascularization technologies represented 6%, 6%, and 5% of total Company revenues in 2013, 2012, and 2011, respectively. The Company estimates that the addressable U.S. market opportunity for TMR was approximately $200 million in 2013.

HeRO Grafts

CryoLife and its subsidiary Hemosphere market the HeRO Graft, a proprietary graft-based solution for ESRD hemodialysis patients with limited access options and central venous obstruction. The HeRO Graft received its initial FDA 510(k) clearance in 2008 and a CE Mark in 2013. It is indicated for ESRD patients who are catheter dependent or approaching catheter dependency, on long-term hemodialysis, and have exhausted all other access options, as well as for patients with failing fistulas and grafts due to central venous stenosis. Prior to the introduction of the HeRO Graft, the only option for these patients was access through percutaneous tunneled dialysis catheters, which cost more and have higher infection rates than the HeRO Graft, limit a patient’s lifestyle, and foster central venous stenosis (narrowing of the venous system). The HeRO Graft overcomes the limitations of catheters by providing a completely subcutaneous graft that functions

 

6

like a regular access graft during dialysis, providing superior blood flow, and achieving a 69% reduction in bacteremia (bacteria in the blood) compared with catheters. The HeRO Graft is the only fully subcutaneous AV access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis. The HeRO Graft traverses the central venous stenosis allowing for long-term hemodialysis access.

In March 2013 the Company received a 510(k) clearance for a next generation HeRO Graft. The revised version features an adaptor that provides the option to pair the HeRO Graft’s proprietary venous outflow component with certain other available dialysis access grafts, including early access arterial grafts. The Company anticipates launching the next generation HeRO Graft during 2014 following scale up and validation of the manufacturing process.

CryoLife began distributing the HeRO Graft in the U.S. in May 2012 when it acquired Hemosphere. The Company completed a controlled European market introduction of the product during the second half of 2013, which will be followed by a broader European launch in 2014.

The Company estimates that the addressable market opportunity for the HeRO Graft in the U.S. was approximately $135 million in 2013. Revenues from the HeRO Graft represented 4% and 2% of total Company revenues in 2013 and 2012, respectively.

Other Medical Devices

ProPatch Soft Tissue Repair Matrix (“ProPatch”). ProPatch is not currently distributed by CryoLife. ProPatch is manufactured from bovine pericardial tissue and treated with the SynerGraft process. It is used to reinforce weakened soft tissues and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. ProPatch is intended to be used for implantation to reinforce defects of the abdominal and thoracic wall, muscle flap reinforcement, hernias, suture-line reinforcement, and reconstructive procedures. ProPatch can also be used to reinforce tissues repaired by sutures or by suture anchors during tendon repair surgeries, including reinforcement of the rotator cuff, patellar tendon, Achilles tendon, biceps, quadriceps, or other tendons. Available in multiple size and shape configurations, ProPatch comes fully hydrated and ready to implant.

In late 2006 CryoLife received 510(k) clearance from the FDA for ProPatch, but did not pursue commercialization at that time. In 2011 CryoLife implemented modifications to streamline the manufacturing process. These modifications resulted in the submission of a new 510(k), which was cleared by the FDA in January 2012. CryoLife is evaluating its alternatives to commercialize ProPatch, which may include partnering with one or more third-parties as well as obtaining clinical data to support indications for direct distribution.

Preservation Services

The Company’s proprietary preservation process involves the recovery of tissue from deceased human donors by tissue banks and organ and tissue procurement organizations (“OTPOs”), the timely and controlled delivery of such tissue to the Company, the screening, dissection, disinfection, processing, and preservation of the tissue by the Company, and the storage and shipment of the preserved tissue. In the operating room, the tissue undergoes a controlled thawing process under the supervision of the medical staff. Thereafter, the tissue is surgically implanted by a surgeon into a human recipient.

The transplant of human tissue that has not been preserved must be accomplished within extremely short time limits. Prior to the advent of human tissue cryopreservation, these time constraints resulted in the inability to use much of the tissue donated for transplantation. The Company’s cryopreservation technologies applied to donated tissue expand the amount of human cardiac and vascular tissues available for transplantation. Cryopreservation also expands the treatment options available by offering alternatives to implantable mechanical, synthetic, and animal-derived devices. The tissues currently preserved by the Company include heart valves, cardiac patch tissues, and vascular tissues.

Cardiac Tissue. The human heart valves and cardiac patch tissues preserved by the Company are used in cardiac reconstruction and heart valve replacement surgeries. The Company currently preserves human aortic and pulmonary heart valves for implantation by cardiac surgeons. In addition, the Company preserves human cardiac patches for surgeons who wish to perform certain specialized cardiac repair procedures. The Company currently preserves human cardiac patches in three primary anatomic configurations: pulmonary hemi-artery, pulmonary trunk, and pulmonary branch. Each of these preserved cardiac tissues maintains a structure which more closely resembles and simulates the performance of the patient’s own tissue compared to non-human tissue alternatives.

In 2008 CryoLife received 510(k) clearance from the FDA for its CryoValve SGPV, and in 2009 CryoLife received 510(k) clearance from the FDA for its CryoPatch SG, both processed with the Company’s proprietary SynerGraft technology.

 

7

The SynerGraft process reduces the presence of allogeneic donor cells, while maintaining the structural integrity of the tissue. CryoLife uses the SynerGraft technology for a portion of its pulmonary valve and cardiac patch processing. In 2013 73% of pulmonary valves and 71% of cardiac patch tissues shipped by CryoLife were processed with the SynerGraft technology.

Based on CryoLife’s records of over 25 years of documented implants, management believes that the acceptance of the Company’s heart valves is due in part to physicians’ recognition of the longevity and natural functionality of the Company’s procured cardiac tissues, the Company’s documented clinical data, and the support of the Company’s physician relations and education staff, clinical research staff, customer service department, and field representatives. Management believes the Company offers advantages in the areas of clinical data and field services as compared to other human tissue processors and that Company procured tissues offer advantages in certain areas over mechanical, porcine, and bovine heart valve alternatives. Management believes preserved human heart valves and cardiac patch tissues have characteristics that make them the preferred replacement option for many patients. Specifically, human heart valves, such as those preserved by the Company, allow for more normal blood flow and provide higher cardiac output than stented porcine, bovine, and mechanical heart valves. Human heart valves are not as susceptible to progressive calcification, or hardening, as are traditional glutaraldehyde-fixed porcine and bovine heart valves, and do not require anti-coagulation drug therapy, as do mechanical valves. The synthetic sewing rings contained in mechanical and stented porcine and bovine valves may harbor bacteria and lead to endocarditis. Furthermore, prosthetic valve endocarditis can be difficult to treat with antibiotics, and this usually necessitates the surgical removal of these valves at considerable cost, morbidity, and risk of mortality. Consequently, for many physicians, human heart valves are the preferred alternative to mechanical and animal-derived tissue valves for patients who have, or are at risk to contract, endocarditis.

The 2013 Society of Thoracic Surgeons Guidelines, as published in the Annals of Thoracic Surgery, have increased the indication from Class II to Class I and broadened the scope for using an aortic homograft during aortic valve replacement surgery due to endocarditis. This means that when endocarditis has functionally destroyed the aortic valve annulus, an aortic homograft is the recommended course of treatment. Previously, the Guidelines’ indication for aortic homograft use was Class II, which meant only that it was an acceptable course of treatment.

The Company estimates that the existing total annual heart valve replacement market in the U.S. was approximately $800 million in 2013. Management believes that its aortic and pulmonary valves compete for approximately 75% of the procedures, which make up this approximate $800 million valve replacement existing market. The Company estimates that in 2013 there were approximately 24,000 congenital heart repair procedures performed in the U.S. Management believes that its cardiac patches compete for 40% of this market. Revenues from cardiac tissue preservation services accounted for 21%, 23%, and 22% of total Company revenues in 2013, 2012, and 2011, respectively.

Vascular Tissue. The human vascular tissues preserved by the Company, including CryoVein and CryoArtery, save the lives and limbs of patients and are used in a variety of vascular reconstruction procedures such as peripheral bypass, hemodialysis access, and aortic infections. In addition, the Company preserves human saphenous vein conduits (3mm to 6mm) for use in peripheral vascular reconstructions. Failure to achieve revascularization of an obstructed vessel may result in the loss of a limb or even death of the patient. When patients require peripheral bypass surgery, the surgeon’s first choice generally is the patient’s own vascular tissue. However, in cases of advanced vascular disease, as many as 30% of patients have unsuitable vascular tissue for transplantation, and the surgeon must consider using synthetic grafts or preserved human vascular tissue. Synthetic vascular grafts are generally not optimal for below-the-knee surgeries because they have a tendency to obstruct over time. Preserved human vascular tissues tend to remain open longer and, as such, are used in indications where synthetics typically fail. In addition, synthetic grafts are not suitable for use in infected areas since they may harbor bacteria and are difficult to treat with antibiotics. Preserved human vascular tissues have advantages for patients with previously infected graft sites. The Company also preserves femoral veins and arteries and aortoiliac arteries for bypass, hemodialysis access, or reconstruction within infected surgical areas.

The Company estimates that the existing U.S. vascular surgical graft market was approximately $120 million in 2013. Revenues from vascular preservation services accounted for 25%, 26%, and 28% of total Company revenues in 2013, 2012, and 2011, respectively.

Seasonality and Segment Information

See Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Seasonality,” regarding seasonality of the Company’s products and services.

See Part II, Item 8, Note 18 of the “Notes to Consolidated Financial Statements” regarding segment and geographic information.

 

8

Distribution and Marketing

Medical Devices

In the U.S., the Company markets its products to physicians and distributes its products through its field representatives and cardiac specialists. Through its field representatives, the Company conducts field training for implanting surgeons regarding the application of its products.

The Company markets its products in the EEA, the Middle East, and Africa (“EMEA”) through its European subsidiary, CryoLife Europa Ltd. (“Europa”), based in Guildford, England. Europa employs direct field representatives in the U.K., Germany, Austria, and Ireland and manages relationships with other independent distributors in the EMEA region. Europa’s team of approximately 30 employees provides customer service, logistics, marketing, and clinical support to cardiac, vascular, thoracic, and general surgeons throughout the EMEA region.

Additionally, the Company markets and distributes its products in other international markets through independent distributors in Canada, Asia Pacific, and the Americas. CryoLife Asia Pacific, Pte. Ltd. (“Asia Pacific”) was established in Singapore in November 2013 and is intended to provide sales and marketing support for the Asia Pacific region beginning in 2014.

Preservation Services

CryoLife markets its preservation services, primarily in the U.S., to OTPOs, implanting physicians, and prospective tissue recipients. The Company works with OTPOs to ensure consistent and continued availability of donated human tissue for transplant and educates physicians and prospective tissue recipients with respect to the benefits of preserved human tissues.

CryoLife’s physician relations and education staff, clinical research staff, and field representatives assist physicians by providing educational materials, seminars, and clinics on methods for implanting tissue preserved by the Company and the clinical advantages, indications, and applications for those tissues. The Company continually trains and educates physicians on clinical aspects of the human tissues preserved by the Company. In addition, the Company sponsors programs where surgeons train other surgeons in best-demonstrated techniques. The Company also assists OTPOs through training and development of protocols and provides materials to improve their tissue recovery techniques to increase the yield of usable tissue.

Procurement of Tissue. Donated human tissue is procured from deceased human donors by OTPOs. After procurement, the tissue is packed and shipped, together with certain information about the tissue and its donor, to the Company in accordance with the Company’s protocols. Additional information is provided to the Company later by the OTPOs, as needed. The tissue is transported to the Company’s laboratory facilities via commercial airlines pursuant to arrangements with qualified courier services. Timely receipt of procured tissue is important, as tissue that is not received promptly cannot be cryopreserved successfully. The OTPOs are reimbursed by the Company for costs associated with these procurement services. The procurement fee, together with the charges for the preservation services of the Company, is ultimately paid to the Company by the hospital or healthcare facility with which the implanting physician is associated.

Since 1984 the Company has received tissue from over 127,000 donors. The Company has active relationships with approximately 35 OTPOs throughout the U.S. Management believes these relationships are critical in the preservation services industry and that the breadth of these existing relationships provides the Company with a significant advantage over potential new entrants to this market. The Company employs approximately 40 individuals in donor services and donor quality assurance to work with OTPOs. This includes two account managers who are stationed throughout the country to work directly with the OTPOs. The Company’s central office for procurement relations is staffed 24 hours per day, 365 days per year.

Preservation of Tissue. Upon receiving tissue, a Company technician completes the documentation control for the tissue prepared by the OTPO. The documentation identifies, among other things, donor age, and cause of death. A trained technician then removes the portion or portions of the delivered tissue that will be processed. The Company’s cardiac and vascular tissues are preserved in a proprietary freezing process conducted according to Company protocols. After the preservation process, the tissues are transferred to liquid nitrogen freezers, initially under quarantine status, for long-term storage at temperatures at or below -135°C. The entire preservation process is controlled by guidelines established by the Company and is conducted under aseptic conditions in clean rooms.

 

9

At the same time the tissue is processed, samples are taken from the donated tissue and subjected to the Company’s quality assurance program. This program, which includes microbiological testing and review of the donor and tissue charts by CryoLife’s tissue quality assurance department and its medical directors, may identify characteristics which would disqualify the tissue for preservation or implantation. Tissue that does not pass testing is disposed of as appropriate or used for research or other purposes if the donor’s family has consented. Once the tissue is approved, it is moved from quarantine to an implantable status.

Distribution of Tissue to Implanting Physicians. After the tissue has cleared quality control assurance and is moved to an implantable status, the tissue is stored by the Company until it is shipped to hospitals at the implanting physician’s request. Cryopreserved tissue must be transported under stringent handling conditions and maintained within specific temperature tolerances at all times. Cryopreserved tissue is packaged for shipment using the Company’s proprietary processes. After the Company delivers the tissue to the courier or shipping company, the Company invoices the institution for its services, which include procurement, preservation, and transportation. At the hospital, the tissue is thawed and implanted immediately or is held in a liquid nitrogen freezer in accordance with Company protocols pending implantation. The Company provides a detailed protocol for thawing the cryopreserved tissue. The Company also makes its field personnel available by phone or in person to answer questions.

The Company provides Company-owned liquid nitrogen freezers to certain client hospitals. The Company currently has approximately 260 of these freezers installed at hospitals throughout the U.S. Participating hospitals generally pay the cost of liquid nitrogen. The availability of on-site freezers makes it easier for a hospital’s physicians to utilize the Company’s tissues by making the tissue more readily available.

The Company has historically shipped tissues into certain countries in Europe, primarily the U.K., Germany, and Austria. Per EU Directives, the regulation of tissue processing in Europe is governed by the relevant country’s Competent Authority. Europa has a license that allows for both marketing and importation through the U.K.’s Human Tissue Authority (“HTA”). Separately, Europa has a marketing license through the German Competent Authority, the Paul-Erlich-Institute (“PEI”). However, because the PEI marketing license does not allow for the importation of tissue into Germany or Austria, Europa has historically relied on the HTA importation license to import tissue into those countries. (At this time, Austria does not have a Competent Authority that has its own regulations.)

In 2013 the HTA temporarily suspended Europa’s licenses but shortly thereafter reinstated them subject to certain conditions, which allowed Europa to continue importing tissues into Europe. Subsequently, the HTA imposed certain additional tissue processing requirements for tissues imported into Europe through the HTA license. Europa will be required to comply with those additional requirements beginning on March 31, 2014. Management does not believe those requirements are necessary in order to ensure the safety of the processed tissue; therefore, management has determined that rather than comply with the additional processing requirements, Europa will cease importing tissues into Europe through the HTA license.

Europa is in discussions with PEI regarding certain requirements that are scheduled to apply to Europa’s marketing license beginning in the later part of 2014. If Europa were able to reach satisfactory agreement with the PEI regarding those requirements, it would still need an import license from one of the regional authorities of the Federal States in Germany to allow it to ship tissues into Germany and Austria. Even if it were to obtain the import license, Europa would not be able to import tissues into the U.K. due to the HTA’s tissue processing requirements. It would, however, be able to import tissues into Germany and Austria. Europa may choose to end these discussions at any time.

Marketing, Educational, and Technical Support

The Company works to maintain relationships with, and market to, surgeons within the cardiac and vascular medical specialties. In the U.S., the Company has approximately 19 cardiac specialists who focus primarily on cardiac surgeons, approximately 28 cardiovascular representatives who focus primarily on vascular surgeons, approximately eight vascular access representatives who focus primarily on nephrologists and dialysis clinics, and seven region managers, in addition to national accounts managers, and sales and marketing management.

Because the Company markets its products and services directly to physicians, an important aspect of increasing the distribution of the Company’s products and preservation services is educating physicians on the use of the Company’s medical device products and preserved human tissues and on proper surgical and implantation techniques. The Company’s trained medical relations and education staff and field support personnel provide support to surgical institutions and surgeons. The Company sponsors training seminars where physicians teach other physicians the proper surgical techniques for the Company’s products and for handling and implanting preserved human tissue. The Company also produces educational videos for physicians and coordinates peer-to-peer training at various medical institutions. In addition, the Company hosts

 

10

several workshops throughout the year including the Central Venous Pathology Summit, Aortic Allograft Workshops, and TMR Workshops. These workshops aim to provide didactic and hands-on training to surgeons. Management believes that these activities improve the medical community’s acceptance of the products and tissues offered by the Company and help to differentiate the Company from other medical device companies and allograft processors.

To assist OTPOs, the Company provides educational materials and training on procurement, dissection, packaging, and shipping techniques. The Company also produces educational videos and coordinates laboratory sessions on procurement techniques for OTPO personnel. To supplement its educational activities, the Company employs a full-time technical trainer, who provides technical information and assistance and maintains a staff 24 hours per day, 365 days per year for OTPO support.

Backlog

The Company currently does not have a backlog of orders related to BioGlue, BioFoam, PerClot, revascularization technologies, or HeRO Grafts. The limited supply of certain types or sizes of preserved tissue, primarily for use in pediatric surgeries, can result in a backlog of orders for these tissues. The amount of backlog fluctuates based on the tissues available for shipment and varies based on the surgical needs of specific cases. The Company’s backlog is generally not considered firm and must be confirmed with the customer before shipment.

Competition

Medical Devices

The Company faces competition from several domestic and international medical device, pharmaceutical, and biopharmaceutical companies in its surgical sealants and hemostats product lines. Many of the Company’s current and potential surgical adhesives, sealants, and hemostats competitors have substantially greater financial and personnel resources than the Company. These competitors may also have greater experience in developing products, conducting clinical trials, and obtaining regulatory approvals and may have large contracts with hospitals under which they can impose purchase requirements that place our products at a disadvantage. Certain of these competitors may obtain patent protection or approval or clearance by the FDA or foreign countries earlier than the Company. The Company may also compete with companies that have superior manufacturing efficiency and marketing capabilities. Additional competitive products may be under development by other large medical device, pharmaceutical, and biopharmaceutical companies. Any of these competitive disadvantages could materially, adversely affect the Company.

BioGlue. The Company’s BioGlue products compete primarily with Baxter International, Inc.’s Tisseel, CoSeal, and TachoSil; Ethicon, Inc.’s (a Johnson & Johnson Company) Evicel and Omnex; Integra LifeSciences Holdings Corporation’s Duraseal product; C.R. Bard, Inc.’s ProGEL; and Tenaxis, Inc.’s ArterX. The Company’s BioGlue competes with these products based on its benefits and features, such as strength and ease of use.

BioFoam. The Company’s BioFoam product competes with other surgical hemostatic agents that include Pfizer, Inc.’s Gelfoam; Baxter International, Inc.’s FloSeal and TachoSil; Ethicon, Inc.’s Spongostan, Instat, Surgicel, and Surgicel Nu-Knit; C.R. Bard, Inc.’s Avitene; and Orthovita, Inc.’s Vitagel. The Company’s BioFoam product competes on the basis of its clinical efficacy and ease of use.

PerClot. The Company’s PerClot product competes with thrombin products, including Pfizer, Inc.’s Thrombin JMI; The Medicines Company’s Recothrom; and Ethicon, Inc.’s Evithrom; and surgical hemostats, including Pfizer, Inc.’s Gelfoam; C.R. Bard, Inc.’s Arista and Avitene; Baxter International, Inc.’s FloSeal; Ethicon, Inc.’s Surgicel, Surgiflo, and Surgifoam products; and BioCer’s HaemoCer. Other competitive products may include argon beam coagulators, which provide an electrical source of hemostasis. A number of companies have surgical hemostat products under development. The Company’s PerClot product competes on the basis of its safety profile, clinical efficacy, absorption rates, and ease of use.

Revascularization Technologies. The Company’s revascularization technologies compete with other methods for the treatment of coronary artery disease, including drug therapy, percutaneous coronary intervention, coronary artery bypass surgery, and enhanced external counterpulsation. Currently, the only directly competitive laser technology for the performance of TMR is the CO2 Heart Laser System manufactured by Novadaq Technologies, Inc. The Company’s revascularization technology competes on the basis of its ease of use, versatility, size of laser console, and improved access to the treatment area with a smaller fiber-optic system.

HeRO Grafts. The Company’s HeRO Graft competes with balloon angioplasty products, including C.R. Bard, Inc.’s Conquest and Boston Scientific’s Mustang. These products treat central venous stenosis and may preclude the future use of

 

11

the HeRO Graft due to total occlusion of the central venous system. No product on the market currently serves as a fully subcutaneous AV access graft for patients while treating central venous stenosis. Other companies either have a fully subcutaneous graft for maintaining AV access, such as Artegraft, Inc.’s Artegraft Bovine Carotid Artery Graft; W.L. Gore & Associates’ Hybrid Vascular Graft; C.R. Bard, Inc.’s Impra; and Atrium’s Flixene, or they have a chronic dialysis catheter for maintaining access in patients with central venous stenosis. The Company’s HeRO Graft competes on the basis of reducing catheter dependency in ESRD patients with central venous stenosis, and benefiting patients through fewer infections, superior dialysis adequacy, higher patency rates, and reduced costs as compared to catheters.

Preservation Services

The Company currently faces competition from at least one non-profit tissue bank that preserves and distributes human cardiac heart valves and cardiac patch tissues and at least two non-profit tissue banks that preserve and distribute human vascular tissues, as well as from several companies that market mechanical, porcine, and bovine heart valves, and synthetic vascular grafts for implantation. Many established companies, some with financial and personnel resources greater than those of the Company, are engaged in manufacturing, marketing, and selling alternatives to preserved human tissue. These competitors may also have greater experience in developing products, conducting clinical trials, and obtaining regulatory approvals. Certain of these competitors may obtain patent protection, approval, or clearance by the FDA or foreign countries earlier than the Company. The Company may also compete with companies that have superior manufacturing efficiency and marketing capabilities. Companies offering mechanical, synthetic, bovine, porcine, or allograft products may enter this market in the future. Any newly developed treatments may also compete with the use of tissues preserved by the Company. Management believes that it competes with other entities that preserve human tissue on the basis of the preference of surgeons and patients for human tissues versus other types of tissues or mechanical devices and on technology, customer service, and quality assurance. Any of these competitive disadvantages could materially, adversely affect the Company.

Heart Valves. Alternatives to human heart valves preserved by the Company include valve repair and valve replacement with mechanical valves, porcine valves, or valves constructed from bovine pericardium. St. Jude Medical, Inc. is the leading supplier of mechanical heart valves. Medtronic, Inc. is the leading supplier of porcine heart valves. Edwards Life Sciences, Inc. is the leading supplier of bovine pericardial heart valves. The Company is aware of at least five companies that offer porcine, bovine, and mechanical heart valves. In addition, management believes that at least one domestic tissue bank offers preserved human heart valves in competition with the Company.

Management believes that the human heart valves preserved by the Company, as compared to mechanical, porcine, and bovine heart valves, compete on the factors set forth above, as well as by providing a tissue that is the preferred replacement alternative with respect to certain medical conditions, such as pediatric cardiac reconstruction, valve replacements for women in their child-bearing years, and valve replacements for patients with endocarditis. The Company believes the CryoValve SGPV enables the Company to compete with other valves by providing a valve processed with a technology designed to remove donor cells and cellular remnants from the valve without compromising the integrity of the underlying collagen matrix. The Company also believes that the CryoValve SGPV and the CryoValve SG aortic heart valve (“CryoValve SGAV”) are important to patient management issues for potential whole organ transplant recipients. Implantation of the SynerGraft treated cardiac tissue reduces the risk for induction of class I and class II alloantibodies, based on Panel Reactive Antibody (“PRA”) measured at up to one year, compared to standard processed cardiac tissues. While the link between immune response and allograft tissue performance is still being debated, there is evidence that an elevated PRA poses a significant risk to future organ transplant patients. Avoiding elevated PRA is important for patients receiving cardiac tissues as some of these patients may ultimately require a heart transplant. In these patients, an increased PRA can decrease the number of possible donors for subsequent organ transplants and increase time on transplant waiting lists.

Cardiac Patches. Alternatives to human cardiac patches preserved by the Company include cardiac repair and reconstruction with small intestine submucosa (“SIS”) or patches constructed from bovine pericardium. CorMatrix Cardiovascular, Inc. is the leading supplier of SIS for cardiac repair and reconstruction with its CorMatrix ECM technology. There are several suppliers of bovine pericardial patches targeted for cardiac repair and reconstruction, including Edwards Life Sciences, Inc., Neovasc, Inc., St. Jude Medical, Inc., and Synovis Surgical Innovations. Management believes that at least one domestic tissue bank offers preserved human cardiac patches in competition with the Company, including LifeNet Health, Inc., which processes allograft patches using its Matracell technology.

Management believes that the human cardiac patches preserved by the Company, as compared to SIS, bovine, or other allograft patches, compete on the factors set forth above with respect to heart valves, and that these human cardiac tissues are the preferred repair and reconstruction alternative for use for cardiac defect repair including Tetralogy of Fallot, Truncus Arteriosis, and Pulmonary Atresia. The Company believes the CryoPatch SG enables the Company to compete with other patches by providing a patch processed with a technology designed to remove donor cells and cellular remnants from the patch without compromising the integrity of the underlying collagen matrix. As discussed above for the CryoValve SGPV

 

12

and CryoValve SGAV, the Company also believes that the CryoPatch SG is important to patient management issues for potential whole organ transplant recipients.

Vascular Tissue. Generally, for each procedure that may utilize vascular human tissue that the Company preserves, there are alternative treatments. Often, in the case of vascular tissue, these alternatives include the repair, partial removal, or complete removal of the damaged tissue and may utilize other tissues from the patients themselves or synthetic products. The attending physician, in consultation with the patient, makes the selection of treatment choices. Any newly developed treatments may also compete with the use of vascular tissue preserved by the Company.

There are a number of providers of synthetic alternatives to veins preserved by the Company and those alternatives are available primarily in medium and large diameters. Two primary synthetic grafts that compete with the Company’s vascular tissue for below-the-knee surgery are W.L. Gore & Associates’ Propaten and C.R. Bard, Inc.’s Distaflo. Artegraft’s bovine carotid artery graft and Hancock Jaffe Laboratories, Inc.’s ProCol can be used for hemodialysis access, and Maquet, Inc.’s Hemashield woven grafts can be used for aortoiliac aneurysm surgery. Currently, management believes there are at least two other non-profit tissue banks that preserve and distribute human vascular tissue in competition with the Company.

General

Other recently developed technologies or procedures are, or may in the future be, the basis of competitive products. There can be no assurance that the Company’s current competitors or other parties will not succeed in developing alternative technologies and products or product enhancements that are more effective, easier to use, or more economical than those which have been or are being developed by the Company or that would render the Company’s technology and products obsolete and non-competitive in these fields. In such event, the Company’s business, financial condition, profitability, and cash flows could be materially, adversely affected. See Part I, Item 1A, “Risk Factors—Risks Relating To Our Business—Rapid Technological Change Could Cause Our Products and Services To Become Obsolete.”

Research and Development and Clinical Research

The Company uses its technical and scientific expertise and its understanding of the needs of the cardiac and vascular surgery medical specialties to attempt to expand its surgical adhesives, sealants, and hemostats businesses and preservation services and to develop or acquire products and technologies for these specialties. The Company identifies market areas that can benefit from medical devices, preserved tissues, and other related technologies and then attempts to develop innovative techniques, products, and services within these areas, to secure their commercial protection, to establish their clinical efficacy, and then to market these techniques, products, and services. The Company employs approximately 37 people in its research and development and clinical research departments, including five Ph.D.s with specialties in the fields of chemistry (protein, material, organic, and bio); biomaterials; molecular biology; and engineering.

In order to expand the Company’s product and service offerings, the Company is currently in the process of obtaining approvals, developing, or investigating several technologies and products, including PerClot, the PHT product platform used in BioGlue and BioFoam, the HeRO Graft, revascularization technologies, human tissue preservation, and technologies related to additional applications of its SynerGraft technology, including ProPatch.

To the extent the Company identifies additional applications for its products, the Company may attempt to license these products to corporate partners for further development of such applications or seek funding from outside sources to continue the commercial development of such technologies. The Company may also attempt to acquire or license additional technologies from third-parties to supplement its product lines.

The Company collects and maintains clinical data on the use and effectiveness of its products and services. The Company uses this data to help direct its continuing efforts to improve its products and services through ongoing research and development and shares this data with surgeons. The Company’s research and development strategy is to allocate available resources among the Company’s core market areas of cardiac and vascular surgery, sealants, and hemostats, based on the size of the potential market for any specific product candidate, the estimated development time and cost required to bring the product to market, and the expected efficacy of the potential product. Research on these and other projects is conducted in the Company’s research and development laboratory or at universities or clinics where the Company sponsors research projects. The Company’s medical and scientific advisory board consults on various research and development programs. The Company’s preclinical studies are conducted at universities and other locations outside the Company’s facilities by third-parties under contract with the Company. In addition to these efforts, the Company may pursue other research and development activities.

 

13

In 2013, 2012, and 2011 the Company spent approximately $8.5 million, $7.3 million, and $6.9 million, respectively, on research and development activities on new and existing products. These amounts represented approximately 6% of the Company’s revenues for each of the years 2013, 2012, and 2011. Of these amounts spent on research and development activities, $69,000, $604,000, and $398,000 was funded by the U.S. Department of Defense in 2013, 2012, and 2011, respectively.

PerClot. CryoLife filed an IDE with the FDA in March 2011 seeking approval to begin clinical trials for the purpose of obtaining PMA to distribute PerClot in the U.S. In April 2011 the FDA disapproved CryoLife’s IDE filing. In March 2012 CryoLife refiled its IDE and the FDA responded with comments in the second quarter of 2012. CryoLife filed a revised IDE in November 2012 and received questions from the FDA in December 2012 related to this filing. In June 2013 CryoLife received conditional approval of its IDE for PerClot from the FDA. As part of the conditional approval for the PerClot IDE, the Company must make certain revisions to the investigational study protocol and clinical product labeling. The Company refiled the IDE submission on September 27, 2013. CryoLife received a second conditional approval on October 30, 2013. The Company has had multiple discussions with the FDA to resolve any remaining issues and expects to obtain FDA approval to begin enrollment into the pivotal trial in the first half of 2014.

BioFoam. In November 2012 CryoLife received an additional indication in Europe to market its BioFoam as an adjunct to hemostasis in cardiovascular surgery when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. The Company will be conducting a 45 patient post-market study in Europe on BioFoam used in cardiovascular applications in 2014. The Company has no current plans to introduce BioFoam in the U.S. Introducing BioFoam in the U.S. would require a clinical trial and FDA premarket approval.

Revascularization Technologies. Cardiogenesis is evaluating the use of biologic materials in conjunction with TMR. The synergy of injecting biologics, such as stem cells or growth factors, with TMR may provide greater angina reduction and improve cardiac function in patients with diffuse coronary artery disease who are not candidates for surgical bypass or intervention.

The PEARL 8.0 handpiece received FDA approval in February 2012. A condition of the approval is to conduct a post approval study on 10 to 22 patients at up to five centers with 30 day follow-up. The Company anticipates the study will be completed in 2014.

HeRO Grafts. The Company is currently working on improvements to the HeRO Graft which may include, among other things, product enhancements to facilitate easier implantation of the device. In April 2013 CryoLife received a CE Mark for the HeRO Graft.

CryoValve SGPV. At the FDA’s request, the Company has committed to conducting a post-clearance study to collect long-term clinical data for the CryoValve SGPV. Data collected in this study will be compared to data from a defined control group implanted with a standard processed human pulmonary heart valve. The Company believes the information obtained from this study may help ascertain whether the SynerGraft process extends the long-term durability of pulmonary valves. Additionally, explant analyses may help determine if the heart valve’s collagen matrix recellularizes with the recipient’s own cells. The study is expected to be completed in mid-2014.

Patents, Licenses, and Other Proprietary Rights

The Company relies on a combination of patents, trademarks, confidentiality agreements, and security procedures to protect its proprietary products, preservation technology, trade secrets, and know-how. The Company believes that its patents, trade secrets, trademarks, and technology licensing rights provide it with important competitive advantages. The Company owns or has licensed rights to 60 U.S. patents and 40 foreign patents, including patents that relate to its technology for BioGlue, PHT, revascularization technologies, HeRO Graft, human cardiac and vascular tissue preservation, and decellularization of tissue. The Company has approximately 14 pending U.S. patent applications and 20 pending foreign applications that relate to the Company’s, PHT, tissues, and other areas. There can be no assurance that any patents pending will ultimately be issued. The remaining duration of the Company’s issued patents range from 2 months to 17 years. The main patent for BioGlue expired in mid-2012 in the U.S. and expired in mid-2013 in the majority of the rest of the world. However, for a competitor to copy BioGlue they would have to develop parts of the manufacturing process that are trade secrets of the Company and then seek FDA approval, which would likely require human clinical trials, or other regulatory approvals. In September 2010 CryoLife entered into a worldwide distribution agreement and a license and manufacturing agreement with SMI for PerClot. Once the Company begins to manufacture PerClot, it will be required to pay royalties based on revenues of PerClot manufactured by the Company. The Company has already prepaid $1.5 million of these royalties. In addition, the Company has a distribution agreement with a third-party for the distribution of PerClot. These products have license rights and trade secrets that provide competitive advantages.

 

14

There can be no assurance that the claims allowed in any of the Company’s existing or future patents will provide competitive advantages for the Company’s products, preserved tissues, and technologies or will not be successfully challenged or circumvented by competitors. There can also be no assurances that the claims allowed in patents licensed or owned by third-parties for products distributed by the Company will not be successfully challenged or circumvented by competitors. To the extent that any of the Company’s products, whether manufactured by the Company or distributed by it, are not effectively patent protected, the Company’s business, financial condition, profitability, and cash flows could be materially, adversely affected. Under current law, patent applications in the U.S. and patent applications in foreign countries are maintained in secrecy for a period after filing. The Company cannot be sure that products manufactured or distributed by it, or the technologies developed by it, do not infringe patents that may be granted in the future pursuant to pending patent applications or that they do not infringe any patents or proprietary rights of third-parties.

The Company may incur substantial legal fees in defending against a patent infringement claim or in asserting claims against third-parties. If the Company loses such litigation, it could be forced to cease marketing the products or services related to the infringing technology or pay significant license fees or damages. In the event that any relevant claims of third-party patents are upheld as valid and enforceable, the Company could be prevented from marketing certain of its products, could be required to obtain licenses from the owners of such patents, or could be required to redesign its products or services to avoid infringement. There can be no assurance that such licenses would be available or, if available, would be on terms acceptable to the Company or that the Company would be successful in any attempt to redesign its products or services to avoid infringement. The Company’s failure to obtain licenses or to redesign its products or services could materially, adversely affect the Company’s business, financial condition, profitability, and cash flows. For example, in September of 2012, the Company received a letter from Medafor stating that PerClot, when introduced in the U.S., will, when used in accordance with the method published in the Company’s literature and with the instructions for use, infringe their U.S. patent. See Part I, Item 1A, “Risk Factors—Risks Relating To Our Business—Our Investment In Our Distribution And License And Manufacturing Agreements With Starch Medical, Inc. Is Subject To Significant Risks, And Our Ability To Fully Realize Our Investment Is Dependent On Our Ability To Sell PerClot In The U.S.”

The Company has confidentiality agreements with its employees, several of its consultants, and third-party vendors to maintain the confidentiality of trade secrets and proprietary information. There can be no assurance that the obligations of the Company’s employees and third-parties, with whom the Company has entered into confidentiality agreements, will effectively prevent disclosure of the Company’s confidential information, or provide meaningful protection for the Company’s confidential information if there is unauthorized use or disclosure, or that the Company’s trade secrets or proprietary information will not be independently developed by the Company’s competitors. Litigation may be necessary to defend against claims of infringement, to enforce patents and trademarks of the Company, or to protect trade secrets and confidential information, and such litigation could result in substantial cost to, and diversion of effort by, the Company. There can be no assurance that the Company would prevail in any such litigation. In addition, the laws of some foreign countries do not protect the Company’s proprietary rights to the same extent as do the laws of the U.S.

Preservation, Manufacturing, and Operations

The Company’s corporate headquarters and laboratory facilities consist of approximately 190,400 square feet of leased manufacturing, administrative, laboratory, and warehouse space located on a 21.5-acre setting in suburban Atlanta, Georgia, with an additional 14,400 square feet of off-site warehouse space and an additional 15,500 square feet of combined manufacturing and office space in Atlanta, Georgia. Approximately 20,000 square feet are dedicated as class 10,000 clean rooms. An additional 8,000 square feet are dedicated as class 100,000 clean rooms. The extensive clean room environment provides a controlled aseptic environment for tissue manufacturing, preservation, and packaging. Approximately 55 liquid nitrogen freezers maintain preserved tissue at or below –135°C. Two back-up emergency generators assure continuity of Company manufacturing operations. The Company’s corporate complex includes the Ronald C. Elkins Learning Center, a 3,600 square foot auditorium that holds 225 participants, and a 1,500 square foot training lab, both equipped with closed-circuit and satellite television broadcast capability allowing live broadcasts from and to anywhere in the world. The Elkins Learning Center provides visiting surgeons with a hands-on training environment for surgical and implantation techniques for the Company’s technology platforms.

BioGlue and BioFoam

BioGlue and BioFoam are manufactured at the Company’s headquarters facility. The laboratory contains approximately 13,500 square feet, including a suite of six clean rooms. Currently, there are approximately 19 technicians and supervisors employed in this area. The laboratory has a potential annual capacity of approximately 2 million syringes of BioGlue and BioFoam. The current production level is about 7% of total capacity. To produce at full capacity levels, the Company would need to increase the number of employees, add work shifts, and install automated filling and pouching equipment.

 

15

Revascularization Technologies

Revascularization technologies consist of laser consoles and handpieces. The manufacturing of the laser consoles is outsourced to a single contract manufacturer. The manufacturing and assembly of the handpieces is outsourced to a different single contract manufacturer. The Company’s corporate headquarters has approximately 1,200 square feet of laser maintenance and evaluation laboratory space.

HeRO Grafts

The manufacturing space for the HeRO Grafts in Atlanta, Georgia contains approximately 3,300 square feet including approximately 1,000 square feet allocated to a suite of eight clean rooms. There are approximately five technicians employed in this area. The Company believes that production levels are at approximately 20% to 25% of total capacity. To produce at full capacity levels, the Company would need to install a second component spraying hood and purchase some additional small equipment, as well as increase the number of technicians and the number of shifts worked.

Other Medical Devices

The Company’s headquarters and off-site manufacturing has additional laboratory space consisting of approximately 20,400 square feet with a suite of eight clean rooms. This laboratory space is expected to house the manufacturing of PerClot and ProPatch.

Tissue Preservation

The Company’s tissue processing laboratory is responsible for the processing and preservation of human cardiac and vascular tissues for transplant. This laboratory contains approximately 17,500 square feet with a suite of seven clean rooms dedicated to tissue processing. Currently, there are approximately 75 technicians and supervisors employed in this area, and the laboratory is staffed 24 hours per day, 365 days per year. In 2013 the laboratory packaged approximately 11,700 tissues. The current processing level is estimated to be at about 30% of total capacity. To produce at full capacity levels, the Company would have to increase the amount of donated tissues, which the Company could attempt to do by revising its tissue acceptance criteria, increasing the number of relationships with OTPOs, or working to increase donor awareness to increase tissue donation. Any attempt to increase the amount of tissues processed could be constrained by the availability of donated tissues. If significant additional donated tissues were obtained, the Company would also need to increase the number of employees or increase the number of hours worked by employees.

Europa

The Company’s European subsidiary, Europa, maintains a leased facility located in Guildford, England, which contains approximately 3,400 square feet of office space. In addition, Europa leases shared warehousing space through its third-party shipper.

Suppliers, Sources, and Availability of Tissues and Raw Materials

The Company’s BioGlue and BioFoam products are comprised of bovine protein and a cross linker that is delivered to the surgical site through a delivery device. The delivery devices are manufactured by a single supplier. Although the Company maintains an inventory of devices, if the single supplier ceased producing delivery devices for other than a short period of time, this would materially, adversely affect the Company’s ability to manufacture BioGlue and could therefore affect the Company’s revenues.

PerClot is produced by SMI for the Company pursuant to a distribution agreement. If SMI were unable to obtain the appropriate raw materials to manufacture PerClot for the Company or if SMI were unable to manufacture PerClot due to other factors, it would materially, adversely affect the Company’s ability to sell PerClot and could therefore materially, adversely affect the Company’s revenues. In addition, if SMI breached its distribution agreement or attempted to terminate the distribution agreement, it would materially, adversely affect the Company’s ability to sell PerClot and obtain revenue growth from the product.

The contract manufacturers for the revascularization technologies’ consoles and handpieces generally acquire certain components from multiple sources. Other laser and fiber-optic components and subassemblies are purchased from single sources. Any significant supply interruption would materially, adversely affect the Company’s ability to sell the revascularization technologies products and obtain revenue growth from these products.

 

16

HeRO Graft components are purchased from single sources in some instances, and switching to a secondary supplier may be difficult. For example, the ePTFE arterial graft used in the HeRO Graft is provided by one manufacturer, and using a secondary supplier may be difficult because of certain of this manufacturer’s patent rights. Any significant supply interruption would materially, adversely affect the Company’s ability to sell HeRO Graft and obtain revenue growth from the product.

The Company’s preservation services business and its ability to supply needed tissues is dependent upon donation of tissues from human donors. The Company must rely on the OTPOs that it works with to educate the public on the need for donation and to foster a willingness to donate tissue. The Company must also maintain good relationships with its OTPOs to ensure that it will receive donated tissue. In addition, future regulations could reduce the tissues available for implantation. The Company also uses various medicines and solutions in its processing. Some of these medicines and solutions are only manufactured by single suppliers, which means if the single supplier ceased or was unable to manufacture a medicine or solution, this could materially, adversely affect the Company’s ability to accept or process tissue, which could materially, adversely affect the Company’s revenues.

Certain raw material components used in the Company’s products and tissue processing have stringent specifications. Accordingly, the Company may need to reject non-compliant raw materials, which could limit the Company’s ability to manufacture its products or process tissues and could materially, adversely affect the Company’s revenues

See also Part I, Item 1A, “Risk Factors.”

Quality Assurance

The Company’s operations encompass the manufacturing of medical devices and the preservation of human tissue. In all of its facilities, the Company is subject to regulatory standards for good manufacturing practices, including current Quality System Regulations, which are the FDA regulatory requirements for medical device manufacturers, and current Good Tissue Practices (“cGTPs”), which are the FDA regulatory requirements for the processing of human tissue. The FDA periodically inspects Company facilities to review Company compliance with these and other regulations. The Company also operates according to International Organization for Standardization (“ISO”) 13485 Quality System Requirements, an internationally recognized voluntary system of quality management for companies that design, develop, manufacture, distribute, and service medical devices. The Company maintains a Certification of Approval to the ISO 13485. Lloyd’s Register Quality Assurance Limited (“LRQA”) issues this approval. LRQA is a Notified Body officially recognized by the EU to perform assessments of compliance with ISO 13485 and the Medical Device Directive. The Medical Device Directive is the governing document for the EEA that details requirements for safety and risk. LRQA performs periodic on-site inspections, generally at least annually, of the Company’s quality systems.

The Company’s quality assurance staff is comprised primarily of experienced professionals from the medical device manufacturing and tissue processing industries. The quality assurance department, in conjunction with the Company’s research and development department, routinely evaluates the Company’s processes and procedures.

Medical Device Manufacturing

The Company employs a comprehensive quality assurance program in all of its manufacturing activities. The Company is subject to many quality system requirements, including Quality System Regulations, ISO 13485, and Medical Device Directive requirements.

All materials and components utilized in the production of the products manufactured by the Company are received and inspected by trained quality control personnel according to written specifications and standard operating procedures. Only materials and components found to comply with Company standards are accepted by quality control and utilized in production.

Materials, components, and resulting sub-assemblies are documented throughout the manufacturing process to assure traceability. Processes in manufacturing are validated to produce products meeting the Company’s specifications. The Company maintains a quality assurance program to evaluate and inspect its own manufactured products and distributed products to ensure conformity to product specifications. Each process is documented along with all inspection results, including final finished product inspection and acceptance. Records are maintained as to the consignees of products to track product performance and to facilitate product removals or corrections, if necessary.

The Company’s manufacturing facilities are subject to periodic inspection by the FDA and LRQA to independently review the Company’s compliance with its systems and regulatory requirements.

 

17

Preservation Services

The Company employs a comprehensive quality assurance program in all of its tissue preservation activities. The Company is subject to human cell and tissue regulations, including donor eligibility and cGTPs, as well as other FDA Quality System Regulations, ISO 13485 requirements, and other specific country requirements. The Company’s quality assurance program begins with the development and implementation of training policies and procedures for the employees of OTPOs. To assure uniformity of procurement practices among the tissue recovery teams, the Company provides procurement protocols, transport packages, and tissue transport liquids to the OTPOs. The Company periodically audits OTPOs to ensure compliance with Company policy and enhance recovery practices.

Upon receipt by the Company, each incoming tissue is assigned a unique control number that provides traceability of tissue from procurement through the preservation processes and, ultimately, to the tissue recipient. Samples from each tissue donor are subjected to a variety of tests to screen and test for infectious diseases. Samples of some tissues are also provided for pathology testing. Following dissection of the tissue to be preserved, the tissue is treated with a proprietary antimicrobial solution and aseptically packaged. After antimicrobial treatment, each tissue must be shown to be free of detectable microbial contaminants before being considered releasable for distribution.

The materials and solutions used by the Company in preserved tissue must meet the Company’s quality standards and be approved by quality assurance personnel. Throughout the tissue preservation process, detailed records of the tissues, materials, and processes used are maintained and reviewed by quality assurance personnel.

The FDA periodically audits the Company’s tissue preservation facilities for compliance with its requirements and has the authority to enjoin, force a recall, or require the destruction of tissues that do not meet its requirements. The States of California, Delaware, Florida, Georgia, Illinois, Maryland, New York, Oregon, and Pennsylvania license or register the Company’s tissue preservation facilities as facilities that preserve, store, and distribute human tissue for implantation. The regulatory bodies of these states may perform inspections of the Company’s facilities as required to ensure compliance with state laws and regulations. Additionally, countries in which CryoLife distributes tissue may also perform inspections of the Company facilities to ensure compliance with those countries’ regulations.

Government Regulation

U.S. Federal Regulation of Medical Devices

The Federal Food, Drug, and Cosmetic Act (“FDCA”) provides that, unless exempted by regulation, medical devices may not be distributed in the U.S. unless they have been approved or cleared for marketing by the FDA. There are two review procedures by which medical devices may receive such approval or clearance.

Some products may qualify for clearance to be marketed under a Section 510(k) process, in which the manufacturer provides a premarket notification that it intends to begin marketing a product, and shows that the product is substantially equivalent to another legally marketed predicate product. In order for the device to be found substantially equivalent to the predicate device, the device must be 1) for the same intended use and 2) have either the same technological characteristics or different technological characteristics that do not raise new questions of safety or effectiveness. In some cases, the submission must include data from clinical studies in order to demonstrate substantial equivalency to a predicate device. Marketing may commence when the FDA issues a clearance letter finding such substantial equivalence.

If the product does not qualify for the 510(k) process, it must be approved through the IDE/PMA process. This can be required either because it is not substantially equivalent to a legally marketed 510(k) device or because it is a Class III device and, therefore, the IDE/PMA process is required by FDA regulations.

The FDCA provides for an IDE which authorizes distribution for clinical evaluation of devices that lack PMA or 510(k) clearance. Devices subject to an IDE are subject to various restrictions imposed by the FDA. The number of patients that may be treated with the device is limited, as is the number of institutions at which the device may be used. Patients must give informed consent to be treated with an investigational device and review by an Institutional Review Board is needed. The device must be labeled that it is for investigational use, may not be advertised or otherwise promoted, and the price charged for the device may be limited. Unexpected adverse events for devices sold under an IDE must be reported to the FDA. After a product is subjected to clinical testing under an IDE, the Company may file a PMA application.

The FDA must approve a PMA application before marketing can begin. PMA applications must be supported by valid scientific evidence to demonstrate the safety and effectiveness of the device for its intended use. A PMA application is typically a complex submission, usually including the results of human clinical studies, and preparing an application is a

 

18

detailed and time-consuming process. Once a PMA application has been submitted, the FDA’s review may be lengthy and may include requests for additional data, which may require the Company to undertake additional human clinical studies.

The FDCA requires all medical device manufacturers and distributors to register with the FDA annually and to provide the FDA with a list of those medical devices they distribute commercially. The FDCA also requires manufacturers of medical devices to comply with labeling requirements and to manufacture devices in accordance with Quality System Regulations, which require that companies manufacture their products and maintain their documents in a prescribed manner with respect to good manufacturing practices, including: design, document production, process, labeling and packaging controls, process validation, and other quality control activities. The FDA’s medical device reporting regulation requires that a device manufacturer provide information to the FDA on death or serious injuries alleged to have been associated with the use of its products, as well as product malfunctions that would likely cause or contribute to death or serious injury if the malfunction were to recur. The FDA further requires that certain medical devices that may not be sold in the U.S. follow certain procedures before they are exported.

The FDA inspects medical device manufacturers and distributors and has authority to seize non-complying medical devices, enjoin and/or impose civil penalties on manufacturers and distributors marketing non-complying medical devices, criminally prosecute violators, and order recalls in certain instances.

These Company products are, or would, upon approval, be classified as Class III medical devices: BioGlue, BioFoam, PerClot, and revascularization technologies. CryoValve SGPV, CryoPatch SG, HeRO Graft, and ProPatch are classified as Class II medical devices.

U.S. Federal Regulation of Human Tissue

The FDA regulates human tissues pursuant to Section 361 of the Public Health Services Act, which in turn provides the regulatory framework for regulation of human cellular and tissue products. The FDA regulations focus on donor screening and testing to prevent the introduction, transmission, and spread of HIV-1 and -2, Hepatitis B and C, and other communicable diseases and disease agents. The regulations set minimum requirements to prevent the transmission of communicable diseases from human tissue used for transplantation. The regulations define human tissue as any tissue derived from a human body which is (i) intended for administration to another human for the diagnosis, cure, mitigation, treatment, or prevention of any condition or disease and (ii) recovered, preserved, stored, or distributed by methods not intended to change tissue function or characteristics. The FDA definition excludes, among other things, tissue that currently is regulated as a human drug, biological product, or medical device, and it also excludes kidney, liver, heart, lung, pancreas, or any other vascularized human organ. The current regulations applicable to human tissues include requirements for donor suitability, processing standards, establishment registration, product listing, testing, and screening for risks of communicable diseases.

It is likely that the FDA’s regulation of preserved human tissue will continue to evolve in the future. Complying with FDA regulatory requirements or obtaining required FDA approvals or clearances may entail significant time delays and expense or may not be possible, any of which could materially, adversely affect the Company.

Possible Other FDA Regulation

Other products and tissues under development by the Company are likely to be subject to regulation by the FDA. Some may be classified as medical devices or human cells and tissue products, while others may be classified as drugs or biological products, or may be subject to a regulatory process that the FDA may adopt in the future. Regulation of drugs and biological products is substantially similar to regulation of Class III medical devices. Obtaining FDA approval to market these products and tissues is likely to be a time consuming and expensive process, and there can be no assurance that any of these products and tissues will ever receive FDA approval.

NOTA Regulation

The Company’s activities in preserving and transporting human hearts and certain other organs are also subject to federal regulation under the National Organ Transplant Act (“NOTA”), which makes it unlawful for any person to knowingly acquire, receive, or otherwise transfer any human organ for valuable consideration for use in human transplantation if the transfer affects interstate commerce. NOTA excludes from the definition of “valuable consideration” reasonable payments associated with the removal, transportation, implantation, processing, preservation, quality control, and storage of a human organ. The purpose of this statutory provision is to allow for compensation for legitimate services. The Company believes that to the extent its activities are subject to NOTA, it meets this statutory provision relating to the reasonableness of its charges. There can be no assurance, however, that restrictive interpretations of NOTA will not be adopted in the future that would call into question one or more aspects of the Company’s methods of charging for its preservation services.

 

19

State Licensing Requirements

Some states have enacted statutes and regulations governing the preservation, transportation, and storage of human organs and tissues. The activities the Company engages in require it to be either licensed or registered as a clinical laboratory or tissue bank under California, Delaware, Florida, Georgia, Illinois, Maryland, New York, Oregon, and Pennsylvania law. The Company has such licenses or registrations, and the Company believes it is in compliance with applicable state laws and regulations relating to clinical laboratories and tissue banks that store, preserve, and distribute human tissue designed to be used for medical purposes in human beings. There can be no assurance, however, that more restrictive state laws or regulations will not be adopted in the future that could materially, adversely affect the Company’s operations. Certain employees of the Company have obtained other required state licenses.

International Approval Requirements

Sales of medical devices and shipments of preserved human tissues outside the U.S. are subject to international regulatory requirements that vary widely from country to country. Approval of a product by comparable regulatory authorities of other countries must be obtained and compliance with applicable regulations for tissues must be met prior to commercial distribution of the products or preserved human tissues in those countries. The time required to obtain these approvals may be longer or shorter than that required for FDA approval.

The EEA recognizes a single medical device approval, called a CE Mark, which allows for distribution of an approved product throughout the EEA without additional general applications in each country. However, individual EEA members reserve the right to require additional labeling or information to address particular patient safety issues prior to allowing marketing. Third-parties called “Notified Bodies” award the CE Mark. These Notified Bodies are approved and subject to review by the “Competent Authorities” of their respective countries. A number of countries outside of the EEA accept the CE Mark in lieu of marketing submissions as an addendum to that country’s application process. The Company has been issued CE Marks for BioGlue, BioFoam, the consoles and handpieces used for TMR, and the HeRO Graft. Additionally, PerClot, which the Company distributes, has a CE Mark.

In addition, the distribution of CryoLife’s preserved human tissues in certain countries in Europe is subject to regulatory approvals or requirements. CryoLife has historically shipped tissues into the U.K., Germany, and Austria. In 2004 and 2006 through three separate directives, the EU passed the EU Tissue and Cells Directives (“EUTCD”), which established an approach to the regulation of tissues and cells across Europe. Pursuant to the EUTCD, each country in the EEA has responsibility for regulating tissues and cells and the procurement and distribution of tissues and cells for use in humans through a Competent Authority. In the U.K. this Competent Authority is the HTA, which has promulgated various directives that affect CryoLife’s shipment of tissues into the U.K. and Europa’s import of these tissues. Europa is a “Licensed Establishment” under HTA Directions, and both Europa and CryoLife are subject to certain regulatory requirements under HTA Directions, including maintenance of records and tracing of shipments from donor to recipient. In Germany, this Competent Authority is the PEI, which enforces various regulations passed by the regulatory authorities in Germany. See discussion above in “Distribution and Marketing – Preservation Services” for the Company’s current regulatory activities with the HTA and PEI.

Recent Regulatory Approvals

June 2013 – PMA supplement approval was received for a design change to the Cardiogenesis SoloGrip III, PEARL 5.0, and PEARL 8.0 fiberoptic handpieces.

June and October 2013 – Conditional IDE approval was received for PerClot.

April 2013 – CE Mark was received for the manufacturing of the HeRO Graft.

March 2013 – 510(k) clearance was received for the HeRO Graft Adaptor.

Certifications, Accreditations, and Inspections

February 2014 – The FDA commenced its reinspection related to the Warning Letter, as defined in the Ongoing Regulatory Items Section below, which will include a quality system inspection of the Company’s products, services, and facilities.

February 2014 – The FDA conducted an inspection of Hemosphere. An FDA Form 483, Notice of Inspectional Observations, was issued.

 

20

October and November 2013 – LRQA conducted a routine ISO 13485 and Canadian Medical Devices Conformity Assessment System inspection. Four minor observations were noted.

September 2013 – The American Association of Tissue Banks conducted a re-accreditation inspection. Three non-conformities were noted.

May 2013 – The FDA conducted an inspection of Cardiogenesis. A Form 483, Notice of Inspectional Observations, was issued.

May 2013 – The South Korean Ministry of Food and Drug Safety conducted a routine quality system inspection. No observations were noted.

April 2013 – The Brazilian National Health Surveillance Agency conducted a routine quality system inspection. One minor recommendation was noted.

All registrations, licensures, certifications, and accreditations were renewed or continued and no regulatory actions are pending from state inspections.

Ongoing Regulatory Items

On January 30, 2013 CryoLife received a warning letter (“Warning Letter”) dated January 29, 2013 from the FDA. The Warning Letter followed a Form 483, Notice of Inspectional Observations, from the FDA (“CryoLife Form 483”) related to the Company’s processing, preservation, and distribution of human tissue and the manufacture of medical devices. The CryoLife Form 483 followed a routine quality system inspection of the Company’s facilities by the FDA during the period September 17, 2012 to October 16, 2012. The Warning Letter relates to certain observations from the CryoLife Form 483 that the FDA believes were either inadequately addressed by the Company’s responses or for which the FDA required further information to fully assess the Company’s corrective actions. The Company responded to the FDA’s requests and implemented corrective actions. The Company believes that these corrective actions have adequately addressed the FDA’s notice of violations contained in the Warning Letter; however, it is possible that the Company’s actions ultimately may not be satisfactory to the FDA. During the second quarter of 2013 the Company received verbal communication from the FDA indicating that these corrective actions appear satisfactory in addressing the issues raised in the Warning Letter. On February 18, 2014 the FDA commenced its reinspection of the Company with respect to the Warning Letter to determine whether it is satisfied with the Company’s actions and responses. This reinspection will include a quality system inspection of the Company’s products, services, and facilities. The Company believes that the Warning Letter and its actions regarding the Warning Letter and CryoLife Form 483 will not have a material effect on the Company. However, it is possible that further actions the Company may be required to take in response to the reinspection or the quality system inspection could materially, adversely affect the availability of the Company’s products and tissues and cost structure, which could affect the Company’s revenues, financial condition, profitability, or cash flows.

On May 23, 2013 CryoLife received a Form 483 related to the Company’s subsidiary Cardiogenesis (“Cardiogenesis Form 483”). The Cardiogenesis Form 483 followed a quality system inspection of the Company’s facilities by the FDA in May 2013. The Cardiogenesis Form 483 includes observations concerning labeling, complaint handling, and field actions. The Company has responded to the FDA’s requests and implemented changes that it believes address the FDA’s observations. Subsequent to receipt of the Cardiogenesis Form 483, as discussed above, Cardiogenesis received PMA supplement approval from the FDA for its redesigned Sologrip and PEARL handpieces. See also Part I, Item 1A, “Risk Factors.”

On February 14, 2014, CryoLife received an FDA Form 483 related to the Company’s subsidiary Hemosphere (“Hemosphere Form 483”). The Hemosphere Form 483 followed a quality system inspection of the Company’s facilities by the FDA in February 2014. The Hemosphere Form 483 includes observations concerning nonconformance inspections and manufacturing, the Company’s corrective and preventive action procedures, and documentation issues. The Company has already had verification of its implementation of corrective action with respect to one observation and expects to respond to the remaining observations from the Hemosphere Form 483 within 15 business days, as required by law. The Company believes that the changes that it will implement will address the FDA’s observations; however, it is possible that the Company may not be able to do so in a manner satisfactory to the FDA, and the FDA could issue a warning letter or take other actions, including requiring a recall or manufacturing hold. The Company believes that the Hemosphere Form 483 will not have a material effect on the Company. However, it is possible that actions it may be required to take in response to the Hemosphere Form 483 could materially, adversely affect the Company’s revenues, financial condition, profitability, or cash flows.

 

21

Environmental Matters

The Company’s tissue preservation activities generate some biomedical wastes, consisting primarily of human and animal pathological and biological wastes, including human and animal tissue and body fluids removed during laboratory procedures. The biomedical wastes generated by the Company are placed in appropriately constructed and labeled containers and are segregated from other wastes generated by the Company. The Company contracts with third-parties for transport, treatment, and disposal of biomedical waste. Although the Company believes it is in compliance in the disposal of its waste with applicable laws and regulations promulgated by the U.S. Environmental Protection Agency and the Georgia Department of Natural Resources, Environmental Protection Division, the failure by the Company, or the companies with which it contracts, to comply fully with any such regulations could result in an imposition of penalties, fines, or sanctions, which could materially, adversely affect the Company’s business.

Employees

As of December 31, 2013 CryoLife and its subsidiaries had approximately 510 employees. These employees included seven persons with Ph.D. degrees, three with M.D. degrees, and one with a D.O. degree. None of the Company’s employees are represented by a labor organization or covered by a collective bargaining agreement, and the Company has never experienced a work stoppage or interruption due to labor disputes. Management believes its relations with its employees are good.

Available Information

It is the Company’s policy to make all of its filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, available free of charge on the Company’s website, www.cryolife.com, on the day of filing. All such filings made on or after November 15, 2002 have been made available on this website.

 

22

Item 1A. Risk Factors.

Risks Relating To Our Business

We Are Significantly Dependent On Our Revenues From BioGlue And Are Subject To A Variety Of Risks Affecting This Product.

BioGlue® Surgical Adhesive (“BioGlue”) is a significant source of our revenues. Any of the following could materially, adversely affect our revenues, financial condition, profitability, and cash flows:

 

  •  

If BioGlue is the subject of adverse developments with regard to its safety, efficacy, or reimbursement practices, or if our rights to manufacture and market this product are challenged;

 

  •  

Our U.S. Patent for BioGlue expired in mid-2012, and our patents in most of the rest of the world for BioGlue expired in mid-2013. Competitors may utilize the inventions disclosed in the expired patents in competing products, although any competing product will have to be approved by the appropriate regulatory authority, such as the U.S. Food and Drug Administration (“FDA”), and portions of BioGlue’s manufacturing process are protected by trade secrets, or

 

  •  

Competitors have obtained FDA approval for indications in which BioGlue has been used off-label and for which we cannot market BioGlue, which has reduced addressable procedures for BioGlue, and such actions could continue to reduce addressable procedures.

Our Products And Tissues Are Subject To Many Significant Risks.

The manufacture and sale of medical devices and processing, preservation, and distribution of human tissues has inherent risks. Any of the following could materially, adversely affect our revenues, financial condition, profitability, and cash flows:

 

  •  

Our products and tissues may be recalled or placed on hold by us, the FDA, or other regulatory bodies. For example, in 2002 the FDA issued an order related to our non-valved cardiac, vascular, and orthopaedic tissues processed from October of 2001 until August of 2002, and pursuant to that order, we recalled these tissues or placed them on quarantine hold (we no longer process orthopaedic tissues);

 

  •  

Our medical devices and our tissues, which are not sterile when processed, allegedly have caused, and may in the future cause, injury to patients, which has exposed, and could in the future expose us to product and tissue processing liability claims, and such claims could lead to additional regulatory scrutiny and inspections;

 

  •  

Our manufacturing operations and tissue processing are subject to regulatory scrutiny and inspections, including by the FDA and foreign regulatory agencies, and these agencies could require us to change or modify our manufacturing operations, processes, and procedures;

 

  •  

Regulatory agencies could reclassify or reevaluate our clearances and approvals to sell our medical devices and tissue services; and

 

  •  

Adverse publicity associated with our medical devices or processed tissues or the industries as a whole that our medical devices and processed tissues are a part of could lead to a decreased use of our medical devices or processed tissues and additional regulatory scrutiny or product or tissue processing liability lawsuits.

As an example of the inherent risks of our manufacturing of medical devices and tissue processing, on January 30, 2013 we received a warning letter (“Warning Letter”) dated January 29, 2013 from the FDA. The Warning Letter followed a Form 483 related to the manufacture of our medical devices and our processing, preservation, and distribution of human tissue (“CryoLife Form 483”). The CryoLife Form 483 followed a routine quality system inspection of our facilities by the FDA during the period September 17, 2012 to October 16, 2012.

The Warning Letter relates to certain observations from the CryoLife Form 483 that the FDA believes were either inadequately addressed by the Company’s responses or for which the FDA required further information to fully assess the Company’s corrective actions. Concerns expressed by the FDA include but are not limited to:

 

  •  

The Company’s responses did not identify adequate corrective actions to be taken to ensure that all complaint investigations are adequately conducted;

 

  •  

The Company’s responses did not identify corrective actions to assure that management reviews the Company’s quality system on a regular and sufficiently frequent basis;

 

23

  •  

The Company’s responses did not identify corrective actions to prevent the reoccurrence of deficiencies noted in personnel training;

 

  •  

The Company should provide additional information describing changes to the Company’s disinfectant system as well as additional information concerning its environmental monitoring program; and

 

  •  

The Company’s responses did not identify corrective actions to ensure environmental trending reports were generated pursuant to procedures.

On May 23, 2013 CryoLife received a Form 483 related to CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”) (“Cardiogenesis Form 483”). The Cardiogenesis Form 483 followed a quality system inspection of the Company’s facilities by the FDA in May 2013. The Cardiogenesis Form 483 contains certain observations including observations concerning labeling, complaint handling, and field actions. Subsequent to receipt of the Cardiogenesis Form 483, the Company received Premarket Approval (“PMA”) supplement approval from the FDA for its redesigned Sologrip and Port Enables Angina Relief with Laser (‘PEARL”) handpieces. We have received no warning letter related to the Cardiogenesis Form 483.

We have responded fully to the FDA’s requests for the CryoLife Form 483 and Cardiogenesis Form 483 and have addressed the FDA’s notice of violations contained in the Warning Letter. On February 18, 2014 the FDA commenced its reinspection of the Company with respect to the Warning Letter to determine whether it is satisfied with our actions and responses. This reinspection will include a quality system inspection of our products, services, and facilities.

In addition, on February 14, 2014, CryoLife received an FDA Form 483 related to the Company’s subsidiary Hemosphere (“Hemosphere Form 483”). The Hemosphere Form 483 followed a quality system inspection of the Company’s facilities by the FDA in February 2014. The Hemosphere Form 483 includes observations concerning nonconformance inspections and manufacturing, the Company’s corrective and preventive action procedures, and documentation issues. The Company has already had verification of its implementation of corrective action with respect to one observation and expects to respond to the remaining observations from the Hemosphere Form 483 within 15 business days, as required by law.

We believe that any further actions regarding the Warning Letter or the CryoLife, Cardiogenesis, or Hemosphere Forms 483 will not have a material impact on the Company. However, it is possible that actions we may be required to take in response to the reinspection or quality system inspection or the Cardiogenesis or Hemosphere Forms 483 could materially, adversely affect our cost structure and the availability of our products and tissues, which could affect our revenues, financial condition, profitability, and cash flows.

If we are unable to satisfy the notice of violations in the Warning Letter, the FDA can institute a wide variety of enforcement actions ranging from making additional public statements to more severe sanctions such as fines; injunctions; civil penalties; recall of our tissues and/or products; operating restrictions; suspension of production; non-approval or withdrawal of approvals or clearances for new products or existing products; and criminal prosecution. The Warning Letter and any further warning letters, recall, hold, or other negative publicity from the FDA resulting from the reinspection or quality system inspection or the Cardiogenesis or Hemosphere Forms 483, or otherwise may decrease demand for our tissues or products or cause us to write down our deferred preservation costs or inventories and could materially, adversely affect our revenues, financial condition, profitability, and cash flows. In addition, any adverse publicity resulting from an FDA action or a recall or hold could encourage recipients of our tissues and our medical devices to bring lawsuits against us.

Our Investment In Our Distribution And License And Manufacturing Agreements With Starch Medical, Inc. Is Subject To Significant Risks, And Our Ability To Fully Realize Our Investment Is Dependent On Our Ability To Sell PerClot In The U.S.

On September 28, 2010 we entered into a worldwide distribution agreement and a license and manufacturing agreement with Starch Medical, Inc. (“SMI”) pursuant to which we distribute and expect to manufacture PerClot. We were also authorized to pursue, obtain, and maintain regulatory approval for PerClot in the U.S. Pursuant to distribution and license agreements, we made an additional contingent payment of $250,000 in 2011 and will pay additional contingent amounts of up to $2.5 million to SMI if certain U.S. regulatory and other commercial milestones are achieved. We will also pay royalties on any sales of PerClot manufactured by us. In September 2011 we entered into an agreement with SMI for an additional $1.0 million to acquire the technology used to produce the key component in the manufacture of PerClot. We anticipate that we will spend between $5.0 million and $6.0 million to gain U.S. regulatory approval in the next several years, most of which we expect to be incurred in 2014 and 2015. We will incur additional costs to begin manufacturing PerClot and to begin marketing PerClot in the U.S. Our costs may be greater than anticipated, as the costs to obtain FDA approval, begin

 

24

manufacturing PerClot, and begin marketing PerClot are estimates, and these costs may ultimately be greater than anticipated.

We will not be able to fully realize the benefit of our investment with SMI in future years unless we are able to obtain the necessary regulatory approvals in the U.S. to distribute PerClot within the timetable anticipated. In June 2013 we received conditional approval of our investigational device exemption (“IDE”) for PerClot from the FDA. IDE approval would allow us to begin clinical trials for the purpose of obtaining PMA to distribute PerClot in the U.S. As part of the conditional approval for the PerClot IDE, we must make certain revisions to the investigational study protocol and clinical product labeling. We refiled the IDE submission on September 27, 2013 and received a second conditional approval on October 30, 2013. We have had multiple discussions with the FDA to resolve any remaining issues and expect to obtain FDA approval to begin enrollment into the pivotal trial in the first half of 2014, but there can be no guarantee that this will occur as we expect. The Company will not be able to sell PerClot in the U.S. in future years unless and until FDA approval is granted. Failure to obtain FDA approval would materially, adversely affect our financial condition, anticipated future revenues, and profitability. There is no guarantee that we will obtain this approval when anticipated, or at all. Estimates regarding the timing of regulatory approval for PerClot are subject to factors beyond our control, and the approval process may be delayed because of unforeseen scheduling difficulties and unfavorable results at various stages in the process. Our approval efforts for PerClot in the U.S. are subject to delays and cost overages, and management may decide to terminate or delay its pursuit of U.S. regulatory approval for PerClot at any time due to changing conditions in our company, in the marketplace, or in the economy in general. If we are unable to obtain FDA approval by October 1, 2017, SMI may terminate CryoLife’s license to apply for FDA approval, and the parties will have to, in good faith, renegotiate CryoLife’s rights to attempt to obtain FDA approval.

In addition, once we receive approval, we may be unsuccessful in our attempts to sell PerClot in the U.S. as other competing products may have penetrated the market by that time and have substantial market share or significant market protections due to contracts. Any of these occurrences could materially, adversely affect our future revenues, financial condition, profitability, and cash flows.

In addition, if we are ultimately able to obtain approval from the FDA to sell PerClot, we will likely end up in a patent infringement lawsuit with Medafor, Inc. (“Medafor”) or its parent entity C. R. Bard, Inc. (“Bard”). See also “If We Sell PerClot In The U.S., We Will Likely End Up In A Patent Infringement Lawsuit, Which Will Be Expensive, And If We Lose, We May Be Prohibited From Selling PerClot Or May Have To Pay Substantial Royalties Or Damages When We Sell PerClot” below.

If We Sell PerClot In The U.S., We Will Likely End Up In A Patent Infringement Lawsuit, Which Will Be Expensive, And If We Lose, We May Be Prohibited From Selling PerClot Or May Have To Pay Substantial Royalties Or Damages When We Sell PerClot.

Medafor sent us a letter in September 2012 stating that PerClot, when introduced in the U.S., will, when used in accordance with the method published in our literature and with the instructions for use, infringe their U.S. patent. Subsequent to that event, Medafor was acquired by Bard. We do not believe that PerClot will infringe Medafor’s/Bard’s U.S. patent. If we do obtain FDA approval for PerClot, we will likely end up in a patent infringement lawsuit with Medafor/Bard. We believe the potential patent infringement litigation between CryoLife and Medafor/Bard could occur as early as 2014, and we believe that if litigation occurs, the costs of this litigation would be material. If we do obtain FDA approval, but are found by a court to have infringed Medafor’s or another third-party’s patent rights, we may ultimately not be able to sell PerClot in the U.S., or we may have to pay a material license fee that may not allow us to fully realize the benefit of our investment in PerClot. In 2013 we entered into an indemnification agreement with SMI (“Indemnification Agreement”) whereby certain of the royalties and a portion of the milestone payments that we would otherwise be required to pay to SMI under our license agreement can be used to offset our legal fees and certain damages associated with this potential patent litigation. However, the availability of these monies and the timing of these offsets will not likely precisely match the timing of any related legal expenses incurred. Even with the benefits of the Indemnification Agreement, any of the occurrences discussed above could materially, adversely affect our future revenues, financial condition, profitability, and cash flows.

We Continue To Evaluate Expansion Through Acquisitions, Licenses, Investments, And Other Distribution Arrangements In Other Companies Or Technologies, Which Contain Significant Risks.

One of our business strategies is to acquire companies, divisions, technologies, products, and rights through licenses, distribution agreements, investments, and outright acquisitions to grow our business. In connection with one or more of those transactions, we may:

 

25

  •  

Issue additional equity securities that would dilute our stockholders’ value;

 

  •  

Use cash that we may need in the future to operate our business;

 

  •  

Incur debt that could have terms unfavorable to us or that we might be unable to repay;

 

  •  

Structure the transaction in a manner that has unfavorable tax consequences, such as a stock purchase that does not permit a step-up in the tax basis for the assets acquired;

 

  •  

Be unable to realize the anticipated benefits, such as increased revenues, cost savings, or synergies from additional sales;

 

  •  

Be unable to integrate, upgrade, or replace the purchasing, accounting, financial, sales, billing, employee benefits, payroll, and regulatory compliance of the acquisition;

 

  •  

Be unable to secure the services of key employees related to the acquisition; and

 

  •  

Be unable to succeed in the marketplace with the acquisition.

Any of these items could materially, adversely affect our revenues, financial condition, and profitability. Business acquisitions also involve the risk of unknown liabilities associated with the acquired business, which could be material. Incurring unknown liabilities or the failure to realize the anticipated benefits of an acquisition could materially, adversely affect our business if we are unable to recover our initial investment, which could include the cost of acquiring licenses or distribution rights, acquiring products, purchasing initial inventory, or investments in early stage companies. Inability to recover our investment, or any write off of such investment, associated goodwill, or assets, may materially, adversely affect our financial condition and profitability.

Although We May Receive Additional Cash Of Up To $8.4 Million In The Future Related To Medafor’s Earnout And Release Of Escrow Funds Related To Bard’s Acquisition of Medafor, It Is Possible We May Not Receive Any Additional Monies, Or The Amount Of The Additional Monies Received Could Be Significantly Less Than $8.4 Million.

As discussed elsewhere in this Form 10K, we received approximately $15.4 million for our shares of Medafor common stock due to Bard’s acquisition of Medafor. We could receive up to an estimated additional $8.4 million from this transaction in the future, based on information provided by Medafor as part of the September 24, 2013 Medafor Proxy Statement (“Medafor Proxy”). We estimate that up to $525,000 could be paid to us in the fourth quarter of 2014, up to $987,000 could be paid to us in the second quarter of 2015, and up to $168,000 could be paid to us in 2017 related to an escrow release, plus additional amounts of up to $6.7 million could be paid to us in either the second or third quarter of 2015 based on an earnout of net sales of Medafor. We estimate that the amount the Company could receive under this earnout could range from zero to $8.4 million, depending on Medafor net sales during the period from July 1, 2014 to June 30, 2015.

However, we do not have any control over, or visibility regarding, any claims that may have been or will be made against the escrow, whether these escrow amounts will be released, whether Medafor products will meet the sales requirements that would generate the earnout amounts, or whether any setoffs will occur. Additionally, we may not be aware of any of these issues until we are scheduled to receive payments, if any, because of our lack of visibility into what may have occurred. As a result, the amount of additional monies that could be paid to us may be significantly less than the $8.4 million we have estimated we may receive based on information provided in the Medafor Proxy.

The Receipt Of Impaired Materials Or Supplies That Do Not Meet Our Standards, The Recall Of Materials Or Supplies By Our Vendors Or Suppliers, Or Our Inability To Obtain Materials And Supplies Could Materially, Adversely Affect Our Business.

The materials and supplies used in our medical device manufacturing and our processing of tissue are subject to stringent quality standards and requirements, and many of these materials and supplies are subject to regulatory oversight and action. If materials or supplies used in our processes fail to meet these standards and requirements or are subject to recall or other quality action, it is likely the outcome of this event will be the rejection or recall of the processed tissue or devices and/or the immediate expense of the costs of the manufacturing or preservation. In addition, if these materials and supplies are recalled or the facilities that make them are shut down temporarily or permanently, whether by government order, natural disaster, or otherwise, there may not be sufficient materials or supplies available for purchase to allow us to manufacture our products or process our tissues. For example, in 2011 certain supplies of processing solution used in our processing of tissue did not meet our quality requirements. As a result, we ceased processing the tissues that used this solution and expensed $674,000 related to the preservation costs for these tissues, none of which were implanted. Additionally, in 2012, due to problems caused by FDA inspections at the only papaverine manufacturer in the U.S., there was a shortage of papaverine, a

 

26

medicine used in our tissue processing and by many of our recovery partners, which could have disrupted our tissue processing. We were able to change our processing to no longer require the use of papaverine.

Any of these occurrences or actions could materially, adversely affect our revenues, financial condition, profitability, and cash flows.

Healthcare Policy Changes, Including Recent Federal Legislation To Reform The U.S. Healthcare System, May Materially, Adversely Affect Our Business.

In response to perceived increases in health care costs in recent years, there have been, and continue to be, proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. healthcare system. Certain of these proposals could limit the fees we are able to charge for our services, prices we are able to charge for our products, or the amounts of reimbursement available for our products or services and could limit the acceptance and availability of our products and services.

Our Loan To ValveXchange May Become Uncollectible, Which Could Materially, Adversely Affect Our Business.

In July 2011 we purchased approximately 2.4 million shares of Series A Preferred Stock of ValveXchange, Inc. (“ValveXchange”) for approximately $3.5 million. This investment represents an approximate 19% equity ownership in ValveXchange. ValveXchange is a private medical device company that was spun off from Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets. During 2012 we loaned ValveXchange $2 million under a note receivable. See Part II, Item 5, “Notes to Consolidated Financial Statements” for further discussion of the Company’s note receivable, its investment in ValveXchange preferred stock, and the impairment and write-off of such investment.

In accordance with accounting principles generally accepted in the U.S., we regularly review our long-term notes receivable based on available information and make determinations regarding their collectability. We will continue to evaluate our note receivable from ValveXchange for collectability.

The collectability of our note receivable from ValveXchange is subject to certain risks, including business and operational risks of ValveXchange that are outside of our control. These business risks include the fact that ValveXchange must secure material amounts of additional financing, and if it cannot do so, it will likely be unable to meet its obligations. As a result, we may need to foreclose on the underlying collateral to secure repayment under the note receivable. Although CryoLife currently believes that the value of the collateral is adequate to satisfy the note receivable, there is no guarantee of such adequacy. If we subsequently determine that some portion, or all, of the note receivable has become uncollectable, the resulting write-down could materially, adversely affect our financial condition and profitability. In addition, ValveXchange may be unable to raise additional monies in the future, which could severely diminish the collectability of our note receivable.

Our Sales Are Affected By Challenging Domestic And International Economic Conditions And Their Constraining Effect On Hospital Budgets, And Demand For Our Products And Tissues Could Decrease In The Future, Which Could Materially, Adversely Affect Our Business.

The demand for certain of our products and tissues has fluctuated recently and may continue to fluctuate. In challenging economic environments, hospitals attempt to control costs by reducing spending on consumable and capital items, which can result in reduced demand for some of our products and services. If economic conditions worsen, if changes occur in healthcare policies that force or encourage our customers to limit their use of our products and tissues, or if new competitive products or tissues are introduced, demand for our products or tissues could decrease in the future. If demand for our products or tissues decreases significantly in the future, our revenues, profitability, and cash flows would likely decrease, possibly materially. In addition, our manufacturing throughput of our products and our processing throughput of tissue would necessarily need to decrease, which would likely adversely impact our margins and, therefore, our profitability, possibly materially. Further, if demand for our products or tissues materially decreases in the future, we may not be able to ship our products or tissues before they expire, which would cause us to write down our inventories and deferred preservation costs.

Our sales may also be affected by challenging economic conditions in countries around the world, in addition to the U.S., particularly in countries where we have significant BioGlue sales or where BioGlue is still in a growth phase. These factors could materially, adversely affect our revenues, financial condition, and profitability.

 

27

Key Growth Strategies May Not Generate The Anticipated Benefits.

The key elements of our strategy related to growing our business and leveraging our strength and expertise in our core marketplaces to generate revenue and earnings growth are to:

 

  •  

Identify and evaluate acquisition opportunities of and investments in complementary product lines and companies,

 

  •  

Expand our core business,

 

  •  

Develop our pipeline of products and services,

 

  •  

License company technology to third parties for non-competing uses, and

 

  •  

Analyze and identify underperforming assets for potential sale or disposal.

Although management continues to implement these strategies, we cannot be certain that they will ultimately enhance shareholder value.

Uncertainties Related To Patents And Protection Of Proprietary Technology May Adversely Impact The Value Of Our Intellectual Property Or May Result In Our Payment Of Significant Monetary Damages And/Or Royalty Payments, Negatively Impacting Our Ability To Sell Current Or Future Products, Or Prohibit Us From Enforcing Our Patent And Other Proprietary Technology Rights Against Others.

We own several patents, patent applications, and licenses relating to our technologies, which we believe provide us with important competitive advantages. In addition, we have certain proprietary technologies and methods that provide us with important competitive advantages. We cannot be certain that our pending patent applications will issue as patents or that no one will challenge the validity or enforceability of any patent that we own. We also cannot be certain that if anyone does make such a challenge, that we will be able to successfully defend that challenge. We may have to incur substantial litigation costs to uphold the validity and prevent infringement of a patent or to protect our proprietary technologies and methods. For example, in 2008 litigation began against Tenaxis, Inc. (“Tenaxis”) in Germany because we believed that Tenaxis was infringing our patent, and Tenaxis was attempting to nullify our patent. We ultimately settled the lawsuits against Tenaxis after incurring considerable expense. Furthermore, competitors may independently develop similar technologies or duplicate our technologies or design around the patented aspects of such technologies. In addition, our technologies or products or services could infringe patents or other rights owned by others, or others could infringe our patents. If we are forced to defend ourselves in a patent infringement case, the costs of such defense could be expensive, and if we were to lose or decide to settle the lawsuit, the costs of the settlement or amount awarded by a court could be expensive. For example, in 2012 we settled a patent infringement case with CardioFocus, Inc. (“CardioFocus”) related to technology we acquired from Cardiogenesis. The settlement of that patent infringement action required a payment to CardioFocus of $4.5 million. Should we be forced to sue a potential infringer, if we are unsuccessful in prohibiting infringements of our patents, should the validity of our patents be successfully challenged by others, or if we are sued by another party for alleged infringement (whether we ultimately prevail or not), our revenues, financial condition, profitability, and cash flows could be materially, adversely affected. See also, “If We Sell PerClot In The U.S., We Will Likely End Up In A Patent Infringement Lawsuit, Which Will Be Expensive, And If We Lose, We May Be Prohibited From Selling PerClot Or May Have To Pay Substantial Royalties Or Damages When We Sell PerClot.”

Intense Competition May Impact Our Ability To Operate Profitably.

We face competition from other companies engaged in the following lines of business:

 

  •  

The marketing of mechanical, synthetic, and animal-based tissue valves for implantation,

 

  •  

The marketing of surgical adhesives, surgical sealants, and hemostatic agents,

 

  •  

The marketing of revascularization technologies,

 

  •  

The marketing of products addressing dialysis therapies, and

 

  •  

The processing and preservation of human tissue.

Many of our competitors have greater financial, technical, manufacturing, and marketing resources than we do and are well established in their markets.

We cannot give assurance that our products and tissues will be able to compete successfully. In addition, our competitors may gain competitive advantages that may be difficult to overcome. If we fail to compete effectively, this could materially, adversely affect our revenues, financial condition, profitability, and cash flows.

 

28

We May Not Be Successful In Obtaining Necessary Clinical Results And Regulatory Approvals For Products And Services In Development, And Our New Products And Services May Not Achieve Market Acceptance.

Our growth and profitability will depend, in part, upon our ability to complete development of, and successfully introduce, new products and services. We are uncertain whether we can develop commercially acceptable new products and services. We must also expend significant time and resources to obtain the required regulatory approvals. Although we have conducted preclinical studies on certain products and services under development which indicate that such products and services may be effective in a particular application, we cannot be certain that the results we obtain from expanded clinical studies will be consistent with earlier trial results or be sufficient for us to obtain any required regulatory approvals or clearances. We cannot give assurance that we will not experience difficulties that could delay or prevent us from successfully developing, introducing, and marketing new products and services. We also cannot give assurance that the regulatory agencies will clear or approve these or any new products and services on a timely basis, if ever, or that the new products and services will adequately meet the requirements of the applicable market or achieve market acceptance. Delays or rejections may also be encountered by us during any stage of the regulatory approval process if clinical or other data fails to satisfactorily demonstrate compliance with, or if the service or product fails to meet, the regulatory agency’s requirements for safety, efficacy, and quality. Those requirements may become more stringent due to changes in applicable laws, regulatory agency policies, or the adoption of new regulations. Clinical trials may also be delayed due to the following:

 

  •  

Unanticipated side effects,

 

  •  

Lack of funding,

 

  •  

Inability to locate or recruit clinical investigators,

 

  •  

Inability to locate, recruit, and qualify sufficient numbers of patients,

 

  •  

Redesign of clinical trial programs,

 

  •  

Inability to manufacture or acquire sufficient quantities of the product, particular tissue, or any other components required for clinical trials,

 

  •  

Changes in development focus, and

 

  •  

Disclosure of trial results by competitors.

Our ability to complete the development of any of our products and services is subject to all of the risks associated with the commercialization of new products and services based on innovative technologies. Such risks include unanticipated technical or other problems, manufacturing or processing difficulties, and the possibility that we have allocated insufficient funds to complete such development. Consequently, we may not be able to successfully introduce and market our products or services which are under development, or we may not be able to do so on a timely basis. These products and services may not meet price or performance objectives and may not prove to be as effective as competing products and services.

If we are unable to successfully complete the development of a product, service, or application, or if we determine for financial, technical, or other reasons not to complete development or obtain regulatory approval or clearance of any product, service, or application, particularly in instances when we have expended significant capital, this could materially, adversely affect our revenues, financial condition, profitability, and cash flows. Research and development efforts are time consuming and expensive, and we cannot be sure that these efforts will lead to commercially successful services or products. Even the successful commercialization of a new product or service in the medical industry can be characterized by slow growth and high costs associated with marketing, under-utilized production capacity, and continuing research and development, and education costs. The introduction of new services or products may require significant physician training and years of clinical evidence derived from follow-up studies on human implant recipients in order to gain acceptance in the medical community. Our potential new services or products currently under development that are not otherwise discussed in a previous risk factor include the following:

 

  •  

New indications for BioGlue,

 

  •  

Product enhancements to the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”),

 

  •  

ProPatch and related products, and

 

  •  

Use of biologic materials in conjunction with transmyocardial revascularization (“TMR”).

Even if we are able to obtain regulatory approval for any products or services offered, the scope of the approval may significantly limit the indicated usage for which such products or services may be marketed. The unapproved use of our products or tissues could adversely impact the reputation of our company and our products and services. Products or services marketed pursuant to FDA or foreign oversight or foreign approvals are subject to continuing regulation

 

29

and periodic inspections. Labeling and promotional activities are also subject to scrutiny by the FDA and, in certain instances, by the Federal Trade Commission. The export of devices and biologics is also subject to regulation and may require FDA approval. From time to time, the FDA may modify such regulations, imposing additional or different requirements. If we fail to comply with applicable FDA requirements, which may be ambiguous, we could face civil and criminal enforcement actions, warnings, citations, product recalls or detentions, and other penalties. This could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

In addition, U.S. and foreign governments and regulatory agencies have adopted restrictive laws, regulations, and rules. These include:

 

  •  

The National Organ Transplant Act of 1984 or “NOTA”, which prohibits the acquisition or transfer of human organs for valuable consideration for use in human transplantation, but allows for the payment of reasonable expenses associated with the removal, transportation, implantation, processing, preservation, quality control, and storage of human organs;

 

  •  

U.S. Department of Labor, Occupational Safety and Health Administration and U.S. Environmental Protection Agency requirements for prevention of occupational exposure to infectious agents and hazardous chemicals and protection of the environment, all of which affect our processing and manufacturing operations; and

 

  •  

European Union directives called the EUCTD which require that countries in the European Economic Area take responsibility for regulating tissues and cells through a Competent Authority, and which require us to license Europa, our subsidiary, to ship tissue into the U.K. and a license to distribute tissue into Germany through those countries’ Competent Authorities.

Any of these laws, regulations, and rules could change, or the U.S. or foreign governments and regulatory agencies could adopt more restrictive laws or regulation in the future that could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

The Success Of Many Of Our Products And Tissues Depends Upon Strong Relationships With Physicians.

If we fail to maintain our working relationships with physicians, many of our products and tissues may not be developed and marketed to appropriately meet the needs and expectations of the professionals who use and support our products and tissues. The research, development, marketing, and sales of many of our new and improved products and tissues are dependent upon our maintaining working relationships with physicians. We rely on these professionals to provide us with considerable knowledge and experience regarding our products and tissues and their marketing. Physicians assist us as researchers, marketing consultants, product consultants, and public speakers.

Certain states have begun to regulate interactions with physicians and other healthcare professionals. There are existing legislation and regulations that govern interactions with physicians and other healthcare professionals. For example, beginning in 2014, we will have to disclose payments made after August 2013 to physicians for meals or other services to the Department of Health and Human Services. These existing legislation and regulations currently impact our ability to maintain strong relationships with physicians and may, in the future, further impact our relationships with physicians. If we are unable to maintain our strong relationships with these professionals and do not continue to receive their advice and input, the development and marketing of our products could suffer, which could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

Our Existing Insurance Policies May Not Be Sufficient, And We May Be Unable To Obtain Insurance In The Future.

Although we have significant insurance for products, tissues, securities, and property, it is possible that:

 

  •  

We could be exposed to product liability, tissue processing, and security claims greater than the amount that we have insured;

 

  •  

Because our insurance is a claims-made policy, we may be unable to obtain future insurance policies in an amount sufficient to cover our anticipated claims at a reasonable cost or at all; or

 

  •  

Because we are not insured against all potential losses, national disasters or other catastrophes could adversely impact our business.

Our products and tissues allegedly have caused, and may in the future cause, injury to patients using our products or tissues, and we have been, and may be, exposed to product and tissue processing liability claims. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made

 

30

insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. In addition, our product and tissue processing liability insurance policies do not include coverage for any punitive damages.

If we are unsuccessful in arranging acceptable settlements of future product or tissue processing liability claims or future securities class action or derivative claims, we may not have sufficient insurance coverage and liquid assets to meet these obligations. If we are unable to obtain satisfactory insurance coverage in the future, we may be subject to additional future exposure from product or tissue processing liability or securities claims. Additionally, if one or more claims with respect to which we may become, in the future, a defendant should be tried with a substantial verdict rendered in favor of the plaintiff(s), such verdict(s) could exceed our available insurance coverage and liquid assets. If we are unable to meet required future cash payments to resolve any outstanding or any future claims, this will materially, adversely affect our financial condition, profitability, and cash flows. Further, although we have an estimated reserve for our unreported product and tissue processing liability claims for which we do expect that we will obtain recovery for under our insurance policies, these costs could exceed our current estimates. In addition, insurance rates could be significantly higher than in the past, and insurers may provide less coverage than we have estimated or expected. Finally, our facilities could be materially damaged by tornadoes, flooding, other natural disasters, or catastrophic circumstances, for which we are not fully covered by business interruption and disaster insurance, and, even with such coverage, we could suffer substantial losses in our operational capacity, along with a potential adverse impact on our customers and opportunity costs for which our insurance would not compensate us.

Any of these events could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

If We Are Not Successful In Expanding Our Business Activities In International Markets, It Could Have a Material, Adverse Impact On Our Revenues, Financial Condition, Profitability, and Cash Flows.

Our international operations are subject to a number of risks which may vary from the risks we face in the U.S., including:

 

  •  

Difficulties and costs associated with staffing and managing foreign operations, including foreign distributor relationships,

 

  •  

Unexpected changes in regulatory requirements,

 

  •  

Longer accounts receivable collection cycles in certain foreign countries and additional cost of collection of those receivables,

 

  •  

More limited protection for intellectual property in some countries,

 

  •  

Changes in currency exchange rates, particularly fluctuations in the British Pound and Euro as compared to the U.S. Dollar,

 

  •  

Adverse economic or political changes,

 

  •  

Potential trade restrictions, exchange controls, and import and export licensing requirements including tariffs, and

 

  •  

Potentially adverse tax consequences of overlapping tax structures.

Our failure to adequately address these risks could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

Consolidation In The Healthcare Industry Could Continue To Result In Demands For Price Concessions, Limits On The Use Of Our Products And Tissues, And Limitations On Our Ability To Sell To Certain Of Our Significant Market Segments.

The cost of healthcare has risen significantly over the past decade and numerous initiatives and reforms initiated by legislators, regulators, and third-party payors to curb these costs have resulted in a consolidation trend in the medical device industry as well as among our customers, including healthcare providers. This in turn has resulted in greater pricing pressures and limitations on our ability to sell to important market segments, as group purchasing organizations, independent delivery networks, and large single accounts continue to consolidate purchasing decisions for some of our customers. We expect that market demand, government regulation, third-party reimbursement policies, and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances which may exert further downward pressure on the prices for our products and fees charged for our tissues, which could materially, adversely affect our revenues, financial condition, profitability, and cash flows.

 

31

Our Current Plans To Continue To Pay A Quarterly Cash Dividend May Change.

We initiated the payment of a quarterly cash dividend during the third quarter of 2012 and increased the amount of this dividend in the second quarter of 2013. We anticipate the continued payment of a cash dividend to our shareholders in future quarters. However, the projected timing and amount of any future dividend payments are subject to change based on a variety of factors, including: management’s assessment of our overall needs at the time; our ability to generate current and sustained future earnings and cash flows; and financial requirements, including the requirements of our credit agreement.

Management must determine the proper allocation of available resources among operating needs, capital expenditures, research and development spending, acquisitions or other investments in our business, stock repurchases, dividends, and other needs. Our credit agreement imposes limits on our ability to declare cash dividends, including that we may only make dividend payments if, on the date of the dividend payment, no default or event of default under the agreement has occurred and is continuing, and that we are in compliance with certain financial covenants contained in the agreement, including maintenance of our leverage ratio at a certain level and certain liquidity requirements. Our total annual dividend may vary from current expectations based on management decisions regarding the timing and per share value of any future cash dividends, or may be discontinued at any time, due to any of the factors described above, or other factors, as well as due to changes to the number of shares outstanding.

We Are Dependent On The Availability Of Sufficient Quantities Of Tissue From Human Donors.

The success of our tissue preservation services depends upon, among other factors, the availability of sufficient quantities of tissue from human donors. We rely primarily upon the efforts of third-party procurement organizations, tissue banks, most of which are not-for-profit, and others to educate the public and foster a willingness to donate tissue. If the supply of donated human tissue is materially reduced, this would restrict our growth and could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

Continued Fluctuation Of Foreign Currencies Relative To The U.S. Dollar Could Materially, Adversely Affect Our Business.

The majority of our foreign product and tissue processing revenues are denominated in British Pounds and Euros and, as such, are sensitive to changes in exchange rates. In addition, a portion of our dollar-denominated product sales are made to customers in other countries who must convert local currencies into U.S. Dollars in order to purchase these products. We also have balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency transactions and balances are sensitive to changes in exchange rates. Fluctuations in exchange rates of British Pounds and Euros or other local currencies in relation to the U.S. Dollar could materially reduce our future revenues as compared to the comparable prior periods. Should this occur, it could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

Our Credit Facility, Which Expires In October Of 2014, Limits Our Ability To Pursue Significant Acquisitions And Also May Limit Our Ability To Borrow.

Our credit facility, which expires in October of 2014, prohibits mergers and acquisitions other than certain permitted acquisitions along with certain affirmative covenants that we must satisfy before we can borrow or enter into a permitted acquisition. Permitted acquisitions include certain stock acquisitions and non-hostile acquisitions that have been approved by the Board of Directors and/or the stockholders of the target company if, after giving effect to the acquisition, there is no event of default under the credit facility and there is still at least $1.5 million available to be borrowed under the credit facility. The total consideration that we pay, or are obligated to pay, for all acquisitions consummated during the term of the credit facility, less the portion of any such consideration funded by the issuance of common or preferred stock, may not exceed an aggregate of $15.0 million. Although our lender has modified the credit facility in the past to allow us to make acquisitions that do not affect this aggregate of $15.0 million, this is no guarantee that they will do so in the future. In addition, we must satisfy specified leverage ratios, and there are also varying levels of adjusted earnings before interest, taxes, depreciation, and amortization under the credit facility that we have covenanted to maintain during the term of the credit facility. Failure to satisfy any of these requirements could limit our borrowing ability and materially, adversely affect our liquidity. Therefore, as a result, our ability to consummate acquisitions and fully realize our growth strategy may be materially, adversely affected while this credit facility remains in effect. Any credit facility we subsequently enter into may have similar or more stringent restrictions on our ability to pursue significant acquisitions.

 

32

We Are Dependent On Our Key Personnel.

Our business and future operating results depend in significant part upon the continued contributions of our key field personnel and senior management, many of whom would be difficult to replace, including our Chief Executive Officer, Steven G. Anderson, whose employment agreement expires in December 2015. Our business and future operating results also depend in significant part upon our ability to attract and retain qualified management, processing, marketing, sales, and support personnel for our operations. Competition for such personnel is intense, and we cannot ensure that we will be successful in attracting and retaining such personnel. If we lose any key employees, if any of our key employees fail to perform adequately, or if we are unable to attract and retain skilled employees as needed, this could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

Rapid Technological Change Could Cause Our Products And Services To Become Obsolete.

The technologies underlying our products and services are subject to rapid and profound technological change. Competition intensifies as technical advances in each field are made and become more widely known. We can give no assurance that others will not develop services, products, or processes with significant advantages over the products, services, and processes that we offer or are seeking to develop. Any such occurrence could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.

 

33

Forward-Looking Statements

This Form 10-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. Forward-looking statements give the Company’s current expectations or forecasts of future events. The words “could,” “may,” “might,” “will,” “would,” “shall,” “should,” “pro forma,” “potential,” “pending,” “intend,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “future,” and other similar expressions generally identify forwarding-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements, which are made as of the date of this Form 10-K. Such forward-looking statements reflect the views of management at the time such statements are made and are subject to a number of risks, uncertainties, estimates, and assumptions, including, without limitation, in addition to those identified in the text surrounding such statements, those identified under Part I, Item 1A, “Risk Factors” and elsewhere in this Form 10-K.

All statements, other than statements of historical facts, included herein that address activities, events or developments that the Company expects or anticipates will or may occur in the future, are forward-looking statements, including statements regarding:

 

  •  

Advantages of the human tissues the Company distributes;

 

  •  

Plans, costs, and expected timeline regarding regulatory approval for PerClot, the distribution of PerClot in certain markets after the requisite regulatory approvals are obtained, and the Company’s expectation that it will terminate its minimum purchase requirements after regulatory approval of PerClot;

 

  •  

Expectations regarding, and efforts to respond to the FDA questioning related to, the revised IDE filed for PerClot and the anticipated clinical trials to obtain PMA to distribute PerClot in the U.S.;

 

  •  

Potential benefits and additional applications of the Company’s surgical adhesives, sealants, hemostats, and TMR treatment;

 

  •  

Anticipated timing of completion of the PEARL 8.0 post-approval study and full-market launch;

 

  •  

Revenue trend estimates for the Company’s products and services for 2014;

 

  •  

Plans related to regulatory approval in certain markets for BioFoam, and the subsequent distribution of BioFoam in those markets;

 

  •  

The estimated European market opportunity for cardiovascular and parenchymal tissue sealing;

 

  •  

Commercialization plans for ProPatch;

 

  •  

The Company’s beliefs regarding the adequacy of, and competitive advantages conferred by, its intellectual property protections;

 

  •  

The anticipated benefits of conducting a post-clearance study at the FDA’s request to collect long-term clinical data for the CryoValve SGPV;

 

  •  

Plans regarding HeRO Graft product enhancements, estimates regarding the addressable worldwide market opportunity for the HeRO Graft, and the Company’s intentions to introduce the HeRO Graft more broadly within Europe in 2014;

 

  •  

The Company’s beliefs that the HeRO Graft will fit well within the Company’s product portfolio and that a significant opportunity exists to introduce and expand the utilization of the HeRO Graft in the U.S.;

 

  •  

The Company’s beliefs regarding the potential for competitive products and services to affect the market for the Company’s products and services.

 

  •  

Expected benefits of the Company’s marketing, educational and technical support efforts;

 

  •  

Anticipated benefits of providing on-site freezers;

 

  •  

Expected effect of discontinuance of tissue shipments into Europe beginning April 2014;

 

  •  

The Company’s estimates and assessments of production levels and production capacity;

 

  •  

Expected use of the Company’s additional laboratory space;

 

  •  

Anticipated payment of quarterly dividends each year;

 

  •  

The Company’s expectations regarding the recoverability and realizability of deferred tax assets;

 

  •  

The Company’s estimates of unreported loss liabilities, including unreported product and tissue processing liability claims, the assumptions used to establish those estimates, and the Company’s belief that those assumptions provide a reasonable basis for the estimates;

 

34

  •  

The Company’s estimates of fair value of acquired assets, and its belief that the estimates are reasonable;

 

  •  

The expectation that the Company will continue to renew certain acquired contracts and procurement agreements for the foreseeable future;

 

  •  

Expectations regarding the recognition of stock compensation expense;

 

  •  

The Company’s assessment of the effect of adopting new accounting standards regarding the testing of certain intangible assets for impairment and the reporting of certain reclassified amounts;

 

  •  

Plans and expectations regarding research and development of new technologies and products;

 

  •  

The Company’s expectations about whether and when it may receive additional payments related to its sale of Medafor stock;

 

  •  

The Company’s expectation that general, administrative, and marketing expenses will increase in 2014 as compared to 2013, before consideration of the effects of litigation and business development expenses;

 

  •  

Management’s beliefs that the potential patent infringement litigation between CryoLife and Medafor or Bard could occur as early as 2014, and management’s belief that if litigation occurs the cost of this litigation would be material;

 

  •  

Expectations that research and development spending will increase materially in 2014;

 

  •  

Expectations regarding business consolidations in the healthcare industry that could exert downward pressure on fees charged by the Company;

 

  •  

The Company’s beliefs regarding sales of BioGlue, PerClot, handpieces, and laser consoles and the factors affecting such sales;

 

  •  

The Company’s belief that healthcare policy and law changes may have a material adverse effect on the business;

 

  •  

The Company’s belief that the underlying collateral is sufficient to secure the Company’s $2.0 million loan to ValveXchange;

 

  •  

The Company’s belief that any issues related to the FDA’s observations in the CryoLife Form 483 and the Warning Letter will not have a material effect on the Company;

 

  •  

The Company’s belief that any issues related to the FDA’s observations in the Hemosphere Form 483 will not have a material effect on the Company;

 

  •  

The Company’s beliefs regarding the seasonal nature of the demand for some of its products and services;

 

  •  

The adequacy of the Company’s financial resources and its belief that it will have sufficient cash to meet its operational liquidity needs for at least the next twelve months;

 

  •  

Estimates of contingent payments and royalties that may be paid by the Company and the timing of such payments;

 

  •  

The possibility of a patent infringement lawsuit with Medafor, the impact of such a lawsuit, and the Company’s belief that PerClot will not infringe Medafor’s patent;

 

  •  

The impact on cash flows of funding business development activities and the potential need to obtain additional borrowing capacity or financing;

 

  •  

The Company’s expectations regarding the source of any future payments related to any unreported product or tissue processing liability claims;

 

  •  

Anticipated impact of changes in prevailing economic conditions, interest rates, and foreign currency exchange rates;

 

  •  

The constraints imposed on the Company by its lender under the existing credit facility;

 

  •  

Plans regarding acquisition and investment opportunities of complementary product lines and companies;

 

  •  

The Company’s beliefs regarding the state of relations with its employees;

 

  •  

Plans regarding the licensing of the Company’s technology to third parties for non-competing uses;

 

  •  

Anticipated effect of suppliers’/sources’ inability to deliver critical raw materials or tissues and/or the Company having to source supply from an alternate supplier;

 

  •  

Issues that may affect the Company’s future financial performance and cash flows; and

 

  •  

Other statements regarding future plans and strategies, anticipated events, or trends.

 

35

These statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions, and expected future developments as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the Company’s expectations and predictions is subject to a number of risks and uncertainties which could cause actual results to differ materially from the Company’s expectations, including, without limitation, in addition to those specified in the text surrounding such statements, the risk factors discussed in Item 1A of this Form 10-K and other factors, many of which are beyond the control of CryoLife. Consequently, all of the forward-looking statements made in this Form 10-K are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company or its business or operations. The Company assumes no obligation to update publicly any such forward-looking statements, whether as a result of new information, future events, or otherwise.

 

36

Item 1B. Unresolved Staff Comments.

The Company has no unresolved written comments received from the staff of the SEC regarding its periodic or current reports under the Securities Exchange Act of 1934 not less than 180 days before December 31, 2013 (the end of the fiscal year to which this Form 10-K relates).

Item 2. Properties.

The Company’s facilities are located in multiple sites in Atlanta, Georgia, and in Guildford, England. The corporate headquarters in suburban Atlanta (Kennesaw) consists of approximately 190,400 square feet of leased manufacturing, administrative, laboratory, and warehouse space with an additional 14,400 square feet of off-site warehouse space. Approximately 26,000 square feet are dedicated to clean room work areas. The primary facility has seven main laboratory facilities: human tissue preservation, BioGlue and BioFoam manufacturing, research and development, microbiology, pathology, the revascularization technologies laser maintenance and evaluation laboratory, and additional space expected to house a portion of the PerClot manufacturing with availability for manufacturing of other products. Each of these areas consists of a general technician work area and adjoining clean rooms for aseptic processing or testing of human tissue or for aseptic manufacturing and testing of medical devices. The clean rooms are supplied with highly filtered air that provides a near-sterile environment. The human tissue preservation laboratory contains approximately 17,500 square feet with a suite of seven clean rooms. The current processing level is estimated to be at about 30% of total capacity. To increase the current processing levels, the Company could increase the number of employees and expand its second and third shift. The BioGlue and BioFoam manufacturing laboratory contains approximately 13,500 square feet with a suite of six clean rooms. The current processing level is about 7% of total capacity. To produce at full capacity levels, the Company would need to increase the number of employees, add work shifts, and install automated filling and pouching equipment. The research and development laboratory is approximately 10,200 square feet with a suite of five clean rooms. The microbiology laboratory is approximately 7,300 square feet with a suite of five clean rooms. The pathology laboratory is approximately 1,100 square feet. The revascularization technologies laser maintenance and evaluation laboratory is approximately 1,200 square feet. The additional manufacturing laboratory contains approximately 18,900 square feet with a suite of six clean rooms.

An additional combined manufacturing and office space of approximately 15,500 square feet with a suite of eight clean rooms is in a facility located within the city of Atlanta. This space is used for the manufacturing of the HeRO Graft and is expected to be used for a portion of the PerClot manufacturing.

The Europa facility located in Guildford, England contains approximately 3,400 square feet of leased office and warehousing space. In addition, Europa has shared warehousing space utilized by its third-party shipper.

Item 3. Legal Proceedings.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

 

37

Item 4A. Executive Officers of the Registrant.

The following table lists the executive officers of CryoLife and their ages, positions with CryoLife, and the dates from which they have continually served as executive officers with CryoLife. Each of the executive officers of CryoLife was elected by the Board of Directors to serve until the Board of Directors’ meeting immediately following the next annual meeting of shareholders or until his earlier removal by the Board of Directors or his resignation.

 

Name

    Service as
Executive		      Age     

Position

Steven G. Anderson

      Since 1984         75       President, Chief Executive Officer, and Chairman

Bruce G. Anderson

      Since 2012         47       Vice President, U.S. Sales and Marketing

Jeffrey W. Burris

      Since 2010         42       Vice President and General Counsel

Scott B. Capps

      Since 2007         47       Vice President, Clinical Research

David M. Fronk

      Since 1998         50       Vice President, Regulatory Affairs and Quality Assurance

David C. Gale, Ph.D

      Since 2012         46       Vice President, Research and Development

David P. Lang

      Since 2012         67       Senior Vice President, International Sales and Marketing

D. Ashley Lee, CPA

      Since 2000         49       Executive Vice President, Chief Operating Officer, and Chief Financial Officer

Steven G. Anderson, a founder of CryoLife, has served as CryoLife’s President, Chief Executive Officer, and Chairman of the Board of Directors since its inception. Mr. Anderson has more than 40 years of experience in the implantable medical device industry. Prior to founding CryoLife, Mr. Anderson was Senior Executive Vice President and Vice President, Marketing, from 1976 until 1983 of Intermedics, Inc. (now Boston Scientific Corp.), a manufacturer and distributor of pacemakers and other medical devices. Mr. Anderson is a graduate of the University of Minnesota.

Bruce G. Anderson was appointed to the position of Vice President, U.S. Sales and Marketing in July 2008. Mr. Anderson joined the Company in May 1994 as a field technical representative in Tennessee. During his time at the Company he has served as a Director and then Senior Director of U.S. Sales and Marketing from November 2002 until July 2008, Director of Global Cardiovascular Marketing from April 2001 until November 2002, and Product Manager and then Senior Product Manager for Cardiac Technologies from January 1997 until April 2001. Mr. Anderson is responsible for developing and implementing the Company’s domestic sales and marketing plans and supervising all tissue procurement activities. Prior to joining the Company, Mr. Anderson was an Account Executive at Dun & Bradstreet for four years. Mr. Anderson received his B.A. in History from the University of South Florida.

Jeffrey W. Burris was appointed to the position of Vice President and General Counsel in February 2010. Mr. Burris has been with the Company since February 2008, serving as General Counsel from February of 2008 until February 2010. From 2003 to 2008, Mr. Burris served as Senior Legal Counsel and Legal Counsel for Waste Management, where he was the attorney responsible for acquisitions and divestitures for Waste Management’s Southern Group. From 1997 to 2003, Mr. Burris was an associate with the law firm Arnall Golden Gregory, LLP, focusing on biotechnology and mergers and acquisitions. Mr. Burris received his B.A. in History and Economics from the University of Tennessee and his J.D. from the University of Chicago Law School.

Scott B. Capps was appointed to the position of Vice President of Clinical Research in November 2007. Prior to this position, Mr. Capps served as Vice President, General Manager of CryoLife Europa, Ltd. in the U.K. from February 2005 to November 2007 and Director, European Clinical Affairs from April 2003 to January 2005. Mr. Capps joined CryoLife in 1995 as Project Engineer for the allograft heart valve program and was promoted to Director, Clinical Research in 1999. Mr. Capps is responsible for overseeing and implementing clinical trials to achieve FDA and International approval of CryoLife’s medical products in cardiac, vascular, and orthopaedic clinical areas. Before joining CryoLife, Mr. Capps was a Research Assistant in the Department of Bioengineering at Clemson University working to develop a computerized database and radiographic image analysis system for total knee replacement. Mr. Capps received his Bachelor of Industrial Engineering from the Georgia Institute of Technology and his M.S. in Bioengineering from Clemson University.

David M. Fronk was appointed to the position of Vice President of Regulatory Affairs and Quality Assurance in April 2005 and has been with the Company since 1992, serving as Vice President of Clinical Research from December 1998 to April 2005 and Director of Clinical Research from December 1997 until December 1998. Mr. Fronk is responsible for developing and implementing improved safety processes and procedures for new and existing medical products. Prior to joining the Company, Mr. Fronk held engineering positions with Zimmer, Inc. from 1986 until 1988 and Baxter Healthcare Corporation from 1988 until 1991. Mr. Fronk served as a market manager with Baxter Healthcare Corporation from 1991 until 1992. Mr. Fronk

 

38

received his B.S. in Mechanical Engineering from the Ohio State University and his M.S. in Biomedical Engineering from the Ohio State University.

David C. Gale, Ph.D. has served as Vice President, Research and Development since January 1, 2012. Dr. Gale joined the Company in August 2009 as the Director, Biomaterials and Product Development. He was promoted to Senior Director, Biomaterials and Device Engineering in April 2011. Prior to joining CryoLife, Dr. Gale was with Sinexus, Inc., a start-up medical device company, from January 2007 to August 2009. He joined Sinexus as their Vice President of Research and was promoted to the position of Vice President, Research and Development in July 2007. Dr. Gale has 17 years of experience in biomaterials and medical device product research and development including roles at Abbott Vascular and Guidant Corporation. Dr. Gale is the inventor or co-inventor on over 70 issued U.S. patents related to the design and manufacture of medical devices. He received his Ph.D. in Materials Science from the University of Alabama at Birmingham, his M.S. in Chemical Engineering from Auburn University and has received both an M.Sc. in Instrumentation and Analysis and a B.Sc. in Chemistry from Manchester University in the U.K.

David P. Lang has served as Senior Vice President, International Sales and Marketing since December 2012 and has been with the Company since October 2010 as Vice President, Market Development. Mr. Lang is responsible for developing and implementing the Company’s international sales and marketing plans. Prior to joining the Company, Mr. Lang was President and then consultant to Starch Medical, Inc. from 2008 to 2010. From July 2007 until February 2008 he was Director, International Sales of Medafor, Inc. From July 2001 until June 2007 he was Vice President, International Sales of Medafor, Inc. He has over forty years of experience in international medical device sales and marketing, principally beginning as Director of Marketing for Medtronic Europe. His senior management positions included four resident assignments in Paris, Munich, and Shanghai. He was founder of the first Sino-American medical electronics joint venture in China in 1985. Mr. Lang received a B.A. in Economics from Harvard University.

D. Ashley Lee, CPA has served as Executive Vice President, Chief Operating Officer, and Chief Financial Officer since November 2004. Mr. Lee has been with the Company since December 1994 serving as Vice President of Finance, Chief Financial Officer, and Treasurer from December 2002 to November 2004; as Vice President, Finance and Chief Financial Officer from April 2000 to December 2002; and as Controller of the Company from December 1994 until April 2000. From 1993 to 1994, Mr. Lee served as the Assistant Director of Finance for Compass Retail, Inc., a wholly owned subsidiary of Equitable Real Estate. From 1987 to 1993, Mr. Lee was employed as a certified public accountant with Ernst & Young, LLP. Mr. Lee received his B.S. in Accounting from the University of Mississippi.

 

39

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

Market Price of Common Stock

The Company’s common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “CRY.” The following table sets forth, for the periods indicated, the intra-day high and low sale prices per share of common stock on the NYSE.

 

2013

    High      Low  

First quarter

    $ 6.78       $ 5.81   

Second quarter

      6.65         5.52   

Third quarter

      7.80         6.01   

Fourth quarter

      11.15         6.69   

2012

    High      Low  

First quarter

    $ 6.02       $ 4.72   

Second quarter

      5.55         4.19   

Third quarter

      7.27         4.85   

Fourth quarter

      6.99         5.52   

As of February 14, 2014 the Company had 381 shareholders of record.

Dividends

On August 21, 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding. In May 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 from $0.025 to $0.0275 per share of common stock outstanding. Cash dividends have been paid every three months since their initiation in September 2012. In February 2014 the Company announced a quarterly cash dividend for the first quarter of 2014 of $0.0275 per share, which will be paid on March 21, 2014 to all common stockholders of record as of March 14, 2014. The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year; however, this may change. See also Part I, Item 1A, “Risk Factors – Our Current Plans To Continue To Pay A Quarterly Cash Dividend May Change.”

The Company amended its credit agreement with General Electric Capital Corporation (“GE Capital”) to allow the payment of cash dividends up to a maximum of $3.5 million per year, subject to satisfaction of specified conditions. If the Company chooses to issue preferred stock, the holders of shares of that preferred stock could have a preference as to the payment of dividends over the holders of common stock.

 

40

Issuer Purchases of Equity Securities

The following table provides information about purchases by the Company during the quarter ended December 31, 2013 of equity securities that are registered by the Company pursuant to Section 12 of the Securities Exchange Act of 1934.

Issuer Purchases of Equity Securities

Common Stock

 

Period

    Total Number
of Common Shares
Purchased		      Average Price
Paid per
Common Share		      Total Number
of Common Shares
Purchased as
Part of Publicly
Announced
Plans or Programs		      Dollar Value
of Common Shares
That May Yet Be
Purchased Under the
Plans or Programs		  

10/01/13—10/31/13

      29,062       $ 8.95         —         $ 13,476,633   

11/01/13—11/30/13

      28,204         9.80         —           13,476,633   

12/01/13—12/31/13

      50,696         10.94         —           13,476,633   
  

 

 

        

 

 

     

Total

      107,962         10.11         —           13,476,633   

In February 2013 the Company announced that its Board of Directors had authorized the purchase of up to $15.0 million of its common stock through October 31, 2014. The purchase of shares may be made from time to time in the open market or through privately negotiated transactions, on such terms as management deems appropriate, and will be dependent upon various factors, including: price, regulatory requirements, and other market conditions. For the year ended December 31, 2013 the Company purchased 253,000 shares of its common stock through this authorization for an aggregate purchase price of $1.5 million.

Under the Company’s credit agreement with GE Capital, the Company is required, after giving effect to stock repurchases, to maintain liquidity, as defined within the agreement, of at least $20.0 million. The Company is entitled to repurchase up to an additional $8.7 million of common stock under the February 2013 authorization without obtaining its lender’s consent.

The common shares purchased during the quarter ended December 31, 2013 were tendered to the Company in payment of the exercise price of outstanding options and taxes on stock compensation and were not part of a publicly announced plan or program.

 

41

Item 6. Selected Financial Data.

The following Selected Financial Data should be read in conjunction with the Company’s consolidated financial statements and notes thereto, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and other financial information included elsewhere in this report.

Selected Financial Data

(in thousands, except percentages, current ratio, and per share data)

 

     December 31,  
     2013     2012     2011     2010     2009  

Operations

           

Revenues

    $ 140,763      $ 131,718      $ 119,626      $ 116,645      $ 111,685   

Operating income

      13,820        12,612        11,643        9,868        14,496   

Net income2

      16,172        7,946        7,371        3,944        8,679   

Net income applicable to common shareholders - Diluted2

      15,813        7,768        7,224        3,894        8,605   

Research and development expense as a percentage of revenues

      6.0 %      5.5 %      5.8 %      5.1 %      4.7 % 

Income Per Common Share

           

Basic

    $ 0.59      $ 0.29      $ 0.26      $ 0.14      $ 0.31   

Diluted

    $ 0.57      $ 0.28      $ 0.26      $ 0.14      $ 0.30   

Dividend Declared Per Common Share

    $ 0.108      $ 0.050      $ —        $ —        $ —     

Year-End Financial Position

           

Total assets

    $ 174,683      $ 157,156      $ 147,864      $ 137,438      $ 133,859   

Working capital

      85,605        56,073        62,413        82,162        76,312   

Long-term liabilities

      9,214        7,614        4,869        4,168        4,197   

Shareholders’ equity

      144,747        128,112        121,538        113,942        110,446   

Current ratio1

      5:1        4:1        4:1        5:1        5:1   

 

1 

Current assets divided by current liabilities.

2 

The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc.

 

42

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

CryoLife, Inc. (“CryoLife,” the “Company,” “we,” or “us”) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation. CryoLife’s surgical sealants and hemostats include BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (“SMI”). CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”), specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina. CryoLife and its subsidiary, Hemosphere, Inc. (“Hemosphere”), market the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”), which is a solution for end-stage renal disease (“ESRD”) in certain hemodialysis patients. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve® SG pulmonary heart valve (“CryoValve SGPV”) and the CryoPatch® SG pulmonary cardiac patch tissue (“CryoPatch SG”), both of which are processed using CryoLife’s proprietary SynerGraft® technology.

For the year ended December 31, 2013 CryoLife had record annual revenues of $140.8 million, increasing 7% over the prior year. The Company’s cash position was strong as the Company generated $16.8 million in cash flows from operations during 2013 and an additional $15.4 million in cash proceeds from the sale of its investment in Medafor, Inc. (“Medafor”) common stock. The Company experienced increases in research and development expenses during 2013 related to the development of PerClot. During the fourth quarter of 2013 the Company recognized a $3.2 million other than temporary impairment of its investment in the preferred stock of ValveXchange, Inc. (“ValveXchange”). See the “Results of Operations” section below for additional analysis of the fourth quarter and full year 2013 results. See Part I, Item 1, “Business,” for further discussion of the Company’s business and activities during 2013.

Recent Events

C.R. Bard’s Acquisition of Medafor

On October 1, 2013 C.R. Bard, Inc. (“Bard”) completed its previously announced acquisition of the outstanding shares of Medafor common stock. The Company received an initial payment of $15.4 million for its 2.4 million shares of Medafor common stock and recorded an initial gain of approximately $12.7 million on the sale in the fourth quarter of 2013. The Company could receive additional payments totaling up to an additional $8.4 million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015. The first of these additional payments, which the Company believes could be up to approximately $525,000, if released, would be received in late 2014, although this amount is subject to possible offsets. See also Part I, Item 1A, “Risk Factors—Risks Relating To Our Business— Although We May Receive Additional Cash Of Up To $8.4 Million In The Future Related To Medafor’s Earnout And Release Of Escrow Funds Related To Bard’s Acquisition of Medafor, It Is Possible We May Not Receive Any Additional Monies, Or The Amount Of The Additional Monies Received Could Be Significantly Less Than $8.4 Million.” These payments will be recorded as an additional gain when and if received by the Company.

Regulatory Activity

On January 30, 2013 CryoLife received a warning letter (“Warning Letter”) dated January 29, 2013 from the U.S. Food and Drug Administration (“FDA”). The Warning Letter followed a Form 483, Notice of Inspectional Observations, from the FDA (“CryoLife Form 483”) related to the Company’s processing, preservation, and distribution of human tissue and the manufacture of medical devices. The CryoLife Form 483 followed a routine quality system inspection of the Company’s facilities by the FDA during the period September 17, 2012 to October 16, 2012. The Warning Letter relates to certain observations from the CryoLife Form 483 that the FDA believes were either inadequately addressed by the Company’s responses or for which the FDA required further information to fully assess the Company’s corrective actions. The Company responded to the FDA’s requests and implemented corrective actions. The Company believes that these corrective actions have adequately addressed the FDA’s notice of violations contained in the Warning Letter, however, it is possible that the Company’s actions ultimately may not be satisfactory to the FDA.

During the second quarter of 2013 the Company received verbal communication from the FDA indicating that these corrective actions appear satisfactory in addressing the issues raised in the Warning Letter. On February 18, 2014 the FDA commenced its reinspection of the Company with respect to the Warning Letter to determine whether it is satisfied with the Company’s actions and responses. This reinspection will include a quality system inspection of the Company’s products, services, and facilities. The Company believes that the Warning Letter and its actions regarding the Warning Letter and CryoLife Form 483 will not have a material effect on the Company. However, it is possible that further actions the Company

 

43

may be required to take in response to the reinspection or the quality system inspection could materially, adversely affect the availability of the Company’s products and tissues and cost structure, which could affect the Company’s revenues, financial condition, profitability, or cash flows.

Following the receipt of the Warning Letter, on March 28, 2013 CryoLife received a letter from the Human Tissue Authority (“HTA”) in London, U.K., which governs the distribution of tissues into markets in Europe by the Company’s subsidiary, CryoLife Europa, Ltd. (“Europa”). The letter temporarily suspended Europa’s license to import human tissue, due to concerns the HTA had related to the FDA Warning Letter, and directed Europa to issue a recall for tissues previously distributed which had not been implanted. The HTA subsequently issued a variance to allow Europa to continue to import tissue into Europe under certain circumstances for critically ill patients. Subsequent to the issuance of the variance, the HTA reinstated Europa’s license but placed certain conditions on the processing of tissue, which would generate significant additional costs when compared to the Company’s current processes. As a result, the Company plans to cease shipment of tissues into Europe as of March 31, 2014.

On May 23, 2013 CryoLife received a Form 483 related to the Company’s subsidiary Cardiogenesis (“Cardiogenesis Form 483”). The Cardiogenesis Form 483 followed a quality system inspection of the Company’s facilities by the FDA in May 2013. The Cardiogenesis Form 483 includes observations concerning labeling, complaint handling, and field actions. The Company has responded to the FDA’s requests and implemented changes that it believes address the FDA’s observations. Subsequent to receipt of the Cardiogenesis Form 483, as discussed above, Cardiogenesis received Premarket Approval (“PMA”) supplement approval from the FDA for its redesigned Sologrip and Port Enabled Angina Relief with Laser (“PEARL”) handpieces.

On February 14, 2014 CryoLife received a Form 483 related to the Company’s subsidiary Hemosphere (“Hemosphere Form 483”). The Hemosphere Form 483 followed a quality system inspection of the Company’s facilities by the FDA in February 2014. The Hemosphere Form 483 includes observations concerning nonconformance inspections and manufacturing, the Company’s corrective and preventive action procedures, and documentation issues. The Company has already had verification of its implementation of corrective action with respect to one observation and expects to respond to the remaining observations from the Hemosphere Form 483 within 15 business days, as required by law. The Company believes that the changes that it will implement will address the FDA’s observations; however, it is possible that the Company may not be able to do so in a manner satisfactory to the FDA, and the FDA could issue a warning letter or take other actions, including requiring a recall or manufacturing hold. The Company believes that the Hemosphere Form 483 will not have a material effect on the Company. However, it is possible that actions it may be required to take in response to the Hemosphere Form 483 could materially, adversely affect the Company’s revenues, financial condition, profitability, or cash flows.

See also Part I, Item 1A, “Risk Factors.”

Critical Accounting Policies

A summary of the Company’s significant accounting policies is included in Part II, Item 8, Note 1 of the “Notes to Consolidated Financial Statements.” Management believes that the consistent application of these policies enables the Company to provide users of the financial statements with useful and reliable information about the Company’s operating results and financial condition. The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. which require the Company to make estimates and assumptions. The following are accounting policies that management believes are most important to the portrayal of the Company’s financial condition and results of operations and may involve a higher degree of judgment and complexity.

Fair Value Measurements

The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments. The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2013 the Company has not chosen to make any such elections. Fair value financial instruments are recorded in accordance with the fair value measurement framework.

The Company also measures certain non-financial assets at fair value on a non-recurring basis. These non-recurring valuations include evaluating assets such as cost method investments, long-lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations. The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.

 

44

The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels. These levels from highest to lowest priority are as follows:

 

  •  

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;

 

  •  

Level 2: Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and

 

  •  

Level 3: Unobservable inputs or valuation techniques that are used when little or no market data is available.

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist in determining fair value, as appropriate.

Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.

Deferred Preservation Costs

By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory. The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred. Deferred preservation costs are stated at the lower of cost or market value on a first-in, first-out basis and are deferred until revenue is recognized. At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status.

Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services. Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments for tissues not deemed to be recoverable, and includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

The calculation of deferred preservation costs involves judgment and complexity and uses the same principles as inventory costing. Donated human tissue is procured from deceased human donors by organ and tissue procurement organizations (“OTPOs”), which consign the tissue to the Company for processing, preservation, and distribution. Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight-in charges), and indirect costs (including allocations of costs from support departments and facility allocations). Fixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility’s normal capacity.

These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed. The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable. Management estimates quarantine yields based on its experience and reevaluates these estimates periodically. Actual yields could differ significantly from the Company’s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs. These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods.

The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value. The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging. Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation. Impairment write-downs are recorded based on the book value of tissues deemed to be impaired. Actual results may differ from these estimates. Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

 

45

The Company recorded write-downs to its deferred preservation costs totaling $448,000, $195,000, and $270,000 for the years ended December 31, 2013, 2012, and 2011, respectively.

Deferred Income Taxes

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes. The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets. Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.

Assessing the recoverability of deferred tax assets involves judgment and complexity. Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following:

 

  •  

Projected future operating results,

 

  •  

Anticipated future state tax apportionment,

 

  •  

Timing and amounts of anticipated future taxable income,

 

  •  

Timing of the anticipated reversal of book/tax temporary differences,

 

  •  

Evaluation of statutory limits regarding usage of certain tax assets, and

 

  •  

Evaluation of the statutory periods over which certain tax assets can be utilized.

Significant changes in the factors above, or other factors, could materially, adversely affect the Company’s ability to use its deferred tax assets. Such changes could have a material, adverse impact on the Company’s operations, financial condition, and cash flows. The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets.

The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended. The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company’s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control. The Company also believes that its acquisition of Cardiogenesis constituted a change in control. The deferred tax assets recorded on the Company’s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control. A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized. Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.

Valuation of Acquired Assets or Businesses

As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies. The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group or as a business combination, as appropriate. The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.

For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values. In-process research and development acquired as part of an asset group is expensed upon acquisition. The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value. Transaction costs related to a business combination are expensed as incurred. In-process research and development acquired as part of a business combination is accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.

The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief

 

46

from royalty methods. The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates. Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge. Management believes that its estimates are reasonable, but actual results could differ significantly from the Company’s estimates. A significant change in management’s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company’s financial position and profitability. If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company’s financial position and profitability.

New Accounting Pronouncements

In January 2013 the Company adopted Accounting Standards Update (“ASU”), 2012-02, Intangibles-Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test. The adoption of ASU 2012-02 did not have a material effect on the Company’s financial condition, profitability, or cash flows.

In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements. This update also requires companies to disclose the income statement line items affected by any significant reclassifications. The adoption of ASU 2013-02 did not have a material effect on the Company’s financial disclosures.

 

47

Results of Operations

(In thousands)

Year Ended December 31, 2013 Compared to Year Ended December 31, 2012

Revenues

 

     Revenues for the Three
Months Ended
December 31,		      Revenues as a Percentage of
Total Revenues for the
Three Months Ended
December 31,		  
     2013      2012      2013     2012  

Products:

           

BioGlue and BioFoam

    $ 14,766       $ 13,353         42 %      41 % 

PerClot

      808         1,009         2 %      3 % 

Revascularization technologies

      2,128         1,985         6 %      6 % 

HeRO Graft

      1,668         1,106         5 %      3 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total products

      19,370         17,453         55 %      53 % 

Preservation services:

           

Cardiac tissue

      7,488         7,094         21 %      22 % 

Vascular tissue

      8,599         8,138         24 %      25 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total preservation services

      16,087         15,232         45 %      47 % 

Other

      —           115         —   %      —   % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total

    $ 35,457       $ 32,800         100 %      100 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

 

     Revenues for the Twelve
Months Ended
December 31,		      Revenues as a Percentage of
Total Revenues for the
Twelve Months Ended
December 31,		  
     2013      2012      2013     2012  

Products:

           

BioGlue and BioFoam

    $ 58,004       $ 53,211         41 %      41 % 

PerClot

      3,494         3,078         3 %      2 % 

Revascularization technologies

      8,965         8,092         6 %      6 % 

HeRO Graft

      5,731         3,115         4 %      2 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total products

      76,194         67,496         54 %      51 % 

Preservation services:

           

Cardiac tissue

      29,523         29,756         21 %      23 % 

Vascular tissue

      34,975         33,847         25 %      26 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total preservation services

      64,498         63,603         46 %      49 % 

Other

      71         619         —   %      —   % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total

    $ 140,763       $ 131,718         100 %      100 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Revenues increased 8% and 7% for the three and twelve months ended December 31, 2013, respectively, as compared to the three and twelve months ended December 31, 2012, respectively. A detailed discussion of the changes in product revenues and preservation services revenues for the three and twelve months ended December 31, 2013 is presented below.

Products

Revenues from products increased 11% and 13% for the three and twelve months ended December 31, 2013, respectively, as compared to the three and twelve months ended December 31, 2012, respectively. These increases were primarily due to an increase in BioGlue revenues, and to a lesser extent due to the addition of HeRO Graft revenues as a

 

48

result of the Company’s acquisition of Hemosphere in the second quarter of 2012. A detailed discussion of the changes in product revenues for BioGlue and BioFoam; PerClot; revascularization technologies; and HeRO Graft is presented below.

The Company’s sales of products through its direct sales force to U.K. hospitals are denominated in British Pounds, and its sales to German, Austrian, and Irish hospitals and certain distributors are denominated in Euros and are, therefore, subject to changes in foreign exchange rates. If the exchange rates between the U.S. Dollar and the British Pound or Euro decline materially in the future, this would have a material, adverse effect on the Company’s revenues denominated in these currencies.

BioGlue and BioFoam

Revenues from the sale of surgical sealants, consisting of BioGlue and BioFoam, increased 11% for the three months ended December 31, 2013, as compared to the three months ended December 31, 2012. This increase was primarily due to a 12% increase in the volume of milliliters sold, which increased revenues by 8%, an increase in average sales prices, which increased revenues by 2%, and the favorable impact of foreign exchange rates, which increased revenues by 1%.

Revenues from the sale of surgical sealants increased 9% for the twelve months ended December 31, 2013, as compared to the twelve months ended December 31, 2012. This increase was primarily due to a 9% increase in the volume of milliliters sold, which increased revenues by 7%, and by an increase in average sales prices, which increased revenues by 2%.

The increase in sales volume of surgical sealants for the three months ended December 31, 2013 was primarily due to an increase in shipments of BioGlue in certain international markets and, to a lesser extent, an increase in the Company’s domestic markets. The increase in sales volume of surgical sealants for the twelve months ended December 31, 2013 was due to an increase in shipments of BioGlue in certain international markets, partially offset by a volume decrease in the Company’s domestic markets. The increase in international sales of BioGlue was primarily due to increased sales to Japan, to direct markets in Europe, including sales for neurological indications, and to Latin America.

The increase in average sales prices for the three and twelve months ended December 31, 2013 was primarily due to list price increases in domestic markets and due to the routine negotiation of pricing contracts with certain customers.

Revenues from shipments to Japan were $801,000 and $697,000 for the three months ended December 31, 2013 and 2012, respectively, and $4.8 million and $4.1 million for the twelve months ended December 31, 2013 and 2012, respectively. Management is currently seeking expanded indications for BioGlue in Japan and regulatory approval for BioGlue in China and, if successful, believes this will provide additional international growth opportunities for BioGlue in future years.

Management believes that the decrease in BioGlue shipments in its domestic markets for the twelve months ended December 31, 2013 is a result of various factors, including: continued economic pressures on hospitals and the resulting attempts by hospitals to control costs by reducing spending on consumable items such as BioGlue, the efforts of some large competitors in imposing and enforcing contract purchasing requirements for competing non-CryoLife products, and the U.S. market introduction of sealant products with approved indications for use in clinical applications in which BioGlue has been used off-label previously. However, the Company has seen the effect of these factors on its domestic BioGlue shipments slow in recent quarters. In both the third and fourth quarters of 2013 domestic shipments showed a 2% increase in the volume of milliliters sold over the same quarters in 2012. Management believes that BioGlue sales volume in domestic markets could continue to be affected by the factors discussed above, and this may make the recent increases unsustainable in the near or long term.

Domestic revenues accounted for 58% and 57% of total BioGlue revenues for the three and twelve months ended December 31, 2013, respectively, and 61% and 60% of total BioGlue revenues for the three and twelve months ended December 31, 2012, respectively. BioFoam sales accounted for less than 1% of surgical sealant sales for the three and twelve months ended December 31, 2013. BioFoam is currently approved for sale in certain international markets.

PerClot

Revenues from the sale of PerClot decreased 20% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. This decrease was primarily due to a 28% decrease in the volume of grams sold, which decreased revenues by 23%, partially offset by the favorable effect of foreign currency exchange, which increased revenues by 2%, and an increase in average selling prices, which increased revenues by 1%.

 

49

Revenues from the sale of PerClot increased 14% for the twelve months ended December 31, 2013 as compared to the twelve months ended December 31, 2012. This increase was primarily due to an increase in the volume of grams sold, which increased revenues by 14%.

Revenues during these three and twelve month periods were for sales in certain international markets, as PerClot is not yet approved for domestic distribution or widespread international distribution. The decrease in revenues for the three months ended December 31, 2013 was primarily due to fluctuating ordering patterns in certain countries, which can result in some variability in sales from quarter to quarter. The increase in revenues for the twelve months ended December 31, 2013 was primarily due to increased sales in the Company’s markets in Europe, partially due to growth in both new geographies and new surgical indications. The Company expects that overall PerClot revenues will increase in 2014 as compared to 2013; however, revenues may show some variability from quarter-to-quarter.

In June 2013 CryoLife received conditional approval of its investigational device exemption (“IDE”) for PerClot from the FDA. IDE approval would allow the Company to begin clinical trials for the purpose of obtaining PMA to distribute PerClot in the U.S. As part of the conditional approval for the PerClot IDE, the Company must make certain revisions to the investigational study protocol and clinical product labeling. The Company refiled the IDE submission on September 27, 2013. CryoLife received a second conditional approval on October 30, 2013. The Company has had multiple discussions with the FDA to resolve any remaining issues and expects to obtain FDA approval to begin enrollment into the pivotal trial in the first half of 2014.

Revascularization Technologies

Revenues from revascularization technologies include revenues related primarily to the sale of handpieces and, in certain periods, revenues from the sale of laser consoles. Revenues from revascularization technologies increased 7% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. Revenues from the sale of laser consoles were $470,000 and zero for the three months ended December 31, 2013 and 2012, respectively. Revenues from the sale of handpieces decreased 18% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. This decrease was primarily due to a 25% decrease in unit shipments of handpieces, which decreased revenues by 26%, partially offset by an increase in average sales prices, which increased revenues by 8%.

Revenues from revascularization technologies increased 11% for the twelve months ended December 31, 2013 as compared to the twelve months ended December 31, 2012. Revenues from the sale of laser consoles were $932,000 and $279,000 for the twelve months ended December 31, 2013 and 2012, respectively. Revenues from the sale of handpieces increased 5% for the twelve months ended December 31, 2013 as compared to the twelve months ended December 31, 2012. This increase was primarily due to an increase in average sales prices, which increased revenues by 8%, partially offset by a 3% decrease in unit shipments of handpieces, which decreased revenues by 3%.

In June 2013 the FDA approved the Company’s new handpiece design, and the Company made the decision to exclusively distribute the new handpiece beginning late in the second quarter of 2013. The decrease in handpiece volume for the three and twelve months ended December 31, 2013 was primarily due to the slower than anticipated rollout and adoption of the new handpiece design. The Company anticipates that handpiece sales will increase slightly in the first quarter of 2014 as compared to the fourth quarter of 2013, as the new handpiece becomes more widely used and adopted.

The Company expects that overall revascularization technologies revenues will increase in 2014 as compared to 2013. The amount of revenues from laser console sales can vary significantly from quarter-to-quarter due to the long lead time required to generate sales of capital equipment.

HeRO Graft

Revenues from HeRO Grafts include revenues related to the sale of vascular grafts, venous outflow components, and accessories, which are generally sold together as a kit. HeRO Grafts are primarily distributed in domestic markets as a solution for ESRD in certain hemodialysis patients. HeRO Graft revenues for the three months ended December 31, 2013 increased 51% when compared to the three months ended December 31, 2012. Revenues from HeRO Grafts for the twelve months ended December 31, 2013 increased significantly over the corresponding period in 2012 as HeRO Grafts were not marketed by the Company for the full prior year period. The Company began marketing HeRO Grafts following its acquisition of Hemosphere in May 2012. HeRO Graft revenues for the twelve months ended December 31, 2013 increased 12% when compared to the combined pre- and post-acquisition revenues for the twelve months ended December 31, 2012.

This increase was primarily due to an increase in procedure volume and an increase in the number of implanting physicians.

 

50

The Company expects that overall HeRO Graft revenues will increase in 2014 as compared to 2013. As the HeRO Graft implant is currently performed by a relatively small number of physicians, HeRO Graft revenues are subject to more variability quarter-to-quarter due to the timing of surgical cases. As the population of implanting physicians increases, the Company expects this variability in revenues will decrease.

Preservation Services

Revenues from preservation services increased 6% and 1% for the three and twelve months ended December 31, 2013, respectively, as compared to the three and twelve months ended December 31, 2012, respectively. The increase in revenues for the three month period was due to an increase in both cardiac and vascular tissue services revenues. The increase in revenues for the twelve month period was due to an increase in vascular tissue services revenues, partially offset by a decrease in cardiac tissue services revenues. See further discussion of cardiac and vascular preservation services revenues below.

Preservation services revenues, particularly revenues for certain high demand tissues, can vary from quarter-to-quarter and year-to-year due to a variety of factors including: quantity and type of incoming tissues, yields of tissue through the preservation process, timing of receipt of donor information, timing of the release of tissues to an implantable status, demand for certain tissue types due to the number and type of procedures being performed, and pressures from competing products or services. See further discussion of any specific items affecting cardiac and vascular preservation services revenues for the three and twelve months ended December 31, 2013 below.

Cardiac Preservation Services

Revenues from cardiac preservation services (consisting of revenues from the distribution of heart valves and cardiac patch tissues) increased 6% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. This increase was primarily due to an increase in average service fees, which increased revenues by 5%.

Revenues from cardiac preservation services decreased 1% for the twelve months ended December 31, 2013 as compared to the twelve months ended December 31, 2012. This decrease was primarily due to a 7% decrease in unit shipments of cardiac tissues, which decreased revenues by 4%, partially offset by an increase in average service fees, which increased revenues by 3%.

The increase in average service fees for the three and twelve months ended December 31, 2013 was primarily due to list fee increases in domestic markets in November 2012 and July 2013, and due to the routine negotiation of pricing contracts with certain customers.

Unit shipments of cardiac tissues into Europe decreased for the twelve months ended December 31, 2013 as a result of the HTA’s letter suspending CryoLife’s license to distribute tissue in Europe. As tissues distributed in Europe generate lower average fees than tissues distributed in the U.S., the decrease in unit shipments did not result in a proportional decrease in cardiac preservation services revenues. For the three months ended December 31, 2013 the decrease in shipments to Europe was offset by increased shipments in the U.S. The Company’s revenues from shipments of cardiac tissues into Europe under the special access variance allowed by the HTA were $249,000 and $1.1 million for the three and twelve months ended December 31, 2013, respectively, as compared to revenues of $409,000 and $1.8 million for the three and twelve months ended December 31, 2012, respectively. The Company expects to cease the distribution of tissue into Europe as of March 31, 2014.

Revenues from SynerGraft processed tissues, including the CryoValve SGPV and CryoPatch SG, accounted for 53% and 52% of total cardiac preservation services revenues for the three and twelve months ended December 31, 2013, respectively, and 50% and 47% of total cardiac preservation services revenues for the three and twelve months ended December 31, 2012, respectively. Domestic revenues accounted for 93% of total cardiac preservation services revenues for both the three and twelve months ended December 31, 2013, and 90% of total cardiac preservation services revenues for both the three and twelve months ended December 31, 2012.

The Company’s cardiac valves are primarily used in cardiac replacement and reconstruction surgeries, including the Ross procedure, for patients with endocarditis or congenital heart defects.

The Company expects that overall cardiac preservation services revenues in 2014 will be comparable to the revenues in 2013.

 

51

Vascular Preservation Services

Revenues from vascular preservation services increased 6% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. This increase was primarily due to an increase in average service fees, which increased revenues by 9%, partially offset by a 4% decrease in unit shipments of vascular tissues, which decreased revenues by 3%.

Revenues from vascular preservation services increased 3% for the twelve months ended December 31, 2013 as compared to revenues for the twelve months ended December 31, 2012. This increase was primarily due to an increase in average service fees, which increased revenues by 7%, partially offset by a 5% decrease in unit shipments of vascular tissues, which decreased revenues by 4%.

The increase in average service fees for the three and twelve months ended December 31, 2013 was primarily due to list fee increases in domestic markets in November 2012 and July 2013, fee differences due to physical characteristics of vascular tissues, and the routine negotiation of pricing contracts with certain customers.

The decrease in vascular volume for the three and twelve months ended December 31, 2013 was primarily due to decreases in shipments of saphenous veins. The Company believes that the decrease in unit shipments of veins was primarily due to the timing of tissue releases for shipments to domestic markets as compared to the prior year periods, which can vary as discussed above.

The majority of the Company’s vascular preservation services revenues are related to shipments of saphenous veins, which are mainly used in peripheral vascular reconstruction surgeries to avoid limb amputations. These tissues are primarily distributed in domestic markets.

The Company expects that overall vascular preservation services revenues will increase in 2014 as compared to 2013.

Cost of Products and Preservation Services

Cost of Products

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2013      2012      2013      2012  

Cost of products

    $ 4,417       $ 3,080       $ 15,147       $ 11,380   

Cost of products increased 43% and 33% for the three and twelve months ended December 31, 2013, respectively, as compared to the three and twelve months ended December 31, 2012, respectively. Cost of products in 2013 and 2012 includes costs related to BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Grafts.

Cost of products for the twelve months ended December 31, 2013 includes $483,000 in additional costs for revascularization technologies handpieces that were made obsolete by the Company’s decision to exclusively distribute the new handpiece design, which was approved by the FDA in June 2013. Cost of products for the three and twelve months ended December 31, 2013 includes $684,000 in additional contractual costs and inventory impairment costs primarily related to a BioGlue accessory product.

The increase in cost of products in the three and twelve months ended December 31, 2013 was primarily due to the write-offs discussed above and due to an increase in sales volume of BioGlue and HeRO Grafts.

Cost of Preservation Services

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2013      2012      2013      2012  

Cost of preservation services

    $ 8,758       $ 8,675       $ 35,230       $ 35,320   

 

52

Cost of preservation services increased 1% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. Cost of preservation services for the twelve months ended December 31, 2013 was consistent with costs for the twelve months ended December 31, 2012. Cost of preservation services includes costs for cardiac and vascular tissue preservation services.

Cost of preservation services in 2013 was affected by an increase in the per-unit cost of processing tissues and by a decrease in volume of tissues shipped during the period. These largely offset during the three and twelve months ended December 31, 2013. The increase in tissue processing costs includes the write-down of certain cardiac tissues designated for distribution in international markets in the first half of 2013 and the write-down of certain vascular tissues in the fourth quarter of 2013, as these tissues are not expected to ship prior to the expiration date of their packaging.

Gross Margin

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2013     2012     2013     2012  

Gross margin

    $ 22,282      $ 21,045      $ 90,386      $ 85,018   

Gross margin as a percentage of total revenues

      63 %      64 %      64 %      65 % 

Gross margin increased 6% for both the three and twelve months ended December 31, 2013 as compared to the three and twelve months ended December 31, 2012, respectively. Gross margin increased primarily due to an increase in product revenues during the 2013 periods. To a lesser extent, gross margins for the three months ended December 31, 2013 were favorably affected by increases in fees on preservation services and unfavorably affected by additional product costs and write-downs discussed above. Gross margin as a percentage of total revenues in the three and twelve months ended December 31, 2013 was comparable to the three and twelve months ended December 31, 2012, respectively.

Operating Expenses

General, Administrative, and Marketing Expenses

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2013     2012     2013     2012  

General, administrative, and marketing expenses

    $ 16,671      $ 16,775      $ 68,112      $ 65,149   

General, administrative, and marketing expenses as a percentage of total revenues

      47 %      51 %      48 %      49 % 

General, administrative, and marketing expenses decreased 1% for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012. General, administrative, and marketing expenses increased 5% for the twelve months ended December 31, 2013, as compared to the twelve months ended December 31, 2012.

General, administrative, and marketing expenses for the twelve months ended December 31, 2013 included marketing expenses of the expanded sales staff and costs related to the transfer of HeRO Graft manufacturing operations, which were not present in the full corresponding prior year period, due to the acquisition of Hemosphere in May 2012. Medical device excise taxes were $264,000 and $1.0 million for the three and twelve months ended December 31, 2013, respectively, and zero for both the three and twelve months ended December 31, 2012.

General, administrative, and marketing expenses for the twelve months ended December 31, 2012 included a $4.7 million gain on the settlement of the Medafor lawsuit and a $4.1 million loss for the settlement of the lawsuit with CardioFocus, Inc. (“CardioFocus”) related to patent infringement by the Company’s Cardiogenesis laser products. Both of these lawsuits were settled in the second quarter of 2012. Legal fees related to lawsuits, primarily the Medafor and CardioFocus lawsuits, were $3.9 million for the twelve months ended December 31, 2012, and reductions to legal fees for insurance reimbursements for certain litigation expenses were $3.4 million for the twelve months ended December 31, 2012. Business development costs, primarily related to the acquisition and integration of Hemosphere, were $790,000 and $2.7 million for the three and twelve months ended December 31, 2012, respectively.

 

53

The Company expects that general, administrative, and marketing expenses will increase in 2014 as compared to 2013 before Consideration of the effects of litigation and business development expenses. Management believes the potential patent infringement litigation between CryoLife and Medafor or Bard, discussed elsewhere in this Form 10-K, could occur as early as 2014, and management believes that if this litigation occurs, the costs of this litigation would be material.

Research and Development Expenses

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2013     2012     2013     2012  

Research and development expenses

    $ 2,478      $ 2,065      $ 8,454      $ 7,257   

Research and development expenses as a percentage of total revenues

      7 %      6 %      6 %      6 % 

Research and development expenses increased 20% for the three months and 16% for the twelve months ended December 31, 2013 as compared to the three and twelve months ended December 31, 2012, respectively. Research and development spending in these periods was primarily focused on PerClot, the Company’s tissue processing, revascularization technologies, and BioGlue and BioFoam. The increase in research and development expenses for the three and twelve months ended December 31, 2013 was primarily due to planned increases in spending related to PerClot clinical trial development efforts, clinical trial start-up, and non-clinical evaluations. The Company expects that research and development spending will also increase materially in 2014 due to planned increases in spending on PerClot clinical studies.

Gain on Sale of Medafor Investment

The gain on sale of Medafor investment was $12.7 million for the three and twelve months ended December 31, 2013. This gain was recorded upon the sale of the Company’s 2.4 million shares of Medafor common stock to Bard in connection with its October 2013 acquisition of the outstanding shares of Medafor common stock. The Company received an initial payment of approximately $15.4 million and could receive additional payments totaling up to an additional $8.4 million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015. The first of these additional payments, which the Company believes could be up to approximately $525,000, if released, would be received in late 2014, although this amount is subject to possible offsets. See also Part I, Item 1A, “Risk Factors—Risks Relating to Our Business—Although We May Receive Additional Cash Of Up To $8.4 Million In The Future Related To Medafor’s Earnout And Release Of Escrow Funds Related To Bard’s Acquisition of Medafor, It Is Possible We May Not Receive Any Additional Monies, Or The Amount Of The Additional Monies Received Could Be Significantly Less Than $8.4 Million.” These payments will be recorded as an additional gain when and if received by the Company.

Other Than Temporary Investment Impairment

Based on available information the Company determined that the fair value of its investment in ValveXchange preferred stock had declined significantly in the fourth quarter of 2013 and that any of that remaining value was nominal. Therefore, the Company recorded an other than temporary investment impairment of $3.2 million for the three and twelve months ended December 31, 2013 to fully impair the value of its investment. The carrying value of the Company’s investment in ValveXchange preferred stock after this write-down was zero as of December 31, 2013.

 

54

Earnings

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2013      2012      2013      2012  

Income before income taxes

    $ 12,881       $ 2,242       $ 23,292       $ 12,052   

Income tax expense

      3,855         159         7,120         4,106   
  

 

 

     

 

 

     

 

 

     

 

 

  

Net income

    $ 9,026       $ 2,083       $ 16,172       $ 7,946   
  

 

 

     

 

 

     

 

 

     

 

 

  

Diluted income per common share

    $ 0.31       $ 0.07       $ 0.57       $ 0.28   
  

 

 

     

 

 

     

 

 

     

 

 

  

Diluted weighted-average common shares outstanding

      28,208         27,357         27,698         27,411   
  

 

 

     

 

 

     

 

 

     

 

 

  

Income before income taxes increased significantly for the three and twelve months ended December 31, 2013 as compared to the three and twelve months ended December 31, 2012, respectively. This increase was primarily due to the gain on sale of Medafor investment as discussed above and to a lesser extent due to an increase in product revenues, which increased margins, partially offset by an increase in operating expenses, as discussed above.

The Company’s effective income tax rate was approximately 30% and 31% for the three and twelve months ended December 31, 2013, respectively, as compared to 7% and 34% for the three and twelve months ended December 31, 2012, respectively. The Company’s income tax rate for the twelve months ended December 31, 2013 was favorably affected by the full year 2012 research and development tax credit, which was enacted in January 2013 and, therefore, reduced the Company’s tax expense during the first quarter of 2013 and adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards. The Company’s income tax rates for the three and twelve months ended December 31, 2012 were favorably affected by $427,000 in adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards, and unfavorably affected by the tax treatment of certain acquisition related expenses due to the acquisition of Hemosphere and by the research and development tax credit, which had not been enacted for the 2012 tax year.

Net income and diluted income per common share increased for the three and twelve months ended December 31, 2013 as compared to the three and twelve months ended December 31, 2012, primarily due to the increase in income before income taxes, as discussed above.

Diluted income per common share could be unfavorably affected in future periods by the issuance of additional shares of common stock and favorably affected by the Company’s repurchase of its common stock. Stock repurchases are influenced by many factors, including: stock price, available funds, and competing demands for such funds, and as a result, may be suspended or discontinued at any time.

 

55

Year Ended December 31, 2012 Compared to Year Ended December 31, 2011

Revenues

 

     Revenues for the Three
Months Ended
December 31,		     Revenues as a Percentage of
Total Revenues for the
Three Months Ended
December 31,		  
     2012      2011     2012     2011  

Products:

          

BioGlue and BioFoam

    $ 13,353       $ 12,519        41 %      41 % 

PerClot

      1,009         617        3 %      2 % 

HemoStase

      —           (96 )      —   %      —   % 

Revascularization technologies

      1,985         2,415        6 %      8 % 

HeRO Graft

      1,106         —          3 %      —   % 
  

 

 

     

 

 

    

 

 

    

 

 

  

Total products

      17,453         15,455        53 %      51 % 

Preservation services:

          

Cardiac tissue

      7,094         6,629        22 %      22 % 

Vascular tissue

      8,138         8,146        25 %      27 % 
  

 

 

     

 

 

    

 

 

    

 

 

  

Total preservation services

      15,232         14,775        47 %      49 % 

Other

      115         167        —   %      —   % 
  

 

 

     

 

 

    

 

 

    

 

 

  

Total

    $ 32,800       $ 30,397        100 %      100 % 
  

 

 

     

 

 

    

 

 

    

 

 

  

 

     Revenues for the Twelve
Months Ended
December 31,		      Revenues as a Percentage of
Total Revenues for the
Twelve Months Ended
December 31,		  
     2012      2011      2012     2011  

Products:

           

BioGlue and BioFoam

    $ 53,211       $ 49,455         41 %      41 % 

PerClot

      3,078         2,528         2 %      2 % 

HemoStase

      —           1,699         —   %      2 % 

Revascularization technologies

      8,092         5,705         6 %      5 % 

HeRO Graft

      3,115         —           2 %      —   % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total products

      67,496         59,387         51 %      50 % 

Preservation services:

           

Cardiac tissue

      29,756         26,618         23 %      22 % 

Vascular tissue

      33,847         33,175         26 %      28 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total preservation services

      63,603         59,793         49 %      50 % 

Other

      619         446         —   %      —   % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total

    $ 131,718       $ 119,626         100 %      100 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Revenues increased 8% for the three months and 10% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. A detailed discussion of the changes in product revenues, preservation services revenues, and other revenues for the three and twelve months ended December 31, 2012 is presented below.

Products

Revenues from products increased 13% for the three months and 14% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. The increase for the three months

 

56

ended December 31, 2012 was primarily due to the addition of HeRO Graft revenues as a result of the Company’s acquisition of Hemosphere in the second quarter of 2012, and an increase in BioGlue revenues. The increase for the twelve months ended December 31, 2012 was primarily due to an increase in BioGlue revenues, the addition of HeRO Graft revenues, and an increase in revascularization technologies revenues as a result of the Company’s acquisition of Cardiogenesis in the second quarter of 2011, partially offset by a lack of HemoStase revenues as the Company is no longer distributing this product. A detailed discussion of the changes in product revenues for BioGlue and BioFoam; PerClot and HemoStase; revascularization technologies; and HeRO Grafts are presented below.

BioGlue and BioFoam

Revenues from the sale of surgical sealants, consisting of BioGlue and BioFoam, increased 7% for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011. This increase was primarily due to a 4% increase in the volume of milliliters sold, which increased revenues by 3%, and by an increase in average sales prices, which increased revenues by 4%.

Revenues from the sale of surgical sealants increased 8% for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011. This increase was primarily due to an 8% increase in the volume of milliliters sold, which increased revenues by 5%, and by an increase in average sales prices, which increased revenues by 4%, partially offset by the unfavorable impact of foreign exchange rates, which decreased revenues by 1%.

The increase in sales volume of surgical sealants for the three and twelve months ended December 31, 2012 was due to an increase in shipments of BioGlue in certain international markets. For the three months ended December 31, 2012 these increases were primarily in Europe, and for the twelve months ended December 31, 2012 these increases were primarily in Japan and Europe. These increases were partially offset by decreases in the volume of milliliters sold in the Company’s more mature domestic markets of 2% for the three months and 3% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. The Company began shipping BioGlue to Japan in late April 2011, following the Japanese approval of BioGlue for use in the repair of aortic dissections. Revenues from shipments to Japan for the three and twelve months ended December 31, 2012 were $697,000 and $4.1 million, respectively.

Management believes that the decrease in BioGlue shipments in its domestic markets is a result of various factors, including: poor economic conditions and their constraining effect on hospital budgets, the resulting attempts by hospitals to control costs by reducing spending on consumable items such as BioGlue, the efforts of some large competitors in imposing and enforcing contract purchasing requirements for competing non-CryoLife products, and the U.S. market introduction of sealant products with approved indications for use in clinical applications in which BioGlue has been used off-label previously.

The Company’s sales of surgical sealants through its direct sales force to U.K. hospitals are denominated in British Pounds, and its sales to German, Austrian, and Irish hospitals and certain distributors are denominated in Euros and are, therefore, subject to changes in foreign exchange rates. If the exchange rates between the U.S. Dollar and the British Pound or Euro decline materially in the future, this would have a material, adverse impact on the Company’s revenues denominated in these currencies.

Domestic revenues accounted for 61% and 60% of total BioGlue revenues for the three and twelve months ended December 31, 2012, respectively, and 63% and 64% of total BioGlue revenues for the three and twelve months ended December 31, 2011, respectively. BioFoam sales accounted for less than 1% of surgical sealant sales for the three and twelve months ended December 31, 2012. BioFoam is currently approved for sale in certain international markets.

PerClot and HemoStase

Revenues from the sale of PerClot increased 63% for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011. This increase was primarily due to a 68% increase in the volume of grams sold, which increased revenues by 71%, partially offset by a decrease in average sales prices and the unfavorable impact of foreign exchange rates. Revenues during these three month periods were for sales in certain international markets, as PerClot has not yet been approved for domestic distribution or widespread international distribution. This increase was primarily due to increased sales in the Company’s markets in Europe and due to the recent approval of PerClot in additional countries. HemoStase was not distributed during the three months ended December 31, 2012 or 2011.

Revenues from the sale of hemostats, consisting of PerClot and HemoStase, decreased 27% for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011. The revenue decrease in the twelve

 

57

months ended December 31, 2012 was primarily due to a decrease in hemostat sales volume in domestic markets, as discussed further below, and the unfavorable impact of foreign exchange rates, which decreased revenues by 2%.

International hemostat revenues increased 5% for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011. This increase in international hemostat revenues was primarily due to increased PerClot sales into the Company’s markets in Europe and due to the recent approval of PerClot in additional countries, partially offset by the unfavorable impact of foreign exchange rates. International PerClot sales for the twelve months ended December 31, 2012 exceeded combined PerClot and HemoStase international sales for the twelve months ended December 31, 2011, which included large HemoStase orders filled in the first quarter of 2011 in anticipation of a disruption in the availability of hemostats to the Company’s distributors in these countries beginning in 2011. This disruption was due to the Company’s planned March 2011 discontinuance of HemoStase sales subsequent to the termination of its Exclusive Distribution Agreement (“EDA”) for this product.

The decrease in domestic sales volume for the twelve months ended December 31, 2012 was due to the Company’s discontinuation of sales of HemoStase as discussed above. The Company recognized domestic hemostat sales in the first quarter of 2011 and recognized no domestic hemostat sales in the corresponding period in 2012. Domestic hemostat sales ended with the discontinuance of HemoStase sales, as PerClot has not yet been approved for commercial distribution in domestic markets. The Company will not be able to sell PerClot in the U.S. in future years unless and until FDA approval is granted.

The Company’s sales of hemostats through its direct sales force to U.K. hospitals are denominated in British Pounds, and its sales to German, Austrian, and Irish hospitals and certain distributors are denominated in Euros and are, therefore, subject to changes in foreign exchange rates. The unfavorable effect of foreign exchange rates for the three and twelve months ended December 31, 2012 was primarily due to a decline in the value of the Euro when compared to the corresponding periods in 2011.

Revascularization Technologies

Revenues from revascularization technologies include revenues related to the sale of handpieces and accessories and, in certain periods, revenues from the sale of laser consoles. Revenues from revascularization technologies decreased 18% for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011. Revenues from the sale of laser consoles were zero and $541,000 in the three months ended December 31, 2012 and 2011, respectively. Revenues from the sale of handpieces and accessories increased 6% for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011. This increase was primarily due to an increase in average sales prices, which increased revenues by 4%, and an increase in volume, which increased revenues by 2%.

Revenues from revascularization technologies increased for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011, as revascularization technologies were not marketed by the Company for the full twelve month prior year period. The Company began marketing revascularization technologies following its acquisition of Cardiogenesis in May 2011. Revenues from the sale of laser consoles were $279,000 and $541,000 in the twelve months ended December 31, 2012 and 2011, respectively.

Revascularization technologies revenues for the twelve months ended December 31, 2012 decreased when compared to the combined pre- and post-acquisition revenues for the twelve months ended December 31, 2011. Revenues from the sale of laser consoles were $279,000 in the twelve months ended December 31, 2012 and $1.4 million in the combined pre- and post-acquisition period ended December 31, 2011. Revenues from the sale of handpieces and accessories decreased 10% for the twelve months ended December 31, 2012 when compared to the combined pre- and post-acquisition revenues for the twelve months ended December 31, 2011. These decreases were primarily due to increasing competitive pressures and challenges in selling laser consoles in recent periods, both of which have negatively affected handpiece revenues. Revenues from laser consoles were negatively affected by the economic environment, which made hospitals reluctant to invest in large capital purchases.

Preservation Services

Revenues from preservation services increased 3% for the three months and 6% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. The increase for the three and twelve months ended December 31, 2012 was primarily due to an increase in cardiac preservation services revenues. See further discussion of cardiac and vascular preservation services revenues below.

 

58

Cardiac Preservation Services

Revenues from cardiac preservation services (consisting of revenues from the distribution of heart valves and cardiac patch tissues) increased 7% for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011. This increase was primarily due to an increase in average service fees, which increased revenues by 4%, and by the aggregate impact of an increase in volume and tissue mix, which increased revenues by 3%.

Revenues from cardiac preservation services increased 12% for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011. This increase was primarily due to the aggregate impact of an increase in volume and tissue mix, which increased revenues by 9%, and by an increase in average service fees, which increased revenues by 3%.

The increase in revenues from volume and tissue mix for the three months ended December 31, 2012 was primarily due to an increase in cardiac patch shipments, partially offset by a decrease in shipments of pulmonary valves, and the increase for the twelve months ended December 31, 2012 was primarily due to an increase in cardiac valve shipments. Changes in unit shipments of cardiac valves and patches in any one quarter can be affected by the timing of release of these tissues for shipment, which can vary from quarter to quarter. The Company believes that the increase in unit shipments of cardiac valves for the twelve months ended December 31, 2012 was primarily due to the activities of its expanded cardiac sales staff and the Company’s ongoing physician education activities, and may have also benefited from the guidance issued by The Society of Thoracic Surgeons, which indicates that human aortic valves are the ideal replacement in certain cardiac reconstructive procedures involving endocarditis. The Company’s cardiac valves are primarily used in cardiac replacement and reconstruction surgeries for patients with congenital heart defects.

Revenues from SynerGraft processed tissues, including the CryoValve SGPV and CryoPatch SG, accounted for 50% and 47% of total cardiac preservation services revenues for the three and twelve months ended December 31, 2012, respectively, and 39% and 40% of total cardiac preservation services revenues for the three and twelve months ended December 31, 2011, respectively. Domestic revenues accounted for 90% of total cardiac preservation services revenues for both the three and twelve months ended December 31, 2012, and 92% and 91% of total cardiac preservation services revenues for the three and twelve months ended December 31, 2011, respectively.

Vascular Preservation Services

Revenues from vascular preservation services for the three months ended December 31, 2012 were comparable to revenues for the three months ended December 31, 2011. Revenues from vascular preservation services increased 2% for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011, primarily due to a 3% increase in unit shipments of vascular tissues, which increased revenues by 4%, partially offset by a decrease in average service fees, which decreased revenues by 2%.

The increase in vascular tissue volume for the twelve months ended December 31, 2012 was primarily due to increases in shipments of saphenous veins and aortoiliac grafts, which increased due to improved availability of certain tissues. Saphenous veins are primarily used in peripheral vascular reconstruction surgeries to avoid limb amputations, and aortoiliac grafts are primarily used in surgeries to treat abdominal aortic aneurisms. These tissues are primarily distributed in domestic markets.

The decrease in average service fees for the twelve months ended December 31, 2012 was due in part to a list fee decrease for certain vascular tissues in 2012 and fee differences due to physical characteristics of vascular tissues, partially offset by the routine negotiation of pricing contracts with certain customers. 

Other Revenues

Other revenues for the three and twelve months ended December 31, 2012 and 2011 included revenues related to funding allocated from U.S. Congress Defense Appropriations Conference Reports in 2005 through 2008, collectively the (“DOD Grants”). As of December 31, 2012 CryoLife had been awarded $6.1 million and had received a total of $5.4 million for the development of protein hydrogel technology, which the Company is currently developing for use in organ sealing. At December 31, 2012 CryoLife had $1.0 million included in deferred income on the Company’s Consolidated Balance Sheet from the DOD Grants, of which $668,000 remained in unspent cash advances recorded as cash and cash equivalents. In early 2013 the DOD Grants were amended to reduce the total award to $5.4 million. The Company discontinued its BioFoam U.S. clinical trial in the first quarter of 2013 and the remaining unspent funds were returned to the U.S. Department of Defense.

 

59

Cost of Products and Preservation Services

Cost of Products

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2012      2011      2012      2011  

Cost of products

    $ 3,080       $ 2,391       $ 11,380       $ 9,442   

Cost of products increased 29% for the three months and 21% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. Cost of products in 2012 includes costs related to BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Grafts. Cost of products in 2011 includes costs related to BioGlue, BioFoam, PerClot, HemoStase, and revascularization technologies.

The increase in cost of products in the three months ended December 31, 2012 was primarily due to the addition of HeRO Graft revenues. The increase in cost of products in the twelve months ended December 31, 2012 was primarily due to the addition of HeRO Graft and revascularization technologies handpiece revenues, and the increase in BioGlue sales volume, partially offset by the discontinuation of HemoStase sales.

Cost of Preservation Services

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2012      2011      2012      2011  

Cost of preservation services

    $ 8,675       $ 8,631       $ 35,320       $ 34,340   

Cost of preservation services increased 1% for the three months and 3% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. Cost of preservation services includes costs for cardiac and vascular tissue preservation services.

The increase in cost of preservation services in the three and twelve months ended December 31, 2012 was primarily due to increased shipments of cardiac and vascular tissues during these periods, partially offset by a decrease in costs. Cost of preservation services for the three and twelve months ended December 31, 2011 included $674,000 in unusual processing expenses due to certain supplies of processing solutions used in the processing of tissues that did not meet the Company’s quality requirements.

Gross Margin

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2012     2011     2012     2011  

Gross margin

    $ 21,045      $ 19,375      $ 85,018      $ 75,844   

Gross margin as a percentage of total revenues

      64 %      64 %      65 %      63 % 

Gross margin increased 9% for the three months and 12% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. Gross margin increased primarily due to an increase in revenues during the periods. Gross margin as a percentage of total revenues increased in the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011, primarily due to a change in service and product mix as the Company’s higher margin medical devices segment made up a larger percentage of its business in 2012.

 

60

Operating Expenses

General, Administrative, and Marketing Expenses

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2012     2011     2012     2011  

General, administrative, and marketing expenses

    $ 16,775      $ 14,626      $ 65,149      $ 57,302   

General, administrative, and marketing expenses as a percentage of total revenues

      51 %      48 %      49 %      48 % 

General, administrative, and marketing expenses increased 15% for the three months and 14% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively.

General, administrative, and marketing expenses for the twelve months ended December 31, 2012 include a $4.7 million gain on the settlement of the lawsuit with Medafor and a $4.1 million loss for the settlement of the lawsuit with CardioFocus related to a claim of patent infringement by the Company’s Cardiogenesis laser products. Both of these lawsuits were settled in the second quarter of 2012. Legal fees related to lawsuits, primarily the Medafor and CardioFocus lawsuits, were $3.9 million for the twelve months ended December 31, 2012, and reductions to legal fees for insurance reimbursements for certain litigation expenses were $3.4 million for the twelve months ended December 31, 2012.

Business development costs, primarily related to the acquisition and integration of Hemosphere, were $790,000 and $2.7 million for the three and twelve months ended December 31, 2012, respectively. Business development costs, primarily related to the acquisition and integration of Cardiogenesis, were $144,000 and $4.2 million for the three and twelve months ended December 31, 2011, respectively.

General, administrative, and marketing expenses for the three and twelve months ended December 31, 2012 also increased due to an increase in marketing expenses, including the costs of the Company’s expanded sales staff from its recent acquisitions of Hemosphere and Cardiogenesis and increases in spending on advertising.

Research and Development Expenses

 

     Three Months Ended
December 31,		     Twelve Months Ended
December 31,		  
     2012     2011     2012     2011  

Research and development expenses

    $ 2,065      $ 1,800      $ 7,257      $ 6,899   

Research and development expenses as a percentage of total revenues

      6 %      6 %      6 %      6 % 

Research and development expenses increased 15% for the three months and 5% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. Research and development spending for the three and twelve months ended December 31, 2012 was primarily focused on PerClot, HeRO Graft, revascularization technologies, the Company’s SynerGraft products and tissues, and BioFoam.

Earnings

 

     Three Months Ended
December 31,		      Twelve Months Ended
December 31,		  
     2012      2011      2012      2011  

Income before income taxes

    $ 2,242       $ 2,863       $ 12,052       $ 11,466   

Income tax expense

      159         997         4,106         4,095   
  

 

 

     

 

 

     

 

 

     

 

 

  

Net income

    $ 2,083       $ 1,866       $ 7,946       $ 7,371   
  

 

 

     

 

 

     

 

 

     

 

 

  

Diluted income per common share

    $ 0.07       $ 0.07       $ 0.28       $ 0.26   
  

 

 

     

 

 

     

 

 

     

 

 

  

Diluted weighted-average common shares outstanding

      27,357         27,745         27,411         27,759   
  

 

 

     

 

 

     

 

 

     

 

 

  

 

61

Income before income taxes decreased 22% for the three months and increased 5% for the twelve months ended December 31, 2012 as compared to the three and twelve months ended December 31, 2011, respectively. The decrease in income before income taxes for the three months ended December 31, 2012 was primarily caused by an increase in operating expenses as discussed above, partially offset by an increase in gross margin. The increase in income before income taxes for the twelve months ended December 31, 2012 was primarily caused by an increase in gross margin, partially offset by an increase in operating expenses as discussed above.

The Company’s effective income tax rate was approximately 7% for the three months and 34% for the twelve months ended December 31, 2012 as compared to 35% for the three months and 36% for the twelve months ended December 31, 2011. The Company’s income tax rates for the three and twelve months ended December 31, 2012 were favorably affected by $427,000 in adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards. The Company’s income tax rates for the three and twelve months ended December 31, 2012 were also affected by the unfavorable tax treatment of certain acquisition related expenses due to the acquisition of Hemosphere and by the research and development tax credit, which had not been enacted for the 2012 tax year. The Company’s effective income tax rate for the twelve months ended December 31, 2011 was affected by the discrete and favorable effect of deductions taken on the Company’s 2010 federal tax returns, which were filed in the third quarter of 2011. This favorable effect was largely offset by the unfavorable tax treatment, recognized in the second quarter of 2011, of certain acquisition related expenses, which the Company incurred related to its acquisition of Cardiogenesis.

Net income and diluted income per common share increased for the three months ended December 31, 2012 as compared to the three months ended December 31, 2011, primarily due to the decrease in income tax expense. Net income and diluted income per common share increased for the twelve months ended December 31, 2012 as compared to the twelve months ended December 31, 2011, primarily due to the increase in income before income taxes, as discussed above.

Seasonality

The Company believes the demand for BioGlue is seasonal, with a decline in demand generally occurring in the third quarter followed by stronger demand in the fourth quarter. Management believes that this trend for BioGlue may be due to the summer holiday season in Europe and in the U.S. The Company’s market for BioGlue in Japan is still in a growth phase, however, the Company believes that demand for BioGlue in Japan may continue to be lowest in the second quarter of each year due to distributor ordering patterns driven by the slower summer holiday season in Japan.

The Company is uncertain whether the demand for PerClot will be seasonal, as PerClot is a new product and the nature of any seasonal trends in PerClot sales may be obscured.

The Company is uncertain whether the demand for revascularization technologies will be seasonal, as the Company’s data does not indicate a significant trend.

The Company is uncertain whether the demand for HeRO Grafts will be seasonal, as the Company’s data does not indicate a significant trend.

The Company’s demand for its cardiac preservation services has traditionally been seasonal, with peak demand generally occurring in the third quarter. Management believes this trend for cardiac preservation services is primarily due to the high number of surgeries scheduled during the summer months for school-aged patients. Based on experience in recent years, management believes that this trend is lessening as the Company is distributing a higher percentage of its tissues to adult populations.

The Company’s demand for its vascular preservation services is seasonal, with lowest demand generally occurring in the fourth quarter. Management believes this trend for vascular preservation services is primarily due to fewer vascular surgeries being scheduled during the winter holiday months.

Liquidity and Capital Resources

Net Working Capital

At December 31, 2013 net working capital (current assets of $106.3 million less current liabilities of $20.7 million) was $85.6 million, with a current ratio (current assets divided by current liabilities) of 5 to 1, compared to net working capital of $56.1 million and a current ratio of 4 to 1 at December 31, 2012.

 

62

Overall Liquidity and Capital Resources

The Company’s largest cash requirement for the twelve months ended December 31, 2013 was cash for general working capital needs, as the Company’s accounts receivable balance increased significantly from December 31, 2012. The accounts receivable increase was due to the Company’s recent sales, which have not yet been converted to cash, along with the fact that accounts receivable as of December 31, 2012 was lower than normal due to timing of payments. In addition, the Company’s other cash requirements included capital expenditures, repurchases of the Company’s common stock, and cash dividend payments. The Company funded its cash requirements through its existing cash reserves, its operating activities, which generated cash during the period, and the $15.4 million in proceeds from the sale of the Company’s investment in Medafor common stock, discussed further below.

CryoLife’s credit agreement with General Electric Capital Corporation (the “GE Credit Agreement”) provides revolving credit for working capital, acquisitions, and other corporate purposes. The borrowing capacity under the GE Credit Agreement, which expires October 28, 2014, is $20.0 million (including a letter of credit subfacility). The borrowing capacity may be reduced or increased from time to time pursuant to the terms of the GE Credit Agreement. As required under the terms of the GE Credit Agreement, the Company is maintaining cash and cash equivalents of at least $5.0 million in accounts in which General Electric Capital Corporation has a first priority perfected lien. As a result, these funds will not be available to meet the Company’s liquidity needs during the term of the GE Credit Agreement and, as such, have been recorded as restricted cash and securities on the Company’s Consolidated Balance Sheets. Also, the GE Credit Agreement requires that, after giving effect to a stock repurchase, the Company maintain liquidity, as defined in the agreement, of at least $20.0 million. As of December 31, 2013 the outstanding balance under the GE Credit Agreement was zero, and $20.0 million was available for borrowing.

In the twelve months ended December 31, 2013 the Company purchased approximately 253,000 shares of its common stock for an aggregate purchase price of $1.5 million. As of December 31, 2013 the Company had $13.5 million in remaining authorizations under common stock repurchase programs authorized by the Company’s Board of Directors. The Company is entitled to repurchase an additional $8.7 million in additional common stock without obtaining its lender’s consent. The purchase of shares may be made from time to time in the open market or through privately negotiated transactions, on such terms as management deems appropriate, and will be dependent upon various factors, including: price, regulatory requirements, and other market conditions.

As of December 31, 2013 approximately 5% of the Company’s cash and cash equivalents were held in foreign jurisdictions.

On October 1, 2013 Bard completed its previously announced acquisition of the outstanding shares of Medafor common stock. The Company received an initial payment of approximately $15.4 million for its 2.4 million shares of Medafor common stock and recorded an initial gain of $12.7 million on the sale in the fourth quarter of 2013. The Company could receive additional payments totaling up to an additional $8.4 million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015. The first of these additional payments, which the Company believes could be up to approximately $525,000, if released, would be received in late 2014, although this amount is subject to possible offsets. These payments will be recorded as an additional gain when and if received by the Company.

As discussed elsewhere in this Form 10-K, in September 2012, CryoLife received a letter from Medafor stating that PerClot, when introduced in the U.S., will, when used in accordance with the method published in CryoLife’s literature and with the instructions for use, infringe Medafor’s U.S. patent. CryoLife does not believe that it will infringe Medafor’s patent. There have been no further communications between CryoLife and Medafor, or CryoLife and Medafor’s parent company, Bard, related to the September letter. Management believes that patent infringement litigation between CryoLife and Medafor or Bard could occur as early as 2014, and management believes that if litigation occurs, the costs of this litigation would be material.

During 2012 the Company advanced a total of $2.0 million in debt financing to ValveXchange through a revolving credit facility (the “Loan”). The Loan is secured by substantially all of the tangible and intangible assets of ValveXchange. During 2013 CryoLife repeatedly notified ValveXchange that ValveXchange was in default of certain loan covenants, due to factors including ValveXchange’s failure to obtain CryoLife’s consent for certain convertible note financings that ValveXchange obtained during the year. These events of default were ongoing as of February 15, 2014. If ValveXchange is unable to secure material amounts of additional financing, it will likely be unable to meet its obligations, and, therefore, CryoLife may need to foreclose on the related collateral to secure repayment of the Loan. Although CryoLife currently believes that the value of the collateral is adequate to repay the Loan, there is no guarantee of such adequacy.

 

63

The Company believes that its anticipated cash from operations and existing cash and cash equivalents will enable the Company to meet its current operational liquidity needs for at least the next twelve months. The Company’s future cash requirements are expected to include cash to fund business development activities, to fund the PerClot clinical trials, to repurchase the Company’s common stock, to fund the cash dividend to common shareholders, to fund additional research and development expenditures, for general working capital needs, for capital expenditures, and for other corporate purposes. These items may have a significant effect on the Company’s cash flows during 2014. The Company may seek additional borrowing capacity or financing, pursuant to its shelf registration statement, for general corporate purposes or to fund other future cash requirements. If the Company undertakes further significant business development activity in 2014, it may need to finance such activities by drawing down monies under the GE Credit Agreement, obtaining additional debt financing, or using its shelf registration statement to sell equities.

The Company acquired net operating loss carryforwards from its acquisitions of Hemosphere and Cardiogenesis that the Company believes will reduce required cash payments for federal income taxes by approximately $1.5 million for the 2014 tax year.

Net Cash Flows from Operating Activities

Net cash provided by operating activities was $16.8 million for the twelve months ended December 31, 2013 as compared to $19.0 million for the twelve months ended December 31, 2012. The decrease in net cash provided is primarily due to an increase in working capital needs, largely as a result of an increase in receivable balances driven by an increase in revenues, as discussed further below.

The Company uses the indirect method to prepare its cash flow statement, and, accordingly, the operating cash flows are based on the Company’s net income, which is then adjusted to remove non-cash items, items classified as investing and financing cash flows, and for changes in operating assets and liabilities from the prior year end. For the twelve months ended December 31, 2013 these items included a $12.7 million gain on the sale of Medafor common stock, as the cash proceeds are reported in investing activities below, a favorable $5.8 million in depreciation and amortization expense, a $3.2 million impairment expense related to the Company’s investment in ValveXchange, $3.2 million in non-cash compensation, and $1.7 million in write downs of inventory and deferred preservation costs.

The Company’s working capital needs, or changes in operating assets and liabilities, also affected cash from operations. For the twelve months ended December 31, 2013 the increase in working capital needs of $1.6 million was primarily due to the timing difference between recording receivables and the receipt of cash.

Net Cash Flows from Investing Activities

Net cash provided by investing activities was $10.9 million for the twelve months ended December 31, 2013 as compared to $22.9 million used in investing activities for the twelve months ended December 31, 2012. The current year cash provided was primarily due to $15.4 million in proceeds from the sale of the Company’s 2.4 million shares of Medafor common stock, as a result of that company’s acquisition by Bard, partially offset by $4.3 million in capital expenditures. The prior year cash used was primarily due to the payment of $17.0 million for the acquisition of Hemosphere, net of cash acquired.

Net Cash Flows from Financing Activities

Net cash used in financing activities was $3.1 million for the twelve months ended December 31, 2013 as compared to $4.7 million for the twelve months ended December 31, 2012. The current year cash used was primarily due to $3.0 million in cash dividends paid on the Company’s common stock, and $1.5 million in purchases of treasury stock related to the Company’s publicly announced stock repurchase plan, partially offset by $2.2 million in proceeds from the exercise of options and the issuance of stock under the Company’s employee stock purchase plan.

Off-Balance Sheet Arrangements

The Company has no off-balance sheet arrangements.

 

64

Scheduled Contractual Obligations and Future Payments

Scheduled contractual obligations and the related future payments as of December 31, 2013 are as follows (in thousands):

 

     Total      2014      2015      2016      2017      2018      Thereafter  

Operating leases

    $ 24,887       $ 2,799       $ 3,031       $ 2,943       $ 2,980       $ 3,010       $ 10,124   

Purchase commitments

      4,452         2,739         1,713         —           —           —           —     

Contingent payments

      4,500         1,000         —           3,500         —           —           —     

Compensation payments

      1,985         —           —           1,985         —           —           —     

Research obligations

      2,246         1,841         376         29         —           —           —     
  

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

  

Total contractual obligations

    $ 38,070       $ 8,379       $ 5,120       $ 8,457       $ 2,980       $ 3,010       $ 10,124   
  

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

  

The Company’s operating lease obligations result from the lease of land and buildings that comprise the Company’s corporate headquarters and manufacturing facilities, leases related to additional office and warehouse space, leases on Company vehicles, and leases on a variety of office equipment.

The Company’s purchase commitments include minimum purchase requirements for PerClot related to the Company’s transaction with SMI. These minimum purchases are included through 2015, which assumes that the Company receives FDA approval for PerClot in 2016. Upon FDA approval, the Company may terminate its minimum purchase requirements, per the terms of the agreements between the parties, which the Company expects to do. However, if the Company does not terminate this provision, it will have minimum purchase obligations of $1.75 million per year through the end of the contract term in 2025. The Company’s purchase commitments also include obligations from agreements with suppliers.

The contingent payment obligations include obligations related to the Company’s acquisition of Hemosphere and transaction with SMI. The contingent payment obligation for Hemosphere represents the payments that the Company will make if certain revenue milestones are achieved. The schedule includes one contingent milestone payment for $2.5 million that the Company believes it is likely to pay in 2016, although the timing of this payment may change. The schedule excludes one Hemosphere contingent milestone payment of up to $2.0 million, as the Company cannot make a reasonably reliable estimate of when this future payment may be made, if at all. The contingent payment obligation for PerClot represents the payments that the Company will make if certain FDA regulatory approvals and other commercial milestones are achieved. The schedule excludes one PerClot contingent milestone payment of $500,000, as the Company cannot make a reasonably reliable estimate of timing of this future payment.

The Company’s compensation payment obligations represent estimated payments for post-employment benefits for the Company’s Chief Executive Officer (“CEO”). The timing of the CEO’s post-employment benefits is based on the December 2015 expiration date of the CEO’s current employment agreement; however, payment of this benefit may be accelerated upon the occurrence of certain events, including the voluntary retirement of the CEO or termination of the CEO’s employment in conjunction with certain change in control events, and payment could be extended in the event the term of the CEO’s employment contract is extended.

The Company’s research obligations represent commitments for ongoing studies and payments to support research and development activities.

The schedule of contractual obligations above excludes (i) obligations for estimated liability claims unless they are due as a result of a settlement agreement or other contractual obligation and (ii) any estimated liability for uncertain tax positions and interest and penalties, currently estimated to be $2.5 million, because the Company cannot make a reasonably reliable estimate of the amount and period of related future payments as no specific assessments have been made for specific litigation or by any taxing authorities.

Capital Expenditures

Capital expenditures for the twelve months ended December 31, 2013 were $4.3 million as compared to $3.1 million for the twelve months ended December 31, 2012. Capital expenditures in the twelve months ended December 31, 2013 were primarily related to the routine purchases of manufacturing and tissue processing equipment, including support for the Company’s HeRO Graft and PerClot product lines; revascularization technologies lasers; computer and office equipment; computer software; and leasehold improvements needed to support the Company’s business.

 

65

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate Risk

The Company’s interest income and interest expense are sensitive to changes in the general level of U.S. interest rates. In this regard, changes in U.S. interest rates affect the interest earned on the Company’s cash and cash equivalents of $37.6 million, restricted cash of $5.0 million, and interest paid on the Company’s variable rate line of credit as of December 31, 2013. A 10% adverse change in interest rates as compared to the rates experienced by the Company in the twelve months ended December 31, 2013, affecting the Company’s cash and cash equivalents, restricted cash, and line of credit would not have had a material impact on the Company’s financial position, profitability, or cash flows.

Foreign Currency Exchange Rate Risk

The Company has balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency denominated balances are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the U.S. Dollar equivalent of cash or funds that the Company will receive in payment for assets or that the Company would have to pay to settle liabilities. As a result, the Company could be required to record these changes as gains or losses on foreign currency translation.

The Company has revenues and expenses that are denominated in foreign currencies. Specifically, a significant portion of the Company’s international BioGlue revenues are denominated in British Pounds and Euros, and a portion of the Company’s general, administrative, and marketing expenses are denominated in British Pounds and Euros. These foreign currency transactions are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the U.S. Dollar equivalent of net income from transactions conducted in other currencies. As a result, the Company could recognize a reduction in revenues or an increase in expenses related to a change in exchange rates.

An additional 10% adverse change in exchange rates from the exchange rates in effect on December 31, 2013 affecting the Company’s balances denominated in foreign currencies would not have had a material impact on the Company’s financial position or cash flows. An additional 10% adverse change in exchange rates from the weighted-average exchange rates experienced by the Company for the twelve months ended December 31, 2013 affecting the Company’s revenue and expense transactions denominated in foreign currencies, would not have had a material impact on the Company’s financial position, profitability, or cash flows.

Item 8. Financial Statements and Supplementary Data.

Our financial statements and supplementary data required by this item are submitted as a separate section of this annual report on Form 10-K. See “Financial Statements” commencing on page F-1.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

As previously disclosed in the Company’s Current Report on Form 8-K filed on February 22, 2013, our Audit Committee approved the engagement of Ernst & Young LLP as our independent registered public accounting firm effective February 18, 2013. There were no disagreements or reportable events related to the change in accountants requiring disclosure under Item 304(b) of Regulation S-K.

Item 9A. Controls and Procedures.

The Company maintains disclosure controls and procedures (“Disclosure Controls”) as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934. These Disclosure Controls are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosures.

The Company’s management, including the Company’s President and CEO and the Company’s Executive Vice President of Finance, Chief Operating Officer, and CFO, does not expect that its Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the

 

66

objectives of the control system are met. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdown can occur because of simple error or mistake. The Company’s Disclosure Controls have been designed to provide reasonable assurance of achieving their objectives.

The Company’s management utilizes the criteria set forth in “Internal Control-Integrated Framework (1992)” issued by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of its Disclosure Controls over financial reporting. Based upon the most recent Disclosure Controls evaluation conducted by management with the participation of the CEO and CFO, as of December 31, 2013, the CEO and CFO have concluded that the Company’s Disclosure Controls were effective at the reasonable assurance level to satisfy their objectives and to ensure that the information required to be disclosed by the Company in its periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized, and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms.

During the quarter ended December 31, 2013 there were no changes in the Company’s internal control over financial reporting that materially affected or that are reasonably likely to materially affect the Company’s internal control over financial reporting.

The report called for by Item 308(a) of Regulation S-K is incorporated herein by reference to “Management’s Report on Internal Control over Financial Reporting under Sarbanes-Oxley Section 404” on page F-1 of this report.

The attestation report called for by Item 308(b) of Regulation S-K is incorporated herein by reference to “Report of Independent Registered Public Accounting Firm” on page F-2 of this report.

Item 9B. Other Information.

None.

 

67

PART III

Item 10. Directors, Executive Officers, and Corporate Governance.

The response to Item 10 is incorporated herein by reference to the information to be set forth in the Proxy Statement for the Annual Meeting of Stockholders to be filed with the Commission within 120 days after December 31, 2013, with the exception of information concerning executive officers, which is included in Part I, Item 4A, “Executive Officers of the Registrant” of this Form 10-K.

Item 11. Executive Compensation.

The response to Item 11 is incorporated herein by reference to the information to be set forth in the Proxy Statement for the Annual Meeting of Stockholders to be filed with the Commission within 120 days after December 31, 2013.

Item 12. Security Ownership of Certain Beneficial Owners and Management, and Related Stockholder Matters.

The response to Item 12 is incorporated herein by reference to the information to be set forth in the Proxy Statement for the Annual Meeting of Stockholders to be filed with the Commission within 120 days after December 31, 2013.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

The response to Item 13 is incorporated herein by reference to the information to be set forth in the Proxy Statement for the Annual Meeting of Stockholders to be filed with the Commission within 120 days after December 31, 2013.

Item 14. Principal Accounting Fees and Services.

The response to Item 14 is incorporated herein by reference to the information to be set forth in the Proxy Statement for the Annual Meeting of Stockholders to be filed with the Commission within 120 days after December 31, 2013.

 

68

PART IV

Item 15. Exhibits, Financial Statement Schedules.

The following are filed as part of this report:

 

  (a) 1. Consolidated Financial Statements begin on page F-1.

All financial statement schedules are omitted, as the required information is immaterial, not applicable, or the information is presented in the consolidated financial statements or related notes.

 

  (b) Exhibits

The following exhibits are filed herewith or incorporated herein by reference:

 

Exhibit
Number

  

Description

2.1+   Series A Preferred Stock Purchase Agreement Among CryoLife, Inc., The Cleveland Clinic Foundation, and ValveXchange, Inc. dated July 6, 2011. (Incorporated herein by reference to Exhibit 2.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.)
2.2   Agreement and Plan of Merger, dated May 14, 2012, by and among CryoLife, Inc., CL Crown, Inc., Hemosphere, Inc. and a Stockholder Representative. (Incorporated herein by reference to Exhibit 2.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.)
3.1   Amended and Restated Articles of Incorporation of the Company. (Incorporated herein by reference to Exhibit 3.1 to the Registrant’s Form S-3 filed February 22, 2012.)
3.2   Reserved.
3.3   Reserved.
3.4   Reserved.
3.5   Amended and Restated By-Laws. (Incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed July 27, 2011.)
4.1   Reserved.
4.2   Form of Certificate for the Company’s Common Stock. (Incorporated herein by reference to Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1997.)
4.3   Reserved.
4.4   Reserved.
4.5   Reserved.
4.6   First Amended and Restated Rights Agreement, dated as of November 2, 2005, between CryoLife, Inc. and American Stock Transfer & Trust Company. (Incorporated herein by reference to Exhibit 4.1 to Registrant’s Current Report on Form 8-K filed November 3, 2005.)
10.1   Reserved.
10.2+   Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc. as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008.)
10.2(a)   First Amendment, dated May 7, 2009, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc. as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.9(a) to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2009.)

 

69

Exhibit
Number

  

Description

10.2(b)+   Second Amendment, dated November 9, 2009, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc. as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.9(a) to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2009.)
10.2(c)+   Third Amendment, dated January 12, 2010, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010.)
10.2(d)   Fourth Amendment, dated May 28, 2010, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010.)
10.2(e)   Fifth Amendment, dated March 2, 2011, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.)
10.2(f)   Sixth Amendment, dated June 30, 2011, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)
10.2(g)   Seventh Amendment, dated August 30, 2011, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, letter of credit issuer, and agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.)
10.2(h)+   Amended and Restated Credit Agreement, dated October 28, 2011, to the Credit Agreement by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, swingline lender, as letter of credit issuer, and as the agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.2(h) to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2011.)
10.2(i)   First Amendment, dated August 20, 2012, to the Amended and Restated Credit Agreement, dated October 28, 2011, by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, swingline lender, as letter of credit issuer, and as the agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)
10.2(j)   Second Amendment, dated May 23, 2013, to the Amended and Restated Credit Agreement, dated October 28, 2011, by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, swingline lender, as letter of credit issuer, and as the agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013.)

 

70

Exhibit
Number

  

Description

10.2(k)   Third Amendment, dated September 20, 2013, to the Amended and Restated Credit Agreement, dated October 28, 2011, by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, General Electric Capital Corporation, as lender, swingline lender, as letter of credit issuer, and as the agent for all lenders, and GE Capital Markets, Inc., as sole lead arranger and bookrunner. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013.)
10.3   CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)
10.3(a)   First Amendment, dated July 24, 2012, to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)
10.4   CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Appendix 1 to the Registrant’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 17, 1998.)
10.5   Reserved.
10.6   Reserved.
10.7   Form of 2012 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.7 to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)
10.7(a)   Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2002 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed August 7, 2006.)
10.7(b)   Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)
10.8   Form of Incentive Stock Option Grant Agreement under the 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)
10.9   Employment Agreement by and between the Company and Steven G. Anderson dated as of October 23, 2012. (Incorporated herein by reference to Exhibit 10.9 to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)
10.9(a)   Form of Change of Control Agreement (entered into with respect to Jeffrey W. Burris, David M. Fronk and Scott B. Capps). (Incorporated herein by reference to Exhibit 10.9(a) to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)
10.9(b)   Change of Control Agreement, by and between the Company and D. Ashley Lee, dated October 24, 2008. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed October 28, 2008.)
10.10   Form of Secrecy and Noncompete Agreement, by and between the Company and its Officers. (Incorporated herein by reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1 (No. 33-56388).)
10.11   Form of Key Employee Secrecy and Noncompete Agreement, by and between the Company and its Officers and Key Employees (Incorporated herein by reference to Exhibit 10.11 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.).
10.12*   Summary of Salaries for Named Executive Officers.
10.13   Form of Non-Qualified Stock Option Grant Agreement under 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

71

Exhibit
Number

  

Description

10.14   Amended and Restated Technology Acquisition Agreement between the Company and Nicholas Kowanko, Ph.D., dated March 14, 1996. (Incorporated herein by reference to Exhibit 10.14 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004.)
10.15   CryoLife, Inc. Non-Employee Directors Stock Option Plan, as amended. (Incorporated herein by reference to Appendix 2 to the Registrant’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 17, 1998.)
10.16   Lease Agreement between the Company and Amli Land Development—I Limited Partnership, dated April 18, 1995. (Incorporated herein by reference to Exhibit 10.16 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007.)
10.16(a)   First Amendment to Lease Agreement, dated April 18, 1995, between the Company and Amli Land Development—I Limited Partnership dated August 6, 1999. (Incorporated herein by reference to Exhibit 10.16(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999.)
10.16(b)   Restatement and Amendment to Funding Agreement between the Company and Amli Land Development—I Limited Partnership, dated August 6, 1999. (Incorporated herein by reference to Exhibit 10.16(b) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.)
10.16(c)   Amended and Restated Lease Agreement between the Company and Amli Land Development – I Limited Partnership, dated May 10, 2010. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010.)
10.17   CryoLife, Inc. 2008 Non-Employee Directors Omnibus Stock Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008.)
10.17(a)   Form of Non-Employee Director Stock Grant Agreement pursuant to the CryoLife, Inc. 2008 Non-Employee Directors Omnibus Stock Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008.)
10.18   Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)
10.19   CryoLife, Inc. 2004 Employee Stock Incentive Plan, adopted on June 29, 2004. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.)
10.19(a)   First Amendment to the CryoLife, Inc. 2004 Employee Stock Incentive Plan, dated October 27, 2009. (Incorporated herein by reference to Exhibit 10.46 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2009.)
10.19(b)   Second Amendment to the CryoLife, Inc. 2004 Employee Stock Incentive Plan, dated May 24, 2011. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)
10.20   Form of Incentive Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed February 25, 2008.)
10.21   Form of Non-Qualified Employee Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed February 25, 2008.)
10.22   Technology License Agreement between the Company and Colorado State University Research Foundation dated March 28, 1996. (Incorporated herein by reference to Exhibit 10.22 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007.)

 

72

Exhibit
Number

  

Description

10.23   Form of Non-Qualified Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)
10.24   Form of Incentive Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)
10.25   Form of Section 16 Officer Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed February 27, 2006.)
10.26   Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed February 27, 2006.)
10.27   Grant of Incentive Stock Option to D. Ashley Lee, dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2006.)
10.27(a)   First Amendment to Award Agreement between CryoLife and D. Ashley Lee dated May 24, 2011, relating to a Stock Option Grant to D. Ashley Lee dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)
10.28   Form of Incentive Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.29 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.29   Form of Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.30(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.30   Form of Director Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.30(b) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.31   Form of Non-Employee Directors Stock Option Agreement and Grant pursuant to the Amended and Restated Non-Employee Directors Stock Option Plan. (Incorporated herein by reference to Exhibit 10.31 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.32   Form of Incentive Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.32 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.33   Form of Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.33 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.34   Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.34 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.35   Form of Non-Qualified Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.35 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.36   Form of Grant of Non-Qualified Stock Option to Directors. (Incorporated herein by reference to Exhibit 10.36 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)
10.37   Grant of Incentive Stock Option to Steven G. Anderson, dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.37 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

73

Exhibit
Number

  

Description

10.38   International Distribution Agreement, dated September 17, 1998, between the Company and Century Medical, Inc. (Incorporated by reference to Exhibit 10.37 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.)
10.39   CryoLife, Inc. 2004 Non-Employee Directors Stock Option Plan, as amended, adopted on June 29, 2004. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.)
10.40   Form of Directors Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Non-Employee Directors Stock Option Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)
10.41   CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.)
10.42   Settlement and Release Agreement, dated August 2, 2002, by and between Colorado State University Research Foundation, the Company, and Dr. E. Christopher Orton. (Incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2002.)
10.43   Settlement Agreement and Release, dated September 25, 2006, by and between CryoLife, Inc. and St. Paul Mercury Insurance Company. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006.)
10.44*   Summary of Compensation Arrangements with Non-Employee Directors.
10.45   CryoLife, Inc. 2009 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.)
10.46   Reserved.
10.47   Form of 2013 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on 10-Q for the quarter ended March 31, 2013.)
10.48   Reserved.
10.49   Form of Non-Qualified Stock Option Grant Agreement pursuant to the CryoLife, Inc. 2009 Employee Stock Incentive Plan entered into with each Named Executive Officer. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010.)
10.50+   Distribution Agreement between the Company and Starch Medical, Inc., dated September 28, 2010. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed January 18, 2012.)
10.50(a)+   First Amendment to the Distribution Agreement between the Company and Starch Medical, Inc., dated May 18, 2011. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed January 30, 2012.)
10.50(b)   Second Amendment to the Distribution Agreement between the Company and Starch Medical, Inc., dated September 20, 2013. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013.)
10.51+   License Agreement between the Company and Starch Medical, Inc., dated September 28, 2010. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed January 18, 2012.)
10.51(a)   Indemnification Agreement between the Company and Starch Medical, Inc., dated May 21, 2013. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013.)
10.52   CryoLife, Inc. Executive Deferred Compensation Plan. (Incorporated herein by reference to Exhibit 10.52 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2010.)

 

74

Exhibit
Number

  

Description

10.53   Form of Non-Qualified Stock Option Grant Agreement pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.)
10.54   Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2009 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.)
10.55   First Amendment to Award Agreement between CryoLife and D. Ashley Lee dated May 24, 2011, relating to a Stock Option Grant to D. Ashley Lee dated February 21, 2006. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)
10.56+   Loan and Security Agreement by and between ValveXchange, Inc., and CryoLife, Inc. dated July 6, 2011. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.)
10.56(a)   First Amendment to Loan and Security Agreement by and between ValveXchange, Inc., and CryoLife, Inc. dated September 6, 2011. (Incorporated herein by reference to Exhibit 10.56(a) to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2011.)
10.56(b)   Second Amendment, dated July 18, 2012, to the Loan and Security Agreement by and between ValveXchange, Inc. and CryoLife, Inc. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)
10.57   Form of Indemnification Agreement entered into with each of the Registrant’s directors, except Harvey Morgan, and its Executive Vice President, Chief Operating Officer and Chief Financial Officer. (Incorporated herein by reference to Exhibit 99.1 to the Form S-3/A filed by Registrant on January 4, 2005.)
10.58   Form of Indemnification Agreement entered into with Harvey Morgan. (Incorporated herein by reference to Exhibit 99.2 to the Form S-3 filed by Registrant on November 21, 2008.)
10.59   Form of Performance Share Agreement with Named Executive Officers. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed March 22, 2012.)
10.59(a)   First Amendment, dated July 23, 2012, to the 2012 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)
10.60   Amended and Restated CryoLife, Inc. 2009 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 99.1 to the Registrant’s Form S-8 filed June 22, 2012.)
10.60(a)   First Amendment, dated July 24, 2012, to the Amended and Restated CryoLife, Inc. 2009 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)
10.61   Waiver Agreement, dated May 14, 2012, by and among CryoLife, Inc. and certain of its subsidiaries, as borrowers, and General Electric Capital Corporation, as lender and administrative agent for all lenders, under the Amended and Restated Credit Agreement between the parties, dated October 28, 2011. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.)
10.62   Final Settlement Agreement, dated June 28, 2012, by and among CryoLife, Inc. and Medafor, Inc. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.)
10.63   Settlement Agreement, dated June 14, 2012, by and among CryoLife, Inc. and CardioFocus, Inc. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.)

 

75

Exhibit
Number

  

Description

21.1*   Subsidiaries of CryoLife, Inc.
23.1*   Consent of Ernst & Young LLP.
23.2*   Consent of Deloitte & Touche LLP.
31.1*   Certification by Steven G. Anderson pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification by D. Ashley Lee pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32*   Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002.
101.INS**   XBRL Instance Document
101.SCH**   XBRL Taxonomy Extension Schema Document
101.CAL**   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**   XBRL Taxonomy Extension Definition Linkbase
101.LAB**   XBRL Taxonomy Extension Label Linkbase Document
101.PRE**   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith.
** Furnished herewith.
+ The Registrant has requested confidential treatment for certain portions of this exhibit pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

76

3. B. Executive Compensation Plans and Arrangements.

 

1. Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2002 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed August 7, 2006.)

 

2. Employment Agreement by and between the Company and Steven G. Anderson dated as of October 23, 2012. (Incorporated herein by reference to Exhibit 10.9 to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)

 

3. Form of Change of Control Agreement (entered into with respect to Jeffrey W. Burris, David M. Fronk, and Scott B. Capps). (Incorporated herein by reference to Exhibit 10.9(a) to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)

 

4. Change of Control Agreement, by and between the Company and D. Ashley Lee, dated October 24, 2008. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed October 28, 2008.)

 

5. Reserved.

 

6. Form of Secrecy and Noncompete Agreement, by and between the Company and its Officers. (Incorporated herein by reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1 (No. 33-56388).)

 

7. Form of Key Employee Secrecy and Noncompete Agreement, by and between the Company and its Officers and Key Employees. (Incorporated herein by reference to Exhibit 10.11 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

8. CryoLife, Inc. Non-Employee Directors Stock Option Plan, as amended. (Incorporated herein by reference to Appendix 2 to the Registrant’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 17, 1998.)

 

9. CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Appendix 1 to the Registrant’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 17, 1998.)

 

10. CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.)

 

11. CryoLife, Inc. 2004 Employee Stock Incentive Plan, adopted on June 29, 2004. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.)

 

12. CryoLife, Inc. 2004 Non-Employee Directors Stock Option Plan, as amended, adopted on June 29, 2004. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.)

 

13. CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

14. Form of Directors Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Non-Employee Directors Stock Option Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)

 

15. Form of Non-Qualified Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)

 

16. Form of Incentive Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)

 

77

17. Form of Section 16 Officer Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed February 27, 2006.)

 

18. Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed February 27, 2006.)

 

19. Grant of Incentive Stock Option to D. Ashley Lee, dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2006.)

 

20. First Amendment to Award Agreement between CryoLife and D. Ashley Lee dated May 24, 2011, relating to a Stock Option Grant to D. Ashley Lee dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)

 

21. * Summary of Salaries for Named Executive Officers.

 

22. Form of Incentive Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.29 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

23. Form of Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.30(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

24. Form of Director Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.30(b) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

25. Form of Non-Employee Directors Stock Option Agreement and Grant pursuant to the Amended and Restated Non-Employee Directors Stock Option Plan. (Incorporated herein by reference to Exhibit 10.31 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

26. Form of Incentive Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.32 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

27. Form of Non-Qualified Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.33 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

28. Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.34 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

29. Form of Non-Qualified Employee Stock Option Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.35 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

30. Form of Grant of Non-Qualified Stock Option to Directors. (Incorporated herein by reference to Exhibit 10.36 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

31. Grant of Incentive Stock Option to Steven G. Anderson, dated May 4, 2006. (Incorporated herein by reference to Exhibit 10.37 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.)

 

32. Form of 2013 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on 10-Q for the quarter ended March 31, 2013.)

 

78

33. Form of Incentive Stock Option Grant Agreement under the 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

34. Form of Non-Qualified Stock Option Grant Agreement under 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

35. Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 1998 Long-Term Incentive Plan. (Incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

36. * Summary of Compensation Arrangements with Non-Employee Directors.

 

37. Form of Restricted Stock Award Agreement and Grant pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.)

 

38. CryoLife, Inc. 2008 Non-Employee Directors Omnibus Stock Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008.)

 

39. Form of Non-Employee Director Stock Grant Agreement pursuant to the CryoLife, Inc. 2008 Non-Employee Directors Omnibus Stock Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2008.)

 

40. Form of Incentive Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed February 25, 2008.)

 

41. CryoLife, Inc. 2009 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.)

 

42. First Amendment to the CryoLife, Inc. 2004 Employee Stock Incentive Plan, dated October 27, 2009. (Incorporated herein by reference to Exhibit 10.46 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2009.)

 

43. Form of 2012 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.7 to the Registrant’s Annual Report on 10-K for the fiscal year ended December 31, 2012.)

 

44. First Amendment, dated July 24, 2012, to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)

 

45. Form of Non-Qualified Stock Option Grant Agreement pursuant to the CryoLife, Inc. 2009 Employee Stock Incentive Plan entered into with each Named Executive Officer. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010.)

 

46. CryoLife, Inc. Executive Deferred Compensation Plan. (Incorporated herein by reference to Exhibit 10.52 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2010.)

 

47. Form of Non-Qualified Stock Option Grant Agreement pursuant to the CryoLife, Inc. 2002 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.)

 

48. Form of Restricted Stock Award Agreement pursuant to the CryoLife, Inc. 2009 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.)

 

49. First Amendment to Award Agreement between CryoLife and D. Ashley Lee dated May 24, 2011, relating to a Stock Option Grant to D. Ashley Lee dated February 21, 2006. (Incorporated herein by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)

 

79

50. Reserved.

 

51. Second Amendment to the CryoLife, Inc. 2004 Employee Stock Incentive Plan, dated May 24, 2011. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.)

 

52. Form of Non-Qualified Employee Stock Option Agreement pursuant to the CryoLife, Inc. 2004 Employee Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed February 25, 2008.)

 

53. Form of Indemnification Agreement entered into with each of the Registrant’s directors, except Harvey Morgan, and its Executive Vice President, Chief Operating Officer and Chief Financial Officer. (Incorporated herein by reference to Exhibit 99.1 to the Form S-3/A filed by Registrant on January 4, 2005.)

 

54. Form of Indemnification Agreement entered into with Harvey Morgan. (Incorporated herein by reference to Exhibit 99.2 to the Form S-3 filed by Registrant on November 21, 2008.)

 

55. Form of Performance Share Agreement with Named Executive Officers. (Incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed March 22, 2012.)

 

56. First Amendment, dated July 23, 2012, to the 2012 Grant Agreement to Executive Officers pursuant to the CryoLife, Inc. 2007 Executive Incentive Plan. (Incorporated herein by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)

 

57. Amended and Restated CryoLife, Inc. 2009 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 99.1 to the Registrant’s Form S-8 filed June 22, 2012.)

 

58. First Amendment, dated July 24, 2012, to the Amended and Restated CryoLife, Inc. 2009 Stock Incentive Plan. (Incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.)

 

* Filed herewith.

 

80

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CRYOLIFE, INC.
February 21, 2014   By  

/s/ STEVEN G. ANDERSON

Steven G. Anderson

President, Chief Executive Officer, and

Chairman of the Board of Directors

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

   

Title

  

Date

/s/ STEVEN G. ANDERSON

Steven G. Anderson

   

President, Chief Executive Officer, and

Chairman of the Board of Directors

(Principal Executive Officer)

   February 21, 2014

/s/ D. ASHLEY LEE

D. Ashley Lee

   

Executive Vice President,

Chief Operating Officer, and

Chief Financial Officer

(Principal Financial Officer)

   February 21, 2014

/s/ AMY D. HORTON

Amy D. Horton

   

Chief Accounting Officer

(Principal Accounting Officer)

   February 21, 2014

/s/ THOMAS F. ACKERMAN

Thomas F. Ackerman

    Director   February 21, 2014

/s/ JAMES S. BENSON

James S. Benson

    Director   February 21, 2014

/s/ DANIEL J. BEVEVINO

Daniel J. Bevevino

    Director   February 21, 2014

/s/ RONALD C. ELKINS, M.D.

Ronald C. Elkins, M.D.

    Director   February 21, 2014

/s/ RONALD D. MCCALL

Ronald D. McCall

    Director   February 21, 2014

/s/ HARVEY MORGAN

Harvey Morgan

    Director   February 21, 2014

/s/ JON W. SALVESON

Jon W. Salveson

    Director   February 21, 2014

 

81

Management’s Report on Internal Control over Financial Reporting under Sarbanes-Oxley Section 404.

The management of CryoLife, Inc. and subsidiaries (“CryoLife” or “we”) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. CryoLife’s internal control system was designed to provide reasonable assurance to CryoLife’s management and Board of Directors regarding the preparation and fair presentation of published financial statements.

All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

CryoLife management assessed the effectiveness of CryoLife’s internal control over financial reporting as of December 31, 2013. In making this assessment, we used the criteria set forth in the Internal Control-Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment, we believe that, as of December 31, 2013, the company’s internal control over financial reporting was effective based on those criteria.

CryoLife’s independent registered public accounting firm, Ernst & Young, LLP, has issued an audit report on the effectiveness of CryoLife’s internal control over financial reporting as of December 31, 2013.

CryoLife, Inc.

February 21, 2014

 

F-1

Report of Independent Registered Public Accounting Firm on the Financial Statements

The Board of Directors and Shareholders of CryoLife, Inc.

We have audited the accompanying consolidated balance sheet of CryoLife, Inc. and subsidiaries as of December 31, 2013, and the related consolidated statements of operations and comprehensive income, shareholders’ equity, and cash flows for the year ended
December 31, 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of CryoLife, Inc. and subsidiaries at December 31, 2013, and the consolidated results of their operations and their cash flows for the year ended December 31, 2013, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), CryoLife, Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) and our report dated February 21, 2014 expressed an unqualified opinion thereon.

Ernst & Young LLP

Atlanta, GA

February 21, 2014

 

F-2

Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting

The Board of Directors and Shareholders of CryoLife, Inc.

We have audited CryoLife, Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) (the COSO criteria). CryoLife, Inc. and subsidiaries’ management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting under Sarbanes-Oxley Section 404. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, CryoLife, Inc. and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of CryoLife, Inc. and subsidiaries as of December 31, 2013, and the related consolidated statements of operations and comprehensive income, shareholders’ equity, and cash flows for the year ended December 31, 2013 of CryoLife, Inc. and subsidiaries and our report dated February 21, 2014 expressed an unqualified opinion thereon.

Ernst & Young, LLP

Atlanta, Georgia

February 21, 2014

 

F-3

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of

CryoLife, Inc.

Kennesaw, Georgia

We have audited the accompanying consolidated balance sheet of CryoLife, Inc. and subsidiaries (the “Company”) as of December 31, 2012, and the related consolidated statements of operations and comprehensive income, shareholders’ equity, and cash flows for each of the two years in the period ended December 31, 2012. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of CryoLife, Inc. and subsidiaries at December 31, 2012, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2012, in conformity with accounting principles generally accepted in the United States of America.

DELOITTE & TOUCHE LLP

Atlanta, Georgia

February 15, 2013

 

F-4

CRYOLIFE, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands)

 

     December 31,  
     2013      2012  

ASSETS

      

Current assets:

      

Cash and cash equivalents

    $ 37,643       $ 13,009   

Restricted cash and securities

      5,350         323   

Receivables:

      

Trade accounts, net

      17,838         15,941   

Other

      469         579   
  

 

 

     

 

 

  

Total receivables

      18,307         16,520   

Deferred preservation costs

      27,297         27,954   

Inventories

      9,771         10,557   

Deferred income taxes

      5,162         6,100   

Prepaid expenses and other

      2,797         3,040   
  

 

 

     

 

 

  

Total current assets

      106,327         77,503   
  

 

 

     

 

 

  

Property and equipment:

      

Equipment and software

      26,976         24,007   

Furniture and fixtures

      4,390         4,339   

Leasehold improvements

      30,051         29,440   
  

 

 

     

 

 

  

Total property and equipment

      61,417         57,786   

Less accumulated depreciation and amortization

      49,246         46,119   
  

 

 

     

 

 

  

Net property and equipment

      12,171         11,667   

Other assets:

      

Investment in equity securities

      —           5,908   

Restricted cash

      —           5,000   

Goodwill

      11,365         11,365   

Patents, less accumulated amortization of $2,414 in 2013 and $2,530 in 2012

      1,934         2,114   

Trademarks and other intangibles, less accumulated amortization of $4,593 in 2013 and $2,886 in 2012

      19,985         21,968   

Notes receivable

      2,000         2,000   

Deferred income taxes

      16,885         16,564   

Other

      4,016         3,067   
  

 

 

     

 

 

  

Total assets

    $ 174,683       $ 157,156   
  

 

 

     

 

 

  

 

F-5

CRYOLIFE, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

 

     December 31,  
     2013     2012  

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current liabilities:

     

Accounts payable

    $ 4,137      $ 3,156   

Taxes payable

      1,377        619   

Accrued compensation

      4,886        5,055   

Accrued procurement fees

      5,427        4,762   

Accrued expenses

      2,411        4,205   

Deferred income

      316        1,401   

Other

      2,168        2,232   
  

 

 

    

 

 

  

Total current liabilities

      20,722        21,430   
  

 

 

    

 

 

  

Contingent consideration liability

      1,884        1,912   

Deferred compensation liability

      1,533        796   

Deferred rent obligations

      1,686        1,603   

Other

      4,111        3,303   
  

 

 

    

 

 

  

Total liabilities

      29,936        29,044   
  

 

 

    

 

 

  

Commitments and contingencies

     

Shareholders’ equity:

     

Preferred stock $0.01 par value per share, 5,000 shares authorized, no shares issued:

     

Series A Junior Participating Preferred Stock, 2,000 shares authorized, no shares issued

      —          —     

Convertible preferred stock, 460 shares authorized, no shares issued

      —          —     

Common stock $0.01 par value per share, 75,000 shares authorized, 28,244 shares issued in 2013 and 27,486 shares issued in 2012

      282        275   

Additional paid-in capital

      128,585        122,414   

Retained earnings

      18,741        5,536   

Accumulated other comprehensive income (loss)

      7        (39 ) 

Treasury stock at cost, 413 shares in 2013 and 14 shares in 2012

      (2,868 )      (74 ) 
  

 

 

    

 

 

  

Total shareholders’ equity

      144,747        128,112   
  

 

 

    

 

 

  

Total liabilities and shareholders’ equity

    $ 174,683      $ 157,156   
  

 

 

    

 

 

  

See accompanying Notes to Consolidated Financial Statements.

 

F-6

CRYOLIFE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(in thousands, except per share data)

 

     Year Ended December 31,  
     2013     2012     2011  

Revenues:

       

Products

    $ 76,194      $ 67,496      $ 59,387   

Preservation services

      64,498        63,603        59,793   

Other

      71        619        446   
  

 

 

    

 

 

    

 

 

  

Total revenues

      140,763        131,718        119,626   
  

 

 

    

 

 

    

 

 

  

Cost of products and preservation services:

       

Products

      15,147        11,380        9,442   

Preservation services

      35,230        35,320        34,340   
  

 

 

    

 

 

    

 

 

  

Total cost of products and preservation services:

      50,377        46,700        43,782   
  

 

 

    

 

 

    

 

 

  

Gross margin

      90,386        85,018        75,844   
  

 

 

    

 

 

    

 

 

  

Operating expenses:

       

General, administrative, and marketing

      68,112        65,149        57,302   

Research and development

      8,454        7,257        6,899   
  

 

 

    

 

 

    

 

 

  

Total operating expenses

      76,566        72,406        64,201   
  

 

 

    

 

 

    

 

 

  

Operating income

      13,820        12,612        11,643   
  

 

 

    

 

 

    

 

 

  

Interest expense

      71        179        142   

Interest income

      (4 )      (6 )      (14 ) 

Gain on sale of Medafor investment

      (12,742 )      —          —     

Other than temporary investment impairment

      3,229        340        —     

Other (income) expense, net

      (26 )      47        49   
  

 

 

    

 

 

    

 

 

  

Income before income taxes

      23,292        12,052        11,466   

Income tax expense

      7,120        4,106        4,095   
  

 

 

    

 

 

    

 

 

  

Net income

    $ 16,172      $ 7,946      $ 7,371   
  

 

 

    

 

 

    

 

 

  

Income per common share:

       

Basic

    $ 0.59      $ 0.29      $ 0.26   
  

 

 

    

 

 

    

 

 

  

Diluted

    $ 0.57      $ 0.28      $ 0.26   
  

 

 

    

 

 

    

 

 

  

Dividends declared per common share

    $ 0.108      $ 0.050      $ —     

Weighted-average common shares outstanding:

       

Basic

      26,885        26,967        27,441   

Diluted

      27,698        27,411        27,759   

Net income

    $ 16,172      $ 7,946      $ 7,371   

Other comprehensive income (loss)

      46        (33 )      26   
  

 

 

    

 

 

    

 

 

  

Comprehensive income

    $ 16,218      $ 7,913      $ 7,397   
  

 

 

    

 

 

    

 

 

  

See accompanying Notes to Consolidated Financial Statements.

 

F-7

CRYOLIFE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

     Year Ended December 31,  
     2013     2012     2011  

Net cash flows from operating activities:

       

Net income

    $ 16,172      $ 7,946      $ 7,371   

Adjustments to reconcile net income to net cash from operating activities:

       

Gain on sale of Medafor investment

      (12,742 )      —          —     

Depreciation and amortization

      5,843        5,633        4,960   

Non-cash compensation

      3,240        3,162        2,790   

Other than temporary investment impairment

      3,229        340        —     

Write-down of deferred preservation costs and inventories

      1,693        288        270   

Deferred income taxes

      617        1,227        1,767   

Other non-cash adjustments to income

      298        683        767   

Changes in operating assets and liabilities:

       

Receivables

      (1,637 )      1,363        (2,230 ) 

Deferred preservation costs and inventories

      193        (1,598 )      2,445   

Prepaid expenses and other assets

      (706 )      (583 )      (617 ) 

Accounts payable, accrued expenses, and other liabilities

      572        529        (772 ) 
  

 

 

    

 

 

    

 

 

  

Net cash flows provided by operating activities

      16,772        18,990        16,751   
  

 

 

    

 

 

    

 

 

  

Net cash flows from investing activities:

       

Proceeds from sale of Medafor investment

      15,421        —          —     

Acquisition of Hemosphere, net of cash acquired

      —          (17,040 )      —     

Acquisition of Cardiogenesis, net of cash acquired

      —          —          (21,062 ) 

Capital expenditures

      (4,338 )      (3,070 )      (2,538 ) 

Advances under notes receivable

      —          (2,000 )      —     

Purchases of restricted securities and investments

      —          —          (3,569 ) 

Other

      (206 )      (810 )      (547 ) 
  

 

 

    

 

 

    

 

 

  

Net cash flows provided by (used in) investing activities

      10,877        (22,920 )      (27,716 ) 
  

 

 

    

 

 

    

 

 

  

Net cash flows from financing activities:

       

Proceeds from exercise of stock options and issuance of common stock

      2,207        330        694   

Cash dividends paid

      (2,967 )      (1,373 )      —     

Repurchases of common stock

      (1,523 )      (3,529 )      (3,064 ) 

Other

      (768 )      (143 )      (476 ) 
  

 

 

    

 

 

    

 

 

  

Net cash flows used in financing activities

      (3,051 )      (4,715 )      (2,846 ) 
  

 

 

    

 

 

    

 

 

  

Increase (decrease) in cash and cash equivalents

      24,598        (8,645 )      (13,811 ) 
  

 

 

    

 

 

    

 

 

  

Effect of exchange rate changes on cash

      36        (51 )      19   

Cash and cash equivalents, beginning of year

      13,009        21,705        35,497   
  

 

 

    

 

 

    

 

 

  

Cash and cash equivalents, end of year

    $ 37,643      $ 13,009      $ 21,705   
  

 

 

    

 

 

    

 

 

  

See accompanying Notes to Consolidated Financial Statements.

 

F-8

CRYOLIFE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands)

 

     Common Stock     Additional
Paid In  Capital		     Retained
Earnings  (Deficit)		     Accumulated
Other
Comprehensive
Income (Loss)		     Treasury Stock     Total
Shareholders’
Equity		  
     Shares     Amount                       Shares     Amount        

Balance at December 31, 2010

      29,950      $ 300      $ 133,845      $ (8,408 )    $ (32 )      (2,049 )    $ (11,763 )    $ 113,942   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Net income

      —          —          —          7,371        —          —          —          7,371   

Other comprehensive income

      —          —          —          —          26        —          —          26   
                

 

 

  

Comprehensive income

                    7,397   
                

 

 

  

Equity compensation

      (25 )      —          965        —          —          360        2,049        3,014   

Exercise of options

      84        1        380        —          —          37        27        408   

Employee stock purchase plan

      64        —          286        —          —          —          —          286   

Excess tax shortfall

      —          —          (445 )      —          —          —          —          (445 ) 

Repurchase of common stock

      —          —          —          —          —          (593 )      (2,926 )      (2,926 ) 

Redemption and repurchase of stock to cover tax withholdings

      (6 )      —          (28 )      —          —          (20 )      (110 )      (138 ) 
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Balance at December 31, 2011

      30,067      $ 301      $ 135,003      $ (1,037 )    $ (6 )      (2,265 )    $ (12,723 )    $ 121,538   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Net income

      —          —          —          7,946        —          —          —          7,946   

Other comprehensive loss

      —          —          —          —          (33 )      —          —          (33 ) 
                

 

 

  

Comprehensive income

                    7,913   
                

 

 

  

Cash dividends paid ($0.050 per share)

      —          —          —          (1,373 )      —          —          —          (1,373 ) 

Equity compensation

      37        —          2,410        —          —          229        966        3,376   

Exercise of options

      8        —          37        —          —          —          —          37   

Employee stock purchase plan

      72        1        292        —          —          —          —          293   

Excess tax shortfall

      —          —          (143 )      —          —          —          —          (143 ) 

Repurchase of common stock

      —          —          —          —          —          (639 )      (3,310 )      (3,310 ) 

Redemption and repurchase of stock to cover tax withholdings

      (11 )      —          (66 )      —          —          (26 )      (153 )      (219 ) 

Shares retired

      (2,687 )      (27 )      (15,119 )      —          —          2,687        15,146        —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Balance at December 31, 2012

      27,486      $ 275      $ 122,414      $ 5,536      $ (39 )      (14 )    $ (74 )    $ 128,112   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Net income

      —          —          —          16,172        —          —          —          16,172   

Other comprehensive income

      —          —          —          —          46        —          —          46   
                

 

 

  

Comprehensive income

                    16,218   
                

 

 

  

Cash dividends paid ($0.108 per share)

      —          —          —          (2,967 )      —          —          —          (2,967 ) 

Equity compensation

      352        3        3,465        —          —          —          —          3,468   

Exercise of options

      365        4        2,728        —          —          (102 )      (1,000 )      1,732   

Employee stock purchase plan

      97        1        474        —          —          —          —          475   

Excess tax shortfall

      —          —          (87 )      —          —          —          —          (87 ) 

Repurchase of common stock

      —          —          —          —          —          (253 )      (1,523 )      (1,523 ) 

Redemption and repurchase of stock to cover tax withholdings

      (56 )      (1 )      (409 )      —          —          (44 )      (271 )      (681 ) 
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Balance at December 31, 2013

      28,244      $ 282      $ 128,585      $ 18,741      $ 7        (413 )    $ (2,868 )    $ 144,747   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

See accompanying Notes to Consolidated Financial Statements.

 

F-9

CRYOLIFE, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Summary of Significant Accounting Policies

Nature of Business

CryoLife, Inc. (“CryoLife,” the “Company,” “we,” or “us”) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation. CryoLife’s surgical sealants and hemostats include BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (“SMI”). CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”), specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina. CryoLife and its subsidiary, Hemosphere, Inc. (“Hemosphere”), market the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”), which is a solution for end-stage renal disease (“ESRD”) in certain hemodialysis patients. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve® SG pulmonary heart valve (“CryoValve SGPV”) and the CryoPatch® SG pulmonary cardiac patch tissue (“CryoPatch SG”), both of which are processed using CryoLife’s proprietary SynerGraft® technology.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.

Translation of Foreign Currencies

The Company’s revenues and expenses transacted in foreign currencies are translated as they occur at exchange rates in effect at the time of each transaction. Realized gains and losses on foreign currency transactions are recorded as a component of other (income) expense, net on the Company’s Consolidated Statements of Operations and Comprehensive Income. Assets and liabilities of the Company denominated in foreign currencies are translated at the exchange rate in effect as of the balance sheet date and are recorded as a separate component of accumulated other comprehensive income (loss) in the shareholders’ equity section of the Company’s Consolidated Balance Sheets.

Use of Estimates

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Estimates and assumptions are used when accounting for investments, allowance for doubtful accounts, deferred preservation costs, acquired assets or businesses, long-lived tangible and intangible assets, deferred income taxes, commitments and contingencies (including product and tissue processing liability claims, claims incurred but not reported, and amounts recoverable from insurance companies), stock based compensation, certain accrued liabilities (including accrued procurement fees, income taxes, and financial instruments), contingent consideration liability, and other items as appropriate.

Revenue Recognition

Revenues for products, including: BioGlue, BioFoam, PerClot, HemoStase, revascularization technologies handpieces and accessories, HeRO Grafts, and other medical devices, are recognized at the time the product is shipped, at which time title passes to the customer, and there are no further performance obligations. The Company recognizes revenues for preservation services when services are completed and tissue is shipped to the customer. Revenues from research grants are recognized in the period the associated costs are incurred. Revenues from upfront licensing agreements are recognized ratably over the period the Company expects to fulfill its obligations.

Revenues from the sale of laser consoles are considered multiple element arrangements, and such revenues are allocated to the elements of the sale. The Company allocates revenues based primarily on the revenue these individual elements would generate if sold separately. Revenues from domestic laser consoles sales are typically recognized when the laser is installed at a customer site and all materials for the laser console’s use are delivered. Revenues from the sales of laser consoles to

 

F-10

international distributors are evaluated individually based on the terms of the sale and collectability to determine when revenue has been earned and can be recognized.

Shipping and Handling Charges

Fees charged to customers for shipping and handling of products and tissues are included in product revenues and preservation services revenues, respectively. The costs for shipping and handling of products and tissues are included as a component of cost of products and cost of preservation services, respectively.

Advertising Costs

The costs to develop, produce, and communicate the Company’s advertising are expensed as incurred and are classified as general, administrative, and marketing expenses. The Company records the cost to print or copy certain sales materials as a prepaid expense and amortizes these costs as an advertising expense over the period they are expected to be used, typically six months to one year. The total amount of advertising expense included in the Company’s Consolidated Statements of Operations and Comprehensive Income was $880,000, $1.5 million, and $948,000 for the years ended December 31, 2013, 2012, and 2011, respectively.

Stock-Based Compensation

The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (“RSA“s), restricted stock units (“RSU“s), performance stock units (“PSU“s), and options to purchase shares of CryoLife common stock at exercise prices generally equal to the fair values of such stock at the dates of grant. The Company also maintains a shareholder approved Employee Stock Purchase Plan (the “ESPP”) for the benefit of its employees. The ESPP allows eligible employees the right to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period. The stock options, RSAs, RSUs, and PSUs granted by the Company typically vest over a one to three-year period. The stock options granted by the Company typically expire within seven years of the grant date.

The Company values its RSAs, RSUs, and PSUs based on the stock price on the date of grant. The Company expenses the related compensation cost of RSAs and RSUs using the straight-line method over the vesting period. The Company expenses the related compensation cost of PSUs based on the number of shares expected to be issued if achievement of the performance component is probable using a straight-line method over each vesting tranche of the award. The amount of compensation costs expensed related to PSUs is adjusted as needed if the Company deems that achievement of the performance component is no longer probable, or if the Company’s expectation of the number of shares to be issued changes. The Company uses a Black-Scholes model to value its stock option grants and expenses the related compensation cost using the straight-line method over the vesting period. The fair value of the Company’s ESPP options is also determined using a Black-Scholes model and is expensed over the vesting period. The period expense is then determined based on this valuation and, at that time, an estimated forfeiture rate is used to reduce the expense recorded. The Company’s estimate of pre-vesting forfeitures is primarily based on the recent historical experience of the Company and is adjusted to reflect actual forfeitures at each vesting date.

The fair value of stock options and ESPP options is determined on the grant date using assumptions for the expected term, volatility, dividend yield, and the risk-free interest rate. The expected term is primarily based on the contractual term of the option and Company data related to historic exercise and post-vesting forfeiture patterns, which is adjusted based on management’s expectations of future results. The Company’s anticipated volatility level is primarily based on the historic volatility of the Company’s common stock, adjusted to remove the effects of certain periods of unusual volatility not expected to recur, and adjusted based on management’s expectations of future volatility, for the life of the option or option group. The Company’s model included a zero dividend yield assumption in the periods prior to the Company’s initiation of a quarterly dividend in the third quarter of 2012. The risk-free interest rate is based on recent U.S. Treasury note auction results with a similar life to that of the option. The Company’s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions.

Income Per Common Share

Income per common share is computed using the two class method, which requires the Company to include unvested RSAs that contain non-forfeitable rights to dividends (whether paid or unpaid) as participating securities in the income per common share calculation.

 

F-11

Under the two class method, net income is allocated to the weighted-average number of common shares outstanding during the period and the weighted-average participating securities outstanding during the period. The portion of net income that is allocated to the participating securities is excluded from basic and dilutive net income per common share. Diluted net income per share is computed using the weighted-average number of common shares outstanding plus the dilutive effects of outstanding stock options and awards and other dilutive instruments as appropriate.

Dividends

During 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding. In 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 to $0.0275 per share of common stock outstanding. The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year from cash on hand and will record the dividend payment as a reduction to retained earnings on the Company’s Consolidated Balance Sheets.

Financial Instruments

The Company’s financial instruments include cash equivalents, marketable securities, restricted securities, accounts receivable, notes receivable, accounts payable, and contingent consideration. The Company typically values financial assets and liabilities such as receivables, accounts payable, and debt obligations at their carrying values, which approximate fair value due to their generally short-term duration. Other financial instruments are typically recorded as discussed in the sections below.

Fair Value Measurements

The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments. The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2013 the Company has not chosen to make any such elections. Fair value financial instruments are recorded in accordance with the fair value measurement framework.

The Company also measures certain non-financial assets at fair value on a non-recurring basis. These non-recurring valuations include evaluating assets such as cost method investments, long-lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations. The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.

The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels. These levels from highest to lowest priority are as follows:

 

  •  

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;

 

  •  

Level 2: Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and

 

  •  

Level 3: Unobservable inputs or valuation techniques that are used when little or no market data is available.

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist in determining fair value, as appropriate.

Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.

 

F-12

Cash and Cash Equivalents

Cash equivalents consist primarily of highly liquid investments with maturity dates of three months or less at the time of acquisition. The carrying value of cash equivalents approximates fair value.

In 2012 the Company’s cash equivalents included advance funding received from the U.S. Department of Defense (“DOD”) for the development of protein hydrogel technology. The advance funding was accounted for as deferred income on the Company’s December 31, 2012 Consolidated Balance Sheet and revenue was recognized as expenses were incurred related to these grants. The Company discontinued its BioFoam U.S. clinical trial and returned all of the remaining unspent funds to the DOD in the second quarter of 2013.

Cash Flow Supplemental Disclosures

Supplemental disclosures of cash flow information for the years ended December 31 (in thousands):

 

     2013      2012      2011  

Cash paid during the year for:

         

Interest

    $ 3       $ 22       $ 89   

Income taxes

      5,693         1,263         3,564   

Marketable Securities and Other Investments

The Company typically invests its excess cash for short-term periods in large, well-capitalized financial institutions, and the Company’s policy excludes investment in any securities rated less than “investment-grade” by national rating services, unless specifically approved by the Board of Directors. The Company sometimes makes longer term strategic investments in medical device companies, and these investments must be approved by the Board of Directors.

The Company determines the classification of its investments as trading, available-for-sale, or held-to-maturity at the time of purchase and reevaluates such designations quarterly. Trading securities are securities that are acquired principally for the purpose of generating a profit from short-term fluctuations in price. Debt securities are classified as held-to-maturity when the Company has the intent and ability to hold the securities to maturity. Any securities not designated as trading or held-to-maturity are considered available-for-sale. The Company typically states its investments at their fair values; however, for held-to-maturity securities or when current fair value information is not readily available, investments are recorded using the cost method. The cost of securities sold is based on the specific identification method.

Under the fair value method, the Company adjusts each investment to its market price and records the unrealized gains or losses in other (income) expense, net for trading securities, or accumulated other comprehensive income (loss), for available-for-sale securities. Interest, dividends, realized gains and losses, and declines in value judged to be other than temporary are included in other (income) expense, net. Under the cost method, each investment is recorded at cost. Subsequent dividends received are recognized as income, and the investment is reviewed for impairment if factors indicate that a decrease in the value of the investment has occurred.

Accounts Receivable and Allowance for Doubtful Accounts

The Company’s accounts receivable are primarily from hospitals and distributors that either use or distribute the Company’s products and tissues. The Company assesses the likelihood of collection based on a number of factors, including past transaction history with the customer and the credit worthiness of the customer, as well as the increased risks related to international customers and large distributors. The accounts receivable balances were reported net of allowance for doubtful accounts of $356,000 and $528,000 as of December 31, 2013 and 2012 respectively.

Deferred Preservation Costs

By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory. The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred. Deferred preservation costs are stated at the lower of cost or market value on a first-in, first-out basis and are deferred until revenue is recognized. At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status.

 

F-13

Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services. Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments for tissues not deemed to be recoverable, and includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

The calculation of deferred preservation costs involves judgment and complexity and uses the same principles as inventory costing. Donated human tissue is procured from deceased human donors by organ and tissue procurement organizations (“OTPOs”), which consign the tissue to the Company for processing, preservation, and distribution. Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight-in charges), and indirect costs (including allocations of costs from support departments and facility allocations). Fixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility’s normal capacity.

These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed. The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable. Management estimates quarantine yields based on its experience and reevaluates these estimates periodically. Actual yields could differ significantly from the Company’s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs. These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods.

The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value. The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging. Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation. Impairment write-downs are recorded based on the book value of tissues deemed to be impaired. Actual results may differ from these estimates. Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

The Company recorded write-downs to its deferred preservation costs totaling $448,000, $195,000, and $270,000 for the years ended December 31, 2013, 2012, and 2011, respectively.

Inventories

Inventories are valued at the lower of cost or market on a first-in, first-out basis and the costs are recognized as cost of products upon shipment of the product. Inventories are comprised of BioGlue; BioFoam; PerClot; revascularization technologies lasers, handpieces, and accessories; HeRO Grafts; other medical devices; supplies; and raw materials. Cost of products also includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

Inventory costs for manufactured products consist primarily of direct labor and materials (including salary and fringe benefits, raw materials, and supplies) and indirect costs (including allocations of costs from departments that support manufacturing activities and facility allocations). The allocation of fixed production overhead costs is based on actual production levels, to the extent that they are within the range of the facility’s normal capacity. Inventory costs for products purchased for resale or contract manufactured consist primarily of the purchase cost, freight-in charges, and indirect costs as appropriate.

The Company regularly evaluates its inventory to determine if the costs are appropriately recorded at the lower of cost or market value. The Company also evaluates its inventory for costs not deemed to be recoverable, including inventory not expected to ship prior to its expiration. Lower of cost or market value write-downs are recorded if the book value exceeds the estimated market value of the inventory, based on recent sales prices at the time of the evaluation. Impairment write-downs are recorded based on the book value of inventory deemed to be impaired. Actual results may differ from these estimates. Write-downs of inventory are expensed as cost of products, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

The Company recorded write-downs to its inventory totaling $1.2 million, $77,000, and zero for the years ended December 31, 2013, 2012, and 2011, respectively. The 2013 write-down includes $684,000 in additional contractual costs and inventory impairment costs, primarily related to a BioGlue accessory product, and $483,000 in additional costs for

 

F-14

revascularization technologies handpieces that were made obsolete by the Company’s decision to exclusively distribute the new handpiece design, which was approved by the U.S. Food and Drug Administration (“FDA”) in June 2013.

Property and Equipment

Property and equipment is stated at cost. Depreciation is provided over the estimated useful lives of the assets, generally three to ten years, on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the remaining lease term at the time the assets are capitalized or the estimated useful lives of the assets, whichever is shorter.

Depreciation expense for the years ended December 31 is as follows (in thousands):

 

     2013      2012      2011  

Depreciation expense

    $ 3,837       $ 3,662       $ 3,590   

Goodwill and Other Intangible Assets

The Company’s intangible assets consist of goodwill, patents, trademarks, and other intangible assets, as discussed in Note 9. These assets include intangible assets from the acquisition of Hemosphere, as discussed in Note 4, and assets acquired from Cardiogenesis, as discussed in Note 6.

The Company amortizes its definite lived intangible assets over their expected useful lives using the straight-line method, which the Company believes approximates the period of economic benefits of the related assets. The Company’s indefinite lived intangible assets do not amortize, but are instead subject to periodic impairment testing as discussed in “Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets” below.

Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets

The Company assesses the potential impairment of its long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include, but are not limited to, the following:

 

  •  

Significant underperformance relative to expected historical or projected future operating results,

 

  •  

Significant negative industry or economic trends,

 

  •  

Significant decline in the Company’s stock price for a sustained period, or

 

  •  

Significant decline in the Company’s market capitalization relative to net book value.

If CryoLife determines that an impairment review is necessary, the Company will evaluate its assets or asset groups by comparing their carrying values to the sum of the undiscounted future cash flows expected to result from their use and eventual disposition. If the carrying values exceed the future cash flows, then the asset or asset group is considered impaired, and the Company will write down the value of the asset or asset group. For the years ended December 31, 2013, 2012, and 2011 the Company did not experience any factors that indicated that an impairment review of its long-lived assets was warranted.

CryoLife evaluates its goodwill and other non-amortizing intangible assets for impairment on an annual basis as of October 31 and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of October 31, 2013 the Company’s non-amortizing intangible assets consisted of goodwill, acquired procurement contracts and agreements, trademarks, and other acquired technology. The Company performed an analysis of its non-amortizing intangible assets as of October 31, 2013 and 2012, and determined that the fair value of the assets and the fair value of the reporting unit exceeded their associated carrying values and were, therefore, not impaired. Management will continue to evaluate the recoverability of these non-amortizing intangible assets.

Accrued Procurement Fees

Donated tissue is procured from deceased human donors by OTPOs, which consign the tissue to the Company for processing, preservation, and distribution. The Company reimburses the OTPOs for their costs to recover the tissue and passes these costs on to the customer when the tissue is shipped and the performance of the service is complete. The Company accrues estimated procurement fees due to the OTPOs at the time tissues are received based on contractual agreements between the Company and the OTPOs.

 

F-15

Leases

The Company has operating lease obligations resulting from the lease of land and buildings that comprise the Company’s corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment as discussed in Note 12. Certain of the Company’s leases contain escalation clauses, rent concessions, and renewal options for additional periods. Rent expense is computed on the straight-line method over the lease term and the related liability is recorded as deferred rent obligations on the Company’s Consolidated Balance Sheets.

Liability Claims

In the normal course of business, the Company is made aware of adverse events involving its products and tissues. Any adverse event could ultimately give rise to a lawsuit against the Company. In addition, product and tissue processing liability claims may be asserted against the Company in the future based on events it is not aware of at the present time. The Company maintains claims-made insurance policies to mitigate its financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. Thus, a claims-made policy does not generally represent a transfer of risk for claims and incidents that have been incurred but not reported to the insurance carrier during the policy period. Any punitive damage components of claims are uninsured.

The Company engages external advisors to assist it in estimating its liability and any related recoverable under the Company’s insurance policies as of each balance sheet date. The Company uses a frequency-severity approach to estimate its unreported product and tissue processing liability claims, whereby, projected losses are calculated by multiplying the estimated number of claims by the estimated average cost per claim. The estimated claims are determined based on the reported claim development method and the Bornhuetter-Ferguson method using a blend of the Company’s historical claim experience and industry data. The estimated cost per claim is calculated using a lognormal claims model blending the Company’s historical average cost per claim with industry claims data. The Company uses a number of assumptions in order to estimate the unreported loss liability including: the future claim reporting time lag, the frequency of reported claims, the average cost per claim, and the maximum liability per claim. The Company believes that the assumptions it uses provide a reasonable basis for its calculation. However, the accuracy of the estimates is limited by the general uncertainty that exists for any estimate of future activity due to uncertainties surrounding the assumptions used and due to Company specific conditions and the scarcity of industry data directly relevant to the Company’s business activities. Due to these factors, actual results may differ significantly from the assumptions used and amounts accrued.

The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long-term liabilities and records the related recoverable insurance amounts as a component of receivables and other long-term assets. The amounts recorded represent management’s estimate of the probable losses and anticipated recoveries for unreported claims related to products sold and services performed prior to the balance sheet date.

Legal Contingencies

The Company accrues losses from a legal contingency when the loss is both probable and reasonably estimable. The accuracy of the Company’s estimates of losses for legal contingencies is limited by uncertainties surrounding litigation. Therefore, actual results may differ significantly from the amounts accrued, if any. The Company accrues for legal contingencies as a component of accrued expenses and other long-term liabilities. Gains from legal contingencies are recorded when the contingency is resolved.

Legal Fees

The Company expenses the costs of legal services, including legal services related to product and tissue processing liability claims and legal contingencies, as they are incurred. Reimbursement of legal fees by an insurance company or other third-party is recorded as a reduction to legal expense.

Uncertain Tax Positions

The Company periodically assesses its uncertain tax positions and recognizes tax benefits if they are “more-likely-than-not” to be upheld upon review by the appropriate taxing authority. The Company measures the tax benefit by determining the maximum amount that has a “greater than 50 percent likelihood” of ultimately being realized. The Company reverses previously accrued liabilities for uncertain tax positions when audits are concluded, statutes expire, administrative practices

 

F-16

dictate that a liability is no longer warranted, or in other circumstances as deemed necessary. These assessments can be complex and the Company often obtains assistance from external advisors to make these assessments. The Company recognizes interest and penalties related to uncertain tax positions in other (income) expense, net on its Consolidated Statements of Operations and Comprehensive Income. See Note 10 for further discussion of the Company’s liabilities for uncertain tax positions.

Deferred Income Taxes

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes. The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets. Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.

Assessing the recoverability of deferred tax assets involves judgment and complexity. Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following:

 

  •  

Projected future operating results,

 

  •  

Anticipated future state tax apportionment,

 

  •  

Timing and amounts of anticipated future taxable income,

 

  •  

Timing of the anticipated reversal of book/tax temporary differences,

 

  •  

Evaluation of statutory limits regarding usage of certain tax assets, and

 

  •  

Evaluation of the statutory periods over which certain tax assets can be utilized.

Significant changes in the factors above, or other factors, could materially, adversely affect the Company’s ability to use its deferred tax assets. Such changes could have a material, adverse impact on the Company’s operations, financial condition, and cash flows. The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets.

The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended. The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company’s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control. The Company also believes that its acquisition of Cardiogenesis constituted a change in control. The deferred tax assets recorded on the Company’s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control. A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized. Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.

Valuation of Acquired Assets or Businesses

As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies. The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group, or as a business combination, as appropriate. The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.

For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values. In-process research and development acquired as part of an asset group is expensed upon acquisition. The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value. Transaction costs related to a business combination are expensed as incurred. In-process research and development acquired as part of a business combination is

 

F-17

accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.

The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief from royalty methods. The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates. Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge. Management believes that its estimates are reasonable, but actual results could differ significantly from the Company’s estimates. A significant change in management’s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company’s financial position and profitability. If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company’s financial position and profitability.

Derivative Instruments

The Company determines the fair value of its stand-alone and embedded derivative instruments at issuance and records any resulting asset or liability on the Company’s Consolidated Balance Sheets. Changes in the fair value of the derivative instruments are recognized in the line item change in valuation of derivative on the Company’s Consolidated Statements of Operations and Comprehensive Income.

New Accounting Pronouncements

In January 2013 the Company adopted Accounting Standards Update (“ASU”), 2012-02, Intangibles-Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test. The adoption of ASU 2012-02 did not have a material effect on the Company’s financial condition, profitability, or cash flows.

In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements. This update also requires companies to disclose the income statement line items affected by any significant reclassifications. The adoption of ASU 2013-02 did not have a material effect on the Company’s financial disclosures.

2. Financial Instruments

A summary of financial instruments measured at fair value is as follows (in thousands):

 

December 31, 2013

    Level 1      Level 2      Level 3     Total  

Cash equivalents:

           

Money market funds

    $ 5,349       $ —         $ —        $ 5,349   

Certificates of deposit

      749         —           —          749   

Restricted securities:

           

Money market funds

      350         —           —          350   
  

 

 

     

 

 

     

 

 

    

 

 

  

Total assets

    $ 6,448       $ —         $ —        $ 6,448   
  

 

 

     

 

 

     

 

 

    

 

 

  

Long-term liabilities:

           

Contingent consideration

    $ —         $ —         $ (1,884 )    $ (1,884 ) 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total liabilities

    $ —         $ —         $ (1,884 )    $ (1,884 ) 
  

 

 

     

 

 

     

 

 

    

 

 

  

 

F-18

December 31, 2012

    Level 1      Level 2      Level 3     Total  

Cash equivalents:

           

Money market funds

    $ 1,319       $ —         $ —        $ 1,319   

Restricted securities:

           

Money market funds

      323         —           —          323   
  

 

 

     

 

 

     

 

 

    

 

 

  

Total assets

    $ 1,642       $ —         $ —        $ 1,642   
  

 

 

     

 

 

     

 

 

    

 

 

  

Long-term liabilities:

           

Contingent consideration

    $ —         $ —         $ (1,912 )    $ (1,912 ) 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total liabilities

    $ —         $ —         $ (1,912 )    $ (1,912 ) 
  

 

 

     

 

 

     

 

 

    

 

 

  

The Company used prices quoted from its investment management companies to determine the Level 1 valuation of its investments in money market funds, certificates of deposit, and securities. The Company changed the presentation of its December 31, 2012 money market funds to Level 1 from Level 2, consistent with its current year presentation. The Company recorded contingent consideration liability, classified as Level 3, as a result of its acquisition of Hemosphere in May 2012. Refer to Note 4 for further discussion of the Level 3 contingent consideration liability. Changes in fair value of Level 3 liabilities are listed below (in thousands):

 

     Contingent
Consideration		  

Balance as of December 31, 2012

    $ 1,912   

Gain on remeasurement of contingent consideration

      (28 ) 
  

 

 

  

Balance as of December 31, 2013

    $ 1,884   
  

 

 

  

3. Cash Equivalents and Restricted Cash and Securities

The following is a summary of cash equivalents and marketable securities (in thousands):

 

            Unrealized      Estimated  
            Holding      Market  

December 31, 2013

    Cost Basis      Gains (Losses)      Value  

Cash equivalents:

         

Money market funds

    $ 5,349       $ —         $ 5,349   

Certificates of deposit

      749         —           749   

Restricted cash and securities:

         

Cash

      5,000         —           5,000   

Money market funds

      350         —           350   

December 31, 2012

                     

Cash equivalents:

         

Money market funds

    $ 1,319       $ —         $ 1,319   

Restricted securities:

         

Cash

      5,000         —           5,000   

Money market funds

      323         —           323   

As of December 31, 2013 and 2012 $350,000 and $323,000, respectively, of the Company’s money market funds were designated as short-term restricted securities due to a contractual commitment to hold the securities as pledged collateral relating primarily to international tax obligations. As of December 31, 2013 $5.0 million of the Company’s cash was designated as restricted cash due to a financial covenant requirement under the Company’s credit agreement with General Electric Capital Corporation (“GE Capital”) as discussed in Note 11. As of December 31, 2012 $5.0 million of the Company’s cash was designated as long-term restricted securities under the same covenant. This restriction lapses upon expiration of the credit agreement with GE Capital on October 28, 2014.

There were no gross realized gains or losses on cash equivalents or restricted securities for the years ended December 31, 2013, 2012, and 2011. At December 31, 2013 and 2012 $5.0 million of the Company’s restricted cash had no maturity date.

 

F-19

At December 31, 2013 $328,000 of the Company’s restricted securities had a maturity date within three months and $22,000 of the Company’s restricted securities had a maturity date between three months and one year. At December 31, 2012 $323,000 of the Company’s restricted securities had a maturity date within three months.

4. Hemosphere Acquisition

Overview

On May 16, 2012 CryoLife completed its acquisition of 100% of the outstanding equity of Hemosphere, a privately held company, for $17.0 million in cash, an additional $3.2 million paid for cash acquired, and contingent consideration with a fair value estimated to be approximately $1.8 million at acquisition, for a total purchase price of approximately $22.0 million. CryoLife used cash on hand to fund the transaction and operates Hemosphere as a wholly owned subsidiary.

Hemosphere is the developer and marketer of the HeRO Graft, a proprietary graft-based solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction. CryoLife believes that the HeRO Graft will fit well into its product portfolio of medical devices for cardiac and vascular surgery and believes there is a significant opportunity for CryoLife’s sales team to leverage their strong relationships with vascular surgeons to introduce and to expand utilization of the HeRO Graft in the U.S.

Contingent Consideration

As of the acquisition date, CryoLife recorded a contingent consideration liability of $1.8 million in long-term liabilities on its Consolidated Balance Sheet, representing the estimated fair value of the contingent consideration expected to be paid to the former shareholders of Hemosphere upon the achievement of certain revenue-based milestones. The acquisition agreement provides for a maximum of $4.5 million in future consideration payments through December 2015 based on specified sales targets.

The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. The Company applied a risk-based estimate of the probability of achieving each scenario and then applied a cost of debt based discount rate of 8%. This fair value measurement is based on unobservable inputs, including management estimates and assumptions about future revenues, and is, therefore, classified as Level 3 within the fair value hierarchy presented in Note 2. The Company will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in other (income) expense on the Company’s Consolidated Statements of Operations and Comprehensive Income. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount periods and rates, as well as changes in the timing and amount of Company revenue estimates.

The Company recorded a gain of $28,000 for the year ended December 31, 2013 and a loss of $72,000 for the year ended December 31, 2012 on the remeasurement of the contingent consideration liability. The balance of the contingent consideration liability was $1.9 million as of December 31, 2013 and 2012.

Accounting for the Transaction

The Company has recorded an allocation of the $22.0 million purchase price to Hemosphere’s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values as of May 16, 2012. Goodwill has been recorded based on the amount by which the purchase price exceeds the fair value of the net assets acquired and is not deductible for tax purposes. Goodwill from this transaction has been allocated to the Company’s medical devices segment.

 

F-20

The purchase price allocation as of December 31, 2012 is as follows (in thousands):

 

     Opening  
     Balance Sheet  

Cash and cash equivalents

    $ 3,155   

Receivables

      653   

Inventories

      554   

Intangible assets

      5,790   

Goodwill

      7,145   

Deferred tax assets, net

      5,379   

Other assets

      331   

Liabilities assumed

      (972 ) 
  

 

 

  

Total purchase price

    $ 22,035   
  

 

 

  

CryoLife incurred integration costs of $940,000 for the year ended December 31, 2013 and transaction and integration costs related to the acquisition of approximately $2.4 million for the year ended December 31, 2012. These costs were expensed as incurred and were primarily recorded as general, administrative, and marketing expenses on the Company’s Consolidated Statements of Operations and Comprehensive Income.

Pro Forma Results

Hemosphere’s revenues of $3.1 million from the date of acquisition through December 31, 2012 are included in the Consolidated Statements of Operations and Comprehensive Income. The Company’s unaudited pro forma results of operations for the year ended December 31, 2012 and 2011 assuming the Hemosphere acquisition had occurred as of January 1, 2011 are presented for comparative purposes below. These amounts are based on available information of the results of operations of Hemosphere prior to the acquisition date and are not necessarily indicative of what the results of operations would have been had the acquisition been completed on January 1, 2011. This unaudited pro forma information does not project operating results post acquisition. This pro forma information is as follows (in thousands, except per share amounts):

 

     Twelve Months Ended  
     December 31,  
     2012      2011  

Total revenues

    $ 133,722       $ 124,877   

Net income

      8,758         3,205   

Pro forma income per common share—basic

    $ 0.32       $ 0.11   

Pro forma income per common share—diluted

    $ 0.31       $ 0.11   

Pro forma results for the year ended December 31, 2011 include the Company’s acquisition and integration related costs of approximately $2.4 million, on a pre-tax basis, and other costs as appropriate. Pro forma disclosures were calculated using a tax rate of approximately 34%.

5. ValveXchange

Preferred Stock Investment

In July 2011 the Company purchased 2.4 million shares of Series A Preferred Stock of ValveXchange, Inc. (“ValveXchange”) for approximately $3.5 million. ValveXchange is a private medical device company that was spun off from Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets. The Company’s carrying value of this investment included the purchase price and certain transaction costs, and CryoLife’s investment represented an approximate 19% equity ownership in ValveXchange. As ValveXchange’s stock is not actively traded on any public stock exchange, as the Company does not exert significant influence over ValveXchange, and as the Company’s investment is in preferred stock, the Company accounted for this investment using the cost method. The Company recorded its investment as a long-term asset, investment in equity securities, on the Company’s Consolidated Balance Sheets.

 

F-21

Loan Agreement

In July 2011 the Company entered into an agreement with ValveXchange, as amended, to make available up to $2.0 million to ValveXchange in debt financing through a revolving credit facility (the “Loan”). The Loan includes various affirmative and negative covenants, including financial covenant requirements, and expires on July 30, 2018, unless terminated earlier. Amounts loaned under the Loan will earn interest at an 8% annual rate and are secured by substantially all of the tangible and intangible assets of ValveXchange. The Company incurred loan origination costs, net of fees charged to ValveXchange, of approximately $117,000, which are being expensed on a straight-line basis over the life of the loan facility. The Company advanced $2.0 million to ValveXchange under the Loan in 2012. The $2.0 million advance is recorded as long-term notes receivable on the Company’s Consolidated Balance Sheets as of December 31, 2013 and 2012.

During 2013 CryoLife repeatedly notified ValveXchange that ValveXchange was in default of certain loan covenants, due to factors including ValveXchange’s failure to obtain CryoLife’s consent for certain convertible note financings that ValveXchange obtained during the year. These events of default were ongoing as of February 15, 2014.

Investment and Loan Analysis

During the quarter ended September 30, 2012 the Company reviewed available information to determine if factors indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment. The Company determined that available information indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment. The Company used available information to analyze its investment for impairment, and the information indicated that the fair value of the investment was less than the carrying value. Therefore, based on this analysis, the Company believed that its investment in ValveXchange was impaired in the third quarter of 2012, and the impairment was other than temporary. As a result, the Company recorded an other non-operating expense of $340,000 to write down its investment in ValveXchange preferred stock. During the quarters ended December 31, 2012, June 30, 2013, and September 30, 2013 the Company reevaluated its investment in ValveXchange preferred stock for impairment. At the time of each of these analyses, the Company did not believe that its investment in ValveXchange was impaired further.

During the quarter ended December 31, 2013 the Company determined that available information, including ValveXchange’s financial condition and cash position, indicated that the Company should reevaluate its investment in ValveXchange preferred stock for impairment. The Company used available information, including new information obtained in the fourth quarter of 2013, to analyze its investment for impairment, and this information indicated that the fair value of the investment had declined significantly and any remaining value was nominal. Therefore, based on this analysis, the Company believes that its investment in ValveXchange was fully impaired as of December 31, 2013, and the impairment was other than temporary. As a result, the Company recorded an other non-operating expense of $3.2 million to write-down its investment in ValveXchange preferred stock. The carrying value of the Company’s investment in ValveXchange preferred stock after this write down was zero as of December 31, 2013. The carrying value of the Company’s investment in ValveXchange preferred stock was $3.2 million as of December 31, 2012.

ValveXchange is currently attempting to raise additional funds to support its short-term and long-term operations. If ValveXchange is unable to secure material amounts of additional financing, it will likely be unable to meet its obligations, and, therefore, CryoLife may need to foreclose on the related collateral to secure repayment of the Loan. Although CryoLife currently believes that the value of the collateral is adequate to repay the Loan, there is no guarantee that the security for the notes will be sufficient to repay the Loan.

Option Agreement

Concurrently with the Loan described above, CryoLife entered into an option agreement with ValveXchange through which CryoLife obtained the right of first refusal to acquire ValveXchange during a period that extends through the completion of initial commercialization milestones and the right to negotiate with ValveXchange for European distribution rights. The Company’s rights may be modified or reduced in connection with a future round of financing.

 

F-22

6. Cardiogenesis Acquisition

Overview

On May 17, 2011 CryoLife completed its acquisition of all of the outstanding shares of Cardiogenesis for $0.457 per share or approximately $21.7 million. CryoLife used cash on hand to fund the transaction and operates Cardiogenesis as a wholly owned subsidiary.

Cardiogenesis is a leading developer of surgical products used in the treatment of patients with severe angina resulting from diffuse coronary artery disease. Cardiogenesis markets its revascularization technologies, which include the Holmium: YAG laser console and single use, fiber-optic handpieces. These products are FDA approved for performing a surgical procedure known as Transmyocardial Revascularization, used for treating patients with stable angina that is not responsive to conventional therapy.

Accounting for the Transaction

The Company recorded an allocation of the $21.7 million purchase price to Cardiogenesis’ tangible and identifiable intangible assets acquired and liabilities assumed based on their acquisition date fair values. The allocation of the purchase price to intangible assets was based on valuations performed to determine the fair value of such assets as of the acquisition date. Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired. The liability amounts recorded included the Company’s estimate of contingent liabilities assumed.

The purchase price allocation as of December 31, 2011 was as follows (in thousands):

 

     Opening  
     Balance Sheet  

Cash and cash equivalents

    $ 650   

Receivables

      1,055   

Inventory

      852   

Property and equipment

      248   

Intangible assets

      11,900   

Goodwill

      4,220   

Net deferred tax assets

      5,002   

Other assets

      230   

Liabilities assumed

      (2,445 ) 
  

 

 

  

Total purchase price

    $ 21,712   
  

 

 

  

CryoLife incurred approximately $3.0 million in transaction and integration costs related to the acquisition in the year ended December 31, 2011. The Company did not incur significant transaction or integration costs related to the Cardiogenesis acquisition in 2012 or 2013.

Pro Forma Results

Cardiogenesis’ revenues of $5.7 million from the date of acquisition are included in the Company’s Consolidated Statements of Operations and Comprehensive Income for the year ended December 31, 2011. Unaudited pro forma results of operations for the year ended December 31, 2011, assuming the Cardiogenesis acquisition had occurred prior to 2011, are presented for comparative purposes below (in thousands):

 

     2011  

Total revenues

    $ 123,951   

Net income

      7,962   

Pro forma disclosures were calculated using a tax rate of approximately 36%.

 

F-23

Legal Action

In 2008 CardioFocus, Inc. (“CardioFocus”) filed a complaint in the U.S. District Court for the District of Massachusetts (“Massachusetts Court”) against Cardiogenesis and a number of other companies. The litigation related to an alleged infringement by Cardiogenesis of two patents held by CardioFocus that have now expired.

On June 14, 2012 Cardiogenesis entered into a settlement agreement with respect to its litigation with CardioFocus. The settlement provides that each party release the other from all claims and liabilities related to the patents in question and that all claims and counterclaims in the litigation be withdrawn with prejudice. Pursuant to the terms of the settlement agreement, Cardiogenesis paid $4.5 million in cash to CardioFocus. Cardiogenesis and CardioFocus agreed and acknowledged that each party would bear its own costs and expenses, including attorneys’ fees, incurred in or as a result of the litigation.

On June 14, 2012 the parties filed a stipulation of dismissal with prejudice in the Massachusetts Court.

Accounting for the Settlement

As a result of the settlement described above, the Company recorded an additional loss of $3.6 million in general, administrative, and marketing expenses on its Consolidated Statements of Operations and Comprehensive Income in the second quarter of 2012 for a total of $4.1 million in legal settlement expenses for the year ended December 31, 2012. The Company paid the $4.5 million settlement payment to CardioFocus in July 2012 using cash on hand.

7. Medafor Matters

Investment in Medafor Common Stock

In 2009 and 2010 CryoLife purchased shares of common stock in Medafor, Inc. (“Medafor”). As financial information for Medafor is not readily available and as the Company does not exert significant influence over the operations of Medafor, the Company accounted for its investment in Medafor common stock using the cost method. The Company recorded the stock as a long-term asset, investment in equity securities, on the Company’s Consolidated Balance Sheets. The carrying value of the Company’s 2.4 million shares of Medafor common stock was approximately $2.6 million as of December 31, 2012, prior to the sale of this investment in 2013 as described below.

In connection with its purchase of Medafor common stock, the Company entered into agreements with the sellers that could have required CryoLife to make additional payments to the sellers if CryoLife acquired or merged with Medafor within a specified time period. The Company accounted for these provisions as an embedded derivative. The last of these provisions expired in June 2013, and as of December 31, 2013 a derivative no longer exists. As of December 31, 2012 the value of this derivative was zero.

C.R. Bard’s Acquisition of Medafor

On October 1, 2013 C.R. Bard, Inc. (“Bard”) completed its previously announced acquisition of the outstanding shares of Medafor common stock. The Company received an initial payment of approximately $15.4 million for its 2.4 million shares of Medafor common stock and recorded an initial gain of $12.7 million on the sale in the fourth quarter of 2013. The Company could receive additional payments totaling up to an additional $8.4 million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015, based on information provided by Medafor as part of the September 24, 2013 Medafor Proxy Statement. The first of these additional payments, which the Company believes could be up to approximately $525,000, if released, would be received in late 2014, although this amount is subject to possible offsets. These payments will be recorded as an additional gain when and if received by the Company.

Distribution Agreement and Legal Action

CryoLife distributed a powdered hemostat for Medafor from 2008 to 2010. CryoLife filed a lawsuit against Medafor in 2009 in the U.S. District Court for the Northern District of Georgia (“Georgia Court”). In 2010 Medafor filed counterclaims against CryoLife in the same case. The litigation related to an exclusive distribution agreement that the parties entered into in April 2008.

In June 2012 the parties entered into a settlement agreement. Per the settlement, Medafor paid $3.5 million in cash to CryoLife in the third quarter of 2012. On June 29, 2012 the parties jointly filed stipulated dismissals with prejudice with the

 

F-24

Georgia Court. As a result of the settlement, CryoLife recorded a gain of $4.7 million as a reduction in general, administrative, and marketing expenses on its Consolidated Statements of Operations and Comprehensive Income in the second quarter of 2012 and recorded a reduction in accounts payable of $1.2 million to write off a payable for previous inventory purchases, which was discharged pursuant to the settlement agreement.

CryoLife received a letter from Medafor in September 2012 stating that PerClot®, when introduced in the U.S., will, when used in accordance with the method published in CryoLife’s literature and with the instructions for use, infringe Medafor’s U.S. patent. CryoLife does not believe that it will infringe Medafor’s patent. There have been no further communications between CryoLife and Medafor or CryoLife and Bard related to the September letter.

8. Deferred Preservation Costs and Inventories

Deferred preservation costs at December 31, 2013 and 2012 are comprised of the following (in thousands):

 

     2013      2012  

Cardiac tissues

    $ 12,239       $ 11,950   

Vascular tissues

      15,058         16,004   
  

 

 

     

 

 

  

Total deferred preservation costs

    $ 27,297       $ 27,954   
  

 

 

     

 

 

  

Inventories at December 31, 2013 and 2012 are comprised of the following (in thousands):

 

     2013      2012  

Raw materials and supplies

    $ 5,706       $ 5,836   

Work-in-process

      767         830   

Finished goods

      3,298         3,891   
  

 

 

     

 

 

  

Total inventories

    $ 9,771       $ 10,557   
  

 

 

     

 

 

  

9. Goodwill and Other Intangible Assets

Indefinite Lived Intangible Assets

As of December 31, 2013 and 2012 the carrying values of the Company’s indefinite lived intangible assets are as follows (in thousands):

 

     2013      2012  

Goodwill

    $ 11,365       $ 11,365   

Procurement contracts and agreements

      2,013         2,013   

Trademarks

      841         870   

Other

      —           250   

Based on its prior experience with similar agreements, the Company believes that its acquired contracts and procurement agreements have an indefinite useful life, as the Company expects to continue to renew these contracts for the foreseeable future. The Company believes that its trademarks have an indefinite useful life as the Company currently anticipates that these trademarks will contribute cash flows to the Company indefinitely.

A roll-forward of the goodwill balances for the Company’s medical devices reportable segment is as follows (in thousands):

 

     2013      2012  

Balance as of January 1,

    $ 11,365       $ 4,220   

Goodwill from Hemosphere acquisition

      —           7,145   
  

 

 

     

 

 

  

Balance as of December 31,

    $ 11,365       $ 11,365   
  

 

 

     

 

 

  

 

F-25

Definite Lived Intangible Assets

As of December 31, 2013 and 2012 gross carrying values, accumulated amortization, and approximate amortization periods of the Company’s definite lived intangible assets are as follows (dollars in thousands):

 

     Gross      Accumulated      Amortization  

December 31, 2013

    Value      Amortization      Period  

Acquired technology

    $ 14,020       $ 2,677         11-16         Years   

Patents

      4,348         2,414         17         Years   

Distribution and manufacturing rights and know-how

      3,559         714         15         Years   

Customer lists and relationships

      3,370         572         13-17         Years   

Non-compete agreement

      381         267         10         Years   

Other

      202         171         1-3         Years   
     Gross      Accumulated      Amortization  

December 31, 2012

    Value      Amortization      Period  

Acquired technology

    $ 14,020       $ 1,538         11-16         Years   

Patents

      4,644         2,530         17         Years   

Distribution and manufacturing rights and know-how

      3,559         473         15         Years   

Customer lists and relationships

      3,370         330         13-17         Years   

Non-compete agreement

      381         229         10         Years   

Other

      198         123         1-3         Years   

Amortization Expense

Amortization expense recorded in general, administrative, and marketing expenses on the Company’s Consolidated Statements of Operations and Comprehensive Income for the years ended December 31 is as follows (in thousands):

 

     2013      2012      2011  

Amortization expense

    $ 2,006       $ 1,971       $ 1,370   

As of December 31, 2013 scheduled amortization of intangible assets for the next five years is as follows (in thousands):

 

     2014      2015      2016      2017      2018      Total  

Amortization expense

    $ 1,948       $ 1,905       $ 1,898       $ 1,850       $ 1,844       $ 9,445   

10. Income Taxes

Income Tax Expense

Income before income taxes consists of the following (in thousands):

 

     2013      2012      2011  

Domestic

    $ 23,004       $ 11,686       $ 11,238   

Foreign

      288         366         228   
  

 

 

     

 

 

     

 

 

  

Income before income taxes

    $ 23,292       $ 12,052       $ 11,466   
  

 

 

     

 

 

     

 

 

  

 

F-26

Income tax expense consists of the following (in thousands):

 

     2013     2012     2011  

Current:

       

Federal

    $ 6,304      $ 2,778      $ 2,634   

State

      396        180        103   

Foreign

      96        98        84   
  

 

 

    

 

 

    

 

 

  
     6,796        3,056        2,821   
  

 

 

    

 

 

    

 

 

  

Deferred:

       

Federal

      1,142        1,274        1,087   

State

      (818 )      (227 )      183   

Foreign

      —          3        4   
  

 

 

    

 

 

    

 

 

  
     324        1,050        1,274   
  

 

 

    

 

 

    

 

 

  

Income tax expense

    $ 7,120      $ 4,106      $ 4,095   
  

 

 

    

 

 

    

 

 

  

The Company’s income tax expense in 2013, 2012, and 2011 included the Company’s federal, state, and foreign tax obligations. The Company’s effective income tax rate was approximately 31%, 34%, and 36% for the years ended December 31, 2013, 2012, and 2011, respectively. The Company’s income tax rate for the twelve months ended December 31, 2013 was favorably affected by the full year 2012 research and development tax credit, which was enacted in January 2013 and, therefore, reduced the Company’s tax expense during the first quarter of 2013 and adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards. The Company’s income tax rates for the three and twelve months ended December 31, 2012 were favorably affected by adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards, and unfavorably affected by the tax treatment of certain acquisition related expenses due to the acquisition of Hemosphere and by the research and development tax credit, which had not been enacted for the 2012 tax year.

The income tax expense amounts differ from the amounts computed by applying the U.S. federal statutory income tax rate of 35% to pretax income as a result of the following (in thousands):

 

     2013     2012     2011  

Tax expense at statutory rate

    $ 8,152      $ 4,220      $ 4,013   

Increase (reduction) in income taxes resulting from:

       

Non-deductible transaction costs

      —          151        540   

State income taxes, net of federal benefit

      183        296        150   

State valuation allowance adjustment

      (760 )      (427 )      100   

Equity compensation

      (29 )      32        149   

Non-deductible entertainment expenses

      207        188        142   

Foreign income taxes

      96        (199 )      3   

Domestic production activities deduction

      (402 )      (407 )      (727 ) 

Research and development credit

      (392 )      —          (314 ) 

Other

      65        252        39   
  

 

 

    

 

 

    

 

 

  
   $ 7,120      $ 4,106      $ 4,095   
  

 

 

    

 

 

    

 

 

  

Deferred Taxes

The Company generates deferred tax assets primarily as a result of write-downs of deferred preservation costs, inventory, and in-process research and development; accruals for product and tissue processing liability claims; asset impairments; and, in prior periods, due to operating losses. The Company acquired significant deferred tax assets, primarily net operating loss carryforwards, from its acquisitions of Hemosphere and Cardiogenesis in the second quarters of 2012 and 2011, respectively. See Note 4 and Note 6 for a further discussion of the Company’s acquisitions of Hemosphere and Cardiogenesis, respectively.

 

F-27

The tax effects of temporary differences which give rise to deferred tax assets and liabilities at December 31 are as follows (in thousands):

 

     2013     2012  

Deferred tax assets:

     

Allowance for bad debts

    $ 131      $ 194   

Deferred preservation costs and inventory write-downs

      1,077        392   

Investment in equity securities

      1,959        925   

Property

      2,737        2,644   

Intangible assets

      422        502   

Accrued expenses

      3,766        3,782   

Loss carryforwards

      15,689        17,539   

Credit carryforwards

      241        2,166   

Stock compensation

      2,409        2,319   

Other

      1,108        969   

Less valuation allowance

      (1,532 )      (2,292 ) 
  

 

 

    

 

 

  

Total deferred tax assets

      28,007        29,140   
  

 

 

    

 

 

  

Deferred tax liabilities:

     

Prepaid items

      (451 )      (314 ) 

Intangible assets

      (5,289 )      (5,814 ) 

Other

      (220 )      (348 ) 
  

 

 

    

 

 

  

Total deferred tax liabilities

      (5,960 )      (6,476 ) 
  

 

 

    

 

 

  

Total net deferred tax assets

    $ 22,047      $ 22,664   
  

 

 

    

 

 

  

As of December 31, 2013 the Company maintained a total of $1.5 million in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $22.0 million. As of December 31, 2012 the Company maintained a total of $2.3 million in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $22.7 million.

As of December 31, 2013 the Company had approximately $3.2 million of tax-effected state net operating loss carryforwards that began to expire in 2013, $61,000 in research and development tax credit carryforwards that will begin to expire in 2022, and $163,000 in credits from the state of Texas that will fully expire by 2027.

Uncertain Tax Positions

A reconciliation of the beginning and ending balances of the Company’s uncertain tax position liability, excluding interest and penalties, is as follows (in thousands):

 

     2013     2012     2011  

Beginning balance

    $ 2,004      $ 1,788      $ 1,822   

Increases related to current year tax positions

      281        231        78   

Decreases related to prior year tax positions

      (185 )      (15 )      (112 ) 
  

 

 

    

 

 

    

 

 

  

Ending balance

    $ 2,100      $ 2,004      $ 1,788   
  

 

 

    

 

 

    

 

 

  

 

F-28

A reconciliation of the beginning and ending balances of the Company’s liability for interest and penalties on uncertain tax positions is as follows (in thousands):

 

     2013     2012     2011  

Beginning balance

    $ 489      $ 418      $ 391   

Accrual of interest and penalties

      66        79        65   

Decreases related to prior year tax positions

      (133 )      (8 )      (38 ) 
  

 

 

    

 

 

    

 

 

  

Ending balance

    $ 422      $ 489      $ 418   
  

 

 

    

 

 

    

 

 

  

As of December 31, 2013 the Company’s total uncertain tax liability, including interest and penalties of $2.5 million, was recorded as a non-current liability on the Company’s Consolidated Balance Sheets. As of December 31, 2012 the Company’s total uncertain tax liability, including interest and penalties of $2.5 million, was recorded as a reduction to deferred tax assets of $103,000 and a non-current liability of $2.4 million on the Company’s Consolidated Balance Sheets.

Other

The Company’s tax years 2010 through 2013 generally remain open to examination by the major taxing jurisdictions to which the Company is subject. However, certain returns from years prior to 2010, in which net operating losses and tax credits have arisen, are still open for examination by the tax authorities.

11. Debt

GE Credit Agreement

On October 28, 2011 CryoLife amended and restated its March 26, 2008 credit agreement with GE Capital (the “GE Credit Agreement”) which provides revolving credit for working capital, acquisitions, and other corporate purposes. The amendment increased the borrowing capacity under the GE Credit Agreement from $15.0 million to $20.0 million (including a letter of credit subfacility) and extended the expiration from October 31, 2011 to October 28, 2014. The initial commitment may continue to be reduced or increased from time to time pursuant to the terms of the GE Credit Agreement. The Company amended the agreement to allow the payment of cash dividends up to a maximum of $3.5 million per year, subject to satisfaction of specified conditions.

The GE Credit Agreement places limitations on the amount that the Company may borrow and includes various affirmative and negative covenants, including financial covenants such as a requirement that CryoLife (i) not exceed a defined leverage ratio, (ii) maintain a minimum adjusted earnings subject to defined adjustments as of specified dates, and (iii) not make or commit capital expenditures in excess of a defined limitation. As required under the terms of the GE Credit Agreement, the Company is maintaining cash and cash equivalents of at least $5.0 million in accounts in which GE Capital has a first priority perfected lien. These amounts are recorded as restricted cash as of December 31, 2013 and 2012 on the Company’s Consolidated Balance Sheets, as they are restricted for the term of the GE Credit Agreement. Also, the GE Credit Agreement requires that after giving effect to a stock repurchase the Company maintain liquidity, as defined within the agreement, of at least $20.0 million. The GE Credit Agreement includes customary conditions on incurring new indebtedness. Commitment fees are paid based on the unused portion of the facility. As of December 31, 2013 the Company was in compliance with the covenants of the GE Credit Agreement.

Amounts borrowed under the GE Credit Agreement are secured by substantially all of the tangible and intangible assets of CryoLife and its subsidiaries and bear interest as determined by GE Capital at either LIBOR, with a minimum rate of 4.25%, or GE Capital’s base rate, with a minimum rate of 3.25% each, plus the applicable margin.

As of December 31, 2013 the outstanding balance of the GE Credit Agreement was zero, the aggregate interest rate was 6.50%, and the remaining availability was $20.0 million. As of December 31, 2012 the outstanding balance of the GE Credit Agreement was zero, the aggregate interest rate was 6.50%, and the remaining availability was $20.0 million.

 

F-29

Other

Total interest expense was $71,000, $179,000, and $142,000 in 2013, 2012, and 2011, respectively, which included interest on debt and uncertain tax positions.

12. Commitments and Contingencies

Leases

The Company’s operating lease obligations result from the lease of land and buildings that comprise the Company’s corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment. In prior years, the Company’s capital lease obligations resulted from the financing of certain of the Company’s equipment. As of December 31, 2013 and 2012 the remaining obligations under the Company’s capital leases was zero.

The term of the lease of the land and buildings that comprise the Company’s corporate headquarters was originally 15 years. During the second quarter of 2010 the Company signed an amendment to the lease on its corporate headquarters extending the lease until 2022. The Company has a deferred rent obligation of $1.7 million as of December 31, 2013 and $1.6 million as of December 31, 2012 recorded on the Company’s Consolidated Balance Sheets, primarily related to the lease on its corporate headquarters. Total rental expense for operating leases was $3.0 million in 2013 and $2.7 million in both 2012 and 2011.

Future minimum operating lease payments under non-cancelable leases as of December 31, 2013 are as follows (in thousands):

 

     Operating  
     Leases  

2014

    $ 2,799   

2015

      3,031   

2016

      2,943   

2017

      2,980   

2018

      3,010   

Thereafter

      10,124   
  

 

 

  

Total minimum lease payments

    $ 24,887   
  

 

 

  

Liability Claims

At December 31, 2013 and 2012 the Company’s unreported loss liability was $1.5 million and $1.7 million, respectively. The related recoverable insurance amounts were $580,000 and $620,000 as of December 31, 2013 and 2012, respectively. The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long-term liabilities and records the related recoverable insurance amounts as a component of receivables and other long-term assets, as appropriate. Further analysis indicated that the liability as of December 31, 2013 could be estimated to be as high as $2.7 million, after including a reasonable margin for statistical fluctuations calculated based on actuarial simulation techniques.

Employment Agreement

The Company has an employment agreement with its Chief Executive Officer (“CEO”) that confers benefits which become payable upon the occurrence of certain events, including the voluntary retirement of the CEO or termination of the CEO’s employment in conjunction with certain change events. As of both December 31, 2013 and 2012 the Company had $2.1 million in accrued expenses and other current liabilities on the Consolidated Balance Sheets representing benefits payable upon the CEO’s voluntary retirement, for which he is currently eligible. The CEO’s current agreement took effect on January 1, 2013 and terminates on December 31, 2015. A payment of $100,000 was made in January 2013 in accordance with the terms of the new agreement.

 

F-30

PerClot Technology

On September 28, 2010 the Company entered into a worldwide distribution agreement (the “Distribution Agreement”) and a license and manufacturing agreement (the “License Agreement”) with SMI of San Jose, California for PerClot, a polysaccharide hemostatic agent used in surgery. The Distribution Agreement contains certain minimum purchase requirements and has a term of 15 years. Following the start of manufacturing and U.S. regulatory approval, CryoLife may terminate the Distribution Agreement and the related minimum purchase requirements and sell PerClot pursuant to the License Agreement. The Company will pay royalties to SMI at stated rates on net revenues of products manufactured under the License Agreement and will pay additional contingent amounts of up to $2.5 million to SMI if certain FDA regulatory and other commercial milestones are achieved. The Company expects to record future contingent payment amounts of up to $2.5 million initially as research and development expense or, after FDA approval or issuance of a patent, as acquired intangible assets.

13. Shareholders’ Equity

Common Stock Repurchase

On November 1, 2011 the Company announced that its Board of Directors had authorized the Company’s purchase of $15.0 million of its common stock through December 31, 2012. This program expired on December 31, 2012. In February 2013 the Company’s Board of Directors authorized the purchase of up to $15.0 million of its common stock through October 31, 2014.

For the year ended December 31, 2013 the Company purchased approximately 253,000 shares of its common stock for an aggregate purchase price of $1.5 million. As of December 31, 2013, the Company had $13.5 million in remaining authorizations under the repurchase program. For the year ended December 31, 2012 the Company purchased approximately 639,000 shares of its common stock for an aggregate purchase price of $3.3 million. These shares were recorded, at cost, as part of treasury stock on the Company’s Consolidated Balance Sheets.

Treasury Stock

On August 7, 2012 the Company retired 2.7 million shares of treasury stock with an aggregate value of $15.1 million. The retirement was recorded as a reduction of $15.1 million in treasury stock, $27,000 in common stock, and approximately $15.1 million in additional paid in capital. These shares remain available for issuance as authorized unissued shares.

Cash Dividends

On August 21, 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding. In May 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 from $0.025 to $0.0275 per share of common stock outstanding. The Company paid dividend payments from cash on hand of $3.0 million and $1.4 million for the years ended December 31, 2013 and 2012, respectively.

Shareholder Rights Plan

The Company has a shareholder rights agreement entered into in 1995 and amended in 2005. Under the rights agreement, each share of the Company’s common stock outstanding on December 11, 1995 is entitled to one “Right,” as defined in, and subject to, the terms of the rights agreement. A Right entitles the registered holder to purchase from the Company one one-hundredth of a share of Series A Junior Participating Preferred Stock (“Series A Stock”) of the Company at $33.33 per one one-hundredth of a Preferred Share, subject to adjustment. Additionally, each common share that has or shall become outstanding after December 11, 1995 is also entitled to a Right, subject to the terms and conditions of the rights agreement. The Rights, which expire on November 23, 2015, may be exercised only if certain conditions are met, such as the acquisition of 15% or more of the Company’s common stock by a person or affiliated group (together with its affiliates, associates, and transferees, an “Acquiring Person”). Rights beneficially owned by an Acquiring Person become void from and after the time such persons become Acquiring Persons, and Acquiring Persons have no rights whatsoever under the rights agreement.

Each share of Series A Stock purchasable upon exercise of a Right will be entitled, when, as, and if declared, to a minimum preferential quarterly dividend payment of $1.00 per share but will be entitled to an aggregate dividend of 100 times the dividend declared per share of common stock. In the event of liquidation, each share of the Series A Stock will be entitled to a

 

F-31

minimum preferential liquidation payment of 100 times the payment made per share of common stock. Finally, in the event of any merger, consolidation, or other transaction in which shares of common stock are exchanged, each share of Series A Stock will be entitled to receive 100 times the amount received per share of common stock. These rights are protected by customary antidilution provisions.

In the event the Rights become exercisable, each Right will enable the owner, other than Acquiring Persons, to purchase shares of the Company’s Series A Stock as described above. Alternatively, if the Rights become exercisable, the holder of a Right may elect to receive, upon exercise of the Right and in lieu of receiving Series A Stock, that number of shares of common stock of the Company having an exercise value of two times the exercise price of the Right. In the event that, after a person or group has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction or 50% or more of its consolidated assets or earning power are sold, proper provision will be made so that each holder of a Right will thereafter have the right to receive, upon the exercise of a Right, and in lieu of Series A Stock of the Company, that number of shares of common stock of the person with whom the Company has engaged in the foregoing transaction (or its parent) that at the time of such transaction will have a market value of two times the exercise price of the Right. In addition, after any person or group becomes an Acquiring Person and prior to the acquisition by the person or group of 50% or more of the outstanding common stock, the Board of Directors may elect to exchange all outstanding Rights at an exchange ratio of one share of common stock (or fractional share of Series A Stock or other preferred shares) per Right (subject to adjustment).

14. Employee Benefit Plans

401(k) Plan

The Company has a 401(k) savings plan (the “Plan”) providing retirement benefits to all employees who have completed at least three months of service. The Company made matching contributions of 40% of each participant’s contribution for up to 5% of each participant’s salary in 2013 and 2012. In 2011 the Company made matching contributions to the plan of 20% of each participant’s contribution for up to 5% of each participant’s salary. Total Company contributions approximated $541,000, $500,000, and $204,000 for the years ended December 31, 2013, 2012, and 2011, respectively. Additionally, the Company may make discretionary contributions to the Plan that are allocated to each participant’s account. No discretionary contributions were made in any of the past three years.

Deferred Compensation Plan

On January 1, 2011 CryoLife initiated a nonqualified Deferred Compensation Plan (“Deferred Plan”). The Deferred Plan allows certain employees of CryoLife to defer receipt of a portion of their salary and cash bonus. The Deferred Plan provides for tax-deferred growth of deferred compensation. Pursuant to the terms of the Deferred Plan, CryoLife agrees to return the deferred amounts plus gains and losses, based on investment fund options chosen by each respective participant, to the plan participants upon distribution. All deferred amounts and deemed earnings thereon are vested at all times. The Company has no current plans to match any contributions. Amounts owed to plan participants are unsecured obligations of CryoLife. CryoLife has established a rabbi trust in which it will make contributions to fund its obligations under the Deferred Plan. Pursuant to the terms of the trust, CryoLife will be required to make contributions each year to fully match its obligations under the Deferred Plan. The trust’s funds are invested in Company Owned Life Insurance (“COLI”) and the Company plans to hold the policies until the death of the insured.

The Company’s deferred compensation liabilities are recorded as a component of other current liabilities or long-term deferred compensation liabilities, as appropriate, based on anticipated distribution dates. The cash surrender value of COLI is recorded in other long-term assets. Changes in the value of participant accounts and changes in the cash surrender value of COLI are recorded as part of the Company’s operating expenses and are subject to the Company’s normal allocation of expenses to inventory and deferred preservation costs.

 

F-32

15. Stock Compensation

Overview

Under the Company’s plans, the Company is currently authorized to grant the following number of shares and the Company has available for grant up to the following number of shares as of December 31, 2013 and 2012:

 

     Authorized
Shares		      Available for Grant  

Plan

       2013      2012  

1996 Discounted Employee Stock Purchase Plan, as amended

      1,900,000         749,000         847,000   

2004 Employee Stock Incentive Plan

      2,100,000         60,000         41,000   

2008 Non-Employee Directors Stock Incentive Plan

      300,000         —           27,000   

2009 Employee Stock Incentive Plan

      4,100,000         2,221,000         2,847,000   
  

 

 

     

 

 

     

 

 

  

Total

      8,400,000         3,030,000         3,762,000   
  

 

 

     

 

 

     

 

 

  

During 2012 the Company amended the 2009 Employee Stock Incentive Plan to increase the authorized shares under the plan by 2.1 million shares. Upon the exercise of stock options or grants of RSAs, RSUs, or PSUs, the Company may issue the required shares out of authorized but unissued common stock or out of treasury stock, at management’s discretion.

Stock Awards

In 2013 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled 467,000 shares of common stock and had an aggregate market value of $3.1 million. The PSUs granted in 2013 represent the right to receive from 50% to 150% of the target numbers of shares of common stock. The performance component of PSU awards granted in 2013 is based on the attainment of specified levels of adjusted EBITDA, as defined in the grant, for the 2013 calendar year. The PSUs granted in 2013 earned approximately 115% of the target number of shares.

In 2012 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled 451,000 shares of common stock and had an aggregate market value of $2.4 million. The PSUs granted in 2012 earned approximately 125% of the target number of shares.

In 2011 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors and certain Company officers and RSUs to certain employees, which together totaled 421,000 shares of common stock and had an aggregate market value of $2.2 million.

 

F-33

A summary of stock grant activity for the years ended December 31, 2013, 2012, and 2011 for RSAs, RSUs, and PSUs, based on shares granted at goal, is as follows:

 

           Weighted  
           Average  
           Grant Date  

RSAs

    Shares     Fair Value  

Unvested at December 31, 2010

      364,000      $ 7.07   
  

 

 

    

Granted

      360,000        5.18   

Vested

      (128,000 )      7.28   

Forfeited

      (44,000 )      5.48   
  

 

 

    

Unvested at December 31, 2011

      552,000        5.91   
  

 

 

    

Granted

      229,000        5.39   

Vested

      (142,000 )      7.00   
  

 

 

    

Unvested at December 31, 2012

      639,000        5.48   
  

 

 

    

Granted

      232,000        6.10   

Vested

      (215,000 )      5.80   

Forfeited

      (34,000 )      5.31   
  

 

 

    

Unvested at December 31, 2013

      622,000        5.62   
  

 

 

    

 

           Weighted         
           Average         
           Remaining      Aggregate  
           Contractual      Intrinsic  

RSUs

    Shares     Term in years      Value  

Outstanding at December 31, 2010

      58,000        1.85       $ 313,000   
  

 

 

       

Granted

      61,000        

Vested

      (19,000 )      

Forfeited

      (3,000 )      
  

 

 

       

Outstanding at December 31, 2011

      97,000        1.66         466,000   
  

 

 

       

Granted

      64,000        

Vested

      (37,000 )      

Forfeited

      (4,000 )      
  

 

 

       

Outstanding at December 31, 2012

      120,000        1.54         747,000   
  

 

 

       

Granted

      73,000        

Vested

      (54,000 )      

Forfeited

      (10,000 )      
  

 

 

       

Outstanding at December 31, 2013

      129,000        1.56         1,425,000   
  

 

 

       

Vested and expected to vest

      118,000        1.55       $ 1,314,000   

 

F-34

           Weighted         
           Average         
           Remaining      Aggregate  
           Contractual      Intrinsic  

PSUs

    Shares     Term in years      Value  

Outstanding at December 31, 2011

      —          —         $ —     
  

 

 

       

Granted

      159,000        

Vested

      —          

Forfeited

      —          
  

 

 

       

Outstanding at December 31, 2012

      159,000        0.93         989,000   
  

 

 

       

Granted

      182,000        

Vested

      (99,000 )      

Forfeited

      (6,000 )      
  

 

 

       

Outstanding at December 31, 2013

      236,000        0.81         2,612,000   
  

 

 

       

Vested and expected to vest

      224,000        0.78       $ 2,487,000   

Stock Options

The Compensation Committee of the Company’s Board of Directors authorized grants of stock options from approved stock incentive plans to certain Company officers and employees totaling 162,000, 159,000, and 599,000 shares in 2013, 2012, and 2011, respectively, with exercise prices equal to the stock prices on the respective grant dates.

A summary of the Company’s stock option activity for the years ended December 31, 2013, 2012, and 2011 follows:

 

                  Weighted         
                  Average         
           Weighted      Remaining      Aggregate  
           Average      Contractual      Intrinsic  
     Shares     Exercise Price      Term in years      Value  

Outstanding at December 31, 2010

      2,281,000      $ 6.74         3.46       $ 603,000   
  

 

 

          

Granted

      599,000        5.13         

Exercised

      (260,000 )      4.53         

Forfeited

      (100,000 )      5.60         

Expired

      (320,000 )      5.30         
  

 

 

          

Outstanding at December 31, 2011

      2,200,000        6.83         4.00         —     
  

 

 

          

Granted

      159,000        5.67         

Exercised

      (48,000 )      5.64         

Forfeited

      (2,000 )      7.01         

Expired

      (249,000 )      7.03         
  

 

 

          

Outstanding at December 31, 2012

      2,060,000        6.74         3.66         1,225,000   
  

 

 

          

Granted

      162,000        6.12         

Exercised

      (365,000 )      7.48         

Forfeited

      (49,000 )      5.56         

Expired

      (14,000 )      6.69         
  

 

 

          

Outstanding at December 31, 2013

      1,794,000        6.57         3.31         8,274,000   
  

 

 

          

Vested and expected to vest

      1,781,000      $ 6.57         3.29       $ 8,205,000   

Exercisable at December 31, 2013

      1,372,000      $ 6.86         2.75       $ 5,971,000   

 

F-35

Other information concerning stock options for the years ended December 31 is as follows:

 

     2013      2012      2011  

Weighted-average fair value of options granted

    $ 2.54       $ 2.67       $ 2.54   

Intrinsic value of options exercised

      673,000         10,000         261,000   

Employees purchased common stock totaling 97,000, 72,000, and 64,000 shares in 2013, 2012, and 2011, respectively, through the Company’s ESPP.

Stock Compensation Expense

The following weighted-average assumptions were used to determine the fair value of options:

 

     2013     2012     2011  
     Stock     ESPP     Stock     ESPP     Stock     ESPP  
     Options     Options     Options     Options     Options     Options  

Expected life of options

      4.3 Years        .50 Years        4.3 Years        .50 Years        4.0 Years        .50 Years   

Expected stock price volatility

      0.60        0.39        0.60        0.48        0.65        0.39   

Dividends

      1.91 %      1.59 %      N/A        N/A        N/A        N/A   

Risk-free interest rate

      0.70 %      0.13 %      0.71 %      0.12 %      1.25 %      0.14 % 

The following table summarizes stock compensation expenses (in thousands):

 

     2013      2012      2011  

RSA, RSU, and PSU expense

    $ 2,616       $ 2,204       $ 1,408   

Stock option and ESPP option expense

      852         1,172         1,606   
  

 

 

     

 

 

     

 

 

  

Total stock compensation expense

    $ 3,468       $ 3,376       $ 3,014   
  

 

 

     

 

 

     

 

 

  

Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the Company’s ESPP. These amounts were recorded as stock compensation expense and were subject to the Company’s normal allocation of expenses to deferred preservation costs and inventory costs. The Company capitalized $228,000, $214,000 and $224,000 in the years ended December 31, 2013, 2012, and 2011, respectively, of the stock compensation expense into its deferred preservation costs and inventory costs.

As of December 31, 2013 the Company had total unrecognized compensation costs of $532,000 related to unvested stock options and $2.8 million related to RSAs, RSUs, and PSUs, before considering the effect of expected forfeitures. As of December 31, 2013 this expense is expected to be recognized over a weighted-average period of 1.13 years for stock options, 0.92 years for RSAs, 2.27 years for RSUs, and 0.81 years for PSUs.

 

F-36

16. Income Per Common Share

The following table sets forth the computation of basic and diluted income per common share (in thousands, except per share data):

 

     2013     2012     2011  

Basic income per common share

       

Net income

    $ 16,172      $ 7,946      $ 7,371   

Net income allocated to participating securities

      (367 )      (180 )      (149 ) 
  

 

 

    

 

 

    

 

 

  

Net income allocated to common shareholders

    $ 15,805      $ 7,766      $ 7,222   
  

 

 

    

 

 

    

 

 

  

Basic weighted-average common shares outstanding

      26,885        26,967        27,441   
  

 

 

    

 

 

    

 

 

  

Basic income per common share

    $ 0.59      $ 0.29      $ 0.26   
  

 

 

    

 

 

    

 

 

  

Diluted income per common share

       

Net income

    $ 16,172      $ 7,946      $ 7,371   

Net income allocated to participating securities

      (359 )      (178 )      (147 ) 
  

 

 

    

 

 

    

 

 

  

Net income allocated to common shareholders

    $ 15,813      $ 7,768      $ 7,224   
  

 

 

    

 

 

    

 

 

  

Basic weighted-average common shares outstanding

      26,885        26,967        27,441   

Effect of dilutive options and awardsa

      813        444        318   
  

 

 

    

 

 

    

 

 

  

Diluted weighted-average common shares outstanding

      27,698        27,411        27,759   
  

 

 

    

 

 

    

 

 

  

Diluted income per common share

    $ 0.57      $ 0.28      $ 0.26   
  

 

 

    

 

 

    

 

 

  

 

a 

The Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share. Accordingly, stock options to purchase 656,000, 1.7 million, and 2.0 million, shares for the years ended December 31, 2013, 2012, and 2011, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.

17. Transactions with Related Parties

An investment banking services company employee became a member of the Company’s Board of Directors and a shareholder of the Company in 2012. The Company made stock repurchases of $321,000, $794,000, and $2.9 million in 2013, 2012, and 2011, respectively, which includes the cost of stock and commissions of less than 1%, and expensed $818,000 in 2011 for investment banking services from that company. The Company did not record expenses for investment banking services from that company in 2013 or 2012.

A member of the Company’s Board of Directors and a shareholder of the Company is a current employee of and the former Chief of Thoracic Surgery of a university hospital that generated preservation services and product revenues of $353,000, $267,000, and $198,000 for the Company in 2013, 2012, and 2011, respectively. Additionally, the son of this member of the Company’s Board of Directors receives a retainer for performing heart and lung transplants from a medical center that generated preservation services and product revenues of $345,000, $312,000, and $219,000 for the Company in 2013, 2012, and 2011, respectively.

The Company expensed $47,000, $22,000, and $45,000 in 2013, 2012, and 2011, respectively, relating to supplies for clinical trials purchased from a company whose Chief Financial Officer is a member of the Company’s Board of Directors and a shareholder of the Company.

A relative of the Company’s CEO is employed as a vice president of the Company. His compensation and benefits are set and subject to review by the Compensation Committee of the Board of Directors.

 

F-37

18. Segment and Geographic Information

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Graft. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues.

The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services. The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.

The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands):

 

     2013      2012      2011  

Revenues:

         

Medical devices

    $ 76,194       $ 67,496       $ 59,387   

Preservation services

      64,498         63,603         59,793   

Othera

      71         619         446   
  

 

 

     

 

 

     

 

 

  

Total revenues

      140,763         131,718         119,626   
  

 

 

     

 

 

     

 

 

  

Cost of products and preservation services:

         

Medical devices

      15,147         11,380         9,442   

Preservation services

      35,230         35,320         34,340   
  

 

 

     

 

 

     

 

 

  

Total cost of products and preservation services

      50,377         46,700         43,782   
  

 

 

     

 

 

     

 

 

  

Gross margin:

         

Medical devices

      61,047         56,116         49,945   

Preservation services

      29,268         28,283         25,453   

Othera

      71         619         446   
  

 

 

     

 

 

     

 

 

  

Total gross margin

    $ 90,386       $ 85,018       $ 75,844   
  

 

 

     

 

 

     

 

 

  

Net revenues by product for the years ended December 31, 2013, 2012, and 2011 were as follows (in thousands):

 

     2013      2012      2011  

Products:

         

BioGlue and BioFoam

    $ 58,004       $ 53,211       $ 49,455   

PerClot

      3,494         3,078         2,528   

HemoStase

      —           —           1,699   

Revascularization technologies

      8,965         8,092         5,705   

HeRO Graft

      5,731         3,115         —     
  

 

 

     

 

 

     

 

 

  

Total products

      76,194         67,496         59,387   

Preservation services:

         

Cardiac tissue

      29,523         29,756         26,618   

Vascular tissue

      34,975         33,847         33,175   
  

 

 

     

 

 

     

 

 

  

Total preservation services

      64,498         63,603         59,793   

Othera

      71         619         446   
  

 

 

     

 

 

     

 

 

  

Total revenues

    $ 140,763       $ 131,718       $ 119,626   
  

 

 

     

 

 

     

 

 

  

 

a 

For the years ended December 31, 2013, 2012, and 2011 the “Other” designation includes grant revenue.

 

F-38

Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2013, 2012, and 2011 were as follows (in thousands):

 

     2013      2012      2011  

U.S.

    $ 109,325       $ 103,804       $ 95,975   

International

      31,438         27,914         23,651   
  

 

 

     

 

 

     

 

 

  

Total revenues

    $ 140,763       $ 131,718       $ 119,626   
  

 

 

     

 

 

     

 

 

  

At December 31, 2013 and 2012 over 95% of the long-lived assets of the Company were held in the U.S., where all of the Company’s manufacturing facilities and the corporate headquarters are located. At December 31, 2013 and 2012 the Company’s $11.4 million of goodwill was allocated entirely to its Medical Devices segment.

 

F-39

SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

(in thousands, except per share data)

 

     First      Second      Third      Fourth  
     Quarter      Quarter      Quarter      Quarter  

REVENUE:

            

2013

    $ 35,536       $ 33,520       $ 36,250       $ 35,457   

2012

      32,301         33,188         33,429         32,800   

2011

      30,196         29,379         29,654         30,397   

GROSS MARGIN:

            

2013

    $ 23,276       $ 21,479       $ 23,349       $ 22,282   

2012

      21,292         21,371         21,310         21,045   

2011

      18,504         19,053         18,912         19,375   

NET INCOME:

            

2013

    $ 2,192       $ 1,785       $ 3,169       $ 9,026 * 

2012

      991         3,334         1,538         2,083   

2011

      1,666         1,820         2,019         1,866   

INCOME PER COMMON SHARE—DILUTED:

            

2013

    $ 0.08       $ 0.06       $ 0.11       $ 0.31 * 

2012

      0.04         0.12         0.06         0.07   

2011

      0.06         0.06         0.07         0.07   

 

* The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.

 

F-40

EX-10.12 2 d644771dex1012.htm EX-10.12 EX-10.12

Exhibit 10.12

SUMMARY OF SALARIES FOR

NAMED EXECUTIVE OFFICERS

(as of December 31, 2013)

The following summarizes, as of December 31, 2013, the salaries of the Company’s Chief Executive Officer and the other officers who were named in the Summary Compensation Table in the proxy statement for the Company’s 2013 Annual Meeting of Stockholders (the “Named Executive Officers”).

The executive officers of the Company serve at the discretion of the Board of Directors. The Compensation Committee of the Board reviews and determines the salaries that are paid to the Company’s executive officers, including the Named Executive Officers.

 

Named Executive Officer

    Salary

Steven G. Anderson

    $664,000

Chairman of the Board, President, and Chief Executive Officer

   

D. Ashley Lee

    $365,000

Executive Vice President, Chief Operating Officer, and Chief Financial Officer

   

Jeffrey W. Burris

    $293,000

Vice President and General Counsel

   

David M. Fronk

    $275,000

Vice President, Regulatory Affairs and Quality Assurance

   

Scott B. Capps

    $270,000

Vice President, Clinical Research

   
EX-10.44 3 d644771dex1044.htm EX-10.44 EX-10.44

Exhibit 10.44

SUMMARY OF COMPENSATION ARRANGEMENTS

WITH NON-EMPLOYEE DIRECTORS

(Effective as of December 31, 2013)

The following summarizes the compensation and benefits received by the non-employee Directors of CryoLife as of December 31, 2013. It is intended to be a summary of compensation arrangements, and in no way is intended to provide any additional rights to any non-employee Director.

Annual Retainer and Committee Chair Fees

Each of the non-employee Directors of the Board of Directors of CryoLife receives an annual cash retainer of $40,000. Each committee chair also receives a fee in addition to the annual cash retainer in the amounts shown in the following table.

 

Annual Fees For Committee Chairs

       

Audit Committee

    $ 15,000   

Compensation Committee

    $ 10,000   

Nominating and Corporate Governance Committee

    $ 7,500   

Regulatory Affairs and Quality Assurance Policy Committee

    $ 7,500   

The Presiding Director also receives an additional $25,000 retainer paid in cash. CryoLife pays all cash retainers on a monthly basis. Currently, the Presiding Director is also the Chairman of the Nominating and Corporate Governance Committee and he does not receive any additional compensation for his position as Chairman of that committee.

Effective June 1, 2013, each committee member other than the Presiding Director also receives a fee, in addition to the annual cash retainer, in the amounts shown in the following table.

 

Annual Fees For Committee Members

       

Audit Committee

    $ 7,500   

Compensation Committee

    $ 5,000   

Nominating and Corporate Governance Committee

    $ 3,750   

Regulatory Affairs and Quality Assurance Policy Committee

    $ 3,750   

Restricted Stock Grants

Non-employee Directors of CryoLife are eligible for equity grants, which are generally made in May of each year. The annual equity portion of nonemployee Director compensation for fiscal 2013 was paid in the form of a grant of 10,000 shares of restricted stock. These shares were issued following the annual meeting of stockholders and vest on the first anniversary of issuance. The size and terms of the annual equity grant are subject to annual reevaluation by the Compensation Committee. If a Director ceases to serve as a Director for any reason, he will forfeit any unvested portion of the award.

EX-21.1 4 d644771dex211.htm EX-21.1 EX-21.1

Exhibit 21.1

SUBSIDIARIES OF CRYOLIFE, INC.

 

Subsidiary

   

Jurisdiction

Cardiogenesis Corporation.

    Florida

CryoLife Europa, LTD.

    England and Wales

AuraZyme Pharmaceuticals, Inc.

    Florida

CryoLife International, Inc.

    Florida

CryoLife Asia Pacific, Pte. LTD.

    Singapore

Hemosphere, Inc.

    Florida

Eclipse Surgical Technologies

    The Netherlands
 EX-23.1 5 d644771dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

(1) Registration Statement No. 333-182296 on Form S-8 pertaining to the Amended and Restated CryoLife, Inc. 2009 Stock Incentive Plan,

 

(2) Registration Statement No. 333-182297 on Form S-4 filed on June 22, 2012,

 

(3) Registration Statement No. 333-179629 on Form S-3 filed on February 22, 2012,

 

(4) Registration Statement No. 333-167065 on Form S-8 pertaining to the CryoLife, Inc. Employee Stock Purchase Plan,

 

(5) Registration Statement No. 333-159608 on Form S-8 pertaining to the CryoLife, Inc. 2009 Employee Stock Incentive Plan,

 

(6) Registration Statement No. 333-150475 on Form S-8 pertaining to the CryoLife, Inc. 2008 Non-Employee Directors Omnibus Stock Plan,

 

(7) Registration Statement No. 333-59849 on Form S-8 pertaining to the CryoLife, Inc. 1998 Long-Term Incentive Plan,

 

(8) Registration Statement No. 333-104637 on Form S-8 pertaining to the CryoLife, Inc. 2002 Stock Incentive Plan,

 

(9) Registration Statement No. 333-119137 on Form S-8 pertaining to the CryoLife, Inc. 2004 Employee Stock Incentive Plan and the CryoLife, Inc. 2004 Non-Employee Directors Stock Option Plan,

of our reports dated February 21, 2014, with respect to the consolidated financial statements of CryoLife, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of CryoLife, Inc. and subsidiaries included in this Annual Report (Form 10-K) for the year ended December 31, 2013, filed with the Securities and Exchange Commission.

Ernst & Young LLP

Atlanta, Georgia

February 21, 2014

EX-23.2 6 d644771dex232.htm EX-23.2 EX-23.2

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-182296, 333-159608, 333-150475, 333-59849, 333-104637, 333-119137, and 333-167065 on Form S-8, 333-182297 on Form S-4, and 333-179629 on Form S-3 of CryoLife, Inc. of our report dated February 15, 2013, relating to the consolidated financial statements of CryoLife, Inc. appearing in this Annual Report on Form 10-K of CryoLife, Inc. for the year ended December 31, 2013.

DELOITTE & TOUCHE LLP

Atlanta, Georgia

February 21, 2014

EX-31.1 7 d644771dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

I, Steven G. Anderson, certify that:

 

1. I have reviewed this annual report on Form 10-K of CryoLife, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 21, 2014

 

/s/ STEVEN G. ANDERSON

Chairman, President, and
Chief Executive Officer
 EX-31.2 8 d644771dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

I, D. Ashley Lee, certify that:

 

1. I have reviewed this annual report on Form 10-K of CryoLife, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 21, 2014

 

/s/ D. ASHLEY LEE

Executive Vice President,

Chief Operating Officer, and

Chief Financial Officer

 EX-32 9 d644771dex32.htm EX-32 EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of CryoLife, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Steven G. Anderson, the Chairman, President, and Chief Executive Officer of the Company, and D. Ashley Lee, the Executive Vice President, Chief Operating Officer, and Chief Financial Officer of the Company, hereby certifies, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ STEVEN G. ANDERSON

     

/s/ D. ASHLEY LEE

STEVEN G. ANDERSON      D. ASHLEY LEE
Chairman, President, and Chief Executive Officer      Executive Vice President, Chief Operating Officer, and Chief Financial Officer
February 21, 2014      February 21, 2014
 EX-101.INS 10 cry-20131231.xml XBRL INSTANCE DOCUMENT 0000784199 cry:DilutedMember 2013-01-01 2013-12-31 0000784199 cry:BasicMember 2013-01-01 2013-12-31 0000784199 cry:DilutedMember 2012-01-01 2012-12-31 0000784199 cry:BasicMember 2012-01-01 2012-12-31 0000784199 cry:DilutedMember 2011-01-01 2011-12-31 0000784199 cry:BasicMember 2011-01-01 2011-12-31 0000784199 us-gaap:TreasuryStockMember 2012-08-05 2012-08-07 0000784199 us-gaap:CommonStockMember 2012-08-05 2012-08-07 0000784199 us-gaap:AdditionalPaidInCapitalMember 2012-08-05 2012-08-07 0000784199 2012-08-05 2012-08-07 0000784199 cry:MaturityDateWithinThreeMonthsMember 2013-12-31 0000784199 cry:MaturityDateBetweenThreeMonthsAndOneYearMember 2013-12-31 0000784199 cry:MaturityDateWithinThreeMonthsMember 2012-12-31 0000784199 2013-01-30 2013-02-01 0000784199 2011-10-30 2011-11-01 0000784199 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0000784199 us-gaap:TreasuryStockMember 2012-01-01 2012-12-31 0000784199 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000784199 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000784199 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000784199 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000784199 us-gaap:RetainedEarningsMember 2013-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000784199 us-gaap:RetainedEarningsMember 2012-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000784199 us-gaap:RetainedEarningsMember 2011-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0000784199 us-gaap:RetainedEarningsMember 2010-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0000784199 2010-01-01 2010-12-31 0000784199 cry:TwoThousandNineEmployeeStockIncentivePlanMember 2012-12-31 0000784199 cry:TwoThousandFourEmployeeStockIncentivePlanMember 2012-12-31 0000784199 cry:TwoThousandEightNonEmployeeDirectorsStockIncentivePlanMember 2012-12-31 0000784199 cry:OneThousandNineHundredNinetySixDiscountedEmployeeStockPurchasePlaneAsAmendedMember 2012-12-31 0000784199 cry:TwoThousandNineEmployeeStockIncentivePlanMember 2013-12-31 0000784199 cry:TwoThousandFourEmployeeStockIncentivePlanMember 2013-12-31 0000784199 cry:TwoThousandEightNonEmployeeDirectorsStockIncentivePlanMember 2013-12-31 0000784199 cry:OneThousandNineHundredNinetySixDiscountedEmployeeStockPurchasePlaneAsAmendedMember 2013-12-31 0000784199 cry:TwoThousandNineEmployeeStockIncentivePlanMember 2012-01-01 2012-12-31 0000784199 us-gaap:EmployeeStockOptionMember 2012-01-01 2012-12-31 0000784199 cry:EmployeeStockPurchasePlanOptionsMember 2012-01-01 2012-12-31 0000784199 us-gaap:EmployeeStockOptionMember 2011-01-01 2011-12-31 0000784199 cry:EmployeeStockPurchasePlanOptionsMember 2011-01-01 2011-12-31 0000784199 cry:EmployeeStockPurchasePlanOptionsMember 2013-01-01 2013-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2010-01-01 2010-12-31 0000784199 us-gaap:RestrictedStockMember 2013-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2012-12-31 0000784199 us-gaap:RestrictedStockMember 2012-12-31 0000784199 us-gaap:PerformanceSharesMember 2012-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2011-12-31 0000784199 us-gaap:RestrictedStockMember 2011-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2010-12-31 0000784199 us-gaap:RestrictedStockMember 2010-12-31 0000784199 us-gaap:RestrictedStockMember 2012-01-01 2012-12-31 0000784199 us-gaap:PerformanceSharesMember 2012-01-01 2012-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2012-01-01 2012-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2011-01-01 2011-12-31 0000784199 us-gaap:RestrictedStockMember 2011-01-01 2011-12-31 0000784199 cry:StockOptionsRsasRsusPsusMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 cry:StockOptionsRsasRsusPsusMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 cry:MedaforSettlementMember 2012-04-01 2012-06-30 0000784199 cry:CardioFocusSettlementMember 2012-04-01 2012-06-30 0000784199 us-gaap:AllOtherSegmentsMember 2013-01-01 2013-12-31 0000784199 cry:VascularTissueMember 2013-01-01 2013-12-31 0000784199 cry:TotalProductsMember 2013-01-01 2013-12-31 0000784199 cry:TotalPreservationServicesMember 2013-01-01 2013-12-31 0000784199 cry:RevascularizationTechnologiesMember 2013-01-01 2013-12-31 0000784199 cry:PerClotMember 2013-01-01 2013-12-31 0000784199 cry:InternationalMember 2013-01-01 2013-12-31 0000784199 cry:HeROGraftMember 2013-01-01 2013-12-31 0000784199 cry:CardiacTissueMember 2013-01-01 2013-12-31 0000784199 cry:BioGlueAndBioFoamMember 2013-01-01 2013-12-31 0000784199 country:US 2013-01-01 2013-12-31 0000784199 cry:HemosphereMember 2012-05-15 2012-12-31 0000784199 us-gaap:AllOtherSegmentsMember 2012-01-01 2012-12-31 0000784199 cry:VascularTissueMember 2012-01-01 2012-12-31 0000784199 cry:TotalProductsMember 2012-01-01 2012-12-31 0000784199 cry:TotalPreservationServicesMember 2012-01-01 2012-12-31 0000784199 cry:RevascularizationTechnologiesMember 2012-01-01 2012-12-31 0000784199 cry:PerClotMember 2012-01-01 2012-12-31 0000784199 cry:InternationalMember 2012-01-01 2012-12-31 0000784199 cry:HeROGraftMember 2012-01-01 2012-12-31 0000784199 cry:CardiacTissueMember 2012-01-01 2012-12-31 0000784199 cry:BioGlueAndBioFoamMember 2012-01-01 2012-12-31 0000784199 country:US 2012-01-01 2012-12-31 0000784199 cry:CardiogenesisMember 2011-05-16 2011-12-31 0000784199 us-gaap:AllOtherSegmentsMember 2011-01-01 2011-12-31 0000784199 cry:VascularTissueMember 2011-01-01 2011-12-31 0000784199 cry:TotalProductsMember 2011-01-01 2011-12-31 0000784199 cry:TotalPreservationServicesMember 2011-01-01 2011-12-31 0000784199 cry:RevascularizationTechnologiesMember 2011-01-01 2011-12-31 0000784199 cry:PerClotMember 2011-01-01 2011-12-31 0000784199 cry:InternationalMember 2011-01-01 2011-12-31 0000784199 cry:HemoStaseMember 2011-01-01 2011-12-31 0000784199 cry:CardiacTissueMember 2011-01-01 2011-12-31 0000784199 cry:BioGlueAndBioFoamMember 2011-01-01 2011-12-31 0000784199 country:US 2011-01-01 2011-12-31 0000784199 cry:SonOfMemberOfBoardOfDirectorsMember 2013-01-01 2013-12-31 0000784199 cry:SonOfMemberOfBoardOfDirectorsMember 2012-01-01 2012-12-31 0000784199 cry:SonOfMemberOfBoardOfDirectorsMember 2011-01-01 2011-12-31 0000784199 us-gaap:MoneyMarketFundsMember 2013-12-31 0000784199 us-gaap:MoneyMarketFundsMember 2012-12-31 0000784199 cry:NoMaturityDateMember 2013-12-31 0000784199 cry:NoMaturityDateMember 2012-12-31 0000784199 cry:GECreditAgreementMember us-gaap:MinimumMember 2013-12-31 0000784199 cry:MemberOfBoardOfDirectorsMember 2013-01-01 2013-12-31 0000784199 cry:MemberOfBoardOfDirectorsMember 2012-01-01 2012-12-31 0000784199 cry:MemberOfBoardOfDirectorsMember 2011-01-01 2011-12-31 0000784199 cry:MedaforIncMember 2013-10-20 2013-10-21 0000784199 cry:MedaforIncMember 2012-07-01 2012-09-30 0000784199 us-gaap:ConvertiblePreferredStockMember 2013-12-31 0000784199 cry:SeriesJuniorParticipatingPreferredStockMember 2013-12-31 0000784199 us-gaap:ConvertiblePreferredStockMember 2012-12-31 0000784199 cry:SeriesJuniorParticipatingPreferredStockMember 2012-12-31 0000784199 cry:HemosphereMember 2012-01-01 2012-12-31 0000784199 cry:CardiogenesisMember 2011-01-01 2011-12-31 0000784199 cry:PaymentMember cry:CardiogenesisMember 2012-07-01 2012-07-31 0000784199 cry:CardioFocusSettlementMember 2012-07-01 2012-07-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000784199 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000784199 cry:CEOPostEmploymentBenefitsMember 2013-12-31 0000784199 cry:CEOPostEmploymentBenefitsMember 2012-12-31 0000784199 cry:ValvexchangeIncMember 2013-12-31 0000784199 cry:ValvexchangeIncMember 2012-12-31 0000784199 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000784199 cry:NonAmendedMember cry:GECreditAgreementMember 2011-10-28 0000784199 cry:AmendedMember cry:GECreditAgreementMember 2011-10-28 0000784199 cry:GECreditAgreementMember 2013-12-31 0000784199 cry:GECreditAgreementMember 2012-12-31 0000784199 cry:CardioFocusSettlementMember 2012-01-01 2012-12-31 0000784199 cry:ObsoleteRevascularizationTechnologiesHandpiecesMember 2013-01-01 2013-12-31 0000784199 cry:BioGlueAccessoryProductMember 2013-01-01 2013-12-31 0000784199 us-gaap:TrademarksMember 2013-12-31 0000784199 cry:ProcurementContractsAndAgreementsMember 2013-12-31 0000784199 us-gaap:TrademarksMember 2012-12-31 0000784199 us-gaap:OtherIntangibleAssetsMember 2012-12-31 0000784199 cry:ProcurementContractsAndAgreementsMember 2012-12-31 0000784199 us-gaap:AllOtherSegmentsMember 2013-01-01 2013-12-31 0000784199 us-gaap:AllOtherSegmentsMember 2012-01-01 2012-12-31 0000784199 us-gaap:AllOtherSegmentsMember 2011-01-01 2011-12-31 0000784199 cry:HemosphereMember cry:MedicalDevicesSegmentMember 2012-01-01 2012-12-31 0000784199 cry:MedicalDevicesSegmentMember 2013-12-31 0000784199 cry:MedicalDevicesSegmentMember 2012-12-31 0000784199 cry:MedicalDevicesSegmentMember 2011-12-31 0000784199 us-gaap:CustomerListsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 us-gaap:CustomerListsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 cry:AcquiredTechnologyMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 cry:AcquiredTechnologyMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 us-gaap:PatentsMember 2013-01-01 2013-12-31 0000784199 us-gaap:NoncompeteAgreementsMember 2013-01-01 2013-12-31 0000784199 cry:DistributionAndManufacturingRightsAndKnowHowMember 2013-01-01 2013-12-31 0000784199 us-gaap:CustomerListsMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000784199 us-gaap:CustomerListsMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000784199 cry:AcquiredTechnologyMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000784199 cry:AcquiredTechnologyMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000784199 us-gaap:PatentsMember 2012-01-01 2012-12-31 0000784199 us-gaap:NoncompeteAgreementsMember 2012-01-01 2012-12-31 0000784199 cry:DistributionAndManufacturingRightsAndKnowHowMember 2012-01-01 2012-12-31 0000784199 us-gaap:PatentsMember 2013-12-31 0000784199 us-gaap:NoncompeteAgreementsMember 2013-12-31 0000784199 us-gaap:CustomerListsMember 2013-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember 2013-12-31 0000784199 cry:DistributionAndManufacturingRightsAndKnowHowMember 2013-12-31 0000784199 cry:AcquiredTechnologyMember 2013-12-31 0000784199 us-gaap:PatentsMember 2012-12-31 0000784199 us-gaap:NoncompeteAgreementsMember 2012-12-31 0000784199 us-gaap:CustomerListsMember 2012-12-31 0000784199 cry:OtherFiniteLivedIntangibleAssetsMember 2012-12-31 0000784199 cry:DistributionAndManufacturingRightsAndKnowHowMember 2012-12-31 0000784199 cry:AcquiredTechnologyMember 2012-12-31 0000784199 us-gaap:FairValueInputsLevel3Member 2013-12-31 0000784199 us-gaap:FairValueInputsLevel3Member 2012-12-31 0000784199 2012-05-14 2012-05-16 0000784199 us-gaap:RestrictedStockMember 2013-01-01 2013-12-31 0000784199 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-12-31 0000784199 us-gaap:EmployeeStockOptionMember 2013-12-31 0000784199 cry:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockUnitsMember 2013-12-31 0000784199 2013-07-01 2013-09-30 0000784199 2013-04-01 2013-06-30 0000784199 2013-01-01 2013-03-31 0000784199 2012-10-01 2012-12-31 0000784199 2012-07-01 2012-09-30 0000784199 2012-04-01 2012-06-30 0000784199 2012-01-01 2012-03-31 0000784199 2011-10-01 2011-12-31 0000784199 2011-07-01 2011-09-30 0000784199 2011-04-01 2011-06-30 0000784199 2011-01-01 2011-03-31 0000784199 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000784199 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000784199 cry:TexasTaxCreditMember 2013-12-31 0000784199 us-gaap:BaseRateMember cry:GECreditAgreementMember us-gaap:MinimumMember 2013-12-31 0000784199 cry:LiborRateMember cry:GECreditAgreementMember us-gaap:MinimumMember 2013-12-31 0000784199 cry:PreservationServicesMember 2013-01-01 2013-12-31 0000784199 cry:MedicalDevicesMember 2013-01-01 2013-12-31 0000784199 cry:PreservationServicesMember 2012-01-01 2012-12-31 0000784199 cry:MedicalDevicesMember 2012-01-01 2012-12-31 0000784199 cry:PreservationServicesMember 2011-01-01 2011-12-31 0000784199 cry:MedicalDevicesMember 2011-01-01 2011-12-31 0000784199 cry:MedaforIncMember 2013-10-01 2013-12-31 0000784199 2013-10-01 2013-12-31 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2013-10-01 2013-12-31 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2013-01-01 2013-12-31 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2012-07-01 2012-09-30 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2013-12-31 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2012-12-31 0000784199 us-gaap:TreasuryStockMember 2013-12-31 0000784199 us-gaap:CommonStockMember 2013-12-31 0000784199 us-gaap:TreasuryStockMember 2012-12-31 0000784199 us-gaap:CommonStockMember 2012-12-31 0000784199 us-gaap:TreasuryStockMember 2011-12-31 0000784199 us-gaap:CommonStockMember 2011-12-31 0000784199 us-gaap:TreasuryStockMember 2010-12-31 0000784199 us-gaap:CommonStockMember 2010-12-31 0000784199 2013-05-26 2013-05-28 0000784199 2012-08-22 2013-05-27 0000784199 2012-08-20 2012-08-21 0000784199 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0000784199 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0000784199 us-gaap:MoneyMarketFundsMember 2013-12-31 0000784199 us-gaap:CertificatesOfDepositMember 2013-12-31 0000784199 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0000784199 us-gaap:MoneyMarketFundsMember 2012-12-31 0000784199 2011-12-31 0000784199 2010-12-31 0000784199 cry:HemosphereMember 2012-05-15 2012-05-16 0000784199 cry:HemosphereMember 2012-12-31 0000784199 cry:CardiogenesisMember 2011-12-31 0000784199 cry:CardiogenesisMember 2011-01-01 2011-12-31 0000784199 cry:CardiogenesisMember 2011-05-17 0000784199 cry:HemosphereMember 2013-01-01 2013-12-31 0000784199 cry:CardiogenesisMember 2013-01-01 2013-12-31 0000784199 cry:HemosphereMember 2011-01-01 2011-12-31 0000784199 cry:HemosphereMember 2012-05-16 0000784199 us-gaap:FairValueInputsLevel1Member 2013-12-31 0000784199 us-gaap:FairValueInputsLevel1Member 2012-12-31 0000784199 cry:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember 2013-01-01 2013-12-31 0000784199 cry:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockUnitsMember 2013-01-01 2013-12-31 0000784199 cry:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember 2012-01-01 2012-12-31 0000784199 cry:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockUnitsMember 2012-01-01 2012-12-31 0000784199 cry:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember 2011-01-01 2011-12-31 0000784199 cry:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockUnitsMember 2011-01-01 2011-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000784199 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000784199 2013-06-30 0000784199 2014-02-14 0000784199 cry:StarchTechnologyPurchaseMember 2010-09-27 2010-09-28 0000784199 cry:MedaforIncMember 2012-12-31 0000784199 cry:RsasToNonEmployeeDirectorsRsusToCertainEmployeesAndRsasAndPsusToCertainCompanyOfficersMember 2013-01-01 2013-12-31 0000784199 cry:RsasToNonEmployeeDirectorsRsusToCertainEmployeesAndRsasAndPsusToCertainCompanyOfficersMember 2012-01-01 2012-12-31 0000784199 cry:RsasToNonEmployeeDirectorsRsusToCertainEmployeesAndRsasAndPsusToCertainCompanyOfficersMember 2011-01-01 2011-12-31 0000784199 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-12-31 0000784199 us-gaap:PerformanceSharesMember 2013-01-01 2013-12-31 0000784199 us-gaap:RestrictedStockUnitsRSUMember 2013-12-31 0000784199 us-gaap:PerformanceSharesMember 2013-12-31 0000784199 cry:CRBardIncMember us-gaap:ScenarioForecastMember 2014-07-01 2017-12-31 0000784199 us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 us-gaap:MaximumMember 2013-01-01 2013-12-31 0000784199 us-gaap:MaximumMember 2012-01-01 2012-12-31 0000784199 us-gaap:MaximumMember 2011-01-01 2011-12-31 0000784199 cry:AmendedMember cry:GECreditAgreementMember 2013-05-22 2013-05-23 0000784199 cry:ValvexchangeIncMember 2011-07-01 2011-07-31 0000784199 cry:GECreditAgreementMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000784199 2013-05-28 0000784199 cry:MedaforSettlementMember 2012-06-30 0000784199 cry:StarchTechnologyPurchaseMember 2013-12-31 0000784199 2011-01-01 2011-12-31 0000784199 cry:VascularTissuesMember 2013-12-31 0000784199 cry:CardiacTissuesMember 2013-12-31 0000784199 cry:VascularTissuesMember 2012-12-31 0000784199 cry:CardiacTissuesMember 2012-12-31 0000784199 cry:ValvexchangeIncMember us-gaap:SeriesAPreferredStockMember 2011-07-31 0000784199 cry:MedaforIncMember 2013-09-29 2013-09-30 0000784199 us-gaap:CashEquivalentsMember us-gaap:MoneyMarketFundsMember 2013-12-31 0000784199 cry:RestrictedCashAndSecuritiesMember us-gaap:MoneyMarketFundsMember 2013-12-31 0000784199 cry:RestrictedCashAndSecuritiesMember cry:RestrictedCashMember 2013-12-31 0000784199 us-gaap:CertificatesOfDepositMember 2013-12-31 0000784199 us-gaap:CashEquivalentsMember us-gaap:MoneyMarketFundsMember 2012-12-31 0000784199 cry:RestrictedCashAndSecuritiesMember us-gaap:MoneyMarketFundsMember 2012-12-31 0000784199 cry:RestrictedCashAndSecuritiesMember cry:RestrictedCashMember 2012-12-31 0000784199 cry:ValvexchangeIncMember 2013-01-01 2013-12-31 0000784199 cry:HemosphereMember 2012-01-01 2012-12-31 0000784199 cry:StarchTechnologyPurchaseMember 2010-09-28 0000784199 cry:CRBardIncMember us-gaap:ScenarioForecastMember 2014-07-01 2014-12-31 0000784199 2013-01-01 2013-01-31 0000784199 2012-01-01 2012-12-31 0000784199 2013-01-01 2013-12-31 0000784199 2013-12-31 0000784199 2012-12-31 cry:segment iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:USD 4762000 5427000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accrued Procurement Fees</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Donated t</font><font style="display: inline;font-size:10pt;">issue is procured from deceased human donors by OTPOs, which consign the tissue to the Company for processing, preservation, and distribution.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company reimburses the OTPOs for their costs to recover the tissue and passes these costs on to the customer when the tissue is shipped and the performance of the service is complete.&nbsp;&nbsp;The Company accrues estimated procurement fees due to the OTPOs at the time tissues are received based on contractual agreements between the Company and the OTPOs.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 1.25 1.15 100000 525000 2500000 2400000 0.19 5000000 323000 1319000 749000 5000000 350000 5349000 5000000 323000 1319000 749000 5000000 350000 5349000 0.15 2400000 2400000 27954000 11950000 16004000 27297000 12239000 15058000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Preservation Costs</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory.&nbsp;&nbsp;The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred.&nbsp; </font><font style="display: inline;font-size:10pt;">Deferred preservation costs are stated at the lower of cost or market value on a first</font><font style="display: inline;font-size:10pt;">&#8209;in, first</font><font style="display: inline;font-size:10pt;">&#8209;out basis and are deferred until revenue is recognized.&nbsp; </font><font style="display: inline;font-size:10pt;">At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services.&nbsp;&nbsp;Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments </font><font style="display: inline;font-size:10pt;">for tissues not deemed to be recoverable, and includes,</font><font style="display: inline;font-size:10pt;"> as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The calculation of deferred preservation costs involves judgment and complexity and uses the </font><font style="display: inline;font-size:10pt;">same principles as inventory costing</font><font style="display: inline;font-size:10pt;">.&nbsp; </font><font style="display: inline;font-size:10pt;">Donated human tissue is procured from deceased human donors by </font><font style="display: inline;font-size:10pt;">organ and tissue procurement organizations </font><font style="display: inline;font-size:10pt;">(</font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-size:10pt;">OTPOs</font><font style="display: inline;">&#x201D;</font><font style="display: inline;font-size:10pt;">), which consign the tissue to the Company for processing, preservation, and distribution.&nbsp;&nbsp;Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight</font><font style="display: inline;font-size:10pt;">&#8209;in charges), and indirect costs (including allocations of costs from support departments and facility allocations).&nbsp; </font><font style="display: inline;font-size:10pt;">F</font><font style="display: inline;font-size:10pt;">ixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility&#x2019;s normal capacity</font><font style="display: inline;font-size:10pt;">.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed.&nbsp;&nbsp;The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable.&nbsp;&nbsp;Management estimates quarantine yields based on its experience and reevaluates these estimates periodically.&nbsp;&nbsp;Actual yields could differ significantly from the Company&#x2019;s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs.&nbsp;&nbsp;These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value.&nbsp;&nbsp;The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging.&nbsp;&nbsp;Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation.&nbsp;&nbsp;Impairment write-downs are recorded based on the book value of tissues deemed to be impaired.&nbsp;&nbsp;Actual results may differ from these estimates.&nbsp;&nbsp;Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company&#x2019;s estimates change.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company recorded write-downs to its deferred preservation costs totaling $</font><font style="display: inline;font-size:10pt;">448,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">195,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">270,000</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively. </font></font> </p> <p><font size="1"> </font></p> </div> </div> 270000 195000 448000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Dividends</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">During 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of </font><font style="display: inline;font-size:10pt;">$0.025</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;In 2013 the Company announced that its Board of Directors approved a </font><font style="display: inline;font-size:10pt;">10%</font><font style="display: inline;font-size:10pt;"> increase in the quarterly cash dividend beginning in the second quarter of 2013 to </font><font style="display: inline;font-size:10pt;">$0.0275</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year from cash on hand and will record the dividend payment as a reduction to retained earnings on the Company&#x2019;s Consolidated Balance Sheets.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 24007000 26976000 1700000 1500000 620000 580000 100 1.00 2500000 1200000 540000 151000 -2445000 1598000 -193000 0.10 P15Y <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Legal Contingencies</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company accrues losses from a legal contingency when the loss is both probable and reasonably estimable.&nbsp;&nbsp;T</font><font style="display: inline;font-size:10pt;">he accuracy of the Company&#x2019;s estimates of losses for legal contingencies is limited by uncertainties surrounding litigation.&nbsp;&nbsp;Therefore, actual results may differ significantly from the amounts accrued, if any.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company accrues for legal contingencies as a component of accrued expenses and other long</font><font style="display: inline;font-size:10pt;">&#8209;term liabilities.&nbsp;&nbsp;Gains from legal contingencies are recorded when the contingency is resolved.&nbsp; </font></font> </p> <p><font size="1"> </font></p> </div> </div> 2500000 2500000 20000000 117000 2018-07-30 0.08 2000000 0.50 0.50 2114000 1934000 3500000 0.01 0.01 0.01 1.50 0.50 0.95 0.95 8400000 100 100 33.33 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Amortization expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,006&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,971&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,370&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Unrealized</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Estimated</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Holding</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Market</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Cost Basis</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gains (Losses)</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Certificates of deposit</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted cash and securities:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cardiac tissues</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,239&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,950&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vascular tissues</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,058&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,004&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred preservation costs</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,297&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,954&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Depreciation expense</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,837&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,662&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,590&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Weighted-average fair value of options granted</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.54&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.67&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.54&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intrinsic value of options exercised</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>673,000&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,000&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>261,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Authorized</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Available for Grant</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Shares</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1996 Discounted Employee Stock Purchase Plan, as amended</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,900,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>847,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2004 Employee Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,100,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2008 Non-Employee Directors Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>300,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2009 Employee Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,100,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,221,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,847,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,400,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,030,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,762,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 2487000 1314000 224000 118000 P9M11D P1Y6M18D P7Y 2200000 2400000 3100000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">13.&nbsp;&nbsp;Shareholders&#x2019; Equity </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Common Stock Repurchase</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On November 1, 2011 the Company announced that its Board of Directors had </font><font style="display: inline;font-size:10pt;">authorized the Company&#x2019;s purchase of $</font><font style="display: inline;font-size:10pt;">15.0</font><font style="display: inline;font-size:10pt;"> million of its common stock through December 31, 2012.&nbsp;&nbsp;T</font><font style="display: inline;font-size:10pt;">his program expired on December 31, 2012.&nbsp;&nbsp;In February 2013 the Company&#x2019;s Board of Directors authorized the purchase of up to $</font><font style="display: inline;font-size:10pt;">15.0</font><font style="display: inline;font-size:10pt;"> million of its common stock through October 31, 2014.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">For the year ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company purchased approximately </font><font style="display: inline;font-size:10pt;">253,000</font><font style="display: inline;font-size:10pt;"> shares of its common stock for an aggregate purchase price of $</font><font style="display: inline;font-size:10pt;">1.5</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, the Company had </font><font style="display: inline;font-size:10pt;">$13.5</font><font style="display: inline;font-size:10pt;"> million in remaining authorizations under the repurchase program.&nbsp;&nbsp;For the year ended </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> the Company purchased approximately </font><font style="display: inline;font-size:10pt;">639,000</font><font style="display: inline;font-size:10pt;"> shares of its common stock for an aggregate purchase price of $</font><font style="display: inline;font-size:10pt;">3.3</font><font style="display: inline;font-size:10pt;"> million.&nbsp; </font><font style="display: inline;font-size:10pt;">These shares were recorded, at cost, as part of treasury stock on the </font><font style="display: inline;font-size:10pt;">Company&#x2019;s Consolidated Balance Sheets.</font><font style="display: inline;font-size:10pt;">&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Treasury Stock&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On August 7, 2012 the Company retired </font><font style="display: inline;font-size:10pt;">2.7</font><font style="display: inline;font-size:10pt;"> million shares of treasury stock with an aggregate value of $</font><font style="display: inline;font-size:10pt;">15.1</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;The retirement was recorded as a reduction of $</font><font style="display: inline;font-size:10pt;">15.1</font><font style="display: inline;font-size:10pt;"> million in treasury stock, $</font><font style="display: inline;font-size:10pt;">27,000</font><font style="display: inline;font-size:10pt;"> in common stock, and approximately $</font><font style="display: inline;font-size:10pt;">15.1</font><font style="display: inline;font-size:10pt;"> million in additional paid in capital.&nbsp;&nbsp;These shares remain available for issuance as authorized unissued shares.&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash Dividends&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On August 21, 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $</font><font style="display: inline;font-size:10pt;">0.025</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;In May 2013 the Company announced that its Board of Directors approved a </font><font style="display: inline;font-size:10pt;">10%</font><font style="display: inline;font-size:10pt;"> increase in the quarterly cash dividend beginning in the second quarter of 2013 from $</font><font style="display: inline;font-size:10pt;">0.025</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">$0.0275</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;The Company paid dividend payments from cash on hand of $</font><font style="display: inline;font-size:10pt;">3.0</font><font style="display: inline;font-size:10pt;"> million and </font><font style="display: inline;font-size:10pt;">$1.4</font><font style="display: inline;font-size:10pt;"> million for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, respectively.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Shareholder Rights Plan</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has a shareholder rights agreement entered into in 1995 and amended in 2005.&nbsp;&nbsp;Under the rights agreement, each share of the Company's common stock outstanding on December 11, 1995 is entitled to one &#x201C;Right,&#x201D; as defined in, and subject to, the terms of the rights agreement.&nbsp;&nbsp;A Right entitles the registered holder to purchase from the Company one one-hundredth of a share of Series A Junior Participating Preferred Stock (&#x201C;Series A Stock&#x201D;) of the Company at $</font><font style="display: inline;font-size:10pt;">33.33</font><font style="display: inline;font-size:10pt;"> per one one-hundredth of a Preferred Share, subject to adjustment.&nbsp;&nbsp;Additionally, each common share that has or shall become outstanding after December 11, 1995 is also entitled to a Right, subject to the terms and conditions of the rights agreement.&nbsp;&nbsp;The Rights, which expire on November 23, 2015, may be exercised only if certain conditions are met, such as the acquisition of </font><font style="display: inline;font-size:10pt;">15</font><font style="display: inline;font-size:10pt;">% or more of the Company's common stock by a person or affiliated group (together with its affiliates, associates, and transferees, an "Acquiring Person").&nbsp;&nbsp;Rights beneficially owned by an Acquiring Person become void from and after the time such persons become Acquiring Persons, and Acquiring Persons have no rights whatsoever under the rights agreement.</font></font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Each share of Series A Stock purchasable upon exercise of a Right will be entitled, when, as, and if declared, to a minimum preferential quarterly dividend payment of $</font><font style="display: inline;font-size:10pt;">1.00</font><font style="display: inline;font-size:10pt;"> per share but will be entitled to an aggregate dividend of </font><font style="display: inline;font-size:10pt;">100</font><font style="display: inline;font-size:10pt;"> times the dividend declared per share of common stock.&nbsp;&nbsp;In the event of liquidation, each share of the Series A Stock will be entitled to a minimum preferential liquidation payment of </font><font style="display: inline;font-size:10pt;">100</font><font style="display: inline;font-size:10pt;"> times the payment made per share of common stock.&nbsp;&nbsp;Finally, in the event of any merger, consolidation, or other transaction in which shares of common stock are exchanged, each share of Series A Stock will be entitled to receive </font><font style="display: inline;font-size:10pt;">100</font><font style="display: inline;font-size:10pt;"> times the amount received per share of common stock.&nbsp;&nbsp;These rights are protected by customary antidilution provisions.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In the event the Rights become exercisable, each Right will enable the owner, other than Acquiring Persons, to purchase shares of the Company&#x2019;s Series A Stock as described above.&nbsp;&nbsp;Alternatively, if the Rights become exercisable, the holder of a Right may elect to receive, upon exercise of the Right and in lieu of receiving Series A Stock, that number of shares of common stock of the Company having an exercise value of two times the exercise price of the Right.&nbsp;&nbsp;In the event that, after a person or group has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction or </font><font style="display: inline;font-size:10pt;">50</font><font style="display: inline;font-size:10pt;">% or more of its consolidated assets or earning power are sold, proper provision will be made so that each holder of a Right will thereafter have the right to receive, upon the exercise of a Right, and in lieu of Series A Stock of the Company, that number of shares of common stock of the person with whom the Company has engaged in the foregoing transaction (or its parent) that at the time of such transaction will have a market value of two times the exercise price of the Right.&nbsp;&nbsp;In addition, after any person or group becomes an Acquiring Person and prior to the acquisition by the person or group of </font><font style="display: inline;font-size:10pt;">50</font><font style="display: inline;font-size:10pt;">% or more of the outstanding common stock, the Board of Directors may elect to exchange all outstanding Rights at an exchange ratio of one share of common stock (or fractional share of Series A Stock or other preferred shares) per Right (subject to adjustment).</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 2400000 P15Y 2886000 4593000 38000 8000 133000 65000 79000 66000 270000 288000 1693000 false --12-31 FY 2013 2013-12-31 10-K 0000784199 27894710 Yes Accelerated Filer 155031053 CRYOLIFE INC No No cry 3156000 4137000 15941000 17838000 4205000 2411000 1603000 1686000 46119000 49246000 -39000 7000 122414000 128585000 -445000 -445000 -143000 -143000 -87000 -87000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Advertising Costs</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The costs to develop, produce, and communicate the Company&#x2019;s advertising are expensed as incurred and are classified as general, administrative, and marketing expenses.&nbsp;&nbsp;The Company records the cost to print or copy certain sales materials as a prepaid expense and amortizes these costs as an advertising expense over the period they are expected to be used, typically six months to one year.&nbsp;&nbsp;The total amount of advertising expense included in the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income was $</font><font style="display: inline;font-size:10pt;">880,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">1.5</font><font style="display: inline;font-size:10pt;"> million, and $</font><font style="display: inline;font-size:10pt;">948,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively. </font></font> </p> <p><font size="1"> </font></p> </div> </div> 948000 1500000 880000 3014000 1408000 1606000 3376000 2204000 1172000 3468000 2616000 852000 528000 356000 1370000 1971000 2006000 2000000 1700000 656000 157156000 174683000 77503000 106327000 1642000 1642000 6448000 6448000 1.00 0.11 0.32 0.11 0.31 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:78.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:19.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.40%;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>123,951&nbsp; </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,962&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Twelve Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">December 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>133,722&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>124,877&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,758&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,205&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Pro forma income per common share - basic</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.32&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Pro forma income per common share - diluted</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.31&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.457 7962000 3205000 8758000 123951000 124877000 133722000 3000000 -72000 28000 4500000 1912000 1884000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">6.&nbsp;&nbsp;Cardiogenesis Acquisition</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Overview</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On May 17, 2011 CryoLife completed its acquisition of all of the outstanding shares of Cardiogenesis for </font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">0.457</font><font style="display: inline;font-size:10pt;"> per share or approximately $</font><font style="display: inline;font-size:10pt;">21.7</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;CryoLife used cash on hand to fund the transaction and operates Cardiogenesis as a wholly owned subsidiary.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Cardiogenesis is a leading developer of surgical products used in the treatment of patients with severe angina resulting from diffuse coronary artery disease.&nbsp; </font><font style="display: inline;font-size:10pt;">Cardiogenesis markets its revascularization technologies, which include the Holmium: YAG laser console and single use, fiber-optic handpieces.&nbsp;&nbsp;These products are </font><font style="display: inline;font-size:10pt;">FDA </font><font style="display: inline;font-size:10pt;">approved for performing a surgical procedure known as Transmyocardial Revascularization, used for treating patients with stable angina that is not responsive to conventional therapy.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accounting for the Transaction&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company recorded an allocation of the </font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">21.7</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> purchase price to Cardiogenesis&#x2019; tangible and identifiable intangible assets acquired and liabilities assumed based on their acquisition date fair values.&nbsp;&nbsp;The allocation of the purchase price to intangible assets was based on valuations performed to determine the fair value of such assets as of the acquisition date.&nbsp;&nbsp;Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired.&nbsp;&nbsp;The liability amounts recorded included the Company&#x2019;s estimate of contingent liabilities assumed.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The purchase price allocation as of December 31, 2011 was as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Opening</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Balance Sheet</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>650&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Receivables</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,055&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Inventory</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>852&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Property and equipment</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>248&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,900&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,002&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>230&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Liabilities assumed</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,445) </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total purchase price</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,712&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">CryoLife incurred approximately $</font><font style="display: inline;font-size:10pt;">3.0</font><font style="display: inline;font-size:10pt;"> million in transaction and integration costs related to the acquisition in the year ended December 31, 2011.&nbsp;&nbsp;The Company did not incur significant transaction or integration costs </font><font style="display: inline;font-size:10pt;">related to the Cardiogenesis acquisition </font><font style="display: inline;font-size:10pt;">in 2012 or 2013.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;text-align:left;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Pro Forma Results</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Cardiogenesis&#x2019; revenues of $</font><font style="display: inline;font-size:10pt;">5.7</font><font style="display: inline;font-size:10pt;"> million from the date of acquisition are included in the Company&#x2019;s Consolidated Statement</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;"> of Operations and Comprehensive Income for the year ended December 31, 2011.&nbsp; </font><font style="display: inline;font-size:10pt;">U</font><font style="display: inline;font-size:10pt;">naudited pro forma results of operations for the year ended December 31, 2011, assuming the Cardiogenesis acquisition had occurred </font><font style="display: inline;font-size:10pt;">prior to 2011</font><font style="display: inline;font-size:10pt;">, are presented for comparative purposes below (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:78.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:19.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:13.40%;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>123,951&nbsp; </td> </tr> <tr> <td colspan="3" valign="bottom" style="width:86.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,962&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Pro forma disclosures were calculated using a tax rate of approximately </font><font style="display: inline;font-size:10pt;">36</font><font style="display: inline;font-size:10pt;">%.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Legal Action</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In 2008 CardioFocus, Inc. (&#x201C;CardioFocus&#x201D;) filed a complaint in the U.S. District Court for the District of Massachusetts (&#x201C;Massachusetts Court&#x201D;) against Cardiogenesis and a number of other companies.&nbsp;&nbsp;The litigation related to an alleged infringement by Cardiogenesis of two patents held by CardioFocus that have now expired.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-family:Tms Rmn;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On June 14, 2012 Cardiogenesis entered into a settlement agreement with respect to its litigation with CardioFocus.&nbsp;&nbsp;The settlement provides that each party release the other from all claims and liabilities related to the patents in question and that all claims and counterclaims in the litigation be withdrawn with prejudice.&nbsp;&nbsp;Pursuant to the terms of the settlement agreement, Cardiogenesis paid $</font><font style="display: inline;font-size:10pt;">4.5</font><font style="display: inline;font-size:10pt;"> million in cash to CardioFocus.&nbsp;&nbsp;Cardiogenesis and CardioFocus agreed and acknowledged that each party would bear its own costs and expenses, including attorneys&#x2019; fees, incurred in or as a result of the litigation.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-family:Tms Rmn;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On June 14, 2012 the parties filed a stipulation of dismissal with prejudice in the Massachusetts Court.</font></font> </p> <p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Accounting for the Settlement</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As a result of the settlement described above, the Company recorded an additional loss of $</font><font style="display: inline;font-size:10pt;">3.6</font><font style="display: inline;font-size:10pt;"> million in general, administrative, and</font><font style="display: inline;font-size:10pt;"> marketing expenses on its Consolidated Statement</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;"> of Operations and Comprehensive Income in the second quarter of 2012 for a total of $</font><font style="display: inline;font-size:10pt;">4.1</font><font style="display: inline;font-size:10pt;"> million in legal settlement expenses for the </font><font style="display: inline;font-size:10pt;">year ended</font><font style="display: inline;font-size:10pt;"> December 31, 2012</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;The Company paid the $</font><font style="display: inline;font-size:10pt;">4.5</font><font style="display: inline;font-size:10pt;"> million settlement payment to CardioFocus in July 2012 using cash on hand.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">4.&nbsp;&nbsp;Hemosphere Acquisition</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Overview&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On May 16, 2012 CryoLife completed its acquisition of </font><font style="display: inline;font-size:10pt;">100</font><font style="display: inline;font-size:10pt;">% of the outstanding equity of Hemosphere, a privately held company, for </font><font style="display: inline;font-size:10pt;">$17.0</font><font style="display: inline;font-size:10pt;"> million in cash, an additional $</font><font style="display: inline;font-size:10pt;">3.2</font><font style="display: inline;font-size:10pt;"> million paid for cash acquired, and contingent consideration with a fair value estimated to be approximately $</font><font style="display: inline;font-size:10pt;">1.8</font><font style="display: inline;font-size:10pt;"> million at acquisition, for a total purchase price of approximately </font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">22.0</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;">.</font><font style="display: inline;font-size:10pt;"> &nbsp;CryoLife used cash on hand to fund the transaction and operates Hemosphere as a wholly owned subsidiary.&nbsp;&nbsp;</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Hemosphere is the developer and marketer of the HeRO Graft, a proprietary graft-based solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction.&nbsp; </font><font style="display: inline;font-size:10pt;">CryoLife believes that the HeRO Graft will fit well into its product portfolio of medical devices for cardiac and vascular surgery and believes there is a significant opportunity for CryoLife&#x2019;s sales team to leverage their strong relationships with vascular surgeons to introduce and to expand utilization of the HeRO Graft in the U.S.&nbsp;&nbsp;</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Contingent Consideration&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of the acquisition date, CryoLife recorded a contingent consideration liability of </font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">1.8</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> in long-term liabilities on its Consolidated Balance Sheet, representing the estimated fair value of the contingent consideration expected to be paid to the former shareholders of Hemosphere upon the achievement of certain revenue-based milestones.&nbsp;&nbsp;The acquisition agreement provides for a maximum of $</font><font style="display: inline;font-size:10pt;">4.5</font><font style="display: inline;font-size:10pt;"> million in future consideration payments through December 2015 based on specified sales targets.&nbsp;&nbsp;</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach.&nbsp;&nbsp;The Company applied a risk-based estimate of the probability of achieving each scenario and then applied a cost of debt based discount rate of </font><font style="display: inline;font-size:10pt;">8</font><font style="display: inline;font-size:10pt;">%.&nbsp;&nbsp;This fair value measurement is based on unobservable inputs, including management estimates and assumptions about future revenues, and is, therefore, classified as Level 3 within the fair value hierarchy presented in </font><font style="display: inline;font-size:10pt;">Note 2</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;The Company will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in other (income) expense on the Company&#x2019;s Consolidated Statement</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;"> of Operations and Comprehensive Income.&nbsp;&nbsp;Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount periods and rates, as well as changes in the timing and amount of Company revenue estimates.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company recorded a gain of $</font><font style="display: inline;font-size:10pt;">28,000</font><font style="display: inline;font-size:10pt;"> for the </font><font style="display: inline;font-size:10pt;">year ended</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and a loss of </font><font style="display: inline;font-size:10pt;">$72,000</font><font style="display: inline;font-size:10pt;"> for the year ended December 31, 2012 on the remeasurement of the contingent consideration liability.&nbsp;&nbsp;The balance of the contingent consideration liability was $</font><font style="display: inline;font-size:10pt;">1.9</font><font style="display: inline;font-size:10pt;"> million as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">.</font><font style="display: inline;font-size:10pt;">&nbsp;&nbsp;</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accounting for the Transaction</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has recorded an allocation of the $</font><font style="display: inline;font-size:10pt;">22.0</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> purchase price to Hemosphere&#x2019;s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values as of May 16, 2012.&nbsp;&nbsp;Goodwill has been recorded based on the amount by which the purchase price exceeds the fair value of the net assets acquired and is not deductible for tax purposes.&nbsp;&nbsp;Goodwill from this transaction has been allocated to the Company&#x2019;s medical devices segment.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The purchase price allocation as of December 31, 2012 is as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Opening</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Balance Sheet</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,155&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Receivables</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>653&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Inventories</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>554&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,790&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,145&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax assets, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,379&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>331&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Liabilities assumed</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(972) </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total purchase price</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,035&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">CryoLife incurred integration costs of </font><font style="display: inline;font-size:10pt;">$940,000</font><font style="display: inline;font-size:10pt;"> for the year ended December 31, 2013 and transaction and integration costs related to the acquisition of approximately $</font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million for the </font><font style="display: inline;font-size:10pt;">year ended</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;">. &nbsp;</font><font style="display: inline;font-size:10pt;"> These costs were expensed as incurred and were primarily recorded as general, administrative, and marketing expenses on the Company&#x2019;s Consolidated Statement</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;"> of Operations and Comprehensive Income.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Pro Forma Results</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Hemosphere&#x2019;s revenues of </font><font style="display: inline;font-size:10pt;">$3.1</font><font style="display: inline;font-size:10pt;"> million from the date of acquisition through December 31, 2012 are included in the Consolidated Statement</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;"> of Operations and Comprehensive Income.&nbsp;&nbsp;The Company&#x2019;s unaudited pro forma results of operations for the </font><font style="display: inline;font-size:10pt;">year ended</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">assuming the Hemosphere acquisition had occurred as of January 1, 2011 are presented for comparative purposes below.&nbsp;&nbsp;These amounts are based on available information of the results of operations of Hemosphere prior to the acquisition date and are not necessarily indicative of what the results of operations would have been had the acquisition been completed on January 1, 2011.&nbsp;&nbsp;This unaudited pro forma information does not project operating results post acquisition.&nbsp;&nbsp;This pro forma information is as follows (in thousands, except per share amounts):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Twelve Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">December 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>133,722&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>124,877&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,758&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,205&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:11pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Pro forma income per common share - basic</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.32&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:73.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Pro forma income per common share - diluted</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.31&nbsp; </td> <td valign="bottom" style="width:03.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> </tr> </table></div> <p style="margin:0pt -0.9pt 0pt 0pt;line-height:100%;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Pro forma results for the </font><font style="display: inline;font-size:10pt;">year ended</font><font style="display: inline;font-size:10pt;"> December 31, 2011 include the Company&#x2019;s acquisition and integration related costs of approximately $</font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million, on a pre-tax basis, and other costs as appropriate.&nbsp;&nbsp;Pro forma disclosures were calculated using a tax rate of approximately </font><font style="display: inline;font-size:10pt;">34%</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 940000 1800000 650000 3155000 230000 331000 1055000 653000 5002000 5379000 11900000 5790000 852000 554000 2445000 972000 248000 21700000 21712000 22000000 22035000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Valuation of Acquired Assets or Businesses</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"> &nbsp;As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies.&nbsp;&nbsp;The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group, or as a business combination, as appropriate.&nbsp;&nbsp;The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values.&nbsp;&nbsp;In-process research and development acquired as part of an asset group is expensed upon acquisition.&nbsp;&nbsp;The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value.&nbsp;&nbsp;Transaction costs related to a business combination are expensed as incurred.&nbsp;&nbsp;In-process research and development acquired as part of a business combination is accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief from royalty methods.&nbsp;&nbsp;The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates.&nbsp;&nbsp;Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge.&nbsp;&nbsp;Management believes that its estimates are reasonable, but actual results could differ significantly from the Company&#x2019;s estimates.&nbsp;&nbsp;A significant change in management&#x2019;s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company&#x2019;s financial position and profitability.&nbsp;&nbsp;If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company&#x2019;s financial position and profitability.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 0 0 3200000 35497000 21705000 13009000 37643000 1319000 1319000 749000 5349000 749000 5349000 -13811000 -8645000 24598000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Cash equivalents consist primarily of highly liquid investments with maturity dates of three months or less at the time of acquisition.&nbsp;&nbsp;The carrying value of cash equivalents approximates fair value.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;">In 2012 the Company&#x2019;s cash equivalents included advance funding received from the U.S. Department of Defense (&#x201C;DOD&#x201D;) for the development of protein hydrogel technology.&nbsp;&nbsp;The advance funding was accounted for as deferred income on the Company&#x2019;s December 31, 2012 Consolidated Balance Sheet and revenue was recognized as expenses were incurred related to these grants.&nbsp;&nbsp;The Company discontinued its BioFoam U.S. clinical trial and returned all of the remaining unspent funds to the DOD in the second quarter of 2013.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash Flow Supplemental Disclosures</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Supplemental disclosures of cash flow information for the years ended December 31 (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash paid during the year for:</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Interest</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>89&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income taxes</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,693&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,263&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,564&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">3.&nbsp;&nbsp;Cash Equivalents and Restricted Cash and Securities</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The following is a summary of cash equivalents and marketable securities (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Unrealized</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Estimated</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Holding</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Market</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Cost Basis</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gains (Losses)</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Certificates of deposit</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted cash and securities:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">$350,000</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">323,000</font><font style="display: inline;font-size:10pt;">, respectively, of the Company&#x2019;s money market funds were designated as short-term restricted securities due to a contractual commitment to hold the securities as pledged collateral relating primarily to international tax obligations.&nbsp; </font><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">$5.0</font><font style="display: inline;font-size:10pt;"> million of the Company&#x2019;s cash was designated as restricted cash due to a financial covenant requirement under the Company&#x2019;s credit agreement with </font><font style="display: inline;font-size:10pt;">General Electric Capital Corporation (&#x201C;GE Capital&#x201D;) as discussed in</font><font style="display: inline;font-size:10pt;"> Note 11</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;A</font><font style="display: inline;font-size:10pt;">s of </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> &nbsp;$</font><font style="display: inline;font-size:10pt;">5.0</font><font style="display: inline;font-size:10pt;"> million of the Company&#x2019;s cash was designated as long-term restricted securities under the same covenant.&nbsp; </font><font style="display: inline;font-size:10pt;">This restriction lapses upon expiration of the credit agreement with GE Capital on October 28, 2014.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">There were </font><font style="display: inline;font-size:10pt;">no</font><font style="display: inline;font-size:10pt;"> gross realized gains or losses on cash equivalents or restricted securities for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">.</font><font style="display: inline;font-size:10pt;"> &nbsp;At </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">$5.0</font><font style="display: inline;font-size:10pt;"> million </font><font style="display: inline;font-size:10pt;">of the Company&#x2019;s restricted cash had no maturity date.&nbsp;&nbsp;At </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">$328,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">of the Company&#x2019;s restricted securities had a maturity date within three months</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">$22,000</font><font style="display: inline;font-size:10pt;"> of the</font><font style="display: inline;font-size:10pt;"> Company&#x2019;s restricted securities had a maturity date between three months and one year.&nbsp;&nbsp;At </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">323,000</font><font style="display: inline;font-size:10pt;"> of the Company&#x2019;s restricted securities had a maturity date within three months.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">12.&nbsp;&nbsp;Commitments and Contingencies</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Leases</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company's operating lease obligations result from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment.</font><font style="display: inline;font-size:10pt;"> &nbsp;In prior years, the Company's capital lease obligations resulted from the financing of certain of the Company's equipment.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> the remaining obligations under the Company&#x2019;s capital leases was </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The term of the lease of the land and buildings that comprise the Company&#x2019;s corporate headquarters was originally </font><font style="display: inline;font-size:10pt;">15</font><font style="display: inline;font-size:10pt;"> years.&nbsp;&nbsp;During the second quarter of 2010 the Company signed an amendment to the lease on its corporate headquarters extending the lease until 2022.</font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-size:10pt;">The Company has a deferred rent obligation of $</font><font style="display: inline;font-size:10pt;">1.7</font><font style="display: inline;font-size:10pt;"> million as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">$1.6</font><font style="display: inline;font-size:10pt;"> million as of </font><font style="display: inline;font-size:10pt;">December 31, </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> recorded on the Company&#x2019;s Consolidated Balance Sheets, primarily related to the lease on its corporate headquarters.&nbsp;&nbsp;Total</font><font style="display: inline;font-size:10pt;"> rental expense for operating leases was $</font><font style="display: inline;font-size:10pt;">3.0</font><font style="display: inline;font-size:10pt;"> million in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">2.7</font><font style="display: inline;font-size:10pt;"> million in both </font><font style="display: inline;font-size:10pt;">2012 </font><font style="display: inline;font-size:10pt;">and</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Future minimum operating lease payments under non-cancelable leases as of December 31, 2013 are as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Operating</font></p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Leases</font></p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2014</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,799&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2015</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,031&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2016</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,943&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2017</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,980&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2018</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,010&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Thereafter</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,124&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total minimum lease payments</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,887&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Liability Claims</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">At December 31, 2013 and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> the </font><font style="display: inline;font-size:10pt;">Company&#x2019;s</font><font style="display: inline;font-size:10pt;"> unreported loss liability</font><font style="display: inline;font-size:10pt;"> was $</font><font style="display: inline;font-size:10pt;">1.5</font><font style="display: inline;font-size:10pt;"> million and $</font><font style="display: inline;font-size:10pt;">1.7</font><font style="display: inline;font-size:10pt;"> million, respectively.&nbsp;&nbsp;The </font><font style="display: inline;font-size:10pt;">related recoverable insurance amounts </font><font style="display: inline;font-size:10pt;">were $</font><font style="display: inline;font-size:10pt;">580,000</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">620,000</font><font style="display: inline;font-size:10pt;"> as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and 2012, respectively.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long</font><font style="display: inline;font-size:10pt;">&#8209;term liabilities and records the related recoverable insurance amounts as a component of receivables and other long</font><font style="display: inline;font-size:10pt;">&#8209;term assets</font><font style="display: inline;font-size:10pt;">, as appropriate</font><font style="display: inline;font-size:10pt;">. &nbsp;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">Further analysis indicated that the liability as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> could be estimated to be as high as $</font><font style="display: inline;font-size:10pt;">2.7</font><font style="display: inline;font-size:10pt;"> million, after including a reasonable margin for statistical fluctuations calculated based on actuarial simulation techniques.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Employment Agreement&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has an employment agreement with its Chief Executive Officer (&#x201C;CEO&#x201D;) that confers benefits which become payable upon </font><font style="display: inline;font-size:10pt;">the</font><font style="display: inline;font-size:10pt;"> occurrence of certain events, including the voluntary retirement of the CEO or termination of the CEO&#x2019;s employment in conjunction with certain change events.&nbsp;&nbsp;As of both </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> the Company had $</font><font style="display: inline;font-size:10pt;">2.1</font><font style="display: inline;font-size:10pt;"> million in accrued expenses and other current liabilities on the Consolidated Balance Sheets representing benefits payable upon the CEO&#x2019;s voluntary retirement, for which he is currently eligible.&nbsp;&nbsp;The CEO&#x2019;s current agreement took effect on January 1, 2013 and terminates on December 31, 2015.&nbsp;&nbsp;A payment of $</font><font style="display: inline;font-size:10pt;">100,000</font><font style="display: inline;font-size:10pt;"> was made in January 2013 in accordance with the terms of the new agreement.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:lime;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">PerClot Technology</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:lime;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On September 28, 2010 the Company </font><font style="display: inline;font-size:10pt;">entered into a worldwide distribution agreement (the &#x201C;Distribution Agreement&#x201D;) and a license and manufacturing agreement (the &#x201C;License Agreement&#x201D;) with SMI of San Jose, California for PerClot, a polysaccharide hemostatic agent used in surgery.&nbsp;&nbsp;The Distribution Agreement contains certain minimum purchase requirements and has a term of </font><font style="display: inline;font-size:10pt;">15</font><font style="display: inline;font-size:10pt;"> years.&nbsp;&nbsp;Following the start of manufacturing and U.S. regulatory approval, CryoLife may terminate the Distribution Agreement and the related </font><font style="display: inline;font-size:10pt;">minimum purchase requirements</font><font style="display: inline;font-size:10pt;"> and sell PerClot pursuant to the License Agreement.</font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-size:10pt;">The Company will pay royalties to SMI at stated rates on net revenues of products manufactured under the License Agreement and will pay additional contingent amounts of up to $</font><font style="display: inline;font-size:10pt;">2.5</font><font style="display: inline;font-size:10pt;"> million to SMI if certain FDA regulatory and other commercial milestones are achieved.&nbsp;&nbsp;The Company</font><font style="display: inline;font-size:10pt;"> expects to record future contingent payment amounts of up to $</font><font style="display: inline;font-size:10pt;">2.5</font><font style="display: inline;font-size:10pt;"> million initially as research and development expense or, after FDA approval or issuance of a patent, as acquired intangible assets. </font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font></font> </p> <p><font size="1"> </font></p> </div> </div> 0.050 0.108 0.050 0.025 0.025 0.108 0.0275 0.01 0.01 75000000 75000000 27486000 28244000 29950000 -2049000 30067000 -2265000 27486000 -14000 28244000 -413000 275000 282000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">14.&nbsp;&nbsp;Employee Benefit Plans</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">401(k) Plan</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has a 401(k) savings plan (the "Plan") providing retirement benefits to all employees who have completed at least three months of service.&nbsp;&nbsp;The Company made matching contributions of </font><font style="display: inline;font-size:10pt;">40%</font><font style="display: inline;font-size:10pt;"> of each participant's contribution for up to </font><font style="display: inline;font-size:10pt;">5%</font><font style="display: inline;font-size:10pt;"> of each participant's salary in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;In </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> the Company made matching contributions to the plan of </font><font style="display: inline;font-size:10pt;">20%</font><font style="display: inline;font-size:10pt;"> of each participant&#x2019;s contribution for up to </font><font style="display: inline;font-size:10pt;">5%</font><font style="display: inline;font-size:10pt;"> of each participant&#x2019;s salary.&nbsp;&nbsp;Total Company contributions approximated $</font><font style="display: inline;font-size:10pt;">541,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">500,000</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">$204,000</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, 2012, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.&nbsp;&nbsp;Additionally, the Company may make discretionary contributions to the Plan that are allocated to each participant's account.&nbsp;&nbsp;No discretionary contributions were made in any of the past three years.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Compensation Plan</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">On January 1, 2011 CryoLife initiated a nonqualified Deferred Compensation Plan (&#x201C;Deferred Plan&#x201D;).&nbsp;&nbsp;The Deferred Plan allows certain employees of CryoLife to defer receipt of a portion of their salary and cash bonus.&nbsp;&nbsp;The Deferred Plan provides for tax-deferred growth of deferred compensation.&nbsp;&nbsp;Pursuant to the terms of the Deferred Plan, CryoLife agrees to return the deferred amounts plus gains and losses, based on investment fund options chosen by each respective participant, to the plan participants upon distribution.&nbsp;&nbsp;All deferred amounts and deemed earnings thereon are vested at all times.&nbsp;&nbsp;The Company has no current plans to match any contributions.&nbsp;&nbsp;Amounts owed to plan participants are unsecured obligations of CryoLife.&nbsp;&nbsp;CryoLife has established a rabbi trust in which it will make contributions to fund its obligations under the Deferred Plan.&nbsp;&nbsp;Pursuant to the terms of the trust, CryoLife will be required to make contributions each year to fully match its obligations under the Deferred Plan.&nbsp;&nbsp;The trust&#x2019;s funds are invested in Company Owned Life Insurance (&#x201C;COLI&#x201D;) and the Company plans to hold the policies until the death of the insured.</font></font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s deferred compensation liabilities are recorded as a component of other current liabilities or long-term deferred compensation liabilities, as appropriate, based on anticipated distribution dates.&nbsp;&nbsp;The cash surrender value of COLI is recorded in other long-term assets.&nbsp;&nbsp;Changes in the value of participant accounts and changes in the cash surrender value of COLI are recorded as part of the Company&#x2019;s operating expenses and </font><font style="display: inline;font-size:10pt;">are subject to the Company&#x2019;s normal allocation of expenses to inventory and deferred preservation costs.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 7397000 7913000 16218000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Principles of Consolidation</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&nbsp;&nbsp;All significant inter-company accounts and transactions have been eliminated in consolidation.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">5.&nbsp;&nbsp;ValveXchange </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Preferred Stock Investment</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">In July 2011 the Company purchased </font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million shares of Series A Preferred Stock of </font><font style="display: inline;font-size:10pt;">ValveXchange, Inc. (&#x201C;ValveXchange&#x201D;) for approximately $</font><font style="display: inline;font-size:10pt;">3.5</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;ValveXchange is a private medical device company that was spun off from Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company&#x2019;s carrying value of this investment included the purchase price and certain transaction costs, and </font><font style="display: inline;font-size:10pt;">CryoLife&#x2019;s investment represented an approximate </font><font style="display: inline;font-size:10pt;">19</font><font style="display: inline;font-size:10pt;">% equity ownership in ValveXchange.&nbsp; </font><font style="display: inline;font-size:10pt;">As ValveXchange&#x2019;s stock </font><font style="display: inline;font-size:10pt;">is not actively traded on any public stock exchange, as the Company does not exert significant influence over ValveXchange, and as the Company&#x2019;s investment is in preferred stock, the Company accounted for this investment using the cost method.&nbsp;&nbsp;The Company recorded its investment as a long-term asset, investment in equity securities, on the Company&#x2019;s Consolidated Balance Sheets.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Loan Agreement</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In July 2011 the Company entered into an agreement with ValveXchange, as amended, to make available up to </font><font style="display: inline;font-size:10pt;">$2.0</font><font style="display: inline;font-size:10pt;"> million to ValveXchange in debt financing through a revolving credit facility (the &#x201C;Loan&#x201D;).&nbsp;&nbsp;The Loan includes various affirmative and negative covenants, including financial covenant requirements, and expires on </font><font style="display: inline;font-size:10pt;">July 30, 2018</font><font style="display: inline;font-size:10pt;">, unless terminated earlier.&nbsp;&nbsp;Amounts loaned under the Loan will earn interest at an </font><font style="display: inline;font-size:10pt;">8%</font><font style="display: inline;font-size:10pt;"> annual rate and are secured by substantially all of the tangible and intangible assets of ValveXchange.&nbsp;&nbsp;The Company incurred loan origination costs, net of fees charged to ValveXchange, of approximately </font><font style="display: inline;font-size:10pt;">$117,000</font><font style="display: inline;font-size:10pt;">, which are being expensed on a straight-line basis over the life of the loan facility.&nbsp;&nbsp;The Company advanced $2.0 million to ValveXchange under the Loan in 2012.&nbsp;&nbsp;The </font><font style="display: inline;font-size:10pt;">$2.0</font><font style="display: inline;font-size:10pt;"> million advance is recorded as long-term notes receivable on the Company&#x2019;s Consolidated Balance Sheets as of December 31, 2013 and 2012.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">During 2013 CryoLife repeatedly notified ValveXchange that ValveXchange was in default of certain loan covenants, due to factors including ValveXchange&#x2019;s failure to obtain CryoLife&#x2019;s consent for certain convertible note financings that ValveXchange obtained during the year.&nbsp;&nbsp;These events of default were ongoing as of February 15, 2014.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Investment and Loan Analysis </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">During the quarter ended September 30, 2012 the Company reviewed available information to determine if factors indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment.&nbsp;&nbsp;The Company determined that available information indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment.&nbsp;&nbsp;The Company used available information to analyze its investment for impairment, and the information indicated that the fair value of the investment was less than the carrying value.&nbsp;&nbsp;Therefore, based on this analysis, the Company believed that its investment in ValveXchange was impaired in the third quarter of 2012, and the impairment was other than temporary.&nbsp;&nbsp;As a result, the Company recorded an other non-operating expense of </font><font style="display: inline;font-size:10pt;">$340,000</font><font style="display: inline;font-size:10pt;"> to write down its investment in ValveXchange preferred stock.&nbsp;&nbsp;During the quarters ended December 31, 2012, June 30, 2013, and September 30, 2013 the Company reevaluated its investment in ValveXchange preferred stock for impairment.&nbsp;&nbsp;At the time of each of these analyses, the Company did not believe that its investment in ValveXchange was impaired further.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">During the quarter ended December 31, 2013 the Company determined that available information, including ValveXchange&#x2019;s financial condition and cash position, indicated that the Company should reevaluate its investment in ValveXchange preferred stock for impairment.&nbsp;&nbsp;The Company used available information</font><font style="display: inline;font-size:10pt;">, including new information obtained in the fourth quarter of 2013,</font><font style="display: inline;font-size:10pt;"> to analyze its investment for impairment, and </font><font style="display: inline;font-size:10pt;">this</font><font style="display: inline;font-size:10pt;"> information indicated that the fair value of the investment had declined significantly and any remaining value was nominal.&nbsp;&nbsp;Therefore, based on this analysis, the Company believes that its investment in ValveXchange was fully impaired as of December 31, 2013, and the impairment was other than temporary.&nbsp;&nbsp;As a result, the Company recorded an other non-operating expense of </font><font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;">3.2</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> to write-down its investment in ValveXchange preferred stock.&nbsp;&nbsp;The carrying value of the Company&#x2019;s investment in ValveXchange preferred stock after this write down was </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;"> as of December 31, 2013.&nbsp;&nbsp;The carrying value of the Company&#x2019;s investment in ValveXchange preferred stock was </font><font style="display: inline;font-size:10pt;">$3.2</font><font style="display: inline;font-size:10pt;"> million as of December 31, 2012.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">ValveXchange is currently attempting to raise additional funds to support its short-term and long-term operations.&nbsp;&nbsp;If ValveXchange is unable to secure material amounts of additional financing, it will likely be unable to meet its obligations, and, therefore, CryoLife may need to foreclose on the related collateral to secure repayment of the Loan.&nbsp;&nbsp;Although CryoLife currently believes that the value of the collateral is adequate to repay the Loan, there is no guarantee that the security for the notes will be sufficient to repay the Loan. </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Option Agreement</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Concurrently with the Loan described above, CryoLife entered into an option agreement with ValveXchange through which CryoLife obtained the right of first refusal to acquire ValveXchange during a period that extends through the completion of initial commercialization milestones and the right to negotiate with ValveXchange for European distribution rights.&nbsp;&nbsp;The Company&#x2019;s rights may be modified or reduced in connection with a future round of financing.</font><font style="display: inline;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 5908000 2600000 3200000 0 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">7.&nbsp;&nbsp;Medafor Matters</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Investment in Medafor Common Stock</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In 2009 and 2010 CryoLife purchased shares of common stock in Medafor, Inc. (&#x201C;Medafor&#x201D;).&nbsp;&nbsp;As financial information for Medafor is not readily available and as the Company does not exert significant influence over the operations of Medafor, the Company accounted for its investment in Medafor common stock using the cost method.&nbsp;&nbsp;The Company recorded the stock as a long-term asset, investment in equity securities, on the Company&#x2019;s Consolidated Balance Sheets.&nbsp; The carrying value of the Company&#x2019;s </font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million shares of Medafor common stock was approximately </font><font style="display: inline;font-size:10pt;">$2.6</font><font style="display: inline;font-size:10pt;"> million as of December 31, 2012, prior to the sale of this investment in 2013 as described below.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In connection with its purchase of Medafor common stock, the Company entered into agreements with the sellers that could have required CryoLife to make additional payments to the sellers if CryoLife acquired or merged with Medafor within a specified time period.&nbsp;&nbsp;The Company accounted for these provisions as an embedded derivative.&nbsp;&nbsp;The last of these provisions expired in June 2013, and as of December 31, 2013 a derivative no longer exists.&nbsp;&nbsp;As of December 31, 2012 the value of this derivative was </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">C.R. Bard&#x2019;s Acquisition of Medafor</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">On October 1, 2013 C.R. Bard, Inc. (&#x201C;Bard&#x201D;) completed its previously announced acquisition of the outstanding shares of Medafor common stock.&nbsp;&nbsp;The Company </font><font style="display: inline;font-size:10pt;">received an initial payment of approximately </font><font style="display: inline;font-size:10pt;">$15.4</font><font style="display: inline;font-size:10pt;"> million for its </font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million shares of Medafor common stock and recorded an initial </font><font style="display: inline;font-size:10pt;">gain of </font><font style="display: inline;font-size:10pt;">$12.7</font><font style="display: inline;font-size:10pt;"> million on the sale</font><font style="display: inline;font-size:10pt;"> in the fourth quarter of 2013.&nbsp;&nbsp;The Company could receive additional payments totaling up to an additional </font><font style="display: inline;font-size:10pt;">$8.4</font><font style="display: inline;font-size:10pt;"> million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015,</font><font style="display: inline;font-size:10pt;"> based on information provided by Medafor as part of the September 24, 2013 Medafor Proxy Statement</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;The first of these additional payments, which the Company believes could be up to approximately </font><font style="display: inline;font-size:10pt;">$525,000</font><font style="display: inline;font-size:10pt;">, if released, would be received in late 2014, although this amount is subject to possible offsets.&nbsp;&nbsp;These payments will be recorded as an additional gain when and if received by the Company.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Distribution Agreement and Legal Action</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">CryoLife distributed a powdered hemostat for Medafor from 2008 to 2010.&nbsp;&nbsp;CryoLife filed a lawsuit against Medafor in 2009 in the U.S. District Court for the Northern District of Georgia (&#x201C;Georgia Court&#x201D;). &nbsp;In 2010 Medafor filed counterclaims against CryoLife in the same case.&nbsp;&nbsp;The litigation related to an exclusive distribution agreement that the parties entered into in April 2008.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In June 2012 the parties entered into a settlement agreement.&nbsp;&nbsp;Per the settlement, Medafor paid </font><font style="display: inline;font-size:10pt;">$3.5</font><font style="display: inline;font-size:10pt;"> million in cash to CryoLife in the third quarter of 2012.&nbsp;&nbsp;On June 29, 2012 the parties jointly filed stipulated dismissals with prejudice with the Georgia Court.&nbsp; As a result of the settlement, CryoLife recorded a gain of </font><font style="display: inline;font-size:10pt;">$4.7</font><font style="display: inline;font-size:10pt;"> million as a reduction in general, administrative, and marketing expenses on its Consolidated Statements of Operations and Comprehensive Income in the second quarter of 2012 and recorded a reduction in accounts payable of </font><font style="display: inline;font-size:10pt;">$1.2</font><font style="display: inline;font-size:10pt;"> million to write off a payable for previous inventory purchases, which was discharged pursuant to the settlement agreement.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">CryoLife received a letter from Medafor in September 2012 stating that PerClot</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">, when introduced in the U.S., will, when used in accordance with the method published in CryoLife&#x2019;s literature and with the instructions for use, infringe Medafor&#x2019;s U.S. patent.&nbsp;&nbsp;CryoLife does not believe that it will infringe Medafor&#x2019;s patent.&nbsp;&nbsp;There have been no further communications between CryoLife and Medafor or CryoLife and Bard related to the September letter.</font> </p> <p><font size="1"> </font></p> </div> </div> 3500000 340000 340000 3229000 3200000 3200000 12742000 12700000 12700000 43782000 9442000 34340000 46700000 11380000 35320000 50377000 15147000 35230000 9442000 11380000 15147000 34340000 35320000 35230000 2634000 2778000 6304000 84000 98000 96000 2821000 3056000 6796000 103000 180000 396000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">11.&nbsp;&nbsp;Debt</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">GE Credit Agreement</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">On October 28, 2011 CryoLife amended and restated its March 26, 2008 credit agreement with GE Capital (the &#x201C;GE Credit Agreement&#x201D;) which provides revolving credit for working capital, acquisitions, and other corporate purposes.&nbsp;&nbsp;The amendment increased the borrowing capacity under the GE Credit Agreement from $</font><font style="display: inline;font-size:10pt;">15.0</font><font style="display: inline;font-size:10pt;"> million to $</font><font style="display: inline;font-size:10pt;">20.0</font><font style="display: inline;font-size:10pt;"> million (including a letter of credit subfacility) and extended the expiration from October 31, 2011 to October 28, 2014.&nbsp;&nbsp;The initial commitment may continue to be reduced or increased from time to time pursuant to the terms of the GE Credit Agreement.&nbsp;&nbsp;The Company amended the agreement to allow the payment of cash dividends up to a maximum of $</font><font style="display: inline;font-size:10pt;">3.5</font><font style="display: inline;font-size:10pt;"> million per year, subject to satisfaction of specified conditions.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The GE Credit Agreement places limitations on the amount that the Company may borrow and includes various affirmative and negative covenants, including financial covenants such as a requirement that CryoLife (i) not exceed a defined leverage ratio, (ii) maintain a minimum adjusted earnings subject to defined adjustments as of specified dates, and (iii) not make or commit capital expenditures in excess of a defined limitation.&nbsp;&nbsp;As required under the terms of the GE Credit Agreement, the Company is maintaining cash and cash equivalents of at least $</font><font style="display: inline;font-size:10pt;">5.0</font><font style="display: inline;font-size:10pt;"> million in accounts in which GE Capital has a first priority perfected lien.&nbsp;&nbsp;These amounts are recorded as restricted cash as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> on the Company&#x2019;s Consolidated Balance Sheets, as they are restricted for the term of the GE Credit Agreement.&nbsp;&nbsp;Also, the GE Credit Agreement requires that after giving effect to a stock repurchase the Company maintain liquidity, as defined within the agreement, of at least $</font><font style="display: inline;font-size:10pt;">20.0</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;The GE Credit Agreement </font><font style="display: inline;font-size:10pt;">includes customary conditions on incurring new indebtedness.&nbsp;&nbsp;Commitment fees are paid based on the unused portion of the facility.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company was in compliance with the covenants of the GE Credit Agreement.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Amounts borrowed under the GE Credit Agreement are secured by substantially all of the tangible and intangible assets of CryoLife and its subsidiaries and bear interest as determined by GE Capital at either LIBOR, with a minimum rate of </font><font style="display: inline;font-size:10pt;">4.25</font><font style="display: inline;font-size:10pt;">%, or GE Capital&#x2019;s base rate, with a minimum rate of </font><font style="display: inline;font-size:10pt;">3.25</font><font style="display: inline;font-size:10pt;">% each, plus the applicable margin.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the outstanding balance of the GE Credit Agreement was </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;">, the aggregate interest rate was </font><font style="display: inline;font-size:10pt;">6.50</font><font style="display: inline;font-size:10pt;">%</font><font style="display: inline;font-size:10pt;">, and the remaining availability was $</font><font style="display: inline;font-size:10pt;">20.0</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> the outstanding balance of the GE Credit Agreement was </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;">, the aggregate interest rate was </font><font style="display: inline;font-size:10pt;">6.50</font><font style="display: inline;font-size:10pt;">%</font><font style="display: inline;font-size:10pt;">, and the remaining availability was $</font><font style="display: inline;font-size:10pt;">20.0</font><font style="display: inline;font-size:10pt;"> million.&nbsp; </font></font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Other</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Total interest expense was $</font><font style="display: inline;font-size:10pt;">71,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">179,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">142,000</font><font style="display: inline;font-size:10pt;"> in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, which included interest on debt and uncertain tax positions.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.0425 0.0325 796000 1533000 1087000 1274000 1142000 4000 3000 1274000 1050000 324000 6476000 5960000 1401000 316000 183000 -227000 -818000 502000 422000 925000 1959000 22664000 22047000 29140000 28007000 6100000 5162000 16564000 16885000 17539000 15689000 3200000 969000 1108000 2644000 2737000 2166000 241000 163000 61000 2319000 2409000 3782000 3766000 194000 131000 392000 1077000 2292000 1532000 5814000 5289000 348000 220000 314000 451000 204000 500000 541000 0.05 0.05 0.05 0.20 0.40 0.40 3590000 3662000 3837000 4960000 5633000 5843000 0 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Derivative Instruments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">The Company determines the fair value of its stand-alone and embedded derivative instruments at issuance and records any resulting asset or liability on the Company&#x2019;s Consolidated Balance Sheets.&nbsp;&nbsp;Changes in the fair value of the derivative instruments are recognized in the line item change in valuation of derivative on the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income.&nbsp; </font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">15.&nbsp;&nbsp;Stock Compensation</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Overview</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Under the Company&#x2019;s plans, the Company is currently authorized to grant the following number of shares and the Company has available for grant up to the following number of shares as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Authorized</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Available for Grant</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Shares</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1996 Discounted Employee Stock Purchase Plan, as amended</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,900,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>847,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2004 Employee Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,100,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2008 Non-Employee Directors Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>300,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2009 Employee Stock Incentive Plan</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,100,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,221,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,847,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:55.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,400,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,030,000&nbsp; </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,762,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">During 2012 the Company amended the 2009 Employee Stock Incentive Plan to increase the authorized shares under the plan by </font><font style="display: inline;font-size:10pt;">2.1</font><font style="display: inline;font-size:10pt;"> million shares.&nbsp;&nbsp;Upon the exercise of stock options or grants of RSAs, RSUs, or PSUs, the Company may issue the required shares out of authorized but unissued common stock or out of treasury stock, at management&#x2019;s discretion.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock Awards</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In 2013 the</font><font style="display: inline;font-size:10pt;"> Compensation Committee of the Company&#x2019;s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled </font><font style="display: inline;font-size:10pt;">467,000</font><font style="display: inline;font-size:10pt;"> shares of common stock and had an aggregate market value of $</font><font style="display: inline;font-size:10pt;">3.1</font><font style="display: inline;font-size:10pt;"> million.&nbsp;&nbsp;The PSUs granted in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> represent the right to receive from </font><font style="display: inline;font-size:10pt;">50</font><font style="display: inline;font-size:10pt;">% to </font><font style="display: inline;font-size:10pt;">150</font><font style="display: inline;font-size:10pt;">% of the target numbers of shares of common stock.&nbsp;&nbsp;The performance component of PSU awards granted in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> is based on the attainment of specified levels of adjusted EBITDA, as defined in the grant, for the </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> calendar year.&nbsp;&nbsp;The PSUs granted in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> earned approximately </font><font style="display: inline;font-size:10pt;">115%</font><font style="display: inline;font-size:10pt;"> of the target number of shares.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:7pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">In </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">the</font><font style="display: inline;font-size:10pt;"> Compensation Committee of the Company&#x2019;s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">451,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">shares of common stock and had an aggregate market value of $</font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million.&nbsp; </font><font style="display: inline;font-size:10pt;">The PSUs granted in 2012 earned approximately </font><font style="display: inline;font-size:10pt;">125%</font><font style="display: inline;font-size:10pt;"> of the target number of shares.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">In </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">the</font><font style="display: inline;font-size:10pt;"> Compensation Committee of the Company&#x2019;s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors</font><font style="display: inline;font-size:10pt;"> and certain Company officers and</font><font style="display: inline;font-size:10pt;"> RSUs to certain employees</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">which together totaled</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">421,000</font><font style="display: inline;font-size:10pt;"> shares of common stock and had an aggregate market value of $</font><font style="display: inline;font-size:10pt;">2.2</font><font style="display: inline;font-size:10pt;"> million.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A summary of stock grant activity for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> for RSAs, RSUs, and PSUs, based on shares granted at goal, is as follows:</font><font style="display: inline;font-size:10pt;">&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Average</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Grant Date</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">RSAs</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Fair Value</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2010</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>364,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.07&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>360,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.18&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(128,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.28&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(44,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.48&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2011</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>552,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.91&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>229,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.39&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(142,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.00&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2012</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>639,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.48&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>232,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.10&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(215,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.80&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(34,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.31&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2013</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>622,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.62&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">RSUs</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2010</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.85&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>313,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested </font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(3,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.66&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>466,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(37,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>120,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.54&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>747,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(54,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(10,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>129,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.56&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,425,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.55&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,314,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">PSUs</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.93&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>989,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>182,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(99,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>236,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.81&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,612,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>224,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.78&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,487,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock Options</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Compensation Committee of the Company&#x2019;s Board of Directors authorized grants of stock options from approved stock incentive plans to certain Company officers and employees totaling </font><font style="display: inline;font-size:10pt;">162,000</font><font style="display: inline;font-size:10pt;">, &nbsp;</font></font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">159,000</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">599,000</font><font style="display: inline;font-size:10pt;"> shares in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, with exercise prices equal to the stock prices on the respective grant dates.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A summary of the Company&#x2019;s stock option activity for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> follows:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted </font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Average</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Exercise Price</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2010</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,281,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.74&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.46&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>603,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>599,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.13&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(260,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.53&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(100,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.60&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(320,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.30&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,200,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.83&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.00&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.67&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(48,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.64&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.01&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(249,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.03&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,060,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.74&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.66&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,225,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.12&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(365,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.48&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(49,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.56&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(14,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.69&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,794,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.57&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.31&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,274,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,781,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.57&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.29&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,205,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercisable at December 31, 2013</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,372,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.86&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.75&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,971,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Other information concerning stock options for the years ended December 31 is as follows:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Weighted-average fair value of options granted</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.54&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.67&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.54&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intrinsic value of options exercised</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>673,000&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,000&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>261,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Employees purchased common stock totaling </font><font style="display: inline;font-size:10pt;">97,000</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">72,000</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">64,000</font><font style="display: inline;font-size:10pt;"> shares in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, through the Company&#x2019;s ESPP. </font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock Compensation Expense</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The following weighted</font><font style="display: inline;font-size:10pt;">&#8209;average assumptions were used to determine the fair value of options:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expected life of options</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.3 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.3 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.0 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expected stock price volatility</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.60&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.39&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.60&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.48&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.65&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.39&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Dividends</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.91%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.59%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.70%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.13%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.71%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.12%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.25%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.14%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The following table summarizes stock compensation expenses (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">RSA, RSU, and PSU expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,616&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,204&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,408&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Stock option and ESPP option expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>852&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,172&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,606&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total stock compensation expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,468&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,376&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,014&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the Company&#x2019;s ESPP.&nbsp;&nbsp;These amounts were recorded as stock compensation expense and were subject to the Company&#x2019;s normal allocation of expenses to deferred preservation costs and inventory costs.&nbsp;&nbsp;The Company capitalized $</font><font style="display: inline;font-size:10pt;">228,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">214,000</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">224,000</font><font style="display: inline;font-size:10pt;"> in the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, of the stock compensation expense into its deferred preservation costs and inventory costs.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company had total unrecognized compensation costs of $</font><font style="display: inline;font-size:10pt;">532,000</font><font style="display: inline;font-size:10pt;"> related to unvested stock options and $</font><font style="display: inline;font-size:10pt;">2.8</font><font style="display: inline;font-size:10pt;"> million related to RSAs, RSUs, and PSUs, before considering the effect of expected forfeitures.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> this expense is expected to be recognized over a weighted-average period of </font><font style="display: inline;font-size:10pt;">1.13</font><font style="display: inline;font-size:10pt;"> years for stock options, </font><font style="display: inline;font-size:10pt;">0.92</font><font style="display: inline;font-size:10pt;"> years for RSAs, </font><font style="display: inline;font-size:10pt;">2.27</font><font style="display: inline;font-size:10pt;"> years for RSUs, and </font><font style="display: inline;font-size:10pt;">0.81</font><font style="display: inline;font-size:10pt;"> years for PSUs.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> -1373000 -1373000 -2967000 -2967000 0.26 0.29 0.59 0.06 0.26 0.06 0.07 0.07 0.04 0.28 0.12 0.06 0.07 0.08 0.57 0.06 0.11 0.31 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Income Per Common Share</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Income per common share is computed using the two class method</font><font style="display: inline;font-size:10pt;">,</font><font style="display: inline;font-size:10pt;"> which requires the Company to include unvested RSAs that contain non-forfeitable rights to dividends (whether paid or unpaid) as participating securities in the income per common share calculation.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Under the two class method, net income is allocated to the weighted-average number of common shares outstanding during the period and the weighted-average participating securities outstanding during the period.&nbsp;&nbsp;The portion of net income that is allocated to the participating securities is excluded from basic and dilutive net income per common share.&nbsp;&nbsp;Diluted net income per share is computed using the weighted-average number of common shares outstanding plus the dilutive effects of outstanding stock options and awards and other dilutive instruments as appropriate.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">16.&nbsp;&nbsp;Income Per Common Share</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The following table sets forth the computation of basic and diluted income per common share (in thousands, except per share data):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Basic income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,172&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,946&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,371&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to participating securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(367) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(180) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(149) </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to common shareholders</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,805&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,766&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,222&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,885&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,967&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,441&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.59&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.29&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.26&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Diluted income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,172&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,946&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,371&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to participating securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(359) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(178) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(147) </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to common shareholders</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,813&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,768&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,224&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,885&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,967&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,441&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Effect of dilutive options and awards</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>813&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>444&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>318&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Diluted weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,698&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,411&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,759&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Diluted income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.57&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.28&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.26&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:10pt;"><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%">a</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share.&nbsp;&nbsp;Accordingly, stock options to purchase </font><font style="display: inline;font-size:10pt;">656,000</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">1.7</font><font style="display: inline;font-size:10pt;"> million, and </font><font style="display: inline;font-size:10pt;">2.0</font><font style="display: inline;font-size:10pt;"> million, shares for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.36 0.36 0.34 0.34 0.31 0.35 19000 -51000 36000 5055000 4886000 224000 214000 228000 2800000 532000 P1Y1M17D P9M22D P11M1D P2Y3M7D <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2.&nbsp;&nbsp;Financial Instruments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A summary of financial instruments measured at fair value is as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 1</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 2</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 3</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Certificates of deposit</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total assets</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,448&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,448&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Long-term liabilities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total liabilities</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:0pt;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 1</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 2</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 3</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total assets</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,642&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,642&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Long-term liabilities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total liabilities</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company used prices quoted from its investment management companies to determine the Level 1 valuation of its investments in money market funds, certificates of deposit, and securities.</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;"> The Company changed the presentation of i</font><font style="display: inline;font-size:10pt;">ts</font><font style="display: inline;font-size:10pt;"> December 31, 2012 money market funds to Level 1 from Level 2, consistent with its current year presentation.&nbsp;&nbsp;The Company recorded contingent consideration liability, classified as Level 3, as a result of its acquisition of Hemosphere in May 2012.&nbsp;&nbsp;Refer to </font><font style="display: inline;font-size:10pt;">Note 4</font><font style="display: inline;font-size:10pt;"> for further discussion of the Level 3 contingent consideration liability.&nbsp;&nbsp;Changes in fair value of Level 3 liabilities are listed below (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Contingent Consideration</font></p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, 2012</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,912&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Gain on remeasurement of contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28) </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, 2013</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,884&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.08 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Contingent Consideration</font></p> </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, 2012</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,912&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Gain on remeasurement of contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28) </td> </tr> <tr> <td valign="bottom" style="width:85.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, 2013</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,884&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Fair Value Measurements</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments.&nbsp;&nbsp;The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company has not chosen to make any such elections.&nbsp;&nbsp;Fair value financial instruments are recorded in accordance with the fair value measurement framework.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company also measures certain non-financial assets at fair value on a non-recurring basis.&nbsp;&nbsp;These non-recurring valuations include evaluating assets such as cost method investments, </font><font style="display: inline;font-size:10pt;">long</font><font style="display: inline;font-size:10pt;">&#8209;lived assets, and non-amortizing intangible assets for impairment;</font><font style="display: inline;font-size:10pt;"> allocating value to assets in an acquired asset group; and applying accounting for business combinations.&nbsp;&nbsp;The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down. </font><font style="display: inline;font-size:10pt;">&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.&nbsp;&nbsp;These levels from highest to lowest priority are as follows:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 1:&nbsp;&nbsp;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 2:&nbsp;&nbsp;Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="margin:0pt 6.5pt 0pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 3:&nbsp;&nbsp;Unobservable inputs or valuation techniques that are used when little or no market data is available.</font></p></td></tr></table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The determination of fair value and the assessment of a measurement&#x2019;s placement within the hierarchy requires judgment.&nbsp;&nbsp;Level 3 valuations often involve a higher degree of judgment and complexity.&nbsp;&nbsp;Level 3 valuations may require the use of various </font><font style="display: inline;font-size:10pt;">cost, market, or income valuation methodologies</font><font style="display: inline;font-size:10pt;"> applied to unobservable management estimates and assumptions.&nbsp;&nbsp;Management&#x2019;s assumptions could vary depending on the asset or liability valued and the valuation method used.&nbsp;&nbsp;Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company may also engage external advisors to assist in determining fair value, as appropriate.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</font> </p> <p><font size="1"> </font></p> </div> </div> 1912000 1912000 1884000 1884000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Financial Instruments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s financial instruments include cash equivalents, marketable securities, restricted securities, accounts receivable, notes receivable, accounts payable, and contingent consideration.&nbsp;&nbsp;The Company typically values financial assets and liabilities such as receivables, accounts payable, and debt obligations at their carrying values, which approximate fair value due to their generally short-term duration.&nbsp;&nbsp;Other financial instruments are typically recorded as discussed in the sections</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">below.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 1538000 473000 123000 330000 229000 2530000 2677000 714000 171000 572000 267000 2414000 1948000 1844000 1850000 1898000 1905000 14020000 3559000 198000 3370000 381000 4644000 14020000 3559000 202000 3370000 381000 4348000 9445000 P15Y P10Y P17Y P16Y P11Y P3Y P1Y P17Y P13Y P15Y P10Y P17Y P16Y P11Y P3Y P1Y P17Y P13Y <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Translation of Foreign Currencies</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s revenues and expenses transacted in foreign currencies are translated as they occur at exchange rates in effect at the time of each transaction.&nbsp;&nbsp;Realized gains and losses on foreign currency transactions are recorded as a component of </font><font style="display: inline;font-size:10pt;">other (income) expense, net</font><font style="display: inline;font-size:10pt;"> on the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income.&nbsp;&nbsp;Assets and liabilities of the Company denominated in foreign currencies are translated at the exchange rate in effect as of the balance sheet date and are recorded as a separate component of accumulated other comprehensive income (loss) in the shareholders' equity section of the Company&#x2019;s Consolidated Balance Sheets.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 4339000 4390000 4220000 4220000 11365000 7145000 11365000 11365000 11365000 7145000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">9.&nbsp;&nbsp;Goodwill and Other Intangible Assets</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Indefinite Lived Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> the carrying values of the Company&#x2019;s indefinite lived intangible assets are as follows (in thousands):</font></font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Procurement contracts and agreements</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,013&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,013&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Trademarks</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>841&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>870&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>250&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Based on its prior experience with similar agreements, the Company believes that its acquired contracts and procurement agreements have an indefinite useful life, as the Company expects to continue to renew these contracts for the foreseeable future.&nbsp;&nbsp;The Company believes that its trademarks have an indefinite useful life as the Company currently anticipates that these trademarks will contribute cash flows to the Company indefinitely.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A roll-forward of the goodwill balances for the Company&#x2019;s medical devices reportable segment is as follows (in thousands):&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of January 1, </font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill from Hemosphere acquisition</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,145&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, </font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:85.60%;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:04.22%;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="top" style="width:10.18%;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Definite Lived Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of December 31, 2013 and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> gross carrying values, accumulated amortization, and approximate amortization periods of the Company&#x2019;s definite lived intangible assets are as follows (dollars in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Accumulated</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization </font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Period</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Acquired technology</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,020&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,677&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">11</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">16</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Patents</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,348&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,414&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Distribution and manufacturing rights and know-how</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,559&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>714&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Customer lists and relationships</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,370&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>572&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">13</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">17</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-compete agreement</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>267&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>202&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>171&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">3</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Accumulated</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization </font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Period</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Acquired technology</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,020&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,538&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">11</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">16</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Patents</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,644&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,530&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Distribution and manufacturing rights and know-how</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,559&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>473&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Customer lists and relationships</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,370&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>330&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">13</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">17</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-compete agreement</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>229&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>198&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>123&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">3</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Amortization Expense</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Amortization expense recorded in general, administrative, and marketing expenses on the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income for the years ended December 31 is as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Amortization expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,006&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,971&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,370&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> scheduled amortization of intangible assets for the next five years is as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2014</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2015</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2016</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2017</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2018</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Amortization expense</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,948&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,905&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,898&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,850&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,844&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,445&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Goodwill and Other Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s intangible assets consist of goodwill, patents, trademarks, and other intangible assets, as discussed in </font><font style="display: inline;font-size:10pt;">Note 9</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;These assets include intangible assets from the acquisition of Hemosphere, as discussed in </font><font style="display: inline;font-size:10pt;">Note 4</font><font style="display: inline;font-size:10pt;">, and assets acquired from Cardiogenesis, as discussed in </font><font style="display: inline;font-size:10pt;">Note 6</font><font style="display: inline;font-size:10pt;">. &nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company amortizes its definite lived intangible assets over their expected useful lives using the straight-line method, which the Company believes approximates the period of economic benefits of the related assets.&nbsp;&nbsp;The Company&#x2019;s indefinite lived intangible assets do not amortize, but are instead subject to periodic impairment testing as discussed in &#x201C;Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets&#x201D; below.</font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 18504000 75844000 49945000 25453000 446000 19053000 18912000 19375000 21292000 85018000 56116000 28283000 619000 21371000 21310000 21045000 23276000 90386000 61047000 29268000 71000 21479000 23349000 22282000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Impairments of Long</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&#8209;Lived Assets and Non-Amortizing Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company assesses the potential impairment of its long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable.&nbsp;&nbsp;Factors that could trigger an impairment review include, but are not limited to, the following:</font></font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.45pt 3pt 0pt;"> <font style="margin:0pt 6.45pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.45pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant underperformance relative to expected historical or projected future operating results, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant negative industry or economic trends, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant decline in the Company&#x2019;s stock price for a sustained period, or</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="margin:0pt 6.5pt 0pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant decline in the Company&#x2019;s market capitalization relative to net book value.&nbsp; </font></p></td></tr></table></div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">If CryoLife determines that an impairment review is necessary, the Company will evaluate its assets or asset groups by comparing their carrying values to the sum of the undiscounted future cash flows expected to result from their use and eventual disposition.&nbsp;&nbsp;If the carrying values exceed the future cash flows, then the asset or asset group is considered impaired, and </font><font style="display: inline;font-size:10pt;">the Company will </font><font style="display: inline;font-size:10pt;">write down the value of the asset or asset group.&nbsp;&nbsp;For the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> the Company did not experience any factors that indicated that an impairment review of its long-lived assets was warranted.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">CryoLife evaluates its goodwill and other non-amortizing intangible assets for impairment on an annual basis as of October 31 and, if necessary, during interim periods if factors indicate that an impairment review is warranted.&nbsp;&nbsp;As of October 31, 2013 the Company&#x2019;s non-amortizing intangible assets consisted of goodwill, acquired procurement contracts and agreements, trademarks, and other acquired technology.&nbsp;&nbsp;The Company performed an analysis of its non-amortizing intangible assets as of October 31, 2013 and 2012, and determined that the fair value of the assets and the fair value of the reporting unit exceeded their associated carrying values and were, therefore, not impaired.&nbsp;&nbsp;Management will continue to evaluate the recoverability of these non-amortizing intangible assets.</font> </p> <p><font size="1"> </font></p> </div> </div> 11238000 11686000 23004000 228000 366000 288000 11466000 12052000 23292000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">10.&nbsp;&nbsp;Income Taxes</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Income Tax Expense</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Income before income taxes consists of the following (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="top" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Domestic</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,686&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,238&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>288&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>366&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>228&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income before income taxes</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,292&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,052&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,466&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Income tax expense consists of the following (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Current:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Federal</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,304&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,778&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,634&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>396&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>180&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>103&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>98&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>84&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,796&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,056&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,821&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Federal</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,142&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,274&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,087&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(818) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(227) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>183&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> &nbsp;-</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>324&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,050&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,274&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income tax expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,120&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,106&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,095&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company&#x2019;s income tax expense in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> included the Company&#x2019;s federal, state, and foreign tax </font><font style="display: inline;font-size:10pt;">obligations.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company&#x2019;s effective income tax rate was approximately </font><font style="display: inline;font-size:10pt;">31</font><font style="display: inline;font-size:10pt;">%</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">34</font><font style="display: inline;font-size:10pt;">%</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">36</font><font style="display: inline;font-size:10pt;">%</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.&nbsp;&nbsp;The Company&#x2019;s income tax rate for the twelve months ended December 31, 2013 was favorably affected by the full year 2012 </font><font style="display: inline;font-size:10pt;">research and development tax credit, which was enacted in January 2013 and, therefore, reduced the Company&#x2019;s tax expense during the first quarter of 2013 and adjustments to valuation allowances on certain of the</font><font style="display: inline;font-size:10pt;"> Company&#x2019;s state net operating loss carryforwards, based on revised estimates of utilization of these </font><font style="display: inline;font-size:10pt;">carryforwards.&nbsp;&nbsp;The</font><font style="display: inline;font-size:10pt;"> Company&#x2019;s income tax rates for the three and twelve months ended </font><font style="display: inline;font-size:10pt;">December 31, 2012 </font><font style="display: inline;font-size:10pt;">were favorably affected by adjustments to valuation allowances on certain of the Company&#x2019;s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards, and unfavorably affected by the tax treatment of certain acquisition related expenses due to the acquisition of Hemosphere and by the research and development tax credit, which had not been enacted for the 2012 tax year.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The income tax expense amounts differ from the amounts computed by applying the U.S. federal statutory income tax rate of </font><font style="display: inline;font-size:10pt;">35</font><font style="display: inline;font-size:10pt;">% to pretax income as a result of the following (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Tax expense at statutory rate</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,152&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,013&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Increase (reduction) in income taxes resulting from:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-deductible transaction costs</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>151&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>540&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State income taxes, net of federal benefit</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>183&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>296&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>150&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State valuation allowance adjustment</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(760) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(427) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>100&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Equity compensation</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(29) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>149&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-deductible entertainment expenses</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>188&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>142&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign income taxes</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(199) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Domestic production activities deduction </font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(402) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(407) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(727) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Research and development credit</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(392) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(314) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>65&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>252&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,120&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,106&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,095&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Taxes</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company generates deferred tax assets primarily as a result of write-downs of deferred preservation costs, inventory, and in-process research and development; accruals for product and tissue processing liability claims; asset impairments; and, in prior periods, due to operating losses.&nbsp;&nbsp;The Company acquired significant deferred tax assets, primarily net operating loss carryforwards, from its acquisitions of Hemosphere and Cardiogenesis in the second quarters of 2012 and 2011, respectively. &nbsp;See </font><font style="display: inline;font-size:10pt;">Note 4</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">Note 6</font><font style="display: inline;font-size:10pt;"> for a further discussion of the Company&#x2019;s acquisitions of Hemosphere and Cardiogenesis, respectively.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The tax effects of temporary differences which give rise to deferred tax assets and liabilities at December 31 are as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax assets:</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Allowance for bad debts</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>194&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred preservation costs and inventory write-downs</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,077&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>392&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Investment in equity securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,959&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>925&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Property </font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,737&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,644&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>422&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>502&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Accrued expenses</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,766&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,782&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,689&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,539&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Credit carryforwards</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>241&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,166&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Stock compensation</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,409&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,108&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>969&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Less valuation allowance</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,532) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,292) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,007&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,140&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax liabilities:</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Prepaid items</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(451) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(314) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,289) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,814) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(220) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(348) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred tax liabilities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,960) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,476) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,047&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,664&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company maintained a total of $</font><font style="display: inline;font-size:10pt;">1.5</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $</font><font style="display: inline;font-size:10pt;">22.0</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> the Company maintained a total of $</font><font style="display: inline;font-size:10pt;">2.3</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;"> in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $</font><font style="display: inline;font-size:10pt;">22.7</font><font style="display: inline;font-size:10pt;"> million</font><font style="display: inline;font-size:10pt;">.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">As of December 31, 2013 the Company had approximately $</font><font style="display: inline;font-size:10pt;">3.2</font><font style="display: inline;font-size:10pt;"> million of tax-effected state net operating loss carryforwards that began to expire in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">61,000</font><font style="display: inline;font-size:10pt;"> in research and development tax credit carryforwards that will begin to expire in 2022, and $</font><font style="display: inline;font-size:10pt;">163,000</font><font style="display: inline;font-size:10pt;"> in credits from the state of Texas that will fully expire by 2027.</font><font style="display: inline;font-size:10pt;">&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Uncertain Tax Positions</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A reconciliation of the beginning and ending balances of the Company&#x2019;s uncertain tax position liability, excluding interest and penalties, is as follows </font><font style="display: inline;font-size:10pt;">(in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Beginning balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,788&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,822&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Increases related to current year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>281&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>231&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>78&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Decreases related to prior year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(185) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(15) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(112) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Ending balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,100&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,788&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A reconciliation of the beginning and ending balances of the Company&#x2019;s liability for interest and penalties on uncertain tax positions is as follows </font><font style="display: inline;font-size:10pt;">(in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Beginning balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>489&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>418&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>391&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Accrual of interest and penalties</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>79&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>65&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Decreases related to prior year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(133) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(8) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(38) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Ending balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>422&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>489&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>418&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">As of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s total uncertain tax liability, including interest and penalties of $</font><font style="display: inline;font-size:10pt;">2.5</font><font style="display: inline;font-size:10pt;"> million, was recorded as a non-</font><font style="display: inline;font-size:10pt;">current liability on</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s Consolidated Balance Sheet</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;As of </font><font style="display: inline;font-size:10pt;">December 31, 2012</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s total uncertain tax liability, including interest and penalties of $</font><font style="display: inline;font-size:10pt;">2.5</font><font style="display: inline;font-size:10pt;"> million, was recorded as a reduction to deferred tax assets of $</font><font style="display: inline;font-size:10pt;">103,000</font><font style="display: inline;font-size:10pt;"> and a non-current liability of $</font><font style="display: inline;font-size:10pt;">2.4</font><font style="display: inline;font-size:10pt;"> million on the Company&#x2019;s Consolidated Balance Sheet</font><font style="display: inline;font-size:10pt;">s</font><font style="display: inline;font-size:10pt;">.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Other</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s tax years 2010 through 2013 generally remain open to examination by the major taxing jurisdictions to which the Company is subject.&nbsp;&nbsp;However, certain returns from years prior to 2010, in which net operating losses and tax credits have arisen, are still open for examination by the tax authorities.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 3564000 1263000 5693000 4095000 4106000 7120000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Income Taxes</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes.&nbsp;&nbsp;The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets.&nbsp;&nbsp;Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Assessing the recoverability of deferred tax assets </font><font style="display: inline;font-size:10pt;">involves judgment and complexity.&nbsp;&nbsp;Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following: </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Projected future operating results, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Anticipated future state tax apportionment, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Timing and amounts of anticipated future taxable income, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Timing of the anticipated reversal of book/tax temporary differences, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Evaluation of statutory limits regarding usage of certain tax assets, and </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-size:10pt;">Evaluation of the statutory periods over which certain tax assets can be utilized.&nbsp; </font></p></td></tr></table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Significant changes in the factors above, or other factors, could materially, adversely affect the Company&#x2019;s ability to use its deferred tax assets.&nbsp;&nbsp;Such changes could have a material, adverse impact on the Company&#x2019;s operations, financial condition, and cash flows.&nbsp;&nbsp;The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended.&nbsp;&nbsp;The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company&#x2019;s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control.&nbsp;&nbsp;The Company also believes that its acquisition of Cardiogenesis constituted a change in control.&nbsp;&nbsp;The deferred tax assets recorded on the Company&#x2019;s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control.&nbsp;&nbsp;A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized.&nbsp;&nbsp;Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 727000 407000 402000 3000 -199000 96000 4013000 4220000 8152000 142000 188000 207000 149000 32000 -29000 39000 252000 65000 150000 296000 183000 100000 -427000 -760000 314000 392000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Uncertain Tax Positions</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company periodically assesses its uncertain tax positions and recognizes tax benefits if they are &#x201C;more-likely-than-not&#x201D; to be upheld upon review by the appropriate taxing authority.&nbsp;&nbsp;The Company measures the tax benefit by determining the maximum amount that has a &#x201C;greater than 50 percent likelihood&#x201D; of ultimately being realized.&nbsp;&nbsp;The Company reverses previously accrued liabilities for uncertain tax positions when audits are concluded, statutes expire, administrative practices dictate that a liability is no longer warranted, or in other circumstances as deemed necessary.&nbsp;&nbsp;These assessments can be complex and the Company often obtains assistance from external advisors to make these assessments.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company recognizes interest and penalties related to uncertain tax positions in other (income) expense, net on its Consolidated Statements of Operations and Comprehensive Income.&nbsp;&nbsp;See </font><font style="display: inline;font-size:10pt;">Note 10</font><font style="display: inline;font-size:10pt;"> for further discussion of the Company&#x2019;s liabilities for uncertain tax positions.&nbsp; </font></font> </p> <p><font size="1"> </font></p> </div> </div> -772000 529000 572000 -1767000 -1227000 -617000 617000 583000 706000 2230000 -1363000 1637000 318000 444000 813000 2013000 250000 870000 2013000 841000 142000 179000 71000 89000 22000 3000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">8.&nbsp;&nbsp;Deferred Preservation Costs and Inventories</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Deferred preservation costs at </font><font style="display: inline;font-size:10pt;">December 31, 2013 </font><font style="display: inline;font-size:10pt;">and 2012 </font><font style="display: inline;font-size:10pt;">are comprised of the following (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cardiac tissues</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,239&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,950&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vascular tissues</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,058&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,004&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred preservation costs</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,297&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,954&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Inventories at </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> are comprised of the following (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Raw materials and supplies</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,706&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,836&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Work-in-process</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>767&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>830&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,298&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,891&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total inventories</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,771&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,557&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 3891000 3298000 10557000 9771000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Inventories</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Inventories are valued at the lower of cost or market on a first</font><font style="display: inline;font-size:10pt;">&#8209;in, first</font><font style="display: inline;font-size:10pt;">&#8209;out basis and the costs are recognized as cost of products upon shipment of the product.&nbsp;&nbsp;Inventories are comprised of BioGlue; BioFoam; PerClot; revascularization technologies lasers, handpieces, and accessories; </font><font style="display: inline;font-size:10pt;">HeRO Grafts; </font><font style="display: inline;font-size:10pt;">other medical devices; supplies; and raw materials.&nbsp; </font><font style="display: inline;font-size:10pt;">Cost of products also includes, as incurred, </font><font style="display: inline;font-size:10pt;">i</font><font style="display: inline;font-size:10pt;">dle facility expense, excessive spoilage, extra freight, and rehandling costs. </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Inventory costs for manufactured products consist primarily of direct labor and materials (including salary and fringe benefits, raw materials, and supplies) and indirect costs (including allocations of costs from departments that support manufacturing activities and facility allocations).&nbsp;&nbsp;The allocation of fixed production overhead costs is based on actual production levels, to the extent that they are within the range of the facility&#x2019;s normal capacity</font><font style="display: inline;font-size:10pt;">.&nbsp; </font><font style="display: inline;font-size:10pt;">Inventory costs for products purchased for resale or contract manufactured consist primarily of the purchase cost, freight-in charges, and indirect costs as appropriate.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company regularly evaluates its inventory to determine if the costs are appropriately recorded at the lower of cost or market value.&nbsp;&nbsp;The Company also evaluates its inventory for costs not deemed to be recoverable, including inventory not expected to ship prior to its expiration.&nbsp; </font><font style="display: inline;font-size:10pt;">Lower of cost or market value write-downs are recorded if the book value exceeds the estimated market value of the inventory, based on recent sales prices at the time of the evaluation.&nbsp;&nbsp;Impairment write-downs are recorded based on the book value of inventory deemed to be impaired.&nbsp;&nbsp;Actual results may differ from these estimates.&nbsp;&nbsp;Write-downs of inventory are expensed as cost of products, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company&#x2019;s estimates change.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company recorded write-downs to its inventory totaling $</font><font style="display: inline;font-size:10pt;">1.2</font><font style="display: inline;font-size:10pt;"> million, $</font><font style="display: inline;font-size:10pt;">77,000</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.&nbsp;&nbsp;The </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">write-down includes </font><font style="display: inline;font-size:10pt;">$684,000</font><font style="display: inline;font-size:10pt;"> in additional contractual costs and inventory impairment costs, primarily related to a BioGlue accessory product, and </font><font style="display: inline;font-size:10pt;">$483,000</font><font style="display: inline;font-size:10pt;"> in additional costs for revascularization technologies handpieces that were made obsolete by the Company&#x2019;s decision to exclusively distribute the new handpiece design, which was approved by the </font><font style="display: inline;font-size:10pt;">U.S. Food and Drug Administration (&#x201C;FDA&#x201D;) </font><font style="display: inline;font-size:10pt;"> in June 2013.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 5836000 5706000 830000 767000 0 77000 1200000 684000 483000 14000 6000 4000 2700000 2700000 3000000 29440000 30051000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Leases </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company has operating lease obligations resulting from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment as discussed in </font><font style="display: inline;font-size:10pt;">Note 12</font><font style="display: inline;font-size:10pt;">.</font><font style="display: inline;font-size:10pt;"> &nbsp;Certain of the Company&#x2019;s leases contain escalation clauses, rent concessions, and renewal options for additional periods.&nbsp;&nbsp;Rent expense is computed on the straight</font><font style="display: inline;font-size:10pt;">&#8209;line method over the lease term</font><font style="display: inline;font-size:10pt;"> and the related liability is recorded as deferred rent obligations on the</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">Company&#x2019;s Consolidated Balance Sheets</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Legal Fees </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company expenses the costs of legal services, including legal services related to product and tissue processing liability claims and legal contingencies, as they are incurred.&nbsp;&nbsp;Reimbursement of legal fees by an insurance company or other third-party is recorded as a reduction to legal expense.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 4100000 29044000 29936000 157156000 174683000 21430000 20722000 1912000 1912000 1884000 1884000 103000 2400000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Liability Claims</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">In the normal course of business, the Company is made aware of adverse events involving its products and tissues.&nbsp;&nbsp;Any adverse event could ultimately give rise to a lawsuit against the Company.&nbsp;&nbsp;In addition, product and tissue processing liability claims may be asserted against the Company in the future based on events it is not aware of at the present time.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company maintains claims</font><font style="display: inline;font-size:10pt;">&#8209;made insurance policies to mitigate its financial exposure to product and tissue processing liability claims.&nbsp;&nbsp;Claims</font><font style="display: inline;font-size:10pt;">&#8209;made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect.&nbsp;&nbsp;Thus, a claims</font><font style="display: inline;font-size:10pt;">&#8209;made policy does not generally represent a transfer of risk for claims and incidents that have been incurred but not reported to the insurance carrier during the policy period.&nbsp;&nbsp;Any punitive damage components of claims are uninsured. </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company engages external advisors to assist it in estimating its liability and any related recoverable under the Company's insurance policies as of each balance sheet date.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company uses a frequency</font><font style="display: inline;font-size:10pt;">&#8209;severity approach to estimate its </font><font style="display: inline;font-size:10pt;">unreported product and tissue processing liability claims</font><font style="display: inline;font-size:10pt;">, whereby, projected losses are calculated by multiplying the estimated number of claims by the estimated average cost per claim.&nbsp;&nbsp;The estimated claims are determined based on the reported claim development method and the Bornhuetter</font><font style="display: inline;font-size:10pt;">&#8209;Ferguson method using a blend of the Company's historical claim experience and industry data.</font><font style="display: inline;font-size:10pt;"> &nbsp;The estimated cost per claim is calculated using a lognormal claims model blending the Company's historical average cost per claim with industry claims data.&nbsp;&nbsp;The Company uses a number of assumptions in order to estimate the unreported loss liability including: the future claim reporting time lag, the frequency of reported claims, the average cost per claim, and the maximum liability per claim.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company believes that the assumptions it uses provide a reasonable basis for its calculation.&nbsp;&nbsp;However, the accuracy of the estimates is limited by the general uncertainty that exists for any estimate of future activity due to uncertainties surrounding the assumptions used and due to Company specific conditions and the scarcity of industry data directly relevant to the Company's business activities.&nbsp;&nbsp;Due to these factors, actual results may differ significantly from the assumptions used and amounts accrued.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long</font><font style="display: inline;font-size:10pt;">&#8209;term liabilities and records the related recoverable insurance amounts as a component of receivables and other long</font><font style="display: inline;font-size:10pt;">&#8209;term assets.&nbsp;&nbsp;The amounts recorded represent management's estimate of the probable losses and anticipated recoveries for unreported claims related to products sold and services performed prior to the balance sheet date.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 0 0 0.0650 0.0650 20000000 15000000 20000000 20000000 2000000 2000000 2700000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Marketable Securities and Other Investments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company typically invests its excess cash for short-term periods in large, well</font><font style="display: inline;font-size:10pt;">&#8209;capitalized financial institutions, and the Company's policy excludes investment in any securities rated less than "investment</font><font style="display: inline;font-size:10pt;">&#8209;grade" by national rating services, unless specifically approved by the Board of Directors.&nbsp;&nbsp;The Company sometimes makes longer term strategic investments in medical device companies, and these investments must be approved by the Board of Directors.</font></font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company determines the classification of its investments as trading, available-for-sale, or held-to-maturity at the time of purchase and reevaluates such designations quarterly.&nbsp;&nbsp;Trading securities are securities that are </font><font style="display: inline;font-size:10pt;">acquired principally for the purpose of generating a profit from short-term fluctuations in price</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;Debt securities are classified as held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity when the Company has the intent and ability to hold the securities to maturity.&nbsp;&nbsp;Any securities not designated as trading or held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity are considered available-for-sale.&nbsp;&nbsp;T</font><font style="display: inline;font-size:10pt;">he Company typically states its investments at their fair values; however, for </font><font style="display: inline;font-size:10pt;">held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity securities or </font><font style="display: inline;font-size:10pt;">when current fair value information is not readily available, investments are recorded using the cost method.&nbsp;&nbsp;The cost of securities sold is based on the specific identification method.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Under the fair value method, the Company adjusts each investment to its market price and records the unrealized gains or losses in other (income) expense, net for trading securities, or accumulated other comprehensive income (loss), for available-for-sale securities.&nbsp;&nbsp;Interest, dividends, realized gains and losses, and declines in value judged to be other than temporary are included in other (income) expense, net.&nbsp;&nbsp;Under the cost method, each investment is recorded at cost.&nbsp;&nbsp;Subsequent dividends received are recognized as income, and the investment is reviewed for impairment if factors indicate that a decrease in the value of the investment has occurred. </font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Nature of Business</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">CryoLife, Inc. (&#x201C;CryoLife,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; or &#x201C;us&#x201D;) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation.&nbsp;&nbsp;CryoLife&#x2019;s surgical sealants and hemostats include BioGlue</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> Surgical Adhesive (&#x201C;BioGlue&#x201D;), BioFoam</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> Surgical Matrix (&#x201C;BioFoam&#x201D;), and </font><font style="display: inline;font-size:10pt;">PerClot</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">, an absorbable powdered hemostat, which the Company distributes </font><font style="display: inline;font-size:10pt;">international</font><font style="display: inline;font-size:10pt;">ly</font><font style="display: inline;font-size:10pt;"> for </font><font style="display: inline;font-size:10pt;">Starch Medical, Inc. (&#x201C;SMI&#x201D;).&nbsp; </font><font style="display: inline;font-size:10pt;">CryoLife&#x2019;s subsidiary, Cardiogenesis Corporation (&#x201C;Cardiogenesis&#x201D;), specializes in the treatment of</font><font style="display: inline;font-size:10pt;"> coronary artery</font><font style="display: inline;font-size:10pt;"> disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.&nbsp; </font><font style="display: inline;font-size:10pt;">CryoLife and its subsidiary, Hemosphere, Inc. (&#x201C;Hemosphere&#x201D;), market the </font><font style="display: inline;font-size:10pt;text-decoration:underline;">He</font><font style="display: inline;font-size:10pt;">modialysis </font><font style="display: inline;font-size:10pt;text-decoration:underline;">R</font><font style="display: inline;font-size:10pt;">eliable </font><font style="display: inline;font-size:10pt;text-decoration:underline;">O</font><font style="display: inline;font-size:10pt;">utflow Graft (&#x201C;HeRO</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">Graft</font><font style="display: inline;font-size:10pt;">&#x201D;)</font><font style="display: inline;font-size:10pt;">, which is a solution for end-stage renal disease (&#x201C;ESRD&#x201D;) in certain hemodialysis patients.</font><font style="display: inline;font-size:10pt;"> &nbsp;The cardiac and vascular human tissues distributed by CryoLife include the CryoValve</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> SG pulmonary heart valve (&#x201C;CryoValve SGPV&#x201D;) and the CryoPatch</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> SG pulmonary cardiac patch tissue (&#x201C;CryoPatch SG&#x201D;), both </font><font style="display: inline;font-size:10pt;">of which are </font><font style="display: inline;font-size:10pt;">processed using CryoLife&#x2019;s proprietary SynerGraft</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> technology.&nbsp; </font></font> </p> <p><font size="1"> </font></p> </div> </div> -2846000 -4715000 -3051000 -27716000 -22920000 10877000 16751000 18990000 16772000 1666000 7371000 7371000 1820000 2019000 1866000 991000 7946000 7946000 3334000 1538000 2083000 2192000 16172000 16172000 1785000 3169000 9026000 7222000 7766000 15805000 7224000 7768000 15813000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">New Accounting Pronouncements</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;"></font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">In January 2013 the Company adopted Accounting Standards Update ("ASU"), 2012-02, Intangibles-Goodwill and Other (Topic 350): </font><font style="display: inline;font-style:italic;font-size:10pt;">Testing Indefinite-Lived Intangible Assets for Impairment</font><font style="display: inline;font-size:10pt;">, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test.&nbsp;&nbsp;The adoption of ASU 2012-02 did not have a material effect on the Company's financial condition, profitability, or cash flows.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220):&nbsp; </font><font style="display: inline;font-style:italic;font-size:10pt;">Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</font><font style="display: inline;font-size:10pt;">, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements.&nbsp;&nbsp;This update also requires companies to disclose the income statement line items affected by any significant reclassifications.&nbsp;&nbsp;The adoption of ASU 2013-02 did not have a material effect on the Company's financial disclosures.</font> </p> <p><font size="1"> </font></p> </div> </div> 2000000 2000000 2 64201000 72406000 76566000 11643000 12612000 13820000 24887000 2799000 3010000 2980000 2943000 3031000 10124000 2100000 2100000 3067000 4016000 26000 26000 -33000 -33000 46000 46000 26000 -33000 46000 21968000 19985000 2232000 2168000 3303000 4111000 -767000 -683000 -298000 -49000 -47000 26000 579000 469000 446000 619000 71000 4500000 4500000 547000 810000 206000 3064000 3529000 1523000 1373000 2967000 17000000 21062000 17040000 2538000 3070000 4338000 3569000 2000000 0.01 0.01 5000000 2000000 460000 5000000 2000000 460000 0 0 0 0 3040000 2797000 694000 330000 2207000 3500000 -476000 -143000 -768000 15421000 15400000 57786000 61417000 11667000 12171000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Property and Equipment</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Property and equipment is stated at cost.&nbsp;&nbsp;Depreciation is provided over the estimated useful lives of the assets, generally </font><font style="display: inline;font-size:10pt;">three</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">ten</font><font style="display: inline;font-size:10pt;"> years, on a straight</font><font style="display: inline;font-size:10pt;">&#8209;line basis.&nbsp;&nbsp;Leasehold improvements are amortized on a straight</font><font style="display: inline;font-size:10pt;">&#8209;line basis over the remaining lease term at the time the assets are capitalized or the estimated useful lives of the assets, whichever is shorter.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Depreciation expense for the years ended December 31 is as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Depreciation expense</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,837&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,662&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,590&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> P10Y P3Y <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED)</font> </p> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">(in thousands, except per share data)</font> </p> <p style="margin:0pt;text-align:center;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">First</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Second</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Third</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Fourth</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">REVENUE:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,536&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,520&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,250&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,457&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,301&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,188&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,429&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,800&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,196&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,379&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,654&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,397&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">GROSS MARGIN:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,276&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,479&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,349&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,282&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,292&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,371&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,310&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,045&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,504&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,053&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,912&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,375&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">NET INCOME:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,192&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,785&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,169&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,026&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">*</font></p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>991&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,334&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,538&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,083&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,666&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,820&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,019&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,866&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">INCOME PER COMMON SHARE&#x2014;DILUTED:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.08&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.31&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">*</font></p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.04&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.12&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;text-align:center;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display: inline;font-size:10pt;">*</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a </font><font style="display: inline;font-size:10pt;">$12.7</font><font style="display: inline;font-size:10pt;"> million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc.</font><font style="display: inline;font-size:10pt;"> and the unfavorable effect of a </font><font style="display: inline;font-size:10pt;">$3.2</font><font style="display: inline;font-size:10pt;"> million </font><font style="display: inline;font-size:10pt;">other than temporary investment impairment as a result of </font><font style="display: inline;font-size:10pt;">the</font><font style="display: inline;font-size:10pt;"> impairment and</font><font style="display: inline;font-size:10pt;"> write-down</font><font style="display: inline;font-size:10pt;"> of</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s investment in ValveXchange preferred stock.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 16520000 18307000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Products:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">BioGlue and BioFoam</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,004&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,211&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,455&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">PerClot</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,494&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,078&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,528&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">HemoStase</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,699&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Revascularization technologies</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,965&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,092&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,705&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">HeRO Graft</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,731&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,115&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total products</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,194&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,496&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,387&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cardiac tissue</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,523&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,756&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,618&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vascular tissue</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>34,975&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,847&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,175&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,498&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,603&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,793&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;text-decoration:underline;"></font></font><font style="display: inline;font-size:10pt;text-decoration:underline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font> </p> <p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%">a</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%"></font><font style="display: inline;font-size:10pt;">For the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> the &#x201C;</font><font style="display: inline;font-size:10pt;">Other&#x201D;</font><font style="display: inline;font-size:10pt;"> designation includes grant revenue.</font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 2900000 794000 321000 818000 0 0 45000 22000 47000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">17.&nbsp;&nbsp;Transactions with Related Parties</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">An investment banking services company employee became a member of the Company&#x2019;s Board of Directors and a shareholder of the Company in 2012.&nbsp;&nbsp;The Company made stock repurchases of $</font><font style="display: inline;font-size:10pt;">321,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">794,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">2.9</font><font style="display: inline;font-size:10pt;"> million in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, which includes the cost of stock and commissions of less than </font><font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">%, and expensed $</font><font style="display: inline;font-size:10pt;">818,000</font><font style="display: inline;font-size:10pt;"> in </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> for investment banking services from that company.&nbsp;&nbsp;The Company did not record expenses for investment banking services from that company in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;"> or </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A member of the Company&#x2019;s Board of Directors and a shareholder of the Company is a current employee of and the former Chief of Thoracic Surgery of a university hospital that generated preservation services and product revenues of $</font><font style="display: inline;font-size:10pt;">353,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">267,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">198,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">for</font><font style="display: inline;font-size:10pt;"> the Company in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.&nbsp;&nbsp;Additionally, the son of this member of the Company&#x2019;s Board of Directors receives a retainer for performing heart and lung transplants from a medical center that generated preservation services and product revenues of $</font><font style="display: inline;font-size:10pt;">345,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">312,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">219,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">for</font><font style="display: inline;font-size:10pt;"> the Company in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company expensed $</font><font style="display: inline;font-size:10pt;">47,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">22,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">45,000</font><font style="display: inline;font-size:10pt;"> in </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, relating to supplies for clinical trials purchased from a company whose Chief Financial Officer is a member of the Company's Board of Directors and a shareholder of the Company.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A relative of the Company&#x2019;s CEO is employed as a vice president of the Company.&nbsp;&nbsp;His compensation and benefits are set and subject to review by the Compensation Committee of the Board of Directors.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 6899000 7257000 8454000 5000000 5000000 5000000 5000000 5000000 5000000 323000 5350000 323000 323000 350000 350000 323000 350000 5536000 18741000 198000 219000 267000 312000 353000 345000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Revenue Recognition</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Revenues for products, including: </font><font style="display: inline;font-size:10pt;">BioGlue, BioFoam, PerClot, HemoStase, revascularization technologies handpieces and accessories, HeRO Grafts, and other medical devices,</font><font style="display: inline;font-size:10pt;"> are recognized at the time the product is shipped, at which time title passes to the customer, and there are no further performance obligations.&nbsp;&nbsp;The Company recognizes revenues for preservation services when services are completed and tissue is shipped to the customer.&nbsp;&nbsp;Revenues from research grants are recognized in the period the associated costs are incurred.&nbsp;&nbsp;Revenues from upfront licensing agreements are recognized ratably over the period the Company expects to fulfill its obligations.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Revenues from the sale of laser consoles are considered multiple element arrangements, and such revenues are allocated to the elements of the sale.&nbsp;&nbsp;The Company allocates revenues based primarily on the revenue these individual elements would generate if sold separately.&nbsp;&nbsp;Revenues from domestic laser consoles sales are typically recognized when the laser is installed at a customer site and all materials for the laser console&#x2019;s use are delivered.&nbsp;&nbsp;Revenues from the sales of laser consoles to international distributors are evaluated individually based on the terms of the sale and collectability to determine when revenue has been earned and can be recognized.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 30196000 119626000 95975000 49455000 26618000 1699000 23651000 59387000 2528000 59793000 5705000 59793000 59387000 33175000 446000 446000 29379000 5700000 29654000 30397000 32301000 131718000 103804000 53211000 29756000 3115000 27914000 67496000 3078000 63603000 8092000 63603000 67496000 33847000 619000 619000 33188000 3100000 33429000 32800000 35536000 140763000 109325000 58004000 29523000 5731000 31438000 76194000 3494000 64498000 8965000 64498000 76194000 34975000 71000 71000 33520000 36250000 35457000 59387000 67496000 76194000 59793000 63603000 64498000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash paid during the year for:</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Interest</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>89&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income taxes</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,693&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,263&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,564&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">RSA, RSU, and PSU expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,616&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,204&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,408&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Stock option and ESPP option expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>852&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,172&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,606&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total stock compensation expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,468&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,376&nbsp; </td> <td valign="bottom" style="width:04.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,014&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Current:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Federal</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,304&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,778&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,634&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>396&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>180&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>103&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>98&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>84&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,796&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,056&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,821&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Federal</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,142&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,274&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,087&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(818) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(227) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>183&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> &nbsp;-</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>324&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,050&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,274&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income tax expense</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,120&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,106&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,095&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax assets:</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Allowance for bad debts</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>194&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred preservation costs and inventory write-downs</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,077&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>392&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Investment in equity securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,959&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>925&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Property </font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,737&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,644&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>422&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>502&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Accrued expenses</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,766&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,782&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,689&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,539&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Credit carryforwards</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>241&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,166&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Stock compensation</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,409&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,108&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>969&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Less valuation allowance</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,532) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,292) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,007&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,140&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax liabilities:</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Prepaid items</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(451) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(314) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,289) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,814) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(220) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(348) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total deferred tax liabilities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,960) </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,476) </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,047&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,664&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Basic income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,172&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,946&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,371&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to participating securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(367) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(180) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(149) </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to common shareholders</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,805&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,766&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,222&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,885&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,967&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,441&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.59&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.29&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.26&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Diluted income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,172&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,946&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,371&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to participating securities</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(359) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(178) </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(147) </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net income allocated to common shareholders</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,813&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,768&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,224&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Basic weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,885&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,967&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,441&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Effect of dilutive options and awards</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>813&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>444&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>318&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Diluted weighted-average common shares outstanding</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,698&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,411&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,759&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Diluted income per common share</font></p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.57&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.28&nbsp; </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.12%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.26&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%">a</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share.&nbsp;&nbsp;Accordingly, stock options to purchase </font><font style="display: inline;font-size:10pt;">656,000</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">1.7</font><font style="display: inline;font-size:10pt;"> million, and </font><font style="display: inline;font-size:10pt;">2.0</font><font style="display: inline;font-size:10pt;"> million, shares for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Tax expense at statutory rate</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,152&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,013&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Increase (reduction) in income taxes resulting from:</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-deductible transaction costs</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>151&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>540&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State income taxes, net of federal benefit</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>183&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>296&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>150&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">State valuation allowance adjustment</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(760) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(427) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>100&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Equity compensation</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(29) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>149&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-deductible entertainment expenses</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>188&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>142&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign income taxes</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(199) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Domestic production activities deduction </font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(402) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(407) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(727) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Research and development credit</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(392) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(314) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>65&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>252&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,120&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,106&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,095&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 1</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 2</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 3</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,349&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Certificates of deposit</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>749&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>350&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total assets</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,448&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,448&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Long-term liabilities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total liabilities</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,884) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:0pt;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:4.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:4.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 1</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 2</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Level 3</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash equivalents:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,319&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Restricted securities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Money market funds</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>323&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total assets</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,642&nbsp; </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,642&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Long-term liabilities:</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Contingent consideration</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> </tr> <tr> <td valign="bottom" style="width:41.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total liabilities</font></p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,912) </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2014</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2015</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2016</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2017</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2018</font></p> </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Total</font></p> </td> </tr> <tr> <td valign="bottom" style="width:24.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Amortization expense</font></p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,948&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,905&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,898&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,850&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,844&nbsp; </td> <td valign="bottom" style="width:04.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:07.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,445&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Accumulated</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization </font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2013</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Period</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Acquired technology</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,020&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,677&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">11</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">16</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Patents</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,348&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,414&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Distribution and manufacturing rights and know-how</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,559&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>714&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Customer lists and relationships</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,370&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>572&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">13</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">17</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-compete agreement</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>267&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>202&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>171&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">3</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Accumulated</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization </font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;text-decoration:underline;">December 31, 2012</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Amortization</font></p> </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Period</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Acquired technology</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,020&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,538&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">11</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">16</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Patents</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,644&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,530&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Distribution and manufacturing rights and know-how</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,559&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>473&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Customer lists and relationships</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,370&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>330&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">13</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">17</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Non-compete agreement</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>229&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10&nbsp; </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>198&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>123&nbsp; </td> <td valign="bottom" style="width:04.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">-</font><font style="display: inline;font-size:10pt;">3</font></p> </td> <td valign="bottom" style="width:05.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Years</font></p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Operating</font></p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Leases</font></p> </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2014</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,799&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2015</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,031&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2016</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,943&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2017</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,980&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2018</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,010&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Thereafter</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,124&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:84.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total minimum lease payments</font></p> </td> <td valign="bottom" style="width:02.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,887&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of January 1, </font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill from Hemosphere acquisition</font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,145&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:70.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Balance as of December 31, </font></p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="top" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Domestic</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,686&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,238&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Foreign</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>288&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>366&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>228&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income before income taxes</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,292&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,052&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,466&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,365&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Procurement contracts and agreements</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,013&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,013&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Trademarks</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>841&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>870&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>250&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Raw materials and supplies</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,706&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,836&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Work-in-process</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>767&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>830&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,298&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,891&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:68.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total inventories</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,771&nbsp; </td> <td valign="bottom" style="width:05.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,557&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">First</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Second</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Third</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Fourth</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Quarter</font></p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">REVENUE:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,536&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,520&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,250&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,457&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,301&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,188&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,429&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,800&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,196&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,379&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,654&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,397&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">GROSS MARGIN:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,276&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,479&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,349&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,282&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,292&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,371&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,310&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,045&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,504&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,053&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,912&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,375&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">NET INCOME:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,192&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,785&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,169&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,026&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">*</font></p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>991&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,334&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,538&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,083&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,666&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,820&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,019&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,866&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">INCOME PER COMMON SHARE&#x2014;DILUTED:</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.08&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.11&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.31&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">*</font></p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.04&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.12&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:45.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">2011</font></p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.06&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.07&nbsp; </td> <td valign="bottom" style="width:03.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;text-align:center;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display: inline;font-size:10pt;">*</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a </font><font style="display: inline;font-size:10pt;">$12.7</font><font style="display: inline;font-size:10pt;"> million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc.</font><font style="display: inline;font-size:10pt;"> and the unfavorable effect of a </font><font style="display: inline;font-size:10pt;">$3.2</font><font style="display: inline;font-size:10pt;"> million </font><font style="display: inline;font-size:10pt;">other than temporary investment impairment as a result of </font><font style="display: inline;font-size:10pt;">the</font><font style="display: inline;font-size:10pt;"> impairment and</font><font style="display: inline;font-size:10pt;"> write-down</font><font style="display: inline;font-size:10pt;"> of</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s investment in ValveXchange preferred stock.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Opening</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Balance Sheet</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>650&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Receivables</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,055&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Inventory</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>852&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Property and equipment</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>248&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,900&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,002&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>230&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Liabilities assumed</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,445) </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total purchase price</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,712&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Opening</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Balance Sheet</font></p> </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,155&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Receivables</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>653&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Inventories</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>554&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Intangible assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,790&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Goodwill</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,145&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Deferred tax assets, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,379&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other assets</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>331&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Liabilities assumed</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(972) </td> </tr> <tr> <td valign="bottom" style="width:86.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total purchase price</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,035&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">U.S.</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>109,325&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>103,804&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>95,975&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">International</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,438&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,914&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,651&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Revenues:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,194&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,496&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,387&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,498&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,603&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,793&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cost of products and preservation services:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,147&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,380&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,442&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,230&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,320&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>34,340&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total cost of products and preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>50,377&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>46,700&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43,782&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Gross margin:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,047&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>56,116&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,945&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,268&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,283&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25,453&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total gross margin</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,386&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>85,018&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>75,844&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">PSUs</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> -- </font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.93&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>989,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>182,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(99,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>236,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.81&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,612,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>224,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.78&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,487,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">RSUs</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2010</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.85&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>313,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested </font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(3,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.66&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>466,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(37,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>120,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.54&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>747,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(54,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(10,000) </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>129,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.56&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,425,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:32.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:18.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,000&nbsp; </td> <td valign="bottom" style="width:03.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.55&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,314,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Average</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Grant Date</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">RSAs</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Fair Value</font></p> </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2010</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>364,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.07&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>360,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.18&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(128,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.28&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(44,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.48&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2011</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>552,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.91&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>229,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.39&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(142,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.00&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2012</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>639,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.48&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>232,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.10&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(215,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.80&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(34,000) </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.31&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:31.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Unvested at December 31, 2013</font></p> </td> <td valign="bottom" style="width:20.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>622,000&nbsp; </td> <td valign="bottom" style="width:04.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:13.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.62&nbsp; </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Average</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Weighted </font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Remaining </font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Average</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;"> Contractual</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Shares</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Exercise Price</font></p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Term in years</font></p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2010</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,281,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.74&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.46&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>603,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>599,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.13&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(260,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.53&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(100,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.60&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(320,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.30&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2011</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,200,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.83&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.00&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>159,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.67&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(48,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.64&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.01&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(249,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.03&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,060,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.74&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.66&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,225,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Granted</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.12&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercised</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(365,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.48&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Forfeited</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(49,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.56&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expired</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(14,000) </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.69&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Outstanding at December 31, 2013</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,794,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.57&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.31&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,274,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vested and expected to vest</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,781,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.57&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.29&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,205,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:30.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Exercisable at December 31, 2013</font></p> </td> <td valign="bottom" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,372,000&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:12.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.86&nbsp; </td> <td valign="bottom" style="width:03.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:06.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.75&nbsp; </td> <td valign="bottom" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,971,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Stock</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">ESPP</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">Options</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expected life of options</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.3 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.3 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">4.0 Years</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">.50 Years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Expected stock price volatility</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.60&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.39&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.60&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.48&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.65&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.39&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Dividends</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.91%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.59%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">N/A</font></p> </td> </tr> <tr> <td valign="bottom" style="width:27.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.70%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.13%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.71%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.12%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.25%&nbsp; </td> <td valign="bottom" style="width:02.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.14%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">18</font><font style="display: inline;font-weight:bold;font-size:10pt;">.&nbsp;&nbsp;Segment and Geographic Information</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has </font><font style="display: inline;font-size:10pt;">two</font><font style="display: inline;font-size:10pt;"> reportable segments organized according to its products and services: Medical Devices and Preservation Services.&nbsp;&nbsp;The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Graft.&nbsp;&nbsp;The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.&nbsp;&nbsp;There are no intersegment revenues.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The primary measure of segment performance, as viewed by the Company&#x2019;s management, is segment gross margin, or net external revenues less cost of products and preservation services.&nbsp;&nbsp;The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company&#x2019;s operating segments (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Revenues:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,194&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,496&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,387&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,498&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,603&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,793&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cost of products and preservation services:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,147&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,380&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,442&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,230&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>35,320&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>34,340&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total cost of products and preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>50,377&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>46,700&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43,782&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Gross margin:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Medical devices</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,047&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>56,116&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,945&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,268&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,283&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25,453&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total gross margin</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,386&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>85,018&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>75,844&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Net revenues by product for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> were as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Products:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">BioGlue and BioFoam</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>58,004&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,211&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,455&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">PerClot</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,494&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,078&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,528&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">HemoStase</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,699&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Revascularization technologies</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,965&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,092&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,705&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">HeRO Graft</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,731&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,115&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;"> --</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total products</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,194&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,496&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,387&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Preservation services:</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cardiac tissue</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,523&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,756&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,618&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Vascular tissue</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>34,975&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,847&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,175&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total preservation services</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,498&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,603&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,793&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Other</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">a</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>71&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>619&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;text-decoration:underline;"></font></font><font style="display: inline;font-size:10pt;text-decoration:underline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font><font style="display: inline;font-size:10pt;text-decoration:underline;"></font> </p> <p style="margin:0pt 0pt 0pt 18pt;text-indent: -18pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%">a</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4.8pt;position:relative;line-height:100%"></font><font style="display: inline;font-size:10pt;">For the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> the &#x201C;</font><font style="display: inline;font-size:10pt;">Other&#x201D;</font><font style="display: inline;font-size:10pt;"> designation includes grant revenue.</font><font style="display: inline;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 35pt;text-indent: -35pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Net revenues by geographic location attributed to countries based on the location of the customer for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> were as follows (in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;background-color:yellow;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">U.S.</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>109,325&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>103,804&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>95,975&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">International</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,438&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,914&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,651&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Total revenues</font></p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,763&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>131,718&nbsp; </td> <td valign="bottom" style="width:04.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:08.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119,626&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:6pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">At </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> over </font><font style="display: inline;font-size:10pt;">95</font><font style="display: inline;font-size:10pt;">% of the long</font><font style="display: inline;font-size:10pt;">&#8209;lived assets of the Company were held in the U.S., where all of the Company&#x2019;s manufacturing facilities and the corporate headquarters are located.&nbsp;&nbsp;At </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;"> the Company&#x2019;s $</font><font style="display: inline;font-size:10pt;">11.4</font><font style="display: inline;font-size:10pt;"> million </font><font style="display: inline;font-size:10pt;">of goodwill was allocated entirely to its Medical Devices segment.</font></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 57302000 65149000 3600000 4700000 68112000 2790000 3162000 3240000 P3Y P1Y 44000 3000 4000 6000 34000 10000 5.48 5.31 360000 61000 159000 229000 64000 182000 232000 73000 5.18 5.39 6.10 364000 58000 552000 97000 159000 639000 120000 236000 622000 129000 7.07 5.91 5.48 5.62 P1Y10M6D P1Y7M28D P11M5D P1Y6M15D P9M22D P1Y6M22D 128000 19000 142000 37000 99000 215000 54000 7.28 7.00 5.80 0.0159 0.0191 P6M P4Y P6M P4Y3M18D P6M P4Y3M18D 0.3900 0.6500 0.4800 0.6000 0.3900 0.6000 0.0014 0.0125 0.0012 0.0071 0.0013 0.0070 2100000 8400000 1900000 300000 2100000 4100000 3762000 847000 27000 41000 2847000 3030000 749000 60000 2221000 261000000 10000000 673000000 320000 249000 14000 100000 2000 49000 599000 599000 159000 159000 162000 162000 2.54 2.67 2.54 603000 313000 466000 1225000 989000 747000 8274000 2612000 1425000 2281000 2200000 2060000 1794000 6.74 6.83 6.74 6.57 P3Y5M16D P4Y P3Y7M28D P3Y3M22D 5971000 1372000 6.86 P2Y9M 8205000 1781000 6.57 P3Y3M15D 0.85 421000 451000 467000 4.53 5.64 7.48 5.30 7.03 6.69 5.60 7.01 5.56 5.13 5.67 6.12 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&#8209;Based Compensation</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#x201C;RSA&#x201D;s), restricted stock units (&#x201C;RSU&#x201D;s), performance stock units (&#x201C;PSU&#x201D;s), and options to purchase shares of CryoLife common stock at exercise prices generally equal to the fair values of such stock at the dates of grant.&nbsp;&nbsp;The Company also maintains a shareholder approved Employee Stock Purchase Plan (the &#x201C;ESPP&#x201D;) for the benefit of its employees.&nbsp;&nbsp;The ESPP allows eligible employees the right to purchase common stock on a regular basis at the lower of </font><font style="display: inline;font-size:10pt;">85</font><font style="display: inline;font-size:10pt;">% of the market price at the beginning or end of each offering period.&nbsp;&nbsp;The stock options, RSAs, RSUs, and PSUs granted by the Company typically vest over a </font><font style="display: inline;font-size:10pt;">one</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">three</font><font style="display: inline;font-size:10pt;">-year period.&nbsp;&nbsp;The stock options granted by the Company typically expire within </font><font style="display: inline;font-size:10pt;">seven</font><font style="display: inline;font-size:10pt;"> years of the grant date.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company values its RSAs, RSUs, and PSUs based on the stock price on the date of grant.&nbsp;&nbsp;The Company expenses the related compensation cost of RSAs and RSUs using the straight-line method over the vesting period.&nbsp;&nbsp;The Company expenses the related compensation cost of PSUs based on the number of shares expected to be issued if achievement of the performance component is probable using a straight-line method over each vesting tranche of the award.&nbsp;&nbsp;The amount of compensation costs expensed related to PSUs is adjusted as needed if the Company deems that achievement of the performance component is no longer probable, or if the Company&#x2019;s expectation of the number of shares to be issued changes.&nbsp;&nbsp;The Company uses a Black-Scholes model to value its stock option grants and expenses the related compensation cost using the straight-line method over the vesting period.&nbsp;&nbsp;The fair value of the Company&#x2019;s ESPP options is also determined using a Black-Scholes model and is expensed over the vesting period.&nbsp;&nbsp;The period expense is then determined based on this valuation and, at that time, an estimated forfeiture rate is used to reduce the expense recorded.&nbsp;&nbsp;The Company&#x2019;s estimate of pre-vesting forfeitures is primarily based on the recent historical experience of the Company and is adjusted to reflect actual forfeitures at each vesting date.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The fair value of stock options and ESPP options is determined on the grant date using assumptions for the expected term, volatility, dividend yield, and the risk-free interest rate.&nbsp; </font><font style="display: inline;font-size:10pt;">The expected term is primarily based on the contractual term of the option and Company data related to historic exercise and post-vesting forfeiture patterns, which is adjusted based on management&#x2019;s expectations of future results.&nbsp;&nbsp;The Company&#x2019;s anticipated volatility level is primarily based on the historic volatility of the Company&#x2019;s common stock, adjusted to remove the effects of certain periods of unusual volatility not expected to recur, and adjusted based on management&#x2019;s expectations of future volatility, for the life of the option or option group.&nbsp;&nbsp;The Company&#x2019;s model included a zero dividend yield assumption in the periods prior to the Company&#x2019;s initiation of a quarterly dividend in the third quarter of 2012.&nbsp;&nbsp;The risk-free interest rate is based on recent U.S. Treasury note auction results with a similar life to that of the option.&nbsp;&nbsp;The Company&#x2019;s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Shipping and Handling Charges</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Fees charged to customers for shipping and handling of products and tissues are included in product revenues and preservation services revenues, respectively.&nbsp;&nbsp;The costs for shipping and handling of products and tissues are included as a component of cost of products and cost of preservation services, respectively.</font></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">1.&nbsp;&nbsp;Summary of Significant Accounting Policies</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Nature of Business</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">CryoLife, Inc. (&#x201C;CryoLife,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; or &#x201C;us&#x201D;) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation.&nbsp;&nbsp;CryoLife&#x2019;s surgical sealants and hemostats include BioGlue</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> Surgical Adhesive (&#x201C;BioGlue&#x201D;), BioFoam</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> Surgical Matrix (&#x201C;BioFoam&#x201D;), and </font><font style="display: inline;font-size:10pt;">PerClot</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">, an absorbable powdered hemostat, which the Company distributes </font><font style="display: inline;font-size:10pt;">international</font><font style="display: inline;font-size:10pt;">ly</font><font style="display: inline;font-size:10pt;"> for </font><font style="display: inline;font-size:10pt;">Starch Medical, Inc. (&#x201C;SMI&#x201D;).&nbsp; </font><font style="display: inline;font-size:10pt;">CryoLife&#x2019;s subsidiary, Cardiogenesis Corporation (&#x201C;Cardiogenesis&#x201D;), specializes in the treatment of</font><font style="display: inline;font-size:10pt;"> coronary artery</font><font style="display: inline;font-size:10pt;"> disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.&nbsp; </font><font style="display: inline;font-size:10pt;">CryoLife and its subsidiary, Hemosphere, Inc. (&#x201C;Hemosphere&#x201D;), market the </font><font style="display: inline;font-size:10pt;text-decoration:underline;">He</font><font style="display: inline;font-size:10pt;">modialysis </font><font style="display: inline;font-size:10pt;text-decoration:underline;">R</font><font style="display: inline;font-size:10pt;">eliable </font><font style="display: inline;font-size:10pt;text-decoration:underline;">O</font><font style="display: inline;font-size:10pt;">utflow Graft (&#x201C;HeRO</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">Graft</font><font style="display: inline;font-size:10pt;">&#x201D;)</font><font style="display: inline;font-size:10pt;">, which is a solution for end-stage renal disease (&#x201C;ESRD&#x201D;) in certain hemodialysis patients.</font><font style="display: inline;font-size:10pt;"> &nbsp;The cardiac and vascular human tissues distributed by CryoLife include the CryoValve</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> SG pulmonary heart valve (&#x201C;CryoValve SGPV&#x201D;) and the CryoPatch</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> SG pulmonary cardiac patch tissue (&#x201C;CryoPatch SG&#x201D;), both </font><font style="display: inline;font-size:10pt;">of which are </font><font style="display: inline;font-size:10pt;">processed using CryoLife&#x2019;s proprietary SynerGraft</font><font style="display: inline;font-size:10pt;font-size:5pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display: inline;font-size:10pt;"> technology.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Principles of Consolidation</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.&nbsp;&nbsp;All significant inter-company accounts and transactions have been eliminated in consolidation.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Translation of Foreign Currencies</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s revenues and expenses transacted in foreign currencies are translated as they occur at exchange rates in effect at the time of each transaction.&nbsp;&nbsp;Realized gains and losses on foreign currency transactions are recorded as a component of </font><font style="display: inline;font-size:10pt;">other (income) expense, net</font><font style="display: inline;font-size:10pt;"> on the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income.&nbsp;&nbsp;Assets and liabilities of the Company denominated in foreign currencies are translated at the exchange rate in effect as of the balance sheet date and are recorded as a separate component of accumulated other comprehensive income (loss) in the shareholders' equity section of the Company&#x2019;s Consolidated Balance Sheets.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Use of Estimates</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Estimates and assumptions are used when accounting for investments, allowance for doubtful accounts, deferred preservation costs, acquired assets or businesses, long</font><font style="display: inline;font-size:10pt;">&#8209;lived tangible and intangible assets, deferred income taxes, commitments and contingencies (including product and tissue processing liability claims, claims incurred but not reported, and amounts recoverable from insurance companies), stock based compensation, certain accrued liabilities (including accrued procurement fees, income taxes, and financial instruments), contingent consideration liability, and other items as appropriate.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Revenue Recognition</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Revenues for products, including: </font><font style="display: inline;font-size:10pt;">BioGlue, BioFoam, PerClot, HemoStase, revascularization technologies handpieces and accessories, HeRO Grafts, and other medical devices,</font><font style="display: inline;font-size:10pt;"> are recognized at the time the product is shipped, at which time title passes to the customer, and there are no further performance obligations.&nbsp;&nbsp;The Company recognizes revenues for preservation services when services are completed and tissue is shipped to the customer.&nbsp;&nbsp;Revenues from research grants are recognized in the period the associated costs are incurred.&nbsp;&nbsp;Revenues from upfront licensing agreements are recognized ratably over the period the Company expects to fulfill its obligations.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Revenues from the sale of laser consoles are considered multiple element arrangements, and such revenues are allocated to the elements of the sale.&nbsp;&nbsp;The Company allocates revenues based primarily on the revenue these individual elements would generate if sold separately.&nbsp;&nbsp;Revenues from domestic laser consoles sales are typically recognized when the laser is installed at a customer site and all materials for the laser console&#x2019;s use are delivered.&nbsp;&nbsp;Revenues from the sales of laser consoles to international distributors are evaluated individually based on the terms of the sale and collectability to determine when revenue has been earned and can be recognized.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Shipping and Handling Charges</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Fees charged to customers for shipping and handling of products and tissues are included in product revenues and preservation services revenues, respectively.&nbsp;&nbsp;The costs for shipping and handling of products and tissues are included as a component of cost of products and cost of preservation services, respectively.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Advertising Costs</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The costs to develop, produce, and communicate the Company&#x2019;s advertising are expensed as incurred and are classified as general, administrative, and marketing expenses.&nbsp;&nbsp;The Company records the cost to print or copy certain sales materials as a prepaid expense and amortizes these costs as an advertising expense over the period they are expected to be used, typically six months to one year.&nbsp;&nbsp;The total amount of advertising expense included in the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income was $</font><font style="display: inline;font-size:10pt;">880,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">1.5</font><font style="display: inline;font-size:10pt;"> million, and $</font><font style="display: inline;font-size:10pt;">948,000</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively. </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&#8209;Based Compensation</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#x201C;RSA&#x201D;s), restricted stock units (&#x201C;RSU&#x201D;s), performance stock units (&#x201C;PSU&#x201D;s), and options to purchase shares of CryoLife common stock at exercise prices generally equal to the fair values of such stock at the dates of grant.&nbsp;&nbsp;The Company also maintains a shareholder approved Employee Stock Purchase Plan (the &#x201C;ESPP&#x201D;) for the benefit of its employees.&nbsp;&nbsp;The ESPP allows eligible employees the right to purchase common stock on a regular basis at the lower of </font><font style="display: inline;font-size:10pt;">85</font><font style="display: inline;font-size:10pt;">% of the market price at the beginning or end of each offering period.&nbsp;&nbsp;The stock options, RSAs, RSUs, and PSUs granted by the Company typically vest over a </font><font style="display: inline;font-size:10pt;">one</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">three</font><font style="display: inline;font-size:10pt;">-year period.&nbsp;&nbsp;The stock options granted by the Company typically expire within </font><font style="display: inline;font-size:10pt;">seven</font><font style="display: inline;font-size:10pt;"> years of the grant date.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:16pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company values its RSAs, RSUs, and PSUs based on the stock price on the date of grant.&nbsp;&nbsp;The Company expenses the related compensation cost of RSAs and RSUs using the straight-line method over the vesting period.&nbsp;&nbsp;The Company expenses the related compensation cost of PSUs based on the number of shares expected to be issued if achievement of the performance component is probable using a straight-line method over each vesting tranche of the award.&nbsp;&nbsp;The amount of compensation costs expensed related to PSUs is adjusted as needed if the Company deems that achievement of the performance component is no longer probable, or if the Company&#x2019;s expectation of the number of shares to be issued changes.&nbsp;&nbsp;The Company uses a Black-Scholes model to value its stock option grants and expenses the related compensation cost using the straight-line method over the vesting period.&nbsp;&nbsp;The fair value of the Company&#x2019;s ESPP options is also determined using a Black-Scholes model and is expensed over the vesting period.&nbsp;&nbsp;The period expense is then determined based on this valuation and, at that time, an estimated forfeiture rate is used to reduce the expense recorded.&nbsp;&nbsp;The Company&#x2019;s estimate of pre-vesting forfeitures is primarily based on the recent historical experience of the Company and is adjusted to reflect actual forfeitures at each vesting date.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The fair value of stock options and ESPP options is determined on the grant date using assumptions for the expected term, volatility, dividend yield, and the risk-free interest rate.&nbsp; </font><font style="display: inline;font-size:10pt;">The expected term is primarily based on the contractual term of the option and Company data related to historic exercise and post-vesting forfeiture patterns, which is adjusted based on management&#x2019;s expectations of future results.&nbsp;&nbsp;The Company&#x2019;s anticipated volatility level is primarily based on the historic volatility of the Company&#x2019;s common stock, adjusted to remove the effects of certain periods of unusual volatility not expected to recur, and adjusted based on management&#x2019;s expectations of future volatility, for the life of the option or option group.&nbsp;&nbsp;The Company&#x2019;s model included a zero dividend yield assumption in the periods prior to the Company&#x2019;s initiation of a quarterly dividend in the third quarter of 2012.&nbsp;&nbsp;The risk-free interest rate is based on recent U.S. Treasury note auction results with a similar life to that of the option.&nbsp;&nbsp;The Company&#x2019;s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Income Per Common Share</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Income per common share is computed using the two class method</font><font style="display: inline;font-size:10pt;">,</font><font style="display: inline;font-size:10pt;"> which requires the Company to include unvested RSAs that contain non-forfeitable rights to dividends (whether paid or unpaid) as participating securities in the income per common share calculation.&nbsp; </font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">Under the two class method, net income is allocated to the weighted-average number of common shares outstanding during the period and the weighted-average participating securities outstanding during the period.&nbsp;&nbsp;The portion of net income that is allocated to the participating securities is excluded from basic and dilutive net income per common share.&nbsp;&nbsp;Diluted net income per share is computed using the weighted-average number of common shares outstanding plus the dilutive effects of outstanding stock options and awards and other dilutive instruments as appropriate.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Dividends</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">During 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of </font><font style="display: inline;font-size:10pt;">$0.025</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;In 2013 the Company announced that its Board of Directors approved a </font><font style="display: inline;font-size:10pt;">10%</font><font style="display: inline;font-size:10pt;"> increase in the quarterly cash dividend beginning in the second quarter of 2013 to </font><font style="display: inline;font-size:10pt;">$0.0275</font><font style="display: inline;font-size:10pt;"> per share of common stock outstanding.&nbsp;&nbsp;The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year from cash on hand and will record the dividend payment as a reduction to retained earnings on the Company&#x2019;s Consolidated Balance Sheets.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Financial Instruments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s financial instruments include cash equivalents, marketable securities, restricted securities, accounts receivable, notes receivable, accounts payable, and contingent consideration.&nbsp;&nbsp;The Company typically values financial assets and liabilities such as receivables, accounts payable, and debt obligations at their carrying values, which approximate fair value due to their generally short-term duration.&nbsp;&nbsp;Other financial instruments are typically recorded as discussed in the sections</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">below.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Fair Value Measurements</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments.&nbsp;&nbsp;The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> the Company has not chosen to make any such elections.&nbsp;&nbsp;Fair value financial instruments are recorded in accordance with the fair value measurement framework.</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company also measures certain non-financial assets at fair value on a non-recurring basis.&nbsp;&nbsp;These non-recurring valuations include evaluating assets such as cost method investments, </font><font style="display: inline;font-size:10pt;">long</font><font style="display: inline;font-size:10pt;">&#8209;lived assets, and non-amortizing intangible assets for impairment;</font><font style="display: inline;font-size:10pt;"> allocating value to assets in an acquired asset group; and applying accounting for business combinations.&nbsp;&nbsp;The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down. </font><font style="display: inline;font-size:10pt;">&nbsp;</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.&nbsp;&nbsp;These levels from highest to lowest priority are as follows:</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 1:&nbsp;&nbsp;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 2:&nbsp;&nbsp;Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="margin:0pt 6.5pt 0pt 0pt;font-family:Symbol;line-height:normal;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="display: inline;font-size:10pt;">Level 3:&nbsp;&nbsp;Unobservable inputs or valuation techniques that are used when little or no market data is available.</font></p></td></tr></table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The determination of fair value and the assessment of a measurement&#x2019;s placement within the hierarchy requires judgment.&nbsp;&nbsp;Level 3 valuations often involve a higher degree of judgment and complexity.&nbsp;&nbsp;Level 3 valuations may require the use of various </font><font style="display: inline;font-size:10pt;">cost, market, or income valuation methodologies</font><font style="display: inline;font-size:10pt;"> applied to unobservable management estimates and assumptions.&nbsp;&nbsp;Management&#x2019;s assumptions could vary depending on the asset or liability valued and the valuation method used.&nbsp;&nbsp;Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company may also engage external advisors to assist in determining fair value, as appropriate.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Cash equivalents consist primarily of highly liquid investments with maturity dates of three months or less at the time of acquisition.&nbsp;&nbsp;The carrying value of cash equivalents approximates fair value.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">In 2012 the Company&#x2019;s cash equivalents included advance funding received from the U.S. Department of Defense (&#x201C;DOD&#x201D;) for the development of protein hydrogel technology.&nbsp;&nbsp;The advance funding was accounted for as deferred income on the Company&#x2019;s December 31, 2012 Consolidated Balance Sheet and revenue was recognized as expenses were incurred related to these grants.&nbsp;&nbsp;The Company discontinued its BioFoam U.S. clinical trial and returned all of the remaining unspent funds to the DOD in the second quarter of 2013.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash Flow Supplemental Disclosures</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Supplemental disclosures of cash flow information for the years ended December 31 (in thousands):</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Cash paid during the year for:</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Interest</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>89&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Income taxes</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,693&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,263&nbsp; </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,564&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:62.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Marketable Securities and Other Investments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company typically invests its excess cash for short-term periods in large, well</font><font style="display: inline;font-size:10pt;">&#8209;capitalized financial institutions, and the Company's policy excludes investment in any securities rated less than "investment</font><font style="display: inline;font-size:10pt;">&#8209;grade" by national rating services, unless specifically approved by the Board of Directors.&nbsp;&nbsp;The Company sometimes makes longer term strategic investments in medical device companies, and these investments must be approved by the Board of Directors.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company determines the classification of its investments as trading, available-for-sale, or held-to-maturity at the time of purchase and reevaluates such designations quarterly.&nbsp;&nbsp;Trading securities are securities that are </font><font style="display: inline;font-size:10pt;">acquired principally for the purpose of generating a profit from short-term fluctuations in price</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;Debt securities are classified as held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity when the Company has the intent and ability to hold the securities to maturity.&nbsp;&nbsp;Any securities not designated as trading or held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity are considered available-for-sale.&nbsp;&nbsp;T</font><font style="display: inline;font-size:10pt;">he Company typically states its investments at their fair values; however, for </font><font style="display: inline;font-size:10pt;">held</font><font style="display: inline;font-size:10pt;">&#8209;to</font><font style="display: inline;font-size:10pt;">&#8209;maturity securities or </font><font style="display: inline;font-size:10pt;">when current fair value information is not readily available, investments are recorded using the cost method.&nbsp;&nbsp;The cost of securities sold is based on the specific identification method.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Under the fair value method, the Company adjusts each investment to its market price and records the unrealized gains or losses in other (income) expense, net for trading securities, or accumulated other comprehensive income (loss), for available-for-sale securities.&nbsp;&nbsp;Interest, dividends, realized gains and losses, and declines in value judged to be other than temporary are included in other (income) expense, net.&nbsp;&nbsp;Under the cost method, each investment is recorded at cost.&nbsp;&nbsp;Subsequent dividends received are recognized as income, and the investment is reviewed for impairment if factors indicate that a decrease in the value of the investment has occurred. </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accounts Receivable and Allowance for Doubtful Accounts</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company&#x2019;s accounts receivable are primarily from hospitals and distributors that either use or distribute the Company&#x2019;s products and tissues.&nbsp;&nbsp;The Company assesses the likelihood of collection based on a number of factors, including past transaction history with the customer and the credit worthiness of the customer, as well as the increased risks related to international customers and large distributors.&nbsp;&nbsp;The accounts receivable balances were reported net of allowance for doubtful accounts of $</font><font style="display: inline;font-size:10pt;">356,000</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">528,000</font><font style="display: inline;font-size:10pt;"> as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012 </font><font style="display: inline;font-size:10pt;">respectively.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Preservation Costs</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory.&nbsp;&nbsp;The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred.&nbsp; </font><font style="display: inline;font-size:10pt;">Deferred preservation costs are stated at the lower of cost or market value on a first</font><font style="display: inline;font-size:10pt;">&#8209;in, first</font><font style="display: inline;font-size:10pt;">&#8209;out basis and are deferred until revenue is recognized.&nbsp; </font><font style="display: inline;font-size:10pt;">At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services.&nbsp;&nbsp;Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments </font><font style="display: inline;font-size:10pt;">for tissues not deemed to be recoverable, and includes,</font><font style="display: inline;font-size:10pt;"> as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The calculation of deferred preservation costs involves judgment and complexity and uses the </font><font style="display: inline;font-size:10pt;">same principles as inventory costing</font><font style="display: inline;font-size:10pt;">.&nbsp; </font><font style="display: inline;font-size:10pt;">Donated human tissue is procured from deceased human donors by </font><font style="display: inline;font-size:10pt;">organ and tissue procurement organizations </font><font style="display: inline;font-size:10pt;">(</font><font style="display: inline;">&#x201C;</font><font style="display: inline;font-size:10pt;">OTPOs</font><font style="display: inline;">&#x201D;</font><font style="display: inline;font-size:10pt;">), which consign the tissue to the Company for processing, preservation, and distribution.&nbsp;&nbsp;Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight</font><font style="display: inline;font-size:10pt;">&#8209;in charges), and indirect costs (including allocations of costs from support departments and facility allocations).&nbsp; </font><font style="display: inline;font-size:10pt;">F</font><font style="display: inline;font-size:10pt;">ixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility&#x2019;s normal capacity</font><font style="display: inline;font-size:10pt;">.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed.&nbsp;&nbsp;The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable.&nbsp;&nbsp;Management estimates quarantine yields based on its experience and reevaluates these estimates periodically.&nbsp;&nbsp;Actual yields could differ significantly from the Company&#x2019;s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs.&nbsp;&nbsp;These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value.&nbsp;&nbsp;The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging.&nbsp;&nbsp;Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation.&nbsp;&nbsp;Impairment write-downs are recorded based on the book value of tissues deemed to be impaired.&nbsp;&nbsp;Actual results may differ from these estimates.&nbsp;&nbsp;Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company&#x2019;s estimates change.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company recorded write-downs to its deferred preservation costs totaling $</font><font style="display: inline;font-size:10pt;">448,000</font><font style="display: inline;font-size:10pt;">, $</font><font style="display: inline;font-size:10pt;">195,000</font><font style="display: inline;font-size:10pt;">, and $</font><font style="display: inline;font-size:10pt;">270,000</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively. </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Inventories</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Inventories are valued at the lower of cost or market on a first</font><font style="display: inline;font-size:10pt;">&#8209;in, first</font><font style="display: inline;font-size:10pt;">&#8209;out basis and the costs are recognized as cost of products upon shipment of the product.&nbsp;&nbsp;Inventories are comprised of BioGlue; BioFoam; PerClot; revascularization technologies lasers, handpieces, and accessories; </font><font style="display: inline;font-size:10pt;">HeRO Grafts; </font><font style="display: inline;font-size:10pt;">other medical devices; supplies; and raw materials.&nbsp; </font><font style="display: inline;font-size:10pt;">Cost of products also includes, as incurred, </font><font style="display: inline;font-size:10pt;">i</font><font style="display: inline;font-size:10pt;">dle facility expense, excessive spoilage, extra freight, and rehandling costs. </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Inventory costs for manufactured products consist primarily of direct labor and materials (including salary and fringe benefits, raw materials, and supplies) and indirect costs (including allocations of costs from departments that support manufacturing activities and facility allocations).&nbsp;&nbsp;The allocation of fixed production overhead costs is based on actual production levels, to the extent that they are within the range of the facility&#x2019;s normal capacity</font><font style="display: inline;font-size:10pt;">.&nbsp; </font><font style="display: inline;font-size:10pt;">Inventory costs for products purchased for resale or contract manufactured consist primarily of the purchase cost, freight-in charges, and indirect costs as appropriate.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company regularly evaluates its inventory to determine if the costs are appropriately recorded at the lower of cost or market value.&nbsp;&nbsp;The Company also evaluates its inventory for costs not deemed to be recoverable, including inventory not expected to ship prior to its expiration.&nbsp; </font><font style="display: inline;font-size:10pt;">Lower of cost or market value write-downs are recorded if the book value exceeds the estimated market value of the inventory, based on recent sales prices at the time of the evaluation.&nbsp;&nbsp;Impairment write-downs are recorded based on the book value of inventory deemed to be impaired.&nbsp;&nbsp;Actual results may differ from these estimates.&nbsp;&nbsp;Write-downs of inventory are expensed as cost of products, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company&#x2019;s estimates change.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company recorded write-downs to its inventory totaling $</font><font style="display: inline;font-size:10pt;">1.2</font><font style="display: inline;font-size:10pt;"> million, $</font><font style="display: inline;font-size:10pt;">77,000</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">zero</font><font style="display: inline;font-size:10pt;"> for the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;">, respectively.&nbsp;&nbsp;The </font><font style="display: inline;font-size:10pt;">2013</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">write-down includes </font><font style="display: inline;font-size:10pt;">$684,000</font><font style="display: inline;font-size:10pt;"> in additional contractual costs and inventory impairment costs, primarily related to a BioGlue accessory product, and </font><font style="display: inline;font-size:10pt;">$483,000</font><font style="display: inline;font-size:10pt;"> in additional costs for revascularization technologies handpieces that were made obsolete by the Company&#x2019;s decision to exclusively distribute the new handpiece design, which was approved by the </font><font style="display: inline;font-size:10pt;">U.S. Food and Drug Administration (&#x201C;FDA&#x201D;) </font><font style="display: inline;font-size:10pt;"> in June 2013.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Property and Equipment</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Property and equipment is stated at cost.&nbsp;&nbsp;Depreciation is provided over the estimated useful lives of the assets, generally </font><font style="display: inline;font-size:10pt;">three</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">ten</font><font style="display: inline;font-size:10pt;"> years, on a straight</font><font style="display: inline;font-size:10pt;">&#8209;line basis.&nbsp;&nbsp;Leasehold improvements are amortized on a straight</font><font style="display: inline;font-size:10pt;">&#8209;line basis over the remaining lease term at the time the assets are capitalized or the estimated useful lives of the assets, whichever is shorter.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Depreciation expense for the years ended December 31 is as follows (in thousands):</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.25pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:55.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Depreciation expense</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,837&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,662&nbsp; </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:11.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:13.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,590&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Goodwill and Other Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company&#x2019;s intangible assets consist of goodwill, patents, trademarks, and other intangible assets, as discussed in </font><font style="display: inline;font-size:10pt;">Note 9</font><font style="display: inline;font-size:10pt;">.&nbsp;&nbsp;These assets include intangible assets from the acquisition of Hemosphere, as discussed in </font><font style="display: inline;font-size:10pt;">Note 4</font><font style="display: inline;font-size:10pt;">, and assets acquired from Cardiogenesis, as discussed in </font><font style="display: inline;font-size:10pt;">Note 6</font><font style="display: inline;font-size:10pt;">. &nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company amortizes its definite lived intangible assets over their expected useful lives using the straight-line method, which the Company believes approximates the period of economic benefits of the related assets.&nbsp;&nbsp;The Company&#x2019;s indefinite lived intangible assets do not amortize, but are instead subject to periodic impairment testing as discussed in &#x201C;Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets&#x201D; below.&nbsp; </font><font style="display: inline;font-size:10pt;"></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Impairments of Long</font><font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&#8209;Lived Assets and Non-Amortizing Intangible Assets</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company assesses the potential impairment of its long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable.&nbsp;&nbsp;Factors that could trigger an impairment review include, but are not limited to, the following:</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.45pt 3pt 0pt;"> <font style="margin:0pt 6.45pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.45pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant underperformance relative to expected historical or projected future operating results, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant negative industry or economic trends, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="margin:0pt 6.7pt 3pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.7pt 3pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant decline in the Company&#x2019;s stock price for a sustained period, or</font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="margin:0pt 6.5pt 0pt 0pt;font-family:Symbol;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:0pt 6.5pt 0pt 0pt;"> <font style="display: inline;font-size:10pt;">Significant decline in the Company&#x2019;s market capitalization relative to net book value.&nbsp; </font></p></td></tr></table></div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">If CryoLife determines that an impairment review is necessary, the Company will evaluate its assets or asset groups by comparing their carrying values to the sum of the undiscounted future cash flows expected to result from their use and eventual disposition.&nbsp;&nbsp;If the carrying values exceed the future cash flows, then the asset or asset group is considered impaired, and </font><font style="display: inline;font-size:10pt;">the Company will </font><font style="display: inline;font-size:10pt;">write down the value of the asset or asset group.&nbsp;&nbsp;For the years ended </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2012</font><font style="display: inline;font-size:10pt;">, and </font><font style="display: inline;font-size:10pt;">2011</font><font style="display: inline;font-size:10pt;"> the Company did not experience any factors that indicated that an impairment review of its long-lived assets was warranted.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">CryoLife evaluates its goodwill and other non-amortizing intangible assets for impairment on an annual basis as of October 31 and, if necessary, during interim periods if factors indicate that an impairment review is warranted.&nbsp;&nbsp;As of October 31, 2013 the Company&#x2019;s non-amortizing intangible assets consisted of goodwill, acquired procurement contracts and agreements, trademarks, and other acquired technology.&nbsp;&nbsp;The Company performed an analysis of its non-amortizing intangible assets as of October 31, 2013 and 2012, and determined that the fair value of the assets and the fair value of the reporting unit exceeded their associated carrying values and were, therefore, not impaired.&nbsp;&nbsp;Management will continue to evaluate the recoverability of these non-amortizing intangible assets.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accrued Procurement Fees</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Donated t</font><font style="display: inline;font-size:10pt;">issue is procured from deceased human donors by OTPOs, which consign the tissue to the Company for processing, preservation, and distribution.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company reimburses the OTPOs for their costs to recover the tissue and passes these costs on to the customer when the tissue is shipped and the performance of the service is complete.&nbsp;&nbsp;The Company accrues estimated procurement fees due to the OTPOs at the time tissues are received based on contractual agreements between the Company and the OTPOs.</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Leases </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company has operating lease obligations resulting from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment as discussed in </font><font style="display: inline;font-size:10pt;">Note 12</font><font style="display: inline;font-size:10pt;">.</font><font style="display: inline;font-size:10pt;"> &nbsp;Certain of the Company&#x2019;s leases contain escalation clauses, rent concessions, and renewal options for additional periods.&nbsp;&nbsp;Rent expense is computed on the straight</font><font style="display: inline;font-size:10pt;">&#8209;line method over the lease term</font><font style="display: inline;font-size:10pt;"> and the related liability is recorded as deferred rent obligations on the</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">Company&#x2019;s Consolidated Balance Sheets</font><font style="display: inline;font-size:10pt;">.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Liability Claims</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">In the normal course of business, the Company is made aware of adverse events involving its products and tissues.&nbsp;&nbsp;Any adverse event could ultimately give rise to a lawsuit against the Company.&nbsp;&nbsp;In addition, product and tissue processing liability claims may be asserted against the Company in the future based on events it is not aware of at the present time.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company maintains claims</font><font style="display: inline;font-size:10pt;">&#8209;made insurance policies to mitigate its financial exposure to product and tissue processing liability claims.&nbsp;&nbsp;Claims</font><font style="display: inline;font-size:10pt;">&#8209;made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect.&nbsp;&nbsp;Thus, a claims</font><font style="display: inline;font-size:10pt;">&#8209;made policy does not generally represent a transfer of risk for claims and incidents that have been incurred but not reported to the insurance carrier during the policy period.&nbsp;&nbsp;Any punitive damage components of claims are uninsured. </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company engages external advisors to assist it in estimating its liability and any related recoverable under the Company's insurance policies as of each balance sheet date.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company uses a frequency</font><font style="display: inline;font-size:10pt;">&#8209;severity approach to estimate its </font><font style="display: inline;font-size:10pt;">unreported product and tissue processing liability claims</font><font style="display: inline;font-size:10pt;">, whereby, projected losses are calculated by multiplying the estimated number of claims by the estimated average cost per claim.&nbsp;&nbsp;The estimated claims are determined based on the reported claim development method and the Bornhuetter</font><font style="display: inline;font-size:10pt;">&#8209;Ferguson method using a blend of the Company's historical claim experience and industry data.</font><font style="display: inline;font-size:10pt;"> &nbsp;The estimated cost per claim is calculated using a lognormal claims model blending the Company's historical average cost per claim with industry claims data.&nbsp;&nbsp;The Company uses a number of assumptions in order to estimate the unreported loss liability including: the future claim reporting time lag, the frequency of reported claims, the average cost per claim, and the maximum liability per claim.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company believes that the assumptions it uses provide a reasonable basis for its calculation.&nbsp;&nbsp;However, the accuracy of the estimates is limited by the general uncertainty that exists for any estimate of future activity due to uncertainties surrounding the assumptions used and due to Company specific conditions and the scarcity of industry data directly relevant to the Company's business activities.&nbsp;&nbsp;Due to these factors, actual results may differ significantly from the assumptions used and amounts accrued.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long</font><font style="display: inline;font-size:10pt;">&#8209;term liabilities and records the related recoverable insurance amounts as a component of receivables and other long</font><font style="display: inline;font-size:10pt;">&#8209;term assets.&nbsp;&nbsp;The amounts recorded represent management's estimate of the probable losses and anticipated recoveries for unreported claims related to products sold and services performed prior to the balance sheet date.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Legal Contingencies</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">The Company accrues losses from a legal contingency when the loss is both probable and reasonably estimable.&nbsp;&nbsp;T</font><font style="display: inline;font-size:10pt;">he accuracy of the Company&#x2019;s estimates of losses for legal contingencies is limited by uncertainties surrounding litigation.&nbsp;&nbsp;Therefore, actual results may differ significantly from the amounts accrued, if any.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company accrues for legal contingencies as a component of accrued expenses and other long</font><font style="display: inline;font-size:10pt;">&#8209;term liabilities.&nbsp;&nbsp;Gains from legal contingencies are recorded when the contingency is resolved.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Legal Fees </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company expenses the costs of legal services, including legal services related to product and tissue processing liability claims and legal contingencies, as they are incurred.&nbsp;&nbsp;Reimbursement of legal fees by an insurance company or other third-party is recorded as a reduction to legal expense.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Uncertain Tax Positions</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company periodically assesses its uncertain tax positions and recognizes tax benefits if they are &#x201C;more-likely-than-not&#x201D; to be upheld upon review by the appropriate taxing authority.&nbsp;&nbsp;The Company measures the tax benefit by determining the maximum amount that has a &#x201C;greater than 50 percent likelihood&#x201D; of ultimately being realized.&nbsp;&nbsp;The Company reverses previously accrued liabilities for uncertain tax positions when audits are concluded, statutes expire, administrative practices dictate that a liability is no longer warranted, or in other circumstances as deemed necessary.&nbsp;&nbsp;These assessments can be complex and the Company often obtains assistance from external advisors to make these assessments.&nbsp; </font><font style="display: inline;font-size:10pt;">The Company recognizes interest and penalties related to uncertain tax positions in other (income) expense, net on its Consolidated Statements of Operations and Comprehensive Income.&nbsp;&nbsp;See </font><font style="display: inline;font-size:10pt;">Note 10</font><font style="display: inline;font-size:10pt;"> for further discussion of the Company&#x2019;s liabilities for uncertain tax positions.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Deferred Income Taxes</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes.&nbsp;&nbsp;The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets.&nbsp;&nbsp;Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Assessing the recoverability of deferred tax assets </font><font style="display: inline;font-size:10pt;">involves judgment and complexity.&nbsp;&nbsp;Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following: </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Projected future operating results, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Anticipated future state tax apportionment, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Timing and amounts of anticipated future taxable income, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Timing of the anticipated reversal of book/tax temporary differences, </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="margin:0pt 0pt 3pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt 0pt 3pt;"> <font style="display: inline;font-size:10pt;">Evaluation of statutory limits regarding usage of certain tax assets, and </font></p></td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt;font-family:Symbol;line-height:100%;font-size:10pt;;"> &#xB7;</font> </p> </td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top"> <p style="line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-size:10pt;">Evaluation of the statutory periods over which certain tax assets can be utilized.&nbsp; </font></p></td></tr></table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Significant changes in the factors above, or other factors, could materially, adversely affect the Company&#x2019;s ability to use its deferred tax assets.&nbsp;&nbsp;Such changes could have a material, adverse impact on the Company&#x2019;s operations, financial condition, and cash flows.&nbsp;&nbsp;The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended.&nbsp;&nbsp;The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company&#x2019;s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control.&nbsp;&nbsp;The Company also believes that its acquisition of Cardiogenesis constituted a change in control.&nbsp;&nbsp;The deferred tax assets recorded on the Company&#x2019;s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control.&nbsp;&nbsp;A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized.&nbsp;&nbsp;Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Valuation of Acquired Assets or Businesses</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"> &nbsp;As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies.&nbsp;&nbsp;The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group, or as a business combination, as appropriate.&nbsp;&nbsp;The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values.&nbsp;&nbsp;In-process research and development acquired as part of an asset group is expensed upon acquisition.&nbsp;&nbsp;The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value.&nbsp;&nbsp;Transaction costs related to a business combination are expensed as incurred.&nbsp;&nbsp;In-process research and development acquired as part of a business combination is accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief from royalty methods.&nbsp;&nbsp;The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates.&nbsp;&nbsp;Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge.&nbsp;&nbsp;Management believes that its estimates are reasonable, but actual results could differ significantly from the Company&#x2019;s estimates.&nbsp;&nbsp;A significant change in management&#x2019;s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company&#x2019;s financial position and profitability.&nbsp;&nbsp;If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company&#x2019;s financial position and profitability.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Derivative Instruments</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;font-size:10pt;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;font-size:10pt;">The Company determines the fair value of its stand-alone and embedded derivative instruments at issuance and records any resulting asset or liability on the Company&#x2019;s Consolidated Balance Sheets.&nbsp;&nbsp;Changes in the fair value of the derivative instruments are recognized in the line item change in valuation of derivative on the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Income.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">New Accounting Pronouncements</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;"></font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;"></font><font style="display: inline;font-size:10pt;">In January 2013 the Company adopted Accounting Standards Update ("ASU"), 2012-02, Intangibles-Goodwill and Other (Topic 350): </font><font style="display: inline;font-style:italic;font-size:10pt;">Testing Indefinite-Lived Intangible Assets for Impairment</font><font style="display: inline;font-size:10pt;">, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test.&nbsp;&nbsp;The adoption of ASU 2012-02 did not have a material effect on the Company's financial condition, profitability, or cash flows.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220):&nbsp; </font><font style="display: inline;font-style:italic;font-size:10pt;">Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</font><font style="display: inline;font-size:10pt;">, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements.&nbsp;&nbsp;This update also requires companies to disclose the income statement line items affected by any significant reclassifications.&nbsp;&nbsp;The adoption of ASU 2013-02 did not have a material effect on the Company's financial disclosures.</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 113942000 -32000 133845000 300000 -8408000 -11763000 121538000 -6000 135003000 301000 -1037000 -12723000 128112000 -39000 122414000 275000 5536000 -74000 144747000 7000 128585000 282000 18741000 -2868000 64000 64000 72000 72000 97000 97000 -25000 360000 37000 229000 352000 260000 84000 37000 48000 8000 365000 365000 -102000 286000 286000 293000 292000 1000 475000 474000 1000 3014000 965000 2049000 3376000 2410000 966000 3468000 3465000 3000 408000 380000 1000 27000 37000 37000 1732000 2728000 4000 -1000000 6000 20000 11000 26000 56000 44000 -138000 -28000 -110000 -219000 -66000 -153000 -681000 -409000 -1000 -271000 -2687000 2687000 -15119000 -27000 15146000 593000 639000 253000 -2926000 -2926000 -3310000 -3310000 -1523000 -1523000 15000000 15000000 13500000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Beginning balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,788&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,822&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Increases related to current year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>281&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>231&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>78&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Decreases related to prior year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(185) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(15) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(112) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Ending balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,100&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,004&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,788&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;background-color:yellow;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">A reconciliation of the beginning and ending balances of the Company&#x2019;s liability for interest and penalties on uncertain tax positions is as follows </font><font style="display: inline;font-size:10pt;">(in thousands):</font></font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> <font style="display: inline;font-size:10pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2013</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2012</font></p> </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-size:10pt;">2011</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Beginning balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>489&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>418&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>391&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Accrual of interest and penalties</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>79&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>65&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Decreases related to prior year tax positions</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(133) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(8) </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(38) </td> </tr> <tr> <td valign="bottom" style="width:57.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">Ending balance</font></p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>422&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>489&nbsp; </td> <td valign="bottom" style="width:04.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">$</font></p> </td> <td valign="bottom" style="width:09.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>418&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 619000 1377000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Accounts Receivable and Allowance for Doubtful Accounts</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The Company&#x2019;s accounts receivable are primarily from hospitals and distributors that either use or distribute the Company&#x2019;s products and tissues.&nbsp;&nbsp;The Company assesses the likelihood of collection based on a number of factors, including past transaction history with the customer and the credit worthiness of the customer, as well as the increased risks related to international customers and large distributors.&nbsp;&nbsp;The accounts receivable balances were reported net of allowance for doubtful accounts of $</font><font style="display: inline;font-size:10pt;">356,000</font><font style="display: inline;font-size:10pt;"> and $</font><font style="display: inline;font-size:10pt;">528,000</font><font style="display: inline;font-size:10pt;"> as of </font><font style="display: inline;font-size:10pt;">December 31, 2013</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">2012 </font><font style="display: inline;font-size:10pt;">respectively.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 0 0 0 323000 22000 328000 15100000 15100000 27000 15100000 14000 413000 639000 253000 2700000 74000 2868000 3300000 1500000 149000 147000 180000 178000 367000 359000 1822000 1788000 2004000 2100000 112000 15000 185000 391000 418000 489000 422000 78000 231000 281000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Use of Estimates</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:10pt;">The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Estimates and assumptions are used when accounting for investments, allowance for doubtful accounts, deferred preservation costs, acquired assets or businesses, long</font><font style="display: inline;font-size:10pt;">&#8209;lived tangible and intangible assets, deferred income taxes, commitments and contingencies (including product and tissue processing liability claims, claims incurred but not reported, and amounts recoverable from insurance companies), stock based compensation, certain accrued liabilities (including accrued procurement fees, income taxes, and financial instruments), contingent consideration liability, and other items as appropriate.</font></font> </p> <p><font size="1"> </font></p> </div> </div> 27759000 27411000 27698000 27441000 26967000 26885000 The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock. For the years ended December 31, 2013, 2012, and 2011 the “Other” designation includes grant revenue. The Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share. Accordingly, stock options to purchase 656,000, 1.7 million, and 2.0 million, shares for the years ended December 31, 2013, 2012, and 2011, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding. EX-101.SCH 11 cry-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statement Of Operations And Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statement Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statement Of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Summary Of Cash Equivalents And Marketable Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Hemosphere Acquisition (Business Acquisition Purchase Price Allocation) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Cardiogenesis Acquisition (Business Acquisition Purchase Price Allocation) (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Deferred Preservation Costs And Inventories (Schedule Of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 40905 - Disclosure - Goodwill And Other Intangible Assets (Scheduled Amortization Of Intangible Assets For Next Five Years) (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Income Taxes (Schedule Of Income Before Income Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Income Taxes (Schedule Of Components Of Income Tax Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 41004 - Disclosure - Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details) link:presentationLink link:calculationLink link:definitionLink 41005 - Disclosure - Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Commitments And Contingencies (Schedule Of Future Minimum Operating Lease Payments) (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details) alt link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Consolidated Statement Of Shareholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Cash Equivalents And Restricted Cash And Securities link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Hemosphere Acquisition link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - ValveXchange link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Cardiogenesis Acquisition link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Medafor Matters link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Deferred Preservation Costs And Inventories link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Goodwill And Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Stock Compensation link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Income Per Common Share link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - Transactions With Related Parties link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - Segment And Geographic Information link:presentationLink link:calculationLink link:definitionLink 11901 - Disclosure - Selected Quarterly Financial Information link:presentationLink link:calculationLink link:definitionLink 20101 - Disclosure - Summary Of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30103 - Disclosure - Summary Of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Hemosphere Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Cardiogenesis Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Deferred Preservation Costs And Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Goodwill And Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Commitments And Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 31503 - Disclosure - Stock Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 31603 - Disclosure - Income Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 31803 - Disclosure - Segment And Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 31903 - Disclosure - Selected Quarterly Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Supplemental Disclosures Of Cash Flow Information) (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Depreciation Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Narrative ) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Hemosphere Acquisition (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Hemosphere Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - ValveXchange (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Cardiogenesis Acquisition (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Cardiogenesis Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Medafor Matters (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Deferred Preservation Costs And Inventories (Schedule Of Deferred Preservation Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Carrying Values Of Indefinite Lived Intangible Assets)(Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Goodwill By Reportable Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Gross Carrying Values, Accumulated Amortization, And Approximate Amortization Periods Of Definite Lived Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Goodwill And Other Intangible Assets (Summary Of Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41006 - Disclosure - Income Taxes (Schedule Of Uncertain Tax Position Liability And Liability For Interest And Penalties On Uncertain Tax Positions) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Commitments And Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Stock Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41502 - Disclosure - Stock Compensation (Schedule Of Shares Available For Grant) (Details) link:presentationLink link:calculationLink link:definitionLink 41503 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For RSAs) (Details) link:presentationLink link:calculationLink link:definitionLink 41504 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For RSUs) (Details) link:presentationLink link:calculationLink link:definitionLink 41505 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For PSUs) (Details) link:presentationLink link:calculationLink link:definitionLink 41506 - Disclosure - Stock Compensation (Summary Of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41507 - Disclosure - Stock Compensation (Summary Of Other Information Concerning Stock Options) (Details) link:presentationLink link:calculationLink link:definitionLink 41508 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details) link:presentationLink link:calculationLink link:definitionLink 41509 - Disclosure - Stock Compensation (Summary Of Stock Compensation Expenses) (Details) link:presentationLink link:calculationLink link:definitionLink 41701 - Disclosure - Transactions With Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 41801 - Disclosure - Segment And Geographic Information (Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments) (Details) link:presentationLink link:calculationLink link:definitionLink 41802 - Disclosure - Segment And Geographic Information (Summary Of Net Revenues By Product) (Details) link:presentationLink link:calculationLink link:definitionLink 41803 - Disclosure - Segment And Geographic Information (Schedule Of Net Revenues By Geographic Location) (Details) link:presentationLink link:calculationLink link:definitionLink 41901 - Disclosure - Selected Quarterly Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 cry-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 13 cry-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 14 cry-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 15 cry-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment And Geographic Information (Tables)
 12 Months Ended
Dec. 31, 2013
Segment And Geographic Information [Abstract]  
Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Revenues:

 

 

 

 

 

 

 

 

Medical devices

$
76,194 

 

$
67,496 

 

$
59,387 

Preservation services

 
64,498 

 

 
63,603 

 

 
59,793 

Othera

 
71 

 

 
619 

 

 
446 

Total revenues

 
140,763 

 

 
131,718 

 

 
119,626 

 

 

 

 

 

 

 

 

 

Cost of products and preservation services:

 

 

 

 

 

 

 

 

Medical devices

 
15,147 

 

 
11,380 

 

 
9,442 

Preservation services

 
35,230 

 

 
35,320 

 

 
34,340 

Total cost of products and preservation services

 
50,377 

 

 
46,700 

 

 
43,782 

 

 

 

 

 

 

 

 

 

Gross margin:

 

 

 

 

 

 

 

 

Medical devices

 
61,047 

 

 
56,116 

 

 
49,945 

Preservation services

 
29,268 

 

 
28,283 

 

 
25,453 

Othera

 
71 

 

 
619 

 

 
446 

Total gross margin

$
90,386 

 

$
85,018 

 

$
75,844 

 

Summary Of Net Revenues By Product

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Products:

 

 

 

 

 

 

 

 

BioGlue and BioFoam

$
58,004 

 

$
53,211 

 

$
49,455 

PerClot

 
3,494 

 

 
3,078 

 

 
2,528 

HemoStase

 

--

 

 

--

 

 
1,699 

Revascularization technologies

 
8,965 

 

 
8,092 

 

 
5,705 

HeRO Graft

 
5,731 

 

 
3,115 

 

 

--

Total products

 
76,194 

 

 
67,496 

 

 
59,387 

 

 

 

 

 

 

 

 

 

Preservation services:

 

 

 

 

 

 

 

 

Cardiac tissue

 
29,523 

 

 
29,756 

 

 
26,618 

Vascular tissue

 
34,975 

 

 
33,847 

 

 
33,175 

Total preservation services

 
64,498 

 

 
63,603 

 

 
59,793 

 

 

 

 

 

 

 

 

 

Othera

 
71 

 

 
619 

 

 
446 

Total revenues

$
140,763 

 

$
131,718 

 

$
119,626 

aFor the years ended December 31, 2013,  2012, and 2011 the “Other” designation includes grant revenue.    

Schedule Of Net Revenues By Geographic Location

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

U.S.

$
109,325 

 

$
103,804 

 

$
95,975 

International

 
31,438 

 

 
27,914 

 

 
23,651 

Total revenues

$
140,763 

 

$
131,718 

 

$
119,626 

 

XML 17 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cardiogenesis Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) (Cardiogenesis [Member], USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Cardiogenesis [Member]
  
Business Acquisition [Line Items]  
Total revenues $ 123,951
Net income $ 7,962
XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hemosphere Acquisition (Narrative) (Details) (USD $)
 0 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 8 Months Ended 12 Months Ended
May 16, 2012
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
May 16, 2012
Hemosphere [Member]
Dec. 31, 2012
Hemosphere [Member]
Dec. 31, 2013
Hemosphere [Member]
Dec. 31, 2012
Hemosphere [Member]
Class of Stock [Line Items]                                        
Percentage of outstanding equity acquired                                 100.00%      
Cash paid for acquisition                                 $ 17,000,000      
Cash acquired from acquisition                                 3,200,000      
Fair value of contingent consideration                                 1,800,000      
Total purchase price                                 22,000,000 22,035,000   22,035,000
Maximum amount of future consideration payment                                 4,500,000      
Cost of debt based discount rate 8.00%                                      
Gain (loss) on revaluation of contingent consideration                           28,000 (72,000)          
Contingent consideration liability   1,884,000       1,912,000               1,884,000 1,912,000          
Business acquisition, integration costs                                     940,000  
Business acquisition, transaction and integration costs                                       2,400,000
Revenues   $ 35,457,000 $ 36,250,000 $ 33,520,000 $ 35,536,000 $ 32,800,000 $ 33,429,000 $ 33,188,000 $ 32,301,000 $ 30,397,000 $ 29,654,000 $ 29,379,000 $ 30,196,000 $ 140,763,000 $ 131,718,000 $ 119,626,000   $ 3,100,000    
Income tax rate                           31.00% 34.00% 36.00%       34.00%
EXCEL 19 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`U.APIA@(``!!]I;X#\K8* M#L;8M$HRB_XLVY$Z?0`7;A(4P,CV3).WKR$SHVJ49A0U4L\&1+#O/?'B6W$7 M-_NN31[(^<;V2Y:EUJR`WEVLWK[9G%W M&,@G<7?OEVP;PO"!1]_/B9QU'J6?#PN''LMF1F&MJE,B$GY0U^_Z#)[[)#& MG=,:OVT&_R[&8/QDA_'-WQL\[OL6C\8U-26WQH6OIHLQ^+[EOZS;_;1VEYXO M]J9IG_*?:;_M-CSZ99=.P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7 M:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ M['*ED3!1RF%HT9,9J&74"T\U<%J"`=[!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$ M%``&``@````A`"RF6]X;`P``1C,``!H`"`%X;"]?0R=W]K^.A^I&&O.^[1LELKJK4K?KUOMLVZMOCYP]157EL MNW5[Z+O4J'/*ZG[Y_MW=EW1HQ_)+>;<_Y:J]:?4 ME7]2&LNA[;!-8Z.N+^7Z\H[VLS*SJM\81]CC M"!K':O(X5L-Q`GN<@,;QACR.-W"%1"H0.6Y_0GL)>*H%+I=E+ MI>%2:?92:;A4AAT=`[-CV8E;'L*M*=A,]!`"%IV\[*P>3EV M\W*P>7EV=CS,CF=+PD-)!+8D`I1$8$LB0$E$]J)'N.B1[:R(G37E-[`W-$%( M';8_H3Z%O54"MTK86R5PJPS[LS+PPS)L?1H89,?VE8.^PK-@(#1""[ M)L.6'-BV"M!6[!H(6Z!F,T=#YF@V"(GF1L+(2$)%2X:$K*M?S]-VA8;?!3*/MG0TGS+]QH@ M]>[]0YKT[G11FCP[[0=OAOV>SJ(\-MGZM/_]]N-?BWZOM"J+59)G^K2_UV7_ M_=F??[R[SXO?O_+\=P\"67G:WUB[?3L8E-%&IZI\DV]UAG=6>9$JBV6Q'I3; M0JNXW&AMTV0P&@YG@U29K/^H\+9XB4:^6IE(7^;1+M69?10I=*(LPB\W9EOV MS]ZM3*)_/&;44]OM%Y4B[H>DWTM4::]B8W5\VI]BF=]KYX5BMSW?F03OGHR' MX_[@[)#D3=&+]4KM$GN+])[54:_19#2:59^L2O'#Z/NR^5*U[#W\-%F%P>'CM;VW6&_O\(N0'I%]7$->I__:R.KWGBH0? MLCB\RJRQ^_`Z>ZR^R='"JNK7R"SH]XJW!O\4UW%0!(1'>*%)9G)!,7>RCD2PM`JKZ'7Y=A5^WNB"9":E,O,$X M*A>JW)`*"G^HRO3E*LN-XEA.T.$W%RU*J9-"7^L-5C^8D,V]'L]REJ2KV M52F69IT9S(-"93Y$4;[++*F<<*L7;9F/)D-WC4J`26F+>IRXR2?;OP/E=SI?Z.-RM;.5;F?@614%;')USK3I4'HW1>><>""S\\Z5IBN\+.R%E;# M$7/W`H'DI5[IHL!XW12ZU,5=[5SA15[6160=&.\!ID!`^2G/XWN3)'7EOUJ4 M$(V$3Z_-KT2'K,-S%@@JKV'VJ0YOU0.,O4$0;L27%Q1>ZE_,6C!DV`)!VT6> MIL96(_R("HS&8H?!3F-:EV7L`L%=-2EZDR_T:P4FUM9=\ZY.E,W$M0]5?H&G:K*D6=P M5F3C*#!T(P'=;8%P553O=>%/8S?AMVKKJV!2A=L.AG`D(%SJ=6VGU6;Q2>?K M0FTW)GK>,)R(F,*1H'"I$XV!C\-_=HA`%\D^)&-QA!C#QRV3S='O:FR.`5RD M&8R1(-.O!+P.-AO`3TA)0$N9-!:)2<&`.=#`8$A&,.OW2C)V1X+MMG0NDK#0.,0UK(( MKU&QK08PIZ;K8^&KTBHZ@JF.A`>/'PN4CSA&EQ"3/!8D^^?=J2Y\BT(2,/L' MWE5BF"<"9O^"Y6ZA;SK*L7'BAJ8)B.=T(JGV'M?8$R<\IEBT:NWW,FY:@,VB`6DB MV#[B95]446!CI=0";!8D)-@^(G2^*PW.=XX0&\=$H'U$Z*EM)#3EJ<6B52,^ MDX:7VBJ3N&&P`TT%SL?-N:H-A1&,V(&F`N?C0E5M6`@[35/AJ<#YN%!5&Q*: M,LU8M`K3.C-WU09[%44B./;O-\QQ@,V*E`3(?B4'9&Q6I"1`]N]<;DQ.?03) M?B4W)AZNJ4#9K\26../68]%JF5^(+7'&GZ`Z89]PV+5D2.SC+:Z'B'&R?<5==O4$`S[AH6+]6I;A/XRX;%2W6N M5BL=<3Q.?0391_.JD2>=``<.*K0`^ZC0=SP58B.:L:%AT4JLNE7L:$^`8PI= M7C#L/XDY)XTQ&^%<0.Q72;.]S%\YMP2Z+!2(:U'LM?D"(5!+AEXWJ3_78N89L\/R[ MSMG_````__\#`%!+`P04``8`"````"$`[V'IJR6/6+=MNY]+QH MOBNJO8L>'IM;?-3K=;4L5;U\WY7[#ITTY;;H@'^[J0[MT=MN>8N[7=&\O1\> MEO7N`"Y>JFW5_>B=NLYN^?CU=5\WQQK+>`@'XZ>PJW1J0D>)[__]'M>HV"]>/9F'L M^0+@SDO9=E\J[=)UEN]M5^_^19#0I`8GTC@)@+VQRYE,0A%&U[W,D5$?H"JZ MXOFIJ3\"Q7H:2>?M9?>%T310GV^/:?IT_P; MI'1I(!E"8$<,$$$1^1&A@]9>E?6'.=`=.$,F.&*>A&E*#R/,LBF M&$D1^13A!Q2BIA#AC:&20'P:R.4`-!@:QTZ@Q^AEB($Z#DF.*+O\*D)=0A#V M\!B[#)?9:_#"A=P,S(3G4VX98N*^?^)(I"RSN6V/XB!EL2G;'J9^$@_^"6_8 MT3V\-9CR#GBW M(R3`=(\=BIQM(Y2"1J1L:Q",=2!\XWOX:C#E*[R0/C5##.99!%XH2@A0@I5%< MWJ`:S`O`\ILAQA0@%,&XP3#_Q"[\A'6@U-'QR+*;&1`&$7I^S``Y`011 MS/5-48`?)^G["^YX`DM";[%T"B,,D&(M, M*Z`%[';R*'?P<]B1PF/C+A.7-!%;_SI$7830$+22W1X"ZA[)OV#]FPD$8?ZC M1(BQ]"8``H#-S9*@B(QV\BA^E#P3HTR?M6$X(?DD",?*&^ZV M/98AVQB*K(\2ZVQ*F6M9NYTYBB!ESK*:"00A\S@*HTG;$X`,/`90Q$,4R'-G M2:&U[7;RJ(24/!_WO%,I"A!1,#Z"9EYKVNWD40$I>=83 MF3C*I/XV$K..RHE5Q)->MQ>+LT*E]>QVUJA^E#4_X@@$X:'L@<644^ND4\A: M,2XFJ99WJ6N/9NHJV(,S`\(F?Q`RMA*&&]0@8,0,4Y8Y41`*:T"F=:R3K2D! M^D`S/[DILM@:_93T7^3-D`S0E`2"]D`$4!(K`F+"6O M]>WFS2I1#0EY/OXR`S+#'T%@Y M2HH)!$%#()%-,[7ZV8P@"I>)1_ZQ-"E#X>C=FF@TKKM46)Y083EN/!,7@HY/ M%AY+>6Z\'`'\384R]M--2MCKUPKV6-(O8*^_:NA7L7<-5GXP"@,Z30(K10#Q-:DH.3O$F;_A#!/%,*`SBL$`9Q0"&H_ MJQ"^%MK;\Z[1["`D6=<1J:ED<7YICD\Z%#%EM;BN;[+D6&FZDI M:391,@/"E]\BDOSU1TX`<2HFQ/$IYNVYGXY90>IXN85W/[NR>2WS\5,O@4JV_@9H/!KC3.A2OY>]%\UKM6V=;KF&I-XOAT0W>BN&' MKC[T5RTO=0>W6?VO&[B]+.%2!^3.==9UW1T_Z'NWX3[T^3\```#__P,`4$L# M!!0`!@`(````(0!(DH37R0(``*D'```9````>&PO=V]R:W-H965T5-F^-?/NZLY M1MJ0)B>U;%B&GYG&UZN/'Y8[J1YTQ9A!P-#H#%?&M`O?U[1B@FA/MJR!+X54 M@AA8JM+7K6(D[X)$[4=!D/B"\`8[AH6ZA$,6!:?L5M*M8(UQ)(K5Q$#^NN*M M/K`)>@F=(.IAVUY1*5J@V/":F^>.%"-!%_=E(Q79U.#[*8P)/7!WBQ&]X%1) M+0OC`9WO$AU[3OW4!Z;5,N?@P)8=*59D^"9NON.YZ;*\"3QIK-@$@(<;9@V M=]Q28D2WVDCQQX'"/94CB?8D<-^3A)$7S:?A-'F;Q7<9=09OB2&KI9([!)L& M-'5+[!8,%\!LG250GY>=@24;&#>I\"R`Y3F+R9@@T:I!`%X2`%!YIWO3U5G/R/H@V"QIWXB>?S@:##Q">8 MI$><>0;(J>?7RVW!&08S?26AW).>N.O)VH%FKAMI?,SL3!>VV^6Z%CS2C0>Z M#I3L=8-I__E,-WF/K@6/=(_$SJ\#[77GZ3_\SMZC:\$CW6,#G:X#'72GP`_.5:O]]>"1[JSGMCI.M!!-SZVX:S.Z7MT+7B@FPQE'<9MJS2.CUUPLFYD MNHDBF"K9)U;7&E&YM>,PA%W1OW63>@V3.NH.9/\!)F5+2O:-J)(W&M6L@-#` MF\'.4F[6NH61;7?B-]+`C.P>*_@E,IA(@0?@0DIS6-AIWO]D5W\!``#__P,` M4$L#!!0`!@`(````(0"3_@1=\P,``,\.```9````>&PO=V]R:W-H965T";@)&@! M(^QL=O]]QPQAL9T2]F4WV,>'<'JK4T9;^RQ$LW9=GIUI ME7*'-;2&F2-KJU3`8WMR>=/2-.\65:7K>U[D5FE1V\BP;N=PL..QR&C"LDM% M:X$D+2U3`?KYN6CXC:W*YM!5:?MZ:;YEK&J`XE"4A?CH2&VKRM8_3C5KTT,) MOM_)(LUNW-V#05\56N2L7F':;O``',NQ62X];^YFL$Q+: M[F[3!>B?@E[YZ+?%S^SZ2UODOQ4UA6A#GF0&#HR]2NB/7`[!8M=8_=)EX(_6 MRNDQO93B3W;]E1:GLX!TA^!(&EOG'PGE&404:!R_DY&Q$@3`7ZLJ9&E`1-+W M[O^UR,5Y:P>1$RZ]@`#<.E`N7@I):5O9A0M6_8L@(D4-)'Y/L@#U_;SO^$\A M":/'+"XJZ@PFJ4AWFY9=+:@:>"=O4EF#9`W,-V>H8_#Z?U9!GB1YEBQ;&\H= M7'#(S]N.!(NGC?L&0VA"<01D)0D\5%R-HM>@JQ7."S[AU]O;ZO!Y[??[3 MO"(<]M9\X1)L"->$Q0CZ%!ZJQO8X#_(&]Y_2L**G$(KX2!4O-V8`'Z[I4I>+ M#!-:<<<(6N(V#0/H)5I^]F.$[Z],1(*(^T85&TO5QK1\"3;D!VJ,8P1%G7S? M]Q9+4[\*B:*%`4D0,L.`[.&C#^2T`0DV#&C5&R,(#731-^*/B/OBL(RF$$K\ M5ZK\>64D%QDVM%J/$80V(F)$>(_S4R:F$(H)`H4_3L(\%]TJPX:V(>,>U==3 M"#Z,=#R&)#WDOEO5B^QIHX*:Z04[H?9=76I;@R#JO@K\M/80M$N\P'";3)*H M5F0/_+H5[)R:%>.P@*A)*PCI,R?WN)ZYA$RQJ%YD.QQYF=[G!)NGYD'OTCUJ MTL-4%\:M/LFB>H`W?<#\\:1!$37IX"$DF650/LD'.SP.V4S4/D=;.8GE4 M!Z=]QXO,FM_WB`F7\GXA2>Y#T`+>'_!X7='V1/>T++F5L8N\&_C0L8;1X=[R M[,MSJ38>R_M,=R,9)N`ZT:0G^GO:GHJ:6R4]`J7G+$%5BQ<2?!"LZ0[U!R;@ M(M']/,/%D<)IVG,`?&1,W![@Q>YP%=W]!P``__\#`%!+`P04``8`"````"$` MHK6A-]\"``##!P``&0```'AL+W=O';`@%6,D>TT[;_?-0X4R-9V+PEP MCX_/.==<-C=/O$:/5"HFFL3!KN\@VF0B9TV9.#]_W%TM':0T:7)2BX8FSC-5 MSLWVXX?-2<@'55&J$3`T*G$JK=NUYZFLHIPH5[2T@4HA)"<:;F7IJ592DG>+ M>.T%OA][G+#&L0QK^1X.410LHZG(CIPVVI)(6A,-^E7%6M6S\>P]=)S(AV-[ ME0G>`L6!U4P_=Z0.XMGZOFR$)(<:?#_A!%7GI> M>2L/F+:;G($#$SN2M$B<6[Q.8\?;;KI\?C%Z4J-KI"IQ^B19_H4U%,*&-ID& M'(1X,-#[W#R"Q=[%ZKNN`=\DRFE!CK7^+DZ?*2LK#=V.P)#QMRI6F*.(%X#<^_, MZAB\_LLJ>#0DMX:EXP(7"MKSN,5AC#?>(X2:G4$["X)7X@4T1>Q[A$G0\*:C M!QX('E1#%G/5(73U[_WH19I%,Y&!/Q=Y"0IF(B\1X6(*22\A>+31Q$DX=?*Z M`P.&LS-*,(JBZ=X[BX%6#BG'4\3^343Z&F*B'K89]^%U]0:<.)#-H"R*5E-M M.XNY[HY0$/K^+-G]N(YQO)QY2Z?U(%P._!/=\-:]7[C%Q9W7:8VEG#J2SIGM:U0IDXFD&)(:GAJ9WA.YCAW<3SA@+,T):4 M]"N1)6L4JFD!2WWW&A*3=@K;&RW:[L4^"`W3L[NLX&-)883X+H`+(71_8^;\ M\/G=_@$``/__`P!02P,$%``&``@````A`-$%`P2Q`P``"`P``!D```!X;"]W M;W)K&ULE%9=CZLV$'VOU/^`>-^`(7PD2G)U`6U[ MI5:JJGX\.^`DU@)&MK/9_?<=8P+8].[-ONP&YOAPYLPPS.[+6U,[KX0+RMJ] MBU:^ZY"V9!5MSWOW[[^>GU+7$1*W%:Y92_;N.Q'NE\///^UNC+^("R'2`896 M[-V+E-W6\T1Y(0T6*]:1%B(GQALLX9*?/=%Q@JO^4%-[@>_'7H-IZVJ&+7^$ M@YU.M"0%*Z\-::4FX:3&$O2+"^W$G:TI'Z%K,'^Y=D\E:SJ@.-*:RO>>U'6: MYP MJI"C M(OFJ6'HNR$)`?5X/*(R#G?<*II8#*-,@>"I#EDB`Q^9$K(ER$HC7R+"M4E2+"%H]B`CD]#,Y.,,%!AZ9^9@ M%$7FLS.-@5*.+L3"=G##T)I_1J\`+O9:)F0;%NC&2A>)Y M./0CZW0Q#P=I,+WUAFKUO9X-PX_;68$7JA.SN)D&:=4(K>U98H2#9#)3CS\C M[*<3N:%Z\QG5"KQ0;54XTR#=&T\ILL*Y$0Z"2996/0^C]#L-C6!U7E/M3#,1NJ3]'"/]&A;=V)-@&Q` M#>,CF)[JK]+AR_0TSIG5@/3F#G4L9IJ=U@NQX M;L37R+>JH7:VZ?S:WTPS2BO7"YG>5QK"SR0G=2VI/3%Y)U_7)P9!(VL/[G!39N`FN( MOP+PB3%YOU"[XKC#'_X#``#__P,`4$L#!!0`!@`(````(0`;.(AL`P0``(D- M```9````>&PO=V]R:W-H965TY_?V.&!-NTV;SLALS7PV?&8\]D M\_FMJ:U7VO.*M5N;+%S;HFW!RJH];NV?/YZ?EK;%1=Z6>&CYUCX)T:T=AQ*X;.4U>M39Z6/>/^&"'0U70C!7GAK8"G?2TS@7P\U/5\:NWIGC$79/W+^?N MJ6!-!R[V55V)]\&I;37%^NNQ97V^KR'N-Q+DQ=7W\#!SWU1%SS@[B`6XN?+;XB5W^[*OR6]52 MR#;LD]R!/6,O4OJUE%_!8F>V^GG8@7]ZJZ2'_%R+[^SR%ZV.)P';'4)$,K!U M^9Y17D!&P9?+&B1K\'R-##ENL?XN5(A1.ODBO0R^(`H.^_.Z(WY,-LXK)+4810F*X$Q, M(EV17A4R@])OIGSA`/"-&G)A4ONPJ[_>CRND7&1`>JX).1=Y!N1Z))M+ MB/(B+1)?C^1^!%(,M:-D,`Q#_=T):F`K;UF.=$7ZH2*[I]#HX37J/MRGE^*M M#;F9R%Q79TM0$P\EM"2AF7O5''B>L3K3S"[Q;\XU:#ARCT-+L0EM;'>"&GCY M%-CMS4,=IU?%<#)"H^8RU1H&4U`:=:13RX/Z<5:=9@BDLC)W!Q/Y[K06TR&^]-1A%"FT6;:M8GLIHR M.C8=";2U M*P=`#T%V*26$^S5.L*>IZ)%Y_R:C:"3W5S-R='+GILP,%THYZO"R13T.CPU- MA5>NV3'KUZ8G[^C(Z*HI4:V>V9Q/!:4SR_;T.#,V,Y69S!..(NR7\ MPE`L2QGM`7'-^UNWNZLI;"3'B1@'QH;V1YK2NN96PR$E\ MF*5O!AB$N_Q(_\[[8]5RJZ8'6.HN8NAZ/8[2^"!8-TQG>R9@!!X^GN`G#X4Y MT%V`^,"8N#[(8?WV(VKW/P```/__`P!02P,$%``&``@````A`#_O?ZMN!``` M#!```!D```!X;"]W;W)K&ULE%=1CZ,V$'ZOU/^` M>-^`#9@0)3D=K+8]J2=557OW3(B3H`4<`=GL_ON.&2=@L\F%E]W`?!Y_\\UX MS"R_O)>%]<;K)A?5RB8SU[9XE8EM7NU7]G__OCS-;:MITVJ;%J+B*_N#-_:7 M]>^_+<^B?FT.G+<6>*B:E7UHV^/"<9KLP,NTF8DCK\"R$W69MO!8[YWF6/-T MVRTJ"X>Z+G/*-*]L]+"H'_$A=KL\X\\B.Y6\:M%)S8NT!?[-(3\V%V]E]HB[ M,JU?3\>G3)1'<+')B[S]Z)S:5IDMONTK4:>;`N)^)WZ:77QW#R/W99[5HA&[ M=@;N'"0ZCCER(@<\K9?;'"*0LELUWZWLKV214&([ZV4GT(^1`[HZ&Q,V+\(49')/<0&C=P\C@W"5[9$.8U+XS.]9UC MQ(0JM89FB6:-;J0,BFC(21;6KU,F%QGU%?;Y#5($&M+C2G5H@Y8_:J'2YQ0YO<#%%B!<(\4M\XI8DRJ^(C`TUU8K+=/EQ>!)NSUKO\/F2L M>@52._NN84]TNT=ZN\Y,=M_'F6&O'C+S7;V,8H(8E2SB&DTW47;5)M@M7I.: M/?FDVP?]25>*(0B)/9'`ZRL<#Z7RH@"4WFJK\IMH@F:?=/M19^U<7HX`G;NN M<783'1"1@>QZ/B?U?((M&S+6WY*!D;!8@4"]'J3G/+D+T?E-ZO]D?`$P\]J) M%0@+ZLD/1F<4G2B[1_JZT)E-N@+((W>``JF""NBXL:&7"V!^D]NDJX",[X)! MN:C#@!@E"J7&*4Z4CXMH?E\4FFATTFW0H8V.RXR=8P6Z:!*9@$0',#_L>[;. M;=)M0/$S?=C:&#-**58@_&($T7SSF!H`QLQBP^$+9Y.2UWN>\*)HK$R_X]K?=YU5@%WX%+=Q9"`ZIQ MFL.'5AR[@6$C6IC"NI\'F+HYS`7N#,`[(=K+@YP7KW/\^G\```#__P,`4$L# M!!0`!@`(````(0![_E,#B`,``%H+```9````>&PO=V]R:W-H965T+:HK;^K[H5=CVKA:8:/A_8F8W4+$CM:4?G2B;I.G2T?]@WC>%=!W,]HAK.S=O

-CF->>`L/E#:KG$($*NT.)\7:O4/+%"'7VZRZ!/VBY"@& MOQU1LN,G3O,OM"&0;:B3JL".L4=%?_L^)G0 M?2FAW'.(2`6VS%]2(C+(*,A,IG.EE+$*#,!?IZ:J-2`C^+G[?Z2Y+-=N$$[F MD1\@H#L[(N0]59*NDQV$9/5O3>HBNHA,3R(S<'_"IY-I/$?S\&T53SOJ`DRQ MQ)L59T<'N@;V%"U6/8B6H'R.3/NXQ/I:J!"C$KE3*IT61"&@/D\;%$3SE?<$ M2F>0P?GX6F0;MWM&<[3Q M&Q1;<&+"%IJ:*'HEZ9'I_7JG*++MV>KBK>:$.MG(]\U62`QXU$CI$#8:R4BX MNK\'A^-UTXILFH8ST':M23K3LWAAF390U'>!/@R':+#H&\BPO/@7RXIL6@[C MOG[=KEO-T8Y#*YQD"$96-.D0#/NN,>PB.+6'*7[?Q]BMLHR/KQLEO7;/71T$ M5K)/(B?<3K:)!CULVE<7U+L[!$84.]_0(O81>&+I,W`V.,2Z>B0F;+>0&H/4 M'J?5@Q[2OO6(HR>`FO`]24A5"2=C!S6^(/B:+F_U:+55HU4W'%T`F&Q:O"=? M,=_31C@5*6"I/XG@".-Z-M(/DK7==;MC$F::[F<),RR!B]V?`+E@3)X?U/1U MF8HW?P```/__`P!02P,$%``&``@````A`%3ZX>^\!0``71X``!D```!X;"]W M;W)K&ULG)G;;NHX%(;O1YIWB')?@@EG`5L-.2^_+3Z*\K7:4UIK MH'"LEOJ^KD]SPZC2/HU%LMUE*[2)]R^FQYB(E/20UU+_:9Z>J5^3RI'Q].SVE17X" MB9?LD-6?C:BNY>D\V!V+,GDY0+M_DF&2MMK-AXY\GJ5E417;N@=R!J]HM\TS M8V:`TFJQR:`%+.U:2;=+_9G,8S+2C=6B2="_&?VHKO[7JGWQX979)LZ.%+(- M/C$'7HKBE:'!AH6@L-$I[38._%EJ&[I-W@[U7\6'3[/=O@:[1]`BUK#YYM.F M50H9!9G>H*E&6AR@`O!;RS/6-2`CR<_F[T>VJ?=+W1SW1I.^20#77FA5NQF3 MU+7TK:J+_#\.$5:IB\C@+#*$VI^_'_0&TQ$9C1]0@>?QJH!<6Q?(A[H.!F]/ MDQX[J9/5HBP^-.AS4./JE+`>3.8$%-O$\&9<4O6K3$'KF,HSDUGJ,%H@"178 M^[XBYF2Z,-[!D_0,63<@D5BW!,L:T[7E@,,#/*^,<.6`UP:NJB(^Q9=%`SD0 MMAIM/:(V<"5*)B-1-VXAUA$AO9<<0UJ%'-_N=&TJ&T4+BY)+767M64B!V#CBX(B+(]X9X?YV MIKEF6^WC,@&.A#@2X4BL1$27V0;[>EI&W.7[<>E-*RVL+<(IA75K'+%QQ,$1 M%T<\'/'/R&S(][UPH'5^U_$_IO,D[<4"L80IER"=$B%>C0A'8B4B6L^VZM?6 MW[?68B=:G:E[)FV;K#.E[`)<2('8N(IS0=@!F50+5_6E=_GR:]4H+2Q\'`EP M),21"$=B)2(:R[;XWS"6GPR(8WLF'0!9A%,*U]8X8N.(R9-;1;AE+(+H(B-JSAG M1/7:=>]@//Q1/HX$.!+B2(0CL1(1;6;'(MCA46EJ\L9LT-A(NT`(:-.^_2QC2&/#]FKF)FG*-EE;%B8Y+1V#1H MD;)]5APWYL\?P;>%:51U4NR3,ROHQOR@E?E]^_MOZRLK7ZH3I;4!"D6U,4]U M?5E95I6>:)Y4(W:A!?SGP,H\J>%G>;2J2TF3?5,I/UOV>#RS\B0K3*&P*K^B MP0Z'+*4>2U]S6M1"I*3GI(;^5Z?L4G5J>?H5N3PI7UXOWU*67T#B.3MG]4I_! M"+CM1DD/&_.)K&(R,ZWMNC'HGXQ>J[N_C>K$KF&9[?_("@IN0YQX!)X9>^%H MO.=%4-GJU0Z:"/Q5&GMZ2%[/]=_L&M'L>*HAW`Z,B`]LM?_P:)6"HR`SLAVN ME+(S=``^C3SCJ0&.)._-]S7;UZ>-.9F-G/EX0@`WGFE5!QF7-(WTM:I9_J^` M2"LE1.Q6!+Y;$>*,IK8S7SRB,FE5H-U.Q1[9"X5_S$@>#H: M5Y:?(LYHX3C3V6*.VF()BYN(>4F=;- M-[QQ7RT(1(%(!TZ$:D'4%=QUA MNEW!7=.3I=+TK@_9\/C%1_/;["!D36280#(ST%A.EH;!/J`U%?02B/Y=; MBOO09TN2O?#(W=O+,W("4Y#>9EY)LEDMV*D%GEK@JP6!*+@W!\8UD\<5?@6* M!J&%K!0CD&32M&_2])+O!*8>1=L&(_R`+H"@L];1B@CWJ&$AQ(^2@0H M$:)$A!*QCI`,!W,?STI>:6-"YM^\)-/Q6`Z[*R#HR`U2#1?$O)E7E=J>YG\^ MJAR@1(@2$4K$.D(R&=Z3CYO,*_5,5N8Y5T`ZD_L$F=C*(^KU(256/DH$*!&B M1(02L8Z0/(#(QGO0( M'VTE0(D0)2*4B'6$9#/?VRCK+/RMQBO)=L/\H1HN()WA@A"&+B*CR,!CH0X M$N%(K$5DZ_DN1K$>7W<3L?=1K%=6#FY+::T70AK$PU5\'`E:I(TQ&9C)0AR) M\(9B+2);S[='BO7X&Y2(395BO;(W=5NJG;@'1KMK":WSHBD-XN,J`8Z$.!+A M2*Q%9.=A2/?.ZU^EA-.]"5Y92+LMI3%KAR,>CO@X$N!(B"/1`-+?0,0#U.<\ M(+O.=TU*OG]AJA%[+27?U3T^/XR%&&G=1Q$/5_%Q),"1$$>B%FDGK*&E5ZQ5 MD:WGFZ?'K1=;+MEZHNS773AW1ZU'$0]7\7$DP)$01R(^47!3RNM]+;)<;3A!^K*N4[LH(3X7ZY:Z_<0=Y> MP=E@G_?L%1P1]LM]>P4GA5!NW1J&NXM+&ULG%7+;MLP$+P7Z#\0O$?4RX\8EH/80MH`#5`4?9QIBI*(B*)`TG'R M]UV*MFK9;1+T8HOB['!FE[M:WCS+!CUQ;81J,QP%(4:\9:H0;97A']_OKN88 M&4O;@C:JY1E^X0;?K#Y^6.Z5?C0UYQ8!0VLR7%O;+0@QK.:2FD!UO(6=4FE) M+2QU14RG.2WZ(-F0.`RG1%+18L^PT._A4&4I&,\5VTG>6D^B>4,MZ#>UZ,R1 M3;+WT$FJ'W?=%5.R`XJM:(1]Z4DQDFQQ7[5*TVT#OI^CE+(C=[^XH)>":654 M:0.@(U[HI>=K:EQF^C19YBLEJV>?GI^![<_*,3*WVG[0H MOHB60[*A3*X`6Z4>'?2^<*\@F%Q$W_4%^*I1P4NZ:^PWM?_,155;J/8$##E? MB^(EYX9!0H$FB">.B:D&!,`ODL+=#$@(?>[_]Z*P=8:3:3"9A4D$<+3EQMX) M1XD1VQFKY"\/B@Y4GB0^D*2@_K`?!_%\$DVF;[,0KZ@WF%-+5TNM]@@N#9QI M.NJN8+0`YJ,SKV/P^B^KX-&1W#J6G@M<&"C/TRI*TFA)GB"I[`!:>Q"TQ!_0 M&+$Y(EP&'6]^\H*`X$$UY.)<=0)5_7L]CB)=T)G(.#P7>0F*ST1>(I)T#,DO M(=')02,GR?\X<4%PATXRF<[G8PUKCX&2#MF>CA&;-Q'Y:XB1"SCFM!ZOU\&! M,PPY&I1-TF2L;>TQL_XJN5DWWMZ<;D?7L[,BPBAP)_CH*)F%0[07[?O&PO=V]R:W-H965TU6=G+;)L3B)M?]35/[7AU]_N7\ORI?J($3M0813M?8/=7U>!4&5 M'D2>5)/B+$XPLBO*/*GA8[D/JG,IDFTS*3\&X70Z#_(D._D8854.B5'L=EDJ M'HOT-1>G&H.4XIC4P%\=LG-UB9:G0\+E2?GR>OZ2%OD90CQGQZS^V03UO3Q= M?=^?BC)Y/L*Z/UB4I)?8S0\#)8!1'JXWV:P`IEV MKQ2[M?^-K3;1P@\>[IL$_9N)]TK[OU<=BO??RFS[1W82D&VHDZS`1[0\UE'L&*Y(+6VU_/HHJA8Q"F$DX MDY'2X@@`\-/+,[DU("/)1_/O>[:M#VN?SR>SQ90SD'O/HJJ?,AG2]]+7JB[R M_U#$5"@,$JH@'.C5>#@)[V9L-N^/$B!1L\#'I$X>[LOBW8-=`]>LSHG<@VP% MD2\K0X[K6F\M%=8H@WR349I8L(H*ZO/VP'@8W@=OD-14B6(4P9EH152QN2AD M+8#O"@E+-R$Y%+$[_1,7C&V10;UQE;PZ!J$4$+Z=$HWG12O?0C> M)H.'_!JX26N,HD@3S:EBXU(0.`BBP\DZ]Z=03@*==OV[.PH0H\2%Z%(01#@* M.J([?U)LY:\M#.8/10OUQ`C8?`R;%%&QIY@PE\P8KG"\6!I4^ MS&:\G4V@%F.@I-B`,JX:H\152)>"H$G;,WI*_UZ3DWKV&DI MDV*:/>ANYEY#$18UXE%;M68K;LCP/&IG$RP&74U/G9NK45,P:Z\IC=IL$6LO MC%QT?,;;(T+!#)_H`<-&;G2W&=WG,4.57D_(J]GA^E044W;KT5N/88\W<,T# MHE0ZKL6*@;HE%%0V[O&@V.Z=#9FAIIM!U=PEH9@01L?L*;M4T_W8<5`8JG!' M\MEL2;?%YO8X11ME%_)NS4"SCPIJHJ8O+^R3H@]'B]:K*=8HLV"V6T#&K(." M*KVDH#([C(IU4T4Q#?L8=C_`;!\!$*.`L5+I(-9!&>PE[%-FTLSJ<1.E<6(. M]A,VRE`:=?]!T3V#\T7;FM4QOCE.2AV.\I1&3=&L@Z(T>%!F"^N.65YP[>,P MO^4HX2A':=04B^FAFXS$2N4JJ5-"\_8I+PG1`IPM6FFK7L9I5(5O#,>FC8WAVG^8'TCP*2:@MG[#C6(!3?.AG&$9%AK2Q1KE&_( M)VL#JZ-!*Q5XX$-'PY?6TC[5C^\V(+\HB.<6OU/'V;:+J9@HQPC MQ%ZO@VF!5?=#C7K<71C5WZ@0:EC[KH%@R0NX'.6J$`G[*9?@`EU$: M)Z;+B"CF*)?AG2YC%#)6*AV0L:5URB]FHSF6KJ*8AN<,/#RV]\"^,^Z^8HXJ M'=4*XT+TRFAF(8'N6\N(O25GN:N5#H@9-M\V.]344SI M!)H'#2M[A/Y!<;GYL*]4.JY9=J>$@G[*A2(T#_AYO6FS7U.X#`;]4H7I7@G% M!(V>SYZR2[5IDM9W/!&J]*N#\UNI[%%1S%$>%'5Y4&0\P\1*I6-:C!BH6T(! M#?<9N"_1A=SE1DTW@RJW2T(Q#0_J*3>:!CTV=KEM:V',W+7RG;;<.OHRB`HQ M\;4UOM7-1;D7&W$\5EY:O,I7T@R^SKS^%E^7Q_"ZO'FW'%P'X&WU.=F+'TFY MSTZ5=Q0[F#J=+*"6);[OQ@]U<6[>J3X7-;RG;OY[@+]+$/`2>#H!\:XHZLL' M^1;W^I<.#_\#``#__P,`4$L#!!0`!@`(````(0#GHSRPD0,``*0,```9```` M>&PO=V]R:W-H965T[$O)^13'.K]KMS9U\17/.!-M+#^1\/=#[G)_\)Q^4%K." M0@;*=H>3_=S]AJ;;L>LO9JT_OR@YBYO_CCBR\X;3X@>M"9@-TZ0F8,?8LT*_ M%ZH).OMWO;-V`O[F3D'V^%3*?]AY2^CA*&&V$TA(Y34MWE(B@3*O%%9=2I1+&'XN`S&N.+!EPO(PE#+PZ3\>0S^<#: M:$V!Z]64H2/QM;_M=*58XL6,L[,#2P`<%`U6"PI-05?-4_S;>8()4GV^J4YM M5Z`%U-;+`D5H//-?H"+R"[34$&AV4&@2JWLBBDTDO7^2);*^)VR1[!Y!`3(? MM+EG;)GMAX@/?G:F0N'9ID:PA!X7_]54U@B4#8$V#Z#$JH3MQXSA'"S56^<^=DS!RC&U?2@SEKKAQAV[(;6[K.V& MS&[8V`W;:\-[84/UOSMLY`.;Q_!\%`P;W$G<^J6&H+?;EF-3&+52Z2] MQ+J7R'J)32^Q_8@P;(0=:;B-"IZ[4'2=0R@*`].DI8;&>O-"T2@QXZN>>-H3 M7_?$L]MX'-K#V]R&QRBV1K?58;"O2_&]"`SCX*4UW#@%F\8E@;7=+C7S^,GM M(ESU$FDOL>XELEYBTTML-3%J:\`PV;`0WMG#+52P:2'4GO6N66KH][77$T][ MXNN>>'8;?U![MV'#EG9^X=2H4GQ<`=HX?2K4QXR*\`-9D;(43LY.ZL07@M]= MJSZ,+M$4]F[8QJWV%9JNVG:_"\`AL<$'\A?F!UH+IR1[D`R\,:P(KH^9^D:R MIGV9[IB$XV'[]PA?`P1>$X$'\)XQ>;U1!]GN^V+Q/P```/__`P!02P,$%``& M``@````A``=@?!5+!0``&QL``!D```!X;"]W;W)K&ULE)G;;JLX%(;O1YIW0-SO<,JAB9)L;<)9,])H-(=K2IP$-4`$M&G??B]C MH-AD>]%>M(WS>=G^?[-LX^WW]^RJO)&R2HM\IQHS755(GA3'-#_OU'__\;X] MJ4I5Q_DQOA8YV:D?I%*_[W__;7LORI?J0DBM0(2\VJF7NKYM-*U*+B2+JUEQ M(SE\,Y+7 M+$A)KG$-_:\NZ:WJHF7)E'!97+Z\WKXE17:#$,_I-:T_FJ"JDB6;\)P79?Q\ MA7&_&_,XZ6(W'T;ALS0IBZHXU3,(I[&.CL>\UM8:1-IOCRF,@,JNE.2T4W\8 MF\A8J-I^VPCT7TKNU>!_I;H4=[],CW^D.0&UP2?JP'-1O%`T/-(BJ*R-:GN- M`W^5RI&V.7XXI$I`40@S,YMN),45.@"_E2RE M4P,4B=^;O_?T6%]VJK6<+5:Z90"N/).J]E(:4E62UZHNLO\99-!.]4',-H@% MO6^_-V?FT\)8++\09=Y&6?91S-5L9>AK:S6]*ZMN/%3)=D#FU`%I3)Q&:R>N MX_VV+.X*3&`8?G6+Z>-@;`R(W*G,-.EU_Y7L(!6-\H.&:8*!HA7,E;<]J+S: M:F]@<-)"-H/@^?R$>.+0$=0"&M=Y&'?-UW(?0#SA=407U^\*!ETQ+8.O%3R` M>"+LB"YN-"C00.%>9IA'(YDMD/OQ9.Y4I;5&JC[Q?;`9-%35Y(G#F+#F/.(\ M:FFI\Y`[AH26O#$AMN2/$<.T%GQ+P1@26@K'A-A2-$8,^X"`6.%V5X81;"A/.G0)Y4R!_"A1,@<(I4(1`G-20#+\@-:4Y MJ5G!0&JQP!&KN&*!)Q;X70'GCC#E@BE0.`6*$(B3"Q8(3BZ:H/',06L!-TRU MYM+BGS*;0="9/A\O>>*`$@Y*N"CAH82/$@%*A"@1R0C.$UC'.4_DV8+2.Q6R M42\SY"$A`=L,DGF!$@Y*N"CAH82/$@%*A"@1=03=2IBS3[4X'V!+]`4?*#WR M05AY;`;)?$`)!R5)`"5"E(@8L6JV=-9"IS]]CN"\H,>NX492_DQ0 M>N2%D'UL!LF\0`D')5Q&K.?-$/69(>PN/32"CQ(!2H0H$*Q_!PQ,>1`$="'(FD"&\./;4-<]=$ M<]AA3UC8A?1A&XR2FH,B3ANESU*Z,`=0'''%PQ&T1R1KDX8B/-Q3@2(@CD13A;0'M M.%LF9C):35QF5L+YUS88Q52S3',]FN\''IF/UW:G)20>NSCBX8B/=B7@";85 MZ?>VS?,;XNU$4H0WAYXOO_#,L..H\,R(9WCZ1ARLD^AY:!&VAU^L]:>1;PX> MQ<41#T=\'`E:A'572-PA]Z7UR#-Z)_%K19@A[,Z!O0?/2'DF!W*]5DI2O-+[ M!`MV0'TIN^NPC0V\FX;7?6*YN;'G#\H/YN;0E&M]!;B:N,5G\F=;?"UQ"$7@;KL\`/A5%W7V`#FG]M=;^ M)P```/__`P!02P,$%``&``@````A`%((12H4"```+C```!D```!X;"]W;W)K M&ULG)I9<^*Z%H7?3]7Y#Q3O![#,Z$IRJIGG>7@F MX"14`TYATNG^]V?+L@%M^7K!S4,(*Y^7->PMR9:>_OU]V*=^N2=_YQV?TU8F METZYQXVWW1W?G].+>?.?Z:?_X;KG M%#D<_>?TQ_G\Z62S_N;#/:S]C/?I'ND_;][IL#[3U]-[UO\\N>MM<-%AGQ6Y M7#%[6.^.:>7@G.[Q\-[>=ANW[FV^#N[QK$Q.[GY]IO+['[M//W([;.ZQ.ZQ/ M/[\^_]EXAT^R>-WM=^<_@6DZ==@XG?>C=UJ_[JG>OZW\>A-Y!U\,^\-N<_)\ M[^V<(;NL*JA9YTJVDB6GEZ?MCFH@FSUUTS\L9V79Z>S+4]!`RYW[[=_\ MG?(_O._6:;?M[XXNM3;UD^R!5\_[*='.5DIT<=:XNAGTP/B4VKIOZZ_]>>I] MM]W=^\>9NKM`-9(5<[9_ZJZ_H18EFXPH2*>-MZ<"T._482=#@UID_3OX_-YM MSQ_/:;N8*91RMD5XZM7US\V=M$RG-E_^V3NL%&2%5LI$A"8VE3[\O\B(A1#D]*MR#%] M7BY^N!X6A9'J5>JWJ\W#-;&BCI5_7'SNK@O%?5@,+3`>C2XK"@R+^N=2BL?C MRZ)N5:UR;5QA9_*B4"H_%.U1ZXIKJ]CB__")FD=!\F15)@<#0WU]7K\\ MG;SO%(VVU.?^YUJ.W98CK:,A027P99#X7V,$#0[2Y8>T>4Y3$%/Z^S2P_7JQ M1"G_E/U%H]$FA*IQD&WI4"V"Y.@CK>M<:'"AR846%]I%_I<&'!A M&`DWC:!7;A014>7&7)@H@7[?-*0M=)MI#*03LXB(;C2/A%O?0D6_:A$'\0Y: MQD"ZS2J&$#?WRE+H7>*/LD*+O_BI*`HS2/Y`\DE:2VYN%#C0IT+#2XTN=#B M0IL+'2YTN=#C0I\+`RX,N3#BPI@+$R5H\7,SB@63T_0.9G8',X]A1(E%Q^(> M:'D/M(J%KF.'%D2TH'H@B"2M!1$7:ERHESHZ4-#WE MW8RA]HUQD`-5Q5`1+N,L"]P:).J0:$"B"8D6)-J0Z$"B"XD>)/J0&$!B"(D1 M),:0F$!B"HD9).:06$!B"8E5$J$E$3U;:DDDGYIL>M)+7KW*JY[3-(%?$H6F M;K;0JBHH*9L@48=$`Q)-2+0@T89$!Q)=2/0@T8?$`!)#2(P@,8;$!!)32,P4 M40F6J[E,GMZ@W/ZPQ?8<^BT@L83$*HG0,HM>NVB9E9Q1DM8SRBY?U\)J>E), M4D)!H@Z)!B2:D&A!H@V)#B2ZD.A!H@^)`22&D!A!8@R)B2)*03((JV31C@-[ M?)MB9,:0()_TQ]HY+,H"$DM(K)((+8_DE@U_KX=G*'F5GD\T0[&G_*J"DA(* M$G5(-"#1A$0+$FU(="#1A40/$GU(#"`QA,0($F-(3"`Q540Q2#E;33UZKLR@ MQQP2"T@L(;%*(K1LHCT`+9N29R5)\RPJL+=N506%K510L[3>3#4-H5`RDK2-66?KHQ>UHB+!SEH%T M-21G5^3J17?IW2*B4BSD#:2O(W;)+.[@%J&25,QV&=XB5CY7*LIPU@LSTAB; M9ABSVF.-H3L)\UZ36R9ACI8V2`D6&(J,5%L6S%//6, M=*9@Y)K@X4XS,,#+'R")$PD65G&3Y=+W$+JM$1$\TN1EW MFV@@P=3>'4LPOC"4QV=H^9B0/36,U#'2P$@3(RV,M#'2P4@7(SV,]#$RP,@0 M(R.,C#$RP<@4(S.,S#&RP,@R1%0"YN7JGB?@*M%%SRZY2_E`=JE-399=QN)0 M48G9!9&Z/*R6G*,-C#0QTL)(&R,=C'0QTL-('R,#C`PQ,L+(&",3C$PQ,L/( M/$34:\A\\"#/GB,7V&6)$7EZ6`9F_(U4=JG3P>H0X,$]O;LU=[_W4QOO2Y[\ MM)MZ1SBT_V[J7>'0-KRI]X1#N_&FWA<. M;M5RZ!"?R0\MAP[FF7I5.-4XGYIPZ%2# MR=>%0X<;3+TA'#KC8.I-X=!1!U-O"8=./)AZ6SAT\('T[*5CZ+3VY_K=':Q/ M[[NCG]J[;]2GN4R)%O\G==Y;?3E[G\'9SU?O3.>T@S\_Z%R^2R<4S+=SDI"B;\];^^Z_GI]BV*,N:(JM(@[?V.Z;VM]W//VUNI'NA M%XR9!0H-W=H7QMJUZ]+\@NN,.J3%#;2<2%=G#!Z[LTO;#F>%Z%17KN]Y"[?. MRL:6"NMNC@8YG/7YPB#=$3CBQM;%>XII#A$% M&<>/N%).*I@`_+7JDI<&1"1[$_]O9<$N6SM8.-'2"Q#@UA%3]EQR2=O*KY21 M^E\)H5Y*BOB]2`"S[]M]QX\C%"V^H!+V*C!NK^('3NA'RWC&7%SI2X0IS5BV MVW3D9D'MPYSOO)+H"32&IKSODQ\'&?85,Y#V4 M2`@6T@CY*K'_3`2ABJ0/1O*0RAPDLPK$1$)O$7LCX(++T2JD0;<:0$$]+H7! M*N^D6]5GD$@H%DGG`=KK+](',M%JG*:(ZL',*%:@DNZMF"UP&.KV+A&!/G8B M&2BQ,5D+=7;[22*=)`XF0O$'$YGOC\-;&Z(WSCW0)I](Q&1ODD@EL115MH@^ M:DPFS]1?L0:+:[XU#JO64+!4$Y-(QN1MDD@EL9!+V8LB=8B#24`QM_B*.0ZK MYD+]&R(1D[=)(AT(_IF*(^T;=!A:/XKGHW84:\NO6..P;DVKF$0R)F^31#H0 MW)L?QEK:AM9);_RT<[<)F#\G'%:]!4N])B5C\C9)I)+H:Q*M/"U^!Y."DKG5 M5]QQ6'47Z>8D,DPL6&BK93_1GMZWA[ZO^Y+-CV.G^$*P>W(7Y\T_HD2AT#DO8J,HE/?AAJ M97XP#J-FD>_[\SW*4X+J41L\@3L#7Z<&`_MI).T1N:?[:(FT8N%7$S[,"-Q] MA*1#>?&0)^H:=V>\QU5%K9Q<^:7"APUU?"LO/`E:PW$1+AK:^SU:PZF17V7& M!KB'M-D9_YYUY[*A5H5/(.DY2]B-.WF3D0^,M.*$>B0,;B#BYP5NG!@.HIX# M\(D0-CSP`<8[[.X_````__\#`%!+`P04``8`"````"$`&I!3RV0"```4!@`` M&0```'AL+W=OH,1T&($:^9RD6]RO"OGXNG(4;&TCJGE:IYAM^YP<_3SY\F.Z77IN3<(F"H M389+:YLQ(8:57%(3J(;7\$^AM*06CGI%3*,YS=LB69$X#%,BJ:BQ9QCK1SA4 M40C&YXIM)*^M)]&\HA;\FU(TYL@FV2-TDNKUIGEB2C9`L125L.\M*4:2C5]7 MM=)T64'N?=2G[,C='F[HI6!:&578`.B(-WJ;>41&!)BFDUQ``M=VI'F1X9=H M/$LQF4[:_OP6?&?.[I$IU>Z+%ODW47-H-HS)#6"IU-I!7W/W"(K)3?6B'<"; M1CDOZ*:R/]3N*Q>KTL*T$PCD)#R1P/9!$:="/D\'P M`1;B';4!Y]32Z42K'8*E`4W34+>"T1B87;(4^G,_&41R-2^NJ"T%M(%I;*=1 M/.Q/R!9ZR`Z@V1U0AR"@WED`V6L+O7]:<$77%L*H$VA]SNZ`SC`7)GJ7)C[. M[\`9!O93_F1TI>TQ_3-,VB$NE`%R'O]C90>&[3EC[=TH>\P#RK![CRL[\%7F M,.D2^7Y[S."P$;U13T?X0=^$HX/O%Z88_QPH-1&G>^O*Q_L?W>-W3% MOU.]$K5!%2]@@F$P`./:O];^8%73+M=267@=V]L2OKX&ULG)K;;JLX%(;O1YIW0-SO@"'DI*9;FW"& MD4:C.5Q30A+4$"*@I[>?90Q);"@K[4W;K'S^;?Q[V<;NP\_W_"B]IF65%:>U M3":J+*6GI-AFI_U:_N=OY\="EJHZ/FWC8W%*U_)'6LD_'W__[>&M*)^K0YK6 M$BB6)_?(Y7'Y_'+^D13Y M&22>LF-6?S2BLI0G*W]_*LKXZ0C/_4ZF<=)I-Q]Z\GF6E$55[.H)R"FLH?UG M7BI+!90>'[89/`'M=JE,=VOY%UE%9"8KCP]-!_V;I6_5S=]2=2C>W#+;1MDI MA=X&GZ@#3T7Q3%%_2T-06.F5=AH'_BRE;;J+7X[U7\6;EV;[0PUV&_!$],%6 MVP\KK1+H49"9:`952HHC-`!^2GE&AP;T2/S>_'[+MO5A+>NSB3%7=0*X])16 MM9-125E*7JJZR/]C$&FEF(C6BL#O5H08DZEFS!=?4=%;%:BW4]$FVL(@QNP+ M;9FU*LN+BO8-%0)&L'Z!)V];H\TG9*I^I2VDZQCZ1Z>RO/N9%.958[T5U_'C M0UF\29!/T*;J'-/L)"LJW9G.++H,@\]&`=A/57Y1F48,#*Y@Z+X^$NCN!^45 MQEO20N80I!,>VC`(YI2K$D]8'4%'(*W<%@-.%[C1('.A-6X'=3(>"\#/:\V: MV#R_@[I201>X+;68\4T.!Z$Y#T5#T$W]"CAVL0V'W M(;'501\AVE+E*PL'(:%%T1"D7\<-YS9,9YS;XRY3FKK<#5&3!1:7P$8,6&+` M%@,."PA6+/D'=^^!O'L@_QXH&(*6PA@*[X&B0>@Z8CDSIE\R@]*<&2QP8X88 ML,2`+08<%K@Z[(H!3PSX8B#H`K>YM10R/;P'BCH(QAO74;#XQ3*8.0773`:-^8H2%DK8*.&@A(L2'DKX'4&W2]KD.MTT(SCH MOKUVF-!;(4I$8P3GZ5SP='R%H33OI2%F*$/&G$0)BQ'S9CMI+-6%J@HKK8UJ M."CAHH2'$CXC6$NU&;13;&F`:H0H$8T1G)OTC?QV4S_N)J5Y-R$SAL/:0D5LE'"$:@:RQT5%/)3P42)`B1`EHC&" M"_2LQ;='3;&>M\)&W&RI,7-QQ,(1&T<<''$OR.!*Z%V^_C3E?!P)<"3$ MD6@4X0VF[_.WL_!]^U_"C@&XC9(N+B=F2[6YJ75I"=R,)./V+/!$0M' M;!QQ<,3%$0]'?!P)<"1L$98AB^E`@D2C*KS)](!`-!E?APD[5Q!,%EZRS98: M-9D)C2`6KF+CB(,C+HYX..+C2-`BS$%#,WJS5XB+1*,([S'T+N?Q^!Z+4%Q8 MB'55..4S6VK$N`V.6#ABXXB#(RZ.>"W"7-&I*>*BXN,J`8Z$.!*-(KRY]'3C M&PG,#D6$!!;>U$UZ28;-T@QAO39;$#*T%G.,0:;+7M?:;55M3LQUM:_CX,UQ M<<3#$1]'`AP)<21J$?;44V&SP_M,3SR^X3,[*!%\%L\TX/(5]1E%+%S%QA$' M1UP<\7#$QY$`1T(*RDI7NBU M-!T>ERB[,M^0%=P.PL&T$'?("N[_^G%36YG3@?A&6VV&XI:V@N/ZOHZMK>#4 MGAZ(7RJ&F_)SO$__B,M]=JJD8[J#)JN3.21]R>[:V8>Z.#=7=$]%#7?DS9\' M^)^(%"XZU0G`NZ*HNP^T@LM_63S^#P``__\#`%!+`P04``8`"````"$`Y,HF MJ1@#``":"0``&0```'AL+W=O?I<=92A;0-YO_HSE)^XU>""OB4YHYR6P@$Z5PN]S'GA M+EQ@6B\+`AE(VRV&RY7]X*>9[]GN>JD,^D/P@9\]6[RFAR^,%-](A\%MJ).L MP);2G80^%W(*@MV+Z"=5@1_,*G")]HWX20]?,:EJ`>6.(".96%J\/6*>@Z-` MXP219,II`P+@UVJ)W!K@"'I5_P=2B'IEA[$3)5[H`]S:8BZ>B*2TK7S/!6W_ M:I!_I-(DP9$D!/7']<`)YI$?Q==97*U()?B(!%HO&3U8L&O@G;Q'<@_Z*3#+ MS&;O9@8IR9@'&:1"`(<#9`7!`X MJ(3&5#OD.!9LG8'HU)5(V#)%B,M&?F^B)Z MIWZPHV[7)<&F+C!M/C)-@^#U@_BQ:5,(P[38%">/P/7-)8.N5E:#ID1.(0R1 MB2ERNK(2;#IX65F-B?7I#8)P81J<&>O^(O*&=4.7;'%G]\>T+@DV=4%E1R_> M:-"4:5,(0]S"%'=;9670U0?K8^I$7C4Z/ M;)8RR2,@]KSQN=6M4'>*%K,*9[AIN)73O6QS`>R:85:WX(V?PET*K6\TGT%K M5O/NL`"=L4<5_HY813IN-;@$2L])X,`RW5OU0-!>7=];*J`GJL<:OH$PW-*> M`^"24G$:R.X]?%6M_P$``/__`P!02P,$%``&``@````A`#&ULE%5;;YLP%'Z?M/^`_%ZN MX1(44C54W2IMTC3M\NR``:N`D>TT[;_?L9V00+8N?0'L\YW/W[GXL+I]Z5KK MF7!!69\ASW:11?J"E;2O,_3SQ\--@BPA<5_BEO4D0Z]$H-OUQP^K/>-/HB%$ M6L#0BPPU4@ZIXXBB(1T6-AM(#Y:*\0Y+6/+:$0,GN-1.7>OXKALY':8],@PI MOX:#514MR#TK=AWII2'AI,42](N&#N+(UA77T'68/^V&FX)U`U!L:4OEJR9% M5E>DCW7/.-ZV$/>+M\#%D5LO+N@[6G`F6"5MH'.,T,N8E\[2`:;UJJ00@4J[ MQ4F5H3LOS6/DK%#+L`W;I6DPKM6?F?[SX36C81JAQ"0BBLM7^^)*""A0&/[H6(J6`L"X&EU M5'4&)`2_Z/>>EK+)4!#98>P&'L"M+1'R@2I*9!4[(5GWVX"\`Y4A\0\D`:@_ MV'W;3T(OC/[/XAA%.L![+/%ZQ=G>@J:!,\6`50MZ*3"KR!;_C`Q"4CYWRDF[ M`EI`-9[77N"Y*^<9YL(DY"4[FB2IHI^M5*?!< M53)393`+K2J.XJDU/[?*> MJ(K?HTJ!YZI.U\=TM\&8^BWC^'2L-L/(5!3&[+EA>$JED64&HID7'>$UR4G; M"JM@.S7L?`AVW#5S>..E<*-@`,[VM\9#3`?!UR3KYC7M!=62RJ@=.T8 MRL?-A#4+R09]B;=,PF34GPW\"`G<5=<&<,68/"[4#!]_K>L_````__\#`%!+ M`P04``8`"````"$`3R3/4UH#``"$"P``&0```'AL+W=OZY]?3[CA\V)\0=1$"(M8*C%UBZD;-:N*]*"5%@XK"$U MK.2,5UC"(S^XHN$$9VU05;J^YT5NA6EM:X8U?PL'RW.:DCN6'BM22TW"28DE MZ!<%;<2%K4K?0E=A_G!LKE)6-4"QIR65SRVI;57I^LNA9ASO2\C["2UP>N%N M'T;T%4TY$RR7#M"Y6N@XYVOWV@6FW2:CD(&RW>(DW]JW:)V@P'9WF]:@WY2< M1.^W)0IV^L1I]I76!-R&.JD*[!E[4-`OF7H%P>XH^KZMP'=N923'QU+^8*?/ MA!X*">4.(2.5V#I[OB,B!4>!QO%#Q92R$@3`7ZNB:FN`(_BI_7^BF2RV=A`Y MX=(+$,"M/1'RGBI*VTJ/0K+JCP:A,Y4F\<\D`:@_K_N.OPI1&,VSN%I1F^`= MEGBWX>QDP:Z!;XH&JSV(UL"L,HO`GYV%( M`'/>+T$%0;%['H!1`QMB#5KT0%'G0NMW,H4P1`))7^1T%15X:T.^78'"I?GA M6$.6NL0HB$)S/7E]W9`%F_SMLA38E`6>!>:'8PV"SW?:AYY-(0QQD2E.G8#Y MO:6"9@NK05,BIQ"&R*4I#L^Q M'GKT3%`1?B`)*4MAI>RH!AH?=D[W5@];,5K'OKHO!^\3&,+:]VZW`#-0@P_D M&^8'6@NK)#E0>LX2>C/74Y1^D*QI+^H]DS#]M#\+F'8)W,>>`^"<,7EY4'-: M-S_O_@(``/__`P!02P,$%``&``@````A`&/TS3OG`@``"`@``!D```!X;"]W M;W)K&ULG%5;;]HP%'Z?M/\0^;U)'"!<1*C*JFZ5 M-FF:=GDVB4.L)G%DF]+^^QW[@`G0M64OA.1\Y_O.SF#AZYTD*V&:%A M3`+>YK(0[3HCOW[>74U(H`UK"U;+EF?DF6MRO?CX8;Z5ZD%7G)L`&%J=DU3K2G>*L<$Y-'25QG$8-$RU!AIEZ#X3_1(UG)8JOHN50;>B3[^ MJZ#@)=O4YH?W+/K2A,E9%!&H[&\8`"/%AQ;>Z$I21!OM%&-G\01'=42)+L2."Y(Z%)F$Q& M=)2^S1)A1"[!6V;88J[D-H"I`4W=,3N#=`;,-K,4ZO-R9I"2];FQ3LX5T!K: M\;B@0TKGT2/4,-^!E@B"(^!!B4=$H.Y#`-G3$`9OAF"=3D)(XM,0$#1QO>TK M#OY'T3I!XWKYI-.QS\@59HF881_C$4SN`X/LP'RB(&96E,D\-X'=46]NL%J3KTB?+YAK"4&=E-[G`R.?0`I7$A MX[YJN%KS3[RN=9#+C5VV%.;/?\6+8`D70>*.NS?`'N[8FG]C:BU:'=2\!-&ULE)I+C^(X%(7W(\U_B+)OP`F/`A4UZI"G-".-1O-8IR!`U$!0 MDNKJ_O=S'3L0.^`#M8`B?#ZQCZ\=7^/7WWX<#];WK*SRXK2TV6!D6]EI76SR MTVYI__-W^.7%MJHZ/6W20W'*EO;/K+)_>_OUE]?/HOQ6[;.LMDCA5"WM?5V? M%\-AM=YGQ[0:%.?L1-]LB_*8UO2QW`VK\T-> M_VQ$;>NX7B2[4U&F[P=J]P\V3M>M=O.A)W_,UV51%=MZ0')#4=%^F^?#^9"4 MWEXW.;6`VVZ5V79I?V6+Q)G:P[?7QJ!_\^RSZOQO5?OB,RKSS>_Y*2.WJ9]X M#[P7Q3>.)AM^B0H/>Z7#I@?^+*U-MDT_#O5?Q6>&N1(^J-Y_\PW]7YIN]/!9#9R&>'6>U;58FE]5'K=E*+J[B1X_K=.WU[+X MM&A(4H=6YY0/<+8@Y39L1"=?`NE>'%$`<9&O7&5I4PTI1"H*_N]O;,R*VU(=2"62EN## MCMRZ6$;1W;7L]@AKG>$P=Z9MCR MMYP7ZEFNQ:`G()/ED/`A$4`BA$0$B5@0TR8XG(E+P:&&1M(%INZ\"RAVTS/I M>;MYH9[=+VH-/`%1/>Y&."1\2`20""$102(6A+";B;&HMC;I$B[OCTZ/*(;3 MX_MYPWFAGN%SM0J>@$R&0\*'1`")$!(1)&)!2,/=FXZ;1!3'::W3==P\>7-8 M=]K1!I@$Q&0\*'1""(=G2S6TY#D0@2,202$Z$X3[*=7S6UN+>I*:BR?Y M8#8)OFC(2B(FTS45N5IL`IE>6$\SP)HA1J)G;QLK!2BZ1MJB(=&`T77UK_8( M3X@Z4\UC`X")-$I=F>M)CRS[E3VYUI98H"'-G MROI=#72>-SUNNQ#HOI.UK11/4D;CA9`!\;%*@)$0(Q%&8HG( MW2$USA)C>=5TGD1IIC\0[2+UTJ89?;N%F1(T.)CE0`C(48BC,07Y([MIM:HMO/\ M2K/]@2E&9&6:[?KF"S/E;M)VB/A8)J;TGJJDYBN_.C;05^]Z4TIH+&`D9[18Z M!L3'*@%&0HQ$&(DQDA@1U7&:);HS#'"/Y69.C5)R&@YS%U]K!)@),1(A)$8(XD141TG8YZ( M4T7*(^`Y$`HET?LU0DY80:T08B3&2&!'5<"TE!=/*C51TJFU$>/SL M$?6*T6^(^%@EP$B(D0@C,482(Z(ZSE.HSE(1."X2+IJ%+S\QTR&6WD1N2LO$ M$I%.PX%>\3$22*0]L7'S=R0L$V$DQ@@_X'>_2<)S<8!/',$Z9N4N6V6'0V6M MBP]^.(^?"KIP8`U8!(]MIVG^_:QQ8@#9M7Q+L>WQ\[KF7R_KFJ2J=1R85%W6, M?-=##JNI2'F=Q^CWK[NK:^0H3>J4E*)F,7IF"MUL/G]:'X5\4`5CV@&&6L6H MT+I98:QHP2JB7-&P&B*9D!71L)0Y5HUD)&T/524./&^.*\)K9!E6\CT<(LLX M98F@AXK5VI)(5A(-^E7!&]6Q5?0]=!61#X?FBHJJ`8H]+[E^;DF14]'5?5X+ M2?8EY/WD1X1VW.UB0E]Q*H42F7:!#ENATYR7>(F!:;-..61@;'O/'\Z.ZNS9484X?I$\_<9K!F9#F4P!]D(\&.A]:K;@,)ZE1?77@OP3E24)3B01J#_%`S>XGOFS M^=LLV"IJ$TR()INU%$<'F@;N5`TQ+>BO@+G+S.KH1"27$`/U<,VYUZ9#0GB#+GMN#L4(/.H50D.,T["@9=0VC.>.'-Y=#B>C M\/\2#M3#^_5Q]>;01/U(WM:">O7>;%2"-^+)Z_%!`O-A`I=M-^")\)&PK04M M6M=GD>]YWDCY``#A,0!&K;G&,@1>=`ZPVNTDM8.F8C)G.U:6RJ'B8*9D`%?W MN_T`OPW,&SK:W\)@;\<@[@,P6!N2L^]$YKQ63LDRH/3&ULG)Q9 M<^JX%H7?;]7]#Q3O'?#$5$FZ#GB>`'.'9PXA"75"2`&G3_>_;PE9QMH"+^B7 M#$O?WK:LY6U;'AY__W/[T?ICO3]L=I]/;>.AVVZM/U>[E\WGVU/[O__Q?QNT M6X?C\O-E^;'[7#^U_UH?VK\___M?C[]V^Q^']_7ZV&(9/@]/[??C\6O4Z1Q6 M[^OM\O"P^UI_LI;7W7Z[/+)_]V^=P]=^O7PY!6T_.F:WV^MLEYO/ML@PVM^2 M8_?ZNEFMW=WJYW;]>11)]NN/Y9&M_^%]\W60V;:K6])ME_L?/[]^6^VV7RS% M]\W'YOC7*6F[M5V-HK?/W7[Y_8/U^T_#7JYD[M,_6OKM9K7?'7:OQP>6KB-6 M5._SL#/LL$S/CR\;U@.^V5O[]>M3^YLQ6IB]=N?Y\;2!_K=9_SK4_FX=WG>_ M@OWF)=U\KMG69N/$1^#[;O>#H]$+EUAP1XOV3R,PV[=>UJ_+GQ_'8O MWH]LN!W6(]ZQT. MX?3NR&*76=CO*LO-J\!6]M0/]KL*OKL?O3))OY[D[GZP7>NT*NQWM2HW]V-8 M!K/?5?#=_3"8C<2HLG$[I[F[)X8<6/Y'E>?FOAC,#V(U%&/7,V14HO&.R/.Q?*[",6>O;1C0N5UC'.WKFU MI](XQMDYC0OMB$)PJBON\KA\?MSO?K58L6:6.7PM>>DW1CR9K"AB8U4UYEJ) M8;6%9_G&TYR2L>IQ8'7QCV?#L8:/G3]8,5N5T%A`K+-GR+0,%9I(B!'RL4$.'(\B`V=VR9B,!50?.%/MV$0G#-.R5,C5(5LE/)U@:0CD MZQ!%`AUA>1QU8>%%J*="T46HKT+Q!8ANP^0"8UH#-5%Z$2*[478)LKMJIER' MR)!-)5%Y40IG^]+M.I>(C"FD<(XQ:,\7DF%!BF'984(S+"_A=Y8>GH8[6*[3 M6`B#2IA0P:6"1P6?"@$50BI$5(BID%`AI4)&A5P*M>WKT+&>2DAN@1D5YE0H MJ+"H")#P(1%`(H1$ M!(D8$@DD4DADD,@A,95$93@I7!W*N21D2"&%JR$+2;`0Q9*L1"B6;#[`<5,B;",OD&Z/*<1A1+!5L$D*[&H12@UCUU;*G;CEVGX,,RCB.T)'Q(!)`((1%!(H9$`HD4$ADD^3<]U(;3>'9%/' M]79C:/7)\A.E?3`T2'RJM`^[#MF^F=(^<+JD>.;U]F'7&I#M,Q7MM=I7#V#Y MM-)'`XIZ0-\9V&0-%K4`Q6QL3DHQVVV5CT<1TSETD6,!#>W3+M9]&)*-/A'M M#971A80'"1^L10`SA)"((!%#(H%$"HD,$KD@KH[)5&:HJAX(F-.`0@K7S_DD M0<_Y^$3[/_#B*4PS(S';N*1$"30,JT>`20DTV1$C'D9\M"8!SA%B),)(C)$$ M(RE&,HSD)7)U?*95CLJ:*&2NA125S9Y\'KANS]N.Y/QF)#N4@[G$DFKHS00C+D8\C/@8"3`28B3"2(R1!",I M1C*,Y!B95LC9IF+X&P9VK@45E=)@4YE7LRF?":_;%%11,7'.LE53AX8VM<-O MC3,/-W1B@A$7(QY&?(P$&`DQ$F$DQDB"D10C&4;R$A'']W[/&)(+E&F5X^Q- M,:PBI->WZ9327`LIE*4X0VM`KNH7]1#E.H@_#J'X\L;RR<.TDT]R>3@^)0<& M%8D:/.SB+!Y&?(P$&`DQ$F$DQDB"D10C&4;R$BE/0!TVR:'>\IU6.(F459'-GFB_E")U]*101XO0,@UQUS*O%RI!" M68H]'-(9ND4]1#4FGU._PYAB"EXQID/[-.;/B2%C0L3%63R,^!@),!)B),)( MC)$$(RE&,HSD&)E6B/39K%+.YW.:.>7`RJ`"!RTJA`6I]N2S['5[WGA<%Y/S M[`SD?-ZI/V)AR"G\,T5Z,\&(BQ$/(SY&`HR$&(DP$F,DP4B*D0PC.4:F%2(= M-ZN4JP,[KQ`95%3*U:!%A6@VY?/S=9N"RR(QG:]44?VR2,[Y7UV?"7\TMKG. MNACQ,.)C),!(B)$((S%&$HRD&,DPDI=(>72W[2&YQSVM!CQ,1)@ M),1(A)$8(PE&4HQD&,E+1!B4/?9BD6N<:97C;%`QK#+$HH_*S+600EV*;=%G M,!?U$,6@)KUIU%PX3SBY7M=OEY=4P\7X!",N1CR,^!@),!)B),)(C)$$(RE& M,HSD)2)RQ,1*RJ(>HQKSO=I%YX7:1 M1=_>&)=4HS'E#8*K1WT79_$PXF,DP$B(D0@C,482C*08R3"28V1:(6=KPE&; M:T%%I5P=ZD6%L"6I]F3'YG]P8#=Y&+Q=5%*--A6)&A`79_$PXF,DP$B(D0@C M,482C*08R3"28V1:(6>;PE&;:T%%I3385.;5;,KO`=#S3Z//7[]%;UZ)NP!CQ,1)@),1(A)$8(PE&4HQD&,DKA#^E3I_\FY:M M0S9I=!YGQR0/",Z4).SNDSJW/[\M2Z%DL6TRU[.`6=0*S%SW#ZW-(_%)K*`: MO0T1UX2(AQ$?(P%&0HQ$&(DQDF`DQ4B&D;Q$Q%L)NK?%MH?>%IA(8'G'C]+$UUR=/BL#K_#<^>[H>Q;'%HA MTFKO6%)L6J!6HFURO38Y8_)TP]4E3Y=\70IT*=2E2)=B74IT*=6E3)=R79KJ MTDR7YKI4Z!+_$,IIXP_Y&S-B>,6'3<0'"+;K_=MZLO[X.+16NY_\HR7L4O7Y ML9+%%U5FYFAN\01$+\P1>V=5U[^9#OL$R^G;)R2"#;/\.`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`;O6/J+:.?3QV*0 M>F"[(15&W^HR>&'07^J]F-],3'MV>RG2CL*DKP2V!TU=F,W3V97):\$@O_1\ M4%(^[$&;.OKD@_+2,9K:^>R1\L(QFLKI?-`1&P@NXXJS/J^_?CD>W@=DL"8E MS)_,OH%QG, M-C5:,$0.MD&F9D&05Y.E*)KQ/2CBT_6/`AFLHH_!#-9!1]@-3G M,/[`F-:MW%#R(5)>1NE':#*66\H8NGZM*5V6:\E6?UX(3GE/R0)-C MJ$=><4.2I((ETX14L-V%2C5YNW(]>-BVVV;2EU[DG;S=NQ MDN]+VZV)J0PR@;S=N%5&JE#:;EKJBSZ2MH^MN7+\\?5V]JCW*A6RLVVU2F:(?*`HB:5G5E"X4#A0N%!X4,10!%"$4$10Y%` MD4*109%SP8>Q%0^T=F7!!4\I>:`UI>)"'?G(^4Z/4J0:3L(,=94B%`X4+A0> M%#X4`10A%!$4,10)%"D4&10Y%[RN5CS06E<%%SREY('6E(H+M13)^7./4J1: M&16U29B9KDJ$PH'"A<*#PH7-DD_%#X4`10A%!$4,10)%"D4&10Y%R(,N2!UK&MX(*GE#S0FE)QH0Z'9#&N M1RE2#6=FAKI*$0H'"A<*#PH?B@"*$(H(BAB*!(H4B@R*G`M>5RL>:*VK@@N> M4O)`:TK%A5J*]`I#CUJ\<&5WXF+B8>)C$F`28A)A$F.28))BDF&2"](4 M)NRU0DLJ1:1]R!1$&S/ILG>/\F2KY&2!4BS@&/KZ-KTR2Z;YCMI;8N)@XF+B M8>)C$F`28A)A$F.28))BDF&2"]*4)^S80DLJ1:2I&671KQ)$*T^Z%-ZC/-G* M.=G+ICSU*9TOKS=(V9\EO4F@NX`=3%Q,/$Q\3`),0DPB3&),$DQ23#),Q+PE6QZOXA^-JZ\95G4JG,$ M90UU$`>WXF+B8>)C$F`28A)A$F.28))BDF&2"]+4*.RU0DLJ1:1UQ*H$T490 MNJ3>8P1E*_#DE=2,H!],\'R=OE':$`J)0V^$ZAYE74P\3'Q,`DQ"3"),8DP2 M3%),,DQR09KRA%U2:$FEB+160R6(5IYTF;U'>;)5>3#!\Z7[UOU9TAOHNDO/ MP<3%Q,/$QR3`),0DPB3&),$DQ22K"9MV;\F5=?D,-Q=--*7)NJS.&,^5!>Q" MRRBEQR`W>"J/45UGR%,[77?O491LF5XJ2EM=RU\8?#&_HRHA<7`K+B8>)CXF M`28A)A$F,28))BDF&2:Y($UAPEXKM*121%JKH1)$&S/I6GR/\F1+]VA*YPO\ MK3NTI#<`HT$3$A>WXF'B8Q)@$F(281)CDF"28I)AD@O2E"?LDD)+*D6DM1HJ M0;3RI.OS/=+HZLM\+IIH2I/U*LNP#$.9H`LMHQ21CKKDI:+6I=GO\M"%:ROQRFG. MHE8=9^%+3!Q,7$P\3'Q,`DQ"3"),8DP23%),,DQR041MBDAKI16"\*121%J3 M*D&T\NQWH)CTF`28A)A$F,28))BDF&22X( MK[25B+166B$(3RI%I#6I$D0K3S)!]YC53C8UM*OKH@U>9BLI93J;J'>]%UI**:78<^M6 MN1&_NDZ1SM5-NNC_^7>;%Z[4I:W^MX=%K3JJ;HF)@XF+B8>)CTF`28A)A$F, M28))BDF&22Y(4YJT6CJO3!=:4BDB'<,F;U<;-DD-]2E/RN$-4)B8-; M<3'Q,/$Q"3`),8DPB3%),$DQR3#)!6G*$_9:H265(M)1GKQ=K3SI>G^/T9-= M'N@^5Z>?KM#]&EMBXF#B8N)AXF,28!)B$F$28Y)@DF*2U83-ZN;<-I4[S'+1 M1E.;K%MYRLQ63H4++:64'V4Z5?^O6G6=(L_J=+&_1UVR:P-27=JVPH07 M?9:8.)BXF'B8^)@$F(281)C$F"28I)ADF.2"-*4).[;0DDH1Z1@V>;O:L$F7 M_'N4)[M"@,[5X76$I0F)@XF+B8>)CTF`28A)A$F,28))BDF&22Y(4YZPUPHM MJ121CO+D[6KE29?\>Y0GNT(@C9[ZN3J\C+`T(7$P<3'Q,/$Q"3`),8DPB3%) M,$DQR6I2KZ=/YC-E03T7;32UR?JL3K%N)\J)=Z&EE/*CD/^"KCQ*=9TBS^IT M:;Y'7;*5?*DN;5NY06]A\O7^UA?*$A,'$Q<3#Q,?DP"3$),(DQB3!),4DPR3 M7)"F-&''%EI2*2*MU5`)H@Z;].;-'N5YX?!\"D<6NZTBCIS:KUZBS M.O'U(=R*BXF'B8])@$F(281)C$F"28I)5A,V14\GD[ER7IN+-GB9K>04:SI6 M3N\++:644NSY;*ZD5-HXGF7=3@=Q,'$Q\3#Q,0DP M"3&),(DQ23!),;YV3M?:Z64 M6IE,E"7^"K8BOS&@5PP^?[IOL0L,9/6`OQH7>FBIAQP]Y.HA3P_Y>BC00Z$> MBO10K(<2/93JH4P/Y7IHI8<*/53JH4H*R=U#5[>ON^?__%!E\DGRVCADJ_6Y MX(JLC30[X>"O10J(3D--H>?]"/WZ2@CHNSK M`$C?\.\#4+<8=^3SHTG+2CPC7R#P8=R\(Q_8J_N5>5=\%"_-N^JC^#?+)GMT M^6J`D7AH\@T!;^NG;;H^/NU>3X.7[2,YG/'-C`P;1_8=`^R/\^'M\E'1WP]G M\MT`EU^?R7=!;,FG9XYO"'X\',[\#_JDB6^7^/H_````__\#`%!+`P04``8` M"````"$`W8J)_6`%``"R'```&0```'AL+W=OG1G<)L=XAIXK^=(.XOH^D' M-^W\IB(?A4%"4[K/&B"G\8I68^YJ70V4AOU="!&P9E<2LA^HOXS>UM!5;=C/ M&^COD%S2TG\E/=++-`EWRS`FT-K03ZP'WBA]9ZBW8TE06*N4=O,>V";*CNS] MCU/V![W,2'@X9M#=-D3$`NOMOAV2!M"B(-,P;:84T!-4`'Z5*&36@!;QO_+K M)=QEQX%JM1IV6[<,P)4WDF9NR"15)?A(,QK]PR'C*L5%S*N(!;6_YIL-LV,; M=NL%E>95!:Z%RM-5@,KF<<"U*/QR'*VK2+LL\G(<,+3RJL"UJ,K3<72OA>%: M%'XY#C#AW^XR+T=BW#J6_2ETGH[%`#]P-5=QLT8!O1/48NG_:5Q MQ^<#R/$S?]A/Z$6!60G:)CW[;(XS>DSZ-G2XT8O!]%]C"0814_G%9'(Q&"8I M3`"?0["]WM<^8=0&5VC$(7#$'3(M0X3&-XB-4B;MR`D3.<&5$Z9RPDQ.\.2$ MN9RPD!.6*;H%K%;I%@L,_7A&N_4"*R7U M@JE+#3RJ0J98RW&5,$S+$B&G"C5%8E(E0$:"W"HD(],J`CJV^+#90Z@E0MY# MJ"U"\P>0W(:+!XQI=42AY4.H*T*K1U!3&CCK*B1UV:9*R,VXK2)&*2[!?3!3 M_0_WL5*PJ&#?PC*&+@W_$6?:^ MQZ01Y@CYEFU*^1,AW[8MR;2ND&]V=*G\5,BWFJ8T#D&]:I8&; M+Y)S(5^WNE+\BW*^V6W9TC2\%/.MME2_53D?GMZ5XE^7\XVFWFY)R\5&`"RC M;4@1;@4`'F#>'R%X!]YM7_`.HR7OP.NX.`>/.`05*`QV?W;>O&.4<%!B@A(N M2DQ18H82'DK,46*!$DN46*'$&B4V*+&M(P1?P;NOX"OV(HR_<;%2Z)K'H3I_ MH82#$A.4<%%BBA(SE/!08HX2"Y18HL0*)=8HL4&);1TA^`L^IP5_U:]YC);F MK)0G:=0PD&)"4JX*#%% MB1E*>"@Q1XD%2BQ18H42:Y38H,2VCA!\!=MN@J^>6PI9*70IY%"=OU#"08D) M2K@H,46)&4IX*#%'B05*+%%BA1)KE-B@Q+:.$/S%=F8%@]5/7#DNS5R5Q?`* MU3D+1QP"(BR-3')GAB(NF_G\_&NWR_6;]E^5?3R M8W:`-R_Y:;\ZP]?3:[\XGK+5IG3:[_JF83C]_6I[Z(H(=Z=;8N0O+]MU]I2O MW_?9X2R"G++=Z@SY+]ZVQZ*.ME_?$FZ_.OUX/WY;Y_LCA'C>[K;GWV70;F>_ MOHM>#_EI];R#;[90 M`E[MG5/V\M#]SNZ6S.WV'^_+"OI[FWT4TN=.\99_!*?M)MX>,JAM:"?>`L]Y M_H.CT8:;P+FO>?ME"RQ.G4WVLGK?G?^5?X39]O7M#,UM0XEXP>XVOY^R8@TU M"F%ZILTCK?,=9`#^=_9;+@VHD=6O\OFQW9S?'KJ6T[-=PV*`=YZSXNQO>G//]?P7$JE`BB%D%@6<5Q!Q<@K0X6I4C/"M'NSFZ%2>\*P]G9[+#,]RVY-T*T?H<1?'&[+J57[P MK/UNS"H#%8E&Y7(2#6;>EEG6Z$%JRYMJEM5MR3_4B=Z:X;HYH:/=Z?\H\.##60_^*XX@,7N^/1ZOX@--'TD,\Z"/0,'N4[#_/0A28# M[1?0JW\^,ML9W/=_0E=<5]#H"F1:#$/C&N)=CX=^4@T3U>"KAD`UA*HA4@U3 MU3!3#;%J2%3#7#6DM4&J%5S:14W4I5U*ACXT4=-.(*__1SOQ,+R=ZO1&M>&2 M11-G<5P3MA^35H8&`HU2&E#185"ZD11BP MD!:OSYWUT,!IF"4EN5BV4LR18&!4:R2EM,VX)AH5UH9/728DX9-$0!(A240D M,26)&4G$))&0Q)PD4I)8D,2RC4`Z`SU\06>EI2(01-N1Q\(`Q18AI&4Q#9@@Q+$^OJ%A&3,^Q!UJ4!".6JV=W+B.0$T^O MEU1&8"'H.I:6T@(Q%G.97NPE8B`E$Z6%I`=+U"](C].:])01;"0@IY2>:9I# M+A+<+F.!2-)#/I8UT.MO@A`VN%+%/D(LTT7%+A=9`4*8,>`BQYD+,6)QS2A( MI""PVE>1*49,3Z^%F8PPOEW0HL0(&7I,CY(@Q#-L73-SA`QM0Q=P*B.>80WU MJEO("`2Y)CP9<>WA`"6$=`>[):2[I;ECIH$E;7+2$!"@IZ! MY5_J8"P(#Q[2*&HJZYLG.8[%G"NJE`GF0K6H0O!EPF17=!`@PACJ#1C*!+,M MO[[2=>:(<*ZDDF*" MN;KF%S+B>@,]JTM$6+B#(B'"5E`3H@7;X_:U'O?25*@L?$<"\LJ!T.AI&\#J M->2T38(X"%,4.L&O#64L]I772@X#^;7;@^:4_]S)-V5Y'?OK%+^V'0_]*HIYQ333[W]KPJ4F7[9E@B2&S^61GIK']E*7!&:.51/6BJJ36H-TFBML7PN M-AKQ:22@D9!&(AJ9TLB,1F(:26AD3B,IC2QH9-F*8.GQ8^C;)U7^*PB,<7"P MTXQ?^AE?!;4J3\21IE7::4(C/HT$-!+22$0C4QJ9T4A,(PF-S&DDI9$%C2Q; M$:P\?@[]!>6)8VMTZJ>MYYB`FF4"'Y2547E<,;+TA%>+7B>-TT7WRKSMTTA` M(R&-1#0RI9$9C<0TDM#(G$92&EG0R+(5P=+C!].R]&Y;W_'?;]4%'NR#\.G9 MJ*):U#1ND,N\VW947NY5)HU3BP3)*`$=):21B$:F-#*CD9A&$AJ9TTA*(PL: M6;8B6(*@#R1!8LG'<7+>%5"K\FKDHKS:\JFL)HQ$?!H):"2DD8A&IC0RHY&8 M1A(:F=-(2B,+&EFV(EAY_(SZ'PQ^XF@;S[_J[I;?KP*95K^Z\3VZ/OT*1)Y^ M:TN+`DG$KY)N$7]`(R&-1#0RI9$9C<0TDM#(G$92&EG0R+(5P0KD9].R`HFQ M3QQEF])=%J:9QKKI23=-=).OFP+=%.JF2#=-==-,-\6Z*=%-<]V4ZJ:%;EHB M$ZYX?LXJ5WR][OGJ'3!Q7HO&`EO][6C$+YGQY1(<@S2;16:;RGII?,$NENFFAF_AMV*K"H-BBX<3M5G&/ M;Y^=7K-QMML5G77^SF^N\GU.8VUNU7XW^8T&Q3YB=W!K3;>G_!;N%?O(O(/[ M8#K_G3G@X%QY`^U=7^CM-XG#A=KCZC5+5J?7[:'H[+(7R+;1XQ=#3^)*KOAR MSH_E#<7G_`Q7:.4TE[$?_P<``/__`P!02P,$ M%``&``@````A`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL M[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.` M`<.Z89UC1"SF67 M"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73- M\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?; M=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ M-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW] MN\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS- M;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&, M]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q M509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6 M]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UH MW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[A MO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:O MI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ: MFNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P M5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6 MH0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV M]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(& M9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX= M-@U-9O] M2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)% M&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]6QE":8L>4)MZ6I+/\B%6S#9` MFAX2%RW0*PJ:HFQ>^%!)*K&OZ/_>F>5KUA3)I;C2&JW1BT1I9[[YYK&[PX>N M?GCR/>VK$\5N&"SUX?E`UYS`#M=N\+#4_WIGGLUU+4ZL8&UY8>`L]6F[RS&3IFF]? MOG\(PLBZ]P#JTW!BV;EL]J8BWG?M*(S#37(.XHQPLW%MIXIR82P,D'1]%>Q\ MTT]BS0YW0;+41\4A+?WD_7JI7^A::O(J7`.(W_U[%R;?_R;]Y\T?WKP9_.N[ M[__QR5G_\Z??5S_[Z3O=R-40F>"#9IGG@T:Q\'$JV<@LN+[:A$%IR'@$-"%; MEU^"\%M@XF<0#&`>?NWZ*OY%^VIY<&2(\.S0"R,M`2^#?>Q(8/E.^HV5Y;GW MD8M?VUB^ZSVGAT=X@`5&]CW?!3?A02/5<%H]]X@FMVF.,#B;QGB$VN2#218> M;+;)^GF/39RN:;NN/OQQNI@5S79)TU6-BPJ'?705OB)ZHH?[I6Z:4$.&@P'2 M2AUV)&6+U0#TG4S9Q?1DEHW-L3F3:AD7BU6_H<*Q*9/*%H7FV]F[D]$I7UF= M=5D9/E4&8,+)9=&%U&W([YF)?Z>(DQ-/:,?Q&)/*%7V6>F5MO'-])]8^.M^T M3Z%O!4@LG=38M[DYF0N\XXCG0D"^BCRZJI-O7VYV-':/!YQ4S_U!VMFI.27M M"[K#1;,UG]10/%&+A>:@CF*DQU#[7\XK]W'B,.QXXQW`M@%(T0C_5[+MQ\BZWDX8N$D-B`./7>-*!Y6;)>5K7)7%[?F MZI;I)S.?SQ60\G$P8R?=91+O!VGERL%$BC:8J@BD@ M6(SGBXL1`!E,YDS521&,`PG[L/HS7L)(LS=`/8 M2Z7'KJ\\9Y/`SBUR'Q[QWR3@@#RX.71CXB_[=A))P< MA?.@2SUY=.TOH(S;):=K[%3%L304U6&"J^[);#*83::CBW1C(TFU[ZS=G5^U MKM"]UW]`(W+;;CCA,"B49#O?LO]KH!Y"\X)O[^F$P0%$ZD.`A%3XK3W@V+#T?)ESM]EO[HL16Q1.C04+/ MV:I5VV&>+!*0#](K>()I,[\YC8<8C>$^1'#JDTZL3HWHFU( M/S\<0E'KF,,@53*\-48.TY,3VRI^CS-:QS1!RM:QL"RV'<_[C`O5OV^*M3&T M9:^OGC;D,C.X]@^OP\*KV/`EG/O(7J;KX/0-L%8W"*XBJQFD6=NM]_QQY]\[ MDR$7;#(3F_5X1G7X!EF M@D3P]-$_J=$//`GST4<_-"[W^@-X4:H?@DM8O\QXP$LSLZ`&%]"@;L(C$P&T MIW($X`05"/!2THP#"$\5"&#;GR.``"T1`)R&J.B3!T-2S2`&2I6@_U@JH<;D M5G(JCVAE7?D%_0U6FESY[44SJ;<0Z"7-\*8!0"^5=25658DA;H=,*RF`-PT4 MF##KRIGRAG4U7QDAI.@"AI(1*`--C,B+2E)S06<)H)F1&XGK$!(46(I40P`X M2B`01PP5S;]#BD'1#$RC0=$43"%P<_`)4[AS!%VPO1;;2>/.NA1?88^]4>PPC]Q?89.)-O#8<<"(= M;_I.7)L>^199VSOG";:BZ?G8ITU]KQ>0Y/V-E\'((ZS%5.J'OK>N=5$NG9\> M6/H3T6HYV]2W-N9?1`;?W&Z-D%80V-Q1C0'30C4&]'>&07H82DI3F"1SB,+1 M*3M<*$TP88K5"A.(Q>+34LU:8Y4J1S*RAC<5S!)0T.C2]"'QPSP8EW1 M8U\R(AOEDT\>PDNZVE.ZOK0?/TJ>J+I;7YFG+K%1+.TV$(@J[()*^ MP%2JO#<=TAW4A0[IRBD=U4FX+4W5+F=5EL/:M9F,-!5>SM(VTDAX^MK?&!#< M+'>)UEJ2CCC+=^LZ"G,FR`Y-IW35T0E/+6$RHDHF'KS:0\H>J4LXU18_:6BJ M[FNK@"HP=0HIZ8L9RE%UQBBV;>QID8=MVX;0)'E%P24+#26NYXY$&D-53)V" MJ[9>#:%U<7(7'A]-3[J.7RQ:RRDYY],!C""&MY*8*I+A9S<\? M'7-!T:O:UB:'C*6%\(*54E77,E,%J):A(RXO.E7;VJD'*?NG-3TCLIU%_5ZM"V=JT-^$,SL'7V(>G_VKB078TZ<5%WHN=01_1H M?DIOZ73%PB[!:)M.JPV$(T_\W0IUW2J@"IOO*_180[4#%"*V$G$BO`KUG@]H M/]2N4"LH>1IK\72-15JOZG(4;T"1,K5UJ1BUS$A#0Z>6GJOTBK>4YH M^U!QG0BR'DFZ%RD)LGJW0D5Y14$F"XU@D`DQ5/$E7Q-Z>*V]M`H!E'71!B5- M[B+]M2#$B^&574`F?AZ%#[#:2:=+7:]=DF-E>$4%`%;+_X=H:&8US'DDV^O] M5>E,\=$B7(XZ10\DL+J\D:V<>J.ZN2U.-*1/2VN\.*MN.0Z.;(KBVHP61)8^ MN5L9LD/FAJ/NR@\!5+LBDN$[84#T/+OX+0(BBTFA&,MQEMN7_$AK=6`/2LEV MT\*SZG[@M5#;06#3+=_2"]\(M1\%7T9K,=$4SRZ]L^VMC]:7!' M&GF^%_]TK^+^-0U_``I^L'+P6^U,>VNCC<7R#1O%]SO7@Z=,XXUIN)RRX;Z& MT+])#V9W@S7)*L[O8S^(RH)M<%=9Q52(%S!265"7N\HJSBNB.X@L>/199UE% MUWP,KZ@L"-&NN(K^]ICG?BK(_62?'[$:$UQHL@@N*JOT(S!'98')7665?@3' M45E@",9W*J7T M%,@C%DW@`Q&OIU(*'XUY=B>"[-Y8ZWP!SP<,SC,B,."GQNR=!S\Y'>(/5K.; MN+%#3PS"1W8(27IT["_:"I[)60CB\P&G41%!MT];SPJL)(R>-;QQNQ#'.WTJ M*.Z/85APQ$L8P5L10'^"G_>&7P[7@)>4(3Z&<37<14R1"SP]V+;N(@9&IVCX M^,/=0A%A_A:BE.WB(@/;O#%6?.1PS.,+08121^= M71)91?SQ*85-+2$A^"370@9?(M+?'!!^^QYO\5^`(A:.QMKYR5WQ8=+O7S]9_83#Q!, MV;=^=+^&"1.QU,O7'_"W,R"+X=0$E)L/,?P>`_RK[2)WJ?_G]F:V>'=KCL[F M@YOYV63L3,\6TYMW9]/)ZN;=.W,Q&`U6_P7*?"^(+^'GYI?Z8Y)L+PV#_3"\ M%9_[KAV%<;A)SFWX28YPLW%MQXBW$125^-%Q$M\S1H/!PE@8OL6>A@]"+F,/ MOA5EQF;@/Y?'ECIYD\)G]^&UL MW)W;;AS9E:;O!YAW"`AJ5!5`JG2L4AVLAHHJE=6M*G%$E0W#F(M@9I!,5S(S M.P^BZ"N_0E\.,`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`Y^*Z9 M?K2_?^_^_H-[W3Z"=9Y/ILVR.F")I_/E9;?11T]'HX8&/!XS&G]U6T0W!TQG M"1U>P%SOJG]O^CW=Y?\^?_SPWA=?[.CB=7,Z$3.PKA_J\Q[%/SIX_;M7+U\\ M_[9Z\<-!MXLWRUIB6AU=GA_/I]VG'XWZ*TOSGI^?(S1'Z_GHI[WJZ*Q>-JOJ MU69MC9JH`/HM-H%)256W._./$VY7JWHXLO>XWIU5@&AU4A_-/^QF;RM MI\ULW9O7ZP9>F(S$=]94[ZR:T68Y64_ZBWW=C!IZ.IXV_2'%&TU5CPQ?5WO5 MK.F1^]7ZK+]S;^9K&'K9]MQ=R[/FI$$.QQ6(OFJ6;^NU\'-70R@/!=Z$[\<(E> M6J(WU(OV8"&4[.W5M^F)M5O-3]87B$>WL^>;Y6RRWBPA,;V=3-[I[]YVOD1* MFK/Y=%Q-SA?+^=M&(_9:.Q7LO;WF$XKY<_ M%2Q%6ZR5(;&`A!,U:N3IH^ MTZ=V26J[$^F(?O>QTR&)N[6LT!2; MI@(:JI7T]%[U^:,]C`K_%_R[69^!L']LQMBBC_?N/WR8GDRDF4&>0BKN?[[W M$`ZUCE;55H.>C#P=CV&T^0QM(!#>IY]1O9B@';H;\;I98\HS%-;@C!WIT0>. MR'AE\&U\MFS.8+7)VX8IF@[X>#I?K3[I]OX&QV&U09,[86KM]FJ]5SU$TM-" MBB6"`UN_]M;E_&5M.CO2&]E48;&MKA&T"]>\>809C;`]K7`3)O-E=5@#R:/) M`O;!7$.MA0HU`ZSZ_??-^7&S[#D#;3M;>G=Z'[W_^?W/W1\1"GRYM5#LQN-< M:0PQ=23LK&'^]?237<;1BUGUYFR^6:&``,_FW:A9K-VNK+"QZCT\.T-QV_V+ MR:JI5@NTULFD[Y,]GZ!8F_V7,`;69<;DZJF95M7O7\)JU8MU<[[J$>QZ6*\+ M3BRU2)>,'=+OM9)X;AF6T(PRFHT^^WIW1"V_[U'7RW!+0K;*G3R:P[K]@R("_9`KWQOVMF M;.MTKZK'YPB^/.$UDL^_,65EH0$\?7_T-4NKER/WJ<9093HW8[X[`5^=[%U' MWC2-;KMVHJZ*NL^!H09RKM,Z=CX??OT[U&.%8;+"Z=,^?=^,:T)7Z+UD1W<[ M=/-[?5;/*B0`-UBN;-M<[D0]6C M*3*,-YH,I&[;WS:3TS/ZV*]1C/5ILS6+535OHQZ]*?DN,.L":7R1U;"ML@U* MP_38C7`'"@X0&+G8&8,0E2TN<&*M3I;S\ZKE;@**D[<[G(/Q'S;NL:VJ];S" M"YG/1@2V%!9(YA>_ZU_>_XU[?O9!_N=\MF_]BZ:[_(S?$NQH]L>*,B$KXV0K M;>&9A1L,(R04.V(,OGVS-&:]38,=NX/(G6*Z26`S;+A39L,5UF"/75[_54&3 MZU9QN#,($NYYE^%1M5N.(%@:WEV"/T=7L\6R]S/@M72X#>TBJ1M7QY?1>=V8U2%,1O`5S(JF'#4-PFVOW!PT#]P]<8C">1F*R#P=OU6L;X5!BC-6 MS:YQR@\W:!EB..#$"5*3XQAML"-O7XC7-50HB?CQ9@4U)[-/^'\I@FVR7-.1 MT>9D,F,UV^_UV'*;G,V[9CF2`21$+J'%0GF:T%K^:'ZPMGZ9*-W^]ZIC`OHSN<&B\"5FR@>\ MBTK;]=:OF_/Y:D'`MKG"QB9TN3*GW?2]NK+YU2,>H"3[,UF.)W,B*,UJLMK9 M[6Z%=;3E"BMP2AQP1R9NT`:W#LS^[DVMR%#LG%D1HCA4B((Q$@;L\JESK.+; MB%54'Q,5PC=??[)[F,)I=)VRK>?A086P/WZI\,7.7K+7=;73;R9KEQHI0T'P MHW0^[NYHEURZZKKVL65,?Z^9BRR$4F#I4WR8K(^4]@)9.D%V/Z6OG;-;P?/]1S>:)>Z MZ?)3W;G&#URBIU`QS8/9H5A8`J10A&-1JZ'IF1 M^;9>C4CZ+:MZL8#`$0L3=BSHDL`1[^A?8T51)L?XS:OJ;,.PU=HB_=XC`9;9 M2AA*;`VSSZB9UO:7/_VO546L_=3F08A%S;Q3"GN($5'-@W4UFFY(+7\SF7]' M9L)%`ZKI/X?\U^J/2EG\ZM:C6Y\^^7HTG[(*R'5.Y=`]_;)\3MK&6[R9G#/% M'YJ+ZO6<:>KI27T^F5[Z8VO^J?6Y?O+^_^PY?((0HX.<2*A\WR M8#J/&-4_.X](J*OZ>#5?'BO_6BWF%[B8>'A)=O:JB[,)04NA1T#'EK"2@&Z6 M,Q-+;)%+`P!"X(IS$C&43!9X=/3]"]$9^:TZXGM,*G0"0N]A#)?V_<%\J4"B M61R&:.53WS-+R@0'6D>S:EX$XJO"RQHL)<1,+2]E8I%JH=1'N MR.*AK``#2%46>%5UN5KK=T*SU:9=<>LE%:1J?_15>EC95M<3U@T@E!#LEP66 M)[_>C96_[$C#$'9.26<]O92G]X]<]>O>8'\?\@XONE&\#L;K3>+ON,^O>H/] M?5;\9+-6&+CZ;EF?K`U_?]V\WCWX?U'U\^3]S[9`%UT'4%BXKH"8C6&9["0" M)_N8)T3WR5;+A@I@$LY]>_3ZF=ZVN!"Y<25C!,E9'!+@W*G>__P&R!LTNK8M MJ=;&LG!H0N!L'!G$8T3^IIZ^W2WV_T6W9%C4JJ/OJL5F2H)'"N*,P)>9>6$I MB4)&#)H=_L:V0P9"HM-AO1Y%D.V?W4S8IE/B-7A0EH$9ZMG?,*K0WGG_F("] M_!:7`26N"28KAH&)X0HXL:'9\3Q<4(5B1;!'EV1938QV8M,_%R^NF]'9#-_C M]%(F0UYT<3+@<(DC,UE0E2*:MJXT/I$W;P\1"!-(H;BS)T/'#9RH'HXH-:`C M_\@K/+=P0*]N9,\PCO&[=Y3MEPL<=:P]\EUL9#9F\)^9^ON?GT[IN/"SS4C< MC\G8M*QO$R:Y=LJK*)I_1KJ36'1#?>9T0FJ=J5DM6#MW>7^]I:H+"DMYIND^ M)S',V-6!%=8.^?2B3=BRQG6I1,%6E_)-&)$^,Y^"TLWJ=91[Q9Z4I>ECTZC& M'#QKH`F15_Q=Y=U';7#>LG.-!^YY)IJN<24UX::6%+5T,!*^QI%5@5QU"O2[ M.ZM*,^W\3$9V.9G+\FW:,B\E2Y?*>S&KFKTG'3_#/M5PGD(;3+:K[V*WC3@M ME]$;EGWB%GJ*"H24AQ%)N]4MS@Y>!:7M+E*17=8B*S,O]KRS1I6F=0GN9-PB ML_1EHG)FWN.HE;>3/(K<>P%TGTXK2K<]DU(2#%FX>26@)B`2KK;2#(VG&.LTD#A#>.S$[:6$`H-]\%P(,Q@&\Z5(3&_ M)E!!<`),)RA2+F9ISA_/J:X((/]XYN@,K6B)']38SC!VKP"9(?%[_U%1* M(-H23/1(66\\NBQ10DIJEQ=-GN40[Q9#GV=@&DYQ[QG],79&"$R$S5B(,I62 M@)(#0Q"-(^!GC3.$C![YVC6+8?08<_P!,K4O&='LI%)@)%$U\)H&W(RT7>?R*+HXC)FDEZ//9Z5_^])]3*X1,I>FN M-=JJ2-^W8B!8*9^GV!-:P7)VZL#>S)LG+*\$7,3RC)Q>.F:-P@H)ZT)/TT9? M5E3;3,Y9F/\OU#`0QPC>K)5,S[SE^YP83!"JZANY8E$'`#L9X82G]8S9$$'S MK,*D08+NQVI,+JU-.$.JM(CS5UV-7D0R7J>YIH01;!9\N=*(7U MK(Z/INV;]"7*=Z:XXQ[*;JV5RG`@3I1<`4)BC!Q'`&A?BQ, M(=&JB+=H#0*9%0$K'JF7UZ_0?[0H[86D>A4YD)5*JI0:6B,;DJ2X'N">+ MA0K3:1.A+^EI#F_"!PNQKH=]>(LCA&LV:.DCTP^#:*#9O#K9+/5O922$H%Z> MT!;CFS"_H8L#XZ1+2&!45D@]XXG$<^%1/Z7AA3G31O#1T@4 MPM"N1O536F>:<9@87O7IW*V!+&QW"H\#2!V*!:*S'IVU5%^08JXS/,;W'*2R M-Y)L#0RP62!%!L`CE=`CH?7IL@G;LS,:W(O<84M9(I'!BG$3R62H49JJI8%? M)QS&J119*XX\[.+I*-+1(E*ASE80T)>2!(GU<6YI+;,;L]3ELUY")-=EP7>K M#49-5"85TFDIEVC*2@=410)R2<)X"BE0L;)FC("GY!,K_8,.G^)1&^2//D]T5[ MHK%F@*+5C+7&^`0*JXX'9IVVTFC;V4NHOQ6D;L/7\Z6O"/B9;FRG6BJR/*=[ M4)MY@IEA)!C7"&U&>$$PH1]PP@R?HSS54N7^1I*T2=1CA6-#"8=HHI<)O1^[ MJ>ZPU./7(V&120K-?\T[4_WC`-.2:U-SI2(KAU`&==\D]'$]J5VBL8&E4CDN8 M:HSZ<)#ZG`,V0@83F(`S8_6Z&%00$KXH[&(I3+F>SCIZB#6S6MEI%#T.(QQ5 M=%5->NK135#--J&I9'DY-A?6]DB\+!L?JBHYLL"*"G/&D:"57-L,>$'U=*E_ M8Z8X,B%]:1#E6Z_F&*C%2F.50V"OI(V3P8X7,R<$!D!`/;9[*)*K^``UQ=L.#;CQ_?U?FWO>KVO3N/ M*M+%4\PI-QMN?_'PL9Z]_UE"H<%5?[=2=)CY4#EEYZSRA0][Q'LY,'K?7^8O M+H+8$K0('+61H"/556"34ZM.A]KO9*)V>;[D!P&6F[9>%64[ZC]`+!PII9.5 MDG=XH2K("I^TN6,,H-E^^J5Z1LG,B`/58@-L*H1!%9CFEX2IP::PA'2&W`>I M.<`,.RH6_OKH*<%$V=J]5@@2*M\;_1B-2I/+^VI;'1ZE5IIF*B(5JZA38!+N]Q,`5M+%"G(U*O*!*9I$#XV!IXO^I3MMXPF''?P@I'5G!D*L;6T- MY';:(R-#YM`RI""6^XZ;/9MJB([LND=IG4;V?27.J)@,)'&W"(4 M>K-FPTZM^@-5JOR'KQOW$\N837_\Z%^21HWTIE$TM2N*4BU9HK86*YO+298N MOCWX,$XW-9[-DW4*W8[1U*^@%FLA3=BBJ#4ML-[%3 M]R665XYX?=\@'<)@L13L:66)9R'M+$W3L=E9A*IK"^S6-XE?9,3`3]K/P95O MF3-.*B=W6#@I"C+,C0'2KB"6C9_C9\,SF+C68!T:W%!`E(\@O]:&@-=BF7TL MCX;"(>(;B&`R\%,M>6=+T^)N/KSM\M9:9QN=5!7WA'"KLT*?I"/%J(;1V81- M,1<\=J1$$RW7PZ@P,SCF)1.ICF#W^HQITP(5Z!U!CNC?<"YS<*NE>J1%#OU& M"95=.OEA35NM1,O.B<#7P/:,(W=HSPS1H$'P;%5=6PE+S[M-?J=!57?3.O13_M'(S(-_)O4 M9V/0:FQN7%Z*NTN.\]T-><7W[:_FS!;>TU;&_(T8AI])OVA_!.;9-TBYK^%% M2C7Q2M[NZV3$12:UUZLL:E:.5H@#3]W;46"8D;`CA,KZ+\( M;C%G\Y$4NSVC2I#`#]ZGK980D*[`"4E*[!/DRQ)ADSV1FX9\6\RU'%/Z7/F7 M-!^A(`OH65%O8.?M+2_9SQFON^G%?@?&MO@>P%@7(>^DG%V01&8\R;WJ[5RY M+2[0((:7ZEVKRTDSU=[!*N+@Y63UT_X)6LI=7:DP;9@6HHEO]7@%F15&U!5? M9L4P>")M80(F*D,GJ?<,1&EK&$OEH?+9F=L"SVE@JU4NQ>)F*.:V."(A6-[X M-E_0Q1>SFDXV5A2+3:@`^B#3H>K]!@.(V9*1NUEPS*X@0UY+\C+())P?*Y=5^VLPVG%WB*KN\QQ:0;O?+CCUN(L*8A_A` M$K6]4\@63L:42N'.]O(D-OIT.=\L!BGJ,)S=I;KZ8[,$V.)0E;.E(H.;."6P M%38T\=;X;B"7>*G[$^(^("A=5QC2JM;#ILY]1U?KL\ERG)YK!?*&\EQW"((V M.Q,-G!*86'(J'W"9<:B.>TD(5R"JP5.1]")DA<>&\67S#J"O#!T>$A><.C1 M1_>A]'+7?'SRPG,)ARAR^K.+U)2A[+B`PU9FO`O?9E]([XJH(TPB'78N[+SU M!2=`%)L(&R_)>,X#"K#2FJ!FHLO&DE1T90:DJ23AD2J?Y$\&:%LZQEP/B--R M'DX@\39ZQDY1'`(NV\STUR>BXF+K*I/B'&3P%%-0HJ6W0!2-JM?%$^QP3R?\ M:,(K^\MLO-!U7`@"3%XLQ/9D:#4[1Z,QZ7D/(UH.#2$DMBS5,-8I>041B@&Z M&V#SB>/TW79FR^]@P1XY;D+=Q73C\I9G5F!W2;:^X@]1U+(\PY:[*-)T8L2K M$F[/TLG4CDP^>;8Q9U_)?:T<$-!%MNK%W&I42GB-YMFGF)= MW;O[+Q(=/R(;$MKJ@^U)MC&":(APS]F&:!_ZX8&@PA;S^8>LYDT!5)8RGJU1 M2*U1(6"Y5!Q"RVUGF"BHF&WUO7)J>[I3">/Z2-41^]EF[)47;?:YRZT%T6R`P92U]E>HX$=]52""4X)21NEY M),A@O@7J[=!?OEL2,J8Z-2EUOU:28\2=`_)%L[AGSNDO]<+VR1C@SS9KGF$P M25H;:XX@2[LH])SNW]0VI5R[/_S,1?:7/1Y1E'0W]AU<-_; MG6B>\+V":X++L2TBX;!CCNMB\5M%!R8[6SR5>MK!6^EQLKY877F(7,Z,NRD2Z0-4!*O)RN3N,M*.=VHU.+(H#-U MFK![7,]SD/L*5LH,!,](!I9CJX4O.2-IL$B9J3_%_?UFS]2U7+?V#B5MJQ48J+$! MA/8J9B%"B]96>8<"$4@1(L.KXS5I%$YC&K($)*D/=9]*N:3ECU5_*]%.!,E& MNP7H;K)QFE%,S3*`,3O-P.OYS.""T"T'F-)4WV[AVC^C#$?%M7([,CLQX0ON MW>'&5H#W)+$7I#9E)`5:M"44S`U6HS,E"O#W MB$P1>N*26M!]?KQ2/EGRJ[5L9L4/DQD.41LG2S+==IQ6""X>+^=89Q:.R%2& M&OZ#UV.<$3)7.`=**F_"7S$1IP42?4(-`M?]_NR#[TN(>][Y4UOAB=V?V!BAAA;6"K^7&`-9A?AA*O=-,' M!`HJ6XS5RD>(^JGLC#>(PQ?CRN^IW]9$)>#!07A,L4<389G!+0,:SVKO1+[5 M*F4[ZG(OS70CO4OV6>:1H#H4?BL6V:'_PV9\JF8&%,YD#]HE2N=(1$'!.0>+ M$#+C:4I/&]5_:6ZI`YL9T$.IU3OBG;OZDRZ-P8T'H9=Z>4MY%-=YLE^Z:M6I MYQ`OFRIY\88O#.B/E[XV6FI:[U](9!=6[FFK*5P9QMP^R< MD"+<7>%[FFP=330-C6FJO%Z(F)YD'5*(!8M1\G38[I+`+?"BH27#6HUY1V]I M?0*38QF"8Q7X"$+I5`$.G%F.@>[:D\*Q M/[YMO:8N$>QY80&SW[@WKCO8:"LB/#$QQ$&8@CY$S`HCQ>.>5/@0>*#T7[!N MAN/Z3/(:I3;B6]`C)>O381:S.?P^)V/4-Q![VX\12;HFNM/6?1IV(&]W;WM? M6(!A*PYB,M?K,"0!4\-2^N[M12X(EU`[^>78Z77$M%CC+5+CM^B0#=.:@F*"PO382. M^2&7W3-U12,#)8*';95=R_T^'+[KFQ#&**G\4`.*Y5/Y<\XNMQA?*_+*+GZ`E`WW<7XS_)9 MD&X5WY.M=EJ4GQDQ=C>>LM/*D^*C/8D-=E1IZ7P"4XYKI3_I664V10M1XXUK MZ5J>QWWFRU[K%W&':U?`;W=_>-`W?>_?[__V^(O^;R^??:P/\#W=B.N8=]1#MT84W@,XD5[.J6[K#<0)X%X&Y!PJ,*. MAN\(+PN%?*\0I"+<47@09&].`>T+O@6#[Q57PMM)@&VT)]=M&A$U$RHX1O^( M6)]N"*+&R^/9LN*5,S;$8,O-/VY7Y\:B`226YZRZU;9F`@C5N+DE6S+=G*%T MK;A!?H6*RO+EXW'E.+:T0H_20,*NJ%[JAWLSYB:JK8`28;..7_W$?TS,^]D^_@$VB..NV2R``SE*^<;=`MZ[P;SNVJ'D\UJBKHM)W(\1VC-E)D'E+QS^QR9#\486>::F"J4^F!'C;,`3-8!>;T#/%$8OAY:]MUPB+%G#?>LY_97J8 MGR$02ARC`)#^30!"D"RZ%/7MNJ`K0;+,`QG0X'7JSF;R5+&B5A9F&$6)D/!N MNVFR?0?G9%.7R4)P36_TMK;'YBTX<.I`YDJ/5=NC0LB8V>XU%2@>5I\ M<"K%.IBM$2M2`45/T(KMA`:*O&,I:L58?&2!D-DT><4H$V*@_MF=;(2VI4A% MV"BOT7Z#^XNIV#D.!LK.K#8L044%V5#-NN/,)N3>3E=9#J=Z?\PIS99..8]; M-P,TCJ&;3A\\DF M-#W!,T''GKKY*5W?\+PU&3(*&AOYD_YM*V]`YL[D)2`^>X?',;=[DW8Q('5; M7^XM:X4T8*0OSY0"N:"%WY(N;@`:\GF+*VA@\VJWJ6`8.7C;FP&'9!X#]]36 M7C_B]B'<`XGW.&4=U=(-X\2:K;'(U%`C&?W+_;8AWDZ:"Q:HW6D#E*H1#,^1 M%\PA4DF,(DG`P79Z+WPB-PL+;A(6V7EZ8.!.+__^-.537N?DC_':TZT3KL_2 M"=?4_`H5Y/Y[ZM8IXF$^-@BH#>?)0)GX^$)?ED&6X0!L1[_`+A>Z4SBG#(L% M)PAVI.>B009;&P^D;[^`L/9K[[+P)U3V6$UHQNGD)SS:,[Y!9/JA:BLBV/>FF`Z/62+LQ_8`O01\7B%@F1SA16? M6L(>\B8P[[,"\4TFV$MYFE@Q5XM)M^1;P_)83DFSU5IZ0<],C/"9RK0:2Z;2 M'8O)'9E\3%Q.-Q-4C/R*P\YJ))%K6GF[HL)?_1#NLR9UN MI6_]5@'&]MNPT$8G.70XR(XK&W_H;[?"!VY^#(ZVX92;0B_*^#= MPY,N/"[JK85@`*IC<7(JV,%X'O8&MH3\#`]0!\7=\H4E4UO;2YJI&D&%"E3: MIZ@CXD?VPW+$@+1NR31D$SDW%JSK<.:3'Q<@2II.DG8?2`R@Q*/W(T0!9*)& M=9!R&482"&1R#Y!*VQ%%Q<:8OK56-]P*4_*4#!P.;/-WM/"H8Z*_P92%?"T! MRU?STG&4#@2?='!<:C6;'WE*))<(J;@^:WCQ"T:EJ.LJ^G,$9$AEN6N%_[!2G)MZ-%G(C MU?K)&P%Y6\.F/;R*[@"`(O2K7?%X&Q=]YI"P(CLKG9BN`2D1Q$P-V,+DF'<6D`)8#. MP0.7<=V[_TM>M_J$(U6[A_I%;W9]\NK-X:O0&?^(=?WY'[2N8;7'$3_/]5J\ MFMN69'BTB*-_)34F6[,$P1)&7$#&R>+",#*0N$JQ#`;(-5YPJ7&;;N7()ZPC M!&/[(_<`J>=RF9H\H3$KSB"%(;(.Y%8$<:,D-Z]9!*G& M%`?Q_4RNB?&$G7735J,&S,$S[6^]08QYF6/F?=->,N"BWIXPI%>#22MC?Z<> ML`-BIL$@I5E`V_8],7I;\IO>MVVPPD/=?R&.Q@8Y1KL!_(4)8?-KP,CQB8Y)*L-@O?0&U,E31!E`4-N?S2PJ`VWE/GJ.AVZ_:D MXN8YYFM\KLT+Y#!NR1VW@*,\+:8Q*S4S*SZFHK\3.7*XH&.G:>X^`22=X("" M>2X<&[RR%`LY#8Q8W'FT],>LDG M7-YNI3K!D=.3[L[I"5VC@.$M-DEWZJV1S96^]_?KG# MH'67:,NL!>PR=>)(IT\G`8>TEB^'"7N*4/8IR">V3F*4OGIH!0L9GZ.GQ!@4 MTYB!AU/!F(+Y]'&[:&$?9DY^78K/VS`."TF/OX`K_3N"5OZ5;?1R,7DHD[[Y M_*=B:N%6;=GL;MS'W3*!+2YU8GR=0BHO9MO")J-Y^_TW4[%7L>X'>3>NVED$ MF-#=.<2+$A41TF M6A%-U*`-G?,-;6.F$.KX9H'E-RT"MRQ7KB@F3MAWYGAN[3^,*^ M+.UTNGW_<[MGPP!:.[\C20@IM$ M)K2(%M*)@=@Y'71#1E\?1OCJY3*_RK= MU?85&W;E!6UVX1(VCAQ2OQC?MX,H#U$ANZGMJ_*FMJ\B"+Z=9B0=DPQ?+U)= MUA?(7IC1S!]([BS8RHD<294R-0_44>H7]ZZ[P>>K>8';$91)E,SS9$D# MWROY$._MOO+6L1#OG5SC5A`NR(C.,#HR&WRMJ+=CU=_'B4@B4^YH%KB4/&:Q M;#182M;9+2X_1UT0"!D;W'()>.K&F(88I8=Y*.1/'IYO9,?!@]LMW^YVCN3# M???VYI]MS+6;6'I&%C$?U(:\SO^O)E4[C0\WH-IWKS:APN4($TH$^]LLI>/6 MK'";R.-B5QM%>;)]V_GQF4)X(A700O?V%#J!UEM]F3[@T5 M:"`._W4L'8NOIH!4MJ,'C)J6"JT)<^_._?8BL-N??^[W@XD&=J1>8B!L^-LL MF(2V,G?>_]S.#+W!2X3<#NFW7[X^,'@\$H\.:A>:7JT)H<;OE;->$YUE8X` M<'$,1G`$ZDKW']^&?G*(_\KQ M-P)@]*1*7\L)=0%^JY7J?:V5@NMMDDR[9UJ7"E=X-"Y9\/B[?QI9(3SCM1:Y M-JM&=T+KPDU/5<&)RD"K:+P]6NCUP-!0Y?W&J%1BR*Y-5R$1IK3+GM#=$\_B MOE1XQ&J(X"`1SYT6"QN>*P*EVWEW]]'>%]76CD962P<<2]"4\/B4+?-8UOR% M:-ULN1:05I&0D54?W6R6O>W:HFT*O5PCPNH/'1['=ZZK&QT:H/_B\ M7W_Y8.^SSP9J0:G6_.)NO_5W\*_%_,1YKZ#BDM.^^2C:4V."[L!OH'4I7Z3W M.V?7DNV#K7<:`P`9&/=VSD!%?-0"+W^2$<^P7O[2ZX6'G1.H/U![77V1C$HT M1^QXP!N`U9U(#@<6A>JR0-OO;>T8Y:%/+;%4.EIG_1V47R7;\?YG`\?3AIV( M@IJ*/9M0>$$;SK%.[W-"#,$4''=7ET29F%`.)6W)$_%P2_7MAE%.9^A'-4FJP*F6]BGU;:%8K-KK5C6>6YU" MHH6?RA)DI'("/D#R!Z5?@"*?E$I:VR@1]8!67-OE'L#X16YE./>22/_^2R.N M<[JQXP^`RQ2.EDLR M65*[@7ZQHIOMPBZ-WSGL49R*D84$CBHO;ISP'$\N5TMYD)H2JE/=->>U!2G* MIY@4<:P0ZG;[9T1,]9T899?7<_P_AG4MM$Z*%32)\N-?EB.LG,FM.Z8)Q MH>X&.542O)4Q/CC((8E>MT_*I6#@F.)EOT24$IO]]A+S,LS`0ELS!N,!&BFW%)`W\0B9`$BVU]^4-J*#T:J?%>F5F0$5+>9F_$];@AST17$X,95(8;]P6.U.HPC) M!QNV0]KBG0U\==O+E!5BRAG>9\:.&?;Y`^"@X!W.A)%9-`_"#EO;,\\H!-8/ M]>YRSHCJZ0-=F:W1QYQ0D[A+J^64(6(*#;+$3"&7/<^6PBJ;( M`G38/W];N9.A2J:,;9H;+1]XBM]L74SFV4S;;7:RC!RF^0IPU+6E#^ZI=^*9 M.DB8&3KRSE@`D.,\!!=D3U.7FY$Y-JON:D@K#WX MB84D(F$7):,)U"1,:[:_F`_S;X2>D>77?A("OAVT"G,GZ_XYNR3B`>*,;Z5# M\071V/MK=ZA+_Z""IJ?*3[<#<_8QN$T,7I3,,Y9^"631J\,-O%Y5`*-+JN6, MDEMCWK0&#W@]?V)C^RX8(Y:<71/O5/,I"4D2;*+W?3Z9[/(K8NO,GFDTSZJY MJYMULQ7Q!9B!1M<1JR8OU98*N1#V+JK!($KH_JC=4XW)5/5@4 MW/S=ZH2VSBP3B3T_IN`U;"L;V[2F[X]'1E`"03[;Y%B1]GRA_3>S#%)Z8P\Z MB!E2W;0?*M$O+2V4^^4C-+;+>A(,;59)L%9*FAI^Z\2\7??IP?4D!P1=^/(0 M6B=2=I9_R-MBY4SMK4&5KV[+AXY4J6QMENC'`W(@/DFND*N56^S)]84^X:=Y MYXF$`-@079X9-BXL4I`^^SL;R53%66%,2.,K)59.G\-_5!`L[`8(?21T''=].61M)T$BZT$RD)(N!3NV MZMZ+"-O6:YA<)YS7B7I1]!`Q$AD#]DWWW!&\DPCZMN&KW(2+'8QB((N;Z!:$ MAL`1;.)]ZE;Z"`R!;%@4,%Y_WP0ERT%=\4X!O?1N[8;,Q%F MH@K';3B.ES%+)H%)2M)Y+I=`<;68%K\V%S5V\L(.5;JYV<88I8*3DK::(4MRLD_Q=)S5Q*`6!@M>2[YDN'J%\VFNYTW<1S@XZ51X8!E<0)4A1?CZIOXHN".#_2]Y`/.#J0']NFQ#O@-,_P+ M7VDJ9)L+=K2+Z4Z>;2N6M5B84UG+Y_06'N2BH;L MK(!FUNX,C,07VEB1ZLM,:_JW_OICX!/9D&'G9C!*RT8!^OF[EC`^QP5H("93 M1D4>QIL"GMJO+/A$X#(C+O&%#1;A2-5Q'/Y-9QVQQW'0<,^@;'M^&.[U[PTJ M"N'TON&ZC6[.*5>,W,9=S8W&DZELRF*9Q_+0SQ)3(VW<8;9IOSC:2[OB67IING(W.=]VV<\7` M"<+7?N#HA&'@:AT),D#8/>7V:["LQ6N/NE_LV[V2LC#3E^)P8XL0UR]D<(FU MQ_6YKB,1\-OE_F8#IUE!-=J)#88.H)4\Y+>:R,,#A79=:P)WYOO5DVRV4J!M MTSGRA%S9*&-/+#A1"AM*J=V_S)YNN]HYP%1SV!Y0Z;*]L)NM)-^LLX`C<.X_ M]4T*N_3#HGTZ3@BO)//!&%Z'-X.-/HS+%5S$8#W&'>?%B)K$L4]A&%K%+MN% M/TG9Q"?7\O6::0ZX@?ES#K%)D>!I6Z2Z,EE<,IV<68-]RZJU8I<+>SYCBN0@ M+];:$GNP;SI9.7CHH*1OOIDO9V>;1A>;0\CGS?)TLT*11"L/O-85P2]V>5O+ MLI5%5,D'VG)T):95.:85V5P*3A.; M%.K"(X',^4MKF&(>6E5LF*T'I$==<3>`5I:YW-`GL;#/VEL,+],M+/5P7A/] M)M+3"FS)6UL*A6APY\*AK16OG2*(@7T*2?>VUO"*G>YHX2\W,2\-M(2&X7)W=GJQX[>M&(5;=@?VI>4+EC]PT`56ZFC MN6(:R9AVPGIL*JZ>-"LY,;%5+8)(TC7I^V]#^J?5-7F]$NE1TIHN5>D.WEVC MRE`IOM60NO+!X9766L`]BH]%@T4EJ<1CT,B_O9/4ARE.;ASD;@W9-Z$XM38) M4D'=0*FTPM94@Y%ULX7`/#QK.W2@7``=XA(JB.GL-J!8.P;^DY=$\*>`J:(M M2-[`1^B'?8`A7HDUF@N+^6T](S?1,T>V\ZAQ'RMI5["0U!(QW"U%=. M;Y8Y>FD<85__[+)AR4[A7%LT"K$5Y@/Q/LW$\1`PGU7;?L*T\N']#T4H&'"` M&L"OS<7/>"4+W\CX.D7=S,S*L[1X%>I,@?WLF`F`I+=@2@3'I"BK-_6[ZC"R,-TXYO5B[&Z'GUPRS]9"@E(`640J[M[" MP_0\CT.G$,PJO:$1#X_CF&`<=7&:D;XF*=V0T.4VB,M]M/EL?S;GI/N?A53' M^`P+.PYN9>&10PUKH"@<5?^RENH-OJ1,?]N"DG/RYUPG!)5@?\&Q1SX7ON%#FPNHU.9M&6_G.2CT5-B(BW7Y#+6>8E&,URQ>: MXI]LY=0A5Y1DYH1/VA.L%ZE0O[15UJ%]05@RP(VIV80*!(>2*LR:'RMLQ](( MS7G:WA%JT%'5)6&L0692,9"P:)OJF3LM`X6:L,&Y:H"[QJ4,"KC8Q>:R^VWU MPU?]X#II0_X?=>>Z&]=Q[?E7(0(9QP8HA=W-ZYDY`FA* M6A)CBB2:;,G*I_,*\W$^#.`GF(?PH\R3S.^_5JVJVK6K2]=E MU;K?"AE:W&ZO!6+/&`-+7H`_)D><9+1K_*:Z6YR3>6XM:PQNKVE:^;UY.C=, M'8B[V9,K%$$DG&,I8?VXUS/Y\(H2T<4>@:9ENT^B@X4O0@RD$P")EV!]*JB$ ML`QN?E.95J.HN,C-O2^VQMPPR.N1YG*X#ASN.3(*]5)I*JF]J8QQG?>TVVSRJ`EJPU MX%+UY549@_>7J?VAXQV:EF:[E!"R*E/#.;@#BN[Y)TA3+8M#Y^5,DP&)IY5W MQ.?A*>+SVK9N1`(WQ&JNA3ORQQ@:$S(D2K\:SAX%U,>(A\Q4&_SMR[1]XSO! MY\=0'.\9E?".AA(&XJ$>Z.#^*4HSRA_LH.\19("0!F-><83P/-FIO"N=;GC9[.#$+IBU:QN7M.];0<)D,**$NK;C%WB.326^5JLM7EM;R^ MO%.S]=9RIX[E"AM-W-#2<^\U8.`P>CF:)YV,5'S>"MM[DL22? MRESY-)B7^D=J8I[/LA5(W/2`VV#"1!H63"QB"MW,'48,P1F5-*>15+)\);>M MW/FCL\5`_B>02^Y-Z/*T,5]=(3'9;XLGCP_+F14!8E+"-^TMR'.&A^F[D9)C M_=)-HQ&K)P-=AD,+C]I1%*,KB,`>23C``X8V=GPD(;9N`B M&E".0.QCK]"EXABTKFB/.E[6 MB!JL4O;.?0_.X*ZMYSEZDE]X;''V#F4?U"K],)).:J&I-DGZ9EF4#LK@I50Q M0\:!&F-"*6$@V`Z+"L!)!W`TM!7O%VTIY6C=FP3,.Y/=("YP!]J[E!%G]+]$ ME?-E]Z`YWF[!ZG">B<03VIG>[5D.=ZFJP,GW<1?]C_PC?XK;D$0P^P%#:8F< M#W#X6F$G&.[8\K$\0SEH]*6HKR37*,V#CM1-QBYPOY[/?S#=DS8%IZ@U9V_D M!X*`(HEM4,YA"I#%=^$S3')B!K+4(;5?"O^5=VDU,6).))A2QNF`9(SORBF> M!??UF]89>\YE+*0(Z-8`-'E,2^\&*I[EMY6ZP$H^JJB.`4X8T/$OUSXPB4Q( MY:I@-H#&;S\*L/Z'7>9DLMV\*SGPP5:/D\7C//"*[<*;`&O>W$CRX`$!?3Q+ M=S"MIT(+A&EM=*).#"C!(E1P`:A>FJ\4EME;&0@*F\,.XB:?DG\?JG\I]19. M^V4CMH3HI,RI"PGH>]WH:(^?`1]]--C$8%W#+)I4A6[&I'@J?@SVJA$&4'9V M9/A'.DCT3#4G*N-Y5$#9QRS+DN&<"&(1\.MH?,+(I'6:7[47%8H9&K`AZ*!_ MP&"`E359%A2OJ8+?C!ESW\+Y1&0L1(XL"P@M$0LM21PR4YQPZ9)^_VR58!:& M_8Q5,-5H,IA@12_&_KOXPZT&"`6_KLY-><^.B)N84I,TC^HK%QKT+Y<6"6:V M54`(V++N;UPP`?1L3MA:\9?%Y2=21P-DBR5"@B.UD3T*U'S0%G>GG7D_( MR=S"S5QR!)XC&S(S<=^"M)C0J6\NV;I;XK`ACE])>_SZ!M[TR=,]\T""?E+` M942C`#/VX%>^YP:!,-PDLM0-2!(D#BW-P(?&^LK7U.P=DHC#COQ%W0^JZ#Q.VR-02(8(?/'A%H5]Q@8:E:9;W&"U.AC>[.2*+[ MN^Q!$YSYECC1.3X`B6&[;M*4?;]OZDLU3O1+,9@21:AL/_-KO>Z*?='4_4!S M:L(/%Y# MAFIM'?L#R5H,LJ*7#C^246^L5?J48L*&T9@\$F51$`7J=,D:.`^[YR6\+/T& M3`O+>HZXUECKB2E3B"IX%B=M,COT7)\K/`E`0P4/4(G0IH9'\1E$9,T$Z(`H M7#"XP/>-)^D_$%I*:`$XPW55="PT\VB\:-7I#5V2-^3K=A>T`Q>[;7B2X=^Z M*6<:[K>K$M#*QA0HG>5MDCX0U5"EL8)+>4:1D_YASL<].@_Q:"RZ/AY&'EKS M40K\FX*[E4U/\`:ENW.?YSML/S_$FH'LBG/%T3E.$1XFSL7IPR/R7T!M60WT M=#_%,\#QY`40(KM9<-"6RB.G^_72,G_UOL-1A*_D([$4\3*G#9`Y#AVS?1"U M,!([6&WM&OH=I&@&)R`4'BY>3U:MT5A([@>6/O>J3QRHE4_`322+#ZC_<][Q M78M]+8^R`P0XWB_:-O))?8_(V7>S23![N:!27!%!&W>(#VI9W?=./[]8^W?$ MCXPW=3*I:1WDIKR`HZPF8>%XCN2T^N.5/$AK7_YN__4??P>[5_W6PPU*N'`> M):OK^F&GX\&7AY=7U)#/MC:^^M>TI:K[\MGO'__7Z[_)M/ZWWTU^VW;/AY(1 MP.EYT2.]5+PL>&W?S0O)Z.?P/F^%Z*"L%OEW6F#P!54%(-%@?'X%4%KWG?JO M9^%XD9IPP,[2"T2DT>!+9%\>BU#[6)*%D-Z82B*V=%?IL=UP4+\J,N%E+<;? MKL=G97P]N)DBS0>'//YTQW=RA@BQ#I@Y'Y%QJG7?M1BC^D-6 M;)B;R!+\#.1$Q_5:U\9IGN/``QY#=ER1=`BB4TNGM!3KHOR9AISUY6@57W=& MOI7VGLV/%W<0GR]_9K0E*=P&XM<214VG4%1V75?H^G>DJ5>6["NJ`L'V4\K8 M*RKD.7EJ_^$=+Y9F]\-"\JT4+SC&A2D4[5;^T916K`LUZ18[`[HJ9U1-UZP?]2&O$=W1NG+LL?DSTR7UR010>#(/.N:J&";.0Z3 M?+!D%OU\0:(%].0^D=Z["?W1C9;.G,TUG3>IU=#2W\>0M4PBSFG^0.&0!_TY290T46NE92&P`PJI!_IM!"@,_A4$F!9,M4B/R&X>/\M7 MTE?ZSMJ?]X_E^#RY^3U%3XXSW[$/GUSI-V=G\\[3^>M8\/=)&MC&9$J!2NME?'X^]`Y7S1MET* MV@ZQM3[;[%QF^?!A^^(!Z>Y^%QHX!0'0S%*9=NUK.[W17B$[<&M)O2B7KXT6 MBY8P;J.TO4Z/VO%C:S!SHS+%4!I!]=&(Z(QA4,#2+K(^FW2`,)MV M+N>6K=#R/@EY4N1"JW6;^FVRV)#&MCD)B&.0EA:N"O&AED=JYB>4,->W M.=&`;S2Y6%7388^+9FW0(0CG.%G?W>U< MFFLL\FEAD6O[V*$5/[+?]8S(^)*T7=A(NY!?,,0MHFCF!RW.72]+YG&[+#U; MO2QQG-RER81/+;E.&M%@&K=W$+(0;Z'^N]#FC_F6R18P3U/&V6G[PQ\H`4%/ M;!]_9Q<8MT\/%"WZ6IT-VU^\#.#+;ZG'F%]_U?[Z)WG8VH<5"`T"`F'9ZEA` M`*5V".N#/I8X^UUJF!E;I7.H7BJIQK^KN6D8WL;IN4"EF5;4_>(U)W6,92-$'6X\V MHDUK#P9V6.H=--QTM5-[(Z?&%,5,1=P7*F)+JJ_M=53E:RXDNOECUI4>&RY_ MOJ$F0%M^>DYN#%K*VL'1E>ZC1)Q[KPJ9EFHX^LW3^,GZCFJQXR80$R/O/ARF M](?XA8"PCG.F[U0@J4ZQ;-BN$PN@Z$P.J8F5M#.4T5[.CZZ@)X]CXHZ/JS`2 M9JX`4MZ[>'KT5.*.1PG&S398UO<^P;#PM1EJD\GOEZ%$[NSH`EMF&;$P'#6Q M#VBBVKU<.$+KS^R,I?K?_9N1A!O0]!UX6ZW'EJMD)#:'6UW"A+H.Z,DQHC./ M6(9?D_GS3QV^4(U=[54S6`9@F<#PV&0_5_](%[MYAT8C)C2=6E/@7S5XZ4/3 MC([.9Q!?M3]CBR3_J[8GQ&X9=Z6T[2L(DO+0OJR>__D[4US_,A(F7Z?C+SU;*(%.VQ%CO9V/@B((_;`HL?MQ8\71:CM6+R>*()RXZW> M26/C!/`[GA],=BH.#K()W65(U%&1![/2C)M4"OQOHDPCC(B$N>VQ2@=TCDPK MA6)5P[CLRBP+Q!#XL9B]MT]EH0\FCW:S7%'%4#GX=#X`G$62PA%O5:'CJ0X(I\-Z>H) MB?"N2.#T*K'VN*MOX=WB;"E?!QS\28?]A_NK%VC>+HS>DJ=N-]VQR M;CE:;_7PH<=AJ?\A.YI-Z%#(Z'P(0I"Z3=<>X(,H4YW:I33)P-V3?L5E?;N=*$:46^:8)9 M-%WGQ%D(/R4URE(2/(C&<$AA0=%SUP?NR`H^QN#G:VJ.WF,1F'1A#_-GL>YZ M[[IZ(KRJZ,5DU7K>-;M)J:>N4<(X9+)#N67L8FOK4`:TR&J+SE);K>"?6)76 MR&E*/C9MH-0%ZPKAP&QB5EIEX0$58TBXSX)BW\.U*=,@6H3"-XP=`6N-Q^F^ MAWJNW^'=E4Y,BK`V4)&=)7DY@-X)94VKY)4H/$BI(HFRWM/MAWZPI&G:T1PV M@,U-W>"PUJG"@S>2XMX)0\#;?+25&1G`2U'DX9:NCCZYGYB.\;JQNJ@N2(6M MDAZ7^D)(27*TY>Y.JJ\D^:4K%U43ALQ7D:'`DNU?^@9C-H4[`:;A/RU*P!*(ZSHUHO(5QC92-BV>?#W.RR8(S2&CKJ52J),4`3*:E#\5SZI1S%EV##\#J285)0PIA M81Z-:8MA[TPI>$TE__NEYNJD2_E&NJC1_[&,A'*O+T;@%*LT;@1_"&S-1:"?E2XB5[1`N52#VO&P)631[2Q M8_4]S;NK!PL,1MQX@8AVVNCVWOS7]>8R'_54?G`U^/IZM3[:VQG;J]E8G8K:UU?'+5WDX M?AKM#%OK.[UK57;6)YN=B9]$%X"Z%IZC'H\ZV^E$^CQ+H;^0V6PRWNBW)3\Q MD+Z=ZK!C=[;OR#\SZVPG3`\$+5$)-7.6ZQ5CSNPWJ1_./_9'FYDK!E>[30!8BUS%&K$T?1?F#I022,$/ M\DEB+NU8R[-?,6:3"SJS!-Y+C=@0?(-6(NY?<`/9=#D?&G`-TGV,#`]J&^3S MY7][F.3DK3W3G1<*Y""^1_&,AN-&NKDX$YZ328&D@L7B&:8<">K%J\'S1O7/ M`A)C1M"SEBO\82/\RBW*>!0'JIG7\L)ZO'!:*-!F2D4K!L-)=X!@^;N1HVW< MBA$F0Y":$)E)#[,>^*@`:[!]N3\OU:]/1.'L+U(:75&@S3]PN,JJJM#R1)XL M$0\)<,'-/68::@'X&`G#^CR+G')7^=D%(^'7E0.%(]&^7$MK=\V/U=I!7BDW M;G?6YY@57\UW@>2)MAV*M9#^1Z?F]-R_%96DT[<'""&]U2&*E>P(&T9O*!,/22SE&AZF+/Q@.B4JMW0@^"/[`8>^NB+6'0KRS MDW9A&X]FG55M/!+-M._>9Y+3,QR!8]@P36?`GO^H3!(D("H;DOI(`$V".=F+ M!^Y<-CY<88IKGY50"G&49=YJ"41P%3U8I/]06H!`B=4K,1()>A*;()H-`6%B M\!EFENW(P,(X(5M!UA2$&5U/8#9>V])@L>4.V3CSZ<"]C4:U.B^,DCBZ+6CRV.*M09PA%A MF'UAXVV*67#(%JIH','.Z,E;M-1-.:BNKY9BUZF8[4!^6[NQX("D1T*]\.7D M66=,U8=A*\L'KJ+J#SHY>/S5.5F;9FS>Y)M2UGB(-YKTLS>T8B,2IZC*CW[* M9C,=GU$L#!>D()AIZ/Q/.RIKV%DG6AGR6W<(?<]\5`P!./.95'EB6::+P!I; M1]@=/LE:MS-R<>0/7=)FJX;-7E8)4O-N+2X]KD+GAR]RD"@W4$"CJ,^.@U&X MOWYD,_B]6!S2!3)-7=WL1E#6)J54!*HD\.4Q-=ZXS866`3=6ZS9;8@WT,`"U M-,K\1_+8!JYZA`?`HOS!F\+4B_!-#X=JM\[JV`V,(M&'+618_D.00[Y,UNRL MS3X)^DF\0.0"D<--!4&IPM>4:&65WKXH'9+\.]Z!!V+.553?H?Y_UW?E9+Y(5W%D'(4 M2*?V)BQ?"BYD:&B+XBGY)&S/B7ZNH3"4L25+Y(X04^6@;Q%0OBF&+C#3Z!OKOQVS9-Q)>[;*W`UQ@H M[76TO$"0T2YHTZ2B-&5(5#ZR%AF;TP`WLW=/9#[X-HTHSTLF>^B\4#F,#(CP M&[?_F(A@/Y]!SLG6J?57K69F"&S+:BBZKS8\<5EE7X9@8%%7:BAZ"J*P2B_E MJ,_+Q>G@B62KT>J;(SFJ`7I((0-\14@I92OUS.(C&:B2=_5XQJ#QU9VC>8E' M>*%SCD7:S_AX%1,T?AR3\8Q`K+OK!."HJLC7$-63I%$Y]5.'@L`OVS30`R-0 M%>#N6Z'_@&W-U$!X]:76S*[9:J[CF6RE_*>QXZX/_N>%QXMFC;D]*_I[7&$DI*]MYS[1&+S%/V''M04&S'/U9^_V.UF4R0@- M3I!:F$1GER8G7=@Q`/[54-K:,9;RLCB"D&YE-6GF_K*3G2P6\X]=WM*\51_` MV.0BES+HS@%`::TH_Z:BFH'T2B@M5&!5ME`SD_1EG&Q*E$A`;3;1GJMQ`BN?Y!3X40-9[^B, MGU",&%2U7WO=5&I][=89!\C'T9C5EKW/`D%<^12®AL(@@)J0C`U<+%S]$ MDAFBU0>SY"+E6*I;-^_85(.LMIHQY:EN4UIMRY39JMU(GY2`F>]\1*`S@U4` M';WL`Q:`^'"+-RW(F]7U2&G_Q@]"Y@Q0L*`K_P56\G09QU%E?7WJ42Z93I_? M(/@[X#0X_-0/&&"UK.SQ&'8K0#>$269)MS&!.DQ>YS.845LJSE)O3%U'*G9A`O(0G%ON.:,VPI")#C) M@7B?RXS,S"F\K`.76[F17(^G?F#UW?+*40.QL&?N(_G5CN_RMF5>5/!L-Z>$H3P\]$NH!D(PRTU8KD M1V;Q'2*;5$*S3D"2BI7J`/\VQ[>Y`I1_G[5HUD&Z:7_V:>N0ZVM5-=^0"F\V MSH7NR#GB'JKW5Y'3A/$A_EGN7K2:2E'9]=*R!^V.L)Z?N=O:EZBS$FE4*;VUL>ZZRP&>S\GZBU> M7M5K&(J;"`C=(!L$=>\3J0U>/)P,EN*1S=4B9;F8$IZC%J@F%=2;I+*?X1N1_95:;SE!:\Z3-Z`!58+`DY(/9 M+'4DJ:[)F^+IG9K&C3(#&_"Z7NKR4&6\CL=^-))I+\`*0++2HX)OINS0$F@U MHZG\%+F<+,Z.Q7Z\M7"&2>MM21T6;G&ZL#MWD+CAG$?*$D*S6NM$'0F.#YP( M'#AMF\^U2_.]@V<#1$SV$6Y6<.\R"5_=44DP,MBY_@YZ2 M7GG"GV=_&A:N+M1T MW@PR\Y:D11E'\Y^@'+L$4^G,UIR`H?!C+67UHU"A#A!PLZ%L6G+.ESI`C/A,\1K5Y0/%_3];L'4AJWW&3@GVP9Z3Z6/:2N58P#+I(^KHX#A!V4K`ZB M*Q_9DWP^9ZY;,&*FZN)!B7\$.XA.-J=<;GN3KM4-EP+W_='FB M;0+>5^VFU.DP#7HC*`MV#83IS&<[,`B[%NAA`Z!]Q?X4](?-L%7Y=N`=S`,# M6AQ=?1I1]NU)>IU0:%^=.(0U%KLNTNC9<2=)KZ*&-KC#J@?G#W M=-((;?)#?HN,2`@Z='J#\G!3P+#ZU"]W=ZF0RO)2` MUSUC8D,*?%W)-]1^.NWU`9E,UO-;C3&+R=2B7@G75. M9YTAIY/UG5[_@ZR(Y8A)(P=G5>1!@J0D`QL3("J)5N/3 MSM@9C"G\/;:^VE@?+`7Y?>=*!DRJ79=),0),E<(0N@IB=$3)=YT<^'N:@0QH99W;ZN3 M(K2SOK?=(1?(6J`C'_)7IM5LC]-JOK7+&O=-@6^I][GB=!N["6+/+D^6J$// M(__$X6A//?V$VBWL,)@NR7%XIK"3W8FM0KNU)V9SG-P@SG&P94S(CT'3[S@F M"H;04VY0R]0H8/C$OO2.`:J9P/QJCA*F5]_I',E*')/Z=V6Z+?=]0B7Y]@3L M(CC]7%%6_(-*1/%<%43;O.1JBP,+46XK,(WOV3@`,VPDRV/$/V,K`N% MM,>-L+$ES+L]V4R%&<-YA&DE7P`WQLW-N2^I,6*EGF&!"5>ESU;;,X.L.J<, M@FHP%%`UKT\N`_-O@];($&!CA:RB&0>EZ=JR96@'=*8F9P"\EJL5-/510`@T MX#KW:S,1]8E!IQG&"$.-5.CMVH/5T_:MB!&^O/3XMTV]7*Y4'M4 M`X+F!G0L4$?%/ZK=9M!1GSFP"*RJL:T=-.ZK>\,0.4%'H>)*[ M,:=]5P#V=--CXJ;N46)GGIRG+U/D!8)S?BSNA0N-*]WGGZ[%X)478#]&6KMD M`TI(&$>Q^0+$D=`8(:"?&F%@T.%-(F?.[4IMWI-K`@[TGE:TJ/[#4PAB[Y#L M:-Z.;8=1K3W]@NQX M$>&O%)2)`'"S$6QI@A%38YZD3UI9A,3[9I7RSI=^C6P%C\"ES'5OD;_C0D2O M]P6"`^JHA@]'Y9!0!+S(A9RF/*^Z^!^R'6G?W\U/C^3\^$[.XL4H[;_Y>76F MY^,=8PK-^PUF/:YR"%AKO`R>*(_8,CW'7T@@[AEIHQ9L%/=/V`Q8_ZJ%-M:# M(+2,9$O.*S-4(C3-F3.M0.N2)%5'J0PH"3CFE)7K$?>*_.H?(G9N#$=\O"#[ M_3/_]%7QJHMYI,69+SA3SS";3YA>A=#+'J4$E+U[PJ]FN%>2GU[TC$9C9\7K M_W?*[P,1#[6VH\7BD]CLP&6>V(;Y0_NINX$X@RW+8F[,E&G%6/@5"+>&).'N MK'4:$*@Y=S;.F0_A+"-`W+ZPNF-UKANQVN=C!ZT.+="U.N?!D0T/?:B)1-IB M:LQ@"YVC.5'Z;Y(=44YS+--^4BW>K"S-^4S,]&D M#,$<\(A+23/Q$[#7/\`^?&1H0NZEM@1DK&'<[EGM28>)6'9](W)24>OEB/M` MIQL,').B)(Z.>[+G@7#Z6:X6ZQU^FG0]9W[TO-$Y67Q(@W:.G$/D#',']'(Q M\_Q'%&;76?>[7WI64H6KX$@UDA!0P<011AP\>O6(+G&+4T/I_>5SB`-%J),-*/-#&9X>/`FQQ.@-)4ZVJAQ\L5:1Q&<0MQAMK4;$C+F2F\KE M8G`C3`RM1KC(%PZ=6@E'<6V*]*3U,FN):9MQ` M`.3V99]A+=22Y6%9MG'*8*VL#^=Z\[62ZD/ED!%3B"4U[O_Q$V(:,TQ.K@P\ M#\PY2D&;E8H74`N7OG89"`3W](8Z#G/,C031*U99FB1M3:VI(7KW&S#`[",2 MM$.1%U(X&@).&99:,>OFWA^/V%I!@KLR%5LEM=CJOF!\9-!:$@M4JVRL MBKM$KY*(KA;4@U4-E%A#0+\]GE.T-:8%8:!6VQTQ!3?#4T0P!V(-%VYS$&2V MCE7@$461()OY""?BSW?T0")YVLW].&*S(LVOP+X!T(8=71XJ[([SHX_7=-?" MFG);/SX'M*:#)5*ZS;GP/9V.B$]<%.<#:/'-_)(0U)$W(DQ_'\@G85K8FCI1 MV*HRHOF"7&"$@1J+RJM.J_&>@1YR^MD*/HOY)80!)Z`N2_^G6N, M*"T;J)Q7"K:+(&21#<0P$^ZC+)P+&+NC\V0/07TN)[IC("ZSV54FMN-X:?DI MM>F\G@'BIO*LE!:)K653.21]@D@W@]&F0*CX&O>2^T,(&NO\*UG"RAIQX(<- M"O``EMN?2?VX"C>`*P0:(T[83I6I5%W36L5EX_U&39F5;U:<'.:D<:RO`4?% M#O\9K<.A=!JN-RD^8K*?C%=#$'3DH.\T"2]"/W#3,Y)4Z@4EI]'A'VD=G%"4*Z!F#KPR!>H5N@V5#=W[\#B356:H"B?+)G3W=<4+ M*@DA_[BXC>2A$0](?'!^F>(?U=4.<1/)UN^X-X6<'WKR?$3:2 M%?!OOSLD[?-Z35?&O+JDBW_A.%D&; MOAY0B'<_D\?2V+N8(3]REND5?*GVH\Z]O47.+Z+C#"DANW[G[P7@33>$=1'< MM5P.X90IW*(O[^!OBH%B7@N/=(?3--B$#6'/W`(O.J.U8U MS"%K"(YBGU6.C-J><6;-BN&@UW:S`SS2W^%7C*7 MUF8+?CD")E;+(?^^=/;)33->*D)`[RE3F@Z0?91T`CIY&A3%@XL/L?WF\6=\ M>HN_8]>@>]M8.L'[+`,J+SM([LA.QU6#(\)[NJ;`B/1]^H.!0ZYW@14$Z#^* M$.]JI6[Y"B>T5B)$,X8.R>[36:?-B**5O2CJGU(FQ\KQ4-]ZA>9TT-G8Z#17 M\=8C.=`Y!DY[G-.=]>E>I\"=YWO][BT9,W#OCCP"F(>);OAFW!L;/=@<5N+_K[#"/* MN-#;2V[';,>A$MS_`[EXGC.:G%F*JL\>]]9V=SG>3C?6MK7\D7WK@=2N^#[?W$+0>T;0>1`=V#TG?DXE!4Y$>/?:BHNZVJ6B'D&V MK3.J0CWQP:%WS+[0XV0_&;,GQSUF/C=C'`&5DVQ2HRB8!2K"/1,EH/+9=K__ M`PFA'@M3BH=NJG&DSMKS"(/H#S3IM%0B;^J4//K%#Z,/=C<[&+*[TTM*0GH;NK3[YYY((JL$W`7G-'*:EH13]"MZH`K68K5>=7.2ZR;VP( M"NS6#*0"%A>:YB7)AX620"X_D;PW)*QQ.O5T6IZ`BUZHX<^XU55_T^H6G8@7 ML4_+M-(%]#'_Y8>Y*9B>#&K8?%CPI;,-3C&=Q!UK;)?(+EF.I9BSP),SZ0G) M%>D+K$8V$]H6K/17836W1[Q!5-D.M?9P"!1D/E=KX5&H8G]M@8Q[R%8_2FM( M[KG*P>2S$CBETJMNL)2-7"E!F;R#JRFDQ%W7H5M M=&@`KQB(Y55M:EH&D-F,F>95SYW*2==\C$\+UC2GDF=G++%O:,4L_QKRM?NLKE,-_=E/ZQ_;W["9\)BW3\U-+(_.3>[(Y[[$M(EIZ(=>I.KM3K2?[J^.>GH;)..!'\2_BESL2!,,>:6 M-(2G27E%6\_N&[RX_M&F:H!AU%=*>[@H[,.E@2TE*O9%TTY,+*+`T6 M9%VNQ_/->K)F:Z>3'S29/9SLM`-\3R&G]')ZVA=ATKXTV^T(N6E/:9OT!%\O MMV_2U:S6MV:=$]SD"K#."4YYNS/=YDY'@,]Z;TZGG:.:]#1(4K%&W'1`'VM/ MO>]="[F:AB)9`T:>4I1_F6NHE1,'OUVV7:?"]G89XCO)D M._3-K5E=_%K?[6B'CWF[A_A[W-'7&9N4.W4Y.SSZ<6RNU;_=8D\D+WO]=KO? M\MLJG$]O'/MUMV>^*KIXH<*@4U%7`6-+BM"]'0!/V!GNW9-V-7;=28X`FB MZH0F39N^'+\N!X^:^3V;$XPY.F\AL+T^ZWD\IIC&O0VO;\\ZIV'AMW;D MV5X'C)/=#D>?;'2X;^_K'FGU+JG;IM=M9W(N$-OJ/)ZN[TX[\@_5=*YN;R-( M3FB9VSOT]>E.!S9D].]V5)');F?//_\TNB:T,^)LVGFHPH$.:&GOV]/&-MU:H\"JWE;F6+N(^9LW*D*$TQ>VY,T%%9(8QO]GDR^T M,IH,^C2S[2\TE9FN+B?ZW2@Z^]$5&^52NM;*;<&#,]V,8YL)O[3:XI$EI4NF M5LQHE25OCCY<+K`.R?6R7:*&IW"N2O`]F=YEK\SE$-;-%O*3[-P=?GSC5:!YV88-6&=LT4+`E'9W^ M%2U8*S)S.U)@U0O\?GM6," M6"<:^`RD5WW'!6T0+684V!^4;Q2D)8L%]#P^8CD568J@7+#:6V)YQO:7JO.HIC%^P\=G6%W*Z72VXBNK'>$%L M3=PG=0W3B/=6N@X9)J__III<,[;B?)<.]1VIA\CH.531:,A,A9Z^S('RK\1A M"N3,X567[X[DK$S74P^S6P^'JJ#+(E+M"B>]6IJMS8Y4-'UEL)9U*T`$R'$2 MQ[@VN3RKG6/:TRLF/)=E/%:RI&JQ=\T@Z`63L00N%+(C2K0>S'@KCJM0JH&2< M7/[#JI51#V"6`)WN*+#^E\SD"1T]*6_NZAP"\;LF#9R-I,"I>EIJ_]F%F.6P MML(^,Q$@,LE^W/;-$?UO+!4,TM^60)7 MU!AXBN:IU9=*H-VYSF;^%KV%@Y(&KOC::.JO@Z*(#'%9I*`265+OSM`(WTHU M5HA>@B1CFP9(F*H=U;5M[J6=?8)Z3?\3/N3>]K2;V, M\QIM]EKM;_5\L[3E[WDA>+S;D?#?*B`Q4(O;=9+:N[W; M`<%D!P]NY_D!+(`'*NFF72$Q@HW.0J;K MLTGG,0;^1D<`[FUWWOU6S8@[4KY=09-"4BBB?=&N_^J=^AYNAXYZD/%=0U:D M.Z*TEVKNQ!6RI`2\'\56.LNKQFK7Z&^+,W=X2/NR[N39[&T(/-X>$W!?7=@W MUC8()9J16K%6@CER`7/%L)*/;W)9W&28H=HY*U3HE%WK!*K3*!Z]KFD(?YT"D_G_8Y$K+U^%""B:`'DVUJ/%-!Y6[W1CJOK&EMS(2%"YJ#JY>_YA4D#8\=F%]8D4Z!$6>)WIZ9Q7"/M>6NVS@0'JF8%$-I;+@PI0[D6Z$J M0EKW5A>^SBM,RVJWIL#2F&$01=GIN?$)KO0D8EBFRK?(=)V21]R)5F]WQ"BG MW5!I3SOI^<]A8&86#R9W95K^!L.L@/1HZJ>#,QL#IVL]_F;H$.+`F_WU#UQN MNS[:?&;0;;.G3FQ..D)YULO\(TU"9H\X;7^A+?!Z6D7G7KM?+)O,!>PB:0B? M#%695=')O;]FEQM%F.'#A;9RK)F_D3B*]GL`J!"J3J62D[:604RYN>A";;GV MN_)V(([^47O*#J15-@NG_(`0DG'4)'C[8)#L5=EUDE"4$IPX;PZ.3/?'_U5@0ANLX9'_Q6?^C69 M8M)KS6%>6FR%8E"*R$R7^,/E1]K^+-:SIQ6/X7*A"^0D9'R!SG004%JIV?0^ M[-CGSHR4%<`MS\*3\ M^3IW_GCD;'NBZZ#_O,_%&TKM_$M+M).)[59OM3]]\Y24?C,R6"$M`T.G?"T`5FR<[!2/"]LVC'JP?4 MTVYD113,>C#=J![H`NET4T6NXH%R$["H@20/RVZ?^=I6SL?5\'3"H>Q6NTV5GN+WEIAZ MBE.4QH2G7"5H%_X,[[FO"_!PDQEY$SXM-:6RB.L*WE(;#PB\A;OJ3%OFUB<0 M`;2SS35:/S]\OWR9G/IZAOTJX'Y;PQ6/'XFS[,P99#.%4XT@F6.=)RK#D"J.@X&T0N M.@`/SE2+97FD6C7N!\:K%IZ/P'`/09[;+Q0BO@MMA\GFB)?8N3.%:X\M&W:J MOR`FIT5SM1!Z+!+XN5&WN<(-L(5P17N$C+^=P0F/$D?4-<]X3RUD;)))/`=L M5C0?V)+K[DVO03]\EQ%KD^2I]1\QY06"DB]L:0S*BL9.`S%'Q!YM]#Y+,>*0 M9(_-"<#;Q'FRB!T*JII11-PA$C^/\VNP:<4;<53)[//^\/AL!74WDD- M;V6F)OR67J*Q0``4-8Y(#X]E8Q;K0D@AG#6&A^I9$21D/*>9"O+DV^=?OWBE M:E*NPRALSQ0*YMQ\--TB?P9653XVPT`G:)DW*S_%E4-`6XW0"/=0`V](K-`X M11&*]X).>"PXWGN"?06Q"P7JEB+)MQ!@[1V),$5-4YQ.C][2ZN8M7+I`SG:O MM[8?;6VD]"'-4^[B2.V8_#H]O3E0AF[!63>Q_@D7W)["8W<"9VPRV<29VV9W MS(F&-VVRLR>[S.7;`T+(X?>2331.#!M&NR)+*>D&AO;N9H*UB)484@\-ZNP] M&5D8A=EX-2XF,`H@9ADW%(Q\+;>^?)M-XHW3ZL]%>+?.]:T2)48K.`2?&.:* M.U[^!=0N$5!+JZCRX,`ZR_[('D3OUPAQVLVL1O?+LW/YZ9)<.6%8#P(.YB!I M/5D*7-AZFC*WG'$,ZR02ZS4/GTTV<&=5K58>G(L+/!(@X=@9E.B"2`K)+Z8*=RA_BMC+X>06R[?0]H M3[)(BC2XL=+!@HGD)NXT0G!A3*V"9#S0A)^#"SYK'QLT>[JE4@)JLN7^!-OY MDY+]-PRK"WKR,]1PLQP`8*W6-=D.E9FEQ3J.>X'D"K1T`U%'4[Y`[EHKE.E4 M:,#_!))`)]]3'8& MF6R,8S*@(>X5W?;4+@;?VZ27SNU'&&!T>H@.4.T8],3:[:28]PWX_5N["[1X MNKSPHE3HU#)OLKO:Q7P=6I6;12_FW+/C`2\ M'\5M:5+"R!/DZ>4%Y&9+LYPK`)84(A>@[HM3#\O_\Y__PYAT@#)T9T M]M[$JC%-5IP#5CY]'X]QVB7P\O6E_LT'[[AJ6/^M.0MKL6O07,D3/Y>_YNB: M>T6*%6#<2QY7BHNL9IKKRJG:3)XFBJA/EA[+RX:CBCHQ?&"`E-+K1YF.-RI; MQ2HV'^A(H7V*87CYR9Q$V6O5@Y02H!6=:1.8/LTGM!I/0[.#=V?P-M538 M>%:9\,*TH(5U'CMX^L(\O@;?D\L+4@>YU\-33R-GZQA*P0,9/9AR![]+:H%5 M\@[97/X1KAX5'`4:TUQ13C8/QK;5PW')`AV05*A`,T] M[10@Y#RR27<'ZJ@5E&8RJA9:R&&3USF2\R^]I];:XG_%`! M!/Z(1;/J<'\KHG%.UP26>SHHTXY&LSEL\J3^.5.JT9'@170!*T,U=/K7P`0I M&\J#?9O>'8YC>/WZN^<"YVLH_-^)FZA5/,TQ:+U.VT`=?H(!#`S?U/DG+BU0 MPS-M@"YBUO"0VYYP(:-GF@,+J%]S=Q,W4F7$Z&]%3C1Y\,"IE($1BD!V^%4> M;6?UKMWJ!+7F@5K^+'=ATKG"1;VQ9@,98&6E"/@ZQ"Y5@V`2`M]NU1M/7ON, MD,8^5FS!,)?I0I3=O8-KN@<'3-52;M`R;G1,'07?LF0@XK7%Y2=/0)'DT2GB MS4KA.GENC$4HSDE@+5^.DJ2^""9:`H":Q2`;+<"P*T]9&;TZ//B*CCT/G`M1*2X(<` M/#BIU(_4LL55B[B0KUI?TBCO6&<*H,D=*4._GVL>Z@ZB)"1ZN<8,*0R]*.7< MM#S`H9Z":O+@FHA"EXD3#-V:Z91;C?>UFJN_NSP_15S^R]I3OKX9W8S4>V>U MXZ:O+'/#CL!:#X5`3!..]`<@GUO&K[W*SOEV\3#&[U%]:2N]6',^3_RR.KBC MW!S9M`*I$%]?IN8R3P#3";2)*J7<.(^G_\T4M'SR)K(SHP#6P\`L#]Q\K#JS M1Z)"*USB%@"D&_3Q=G'T7L=L1X6PZK_]_&+MV?R8]!L8B`F;:F^VM,YFFHW4 MBT]T,X@MW[:%)C2\.9)N>[4E61Y_E6. M4EFRW;(I#H=KC]H2QCC3-;:A`6=-J]0J'>#81HG!8\"7T7R8AY@'J&>I1YDG MF=]_K8C8L2-B'PYD=JD_M%19PF?O'9<5ZWX+X-W+15Q9\Y23J]3IOX*KI(3\ M&\F#',<"G,@=%]8=1W!1WM:K>UXL._T?P`B?NE(W.)^RAALCXQ=V]V^\&]8#+I,EI9GPPXI'F`LYF&SM%F%*/`VE4, M9GSD4VP9+?OA!OSS.!FH6N+@SK#_A0E+BCV*XQTJ[E8_AZ*W;]X3`AOY?:!] M6+G&3<0Q\Z9T.*/*R&RM'F;)44;IO`%3UKH+/NS8@`N'GO1YJ7L1,&+5LJ-B M%55@`SV]NC\USGJZ$\:LU.S>!D`KK:J'^V(IO;$R^>=)YFH%_$G9+G&EW0F& M_*?NQ@J121(.6GC'U^CAJ8Z0)/<:E56'XRU7PXEE+5>/:=%ZQG^QQ^OOW'IU M1PW#GL>\C(@1_6Z@'59PI9W[S3(T!*BQ!_ZM;%Z@1\0;%KLPCH'0:;P4!N'< MRQ4QUD+ZSLW_!BTW4\"3E&OB4T)R[&)?_Y+KL3M23^I4*(F%<3;:>0 M'V=PA&?HGE8#8^X?U6]XN5:3$B?=7C,ZP%>" MZ-_'<5^^EN_$]7ZC#E>(1K&+5;*;>G860!YO;:TY3 MY3CD>Z-L=JBD70=X*JHR@%@RQY-\53F=S8Y"P:K.N,G,O$-HLR/N>;,M/\:0 M$_>*^0IG2C$$?%U&DXM"62')6"W7:NB\[3",,T77VGO,1[,[`[Q`IBC.NL!/ M1!2MC/^>?$"&PDUQ@$-$-$S70>G/0TH@T<2WU<-<%P7NJTF[-1^4:V&?W@E> M#&J2PUP^Z0O[R:Q6QLF`*9'VXP01.#'2'5A!-K36TLOXZM*-'`[IDI5S)>WK M$.-IV3:,_PB/6#\;PPH[=I=3'H5V)UWS)*DOI9 M?95-J_.C];76"#S8O!:1Y5!J76/R$X`)?:;LK/7&`,(?8QOIM*Y8&%_0H,/* M+\!N^A&BPCZ\YLYIOL=CI#P**47I'?:&5_:2Z]U3(ACYKA=78([=[88"^<.V M64B&4C;)#X_L9!TVP8.E^^'9+C=!,ZT6A%92?!8/]LLE[,^"G#H,/UKMSE(< M#2"^%_DB0959-9#6S)?E^#)+ON`ZHC.H,9(7- MT_-,9I6R0I,A!ZCAZ<0KK42KB6WP7)U+`PF_^%P@=^1+3^+*LJ%Y.9*L5-`H MK75FYO#52^4=(D32W M-.?<%U\+P`-E6O>X%.<4$EK#0Y4[#>A7=DI'9KM$E(>1H,M=8\,[C79Y7T)5F:\O79OR4Q?T#.$3H09B$'6$#6<$05V60BKZ2EP"*`>8 M`J&:EHTPDF3L0*S/`QLT>[X`I(EN[A#BQGM8RS&*JPNA<[B_JAQ41L_1.]>? MLWA-$R0T2!1$BK%X+MPA/`?5AB/@3OM/`"WG`PDPQJ;`$S)(;X2T_HD8:7_9 MTBF0NQT^VP'76GY\GR3VNLJ5EK@<-: M7"R7*RY,)*J/G2\WSLVUHW!`5H#7>=?$YW1M&ID`_(\%4'&O6_F41,PVCV,9 M2DYDO$F.6RX'W:2/Y*E3#BF(%'YX$K2N_F%LR5B(&-(#H44F":\3GS1V@?I@ MT#<"K<_<6)46ZR%TES&"GE%5C0AZE,#=X8Z+K`P7^A@@[-"7`7)W1`AV)]EO MTOWK!ZILLJ%8L-3=]X0"3-?6(\R&V7LNMR%[)6MK\Q!@"[HX,I!`CQPJH*6^ M,-DLQ)2^DG]DX/&*',CC\Z\XMN^/@]&.3]@'2PY[8VV.?XY[:#`UTS!R`\-Y M%_K4LG.5"J5$/Y7CL:D"P_16KGSF).CXW7`B2OM+K"&R?<^@O;E63JTRX"*[ M!*A&M"XELWJD."0:-:I!>*K$H$M:GI/L[*WED@L*Y M\&?=U/QUX8[QZI.T'V;$_``,K:M)!9(ZK%(&5)H;BYO%FE%_$^Z63.T?Q MR:\2Y.24#B.B4+NUT#A/A,&-*SA5H]2-A`Q-$)&CZ1N!$J9%K_`KRCA&TQA6 MQ=S>N7(`W;GU=G%M)FWWJ@7\W!@R`S+;27J3)WWQ'MR[3OO"%.J"L34+@>05P,I>G MY#73`@Q5<"%'B/O!_$O!H_"'*-BRW;-6Q0GBZD3@5AA#?!C?DA$B\,[WCR;M M;$?H!H:(S!%"(-5E2&3!4I5UT3_I4)MB$'E#8YPYXYO[V4Z.,()+0`H4P$`B?FYZ:3B$2G/06;/F8M:+U&&B,F1KR]VC/%Q.J M7U``S;57;T*SWY">P;"\DJ<_9^AD8R7<,@4*$1ZO*".R,3T^/D,-4M`%0G0S M,-X;9DRBMS2!5-> MA55)"Q>H98FE37`^ONIN>6Y#.=J;P\**U03=-$S&"I03YU5FQDC['\Q=AO`D MK8,-:]`HP_)CZ3*W>WFL^CQ37K6^_*N+R\\?48Z#O)4K@P-*`X#R7?-IBIM\EC M'VKE)R:QI)=6#<*V4]BU!,#VERFW40V`H.IDA?A!PW1/X_C>(ZR\"P-'?PLPI#VD<+:H+B-M-^ZSZ(;8@C2\E2Q!PE\RYOY6 M*IS&R#U45U;/';5$<[1`8D:_!X?;:)8'AV_Y?Q[LVQ\YCY!5Y,U<]6M2/\*Z M\**8(IY(&X&OEYDA:(FD1>*_4MZX2^UD(@TSZFWKPEZ2 M[B1,/L7!%:7++_\L#2Z7K MC[*NE*%CF'<$>M@"3(8P"UH(A#$!9TS\!O%4.E4=JG+0`1(Z79OW0\<3-N%" MS'"UO=PT.7X_Q`>(1.8;B-=I<*QJ%(ZP7!L2-5E5FG1ZK<3H6+[0==%P4!JJ M6W=MR95G+X^>;YL$0<>T&G=VK$%L$D_@US\-""=J87%*>;R4\[3D)KSDY&;\ MS#V"M!];L-@1MP<9K2G0?YL4:+FJ50A[_HL6*EKX^]]6UX)T::.7T>3MU)`U M_A+'.@+BC<-=L0A&?;CJ5!"XTH*'VY9'SORX;.8_ZXD;-"/C*QE:8']]KI=Q MQ[__S>WPDI]QAJXA#$75%F-H*]T%]3K"DIJV,4P^6@\249Q)5"-T;"64.#64 M6=!%6=U6H^]R.1R9?V8A!MR,[`L>__Y2A1/P+XPL5_FO_KG26I[^F9MM/N"( MJ39#R@3RMOSY)[,BGI,I4C[1^LK?7DQQN/VB_-'RR5MS4`G/ZW+0Y?+ER;IY M>.O%;RRU+@^P-=8[F@QIQ622-OHZ_F+^J7(I&TNM:[A>7-(HB+;&%137EEI7 MM\W;_+B<<6VMK6\^75MJ=9[DRL&V*KRVU.J$#00;:O.\!:Z4"PPIU_7IK$P& M5KZ^U*I17EMJ%32S[,;56/,6.*D6N#*PCK6E];K=>)MO'G`Y,UYN5*AR].V8 M6U\^V%&@QZI`JSO/7BJNPT5U)^4W4K/+WX[D/$)Q,*]^^7`OBRPN0DIKFVWL M&"]MUMWBGTYHD=*TJ[Q'<77D;=@Y)56`NV7I%2%L#1ARM$)HW*G&-7<#2Q_@ M);J-'\,:0';HQ`.);UE-A^7B(\%E/`SY7\O91\TS/FB M?DWAL-T47MNRHXQJ73`H%VCKI"38Y`"QC"@R9!2WE)$IW=CUM_`D>$RR<)GM M/WG?*XSLJ8)1U8ZN!!_:G2V_AVZHOIU7I3.U33Q1VZL6O/O-4Y;)&">%H4`G M.I;0=;R-M^M+K3LG)TNK#9ZS[CV2*['Q-!QCX\%2ZVZON-A*W5I=6FO0.V*^ MH>/L>AUAN57TC<;+`&#(6;B^U+I(<[6I5[&2QCT4_-H2&$O+#<4'?:VQ0YC- MD'([:4I'+JD=XOZ!U.JS0&NKM:6G&TT-=ZTI<]:76A>8T#U_:X`ITMVN`2\J M$QJ0V=3MIVT<57_^`?2E!V"C%0]C+0\(QX![%HMH*%RU6'X\V1B0!6!.@TBH MTFM(SC7=7=W>W1[\14T5S;5EV;M$GK&@35O->4U(8X"YF2HY4I!0*1HG7@H\ MX5;4GK%8DD9D'D](L;?.M.]DWJ7H8/0>&VNL32$*SQM8OM*DB*0?UZ-'IEW1 M_OJ0(D6'HZ;$7;F3$KMK+5:4$A8SDE5$DIJIDD!^\2RHW8>\LJ&)A M="E#=@_W]YJ\]JO0?>7FW\W,=,I=PHX"^_VMG_@OK\.*"\SE<]*HNM.$'*YQ^^+('!O5#C%F=&*C18&)94Z[(NI\6HY6%+"=]#(M;0 MQ-S[M=&0L5PUW[HLVUNT#0.DW-:$N]\;CJX)$JJQ6\S2<6.W!()IHH_<,%@3 MA+'\S>%%6/B#2`4)/':4?.;YCW9U(Q$J,L(B.)2@XEVTX#.YOU/&H9^:3Q1% M32C-CF-F^KDDG$W-[=;G\H""%X3TNP_0['&J$A'2!9(\198K8>OLXD9[,F.7 M6R739=+^HJ^AAWS9BIL\.G1%8>Z8NV<[SC-@AH%G_FY[_[>DO*0$)XNR]9)< M;((N)28FOO0;N80Z>LA/K;'L>CCZZ?ZXXJ:\#<'/IGM%K!A0,"S[=M*99W__ MFYP,A+^*/%PBS1[(F@,:V!E!<6+4=]U>019M0XD`+4O(="-?NLD\R5>4 M<3Q#^5-,$Y\BB5^RF(6,H6,[LXO1F0#E/7FJR7STG-?A?:(+!O8HM3`-`-"/ M/8$K;)=0-X4VT+''$9)RZ!2CK8\1(D'E9/K`P0,)/Q[AHUG)GOH&B;1L]'Z, M]"^'2_9`VV^%8N!2JAK=9VFYK%O,=>##`F>>-H74#&1D@W@6 M!'RAP,62Y_O-X6-!OT&FV(@@TD1,/B>D,&09BPE]^>T@0MY<#R M;"V/LES%T/=L02=FN_5BK$J?H]AZ+;F#N-N2JPZS"W'Q^V$#G M82\WP(4[FRVW.;]OM0Q]LJ%66[>*+J/-U7M9;IJF_-HXH>%"3]]QLQ/I#O;87O_C MYWU;RS3-\\.?@REU>$5&$%G94B2*_N' MNF(C-03A.^\UK<1AG*;X3D#YB\MKY)-:^T6%`!T7_?,]Q:.D@3.UU04Q57"B MA+2IWMH\F$]T?W8RQ>ZV]<)IN:,B@(ZU\G,?S%]CWULR]T(E-^0H):DM%$S> M;9/&S:7D%^]5$]T?CR^CJV.TOF8!$/._=UVD7!U>Z;IW,X1EW-XWT:%?C96, M@X!5OQ\>A4(!J")C%4=='>S5Z,\*$!P$:V1?57EU'O&M'\Q+_=;-J:C9^9Q6 MNWO+G-MJ.J!(G&6@'4\O[`ZVA('"6*FF,81B&(0BI++K6%@N/`\4.YC9*-Z= M"^!(-)'2L;B4TNI[Z,8C29-21T>CKM.;J=(_3CP#!\,AN'L=>U!TMY*BZ\-F M!H(HJF4>A'(;MT5EODG?@CXA7)]='P*,CQA\5OC$`[I6FJ%'_Z$_^-Q!OT7; MWO0XILP736?X.P_.`17-:#2(5Y`XI<&)>($;>E&5=A?LG48.:YHH^=9@[F*N M$W';O_?9PLAB%4&'2`!0,!6DT7$IXA]Y6VE^/^).1:[..QD=>G-9G<)4*;YP MN"NE/6%Z?[)[!\W,]GLHI:WT[-&$PYJ&#%IK@9XW2/UQXOT.97IZ>FK`H/%6 M"$++NLBP.T*NLS?;Z.2,L*KZO/+BD>L/F#]WHAZ.7%T[!$9J^$@;`5A:&E)+ MH)-UQOTF5+UH.;3%#B7X2@^6!:$K,D6OI]9G7,G#+C;(Z*((6\Z[NT-NU:(9 M0&[B@>E(>^,0";\OY`I<;-O21QF#Z$C.\R%TF!8>"2ORA2YZ5F`N[:S0EQ8P,@`IO^4$F4Q;9#9I^)55+AC2AU9%9C&&Y;(0H<>Z0K(M(^ M?>JS6SGA'.D\S@FN55Y[M=S5+J0\NVZ2LV=:=YL![O$'1M>*I&\8^>A>QK)\ MRO#Y9U8.`^ST%R%;JG.W*BJT%/V8N98@MS-T;8H'(AD-)P37FR_+[YX>SMZ; MF-IFEI]F:M_ZB0MU*`,4&9AE7.#/`E_,DZF;MO,XJ_:VV*PY@JK24XU3$%^8 M\NY]]FT@QCYS9[OY>%3]9FJ3Z5=0;6!8G(T@&A3"?QZ]#E3\',!$?WTLJ M-3L,K]K*M8[RBZL`0U/_3D%N73M#'YMS5AB:1QO'B!R3\F9>`H^>G5W^1.+E M8_WQXG+Z\7%L;2VB^3*]DB:.2]T=%#0$^G"!(?8>\G%*_'EVL*="JW?7:6G- MA;-9/^1Z@1$,Q4J%6I]R&+#8$]H+GTU/#'IQ;=0$J_-FJLW&P26TI1[8(AEQ MW@B&$ON&>1&JMF7I?K3&IT9T<;#`HE4A`!AHO`\YP&XS@HA)'%TYBN78Q@&H M"T?+8'ANCK-Z&;7YKH_,=)&HL?1PIP>9",%T!%'_.KWDD*5>,"]]7)`)K/9* M#BB6&M;RWT3$]`#!,ZB]\!3`)5R$\(TR"]A!17?$KIV M,<0J4A,/1N4GKIK=OE''O1R(SLV%,SE3[(I#PXIO#?Y$NCIU2BP9SP8>L:W* MQW']%$5C=:OA<"'C;-*X\N8I8=[5EKF_/B&&T\C<8)R-.D?-3'B+Z_LZ9<,7 M9OP_P'?2\OFMCQN>JM66TW"\NHPWJ;'E,86@&RUGRQAM9+WEW<)=-5YM)((0 M-IBT0>?I^L-))^)JN/)ZN-WSWNMCA2E[BVMHP_M;&= MU?7'&ZW4R-4)^2N-_?R4\9HJV*GDAA;,,.3'K>`F!:M;JPV/*EFE*RV?(&&@ ME5;B$VE%JZTD+`=:3MDE6+8`2RLA9A/=M84N&S@Q6XX\N94C[Q$[C))16J'X MR(*Q*0ERLP4M_H8L"#44MT69]]UTJ1+RG@:!;#(NR.02!):=W>!"&#XK+6=N[I6NU+'%Y3'UV.3I2Z=:W9P5QE MHQQD$\]Y`PLQ\+8:%+`&P33>[G27X$S<:5F7(,J&MMI<$C^7VCE;5-9&&]10N_!'TNZ$SE-'"RK596V62B^N@Z M],#OX];[$2"9`ALWWI_2!%CGD"^%U^_L@WYQ3\H6-Z`1B0E:-7U&O3Y[KQ:1 M6/Y)G?5,W\!0>M>!L*O,?5BRG?>=P6.]GS1HWWUL5;G6O9G@(%HF+VA%Z>U@ M#'J+SN!#^`S* M:=`,5B=50./Z*4&1K58R"IV7U]<:093MNJAL8GQ7#K211:RWNH+*<"G>.0:X MS&M3H_N&N&>I?)C1C@8/H7UYRJ15+5!2BB]/B-J#@G$": M`@38#5$_CI9JT*LK3#BT#H<`ZE]O<&'-/C-"YS69:]FK:>KMW\VQ[P]W7^WN M'.T^'_WKV^V#H]V#5_\V>O'RS?:;G9?;KT8OW[S8.WB]??1R[\WHX=LWVV^? MO^351R6&+11<+S]ZUQ^OK#6T5\99;84224^9M#+.)0LV&S3)[ZNM MW&G&V6QIL734&+BMCF'$F6PV9]=/!WN'AZ/7VP4\OWU3` M@U&LM)+&$)]9: M7%;^VY:VS?M;K6Q]WI^TN/*;W2,H:&?O=8UWM)EI[4PY]0WV#K*TL#QX\T6E3!(RZ+E[=8@#J+1_N[!"%B] MAM4<_KQ]L/O__L__??[RU5OX385X7!+2H!U^;5`ROS:VJ:3:6D/CW08-_-,1 MTN"=<9O8.EXVS(2[%+M4'>R:@8CPDQB13\J/I,N[Z1?B.TK#[?+)IO2>SZ\3 MPFOUY'KZ;:26A%&/D2?20D&]D&60G[BF+2?Q,,=`>XQP^69+G3;$3 MNU4>$;:S=+`T>H8B'1[SL7JQ2JQ*=.4=?H,C#%\8JS`Y;/ZK::`[!G!P#.B8_CDBSUHBOPILW[]3,GXDU,Z MH;?4AWS4"Q71?YG]CQ/KLR;OZ3N_U<."G;6,#FT(]K@>!(665IPGA)9HL-[U M@8D-]1[NZZ_OE9Q\,U6.(&&0T;/0G[LDU7W4&EK2R=O,6SMYM_SR58MR*\*! MALN[J.LD"](AT!K5J:]?^<%;(C*\N'M%6TA\F]7SPP]GGS[I^!59^!E+W8H$ M=\@]>-]X63CVA%POE`]I2C&D44ZZHRN5-*#]H3O]2"[A)*O97UN/:Z,(E`#4 M.VL2J"_-D@"%(SY4GX8CN"*U(%Z4;%-NJX;/^M+(EGE^>7-\_>[F/)Y8-0P^ M!CS51%8UJ5;Z22A7;N@(E-.&%>4BL84I[4N;GS=5,:](G-&*D:;LGF=(+=*K4SR><@=UH\N$2.@U].+(5X$;6/9&0 MZR) M\(W%O%+7QU<&W&TW*$!2Z["V[9,+>IA"$>S^DFQ0][:/<+?73#^?!/*H)Q$Z MJ(W;O$E*+'E%^."<&Q-KPH'G^`77HD6_:87]AOWL?4Z&;$^@+J`9P(D(&P8C;8JHW*(!OV]$7408AI;:[;;]X6L/-`&[Z]%P2Q18`G5[=FU/8)0P-*YQO6)G MV6<"R"OU[1I-1J^Z)J7EL99,S%C%`0A,?:_,L,3M,A:VP`:;PS898KD@^0VO M/IG!;+A$9HBV&><^,MKRU;Z]PHKHC!R=`Q#=`T;[4Y+\5)Z;3-XN80, M+=]>3&^X``I`P$LED3YRP8;/XRXEKJP@PM[>2?^=PC!Z[I<6 M-2D6]%BB]N8C(7&A1&"?A@`\8>_;G)GT>UT;".?<(@G M17#VE^>0+(]$2L0;HLZX9D@J:59$HF>K4N!H^HWC6`2[P@?/O-2D^WP>K*5] M6)OD<.)QRMOVJ%UY:KG6W\TU.E"DN\\HY\V?*(QM1L&EXYS#-R.8M82W*J-6 M`I?`--J_#/PF?NWJ5_8(1D6/*@7GI7\&F3\2")T8&70WBO$$#4QT^\FSBJXF2FF$XL*\D)H<>@) MOUV#7D&!O)%:'VB3V6M07NB.IB]5_E.M+.-Q[\/54)4S=B1ID^X M9Y70::ESWH]<\EW4160:@496C9\/5D^:;?//L9IJ.V2)HW6E@NEE.$`1^^(EF&FUV*<2OHA@PCC=!.Z!K$5(*/,RHZR6F26!5@#F.ROD9# M]BO-E,1-0\>_>65Z.OE]>SCU;^7HV^?0IS$=:77A+S6\A75?'/Y&+UUT.1HIR@C M5Z:C^O%"Q%[T8?E[I(SIXBS[I1P%Y]D)86LZJ3GD.MJWMQ<)S)6CMJY+&!UH]/HLE!F))NK".7/G]&VS=E%?F6X MJ477;V",*81LNI8EBLWYTF)502G^7JXGRKNH;I?/HS/I%-]%Y\@HWWH0*E7+ MWU]/\5@@38=&?S!>]L22\L,>RU?[@6VXC7?3-@Z$]$F#CO[WZ+9=_!)<$*`4 M>FXF_Y$$8O1X_J7,!D#ZQ3S1HK1F)%ECT`-:Z_ M?U(&-Z@.=1&L++?U()0(E[\_.[/,5ZGTE'Q2^CD+K^DIXT6V',YF.BAFM64I;DT88YKV2XCA']T2)Y(G=&`P[C]$Z8X M,-6E2E"MNL70'5)=22!2^WP.\1Q2I';M%S%EDP[/Q2U\KQ4#4_W:<\FH(_;_I_%T`G&RRN%-9PRSKBFR7>=YI=8+/F9"S? MFL.UQ)6$?5G,;Q#8\X>YYPXRUW?/HYR(PM]QLV7XRCA+)/C=E^ MV]P[7^0]U_I/HE>P$#[E'-%LF=JEB/HR]"Q@@$YD<0>;^03+K\UGPC>GL^/K M<`M*-%YU87&ED(L_CQZ*.3\22R9G-D40[[#F%./)8*<.#]>4.LTQ$]N?$9R^ MN-+]"ZQ'PN768:('IX1%<%DIR:6U]2$*3JO:[HYV-!BP6H#,AR;*>/3"L:W> M=-G`D=$^'K7]-0J9F7\3<.(WL`NUDP-!_F"Y7.KF]K=_%O*/2MC#S[ODEUN] M2>;,L2Y)\I>\)O65P\?H7MS^&<]EEG^Z.4^,J^(P^5)#ME*$9KDK/)&R-+:Q M3F,@,+"E$/VL/HB>0XA)I/GDXXRN=AXG](80\TV1;IXK<[_'[AZD:UR9%[^< M<,X'QHG*]R4_X8PD-%'X3XI.='R5[[VZA"AA#S$%QBI2+\^_R,3"TR5-1LDD MCZFC=*\+'>AH,%!WW5QX(',@./.0P^'>"Q+[D/K8Y`%:#=KI&>[CC$]9[IT8 M;R/#8CNQY7-].SW](L.AG@7/20GCTJN^QPO+LF=0<.\OO:LCD%E*_IBAT@H7R0@SJ6T8_3H(8XR MQ^[*ZYSU7FF+!C#T'&11D[]YD$,50H1.\"U7+V8`#`)<*\U`7.+#G!/^W>74G+E^LZCJ MCQV18TA:A71/F7,0+\'NV\(1ZW/9_^K*W,=[)]Z&'WHUGV^C'">N.,.UH7$.;XY1*<^4 M$8OB&V3!ZUQ$T81XGLIM@COOU(&W3-3;$U:C:;1QRZ4B>ETYCFOF8UQI(KWR MU9>D":K+1R0;%T50NH5B4KIQJ<%+?V[P&'[-HR?E9'M9,"5PI>*+9$NH7#7- M7HX3%_U>6C;J;,ROOON*ME.OFP@!:XPD6^*&$J=CZ^^I%C:5),KS8*8NO$+K MW.)#A^0[%G2E_?%K-6^X1%?%D-L-':@=Q;JF)'2D'"M M@*ZT_=_.B)5I:"G%I[#W;-@8XA+P+`L81>KJ1AG6L-]NM<.8FM)2$-!=\&L@ M\2L/$LSYL*?+M]7V.5_/I4MCMS3G./)^'(.,)!6AWO;BO(7(]Y1EI(T>YOO/ M'BRPWY0CIC%C7D:9*M4;GYW>/4WMT:T"I4MU(TE:189D"?4S?^?"?VCI0XRX MFVXHO[LD))$=Z?X6#I<[6M>6>?I1\B@.ARW0HTZY'>WSK\.OW/TDTA?/6OE] M"QP^0L#:/\5ZQI#`,8B\:<)Y$NI9S[/_)PH\)>W&CTMX]M_+(P#EFVG:A7'4 MNSX4F/J/R%]<`.BFCRNJ?Q2CIM^'`=[(PRRA@WVDJ@6WICQZ7+[R8#P0!89[ M>Z]."0-!]W6O'O=`-0N.X__]XO+KDY_)(!\BJ`?CM79P?^<&Y42]\%XQF0]V M8*V\<#A@_PX3A)+T+2&%P$(BL<'YG0$,K:Y,&<";?9=S>$"[0VN)44*V,>Z] M]_N`&K1%)[EEMT6.P9UWNSZPD'K<>^\V>EWCB;'&^9M:D`MTZ5<]PMCU(H8% MZ'/!>8*?Z9Z9Q@NLH[?\8-Y:\*&R=P;?7"O1=?#-]87?K*R?P3$WRS&#>SBD M4]_%7Z+4XA"^,Z:.8U67R<_5"+KN)18OIXT9?,ZMZX"/Y;]!N>2(,;&L#;E]RDK&Y]=QY* M:`PR=*^69R9Y^::(#=*A/8F[W$27'=X?)S=(.KLASWD;!M^M8S+,!;)#^2=D M%':K+Q=W-/N&/734X5;D1>6+SIBT(O>\EL_[B-U7Q@V3JH*`!>A_>%`)Q7D5 M`PL,ON.PP?/AR%_N*#TW+!Q\^L*K5,OG8>D"6&)<8<3RU6CF#*ZD>Z&YE.[Q M'=82/RH7,PSRCIET[[0*+18`_7.4(4HD3\CJM,1JB[IY>K]"'23WNG&^^.+B M=@R50ZZ6E+DL5VN!=6'?X`>NXP?=AEE=SQ+L"%$T]!]3^K'`PI_-""98Z4`P M*4K(D3$MCC7P]+D"M[>:IZ]>/ML[\!,?XA+DN9$<*:8]](;[/3=-BE=1,:]) MG2F[>W"`;:S/><\MQP['69"5+P@(Z2*VN7*28&X_K/0N?(4O/E[;'7K^EX"- MH0>YZO)$:Z2A!",;461!.FT*4Y5#S)E=,2058HI`^)_-(&%C?RC!@`@-_+TA M`@O-7JX9ST07X-+2IN;EHPOH MY>?/VG;YP9Q-YH[)8[><[_!U=T!)'+<"[W/F!P3H+2*/Z1?J#Z;'S9O[7"E( M[5J_9_/(/*/8])W*]H=HS[)E M:,BH])WET@^&QH/I$GX]'86)1_OD,X+WX*=K"UH@G0J#QB"Z/S\_H8PM!T%S`_/[AVC'Z]L-\*DK8\S@K]S4K MCQ`JM=?,8]_NJU7"Q<]=6A3Z<3AU^SQ329LSOR7_5P6G`,ATUJ1!EC,<$!-4 M^99YMZ*/%'3T#<3!BR;^W&C7$M?L!IT`5W$PG/A M/JX',;YWJW+Q8G:\-%KV^JR*VUGQUO*&,:XJ5^#-Y9?T9:51B!^#GZ4X0Z[? MD!.CJT)!,*.T$DD/"PG(A6QD^2(DD.=4IPSEPMSZ62>O8EY-NYAK<.4=B=RZ MAP-COJ1*>_$MW`]^/(7#T/Q;VROW[.^;,.F]V\SZB7'&_XES&^9:5IJ9WF,3 MPRK.*HIX'@K28F31(WFFUW!>-+2HOJ"1$&R1=067K/0J+@^YKC;A'EM(#"U' M<@+%"W)25=8T2Z[C\RQQ\R3#DW+`E(#E9QN.S=BL,;]T;Q1KF_KJNBD_6=(6 MTD/+VR_G?'.3KN&QJ\V4]9,TT?0Q-27'9^_?`PB[+BK?1*KXNVUD MUP?=EQ-Y$1OQ=`V)LU[EO3#L7+A]'<38A7MW*C'?PKM`-"G&.@H%(=-?;8&$>2+[XN8LY&(E$! MO:$\I6Z,:[M".!^@TF&<0O5)UYS@+CHW/08X2Z%?MEFTF?>X("\227;L]"1C M&UZH:$BC4G6RK/@-\,$Y:>^C.(ZL'EE,SHDRW.-/-3L*Z MXGR7[RAO(Y%K"$K;B9]ZKIVNBO3$H'#[F,5@].%XBP>/1 MH"F6%,+J4D-P3\6OH(]8FET6+/I3=[-;K@]6\GL[:*78'6J02N?'9#Q7-,9: M[7S])#G`V'AE2O19F`^^"\#(VUJW+6VB2D'B6+R=Y+[1E$)NP^RV>0R"W>D_(\>GF`..\ MVQ'<"DKC,28W4I<9:T'B[":3[!65M!G34#;L6VM.*=E4^9:'Q)5Z#@P+,V(3 MNE%\^(5NQMV>LWIHNN[]Q@IC8QR0#L\*#34<9,_1ZK(.."7.)7E\O\\C`.[W M=0:@^PW0`:0$X/W&^PVX*$Z9X>)0GF&7P%RY([-L6(@WB6K\SACANB)=$>@J M8==/P-0!:3G6P1#E^0N8.81&O8DJ0!TDW_!.R'>3?FC>)H2MRFTK\12EV/HM M`J%ZC^RAEKB+[VVD\3;GOD>'D2")UIOOS871?P@`QNT%SUW(PD=^;RQU>7XK MEF:ZT\#Y),F/EM4ZP.8*NQP=?UQT#EN`?'J(VV"!;:FY^TV>2SJ##=$#FBDZ M_^#CWJPEGYD[I1PF0Y/V1FWLI4++N`V*XE#R%^?C\[^+3]G]'6>R,J#N.-87KQ M5BZ[.F!BQ9G6XDSC-OM-,Z4E#?#]^8"\#S"B!1095DDVO1E_&P/NV)N'`K.F MRX.-#A?@>4U6&LM=]]XEJGT2U3Y206X^6E/&J]';Q?LA9DLI@?0@($"'4@/B M33W=8G_%09/K0=02RFF:.^V@VG@LE\(%$=!L[4.-]/SKGMDN=8FOV\N(P@GO M3K:K6YT$(6T&R[?H!RE3\3$J)<62U@CF06"@]UB_$.%`[=G8/_:>XE.?[KMV6NR_DKETBD*R[D MF\1DZ_HS%(&2ZG(2H8+XA%S'"2?[^&[%?]H[W?]T3;6G207R`,N^QNZXT^`$ M*$"9`9EPOP9*:.W.8'E410W1`8LL$?D]/'MD;\^"+NT!7#W1&#DU/CP+KX8@ M57A%5)5<97*8%C?^A>8K5[$'K0C[@ALIOL.'.K\K]?WD1E#F"CN*E\TP?]QL M\&I[[]`P\97%&>!1LY,I[2UMO;9%1:C"!OBY#^:OL=J3TL6.96!6!Y8HH.60 M75)'1;_V_/P[WO<>C^*S%/=>YY+9Y67:"8V74+N\`8=7OZ\L8<3&'WS1YA$7 M?$W1&\TL"3`OF;*\$$\1"(,L<_$O\%+_0D41M!B[I#6AT^^'0#7Z=@UEKD;J M]D77*N\2L$^X7`DTMUJ>^0??1WD;@GFU9ZI]]"X?2**+7X6Z"8]LO[%;P2?6 M444"O*6(VN`]NU1U`7^D$-`@UR:W3MV3/82?#\\V2X4BNF5#Z6[^-G<,9D`K M/SP$05G-O1:(!I+YWH6K%I(5?PK"#N[D>-JE/%9+CZ6!"G)E'9ASU?9A``5! M)Y7I:L&'D8@M-G;G1M(+Z#I7`Y<9A';8?NV!\"!?Z3P4ZJ+SGL%FJ0YAE@HJ MGA]G3.S2T@:$;3_>/Y7 M,N)OO7&VHI<%NJ%G'3:DH$;DS;J2+X!^),TK77]A[$IM=T$*_GYQ.1UNEPQR M[)PC^(;@K&94)*XBLH;>8$_S.O4.?=9=#3TXLB-^V/UP5)MB+9I=G(R\V'UP MM*(H?O"]..M=L'$1QI7'ZTI_`%XD;#*IL_L-)84**6YS@]&2!^3Y MI?7=5/,8D]C`(&0L)=T[*C'-T,$N>B_M`N+9+V`MZ2Z_7[1\UEV?63X)-T8^ M?,7EI-QT4%P<.7HR"A='EM_!B:1+##<'HZ8T5[L'>XW]\>KJ^NG_%P```/__ M`P!02P,$%``&``@````A`'LWMG$\6R+UAG+ MB_JTL[_]\_PIM"W>I76>EJRF._N=7(VBKMX+(]N;QI:9K+357I^IZW,5>E[0$>B+!;+3WN M["]DD_C$=O=;&:#O!;WRT6>+G]GUM[;(_RAJ"M&&[_DZ+T[F#XUZ"1\*Q3?[^1'D&$04SCK\4EC)6`@#\ MMJI"I`9$)'V3?Z]%WIUW]F+E+-?>@H#<.E#>/1?"I&UE%]ZQZE\428\&(WYO M9`'T_;KO^.&2+%<_M^(BD73P*>W2_;9E5PNR!N[)FU3D(-F`9>'9`N)SVS-P M2>SY(C;)K:#F3\;(?CK)`@8,D'\.9DTN(5:C(4^\:HR22 M4)[C$74YN;NL0*WF0`FQ!J7=-4;)2D(M/?FC<9D4"MIZ#IH0:VC:HQ:CY&Z\ M[BXK4**9C2J%^1"%6(/24B=&"<9K?3M@1HD"%\V!$V(-[D?EP=*`$H3S0S\( MX#RUTU0DZR![%-8T(TUF*#&B&F2J)BB7H\PS0\) MP>H.UH<(17I5Z35])LJJHB>B4:+BB7+].!X6=P5/.\&8H";`4JQF:7)G446: MU1O$2Y?VZ(:39P,UQ@,U250\K4L\F'=8Z8SQ.-'-;HN#Y M6L-X+.ODKI^\9JYT][1J2_$/<:?-WT`Z*U93'DB>>_ M7U\N?N0D@N$$AP-.1=L336A9@23GK.&6M+B2(@7'6ODW'%@'8QR\N,91G<*`X;G M@/C(6/=Q(8;.X9\!^_\```#__P,`4$L#!!0`!@`(````(0!B/]@WNP<``'4G M```8````>&PO=V]R:W-H965T&ULE)I;;]M($D;?!]C_(/`] M%OM*TK`\&"G(S@`SP&*QEV=:HFTADBB(3)S\^^E+6>ZJIMOLER2*CYH?JYI] MFC3O?OUQ/"R^=Y=AWY]6!;LIBT5WVO:[_>EI5?SW/U\^U<5B&-O3KCWTIVY5 M_.R&XM?[?_QR]])?O@[/737.6/TCX_[;?>YWWX[=J?1#W+I M#NUH\@_/^_/P.MIQ.V>X8WOY^NW\:=L?SV:(A_UA/_YT@Q:+X_;VCZ=3?VD? M#N:\?S#9;E_'=A^BX8_[[:4?^L?QQ@RW]$'CW[D"_6_?O0S!OQ?#<__RS\M^]^?^U)EJFS[9#CST_5>+_K&S M_V6^O(R^_<5UX%^7Q:Y[;+\=QG_W+[]W^Z?GT;1;F3.R)W:[^_FY&[:FHF:8 M&Z[L2-O^8`*8/Q?'O9T:IB+M#_?WRWXW/J\*H6]450IF\,5#-XQ?]G;(8K'] M-HS]\?\>8C"4'X3#(,*DAY_S&UXKIO3'HRQ](G>"G]NQO;^[]"\+,VO,,8=S M:^<@NS4C3Y^1.17+_F9A]Q43=C!M^'XOQ-WRNZG<%I!UC'!,;&)"R"NR-+&N MV$L3,)5^,AKCV@73@EECDNSA83@*#Q*9F;[ M_&06)AVM23*/F*-?*TL*NTD1*)K.B69A4K2&1/.(+QJK:E''54.(:B0+$12N MR@EG81Q.DGZM/>+#28UFDKM4-B&@*@2@8-9PLYNV( MJ\+G:ZH*32=?.Q@&ZELJXZ#WBL?RS.!7]7"-DV^KNE]^W8BO^133MG.X_1N$ M:'L"`8)ZR^Q2/7OF.9J4C]H!F-?V3G47(:*TS7T[`QPO2Q`L-H0D"]D:F-?6 M:<%1[Z"_?B`/594JWU^*F5VSYQ?0K_!F^.M**ZDFW(BK(K4:)Q%XGA9*N&Q2A15"3#)>*%(W(X_6(MP/#/,?(]P2Y/J48\` M`[./"6V/?UWE_.619G!`8I)YU[&]I:9!J5&`@:"-0)L]R(F$PAA"<$SB$QM3 MFF^GEQL>>T51KP#S&K.II^H9BH6S1B?F8Y99>&P639JY!L8'=/OYN-](+-:, M`8+KF.45'GLEVK<"`_73]63]0J\PK72BT<0K'S0X]DET-\>1*THVH1.$B#*Q M6%O%S;^>'8VO9TV]#`S4KY+:W-<%W?,7"H9499YJA1!JLED]$[!--;0P,-%A44_%"G^C$ M9D9DZ<319/I1&0,#Q:OQC@^*YZWD$65NB]^?>D0FZ8M7Q!+15,;`P+'EU%T= M0F2%;YSQU",2^2!>+`]-92R0&"2;V/0C1/(R4;TL=8@)=5`%`^.K)Z96/D08 M_Z(3P,7+,H>8,`<5&S`^'6=8JC#U0G%P+M!#$1PORQLB]H:F&P-@(%Y9<71P MR!>ZA3/W8/KM-%%`F64.1^-+MWH;V!U\#8P/R.H:2=7GPTC#T"G@>%G6D/$# MK8J*#1B(I\2$UA!2->\[369)P]&D>-1IP$`Z/;7N$23QM$AF2A-$QU47UQ;[.L(?UR;RI^?9A54>4"X^/QIA&H=9`OU`9O2O>X MXWJC@@-F>&J&631'`\X@U[\Z$_?-8A8W]4U+[` M0!UK='E"%9%AS#/+8&^(0V;90\;VJ$B!UL#`)6)^ESJUM2<0EXF;.)FE$$?C MRZ2B_@4&(M85_B415#!TB%)XJN(2$H?,NQ>6L4LJ*F)@?,Z)#2#Z^:?$@TM% M+#(OHOL6*275'3`^XB=>3^D8,Q42#JJDRK*)HW&\FLH.&.BTE)6<*".&>,T2 MPE-$*3,KZ6\DPL6QIN)S([_^)H>]'H?0=G2)ZF1G5^P%%I19T(Z=_*9%$ M<-.S-*.\'I*K.#"I53R)X'A9DE'QS4E-+0A,&*\F(MJD&1R0:"9]>Z)BO=14 M+\"$`5I?QH6A^[1;"3*F\I,M8M_;X_HH1_-ZT[NG\_F M];;.O&14WACXL>_'UP_VQ:SK"W/W?P,``/__`P!02P,$%``&``@````A`/D+ M/##G`P``MPX``!D```!X;"]W;W)K&ULE%==;YLP M%'V?M/^`>!]@"/E2DJD$=9NT2=.TCV<"3H(*&&&G:?_][K43:D,+Z4L;\/'Q M.?=><^W5YZ>RL!YIPW-6K6WB>+9%JY1E>758VW]^WW^:VQ87294E!:OHVGZF MW/Z\^?AA=6;-`S]2*BQ@J/C:/@I1+UV7IT=:)MQA-:U@9,^:,A'PV!Q<7C2DLG!]SYNZ99)7MF)8-K=PL/T^3VG,TE-)*Z%(&EHD`O3S8U[S*UN9WD)7 M)LW#J?Z4LK(&BEU>Y.)9DMI6F2Z_'2K6)+L"?#^129)>N>5#C[[,TX9QMA<. MT+E*:-_SPEVXP+1993DXP+!;#=VO[3NRC$EHNYN5#-#?G)ZY]MOB1W;^TN39 M][RB$&W($V9@Q]@#0K]E^`HFN[W9]S(#/QLKH_OD5(A?[/R5YH>C@'2'X`B- M+;/GF/(4(@HTCB]EI*P``?#7*G,L#8A(\B3_G_-,'-=V,'7"F1<0@%L[RL5] MCI2VE9ZX8.4_!2(HJB7Q+R034'\9]QU_'I)P.L[B*D728)R(9+-JV-F"JH$U M>9U@#9(E,%^=*1VMU[>L@CPDN4.6M0WE#BXXY.=Q0\*`K-Q'"&IZ`46O@$S$ M]HI`V\@;:R]<$-RJAECHJE_/PU4<@E'MWA/01P<2$Q'T(\5X< M&VJ#]ZA%,-2')@Y"V=$7*1#DJW4P->5M1Q'Q$,*0#\OHP<82"6`+#0<=)ZUM M"%*K$&P$ILA(@6:R8#QS;#LP%NMC`K0Z8+28]0*P#_`6,OU5!V,&US^-PZ!'E!$ M`Y!XD,7T@#WO=@^J0W9:0'<[$(52/2`PBT'M!Q-!7BDG`^$3W,]MMDT#V/-N M-Z`ZI&&`S!G$P"HD'64P/D,MW>$#T:#L@"C50)=MQ2#P(,3U@ MZ]/R<./&5@W3R$<8S+OY4*C%1)TJ'.U0=LG&"`!O$ABSUQB4"W5/4,?HDC8' MNJ5%P:V4G?`.X,/"[=OV?G+GX_FS\S[">XN\>;0#<&VHDP/]D32'O.)60?=` MZ3DST-2HBX=Z$*R6A_<=$W!AD#^/<$&D<&KV'`#O&1/7!UC8;:^&PO=V]R:W-H965T M<9]>0 MQ%J5E+J;W6]_>QAF9+K5=GE6ZT<3ZO]RVJ;[=/'ZJ_T6/WKZ;__>?C,#M^.[VEZ MJD"&_?&Q^GXZ??3J]>/Z/=VMCK7L(]U#RVMVV*U.\.?AK7[\.*2KESQHMZW; MC4:[OEMM]E69H7>X)T?V^KI9IX-L_7V7[D\RR2'=KDZP_\?WS<=19=NM[TFW M6QV^??_XLLYV'Y#BZV:[.?W*DU8KNW4O>-MGA]77+?3[I]5:K57N_`^2?K=9 M'[)C]GJJ0;JZW%':9[?NUB'3T\/+!GH@#GOED+X^5O^V>DO;JM:?'O(#],\F M_3R6OE>.[]GGZ+!Y"3?[%(XVU$E4X&N6?1-H\"(D"*Z3:"^OP.Q0>4E?5]^W MIT7VZ:>;M_<3E-N!'HF.]5Y^#=+C&HXHI*G9CLBTSK:P`_!_9;<1UH`CLOJ9 M?WYN7D[OC]5FN^9T&DT+\,K7]'CR-B)EM;+^?CQENW\EE/=()[&+)/!9)+'M MFM5JM$6.&W'-(@X^B[A.K>LXK7:W\;S\M53[Q16T6]N#&,;%4X<07%7+OGJK:"7L7L;93L[N.Y7!& MLU09Q9%.9O@WLTJ%UAG&]S;6UOY07RYJ[=U.2KD M@\Q@=5H]/1RRSPJ,W.".X\=*G`>LGLBFAA=98SW@7!MO8*`16?X6:?)D,)0< M89#\\60YEOM0_P$CV[J`^A*"(W6&[*9E0L\*$B.92#W`PA`+'A9&6/"Q$&!A MC(4)%D(L1%B88B%60JG#9F]GBE"]G6-A@84$"\N24(>JZM+"[YV4M@DEOGSF M4)44468ENQUSI_L2*=?1-HEG1:AN#6A6RVXVS:@AA5HFX5$"TB!H1"&,^!2! M/(ZYL>`BU#:A\44(';#)!:B!?!]>8.QFU]Q:=!%"/[/I):C5,#/%$KI1PYDB M5`WG2CB[&1_7A4)43**$[Y4#`09_H63SA_X5T3!'*<\R#@VZGU?0G"* MTB,1JNNS(E1/!DJX&C)D"8\E1BSALT3`$F.6F+!$R!(12TQ9(F:)F2)4H>9* MN%JHA2)42**$JR%+16"/@H6(1ZV.F(DSPZP(?*R"];4#+1L-"7W)=/+3J=NP ML45ELPL3GG,.!R<9E),TK38:+(;E9JO316.@5VZV+1>-\R.CN=%%`[I?;K8< M/)H%Y>9F$P\FXW*SZZ*#,RFW6MTV.CAAN=ENX*E(5&ZVNGA\F!K-;9P\-INM M#CHL,]G>RJ_&Q!QF7@[HN"VTLPO,)P;?[*"^+TN\,6*"ZX@;^3.^B$)6=&S4 MI;Z$8,/::Z@3SXI0OZJ!$JZ&#%G"8XD12_@L$;#$F"4F+!&R1,024Y:()=$N MYN#=!OI%SU0&5:9Y.:#3P5Y?8#XQ>!L;95GB#6_",/4'WA11IC?=%II=]25S MRYJ*4'T>*.&Z-5G"8XD12_@L$;#$F"4F+!&R1,024Y:()2&M:;>[7:?10!.S MF4JB*C4W8]QVA\0L<$QBQ'1:+8O$+$LQADOA%H#ATMO72H)&[L0GN;YD;KE3 M$:K/`R5<=R=+>"PQ8@F?)0*6&+/$A"5"EHA88LH2L23\";"PQ M8@F?)0*6&+/$A"5"EHA88LH2L22D-[M6DYQY9Q+`5ZUHECHOIVFU6B3-XJXT M23E-T^J2-$LNC>%OL0SS!P;/PTR'NVU\?55`MQRN$6UQK5SW.(]X/#+B$9]' M`AX9\\B$1T(>B7ADRB-Q@113VD[;I1:;Z32J;',4U;+H!'5!HA(4U7%<:N=R ME&E=L4A`UGGNN5$EU@_1^.PZ>'@N(#5YHHLZ,@G^U:/[&@.4QD+M0]3>0),F M#[>C$]W(:._4X/B5_W6&7]"OTC<"&C6\P0"U6RA^C-H;Z+A-C/8[=BC\W8#( M"*`]F#+M,6IWVL8LUT7C]JS`2[>^4`);_$)*_]#<94$2)#@!*OJR'&%Z7BPL M8,_S63"(R&/ M1#PRY9&X0.1XW7;:8$1S76RFDYQ':UG&8KHM[C_@H`4)2HP-P1-3-&A9#C)] M*Q8;RKZ]?1-"/)R!!FBXN,,WR0KJIE]+BQS%TKM2;LPO6,3C-SWB$9]'`AX9 M\\B$1T(>B7ADRB,QC\PT/*1.6!5BGGU.BT,>3S>CPRXA&?1P(>&?/(A$="'HEX M9,HC,8_,-'(V+ENU!0E*M'*UU$N-$..*Q8KR2'NG<>4:1WF&X+;0U*\O'F(# M=]_TK4+4$1CP04,>\7ADQ",^CP0\,N:1"8^$/!+QR)1'8HV(1]B^--OH-#K3 M[:ID"3DD8A'ICP2\\A,(ZIJ62F$56UN5:N5FVA$164:.5JT%(C MQ+ABB>,/C"M71LHC[H6)@5H^N;I?SY9"5&<&6KD:-.01CT=&/.+S2,`C8QZ9 M\$C((Q&/3'DD+A#Y,-Z7)ED>UBE4R>9F!#Q;AR<&N,@)BL`/NBS+VS`OP,0R M1MFNS,1`KGK87?V`6E^\A``C94EZIM*`2D,J>50:446?$FNCAY/F/GBNM()0TIY5%I1"6? M2@&5QE2:4"FD4D2E*95B*LVH-*?2@DH)E<2[G_G(Z>9O<>;OW\AW.>5K5KOT M\)8^I]OML;+.OHOW-,4BF5;5.Z1N3PP6<,11"_QTX?72_`U1TJ)?/,4M5@]> M1:*Y8@BXI/?M'KRP_`2"-7G=@]>]*!Z8L.N"KVN=PA>1/U8O:71ZO"V MV1\KV_05#@"\?`@#W4&^RBK_.&4?^3M'7[,3O(*:?WV'5XY3>'8:'L6J5EZS M[*3^$!O0+S$__1\``/__`P!02P,$%``&``@````A`("@)E1)`P``Y0H``!D` M``!X;"]W;W)K&ULC%9=;YLP%'V?M/^`>"]@0J"- MDE1-4+=*FS1-^WAVP`2K@)'M-.V_W[6=D!A6Z$L;\+G'Y]Q[L>_R_K6NG!?" M!67-RD5>X#JDR5A.F_W*_?WK\>;6=83$38XKUI"5^T:$>[_^_&EY9/Q9E(1( M!Q@:L7)+*=N%[XNL)#46'FM)`RL%XS66\,CWOF@YP;D.JBL_#(+8KS%M7,.P MX!_A8$5!,Y*R[%"31AH23BHL0;\H:2O.;'7V$;H:\^=#>Y.QN@6*':VH?-.D MKE-GBZ=]PSC>5>#[%44X.W/KAP%]33/.!"ND!W2^$3KT?.??^<"T7N84'*BT M.YP4*_A`M@/GLS.CHO+YG%3PJ MD@?%HKG`A8#ZO*S1',5+_P62FIU`&P.";^("LA';,T)E4/&F5R]\$-RIAEST M5<^@JO^OQUFD"NJ)#`-D2]@,0:&-V`X1L\B&I$,(NMK([:RS$Q4$ M/72=293P3E]!*F@@?K+!GK_C0&-)7\2D8XA+!MW0QO3 M/:2")GO(@,9L3"+2,81E`VY_JQSC3:31@SKTO^43RAQ!M_/^/6`M(Y3TUM5` MHK)DPE$<7`X"H]Q,&^8RK@G?DRVI*N%D[*`F"03-V[TU4\Y&33EZ3ND68,AH M\9Y\QWQ/&^%4I(#0P$O@".%F3#$/DK7ZYMLQ">.%_EG".$G@C@T\`!>,R?.# M&H2Z`77]#P``__\#`%!+`P04``8`"````"$`<"UX#'4&``!F(0``&0```'AL M+W=O-F<@O;6%-FA MOZFZ!.%RN0JJK+SZ&.&AF1.C/A[+O)!U_E(5UPZ#-,4EZR#_]ES>VGNT*I\3 MKLJ:3R^W=WE=W2#$ZR9XOH/N+B+/\'KM_,0E?E7E3 MM_6Q6T"X`!.=:MX&VP`B/3T>2E"@AMUKBN/._R`>9+3Q@Z?'?H#^+8O7=O2[ MUY[KUU^:\O![>2U@M*%.J@+/=?U)H;\=U%MPKJ/X2$#H5!0AT$?NH@8;B(PV2]>4N4 M2$>)AR@B7(2;1"0K=RX!ZNJ'269=]O38U*\>]!YDWMXRU(:C;H(0->NHDI(T@,N`Q7$8$$](^^.JFG0^# M-60HQ&;)9""TC?O.62XV";V>XG7X/@1A,J6-(")@W+D(=RW434Q$'*UIDGN$ MM`BQ$/&6?%$Z973()$N\;I9,!*VH('LU%#P1PIL*H15.XQ48%BM72H!D.P'D M&$BV!""YKVGN:F*X.TK=--&PI<.[1P@U;->3#-/Q]?54HAQ?7\7C^XD`M4U@ MJZ=;@+J)"XC9&.\16O=%",/-.(-^ZJ<$$"1%7#L)$!*`:-A.-:RD]2(B0$%:))$I+`A5(NRRK=K08-E=6$NO%=_*H#BL181QVSSD1HHAD@K0N4H M\QS)L1NZ0*ME,OC61%-C&2S!U(U(*T(U*/L<:9BWXQ5HNC`5AFV>8`[+&%S9JW!B4AK%*(A_"%_[^]R+EF:L@QVZD:D%:%:F+_;>RHT^7K$>TI3 MV%/"M&VGA&G?3@C;QCV$YIC?4#T]V2U.!*B8.Q^WO$DTW92G.HZE3-**T!H8 M[-QM@:'1SKEM:&JE6C*JF5J]DRNM$:A6IB-S[/`T&CGD_9":JP%VHMM]%,= M:TQ-Y$P#?4.H'(.CNS?R(1HQ=9*$;^0U94DT=2/2BE`MRC=';CBS-.BVCMU) M:/-D=$4W(JT(U<*CD M;-KS]HJ0&C[U9==3?=TJ!$.8$2J$N;VCL0PN+S9\!QPA97XZSG4W(JT(U0!/ M&D^.F<50=SEWP!%25BU.1%JC4"T_9/41.K2KL9`:/HF?-);;Y_6#S,-!A1A\ M7JT5C@8S^7PR6;EL]JP;S(G(R(90+0:3=V^)(S1YU\J%E'E$M18G(O6SS%&H M%H/)SZ@+VC=K,/YQ"AQ8JREESD)K043_A6_Z<%(=>W\_"FK!8VT\KZV*YE2D MQ>72>GG]HHZL0S@<&-X=CM,_A.J@D[V_AV/V_DPZ&"[`*? MI3A"R.5B#9.CP7-R?-'5M_Z4^+GNX'R[__4,_\]0P/'L<@'PL:Z[^PMX<##\ MA\33_P```/__`P!02P,$%``&``@````A`,[7V5?O`P``W`\``!D```!X;"]W M;W)K&ULC)==;ZLX$(;O5]K_@+@_`1-"/I3DZ"15 M=X^T1UJM]N/:`2=!!8RPV[3_?L<>FF##,?2B#?GTO"^^--2+G MU M1*C$SK]*66^"0*175E(QXS6KX)LS;THJX;*Y!*)N&,WTHK((HC!,@I+FE8\1 M-LV4&/Q\SE/VQ-/7DE42@S2LH!+XQ36OQ6>T,IT2KJ3-RVO])>5E#2%.>9'+ M#QW4]\IT\_U2\8:>"LC[G<0T_8RM+WKARSQMN.!G.8-P`8+VQ,7POY%[_]SO++54*[%Y"12FR3?3PQD4)%(?/D]EB&(,:IJWHT!=%IN+85\SCNR0`P#LE MY&Y3QC^M_R>E6@39^-Z#DBQM2A3%'5%R1]#)'ET*`Q+NU(5TEU")=S[$?L#% MB[5YZP.*$EWA51RJ'U-Q1,4PO@$'DNEP2FS"+6.K+`?4(-L\G`^P&8IE`GO6 M@]Y@@TYVV:9Y4"TR&4FW=`$8#C"4Z!D9VP56&O(Z)L:#>[E0SG8`*J+7VR$PD.@"Y@ MWXJM"/F2(3J,@H)8)7!WBLEF39%I7B1#XR2QYNVA50U7"-WHE)B@$*9;Q(EV M5*O&[8@J)ZA+8H):XV7$CD-SI;T#]?.MD5@C9:(?!V>+-7L/.C9L8H[Q[)28;;;&RT0_XHB`Q^?^ MAD#Z+XD$54Y0E\0$M:;-2+^'QDS?CZCJ["Z=_:5M^.1!`R&ULE%==CZLV$'VOU/^`>%_`?&ZBD*L%M.V56JFJ>F^?"3@)6L`(.YO=?]\Q M!F*;+;MY20(^/IPS,V8FNV]O36V\XIY6I(U-9#FF@=N"E%5[BLT?_SP_/)H& M97E;YC5I<6R^8VI^V__ZR^Y*^A=ZQI@9P-#2V#PSUFUMFQ9GW.34(AUN8>5( M^B9G<-F?;-KU."^'34UMNXX3VDU>M:9@V/9?X2#'8U7@C!27!K=,D/2XSAGH MI^>JHQ-;4WR%KLG[ETOW4)"F`XI#55?L?2`UC:;8?C^UI,\/-?A^0WY>3-S# MQ8*^J8J>4')D%M#90NC2\\;>V,"TWY45..!A-WI\C,TGM,V0;]K[W1"@GQ6^ M4NFW0<_D^EM?E7]4+89H0YYX!@Z$O'#H]Y+?@LWV8O?SD(&_>J/$Q_Q2L[_) M]7=_\\J>.0D3YPE-J'<83N%_+SN MD1]Z._L5@EJ,H.0#D(I()P2/(.?-I!LV")Y50RQDU1_G81+'P5S"%O@Q0M(?W:.=@7;NGAUZ` MA';76TI+%8"[-)?)`"\$Z3=SBO;H'NT2^77I3K9( MY^"%^$B+O0"-->\N`YLJ@`\.128#M$.A:$?PJI0C_[7WSK!KX4*O_A&U&8YN M8/G:>JJM;VXO^+$_<6VQ*?9'EG.+DFJ!]S&I>+[6`9#H?FH+"#=:(D:4D!!: MFL)460XL3]N>:>OH%@'5`6]W]SL035)U$-W>#T,0$R104Q)N"L0I&)>C(4>W M`(\)D/=&,`[-T5'E\R9WOWS1&C7Y6H03)%"3?$];3\?UM6.L44AEJ+K@/>Y^ M%Z(S:BZTB2>!\?E6R8$5:NNIMBY)'!.A[I=.BK`@9FLQ>C:X/^$4US4U"G+A M<[,+R9WOSC/]D\MG-NU^PF=]?M^>%V#4[O(3_C/O3U5+C1H?@=*Q(NBJO1C6 MQ04CW3#P'@B#(7OX>88_51@F3<<"\)$0-EWP!\Q_T_;_`0``__\#`%!+`P04 M``8`"````"$`WX6T0G8$``"F$0``&0```'AL+W=OJ96JZISVFA`G00LXPF2S M^^\[@TD6VRS0F^P&/Q[\SHS'XVR^O1>Y\48KGK%R:Y*9;1JT3-DA*T];\^>/ MEZ>E:?`Z*0])SDJZ-3\H-[_M?OUE1;\US7E[5E\?1,BX3/ MV(66,')D59'4\+4Z6?Q2T>303"IRR[%MSRJ2K#2%A74UQ08['K.41BR]%K2L MA9&*YDD-Z^?G[,+OUHITBKDBJ5ZOEZ>4%19+>;3=?-/-%EE:,LV,]`W.66*BN>66M++"TVQPR4(!N-RIZW)K/9!T3 MS[1VF\9!_V3TQCO_&_S,;K]5V>&/K*3@;8@31F#/V"NBWP_X""9;VNR7)@)_ M5<:!'I-K7O_-;K_3['2N(=P+4(3"UH>/B/(4/`IF9LX"+:4LAP7`IU%DF!K@ MD>2]^7O+#O5Y:[K>;.';+@'OV1HTC32*Z]9\:^`2&M*&'%:(S"C->(X M4XU88D&-OBBID]VF8C<#D@9>R2\)IB!9@V$4YH)[Q#(>4K]2"A+1R#-:V9J0 M[3"=0WC>=F3NNQOK#7R:ME#0`\E$>"?0@6@W4A_$G0<6*'C(`-]T9?3'Y;Y: MA'&U]]<$X@'8?BS?45:F$^Y<1B(=(3:1F;B'F?N?AB1)KBP)(S/_,N7NTG`2 M1+"CA!!_*:\B$-"\`WDR$8X2T2@1#Q&24%C(]-@AO#7!CX]00:8MY.4'`O*; M1%PZ_MRV;9D(NP1QG(5&1(*`S\>+%"?%71N>[79-2/H@:-/U(:SJ6RAI%`AH M8&WA*!&-$O$0(0GT9('3,A4GC6:J@(:$CA+1*!$/$9)07Q8Z7&405B/I?>[U MIL`%`O)$R81#74O4+K#RM?&H.[Y8:N.Q&._WH*0-6Y7.03"L#6%5FZN6&0$) M;;ZT/1KM87?+:`RH7L@D@$]_'$+3%&(I_[DW"2B M1Y"/",^7#X"@I>X[3P]`J!"Z#R*)Z-FP3[@ND"11K:JEL@+B?^CRI9>GP2E7Z>#-'<):Z5Y=*:QJTE"QJJ33?80^E M9$PTCL2#B*P8NX=.L$>"+'H-)EY3]<62H@_[RF\$C'W/*VT MQ1+A$JETR1JQ<>AHG)C0HMV0M2[5Q@!NLZA5]+#$)7J%#5ND&W@MI$.M37,* MX[497]1O1<@5UV)Q;2QH=:(AS7-NI.R*5UX'FI?'T\=U_-G!ZY7R/,!K.CZW M'@-P2[XD)_IG4IVRDALY/8))>^9#J"MQSQ9?:G9I+JM[5L/]N/GW#+^'4+@E MVC.`CXS5]R_X@LD76DTFMUY)L1)4`%'F#3MW^\U)@RV4YR^I,4Y7.SC:^R; MY=>WJC1><4,+4J],-+--`]HM6Y8^$J[+F MY7)^RDEUAA"[HBS:]RZH:51Y].U8DR;;E3#N-^1E^2UV=Z&$KXJ\(90PXC M8@.+]N\QICD8A3`S9\XBY:2$#L"G414L-!O+DKZD@UD#`25QV)]^%* MN(V$W00I,5*)4!"*O=AP"+)[\.V+Q%9+Q%HBT1+I%"&H@*Z.)W5Z,AF\,L'T M,#KD^5+*;3@TI4!+Q%HBX83/5]A\8=NVZ#F="B$8@(E_W`"#90.NG`0<@@X, MFN0DT!*QED@XT1L(83.5#0B`J$@0`"^[QP4P6!;@R^\W#DT)T!*QED@XP04\ M+>ZDP%0(P4#P&0,,5@Q($[SAT)0!+1%KB803O0%?S8"I"((`=L8;[7W3;P$& M*P("FI*AAZ)]4AR!X&C@K1#I7>I M\/<$BE[8`6FT-I@7_6$!\6.5N%6&TMEKTU.37GB@"2361TGN('`LE:8IO4-] M)(6=MD92-$G"SV:BC$#>-!"G@FY+#YU`3>:M@"#'F2OY'@N(;[L*D0B$XZ,[ M.Z>`+$)A:Q&3@YVS1AX>7#3\=";Z"*4LW4`MR%XS$S._U2.Q'DEZA(MW("T4 M9ZPN_;@OW`BO.WE%5>'FB+>X+*F1DPNK*3V8U:%UJ'>?'5872.T;%$&1H+9O M402U@MH>HPA*!FBWAD!0MIZS(_XG:XY%38T2'Z`+]BR`$U'#"U]^T9)S5_?M M2`L%:_?O"7Z@P%"GV#.`#X2TMPOV@.$GC_7_````__\#`%!+`P04``8`"``` M`"$`ER00%$D&```K'0``&0```'AL+W=O5>M+I=`^O64(2U!`B8+OMM[\Q8[)X M<(%T7R0;_//@_\S8'O#C^V_5V?A:-&U97W8FLS:F45SR>E]>CCOSG[\_O@M- MH^VRRSX[UY=B9WXO6O/]TZ^_/+[6S9?V5!2=`18N[ZJ;(.?C9'N[TV1;;O.U5GV]EL?+O*RHN)%AZ:-3;JPZ',B[3.7ZKB MTJ&1ICAG'8R_/977=K!6Y6O,55GSY>7Z+J^K*YAX+L]E][TW:AI5_O#I>*F; M[/D,NK\Q-\L'V_V/B?FJS)NZK0^=!>9L'.A4MR7H$"XW6B*P\[\ MP!ZX$YKVTV/OH'_+XK4=_6^TI_KUMZ;UJT.7@4S%B.)RSE]1D& M`)]&58K4`(]DW_KOUW+?G7;FUK>\8+-E@!O/1=M]+(5)T\A?VJZN_D.(25-H MQ)%&MC!Z;'>VENMX07B/%5=:@6]IA3F6$WK,\^\8"XRZ%P3?]X_%1N_TSDZS M+GMZ;.I7`S(8]+?73,P']@"6!R^C3VY^_Y';P=_"R`=A96?"U`./MI`K7Y^8 M&X:/]E<(<"ZA6`.I1#(0(IK";DHO\-$%&Q3<9$"@QC+T23*,5L!BM,-M8KP` MMF_#=\C(IL3659%TBK`-4QFN8=S@S9`B"7)N+$E$QH4(S4L3G2#31TH8"V@@ M$()LO,GUU7$FBT2Z2/`Y0A$*`Z%"M[![4]XD"3*.;*NTB,VG\.1(KU(FR:;0/S.>F M@*FZB*QU,4)2'7,G8TL4P-'H3Q5BVT]/-;\Y$BOT1??H$_!$']D28H3DW`LB MC<`QH5U^4H70+3]<)=3E1UE<&"R9ZR/8TU1B0!-44H-&]>Y]#B<2T4=`;N)B M9+!Y:1?('N&S5E29H@)8G:@,ZP5UFXBV:A+%DI(RM\%TIB42F=&0+B-\%E%E MBDIA)%/L_LN;(L/Z@LA]JR]PV9%4U&^+OC6J/V1(TC2H2`TJ&)F^"1NW>Y8?J/U3TLZ(%[AL7Z,2F)]0*7K1&1I- M9BA2J#*P7%(@)&S<#BI)+J1*NVMY$Y78'SZ7BAOQ;/83*K&\(+$DL8A[VSL3 M57J61[R0*.V!1WZ44JM:&(&X;-6E+@ZI`A:MVWVONM#6FWL:*P5Y&^"RB*H;D MO#^Q'=%K$FRZ&$MJK`6"35:S1$--%./MQH8(PF>MJ(I)O33_E.;HZJ2`)%DL MJ:"O!D,GT#S'*`ASG.F#>"J169DX'+R1O]F.'PA5E6#E)^(J>I&XNB&9>+&# M%);ZH;.92DDD,B,E74;X+*+*)8730E`U!9/'Z!XD7BN#,]#77A1,WUHE$IF5 MB59F$#YK195)2J<%F;J2R27S+W:0FAE@LHRDRPB?1529FN)I^;6M@V41S)!; MF:UY;RNI6;EH:`9)EZWP6425*RJ547&Q$%6L:Y2BPIV\U(13)9&\\G%<]U93 M)72O-15"^UY3$GI/H48\F\+CDJIHCD52G,^MD=X)#R0).1S86P(>Z[H8?<&/[=LSY]#\```#__P,`4$L#!!0`!@`(```` M(0"J4$5#O0(``!<'```9````>&PO=V]R:W-H965TF-)1+&&&M"O:][I$YO(WT,GJ+H_ M=%>Y%!U0['G#S9,CQ4CDJ[NJE8KN&_#]&$UI?N)VBPMZP7,EM2Q-`'3$"[WT MO"1+`DR;=<'!@4T[4JQ,\4VTRF:8;-8N/[\X.^JS9Z1K>?RD>/&%MPR2#66R M!=A+>6^A=X5]!<'D(OK6%>";0@4KZ:$QW^7Q,^-5;:#:,S!D?:V*IXSI'!(* M-$'L9.2R`0'PBP2WG0$)H8_N_\@+4Z=XD@2S>3B)`([V3)M;;BDQR@_:2/'; M@R(KJB>)GTFFH/YY/P[BQ2R:)6^S$*_(&19DAO+XKC`A8;R/&RB612MR0,D-7\&;3T(KL0+:(C8G1#6MN7- MSEX0$-RKAER,54^@JG^OQTFD#1J)#,.A@NTE)AXB=I>(R70(R2XA4?B2C(&1 MR=#(ZP8L&%KG+('SZ4C>UF.@DGV2DZ&ZW9N([#7$0#T<\_]EL$$IAASU"A>+ MY5#CUF.6KI/B8#9*\&ZXG((XL8C>F%?N!Y2_OX*IBNU8TVB4RX,=/A&0>:_@` M,;B680#@4DIS6MC9V7_2-G\```#__P,`4$L#!!0`!@`(````(0"9UX@/]0,` M`*@.```9````>&PO=V]R:W-H965T,ZJK4DLQS1HE;(LKXY;\\>_SP^/IL%%4F5)P2JZ-=\I-[_L M?O]MUY1 MR#;4"2NP9^P%H=\R;()@>Q3]W%;@[\;(Z"$Y%^(?=OF3YL>3@'+[X`B-K;/W MF/(4,@HTENLC4\H*$`#?1IGCT(",)&_M[R7/Q&EK+I:6OW(6!.#&GG+QG".E M::1G+ECYGP21CDJ2N!W)`M3+?G=A>:Z_>KR'Q>M8X+=C(:[E/OK$7][68DM? M;9KB1"2[3<,N!HP]4,[K!$0@F">O6@I8J( M;B+B*80B'UXSE'\=(M-)QR"8+`.%A*P>59&A!$W9N(F(IQ"*#1C50QO3\A&L M5B%PM$$22LQ0/0SZA6HQF@.*/P(Y?L^DV%C>8P/!N@UMI(02$WCMM'4LK3N: M[H[U[D]4K^Y1C6!5M4M6?3;D#)"83C6Q`B=0/E\?M&I%,F!8+O#C7EY#8DGH2H M7G`SG#WLB-PZA_O(>`7K0$,+4+%?4[B=:M$L5'P+I7K!W7.^%[G7JEZTV1L2 M">K7L86V9T8ZP--VHU@'#!A4\;ASSA@2Y%8$7!^4=RKHG M#7#PJ:NTA7E2PW>X[X)Y0)T?Z M5](<\XH;!3T`I6.M8#=OY$U#/@A6M^?L/1-P0VC_GN!&2.&`ZU@`/C`FK@_X M@OZ.N?L?``#__P,`4$L#!!0`!@`(````(0#"AZE66@0``)<1```8````>&PO M=V]R:W-H965T&ULE)A;CZLV$,??*_4[(-Y/P"3DIB1'"VC; M([52U>NS`TZ"%G"*G_?"^77K>2R]D!*S&;V2"KXYT;K$'-[69X]=:X*SYJ*R\`+?7WHESBM71MC6 M4V+0TRE/24+36TDJ+H/4I,`<]+-+?F5=M#*=$J[$]=OM^B6EY15"'/,BYY]- M4-1#KLLAP< MB+0[-3GMW1>T3=#:]0Z[)D%_Y^3.E-<.N]#[3W6>_9)7!+(-=>+X^`?R;Y^<)AI1#2(+*QS3X3PE(H`ZPU"T(1-:4%A(!'I\S%_01IQ!]279[Q MR]Z=+V?ARI\CP)TC8?PU%R%=)[TQ3LM_)(3:4#)(T`:!YWO[_?-!YFT0>.Z" M!+-@':)P^82411L%GHA6R">#RK\?_)WW#K5-6R*2!#SV!-*)N"-$(4701/G` M`[6]9"B%*OGQ[=`I$[!0UD6-Y`>JD,`08A-SG4AL8M$3FE0HN"I59'<.S3,N M65P$G)*JL(_>9":2!)2K3^92)^+O$LD8H7F`950/X]H%O'`'KXI'1 M8)%$PJ8]%V@Y-]S%\GO5G2E]C-"DKYZ1+F!#NM&2D414: M_.I0]L3Q.U[`AOIA,Y#M*A%-O='1L8V8ZL<(3?WF&?4"-M0;"T<2T=0;/1W; MB!$D&2,T]0BVQ^G);VA#O[&=1"VC&3!O_0>,Z6`4T2V(P37Y_D%RS*E;9F!L M*E'+J!8"H[OC!XQE02ZEAAD0W8*8<-,MR'FH63`[&$E&73LP6_@!,^AK?Q/8 M809$MR`&W'0+)T-@\;0H5?Q])6F35%`J%(9QO_'!H M+=V#F('3/[3:=Y+- M6!;&$&E!'GOE^:LD]9G$I"B8D]*;.,8BJ&#_:7\N;P_,_1=PPKWB,_D5U^>\ M8DY!3G"I/UM!.]3RC"S?<'IM3G='RN%LV[R\P!\@!$Y6_@S@$Z6\>R-.Y/U? M*H?_````__\#`%!+`P04``8`"````"$`A/K&#?`"``!5"```&0```'AL+W=O MD\Q])]*]7WW\L#QP\2)+0I0##K7,W%*I M9N'[$I>$(>GQAM0P4G#!D()'L?-E(PC*VTFL\J,@F/H,T=HU#@MQBP8LP8LMK2BZKTU=1V&%\^[F@NT MK2#NMW""<.?=/HSL&<6"2UXH#^Q\`SJ.>>[/?7!:+7,*$>BT.X(4F?L0+C8S MUU\MV_S\HN0@SWX[LN2'3X+F7VA-(-FP37H#MIR_:.ESKE_!9'\T^ZG=@&_" MR4F!]I7ZS@^?"=V5"G8[@8!T7(O\_9%(#`D%&R]*M!/F%0#`I\.HK@Q("'IK MOP\T5V7FQE,O28,X!+FS)5(]46WI.G@O%6>_C2@\6AF3Z&@2`_UQ//*B61(F MT^LNOB%J`WQ$"JV6@A\<*!I84S9(EV"X`.C.6A$'8VUB8D+]SS,MX6IRYX'[*1I+VOFU:UT8S.=-,;<7FDL)B M`Y/;V;08:O1LW3B9VRNOC>82VR6%Q09GX'8V+1[D+4@&;$:3FD*,XS2*;,'& M$D2367K*O$4V_1\R+1Z01:=*,3MJ-(9LEB:S`=?Y M-*1+AHDSHGF;N,"+AVFSA\-3OO0&+>4ZGIXTPAM4^]J(>KS3^FURX0;0 M'MWP",^T=]/]&!$[LB%5)1W,][IUAQ!T_];<*FNX5=H>[/<#T-4;M"-?D=C1 M6CH5*6!JX*504,+<"^9!\:;M/5NNH)^W/TNXO@DTR\`#<<&YZAYTM^O_$*S^ M````__\#`%!+`P04``8`"````"$`""6YTLH(``#M.0``&0```'AL+W=O3AV0Q\^F[N_?FW6M9_I+E]EV_NZ MT6C5:^EVF3VOMJ_W]7GB?+NMU_+]8ON\6&?;]+[^.\WK?SW\^T^W]#\OV6ZSV-.?N]=F_KY+%\_%0IMU MD[5:-\W-8K6MBPS6[I('[)MEI>D MVRQV/S[>ORVSS3NE>%JM5_O?1=)Z;;.TO-=MMEL\K:G?OXSV8GG(7?RAI=^L MEKLLSU[V#4K7%`W5^]QK]IJ4Z>'N>44]X*N]MDM?[NO?#6MN=.O-A[MB!?V] M2C_SD]]K^5OV.=RMGOW5-J6U3=N);X&G+/O!J??,0[1P4UO:*;9`M*L]IR^+ MC_5^FGVZZ>KU;4^;NT,]XAVSGG_;:;ZD-4II&JS#,RVS-36`?M8V*SXT:(TL M?A6?GZOG_=M]W;QI=+HMTR!>>TKSO;/B*>NUY4>^SS;_"&24J4025B:ASS*) MT6FT6:=[>TT6L\S2_LK"&NRV8W1NKF@+M;KH$'T>VD+-NK`C-^7"]'E<^.JU MT2V34(E]);FZ'[TR"WT>LUS<#X/&D=BL?$"5FXQ=W1/C.#I.MNS_V";&8=/R M7X[-N;PW-")$;VC5'A>_OC>T08HTC+I5IF'LXG':%)53%**]V"\>[G;99XWV M;I0M?U_P?:5A\=2'$A0%Y3M/&ABI@;$:\-5` MH`8F:B`\!$Y6@MRYZ"`.G8O5P%0$Z&?%BIR=0&8"G!:(^CV)3I3&SG5QDD2J M!3HP7%$+7$NU(`)4"X?J>%2)K08&:L!1`T,UX*H!3PV,U,!8#?AJ(%`#$S40 MJH%(#<1J8"H"IYO/Z"CC?W:!22XP\VHC;68ZDE^QF;FF$]+3G31K*Q7:%XA^ M'O?DRL[@$0H;B@$4#A1#*%PH/"A&4(RA\*$(H)A`$4(101%#,85B!D4"Q;Q* M2!5`UR52!?"S19/.TJL/_GRI^SKM3H^#W&!M96_;%XA:"'PH9B`(4#Q1`*%PH/BA$48RA\*`(H)E"$4$10Q%!, MA>B*L=]M%?^4$H!)$BCF54(J`;J5<44)<*V5@'*%U1>HJ@2@L*$80.%`,83" MA<*#8@3%&`H?B@"*"10A%!$4,113(6Z*$C#I/CW]4RH`YDB@F%<)J0+X(XC3 M^V;5!P&NM0I0[@WT!:JJ`"AL*`90.%`,H7"A\*`803&&PH`>:L6@#!5!0"%#<4`"@>*(10N M%!X4(RC&4/A0!%!,H`BAB*"(H9@*(0J`B4.`>@Q0B-G1#A,)_)YY91*I!OBC M*JD(+KL@+A:3JX&NB)7KW7ZIJNH!$QN3`28.)D-,7$P\3$:8C#'Q,0DPF6`2 M8A)A$F,R+8FHCS8?^=HI$LZ28#*O)')]\*='EY\F\4>VRE&"ZD*Y\]LO57DK MH-5H*4\T'DM043@V)@-,'$R&F+B8>)B,,!ECXF,28#+!),0DPB3&9(K)#),$ MDWDED:N"/UDZK8H+CQKB@91R'U49_'U#J(K!_XB)C3(28N)AXF(TS& MF/B8!)A,,`E+4I[L\+-]^6HWDL"W+C\=DD6,OV6*R0R3!)-Y)9&+@S^0.RV. MZBMK/BE'.61TE171+TUE28@TAXNKV[:V.FV<98")@\FP)&5;>H:^:5V)B,,!ECXF,28#+!),0DPB3&9(K)#),$DWE)1`6QHH*^QJY<'_R)WFE] M@),I\0!0J0MUSI)1]9BPF([[6!+QP-+LM&E.OEKEMFQHEKR^)QC(QNP4-_WD MTUQ'-IV.>:-]UU`V[-S-8HQ;_<1\)!N:!6UH><:R:9D]??WX MDF&]FXY^3AHHQNSJ;9Y(AEK3T]=/*!FCW>K>F%JC(QF91K=X""%OC5A&]&5, M_[IIB2KVK#,IC\E7H3J`$IQE7DGD2N%/_JZH%/&@4*D4=4X3O3L#CR"0V#C+ M`!,'DR$F+B8>)B-,QICXF`283#`)2W*\X6@J>\1(`\KDAE@#RKW^*6[%#),$ M$_XZ%Q^27WWY:JJH!_®A'9)/N7M/'=+W.:\OL@[^(Q5KT`/X8%F^)39A% MLWYI[K(2#YE%DW_U>,0LF@.LQV-FQ>?B+K-H[K+N/6;1%&8]/F(6S636XV-F MT81F/>XSB^8UZ_&`632]68_36W'?S\4?#8M>]]!]:%CQN7C"WZX[X_O,ZI_- MSRR:&*[GMYE%\\/U^(!9-$UGS(+)HT3O'F<4/2RW;OB] M5]N\MDY?:`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`&R']/'N_- MT!"+W/[U^;0K%[[_^OKC\VGOXL/@\KS7$?&37]ILDIZ3HG\=4KZ'SX.!OV+CY>B9$_%OJLH?UW%SL7>"J)NVUSYZRIT>X== M2O1N:\K?X]IXZ2K*W\/:*%-K>R7Y>V0;KUQ-^>LO=?FATS^_,+[88\:.#)OM M)/FT&%@YH9M M4B6/WBH)\MX M^P;N9Y&I)5NUFD4?M0=NK$PWGFH76F2X$]EY"20'*4!*D`JD!FE`1B!CD`G( M%&0&,@=9@"Q!5C%17I.-!UXS6\N1BZ%1([&7K*9[5D,GM,^/.Y&='T%RD`*D M!*E`:I`&9`0R!IF`3$%F('.0!<@29!43Y4=QF?+C_EEGI+?N\F:^L<3,U\B! M5\DLVPGY:AE(#E*`E"`52`W2@(Q`QB`3D"G(#&0.L@!9@JQBHKPC<=81WC'2 MVCN6]&3I#=ZY.D^\LQ/:>0OU=5#$$R4!RD`*D!*E`:I`&9`0R!IF`3$%F('.0!<@2 M9!43Y0K9&XYPA9'6KK!$7!%/E#3FW@GM)@I(#E*`E"`52`W2@(Q`QB`3D"G( M#&0.L@!9@JQBHKPCV_L1WC'2VCN62-;I#3]TY')',I`\_KB_^^UF(TNJ9!TM&V9/LCJ7ZQDMNB];Q5(SFO4.=4V]/[YTSSL] MO4)G0<`;('>H%U*2(D@Y-4E&4@8!4:-[:](GYK:AM__:_'RKMW(TL^NNS<(D MG//MO#&'*F(!%H[!ZS,74''\3`1^;>YA0W]9R+=654[09=_RI-YUQ%Y:SE2HZU*AN.D.Q4T'RGW%(%40E0KIIILD(IX4_U8N:Z+')%QP2,++X`PG M]68NZ]5L'PG9;EBY0W$N&Z3>R&6#@%Q:]];D"OMZ>U@N*]DXNFN1B:9WT='@ M/#TE\A5C*2:S7DK"MIVN/I)9)R4[E#=PX2ON55]Z*:6^%[)+;3'1M==B!YUU MF.P]'1\6)09+,O:AJ]@/(R+S*&X^DQ\GI:QCKQCI*KTN*=E9NG<98EIM"KGB M?\`41DNR;EF4F"(XQ(9N.X>H+WTC MWE*O#=:6CG0&QYX<=9F+.!1E&4.BC"@G*HA*HHJH)FJ(1D1CH@G1E&A&-"=: M$"V)5@IIMYF$(%XDW]G-;/X0QTE=EU+$NQE01JFRQ32+3@ND)9+ M8\5S47-\9CTQL.T/SM/3\R#E*V9$.5%!5!)51#51 M0S0B&A--B*9$,Z(YT8)H2;122'LL39OV[Y'F*8LDZ',H.C@8$F5$.5%!5!)5 M1#510S0B&A--B*9$,Z(YT8)H2;122+LGS?/><0_SN9Y%RCU`&:5RHH*H)*J( M:J*&:$0T)IH038EF1'.B!=&2:*60=H_)Q(Y8[VSBIM8[B^*C'K/VR1R+,KZ, M*"I6%>XD;K5U00IT:6-93*D>(#\6R=Q/9MGJ7'C4J\K M^T)!YZ(7#CCLT8*O)`O?;P^0%?9KBM9,BKJJMLK8GUP5Y00 M_WV3]M.T;GN__\*\S-CV[%GTT-&VIL[P'$JLF[A\Z*1BZWI=RKK=9);F7GUD M7>HJVW4E\ZJBKKJ]8C*)&G_%PZQ[7%;69U;FD#9I-YEZ0R>E3.IT:9.&B;5= MMG.O/C:IK1CI*GV[M*YDUE345?MVB\E4:?P5 ME>'?-*G)2N*PX1V3VB0FC@_DA@A,VD_:-'1"TC2_86<.F;MM87STDKF:>^WQ M(+47C'25[;J2Z5M15^W0Y;D/;OI)I<9)F'$:FOFF-4T2<80U; M6+E#R@P[J^H@ M%>E"E!ZD8-+W$I_#HG1S8S0Y8W-([[^(TGU%F6P[6S!*]U(R%G=2C-+]%6-3 MNW;M55^VJH]NRF^'0$7UM4-[HG0O(9%EU/(PNO1BD*9,[VPG3(WZK:E1$F\, MO50P5.90LI^$=KJ@QZD/%0M7,5I?RW9=22,J-J)NK=C!^F`;<>">8D+Z>'T] M/$JWR8!::BU*AG02>@S[3BH8*7-(6Y=1.BH6KJ*RKFN7WOF3R+!B(^KV1F#' MMNH/L^X@S8'V#]BMN%YY'=(F193NI2*3>EW*#'@,GQ4+AV*3MNKJ)7M<15VU MUZ7"&T3IK5)O!4$#T:4&[#LF->*)22U*3)KT9KB]CCZQ=2@9I*)22U2)D64OKU,8E&G2OZ$ M9J8G@#DK%@XIB[;I2AM145?MT)XHW5_M,&N:!")>4=\9H#;?B)?1@45R7.^C MI"%11I03%40E4454$S5$(Z(QT81H2C0CFA,MB)9$*X54##$P:#G91W8D:4$Q5$)5%%5!,U1".B,=&$:$HT(YH3 M+8B61"N%M,?2I/.=]D">P[[F&B:HY)9+\W=X^C"97$Q<,@%2;4KJ)'.:4*HI*H M(JJ)&J(1T9AH0C0EFA'-B19$2Z*50MIC)G\[8@FTZ9Y:`BU2$PHH&P#E1`51 M2501U40-T8AH3#0AFA+-B.9$"Z(ET4HA[1Z3`![A'I>.QNN=12J``,H&0#E1 M0502540U44,T(AH338BF1#.B.=&":$FT4DBYY^*XE'LKKI,9A^+'=SR*\FNB MG*@@*HDJHIJH44CWV223AP_)"Y=[1D/2(=5G*Q4=IF9>*I@A)RJ(2J**J"9J M%-)]-NE>W.=_ZZS[PB6-L2DLDES6[UI#+_7FNV%!P-?)'8K,5P2I-]X-"P)> M3>60/,S@41VDG)HDMFV"@-311DMST]1HAYUF7S!G=4B=``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`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`WP=]HQ%AA\?BRX41CZ^;22 M5WXT#8.SO'VY??_VZ?#]`J<\QLOSMULW@10W+F\@LZ`500N!, M_QE"N#3O+O%?,4B6NO(//F8F1])*A^S&D%$=(A61FDA#I"72$>DE42)A5OL9 M(KDTF-LQ*0B5[*D4@DZI-(:,*A&IB-1$&B(MD8Y(+XE2"3.X4BE_^8O3BHL> MQ(A%?/!DCIE*R&-'R!@4FY5$*B(UD89(2Z0CTDNB:L?%:$+M+EK7[@EJCV7M MB)1$*B(UD89(2Z0CTDNB"L7%0Q:.QD(A61FDA#I"72$>DE4;4[IS2A^"%<5Q\0RH^5[1B5C"I& M-:.&4H M5TC7[!S1A)J]@5(U>Z1J)E06A"I&-:.&4N`7MRY?[N]\_'#!) M841GQOP`Q:KFZUKFJ$*4$/B=]DT]O1&PY M?1<;GCSZ/D;IHT]=K3O$&;)3'7+>*/:V3O6'1VXH"`W-N-T5/FJ1QFT9D6YH M5C-5B%+B4ZXFG\NL'UO.U<6&Z;CZB/1QI66$EM5YO?^_K-XQ*ED]4K(6!0US M'[7`GU'\S#`/4;!K8]1R93QS!8G=*:.4/B=]$QHN='ISKK6H5TC7[%SK M^<-]YDVN'.X!J9JE%?;WG3FJ8E0S:ABUC#I&O4*Z9N>3)]3L;;6J.3AML>[" MDRYS(2@958QJ1@VCEE''J%=(UXP+LZKYA_RX,I(*9I.4V7HH[X\12`-%HT9UCE0+&BG7===(\3K6H>*:.R M7!N3NXL-T_W)DE$5$*[X48::HQI&+3?L.*I72,OC+*64Y_2E(^4I,MULNM!^!"5Q"IG(9=6V;KB$*6&).5J\KFL!>9< M':,^G^N(WW4/PY1^]KP^:UDW9#&>QQM9+>O*C,%=:"B7=1')0;+<&,]8A2@E MJ]^CR-7D5<76PHEG41Z>-*)Z@>EM8Z_YBL[*@Q+2>C9-> M&:+6N!"G"6!CQ*]BKC2FZ]@PY6HBTKGH;`_'E7)UL6'*U4>D@P'I,;BQIW9L*"XMC*J8*Q58I1YSR\O*[^T`0V=UF,F!YI,>FZ$!J*N;R,2-VMW)JYO`I12E&_1Y&K MB;GD7#Z;IP$TG!$MY^IB0W%=B$CF6F[3V:5E1=1/D-5E,;)Z!%FC\]VYIY^( MDM>%B*!(NBYL[74A1"D-*5>3SV6O"YRKBPW%=2$B=5R;=+9H#5];BIQE6>:\ M$@E(#X7"7!,L?8/`;F3171Z.DO" M^/0-A1QE:AAS58QJ1@VCEE''J%=(*^1G/!VLW'J-C/):.*49I[7_"-](`PY\1.W3$J&56, M:D8-HY91QZA72-<\S7$OV'$'I&KV40*5'%4QJADUC%I&':->(5VS,YGGG^(P MH_9B%Q">'J=^]E'"B)4Q*CF&BE'-J&'4,NH8]0KIFITIG%"S]Y!R6EMX)%UK M1*G`DE'%J&;4,&H9=8QZA73-/\5\+MA\!J2D"%%''Q[$-&DU4L4T2;XZ11UY M>)`"XLAK.4V7HHX\/$@!2*-%^SD.<<$.,2!EV5?7UK+'AM(XD:I<#AN$ZF;W+I%W.S]FHY?1<;GDS?QRA]]$>6H6[QHLY<9]EG*_?E ML-RGT(#C!ZJ&EN:B[`VGZ0-3V"XT5'-9:)BDK#BJ9M0P:AEUC'J%]!"=9DO= MNLZLP`,R,ICU\"Y&I9K+@-SU=!QW\YEI6''#FE$3D'O@.^9:79ME9\L-.T9] M/E=:8VK]IEG1JN6''J,_G2O.P5L[9Z?.]V]*[;^G=`E+*K0HS;>UBE%0NY)+GZZHP MH3VG222OOIVOIG.F?,/1DRPY#5'0$K,!5UG?3LLGN.:J@SMW-HR>;-9NK(%07U#,5?5L6'* MU42D> MM"QY\1*0O+'*J&14,:H9-8Q:1AVC7B&MQ;0%QY(7'`&YQ^+CP%G9==$40D'K4LIH9>[I+4>.P8%0QJADUC%I&':->(2V1<[SG M6X:5-\AR/@Y(#0L?)5#)416CFE'#J&74,>H5TC5/L^0KMN0!F:XW<_TN1:6N M][F$,A5'U8P:1BVCCE&OD);!><\)7>_"S8S@D7C4LEL1*AE5C&I&#:.64<>H M5TC7[%QHK!G7W=//E%?!U(I'ZP')AR\1I4MZR:AB5#-J%-)'+EWJZT?.;G05 M_*+XC$1$\LC)558<53-J%-)'[OR-T-QZD;/L-;[&3://(]CK>'KM8M31!R$I M(+:I`I*&+T4=>1"2`I!&%RN=%P[0%GO>1UQ6;+P"4HN)E5@(#HN"76PH/J+* MJ(JY4K_7'-4HI(N4E@I%OG(6L:-:>62*L;GNBGA\40;4KV)DN5O+2&*K03YVL94^F*S1W&BAO6C)I\KG00 MNK^=T1%3VRL5>ULDS1,^<^FF-57Q:FZ-1(R2G1QRX4]:D\S3^^6&!,0T"JY/G:'/DN1LF20RY=LKF95W'#FE$3D"Y9 MW)O1)4NC]'K)[)/6'JF2[;?B=S%(5AQ2J8H79@JHN&'-J`G(5)QF!5WQ))OD M?I_$=K)'NN)%FC?\U2HT5*=RR*5+IE,YI$]:U9RKB<>E=*)XDNV=BS5R9LMF%KCU3)8MX(XSH$R8I#*M7) MRW3ZA8JI81UWF'(U`1GUTLFE*S9>S1K2L]SWFBU<0$J(E?VUU5V(DG>W`\*3 M(/\D:1J39S83CQR4`IN,*9M\(WI(HD=_1#`MZ1),=B5$X1H; M5QQE1+B>B89FIJA"E)@&_\79,^I6`T.NQ MFEV,$DL.1E5L*/J4HQJ%]*'CQ!GGJC,.W86;[O+(#-@T-?I3=Q.BTG&6C"I& M-:-&(5V-LS+1-YY137`^XC[$QB-3C9UZ8Y2L)N2*3S:7::;T2IN5#-J`AKS;(X] M2-PX5R)[]8?FVB&+&;H9-T47G=!.3K41!05F]D%N%0+4'./W)=(T)LU\D4X: M/:JEA7)]_6/UL[7:!*1F6OOIHUV(4C.M;P@CZ(?`UC:J0B.E0&@D9UF=9[40 M7_O7$CC+(H?`*S.L=SAJA@VF1\ZP(4K.L(2J36B8SH`Z(/QZ3YRM&X7TH3OO M(0_]QWHO^!PY5053@],Q7>Y69MK9;7R4,[!C%-V-*6,4:AVC5BMKHT*4ZM1S MTC?Y]$>WY#&G._>`(FG!+L0)5#)J&)4,VH8M8PZ1KU":O!L MI<>*6LR6/_!UMB&3EB,@_;1E9=:$NQ05!WO)J&)4,VH8M8PZ1KU"6J%IWFO+ MWBL@,01VC$I&%:.:4<.H9=0QZA72-5O3YJ:4'QL5[.>V'IE1D5;WWL^EJ#0J MQH8151Q5,VH8M8PZ1KU"6J%I1G#+1C`@-2I\E$`E1U6,:D8-HY91QZA72-<\ MS1)NV1(&I#Z0,;/?3M^EJ-C/):.*4H5TS=JF:/3)GO5D[[[9C5.IZ0A5' MU8P:1BVCCE&OD);!6;4),@2S)SS5UB/5]81*CJH8U8P:1BVCCE&OD*[9&;`) M-7N_IKK>(_EI@RVADE'%J&;4,&H9=8QZA73-UB&^,MR][5,U!R M34`,[R8@AI<3$,/;"8CA]022F?*G^;SBFHU>9/(NV\A4^;ZM6.>@?&(HGQC* M)X;RB:%\8BA?,E-^SO)-OMM:7+/?BTRK$N*.?N`CML*O?,9+`33RK81NT,AF M,HM**#9&Q$Q0C#)!L3'.W73`3^N;I2[T&R.0R>AG#:%=A9^WJ"RNV2E&IN\9 MTG/(&.9^XG-<8_-*?`R#+QG#5JMT:\C?38QA6NMP<"?W`,%#F-Z#N8F'/O!A M8@_H@W/V@([([4%\J&DRD)2+]G&L-$>9CW0CJ, M(]'4C%B,Q2DD[#1=^C",0U.8WK$I35(0/[<'.TFA"V@/Z()S]H!>R>XA35*F:YQ) M/]4UYT[OWNSKOJ$%`%[F1`RJ$\-@)@:)B4%/8A"/&,0C!J4D,[(X'R]E>M^ORP]K`4P^XXA8K<#^'= M8>I\"$S9Y&\HFA?,E,^1$1F\HPNCY#V*P!3U?/.![#3I76H>G) M/4#PW![LKX2C#V@/Z(-S]H"!G-U#6O29L8WC56/[E4N=LUKFDRQ%9#B#TJ5N M8\8:WFKHFPJ'"L%#.@POT=0,>`QN:HK!30SJ9M,EJS_T']2EIE"7&*3,I1/? M?#92.D-\:IB?MW*(;S<3MU>+R)3":V/=H3#9="AL;+K]Y2:(ZR-$OT!JZCS'/ME=X$KY4_3TCEC/&IZY_DW#CM<-PQ&\NWQMW1## M8)]2-ONKS-`Y[%3-&IZ=W@.D#V%J#VLS+Z$':`_H@7/V@$[)[4',2V:H.^]L MA_JQ;[(.[XH\=XKWIEQWUFC4A;QV`8S!/X;%2QD&/S%T`S$,=V+0G!@$)@:! MB4%-R8QTSF1+Z5Z;<+TIUXIXIIRT>AW:,,^A?(I#^<10/C&43PSE$T/YQ%"^ M9*9\9[*GE.]-N2X_&'5YT:#/G^&=@=@3OE^=/C<%08A!$&(0A!@$(09!B$$0 M8A!$,BW(\"ZS"8*$=Y\I0=3[T(:^W^'WOWWY:16%%^H2PQMUB>&5NL3P3EUB M>*DN,;Q5EQA>JRN9*=_9;EG^[_9?OSY?W!W^ M>(0#P7<&!;YXVG]Z=_D!X^IF&%PH- M16>VX&XCC@ZW'#/;-FB%CS)FMFQ1 M$C["E]N"SL0'W7);T)7X@%=N"SH2'X/*;5E@RW"AL"HLD`T_'IUILX0*^)6; MW!;4@Q]^R6Q9H1[\/$IN"^K!KX+DMN`(\-L9F2US])W_](4]ZCG$]JVX*CQF^#9;84PPF5W>*&=_8("AQ!?FR[H9T? MV>ZDQ@4C+FXF98RIPM+C/QEO@ MWFY?H8;F]W`?N6VP6TYH;/;?BUN?LVU^>`.(G,,'YQ@.8[3)G?6_+JX M^?7(O(C3*7LV81K*S4*[Q?*FQ*]0LR[X#>R;)KL%/VN-G>3:X%#%Y/>--DM>-'X7^_ M[&\_[I]<`.YZ?#H<7N(_<%!7WP]/OP]7\O?_$@```/__`P!02P,$%``&``@` M```A`*3!`YQJ`P``'`P``!D```!X;"]W;W)K&UL ME%9;;YLP&'V?M/^`>&_`Y!Z%5.VJ;I,V:9IV>7;`)%8!(]MIVG^_[[,IY98% M7I+P]7".SW>KM[H\,ZFXR$.73'S787DD8IX?0O?WK\>;E>LH3?.8IB)G MH?O*E'N[^_AA>Q;R21T9TPXPY"ITCUH7&\]3T9%E5$U$P7+X2R)D1C4\RH.G M"LEH;%[*4B_P_86749Z[EF$CAW"().$1>Q#1*6.YMB22I53#^=61%^J-+8N& MT&54/IV*FTAD!5#L>>VM/6#:;6,.#C#MCF1)Z-Z1S7U`7&^W-0GZP]E9U7X[ZBC.GR6/ MO_&<0;:A3EB!O1!/"/T:8PA>]CIO/YH*_)!.S!)Z2O5/+5;+K?<,F8M*S+W%P&>%(17"`]%*&=2&*R,8 ME3&U>)1[&ZC+!/TRTS$R"`Y=^*P.OUBM*EZK;#&S.J9"-`P"9+A!!(=NL*[3 M=G)K00.DH:F&2R/82%?)M1$"8U++P[K?Y6*,%(*;4C8"4CA^]?98CN%%<)/7 M1@BTR;N%M=]O`;?TX!E`<%/*1LBL8P&*6>?%I1%,S8:X,F?X8E/#1D"C;N?" M8&'=ZKI79AK133%#@"NJXXC@=-=2A9:F:ZCA%0V[%*"[JQ8S3$:C[NC"#&,9 MZ[)7U.QN:*B5ZZ+'46L_F,WN!Y,ES,`5&;L(&C(VU"K3M+_K$#7"E)W]AIH- M]96I-?_&%)E/KGNRD]]0L:&6I]D%3Z.V`>FN@S+4LP_(J(5@T*VN[ED)LPL; M@8Q:"0;=$KNX%$C/5IB3(?W6W0J&JS-$\_[:!*/6@D$W/96AGGX+6FOA_X-C MT"WJ.O8O9NTK&Y(%]8FFJG$B<\)X5P.VCBE9WP+L`WV_'9YL[D,3_ M+]5?X&Y6T`/[3N6!Y\I)60*F%&YK0<"LS/X]P"V=P`_%Q MFA(A]-L#"E3W^MT_````__\#`%!+`P04``8`"````"$`9*T)GB0'```]'@`` M&0```'AL+W=O[T9>\JHORL`S"JTDPR@]9N2X.3\O@[\\?WMT$H[I)#^MT5Q[R9?`M MKX/W][_^V42>JP&-9/I/KQS5!&#SV1G_0%?BS&JWS M3?JR:_XJ7W_/BZ=M@W)?XXGHP6[7WU1>9\@HPEQ%UQ0I*W<@@']'^X):`QE) MO^K?UV+=;)=!/+NZGD_B$.ZCQ[QN/A04,AAE+W53[O\U3J$-98)$-@A^!X*< M&!C;@?BU`ZUE$^BC(`T59!EA)2%"-TG^YGRUF=^,O*%=F?5:^3R@] MDM:#:D-A%0/&X-N11G;_!](4A4BWTZU:H'^*R&'8>K1#%`,$0Y3191BCHX=[ MLHC@BYD8'\KFUF$$6YZC;A2U-D20Q@Z!&?9[FDXF3I\ZI9:\X(KB&:#Y. M]G2BM+-3ZD!"0)D+JR2OU$MD(CU%"`]KE7%G+RY2F^&0?4#$4L2 M)K%EA-_(F)%FP7=U=H!9GGRT!.OMS]QPYD M3Z`$).F2>C*Z;^3+:BWG9*!XUI4U"3U("4@2(+T\GX!15U$P`PD"'J1HQ\)B M-5Z2`(GF^02,Q`H"!@IY!BPT[Y*B8"8"H88D`9+)\PD8414$#"0(6(@3X)`D M0%IY/@&CK(*`@5#D=FDGH8&N,6FW9>"8+*50]5[>.B9-9)S,F5.K=+,MLN=5 MB;`0AH%^C7&VM"=.(ZR"JH$$5>N%Q=51G2VN,-Q@:[>8M0-/02NP8 M.J?0I'5@B\="#L-^H&3H;`%O,/1U/C)0S]`YX">M`V=HP\@<]@,E0U+H\W-H M]%SDT$`]0Z?IDL@Z<(8VC&38#Y0,2:\90W=1G;7^Z377.:%9",1YJSF+/;%> MT[@3--5"8F#8G^TD>Q+[GV9O=@R1=@MA"?4+)70/3)'QFG+M'9`%ZP6A9K'Z MPX1\(-H\3CS0F1IGMB#Q1`9BAY4D\B`E($F,]AE&[(VU9G8E0",2% M+S@ZCMR3+"2/H*&SKR>]5WL@4`*2;"_:[."T#L;\O6(C-EOB0$I`D0&K*TO4& M`:OC/"D&B@*9S_R MK27VE=M"U!1LU?4G'ILQJ]R\C3@D"5^DW+BH\)3`*G=_[$FL%[+4EXQ[&0+F MQL)\==_GU5.>Y+M=/B73L\RAT7/YUEN8-%? MLSW+HKUY\2P36/2UBF>AVQI]M^%9(EBTJGF6&!9]KO(L4UATF3S+-2SZ.L:U MA(B&CQO(K&=!-)SRABR(AL\!`Y8(><-18\B"O&'#'[(@;^8\X3)`L,%8"#48 M"8&T'KAQ0N0?7^@&Y@Z1?WP*&[(@__A&Y5OP8@[+T/Q)"`)XR_7'X%+N82C6 MBJ8?\%]A\D%_*OV`_\/T]L%<^KF/CAH.EA`5'"P@5H1>$.,N$"[OCNE3_BFM MGHI#/=KE&RRGB5:@RES_F3\:^Y+^6#:XMM/OZUM&PO M=V]R:W-H965T$1NO[\5>?3*E1:R MW,5D,HTC7J8R$^5Q%__S]].WNSC2AI49RV7)=_$[U_'W_<\_;2]2O>@3YR8" MA%+OXI,QU29)='KB!=,36?$2_CE(53`#C^J8Z$IQEME!19[0Z729%$R4L4/8 MJ"$8\G`0*7^4Z;G@I7$@BN?,P/SU253Z`ZU(A\`53+V!:Y,.\6 M-(Z*=//C6$K%GG/0_4;F+/W`M@\=^$*D2FIY,!.`2]Q$NYK7R3H!I/TV$Z`` MRQXI?MC%]V3S0-=QLM_:`OTK^$5[OR-]DI=?E8F@68!25PQ;CVP`N%\(*,#<>TS>Q=#, M,%<-U7_=K\C=-GF%BJ5USH/+@<\FAS09"9`VS,`VG!F3D1E+BE-Y<`&?AO;3 MS,;08/(NAL]F\BNR;G`=L\N9>SG+)J,E$%*&"\1DUPT>=5A;ES2`&OIA.#4F M6^JFN"Y"8'M\3H9.^U4NQU!ALB!-K$DW"E$]&= M!^\!3&Y3N0A4"YW#EP!;V\>U9D$6$ZCNU]L,Q[4I7`2JY*NYTO"X;#[MUUPV MNTU6AWK6A.#F]BIE%2W!A&XIL@,#EMHHVIIF_4V&Z^@3W]#DS,&]"-RFM0#@ M<=T^(Z,,PF8'0IPA!*TVOR($M[!7P1M",#M@C![88OL)#%A8*& M6US1-,H"2-<#ZE"?IE$N0+HV4(<"(5<,FXPR`IL=+$YM!;1C!:3/"U9K/"7< M,`,[,J#IM8-5_^K0479@L]ML=:AG=6A@!U\WL\T.H&L/:+OTYUNOY:9TE`?8 M[(#-V4*/4=/``W#KS.YF`U;'C@QH:C]H&]OG*:(M:I0?T*X?U"$PV/#M@ZT5 M^@&=P^1N+%/7#2R2-4_O]3.[N,Q4[\C^8.HI21SD_`.9T MLH*V4>Y"Y!Z,K*"\<"^1!BXT]N<)+JX<#N]3/#`0`,``(<*```9````>&PO=V]R:W-H965T M[J:NHS2M,UJ*FB7N&U/N_?+CA\5.R&=5,*8=8*A5XA9:-W/?5VG!*JH\ MT;`:_LF%K*B&1[GQ52,9SD'H]'$KRBO7N`V#R?T%4^E4"+7'M#YUM'3F&?^S`>FY2+C$`&FW9$L3]P5F3^0V/67"Y.@ M/YSM5.>WHPJQ^RQY]HW7#+(-=<(*K(5X1NC7#$WPLG_R]I.IP`_I9"RGVU+_ M%+LOC&\*#>4>0T08V#Q[>V0JA8P"C1>,D2D5)3@`GT[%L34@(_35?.]XIHO$ M#8DW'8^CR30&FC53^HDCI^ND6Z5%]=>BR)[+L@1[%O@^L$R\<3P*"8A>(?&M M1R;`1ZKI%G&8;#P7R!U MZ1[S8#'PV6)(B_!!M%4&M>'*"$9ES"VZ\F`-79G_CO1DPEMD$`S%Z3@?AV'K MOE6VF*B#F;2(GC)`A@>(X,0-9AW:T]Q:T`!IZ(?AT@@VTFURK87`G+1%C,/H M?)236Z00W)>R%I#"^>NV1WP++X+[O-9"H$TZ(8S/AX!K>O`,(+@O92TD.@D! MBMGEQ:T11-`^[P\9OM47L!80Z,9RH>FP:%W1][4,NB^V-QVIQ>T`N04_CKN-X%1WJ+%683SR8!*N9-"N M@YZ*-1UE<'8A)ISICO`5-;L!>FK6="ZFHRU@3JT)'!E78[+SWU.QIGY,T>A" M3#?M!'*Z%/8F4#NITTUK`>X$Q[-T,)G;@ETX]MBWIV+%Y(9]8F6IG%1L\4@/ MX)QKK>UU8Q6@:\?V:+ZRUQ"__0>N`0W=L.]4;GBMG)+EP#GR\-B7]B)A'[1H MS&&\%AK.?_.S@`L?@[/.=&$NA#X\8%+:*^3R'P```/__`P!02P,$%``&``@` M```A`#-*P"L5*0``0.H``!D```!X;"]W;W)K&UL MK)W=7S;:M)\<_E^*N8[%^255-3W\P<*[(2JV);+DE)]K[[ M>4$L--9:+R*QY9QL[SP-H+N?!:`70%+]_K_^_?7+JS]O[A]N[[[]]+IZ<_'Z MU'J^^?;KZ/U?'_[G_WC_ MU]W][P^?;VX>7Z&%;P\_O?[\^/C]W=NW#]>?;[Y>/;RY^W[S#4=^O;O_>O6( M_[S_[>W#]_N;JT^G2E^_O)U=7"S??KVZ_?8ZMO#N_IPV[G[]]?;Z9G=W__UR].U:KV>NW']Z?#/W?VYN_'M3_?_7P M^>ZO]O[VT^'VVPUT(U`A!+_BO:?`D+EMU2[.87@?]V_^G3SZ]4?7Q[_ M]]U?W\%;BG7AL;D.3KU]=__'P>/?U_\5"E305 M&YE)(_A7&IDOWRQ6%_,*YSRWD;DT@G_3E>":UXMJL0RM/''Z2ZF)?U/-Q9OJ M\N*Y>FCU=._X-]4[\XQ+J8E_4\WJO&M=24W\FVJ>>4X,V=/5XM]4\\QS;J0F M_DTUSSQGA?X8NT?HF-(_SCQK-78M_)]4]]SSIAY5Y2YUF7O4$WVA2MTH_)]T MUJ>O^&T<$J<1MKMZO/KP_O[NKU>8MW#=#]^OPBQ8O0O-I;$53S^.MK\;;!AE MH96?0S,_O4;8,(X>,$7\^6%U6;U_^R=&];64^-! MZT'G0>_!X,'>@X,'1P7>PN2H$Z'\)W2&9H+.).)C`MGOS-K=IA*IRLZ#VH/& M@]:#SH/>@\&#O0<'#XX*&'?H??^$N]#,3Z_QOZHK.ED?8YF9[J]+YW,L,@HE M4A-IB+1$.B(]D8'(GLB!R%$3HQ9/C7]";6@&#T_,L/AHZ3.76\< M"Z5J.R(UD89(2Z0CTA,9B.R)'(@<-3'&D%%,,!9*6V.1P%B2L26R(U(3:8BT M1#HB/9&!R)[(@N0XV%DL,=D9I(0Z0E MTA'IB0Q$]D0.1(Z:&&.8:R88"Z6ML4CFE[E#$=D1J8DT1%HB'9&>R$!D3^1` MY*B)T8/Y>H*>4-KJB01ZT8'1D>#K*R0#.LUQ--/ MP+!F%N)$'5=Q-1I>;>L`P--Y@O M?<>H9M0P:AEU!MF["3F>OINX&'X3=HD>/]]>__[Q#D]4=,Q"!Y]CT2M+82,5 MV/`2$_]]]_UD8H*6F`Z:GAQ1A6E87??*WO`V[/3Y[E"LN+85:Z[8"%IL3EL4 MLXO*Y=FM%)CEW+*C.GDQ:96%A,XKFR%G.3E*P@I=!SM_8]^)2:&1)`AA5Y(V M]EZWF`U(DE2$JUQQX?+`FBLV@L*&I*KHEGDM5^S*%?].5\CFM*YGS,3DSYB) M*'1B=9TNHEM,(V1&VL*LJ2JZA*;FBHV@F:WH1FC+%;MRQ3Q";4<*B9PV$Z:A MV3+L;9=F'MU]8@IH)$7D)-$8DU)Z-I*V[+W2&*.*3171)>;)T>Y\YNRV4@IB M\FQ4/&/NZ592R-V\I&HQ=:Z.&:`1%I$5MG3#9AOF+#\I171INN/2#9N:*S:" M7,4\;$Z/E98K=N6*>0`889C2_@%AIU9LIBO("*N6OH>E4CG>.T&7"/O8459+ MUU%JKMB4*_IAR!6[QYN9V.IU(UVC&I&#:.6 M4<>H9S0PVC,Z,#H:9/UAP$[Q%XH[?Q&IGK4-"0U**;1C5#-J&+6,.D8]HX'1 MGM&!T=$@*RMDWKJSA01NOCXE<%-G/4GBU6)R%A&LZ<=F3I-.Z<(VE\H=<:R8 M4,VE&D8MHXY1SVA@M&=T8'0TR+H-N;MV^\RL)ZF^]A>1ZG7;L$KS'9%0S:4: M1BVCCE'/:&"T9W1@=#3(R@H9M99U6DF\Z.DKN;GV&)'MARN?*(?/6+U:0C67 M:ABUC#I&/:.!T9[1@='1(*LV9/M:[3/],"X.3/82D>F'A':HX?S5C!I&+:.. M4<]H8+1G=&!T-,C("A]N&EDO[H>GENR#19#KAV[=MD<5+CI#^Q>E,/7Q7;JV^S:62Y1VCFE'#J&74,>H9#8SVC`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`K;$U3%5U$;]JRPD*6JH4]O62&*O:F>6LFI*,3S$@FK'8*+R-R9JC/ M2"EM)J*4"LRJ16&(4;4FG2^WU`JR/6;C'A@=5^P-,EX6Q61\ZC>)3JW8!%R0 MT^7ZPS:5RC>Y$Y1FI'DA%>!:#:-6D+/EGI(=5^P-LK9\JOVB5&#!&;@@8PL9 MH_N>8RJE;<6V0L5^P-LL(PA,VP\\+.^QK1 M(C3C^E=$V%1+R_:ME%)HQZAFU#!J&76,>D8#HSVC`Z.C05:B3]>?GM4Q8ZYK[EG27SV:!.E[)E0O"#6"W+:; M2P3;7"IUR4Z0WD7BY@>#K(:06T[0$%-1HT&R4ZV!$M;=@E#-J!'D-+A\H6VG-(AET);UDS(&">8B0FF,2,YIS8C*%_Z;D&H9M0( MIYOM:J[8,&H9=8QZ1H-!UHQ/QY\QPVGW,B)C9EVY*7B;2N6AM!.45L'5AA?! M7*MAU#+J&/6,!H.LEI`+__#LMXP9M7Y<"#*V5FLW+6]3*6TKMH4T][0?/B_( MBB54YVNXG991QZAG-!AD987$]\=EQ?39R(K(R%I7[GFX74HI+2LB-X\YRS57 M;!BU@NP:N'+/JXXK]HR&4L6&4"4J3 MUGQ5&(=4J^&&6D8=HY[18)#5$O)CK>5%*=LR9MG&5D2N'[GAM)6*:O[9"4J3 M5F'CCBLUC%I&':.>T6"0E152YA^7%1-O(TMR<=VUUO3W9I:4L>\$V4EKYA*F MFBLVC%I!=M*:Y>SH]$V1CBOVC(9R6SF#L5I#RJRU/C-IQ0S;^).D6_LK3%J4 MFN^6TI:9M/P/;6LII7IIPZAEU#'J&0T&&3,KG_D_;>94W$[G@MPP])E6*J6F MMZ'$J=FW)B5I%QM#TDI M-0/M!.%CIK3W4'.IAE'+J&/4,QH,LET,7<"X>&:>"L7=/4=D1MYZYK+'+6:C M4X_3?4G:0I<:L[+UG`8?56RXK5:0[4MS]S3MN&*?$,XR7@1O/Y2;SP]8JS0D MRN<_%,/?U_%*(U(?9&VEE$([1C6CAE'+J&/4,QH8[1D=&!T-LK)"^CQ!5LRV M=0:QBF@=_V!U^,.Y6T8[1C6CAE'+J&/4,QH8[1D=&!T-LK)\RO_,8.78+OU31Y`Q$TOIY"65RK)J M1HT@9\8EF&TNE>02Y&9D+/JH>/3O;,^VUK'S%<_>029'VBL MYWFI''^@D4IE8;N$T//'I(,_VTJEO0ID MGTOEMOBSK5R*M!:SZ!_Y;&L=LV>C6)!.SWA/6"JJN]L)"A-J-C5WPZGFBDVZ MB)R;M,`_IL.[,SPSSF#T;I1&9?)UW M7-92*G>^G:#PES_&NUG/W9BNN6+#J&74,>H9#099,]/2[C6GW8*<&==GMJF4 M-A/;"C]$469J\C"PCH^ M5^2Q1WE[PVVU@MQ:V46MXXJ]()4!#>6V\AZ.U3HME5]S*B_(=3BWS-^F4MJ? MM&4[G'MPUERQ8=0RZACUC`:#K)F0`T^8U4-QE]9&Y,RX*6B[EE+:3$38X3A] MTKPI?"[/M1I&+:..4<]H,,AHV?AL_T7C\-2*M27(V7)#8)M**5N"TF[QDC>+ MN5+#J&74,>H9#09962%SUGWH9;)B_JT3AHVDY';21:Q6I];/9RW6;SAY8,@=,*4IF\3TA)C M1;U9S*4:1BVCCE'/:##(NO`I_]/)YX;S>4%FX/%F<2JE-4A;L)$?@)=Y!_:T M\JFY8L.H%>3ZDENW=5RQ3TB/!,[GR\WGJ=@J#7FV'K7/*`W%W5P6D=H9WFX( M[1C5C!I&+:..4<]H8+1G=&!T-,C*"GGV!%DQ+3=S643AC_RH;D1SV5@JCH M9S0PVC,Z,#H:9&65%@$O^N.]&UX("()'W0\I`8D5E>U=KIBZ9LVH8=0RZACU MC`9&>T8'1D>#K-II"X$-+P0$*3-;1CM&-:.&4#-J(7&?+B[2X3[D92Z6>M6-4,VH8M8PZ1CVC@=&>T8'1T2#C#]_H MF"0PEK?/V,2PR9SD;`L,;S0*Y\*[*W,YO-*(&-YI1`PO-2*&MQH1PVN-B.&] M1L3P8B-B>+,1,;S:2#.GSJ\IGLY.J@M>/22FE$!=+*<8U!&#.F)01PSJB$$= M,:@C!G7$H(X8U!&#.LV9R2F?\0Y,K6L*#"HB^VICQ.@CAC4 M$8,Z8E!'#.J(01TQJ",&=9HY=2'SG]+KXDK!]KK(]+JTNA!FU!&#.F)01PSJ MB$$=,:@C!G7$H(X8U!&#.LVR:P20PV(XL#Q=D,2X`I-N.2P=J,S-H49FP2 M@TUBL$D,-HG!)C'8C,S9S(OZ4PX%FV,Q93,R:Y,8;$96M.G7(L\]AWG%45U$ M9FT*,S:)P28QV(S,&%G['VA"\%@L&8%@:@Z"QW)J1>1_)PS!8['4'+IK9%;P M6$XWY^(%YV,Q-.=Z\+1%2G7!JY3$K/-83CU=\``G!N?$X#PRXWRU`V4 MF`U%+&=#(0S_C#M$_-V,L;D\SV/5]:7;[T9TQF)))Z(C9\W-(3IC M.=6<_[('HC,62\TA.M0?T$E0]IY^B\R/?^*CDO:IF MVA>&2.4+Y=\SIZHF>%+5?DS*;_U+9\BV\>+4N`H*+X$9@T=[NWB9JA3#DV\L MME[DSPY.SP&\8#464Q>'-ZQ*U?S-$KQBM=BI.;QW5:H^><%X%VOQ M#'FSVTYZIU>WZA`_\Z"15[W:^,5%D8D??\&DDJI*$=YQ&ZO:KY@LW/R&]][* M&4S\B"%8TAR6&BI8;GY#L*@J@D4,P2*&R!!#9(@A#)HYYV$E-,5Y7#E9YY$9 MY^N%FWJWE7F7[:FKPGFLFCX`GH7/--WG:C`N[1OCQ&`\,OO1RL)M-<$X585Q M8C!.#,:)P3@Q&-?,&0\+J"G&XX++&I=%F!Y^_-/NRKQO-QF/59-Q;,"4C$O[ MQC@Q&(_,&7??;(!QJ@KCQ&"<&(P3@W%B,*Z9,PY-QOC+'NRA?[N/ORIAKNN[ MIRZZ?JQJIYO(TJ?Y\_"W+[GK4T4\+(@A$)'90/A79R(05!6!((9`$$,@B"$0 MQ!`(S5P@PI)-=_T7!B*N_.R(D-4@3IYG6_K]?L4O)L8<%*O:YS:_/92K(A1R MUCQ.$`JY.LP`^4J6[JF*4%!5A((80E%L+C]"3\,:T:&JB`XQ1"^Z)'%>1-C*RLM21*3V1]0(TS572'*XYJZ0OGE7R\F,UNA`9:@Z1 MD>9L9-P#'I&AJH@,,42&&,)`#&$@AC!HYIR'5>$4YW$5:9U'%H9B%E=X(DNQ MW'TQ&B)+SX?+PI\.3V6L<&H+PB-SLQ*G0%05PHE!.#$()P;AQ"!<,R<\+`FG M"(]+2"L\,B.\]$"68D9X9$EXX4\@5_S&9G1P:@J^(W.^72*&#DY5X9L8?!.# M;V+P30R^-7.^PR)/^W[A4T#6BNI71E5Z4[/M]_PXCE71)]*J%?T^LO0XGET6 MOHN8"JF*"`0UAD#(M=F9AC-1JHI`$$,@B"$0Q!`(8@B$9C80IW70-C*R%M21*3R.I:JZ@5V5FC./ MXY7;?D!D]&KS]"1'9(@A,I&Y>Z=$B:LB,M0<(D,,82"&,!!#SSL-*;HKS M4-Y]@!]N$&P9(2_[($L MK["V<0A-4\]WTR7B(,6R.\0ALO1`K@I_22:54?%#'*@M=/S(0J=3<:!$E*LB M#M0;&V\HDXQ*KV MB_0K-Y0PZ\L9<@@1"F((160N%)0:<56$@II#*(K-N6P!T:&JB`XQ1*?87.ZO M+F!A%?=4P,[[>GXE[]RV$9,5HOJ"?BIGPQ/+Z:_H%\HA%GK%>7HJ(Q;$,/D3 M@WAB$$\,EHG!,C%8ULPI#>LTK?2Y%">NZZPZ6>MAI.713G\4II*7=UN;TIR9 M*/P;TM#9Y0RFLQ?.6O@,1ZH^V__I#`@#,80A,MN&7F+*CI$PI\,]_L%R<$K^X MO+3QBPQOSD[+:P2+&)XLQ!`98H@,,82!&*8N8G!.#,Z)03`Q""8&FYI9=:;4A;75%'6AO%NRIC>1J[_55#&#NEA7*88Z8E!'#.J(01TQJ",&=<2@CAC4 M$8,ZS9RZL$J:HBZNJFRODY664:=77_*LDO>7J_P#ZJ@8F##IA.5]"SR&&VR>&VR>&VR>&VR>&VR>&V]?, MW7[(_G7T7[8`DU>1VTXABPUC118;\>^LSRXJE^+`T5@BN80C:2F[A*.Q7/@= M/5K*Z9FD^KE$:@G&J"48\RVY[3WX&TN@)>7\@?'S_?7O]^YF((4PGW M*5DP('0YH_?O'$4WB\6>_I,WL"IGP(WDUOQ;1R%:3FI$GW,&],_B&9Q*!(#. M@`"<QVQY<6"ZL-ZZC(092+%N#\,ALSNS? MS@GA5!4]FQCL%IMS23[L4E78)0:5Q>9R1N]4AG1ZBDI)OTV6%QEFHC08X8T8 MO!&#)&*01`R2B,$(,1@A!B/$\'`EAH3W.R*E<76%-@;8%U!=87V%!@^P([%-C1,J?%[R"750R0OJT_/W6V5B^6.R`PV)9V?C5,";!*#36*P20PVB<$F,=@D!IO$ M8%,S9S.DTU-LQO3;VI247,^(\@IYU>G0$:DJJ7/")C'8)`:;Q&"3&&P2 M@TUBL$D,-HG!IF;.9LCLI]@,Y=WJ15XLKW[ABC$XHZR=2-NLBL.F)01PSJB$$=,:@C!G7$H(X8U!&#.F)0 M1PSJ-'/J0IH]15U,R^V3(S)\%S5-_QBPPO3RC1G443FH(P9UQ*".&-01@SIB M4$<,ZHA!G69.77T6MW+-LA.S;@'KS!C-)7[^PVR7")UX;IBUB2F]EK; MQ/#%F/*F6:=*I-;[`AL24ZWO$\NMN]V?@RJ16C]:YMR'#/PI]V?NKRUB)F^Z MLS`K/Y8+?_1=+7#R5R&DAZ?F\H=]B$"A*KY.^_[MG]@QO/[P_E0508G%E#8$ MI5!UO7%G161B,7QK,[E#9`I5Z:P(%IT5P2I4I;,B8G161*Q059_5!3&L!9X* MXEE_#KY:Q"6%C6%D-H;",*+'&&XN7$_94(!##4Q4QI*J(X3E5$4.JBA@^4]7%,*Q`GHKAN0,QKF1L$"-#$'7`:),57XH+ M*Q?S1^$W_N\5(*ZQ&!:@:90@KL6J;O,4<:6JB&NQJOO0`G&EJHAKL:H[*^)* M51'78M6\/7N:3!!7JHJX%JOFL[JXAN61CNN_J\NKZW>?_K.[>;B^^88!=/$& MWP^3Z>OG:A&74S9^D;GXT?9DJHI^I\:EVSQ"_&)K-GYR5EO5+?<1/ZJ*^!6K MNK,B?E05\2M6==,RXD=5$;]25?^B;\2/JB)^I:KJCQ"X^(4UVI3XQ36=C5]D M)GXS_P;>;;60JB8(_H7CB%\L9N-7K.I&..)'51$_87CBY%[C/S1$_*@JXG=. M5<2/JB)^YU1%_*@JXO=,51>_L%"<$K^XL+3QB\S$;T-O"*\64M7&S\TIB%\L M9N-7K.I&..)'51&_8E4>?U05\2M6=:,>\:.JB%^QJANZB!]51?Q*5=6O>%S\ MPFIU2OSBZM;&+S+SU;'P!V?PL%,,D2&&)QLQA($8PD`,8X88G!.#8&(03`PV MB<&F9DY=6*U.41=7MU9=9&8?>./?Z8NI:RR6<@+8)`:;Q&"3&&P2@TUBL$D, M-HG!)C'8)`:;FCF;80$[Q69<\%J;D>%C]J0)ZHA!'3&H(P9UQ*".&-01@SIB M4$<,ZHA!'3&HT\RJ6X8/^B:H.Y5W*WEA1AVS7<6L+K"FP-H"ZPJL+["AP/8% M=BBPHV5.75@(3E$GBTF]F;F,S.S()9976%`GY3*#.F)01PSJB$$=,:@C!G6: MN=O'LW32[8?RON=$AJ=W'G1+8?E6_,1?52E@QF5$5FDT+_AOIME:JB M])A>T_?I(5;.@-QV++:9.?]P'8NIW!&NI>J39X#PXAGRLO6TXD4,8C$;@W/. M@$`4SY#S7Q>;D,8_%9OS-JV6<35@^W9D+C0NFT9H8C$\\U,71!PB"Q]JCG&X M]+_R01RD6-X#01RH.4@O-+>947(NQ:QT:@Z&B\WEA-T9#HGV/V!8\G73^2-S MAEWZ#\.Q6/C$:;19ZOQ2#,G76&Q#K\T>6S/2SSD#XE`\@YM*T/EC,1N'<\Z` MT!3/D%?@+C0A:W\J-.=.3#'[M[U?5@3F>4<,79T8^C4Q]&MB\$D,\HAA]B8& M4\20*1%#ID0,F9)F3FE(W;W2^3ILKKVZ_N/A\>YK=W/[V^D!^OK5,YMPR[@, ML%K'I8'NI&Z&1I94Q?6(U/4Q?6+51<9O@2?>A/4$8,Z8E!'#.J(01TQJ",&=<2@CAC4 M$8,Z8E"G653W]N'SS7AU??='^(`G_%%YQ5_= MW_SZT^N/Z+WO3ET8AL8ZX[$J'#N]

C]*Q6;B_V.OI?//@,^XM M\[$06_S0LM3F/)P/W_XN'@NNXRK;M[F"EE71R@I25D4G&VC&>^D*9]J@-;QQ MK70$K>'U8J4CD(BW8Q6.S'&[Y;L--UN^USFZ!WY06&H-5QTG7^]@@=;PD7NA MS@*MX4/;PI$9[A3Y8>D([A1_4*)T!'>*7Y^5CB!`^%U\Z0BZ2KFGA(Y2[B>X M@.+Y`R_WUG@[HO'L/U_\0Y[^Z4X8"O_XAWVZ4O'L"T?PE<\AM_[ MAYD)/_+AZ_R('[#@&'YY4SP6G.,W&<5C86:*^TYNY.'O\(<9%.^=X'KA_0[P M@O,1#:+!T+[PL(;9:.->O9NW9= MZE<]C@SE(WBNAW.5^@.N8QF.E48PKG\5KK_D"_56H5[IV,<-E."E>FSRXR8, M\M)]?<1?X@[W7([W18@W7OC%+38KA&U5.E>S@GS\%K909WT!AZ4S]3@R%(\T MZPIU2E?0X\A0/-(LEN]:?(A`3?QGV';]J6KGJ.^XF?:[F1U'+$^SMXPP=`7^ML'0$PQZ_L"T=P82+[Z&6CF!BQ1\DPY&WXV4_?'C__>JW MF^/5_6^WWQY>?;GY%8GQQ1LD+:_NXZY,_(_'N^](F%^_^N7N$3LVI__[^>;J MT\U]*(W"O][=/:;_""?XZ^[^]U/R_>'_"P```/__`P!02P,$%``&``@````A M`''_^JYE"0``;RP``!D```!X;"]W;W)K&ULK%I= M;^)*$GU?:?\#XGT"_H``2G(U^-O:E597]^X^.^`$:P`C[$QF_OU6N;O=75T. M`5L?7Q_'??\5? M%N-1TQ;';;&OC^7C^&?9C/]X^N<_'M[K\[=F5Y;M"!B.S>-XU[:GU632;';E MH6CNZE-YA&]>ZO.A:.'/\^ND.9W+8ML-.NPG[G0ZGQR*ZC@6#*OS-1SURTNU M*<-Z\W8HCZT@.9?[HH7Y-[OJU"BVP^8:ND-Q_O9V^K*I#R>@>*[V5?NS(QV/ M#IM5]GJLS\7S'OS^X?C%1G%W?S#Z0[4YUTW]TMX!W41,E/N\G"PGP/3TL*W` M`Y1]="Y?'L=?G57NN>/)TT,GT'^K\KTQ_C]J=O5[/8\^\6LYD_7]P#S7/9M'&%G./1 MYJUIZ\/_A)4CN02+*UG@4[',[V;W4\^!'[V6Q),D\"E)YG>./YTCQ87?]N4P M^)3#W*G^[0L#@;9S'3[5I*>&ZQ=&SN5(^+QEIO=R&'S>-E-(UFZF\'GC3)=R M)'S>,E,'XE"$!0:D6/'+JDY$7'5A&A9M\?1PKM]'D/L0.,VIP$KBK)!6!:B0 MMP_9CR(60A59OB+-XQ@$@%AL(,V^/[F._S#Y#JFQD39K;N-0BT!98!X@;6@# MD0W$-I#80&H#F0WD!C`!67IM(%U^AS9(@]HHK]8*,,2RA%`6:DAH`Y$-Q#:0 MV$!J`YD-Y`9`A("4_QU"(`T4,"-(EMZ,>KX6-JX927-J$O0FO3H,B1@2,R1A M2,J0C"&YB1"1H,#]#I&0YG'L0D6XD$K2Z))*O4FO$D,BAL0,21B2,B1C2&XB M1"6HYD2EX8U0E16T[L103JP%XD&EZN59>G:$]$9J6,B0B"$Q0Q*&I`S)&)*; M"/$=]J,;?$=KZKM`P'?E5L"0D"$10V*&)`Q)&9(Q)#<1XBCLH#I$9$C(D M8DC,D(0A*4,RAN0F0AR%"G6#HVA-'16(Z2A#0H9$#(D9DC`D94C&D-Q$B*/8 M%MW@:6=.79608RRJ@N[[=0XY%'$HYE#"H91#&8=R`E&?L2.@5YXZ'JUNH390BD82,N2+M96D M<2E-H@T43/1(.38Z^:;*O,`!+0`I0R M=H$%=3!PY$"]*88SQ`JEE4LE75))(\5E)N`U],D@O3^E]"FGSQ1D^LAF MGP_3:R6H\-B%F<)C,KNP:]^0R:*1(YDL(2@".B9]*^D"?,`#B^%[?;Z'"O*[ M?/_BS:UN)I(&)$(936+1.`LFKAACT&1JC)Y-KB`Y&\?7(4!%Q`[O%T4432(1 M44"XG(:(5@$,8./H1,0EZY\I\(B65M"E]%9+WWKR$$DN0Y7X*OI$65%ZZ\R: M>$X-3V/VH M\+JA@(J6FN2^A$@!M;,Z<(35PJP0;#\(E15.4%6(Y4SO!YU2D;0BJE]#GPS3 M6[4^Y?29&GAQ]KFRHK/759"LC6L?0>S65"W.Y?:BHZ$Q+R$S]R5DYCZ'(C70 MB&9NE7`HY0,S;I43B&J!1P8S3C_Q&^KJG=CA"XPLHW=VL6+\C,:OTB:47$O88^&:;7K9_8YCE] MI@9>G'VNK.CL/UH,/#38$7U[9XDO@NT%$1#9701$=A<&19*+Z,JL$FEE<*5\ M8,:M<@+1P,0#A:V%.\>W\T//?0!6CS!<<10QNQT)6?&H5T'&HQAH^!HJ+BB. M.OA\*R4C16^64\:5#'-952+E7!F'\D&NCQI*[,>9E&987?4\K6.QTAR)`2*U MZM90(SKDP--*OFT+SF'^T_ M>/Y@$0H,US?F^'K5SE0!T5"=6]UN(`PF=QTU!P!?K.!U\`"^7,';TP'< MF\(O=X\0[5_P\-YE=TG1^@;>C*WPY1=G@Y==*WR?Q;^!]UZQ;N>7;OU'9PL;>$>W)PH7(\>JGK M5OV!/]!?%7[Z/P```/__`P!02P,$%``&``@````A`,(FOD$+`P``=0D``!D` M``!X;"]W;W)K&ULE%9;;YLP%'Z?M/^`_-X`N3%0 M2)6NZE9IDZ9IEV<'#%@%C&RG:?_]SK$3!@EIZ`N"D\_?=ZX^6=V^5*7SS*3B MHHZ)/_&(P^I$I+S.8_+[U\/-)^(H3>N4EJ)F,7EEBMRN/WY8[85\4@5CV@&& M6L6DT+J)7%TJTHKXEEB.08 M#I%E/&'W(ME5K-:61+*2:O!?%;Q11[8J&4-74?FT:VX2435`L>4EUZ^&E#A5 M$CWFM9!T6T+<+_Z<)D=N\W%&7_%$"B4R/0$ZUSIZ'G/HABXPK5%LKSKOCBK$_HODZ3=>,\@VU`DKL!7B":&/*9K@L'MV M^L%4X(=T4I;17:E_BOU7QO-"0[D7$!$&%J6O]TPED%&@F4R-&XDHP0%X.A7' MUH",T)>83$&8I[J(R6PY603>S`>XLV5*/W"D)$ZR4UI4?RW(-TY9+N/:/=5T MO9)B[T"]`:T:BMWC1T`\[`LX@=@-@F,"_0@R"A+XO`Z7X*A.B3#%K34$PXQN.I[=#W`CF8@O_M;)>URW4SQ_*E]'FWLTG7;7V#I-31GWZG,>:VO.O!;P]X;!JO+P@LB$T,&ULK%G;CJ-&$'V/E']`O*\Q&%_&LKT:&^BLM)&B:),\,QC;:(RQ@+GL MWZ>*[H;N+NQE-GE9UJ>K#G6J^E)#KSZ_YV?K-2VKK+BL;77=&U_3RO[\^;77U9O1?E5P^OUP_)45^!8JG[)S5WQM2V\J3 MY9?CI2CCIS/H?G?].)'B>$;3+WN$ MP-DAWE%3@3]*:Y\>XI=S_6?Q]EN:'4\UE'L*BE#8O3VI[,1M/Y>.*"N?645G64(:5M)2]57>3_<"-7 M4'$23Y#`LX?DCN-$.,)3.'JCQ73JSQ9S>/L=1U\XPE,X/G11W_$#UD8N/(6? MZX^\Q=2=SE#O'<^9\(3GQT*="T=X#@G5X05JZAW$=;Q9E<6;!8L(2E!=8UR2 M[A*X9*%YR&WI;U4>2HXDC\BRMF'U0U$KF*ZO&W_FKIQ7F&*)L-E2&\-B)RUP M/B%M8`*A"40FP!3``8FM3IA$_X-.9$&=,L*M!#KAGBY[)RVD2V`"H0E$)L`4 M0!,%$]P4-8&UWK]*9:W0"=:C5BLCZ"VW\=2"S@Q=K4DKC"`A02*",!71Q,$B M-,7A%O3!F8DL:]M[T.0:$V\KC.[);4U:N00)"1(1A*F()A>DJ7+OUQ"-&U4R MFBU'L/K*$IP8-6N-I%M`D)`@$4&8BF@B8!L;+@*-=1$<`1$ROAU!`H*$!(D( MPE1$BQCV/#5BW/^\Z0@$?G">(8\NAB,3*+A2$=^H2&LD%0<$"0D2$82IB*8/ M.S)E?[\_K=!8%\$1$"'CVQ$D($A(D(@@3$6TB&&I#H\8C?6(.3)IFJ/F%-D1 M)"!(2)"(($Q%M(A=6'7#0VZL]9@%Y"I!2VC>9CZ@4$BAB$),@_3(\;A4I@<_ M_D?8)M6G+'G>%C!WP:9GVDS@F!>'/S]S88^5DV3K M"20Q%KZ`8+ETU9X;[R2!T M^FX1Z_G"#N'.S!FXU)#%2!B'U`,)FT*P4J"`0B&%(@HQ#=(580>A*.K9$=5- M@O<;VB8A6A!(ME(>LQ^`(X"((5!(K2(*,0W2Q6"[,%P,;RXT,6J_P4]9F%$D M<@*%U"JB$-,@/7)L&X9'SIL,+7(.J?V!2Z"`0B&%(@HQ#=(CQ_9A>.2\V=`B MYQ!459Z/.U=`W3$04"BD4$0AID%:Y)[1WOQ4D]"0Z&M90+"QM(*DUA6+ZU@ MYU/V$K-)$%:PF&2N(NEXEYY)*YW^1I/@8=^A).S^QMA8&XGIZY[F9C<@'!4Q M@>0"?R4+9C=`'2,*L5ZNQ8UN`'I83;(Y1P;U10V)D8F^OFAA=@/"4>V+)*26 MU5^81[^P4E(82<>NQV(2TKENG/,>6*G%_[E,((F1"0%I?='"/"R;M_^P+Y)6 ML,MWTV1A++Q06&G)X4'<;[M8/WVW%O6M%'L59;&8^1JXN_".1ST<\#,S-D'* MX4"A@$(AA2(*,0W2%6%WHBCZP?+GO8P6N6AONEUJ!S<;C9@."B@44BBB$-Z2 M=%P\J""HWI@>EO!]H^>] M+KP8NF(ZLG/=)?[-3D?@;W3PZ1O9>>-E`&=OCP^,L-X1N.IZ]'H\MOB2/MP# MHCY\LH1OS?3-CS[P]Z;07\+76G!PVBK!%=&ULE%?;;J,P$'U?:?\!\=Z`"9`V2E*U6W6WTJZT6NWEV0$GL0H8 MV4[3_OW.V)1R2PLO29B,S_'<3B:KZ^<\7KJ,T+5*:B8*MW1>FW.O-YT^KDY"/ZL"8=@"A4&OWH'6Y]#R5'%A.U4R4 MK(!O=D+F5,.CW'NJE(RFYE">>8'OQUY.>>%:A*4<@R%V.YZP.Y$<`L269UR_&%#7R9/EP[X0DFXSB/N9A#1Y MQ38//?B<)U(HL=,S@//L1?LQ7WE7'B!M5BF'"##MCF2[M7M#EK=!Z'J;E4G0 M7\Y.JO'940=Q^BIY^IT7#+(-=<(*;(5X1->'%$UPV.N=OC<5^"F=E.WH,=._ MQ.D;X_N#AG)'$!$&MDQ?[IA*(*,`,PLB1$I$!A>`5R?GV!J0$?ILWD\\U8>U M&T2SRR@*X\L%P&R9TO<<,5TG.2HM\G_6BU18%B6H4."]0IG'LVCASPF0?@#B MV1N9`.^HIIN5%"<'N@8H54FQ!\D2@(-F%XM?*> M('5)Y7-K?>"U]B&UAP>D-3.PC6=&9V3&W.)5;JVA21,,T\RGT*#SVH77^O)A MY->XEMGZA`V?N/9H!0@NXP-$9VB+JP9L/[?6:00U],-X:G0VU'5RK87`G#3R M<*:,\10J=&Y360M0X?PUVV,Q!1>=V[C60MJE/-,B*-.C9P"=VU36`E3=$*"8 M35Q4C<`/9SCR[\\9'FQS6`MIECZ,YL-]AW5K\K[/9;S;9)4)V+H1$9SN1JJ, M$,:@0A]%9`YV6"JE:,<4GHEIDEH0JPXP375+5Z:AF'"@&S%]D"X[_BUH:^KT M6G0F$)SA\6SHW4F;-0VT&_XB-:&Q.',_'M%OYF2'IM*`=G7.*!V9)`+&N\-6 MR'38K$4-!=?3` M:%P(EWM?&(*^,%0FX&BT7ORV3[0CPKD>+0RP[7:%X=6T>&L]N]#:?2]GQ2+87:(&BN/?VV7&4Q%C; M"FSO9O??]U`D10Z'Z\A!7M:;P^'HS`PUAY3EF]]^;#>C[\W^L&YWM^/L8CH> M-;M5^[C>/=^.__Q#?;D:CP['Y>YQN6EWS>WX9W,8_W;W][_=O+7[KX>7ICF. MX&%WN!V_'(^O\\GDL'IIMLO#1?O:[##RU.ZWRR/^W#]/#J_[9OG83=IN)OET M.IMLE^O=V'B8[X?X:)^>UJM&M*MOVV9W-$[VS69Y!/_#R_KUX+QM5T/<;9?[ MK]]>OZS:[2MM?OEPP9Q_\C*Y[FX>UXA`IWVT;YYNQ_?97,VFX\G=39>@O];-VR'X M_^CPTK[]8[]^_-=ZUR#;J).NP$/;?M6FOS]J"),G;+;J*O"?_>BQ>5I^VQS_ MV[[]LUD_OQQ1[@H1Z<#FCS]%FD@(\L?W>?; M^O'X=XE9W8B/MTE\5_.<6(R MW!5,+(_+NYM]^S;"78`<'EZ7^I[*YICI*F4\]+7[5>E0,^WD7GNY'>/V154. M6&_?[\KL\F;R'6MD96T6W":C%K6ST`M"NQ4Q(&-`!<`$$?5AH>B?$);VHL-R MA!8.\''F40S.PDT1,2!C0`4`B0'K[Q-BT%YNQ[A&7YJLNJ:D%]8FK-^,FM2] M21\80R1#5(B0V'"+?$)LV@MZ0Q!;P6(S-OFIV'J3/C:&2(:H$"&QX2;^A-BT M%]3M.@BNS*YH51;6Z%1PO4D?'$,D0U2(D.#0(\+@TAW=M05MW,7@KKTP2`%% MZ9=CF47+L>Z-W#3!$,D0%2*$\N4YE+4QI6R0HNR[0,T0P1#)$!4BA!^J-SRE MVICR,T@1WN%E/J4+I>Z-^I0R1#)$A0BAC%4YG+(VII0-$J:4(8(ADB$J1`B_ M#`LL)*AEK;C2FPVKC<.537NB[#OG\(<&X!=QSL3,3`R"%'ZBJX+DD"(0C4JK M72#6IV^^S&@C.HB[VL)"`:>:0X)#DD.*0)2F%K2`IDY^!3+G[BF,+A+^!HHR M'TMPUENYP`6')(<4@6A(6LB"D-[)O)6],/,&(IEGD,@8)#FD"$1I:DT:3M,J M6$C30%$S*:)FDO56/L$,DMQ*$8@RUX(3,-=K9E9<^`WW\!O62E<8E8&B95/& M4?56/BH&27V,03\("JD(1*/2FA1$]"A,IITC-S-&SN^6/+^O5UT4+M[!)<"UPQ#0'SYR+G(4(56N% M]AI0C=J:<+X*'2.EFE"TK/)4_VA??T456XZ>*Q>TW$"Z+WIB\='+&N6A45Y$ M1P'AK-"?>E=E[GW1@+30#%Z0N9&E<$%:B!#/BNC(7UNK,N]7C7"^$'A`TT^D M-+6J#*=I-(C0-!"A6>91ZFJ=6?1T0M/ZHC3]0872U)HPG*91$$+30)1F$>_A M]>XUIFE]$9J%WXI2FF>I4<[5R$*$9G'I:]?=DK6U(MFTOBA-WRHH32T`P[-I MY()DTT"$9L58&B/"TKJB+'V7H"S/4A[]^"$Z15B(L"R+>%-BK0A-ZXO2]&)+ M:9ZE/,@BHVEE!O=#?[\65[YTMN;&BM"TOBC-7_0C_4`@K/F'M*!S0F7+0B3) MQ56<9&M5^0=]PD%::;[??'T5F70K,F*T7O_4Z48IG6=ER@B[3@^-D]]K[(1]59NHR&LKV#++3FD M"$0CBL1.+ZZ//0PHN!!:B)XM8G&NO96/RO@B43%(D8DT*JU0@]NDYA9F)`4_B)+AC)(44@RER+UG#F5N*"\UQAH!GM2;&J>RM'4W!(:0X)#DD"(0I:E%+\A\XNP2'`@**Y%A M@@V$VKK4U=8J@`2')(<4@0C-,I+;TS0[:]K++12>1QT4G$DA2I?!D4@2O,=Q1QTD,76*6[0%B+LC54` M"6XEG2^S>CG!7$PO>JTA^J:-Q:Y@;?N*6VCNX(`]'XV)<"=F+0A02'I(7PV,ME0;DK MHOY!,+ZN-)BS!+;D`FNA@&;-(<$AR2%%($KS+#4MN9I:B.2\+..SB;=RV10< MDAQ2!*+,M9H-7RU&^\(CJMZPF[VPXU1S2'!(V_E@A$6$:]T$(STGG9R<);>>96K\T[8?H5 M(,FM%($H>8,DMZ7LU($HLS/4M6*JZJ%HIS[ATBF`7DKQTEP2')( M$8@R/TM"*RZA%L)9TG&J.20X)#FD"$1IGB6AV,ZR6]5`Y"A=EO'#4CL15BX8 MP2')(44@ROPL"=5?,L5-ADNHM0IN-,$AR2%%($HSDM`/'J7Q:)'Q-U"TM..' M&'8B":F?Z(HAN94B$`WI+&VMN+9:*.!4?[GJ=-=5/ M"^&9@LM3S2'!(&0V=:]JQR-5CCG=-VMLI,!(=^AF(R5&NKN8 MC508Z9H5&YEAI#L(LY%+C'3IC4=*S,'V.1%IB3G8L:9&D!WL"%,CR`XV88F1 M"MG!1B8U@E?!Z4N@Y8XQ%,8J0$ M`QR+$B,9*H?7>U(CJ!R^QDB-P!M>04F-(![SB"9FG2$><[QD(X@'+S(DO&%* MLFZ8D+1'^,GH,]0,[[@EKI"A9GBM+#6"M8ZWLQ(C93'7CPA2(R5&4AG#KQ_N MD[[TY5.>@V%.:F11YIB32@H>/F%.:F118`1'27Z=1:$S MF4QE@65OA&;2KU3\4N1U^=S\>[E_7N\.HTWSA(8[[=[&V)O?FI@_CO:MC(?V MB-^(="]HO.`W00V.%=,+[-B>VO;H_@"I2?\KH[O_`P``__\#`%!+`P04``8` M"````"$`O5^W8"J=+7$VKN3[J33Z1Y>IQ!*M$!0DFYWO_V- M/2;-.,:!OMENZ2_#_#UC_R>0QT_?CX?)MZ)NRNJT"M@L#";%:5-MR]/+*OCG M[R_313!IVORTS0_5J5@%/XHF^/3T\T^/;U7]M=D713N!"*=F%>S;]OPPGS>; M?7',FUEU+D[PEUU5'_,6?JU?YLVY+O*MONAXF/,P3.;'O#P%&.&AOB5&M=N5 MFT)6F]=C<6HQ2%T<\A;R;_;EN;E$.VYN"7?,ZZ^OY^FF.IXAQ'-Y*-L?.F@P M.6X>?GLY577^?`#=WUF4;RZQ]2^#\,=R4U=-M6MG$&Z.B0XU+^?+.41Z>MR6 MH$`M^Z0N=JO@,WN0$0OF3X]Z@?XMB[>F]_])LZ_>?JG+[>_EJ8#5ACJI"CQ7 MU5>%_K95+\'%\\'57W0%_JPGVV*7OQ[:OZJW7XOR9=]"N6-0I(0];'_(HMG` MBD*8&8]5I$UU@`3@W\FQ5*T!*Y)_US_?RFV[7P4BF<5I*!C@D^>B:;^4*F0P MV;PV;77\#R&MJ`O"31`!V9N_\QE?Q"Q.[H@2F2CP\SW*C:G,499>)9FW^=-C M7;U-H/4@\>:/\ M&Q1F8YBU@Z%$=B%4%518V7MA#OEV2<-Z]I-VU_*2FX)5;I>H:WP!8G?)DDR$77R]/&MDH&J=D(02V2@A M?011`6_35^'/7L&K`-:HRXSQ]]7![)%)L5L2EL+!:`G,^DBZC)(!(0DA4M8G M2/JP6?OIWU8$=9%=!%L&,I!')]4NPB@A?011D5`5_B(HV"H"LW);(Y/H(DP9 M3R-'%9#Q*)0^@N2?WI._@JW\A;53U\A@_O$B$OWZZS;+")&((2'[1+143?;> MAR1[-1/TSDK_ZBO8SE[0[;E&!K,7/"+OC-D3@B7#ZL@^P=,EB4&R7]+L;]L! MZB)+!4LM%A7\*_W7'/ MA'VH,I^IXKX>1Z07H:50+MB3XC^8F*)I+S%A[VD#82FF+!&D$8P&#&0VC$A< MU>@C4\X5\GXX4!'*!'LB;JP'6B?MJX7=5PB91)T;NT],6>SH/:GN&F#=3'=& M47Q=BO+#GI21>J![4@F#X1DA4X\T'(Y"&2-([-PZZW;9LWZ?AN[QCY*.`Q%$F*:TB!4B/+'^X6@JU(A]N3'^M;+$BL+LT<( MLUA2?]:,M./$UZ=8IHSR?C5HK^30BNQ)2H=>!;!ANY/-.M>R<41Z$5(8_B$G MUU=9AU=DCU4&,OL]CCA94"R,83QRI1>A6NXRTV21D>TSA4!634;R[_L<45;5?"=G0#>58Y,X@1J@9*N^EI%Z*)K68W#T5+>A=D>HLP,$`[IE\3QUU3*L+R]1$1Z.=D@\3V=,(1,GN=Q7KV[I;0B"", MB%VC%HTCPN1Z*=2GFOWMX5>AZ9$#RS!&1)HX3)`BS/$1D*1(E%[?X,(R\MO& M7GT550+K3==Z;2`C181TRL-Z4"9*&;G'T(RD#%_03T5)5PEEFW\O"GHNW?+VM*5#7Q83OBX(219&"`8RA8-/B5PM MUF=$'"V)M]*:6`X_LN4=SA[;.S@CC5BH)PVVE5(7EZR,JT*II M+>SY1(S[^3@BO0B5\"$_%^BR=#09G%P(05-<'4U,'`\BO0B5C"Y>CV].5 M@3SY908Q.QS:Q?4YM3<.%7&7HPN7H]MSE8&\(C".!Y'>*$1"9-GY;6:HK[*^ M-!M\V&`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`USERQ=I-WQW29@_S\Y[%UI6$6VO^K7K_WS MY>UQFJ[NEODB%1:??*O.%[UW(:>3W8_SY7CXGX<$A/)!$@AB7R%(DMV);+$: M$2.%&/:U222[.0%+UE=A7YN#;\_>DO7!]K4Y>+P$*PAB7QL)TKM<+#9I?GLF M.02QKQ!DPTDP]_U9EX?<7K9/#Z?CU\2..=MCY\^M&\'BWL9KZL+W8ELIUPK% M5H@+\KN+4L>R-7"VU?WS2:P6#_.?MB)WP!2>L1-*CTDP4X:8%#,RQ&2842%F MB1D=8E:8,2$F;YFYU;`5TA9U7\CPP&KT1$+ND;DKZA MZ!N:OF%Z;Z#L[7"Z/7L'/TYMJ%Y/KDGVGLGK6D@7I!;*?JM(TW5&.D?V@=DZ M6Y#P"K6GI(PT:A4B7Y$:,GU`B'23=1&0+':BN%T6!U-9-D06SZQJ69+-9KFP M_V&D](C]?ZLNJ4K)$HHEM"=\(K-DD6T&B9A8$*22G;EN5\G!1*6$EKYG[/FO M25"RA/2$O\`\S@JDCIWJ;U?'P52=;L+Q$X-G8NJPA&0)U1!N M,D](!>JF\6H'F88@AR-E['ISNS(.ILJ06:'P3$P9EI`LH5A"LX3Q1%.=FZZ+ MD4#.??<6Y_B:XF`B4$[FEL(S,8$:PO7;9D6GY:;U:K\KEM">@"G03CQX^C/] MYG0ANI4=*6,-S^W*.)@J0^:#PC/-?.CF99Q7Z8&(=)(E%$OH?AKI:K@ZF%@( MI)"P]PBW2U335*-N4?03#T"9-WA$']28KHE\LFV^7CH\HENDGE:Z45/G9U!K MWS-@89RINWE4"6\!D=G)B9TH`/+58]W*H'@`B%4/CR@>T2B3-!]D8A"0X`K# M,CFK>+M,WEABF;JQ"_7CH8@*I6B0NH/79-V1;7.DBIH(5Q'-1S$M0O/`&CD? M>;M&WG5BC<@,6P@/^5):A4K)`Q$1)<2(((I'-(^82+)8)YO*")T<3>3=Y^XFLB,6+@M'BME M5"46D7P4Q2,:D&:)W5!3:2(`ULEYR]MU\DX4ZT2-HVCLZM52*'E$\HCB$0T( MZ+3$G1'7) M1U`\HEND/HD0`[%0$B+MLL!*.>,Y7BEO5Y%2U/L4HN]I9V[-I=[)`Q$I)<2( M((I'-,[$[L'35$PT"!;,6=&>8$Q)>>.*A:(F7#3NUG6E-?]4)M_L1X9(K4DG M1DQ"`!@[8I&2"5&A,\S(HJ+)X4F>D!,81(A$+*^54S+*?M01Q2,:)3-+DM7PELE$PZ!:2D9Y\IHF:@WVD`"**%'RB`3$ M:YYO,E(QB@^A><1VT=-* MM\U7%V#3(C0"UFB4)4\"EIPN4P5`$0%*'I$\HGA$\X@!I"E9T4F-A;+7,Z*8 M'$V*:4F6L2+Q4%0H%I$0I9G#4WJWK?C3:!XQD=-@G4:Y+D&34U$@^A.(1W2)N2&U69'(ST.R32-.\:\<*C?+C2_O*5M-D9T3QB``DEBZHH'66Z:YKJ MU*T(?H<7H(@,98O4-DYD72?6(63;?K52%(]H'C$M,D@$JS3*=*V7W#X:3NBX-90J:S$IIA:(BEZ'4FS.FL M6U?M.:Y6G4;GL:>AFS$F&@.+-,J)IP$GOJ8&"B!0(5FM`WUZ1QIHD&05MDH6U[39+$;[/$"%-&AY!$)"%3;2N1=9]?5HO@8 MFD=,Y#18IU&V/`M\/X7.T`5`49U\G`@B^2BJ1=RJ3^=GW;9>G>--BY``6*%1 MECP+6/+!'B]`D43RB.(1S2,&D*9D$]%99ZS4*%.>!4SY8),7H*A2K&^7 M$,5?P"S9K(BI4/QI-(^8R&FP3O9R^H8\ON^4.9K,38--7H#\"D0<50F-_O+3 M;/`]R_;@JR-%\8CF$4,3N59'Q(8S^@3L-_T"=I'U[7>Z#.RI`!&I-,DCBD3#*S.*..=!8SW8(,7(!A+@<^A2R"BA>3/%$$4'T6C5*Q*PZ(V"$EQ MMEBI4:X["[AN:FL+@'P=D8]<2M28T6-EVQPIH\;47T4T'\6T2.T`>K<&6)U1 MQCL+&.]>Y'J@%`#Y.MH$[MX`B-2(Y!'%(YI'#""A9)%.RU&FNZ;IPD9NK0J` M(C*4+5)O_JS)VB[;YJN%HGA$\XAI$9H'UFB4X5X&#/=@AQ>@J$:\X>:C*![1 M@/A2F8GEX#M-$0#K-,IV+P.V>[##"U!4)Q\G@D@^BN(1#0CHE"P#W[N,1L%: M$>-]V[[E,F#`<[)W40`$6QMT&L>MV8(<+=OVR-AC[;MNH]0#*Z'FSN#VU;K+ M$JMD>[5ONV]4R1U%9JG![N[20]";R\`F"A#1PO)!(HCBHVB<2A;81(D&P8J- M,N++@!&GLW$!D/^I;D*_=5BB9KL7MJ2;>1(3ZSSK>MOOGR"`+`8:-_^"NM'W7/YJB$/=%XGZ%3MXOQ7T9 M>E^*>QEZ7XE[%7I?BWO[._5A?&,?B5&_/V]/;)](\;E]K?ZQ/;WN/\Z3]^K% MIKRX+.PB_'XZ7YPSTU MHWV:R=/_`0``__\#`%!+`P04``8`"````"$`7GWW!H<"``#D!0``&````'AL M+W=O@.Q_?K)>[ZRO'E1-7D&8Z5N,II$ M,270")W+ILSHKY_W5S-*K.--SFO=0$9?P=*;U>=/R[TV3[8"<`0)C^V@E"BQ>"@;;?BVQKA? MDC$7/;M;G.&5%$9;7;@(<2P8/8]YSN8,2:ME+C$"GW9BH,CH;;+8C"E;+;O\ M_):PMT?/Q%9Z_\7(_)ML`).-9?(%V&K]Y*4/N=_"R^SL]GU7@.^&Y%#P7>U^ MZ/U7D&7EL-H3#,C'M$\C=+9))E,_T]AP5$7 MX!UW?+4T>D^P:?"=MN6^!9,%DGUD(\Q/\#'$^J]0,48/N?64C&*WXW6+Y7E> M);/YDCUC3L5!LWY',3(CSV^G_7>BA=[*[X*WMLZ;"![\):^ M>>^Y8C0>)"=.,$/'3OIL77;D+V%6CPPD\WC@!Y-!,S[23$\5FTN*$X\(.?9X MV9L79Q03,"0GF2>G;UX'S;PK:QPE\>ST'`?/,_KS>#(RP.PSS;>KK]V9_C4/>C00;#G#(6E["(S>E;"RIH4!D'%WC5)DP MIF'A=-NU^E8['*_NL<*O*6!_Q!&*"ZU=O_#=-WR?5W\!``#__P,`4$L#!!0` M!@`(````(0"P61ZG#2D```_]```8````>&PO=V]R:W-H965T&ULK)W=CMQ&MJ7O!YAW$'1_K,JL?\'V02N3OY@!!H,S,]=JN6P+;:D,E=SN M\_:S=D8$N7=\(:59.C>M]L<(%M?B9G`Q,I/Q_;__Z\-O+_[Y\.GI_>/''U[N MOKMX^>+AX[O'G]Y__.6'E__G/_I_NWOYXNGSVX\_O?WM\>/##R__\^'IY;__ M^-__V_=_/G[ZQ].O#P^?7V@/'Y]^>/GKY\^_OW[UZNG=KP\?WCY]]_C[PT=M M^?GQTX>WG_6?GWYY]?3[IX>W/YTZ??CMU?[BXN;5A[?O/[Y,>WC]Z:_LX_'G MG]^_>S@^OOOCP\/'SVDGGQY^>_M9Q__TZ_O?G\K>/KS[*[O[\/;3/_[X_=_> M/7[X7;OX^_O?WG_^S]-.7[[X\.[U],O'QT]O__Z;=/]K=_7V7=GWZ3^P^P_O MWWUZ?'K\^?-WVMVK=*#4?/_J_I7V]./W/[V7`K/]Q:>'GW]X^;?=ZWF_NW_Y MZL?O3P[]W_VRYW?ZZU_I>)4[ZM_<<7?]W>WNXO[R5H?]E8[:>M*K?QN'^A?UWN2=Z-]MAWV; M.^K?;8>MZ_5TV/HW=]S?_B6]][FC_MUVJ#N58JH,J\E\UK_J\:M46J=*/;[] M_/;'[S\]_OE"U[^*Y^GWMS::[%[;;DN-IM.T5.V7BE;5:GOYF^WFAY=R0/7X MI$OMGS_N[O??O_JGKHYWN3KZB0OC9:3#-*! M]"`#R`@R@!.VZ)C=HM]91>R*7E\O=X0!R!.E`>I`!9`290&9/@E"-4$&H M!85;Q='-(Y[M*'J0R*4&$7?^Z]O`TF@Y_R`=2`\R@(P@$\CL2;#%,E/PY>LC MW*EY5)^1Y!=E!Z(C44?4$PU$(]%$-`<4-5M@\J'QC.:4KW2/*P+?[!*J+OG; MZI)?6Y6.1Z*.J"<:B$:BB6@.*-I@<6F##2E=!1L2"J<>Z+@#ZHAZHH%H))J( MYH"B9LM#7K,-`_OK9PP#NYRL?%4D5`T$=W55+*W6J@#J\NZ=M3W10#02341S M0-$ART+>H3,71XY.WH:$W*$?=D!'HHZH)QJ(1J*):`XH:K8,M$%SBDSA2L@I M2J7N[@'W]:E?6JVG'JBS%*X[C`:7TJHG&HA&HHEH#BC:8`EI@PTI4`4;J*!:"2:B.:`HF9+2QLTIW`5-.>\Y8>#_<6N/O5+J_74`W6:X<5P`#2PU4@T M$Q`="3JB'JB@6@DFHCF@*+F.AH^^S%AS]284<@' M^PO,G>5LN5XOQ[5C*92.J"<:B$:BB4B?*Z2B.QU$=,C2W%^_./8I_/F+(R,W MO!V(CD0=44\T$(U$$]$<4-1L^6R#YA3G@N:<\.*`4,TF'O9+JW*>CT0=44\T M$(U$$]$<4+3!4MP&&U+H"S8@!Q[V0$>BCJ@G&HA&HHEH#BAJMC#F-3\S']@G M7M6T04;5<%!/#JZMUIK(`7$=(3JVZHD&HI%H(IH#BOYLRXQ[9L:,PG"0,^,J M\,A6'5%/-!"-1!/1'%#4_%^4&??,C!E5-5'/):ZMUII`C.S8JB<:B$:BB6@. M*/IC6BCJ@G&HA&HHEH#BAJMDBV07-*<&%L M7$*=?URHIQ'5HTJ#1Z*.J"<:B$:BB6@.*-A@GW1LL.'4/&;&C'QF)#H2=40] MT4`T$DU$`?&06[EJ.!)U1#W10#02341S M0%%S*S->WMF7I+9.*UTR-F9D?]Y-*]53C6NK4@-'HHZH)QJ(1J*):`XH6K0M M-EXR-F;DZOY`="3JB'JB@6@DFHCF@*+F.C9^/19=,AUF9(/.>NIW]8SBVFH] M]3D=KH-$QU8]T4`T$DU$A(U!'U1`/12#01S0%% MS74ZM*?(F\OOUB\4_N5OJETR.6841X1=/=NXMBJN'8DZHIYH(!J))J(YH MU;;D>&H>DV-&OBR(CD0=44\T$(U$$]$<4-3<2HYW]\^Y45PQ.F94E44]W;BV M6LJ"J"/JB0:BD6@BF@.*%FV+CE>,CAF%LDBM'#JR54?4$PU$(]%$-`<4-=?1 M\=F3T%=,E1E555'/1*ZMUJK(J7(==3NVZHD&HI%H(IH#B@YM2Y573)49N1(X M$!V).J*>:"`:B2:B.:"HN4Z57X\/5TR.&57QH9YP7%NMIS[MRV6MCJUZHH%H M))J(YH"B#=N2XQ638T;AU*=6#AW9JB/JB0:BD6@BF@.*FNOD:`/"LV88KA@J M,ZH&A'K*<6VU5D4.E7Y``.K9<2`:B2:B.:#HT+90><50F9$K@0/1D:@CZHD& MHI%H(IH#BII;H?)YCYE7#)4956513T>NK=:R2/MR1G9LU1,-1"/11#0'%"RZ MWA8J3\UCJ,S(J3D0'8DZHIYH(!J))J(YH*BY#I5?OT_8=UVJ&9>,JOM$/>>X MMEI./5%'U!,-1"/11#0'%&W8%ARO&1PS]`]&1J"/JB0:BD6@BF@.*FEO! MT2S:^&6F:\;&C*KAH)Z,7%NM-<'8R%8]T4`T$DU$<%Q;K:>>L9&M>J*!:"2:B.:` MH@W;8N,U8V-&[CP?B(Y$'5%/-!"-1!/1'%#4W(J-SPL(U\R-&<4185]/1JZM MUK)`2.S8JB<:B$:BB6@.*%JT+3=>,S=F%,HBM7+HR%8=44\T$(U$$]$<4-1< MY\8S`8'9\#I'/-TSUWGH?3WAN+9:3_W2L:".K7JB@6@DFHCF@((--]NRX:EY MS(89N?-\(#H2=40]T4`T$DU$2/"#7-C1M6(4$\XKJU*#1R) M.J*>:"`:B2:B.:!HT;;<>,/C)R;55*X$C4$?5$`]%(-!'-`46' MMJ7*&Z;*C$)5I%8.'=FJ(^J)!J*1:"*:`XJ:6ZG2'C*_'B-NF"`S6NQ9S0P_MTDY#4DZKZK;,N M44.=X=R-_(P&QKF;A+R&1*ICP7FH^W5Y3U6_=98@:+C=%L!.S6,`R\A=*0>B M(U%'U!,-1"/11#0'%#6W`M@S9FANF;XRJ@;4^C%];;4,J$0=44\T$(U$$]$< M4/1G6_JZ9?K**-0$TQ=;=40]T4`T$DU$O,J6>,LF\0:?H^3LY=UH_B:ZOUU"\="^K8JB<:B$:BB6@.*-JP+4;=,D9E MY,[S@>A(U!'U1`/12#01S0%%S76,.G/J&9]N$ZJN^OIQ>VU5SO.1J"/JB0:B MD6@BF@.*-E@.^NN_F[A-L4D_0"AJWF043GUJY="1K3JBGF@@&HDFHCF@J-ER MD]?LPMO&3VIN4P0+?B1DW[U=,_1E_;B=.ZI5,?)(U!'U1`/12#01S0$%B^ZV M9<-3\Y@-,W(U<"`Z$G5$/=%`-!)-1'-`47.=#;\^(MPQ`F94W0SJ9^JUU7+J MB3JBGF@@&HDFHCF@:,.V"'C'")A1./6,@&S5$?5$`]%(-!'-`47-VR+@'2-@ M1M+LK_KJB>VPMEI//2,@6_5$`]%(-!'-`44;MD7`.T;`C/0E_"+P0'0DZHAZ MHH%H))J(YH"B9LMA_F9PYJI/L/%+=_8]K@]*G M*[M9O>K75GDW5;8Y#;J7WA12!1Z*N[,M;E__BVG%@QY$=)[::`XKV MU$'RS-C!L'B7D>K.V;!..F8;4JO*K'5:+[WLN.Q+MUJWKVH"JLNMW&7:%Q3/ M1;7[H;G[JVJ28RS[6L_%5-!7=S^W=[^6:C#^?EL\/36/\;2@8/Q5=8$=5Y471W:$QV).J*>:"`:B2:B.:"HV8*J/_7/?^"_MUU5 MET)",?I?U6-X[NA<.Q)U1#W10#02341S0-$B2ZS>HJ_?RNY3P`U71T)Z"T&I M^T-NY="1J"/JB0:BD6@BF@.*FNL8;&7QC`^#[IF/,ZIJHKJE'M96Q;(C44?4 M$PU$(]%$-`<4_:DC\YF:8#:^3\@5_8'H2-01]40#T4@T$5_#I+/C]0["X8-`N3#>Y1[GI]&$J/A:Y9&1CD5@ZIZW2$W`*36V!R M"TQN@76MLBYNV#F+,P5AHHEM7-,\L$D'TSRP20?3/+!)!],\CVK MY-?I\^NWT=T%(V9AU>A1/ZZZ9JX@58YL M"YN["Z;-PMS)5T'D"+K6O@H"3`4!)OE@D@\F^6"2#R;YGE7R6[GS>5_WW5TP M>Q96C1[5%(7<2EV=@W(+3&Z!R2TPN04FM\#D%IC<\JQR:UL*W5TPAA;FI$H^ MLJGD@TD^F.2#23Z8Y(-)/ICD>U;);P729_WV?'?!3%I852O5%)3,0@2566`R M"TQF@N\4_WA=655599N/-6G;DIYV56KJY8P.06F-P"DUM@<@M,;GE6N67ASKMUKEA2&(R.^(!8B@5,\L%4+&"2 M#R;Y8)(/)OE@DN]9)=^2G)?_+<624F&T)B=%_;-^<'5=3Z#N[.,O>S1>1PRY M!2:WP.06F-P"DUM@<@M,;GE6N67!S[MUKEA24(R.^/!8B@5,\L$D'TSRP20? M3/+!)!],\CVKY%N2VR(_);\H?TF#OB#JV=-=654F%,32U8T>8'($3(Z`R1$P M.0(F1SRK'+%PM\61%`:C(SX@EH(`4T&`J2#`)!],\L$D'TSRP23?LTJ^Q;4M M\E.\B_)SY-,0O8P0]6>NAUU9469]TI4A2T]7#V`R!$R&@,D0,!D")D,\JPRQ M`+?%D!3XHB$^!)9Z`)-\,-4#F.2#23Z8Y(-)/ICD>Q;EGQ9_\?*_8>XL+R03 MK"F+RVB$7FIE?UU/L^_69J4PM%">SXLG5[52'IB6R@/36GE@6BP/3*OE@6FY M/,\JMRS#>;?.W$WRPC'1$9\#<[&$!69.3/+13O+!)!],\L$D'TSRP23?LTJ^ MA3(O_UN*)06\:,T2^ERQW&!6/BQ-4]Q:NI8"DEM@<@M,;H')+3"Y!2:W/*O< ML@SGW3I7+"GS14=\#BS%`J9B`9-\,,D'DWPPR0>3?##)]ZR2;Z',R[=B><9G M=[N\'$WT94E\OE(P)1]6LBF5LG1UE0(FJ\!D%9BL`I-58++*L\HJ"W#>JG.5 MD@)?=,2'P%(I8*H4,%4*F.2#23Z8Y(-)/ICD>U;)M[3FY7_+L)*27[1F28.^ M6#!='Y:X*<6R='7%`B:WP.06F-P"DUM@3?,^B_--2-%Z^C1[/FY+/J]KHCY43^6975KK1Z+T&V!M,R:_-2M>CZUJ8 M%C+VX?)DM%8R!M-2QF!:RQA,BQF#:35CSRJS+-QYL\X,'GD5F^B(#XBY5L)J M-R'R.3 M(V@G1\#D")@<`9,C8'+$L\H1"W!;'$F!+SJ20Z#[RU;)MU"V17X*<5%^8IIS*I?Y86>?R^CL:R*F,,D'DWPPR0>3 M?##)!Y-\,,GWK))OH6R+_!3BHOS$HOS,@GPPR0>3?##)!Y-\,,D'DWS/*OF6 MLKQ\NW5L_A72+B]R$UU)`4XSTZ4`5!2)Z9GI"S]$Y!CV),>6=E_X.9)KH3U5_EE,^YI_?^T'2;N\/$XT,$5`F]IW]UU\ M9E6ZAF:7U>2TKKVT-WL(<7NK/M20U_F/!J]SUZ_^!1G>_`O5@>@G3P$SGH,<.D,1@\E=,%D)IK(%DV]@,@E,)H') M$<\J^188M\A/`3/*SZ%3=\^U:&XQ'556\?&/"61R9-E=N23E")@<`9,C8'($ M3(YX%ATY+;RSP9&\4$]P)"S>DZ,?V7%'UC58WV!#@XT--C78'%DEWU*AE__\ MQX2\/D]T9@F=OE8P(166]LDYF4QF+;M;:X5,9J&=S`*366`RR[/*+`N,WJPS M@T=>O2_AA%U;\*<6R="V%(;?`Y!:8W`*36V!R"TQN>5:Y)1G!K7/%8NVK M[^.'A7Y*L:1VBJ]%JHH%3/+!)!],\L$D'TSRP23?LTJ^Y4M?+.?DISP:"R(Q M>TYS=QI,2(5U@$I!+%V+2W($3(Z`R1$P.0(F1\#DB&>5(Y8IMSB2,ZB?=@G+ M_Y2"2.UB08!)/ICD@TD^F.2#23Z8Y'M6R;>OGAP#W6\==V6A MH)5I\$`[U0J8Y(-)/ICD@TD^F.1[5LFWO.;ENSO-.2=2U(M.)+:.F+J)Y&:J MU[5<]M5TE;RI>\J:5L_;M6=4C9[9H] M;]='R4J(Q:+G"4F!*@I)+`C)S66Y1+OUKEB23DF.I*SS5H8*A8P%0N8Y(-)/ICD M@TD^F.2#2;YGE7Q=C$&^%3?##) M]RS*/RV4X^5_PWTF+[H3BF5=B,<7"V8]UF:K6V3=CJQOL*'!Q@:;&FR.K'++ MLIAWZ\Q])J^Q$QU)>2X^]M_AL;\LS^/KATR.++LKSLD1,#D")D?`Y`B8'/&L M5>MB1'1M,\M/^W&4F^6"2#R;Y8)(/)OF>5?+KE/K< M.V]>=B=62HZ@RCUNH,5#?UBQ)]]YR635LCM7*6"R"DQ6@XI\M)-\,%4*F.2#23Z8Y(-)OF>5?(MO6^2GN!?EYPBH M>G0%L3Z<%T>69N5$Z]H!DR-@<@1,CH#)$3`Y`B9'/*LEE M,LE'7\D'DWPPR0>3?##)]ZR2;PG.R[=B.;WP9>MD0%Z?*!J3\Z%&+S>NK%-, MI5269JY4P.05F+P"DU=@\@I,7H')*\^B5Z>EA[Q79THE+U44'`G+%V7Y9,<= M6==@?8,-#38VV-1@;?.%4O*@M&1G`_]N!+6.CI)5;&@G>2# M23Z8Y(-)/ICD@TF^9Y5\RVM;Y*=\%^7GS*>_XD8/3"6698_6E"]'EJZE2.0( MF!P!DR-@<@1,CH#)$<\J1RS";7$D1;[H2&+NIG+8A1602D&@G>2#23Z8Y(-) M/ICD@TF^9Y5\RVM>_K>,'BG[16MR'M01K,5RC]G$LE#2>DFI6):NKEC`Y!:8 MW`*36V!R"TQN>5:Y9?'.NW5N]$AQ,#KB(V(9/,$D'TS%`B;Y8)(/)OE@D@\F M^9Y5\BVO;9&?\EV4GS-?&#WN,9M8ED\*H\?2U14$F!P!DR-@<@1,CH#)$<\J M1RS";7$D1;[HB(^!I2#`5!!@*@@PR0>3?##)!Y-\,,GWK))OJ3_+ MR0LC16>6T.<'#TPFEC65PN"Q='6U`B:SP&06F,P"DUE@,LNS:-9I&21OUIG! M(R^;%!P)2RGE6B$[[LBZ!NL;;&BPL<&F!ILCJ^1;*-LB/X6X*#\'NSAX8"XU MK+24[[UD3?##)!Y-\,,GWK))OH8&E6"PY],7H@>G4L#93 M*9:E:RD,N04FM\#D%IC<`I-;8'++L\HMRW#>K7.C1\I\T9'$7&$<=F69)C]X MDDD^^DH^F.2#23Z8Y(-)OF>5?`ME6^2G$!?EYV"GDG19%-.I>1$G]Q&#+I^E MJRL(,#D")D?`Y`B8'`&3(YY5CEA.V^)(RG71$9_URN@!)OE@*@@PR0>3?##) M!Y-\,,GWK))OH?G/SZEET:10*TOH\[6"^=3N%3RDDCK`"#UJ9F]QF^]^?`KNN@I/UH][]<)V.KP+7!M.?P4T.+A)Q8. M/Z&SAU_WU.&W>MZOTX75X5L"\H>_7JGGRC!EIR@DL2`DH;-"ZIX2TNAY>;%. M955"+,L\3TA*05%(8D%(0F>%U#TEI-'S\F*=@JF$6`1YGI`47J*0Q(*0A,X* MJ7M*2*/GY<4Z/U`)L3#Q/"$IAD0AB04A"9T54O>4D$;/RXOUN;828O=Y+^3< ME9%R03Q\GQ7RS3PLT9.?A,ATM.BK`1I,`S28!F@P#=!@&J`]J^3;?=[+_X;D MEU?=B=8L.6(=J2\O\-P8%NPI;BU=U[LYV\DMM)-;8'(+3&Z!R2W/*K?L1N_= M.E5$_4KIFI2Z.#=8U6-]@0X.- M#38UV!Q9998E#6_6.4=2,O&UHI5WM8_PRNA#@TD^VDD^F.2#23Z8Y(-)/ICD M>U;)MZ2R17Y*-E%^8N';GI<7]6/COBS=XS[>:#`YLNRN%(X<`9,C8'($3(Z` MR1'/*D5?`M* M7O[S[S3[O#9/M"8%L6KTJ)\;2U?GH"Z?I6LI#+D%)K?`Y!:8W`*36V!RR[/* M+4MCWJUSHT=*;]&1Q)Q4C1Y@D@\F^6"2#R;Y8)(/)OE@DN]9)=\RG)=OQ?*, M'^7L\\(\T9<4$*M*69\!TTVY='7VR:JEJZL4,%D%)JO`9!68K`*359Y55EFX M\U:=JY04!J,C/B`6^6"2#Z9*`9-\,,D'DWPPR0>3?,\J^9;6O/Q3_K!A>',D M2;DO&K-D01]?U^?MXM72K)2%O`*35V#R"DQ>@].EB(SX#%OE@QWU8 MS>?43O+13O+!)!],\L$D'TSR/:OD6UCS\FWL>-8W+O9Y]9WH3,Z"NLN[6EFG MAHI92S-7*V`R"TQF@6*J'S"Y M!2:WP.06F-P"DUM@3?##)]ZR2 M;QENB_R4^:+\G`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`VZ MYC8[#UILH+G-ZD4KDK6V[:Q?._=HI5W;]H5^=A[:N4<+LMJV]GFPS&=+EC:/ MQVKE':Y3;WVN?AYV=AW:.U'+5MJU]'BSW M[-JY1S_;MVU?Z&?GH9U[=A=V'KZ0>RQ'[MHYMM45[TY?)6EMT>/IV5FN+#DY?=VILN=7I;*>$6YW,=D:PB-!. M"!:XVGGK3DK;:>M.2MM9ZU9]VLG@5GW:N>!6[K13@86L=L:ZE3OMA'6K"Z&= MKRQBM!/&C8Z@G2]N=`3M='&C(VAG"XM5[51U*Z_;FVMHBK]LIXEI>MS/$M;QN M)XAK>=W.#U?JT[Z;7ZE/^UYNT:B=C*[D=3L77ZYVZC2V7ZM.^ M@]L-O'W_MCC43D-7\KJ=A:[D=3L)7U ME,IKK9W3VB*OM51+:XN\;F>?O?JTD\A>?=HY9"^OVRGD4EZW,XA%NG:BNY37 M[3QG\:.=/BQ\M+/'7EZWD\=>7K=SA\6X=HK;R^LO9#CU^4+B4)\OY`UY_86T M(:^_D#7D=3NY67!KYS9U:5X]IXC1O'I2P&A5SBE>-$>=4UAKWH%/4:UU!_[; M[O7?VON2R-9?M]/M0Z,EN:Z_5I]2U>_[;8EAQN]GMS MK[_6GCNZEZCVS)%-Q.G[K?Q+;W8V#Z?_L6VOED'MZ&PO=V]R:W-H965T&ULK)S;RH6SX>JK:W9W6M%EF-5+,LE*S[:K=?;U_O1L'YQ>AL];KCW^W_^X_;'=O=U_[Q:'[KM[??EMO-&TE\ M7K^L#W^UHJ.SS7)6?'G=[A:?7^BZ_PPFBR5KMW^`_&:]W&WWVZ?#.T],JXT:=QNSX/KZ?!]*-+I,':-I0^3VOHC7&DSU,:&E`WU+U" M]4?3+89[0-!U)/K/:8T,N/>H_YS43.XQ@>TR86\SQ[K7MX,H7AP6][>[[8\S MFIG(>O^V4/-<,%,J/'QT\KL!]=YXHH&D5#XIF;L1I8=&RIXF@>_W87!S._Y. M`W=I;![0)I`6<[90HU3)QCY(?)#Z(/-![H/"!Z4/*A_4/F@<,*9(=N&D!/Z* M<"H9%4X.Q`,#)[Y>[-B"76(?)#Y(?9#Y(/=!X8/2!Y4/:A\T#A"QH][W*V*G M9.Y&]&_7%:-@*H/UH&U"M[]>2I-Y9](%%$@")`62`&AU=$)X5'6 M,CR:4'C<#G7E36^=4=>A@"1`4B`9D!Q(`:0$4@&I@30N$1&CN>:$B"EK&3%- MHK9*:1<>(\*C%_@GQ:M)#VPQ=?O0:7>1'HT#<5D*HX(QCNV=C:CB-)A8EJLZE7`=NMP?'S%B% MUC%'QP*M2H.<,U;H6*-C(Y",JUI:NW']('YF)>[V;X.HF]O>&X:RE\Q5":XB MXT8YC*"/&RV*F:,52:V$M=PH'R.?&<>);.I$RN\%1^:5M$[)JS+WYGZ#9+"\@G.N$BI[?&R0UTYOX9^@8XHH,^BCC$$C M"M0JC]*JT+%&U!CT[C7*7*B"X80QINL+,4=II,[JC`MO]IRKW6$_%QI-PNY^ ME*!5BB@SR'',T:I`5*)CA58UHD8XROBIBL*-G][+._76K.L2$5:#9!>'J4M; M3:(NAC$MB%2D)S(?WFR6&"MQ-P"MC+4H4TYN85+2CHY6P8ZV726C0:T*VU6S MH]5J&+UWC3)%JH3Y^RG2A9!(D4;TH,5&YQ)NSL:(/KH0]MQ\&1 MV585V5"VCUR,Z<).I%LC.=%%WI)S'FBKJ5U`Q8STTRNUQYX8Y,0B92OKF#&R MCCDZ%FQE'4M&UK%"QYJMK&/#J'64<56EW%!RMR@J7[J MK^:Z.2,[S<2,[/R4&"32I>6=J31#QQP="[:R9RP9V3-6Z%BSE75L&.&,J!;8 M(HC#Y6EK[HT)I=`6GGQ'G!LK)PRQ0[U+(UHG6Q[ED%V^16'@!)$*:(,48ZH0%0BJA#5B!J!9+!4&7E"L)2Y M%RR-1+`T2U1>"R-%!B4'.8$W1*D.4HV.!5B6B"AUKM&H$DL%2I9H;K)\J M5T-=\+FK.(.ZG>3PREN[S-F)AK&]:P=>71I;*^ZX"4L[.\G6RM7RRJ7,6K%6 MCEJ%M7*T8"?96K%6A5JUM;):N)-LK4A+IH>6#H/I.?*^K&2\/JZ1+%Y@)SDT MCO;^%QOD[.LF!HEN#XX9:N7H6*!5:9!SQ@H=:W1L!))Q]8O"#^X^6/RIKZVH MD(HJ!7:2C96(,E8IK.4NV:/(V]I)6,O.URDCFK:[(03RF;'Z8%^2M:Q\P6A0 MOCQ*OF(M*U\S&I1OC)5:2737Z`9'YE65;>YT]D%>=94GYBV-1,:BT-^])`^5 M?:?'QP:)51E8I>B8H6..5@6B$ATKM*H1-<)1Q$]]`4;$[Z=N!ZV*G&X8#0\7 M8^7N7C)R.TD4>75B8JRQHM4I&@UH5:M7L M:+4:1N]=HTR1*H+<+OYS*=*E%/4$OGT]1!J)@AQV+]F(IOH!-C)9)FVC`HG[$\#2\KCWG46HY\P8Z#\B5;#2D76LT+%F*^O8,,):/?++3S^N1^U>MBK>1&<*5>I\MF_"[J5Q'-[_BXW5 M\/9B8JQ$\'4CAN6SH^1SE"\,&I8OV8JW&&\";T53H73-3N[='N:7AJWZI.7P MH2GU%TR62L5+LT9BLH3=2_7M/_(;?A83L]7@=),8*Y'E8^2SH^1SE"_8<7`V M*XU5MWO9DV7=3*?E]5'2S9"TS+*JQ(=NB4=.DKJ@%Y.D1M02ODW.(T`QH@11 MBBA#E",J$)6(*D0UHD8@&<2^G8"(7@VBZSWQ/13:DH/QHI%*J3,M^E_0,(Y. MN&-$":(4488H1U0@*A%5B&I$C4`RMC2&1`<=+DLB9>[--QHYD9D;*P?%B!)$ M*:(,48ZH0%0BJA#5B!J!9+!49>V.Y@^"90IQ=R6K$>7#CEI`<00H090BRA#E MB`I$):(*48VH$4@&2Y68)P1+F7L]2R-WLY,V[925,V/'`HD6T+;,*2UHS64+ M#');P,CN%L0"R1:HA;X;@Y]:RZGM$2\T!M$2N>M';"4V+2/O^V*QM2)'V=9? MLYZG709H;.]ZWM^X8$=W'H;U545EMOQW\3F0I^N!R- MO/+$V]&=&T=WPX"1>9P:OM=JM2KY^YU&KVW<)8/ZGI4:/&Z$HXG_K1!C]<'2 MD*UHIK)YF-BO0L@\J(7)T!4=MPI2U88_#C1RYU-CY:`848(H190ARA$5B$I$ M%:(:42.0#**_"AJ^^:CUOQ\LL]*Q4]?<6-$MC^>1&%&"*$64([+:KYZ>=F?+;??U#O^M"*YO^VP_@&"A\F4 M?H&@_1(`'+GDWR;PCUS/Z'4:"IG/PVBF'I;V'(GH++3$[3M"9]&]U5>+KNA( MFQHX0@V@6R^JS2?!3$WR>(1^:.%3^_U57XM^@*'/_B&D2^G1>:!+[+O"3Y/9 M)TH(GOAA0E'LXQ21WH!0/'IU*!I]P9B'TUE,M0">F1YQSM0S33Q"SS!GZJ$E M'J&'E'3=?4?HL2"=IZ]E*1U1C_!0C1[9T7GZCM`#.#I/WY%Y<#%3+P.A&KW\ M,U-O^^`1>KMGIE[GP2/T^@[EM^\(O3!#Y^E+/;W^0N?I.T(OL]!Y^H[0JRET MGO;(N.MA]$,:;XLOJV:Q^[)^W9^]K)YH$%ZTWSC>Z9_BT'\.5<=<(``!4*P``&0```'AL+W=O/U15NMZN;@HW=[__..Q'W[-SF1?'^[$WF8U'V7%3;//C MZ_WX[[_$;S?C45FMC]OUOCAF]^.?63G^_>'77^[>B_.W#MFQTD'.V7Y=T?C+77XJFVB'S5?"'=;G;V^GWS;%X40A MGO-]7OVL@XY'A\U2OAZ+\_IY3WG_\.;K31.[_@+A#_GF7)3%2S6A<%,]4,SY M=GH[I4@/=]N<,E"RC\[9R_WXT5NF03">/MS5`OV39^^E]?]1N2O>XW.^_2,_ M9J0VS9.:@>>B^*9,Y58A/UY&:QF%_=7--? MO^`X-X[T:1Q]?^+-9U=JU!?\Z&J=+GT.&^F5<:3/82.]-H[T:1QOOI8BK=!Z MJ/0Y;*BWQI$^APW5H^K3Q:#*4$_T15FGNICJV@S7U?KA[ER\CVC!4[F4I[7: M/KREBMI4I9Z9MDX_*E.J3Q7E486Y'Y,`5($EK:WO#\'("Z8+4`E.2I=6&%LG_0QL51FG39/74@$XL1ZI5 M8]&XA"Z(7"!<$+L@<8%T06H!)@0M>A`BH&+IW[J:FE!>M$FQF@CXC#]I&]\N MG"MNLFI-6C&`1$`$D!A(`D0"26W"-*']##11V_G`A:/"W(]]V@$NK!QC=$FE MUJ15"4@$1`")@21`))#4)DPE$H2I=+EBE'4M1I/$DR:JUBQYYDZ%M$:-6P@D M`B*`Q$`2(!)(:A.6.]V`!N2NK'GNF@3S=N-8`0F!1$`$D!A(`D0"26W"$J4; MYH!$E35/5!-*U)[DA3/)K5$[R4`B(`)(#"0!(H&D-F&YTYH@8H8WHDNQHT M8LH89"L#*/(`"8,<96YX-G%GU2D#L61G92MSRV.EG14HHQH=6QG]N#11S\#5 M+M]\>RIH]JC(>]9/0(]%YF')M$NV8!H%M_6ST]R["IQ!K4C+>DNEI+H"6$5E/=AK'EJ9'ZTYUBOI/E2O7LZE95_WACGCH!1<:*B0A6,<9*T%&B52@8GE!\XJ"XV53[N<%M7P#A-<=(A/>()Z- MV]=22=7"=]F$!CGC=.X%$3H*1+%!GTD*@Y`8*S7HPW%Q_50G.4`_W7@R_31B M)1DLG&);><;*U@]0A%8"48PH0201I0QQ&52?.4`&W98R&0QB9;1P%L7*TU8T M1C#<3']:%\>HE]MSKOQ!C']?'?_ M,U:V?HTCW^R<+3%"1X$H-N@3_=!1(DH-XOKYW;BX?I3V@/KSE;FCGT:T#)O* M6ADK)I:QZNHO0BN!*$:4()*(4H9XSJH)__J:4T*Z.6O4MF/^M;O>C!.30#M9 M*$(K@2A&E""2B%*&N`2J]QT@@6Z5[6W'-]VS?4L-H'MJK+II#Q%%B`2B&%&" M2")*&>(RT.B'R*#,G>HWB,K;ZGA@]]!6[%8%[4WHFUA4)UVLP(D5&2NKC$2# MR+]UA/"QL?ILCS%#[69,?BE\:JQ4S;6#"*S1<^%5-!MR$- M?.[(H)&5X"H`%"**$`E$,:($D424,L1S'M8ET]MA MD+-&07?/6QDK"X6((D0"48PH0201J1?9U%#U('3.^L4T_?+/(3N_9JMLOR]' MF^)-O71&W=W#78OU&W%/0="\$N=>N5W2`1KM92[W;Y9J:^Z[0BZT*?5<"6;T M5^J?7]UH@7HEKWZ!#:[X=*5NU)PK]!;?8Q]_HE"]D2A0K[U*O6>TC_/E(XG; MD\9\2:]!]/#%DEX1Z.%72SI1[^'72SIM[N&D;)^P='*T5.="Z$'G0)1SWQ4Z M4R&?OBSHA(1\^J[0`<12'2_@WZ'C!(K6=X4.!RA:?67:SA.]TWA:OV9_KL^O M^;$<[;,7*K]9?81RUF]%ZB^5^=W_N:CH;<;Z"&!';Z]F]%[8;$+[]DM15,T7 M&M2T?1_VX5\```#__P,`4$L#!!0`!@`(````(0#%P^^W5@L``,PX```9```` M>&PO=V]R:W-H965TTW#2[^G[X MHSX,?WOXYS_NWIO]E\-K71\'Y&%WN!^^'H]O\]'HL'JMM\O#3?-6[ZCEN=EO MET?Z<_\R.KSMZ^53VVF[&:7C\62T7:YW0^-AOK_$1_/\O%[55;/ZNJUW1^-D M7V^61XK_\+I^.SAOV]4E[K;+_9>O;Y]6S?:-7#RN-^OCC];I<+!=S7]_V37[ MY>.&\OZ>Y,N5\]W^`>ZWZ]6^.33/QQMR-S*!8LZST6Q$GA[NGM:4@1[VP;Y^ MOA]^3N9J,AZ.'N[:`?IK7;\?@O\/#J_-N]JOG_Y8[VH:;:J3KL!CTWS1IK\_ M:42=1]!;MA7XSW[P5#\OOVZ._VW>_U6O7UZ/5.Z",M*)S9]^5/5A12-*;F[2 M0GM:-1L*@/X=;-=Z:M"(++^WG^_KI^/K_3";W!33<9:0^>"Q/ASE6KL<#E9? M#\=F^[WAZRXO1M]HRFULC8+ MM$FX1>DL]/S1;JL8B!C(&*@`C"C%+D^:-+\@3^U%Y^DB7#C@$T^CI)R%ZU+% M0,1`QD`%@"5%$_H7)*6]W`_I.[KB)<649[&P-F&%)]RD[$RZ3($((!*("@G+ MEB['7Y"M]D++3Y!M5LQX*@MCDY[*MC/IL@4B@$@@*B0L6UI#?D&VV@O5=A:F M.QE'Z5JC4^EV)EVZ0`00"42%A*5+"U^8;K^PN.5&&[=9N6@6AF0D;-TDSB;Q M^M(9N6X5$`%$`E$A84G0`GIY$MJ8)V%(EG?+2PFD`B*`2"`J)"QBJOGE$6MC M'K$A6;AV9)-X!>R,NF$'(H!(("HD+`F:W6$26L,*TH$K-4Q[X=D90O4()U7& M+YZR,^JR`R*`2"`J)"R[A"9UF-[I2Z.UYFE8%,XK1!4B@4@B4@SQR+481YN+ M#Q0F,9I.BY@;XH5%46GRJ#3>RG6L$`E$$I%BB&>IU3G(\DQ]C):S9`RBJ\B% M62:`*D0"D42D&.*1:ZF]/'(KS&$9#(JN_R(N0V?E\JL20`*11*08XLEH);T\ M&:N[83(&LI53/(\LQE8C267296=@-Y3`!5B`0BB4@QQ"/7ZAE$WIZ1QG2% M7BDPB5%AEE,GS*'$1)OOTG8,JE$A$H@D(L403U/K:Y#FF0(9-6;)6($."P2H M2@`)1!*18HA'KK4SB%P7*+O5=R*N+I%18995)\QAB:+#;9ET5OX:`B302B)2 M#+%$TV@KT,[$XF9*B9ZN5MN1[PHLFIA[+/JX72*J$`E$$I%BB"<1[0K.1([B MGQH4J4YTABN]55<11`*11*08XLEHH0ZFWIEDC*R'TRL%I2\158@$(HE(,<0C MUQ(<1/Y!U4F-DK.4K+B34OK#V#0Z=):V8[BH(1*()"+%$,]2RW60Y9GZ&'%G MR8#>ERF@"I%`)!$IAGCD6H(OC]P(-HO<("[^T_A,K!=)VC6P,@`2:"41*89X M,E>)?XKB;U$V\7MD1!4B@4@B4@SQR"/Q/S.!4.)3@VA[X=:ATJ%IARJ&>`!: M+R^?!T9=V3PPB/:?/@"#"@HMN$*CK%K%0K16M*4&HT2&\GL8FV]53WTAJQ**TK'J4O M#(\R$L&>"1O.`M2ZS"`693:%P316+$SKBX?I9P8/4RM.<+V="=/H4[@&:!&@ M\65AQO?X2VO$HK2N>)1^J\6CU+IQ>91&95B4!K$HL]MXXY`9*Q:F]<7"O/52 MQ\.\2HM(<6!F&A2%&:V>I>W(PK2^>)A^3O,P(^'YT!J;H1Y9%$7O%YMV<2ZM M5>%_ZJHLRO/V][U/LZG/F`>N92.8!A\+W&@/FQT6T?+EEY];O_S8P(U5'DI; MSXIKK>@C\/6S1>*,VETH(2AWF4'!WJM$5"$2B"0BQ1`K4=XCBA^X,=NZX>)B MD5Y*@H&-UT-OY;8D%2*!2")2#/$LKU+*W,AB..,L"NN#J$(D$$E$BB$>.:T0 MX25T>KVG)29>HBSB1^1;KR[F6O%6O@S&%W5T2*"51*08XLEHI0O6@S/)6%T, M;LSF!K$R`*K02B"2B!1#/'*M?D'D>B6;TG,K5]]6HC43*F10=*%X9;45ZJQ< M.2KK*Q@-@4@B4@SQ/+5\!GF>J9`5V[!"!@4QE3F@"I%`)!$IAGCD5VEYCEIN M47BN1%0A$H@D(L40CSR2]S-CCCJN%4YOZ8)SI4/!N1*10"01*89XY%H[+Y\M M1FG9LFH0W8EVD[K,#>('TEFT\ZN\E>LH$$E$BB&>S!EMO^@DFZ.T6\1RM%:T M='EIG/E-:GO%5\Y7>Y)MD4`D$2F&6(Y%C]HG[3+6'M;=]N7RDWOKD.N^16&^ M%M%CB?IYL'2<^/VB2=4;=.5TGMNG$5LKZ:VLFVC$E#<@-SSQ:`,0[T1=YJ>O M/;TQBLZF%K$]=#*.MZ*N(ZWA7<%Q*^JL:+WLK+)9-%;"?:._9J3K>-*]0[_A]_1)4VII]R'0A_*AWY7[^E`^]+MM7POE0[\7]+50U/0C M8T]+0GWHJ:F^%NICCG=Q;`EE:C8G)DIZ6E&I*CVOTM%"7 MWAX)]:#'/GMZ)#32]*AD7PN--#V*V-="(TW/]?6UT$B3"F,+O>_TN=\7=>BQ M7^@R]W'ZZMYOUE.VQ_YS,?],%Q\&M*`J]A:1:MA;=JI@[U2E^O65KTQOY_H' M6?SF,IU12U^9Z%1-6?3VR:FR=&#L\5:,YQ6=J+"%#F*48E_+(B-O=+,9^RQR MZD,W:/M::*+0#="^%JJ5.1J,NME-[Y*]+5_J?R_W+^O=8;"IGVE1&[Q.=);9.T/NZ_TUF!-3S>-M<`^-\W1_4%?/>K>0WSX/P```/__ M`P!02P,$%``&``@````A`!IB9XCL`P``70\``!D```!X;"]W;W)K&ULE%=;;YLP%'Z?M/^`>&_`Y+9$2:9V5;=*FS1-NSP[X"16 M`2/;:=I_OW-L2L%`"R\D'([/YW/[?+SY_)2EWB.3BHM\ZY-)Z'LLCT7"\^/6 M__/[[NJ3[RE-\X2F(F=;_YDI__/NXX?-1<@'=6),>V`A5UO_I'6Q#@(5GUA& MU404+(>Y;"VLYQ(8X''C,;D5\SEBN MK1')4JIA_^K$"_5B+8N'F,NH?#@75['("C"QYRG7S\:H[V7Q^OZ8"TGW*?C] M1&8T?K%M7EKF,QY+H<1!3\!<8#?:]GD5K`*PM-LD'#S`L'N2';;^-5G?1"L_ MV&U,@/YR=E&U_YXZBPX>H6/KY/F6J1@B"F8FT1PMQ2*%#<#3RSB6!D2$/IG? M"T_T:>M'4]_;,Z7O.)KRO?BLM,C^V8^D-&$71^5B^"T73Q>3^3*<$L!ZQTA@ M-V+\NJ6:[C927#PH%H!4!<72(VLPW.T(>("ZUZB\]:&88:\*HO^XFX733?`( M$8M+G1NK`\]*AU0:`8!6R(`V'!F5$1E#BENYL8(Z3-0-`_$=#H/*6Q^>U>9G MX:RR:Y&MSJRFLZ@T&@Z"RG!D5(9J6-7,MF-KE09`0ST,AT9E`UT%UTH(M$(3M M.]PCU';B9T5='CD-;\XE,I^`^)T":#<_GFI*%';S8-+!0=(AG5+D=%'/ M,!"-H@.C[82MG`?`Q=JYW=.SD<,0)E\S**:W.<\L2D[@,W0T("TUR/[HD5A[AI[H>%Z8_Z> MX!K+8)0W1'@00K^\X"1878QW_P$``/__`P!02P,$%``&``@````A`'9CMVK@ M`P``(PX``!D```!X;"]W;W)K&ULE)=?;[,V%,;O M)^T[(.X+&(>01$E>O02ZO=(F3=/^7!-P$E3`R'::]MOOV"8T=CI(;]J`?W[L MY_C8/JR_O36U\TH8KVB[<9$7N`YI"UI6[7'C_OW7\]/"=;C(VS*O:4LV[COA M[K?MSS^M+Y2]\!,AP@&%EF_ MJDY-[8=!,/>;O&I=K;!BCVC0PZ$J2$J+GJN-7M:9X1*[) MVRIHTX'$OJHK\:Y$7:A`=R MOI[HO>>EO_1!:;LN*W`@P^XP>U$<8`2XLR=< M/%=2TG6*,Q>T^5=#J)?2(F$O@F'V?7OHA8L(1?,OJ,QZ%1BW5PE#;Q9&\>*! MN?C:EPI3FHM\NV;TXD#NPR,0'#&VRNQ[U)V/2&L)4WB6;&S$T2Z9606WEN[^3L MVOH1X8\`&][F7_$F8=/;S#Y"-#)F;9)(KX2T%D76^9)=6R>MQ5^Q)F'3&H[M M9=/,F+=)(M7$7.5D%"\#<\]F8P+&NLEJY^82&#]/)&R:LX^R1"-Z7@CAN;59 M=A/MZ6U[C&X.=+W7=//GH3-\+;_B2\*F+[RP(IIHYO.1U=QVDT2JB7[1<&P= MQ=F8@&$.P>7U^*HIVK9G7*MIV M:.WWI(=&'>J"8@1)!Q7I\&D96W',AO9IB_+6?]RBKA&,NVYA;:X$RFF9R"/S MWTTC:8_H^RX,`VP-(ZMV.IKLEUL=D0=B0[4M?<*>A9UMLA'%K# M6_TMD*`5E%)0@UOO=V@%%96L\H<&*-&[_$A^S]FQ:KE3DP-(!EX,-Q731;Y^ M$+13U=N>"BC.U<\3?(P1*-("#^`#I>+Z(`<8/N^V_P$``/__`P!02P,$%``& M``@````A`-\V((J8#P``B5,``!D```!X;"]W;W)K&ULK)Q=;R.[#8;O"_0_!+X_B<=?B8TDQ68^-!):H"A.VVNOXVR,3>+`]NZ> M\^]+C:B1J'?&:Z=[[_6;[=C?(+H>#B_7; M:ONX>?MR-_CW[]5O-X.+_6'Y]KA\V;ZM[P9_KO>#O]W_]2^W/[:[K_OG]?IP M01;>]G>#Y\/A?7%UM5\]KU^7^\OM^_J-KCQM=Z_+`_US]^5J_[Y;+Q\;I=>7 MJ]%P.+MZ76[>!L["8G>*C>W3TV:U+K:K;Z_KMX,SLEN_+`\T_OWSYGWOK;VN M3C'WNMQ]_?;^VVK[^DXF/F]>-H<_&Z.#B]?50G]YV^Z6GU_([S^RR7+E;3?_ M`/.OF]5NN]\^'2[)W)4;*/H\OYI?D:7[V\<->6##?K%;/]T-/F4+,YL.KNYO MFP#]9[/^L8_^_V+_O/VA=IO'OV_>UA1MFB<[`Y^WVZ]65#]:1,I7H%TU,_#/ MW<7C^FGY[>7PK^V/>KWY\GR@Z9Z21]:QQ>.?Q7J_HHB2F-W8U*"(+/^X&XSH@S>/A^>[P7AV.;T>CC,2O_B\WA^JC34YN%A]VQ^VK_]U M0ID=5&MDS$;H+QN9!AM']":L1W]9;Y1=CFZFV71F/_V()EUMADU_O>;UY74V MG(^OCRO.6)'^GC74:]:CO_X#3QPJK;1FJ/37:YXVU#DKTM^SAII1$C6?:/_' M?^3QP5ZYK&B2K%@>EO>WN^V/"UJY-._[]Z6M`]G"FO/IY::F3;B^?*,%LGW^_GU[/;J.R7VBF4>4":3$KF7L*EGS18I*%-0I4"EH$Z! M3H&)P!6%I8T-+9E?$1MKQL;&>_7@00C6*`F$E_`J10K*%%0I4"FH4Z!38"(@ M`D'+'@(QIF3IKD$^)ZP651N1$]?2T0,98Z288WHD'1VRN1>&YD4F4MT)>K0!2`JF`*"`U$`W$Q$3X3CO0&;Y; M:>F[(^2[=RL'4@`I@51`%)`:B`9B8B(15R.)[^5EKX[0KY[MW(@!9`2 M2`5$`:F!:"`F)L)1JE["49L`(^H0SYY_:TC&P!$Y_S?#9/Y;(1^H`D@)I`*B M@-1`-!`3$Q$6VT^)N!Q/@$9<>L\H3@%$!:(2485((:H1:41&(.FS;:;BAO(G M/KO>B_8_/W4/F4/)E$.KV$IYQ2(H>E0BJA`I1#4BC<@(),-@6ZDSPN`Z+Q$& MA\34`RHR0"6B"I%"5"/2B(Q`TF?;*YWA,[=6\=0[-)ZUV9!G@`I$):(*D4)4 M(]*(C$#29]OYG.$S-TJQSPYEL<^,KMLP%!F@$E&%2"&J$6E$1B#IL^UX8I_= MF?'2'LP/SYO5UX@@Q6:2JF2"`)F10;/=T[&@_;Y] M[PL:-5)MU%P3)@J%0W:^VA8I&R8.YI1?32!#-UD@*AEE(?,JE%*(:E34*&4$ MDN&Q350BX1!D:4=VT8YC<0!B*@OQO@D7%-;*5I%[) M4I-1FZX5H^/F5;?YB#7G$1&>!)A)/8`)R7V`$"E5PS-8<4H4E2(:E34*&4$DCEF M&_TXQWZR!_"Y(#J^VX2D%$OV@&%2Q'(O%CPL$)6(*D0*48U((S("R3C8COJ, M.+@&/&Y7[2,\N]3B:H7'+Y:*\KGPBG'AIF655.Z2Q<0NX#XR,J9ZC(72W>Q% M-0Y#(S(]QD(AE2&TW?,9(73-M@@AHSB$'07?245>%V2DB;T,8984Z9+%1`C! MF.HQ%HHTAQ`T-6M&(S,]QD*U%2&TC_E$"#^TE396Y%;J41Q9/$NQ5+3]%1[% MVQ^>I;Q45/(]"N2VI?> MHLO'3FQBMV[_[1"X:U%X*5K4K50VS)(=L?1B<:Q/L:^\8F(_;)(NKUE,Q/\4 M^Z;'?M@(9*K36CTZ)Z<=Q,;63#(I#L7/#5@J0@6B$E&%2"&J$6E$1B`9"]O- MGUXYQWQJB#9A1N*1$>5.LH?D0X?BYRF-A=2K4$HAJE%1HY012,;'-L-G+"37.XN%Q(AVNW@##NVNNX]#:6'S3FSZ M';LY&Y,MZ2AM2=E8W)*>9%^QE+VM%0UV!-T4#S9,AS[)ONFQW]=AV6;XC.!S MOQY7,48R^*/DYD(^AJZ[8)1&`OHFIRDB#<94CS%HDD!3X\A,C[&>CFB2-O_' MC^*-N-S]/$IBF'8!+!9U>`6C2:PY'J4A]%)1ZXFVE).SU*3DL`:XH(LJ9-C([S^ORZ12>MC>,IO''9<-QJ"=N@V*Q MR.O"&XLUYS=)[$N6(J_\#E^A+=5M*YF-&A4U(M-M*TR&#*#MY$_?9.P4VX2+ M-AE&<7_H4=@@"T0EH@J10E0CTHB,0-)GV]R?X;,53WQV2+0KE#2P*;!8'`=` MY010A4@AJA%I1$8@&8?TR/"3S1'/!A-&LK2GWWS)64PL'M:D8M*N>6//K^Q02Z]`)1B:A"I!#5B#0B(Y!8C_1H3_K\ MH5:KL2)+/B-1\O%N/TO%R]&C..GQ;K^7BE:C1V$!*8^DK5":W-UFEHI3R2L& M6\8C:2O4%QE6VXG'J?2QL'(_'RW1J4,BK/C-*9:R]:-=CGA[P$O1LFFEYO!E M*B\51]H-XKAYY16E^;02LI0(_BGF3;?YGMHXM4WXL?DX[<958R;)<]?>W\1> MTO/"I%SEK$EB[;Z#J$14(5*(:D0:D1%(YNMYYX(IG@L8W81Y;38]*E*H0 M*40U(HW(""3C8/OI>&W\)`ZN_8ZW/=LP4&@B!W-$!:(2485((:H1:41&(.FS M;8K/\)F[[Y#<#U.'Z%ZYG\$<48&H1%0A4HAJ1!J1$4CZ;'O.,WQV+:J89^Y: M8Y\914>V*:`2485((:H1:41&(.FS;0ECGS^V#ULKR=)W*#[%3UFJ]RE/$/`I M4S*B&]T>54&JYRE/$/`Z-9K10:KG*4\0(#,R:&D?G`;MQ,T2^^-IVQ^+@IF< M8G,6L]]4;.MJ1_O"]N,S![5"R2FV])\9,K0ZR;[R4HE]Z![9IV!?>\VCXS=> M*K'?TU'.?DFCWEB1FEX84^+%`ZX0M;H_-1UA:S1*:/KRHRN-(UR:FTVHA$T=U/@"HV`\KS# M6D8Z])O_KBND0[^,[[@R)AWZOE_7%=*A;\!U72%/78*G8YN2-;I_T*%#CG;Z M>;V@E[)TR-\LZ!TF'7R^H)=X=/!L2!XV]YK3,67TUC]Z^P/JY-.;14$-+EZA M]GJA.J]0QTP>=NG0RP4_=7IN/[[C,QXH5)WR-NP=\I\FBT^4]CC8!YJ-[K2C MD7;(TP_U%_:W^&B)?GN_L#^OQROT^30)?T175>86^7$8^ M-NEPU2K1BQ#?EU_6_UCNOFS>]A&UL MK)W=CMQ&MJ7O!YAW$'1_K,JL?\/V054F?S$##`9G9JYEN6P+;:D,2=WN?OM9 M.R."W#N^4*4SW3=6]\=-)M?B9G"1S,KX[C__^>&W5_]X^O3Y_?/'[U]OOKEX M_>KIX[OGG]Y__.7[U__GO_K_N'O]ZO.7MQ]_>OO;\\>G[U__Z^GSZ__\X;__ MM^_^>/[TM\^_/CU]>:4M?/S\_>M?OWSY_=LW;SZ_^_7IP]O/WSS__O112WY^ M_O3A[1?]WT^_O/G\^Z>GMS\=5OKPVYOMQ<7-FP]OWW]\G;;P[:<_LXWGGW]^ M_^YI__SN[Q^>/GY)&_GT]-O;+]K_S[^^__USV=J'=W]F?OK;WW__CW?/ M'W[7)GY\_]O[+_\Z;/3UJP_OOIU^^?C\Z>V/OTGW/S=7;]^5;1_^#S;_X?V[ M3\^?GW_^\HTV]R;M*#7?O[E_HRW]\-U/[Z7`;'_UZ>GG[U\_;+Z=M]?;UV]^ M^.[@T/]]__3'9_>_7WW^]?F/X=/[G_['^X]/LEL'R@[!C\_/?[/2Z2=#6OD- MUNX/A^!_?7KUT]//;__^VY?__?S'^/3^EU^_Z'A?2Y(I^_:G?^V?/K^3I=K, M-]MKV]*[Y]^T`_KOJP_OK3=DR=M_'O[]X_U/7W[]_O7ES3?7MQ>7&Y6_^O'I M\Y?^O6WR]:MW?__\Y?G#_TM%F[RIM)%MWHC^;6SDA14O\XKZ-Z]X_SJG]1[DS>B?T_;[=N\ MHOX];;=UOAYV6__F%;>W?TKO?5Y1_YZVJQNU8NH,Z\E\U%_T^$UJK4.G[M]^ M>?O#=Y^>_WBE\U_-\_GWMS::;+ZUS98>38=IZ=JO-:VZU;;R8)OY_K4<4#]^ MUJGVCQ\VF\WE=V_^H=/C72YZ;!3%BEVIL'/!MKNO05>#O@9##<8:3#68'7@C M7Q9S=,[\.\RQS9@Y1=5C`:M;V\J(4E%6V=>@JT%?@Z$&8PVF&LP.!",T!L"( M2W5+>R0K36%K:.;>;[UUN-`?[4N8H>/.:JEVQ:2A:;0#J0'F0`&4$FD-F38),<"3:] MW#)6?7"CB'A,Y%*=N?IS?QWMV2U%9;4]2`?2@PP@(\@$,GL2M.L:=()VJX[: M$[F\7$:.'<@>I`/I00:0$60"F3T)0G7-#$+M*G*KK'+RV6`;BAXD_ M'B*6HN7X@W0@/<@`,H),(+,GP1:=KL&6EWO?JJ/V1"YOU^,/L@?I0'J0`60$ MF4!F3X)0C5Y!Z)DIPC9S<,`=Z\VF.MD?@GZHAZHH%H))J(YH"B#9:W?.@\ M8D.*9[I$%C6/FX0T*A2T(]H3=40]T4`T$DU$WU&4/D)H6T M8$="U2!Y5W?%4E5,V^=M.1\[HIYH(!J))J(YH.B0)2WOT)&NR,',=T5"?KS< M`.V).J*>:"`:B2:B.:"HV6*3UWSFP+G)\4LCSS(FZ@:L&A8?2]E+0^=:LW:) M#W>'^[*.53W10#02341S0-$Q"UO>L2-=DK)9.%F6N.:\NK^O3Y:E:K4!J+.\ MKRN6AN-2U1,-1"/11#0'%&VP*':"#2FY!1MRF%MW?;K07:WUJQ=LJQ64,>JGF@@&HDFHCF@X-CVM`QZ*(\9 M-*.00;<7F^ID6:N*YCU11]03#40CT40T!Q1M."V#;IE!,W)C_XYH3]01]40# MT4@T$G^.G!HI208;$@H] M`;2W]T5VW[4^_^F(>J*!:"2:B.:`HF8+=U[SN3V10Z)[H"%CLLPU;FXOJN>A MN[5J[8EEQ8(Z5O5$`]%(-!'-`05_[#UA\.?EGCB4Q\"9D;^F$NV).J*>:"`: MB2:B.:"HN4Z79]Z67"ZQIGNP]EC*=%5^]+5EK2DOLB3JBGF@@&HDF MHCF@Z%B=38]T"0.H74W3LYC5A.U%?7>V5JTV+"L6U+&J)QJ(1J*):`XHVG!: M`-6KP3I;9*2/*&IV1'NBCJ@G&HA&HHEH#BAJ;@70LQZ-V\6SBEH9V3_+J;&] MJ.[K=VM5,6U/U!'U1`/12#01S0%%ATY+G)=,G!F%(30GN_7MXIY5'5%/-!"- M1!/1'%#47,?+'$&7FK5)@+I+H)YH(!J))J(YH&A8G4V/ MC*",H.J.Q@A:6;5;JU8;EA4+ZEC5$PU$(]%$-`<4;;!HZ./8$1M2DE1\*;O^ M>)F03L>"=D1[HHZH)QJ(1J*):`XH:FY%T,L[^U;IJ0_'+YE",[+AR0VA]0N3 MM:JXMB?JB'JB@6@DFHCF@()%5Z>ET$-Y3*$9J?.*P!W1GJ@CZHD&HI%H(IH# MBIK_32GTJIU"JPYX+&4OC:%K33%Q3]01]40#T4@T$5PR>&3DU.Z(]44?4$PU$ M(]%$-`<4-=6*O6KD!R[5C5$PU$(]%$-`<4':HS MZJ*!:"2:B.:` MHN8Z8]JY<]R3CFO$SHZHMZE<$:]7:%FE; MH2V`>JXX$(U$$]$<4+2H3J1'VH*I\SJ'1_J%R^L2\W:)$#=NJ52U1,-1"/11#0'%`VS).AO6XXT M20J._BGH=4+5A;6R:K=6%8%[HHZH)QJ(1J*):`XHVG!:"+UF",W(Q80=T9ZH M(^J)!J*1:"*:`PJ:;UHAU++'B5^3/FPG/@+-J!H_ZQ<$:]72$T0=44\T$(U$ M$]$<4/3GM,QYP\R9D;L+V1'MB3JBGF@@&HDFHCF@J+D.F&>.GS=+\O3C9_T@ MN%2]-'ZN-6N3Y(VO?RC?L:HG&HA&HHEH#B@:5J?3E\?/&T;0C*KQL[)JMU:M M-N0(NK[`[UC5$PU$(]%$-`<4;3@M@MXP@F;DDM..:$_4$?5$`]%(-!'-`47- M_[X(>L,(FE$<0K?U^X&U:FT+Y,V.53W10#02341S0-&BTR+H#2-H1J$MJ*!:"2:B.:`HF9+=W\^4=WD,.@>]F84+ANIRJ$]JSJBGF@@&HDF MHCF@J+E.D>=>-I9XZ2X;V^KMQ^--KGKQLK'4K"<&4+=NJ53U1`/12#01S0%% MPT[+FS?,FQG%RT9MU6ZM*@+W1!U13S00C403T1Q0L.&VCJ`O7ST/Y3%I9N3' M!Z(]44?4$PU$(]%$-`<4-=>Q\OPG%[>,G!E5EXWZ1=%:M;0%44?4$PU$(]%$ M-`<4+:I3Z)&V6,)F4?-XFU!H"Z`]JSJBGF@@&HDFHCF@J+D.DG^A+1@R;W-6 M5.[2<[+TPUO;;?VF:*TJ1NZ).J*>:"`:B2:B.:!HT6DA\Y8A,Z/0%JG*H3VK M.J*>:"`:B2:B.:"HN14RSWKZ;=]/J-Z)9%0-%O4[D;5J[0IF3%;U1`/12#01 MS0%%AT[+F+?,F!FY%M@1[8DZHIYH(!J))J(YH*BYSI@V6-BCFR,#);/F;4)K MEMYE8C\IX(:*ZI7('NMU[?769^91@&4Q'Y)-0/X2S1$-.<6YO'R;D->0R#$- M]7I=WE*UWOHL,VJH,YP;L8]H8)R[3KTN;ZE:;WWV%C3@)IB]6=40]T4`T$DU$>I6R]2!Y^-&FW MUI26V!-U1#W10#02341S0-&QTQ+7'1-71O'AQ67UG&>W5JTVI&VYMVP=JWJB M@6@DFHCF@*(-=0@[,F8P?-TE%,9)H#VK.J*>:"`:B2:B.:"HV2*3SVU'-*>$ MY5\7WR54C9/U`XJU:CWTRXH%=:SJB0:BD6@BF@.*-ECJ.L&&%-*"#0F%0P^T MOP/JB'JB@6@DFHCF@(+F^SHJNKA[XE!YV%2,D1G9G_DMP^+VLGY`L5:5'M@3 M=40]T4`T$DU$EQ7NF MQ8RJBT']%&*M6@]]SI3N!2BK>J*!:"2:B.:`H@VG!W5JV'/FW+F=6QJB<:B$:BB6@.*-I0 M!\@C9_V2$XN:Q_N$]">[!>V(]D0=44\T$(U$$]$<4-1\6@2\9P3,2+_BN&I. M5?KAPH+VI6I%'5%/-!"-1!/1'%#4?%K>NV?>RRAH3E5!,U!75EQMZ(D&HI%H M(IH#BIKKO&<7?9NEQ:[3O[Y_][?'9P/-!X^7FMXC3?IQSQB8D7Z_M1SK7:FR M]?[Q@WXHL+KZ[]>"LDY7-N.-R1^V;*;*E@,W,W(STUJ5]Z:Z.YG7`NU--,U2 MFT^'M6G_]?S[UTS37V(OKJ7PYU/C?4+VJ[N*`U<+$JCF@8,_FHDZ2+P^8J3[&Q86I]9P3ZY/:="-=RBK#UH>AA[)] M*;/?^W-;JY[;Z7?0;<=UY)QE"XN'I/H$_3AZ6C5^PE7U>$@_F(Y/T"^F9_;B M)^A7U)N?L'9M=0Q.BZJ;"V;5A85C<%6=;KM2YER3X7ESP?"KZH27X:G,K:I? MG@>3N\W-51%2[F)5N0LF*YN;6V-)9:7%4'^Z'VOG%%O]>;VY2,P/APM;NTV^ MY;J5R20PF00FD\#D")@<`9,CGE7RZ^3K1KMC3C`%;RX2TU=4R^"E#@*3$V!R M`DQ.@,D),#D!)B?`Y(1GE1,62D]I!*NOQ[7$_//3S068Y(-)/ICD@TD^F.2# M23Z8Y'M6R:]S<&J$DQ^D;BZ6A+R.QGJ2N@YEAU'[<:G3!7\9M>MKH2LJ_23S M\@>X+Q`WF,Q#G3 M?##)]ZR2WTK>Y_V!V^:"^;NP>.M]Q0"55HUN@AF/]]&`9*=0L8&H6,,D'DWPPR0>3?##)!Y-\SZ+\PQ0Z M_LIC0^\9K[0W>2Z>D$W*_#P:^9=A=GM5)5Q-JY/R9^@4,DVL@SK-K`.FJ77` M-+<.F";7`=/L.IY55EFV\U8=Z90\4T]T).5#)U7RP32M$)CD@TD^F.2#23Z8 MY(-)OF>5?`MR7O[9G9(28?0EL6I,J6ZC9-525DXT604FJ\!D%9BL`I-58+(* M3%9Y5EEE2<];=:Q34C*,CB06XER8Y2??@)))/M:5?##)!Y-\,,D'DWS/*OF6 M]+S\<^.6%0N3>6`R#TSF@/#'0V+65%OJ^K6R8UBP^<9>P!DUM@<@M,;H') M+3"Y!2:W/*O>E-DE"_KD*J9[.,,/!IY M@3 M?##)!Y-\SRKYEO"\_+\P\N8)@:(U2X+TS5(]RI9;2]EZ^I#)+=3)+3"Y!2:W MP.06F-SRK'++`J%WZ]CIDP)D="2'RO62+/E@:A8PR0>3?##)!Y-\,,D'DWS/ M*OD6Z;Q\:Y:S_MQF4^8%\I$NL^HJ7;VGD%DI6+K[2YD%)K/`9!:8S`*366`R M"TQF>5:996G/FW6L5U(ZC+V2$V/H%3#)!Y-\,,D'DWPPR0>3?##)]ZR2;VG/ MR[=>L5^L.O';<)L\C5#T98F2?E197T&5,7@I3?##)]ZR2;U'/R[=. M.>\G@S=Y?J%H38Z2ZKTEOVVO<>\K6/-DL-@&&@3;>.-$N96"@XXL-C'EERG6L@R4>=Y(-)/ICD@TD^F.2# M2;YGE7Q+?[]AQ*C_&B(V!R!$R.@,D1,#D")D?`Y(AG ME2,6[DYQ)(7!Z$@.B/[109F6:&5J"-1)/ICD@TD^F.2#23Z8Y'M6R;>XYN7; MZ&&/Y4X-)3K.>&I;?T%'@TFNTFB^7'EPW5F+W%"RK%B8K`.3=6"R#DS6@5(1;H3C$D!XVW96E8:0V[YK'EP56Z!R2TPN04FM\#D M%IC<\JQRRP*==^O8V9,"8&P6'PI+LX!)/ICD@TD^F.2#23Z8Y(-)OF>5?`MT M7OY?:984#J,U2V!TS7*#ET%A7J.#@W)K6;4TD-P"DUM@<@M,;H')+3"YY5ET MZS`5D7?K2+/DJ8N"(V4ZHS6,[C9D^P;K&JQOL*'!Q@:;&FR.K))O@<[+MV8Y MY^L:98(BGV8SB\/*#=X$K66E*V25#YIY6"&35:B356"R"DQ6@R4>=.@5,\L$D'TSRP20?3/(]J^1;TO/R_\*P MDJK6/- MDL-@.'T2TY6N2)5\,#4+F.2#23Z8Y(-)/ICD@TF^9Y5\BW)>OC7+.=D_SW*D M3EDO-OK&1O5.XW%3ZG197!(,TO]:5`R5>2ETZB%083(/3.:!R3PPF05>18$O7G'>B<%QW@VY3"I\WGQ8WM3V:9V6LJ*>CD")D?`Y`B8'`&3(V!R M!$R.>%8Y8F'O%$=2.(R.^,!8AEXPR0>3?##)!Y-\,,D'DWPPR?>LDF]AS\NW ML^F\5T%Y\J/HS)(E?:_@55"8-RD'.C*9M6RN])3,`I-98#(+3&:!R2S/*K,L MZWFSCIT]*1M&1WQ>++T"IEX!DWPPR0>3?##)!Y-\,,GW+,H_3%QT@OPRT9&_ M\&16Y3:\\5G+RH'>;\BZ!NL;;&BPL<&F!ILCJQRQ2'>*(RD"AH:P1&Q/'-V? M"&_()!]UD@\F^6"2#R;Y8)(/)OF>5?(MTITB/T7`*#\Q?:FL'.G=)D^3I*]. M%2;YN6YED@\F^6"2#R;Y8)(/)OF>5?(MHYTB/V6Z*#^Q*#^S5:KD@TD^F.2# M23Z8Y(-)/ICD>U;)MXSFY:<@=N)?36_R[$?1E13_]-73T@!JBL3TM8:O_.&T MJRAKR:.\I=5+>51OJ;H3D&-+1=F2',.6Y-A2]Y4_GW85VE+EG\6TE_S[QRJO&T31'5 MW5C*.S!Y!R;OP.0=F+P#DW=@\LZSRCN+DMZ[8ZV3HF=LG1Q'=15>_-C>XHEP MF/\IWT"0R9%E#119H,* MW;*LZ[H%3':!R2XPV04FN\!DEV>576KZ8->Q;K'ZZE<9RB10_C)-IFY)Z[J' MQ^H6,,D'DWPPR0>3?##)]ZR2;^FN[I9S'@KG69[4*NOU1FU1/:!XW)0Z7?V6 MZQ*NTVM1Z1.9EW.H?RA,)O-0)_/`9!Z8S`.3>9Y5YEGZ\^8=ZYV4%N/IE)A] M96GQ8WN+A\)E0BG_G1`RM=.RN>*<'`&3(V!R!$R.@,D1SRI'+!">XD@*D-&1 M'"K7@4-C+Y@:`DSRP20?3/+!)!],\L$DW[-*OF4Z+_\O7*=S/`Q7I<3"T+N] MYD%E@,@M,9H')+#"9!2:SP&269Y59%O>\6=Y(-)/ICD@TD^F.2#2;YG4?YA"B@OWUVGCSB19X\*3F3F3YI2IM-U M'5KJ$7F_P9I=0?:5_77-VW4LKY18%JN5I%%)!:$Y+*P.PTA]9H2 MTEKS=KW>5$(L59TG).6Q*"2Q("27'1-2KRDAK35OU[O@2HCEG?.$I*04A206 MA.2R8T+J-26DM>;M^L"J$F+)Q0LYUE`IZ<3=S^EG'0]VFS*CTLIT'J!.>PO6 M-]C08&.#30TV1U;)M^SAY;LQXM1O[.8IDJ(U*=M4%Y3UV5Z^2PZS*^6'!&1R M:]E3?,\J^99+ZF:QEU`G=TH*.+%3EM#CK@AW>)R49WER M]\.R:EFUV">KP&05F*P"DU5@L@I,5GE6666IQ%MUK%-2BHF.Y&3C;_KR!%'N M!D_R42?Y8)(/)OE@D@\F^6"2[UDEWU*)EV_#RCDW?7DR*?GBNZ)ZS:XKNM9!G;P#DW=@\@Y,WH').\^B=X>)H[QW1UHG3S05 M6J=,/J5K^N+']JZR;;=9RXKZ?8-U#=8WV-!@8X--#39'5CEB&>L41W(F\W3?,\J^9;,O/R_<(W.,U#%9DG) M+UZC[ZHWKW)K*7-N@_KDC;YZP*HR\-_=50$Q.I(#I7^H%F;1RF,)F>1C M73?##)]ZR2;^G.R[>3Z>59Y94G/>W6L55(RC([DM!A:!4RM`J96 M`9-\,,D'DWPPR0>3?,\J^9;TO'QKE3._N)*GZ8K6Y"2I`^"NW>N;A](L2UEI M#+D%)K?`Y!:8W`*36V!R"TQN>5:Y96'/NW6L65(XC([DP.@?8>;)OES*DWS4 M23Z8Y(-)/ICD@TD^F.1[5LFWL.?EGYOHRCQ="D"N*W`C7>59Y9V'/>W>L=7(X],]@\OQ=\6LK=Y5MNDJE M5<.--)D<09T<`9,C8'($3(Z`R1'/@B/;P^18?]Z15!_?'!7F7GWL&FS?8%V# M]0TV--C88%.#S9%5\BWL>?GGC[R:ET_;JJU9PN1Z\FSOZY='957GH-Q:5BVC ML=P"DUM@<@M,;H')+3"YY5GEEH4][];+I\\V3X[E1]["W"BK9LDA6`R#TSF>5:99^G/FW>L=U):C+V3$Z0.T>+' M]KY^>[0M4W&M#_;DR+)J<4F.@,D1,#D")D?`Y`B8'/&L3?##)]ZR2;PG/R[>SZ:P_(]_FR;*B,TN` M]+U2OSPJJT:SEE5=KX#)+#"9!2:SP&06F,SRK#++\J`WZ]C9D_)C="1G2G># MM`WS;*7[PP93KV!=R0>3?##)!Y-\,,GWK))OD>X4^3D"NMRV+9-DK1<977A2 MG;L8::0`DWPPR0>3?##)!Y-\,,GWK))O^'&:^\=T?.G#Q#5CAS MRJQ9\;I3V;;;KF6K(V1=HZYOL*'!Q@:;&FR.K'+$`MXICJ1`&!WQ(3%?=\+D M6GDL(9-\K"OY8)(/)OE@D@\F^9Y5\BW@>?EV,IWW$'>;)\F*UN0`J0O_,B66!BK7%=5[ MH,=M*7MQY%V+2DOLW8J%R;N4/=U=@+P#DW=@\@Y,WH').\\J[RS[>>^.M4[* MBO%DROE1#?IUVS3R+F5%O1P!DR-@<@1,CH#)$3`Y`B9'/*L`Y^7;R73>8^YMGB,K6K,$2-\L M""YA>JURG5I6+0TDM\#D%IC<`I-;8'(+3&YY5KEE>="[=>ST2?DQ.I*8N\CH M7`%3LX!)/ICD@TD^F.2#23Z8Y'M6R;=(Y^5;LYQW>U@FQ0K7I)08Y8SOE?K] MV3:OZ@R461;-.DQRYT=XK\E`ZC_,2"^H1L0%\O/OCCJVV>8FM= M4WZTUKQ?7[A5NV_QZY3=3W$M[GYBZT[LMGDRJZ.[7Z^IW4\HKNF^8EGMOL4G MO_OKF7JL#5/PBD(2"T(2BKO3.`[UFA+26//R8GW\7@FQ+'.>D)R"_`B3YX<* M0E+942&I;%U30AIK7EZL3SXK(19!SA.2PDL\(HFMNZ/62NBHD'I-"6FL>7FQ M/I:KA%B8.$](BB%12&)!2$)'A=1K2DACSXMU-4"#:8`&TP`-I@$:3`.T9Y5\N\Y[^7\A^>EV!J_9,@M7 M\\L+W'.O9>7*KV>7XD M?5@YX(^%5;U2W8GO7%E9==]@78/U#38TV-A@4X/-D55F6=+P9AWIE3QE4G0D MI1475?,LW7KZ=*G8Q._E$24')SLHEZNJ-='4_I),GUVGP M6NIP@[T6N5-G6;$PF0O&.G3LI@L7<2LT.T M^'%Y04>6LJ)>[00F1\#D")@<`9,C8'($3(YX5CEBX>P41U*8BXXDID\I4G4V M@4D^F.2#23Z8Y(-)/ICD@TF^9Y5\BW1>_E](*7GZI&A-BHQV`%RS5.>8W%K* MBH-R"TQN@?G6+&?\"=8VSYT4?5G"H>^4]?E!L6HI M59995G/6W6L4U(VC([XO%CD@ZE3P"0?3/+! M)!],\L$D'TSR/8OR,:?3X2)MWS,[]2K=F.UIN\[LY%NE_CJJ*UM;95VUL*Y1 MUS?8T&!C@TT--D=6>651[X16R1,DA58IDR;Y+WJ0[;=DDI^CYKJNY(-)/ICD M@TD^F.1[5LFWJ.?EGYOG\LQ)\L5UQ69]\'4X@QZWI4SG[G)%0GA9BTJ;R+N4 M27436YB\`Y-W8/(.3-Z!R3LP>>=9Y9TE/>_=D5$F3Y<46R>EQ1CG:MMVVS+3 MDO^"(9D<63977)(C8'($3(Z`R1$P.>)9Y8@EO5,<2EV\GTWEOD,KT2/XY0F8QS6W61[+Y(K66 ME1Z063Z#'NID%IC,`I-98#(+3&:!R2S/*K,LZ'FSCIT]*1C&7LEA<1T\=:J` M23Z8Y(-)/ICD@TD^F.2#2;YGE7P+>E[^V0-O2HS5P+L^WRX#;RY[>>!=BESK M@,D[,'D')N_`Y!V8O`.3=YY5WEGR\]X=:YV4%&/K)%8-O)5MZJ:ES#D")D?` MY`B8'`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`#^W8 M9>FP'8(L_VE^W8:CUSJF[?!GV:\=_6YT3)M[\*!\\]".*99\VL'''05-IMY:HJ.@N;M;2W04FGO]H!STT(YREI#:` MV=/`=CBR;-N.(Y9>V^'5LFL[NEIR;0=7RZWMV&JIM:GT0;GFH1T3+?&T`X_E MG6;<>;2TV@ZKEE7;4=62:G,/'I0-']IQS%)C.S1>ZOBT(Z,EQG80LTS8CH27 M.C[-/=!S4>U;SP\)VY> MGBV)-_=:SX3L&6IKKP\IM;FUPS/+M@H?;7QN<75^\V#H M6#3OSG4D6I^[TT/6O7X%E!>`7DN&YI+)'LPVE^PVUU??[O6?UO9LF:9^;RW3 M3._2WUZF^[W#`6ZZK[^[T'I?.<:'@]P\RH\;&P7T']O/-\L+@,\_?/?[VU^> M_N?;3[^\__CYU6]//^N%X<4W-IG_V+OF]'^^//^N/QUY_>K'YR]?GC\< M_N>O3V]_>OID!2K^^?GY2_D_]@%_/'_ZV^&EY`__7P````#__P,`4$L#!!0` M!@`(````(0!S?=I)Y@T``+E&```9````>&PO=V]R:W-H965TS'_?>I MGJZ>KNHS@\')RWI]J#K3?;JZJIH9S]WOO[:OO1_K_6&S>[OO1U?#?F_]MMH] M;MZ>[_O_^B/[[;;?.QR7;X_+U]W;^K[_Y_K0__WAKW^Y^[G;?SN\K-?''C&\ M'>[[+\?C^WPP.*Q>UMOEX6KWOGZC3YYV^^WR2+_NGP>']_UZ^5@[;5\'H^'P M>K!=;M[ZEF&^/X=C]_2T6:V3W>K[=OUVM"3[]>OR2.,_O&S>#XYMNSJ';KO< M?_O^_MMJMWTGBJ^;U\WQSYJTW]NNYN7SVVZ__/I*\_X5398KQUW_`O3;S6J_ M.^R>CE=$-[`#Q3G/!K,!,3W+BK!?KW9OWS M(/[?.[SL?N;[S>/?-F]K4IO6R:S`U]WNFS$M'PU$S@/PSNH5^,>^][A^6GY_ M/?YS][-8;YY?CK3<4YJ1F=C\\<]D?5B1HD1S-9H:IM7NE09`__:V&Q,:I,CR MUWU_1!?>/!Y?[OOCZZOIS7`3Z]H9(3CA.V)%^LN/-U60TO;FMKW["D6CK8=-/=IQ=W43#V?B# M"UZS'_V\;*0W[$@_+QLI;;1ZI/3SHI'.V(]^7C;2B&*HOJ+YSUEC'=B8J$,L M61Z7#W?[W<\>[5M:]`'Q?6*C18M1MHB=A8FB`UO$@)I"&0AD(=`$0)E"%0"&)`NC3BT M8_X?XA@:(XZ;U<(!7JU1((2S<"Y)"*0AD(5`'@)%")0A4`E`"4&['H084[2T MIR`7%,:+DHT(BMG-C9[HPMJ,9.1<:Y.X,6G$`"0%)`,D!Z0`I`2DDHC2A!(: M:&+2\H4[Q]!0;J8<(+?.3&NP8*M3,C4FC4R`I(!D@.2`%("4@%0243*1(DJF MTR%CK&LUW"06%HFNF]T3,W+3(`D@*2`9(#D@!2`E()5$U$2IWJB)VDQZ9:K5 M\66S^K;8V2+;(L"8,J;-HX9$S]\BT:29; M.R-4R9HT,KL-YVZ-E$"C<5"E$V:B4B"8@AA+K=%DU$1E=@YWWLH]T7%3,)-7 MOSR'NVKEGC;<2FW*MA>H;:RUVHQ(M:-A,(_8&D5^'@F[:6F#:[<09HKR&D%6XE%+9VCYZHS3T.Z)6)V;'6U]@$X8FM*-\"IB%*RHE`&NG*U&FBO, M_CB($J&JG:NK`)C>5X;1YPJ`[:#5CF)(RHKUU!RN3+;WB39Q$(GDUV,65([4 M62_0@3MDJ0-#,EOA62NR5K0@+D(2AE3BIFT59.Z4S=2V`K*\@\RG[GIW%SB, M$J&J@\PG4B7A*#P(G`ZEVES740=)"3'ALY64T#G*VA<-HR!)IVPF)42RO(/, M)VDK(7J6"%4=9#[;:@EIYBH*/U5*1X8E4)8AJ2R>I=A1EE('R6J!9REG)4JI M@WSURQVDN4!7.U2QO*5S]%R5@S17EZRF6Y>;^W.R&I9`5@L%N2_\ZBTV6]NT M*)3WFY*+W[`X*TJ4C14%<5`14V.`;\ODAS7/">?H4KG>7+\E;,* M^'TAT*$>'C[J-:$[D-S>G%>#1W@F8>C:WJ@TMXMBA!*$4H0RA'*$"H1*A"H% M:2DHB%5X?I`XC7D0AQ8:^S6+1P`E"*4(90CE"!4(E0A5"M)S-ITV;LF+[Y.8 M>]56#+%IHIL@\R^3@Q-UB-5>=- M(V_@Y$L9DK>-O%7'?2-OX&@*I"F]5<>M(V]`-%HTTPG+0`E%.[.<<`\OVGH* MICI:*)W*JAPTU#&;4;OG9I@@E#HRGZZ7,Z>=3F M.GH<)#M(ZD[\6<`F4393'1&V.HZ,6@TAZBC(VBF;R7[]+/Z\@S]L-1V97X[2 M07*Y8?Q5!W]'^SDV':T,S@_$MPTP+:8+I47-0.NAQ1\%W[S$;"8SF_,,E`Z; M2C932MMA"+*\@RSL('$8)4)5!YFORCJ`35=Z@8:VB54:,A1H&!RSX[$U$]-. M&)I(S_$()+2.2D+@RL_B*G`0)4(50Z;OEKO(IR:M8-AP?Q"%V%F/&9(Z1,,1 MI`!KIA1D3SW2,>QW:Z8D!++<#2,@@\T-GB5[BI%5'61=.]DTU3(*PS)SUM,< M8]N:J^!D2$L[A@UNS<0$$B93-SNCX1BBTWHJ:8$L[R"##0Z>)7N*D56.S)SH MW.-_P:I?0*)B3W%%X+.TW]A MFCM(1_H$,I,E4]+"R*H.LH[4-+GL\%&;Z\,'0T%NGX2YW7F*0YB#=&X/'%.V MDM'I'#U7[B#-%>2*@JVD@L[1K"7JN,^@3<@&BV:Z65E.@E%.S/=VI98 M?H,SX<99U[])<`Z*VK'!20^82MXGT:GAS">#]/ M6GMZD.%>$Y/:](F,4/TW%C%;F2366&&T.RO*(8T5MGML)=)QYAQ/TN?.2M,' M2UD@?>D<3])7SDK3^\75Z]%ZJKGTJ9N0]U8RR?3$;WUHCZ1A2.8 MCMW[,()/XLGM/*&2C6S4,,SSUD^H!Z`1M/G0:S>^M%Z?7L=1/Q(67'U!`VZU MI^&VS?W+A/C;A:01M4QB,2(FVQ@%EXZOYTF;B-GUG/[2%N4H2?4V/!Z1@/1L M!'ID]$G>^@D];$&C:O-9C"A4[`P'S8#IQ2'OR^?UWY?[Y\W;H?>Z?J*P'=9/ MS._MJT?L+T?^&]VONR.],J3^<]T7>D7,FI["&YI'^YYVNZ/[A88[:%XZ\_!? M````__\#`%!+`P04``8`"````"$`5-D-;B@*```O-```&0```'AL+W=O#1J,] M,]>$.`E:@"-@G=Y^JNUNNZM^8+`T-R'YJ/IM5W57=9/FX<]?VTWO1[$_K,O= M8]^Y&?9[Q6Y5OJUW'X_]?_WE_W'?[QV.R]W;3Q^S0>#P^JSV"X/-^57L:-WWLO]=GFD/_:3[/WRNOPY& M;;NZ1FZ[W'_[_O7'JMQ^D<3K>K,^_JY$^[WM:AY][,K]\G5#S_W+N5VNC';U M!\AOUZM]>2C?CS>CX?]P=-# M%:!_KXN?!^OWWN&S_!GLUV_I>E=0M"E/*@.O9?E-F49O"I'S`+S]*@/_V/?> MBO?E]\WQG^7/L%A_?!XIW7?T1.K!YF^_%\5A11$EF9O1G5):E1NZ`?K9VZ[5 MT*"(+'\]]D=TX?7;\?.Q/Y[Z_%X>BOE62_M_I^.);;_]1&CI:J M1<9:A%ZUR/3&N1U.E,0%MUOM1J_:;31NKWW!D62KFZ97<]-WUUQPHOWHMNURGPZ-GNIZZI=N=^J8<:!^Z72O#HV<^J+M M$+HJ^XX9->J7CG=K1H[3#IWII9$SJ$=]-8D6R^/RZ6%?_NQ19:*G/7PM59US MYDK,3)]Z\#43ZMQ\HHFD5)Z5S&.?TDQ3Y4!%X,>3XTQ'#X,?-'-7VNCEA!&W M<(V%FJ9*=R&!)X$O02!!*$$D02Q!(D$J029!;H$!Q;8),`V*_T>`E8P*L(G, MBP%MQ$6X76-A7!82>!+X$@02A!)$$L02)!*D$F02Y!9@P:2)`L&DYG*FV)O! MJ;RHK-N#VEK!?*)T;RF-8$]4I!B?"\U,3.B[:A2F7G193C16-E M[MS32E9>&IM+2D%C991"4(H:FTM*<6-EE!)02AN;2TI98V641JOVJ75B_:@'A:R4H,V`1`0O"* MP"8&DH!7"C89D-SV8L&E/L:">SF(RIH'41.G6A2/AHZH"6[]/@OR:'S/8[S0 M(K0LLC,AK#PM947Y&O'@M+A8'X4@'ETC'I\4GP[Y\R4@GEXCGIT6=[AX;HNS MU*I=8H?<5N8\N08UV16]P]4&3IN3A?'AR92;)0\]?43!&3$QR$+TC!#%9\1$ M[TG0,T64G1$3[2=GGCP[:D=E;TTOSSRU;Q=3SZ`F.V)DN-J`94?+B.R(WN.A MIX\H,#<@Q$0%#=$S0A2?$1-%($'/%%%V1DQ,^IQY\NS0,W7)CC(7**#LC)AI- MSCQY=M0.LD-VZ@TGRXY&37;$U''I8P_H%-I'!%2T-`\]?42!1F(&ST1Q#=$S M0A2?$1//E*!GBB@[(R:&;\X\>7;4/K)#=O1&U)X[>B=J?9)"TP3R`P0/[W7M..G-YMVD72&,U%>7D^I_AP#R MT,I'%"`*$46(8D0)HA11ABAGB,=4[=$ZQ%1O_.R8:M14#(BFW@;:08?.NG"T M#"\B,]&9/&U&@\0T%-^@B_K!&7W10D(CUNI'!EW4C\_HBZZ2:+-Q^_^D]"K] M[(R^:#2Y-IO1!KM9QM`(;UL(R_ZHVSZ\,N=["8.:[(MRZ&H#*V$+XR-2+?L% M>OJ(@I-BSE#V"_2,$,6GQ.[&8D`GZ)@BRDYI.?+D=-N&TX*J6E=9 M4].@)CGBXJXV8,DYM0UWAB*M'GKZB`)S`RS3SE`$-$3/"%%\1DQ4B`0]4T39 M&3%1#G+FR;-#S]2A<*KUC%KUVMFI$:VU32ESM17+A[9J"Y*'5CZB`%&(*$(4 M(TH0I8@R1#E#/'YR&Z[^IS&:J*-"_^.?RB/70M%E>"IS,3PU:HJ'F+7NJ#9@0<>^KJW4 M0+!3(_J69\3:U/@&T64:3]`/SNBW#:]:OX5&K-6/#+JH'Y_2'UO]M))/M)7= MUJ^2ST[)W\KNE6NK:[NZVBU?OZ93,T[F7J,F]Z+\N]J'%2KM(Q(-7;TVLSQ] M%`O,/7$Q![HZB$4H%I\6&XHADJ!GBB@[+>:(SIHS3SXSU6ZY0W;TYMIN'!HU MV1$7=T>U@17CA49R&HH8>.CI(PJN$PO1,T(4GQ:3`4W0,T6472>6,T^>';5W M[I"=>JO-VGJ-9B.KK0-:C`!YB'Q$`:(0480H1I0@2A%EB'*&>/S4/KE#_.IM M-8M?C<;VL@C00AT7HZ)E67F(?$0!HA!1A"A&E"!*$66(JYHH^`M] M3:$ZTR_Y:$ZG46D$2CZFKS6ZT1,.MW,Z"WB"CZ9TA>J9Y"5&]_1. M]1$-O#.C=ZI>+-\9#\W7+<0[[F1.)]GP^OYD3N?2D$>3.9TR0YY.YG1F#+D[ MG=.)+.3^=$[GJY!'TSF=ED*>3N=T]HGXH'D`^KK&U_*CR);[C_7NT-L4[Y3< M877N;%]_X:/^XZC/.;V61_JB1G7DZ9.^F%/00?*A*EWO97DT?Z@+-%_U>?HO M````__\#`%!+`P04``8`"````"$`N?;@1A0'```%*0``&0```'AL+W=OQ]R\HJ+ZX[ MGTVFOI==]\4AOS[O_+__DA_6OE?5Z?60GHMKMO-_9)7_\?'77QY>B_)K=.17E):_A8/@?5K@%Q@ M;K3?YTVP"4#I\>&00P^4[5Z9'7?^)[9-9LP/'A^T0?_DV6O5^=^K3L5K4N:' M+_DU`[=AG-0(/!7%5X5^/JA#T#CHM99Z!/XHO4-V3%_.]9_%ZV]9_GRJ8;@7 MT"/5L>WA!\^J/3@*,I-PH93VQ1EN`%Z]2ZY"`QQ)O^OWU_Q0GW;^;#E9K*8S M!KCWE%6US)6D[^U?JKJX_&L@W:-6)&Q$X+T187"Y]8(MEN]0F34J\'Y7"2?S M<+%:O^=>YHT*O-]5%N]7@;YK6U9O*N'H'@7&8SUD/*W3QX>R>/4@#\#%ZI:J MK&);4+Z/E7&V';V?#1Z,FA+YI%1V/B0PC$L%$??MD;'5_"'X!F&R;Z!H$%K8 M4'R'5%@H:6X.P&M7>FFW$O=6'<@FY)VXZR:=`P%XT1H"`=,U9#AH[_U6L.KW M734R!S8S[<&RK,!D1?Q;F.[!,S9SR2/L*F;Q>R3('X M[YJBHF3^TXR^FZ,:0>[:([>V>Q(9"#*C'5YG;&.2X"0A2$*21((1EEG0F:Y9 M>`0I>.?#4+3]A\S9."89"#.))#A)"$.L=.BNUU/XLV]#=@&V4(!#)%UB,U<: MK81E$<1.UR(53S-XSN!6J4:N5>NW"^CI(C(0W$?KIQM/),%)0AAB,]=>32=K M9Q:3I$*"$995R_]CE6K4L^HMMXU5!FH[X9R.S6G$24X2@B0D220883D%CZ_W M!Y5JU'/*F4PC`VWT:(>3U4)\<(C8)DQNZ`11+ZS'\W?RHLM/)VSJ3*/2/C]U MXC$QIX?'TO)0U>"=<@!/2`7WO)NU&6^BS$##E]9$3!*<)(0AEGJ$9HME=^+1 M%Y%=8!%:,Y,&$NP:ED4;VZ)Q2!'!L*L(@E.$L(0QJJY/4<;J[H` MVZA8MH3IGL>.9$<-11F$HUP&A$-8GQBL(3L=M,8 M92$K943K@XFI]C*J(GX[:9ND"M'1*<=,V6K7"VOG$1GF[Z6G*`ZF4D M=BW;+U6_=OP:5W,Q4_7:OFV<94[44$@$Q33":430B*21!$5LTU1%ZYA&?VG# M3!U,9296+3?!1B*\N19BO:`122,)BMBFJ=JV8QJ1F:82=B+,61M&S%!(-V,: MX30B!A#(3&=!)@>H7F9B=VSY%3HE_KC,U*W<9^;&70XU%.8;C7`:$30B:21! M$=LTI^0?]\P,3<5.9&9#H:;1I3^M(FA$TDB"(K9ID&7C,S-4="_"W,QL*-0L M(X0@G%81`\A`%3M`N9F)(K9?JOSNS&0C,U.UZOGF+L)#0R&FQ#3":430B*21 M!$5LTZ!+KFGT,S-4K: M$^]10R&.Q#3":40,(/#L=):]F89"32,1'I*(H!%)(PF*V*8Y M2P`BPDS%;D>8^]-6%))U?4PCG$9$@Y@O8)?K>>_K54F+)"AB>^54_B.?EX,K M`/?;GQ"KI\URB48XC0@:D322H(AEFIKFNU/8N$I6MR*?EPV%926-S$G9J]9^3O:QL*-0LNNRG542#F%T"\_6LGY6TB-I]IOHT?+?& M*[.[S&Q5NF3E.3O"I:;P>Z_OE68;F_E0%S>]<>JIJ&'[F?[W M!-L-,]BN-)T`?"R*^OX!;BAH-S`^_@<``/__`P!02P,$%``&``@````A`$"T MT"2V`@``!`<``!D```!X;"]W;W)K&ULC%7;;J,P M$'U?:?\!\5[,)9`F"JF:H.Y6VDJKU5Z>'6/`*L;(=IKV[W>,$\IEM^U+@IGC M,^?,V,/FYIG7SA.5BHDF=0//=QW:$)&SIDS=7S_OKJY=1VGC[">*8-:YE6,N/<(BB8(1F@APY;;0ED;3&&O2KBK7JPL;)1^@XEH_']HH( MW@+%@=5,OW2DKL/)^KYLA,2'&GP_!PM,+MS=8D;/&9%"B4)[0(>LT+GG%5HA M8-IN<@8.3-D=28O4O0W66>RB[::KSV]&3VKP[*A*G+Y(EG]C#85B0YM,`PY" M/!KH?6Y>P68TVWW7->"[='):X&.M?XC35\K*2D.W8S!D?*WSEXPJ`@4%&B_L M9!!1@P#X=3@S)P,*@I^[_Q/+=96Z4>+%2S\*`.X&I>,"%PK:\[0-X(1NT!,4E9Q!.PN"*_$*&B/V%X2Q;7BSP0L$ M@GO54(NIZ@BZ^N]^7$2:33.1P5C";@X*QXC]'!$MQI!L#@G\UT0C)]'8R=L. M#!C.SJ""892,<^\L!EK95WF"V+^+R-Y"C-1#FF$?WE9OP*D+M>F5A=%RHMYB MEMT1BL:Q_3`63KJ2#8/7JW[G2"W")VL4DZ$U-*.,;O0HNUNQD%H&#_=8P5?&PIWT/<`7`BA+PLS M*/OOU_8O````__\#`%!+`P04``8`"````"$`YSQ7'94"``!>!@``&0```'AL M+W=O[.,N;)UFC1ZZ-4$V& MHR#$B#=,Y:(I,_SSQ]W5-4;&TB:GM6IXAI^YP3>KCQ^6!Z4?3,6Y1<#0F`Q7 MUK8+0@RKN*0F4"UO8*=06E(+2UT2TVI.\RY(UB0.PY1(*AKL&1;Z/1RJ*`3C M6\7VDC?6DVA>4POZ325:'SUR4E85J3\&0\[7(G[?<,$@HT`3QU#$Q58,`^$52N,Z`A-"G[O\@ M6"5_>U!TI/(D\9%D`NJ/^W$07T^C:?HV M"_&*.H-;:NEJJ=4!0=/`F::EK@6C!3"?G'D=O==_606/CN36L711Y7 M41S&2_((265'T-J#8"1>0$/$YH1P&72\V[,7!`3WJB$7EZH3J.K?ZW$2Z8)& M(J.AA/48=&%C,T8DDR')=@R)PI>#!DZ2_W'B@J"'SC,Y3X8:UAX#)>VSG0X1 MFS<1V]<0`Q=PS'D]7J^#`V<8Y]#=80#@0BE[6K@KJ/\R MK/X```#__P,`4$L#!!0`!@`(````(0`W!8YEBP0``$`4```9````>&PO=V]R M:W-H965T(8;G@EQ$M2`(TPZW7\_91O0/&:[)#^LW'__>7F:N0XOHWP7I2RG*_>#R/"T\C\='FD5\P$XTAY$]*[*HA,?BX/%30:.=G)2EGC\<3KPL2G(7+2R* M1VRP_3Z)Z3.+SQG-2S12T#0J@3\_)B=^M9;%CYC+HN+U?'J*678"$]LD3>[-/;"T7NX2 M\$"$W2GH?N5^(XO0G[K>>BD#]%]"+[SQV^%'=OFS2'8_DYQ"M"%/(@-;QEX% M],=.O(+)GC'[16;@K\+9T7UT3LN_V>4[30['$M(]!H^$8XO=QS/E,404S`S\ ML;`4LQ0(P%\G2T1I0$2B=_G_DNS*X\H-)H/Q=!@0@#M;RLN71)ATG?C,2Y;] MCR!2F4(C?F4D`/;5N#_P9V,RGG1;\9"1=/`Y*J/ULF`7!ZH&OLE/D:A!L@#+ MPK-1JV?@DICS34R24P'-(1UO:^(/@Z7W!C&,*]`&0;`$:I"O(D(3$8QJB`<$ M:Y;@N\XR@"S>C_^5I9ADL"3U!Z0K&P3-9*2%;V'CA4(!@J-3Z`Z4F`3);L0` M`G7S$2D@:-0`3522H0VAD`0C39+V^`CPR@5_ZP1-].@@9"I3/!F-9AJOYC"9 MC&[Y54A!.3U.2H!54D&@LT+,1+)Z(K.9%M!0'9^3%EZ3/KP$6.4UU0L>(>VT MU/%66M,^M`18I04%-E;3M$$0).N6:!41VA!*+H6B]6X78E+G*D"0C:0-H9"< MJR3MJT"`C0AJ"W"#($SM.!C-M?`UATE`;L,*+0(=JQD\.R^)-HA-U2]O*M1( MKH5@/%2'0W78OU6L2DP3@0YBV+:;?0-J3FL-&X(H6SZM$)6@:,J]RXY@*^_H MOA7*2A0-W8>H1$6G;A#MB"3V=2V2>NV1:_<7.CLU:J\>OK>Z57+@0`]R`FW4 MWZVT4;L(HNZ'1D)"*T0EJ"G%@YL1;/==:4:4E:@-HA+M)1W$U`Y#:"L,=I@[ M2JN,MTLMT<1#1+![HR1GZ:DF6B_95"AK!!_6$?(I(9&S.I6D0EF)/JPEI)>8 M2+0>R:&QHIMZ<4=.*BM8#.UZXO?2$XDVJ.EZ4J':]$0=;M,37].3QZI0SM() M$GWO5Z%LR;5"E'7L?TI7Y*S.*JQ05J(/ZXK?2U\;*ZX/X M0'WWM_X-``#__P,`4$L#!!0`!@`(````(0"G)S[PP@(``#$'```9````>&PO M=V]R:W-H965TP)U":4DMG.J2F%9SFG>+9$WB,$R)I*+!WF&N+_%012$8 MOU5L*WECO8GF-;7`;RK1FH.;9)?82:H?M^T54[(%BXVHA7WI3#&2;'Y?-DK3 M30UU/TW[ M$[FM,IRDP7@2)A'(T88;>R><)49L:ZR2O[PHVEMYDWAOD@#]_GX+CYY[KDB&?62`0E$=#F)$T.<1P].HG'OZ^&\9G2D28>*]7N*`1N8'+,= M6OE^6FY1AB&`/ASHW&OQ'M*+)KZQLPB&3W@"Z15P[&U>RQA`PG[_=TBW:`B9 M)+,AP(QX+)H,2!H#I_P"Z14-`2/&TU5ZT3W$Z'9TC#A0G.7M( M/Z+\&RRY+OF:U[5!3&W=^(FA^OYJ/QEO8O&ULG%C1;J,X%'U?:?\!\3X!0Y.T49)1P>KN2+O2 M:C2S\TR(DZ`"1I@T[=_OM2]A,+!V,GUH$S@^G'/OC4_C]>?W(G?>6"TR7FY< M,O-=AY4IWV?E<>-^__;RZ=%U1).4^R3G)=NX'TRXG[>__[:^\/I5G!AK'&`H MQ<8]-4VU\CR1GEB1B!FO6`EW#KPND@;>UD=/5#5+]FI1D7N![R^\(LE*%QE6 M]2T<_'#(4D9Y>BY8V2!)S?*D`?WBE%7BRE:DM]`52?UZKCZEO*B`8I?E6?.A M2%VG2%=?CB6ODUT.OM_)0Y)>N=6;$7V1I347_-#,@,Y#H6//3]Z3!TS;]3X# M![+L3LT.&_>9K&A`7&^[5@7Z-V,7T7OMB!.__%%G^[^RDD&UH4^R`SO.7R7T MRUY>@L7>:/6+ZL`_M;-GA^2<-U_YY4^6'4\-M'L.CJ2QU?Z#,I%"18%F%LPE M4\IS$`"_G2*3HP$52=[5WTNV;TX;-US,YDL_)`!W=DPT+YFD=)WT+!I>_$"0 MSX'%.Y@L[BX>*E$&:-,EV7?.+`U,#SQ15(F>0K(!9.@NA M/JBC\_I_5L&C)'F6+!L7QAV6"^C/VY8$9+'VWJ"H:0N*)D`Z(KXB9`4E+^U= M\$!PIQIJT5<]W8>K.`F6XJZL$5X`[DYM,!`R1H0/.H2.(<0G'493&^IJKS4V MJY:+H!<]D5#29?<`59\(0="WSLF@Z+$504T(S08\IE_TVVS(11L7BM4I!!N/ M`QL(,ME`Q%*-UMQ7/SH'-7%H-N`3=[\-N6ADXTF7$"'H08GT]7NQX1Z=OJ>) M7NBBS:,CP4.Q_EP7%"'(5',K@IH0FORE+O^VT9&+K)\`!)EL6!'4A-!LR#SO M;9;F+DCPL`O!8"PB!"W4R(1JL/4VQ1H@"&'R=0!%P'0!-/%/]XB7X)'XG]L; M[CX(FGZT0L16!#4A-/D$4JE?_-MF2*VR#E&+,CFQ0Z@1HGN1N=8;I!N]8!I: M]E*"*!RIR:TRMD-H"YFNB.Y%!N']7C`^=2_!((8C@JAI%3AA=@@U0G0O,@OO M]X()"K_[&3>,:F+*V=:+%4*-++H7J%K?BWFS(A(]_,#[(P^(:K>KX'&T&\4M MSQ4QL5^UB.F>Z@YD+M[?#4S3P62%^JX9R?_>P>^TBK8;5@@ULNA>9%3>[P4# MUC99IAANO5@AE)@@NA>9ESTOELG"=-7[,9XL1.'K%"*#%! M-"_!(-O-$Z70^EX5#G>J%F-*P19BV`*H$:([^*5$#VY*]!9E$!JW$-/W(R,+ M>L'S#SP>*%A]9#'+<^&D_"S/-@+X)[6[VIV[/`?R>_7@>@3G,>KPPNMNP'%( ME1S9WTE]S$KAY.P`E/YL"9MLC0&PO=V]R:W-H965TJOPC[BK,G_;-5ND5F#- MV).2?BO4$$R.>K,?]0K\Y$%!-GA?RE_L\)70[4["*=HL*I!-`?/ M*K(IY.=T9!"2FG.G)NFIH!:P',\KE"231?0,.6-#^LM.B>T,]LO.:([KFXYO M[/QF73-*T;O9HD+0QKJY\V-IMJ9U]+T*C.@EGFLV"J=W\\8:;3=Q.&DMCM>^K@ M!OCP_G93=O=;K\3.G+-M?*P_(]/[ATK/J+R@/HD-ZFPD`Z77WT%ZM76/WO8' M=0"<]?I?:SZ59YO-V3\&V$S'MU>YM_G"=4"MLCD4G(`;WC;,;<`0>S2'XR2<_IWQ#&XG>CQJ#7`Y:/"6_,!\2VL1E&0# M+N/1#$J3F^N%>9"LT2?8-9-P+=`_=W`-)'`(CT<@WC`FWQ[4!::]6*[^`P`` M__\#`%!+`P04``8`"````"$`#A,B%0D+```).P``&0```'AL+W=O%Q MZ-R,AX/\L"E>MH>WQ^&??WB_?1H.3N?UX66]*P[YX_!7?AK^_O3O?SW\*(Y? M3^]Y?AZ0PN'T.'P_GS\6H]%I\Y[OUZ>;XB,_T)77XKA?G^G7X]OH]'',UR^E MTWXWFHS']Z/]>GL85@J+XS4:Q>OK=I.OBLVW?7XX5R+'?+<^T_A/[]N/DU'; M;ZZ1VZ^/7[]]_+8I]A\D\66[VYY_E:+#P7ZS"-\.Q7']94?W_=.Y76^,=OD+ MR.^WFV-Q*E[/-R0WJ@:*]SP?S4>D]/3PLJ4[4&$?'//7Q^%G9Y%-[X:CIX%@\^UT+O;_JXP<-:A: M9*I%Z*<6F=TXM^-[)7'![5:[T4_M-IDVGWW!D63+0=-/,^B[:S[P7OO1SS[C MG&DW^MEOG+3(RG'2SU[CG&L_^MEGG`[-GO+SU'_ZC=0Q\T#]I]=8'9HYU8ECK?8Y M9Z'$S/*I)E^]H+K6$ZT!I?)9R3P.*!*X$G@2Q!($$H021!+D$B02I!9@`63%@H$=&VSB?GG$?KN3*:V%/XGILL:Y,ZHD!<(!X0'T@`)`02`8F!)$!2()E- M6'!I]4-P527MN14H&2JGM'5?V@NTU:5PUR9UN(&X0#P@/I``2`@D`A(#28"D M0#*;L'!39%FX+\]A95U&U03CN2)SVG>L.-^/Q9RMK8S?"H@+Q`/B`PF`A$`B M(#&0!$@*)+,)"R(]R/0(HK+F0:S('3W8V$%T1!!KJSJ(0%P@'A`?2``D!!(! MB8$D0%(@F4U8$.GN>P116?,@5F0^J8O3$L@*B`O$`^(#"8"$0"(@,9`$2`HD MLPD+&.U:/0*FK'G`*N+<-P'39%:3%1`7B`?$!Q(`"8%$0&(@"9`42&83%C`J M!CT"IJQYP"IB!TP3*V!`7"`>$!](`"0$$@&)@21`4B"935C`5`/3(V*E.0^9 M1O1,;S:MI49RMQ//C:O&S'BZ1JP)M]=8L:USRK=.OS$S8@&*A8T5$[OE8E%C M9L1B%$L:*R9VQ\72QLR(94R,YT,]WF.?=#.CRG1^WVZ^/A=40,BHI8I/J1_2 M75+5)-"SD?G(9]5NTF1G:=)6]*!F%R7Q-+K2GI-I+>8:,3M-5XGY*!:@6-A8 M71I9U)B9VXQ1+&FL+HFEC9D1RY@83Y-J'"ZEZ8_BHRM-]%U-G:>J_V!YJI!J MD>VDS/BD6JHO`]3>57YGI5M80*ZV2_7%2+4XFJ!/IN)KA96VFE`$[=0( M,]>(V4&_1M_OT!<-9(#ZH4'VI('Q1^WZ,_$D'QNQ9OR)01?UTPY]\9";&;%2 MGV=:]3`],JW,13'2J,ZTJ#E+M:Y4IIN;6VDDTCH3GBYZ>HC\#C$QX0+T#!%% M'6*B6L7HF2!*.\1$MIE&='3$UENI;`)D=[<,7W4P4 M*1<]/42^1C+58G,-T#-$%'6(B>T@1L\$4=HA)M9^QCQY=E37U2,[59/&LE,A MF@"F`"[I01CR`B"D@%ZT\1#ZB`%&(*$(4(TH0I8@RAGA,59_6(Z956\=BJE&] M8XB-=.GH5M`..E2^E;82Z_Z3V'Y<(]84!\^@B_I^A[XH(8$1:_1#@R[J1QWZ M(ABQ$6OT$X,NZJ<=^J+09$:LU.>95@UFCTQ7_2C+M$9UID7PEH[=P^HG7NW# M:\,G4=)<]/00^1K).2(*38">(:*H0TP4FA@]$T1IAY@H-!GS9-FA+J%/=DIS M_EQE4)T=L726VH#V`E,\5L9'9$>4-!<]/41^N]A<;*X!>H:(H@XQ<4\Q>B:( MT@XQ,7TSYLFSHSKGZ]?.1#?:5G^CD5VY#;+S43E:*7+1RD/D(PH0A8@B1#&B M!%&**&.(QX\F6)_X*7,QNRLD*O=<;*]+M36(IU-$+B(/D8\H0!0BBA#%B!)$ M*:*,(1Y3U;#VF).ZP;;GI$;UC@'1O*8G7M&W3F6V*/360]5<5"97FUESVS/H M8N7S._1%"0F,6+.<0H,NZD<=^J*JQ-ILVOS=/;E*/^W0%X4FTV9S*@1V&)L2 MPK-/]]0G^\I%+=9I,;G3: MAR7'&8NTNNCI(?(UXIEVQB*@`7J&B*(.,;%#Q.B9($H[Q,1VD#%/GAW5'O?( M3M5-VP_"$]U@6VVX0W7T>N3BG)G?V?.G+MPQZFL",WRF(_$77+-6+-S/<,LI,* M^GZ'?E/PR@XR,&*-?FC01?VH37\Z%_*QMF)E_9HO+-(V^5M9O3)M=6U55]VR MO;0N_QV%%A+D7J.Z<(CM?ZE]V$IJZ]&=,53URLSR]%#,-V/BL\:!J@YB(8I% M[6)CR"&()2B6MHLYHK)FS).M3'6ZL$=V2G/^S&50G1WQX4MM8,5X97QX0&4, M7/3T$/G7B07H&2**VL5D0&/T3!"EUXEES)-GIU^//L4>72/[\!*B%2(7D8?( M1Q0@"A%%B&)$":(44<80CQ]-L#ZS6YF+V5VAJ?58-`6T0N0B\A#YB`)$(:(( M48PH090BRACB\5-ML+UWEX]%=S?T5-3SU.Q4-]16/Z`1A=9^3'+DYMZ8U5_Q M(7(1>8A\1`&B$%&$*$:4($H190SQ<%,H6+@OETH5.3E=*\2F*Z"5=K2L7$0> M(A]1@"A$%"&*$26(4D090SQ^JENTI^L_Q$\WE_:3!;TLM=*LH66B%R M$7F(?$0!HA!1A"A&E"!*$:FWU9H;JN)7O7U6O3BSSX]O^3+?[4Z#3?%-O5E& M#?/30XVKU]Z>IQ-Z[ZT\$@M7IG2E/+4%5V[I2KF3PI4[\Q:=N$*OUWUN_11Z M[:Y\1TW8/].P6NW5H-0?"83]Y]O%9PH(7GBFL;8.E4;::G^_H!/(+3JS!1VT M;>%3]>)@VRW0.<:%.J2(/G0H<:%.'.(5.F&X4,<'\0H=%URHLX!X9>DX]#EM M(_#HBCHRASYT1(X^I^T*G7>CSRFOC.H8TXN('^NW/%T?W[:'TV"7O])T&I>G M"H_5JXS5+V=];.U+<:97$,L3;._TRFE.KTB-5;%Y+8JS^84&-:I?8GWZ&P`` M__\#`%!+`P04``8`"````"$`_"\\Z5<(``"L)0``&0```'AL+W=O.[LOR\YQU:'[='55`?WXV]?3U9/Q='3* MBO-0,"RK6SC*_;[8YGZY?3WEYT:05/DQ:V#\]:&XU(KMM+V%[I15+Z^73]OR M=`&*I^)8--\XZ7!PVBZ3YW-994]'F/=7R\FVBIO_0>A/Q;8JZW+?/`#=2`R4 MSGDQ6HR`:?VX*V`&3/9!E>]7P\_6,K6GP]'ZD0OT3Y&_U]K_!_6A?(^J8O=[ M<C\U?Y7N<%\^'!I;;A1FQ MB2UWW_R\WH*B0/-@NXQI6QYA`/#OX%2PT`!%LJ^KH0TW+G;-836<3!_`J2=R'N>LZT_D,2*XX.M(1KM+1 M6CPXMCN;\]M?\01>/FZX2D][ML880;< M`:[WC=&"N.&>[#^WC7(D`H''E9\UV?JQ*M\'L%EAJ>M+QK:^M61T*J+$8K0Q M]E&(06PQEL^,9C6$J4/TU+`OWM:6-9T^CMX@F+?2:--CA"T\9<$BE_'Z)A"8 M0&@"D0G$)I"80*H!(]"E%0>VR<\0A]$P<=2L-@KHU+(-(92%2D8<>:U)JPY!`H*$!(D( M$A,D(4BJ(T@D2&L_0R1&`QD:LH*^EV:&3-+JFDRM22L300*"A`2)"!(3)"%( MJB-()LCA2*;^VJ42"[/F:JA);`1B\2K+DX0GD5F[P7R"!`0)"1(1)"9(0I!4 M1]!$H?;<,5%FC26#?0 M'(KMRZ84/47/2D^@5H@*PDCP_`5B.>VR>M*&.;VM[;$UP9O";W]7P1)(CDZQ ML+61'$;FC=K?%4=,.)+61G)8>!QI^SMP(*5@NUY5ZDMYX26Y1REHT)14C`5+ M)9`YI.\V9RPF"7$)M41I`DD.J3)];DS M:SQW@4"8='.W;&-%O!XCVQ3(E]Q8Q056,9!,FD*W<$=]W,X8<\>$.[F%.^WE M[A1`:K,>#\G--JL-`7O[3N44>`T4!(U4%X".L;4\:>5,VAWM*\CA6_K39&K4 MN4`:Z!&I?#J:2$&2QIJ;RE*:1/ET-*F"%(W3+3X6D36,9M=\IXBBYX0RK_+, MQA(0BN2%8^0X3UHY;,E4KTU#65G!KFNM%HZ#XRU0=]2"63E>I8^4%:8W6KF8 MTB?*\2I]JJPP?=<&XL5@3:NY&);;E9_;DJHE>E^T(`+2*Y"TF%G<&INQO]<`4D!&8QD[U+&$U[_:3+Z&9OMH+ MQZA+@;1":A&NJ)^KVZ"\HL64*Y&0-JZTE\OM<@;6E'6RIJ86O#:1.5.%UQT) M5/;&NL020@G4+%`>6P&H?G.XM+NZ9^]+*S9`E2$6;EB/7QY0^48Y71Y\J*TS?94&\-F!%U^;^O<]HC(HF(!B-RL\>>]$&5MH6]BD4 M2`CI2APCZAA3QX1:I0C"6K#^7(_3ZXT4/%>0.0L(MY&N430\Z:A-T*=00*&0 M0A&%8@HE%$H1A&6`9'./#,S<6'H!L4!L]P_M*&'^S!%9]>Q%20_9O^5:3(RL M%2@NO0[?0A])1QO1D[:2TB<*TN=(1I_VTW>9!`O/.GP]_OY'9\DHC,60$$J, MM+,45JBSE)#J+%TBNC"`.:H='EJ$)E*0:@EG1O6*I8%&DRB?KA*F"E(T3E<] ML8BLE_]!$>7C@%Y=>AXC>CI+8?6]SE):@51=1+M&ZQ=8\HZZN+?01]+1P?1= MZR?+/*%/E"/LFW9U:ZO[/D-#BJ):17%PGIU85"@7+4=*56 M$85BZIA0JQ1!*#!M]G!"`G/*/C-]\/5)O:W@GL;T>Y]TNE7@B^Q)1VUG^8H+ MYSMC2P;4,:10U,]E9(F8.B842GNY/FHH6;8F4NIA==/[,LYBR,J(`4*YTC74 M\:2CGBL5I%>#!4F8TDI;CU`Y=IDN4A#BFG:]M=C`E"M1CAU7JB#,]4']L=DS M`XE0E@YN?@?)*0Q-^YY]ID:WZTG'>?=2VI<03F33KH\57;BT0IK*9Y^.*^KG M,AJSF'(E$M+&E?9S=?D;[WI0GFCZ0\\^-F,T))80#EMC=IYT_,ZSC[*"K-16 M@87Y(3*05DAU,8CK]%$_O9&X8DJ?*$>X2SLN6IV4%1J]V\4,7AOV5&'&NPLB MDD^W?`.HQ]3K3P4LG9O+(Z"Y7E@74Y)56BO53?F2"QP5%%`HI%!$H9A""852 M!&&Q[GLX@C,<1`8!3;K9>-)*@WP*!10**111**900B%VW(0-50Q"S%D<'Q&? M^4]Y]9Q[^?%8#[;E*SL:`B_7UH\M+,ZM;.RI.KAB_.+-EO!9!1;0P,/9$CZ5 M4#R9+>'S!\7A9,QGNP??P(D9?KS$X-_8,*`^^\D2OL#V\#O`SU.F2>0LX5LD M==C8+MR!'Y(9M2YP5N:2/>=_9-5S<:X'QWP/@HWYJ\1*G+81?S3R.\U3V<`I M&?[)Y@"GHG(XLC!F+X;V9=FH/^#6H_:U](P$``"&#P``&0```'AL+W=OU*AKBYAX/M]T5.4Y:?*UH+2=+0,A.@ MGQ^+$]=L57X/794UK^?3IYQ5)Z#8%F4A/EI2UZGR^,NA9DVV+6'>[V2:Y9J[ M_1C15T7>,,[V8@)TGA0ZGO/"6WC`M%[N"I@!IMUIZ'[E/I,X)7/76R_;!/U3 MT`LW_G?XD5U^:XK='T5-(=NP3K@"6\9>,?3+#B'H[(UZO[0K\&?C[.@^.Y?B M+W;YG1:'HX#EGL&,<&+Q[B.E/(>,`LTDF"%3SDH0`'^=JL#2@(QD[VU[*7;B MN'+#:#*;^R&!<&=+N7@ID-)U\C,7K/HN@XBBDB2!(H%6D031A$S]Z`&.4'%` MJSENCCE5\="J^&@R)_XBG(/NL59/SKM-8YJ);+ULV,6!VH29\5.&E4YBX-+Y MDPQ=1G^44,@DDCPCR\J%306YXE`%;VM"9K.E]P9+EZN@S94@.R+1$;A.R)L: M@`>".]60Z?]!-;*@:CW<1@/]-(*!0AVANZ0&8"F$=1PJ#*&ZK]>E3B-V@@HT MTA@MYK:"C8P)S%Q'=DC2A70J3<22"4L^E(G;Y\'E1Y:5&RP,X;#^`UD;%75+ M>1?2*3<12SFH-)7?3BP&MP(U[T8B).H6/U%(:U:R^DS$&CMZ9&P,ML>6B#FV M0HRQ3<0:>_[(V!ALCRT1,NWG+9$9--WF!?^S2RKM@B"!EAP\2$?^,4$3$LA+5`VJX2VT0/ME!J0K"C&GSG/L]DY5M`A9B3N2VX#;: M5JR@7O+`I!,=8)2BI@&K,Q3V'6V%:-E&0?Q$H31X<(YN8Q()]0H'-I+H`%.A MHK$5]AUMA6C9]RN4!F\IE%"O<"5$!ID)%`XV1P[ZCK1#M^GZ%RMS-'$JH M5SBHN82H`%.AHK$5]AUMA6C+AD)Y;7APVX.\X892$#9&F@;;/%%1T["KFE1# M5D?B=UO-5H_&_I_5R]/!*@P%037VZ@GI1+1NE^#Y"CXR-0UW[`HZ"BS-X.JO M(_:$\+083@CNL=`73?@^>X/S:+0<$HKD=1=O9(F*,J#4@FQ=>&P8NGYB!O*0 ML3(JH;"OTP1>$RC3@/"!T4-2@'PPR)MN19L#36A9,:$_\-CM7M#K?P$``/__`P!02P,$%``& M``@````A`(&ULK)E;;ZLX$,??5]KO@'@_(9!;BY(<->&N76FU.KO[3(F3H(80`;V<;W_& MV`;;0].TVI?2_!C_XQF/QQ-8?G\K3L8+J>J\/*],>S0V#7+.REU^/JS,?WX$ MW^Y,HV[2\RX]E6>R,G^2VOR^_OVWY6M9/=5'0AH#%,[URCPVS<6UK#H[DB*M M1^6%G.'.OJR*M(&/U<&J+Q5)=^V@XF0YX_'<*M+\;#(%M[I%H]SO\XQX9?9< MD'/#1"IR2AN8?WW,+[50*[);Y(JT>GJ^?,O*X@(2C_DI;WZVHJ919&Y\.)=5 M^G@"O]_L:9H)[?8#DB_RK"KKI`1%)W]KK:[YKCBMS,A_-%N.)#>;&(ZF;(*>2II$]UTU9_,>,;"[%1!PN M`ELSL2&9V-K2K&+K=GM4+)8H;=YY:9.NEU7Y:L!FAE2H M+RDM#;9+OT)D',N/+@??2T'(/:KR0&56)I0AR*X:]LW+VK:=NZ7U`LF><:/- M@)%JL146-+.IKJ<#7P>!#D(=1#J(=9!(P(*X=,&!'?!_!(?*T.`(KS8"]-%R MM$`("S'$TX&O@T`'H0XB'<0Z2"2@!`)V,PK$!+)EN"Z)I*"CH`+)27$_41W= M,!M'SIRY:K+M3+I@(.(C$B`2(A(A$B.2R$2)"10G%!-:JS^Y2HXCXB`2(A(A$ MB,2()#)1'(6S4'&4'1DC>KXWQSQ[VI2LQ1A8Z0D<#>S`H"*J_XS8TVY9M]R& M#GI9.V-;JQU>=U\DB\\U^H@%G0W7T`IMV-T7&A'2B#L;KF&KFS/I[H.&$BG: MEN/#M8_4C_+2GL`#D8)&1X2*JJBA8@1"U=<,9Z*733ZL;3C988J(SX6D>"&; M$)$(C8J132(3)290Z)287/>=6JN^",T]2 MT@JOSY6D"-VB'0YI3\?J+".D'=^BG0QJ]SFI1)NV=)\(=VNNQEL@)>!3;1MM MN97=Q\D3`Y7X3K4][..!`4;AL-94BR<>&&.4#&O-.BTU?K0UE+?P]72U62<) MI[DH)QN.Y+HFD!PL-E"*GX^M`HQ"C"*,8HP2!:D^TRY0]EDJ\!^XS_I'Q7V& MYNPG)NWIMS9"'D8^1@%&(4811C%&B8)4]VG')[O_@<^\0927G*%)O[Y;&R$/ M(Q^C`*,0HPBC&*-$0:K/M'V3??[JST#>!D*)ZFJJ;4^TPK>AA9F6=3@D.C/] M^.IMQ%;R,/(Q"C`*,8HPBC%*%*1&C/:!24F=+?SY`7*0J MX&'D8Q1@%&(4811CE"A(]9FVA)_PF760BL^\J91]EOM,_J,?(1_:8BTR`48A M1A%&,4:)@E2?:7,G^RP5P]N[75A1O8_A"#),Y/=66+W;\/8&8HPO9/I:$_16 M[_2\O8&0B;!,W%N]T_;V!B"C!HUV?]>"=EOC:_,F4BZM#-%]V54.9XYJ!Q^H M6$WT_D_(PZ:3M+16TN=6X*P(5B`&7I4/A94JKTTBPO*Q&'A5/A%6JGS?OJH+ M0GO&=Q;D@\+%NTUY#1A2CG2$/!LA'Z,`HQ"C"*,8HT1!BOOPR%YU_[K/K;G: M!7,D'^D8>1CY&`48A1A%&,48T9<1M+"P>3&?VGCPX@UH@ M-<0=$!KB$Q<>R^$Y/8`;T./@&QOP8M@)^`;H!`=&V/`=@UK;A0L/'O"(8.'" MPP3,XX4+#P@PAVKO>JRJ:&&"`NZ&@W>@)L.L6C6K&P3O?R[I@?R95H?\7!LG MLH=E'KR@3<_[7.'([SI(]"2CT=01?9EV8@/,%VK>W>X M_@4``/__`P!02P,$%``&``@````A`,GR-O^)#```^C\``!D```!X;"]W;W)K M&ULK)M;;R([$L??5]KO@'B?$+HA%Y3D:*#O%VFU M.KO[S!"2H`DA`N;V[;?<=K5=_I-.9S0O)V=^5/W;7657NPQ]\]?/[?/@^WI_ MV.Q>;H?CL_/A8/VRVMUO7AYOA__Y._ET-1P/ MH\/K?KV\;YRVSZ/@_/QBM%UN7H9:8;;OH[%[>-BLUM%N]6V[?CEJD?WZ>7FD M\1^>-J\'5MNN^LAME_NOWUX_K7;;5Y+XLGG>''\UHL/!=C7+'U]V^^679[KO MG^/)'WJ!XS]>CZQ$IW=W<;^@.5-@'^_7#[?#S M>%9/@N'H[J8)T'\WZQ\'Y_\'AZ?=CW2_N:\V+VN*-N5)9>#+;O=5F>;W"I'S M"+R3)@/_V@_NUP_+;\_'?^]^9.O-X].1TCVE.U(W-KO_%:T/*XHHR9P%4Z6T MVCW3`.B_@^U&30V*R/+G[3"@"V_NCT^WP_#B;'IY'H[)?/!E?3@F&R4Y'*R^ M'8Z[[?^TT=A(:9'0B-!?(S*U&AU^$^-'?XW?>'IV-9U.+JXNZ>H=GA?&D_X: MSZ"?XZ5QI+_&,3R;!-/+J^9^.ZYX;1SI+X_5N6+/0(TIOTVXU?\8F:ES_;XR ME"TM8],V_HW1<-[&;N)L-+I',](SJ9F8T?*XO+O9[WX,:+737#F\+E7M&,^4 M,D])'=QVDKXU1VER*I7/2N9V2'6*IM^!%M;WN_$X'-^,OM-J6!FC^0DC:;%@ M"S7UE6[D@]@'B0]2'V0^R'U0^*#T0>6#V@$C"F4;3\KQGXBGDE'QY$#,&=@` M!U[LV()=(A_$/DA\D/H@\T'N@\('I0\J']0.$+&CZ??>3)P;JZ[@MB9M<('$0!(@*9`,2`ZD`%("J8#4+A'!I:>?".[IQSF72F7= MQ)!O?:Y)>-&N]@60"$@,)`&2`LF`Y$`*("60"DCM$A$>>NQ_(#S*6H9'D[$3 M'D,NVX!%0&(@"9`42`8D!U(`*8%40&J7B/#0YN8#X5'6,CR:N.'19&H#%@&) MC9<-80(V*9`,O'*P*8"4X%6!3>T2$1[5^^`&Y4QM.8]/F]77^4[O>$\LNI`V M(GI[HD1DU#0)KYN]RF1\$5Y[Y=^X4$5M2UTXOI)&46O$:SDVNO;)G;0VKI!W MM;0U8J$,A/+6QA$*SN6(BM:(A4H0JEH;*S2^N)1"=6M$0B(A5/P[$_+W[K79 M5IY("'4IG!&E(C.BR9BJK`UXX&TA%\:M:;/T#E&3B26Q$7*F-GBE0#+PRL&F MT,2Y5@E>%7C5+A&15'V%"&5WR!IS&3-&M!MU@N8]CQ?&2H0V"/VYS%JT.W.T M0CDM8M9RHLO(S1S(I\9J(HPG:5?&:G8\-DL'R-K$+8S6V=Q.QHQRGM[6-T3%!E!KT7L;T M4)U!Y*A5]-(JT;%"5!ODY<+>H\R%:C8^D`ME[JTQC<3J"0.O7"[&QLK-A4;Z M0*DI5C%:)8A2@QS'#*UR1`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`VRN8\,=(E@:B6!IY)X1JWZ:UJ^#8H/U*G[!K4'QL&EMW=9L!/YMD]'/#&V5CQQ8Y9VSHRM ME:OEM4NIM6*M#+5R:^5HP;FQM6*M$K4J:V6U\.C86I&63(_JP+K2T^^Y'.A& M3LQQT]N)Y@6.C]G1/O\B@YQ#W=@@,>W-%:UCBEH9.N9H51CD7+%$QPH=:X%D M7/VF\)V"BLV?^@&1>GJ++B7PCV.,E6@1L4MA+2HH=B6$GE;,6K9>)XS<)()\ M:JS>.9=D+2N?,^J4+WK)EZQEY2M&G?*UL5(E[&1P9%Y5V^:NEW?R:EI-MVYI M)#*&IY>!L;)W$QGD[LK0*D&4HF.&5CFB`AU+M*H0U<)1QD]U&F[\?N]QH/L5 M46X,>F>Y:"OW]#(PR)TD8>CUB;&Q$A4(M%+6ZCP-R%`K9T=[XE@PZM0J4:MB M1ZM5,WKK'F6*WFO5>IV[J%_R>,V'0:(AA]-+-J+@MJL1*D[$5G21UBH,O0U` M;*Q$TO2PN@]'4Y:GULC*PRDTRN?LV#GZ@JTZY4N4K]BQ4[YFJ[>"([.MVK^N M!=ES`Z"[2+$B-9*%#DXOR:/9Y-KG>,3(=LZQ02*3X)BB8X:..5O9*Q:,[!5+ M=*S8RCK6C+!7#_WV\[<*7:,BNU)&HM#!Z:6QZCY>C(Q5]_%B;*S23WO) M9RB?]Y(OV(J/&*_'WHZF1.F*G=RG/=27FJU.28OE$ZI.N&OY]"J6C8J79B5, MW^+0/J`M07!Z:?RZJUG$5K1@6BGX3BTV5B++9@R=Y2;M)9^A?,Z.G?*%L6I/ M+T]D60_3&7G52[KNDI995ITX9)E^Z4\153]YZE@>CVWNKPS`MT:TM:#$S&G(VHU*#$"@]P1N$B.@$JP&,'O;5:4BA<:C=SO M&VCY-E;B5"[T9EMDK?P3JU#MX-UH^6/M68QU(R"BJ)&W8?5_5]1D>7".+H=,2/S?:'S M2QXQ:CHNPU'3&V@?^R%PHR(GC4%RX!/_9P_&ZIV]#UNYE2V'8-YR\`@YYF^0!0ABA$EB%)$&:(<48&H1%0AJ@62,?2W2MW%C$ZS(%@: MN8]Y8^6@"%&,*$&4(LH0Y8@*1"6B"I%Z@57=HQZ]#I9^(56_][==[Q_7B_7S M\V&PVGU3+YO2OO3NIL7Z3=AY&,[4AH'*H??)YW`R^TS7P$_HN4X^S7>]GL]\ MHEZL;7:=\$G`K]QZGRS"RYFJRW@=>DOW\\GKTT5.7H,N<=)>W>(I?;K!D[<^ MI_L[>7O3&;W]@@.=!^=TY:9_]VYN'M*8:/.*/HL@F$5T.(R?)/2)^JX-/Z'O MUF;JRS3\A+X\HQ&<^H2^KJ+KG+K]A#Y17RVA&GV51-+SEQC#H/G]0,MEO/F@;/7[V[K?QS-"P]?=D=ZY[IY M]^&)WK%?TV]#SE7/]K#;'?D?Z@+M6_MW_P<``/__`P!02P,$%``&``@````A M`*"+0QE0!P``]"```!D```!X;"]W;W)K&ULK)K; M;N,V$(;O"_0=#-VO;4D^Q$*<(M:10@L4Q;:]5F0Y%M:V#$G9[+Y]AR)%.I-2I.>;4M3Z]KZ^^OT9<' M:]2TV6F;':I3L;9^%HWUV].OOSR^5_6W9E\4[0@43LW:VK?MV9M,FGQ?'+-F M7)V+$_QD5]7'K(6/]>ND.==%MNV2CH>),YTN)L>L/%E"P:L_HU'M=F5>!%7^ M=BQ.K1"IBT/6POB;?7EN>K5C_AFY8U9_>SM_R:OC&21>RD/9_NQ$K=$Q]]CK MJ:JSEP/,^X<]R_)>N_M`Y(]E7E=-M6O'(#<1`Z5S7DU6$U!Z>MR6,`-N^Z@N M=FOKV?929V9-GAX[@_XIB_=&^_^HV5?O<5UN?R]/!;@-Z\17X*6JOO%0MN4( MDB*!JN,HSEUE; M<(!`7310\=^?;-N=/4Z^0YGF,FAS)0A'^'T$KTFN&Y@@-$%D@M@$B0F8"5(- M3,`790[4[O]A#I?AYO2SVO3@XI9C&-%']"F!"4(31":(39"8@)D@U0`R`O8? M,<*%:KE^HO1%P;/@[-"*PIVY>*(;$>/HE;/`(;X*4680$A(2$1(3DA#""$EU M@CR!HX5XPD_9@3N'RZPM!_:_OG7FV(.-C+IEDPI1-A$2$A(1$A.2$,((276" M;`)'D$VW2X9'=V[TD]@(8B_4[O$E62H2$!(2$A$2$Y(0P@A)=8(F"G>,`1/E MT7BB@N@3E42;*"$A(1$A,2$)(8R05"=HHG"+&S!1'HTG*HC=-4#=*>]+HDV4 MD)"02)`Y7-3.<6?&X1&KH+Z@$B+$5(PNM,0[,%5!((3LX%VS?@>]7>`\&MLA MB&Z'))H=A(2$1((8=CS@6<0J2-E!A)B*T>U88:%4!9EVP$&&[!`-Q9BW3^V^ MS+]M*M$Z7K')A<9!M!-HN9O7"-`?DR!8[K2S7,IWC4@0KJIQ\* M8E^\CE2,+F1CH5@%]4()$6(J1AN?;MB)#3'O9.= M#+92(J@X;6".,4._3^R^:LAFC`\)M"XH[+4T_VAB3%%"$QF-2A%"N\[F/=OG MMUT7;M@@NCX'+I>*<8SU\64B,LMQC6T5]/+0/VE:1J\3]EJZ66(0M^5CF3C# M0S7:ZX3*LQ[I2TU&G\HHYZ/18^-YCSC`>-%20G_3[Y2-+1&>C='Q^#)*VYE! MGXC':9SX(4V,*(HENF>I&*HV"$:U4HD,_R[CPO[QAG*`?[+_U/T3"-6,.S>* MS;=EU*78`HI"BB**8HH2BAA%*4+8!MXP#K!!]I>Z#1*A,IH;F\+G+L&9I:U@ M(!%>KKE1?R%-C"B*);I71F00C&JE$GTX+NP?[T,'^"?:5K0-)4+^T?-/1"'_ M9"+>AL:1&/*O0MCXB*)8HGO^$2U&M5*)L'_.95S8/][>#O!/=,/(/]D@:WTL M-._&G`.*0HHBBF**$HH812E">,Z\AQTP9]'RHCD+I-HP9TGVFXA`]4)0"#\V MC(HHBBE**&(4I0AA"WC?.L`"T>8B"P3BFU6[U9/N24;IIR]!H4U01%%,44(1 MHRA%"-O`V\X!-L@N53]]);IS>H@H9!;I/P);:J$#Q34ZL5!&P=KVG434(WTM MB'PLH^Z=,7*H%WGV*?E41N%C1QL],AYZYR'&=^&X;94(6>HZQK=5OX^ZS":@ M**0HHBB6:.8HXQ,:Q2A*$<(V0-D,J#_>HQO?!WN$ZH_<_6645C-!GXB*C=S] M:6)$42S1G*7J^/"_IE-N/:4XO;W:8?VXQ(MQ/LO_MK" MIRB@**0HHBBF**&(490BA*?/^]$!Y2/:5_TN"*\O>46YE_/%IRB@**0HHBBF M**&(4<1?JU[&)>8L7I.*EU['HGXM_.)P:$9Y]<9?@4+3^/2HL'H_^]P==@;? MP'O;;I%-[L#[7'XXFMSUX/4!Y<\S[QD&2G^PF7GP(/T*=T`)EO/:3R#EJE:T M].#A)\U@2P^>95(>/7CP=)!R]N#!PS[*_94'C],HCU8>/!VCG*T\>-@%?*)< M@G?.Y^RU^".K7\M3,SH4.UB0:?>HL!9OK<6'5C[I>JE:>-O&PO=V]R:W-H965T[(RDAD1)RV2R$MD%L5Z\X]_??WRZL_;A\>[^V]O3ZK79R>O;K]]N/]X]^VWMR?_ M\\_FE\7)J\>GFV\?;[[_+OV\>3?[S[S_]X\]?]P^^/GV]OGUXAPK?' MMR>?GYZ^7YV>/G[X?/OUYO'U_??;;_CDT_W#UYLG_.?#;Z>/WQ]N;SZ.3E^_ MG$[.SBY.O][#HEQ_^G3W8?;U?V'/[[>?GN*01YNO]P\X?X?/]]] M?TS1OGXX)-S7FX??__C^RX?[K]\1XM>[+W=/_QZ#GKSZ^N&J_^W;_C0O][=_O7H_K_KQX_W__5/MQ]W-Q]NX7<2%1(P:_W M][\'T_YC0'`^)>]F3,%_/;SZ>/OIYH\O3_]]_U=W>_?;YR?D^QQ-"BV[^OCO MU>WC!TB*,*\GYR'2A_LON`'\[ZNO=Z%O0)*;?[T]F>#"=Q^?/K\]F5Z\/I^? M32N8O_KU]O&IN0LA3UY]^./QZ?[K_T6C2D+%(%,)@G\ER/SUXOQ\=K&8'QYD M)D'PKP2Y?#VOSBZG1\3`U<;6X-^7W\B%!,&_$F3Q>K(XK\XOCI!D+D'P[\OO M!*-T;`[^??F=7$H0_/OR.ZG0,<=;"?_GY?=2I>X6_L]/W`UZ:[R;W&VKXWM< ME?IM^#]'-^HTCJ1Q8*YNGF[>O7FX_^L5ICLT[?'[39@\JZL0.0W).(!V@_1' M8Q2#,T1Y'\*\/4'J,?P>,;/\^:ZJSN=O3O_$;/!!C*X+1M9BF2S"T`]Q5Q[4 M'C0>M!YT'O0>#!ZL/=AXL%7@%%+N]$2._PX]0YB@9Q+B.H$L\,1IERR2R\J# MVH/&@]:#SH/>@\&#M0<;#[8*&.W0_?X.[4(8K`RJ+\YG3JSK:#/1'?;"Z;DS MV0E*I";2$&F)=$1Z(@.1-9$-D:TF1EJL4W^'M"$,EE_,SGJ<+ZQRUV+UG+@[ MDYVX1&HB#9&62$>D)S(061/9$-EJ8L3%`F[$+9G7D507N]&^ M%#*68G$B)%(3:8BT1#I-3"-00!S1B&!M&Q%)->>XW2N'^ M2:D)=!VE23H5.@KJZM130@BKC1!,%2J=E_:6E]&H4MJ(6\A2JI_FYV?6K2:W MINA66;>6W+JBVP]4"B6TD>EY149S*XD@C![=.)?&9;)2HJ18*!>4*C/;O)H= MF[*C&XLM.W9EQSP:3?\)NP*C3)AL)A=AY_J##6WJ-J.G$RG6DTXD/ZC$4?>< M%,N*Y(<5.S:"9KCP3MWIQ*G;LF-7OF+NXU:D4.OQ_N+(&;F*%2/JCC0!7@NR M@EVX(;-,5KI7Q5@STQTOW*"IV;$1Y!SSL!DGGY8=N[)C'@!6L%#"_;Q@4@AJ MP2(R@E47U,/$2@L6T0S3ZJZCS"]<1ZG#WA%SH>J:C2#G2,.0'+NRXX^&82C+ M2#!>\?;,6R&*&Y(17<33H[`;70;Q8*70BE'-J&'4,NH8]8P&1FM&&T9;@VRG MPY1E--PC5C!W8D44#P_'D;`,!WNP4FC%J&;4,&H9=8QZ1@.C-:,-HZU!5JQ0 M?5*'0V.//3*)5:S?3.6)=)3Q&MN"46P]_/)0$*EW-FE^7&6WA&I&#:.64<>H M9S0P6C/:,-H:9*4.96Z2&E7+GFXI1;&>]"+"%9(*2\Q004\U4:T8U8P:1BVC MCE%OD&U?*%4/;U\L;,TJ&!%&=FZ?(#V#$ZHK0HV@<^B3Y_EY7J9D?8N.L$I7 M[,1QFD^K>H-LDT/Q>7B3I535*8W(-%E0OJ=5V)W8+->,&D&NR6YI:[-5;G(, M;YJLD6DR]B9'-'FTMI.K(-WDA%23&=6,&D&NR7Y1SE:[)@O233;(-EG7QA#F M1?OP2:R)=7\7%#*B^JB?#I.5%D?J:^,X\V4R.S;I)E"EJ"NZLJG-5EFO>$6C MET96+UTF)[VXACE\US[ABCDAU#"J)4Z"I5AASDHM60F:6PG<.E6S8U.ZXF3J MKM@F*ZR@^;X6KI+O.'QOD)4SU)0'3S+A\,65,X)"Q:3NR6T2ELE*:R6Q;&/< M)J%FQX91*R@T4]V$FY`[=NP-LL*$`O9P86*Y:P9@1$X8-V,N)V*EA8EH/AO/ M<7ZI)HNS,Y?CFMT:1JT@)XN;P3IV[`VRLH125M$<)59:KXC2J*MF^'Z02WT='AG:,=8P:@79 M87=)4S?%ZDTLJQ:&VL^K%8*X.2HB.^PN22VQTFI%9(?=I9N':R2&]"+4BI75 M:T'3%#GV)KS1:WI4U3U:6V$$66$6;O0LDY42)L6RP\[-^C4[-HS:%,L..R\, M._8&66%"%:J&W?/ST336K'I\"7+"^!Z3K+0P,5:J`2;5.8\O=FL8M8)L?[ET M:T7'CKU!5A9(K&5YT6PT#4%<-XK(J>5ZPU(.'7N#K%BZP,Y?&SJR")ARX2W(J(5*T3[S628KW;=B+'/8O#ASH[5FQX91 M*\@(MCCS:QT[]@99P4+YFP;=3C#>X>T9C+&(-H,Q(G4DO9P26C&J&36,6D8= MHY[1P&C-:,-H:Y#5,)2W6L,]8L5JV(@5D3J27DX)K1C5C!I&+:..4<]H8+1F MM&&T-Q*39KC)%0^)UQEM[0- MJ!DUC%I&':.>TH9S089-L<2MA7I!:B0>#K`RA(CU"AEC`&AFDIM4R4)F[FA*J&36"G`RN,&NS56IS M)\C(0%<32W59(@K/OIII8)J1'`J!:D;KT19&18G/G> MD*W2%3N.U6>K/*\MSIRD0[9"+*N,+K8/4(:K[?`%C;#AU,H(TLH0JI-CMFH$ M.67(,?JLU6.-3UWM>>0K4C6 M4`?K&6G?BCA%FLK/6DE1`*3=5@MZ-8BI6:25>"S)G!HG+E?36JN^9`&.%;B2-R&Q\ MYG3:$+Y\9$^?5H+">:V2PT6"050;W=8PRP=PM#1$991:5 MFX*7,['*0VDE*!TW5)=\VL!>#:.64<>H9S089&4IE^?'SGZ[XCQ-*=>SB(Q: M\X6;EI?)2JL5'7?'#06Q)'1V:CA.RZACU#,:#+)B^0+[16]I0N?6J8\>>T5".E5S8,&H%V4EKDJNC\"7&=S,BR3E=9/8IE)RW]COF;'AE'+J&/4,QH,LLKXRG^/,ES68QC) M5O.Y22M9:66B8YJTSDOC4&)GKX8#M8PZ1CVCP2`K2RB9?WX"<,OCESLJS/!N]-;LU3!J&76,>D:#05:M4$;_O%JQ&#=J1634 M6DQ\J74N5EJMB,)BO5M)%Q,G<\V.#:-6D)NU?*G%CCVCH1SK!Z76>2B=GY/U ML+\W&\.XI7-7[ZD__`EH=Q55XQJ1@VCEE''J&^;TQ_#9*MTQ4Z0>A[5<_C! M("M#J),/GY(N8EFMIR1!1@8JOE?)*BM3,VH$.1G<,4:;K;(,\8I&!KJ)P5S1 MRA#*YB-DB%6VD4$*;]T;!.4VKRX(U8+4K3>"C`S\1#%;91EB>!6KSU:Y9_$3 MQ6R%6%:94`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` MHX_HQSA\1.]&X74R0]?;#1._MF:;U%57C&I&#:.64<>H9S0P6C/:,-H:9*7V M6X?G^^6"]PB"]!%]0FH^9%0S:ABUC#I&/:.!T9K1AM'6("M6J,H/'\2+8&YW MH(+T&IJ0%BLZJF6A9JN&4U(%7(;1AM!<4&6?U"Z7Y$9XN5OEXQ M%A$9_01EL5;)*J.:4<.H9=0QZ@4Y_7)U,19"0[;*^L5;-?H1VIHK6OU"U7R$ M?E)DJ\/<141&/T%9K%6RRJAFU`@R,BS\'^6TV2K)T'&L/EOE]8H>XPS9*L5: M"S*2Q@;9^_)_&+8UL:S*?KNQ9_W@;<4B(J.RH"SI*EEE5#-J!)G6S.>NL[79 M*BG3<:P^6VF5W?'QD*U2K#7'VF0K'#]C2`C M/NU)5LD*Y>:N0.+G/\DJIZA)5\2LO7-@KSG6 M)CD^>ZO;9&7#YYVS'61A-Z63NFAOE=@4A9V: M3M&>63Z8NUD^(I,+7DLOQ4KG0F*9-9\>/;-CPZ@5Y'+AUN6.'7M&`Z,UHPVC MK4%69;3Q&)6#N5,Y(J-R82T5*ZUR1&F>GQ5^!O>2O!I&K2`GL2]7V+%G-#!: M,]HPVAID)3YN?WO)^UM!1N+"4LI;7G%,$A=^Q#.%SGEI&+6"G,*N7NK8L6\MQ5DA"\LI+S=%<>TD$YFA>\8I.!:>HK4IKNR"VG^ MNDG<*G&LGM'`:,UHPVAKD)6^N(T]]C>0+WGK*LA*3W_;FZRRABM!;B%U15_- MC@VC5I#M]^=^G\J./:.A&.O"%65K=MPPVA9CS7.E9E-TW*;TDC>E@DPN"@LI M;TI3+$SCN0J<._WJ%#XGL6'4IEAF(,RIJ*&;Z#G6P&C-:,-H:Y!1&=N4HU;2 M:&^7TL2,T+R6[LRR8*O$TE0_O2C\HFPRTK5[@>%]<*$MN#>KM2OZ\(ZX:*;" M]04V%-BZP#8%MK7,*7[<'K4ZXTUJ8D9Q7EIW9D9QNT\M3?$%/[R2C_:N$%QN MS0KNJ\1D9@6G2MK/+]A)749T])W&LK:&FF.4>"S4E M'`9I=O6OZD%G)U<(7+@J/R))9GO[/UT!:2"&-$1FP_E?U4-FR!69$:9EHAM& MLHI7R`6:R]]QN^+JC+?%B=E%8^'*%.2/-\:).3G<@HO\D2OR)^Q9.3!FY(9M M#^&EA*Z`_!%#_HKAW.R*_)$K\B?LV1M&_HI7R!.NR]\S>^Y]0Y$WVM599/I[ MG`6&<4=V2!(Q)(D8,D(,LQ@QR$\,\A.#UL2@-3$(JYE3T6^?]TG'&^7J+#+U M%4YT>6*0CABD(P;IB$$Z8I".&*0C!NF(03IBD(X8I-/,2>>WM;$(.OH;GM79 M;L.;IW+\"H.;1JYW=KBEW93OQA^$EV#Y9[0A/#$(3PS"$X/PQ"`\,0A/#,(3 M@_#$(#PQ"*^9%7Y\-?@1*V]ZE;@N6M(;Q]7/O%>)Z66665VPPQN\:2>*]W43 MPPN[B?4%-ECFFA_V1\\B;P*TJLN,QJD2&'Y0.#]PG9Y4;EJLJ19KNZE]H M))&REM#(1\J5R:@L%-M9I$H:BE$D*+:SDWMR!UK0;V?AO_93A=_W)OW"F\'& M+V$=N`\8@[@=M#!7#%$Q*V;AF_.[68R*.:@J^QO4=#NSA7_[&X2FK1&$CNSY M*T#MXA6Y;BT=[G(,08?Z%>J^8ZVC)> MRO[A6&*V(/7O28/@<@73LXE!WT+BP&T?75;)[MC;,1FE]@?!R@5PO0GAB$)X8A"<& MX8E!>&(0GAB$)P;AB4%XS9SPH5[7PN_KL[&^MV5`9$AOD@DSIK`\[4$Z8I". M&*0C!NF(03IBD(X8I",&Z8A!.F*03C,G7:BXCY%.*G0SW"/#;*VD$V:D(P;I MB$$Z8I".&*0C!NF(03IBD(X8I",&Z32STHUO7]?2O:PFE9>XF\XHS"B:['Y< MDV:+E(>Z8M8DA@&5[-K$'/$55AZLK<597"Y2^*(P-Q5V-<\;T,^T9% M)$5O?F1K4')=7+JK(C/1%:E.VB$SAUP5R:*K(ED%5[HJ,D971<8*KKJM+HEA MO_)<$@_ZO;`J5)O^P9XP.X"B71C1NQQ>^C=4(H=BED<'W8Q0QO;DJC!'DMNKHZ"WF-9LH5>2VZNJLBK^2*O!9=W561 M5W)%7HNN>49RQ\=7B97]#N5 MO_P$8&P3QF6,II*`_,E5K:M[O(K\D2OR5W1U5T7^R!7Y*[JZ:1GY(U?DK^3J MW[^%_)$K\E=R57]&YO(7=H?'Y"_N)FT5$IG)W\2_&`?C3UQ-$OQ[P)"_:&;S M5W1U(QSY(U?D3QA6G-QK_#D=\D>NR-\AKL@?N2)_A[@B?^2*_.UQ=?D+V\QC M\A>WI39_D9G\7=*+NZJ)N-K\N3D%^8MF-G]%5S?"D3]R1?Z*KCS^R!7Y*[JZ M48_\D2OR5W1U0Q?Y(U?DK^2JOAKJ\A=VJSI_:G.P;RJ5C:Z92B-3!T\8=\20 M)&*8)(DA(\20$6(8/L0@/S%H30Q:$X.PQ""L9D[%L''5*NZ3+FYT[2B(3!T\ M03IBD(X8I",&Z8A!.F*0CABD(P;IB$$Z8I".&*33S$D7-JY:NI<>1D',TF&4 MFQ^NJV2'6]I-R&XF@/`2+!\\07AB$)X8A"<&X8E!>&(0GAB$)P;AB4%X8A!> M,RO\-#SLT\+OZ;.CO3O1%V8.HQ++^Y)5Q:PNL*;`V@+K"JPOL,$RU_RP!3RF M^;*-U+/=-#(L7*E47U:)F>:+769H/C$TGQB:3PS-)X;F$T/S-7/-QRIJFJ_F M_<-_\*":AC"^4T1F51&['Q\*I4CZ0:4P]7,:T,A'\N],0T\35]3;NXFL M\*PRF:&LVYE=3MP&$/TQ1E-E$[0^Y`H07,SL%?*.;=P8(0?13!VX(0>'7`$= MN7B%/+6[W(0=R'.Y.>R\9BH;&9.:R%QJ:/D05[Q0)F455A-G$E M'?(@9GG[CSQ$IL)!]$*XRPG5I6)F1:=P4+@8+M>J3N&P1_@;%(Y;#=OY(W,* M.YG0^:-9>(_I3LU2YQ:4/Y3:OB74_:M]K*+,)T_,E/<3XFAIQ-#MR:&;DT,W3ZN;IYMW;[[>/OQVN[S]\N7QU8?[/[YA MM.+W4!5^]7#[Z>W)>Y2J5^]#+,R8.Y?X6:C9K\9:MO39]`*?(?7%S^;ALU+, M]_@.'ZX7*U>Z'CX;O^17BEF=XS-\J:'X6;B78DQ<:H[K82-4]`OW&><&NI=) M^`Q[SY+?9!$^*\5\?W%V]1Y?,BIXX9/P2JG")W.$PR^LECZ!(,5H[Q>X3O@B M:L$)'X4?QBQ\@B_]XL;QS=_B9Z%1Q8COJXNK]Y@.2UY!^6(GF,ZNMEC="CY3 M9+(8[3WZU'N\X*SD@^N4.]LY;CNNT#Z%YQ"O&`W+V.0*@WY<=IP7QOCD"H.Z M]%FH7:\P:$N?O:^NWI?X=06!2BV:7&V+]E,TM&#_?H9\%U,`G8LR5_@@;@9< M$_'%A=!\?!V0A<;3]=#\XF=X>AZ:7_P,6_>S*^S+2]T.V_"S*^RQ2Y]A2XW> M6OYLLT!'P2_T%>YR<7$5?NV./\&OVUV%WZ[C3_!;=8A6^@2_YH9HI4&!WV9# MM-(G^*4U1"M]@G<#7;5X6P_?`=[TT^.3H?A),ZO@4QIX/3X9BI\T,Z@3-V)NQ/3X9"A^ MTLRONF(OJ!881J7IN:G03CQDYO[18"BTQ5'23-`:/#PO^$QQG;A1=_=\/2Z8 MH]*GNX\>W[WY?O/;[?;FX;>[;X^OOMQ^0EUP-KZ`YN'NM["7CO_Q=/\=WP0] M>?7K_=/3_=?Q_WZ^O?EX^Q`,4!=_NK]_2O^!FSK]Z_[A]['V>/?_`@```/__ M`P!02P,$%``&``@````A`&GB*U<_!P```Q\``!D```!X;"]W;W)K&ULK%G;CJ-&$'V/E']`O*\Q-U^0[=686U9*I"C:),\,QC8: M8RQ@=G;_/M5TT]W5S7B8S;P,XT-U]:E+5Q6P^?R]NAC?BJ8MZ^O6M&=STRBN M>7THKZ>M^??7Y-/*--HNNQZR2WTMMN:/HC4_[W[]9?-2-T_MN2@Z`S1W=M!6Y5/455GS]'S[E-?5#50\EI>R M^]$K-8TJ#[Z!OB1"+P M6-=/1/3+@4"PV-)6)WT$_FR,0W',GB_=7_7+;T5Y.G<0;A\L(H8%AQ]1T>;@ M45`S@9W=O780KBRA>MI"Q=L M(5S90GNV\GUOL5I.MWG)E,"5*8'_[OO+HK[O0QEE7;;;-/6+`><#O-O>,G+: M[`"T##&DMO.HOA94B"91\D"T;$TXV!"O%C+QV\ZVW<7&^@;IDS.A_8@0E@@' M"9(K1&^D`K$*)"J02H`%-G)#(4$^P%"BA1@Z,-P/@+#<48P:)(8ED0K$*I"H M0"H!R"A(W`\PBFC9FK"'B)Z_Q%;LF8P<8B6^(1?AEFI(K"&)AJ0R@JR%T_8! MUA(M4&HD:UU_K5A+99Q[UG(1;JV&Q!J2:$@J(\A:J`K('-GB+V@A_-D"%+CD0R M@O:&RC=];R*,]Z:([?&=0HKX<.%GRETJE2'B0F`$H@-QD.G0HCPC':([E_G3 MOJ9M<<1%+A1?6I*)#LR2(C)+)H/.PM+%9R'B0BI+R*E[++_6M[Z]C+"$_C[0 M)$HP38H`33VO4;-&DOA,//3XE-(4334R(>,B'$DJG" M+$58L#-)NYK.DD@KSJ008NDNE:(5VE0*T62ZX"+%7"0&IDD:S72:K"W)SJ00 MHJDVSM"F0H@E4X59BAZ$69(&,9TE:RAC(GF* M")F4!$4Z%.M0HD,I@G"$2+^1#'JC-K/N)#.GD"L&EM#6H$B'8AU*="A%$&+N M*,WO)Q\">S5](1?AAUE35-\^E_:#F)PE(D=HO@F9H7-%.A3K4*)#*8*PW:2I M38Z8PUJ@%#$&R4/G`(D@1CH4ZU"B0RF",',H=N]@3J1QAW4H!"=V<'#((#RS MKI4^$0FI86&L0XD.I0C"QI!V*(7AIVJRPWJJ'!T*(1N9%%Q$A5J+EM9G7S3H M=Q=G;BO]-&)J0$"$ MDVD64"*DR*L=4*-X+!4"H`8;3KJS:K@OGF6FU7GR0E#-8`JA><&>JXUK6`@V M\8#KC6N0(LV'/RJL%5_%3$KR;S(LO*L^':2P^E94.ZWD5Y:.=HCHXCM M*!$+V4)YWAMTH4%JK;*$/,&,J'?7KSC&'9VU^GIX/WGZA?BD,TB::T,=BG0HUJ%$AU($H>C" M5Z5W'-A>6F%.9REYU&52$A3I4*Q#B0Z1KUXDGZ@NRIQ^Q:*?/JJB.15A<;FT M1EX_DR]4,!OO-AQFG\^<>?``FJ"C*7=@A`W(6#ERQX4[X+>Q._QKG*(-/M,] M].^#%'P/"\9WA\U'=X"MQW`O@)?,.J,'/W@`N_4;>S^`M[0CN+T"1OVSJT9U M#7?&=(7+`%YSZKK"50`O%D=PQP'KQLP+'1?NC!D8.EY`!AE=&PPNL*:_8W'* M\`GREIV*/[+F5%Y;XU(<(0'F_0ELZ$=,^J-C[R\?ZPX^/O:O,L_PL;F`)\HY M>4P]UG4W_("M+?[Y>O$MYYTE:KJVGYFB9.@#7$$[,O]^XZQ#;:'S6:W_7)<'H\?YIFQ MQX-W^?6U.EG/I&Y*>E[9[F1J6^19>?Z)FL[)^D ML;^N?_UE^4+KQ^9(2&L!P[E9V<>VO82.TQ1'4N7-A%[(&4;VM*[R%G[6!Z>Y MU"3?=9.JD^--IX%3Y>79Y@QA?0L'W>_+@L2T>*K(N>4D-3GE+?C?',M+(]FJ MXA:Z*J\?GRY?"EI=@.*A/)7MSX[4MJHB_'8XTSI_.('N5]?/"\G=_4#T55G4 MM*'[=@)T#G<4:[YW[AU@6B]W)2A@8;=JLE_9&S?,O*GMK)==@/XNR4NC_-]J MCO0EJ\O=]_),(-J0)Y:!!TH?F>FW'8-@LH-FIUT&_JBM'=GG3Z?V3_KR&RD/ MQQ;2?0>*F+!P]S,F30$1!9J)=\>8"GH"!^!?JRK9TH"(Y*_=\Z75/0LF M=_/IS`5SZX$T;5HR2MLJGIJ65O]P(U=0<1)/D,!3D'B+B>M/@P]PS`0'/`6' M.UGG2'>=MOE[6],6" M/009:"XYVY%N"+0RSSPK?>;?2CQDG)%L&,O*ALT/.6U@M3ZO7AC(4)E1YN)3`H]PQ1TD). MB4T@,8'4!#(%T$3!JC9%S6"OC^]2F2PV"?:CDBP_,)S>F$( M21"2(B13$4T<[#93'"M!'UR:C&5E>_>*7%B;KBYF*ZRNZ>U->KT(21"2(B13 M$4TO:%/U7D\B,^YD26^V''&#?FU&`IGW2(R0!"$I0C(5T3R&8J9ZS(O'A!76 M]E@6CUO*2_R(DAD4"5XZ&(*S?APX-)%0%:^)_$$O714=$0G'E%3)2'25'`&50^7P@SM=6"2FJ4;> M;*$;Q<*(15U67S\P=FLB7J<$Y!;N;)1[WCN@!8KU?N@H^>!J8!QZG#ABQ,D( M0<2-_%F_9&*!J)'S@_O>\6[M)8);"0HBRL:(YL/1ID4`BLQ_C@#CT",@$#C8 MAOS.C0(6<2,?\M4;X94BC$!2;^3/C8V0<"-7"!,TG6 MJZV`9D/4(PS%&$HPE&(HTR#=<]9:*)Y_M@'D'8IYS!IK:^L*,W4%&I4J&FQD M=&(,)1A*,91ID*Z;M1V*[GO(.!G)-(FB$(Z6#UQMD[&`"-+I;U'E?$WE@J M&(M1*CC$WJS40O/\9?TFFZA:X;(JK`WW/D.580!YL<24*YI&+)Z88RD:Y%F^O-W;5[;:>TA(3:N_,&IA(JS@(?=.*B<.?4PF(9WK MK7.5-2M7=LM-#;G+.Q[M=!*0UH(L?+V;BL3$=WH0::4>`?["V'B)L-*"PYVX M3I^-TP][4:\NK&DQX_7A/H1W/EJ\.*3U(0B*700E&$HQE&F0)@BN!#5!UW=_ M9ZV710&I?0B&8@PE&$HQQ*XL63WE]-QS?@7)[Z0J4A](1$ZGQBKH$[M>A$*P M7O8PO_O`1Z$ICCC8[.#! M*%L4A/`UBM^2!B%\86(/C<#=[V;<7Y@PPK0%@:/VLQ`N M7_";-WZX&0WB%CSJ''+Z>,"=[R4_D-_S^E">&^M$]I"T:??15_-;8_ZC%5_) M#[2%V][N@_D(M_L$6O0IZ_OWE+;R!WCD]'\O6/\+``#__P,`4$L#!!0`!@`( M````(0"[4M*%1!4``()R```9````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`I:%+0IJ!3X(KR,B2'-L:O2(Z7\!DJ,FJ5S.=S._+;$#/12RFW(<40,F0'2`6D M!N*`-$!:()TF)DE4T7Y%DKP,U62J!6HOS:]M#FXYZE":AI`A34`J(#40!Z0! MT@+I-#%IHOIMTC1^6DEA\=%]-F00MX'DBV$[%8%DD91`*B`U$`>D`=("Z30Q M`Z7SQ@PTE-9W_K1Z_?9P__OM-ARN(PF84@D-A=6+V/$'DO6^HH\I.,8W^N/C MY#J;VK52#MQ$Y"(+1>=>J2 M)5J$H-ETV-0E$]ML9J>E8FVUCD'(C0HEITX#0BT(=:-"\6PRN:3J_?=SZ45L M+@,QND_1=J/:R8YJ0+L]1;L; MU8X9,)/@_2S.`MWBT*!]`3ZMK/0J=AH8Y>%.R!O5`E&)J$)4(W*(&D0MHLX@ MFPIO<;7//UQ*L^"(R81(N;]E-(V+H4!4(JH0U8@ MVP17G#JRI$+?9ARFMU2L#N&DCC&2UQ)1A:A&Y!`UB%I$G4$V8][;ZHP=625L MA?4J"2C+AX539(SBPBD158AJ1`Y1@ZA%U!EDQ^R-JA[SFVR:+\E)K69$_\A< M%Q*UUZG%`&E3B4Q,7QVC]IBU&"`R#(_N( MC;'>1P$E:8C&C];09^V11?5(I31Q8Q5$F6:?(NW'YQ*DU*-\*TE,- MO>_&Y:-_LXGW?O>,Q+,]UHD/*$D\U'&.BINRI,2-9#EU5!QEL@Q:;EPK=5"H MU2+JQK7V.2;O<77^WE8,@U,V[B$@F]8\68-%%J+T;8`@O4CFR_3.BZ-HK%+P M:FD8;RF<(*N5U)8&M5II&+4Z058K;E"[++UK_?MI#=[7I#4@2JN,N\@"6DP& M5`JB@S@6@&62_(JC3`Y!RXUKP6[G?L7Y:*5A[%+BF]N'V M:&%DU^`RW=K24!TMB"K1B@.L,6:87#AC4B-ZZ55CALV"+JQK7V5+B)=^EZ*QY91FSJU0G1 M*]#C*+/S%[",0D.3/]::],_I?EMFR7`K4=:+"F0<1]$_WK;]-IDD,]"@3(NH MBS*J**QB8;6KSGMXG;4WG0N3<">@"Q@CFTPX%SA*GPN"R/7%FK9*:GDE\CJC MH1-*RXF6GM')-"Z@?D$*5U.!ES09"IOZOT7.`HM9)K:1AKN1-DM=)S`;5::1BU.D%&:QEWB\VA]_U_?VGR MW8/>YP&9I9E-X@;A.AFBCCQM\Z^GTQ3-R-^HU1I/NEZKXBB3Z5/DW;A\4I(: ME&^E(5G0H5]HP27*]CZ6'3L?_J8!YN/LP!Z8=N$T`EH@I1C<@A:A"UB#J#[)B]A==C M?N-#-_\"<"AJ<65FV3P6TG[+W$J87IK)NB]BC!3#$E&%J$;D$#6(6D2=039C MWBOKC!U9)<%:FT.4W;9ZZ$:7??I4*2D158AJ1`Y1@ZA%U!EDQCP]S\SWX?:$ M8Z1/.$'QL"\158AJ1`Y1@ZA%U!EDQYPZ]S=YJ"D^F6=D4L%1>Q\TBDQT+I7( MQ/35,6K/@\88(%NK09DV1NUYT!@#2,8FS?M?O3G2I)WVH''*UEN55D;F>,^O MT^-=&I)YVG]`EA)%A_40E5^G9E3^HDXP]^N@O!N3GTT3G]:@?"L-#\IW$F5[ M'RNMG1!OG],)F>3^#89[WG4S$$RL((;ZEJ&J$)4(W*(&D0M MHLX@FQ%OK'5&#M?OJ0]/TA!0DH;$.Q?-/2:S78L$74C6O%&U*;O]1P'UE_Z*RG`=G\95`* M.4KGC[7X4<0"WA$CRK%-C<@QHFGHGVC,X(D&MFD1=5$FSF:>Q2ILLW:>-R<' M#JLN().U;`%9XZB8@5*TY`%.G%=>;]"DYB9J[[NHHD<;JS:O-]!J4:L;UXIU MV&8N=?A'UMM@Y,4BW$X#,IG+LZ1L%1*E,\=:>K_F65*C*FQ8(W*,S-[/LUBC M.'_;4,?;H\*1DGJDJX7$J52)UI2HZZ3G59A MFQJ1`YFX2,*"PS8MHBZ16:B*:1.6WG,2"1G*R.;,'@*)E$Z8:S%"9NJ M9Z"AS&&;&I%CY/\9CFBP.`TV;!%UC.2R$D4U?DCK?)4>)R*OTQHZ<5C> MC03<5Y]QLSO-]@1*XI+K@0I5")416B&I%#U"!J$74& MV3%[HP[33WT^\V->,S;\Y$F&E4E/9>..[RO1K83II9FL^R+&2!)+1!6B&I%# MU"!J$74&V8QYXZPS=N3D##Z;GGC*:&Y]=:#-0N]?$E0(B@NG1%0AJA$Y@VS7 MO6<]H^L^/-G4`=$Y%;O.2'<=4.5?X/)CCE$U(F>0[;KVQI2_MQV\Z)AG`9D! M<=3>1Z3K,S%@5'9BGR9)2&\I5/ M$O=?B98>K[ET\0?%A(5 MQU6*EDG(-%G"%3:L$;EQK7@TV-%K,WA\6:#IFP=DAIQ^EK20(#UBEK(C3IX] M5-BP1N08V4<(T^@?[8BU`SL^8G1:\X#,B/-I>JQ*E!XR:]DA1Z,8[AZP88W( M,4J&''>C';)V6L>'C$9K'I`9\G21]+R0*#UDUK)#AHW.\K%AC5J.D1VRNFNS M0]9&Z_B0!SLE1\SM/"`SY/1S684$Q8Z7C))>)B6@PH8U(C>N%:N"'3&-4M>Q M(P7>1R>G54!VQ+-8-_BTXB@]9-8RDSR#K0P-ZSD@QRA)W[ZM[%V.*MU'AAP\ MD:G7;)-H8\9S:`9;&NM6\K>YMS^I#9%"DW/`\H MF>5D1Q82I6>9MQTUB%G:>V+/#L]Q'VX7-R`Q9U8VP MKB5(C5BD[(CC]@OU&AO6B-RX5MQ<=L2)5WN3^Z;;_G2',S*)R.?)1BTXBAYK M2#$L&=$Y&YXQS\&:B'1,7XTZ+M&93-3#2)L!RKE>YF_+@!=)E@(CRDW<\&!7 M\A"EWZ(IB%R+:IA4BHJC](:7AO%ME4Z0U8K%PV;"^Z23-WS.KDIM>$8TZ3*= MA42I.PY$E3344\KRL:$S#6W/O=TYO>=LCG3/`TJ6:RR,O'$Y*G:SS`%5B&I$ MSB`[&&]19##^X[U'JA#['CT:-CG4-[6"TL*;@Q4J&5&Q#*_*JCK)%0C:U"CC M$IF]#]US[9Q.&"E:IUZA?PX<1XIN4:+TO`6MQ2R,=#Y9)NFIL%&-R#$:=);[ M7F"@+R^QL_JV.L/^1T\V.QL]V7CDA"!3:!EQ!B;I"SQ5WV/[8(>1DG&"6&8Z MBYO&KFIO8_2J?MOXV0SI\3,R=39]5T*1ARA39QGY;Q.A#U7,5VFCBAN9&@LZ M3J19)Y^I#X;8%&A#=<)R1T>5#XXJ%EB.BG6RY"CZ0)%$5=(P[H`:HYQ!INL+ M;8Q\U]\T>[V*/249V<*;1WL6"B]'+6C3#@4-GL64$D4+>XC*\]1$R5]4J9"& M!^6=1%GY/;[*?P$-+O=S7WSI59*$!:]%]D8FM^`HA4I$%:(:D4/4(&H1=0;9 MM:,-UO%E3ULTM5*,U"LM!:(2486H1N00-8A:1)U!=LS:2L7]9,0>D7V3S!X-]#:I$5"&J$3E$#:(6 M46>0';.W6F>,.3@S,^:`])W5@E$\QTI$%:(:D4/4(&H1=0;9,7NCI,?\-L<0 M[)9)14`F%1RU]W6]Q1`@I:%BI+U=C/*&D+Y4+[$.+@:(3(,R;8QBF<3-=#&` M9&S24H>8)NVTUP<7Z!P9)3XK/@A@G\4-];W$B,_B**H]\;3)H^\/MXKR%^/Z MK*5?!^6=1%GYY/:L0?E6&AZ4[R3*R*OW\)H)68[YWI->LNM;6NLFR-RIP/?< M<)1:F*4T)&<4$YY^?+_"AC4B-ZX576P_>0TV;!%UXUK1G-A4CCKB^9G?C;D, M]E<7!$$VK?$Y?EC:'*5N74M!?.N:+9,V%0>HJ:BE37QBZ02)3*+2H$HK3:)* M)TA45/&Q:4S==%HB3GJCXA)--B-;(=2M+*.:;SI9>*:F>`?G/ M&<5)7R2G3L$-5=)*1!6B&I%#U"!J$74&V0Q1*DR&#M_E+'UXDH:`U``+CE*H M1%0AJA$Y1`VB%E%GD!WS>8Y_B8Z?D7;\@F+M*!%5B&I$#E&#J$74&63'[,VY MW@E'YMF')_,LQO.YG8JJLGO,N` M3"HX:J_CYS;ZG7PB$]-7QZ@]CC\&2`UN4*:-47L%"^ MDR@K'^_*S"I>I8[_\,[MPVWB!1D_NDSN)0N.4LDJI:&Q^?"=;=BP1N3&M:(U M#S8?&[:(NE$M]5$4F[]?8O-7:/,%F;0N$K-=<)2V^8+$6:>?HJ\X0$U%+6VB M07>"6"8Q'@V*M-(BBG2"6$1]Y[Q-XB\Q^2LT^8QL40"3SU%'3+Y$42F.NS;] M"JU*_J*JNM*0SJZA(=0<)U%&/JTY#S0EW2-75G0E3&UF\ER?4,? MIQIKLZ0V_6\Y)?-S.Z->T\?.1MK,*`>C:L5RN2[)$&(;LJ-K-WJ%'"9E9ZP- M_=[7=-?[M]ZD"2KF&;K MDK[V![7H2X?6;O0*?8\0]6NL33%;K4OZH,V(&EWQ'\'!*\6"4D]/W_%*35?\ MXWV\0H_S:3&/72GR=3FVQ.I\[<9X2VMRC--7Q*_+<'.39(R^]7WM1J_0%[E3 MEL?S[V>^S]C5($>_`/C][NOFO^]>OCX\[RX>-U^H?%WWSZA>PF\(AO]XY1_= M^;1]I=_^H_?^T!L]Z+<>-_1K%]?^*N3'_Q<```#__P,` M4$L#!!0`!@`(````(0`%$%96DA````Y:```9````>&PO=V]R:W-H965TO#XGG]NKP^_FNY/?[]YM__^O)KO?F^ M?5HN=T>D\+J]/G[:[=YZIZ?;^Z?ERV)[LGY;OM*5Q_7F9;&C_]U\.]V^;9:+ MA[+1R_-I^^SL_/1EL7H]U@J]S2$:Z\?'U?TR6M__>%F^[K3(9OF\V%'_MT^K MMZU5>[D_1.YEL?G^X^VW^_7+&TE\73VO=G^5HL='+_>]_-OK>K/X^DSC_K/5 M7=Q;[?)_0/YE=;]9;]>/NQ.2.]4=Q3%?G5Z=DM+-EX<5C4"Y_6BS?+P^OFWU MYL'%\>G-E])!_UTM?VV]?Q]MG]:_TLWJ8;!Z79*W*4XJ`E_7Z^_*-']0B!J? M0NNDC,!D<_2P?%S\>-[-UK^RY>K;TX["'="(U,!Z#W]%R^T]>91D3MJ!4KI? M/U,'Z+]'+RLU-<@CBS^OC]MTX]7#[NGZN'-^$ER<=5ID?O1UN=TE*R5Y?'3_ M8[M;O_Q/&[6,E!;I&!'Z:T4:[;O&GOX:^Q9U[S)H!>?JK@UW.CNF$VM+LR[>BO:?=Q][0HJJ63U3^,2N"-]T`OMRA& M6L8%JW5R&03=\\N+PX/5LM%2__@;O:$[ZM[0/XS,9WIC(]IR(?V,;V@_T[VA M?_R-WMAPMUR\#^_-J5Y;Y5*-%KO%S9?-^M<1[7^T>K9O"[6;MGI*V2Y2/>^J M9?O>JJ7EJE1NE@D*`OP4""H00C"<823"282C"38.Z!4PI8%35:9?]$U)2, MBIIU]YT%+HQM$2%K89M$$L02)!*D$F02Y!(4$O0E&$@PE&`DP5B"B013"682 MS#W`(D0;&$2H0WML_>%GEY%J1<>""+[C0 MM/)MVAVQO4;&2'G=IC+=*S&\V-S-38;D$.UTCS9S%&T+S%'-#E'6W"&:,(=T MKT2H0VW4;5>3(S)"=*QYPQ<[5PS-$B#I'B$V5MHH/S!69C-8@/]TR,UACYP[6(DLHJMIVV MC*VU9B+A48FK M'Y[/5NLF`:9]J]H)J%X7.^:=>@JCPDM;>64FML?0V=@5&B&*$26(4D09HAQ1 M@:B/:(!HB&B$:(QH@FB*:(9HSA`/KDIF_>#N67LF]_6W1HW\K%4=$A3"EEN. M$:(848(H98AW726U'^BZSH'9KJX1Z[I!?MU$YLPT;YU%HQ^8Y+C;G' M5![;Y+&#RK*6R8;]^:&1<)@H-$+3L-NI9E%DD=_]FC3.R+O5D]B&3BNUR'=8 MY^*JBAIWA4IS_[XK3++LNT(CX0H7D+*T#=73:5IC79I"U:RHF3O&BH9?6=7, M'7-'WSN'R*>V$^_),X>U9:I?[BWT(0WU357TARVV4H7O+0;Y.3"B"%&,*$&4 M(LH0Y8@*1'U$`T1#1"-$8T031%-$,T1SAGC49+72?`ZWL40QR$MX0T01HAA1 M@BA%E"'*$16(^H@&B(:(1HC&B":(IHAFB.8,\?#($N63.;`J7?61[38*RH%% M?GMGS?P%+VQ"9V./[0A1C"A!E"+*$.6("D1]1`-$0T0C1&-$$T131#-$0^<"F;%QTQ'X$?&K,S%F#7RTVOU_0RR MHJ^TN!4=G(G%&CDK.T%B@_Q,TEGY6NZ17IF2I,[*:F6HE3LK7\L]*RNU"F=% M6MQ9_TB)TL82Q:#.5?E)0+=UWG&9G\ZY;"-:5%4VU0E$DAHY*^N&V"#F4M,! M7RLX$W=,42M#K=Q9N7X%+?$,M'!6X%)5AS2EL@>F9J:<\7+9MD8\EVW).LA8 MJ052^15S66M%\[JR"EK"^[&]HUOJB6W8*)]:*RXOTNX,Y7.#SB_-O+D*1!0+ M:T$YM==S]ZB9SV]5JOC!V+,!*G.Q&6@DG"X>9X7J.18U]':HR"!U('G]%%M& M;*S89`:MM%Y+;!D9:N7U#6%_,'>D=-/KZGLN5<6,[U*5)+7/U??L]GP#07UH M+;VKD?"N"'EH&C+O&BWFW;98I;%IR+RK&WI:J>T7UQ+K*D.MO+ZA6$2%L>H> MY%WU/0[FW>8)6YKS"6L0=VE;++W06'ENB*P6=X.;!>6V'5MY;TM`K;1>2ZR: M#+5RJ\6T!; M++_86/FS%+72>BVQ5#+4RFL;=L12*>P=F>/?=2G-D8^X5)D+EVK$7-H5?0H[ MVHA-4B-%?]Q6U1%K-38-F4=!*S56/#H=L7PSU,H-NCBSR4U7-"J,Q8%K7M45 M'YB@N@RA;<6F1'<=CMS"!/*W=6GA9DZT=_$9M^-IQ7E%,A0/C>H(4NW%I1M>3UWLXMO!K)DVG-" M8VE$ST/51!9.%_E&:*V9IO5:HA,9=B*O;=B" M_4%WXL`S1:7T%>D'J%IZ*W2R&JQTQJR=&R8&,2\:_K% MM#HB,\Q0*Z_O!)S86OY`[ZHBPO?NG@EKBA7_Q-:(NQ2S=&/EYEU$>W49'N8& M^*:5L?)BD1C$7%JGU1%G7(9:N=5BR2)FZ5K^,)=V/U;XE.;\,#-(N%2,)K16 MGDNM%G>I6'XQ-DP,\EU:JR6_")JA5E[?4&3$A;TC<_Q[6;IR_`=F:6DN7*H4 MQ+8*6;IIY\VUR$HQC\HG@#$V3`QB'M5]X#NT[$2&6KE!#5FZO=MAWJ3!,&]Z M25CS\J?1R!W5(/]35D01HAA1@BA%E"'*$16(^H@&B(:(1HC&B":(IHAFB.8, ML72"OM'`([4G/+K@\6N+4H%]K3!$%"&*$26(4D09HAQ1@:B/:(!HB&B$:(QH M@FB*:(9HSA`/CZJL_,/SDY^R=G6%IAZO52DF?V4FLH;0V=CZ M)4(4(TH0I8@R1#FB`E$?T0#1$-$(T1C1!-$4T0S1G"$>7%7C^<'=L_9,2>AE M1EV-_$\<+?+/;&/E4(Q6":(4488H1U0PQ,/LG8:'_Z1(?>%*/!@TB+(XNQ1#:_7N=QN=@6T3 M6QGGJ\19O?/=1F=@93*#J(2P*'=61D8\?"R<`;7A3E,U1I/3#GOHT#65D+]H M-.*YK_R1=&@;-CX5B*P5K;!JPPRZLB0V5E[6E]B&C?*IM>+RLDI&^=PV;)0O MK!67=QL^#XBJ4-X)R)Y%;$HG/P8:L9P.4-0%%"-*$*6(,D0YH@)1']$`T1#1 M"-$8T031%-$,T9PA%JG@8^5A:+9)J[Z&<3M3B=]:L*:=S-C;> M$:(848(H190ARA$5B/J(!HB&B$:(QH@FB*:(9HCF#/'@RLJW>6L,L-PUR,]O M+'++,4(4(TH0I8@R1#FB`E$?T0#1$-$(T1C1!-$4T0S1G"$>GH^5NP&6NP:Q M\&@K[WB/K)6+6(PH090BRA#EB`I$?40#1$-$(T1C1!-$4T0S1'.&>'A4F?I. MCG%XIAPH%7&@:>1GRM:JRI1%UA8Y`[LIQ@9YD4Z7GR@E*%\;ALVRA?6BO4^$,_2^R@_L`T;Y8?6BLN+,G"$\F/;L%%^8JVX MO/B\:HKR,]NP47YNK;B\^WX8GZWRT897YN_)`O`I1Z"17R`ABA#%B!)$*:(, M48ZH0-1'-$`T1#1"-$8T031%-$,T9XA'2CZ0V1,>?/*BOC9#6PHKD`!%:!4C M2A"EB#)$.:("41_1`-$0T0C1&-$$T131#)%ZY:5SH0Z/?H6E?B_>RW+S;1DN MGY^W1_?K'^KUE%3PWGRIL'EW9K?;NZ52BTX.<86>9??4L]>Z*U=TI7P8(=L$ M9_0JSCJUVZ!%]RFS.6BC7M]9O@4#KIS3E?(','#E@J[4J=VV.KU;^M%53:_I MBOK5>LV5-O6:?D=7=X7Z5JMVVV[W;NECA[HV;6I3OG5$]KI+5^B3I)HV7>I; MK1J]V_2VM@5UK':4ZN9U=Z`;U/7VEL)/[VFHZQ+UJ(ZWU)UK;]VB>]=JA4&W MI[)!O`ME?SV5X.&5G*ZHG`VO4([64VD87J&TJZ\0K^1T17V+$*^$U+6Z MNR34L3I.KQ/H1;H<%`LFH2MI[960/*-^`85W3^B*^CT373FMY.AMO&^+;\OA M8O-M];H]>EX^TG9X5KZW9Z/?YZO_9V=>VO5UO:/W\);O[WJB]RXOZ>4\9^K7 MSH_K]<[^C[I!]2;GF_\+````__\#`%!+`P04``8`"````"$`"DP,'Z0&``"T M&@``&0```'AL+W=O4Y+3AI3WI*E75M?W,$I*@#2$"=O?NWW>,!^.Q<]G<=;\LFX?Q^'EF M[!G'67W\6IVLEZ)IR_J\MMW)U+:*RR*S@(/YW9M'[ON$CI.FQ^+*FLG]:4XPYM]W519!Q^; M@]->FB+;]8.JD\.FTYE39>79%A["YAX?]7Y?YD5Z$DZ8X91WP;X_E MI1V\5?D][JJL>7J^?,CKZ@(N'LM3V7WKG=I6E8>?#N>ZR1Y/H/NKZV?YX+O_ M8+BORKRIVWK?3<"=(XB:FI?.T@%/F]6N!`4\[%93[-?V@QNF;&$[FU4?H'_* MXK55_K?:8_WZ6U/N/I?G`J(->>(9>*SK)V[Z:<B/!P[2'<`BKBPW-)L%\ZKE@;CT6;9>6W*5MY<]M5U?_"B,770DG#)W`$YTP=[((`G^V MF-_OQ4,O\!R\3.;N=.EQ'S=F]W$T/66EB/+QO7]98KYP4648Y&VRM&U"(:+/B*X7YC'4AT(%4`!R1)7;`J MWD$7]\)U#82V`S`*99J&P6(8$NM`H@.I`A`-L";?00/WLK9ACC$W@9X:M%$3 M.--T21,IS$`2`TE5A&B#??,.VK@7*!Z*-L_0)FR@'(X!T+5)$ZG-0!(#256$ M:(/-_0[:N!?(VU+A#9MJ3M.R1:M;ZJ2)5&<@B8&D*D+40950U5VO^4-AX,:] MB&'NK4#(Q) M]UPYD-+D7>1^FMASU&@*B-#TYF/N^IT8N<**T$1?E.98'RA-WA#NIXGM0Z4I M($(S,%@*(\(275&68WV@+'EAOY\EM@&5I8`(2]_S9>HPF,**T$1?E&8@!U*: MO`?<3U-T#+*#L(E`;.0*\Q9CZI"FL"(TT1>E^;UZQ'N#0O.G6H`K&@QA+R`2 M9&]A!!D[TWA`C=%7P!O,R^8#\_WO!9CWB__-')N.NCP0@CJDQ'TD@7$75CX( MD%9F9W#1"A[2RE>.0'3%\#ZB"X*OE3"6-^/[VIR+S4@5)*"9^/;)OY9$:*5` ML0DE)I02B+!G/]38>FM:BA'RQF-49$*Q"24FE!*(TN3M10\RA/@'OR\R[%(0 M6IE8.-QJ_6T[F*GY'S>B6$FCS=`\8Q-*3"@E$!4)6U\5>;M[,VZMY4)`ZB$7 MK6![CC2%U@&`_I-+10#]*\]N=6UKN M*S*]%VW%B-[H@8!Q0TSUJHD#P6I<1'+@`"6#>]6745O3P0K&RQE]?SRZT1SR MGJCD\(VEAAU439:`J#ZF!3YBTFH0$YM0@I"RE5*$^%Y1Q(SNJ1C>-14QRH)\ M0Y=HMVJ?9@)2.D%D0K$))2:4$H@RYGU08?P&3=$U"4T!D>9@0#&_(X%*IE@E M)L0OED`,=?>;)D/8ZY)A-H+8ZZ]V;(IO!$_.T@Q M\)O!)3L4?V3-H3RWUJG8PW*:]A[@UX+^-N,(OPX5<%:; M\@/@OJZ[X0.(=^3O39O_````__\#`%!+`P04``8`"````"$`9+$HWS$!``!` M`@``$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G)%!3\,@&(;O)OZ'AGM+Z1:CI&6)FIU<8N*, MBS>$;RNQ4`)HNW\OZ[HZHR>/Y'UY>+Z/;U,KU'B`S>2-ZV!"NW!HP6[O"B%I:)U\.A:"RXH\$DD&4^%K5`=@J48>U&# MYCZ+#1/#;>LT#_'H=MAR\JZG8=5W6S0:-Z$_P M9O7P-(R:*G/8E0#$#OMIN`^KN,JM`GF[9_V;:Q+OZQ+_SDHI!CLJ'/``,HGO MT:/=*7F9W=VOEX@5.9FG>9$69$UNZ+R@I'@M\:DUWF<34(\"_R:>`&SP_OGG M[`L``/__`P!02P,$%``&``@````A`*3-3?1I!```R!,``!``"`%D;V-0&UL(*($`2B@``$````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````G%C?4]LX$'Z_F?X/F;R7!,IU&,9)!Y*T=.8X M=3O.:_GQ`(*[HYP6>-* M;FS!/;[:><_DN10P-F)9@/:]DW[_/.@,LH_EB\!N+?%\Y0\5FAD1['/W MLW6)!@^3B[)44G"/7@ZOI;#&F=QW)D\"5-)K+B9H70IB::5?#_M)K_F:I((K M&*'@8G54[\&EW9Y!06X(+ MNS;.I%?@;O(IMYXP^0PSO[6YLJ*VN#9HDT5VH3,VT1[CQ;[K.MO2-"U_\6%D MM#-*9MQ#QBZYXEH`2]]X^CO[V92_KR+UJ"E4&KO)V0U6ZYZ0$7>+/2'I@N^K M)4".237ILBBX70?K4SG7$LF#9<,NA#!+[4G(5ZDQJI(KS`764L6SG3+:!A>= M8Y-_EW*%-:V]J_)X"PB2PF-IOVP,15JG_`H*X\H%6$`;$.EDX!.Y]9ZK%?P4 M"Z[GM*P1MYDT<]#@).I^1]PU9!Q+BUUS[[%7D2K'D(.U6%E3"P[LJB([&QE7 M^49"OAF3_9)*5;[?>/0,PX;-;BX?%#`2\AV;8P%LQI^@S8P'.C4C4Q32AW*L M8XUL\-@PL-MB#R5UA@*HJ'QD)"4IA7 MM`RMXQN8N>7E0HI-^VB!*.RGF-U_EB@5K%JS1JW3D"A]#J'<":FG8<>6;1C-O;B6%H95(-*3.(5HP^(@#F3Q)#5_Q&^QZ06Q`&^Q_.8"^'S/:X MB=.$YF(<0T>MA5I_"X5+;OU,&7! M"5)V.R0XL2L&@]<F@RQO709(QC/I-Y MV6G`SX6^@FAZ=B`I_N-E2YR1<#2M%M[7TH2$^8/^16C5,LES$/MIJ8IC/\@= M_I'0?!G#@X_&)SK>,;K'QS%T*1)#8=0N>CB,0H@SM%$C9$0)2"/A!T#H@,75 MM`3L[430,(WF+J5G>Q[_MCM;R"'NT"TB;AH=@F=6O1[GJ_^`)3VBQZ?Z%G>B M8SUM6GR<:LE.5$]+V*(CV(YM.UT5W/!_ M````__\#`%!+`0(M`!0`!@`(````(0`U.APIA@(``!7!E&UL4$L!`BT`%``&``@````A`+55 M,"/U````3`(```L`````````````````OP0``%]R96QS+RYR96QS4$L!`BT` M%``&``@````A`"RF6]X;`P``1C,``!H`````````````````Y0<``'AL+U]R M96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`**UH3?? M`@``PP<``!D`````````````````T2```'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#_O?ZMN!```#!```!D````` M````````````"2P``'AL+W=O_Y3`X@#``!:"P``&0````````````````"N,```>&PO=V]R M:W-H965T M```9`````````````````&TT``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`.<`,@5A!0``/!L``!D`````````````````8#H` M`'AL+W=O!@``&0````````````````#X/P``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`.>C/+"1`P``I`P``!D`````````````````7$D``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.3*)JD8`P``F@D``!D````````` M````````+&@``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`&/TS3OG`@``"`@``!D`````````````````('(``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M``H@Y/;%"P``'4D``!D`````````````````D7\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.FKU69S"```T2T` M`!D`````````````````JIX``'AL+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0!2,I6P&UL4$L!`BT`%``&``@````A`'P$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`("@)E1)`P`` MY0H``!D`````````````````WXH!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)=`CR8#!```ZPT``!D````````` M````````,9D!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`)&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`,*'J59:!```EQ$``!@`````````````````*;0!`'AL+W=O&UL4$L!`BT`%``& M``@````A``@EN=+*"```[3D``!D`````````````````X+L!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#$?D!Y``P``APH``!D````` M````````````#0,"`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`,(FOD$+`P``=0D``!D`````````````````;#D" M`'AL+W=OQ M#]0&``!C'0``&0````````````````"N/`(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`)](GT&I"@``JC0``!D`````````````````ED<"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`*J0`VFN"P``$D4``!@`````````````````*EH"`'AL+W=O M??<&AP(``.0% M```8``````````````````YF`@!X;"]W;W)KIPTI```/_0``&`````````````````#+:`(` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*!J,>I= M#0``R44``!@`````````````````#I("`'AL+W=O&UL4$L!`BT`%``&``@````A M`,7#[[=6"P``S#@``!D`````````````````KZ@"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-\V((J8#P``B5,` M`!D`````````````````=KP"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%39#6XH"@``+S0``!D````````````` M````?PP#`'AL+W=O%@,`>&PO=V]R:W-H965T M`P!X;"]W;W)K&UL4$L!`BT` M%``&``@````A`.<\5QV5`@``7@8``!D`````````````````%B$#`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)`2 M5.UE!```CQ,``!D`````````````````G2L#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/PO/.E7"```K"4``!D` M````````````````=C\#`'AL+W=OU](P$``"&#P``&0`````````````````$2`,`>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,GR-O^)#```^C\``!D````````````````` MA%,#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`&GB*U<_!P```Q\``!D`````````````````HHD#`'AL+W=O&PO=V]R:W-H965T&UL4$L%!@````!A`&$`F1H``'/,`P`````` ` end XML 20 R70.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingencies (Narrative) (Details) (USD $)
 1 Months Ended 12 Months Ended 0 Months Ended
Jan. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
CEO Post Employment Benefits [Member]
Dec. 31, 2012
CEO Post Employment Benefits [Member]
Sep. 28, 2010
Starch Technology Purchase [Member]
Dec. 31, 2013
Starch Technology Purchase [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]                
Remaining obligations under capital leases   $ 0 $ 0          
Original term of lease for corporate headquarters   15 years            
Deferred rent obligations   1,686,000 1,603,000          
Total rental expense for operating leases   3,000,000 2,700,000 2,700,000        
Unreported loss liability   1,500,000 1,700,000          
Recoverable insurance amounts   580,000 620,000          
Liability estimated after a reasonable margin for statistical fluctuations   2,700,000            
Accrued expenses and other current liabilities payable upon the CEO's voluntary retirement         2,100,000 2,100,000    
Additional payment for CEO remaining employed as of January 1, 2013 100,000              
Term of distribution agreement             15 years  
Additional contingent amounts paid if FDA regulatory and other commercial milestones are achieved             2,500,000  
Expected future contingent payment amounts to be initially recorded as research and development expense               $ 2,500,000
XML 21 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Medafor Matters (Details) (USD $)
Share data in Millions, unless otherwise specified
 3 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 6 Months Ended 42 Months Ended 3 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Oct. 21, 2013
Medafor Inc. [Member]
Sep. 30, 2013
Medafor Inc. [Member]
Sep. 30, 2012
Medafor Inc. [Member]
Dec. 31, 2012
Medafor Inc. [Member]
Dec. 31, 2014
C.R. Bard, Inc. [Member]
Scenario, Forecast [Member]
Dec. 31, 2017
C.R. Bard, Inc. [Member]
Scenario, Forecast [Member]
Jun. 30, 2012
Medafor Settlement [Member]
Subsidiary or Equity Method Investee [Line Items]                      
Shares purchased under stock purchase agreement               2.4      
Investment in equity securities     $ 5,908,000         $ 2,600,000      
Value of Medafor derivative               0      
Initial payment received from C.R. Bard for acquisition of outstanding shares of common stock   15,421,000     15,400,000            
Outstanding shares of common stock acquired by C.R. Bard           2.4          
Initial gain on sale of outstanding shares of common stock 12,700,000 12,742,000                  
Additional payments that could be received                   8,400,000  
Approximate amount that could be received from first possible additional payment                 525,000    
Proceeds from legal settlement             3,500,000        
Gain recorded as a reduction in general, administrative, and marketing expenses   68,112,000 65,149,000 57,302,000             4,700,000
Discharged reduction in accounts payable pursuant to settlement agreement                     $ 1,200,000
XML 22 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Schedule Of Stock Grant Activity For PSUs) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2010
Dec. 31, 2013
Performance Stock Units (PSUs) [Member]
Dec. 31, 2012
Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unvested, Beginning Balance, Shares       159,000  
Granted, Shares       182,000 159,000
Vested, Shares       (99,000)  
Forfeited, Shares       (6,000)  
Unvested, Ending Balance, Shares       236,000 159,000
Vested and expected to vest, Shares       224,000  
Outstanding, Weighted Average Remaining Contractual Term in Years       9 months 22 days 11 months 5 days
Vested and expected to vest, Weighted Average Remaining Contractual Term in Years       9 months 11 days  
Outstanding, Aggregate Intrinsic Value $ 8,274,000 $ 1,225,000 $ 603,000 $ 2,612,000 $ 989,000
Vested and expected to vest, Aggregate Intrinsic Value       $ 2,487,000  
XML 23 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash Equivalents And Restricted Cash And Securities (Narrative ) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Restricted Cash and Cash Equivalents Items [Line Items]      
Long-term restricted cash and securities   $ 5,000,000  
Gains or losses realized on cash equivalents 0 0 0
Money Market Funds [Member]
      
Restricted Cash and Cash Equivalents Items [Line Items]      
Short-term restricted securities 350,000 323,000  
No Maturity Date [Member]
      
Restricted Cash and Cash Equivalents Items [Line Items]      
Long-term restricted cash and securities 5,000,000 5,000,000  
Maturity Date Within Three Months [Member]
      
Restricted Cash and Cash Equivalents Items [Line Items]      
Restricted securities 328,000 323,000  
Maturity Date Between Three Months And One Year [Member]
      
Restricted Cash and Cash Equivalents Items [Line Items]      
Restricted securities 22,000    
GE Credit Agreement [Member]
      
Restricted Cash and Cash Equivalents Items [Line Items]      
Restricted cash and securities 5,000,000    
Long-term restricted cash and securities   $ 5,000,000  
XML 24 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Preservation Costs And Inventories (Tables)
 12 Months Ended
Dec. 31, 2013
Deferred Preservation Costs And Inventories [Abstract]  
Schedule Of Deferred Preservation Costs

 

 

 

 

 

 

 

2013

 

2012

Cardiac tissues

$
12,239 

 

$
11,950 

Vascular tissues

 
15,058 

 

 
16,004 

Total deferred preservation costs

$
27,297 

 

$
27,954 

 

Schedule Of Inventories

 

 

 

 

 

 

 

2013

 

2012

Raw materials and supplies

$
5,706 

 

$
5,836 

Work-in-process

 
767 

 

 
830 

Finished goods

 
3,298 

 

 
3,891 

Total inventories

$
9,771 

 

$
10,557 

 

XML 25 R79.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Summary Of Stock Option Activity) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Outstanding, Beginning Balance, Shares 2,060,000 2,200,000 2,281,000  
Granted, Shares 162,000 159,000 599,000  
Exercised, Shares (365,000) (48,000) (260,000)  
Forfeited, Shares (49,000) (2,000) (100,000)  
Expired, Shares (14,000) (249,000) (320,000)  
Outstanding, Ending Balance, Shares 1,794,000 2,060,000 2,200,000 2,281,000
Vested and expected to vest, Shares 1,781,000      
Exercisable, Shares 1,372,000      
Outstanding, Beginning Balance, Weighted Average Exercise Price $ 6.74 $ 6.83 $ 6.74  
Granted, Weighted Average Exercise Price $ 6.12 $ 5.67 $ 5.13  
Exercised, Weighted Average Exercise Price $ 7.48 $ 5.64 $ 4.53  
Forfeited, Weighted Average Exercise Price $ 5.56 $ 7.01 $ 5.60  
Expired, Weighted Average Exercise Price $ 6.69 $ 7.03 $ 5.30  
Outstanding, Ending Balance, Weighted Average Exercise Price $ 6.57 $ 6.74 $ 6.83 $ 6.74
Vested and expected to vest, Weighted Average Exercise Price $ 6.57      
Exercisable, Weighted Average Exercise Price $ 6.86      
Outstanding, Weighted Average Remaining Contractual Term in years 3 years 3 months 22 days 3 years 7 months 28 days 4 years 3 years 5 months 16 days
Vested and expected to vest, Weighted Average Remaining Contractual Term in Years 3 years 3 months 15 days      
Exercisable, Weighted Average Remaining Contractual Term in years 2 years 9 months      
Outstanding, Aggregate Intrinsic Value $ 8,274,000 $ 1,225,000   $ 603,000
Vested and expected to vest, Aggregate Intrinsic Value 8,205,000      
Exercisable, Aggregate Intrinsic Value $ 5,971,000      
Stock Options [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted, Shares 162,000 159,000 599,000  
XML 26 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 27 R73.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plans (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Employee Benefit Plans [Abstract]      
Company's matching percentage of employees' contribution 40.00% 40.00% 20.00%
Company's matching contribution of employees' salary 5.00% 5.00% 5.00%
Company's total contributions $ 541,000 $ 500,000 $ 204,000
XML 28 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Preservation Costs And Inventories (Schedule Of Inventories) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Deferred Preservation Costs And Inventories [Abstract]    
Raw materials and supplies $ 5,706 $ 5,836
Work-in-process 767 830
Finished goods 3,298 3,891
Total inventories $ 9,771 $ 10,557
XML 29 R76.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Schedule Of Stock Grant Activity For RSAs) (Details) (Restricted Stock Awards (RSAs) [Member], USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Restricted Stock Awards (RSAs) [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested, Beginning Balance, Shares 639,000 552,000 364,000
Granted, Shares 232,000 229,000 360,000
Vested, Shares (215,000) (142,000) (128,000)
Forfeited, Shares (34,000)   (44,000)
Unvested, Ending Balance, Shares 622,000 639,000 552,000
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value $ 5.48 $ 5.91 $ 7.07
Granted, Weighted Average Grant Date Fair Value $ 6.10 $ 5.39 $ 5.18
Vested, Weighted Average Grant Date Fair Value $ 5.80 $ 7.00 $ 7.28
Forfeited, Weighted Average Grant Date Fair Value $ 5.31   $ 5.48
Unvested, Ending Balance, Weighted Average Grant Date Fair Value $ 5.62 $ 5.48 $ 5.91
XML 30 R86.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment And Geographic Information (Summary Of Net Revenues By Product) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Product Information [Line Items]                              
Total revenues $ 35,457 $ 36,250 $ 33,520 $ 35,536 $ 32,800 $ 33,429 $ 33,188 $ 32,301 $ 30,397 $ 29,654 $ 29,379 $ 30,196 $ 140,763 $ 131,718 $ 119,626
BioGlue And BioFoam [Member]
                              
Product Information [Line Items]                              
Total revenues                         58,004 53,211 49,455
PerClot [Member]
                              
Product Information [Line Items]                              
Total revenues                         3,494 3,078 2,528
HemoStase [Member]
                              
Product Information [Line Items]                              
Total revenues                             1,699
Revascularization Technologies [Member]
                              
Product Information [Line Items]                              
Total revenues                         8,965 8,092 5,705
HeRO Graft [Member]
                              
Product Information [Line Items]                              
Total revenues                         5,731 3,115  
Total Products [Member]
                              
Product Information [Line Items]                              
Total revenues                         76,194 67,496 59,387
Cardiac Tissue [Member]
                              
Product Information [Line Items]                              
Total revenues                         29,523 29,756 26,618
Vascular Tissue [Member]
                              
Product Information [Line Items]                              
Total revenues                         34,975 33,847 33,175
Total Preservation Services [Member]
                              
Product Information [Line Items]                              
Total revenues                         64,498 63,603 59,793
Other [Member]
                              
Product Information [Line Items]                              
Total revenues                         $ 71 [1] $ 619 [1] $ 446 [1]
[1] For the years ended December 31, 2013, 2012, and 2011 the “Other” designation includes grant revenue.
XML 31 R81.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Stock Options [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options 4 years 3 months 18 days 4 years 3 months 18 days 4 years
Expected stock price volatility 60.00% 60.00% 65.00%
Dividends 1.91%    
Risk-free interest rate 0.70% 0.71% 1.25%
ESPP Options [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life of options 6 months 6 months 6 months
Expected stock price volatility 39.00% 48.00% 39.00%
Dividends 1.59%    
Risk-free interest rate 0.13% 0.12% 0.14%
XML 32 R87.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment And Geographic Information (Schedule Of Net Revenues By Geographic Location) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenues from External Customers and Long-Lived Assets [Line Items]                              
Total revenues $ 35,457 $ 36,250 $ 33,520 $ 35,536 $ 32,800 $ 33,429 $ 33,188 $ 32,301 $ 30,397 $ 29,654 $ 29,379 $ 30,196 $ 140,763 $ 131,718 $ 119,626
U.S. [Member]
                              
Revenues from External Customers and Long-Lived Assets [Line Items]                              
Total revenues                         109,325 103,804 95,975
International [Member]
                              
Revenues from External Customers and Long-Lived Assets [Line Items]                              
Total revenues                         $ 31,438 $ 27,914 $ 23,651
XML 33 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Schedule Of Stock Grant Activity For RSUs) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Outstanding, Aggregate Intrinsic Value $ 8,274,000 $ 1,225,000   $ 603,000
Restricted Stock Units (RSUs) [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unvested, Beginning Balance, Shares 120,000 97,000 58,000  
Granted, Shares 73,000 64,000 61,000  
Vested, Shares (54,000) (37,000) (19,000)  
Forfeited, Shares (10,000) (4,000) (3,000)  
Unvested, Ending Balance, Shares 129,000 120,000 97,000 58,000
Vested and expected to vest, Shares 118,000      
Outstanding, Weighted Average Remaining Contractual Term in Years 1 year 6 months 22 days 1 year 6 months 15 days 1 year 7 months 28 days 1 year 10 months 6 days
Vested and expected to vest, Weighted Average Remaining Contractual Term in Years 1 year 6 months 18 days      
Outstanding, Aggregate Intrinsic Value 1,425,000 747,000 466,000 313,000
Vested and expected to vest, Aggregate Intrinsic Value $ 1,314,000      
XML 34 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingencies (Schedule Of Future Minimum Operating Lease Payments) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Commitments And Contingencies [Abstract]  
2014 $ 2,799
2015 3,031
2016 2,943
2017 2,980
2018 3,010
Thereafter 10,124
Total minimum lease payments $ 24,887
XML 35 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment And Geographic Information
 12 Months Ended
Dec. 31, 2013
Segment And Geographic Information [Abstract]  
Segment And Geographic Information

18.  Segment and Geographic Information

 

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Graft.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues.

 

The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services.  The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. 

 

The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Revenues:

 

 

 

 

 

 

 

 

Medical devices

$
76,194 

 

$
67,496 

 

$
59,387 

Preservation services

 
64,498 

 

 
63,603 

 

 
59,793 

Othera

 
71 

 

 
619 

 

 
446 

Total revenues

 
140,763 

 

 
131,718 

 

 
119,626 

 

 

 

 

 

 

 

 

 

Cost of products and preservation services:

 

 

 

 

 

 

 

 

Medical devices

 
15,147 

 

 
11,380 

 

 
9,442 

Preservation services

 
35,230 

 

 
35,320 

 

 
34,340 

Total cost of products and preservation services

 
50,377 

 

 
46,700 

 

 
43,782 

 

 

 

 

 

 

 

 

 

Gross margin:

 

 

 

 

 

 

 

 

Medical devices

 
61,047 

 

 
56,116 

 

 
49,945 

Preservation services

 
29,268 

 

 
28,283 

 

 
25,453 

Othera

 
71 

 

 
619 

 

 
446 

Total gross margin

$
90,386 

 

$
85,018 

 

$
75,844 

 

Net revenues by product for the years ended December 31, 2013,  2012, and 2011 were as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Products:

 

 

 

 

 

 

 

 

BioGlue and BioFoam

$
58,004 

 

$
53,211 

 

$
49,455 

PerClot

 
3,494 

 

 
3,078 

 

 
2,528 

HemoStase

 

--

 

 

--

 

 
1,699 

Revascularization technologies

 
8,965 

 

 
8,092 

 

 
5,705 

HeRO Graft

 
5,731 

 

 
3,115 

 

 

--

Total products

 
76,194 

 

 
67,496 

 

 
59,387 

 

 

 

 

 

 

 

 

 

Preservation services:

 

 

 

 

 

 

 

 

Cardiac tissue

 
29,523 

 

 
29,756 

 

 
26,618 

Vascular tissue

 
34,975 

 

 
33,847 

 

 
33,175 

Total preservation services

 
64,498 

 

 
63,603 

 

 
59,793 

 

 

 

 

 

 

 

 

 

Othera

 
71 

 

 
619 

 

 
446 

Total revenues

$
140,763 

 

$
131,718 

 

$
119,626 

aFor the years ended December 31, 2013,  2012, and 2011 the “Other” designation includes grant revenue.    

 

Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2013,  2012, and 2011 were as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

U.S.

$
109,325 

 

$
103,804 

 

$
95,975 

International

 
31,438 

 

 
27,914 

 

 
23,651 

Total revenues

$
140,763 

 

$
131,718 

 

$
119,626 

 

At December 31, 2013 and 2012 over 95% of the long‑lived assets of the Company were held in the U.S., where all of the Company’s manufacturing facilities and the corporate headquarters are located.  At December 31, 2013 and 2012 the Company’s $11.4 million of goodwill was allocated entirely to its Medical Devices segment.

 

XML 36 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hemosphere Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) (Hemosphere [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Hemosphere [Member]
    
Business Acquisition [Line Items]    
Total revenues $ 133,722 $ 124,877
Net income $ 8,758 $ 3,205
Pro forma income per common share-basic $ 0.32 $ 0.11
Pro forma income per common share-diluted $ 0.31 $ 0.11
XML 37 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Schedule Of Supplemental Disclosures Of Cash Flow Information) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash paid during the year for:      
Interest $ 3 $ 22 $ 89
Income taxes $ 5,693 $ 1,263 $ 3,564
XML 38 R75.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Schedule Of Shares Available For Grant) (Details)
Dec. 31, 2013
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Authorized Shares 8,400,000  
Available for Grant 3,030,000 3,762,000
1996 Discounted Employee Stock Purchase Plan, As Amended [Member]
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Authorized Shares 1,900,000  
Available for Grant 749,000 847,000
2004 Employee Stock Incentive Plan [Member]
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Authorized Shares 2,100,000  
Available for Grant 60,000 41,000
2008 Non-Employee Directors Stock Incentive Plan [Member]
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Authorized Shares 300,000  
Available for Grant   27,000
2009 Employee Stock Incentive Plan [Member]
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Authorized Shares 4,100,000  
Available for Grant 2,221,000 2,847,000
XML 39 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Tables)
 12 Months Ended
Dec. 31, 2013
Stock Compensation [Abstract]  
Schedule Of Shares Available For Grant

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Authorized

 

Available for Grant

Plan

 

Shares

 

2013

 

2012

1996 Discounted Employee Stock Purchase Plan, as amended

 
1,900,000 

 
749,000 

 
847,000 

2004 Employee Stock Incentive Plan

 
2,100,000 

 
60,000 

 
41,000 

2008 Non-Employee Directors Stock Incentive Plan

 
300,000 

 

--

 
27,000 

2009 Employee Stock Incentive Plan

 
4,100,000 

 
2,221,000 

 
2,847,000 

Total

 
8,400,000 

 
3,030,000 

 
3,762,000 

 

Schedule Of Stock Grant Activity For RSAs

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

 

 

 

Grant Date

 

 

RSAs

 

Shares

 

Fair Value

 

 

Unvested at December 31, 2010

 
364,000 

 

$
7.07 

 

 

Granted

 
360,000 

 

 
5.18 

 

 

Vested

 
(128,000)

 

 
7.28 

 

 

Forfeited

 
(44,000)

 

 
5.48 

 

 

Unvested at December 31, 2011

 
552,000 

 

 
5.91 

 

 

Granted

 
229,000 

 

 
5.39 

 

 

Vested

 
(142,000)

 

 
7.00 

 

 

Unvested at December 31, 2012

 
639,000 

 

 
5.48 

 

 

Granted

 
232,000 

 

 
6.10 

 

 

Vested

 
(215,000)

 

 
5.80 

 

 

Forfeited

 
(34,000)

 

 
5.31 

 

 

Unvested at December 31, 2013

 
622,000 

 

 
5.62 

 

 

 

Schedule Of Stock Grant Activity For RSUs

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

Contractual

 

Intrinsic

RSUs

 

Shares

 

Term in years

 

Value

Outstanding at December 31, 2010

 
58,000 

 

 
1.85 

 

$
313,000 

Granted

 
61,000 

 

 

 

 

 

 

Vested

 
(19,000)

 

 

 

 

 

 

Forfeited

 
(3,000)

 

 

 

 

 

 

Outstanding at December 31, 2011

 
97,000 

 

 
1.66 

 

 
466,000 

Granted

 
64,000 

 

 

 

 

 

 

Vested

 
(37,000)

 

 

 

 

 

 

Forfeited

 
(4,000)

 

 

 

 

 

 

Outstanding at December 31, 2012

 
120,000 

 

 
1.54 

 

 
747,000 

Granted

 
73,000 

 

 

 

 

 

 

Vested

 
(54,000)

 

 

 

 

 

 

Forfeited

 
(10,000)

 

 

 

 

 

 

Outstanding at December 31, 2013

 
129,000 

 

 
1.56 

 

 
1,425,000 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
118,000 

 

 
1.55 

 

$
1,314,000 

 

Schedule Of Stock Grant Activity For PSUs

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

Contractual

 

Intrinsic

PSUs

 

Shares

 

Term in years

 

Value

Outstanding at December 31, 2011

 

--

 

 

--

 

$

--

Granted

 
159,000 

 

 

 

 

 

 

Vested

 

--

 

 

 

 

 

 

Forfeited

 

--

 

 

 

 

 

 

Outstanding at December 31, 2012

 
159,000 

 

 
0.93 

 

 
989,000 

Granted

 
182,000 

 

 

 

 

 

 

Vested

 
(99,000)

 

 

 

 

 

 

Forfeited

 
(6,000)

 

 

 

 

 

 

Outstanding at December 31, 2013

 
236,000 

 

 
0.81 

 

 
2,612,000 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
224,000 

 

 
0.78 

 

$
2,487,000 

 

Summary Of Stock Option Activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted

 

Remaining

 

Aggregate

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

Shares

 

Exercise Price

 

Term in years

 

Value

Outstanding at December 31, 2010

 
2,281,000 

 

$
6.74 

 

 
3.46 

 

$
603,000 

Granted

 
599,000 

 

 
5.13 

 

 

 

 

 

 

Exercised

 
(260,000)

 

 
4.53 

 

 

 

 

 

 

Forfeited

 
(100,000)

 

 
5.60 

 

 

 

 

 

 

Expired

 
(320,000)

 

 
5.30 

 

 

 

 

 

 

Outstanding at December 31, 2011

 
2,200,000 

 

 
6.83 

 

 
4.00 

 

 

--

Granted

 
159,000 

 

 
5.67 

 

 

 

 

 

 

Exercised

 
(48,000)

 

 
5.64 

 

 

 

 

 

 

Forfeited

 
(2,000)

 

 
7.01 

 

 

 

 

 

 

Expired

 
(249,000)

 

 
7.03 

 

 

 

 

 

 

Outstanding at December 31, 2012

 
2,060,000 

 

 
6.74 

 

 
3.66 

 

 
1,225,000 

Granted

 
162,000 

 

 
6.12 

 

 

 

 

 

 

Exercised

 
(365,000)

 

 
7.48 

 

 

 

 

 

 

Forfeited

 
(49,000)

 

 
5.56 

 

 

 

 

 

 

Expired

 
(14,000)

 

 
6.69 

 

 

 

 

 

 

Outstanding at December 31, 2013

 
1,794,000 

 

 
6.57 

 

 
3.31 

 

 
8,274,000 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
1,781,000 

 

$
6.57 

 

 
3.29 

 

$
8,205,000 

Exercisable at December 31, 2013

 
1,372,000 

 

$
6.86 

 

 
2.75 

 

$
5,971,000 

 

Summary Of Other Information Concerning Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Weighted-average fair value of options granted

$
2.54 

 

$
2.67 

 

$
2.54 

Intrinsic value of options exercised

 
673,000 

 

 
10,000 

 

 
261,000 

 

Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

 

Stock

 

ESPP

 

Stock

 

ESPP

 

Stock

 

ESPP

 

Options

 

Options

 

Options

 

Options

 

Options

 

Options

Expected life of options

4.3 Years

 

.50 Years

 

4.3 Years

 

.50 Years

 

4.0 Years

 

.50 Years

Expected stock price volatility
0.60 

 
0.39 

 
0.60 

 
0.48 

 
0.65 

 
0.39 

Dividends
1.91% 

 
1.59% 

 

N/A

 

N/A

 

N/A

 

N/A

Risk-free interest rate
0.70% 

 
0.13% 

 
0.71% 

 
0.12% 

 
1.25% 

 
0.14% 

 

Summary Of Stock Compensation Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

RSA, RSU, and PSU expense

$
2,616 

 

$
2,204 

 

$
1,408 

Stock option and ESPP option expense

 
852 

 

 
1,172 

 

 
1,606 

Total stock compensation expense

$
3,468 

 

$
3,376 

 

$
3,014 

 

XML 40 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cardiogenesis Acquisition (Narrative) (Details) (USD $)
 3 Months Ended 12 Months Ended 8 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2011
Cardiogenesis [Member]
Dec. 31, 2011
Cardiogenesis [Member]
May 17, 2011
Cardiogenesis [Member]
Jul. 31, 2012
CardioFocus Settlement [Member]
Jun. 30, 2012
CardioFocus Settlement [Member]
Dec. 31, 2012
CardioFocus Settlement [Member]
Jul. 31, 2012
Payment [Member]
Cardiogenesis [Member]
Business Acquisition [Line Items]                                            
Acquisition of outstanding shares (per share)                                   $ 0.457        
Total purchase price                               $ 21,712,000 $ 21,712,000 $ 21,700,000        
Transaction and integration costs related to acquisition                                 3,000,000          
Revenues 35,457,000 36,250,000 33,520,000 35,536,000 32,800,000 33,429,000 33,188,000 32,301,000 30,397,000 29,654,000 29,379,000 30,196,000 140,763,000 131,718,000 119,626,000 5,700,000            
Income tax rate                         31.00% 34.00% 36.00%   36.00%          
Loss recorded in general, administrative, and marketing expenses                         68,112,000 65,149,000 57,302,000         3,600,000    
Legal settlement expenses                                         4,100,000  
Settlement payment to CardioFocus                                     $ 4,500,000     $ 4,500,000
XML 41 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Deferred tax assets:    
Allowance for bad debts $ 131 $ 194
Deferred preservation costs and inventory write-downs 1,077 392
Investment in equity securities 1,959 925
Property 2,737 2,644
Intangible assets 422 502
Accrued expenses 3,766 3,782
Loss carryforwards 15,689 17,539
Credit carryforwards 241 2,166
Stock compensation 2,409 2,319
Other 1,108 969
Less valuation allowance (1,532) (2,292)
Total deferred tax assets 28,007 29,140
Deferred tax liabilities:    
Prepaid items (451) (314)
Intangible assets (5,289) (5,814)
Other (220) (348)
Total deferred tax liabilities (5,960) (6,476)
Total net deferred tax assets $ 22,047 $ 22,664
XML 42 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Summary Of Amortization Expense) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Goodwill And Other Intangible Assets [Abstract]      
Amortization expense $ 2,006 $ 1,971 $ 1,370
XML 43 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash Equivalents And Restricted Cash And Securities (Summary Of Cash Equivalents And Marketable Securities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Cash [Member] | Restricted Cash And Securities [Member]
    
Restricted Cash and Cash Equivalents Items [Line Items]    
Cost Basis $ 5,000 $ 5,000
Estimated Market Value 5,000 5,000
Money Market Funds [Member] | Cash Equivalents [Member]
    
Restricted Cash and Cash Equivalents Items [Line Items]    
Cost Basis 5,349 1,319
Estimated Market Value 5,349 1,319
Money Market Funds [Member] | Restricted Cash And Securities [Member]
    
Restricted Cash and Cash Equivalents Items [Line Items]    
Cost Basis 350 323
Estimated Market Value 350 323
Certificates Of Deposit [Member]
    
Restricted Cash and Cash Equivalents Items [Line Items]    
Cost Basis 749  
Estimated Market Value $ 749  
XML 44 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments
 12 Months Ended
Dec. 31, 2013
Financial Instruments [Abstract]  
Financial Instruments

2.  Financial Instruments

 

A summary of financial instruments measured at fair value is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2013

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$
5,349 

 

$

--

 

$

--

 

$
5,349 

Certificates of deposit

 
749 

 

 

--

 

 

--

 

 
749 

Restricted securities:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 
350 

 

 

--

 

 

--

 

 
350 

Total assets

$
6,448 

 

$

--

 

$

--

 

$
6,448 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

--

 

$

--

 

$
(1,884)

 

$
(1,884)

Total liabilities

$

--

 

$

--

 

$
(1,884)

 

$
(1,884)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$
1,319 

 

$

--

 

$

--

 

$
1,319 

Restricted securities:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 
323 

 

 

--

 

 

--

 

 
323 

Total assets

$
1,642 

 

$

--

 

$

--

 

$
1,642 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

--

 

$

--

 

$
(1,912)

 

$
(1,912)

Total liabilities

$

--

 

$

--

 

$
(1,912)

 

$
(1,912)

 

The Company used prices quoted from its investment management companies to determine the Level 1 valuation of its investments in money market funds, certificates of deposit, and securities.  The Company changed the presentation of its December 31, 2012 money market funds to Level 1 from Level 2, consistent with its current year presentation.  The Company recorded contingent consideration liability, classified as Level 3, as a result of its acquisition of Hemosphere in May 2012.  Refer to Note 4 for further discussion of the Level 3 contingent consideration liability.  Changes in fair value of Level 3 liabilities are listed below (in thousands):

 

 

 

 

 

 

 

 

 

Contingent Consideration

Balance as of December 31, 2012

$
1,912 

Gain on remeasurement of contingent consideration

 
(28)

Balance as of December 31, 2013

$
1,884 

 

XML 45 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Scheduled Amortization Of Intangible Assets For Next Five Years) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Goodwill And Other Intangible Assets [Abstract]  
Amortization expense, 2014 $ 1,948
Amortization expense, 2015 1,905
Amortization expense, 2016 1,898
Amortization expense, 2017 1,850
Amortization expense, 2018 1,844
Total $ 9,445
EXCEL 46 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F.3'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9I;F%N8VEA;%]);G-T#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DAE;6]S<&AE#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O&5S/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-O;6UI=&UE;G1S7T%N9%]#;VYT M:6YG96YC:65S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>65E7T)E;F5F:71?4&QA;G,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1R86YS86-T:6]N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E;&5C=&5D7U%U87)T97)L>5]&:6YA;F-I M86Q?23PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U M;6UA#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-A#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E9F5R#I7;W)K#I%>&-E;%=O&5S7U1A8FQE#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-O;6UI=&UE;G1S7T%N9%]#;VYT M:6YG96YC:65S7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-T;V-K7T-O;7!E;G-A=&EO;E]486)L97,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]/9E]3:6=N:69I8V%N=%]!8V-O=6YT-3PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9I;F%N8VEA;%]);G-T#I.86UE/@T*("`@(#QX.E=O#I7 M;W)K#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/D1E9F5R M#I7 M;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D=O;V1W:6QL7T%N9%]/=&AE#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=O;V1W:6QL7T%N9%]/=&AE#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/E-H87)E:&]L9&5R#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>65E7T)E;F5F M:71?4&QA;G-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T-O;7!E;G-A=&EO;E].87)R871I=F5?1#PO>#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T-O;7!E;G-A=&EO;E]38VAE9'5L95]/9C$\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T M;V-K7T-O;7!E;G-A=&EO;E]3=6UM87)Y7T]F7SPO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K7T-O;7!E;G-A=&EO;E]3=6UM M87)Y7T]F7S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]097)?0V]M;6]N7U-H87)E7T-O;7!U=#PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1R86YS86-T:6]N#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?06YD7T=E;V=R87!H:6-?26YF;W)M M830\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H M965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!);F9O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)SQS<&%N/CPO2!296=I'0^)SQS<&%N/CPO6UB;VP\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2!796QL+6MN;W=N(%-E87-O;F5D($ES'0^)TYO/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!0 M=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)UEE'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT.CPO'0^)SQS<&%N/CPO'1U2!S96-U&5S('!A>6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3H\+W-TF5D+"`R."PR-#0@ M3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO3H\+W-T M'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XU+#`P,"PP,#`\2!S=&]C:RP@F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M+#`P,"PP,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-#$T/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO2!I;G9E'0^)SQS<&%N/CPO"!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XW+#$R,#QS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#@T,RPP,#`\2!I;G9E'0^)SQS<&%N/CPO2!O<&5R871I M;F<@86-T:79I=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M;F1I='5R97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&-H86YG92!R871E M(&-H86YG97,@;VX@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA2!3=&]C:R!;365M8F5R73QB'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2!C;VUP96YS871I;VX\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO2!C;VUP96YS M871I;VXL('-H87)E'0^)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO"!W:71H:&]L9&EN9W,\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)SQS<&%N/CPO"!W:71H:&]L9&EN9W,L('-H M87)E'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO"!W:71H:&]L9&EN9W,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO"!W:71H:&]L9&EN9W,L('-H87)E'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2!C;VUP96YS871I M;VXL('-H87)E'0^)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES M92!O9B!O<'1I;VYS+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO65E('-T M;V-K('!U'0^)SQS<&%N/CPO65E('-T;V-K('!U'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO"!S:&]R=&9A;&P\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO"!W:71H:&]L9&EN9W,\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N M/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$)VUA'0M:G5S=&EF>3II;G1EF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)VUA'0M:G5S=&EF>3II M;G1EF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`@F4Z M(#$P<'0G/@T*"0D)/&9O;G0@#(P,40[("8C>#(P,4,[=V4L)B-X,C`Q1#L@;W(@)B-X M,C`Q0SMU#(P,40[*2!D979E;&]P6],:69E)B-X,C`Q.3MS('-U6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I M>F4Z-7!T.W1O<#HM-'!T.W!O$%%.SPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@4W5R9VEC86P@061H97-I=F4@*"8C M>#(P,4,[0FEO1VQU928C>#(P,40[*2P@0FEO1F]A;3PO9F]N=#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="US M:7IE.C5P=#MT;W`Z+31P=#MP;W-I=&EO;CIR96QA=&EV93ML:6YE+6AE:6=H M=#HQ,#`E)SXF(WA!13L\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M"`H)B-X M,C`Q0SM":6]&;V%M)B-X,C`Q1#LI+"!A;F0@/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/E!E3H@:6YL:6YE.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/BP@86X@86)S M;W)B86)L92!P;W=D97)E9"!H96UO6QE/3-$)V1IF4Z,3!P=#LG/FEN=&5R;F%T:6]N86P\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M#(P,4,[4TU))B-X,C`Q1#LI+B9N8G-P.R`\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M2P@0V%R9&EO9V5N97-I6QE M/3-$)V1IF4Z,3!P=#LG/B!C;W)O;F%R M>2!A3H@:6YL:6YE M.V9O;G0M#(P,4,[2&5M;W-P:&5R928C>#(P,40[*2P@ M;6%R:V5T('1H92`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`Z+31P=#MP;W-I=&EO;CIR96QA=&EV M93ML:6YE+6AE:6=H=#HQ,#`E)SXF(WA!13L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M2!H96%R="!V86QV92`H)B-X,C`Q0SM##(P M,40[*2!A;F0@=&AE($-R>6]0871C:#PO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="US:7IE.C5P=#MT M;W`Z+31P=#MP;W-I=&EO;CIR96QA=&EV93ML:6YE+6AE:6=H=#HQ,#`E)SXF M(WA!13L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M2!C87)D:6%C('!A=&-H('1I M6QE/3-$)V1IF4Z M,3!P=#LG/F]F('=H:6-H(&%R92`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6],:69E)B-X,C`Q.3MS('!R;W!R:65T87)Y(%-Y;F5R1W)A9G0\+V9O M;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/B!T96-H;F]L;V=Y M+B9N8G-P.R`\+V9O;G0^/"]F;VYT/@T*"0D\+W`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`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`@F4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY2979E;G5E M(%)E8V]G;FET:6]N/"]F;VYT/@T*"0D\+W`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`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`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SYF;W(@=&AE('EE M87)S(&5N9&5D(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SY$96-E;6)E6QE/3-$ M)V1IF4Z,3!P=#LG/BP@86YD(#PO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SXR,#$Q/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BP@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US M:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY3=&]C:SPO9F]N=#X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF M;VYT+7-T>6QE.FET86QI8SMF;VYT+7-I>F4Z,3!P=#LG/B8C.#(P.3M"87-E M9"!#;VUP96YS871I;VX\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@65E65E($1I#(P,40[#(P,40[2!E<75A;"!T;R!T M:&4@9F%I2!T:&4@0V]M<&%N>2!T>7!I M8V%L;'D@97AP:7)E('=I=&AI;B`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`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`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`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`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`P)3L@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$=VED=&@Z,3AP=#L^ M/'`@6QE/3-$)W=I9'1H M.B`Q."XP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$)VUA6QE/3-$=VED M=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[9F]N="US M:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T M;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/DQE=F5L(#$Z)FYB6QE/3-$ M=VED=&@Z,3`P)3X\=&%B;&4@F4Z(#$P<'0[;6%R9VEN.C!P="`V+C=P="`S M<'0@,'!T.R<^#0H)"0D)/&9O;G0@$(W.SPO9F]N=#X-"@D)"3PO<#X-"@D)/"]T9#X\=&0@6QE/3-$=VED=&@Z,'!T.W=I9'1H.C!P M=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE3H@:6YL:6YE.V9O;G0M2!M87)K970@ M9&%T83L@86YD/"]F;VYT/CPO<#X\+W1D/CPO='(^/"]T86)L93X\+V1I=CX- M"@D)/&1I=B!S='EL93TS1'=I9'1H.C$P,"4^/'1A8FQE('-T>6QE/3-$=VED M=&@Z,3`P)3L@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^ M/'1D('-T>6QE/3-$=VED=&@Z,3AP=#L^/'`@6QE/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$ M)VUA6QE/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I M9'1H.C!P=#MW:61T:#HP<'0[9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L M:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)V1IF4Z M,3!P=#LG/DQE=F5L(#,Z)FYBF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/E1H92!D M971E&ET>2XF;F)S<#LF;F)S<#M,979E M;"`S('9A;'5A=&EO;G,@;6%Y(')E<75I2!D97!E;F1I;F<@;VX@=&AE(&%S2!V86QU M960@86YD('1H92!V86QU871I;VX@;65T:&]D('5S960N)FYB6QE/3-$)V1IF4Z,3!P=#LG M/E1H92!#;VUP86YY(&UA>2!A;'-O(&5N9V%G92!E>'1E6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE.B`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`Q,'!T.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N=#HP<'0[;6%R9VEN M+6QE9G0Z,'!T.W!A9&1I;F#(P,40[*2!F;W(@=&AE(&1E M=F5L;W!M96YT(&]F('!R;W1E:6X@:'ED2XF;F)S M<#LF;F)S<#M4:&4@861V86YC92!F=6YD:6YG('=A28C>#(P,3D['!E;G-E6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\ M<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE M3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H M.B`P.2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XT,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`V,BXV-B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M65A6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XT,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C(N-C8E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P.2XT-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#DN-#8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXR,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XT M,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$ M)VUA6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)W=I9'1H.B`V,BXV M-B4[(&)O3H@:6YL:6YE M.V9O;G0M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`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`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`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/CPO9F]N=#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY5<&]N M('-H:7!M96YT(&]F('1H92!T:7-S=64@=&\@86X@:6UP;&%N=&EN9R!F86-I M;&ET>2P@F5D(&%N9"!T:&4@3H@:6YL:6YE.V9O;G0M'1R82!FF4Z(#$R M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M MF4Z(#$R<'0[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D M9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/E1H92!C86QC=6QA M=&EO;B!O9B!D969E6QE/3-$)V1IF4Z,3!P M=#LG/F]R9V%N(&%N9"!T:7-S=64@<')O8W5R96UE;G0@;W)G86YI>F%T:6]N M3H@:6YL:6YE.V9O;G0M M2!T:&4@3U103W,L(&1I2!A6QE/3-$)V1IF4Z,3!P=#LG/BXF;F)S<#L@/"]F;VYT/@T*"0D\+W`^#0H)"3QP M('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#L[9F]N="US:7IE.B`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`\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/C$Y-2PP,#`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`Q,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMT97AT+6EN9&5N=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.W!A9&1I;F3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N+"`D/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/C3H@:6YL:6YE.V9O;G0MF5R;SPO9F]N=#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@9F]R M('1H92!Y96%R3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z M,3!P=#LG/G=R:71E+61O=VX@:6YC;'5D97,@/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/B0V.#0L,#`P M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!I;B!A9&1I=&EO;F%L(&-O;G1R86-T=6%L(&-O2!P6QE/3-$)V1IF4Z,3!P M=#LG/B0T.#,L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!I;B!A9&1I=&EO;F%L(&-O2!T:&4@0V]M<&%N>28C>#(P,3D[ M&-L=7-I=F5L>2!D:7-T3H@:6YL:6YE.V9O;G0M#(P,40[*2`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY02!A;F0@17%U:7!M96YT/"]F;VYT/@T*"0D\+W`^#0H)"3QP('-T>6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE.B`Q,'!T.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N=#HP<'0[;6%R9VEN M+6QE9G0Z,'!T.W!A9&1I;F2`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B8C.#(P M.3ML:6YE(&)A6QE/3-$)V1IF4Z,3!P=#LG/B8C.#(P M.3ML:6YE(&)A3I4:6UE M6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M M3I4 M:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I M9'1H.B`Q,2XS-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)W=I9'1H M.B`Q,2XS-"4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N M,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`U-2XQ,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,BXQ-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+#8V,B9N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#(N,38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXQ-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S0E.R!B;W)D97(M M=&]P.B`Q<'0@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L M:6,[9F]N="US:7IE.C$P<'0[)SY';V]D=VEL;"!A;F0@3W1H97(@26YT86YG M:6)L92!!F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/E1H92!# M;VUP86YY)B-X,C`Q.3MS(&EN=&%N9VEB;&4@87-S971S(&-O;G-I3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z M,3!P=#LG/BP@86YD(&%S3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/BX@)FYB6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE.B`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`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/E1H92!#;VUP M86YY(&%S2!N;W0@8F4@6QE/3-$=VED=&@Z,3`P)3L@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$=VED=&@Z,3AP M=#L^/'`@6QE/3-$)W=I M9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE M/3-$)VQI;F4M:&5I9VAT.FYO3L@=&5X="UJ=7-T:69Y.B!I;G1E6QE/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW M:61T:#HP<'0[9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H M=#IN;W)M86P[=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:G5S=&EF>3II;G1E M6QE/3-$ M=VED=&@Z,3`P)3L@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\ M='(^/'1D('-T>6QE/3-$=VED=&@Z,3AP=#L^/'`@6QE/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$)VUA'0M86QI9VXZ(&IU'0M:G5S=&EF>3H@ M:6YT97(M:61E;V=R87!H.R!F;VYT+7-I>F4Z(#$P<'0[)SX@)B-X0C<[/"]F M;VYT/@T*"0D)/"]P/@T*"0D\+W1D/CQT9"!S='EL93TS1'=I9'1H.C!P=#L^ M/'`@'0M86QI9VXZ:G5S M=&EF>3MT97AT+6IUF4Z(#$P<'0[;6%R9VEN.C!P="`V M+C=P="`S<'0@,'!T.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SY3:6=N:69I8V%N="!N96=A=&EV92!I M;F1U2!O6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\ M=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS1"=W:61T:#H@ M,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L M:6YE+6AE:6=H=#IN;W)M86P[=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:G5S M=&EF>3II;G1E$(W.SPO9F]N=#X-"@D)"3PO<#X-"@D)/"]T9#X\=&0@6QE/3-$=VED=&@Z,'!T.W=I9'1H.C!P M=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE3H@:6YL:6YE.V9O;G0M28C>#(P,3D[6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T M9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS1"=W:61T M:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS M1"=L:6YE+6AE:6=H=#IN;W)M86P[=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M M:G5S=&EF>3II;G1E$(W.SPO9F]N=#X-"@D)"3PO<#X-"@D)/"]T9#X\=&0@ M6QE/3-$=VED=&@Z,'!T.W=I9'1H M.C!P=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO M3I4:6UE3H@:6YL:6YE.V9O;G0M28C>#(P,3D[6QE/3-$)VUA'0M:G5S=&EF>3II;G1EF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE M6QE M/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE M.B`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`Q,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N M=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.W!A9&1I;FFEN9R!I;G1A;F=I8FQE(&%S7-I6EN9R!V86QU97,@86YD('=E6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@ MF4Z(#$P<'0G/@T*"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1I MF4Z,3!P=#LG/FES6QE/3-$)V1IF4Z,3!P=#LG/E1H92!#;VUP86YY(')E:6UB=7)S97,@=&AE($]44$]S(&9O M2!A8V-R M=65S(&5S=&EM871E9"!P6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1I3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z(#$P<'0[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/CPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SY4:&4@0V]M<&%N>2!H87,@;W!E2=S(&-O2!O9B!O9F9I8V4@97%U M:7!M96YT(&%S(&1I3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B`F;F)S<#M#97)T86EN(&]F('1H92!#;VUP86YY M)B-X,C`Q.3MS(&QE87-E3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/D-O;7!A;GDF(W@R,#$Y.W,@0V]N6QE/3-$)V1IF4Z,3!P=#LG/BX\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE M.C$P<'0[)SY,:6%B:6QI='D@0VQA:6US/"]F;VYT/@T*"0D\+W`^#0H)"3QP M('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#L[9F]N="US:7IE.B`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`F;F)S<#M4:&4@97-T:6UA=&5D(&-O2!I;F-L=61I;F2!O9B!T:&4@ M97-T:6UA=&5S(&ES(&QI;6ET960@8GD@=&AE(&=E;F5R86P@=6YC97)T86EN M='D@=&AA="!E>&ES=',@9F]R(&%N>2!E2!O9B!I;F1U2!D871A(&1I MF4Z(#$P<'0G/@T*"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E M>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,S9P M="`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`Q0SMG2!B96EN9R!R96%L:7IE9"XF;F)S<#LF M;F)S<#M4:&4@0V]M<&%N>2!R979E2!I M2!R96-O9VYI>F5S(&EN=&5R97-T(&%N9"!P96YA;'1I97,@'!E;G-E+"!N970@;VX@:71S($-O;G-O;&ED871E9"!3=&%T96UE M;G1S(&]F($]P97)A=&EO;G,@86YD($-O;7!R96AE;G-I=F4@26YC;VUE+B9N M8G-P.R9N8G-P.U-E92`\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M28C>#(P,3D["!P;W-I=&EO;G,N)FYB3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P M/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M3H@:6YL:6YE.V9O;G0M&5S(')E9FQE8W0@=&AE(&YE="!T87@@ M969F96-T(&]F('1E;7!O2!D:69F97)E;F-E6EN9R!A;6]U;G1S(&]F(&%S"!R971U2!O9B!I=',@9&5F97)R960@ M=&%X(&%SF5D+CPO9F]N M=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I M9VAT.FYO3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\ M<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M&ET>2XF;F)S<#LF;F)S<#M%6QE/3-$=VED=&@Z,3`P)3L@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$=VED=&@Z,3AP=#L^/'`@6QE/3-$)W=I9'1H.B`Q."XP M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$)VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M$(W.SPO9F]N=#X-"@D)"3PO<#X- M"@D)/"]T9#X\=&0@6QE/3-$=VED M=&@Z,'!T.W=I9'1H.C!P=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$)VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)V1IF4Z,3!P=#LG/E!R M;VIE8W1E9"!F=71U6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\+W`^ M/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS1"=W M:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL M93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T.R<^#0H) M"0D)/&9O;G0@6QE/3-$=VED=&@Z,'!T.SX\<"!S M='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[9F]N="US:7IE.C!P=#L^/"]P M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S M='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T.R<^ M#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SY!;G1I8VEP871E9"!F=71U6QE/3-$=VED=&@Z,3AP=#MF M;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N M/3-$;&5F="!S='EL93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL M:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN M.C!P="`P<'0@,W!T.R<^#0H)"0D)/&9O;G0@6QE M/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[ M9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R M9VEN.C!P="`P<'0@,W!T.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY4:6UI;F<@86YD(&%M;W5N=',@ M;V8@86YT:6-I<&%T960@9G5T=7)E('1A>&%B;&4@:6YC;VUE+"`\+V9O;G0^ M/"]P/CPO=&0^/"]T6QE/3-$ M=VED=&@Z,3`P)3X\=&%B;&4@3I4:6UE6QE/3-$)VUAF4Z(#$P<'0[)SX@)B-X0C<[/"]F M;VYT/@T*"0D)/"]P/@T*"0D\+W1D/CQT9"!S='EL93TS1'=I9'1H.C!P=#L^ M/'`@3I4:6UE M3H@:6YL:6YE.V9O;G0M M"!T96UP;W)A6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\ M+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS M1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S M='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T.R<^ M#0H)"0D)/&9O;G0@6QE/3-$=VED=&@Z,'!T.SX\ M<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[9F]N="US:7IE.C!P=#L^ M/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\ M<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T M.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C$P<'0[)SY%=F%L=6%T:6]N(&]F('-T871U=&]R>2!L:6UI=',@6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T M.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL M93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\ M<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P=#LG/@T*"0D) M"3QF;VYT('-T>6QE/3-$)VUA$(W.SPO9F]N=#X-"@D)"3PO<#X- M"@D)/"]T9#X\=&0@6QE/3-$=VED M=&@Z,'!T.W=I9'1H.C!P=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$)VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE.B`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`Q,'!T.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N=#HP<'0[;6%R9VEN M+6QE9G0Z,'!T.W!A9&1I;F2!I3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G M:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0M3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN M9SHP<'0@,S9P="`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`Q M.3MS($-O;G-O;&ED871E9"!"86QA;F-E(%-H965TF5D(&EN('1H92!L:6YE(&ET96T@8VAA M;F=E(&EN('9A;'5A=&EO;B!O9B!D97)I=F%T:79E(&]N('1H92!#;VUP86YY M)B-X,C`Q.3MS($-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F($]P97)A=&EO M;G,@86YD($-O;7!R96AE;G-I=F4@26YC;VUE+B9N8G-P.R`\+V9O;G0^#0H) M"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY.97<@06-C;W5N=&EN M9R!06QE/3-$)V1I6QE.FET86QI8SMF;VYT+7-I>F4Z,3!P=#LG M/E1E7!A2!T;R!P97)F;W)M:6YG('1H M92!Q=6%N=&ET871I=F4@:6UP86ER;65N="!T97-T+B9N8G-P.R9N8G-P.U1H M92!A9&]P=&EO;B!O9B!!4U4@,C`Q,BTP,B!D:60@;F]T(&AA=F4@82!M871E M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL M93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M3I4:6UE6QE/3-$)V1I6QE.FET86QI8SMF;VYT+7-I>F4Z,3!P=#LG M/E)E<&]R=&EN9R!O9B!!;6]U;G1S(%)E8VQA3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0MF4],T0Q/B`\+V9O;G0^/"]P M/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`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`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.VAE:6=H=#HU M+C(U<'0[;W9EF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N,C8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A=&EO;CIU;F1E6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SY,979E;"`Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N M="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/DQE=F5L(#,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-S(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US:7IE.C$P<'0[)SY4;W1A;#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@-#$N,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-A6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N,C8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO M=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+#,T.29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#(N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`Q,"XY,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O M6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O'0M86QI9VXZ M3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XY,"4[(&)O3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XY,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B`M M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY4;W1A;"!A M6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,3`N.3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV+#0T."9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-S(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,"XY,"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DQO;F6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/D-O;G1I;F=E;G0@8V]N6QE/3-$)W=I M9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[ M(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXW,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`T,2XR-B4[(&)O6QE/3-$)V1I6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3`N.3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH,2PX.#0I#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)OF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-S0E.R!B;W)D M97(M=&]P.B`R<'0@9&]U8FQE(",P,#`P,#`[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O M'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[ M(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O'0M M86QI9VXZ3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"3PO M=&%B;&4^/"]D:78^#0H)"3QP('-T>6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C%P=#MB86-K9W)O=6YD+6-O;&]R.GEE;&QO=SLG/B9N M8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P M)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL M93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XY,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXW,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)OF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)OF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW M,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XW-"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XY,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N,C8E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE M6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.VAE:6=H=#HU+C(U<'0[;W9EF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`T,2XR-B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[=&5X="UD96-O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SY,979E;"`R/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB M6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE M/3-$)W=I9'1H.B`T,2XR-B4[(&)O6QE/3-$)V1I MF4Z,3!P=#LG/DUO;F5Y(&UA6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,"XY,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O'0M86QI9VXZ3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N,C8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXW,B4[ M(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O M6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$ M)W=I9'1H.B`T,2XR-B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,B4[ M(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW M-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SY4;W1A;"!L:6%B:6QI=&EE6QE/3-$)W=I9'1H.B`P,2XW-"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`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`P M)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL M93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,RXQ-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#4N,3`E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY#;VYT M:6YG96YT($-O;G-I9&5R871I;VX\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`Q,RXQ-B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ+#DQ,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T* M"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`X-2XQ,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,RXQ-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X- M"@D)/"]P/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\ M+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`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`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W=I M9'1H.B`Q,2XV,"4[(&)O3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#8E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/D5S=&EM871E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@-#@N-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY( M;VQD:6YG/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T."XT-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[=&5X="UD96-O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SY'86EN6QE M/3-$)W=I9'1H.B`P-2XU-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`T."XT-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG M/DUO;F5Y(&UA6QE/3-$)W=I9'1H.B`P,2XX-B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU M-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H M.B`T."XT-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D-E6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXW-#DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/D-A6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)O6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#@N M-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A=&EO;CIU;F1E6QE/3-$)W=I9'1H.B`P,2XX-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M-B4[(&)O6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N-C`E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO M=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#,Q.29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XV,"4[(&)O6QE M/3-$)W=I9'1H.B`T."XT-"4[(&)O6QE/3-$)V1I MF4Z,3!P=#LG/D-A6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XV-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXS,C,F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]TF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C,R,RPP,#`\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B0U M+C`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P M=#LG/B!.;W1E(#$Q/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BXF;F)S<#LF;F)S<#M!/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG M/G,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#LG/B`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`F;F)S M<#M!="`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/F]F('1H92!#;VUP86YY)B-X,C`Q.3MS(')E2!D871E('=I=&AI;B!T:')E M92!M;VYT:',\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!#;VUP86YY)B-X,C`Q.3MS(')E2!D871E(&)E='=E96X@ M=&AR964@;6]N=&AS(&%N9"!O;F4@>65A3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T* M"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQD:78^(#QD M:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G M/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I M;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D]N($UA M>2`Q-BP@,C`Q,B!#3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/B!M:6QL:6]N('!A:60@9F]R(&-A&EM871E;'D@)#PO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXQ+C@\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M&EM871E;'D@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B`F M;F)S<#M#2!O=VYE9"!S=6)S:61I87)Y+B9N8G-P.R9N8G-P.SPO9F]N=#X\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`@F4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A M9&1I;F6QE/3-$)V1IF4Z,3!P=#LG/CPO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY(96UO6QE/3-$)V1IF4Z,3!P=#LG/D-R>6],:69E(&)E;&EE=F5S M('1H870@=&AE($AE4D\@1W)A9G0@=VEL;"!F:70@=V5L;"!I;G1O(&ET6],:69E)B-X,C`Q M.3MS('-A;&5S('1E86T@=&\@;&5V97)A9V4@=&AE:7(@F4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SXF;F)S M<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N M="US:7IE.C$P<'0[)SY#;VYT:6YG96YT($-O;G-I9&5R871I;VXF;F)S<#LF M;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`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`Q.3MS M($-O;G-O;&ED871E9"!3=&%T96UE;G0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M2!C M86X@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[('!A9&1I;F6QE/3-$ M)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@ M:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!F;W(@ M=&AE(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SYY96%R(&5N9&5D/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SY$96-E;6)E6QE/3-$)V1I MF4Z,3!P=#LG/C$N.3PO9F]N=#X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@ M;6EL;&EO;B!A3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL M:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/B9N8G-P.R9N8G-P.SPO9F]N=#X\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$R<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SXF M;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)V1I MF4Z,3!P=#LG/B!M:6QL:6]N/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#LG/B!P=7)C:&%S92!P28C>#(P,3D[3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA MF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#MB86-K9W)O=6YD+6-O M;&]R.GEE;&QO=SLG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T M>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#8N,S8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SY/<&5N:6YG/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`X-BXS-B4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS+#$U-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H M.B`P,2XX."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV-3,F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/DEN=&%N9VEB;&4@87-S971S/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XW-B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D=O;V1W:6QL/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XW-B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/D1E9F5R"!A6QE/3-$)W=I9'1H M.B`P,2XX."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXU+#,W.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DQI86)I;&ET:65S(&%S'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH.33H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,3$N-S8E.R!B;W)D97(M=&]P.B`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`Q+"`R,#$Q(&%R92!P2`Q+"`R,#$Q+B9N8G-P.R9N8G-P.U1H:7,@=6YA=61I=&5D M('!R;R!F;W)M82!I;F9O&-E<'0@<&5R('-H87)E(&%M;W5N=',I.CPO9F]N=#X\+V9O M;G0^#0H)"3PO<#X-"@D)/'`@6QE/3-$)V1IF4Z,7!T M.R<^)FYB6QE/3-$)V)O6QE/3-$)W=I9'1H.B`W,RXP."4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H M.B`W,RXP."4[(&)O3H@ M:6YL:6YE.V9O;G0M'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/E1W96QV92!-;VYT:',@16YD960\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$Q<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P M86X],T0U('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`W M,RXP."4[(&)O3H@:6YL M:6YE.V9O;G0MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR M,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`W,RXP M."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`W,RXP."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXX+#6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$Q<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-3@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XY-B4[(&)O6QE/3-$)W=I9'1H.B`W,RXP."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.38E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\ M9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C,R)FYB6QE/3-$)W=I9'1H M.B`P,RXX-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`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`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXU+B9N8G-P.R9N8G-P.U9A;'9E6&-H86YG92`\+V9O;G0^#0H) M"3PO<#X-"@D)/'`@6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE M6QE M/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)V1IF4Z,3!P=#LG/CPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY);B!*=6QY(#(P,3$@=&AE($-O M;7!A;GD@<'5R8VAA3H@:6YL:6YE.V9O;G0M#(P,40[*2!F;W(@87!P2`D/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/C,N-3PO M9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SX@;6EL;&EO;BXF;F)S<#LF;F)S<#M686QV95AC:&%N9V4@:7,@ M82!P&-H86YG96%B;&4@8FEO<')O6QE/3-$)V1IF4Z,3!P=#LG/E1H92!#;VUP86YY)B-X,C`Q.3MS(&-A M3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D%S(%9A;'9E6&-H86YG928C>#(P,3D[3H@:6YL:6YE.V9O;G0M2!D;V5S(&YO="!E>&5R="!S M:6=N:69I8V%N="!I;F9L=65N8V4@;W9E28C>#(P,3D[2!S96-U28C>#(P,3D[3I4:6UE M6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.W1E>'0M M86QI9VXZ;&5F=#ML:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL M93II=&%L:6,[)SY,;V%N($%G3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G M:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/DEN($IU;'D@,C`Q,2!T:&4@0V]M<&%N>2!E;G1E3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/DIU;'D@,S`L(#(P,3@\+V9O M;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL M:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M2!S=6)S=&%N=&EA;&QY(&%L;"!O9B!T:&4@ M=&%N9VEB;&4@86YD(&EN=&%N9VEB;&4@87-S971S(&]F(%9A;'9E6&-H86YG M92XF;F)S<#LF;F)S<#M4:&4@0V]M<&%N>2!I;F-U2`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)V1IF4Z,3!P=#LG/CPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SY$=7)I;F<@,C`Q,R!#6],:69E)B-X,C`Q.3MS(&-O;G-E;G0@9F]R(&-E65A3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G M/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I M;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D1U M2!R96-O6QE/3-$)V1IF4Z,3!P=#LG M/B0S-#`L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!T;R!W2!R965V86QU871E9"!I=',@:6YV97-T;65N="!I;B!686QV95AC M:&%N9V4@<')E9F5R3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X- M"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/D1U2!D971E3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!I;F9O2!A;F0@86YY(')E;6%I;FEN9R!V86QU92!W M87,@;F]M:6YA;"XF;F)S<#LF;F)S<#M4:&5R969O2!I;7!A:7)E9"!A M2XF;F)S<#LF;F)S<#M!6QE/3-$ M)V1IF4Z,3!P=#LG/C,N,CPO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SX@;6EL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SX@=&\@=W)I=&4M9&]W;B!I=',@:6YV97-T M;65N="!I;B!686QV95AC:&%N9V4@<')E9F5R6EN9R!V86QU92!O9B!T:&4@0V]M<&%N>28C>#(P,3D[ M3H@:6YL:6YE.V9O;G0MF5R;SPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SX@87,@;V8@1&5C96UB97(@,S$L(#(P,3,N)FYB6QE/3-$)V1IF4Z M,3!P=#LG/B0S+C(\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M2!F;W(@=&AE(&YO=&5S('=I M;&P@8F4@2!T:&4@3&]A;BX@/"]F;VYT/CPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M M:&5I9VAT.FYO3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T* M"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.W1E>'0M86QI9VXZ;&5F=#ML:6YE M+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[)SY/<'1I M;VX@06=R965M96YT/"]F;VYT/@T*"0D\+W`^#0H)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B9N8G-P.R9N8G-P M.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)V1IF4Z,3!P=#LG M/D-O;F-U2!W:71H('1H92!,;V%N(&1E'1E;F1S('1H6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<#X\ M9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@/"]D:78^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`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`X-BXS-B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`X-BXS-B4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU M<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-A3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/E!R;W!E6QE/3-$)VUA M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/DEN=&%N M9VEB;&4@87-S971S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XW M-B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#(R,"9N M8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXU+#`P,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)VUA6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/DQI M86)I;&ET:65S(&%S'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XW-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXH,BPT-#4I#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#8N,S8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,2XX."4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XW-B4[ M(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W MF4Z(#$P<'0G/@T*"0D)/&9O M;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/B!M:6QL:6]N(&EN M('1R86YS86-T:6]N(&%N9"!I;G1E9W)A=&EO;B!C;W-T65A2!D:60@;F]T(&EN8W5R M('-I9VYI9FEC86YT('1R86YS86-T:6]N(&]R(&EN=&5G3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,3!P=#LG/B!O9B!/ M<&5R871I;VYS(&%N9"!#;VUP6QE/3-$)V1IF4Z,3!P=#LG/FYA=61I=&5D('!R;R!F;W)M82!R97-U;'1S(&]F(&]P97)A M=&EO;G,@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q+"!A M6QE/3-$)V1IF4Z,3!P=#LG/G!R:6]R('1O(#(P,3$\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P M/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P M6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXQ,"4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q.2XR,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D(&-O;'-P86X],T0S('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#8N-C`E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`Q M,RXT,"4[(&)O6QE/3-$ M)W=I9'1H.B`X-BXV,"4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXQ M,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S`E.R!B;W)D97(M=&]P.B`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`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1I3I4;7,@4FUN.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A M9&1I;F6QE/3-$)W1E>'0M M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL M:6YE.V9O;G0M2!R96QE87-E('1H92!O=&AE3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N(&EN(&-A6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4 M;7,@4FUN.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G M:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A M9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE M6QE M/3-$)V1I'0M86QI9VXZ;&5F=#MB;W)D M97(M=&]P.C%P="!N;VYE("-$.40Y1#D@.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[ M('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M2!R96-O3H@:6YL:6YE M.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/G,\+V9O;G0^ M/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N(&EN(&QE9V%L('-E='1L M96UE;G0@97AP96YS97,@9F]R('1H92`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M65A3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P M=#LG/B!M:6QL:6]N('-E='1L96UE;G0@<&%Y;65N="!T;R!#87)D:6]&;V-U M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P M/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@ M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SXW+B9N8G-P.R9N8G-P.TUE9&%F;W(@36%T M=&5R3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[)SY);G9E6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL M93II=&%L:6,[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@6],:69E('!U M#(P,4,[365D869O#(P,40[*2XF;F)S<#LF;F)S<#M!2!D;V5S(&YO="!E>&5R M="!S:6=N:69I8V%N="!I;F9L=65N8V4@;W9E2!A8V-O=6YT960@9F]R(&ET2!R96-O3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M M:6QL:6]N(&%S(&]F($1E8V5M8F5R(#,Q+"`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`@F4Z(#$P<'0G/@T*"0D) M/&9O;G0@6UE;G0@;V8@87!P2`\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N('-H87)E3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N('5P;VX@=&AE(')E;&5A6QE/3-$)V1IF4Z,3!P=#LG/B!B87-E9"!O;B!I;F9O2!-961A9F]R(&%S('!A6QE/3-$)V1I MF4Z,3!P=#LG/B0U,C4L,#`P/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#LG/BP@:68@6UE;G1S('=I;&P@ M8F4@F4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US='EL93II=&%L:6,[)SY$:7-TF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II M=&%L:6,[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`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`Q,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N M=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.W!A9&1I;F6QE/3-$)V1IF4Z,3!P=#LG/BP@=VAE M;B!I;G1R;V1U8V5D(&EN('1H92!5+E,N+"!W:6QL+"!W:&5N('5S960@:6X@ M86-C;W)D86YC92!W:71H('1H92!M971H;V0@<'5B;&ES:&5D(&EN($-R>6], M:69E)B-X,C`Q.3MS(&QI=&5R871U6],:69E(&1O97,@;F]T(&)E;&EE=F4@ M=&AA="!I="!W:6QL(&EN9G)I;F=E($UE9&%F;W(F(W@R,#$Y.W,@<&%T96YT M+B9N8G-P.R9N8G-P.U1H97)E(&AA=F4@8F5E;B!N;R!F=7)T:&5R(&-O;6UU M;FEC871I;VYS(&)E='=E96X@0W)Y;TQI9F4@86YD($UE9&%F;W(@;W(@0W)Y M;TQI9F4@86YD($)A7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQD M:78^(#QD:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0G/@T*"0D)/&9O M;G0@6QE/3-$)W1E M>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/D1E9F5R3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/F%N9"`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`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-2XT,B4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E9A6QE/3-$)W=I9'1H.B`P-2XT,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P-2XT,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E M>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ M;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q M+"`R,#$S/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/C(P,3(\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#MB86-K9W)O=6YD+6-O;&]R.GEE;&QO=SLG/B9N8G-P M.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\ M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS M1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^ M#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS M-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-2XT,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,C8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/E)A=R!M M871EF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@ M6QE/3-$)W=I9'1H.B`V."XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXW-C6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XS-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXS+#@Y,29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S8E M.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XS M-B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W3I4:6UE3H@:6YL:6YE.V9O M;G0M7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`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`P)3X\ M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS M1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^ M#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS M-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-2XT,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,C8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`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`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,2PS-C4F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX,"4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXR-3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]TF4Z(#$P<'0G M/@T*"0D)/&9O;G0@2!I;F1E9FEN:71E;'DN)FYBF4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$ M)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B M;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B M;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XX-B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XX-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-S`N,#8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-S`N,#8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D) M)FYB6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D)A;&%N8V4@87,@ M;V8@2F%N=6%R>2`Q+"`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#8E.R!B;W)D M97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$)W=I9'1H.B`W,"XP-B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XX,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+#$T-29N8G-P.PT*"0D) M"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N.#8E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ,2PS-C4F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,2PS-C4F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)/"]T6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)V)O6QE/3-$)W=I9'1H.B`X M-2XV,"4[('!A9&1I;F3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUAF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`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`P.2XS."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XX,"4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-38N,S`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY'6EN9SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF%T:6]N(#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@-38N,S`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A M=&EO;CIU;F1E6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SY686QU93PO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XU-"4[(&)O'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/D%C<75I3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU-B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q<'0@ M'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/C$Q/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BT\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M M86QI9VXZ3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/EEE87)S M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XT-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#,T."9N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#0N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR+#0Q-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/D1I'0M86QI9VXZ M3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU M-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XX,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-BXX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-U'0M86QI9VXZ3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XX,"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C$W/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU-B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXR-C6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,"9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N-C(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H M.B`P,2XT-"4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXR,#(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/C$\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U M-BXS,"4[(&)O3H@:6YL M:6YE.V9O;G0M'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$)VUA6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-38N,S`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY'6EN M9SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE6QE M/3-$)V1IF%T:6]N(#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-38N,S`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C M;W)A=&EO;CIU;F1E6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SY686QU93PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-"XU-"4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/D%M;W)T:7IA=&EO;CPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU-"4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/D%C<75I3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q M<'0@'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/C$Q/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/BT\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE M87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XT-"4[(&)O6QE M/3-$)VUA6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ-R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N-C(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`P,2XT M-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XX,"4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C$W/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS.#$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE M87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-BXS M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N-C(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`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`U-RXT."4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U-RXT."4[(&)OF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W=I9'1H.B`U-RXT."4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`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`P.2XV M,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-C`E M.R!B;W)D97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M65L;&]W.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[ M('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`R,#$S/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/B!S8VAE9'5L M960@86UOF%T:6]N(&]F(&EN=&%N9VEB;&4@87-S971S(&9O3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X- M"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT M.FYO3I4:6UE3H@:6YL:6YE.V9O M;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1IF4Z,7!T.R<^)FYBF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXU M,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-RXU,"4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O M6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`P-RXU,"4[(&)O3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P-"XS."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$V/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XS."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY4;W1A;#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,C0N,S`E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/D%M M;W)T:7IA=&EO;B!E>'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#DT."9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N M,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XT-B4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XS."4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ+#@U,"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N,S@E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XT-B4[(&)O6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P M/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@ M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX@/&1I=B!S='EL93TS1&UA MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SXQ,"XF;F)S<#LF;F)S<#M);F-O;64@5&%X97,\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`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`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M M=&]P.B`Q<'0@6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,2PR,S@F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXR.#@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`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`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T M>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/E-T871E/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXS.38F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XU."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I M9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS+#`U-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D1E9F5R6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XV."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#$T,B9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/E-T871E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXH.#$X*0T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS,C0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#`U,"9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N M-C@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/DEN8V]M92!T87@@ M97AP96YS93PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXT+#`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M2`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`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`U-RXS-"4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB M6QE/3-$)W=I9'1H.B`U M-RXS-"4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q M<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M-"XV."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#`Q,R9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@-36QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/DYO;BUD961U8W1I8FQE M('1R86YS86-T:6]N(&-O6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/E-T871E(&EN8V]M92!T87AE6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR.38F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU,B4[(&)O6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D5Q=6ET>2!C;VUP96YS871I;VX\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O M3H@:6YL:6YE.V9O;G0M'!E;G-E M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ.#@F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS)FYB6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/D1O;65S=&EC M('!R;V1U8W1I;VX@86-T:79I=&EE6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXH-#`R*0T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE M/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XU."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXS.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`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`P)3X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG M/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XS."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,#0E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XX,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P-2XU-B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/C(P,3(\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)O6QE/3-$)W=I9'1H.B`V M."XP-"4[(&)O3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO M=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ M,S$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S@E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS M1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.30F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS.3(F;F)S<#L-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XS."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXU,#(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[ M(&)O3H@:6YL:6YE.V9O;G0M M'!E;G-E6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XS."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DQO6QE/3-$ M)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ-RPU,SDF;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`V."XP-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE M/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR+#0P.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N-38E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXY-CDF;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N M.#(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,#0E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/D1E9F5R"!L:6%B:6QI=&EE6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DEN=&%N9VEB;&4@87-S971S M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXH-2PR.#DI#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH-2PX,30I#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-C@N,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE M/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXH-2PY-C`I#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M-C@N,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/E1O=&%L(&YE="!D969E6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,G!T(&1O=6)L92`C M,#`P,#`P.R!B;W)D97(M3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M6QE/3-$)V1IF4Z,3!P=#LG/C$N-3PO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@;6EL;&EO;CPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SX@:6X@=F%L=6%T:6]N(&%L;&]W86YC97,@86=A:6YS="!D969E69O3H@:6YL:6YE M.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q M+"`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`D/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/C,N,CPO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SX@;6EL;&EO;B!O9B!T87@M969F96-T960@'!I6QE/3-$)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/C8Q+#`P,#PO M9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SX@:6X@"!C6QE/3-$)V1IF4Z,3!P=#LG/C$V,RPP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M65L;&]W.R<^)FYB M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I"!0;W-I=&EO;G,\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O M;G0@6QE/3-$)V1IF4Z,3!P=#LG/BAI;B!T:&]U6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T* M"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU M."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-"XV."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`U M-RXS-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/DEN8W)E87-E65A6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR.#$F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O M6QE/3-$)V1IF4Z,3!P=#LG/D1E8W)E87-E6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,3@U*0T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,34I#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D5N9&EN9R!B86QA;F-E/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXR+#`P-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`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`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/D)E9VEN;FEN9R!B86QA;F-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT.#DF;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-"XV."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW.29N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#0N-C@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O6QE/3-$)V1IF4Z,3!P M=#LG/D1E8W)E87-E6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXH,3,S*0T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH."D-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`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`R,#$R/"]F;VYT/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#LG/B!T:&4@ M0V]M<&%N>28C>#(P,3D[2P@:6YC;'5D:6YG(&EN=&5R97-T(&%N9"!P96YA;'1I97,@;V8@)#PO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SXR+C4\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE M.V9O;G0M6QE/3-$)V1I MF4Z,3!P=#LG/B!M:6QL:6]N(&]N('1H M92!#;VUP86YY)B-X,C`Q.3MS($-O;G-O;&ED871E9"!"86QA;F-E(%-H965T M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/G,\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)/&9O M;G0@2!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^ M)SQD:78^(#QD:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1I M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\ M<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3H@:6YL M:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C(P+C`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`\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M2!W M87,@)#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXR,"XP/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N+B9N8G-P.R9N M8G-P.T%S(&]F(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SY$96-E;6)E6QE M/3-$)V1IF4Z,3!P=#LG/BP@=&AE(&%G M9W)E9V%T92!I;G1E3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/BP@86YD('1H92!R96UA:6YI;F<@879A:6QA8FEL M:71Y('=A6QE/3-$)V1IF4Z,3!P=#LG/C(P+C`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3I4:6UE6QE/3-$)V1I65L;&]W M.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P M=#LG/C3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C$T,BPP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/BP@)FYB6QE/3-$)V1IF4Z,3!P=#LG/C(P,3(\ M+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0MF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`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`R,#$S/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/B!A;F0@/"]F M;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z M,3!P=#LG/B0Q+C8\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/D1E8V5M8F5R(#,Q+"`\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M'!E;G-E(&9O6QE/3-$)V1IF4Z,3!P=#LG/C,N,#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@;6EL;&EO;B!I;B`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`X-"XU,"4[(&)O6QE/3-$)V1IF4Z M,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`X-"XU,"4[(&)OF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`X-"XU,"4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SY,96%S97,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D) M/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,BXY."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR+#6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+#`S,29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXR+#DT,R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D) M/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#DX,"9N8G-P.PT*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU M,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`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`D/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/C$N-SPO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@;6EL;&EO;BP@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C4X,"PP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C8R M,"PP,#`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`@F4Z(#$P<'0G/@T* M"0D)/&9O;G0@#(P,4,[0T5/)B-X,C`Q1#LI('1H870@8V]N9F5R M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL M:6]N(&EN(&%C8W)U960@97AP96YS97,@86YD(&]T:&5R(&-U#(P,3D[ M3H@:6YL:6YE.V9O;G0M2`R,#$S(&EN(&%C8V]R9&%N8V4@ M=VET:"!T:&4@=&5R;7,@;V8@=&AE(&YE=R!A9W)E96UE;G0N/"]F;VYT/CPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M M:&5I9VAT.FYO3I4:6UE6QE/3-$)V1IF4Z,3!P=#MB86-K9W)O=6YD+6-O;&]R.FQI;64[)SXF M;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[ M9F]N="US:7IE.C$P<'0[)SY097)#;&]T(%1E8VAN;VQO9WD\+V9O;G0^#0H) M"3PO<#X-"@D)/'`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3QB2!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78^(#QD:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S M='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@F5D('1H92!#;VUP86YY)B-X,C`Q.3MS('!U3H@:6YL:6YE M.V9O;G0M'!I3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E M>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ M;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C(U,RPP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`R,#$S M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BP@=&AE($-O;7!A;GD@:&%D(#PO9F]N=#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXD,3,N-3PO M9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SX@;6EL;&EO;B!I;B!R96UA:6YI;F<@875T:&]R:7IA=&EO;G,@ M=6YD97(@=&AE(')E<'5R8VAA6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`R,#$R/"]F M;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z M,3!P=#LG/B!T:&4@0V]M<&%N>2!P=7)C:&%S960@87!P2`\ M+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C,N,SPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@;6EL;&EO;BXF;F)S<#L@/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#LG/E1H97-E('-H87)E3H@:6YL:6YE.V9O;G0M28C>#(P,3D[6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N M="US:7IE.C$P<'0[)SY42!3=&]C:R9N8G-P.SPO9F]N=#X-"@D) M/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.FYO M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL M93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D]N($%U9W5S="`W+"`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`R,2P@,C`Q,B!T:&4@ M0V]M<&%N>2!A;FYO=6YC960@=&AA="!I=',@0F]A2!C M87-H(&1I=FED96YD(&]F("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C`N,#(U/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/B!T;R`\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N(&%N9"`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`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`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`@:&%S(&)E8V]M92!A;B!!8W%U:7)I;F<@4&5R2!I3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M2!T:&4@<&5R6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X- M"@D)/"]P/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\ M+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R65E M($)E;F5F:70@4&QA;G,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H M(&-L87-S/3-$=&@@8V]LF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SXQ-"XF;F)S<#LF;F)S<#M%;7!L;WEE92!"96YE9FET(%!L86YS/"]F;VYT M/@T*"0D\+W`^#0H)"3QP('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^#0H)"3PO<#X-"@D)/'`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`R,#$S M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BP@,C`Q,BP@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG M/BP@2P@=&AE M($-O;7!A;GD@;6%Y(&UA:V4@9&ES8W)E=&EO;F%R>2!C;VYT6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78^(#QD M:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL M93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY/=F5R=FEE=SPO9F]N=#X-"@D) M/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.FYO M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL M93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/E5N9&5R('1H92!#;VUP86YY)B-X,C`Q.3MS M('!L86YS+"!T:&4@0V]M<&%N>2!I3H@:6YL:6YE.V9O;G0M3I4 M:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)V)O6QE/3-$)W=I9'1H M.B`U-2XX-"4[(&)O6QE M/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U-2XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[ M(&)O6QE/3-$)W=I M9'1H.B`U-2XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`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`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#DP,"PP M,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXX-#6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/C(P,#0@16UP;&]Y964@ M4W1O8VL@26YC96YT:79E(%!L86X\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N,S(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,"4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR-RPP,#`F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$)W=I9'1H.B`U-2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M,"4[(&)O6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/E1O=&%L/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXX+#0P,"PP,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+#`S,"PP,#`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B4@;V8@=&AE('1A6QE/3-$)V1IF4Z,3!P=#LG/C(P M,3,\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M65A6QE/3-$)V1IF4Z,3!P=#LG/B!E87)N960@87!P2`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!#;VUP96YS871I;VX@0V]M;6ET=&5E(&]F M('1H92!#;VUP86YY)B-X,C`Q.3MS($)O87)D(&]F($1IF5D(&%W87)D2!O9F9I8V5R3H@:6YL:6YE.V9O;G0M&EM871E;'D@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/C$R-24\+V9O;G0^ M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[('!A9&1I;F6QE/3-$)V1IF4Z,3!P=#LG/CPO9F]N=#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY);B`\+V9O M;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P M=#LG/B!#;VUP96YS871I;VX@0V]M;6ET=&5E(&]F('1H92!#;VUP86YY)B-X M,C`Q.3MS($)O87)D(&]F($1IF5D(&%W87)D3H@:6YL:6YE.V9O;G0M6QE/3-$)V1I MF4Z,3!P=#LG/B!24U5S('1O(&-E6QE/3-$)V1IF4Z,3!P=#LG/BP@)FYB6QE/3-$)V1IF4Z,3!P=#LG/G=H:6-H M('1O9V5T:&5R('1O=&%L960\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C0R M,2PP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N+B9N8G-P.R`\+V9O;G0^/"]F;VYT/@T*"0D\ M+W`^#0H)"3QP('-T>6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I M;F6QE/3-$)W1E>'0M:6YD M96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE M.V9O;G0M65A6QE M/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R M(#,Q+"`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`N-#8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XR-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU M,B4[(&)O6QE/3-$)W=I9'1H.B`S,2XU-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)W=I9'1H.B`S,2XU-B4[ M(&)O3H@:6YL:6YE.V9O M;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S$N-38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I M9'1H.B`P-"XS,B4[(&)O'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/B!&86ER(%9A;'5E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W M.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S$N-38E.R!B M;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H M.B`R,"XT-B4[(&)O6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,RXU M-"4[(&)O6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[ M(&)O6QE/3-$)W=I M9'1H.B`S,2XU-B4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,RXU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S$N-38E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/D9O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XS M,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+C0X)FYB6QE/3-$)W=I9'1H M.B`P-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXU-3(L,#`P)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+CDQ)FYB6QE/3-$)W=I9'1H.B`P-RXS M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)W=I9'1H.B`S,2XU-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XS M,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+C`P)FYB6QE/3-$)W=I9'1H M.B`P-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV,SDL,#`P)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+C0X)FYB6QE/3-$)W=I9'1H.B`P-RXS M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)W=I9'1H.B`S,2XU-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,C$U+#`P,"D-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,RXU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,S$N-38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$ M)W=I9'1H.B`R,"XT-B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXU+C,Q)FYB6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT M-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)V1I MF4Z,7!T.R<^)FYB6QE/3-$)V)O6QE M/3-$)W=I9'1H.B`S,BXV-"4[(&)O6QE/3-$)V1IF4Z,7!T.R<^ M)FYB6QE/3-$)W=I9'1H M.B`S,BXV-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P M=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O M3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY!9V=R96=A=&4\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US:7IE.C$P<'0[)SY24U5S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P-"XS,B4[(&)O'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/E9A;'5E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`S,BXV-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R M,#$P/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C@U)FYB6QE/3-$)W=I9'1H M.B`P-"XS,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS,3,L,#`P)FYB6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/D=R86YT M960\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV,2PP,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O M6QE/3-$)W=I9'1H M.B`S,BXV-"4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)W=I M9'1H.B`Q."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXY-RPP,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-RXV,"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`Q."XW."4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H.B`Q."XW."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E9E6QE/3-$)W=I9'1H.B`Q."XW."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N M-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XV,B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ+#,Q-"PP,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]T6QE/3-$)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,3@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q."XW M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SX@0V]N=')A8W1U86P\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#0N,S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US:7IE.C$P<'0[)SY);G1R:6YS:6,\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY3:&%R97,\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#,N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SY497)M(&EN('EE87)S/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE M6QE/3-$)V1IF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+2`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-S(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[ M(&)O6QE/3-$)W=I M9'1H.B`S,BXV-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B`M+2`\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#,N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O M6QE/3-$ M)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXQ-3DL,#`P)FYB6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXP+CDS)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US M:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY.#DL,#`P M)FYB6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D=R86YT960\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.#(L,#`P)FYB6QE/3-$)W=I M9'1H.B`P,RXW,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/E9E6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXP."4[(&)O6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O M6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E9E6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE M6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M MF4Z(#$P<'0G/@T*"0D)/&9O;G0@65E3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G M:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#LG/CPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXQ-3DL,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/BP@86YD(#PO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXU.3DL,#`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`@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[ M(&)O6QE/3-$)W=I M9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V M97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O M3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[ M9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/E=E:6=H=&5D(#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY! M9V=R96=A=&4\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D) M/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY M."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I M9'1H.B`P,RXU,B4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/DEN=')I;G-I8SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-2XR,"4[(&)O'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$)W=I M9'1H.B`P,RXR-"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV+C6QE/3-$)W=I9'1H M.B`P,RXR-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,C8P+#`P,"D-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,3`P+#`P,"D-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#(P,"PP,#`F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XV,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XY-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S`N.#0E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H.B`P-2XR,"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-BXV,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)W=I9'1H.B`P M,RXR-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+C`S)FYB6QE/3-$)W=I M9'1H.B`P,RXR-"4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D]U='-T86YD:6YG M(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/D=R86YT960\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XY."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ-C(L,#`P)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV+C$R)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/D5X97)C:7-E9#PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXW+C0X)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE M/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,BXX,B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[ M(&)O6QE/3-$)W=I M9'1H.B`S,"XX-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P-2XR,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXV+C8Y)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,RXU,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$S/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N,C`E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXV,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY M."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.38E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV M('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXX+#(P-2PP,#`F;F)S<#L-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XY."4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.38E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A M<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+#DW,2PP,#`F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R(&EN9F]R;6%T:6]N M(&-O;F-E3I4:6UE3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$ M)V)O6QE/3-$)W=I9'1H.B`U-RXU,B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE M/3-$)W=I9'1H.B`U-RXU,B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XU M."4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0MF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+C4T)FYB6QE/3-$)W=I9'1H M.B`P-"XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU M."4[(&)O6QE/3-$)W=I9'1H.B`P-"XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXR+C4T)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DEN=')I;G-I8R!V86QU92!O9B!O<'1I;VYS(&5X97)C M:7-E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H M.B`P-"XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR-C$L,#`P)FYB M6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE/3-$ M)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P M=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI M9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,3!P=#LG/CDW+#`P,#PO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXL("9N8G-P.SPO M9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXW,BPP,#`\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C8T+#`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`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU M,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXU,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY."4[(&)O6QE/3-$)W=I9'1H.B`R-RXT,B4[(&)O M3H@:6YL:6YE.V9O;G0M M'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/D534%`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-3`E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N M,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY/<'1I;VYS/"]F M;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XY."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SY/<'1I;VYS/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`R-RXT,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$ M)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE M/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ+CDQ)29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#(N-3`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$)VUA'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/DXO03PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XY."4[(&)O6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P,BXU,"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXP+C$S)29N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-3`E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,BXU,"4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C(U)29N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-3`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/E1H M92!F;VQL;W=I;F<@=&%B;&4@3I4:6UE3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$ M)V)O6QE/3-$)W=I9'1H.B`U-RXU,B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE M/3-$)W=I9'1H.B`U-RXU,B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXR+#8Q-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-3@E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#(P-"9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N M-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`U-RXU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/E1O=&%L('-T;V-K M(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P M.2XU."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU."4[(&)OF4Z M(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[ M('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SX\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M'!E;G-E+"!A'!E;G-E(&%N9"!W M97)E('-U8FIE8W0@=&\@=&AE($-O;7!A;GDF(W@R,#$Y.W,@;F]R;6%L(&%L M;&]C871I;VX@;V8@97AP96YS97,@=&\@9&5F97)R960@<')E6QE/3-$)V1IF4Z,3!P=#LG M/BP@)#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXR,30L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/B!A;F0@)#PO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXR,C0L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!I;B!T:&4@>65A6QE/3-$)V1IF4Z,3!P M=#LG/D1E8V5M8F5R(#,Q+"`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`N.#$\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D) M/"]P/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I M=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`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`@6QE/3-$)V1IF4Z,7!T.V)A8VMG65L;&]W.R<^ M)FYB6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#MB86-K9W)O=6YD+6-O;&]R.GEE M;&QO=SLG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$ M=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$ M)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XQ,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,7!T.R<^ M)FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P,RXQ,B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/C(P,3$\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O M6QE/3-$)W=I M9'1H.B`U-RXY-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/DYE="!I;F-O;64@86QL;V-A=&5D M('1O('!A6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXH,3@P*0T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#,N,3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXH,30Y*0T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,RXQ,B4[ M(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+#(R,B9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D97(M=&]P.B`R<'0@9&]U M8FQE(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ M,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[ M(&)O3H@:6YL:6YE.V9O;G0M M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$ M)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ M,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`R<'0@9&]U8FQE M(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`R<'0@9&]U M8FQE(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`R<'0@ M9&]U8FQE(",P,#`P,#`[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S M<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D97(M=&]P.B`R<'0@ M9&]U8FQE(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[=&5X="UD96-O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XQ,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ M,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/DYE="!I;F-O;64@86QL;V-A=&5D('1O('!A6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,S4Y*0T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N,3(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,36QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,30W*0T*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,3`N,3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXW+#(R-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#$N.#(E.R!B;W)D97(M=&]P.B`R<'0@9&]U8FQE(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXR-BPX.#4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#MF;VYT M+7-I>F4Z-7!T.W1O<#HM-'!T.W!O6QE/3-$)W=I9'1H.B`P M,RXQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[ M(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXR-RPW-3DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`U-RXY-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D1I;'5T960@:6YC;VUE('!E M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E>'0M M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,S9P="`P M<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<^ M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.SMF;VYT+7-I>F4Z M(#$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT M.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T M.R<^/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<^/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<^/"]F;VYT/@T*"0D\+W`^ M#0H)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F M=#HP<'0[('!A9&1I;F6QE/3-$)V1I MF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O M<#HM-"XX<'0[<&]S:71I;VXZ2!E>&-L=61E9"!S=&]C:R!O<'1I;VYS(&9R;VT@=&AE(&-A;&-U;&%T M:6]N(&]F(&1I;'5T960@=V5I9VAT960M879E6QE/3-$)V1IF4Z,3!P=#LG/BP@)FYB6QE M/3-$)V1IF4Z,3!P=#LG/C$N-SPO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SX@;6EL;&EO;BP@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXR+C`\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/BP@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#LG/BP@ MF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0MF4],T0Q/B`\+V9O M;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA3I4:6UE6QE/3-$)V1I65L;&]W.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F M=#HP<'0[('!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M2!I;B`R,#$R+B9N M8G-P.R9N8G-P.U1H92!#;VUP86YY(&UA9&4@6QE/3-$)V1I MF4Z,3!P=#LG/BP@)#PO9F]N=#X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXW M.30L,#`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)V1IF4Z,3!P=#LG/C(V-RPP,#`\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SYF;W(\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)V1IF4Z,3!P=#LG/BP@)FYB6QE/3-$)V1IF4Z,3!P=#LG/C(P,3(\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/BP@)#PO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SXS,3(L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/BP@86YD("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!T:&4@ M0V]M<&%N>2!I;B`\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/BP@86YD(#PO9F]N=#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F M;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z M,3!P=#LG/BP@F4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P=#LG M/C0W+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXL("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/BP@86YD("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/B!I;B`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`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXQ.#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#LG/BXF;F)S<#LF;F)S M<#M396=M96YT(&%N9"!'96]G6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`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`U M.2XT."4[(&)O6QE/3-$ M)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O M3H@:6YL:6YE.V9O;G0M M'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N M="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E=F5N=65S.CPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV-RPT.38F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXU.2PS.#6QE/3-$)W=I M9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/E!R97-E6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE M/3-$)W=I9'1H.B`P-"XW,B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ,S$L-S$X)FYB6QE/3-$)W=I9'1H.B`P-"XW M,B4[(&)O6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XW."4[(&)O6QE M/3-$)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1I MF4Z,3!P=#LG/DUE9&EC86P@9&5V:6-E M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`U.2XT M."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/E!R97-E6QE M/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXS-2PR,S`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS-2PS,C`F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/E1O=&%L(&-O6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`P M-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[ M(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XW,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN M-#@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XW."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU-BPQ,38F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR.2PR-C@F M;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR-2PT-3,F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-'!T.W!O'0M86QI9VXZ M3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV,3DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E1O=&%L(&=R;W-S(&UA6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P M."XW."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M-"XW,B4[(&)O6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M65L;&]W.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP M<'0[('!A9&1I;F6QE/3-$ M)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE M.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL M:6YE.V9O;G0M6QE/3-$)V1IF4Z,7!T M.V)A8VMG65L;&]W.R<^)FYB6QE/3-$)V)O6QE/3-$ M)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB M6QE/3-$)W=I9'1H.B`U M.2XT."4[(&)O3H@:6YL M:6YE.V9O;G0M'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-S(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H M:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E!R;V1U8W1S.CPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA6QE/3-$)W=I9'1H M.B`P-"XW,B4[(&)O6QE/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS+#0Y-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-S(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+#`W."9N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#0N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H.B`U.2XT."4[ M(&)O6QE/3-$)V1IF4Z,3!P=#LG/DAE;6]3=&%S93PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I M9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/E)E=F%S8W5L87)I>F%T:6]N('1E M8VAN;VQO9VEE6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-"XW,B4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)O6QE M/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M-"XW,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXU.2PW.3,F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-"XW,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/D]T:&5R/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF M;VYT+7-I>F4Z-7!T.W1O<#HM-'!T.W!O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXV,3DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E1O=&%L(')E=F5N=65S/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ M;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M9&5C;W)A=&EO;CIU;F1E6QE/3-$)V1IF4Z M,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.SMF;VYT+7-I>F4Z(#$P M<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P M=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^ M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<^/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MT M97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<^/"]F;VYT/@T*"0D\+W`^#0H) M"3QP('-T>6QE/3-$)VUA'0M:6YD M96YT.B`M,3AP=#ML:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$R<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-"XX<'0[<&]S:71I M;VXZF4Z(#$R<'0[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM M87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@,3)P="`P<'0@,'!T.R<^/"]F M;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z M,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-"XX<'0[<&]S:71I;VXZ6QE/3-$)V1I MF4Z,3!P=#LG/D9O65A6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`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`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/C(P,3(\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-S(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`U.2XT."4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DEN=&5R;F%T:6]N86P\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,RPV-3$F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/E1O=&%L M(')E=F5N=65S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,3DL-C(V)FYB6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD M96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM M;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^ M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`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`\+V9O;G0^/"]P/@T*"3PO M9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I86P@26YF;W)M871I;VX\+W1D/@T*("`@ M("`@("`\=&0@8VQA6QE/3-$;6%R M9VEN+6QE9G0Z,'!T.VUA'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0MF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SXH:6X@=&AO=7-A;F1S+"!E>&-E<'0@<&5R M('-H87)E(&1A=&$I/"]F;VYT/@T*"0D\+W`^#0H)"3QP('-T>6QE/3-$)VUA MF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O M6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I M9'1H.B`T-2XU,"4[(&)O6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV M,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XV,B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY& M:7)S=#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/E1H:7)D/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@8V]L6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SY1=6%R=&5R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$ M)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/C(P,3(\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS,RPT,CDF;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS,"PQ.38F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O M6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS,"PS.33I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XU-"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG M/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXR,RPR-S8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S M($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXR,2PT-SDF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG M(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXR,RPS-#DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N M-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO M=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR M,BPR.#(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,2PS-S$F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O M6QE/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV M,B4[(&)O6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XU-"4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#4N-3`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XV,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DY%5"!)3D-/344Z/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,RXT-B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[ M(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N M="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR+#$Y,B9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[ M9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV M('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY+#`R-B9N8G-P.PT*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#,N-#8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/BH\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS+#,S-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ+#@R,"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T M-2XU,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T M-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N M-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV M('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C`X)FYB6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D M96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\ M9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C,Q)FYB6QE/3-$)W=I9'1H M.B`P,RXT-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXP+C`T)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXP+C$R)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C`V)FYB6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C`W)FYB6QE/3-$)W=I M9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPOF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY.871U6QE/3-$)V1IF4Z,3!P=#LG/D-R>6],:69E+"!);F,N("@F(W@R M,#%#.T-R>6],:69E+"8C>#(P,40[('1H92`F(W@R,#%#.T-O;7!A;GDL)B-X M,C`Q1#L@)B-X,C`Q0SMW92PF(W@R,#%$.R!O6QE/3-$)V1IF4Z,3!P=#LG/B!3=7)G:6-A;"!!9&AE6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM M-'!T.W!O$%% M.SPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C$P<'0[)SX@4W5R9VEC86P@36%T3H@ M:6YL:6YE.V9O;G0M2!D:7-T3H@:6YL:6YE.V9O;G0MF5S(&EN('1H M92!T3H@ M:6YL:6YE.V9O;G0M3PO9F]N M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SX@9&ES96%S92!U6QE/3-$)V1IF4Z,3!P=#LG M/D-R>6],:69E(&%N9"!I=',@2P@2&5M;W-P:&5R92P@26YC M+B`H)B-X,C`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`Q1#LI(&%N9"!T:&4@ M0W)Y;U!A=&-H/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-'!T.W!O$%%.SPO9F]N=#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SX@4T<@<'5L;6]N87)Y(&-A6]0871C:"!31R8C>#(P,40[*2P@8F]T:"`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0G M/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY0 MF4Z(#$P<'0G/@T*"0D)/&9O;G0@2!A;F0@:71S('=H;VQL>2!O=VYE9"!S=6)S:61I87)I97,N)FYB MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II M=&%L:6,[9F]N="US:7IE.C$P<'0[)SY46QE/3-$)V1I MF4Z,3!P=#LG/E1H92!#;VUP86YY)B-X M,C`Q.3MS(')E=F5N=65S(&%N9"!E>'!E;G-EF5D(&=A:6YS(&%N M9"!L;W-S97,@;VX@9F]R96EG;B!C=7)R96YC>2!T'!E;G-E+"!N970\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M&-H86YG92!R871E(&EN(&5F9F5C="!A2!S96-T:6]N(&]F M('1H92!#;VUP86YY)B-X,C`Q.3MS($-O;G-O;&ED871E9"!"86QA;F-E(%-H M965TF4] M,T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`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`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@2!A;&QO M8V%T97,@2!R96-O M9VYI>F5D('=H96X@=&AE(&QAF5D+CPO9F]N=#X\+V9O;G0^ M#0H)"3PO<#X-"@D)/'`^/&9O;G0@6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^#0H)"3PO<#X-"@D)/'`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/F9O65A6QE/3-$)V1I MF4Z,3!P=#LG/D1E8V5M8F5R(#,Q+"`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`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@2!H87,@65E65E($1I#(P,40[#(P,40[2!E<75A;"!T;R!T:&4@9F%I3H@:6YL:6YE.V9O;G0M65A2!T:&4@0V]M<&%N>2!T>7!I8V%L;'D@97AP:7)E('=I=&AI;B`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`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`R-3PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@<&5R('-H87)E(&]F(&-O;6UO;B!S M=&]C:R!O=71S=&%N9&EN9RXF;F)S<#LF;F)S<#M);B`R,#$S('1H92!#;VUP M86YY(&%N;F]U;F-E9"!T:&%T(&ET3H@:6YL:6YE M.V9O;G0M6QE/3-$)V1I MF4Z,3!P=#LG/B!I;F-R96%S92!I;B!T M:&4@<75A6QE/3-$)V1IF4Z M,3!P=#LG/B!P97(@2!A;G1I8VEP871E M2!D:79I9&5N9',@:6X@36%R8V@L($IU M;F4L(%-E<'1E;6)E65A6UE;G0@87,@82!R961U8W1I;VX@=&\@F4Z(#$P M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[ M)SY&:6YA;F-I86P@26YS=')U;65N=',\+V9O;G0^#0H)"3PO<#X-"@D)/'`@ MF4Z(#$P<'0G/@T*"0D)/&9O;G0@6%B;&4L(&%N9"!D96)T(&]B;&EG871I;VYS(&%T('1H96ER(&-A7!I8V%L;'D@ M3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<#X\9F]N="!S M:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@/"]D:78^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD:78^(#QD:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)/&9O;G0@2!R96-O2UI;G-T M3H@:6YL:6YE.V9O;G0M3H@:6YL M:6YE.V9O;G0MF4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P=#LG/FQO;F<\+V9O;G0^/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6EN9R!A8V-O=6YT:6YG(&9O6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+V9O;G0^#0H)"3PO<#X-"@D) M/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@2!T:&%T('!R:6]R M:71I>F5S(&]B2!A6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I M>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F M="!S='EL93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^ M#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0MF4Z(#$P<'0[)SX@)B-X0C<[/"]F;VYT/@T*"0D)/"]P/@T*"0D\+W1D M/CQT9"!S='EL93TS1'=I9'1H.C!P=#L^/'`@F4Z(#$P<'0[;6%R9VEN.C!P="`V+C=P="`S<'0@,'!T.R<^#0H)"0D\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY, M979E;"`Q.B9N8G-P.R9N8G-P.U%U;W1E9"!P6QE/3-$=VED M=&@Z,3`P)3L@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^ M/'1D('-T>6QE/3-$=VED=&@Z,3AP=#L^/'`@6QE/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$ M)VUA6QE/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I M9'1H.C!P=#MW:61T:#HP<'0[9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L M:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)V1IF4Z M,3!P=#LG/DQE=F5L(#(Z)FYB6QE/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@ M=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS1"=W:61T:#H@,3@N M,#!P=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE M+6AE:6=H=#IN;W)M86P[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0MF4Z(#$P<'0[)SX@)B-X0C<[ M/"]F;VYT/@T*"0D)/"]P/@T*"0D\+W1D/CQT9"!S='EL93TS1'=I9'1H.C!P M=#L^/'`@F4Z(#$P<'0[;6%R9VEN.C!P="`V M+C5P="`P<'0@,'!T.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SY,979E;"`S.B9N8G-P.R9N8G-P.U5N M;V)S97)V86)L92!I;G!U=',@;W(@=F%L=6%T:6]N('1E8VAN:7%U97,@=&AA M="!AF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#L[9F]N="US:7IE.B`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`^#0H)"3QP('-T>6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD M96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM M;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^ M/&9O;G0@3H@:6YL:6YE.V9O;G0M2!O9B!H:6=H M;'D@;&EQ=6ED(&EN=F5S=&UE;G1S('=I=&@@;6%T=7)I='D@9&%T97,@;V8@ M=&AR964@;6]N=&AS(&]R(&QE3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\ M<"!S='EL93TS1"=M87)G:6XZ,'!T.W1E>'0M86QI9VXZ;&5F=#MT97AT+6IU M6QE/3-$)V1I#(P,4,[ M1$]$)B-X,C`Q1#LI(&9O61R;V=E;"!T96-H;F]L;V=Y+B9N8G-P.R9N8G-P.U1H92!A9'9A;F-E(&9U M;F1I;F<@=V%S(&%C8V]U;G1E9"!F;W(@87,@9&5F97)R960@:6YC;VUE(&]N M('1H92!#;VUP86YY)B-X,C`Q.3MS($1E8V5M8F5R(#,Q+"`R,#$R($-O;G-O M;&ED871E9"!"86QA;F-E(%-H965T(&%N9"!R979E;G5E('=AF5D(&%S(&5X<&5N6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G M:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/E-U<'!L96UE;G1A;"!D:7-C;&]S=7)E6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG M/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XT-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-C(N-C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)W=I9'1H M.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-C(N-C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XX,"4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)W=I9'1H.B`V,BXV-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/DEN=&5R M97-T/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XT M-B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)W=I9'1H.B`V,BXV-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG M/DEN8V]M92!T87AE6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,2XX,"4[(&)O3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US M:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#`E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P.2XT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`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`\+V9O;G0^/"]P/@T* M"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P=#LG/C,U-BPP,#`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C4R."PP,#`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`Q0SL\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.R<^)B-X,C`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.V9O;G0M65A6QE/3-$)V1IF4Z,3!P M=#LG/D1E8V5M8F5R(#,Q+"`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`D/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#LG/C3H@:6YL M:6YE.V9O;G0MF5R;SPO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SX@9F]R('1H92!Y M96%R3H@:6YL M:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@:6YL M:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG M/G=R:71E+61O=VX@:6YC;'5D97,@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#LG/B0V.#0L,#`P/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#LG/B!I;B!A9&1I=&EO;F%L(&-O;G1R86-T=6%L(&-O2!P6QE/3-$)V1IF4Z,3!P=#LG/B0T M.#,L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!I;B!A9&1I=&EO;F%L(&-O2!T:&4@0V]M<&%N>28C>#(P,3D[&-L=7-I=F5L>2!D:7-T3H@:6YL:6YE.V9O;G0M#(P,40[*2`\+V9O;G0^/&9O;G0@3H@ M:6YL:6YE.V9O;G0MF4],T0Q/B`\+V9O;G0^ M/"]P/@T*"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@2`\ M+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/B8C.#(P.3ML M:6YE(&)A6QE M/3-$)V1IF4Z,3!P=#LG/B8C.#(P.3ML M:6YE(&)AF4Z(#$P<'0G/@T*"0D)/&9O;G0@3I4:6UE3H@ M:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1I MF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,2XS-B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,2XS-"4[(&)O3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-2XQ,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q M,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXS+#8V,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#(N,38E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M,S0E.R!B;W)D97(M=&]P.B`Q<'0@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US M:7IE.C$P<'0[)SY';V]D=VEL;"!A;F0@3W1H97(@26YT86YG:6)L92!!F4Z(#$P<'0G M/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P M=#LG/BXF;F)S<#LF;F)S<#M4:&5S92!A6QE/3-$)V1IF4Z,3!P=#LG/DYO=&4@-#PO9F]N=#X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXL M(&%N9"!A6QE/3-$)V1IF4Z,3!P=#LG/DYO=&4@-CPO9F]N=#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXN("9N8G-P M.SPO9F]N=#X\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[ M<&%D9&EN9SHP<'0@,S9P="`P<'0@,'!T.R<^/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#LG/E1H92!#;VUP M86YY(&%M;W)T:7IE2!B M96QI979EF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL M93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY);7!A:7)M96YT6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)/&9O;G0@2!A6EN9R!V86QU92!M87D@;F]T(&)E(')E8V]V M97)A8FQE+B9N8G-P.R9N8G-P.T9A8W1O'0M86QI9VXZ:G5S=&EF M>3MT97AT+6IU3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T M>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@'0M86QI9VXZ M:G5S=&EF>3MT97AT+6IUF4Z(#$P<'0[;6%R9VEN.C!P M="`V+C0U<'0@,W!T(#!P=#LG/@T*"0D)"3QF;VYT('-T>6QE/3-$)VUA$(W.SPO9F]N=#X-"@D)"3PO M<#X-"@D)/"]T9#X\=&0@6QE/3-$ M=VED=&@Z,'!T.W=I9'1H.C!P=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X-"@D)"3QP('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E-I9VYI9FEC86YT('5N9&5R<&5R9F]R;6%N8V4@6QE/3-$=VED=&@Z,3`P)3X\=&%B M;&4@'0M86QI9VXZ:G5S=&EF>3MT97AT+6IUF4Z(#$P<'0[;6%R9VEN.C!P="`V+C=P="`S<'0@,'!T.R<^#0H) M"0D)/&9O;G0@3L@=&5X M="UJ=7-T:69Y.B!I;G1E6QE/3-$ M=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[9F]N M="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#IN;W)M86P[=&5X M="UA;&EG;CIJ=7-T:69Y.W1E>'0M:G5S=&EF>3II;G1E6QE/3-$ M)V1IF4Z,3!P=#LG/E-I9VYI9FEC86YT M(&YE9V%T:79E(&EN9'5S=')Y(&]R(&5C;VYO;6EC('1R96YD6QE/3-$=VED=&@Z,3`P)3L@8V5L;'!A M9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$=VED M=&@Z,3AP=#L^/'`@6QE M/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP M('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4 M:6UE6QE/3-$)VUA'0M86QI9VXZ:G5S=&EF>3MT97AT+6IUF4Z(#$P<'0[;6%R9VEN.C!P="`V+C=P="`S<'0@,'!T.R<^#0H) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SY3:6=N:69I8V%N="!D96-L:6YE(&EN('1H92!#;VUP86YY)B-X,C`Q M.3MS('-T;V-K('!R:6-E(&9O6QE/3-$=VED=&@Z,3`P)3L@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$ M=VED=&@Z,3AP=#L^/'`@6QE/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D) M"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$)VUA'0M86QI9VXZ:G5S=&EF>3MT97AT+6IUF4Z(#$P<'0[;6%R9VEN.C!P="`V+C5P="`P<'0@,'!T.R<^ M#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SY3:6=N:69I8V%N="!D96-L:6YE(&EN('1H92!#;VUP86YY)B-X M,C`Q.3MS(&UAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0MF4Z(#$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[<&%D9&EN9SHP<'0@ M,S9P="`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`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`^/&9O;G0@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N M="US:7IE.C$P<'0[)SY,96%S97,@/"]F;VYT/@T*"0D\+W`^#0H)"3QP('-T M>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^#0H)"3PO<#X-"@D)/'`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`\+V9O;G0^/"]P/@T*"3PO M9&EV/B`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`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G M:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A M9&1I;F'0M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0MF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N M="US:7IE.C$P<'0[)SY5;F-E3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S M='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/E1H92!#;VUP86YY('!E2!A"!P;W-I=&EO;G,@86YD(')E M8V]G;FEZ97,@=&%X(&)E;F5F:71S(&EF('1H97D@87)E("8C>#(P,4,[;6]R M92UL:6ME;'DM=&AA;BUN;W0F(W@R,#%$.R!T;R!B92!U<&AE;&0@=7!O;B!R M979I97<@8GD@=&AE(&%P<')O<')I871E('1A>&EN9R!A=71H;W)I='DN)FYB M"!B96YE9FET M(&)Y(&1E=&5R;6EN:6YG('1H92!M87AI;75M(&%M;W5N="!T:&%T(&AA#(P,4,[9W)E871E#(P,40[(&]F('5L=&EM871E;'D@8F5I;F<@2!A8V-R=65D(&QI M86)I;&ET:65S(&9O'!I2!O9G1E;B!O M8G1A:6YS(&%S'1E3H@:6YL:6YE.V9O;G0M"!P;W-I=&EO;G,@:6X@;W1H97(@*&EN8V]M M92D@97AP96YS92P@;F5T(&]N(&ET6QE/3-$)V1IF4Z,3!P=#LG/DYO=&4@,3`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0MF4],T0Q/B`\ M+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0^)SQD:78^(#QD M:78@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I&5S/"]F;VYT/@T*"0D\+W`^#0H)"3QP('-T>6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD M96YT.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G:6XM M;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F="<^ M/&9O;G0@3H@:6YL:6YE.V9O;G0M&5S(')E9FQE8W0@=&AE(&YE="!T87@@ M969F96-T(&]F('1E;7!O2!D:69F97)E;F-E6EN9R!A;6]U;G1S(&]F(&%S"!R971U2!O9B!I=',@9&5F97)R960@ M=&%X(&%SF5D+CPO9F]N M=#X\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G M/@T*"0D)/&9O;G0@6QE/3-$)V1IF4Z,3!P M=#LG/FEN=F]L=F5S(&IU9&=M96YT(&%N9"!C;VUP;&5X:71Y+B9N8G-P.R9N M8G-P.T5S=&EM871E6QE/3-$=VED=&@Z,3`P)3L@8V5L;'!A M9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X\='(^/'1D('-T>6QE/3-$=VED M=&@Z,3AP=#L^/'`@6QE M/3-$)W=I9'1H.B`Q."XP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP M('-T>6QE/3-$)VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0M$(W.SPO M9F]N=#X-"@D)"3PO<#X-"@D)/"]T9#X\=&0@6QE/3-$=VED=&@Z,'!T.W=I9'1H.C!P=#MF;VYT+7-I>F4Z,'!T M.SX\+W`^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X-"@D) M"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/E!R;VIE8W1E9"!F=71U6QE/3-$=VED=&@Z,3AP=#MF;VYT M+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL:6YE M.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P M="`P<'0@,W!T.R<^#0H)"0D)/&9O;G0@6QE/3-$ M=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[9F]N M="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN M.C!P="`P<'0@,W!T.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SY!;G1I8VEP871E9"!F=71U6QE M/3-$=VED=&@Z,3AP=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L M:6=N/3-$=&]P(&%L:6=N/3-$;&5F="!S='EL93TS1"=W:61T:#H@,3@N,#!P M=#L@9&ES<&QA>3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE M:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T.R<^#0H)"0D)/&9O;G0@6QE/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H M.C!P=#MW:61T:#HP<'0[9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE M+6AE:6=H=#HQ,#`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z(#$P<'0[;6%R9VEN.C!P="`P<'0@,W!T.R<^#0H)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY4:6UI M;F<@86YD(&%M;W5N=',@;V8@86YT:6-I<&%T960@9G5T=7)E('1A>&%B;&4@ M:6YC;VUE+"`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@3I4:6UE6QE/3-$)VUA3I4:6UE3H@:6YL:6YE.V9O;G0M"!T96UP;W)A6QE/3-$=VED=&@Z,3AP=#MF M;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L:6=N M/3-$;&5F="!S='EL93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@:6YL M:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN M.C!P="`P<'0@,W!T.R<^#0H)"0D)/&9O;G0@6QE M/3-$=VED=&@Z,'!T.SX\<"!S='EL93TS1'=I9'1H.C!P=#MW:61T:#HP<'0[ M9F]N="US:7IE.C!P=#L^/"]P/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1T;W`^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R M9VEN.C!P="`P<'0@,W!T.R<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SY%=F%L=6%T:6]N(&]F('-T871U M=&]R>2!L:6UI=',@6QE/3-$=VED=&@Z,3AP M=#MF;VYT+7-I>F4Z,'!T.SX\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P(&%L M:6=N/3-$;&5F="!S='EL93TS1"=W:61T:#H@,3@N,#!P=#L@9&ES<&QA>3H@ M:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HQ,#`E.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R M9VEN.C!P=#LG/@T*"0D)"3QF;VYT('-T>6QE/3-$)VUA$(W.SPO M9F]N=#X-"@D)"3PO<#X-"@D)/"]T9#X\=&0@6QE/3-$=VED=&@Z,'!T.W=I9'1H.C!P=#MF;VYT+7-I>F4Z,'!T M.SX\+W`^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X-"@D) M"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#L[9F]N="US:7IE.B`Q,'!T M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT97AT+6EN9&5N=#HP<'0[ M;6%R9VEN+6QE9G0Z,'!T.W!A9&1I;F2!O9B!I=',@9&5F97)R960@=&%X(&%S3I4:6UE M6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M3H@:6YL:6YE.V9O;G0M2!O9B!I M=',@86-Q=6ER960@;F5T(&]P97)A=&EN9R!L;W-S(&-A28C>#(P,3D[2!A;'-O(&)E;&EE=F5S('1H870@:71S(&%C<75I MF5D+B9N8G-P.R9N8G-P.U1H97)E9F]R92P@=&AE($-O;7!A;GD@ M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0MF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`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`^#0H)"3QP/CQF;VYT('-I>F4],T0Q/B`\ M+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUAF4Z(#$R<'0G/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G M:6XM;&5F=#HP<'0[('!A9&1I;F'0M86QI9VXZ;&5F M="<^/&9O;G0@3H@:6YL:6YE.R<^/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#LG M/E1H92!#;VUP86YY(&1E=&5R;6EN97,@=&AE(&9A:7(@=F%L=64@;V8@:71S M('-T86YD+6%L;VYE(&%N9"!E;6)E9&1E9"!D97)I=F%T:79E(&EN2!R97-U;'1I;F<@87-S M970@;W(@;&EA8FEL:71Y(&]N('1H92!#;VUP86YY)B-X,C`Q.3MS($-O;G-O M;&ED871E9"!"86QA;F-E(%-H965TF5D(&EN('1H92!L:6YE(&ET96T@8VAA;F=E(&EN('9A M;'5A=&EO;B!O9B!D97)I=F%T:79E(&]N('1H92!#;VUP86YY)B-X,C`Q.3MS M($-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F($]P97)A=&EO;G,@86YD($-O M;7!R96AE;G-I=F4@26YC;VUE+B9N8G-P.R`\+V9O;G0^/"]F;VYT/@T*"0D\ M+W`^#0H)"3QP/CQF;VYT('-I>F4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV M/B`\+V1I=CX\F4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US='EL93II=&%L:6,[9F]N="US:7IE.C$P<'0[)SY.97<@06-C;W5N=&EN M9R!06QE.FET86QI8SMF;VYT+7-I>F4Z M,3!P=#LG/CPO9F]N=#X\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@6QE/3-$)W1E>'0M:6YD96YT M.C!P=#MM87)G:6XM;&5F=#HP<'0[('!A9&1I;F'0M M86QI9VXZ;&5F="<^/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)V1IF4Z,3!P=#LG/DEN($IA;G5A2!A9&]P=&5D($%C8V]U;G1I;F<@4W1A;F1A3H@:6YL M:6YE.V9O;G0M2!P M97)I;V0@86YD('!R;V-E960@9&ER96-T;'D@=&\@<&5R9F]R;6EN9R!T:&4@ M<75A;G1I=&%T:79E(&EM<&%I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[ M9F]N="US:7IE.B`Q,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMT M97AT+6EN9&5N=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.W!A9&1I;F3H@:6YL:6YE.V9O;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQD:78^ M(#QD:78@6QE/3-$)V)O6QE/3-$ M)W=I9'1H.B`V,BXV-B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB M6QE/3-$)W=I9'1H.B`V M,BXV-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O M6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`V M,BXV-B4[(&)O3H@:6YL M:6YE.V9O;G0M'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#`E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$R M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-A6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-#8E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A M<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS)FYB6QE/3-$)W=I9'1H M.B`P,2XX,"4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#DN-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF M86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXX.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@:6YL:6YE.V9O;G0M&5S/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXU+#8Y,R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#`E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O3I4:6UE6QE/3-$)V1I'0^)SQD:78^(#QD:78@ M6QE/3-$)V)O6QE/3-$)W=I9'1H M.B`U-2XQ,B4[(&)O6QE M/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U-2XQ,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,BXQ-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W=I M9'1H.B`P,BXQ-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`U-2XQ,B4[ M(&)O3H@:6YL:6YE.V9O M;G0M'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N,38E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D1E<')E8VEA=&EO;B!E>'!E;G-E/"]F M;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q M,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXS+#@S-R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#(N,38E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M,S8E.R!B;W)D97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUAF4Z(#$R M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB MF4],T0Q/B`\+V9O M;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$ M)V1IF4Z,7!T.V)A8VMG65L;&]W.R<^)FYB6QE/3-$)V)O6QE/3-$)W=I9'1H.B`T,2XR-B4[ M(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H M.B`T,2XR-B4[(&)O6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.VAE:6=H=#HU+C(U<'0[;W9EF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY,979E M;"`S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE M.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XW M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O M6QE M/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N M.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO M=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU M+#,T.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XY,B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG M/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XY,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY M,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XW-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXW,B4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/DUO;F5Y(&UA M6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS-3`F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[ M(&)O6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)O6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N M.3`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3`E M.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3`E.R!B M;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-#$N,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,"XY,"4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXH,2PX.#0I#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q M,"XY,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXH,2PX.#0I#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N,C8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY M,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)O M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S M<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#$N-S0E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XY,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O'0M86QI9VXZ M3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XY,"4[(&)O3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1IF4Z,7!T.R<^)FYB'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.VAE M:6=H=#HU+C(U<'0[;W9EF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.VAE:6=H M=#HU+C(U<'0[;W9EF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N M,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A=&EO;CIU;F1E6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SY,979E;"`Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[ M9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O M'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/DQE=F5L(#,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-S(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US:7IE.C$P<'0[)SY4;W1A;#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-#$N,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-A6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#$N M,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS M1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#,Q.29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#(N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XY,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XW-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[ M(&)O3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XW M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O M6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,BXW,B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]WF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY4;W1A;"!A6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,3`N.3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXQ+#8T,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-S(E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`Q,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q M,"XY,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XW-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY M,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/DQO;F6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`T,2XR-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D-O M;G1I;F=E;G0@8V]N6QE/3-$)W=I9'1H.B`P,2XW M-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N.3(E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`T,2XR M-B4[(&)O6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,3`N.3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,3`N.3`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXH,2PY,3(I#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O3I4:6UE6QE/3-$)V1I'0^)SQD:78^(#QD:78@ M6QE/3-$)V)O6QE/3-$)W=I9'1H M.B`X-2XQ,"4[(&)O6QE M/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H M.B`X-2XQ,"4[(&)O6QE/3-$)W=I9'1H.B`P,2XW-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I M9'1H.B`X-2XQ,"4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/D)A M;&%N8V4@87,@;V8@1&5C96UB97(@,S$L(#(P,3(\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N-S0E.R!B;W)D97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D=A:6X@;VX@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4 M:6UE6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O M6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE M/3-$)W=I9'1H.B`P-2XU-B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/D5S=&EM871E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-#@N-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SY(;VQD:6YG/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T."XT-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[=&5X="UD96-O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY'86EN6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`T."XT-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/DUO;F5Y(&UA6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-2XU-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[ M(&)O6QE/3-$ M)W=I9'1H.B`T."XT-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D-E6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXW-#DF;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XV-"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[ M(&)O6QE/3-$)V1IF4Z,3!P=#LG/D-A6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XX-B4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXS-3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T."XT-"4[ M(&)O3H@:6YL:6YE.V9O M;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H) M"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@-#@N-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A=&EO;CIU;F1E M6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX-B4[(&)O6QE/3-$)W=I M9'1H.B`P,2XX-B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,3$N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N-C`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A M<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#,Q M.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,"4[(&)O6QE/3-$)W=I9'1H.B`T."XT-"4[(&)O6QE M/3-$)V1IF4Z,3!P=#LG/D-A6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XV-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS,C,F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`X-BXS M-B4[(&)O6QE/3-$)V1I MF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`X-BXS M-B4[(&)O3H@:6YL:6YE M.V9O;G0M'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/D]P96YI;F<\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D-A3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E8V5I=F%B;&5S/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M,2XX."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXU-30F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`X-BXS-B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`X M-BXS-B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R(&%S6QE/3-$)W=I9'1H M.B`P,2XX."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS,S$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I M9'1H.B`P,2XX."4[(&)O6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XX."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,2XW-B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$Q<'0[)SXF;F)S M<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0U M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)V1IF4Z,3%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@8V]L6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SY$96-E;6)E3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$Q<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M M=&]P.B`Q<'0@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.38E.R!B M;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.38E.R!B M;W)D97(M=&]P.B`Q<'0@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY-B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,RXX-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XY-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)V1I MF4Z,3%P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P M.2XY-B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.38E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A M<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C$Q M)FYB6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/E!R;R!F M;W)M82!I;F-O;64@<&5R(&-O;6UO;B!S:&%R92`M(&1I;'5T960\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#$N-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN.38E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A M<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C,Q M)FYB6QE/3-$)W=I9'1H.B`P,RXX-"4[(&)O3I4:6UE6QE/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY"86QA M;F-E(%-H965T/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`X-BXS-B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N-S8E.R!B M;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/E)E8V5I=F%B M;&5S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/DEN=F5N=&]R>3PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXX-3(F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR-#@F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/D=O;V1W:6QL M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@'0M86QI9VXZ3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XW-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/DYE="!D969E'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XW-B4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R M(&%S6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,S`F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`X-BXS-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX."4[(&)O6QE/3-$)VUA M3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`X-BXS-B4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/E1O=&%L('!U6QE/3-$)VUAF4Z(#$R<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P M/@T*"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXQ M,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q.2XR,B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D(&-O;'-P86X],T0S('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@.#8N-C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q,RXT,"4[(&)O6QE/3-$)W=I9'1H.B`X-BXV,"4[(&)O3H@:6YL:6YE.V9O;G0M'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/C(P,3$\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W=I9'1H.B`P,BXQ,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,3$N,S`E.R!B;W)D97(M=&]P.B`Q<'0@3I4:6UE6QE/3-$)V1I3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D M97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XT M,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,C8E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D-A6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`P-2XT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ,2PY-3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`V."XR-B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P M,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[ M(&)O6QE/3-$)VUA6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR-RPR.36QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR-RPY-30F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XS-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-2XT,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M-C@N,C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N M="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/E)A=R!M871EF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,S8E.R!B;W)D97(M=&]P M.B`Q<'0@6QE/3-$)W=I9'1H.B`V."XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXW-C6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XS-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXS+#(Y."9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#4N-#(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS-B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXS+#@Y,29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T* M"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,3$N,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXY+#6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`Q,2XS-B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M M;#L@8VAA6EN9R!686QU M97,@3V8@26YD969I;FET92!,:79E9"!);G1A;F=I8FQE($%S'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`V."XR M-B4[(&)O6QE/3-$)V1I MF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`V."XR-B4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M,S8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/E!R;V-U6QE M/3-$)W=I9'1H.B`P,2XX,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#`Q,R9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N M-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E1R861E;6%R:W,\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P-2XT,B4[(&)O6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D]T:&5R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS M-B4[(&)O6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I2!297!O6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG M/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XX-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX-B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XX,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-S`N,#8E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V M97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D)A;&%N8V4@87,@;V8@2F%N M=6%R>2`Q+"`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#8E.R!B;W)D97(M=&]P M.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I M9'1H.B`W,"XP-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XX,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+#$T-29N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,3`N.#8E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ,2PS-C4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#DN.#`E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ,2PS-C4F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]T'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`U M-BXS,"4[(&)O6QE/3-$ M)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U-BXS,"4[(&)O MF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XT-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)W=I9'1H M.B`P-BXX,"4[(&)O6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@8V]L6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SY!8V-U;75L871E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU-"4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY!;6]R=&EZ M871I;VX\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY097)I;V0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P.2XS."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ-"PP,C`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C$V/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/E!A=&5N=',\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)VUA6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ-R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N-C(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`P M,2XT-"4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXS+#4U.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW,30F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#4N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`P,2XT-"4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXS+#,W,"9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DYO;BUC;VUP971E(&%G6QE M/3-$)W=I9'1H.B`P,2XT-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS.#$F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`U-BXS,"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O M6QE/3-$)V1IF4Z,3!P=#LG/BT\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$ M)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XT-"4[(&)O M6QE/3-$)VUA6QE/3-$)VUA'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M M86QI9VXZ3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SY!8V-U;75L871E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU M-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY!;6]R M=&EZ871I;VX\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY097)I;V0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ-"PP,C`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O M6QE/3-$)V1I MF4Z,3!P=#LG/C$V/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/E!A=&5N=',\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#$N-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XX,"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/EEE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U M-BXS,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M-"XU-"4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XX,"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D-U6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS+#,W,"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-30E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DYO;BUC;VUP971E(&%G6QE/3-$ M)W=I9'1H.B`P,2XT-"4[(&)O6QE/3-$)W=I9'1H.B`P-"XU-"4[(&)O'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXX,"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-2XV,B4[(&)O6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/D]T:&5R/"]F M;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ.3@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P-"XU-"4[(&)O'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/C$\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/EEE M87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T2!/9B!!;6]R M=&EZ871I;VX@17AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78^(#QD:78@6QE/3-$)V)O M6QE/3-$)W=I9'1H.B`U-RXT."4[(&)O6QE/3-$)V1IF4Z M,7!T.R<^)FYB6QE/3-$ M)W=I9'1H.B`U-RXT."4[(&)O6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)W=I9'1H.B`U-RXT."4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`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`P.2XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#`P-B9N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#0N-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-C`E.R!B;W)D97(M M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#$R<'0G/@T*"0D)/&9O M;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO M9&EV/B`\+V1I=CX\'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`R-"XS,"4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`R-"XS,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XT-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XT M-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I M9'1H.B`R-"XS,"4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M)SXR,#$U/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US M:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M6QE/3-$)W=I9'1H.B`P-"XS."4[(&)O'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXR,#$X/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N M="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I M9'1H.B`P,2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XS."4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#@Y."9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#0N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XT-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P-"XS."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-RXU,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY+#0T-29N8G-P.PT*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D\+W1A8FQE/CPO9&EV/@T*"0D\<"!S='EL93TS M1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.FYO3I4 M:6UE6QE/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.3'0O:'1M;#L@8VAA&5S M("A486)L97,I/&)R/CPO6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-"XV."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ,2PV.#8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS-C8F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DEN8V]M92!B969O&5S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUAF4Z(#$R<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.R<^)FYBF4] M,T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\3I4:6UE M3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[ M)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`U-RXS-"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-"XV."4[(&)O6QE/3-$)W=I M9'1H.B`U-RXS-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV M('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#8S-"9N8G-P.PT*"0D)"3PO M=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ.#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#@R,29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.#,F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS)FYB6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[ M(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+#$R,"9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N M-C@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M-"XV."4[(&)O'0^)SQD:78^(#QD:78@6QE/3-$)V)O M6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O6QE/3-$)V1IF4Z M,7!T.R<^)FYB6QE/3-$ M)W=I9'1H.B`U-RXS-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P M.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XV."4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D M97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#`Q,R9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XV."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/DYO;BUD M961U8W1I8FQE('1R86YS86-T:6]N(&-O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU M."4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E-T871E(&EN8V]M92!T87AE6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR.38F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXH-#(W*0T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D5Q=6ET>2!C;VUP96YS871I;VX\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ-#DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U M-RXS-"4[(&)O3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV M."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.#@F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,2XU,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-"XV."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS)FYB6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/D1O;65S=&EC('!R;V1U8W1I;VX@86-T:79I=&EE6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXH-#`R*0T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E)E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]T:&5R/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E M.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU M."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$;6%R9VEN M+6QE9G0Z,'!T.VUA6QE/3-$ M=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$ M)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-C@N,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3$N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N M="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ,S$F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3$N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ.30F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`V."XP-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XS."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXS.3(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V M."XP-"4[(&)O3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR+#8T-"9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU,#(F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M'!E M;G-E6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/DQO6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P M-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ-RPU,SDF;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#0P.29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#4N-38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`V."XP-"4[ M(&)O3H@:6YL:6YE.V9O;G0M M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY-CDF;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`V."XP-"4[(&)O3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W MF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE M/3-$)W=I9'1H.B`P,2XX,B4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-C@N,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D1E9F5R"!L:6%B:6QI=&EE6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XS."4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)W=I9'1H.B`V."XP M-"4[(&)O3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS M."4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA M3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/DEN=&%N9VEB;&4@87-S971S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH-2PR.#DI#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH-2PX,30I M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-C@N,#0E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/D]T:&5R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-2XU-B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH-2PY-C`I#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-2XU-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XS."4[ M(&)O3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D M97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XS."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@-C@N,#0E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E1O=&%L(&YE="!D969E6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3$N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,G!T(&1O=6)L92`C,#`P,#`P.R!B;W)D97(M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`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`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)W=I9'1H.B`U-RXS-"4[(&)O M3H@:6YL:6YE.V9O;G0M M'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D)E9VEN;FEN9R!B86QA;F-E/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B M;W)D97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,S$F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA"!P;W-I=&EO;G,\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH,3$R*0T*"0D)"3PO=&0^#0H)"0D\+W1R/@T* M"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P M,2XU,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D M97(M=&]P.B`Q<'0@3I4:6UE6QE/3-$)V1IF4Z M,3!P=#MB86-K9W)O=6YD+6-O;&]R.GEE;&QO=SLG/B9N8G-P.SPO9F]N=#X- M"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE M/3-$)V1IF4Z,3!P=#LG/D$@2!F;W(@:6YT97)E M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)V)O6QE/3-$)W=I M9'1H.B`U-RXS-"4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`U-RXS M-"4[(&)O3H@:6YL:6YE M.V9O;G0M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P-"XV."4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`P-"XV."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXT,3@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W3H@:6YL:6YE.V9O M;G0M6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-C@E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA"!P;W-I=&EO;G,\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O6QE/3-$)W=I9'1H.B`P-"XV."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`U-RXS M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT,C(F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT.#DF;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT,3@F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU M,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,BXY."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#0N-3`E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY/<&5R M871I;F<\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I6QE M/3-$)W=I9'1H.B`X-"XU,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU M,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3(N.3@E.R!B;W)D97(M=&]P.B`Q M<'0@6QE/3-$)W=I9'1H.B`X-"XU,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P,BXU,B4[(&)O6QE/3-$)W=I9'1H.B`X-"XU,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE M/3-$)W=I9'1H.B`X-"XU,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU M,B4[(&)O6QE/3-$)W=I9'1H.B`X-"XU,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE/3-$)W=I9'1H M.B`X-"XU,"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,BXU,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXY."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,"PQ,C0F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`X-"XU,"4[(&)O6QE/3-$)V1IF4Z,3!P M=#LG/E1O=&%L(&UI;FEM=6T@;&5A6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3(N.3@E.R!B M;W)D97(M=&]P.B`Q<'0@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG M/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XV,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV,"4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-34N.#0E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-34N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/D%U=&AO6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY!=F%I M;&%B;&4@9F]R($=R86YT/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`U-2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SY0;&%N/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,BXU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR M,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M9F]N="US:7IE.C$P<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$)W=I9'1H.B`U-2XX-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/C$Y.38@1&ES8V]U;G1E9"!%;7!L;WEE M92!3=&]C:R!0=7)C:&%S92!0;&%N+"!A6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV,"PP,#`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT,2PP,#`F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXS,#`L,#`P)FYB6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/C(P,#D@16UP;&]Y964@ M4W1O8VL@26YC96YT:79E(%!L86X\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N,S(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#$P,"PP,#`F M;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)W=I9'1H.B`P M,BXU,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXU,B4[(&)O6QE/3-$)VUA MF4Z(#$R<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I M=CX\3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,C`N-#8E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XR-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)W=I9'1H.B`S M,2XU-B4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE M/3-$)W=I9'1H.B`S,2XU-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[ M9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S$N-38E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`R,"XT-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S$N-38E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS-C0L,#`P)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,RXU-"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXW+C`W)FYB6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$)W=I9'1H.B`S,2XU-B4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH,3(X+#`P,"D-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,RXU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,S$N-38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H M.B`R,"XT-B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXU+C0X)FYB6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU-3(L,#`P)FYB6QE/3-$ M)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O M6QE/3-$)W=I9'1H M.B`S,2XU-B4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXW+C`P)FYB6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,SDL,#`P)FYB6QE/3-$ M)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)W=I9'1H.B`P-RXS-"4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O M6QE/3-$)W=I9'1H M.B`S,2XU-B4[(&)O3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,RXU-"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S$N-38E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/D9O M6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+C,Q)FYB6QE/3-$)W=I9'1H.B`P M-RXS-"4[(&)O6QE/3-$)W=I9'1H.B`R,"XT-B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU,B4[(&)O6QE/3-$;6%R9VEN+6QE M9G0Z,'!T.VUA6QE/3-$=VED M=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$ M,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUA MF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXW,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)OF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)OF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US M:7IE.C$P<'0[)SY796EG:'1E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SX@ M079E6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N M-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M."XW."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SY296UA:6YI;F<@/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D M96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE M/3-$)V1I6QE M/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,RXW,B4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O'0M86QI9VXZ M8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0MF4Z M,3!P=#LG/E-H87)E6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY686QU93PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P M.B`Q<'0@6QE/3-$)W=I9'1H.B`Q."XW M."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU."PP,#`F M;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N M-C(E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/E9E6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M,RXW,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XV,B4[(&)O6QE M/3-$)W=I9'1H.B`S,BXV-"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXW M,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C8V)FYB6QE/3-$)W=I9'1H M.B`P-"XS,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT-C8L,#`P)FYB M6QE/3-$)VUA M3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/D=R86YT960\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV-"PP,#`F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXH,S6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,B4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXH-"PP,#`I#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-"XS,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P-"XS,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H M.B`Q."XW."4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]U M='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$S/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ,CDL,#`P)FYB6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ+C4V)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ+#0R-2PP,#`F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)/"]T6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M'!E8W1E9"!T;R!V97-T/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,3@L,#`P)FYB6QE/3-$)W=I M9'1H.B`P,RXW,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C4U)FYB M6QE M/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUAF4Z(#$R<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P M/@T*"3PO9&EV/B`\+V1I=CX\3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,3@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O M3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N M-S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O M6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P M<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG M/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M."XW."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SX@0V]N=')A8W1U86P\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#0N,S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SY);G1R:6YS:6,\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY3:&%R97,\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#,N-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SY497)M(&EN('EE87)S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/B`M+2`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-S(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV M,B4[(&)O6QE/3-$ M)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B`M M+2`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#,N-S(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[ M(&)O6QE M/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ-3DL,#`P)FYB6QE/3-$)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXP+CDS)FYB6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N M="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D=R86YT960\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3@N-S@E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.#(L,#`P)FYB6QE/3-$ M)W=I9'1H.B`P,RXW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/E9E6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`S,BXV-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXP."4[(&)O6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[ M(&)O6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXW,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XS,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,S(N-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/E9E6QE/3-$)W=I9'1H.B`Q."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-RXV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXP."4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4 M:6UE6QE/3-$)V1I3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`S,"XX M-"4[(&)O6QE/3-$)V1I MF4Z,7!T.R<^)FYB6QE/3-$)W=I M9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S`N.#0E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XR M,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@8V]L6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SY796EG:'1E9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O M'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V M97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XY."4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SX@079E6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[ M9F]N="US:7IE.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1I MF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@8V]L6QE/3-$)W=I9'1H M.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY7 M96EG:'1E9"`\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N,C0E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY296UA:6YI;F<@/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI M9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P=#LG/@T* M"0D)"0D))FYB6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O M3H@:6YL:6YE.V9O;G0M M6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@8V]L6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SX@0V]N=')A8W1U86P\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-3(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY);G1R M:6YS:6,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY3:&%R97,\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#,N,C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[9F]N="US:7IE.C$P<'0[)SY%>&5R8VES92!06QE M/3-$)W=I9'1H.B`P,RXR-"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@8V]L6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SY686QU93PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$P M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3(N.#(E.R!B;W)D97(M=&]P.B`Q<'0@6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+C0V)FYB6QE/3-$)W=I9'1H.B`P M,RXU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,#,L,#`P)FYB6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/D=R86YT960\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXU.3DL,#`P)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+C$S)FYB6QE/3-$)W=I9'1H.B`P,RXR M-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D M9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE M/3-$)V1IF4Z,3!P=#LG/D5X97)C:7-E M9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXT+C4S)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$ M)V1IF4Z,3!P=#LG/D9O6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXU+C8P)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,S`N.#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/D5X<&ER960\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#4N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XY."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXH,S(P+#`P,"D-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY M-B4[(&)O6QE/3-$ M)W=I9'1H.B`S,"XX-"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$)W=I9'1H.B`P,RXR M-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV+C@S)FYB6QE/3-$)W=I9'1H M.B`P,RXR-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+C`P)FYB6QE/3-$ M)W=I9'1H.B`P,RXU,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH-#@L,#`P*0T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N M,C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXV M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XY-B4[(&)O6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)W=I9'1H.B`P-2XR,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#`V,"PP,#`F;F)S<#L-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX,B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV M,"4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XY-B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY M."4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P-BXV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXU M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,S`N.#0E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D5X<&ER960\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#4N,C`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XY."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,30L,#`P*0T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#,N,C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^ M#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XY."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P-BXV,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY."4[(&)O6QE/3-$)W=I9'1H M.B`P-2XR,"4[(&)O6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXV+C4W)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXS+C,Q)FYB6QE/3-$)W=I9'1H.B`P,RXU,B4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXX+#(W-"PP,#`F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`S,"XX-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,BXX M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XV,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XY-B4[(&)O6QE M/3-$)W=I9'1H.B`S,"XX-"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M'!E8W1E9"!T;R!V97-T M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ+#6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3(N.#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV+C4W)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXS+C(Y)FYB6QE/3-$)W=I9'1H.B`P,RXU,B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D5X97)C:7-A8FQE(&%T($1E8V5M8F5R(#,Q M+"`R,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#,W,BPP,#`F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,3(N.#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N M92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q M<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N M="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXV+C@V)FYB6QE/3-$)W=I9'1H.B`P,RXR-"4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+C6QE/3-$)W=I9'1H.B`P M,RXU,B4[(&)O6QE/3-$ M)VUAF4Z(#$R<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\ M+V1I=CX\3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA M3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N-3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P.2XU."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O6QE/3-$)W=I9'1H.B`U-RXU,B4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`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`U-RXU,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV-S,L,#`P)FYB6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,"PP,#`F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`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`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY M."4[(&)O6QE/3-$ M)W=I9'1H.B`R-RXT,B4[(&)O3H@:6YL:6YE.V9O;G0M'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@8V]L6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P M<'0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$)VUA6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P M,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,3`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXU M,"4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT M.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SY/<'1I;VYS/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P,BXU,"4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.C$P<'0[)SY/<'1I;VYS/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`R-RXT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ+CDQ)29N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-3`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XP,B4[(&)O M6QE M/3-$)VUA'0M86QI9VXZ3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DXO03PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXU,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M'0M86QI M9VXZ3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XY."4[(&)O6QE/3-$)W=I9'1H M.B`Q,"XP,B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C$S)29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#(N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XP,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXU,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C(U)29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#(N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA2!/9B!3=&]C:R!#;VUP96YS871I;VX@17AP96YS97,\ M+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XU."4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU,B4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P.2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE M/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XU."4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR M,#$Q/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXU M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M M=&]P.B`Q<'0@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#DN-3@E.R!B;W)D97(M=&]P.B`Q<'0@3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/E-T;V-K(&]P=&EO;B!A;F0@15-04"!O<'1I;VX@97AP96YS93PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU,B4[(&)O6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M.2XU."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ+#8P-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,2XU,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P.2XU."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XU."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P M=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#DN-3@E.R!B;W)D97(M=&]P.B`Q M<'0@6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+#,W-B9N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#0N-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`P.2XU."4[ M(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUAF4Z(#$R M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB MF4],T0Q/B`\+V9O M;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,B4[(&)O3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXQ,B4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[ M=&5X="UD96-O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M-36QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N.#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A M<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ-BPQ-S(F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\ M9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+#DT-B9N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#,N,3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`U-RXY-"4[(&)O3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX M,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XX,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-36QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D)A6QE/3-$)W=I9'1H M.B`P,2XX,B4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@-36QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M9&5C;W)A=&EO M;CIU;F1E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,RXQ,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG M/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.#(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ-BPQ-S(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,3`N,3(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ M(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXW+#DT-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N,3(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`Q,"XQ,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)O M6QE M/3-$)W=I9'1H.B`U-RXY-"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XQ,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-36QE/3-$ M)VUA3I4:6UE6QE/3-$)V1IF4Z M,3!P=#LG/D)A6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)W=I9'1H.B`P M,RXQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR-BPY-C6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XQ,B4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,"XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXT-#0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/D1I;'5T960@=V5I9VAT960M879E6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XQ,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XX,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O6QE M/3-$)W=I9'1H.B`P,RXQ,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[(&)O M6QE/3-$)W=I9'1H.B`P,RXQ,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M6QE/3-$)W=I9'1H.B`Q,"XQ,B4[ M(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#L[9F]N="US:7IE.B`Q,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMT97AT+6EN9&5N=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.W!A9&1I M;F3H@:6YL:6YE.V9O;G0M3I4:6UE M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.C$P<'0[)SX\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.V9O;G0M65T(')E8V]G;FEZ960L('=A2P@3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,3!P=#LG/B!M:6QL:6]N+"!S:&%R97,@9F]R('1H M92!Y96%R3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M3H@ M:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`N,#(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I M9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F M;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A M<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW-BPQ.30F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P M."XW."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XW M."4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W MF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXV-"PT.3@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H M.B`P-"XW,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU.2PW.3,F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P M=#LG/D]T:&5R/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-'!T.W!O'0M86QI9VXZ3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,3DF;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/E1O=&%L(')E=F5N=65S M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXQ-#`L-S8S)FYB6QE/3-$)W=I9'1H.B`P-"XW M,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XW."4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG M/D-O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[ M(&)O3H@:6YL:6YE M.V9O;G0M6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ-2PQ-#'0M86QI9VXZ3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)W=I9'1H M.B`P-"XW,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY+#0T,B9N8G-P M.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@3H@:6YL:6YE.V9O;G0M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS-"PS-#`F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U.2XT."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXU,"PS-S'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXT,RPW.#(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I M9'1H.B`U.2XT."4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/D=R;W-S(&UA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)W=I9'1H.B`U.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P M=#LG/DUE9&EC86P@9&5V:6-E6QE/3-$)W=I9'1H.B`P,2XU."4[ M(&)O6QE/3-$ M)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXR."PR.#,F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W3H@:6YL:6YE.V9O;G0M3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW,29N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N M-S(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXT-#8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`U.2XT."4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXX-2PP,3@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXW-2PX-#0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T M2!/9B!.970@4F5V96YU97,@0GD@4')O9'5C=#PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQD:78^(#QD:78@6QE/3-$)VUA MF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#MB86-K9W)O=6YD+6-O;&]R M.GEE;&QO=SLG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE M/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C M:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE M/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)OF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O MF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L M6QE/3-$)W=I9'1H.B`P,"XP M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR,#$S M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P M=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI M;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M-"XW,B4[(&)O6QE/3-$)W=I9'1H.B`U M.2XT."4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/D)I;T=L=64@86YD($)I;T9O86T\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#$N-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-S@E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A M<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU."PP M,#0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M'0M M86QI9VXZ3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3H@:6YL M:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O'0M M86QI9VXZ3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$ M)VUA6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-"XW,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU+#3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P-"XW,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXS+#$Q-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#0N-S(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXW-BPQ.30F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU."4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N M-3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[ M(&)O6QE/3-$)W=I M9'1H.B`U.2XT."4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M M6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3H@:6YL M:6YE.V9O;G0M3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW M."4[(&)O6QE/3-$)W=I9'1H.B`U.2XT."4[ M(&)O6QE/3-$)V1IF4Z,3!P=#LG/E1O=&%L('!R97-E6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXV-"PT.3@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU M."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,RPV,#,F M;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU."4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE/3-$ M)W=I9'1H.B`P-"XW,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W'0M86QI9VXZ3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XU."4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H.B`P."XW."4[(&)O M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-S@E M.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$)VUA3I4:6UE6QE/3-$)W1E>'0M:6YD96YT.C!P=#MM87)G M:6XM;&5F=#HP<'0[('!A9&1I;F6QE M/3-$)V1IF4Z,3!P=#MT97AT+61E8V]R M871I;VXZ=6YD97)L:6YE.R<^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[=&5X="UD96-O6QE/3-$)V1IF4Z,3!P=#MF;VYT+7-I>F4Z-7!T.W1O<#HM-"XX<'0[<&]S M:71I;VXZ6QE/3-$)V1IF4Z,3!P=#LG/BP@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXR,#$Q/"]F;VYT/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#LG/B!T M:&4@)B-X,C`Q0SL\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M6QE/3-$ M;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUAF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)OF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P-"XW,B4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,2XU."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P."XW."4[(&)OF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-3DN-#@E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M6QE/3-$)V1IF4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SXR M,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE M.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ,#DL,S(U)FYB6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ,#,L.#`T)FYB6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE M/3-$)W=I9'1H.B`P."XW."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXY-2PY-S4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`U.2XT."4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)W=I9'1H M.B`P,2XU."4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XW M."4[(&)O6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#@N-S@E.R!B;W)D97(M=&]P.B`Q<'0@6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ-#`L-S8S)FYB6QE/3-$)W=I9'1H.B`P-"XW,B4[(&)O6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XU."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P."XW."4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!&:6YA;F-I86P@26YF;W)M871I;VX@6T%B'0^)SQS<&%N/CPO M'0^)SQD:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`T-2XU,"4[ M(&)OF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W=I M9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P=#LG/B9N M8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O MF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY&:7)S=#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/E-E8V]N9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,2XU<'0@6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P,RXT-B4[(&)O'0M M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z,3!P=#LG/E%U87)T97(\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T M>6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M8V]L6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[)SY1 M=6%R=&5R/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\ M='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D) M"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT M-B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)W=I M9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P,3(\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU M-"4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS,RPT,CDF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXS,"PQ.38F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS,"PS.33I4:6UEF4Z,'!T.R<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN M9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XU-"4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z,'!T.R<^#0H) M"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE/3-$ M)V1IF4Z,3!P=#LG/C(P,3,\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A M<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,RPR M-S8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS M1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,2PT-SDF M;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO M=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,RPS-#DF;F)S M<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A M<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,BPR.#(F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXR,2PS-S$F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)VUA3I4:6UE MF4Z,'!T.R<^ M#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV M,B4[(&)O6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P M,3$\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@ M<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)VUA3I4 M:6UEF4Z,'!T M.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P M,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ."PY,3(F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[ M(&)O3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"3PO='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"3PO M='(^#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@-#4N-3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/DY%5"!)3D-/344Z/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UEF4Z M,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG M/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)V1I MF4Z,3!P=#LG/B0\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI;'DZ(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXR+#$Y,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`P."XU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE.C!P M=#LG/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXY+#`R-B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1IF4Z,3!P=#LG/BH\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I M9'1H.B`P,2XV,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXS+#,S-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)W=I M9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU M-"4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXQ+#@R,"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N-#8E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T M;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)W=I M9'1H.B`T-2XU,"4[(&)O3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT M-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF M;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT M-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)W=I9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z M,3!P=#LG/C(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N-C(E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1IF4Z,3!P=#LG/B0\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXP+C`X)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D) M"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M6QE/3-$)W=I9'1H M.B`P."XU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.C$P,"4[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V]V97)F;&]W.B!H:61D96X[9F]N="US:7IE M.C!P=#LG/@T*"0D)"0D))FYB6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1IF4Z,3!P=#LG/B0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#@N-30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@9F]N="UF M86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#LG(&YO=W)A<#TS1&YO=W)A<#X\9&EV('-T>6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXP+C,Q)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O MF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXP+C`T)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXP+C$R)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXP+C`V)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[(&)O6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXP+C`W)FYB6QE/3-$)W=I9'1H.B`P,RXT-B4[ M(&)O6QE/3-$)W=I M9'1H.B`T-2XU,"4[(&)O6QE/3-$)V1IF4Z,3!P=#LG/C(P,3$\+V9O;G0^/"]P/@T*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#$N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XU M-"4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S<#L\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UEF4Z,'!T.R<^#0H)"0D)"0DF;F)S M<#L\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2`R."P@,C`Q,SQB2`R-RP@,C`Q,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C87-H(&1I M=FED96YD+"!P97)C96YT86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ,"XP,"4\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO3PO=&0^#0H@("`@("`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`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&]N(&-A'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO2!$871E(%M-96UB97)=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO2!$871E(%=I=&AI;B!4:')E92!-;VYT:',@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!$ M871E($)E='=E96X@5&AR964@36]N=&AS($%N9"!/;F4@665A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&EM=6T@86UO=6YT(&]F(&9U='5R92!C;VYS:61E6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!O=VYE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`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`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`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`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!297!O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`Q+#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S MF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#8W-SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(%!E'0^)S$W('EE87)S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S$W('EE87)S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(%!E'0^)S$U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)S$U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO MF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR-C<\6EN9R!686QU93PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(%!E'0^)S$Q('EE87)S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)S$Q('EE87)S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!;365M8F5R73PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(%!E M'0^)S$W('EE87)S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)S$W('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'!E;G-E*2`H1&5T86EL'0^ M)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XD(#(L,#`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0@1FEV92!996%R'!E;G-E+"`R,#$T/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.30X/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E+"`R,#$V/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ+#@Y.#QS<&%N/CPOF%T:6]N(&5X<&5N7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N M/CPO"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS-2XP,"4\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!A'0^)SQS<&%N/CPO2!I;F-L M=61I;F<@:6YT97)E'0^)SQS<&%N/CPO"!L:6%B:6QI='D@"!A'0^)SQS<&%N/CPO"!L:6%B:6QI='D@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M"!#'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(S+#(Y M,CQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!%>'!E;G-E*2`H1&5T86EL'0^)SQS<&%N/CPO"!E>'!E;G-E+"!#=7)R96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#"!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S(%M!8G-T'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO"!E M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#'1087)T7V8Y-S5D-3,U7S,U,CA?-#4U,U]A,&%A7S$Y,&(W-S1C-S5D M-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]F.3'0O:F%V87-C3X-"B`@("`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`@("`\=&%B;&4@8VQA M'0@0FQO8VL@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@9F]R($-%3R!R96UA:6YI;F<@96UP;&]Y960@87,@ M;V8@2F%N=6%R>2`Q+"`R,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!F=71U'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6UE;G1S*2`H1&5T86EL'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`H1&5T86EL2`R."P@,C`Q,SQB2`R-RP@,C`Q,SQBF5D(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPOF5D(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO2!C87-H(&1I=FED96YD M+"!P97)C96YT86=E/"]T9#X-"B`@("`@("`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`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2=S(&UA=&-H:6YG('!E2=S M(&UA=&-H:6YG(&-O;G1R:6)U=&EO;B!O9B!E;7!L;WEE97,G('-A;&%R>3PO M=&0^#0H@("`@("`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`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6UE M;G0@07=A'0^)SQS<&%N/CPOF5D('5N9&5R('!L86X\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF5D(%-H87)E'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO65E(%-T;V-K($EN8V5N M=&EV92!0;&%N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPOF5D(%-H87)E'0^)SQS<&%N/CPO2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.3'0O:'1M;#L@8VAA2!&;W(@ M4E-56UE M;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3:&%R92UB87-E9"!087EM96YT M($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!T;R!V97-T+"!3:&%R97,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M7,\7,\7,\7,\'0^)S$@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA2!&;W(@4%-56UE;G0@07=A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)S$Q(&UO;G1H7,\'0^)SQS<&%N/CPO'0^)SD@;6]N=&AS(#$Q(&1A>7,\'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!/9B!3=&]C:R!/<'1I;VX@06-T:79I='DI("A$971A:6QS*2`H M55-$("0I/&)R/CPO2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET M96US73PO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES86)L92P@4VAA'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS M<&%N/CPO&5R8VES92!0'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES M92!0'!E8W1E9"!T;R!V97-T+"!796EG:'1E9"!!=F5R86=E($5X M97)C:7-E(%!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#8N-3<\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S,@>65A M'0^)S,@>65A'!E8W1E9"!T;R!V97-T+"!796EG:'1E M9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT'0^)SQS<&%N/CPO&5R8VES86)L92P@5V5I9VAT960@079E'0^)S(@>65A'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!T;R!V97-T+"!! M9V=R96=A=&4@26YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!/9B!/=&AE'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO'!E8W1E M9"!L:69E(&]F(&]P=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA7,\'0^)S0@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.3'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`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`@("`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`@/&AE860^#0H@("`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`@/&AE860^#0H@("`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htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Schedule Of Depreciation Expense) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Summary Of Significant Accounting Policies [Abstract]      
Depreciation expense $ 3,837 $ 3,662 $ 3,590
XML 48 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2013
Financial Instruments [Abstract]  
Summary Of Financial Instruments Measured At Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2013

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$
5,349 

 

$

--

 

$

--

 

$
5,349 

Certificates of deposit

 
749 

 

 

--

 

 

--

 

 
749 

Restricted securities:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 
350 

 

 

--

 

 

--

 

 
350 

Total assets

$
6,448 

 

$

--

 

$

--

 

$
6,448 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

--

 

$

--

 

$
(1,884)

 

$
(1,884)

Total liabilities

$

--

 

$

--

 

$
(1,884)

 

$
(1,884)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$
1,319 

 

$

--

 

$

--

 

$
1,319 

Restricted securities:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 
323 

 

 

--

 

 

--

 

 
323 

Total assets

$
1,642 

 

$

--

 

$

--

 

$
1,642 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

--

 

$

--

 

$
(1,912)

 

$
(1,912)

Total liabilities

$

--

 

$

--

 

$
(1,912)

 

$
(1,912)

 

Reconciliation Of Changes In Fair Value Of Level 3 Liabilities

 

 

 

 

 

 

 

Contingent Consideration

Balance as of December 31, 2012

$
1,912 

Gain on remeasurement of contingent consideration

 
(28)

Balance as of December 31, 2013

$
1,884 

 

XML 49 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Schedule Of Supplemental Disclosures Of Cash Flow Information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Cash paid during the year for:

 

 

 

 

 

 

 

 

Interest

$
3 

 

$
22 

 

$
89 

Income taxes

 
5,693 

 

 
1,263 

 

 
3,564 

 

 

 

 

 

 

 

 

 

 

Schedule Of Depreciation Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Depreciation expense

$
3,837 

 

$
3,662 

 

$
3,590 

 

XML 50 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Preservation Costs And Inventories (Schedule Of Deferred Preservation Costs) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Deferred Preservation Costs [Line Items]    
Total deferred preservation costs $ 27,297 $ 27,954
Cardiac Tissues [Member]
    
Deferred Preservation Costs [Line Items]    
Total deferred preservation costs 12,239 11,950
Vascular Tissues [Member]
    
Deferred Preservation Costs [Line Items]    
Total deferred preservation costs $ 15,058 $ 16,004
XML 51 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 6,448 $ 1,642
Contingent consideration (1,884) (1,912)
Total liabilities (1,884) (1,912)
Money Market Funds [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 5,349 1,319
Restricted securities 350 323
Certificates Of Deposit [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 749  
Level 1 [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 6,448 1,642
Level 1 [Member] | Money Market Funds [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 5,349 1,319
Restricted securities 350 323
Level 1 [Member] | Certificates Of Deposit [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 749  
Level 3 [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration (1,884) (1,912)
Total liabilities $ (1,884) $ (1,912)
XML 52 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash Equivalents And Restricted Cash And Securities (Tables)
 12 Months Ended
Dec. 31, 2013
Cash Equivalents And Restricted Cash And Securities [Abstract]  
Summary Of Cash Equivalents And Marketable Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

Estimated

 

 

 

 

Holding

 

Market

December 31, 2013

Cost Basis

 

Gains (Losses)

 

Value

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$
5,349 

 

$

--

 

$
5,349 

Certificates of deposit

 
749 

 

 

--

 

 
749 

Restricted cash and securities:

 

 

 

 

 

 

 

 

Cash

 
5,000 

 

 

--

 

 
5,000 

Money market funds

 
350 

 

 

--

 

 
350 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$
1,319 

 

$

--

 

$
1,319 

Restricted securities:

 

 

 

 

 

 

 

 

Cash

 
5,000 

 

 

--

 

 
5,000 

Money market funds

 
323 

 

 

--

 

 
323 

 

XML 53 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hemosphere Acquisition (Tables) (Hemosphere [Member])
 12 Months Ended
Dec. 31, 2013
Hemosphere [Member]
  
Business Acquisition [Line Items]  
Business Acquisition Purchase Price Allocation

 

 

 

 

Opening

 

Balance Sheet

Cash and cash equivalents

$
3,155 

Receivables

 
653 

Inventories

 
554 

Intangible assets

 
5,790 

Goodwill

 
7,145 

Deferred tax assets, net

 
5,379 

Other assets

 
331 

Liabilities assumed

 
(972)

Total purchase price

$
22,035 

 

Summary Of Unaudited Pro Forma Results Of Operations

 

 

 

 

 

 

 

Twelve Months Ended

 

December 31,

 

2012

 

2011

Total revenues

$
133,722 

 

$
124,877 

Net income

 
8,758 

 

 
3,205 

 

 

 

 

 

 

Pro forma income per common share - basic

$
0.32 

 

$
0.11 

Pro forma income per common share - diluted

$
0.31 

 

$
0.11 

 

XML 54 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Summary Of Significant Accounting Policies

1.  Summary of Significant Accounting Policies

 

Nature of Business

 

CryoLife, Inc. (“CryoLife,” the “Company,” “we,” or “us”) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation.  CryoLife’s surgical sealants and hemostats include BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (“SMI”).  CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”), specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.  CryoLife and its subsidiary, Hemosphere, Inc. (“Hemosphere”), market the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”), which is a solution for end-stage renal disease (“ESRD”) in certain hemodialysis patients.  The cardiac and vascular human tissues distributed by CryoLife include the CryoValve® SG pulmonary heart valve (“CryoValve SGPV”) and the CryoPatch® SG pulmonary cardiac patch tissue (“CryoPatch SG”), both of which are processed using CryoLife’s proprietary SynerGraft® technology. 

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Translation of Foreign Currencies

 

The Company’s revenues and expenses transacted in foreign currencies are translated as they occur at exchange rates in effect at the time of each transaction.  Realized gains and losses on foreign currency transactions are recorded as a component of other (income) expense, net on the Company’s Consolidated Statements of Operations and Comprehensive Income.  Assets and liabilities of the Company denominated in foreign currencies are translated at the exchange rate in effect as of the balance sheet date and are recorded as a separate component of accumulated other comprehensive income (loss) in the shareholders' equity section of the Company’s Consolidated Balance Sheets.

 

Use of Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods.  Actual results could differ from those estimates.  Estimates and assumptions are used when accounting for investments, allowance for doubtful accounts, deferred preservation costs, acquired assets or businesses, long‑lived tangible and intangible assets, deferred income taxes, commitments and contingencies (including product and tissue processing liability claims, claims incurred but not reported, and amounts recoverable from insurance companies), stock based compensation, certain accrued liabilities (including accrued procurement fees, income taxes, and financial instruments), contingent consideration liability, and other items as appropriate.

 

Revenue Recognition

 

Revenues for products, including: BioGlue, BioFoam, PerClot, HemoStase, revascularization technologies handpieces and accessories, HeRO Grafts, and other medical devices, are recognized at the time the product is shipped, at which time title passes to the customer, and there are no further performance obligations.  The Company recognizes revenues for preservation services when services are completed and tissue is shipped to the customer.  Revenues from research grants are recognized in the period the associated costs are incurred.  Revenues from upfront licensing agreements are recognized ratably over the period the Company expects to fulfill its obligations.

 

Revenues from the sale of laser consoles are considered multiple element arrangements, and such revenues are allocated to the elements of the sale.  The Company allocates revenues based primarily on the revenue these individual elements would generate if sold separately.  Revenues from domestic laser consoles sales are typically recognized when the laser is installed at a customer site and all materials for the laser console’s use are delivered.  Revenues from the sales of laser consoles to international distributors are evaluated individually based on the terms of the sale and collectability to determine when revenue has been earned and can be recognized.

 

Shipping and Handling Charges

 

Fees charged to customers for shipping and handling of products and tissues are included in product revenues and preservation services revenues, respectively.  The costs for shipping and handling of products and tissues are included as a component of cost of products and cost of preservation services, respectively.

 

Advertising Costs

 

The costs to develop, produce, and communicate the Company’s advertising are expensed as incurred and are classified as general, administrative, and marketing expenses.  The Company records the cost to print or copy certain sales materials as a prepaid expense and amortizes these costs as an advertising expense over the period they are expected to be used, typically six months to one year.  The total amount of advertising expense included in the Company’s Consolidated Statements of Operations and Comprehensive Income was $880,000, $1.5 million, and $948,000 for the years ended December 31, 2013,  2012, and 2011, respectively.

 

Stock‑Based Compensation

 

The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (“RSA”s), restricted stock units (“RSU”s), performance stock units (“PSU”s), and options to purchase shares of CryoLife common stock at exercise prices generally equal to the fair values of such stock at the dates of grant.  The Company also maintains a shareholder approved Employee Stock Purchase Plan (the “ESPP”) for the benefit of its employees.  The ESPP allows eligible employees the right to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.  The stock options, RSAs, RSUs, and PSUs granted by the Company typically vest over a one to three-year period.  The stock options granted by the Company typically expire within seven years of the grant date.

 

The Company values its RSAs, RSUs, and PSUs based on the stock price on the date of grant.  The Company expenses the related compensation cost of RSAs and RSUs using the straight-line method over the vesting period.  The Company expenses the related compensation cost of PSUs based on the number of shares expected to be issued if achievement of the performance component is probable using a straight-line method over each vesting tranche of the award.  The amount of compensation costs expensed related to PSUs is adjusted as needed if the Company deems that achievement of the performance component is no longer probable, or if the Company’s expectation of the number of shares to be issued changes.  The Company uses a Black-Scholes model to value its stock option grants and expenses the related compensation cost using the straight-line method over the vesting period.  The fair value of the Company’s ESPP options is also determined using a Black-Scholes model and is expensed over the vesting period.  The period expense is then determined based on this valuation and, at that time, an estimated forfeiture rate is used to reduce the expense recorded.  The Company’s estimate of pre-vesting forfeitures is primarily based on the recent historical experience of the Company and is adjusted to reflect actual forfeitures at each vesting date. 

 

The fair value of stock options and ESPP options is determined on the grant date using assumptions for the expected term, volatility, dividend yield, and the risk-free interest rate.  The expected term is primarily based on the contractual term of the option and Company data related to historic exercise and post-vesting forfeiture patterns, which is adjusted based on management’s expectations of future results.  The Company’s anticipated volatility level is primarily based on the historic volatility of the Company’s common stock, adjusted to remove the effects of certain periods of unusual volatility not expected to recur, and adjusted based on management’s expectations of future volatility, for the life of the option or option group.  The Company’s model included a zero dividend yield assumption in the periods prior to the Company’s initiation of a quarterly dividend in the third quarter of 2012.  The risk-free interest rate is based on recent U.S. Treasury note auction results with a similar life to that of the option.  The Company’s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions.

 

Income Per Common Share

 

Income per common share is computed using the two class method, which requires the Company to include unvested RSAs that contain non-forfeitable rights to dividends (whether paid or unpaid) as participating securities in the income per common share calculation. 

 

Under the two class method, net income is allocated to the weighted-average number of common shares outstanding during the period and the weighted-average participating securities outstanding during the period.  The portion of net income that is allocated to the participating securities is excluded from basic and dilutive net income per common share.  Diluted net income per share is computed using the weighted-average number of common shares outstanding plus the dilutive effects of outstanding stock options and awards and other dilutive instruments as appropriate.

 

Dividends

 

During 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding.  In 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 to $0.0275 per share of common stock outstanding.  The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year from cash on hand and will record the dividend payment as a reduction to retained earnings on the Company’s Consolidated Balance Sheets.

 

Financial Instruments

 

The Company’s financial instruments include cash equivalents, marketable securities, restricted securities, accounts receivable, notes receivable, accounts payable, and contingent consideration.  The Company typically values financial assets and liabilities such as receivables, accounts payable, and debt obligations at their carrying values, which approximate fair value due to their generally short-term duration.  Other financial instruments are typically recorded as discussed in the sections below.

 

Fair Value Measurements

 

The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments.  The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2013 the Company has not chosen to make any such elections.  Fair value financial instruments are recorded in accordance with the fair value measurement framework.

 

The Company also measures certain non-financial assets at fair value on a non-recurring basis.  These non-recurring valuations include evaluating assets such as cost method investments, long‑lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations.  The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.  

 

The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.  These levels from highest to lowest priority are as follows:

 

·

Level 1:  Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;

·

Level 2:  Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and

·

Level 3:  Unobservable inputs or valuation techniques that are used when little or no market data is available.

 

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment.  Level 3 valuations often involve a higher degree of judgment and complexity.  Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions.  Management’s assumptions could vary depending on the asset or liability valued and the valuation method used.  Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.  The Company may also engage external advisors to assist in determining fair value, as appropriate.

 

Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.

 

Cash and Cash Equivalents

 

Cash equivalents consist primarily of highly liquid investments with maturity dates of three months or less at the time of acquisition.  The carrying value of cash equivalents approximates fair value.

 

In 2012 the Company’s cash equivalents included advance funding received from the U.S. Department of Defense (“DOD”) for the development of protein hydrogel technology.  The advance funding was accounted for as deferred income on the Company’s December 31, 2012 Consolidated Balance Sheet and revenue was recognized as expenses were incurred related to these grants.  The Company discontinued its BioFoam U.S. clinical trial and returned all of the remaining unspent funds to the DOD in the second quarter of 2013.

 

Cash Flow Supplemental Disclosures

 

Supplemental disclosures of cash flow information for the years ended December 31 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Cash paid during the year for:

 

 

 

 

 

 

 

 

Interest

$
3 

 

$
22 

 

$
89 

Income taxes

 
5,693 

 

 
1,263 

 

 
3,564 

 

 

 

 

 

 

 

 

 

Marketable Securities and Other Investments

 

The Company typically invests its excess cash for short-term periods in large, well‑capitalized financial institutions, and the Company's policy excludes investment in any securities rated less than "investment‑grade" by national rating services, unless specifically approved by the Board of Directors.  The Company sometimes makes longer term strategic investments in medical device companies, and these investments must be approved by the Board of Directors.

 

The Company determines the classification of its investments as trading, available-for-sale, or held-to-maturity at the time of purchase and reevaluates such designations quarterly.  Trading securities are securities that are acquired principally for the purpose of generating a profit from short-term fluctuations in price.  Debt securities are classified as held‑to‑maturity when the Company has the intent and ability to hold the securities to maturity.  Any securities not designated as trading or held‑to‑maturity are considered available-for-sale.  The Company typically states its investments at their fair values; however, for held‑to‑maturity securities or when current fair value information is not readily available, investments are recorded using the cost method.  The cost of securities sold is based on the specific identification method.

 

Under the fair value method, the Company adjusts each investment to its market price and records the unrealized gains or losses in other (income) expense, net for trading securities, or accumulated other comprehensive income (loss), for available-for-sale securities.  Interest, dividends, realized gains and losses, and declines in value judged to be other than temporary are included in other (income) expense, net.  Under the cost method, each investment is recorded at cost.  Subsequent dividends received are recognized as income, and the investment is reviewed for impairment if factors indicate that a decrease in the value of the investment has occurred.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

The Company’s accounts receivable are primarily from hospitals and distributors that either use or distribute the Company’s products and tissues.  The Company assesses the likelihood of collection based on a number of factors, including past transaction history with the customer and the credit worthiness of the customer, as well as the increased risks related to international customers and large distributors.  The accounts receivable balances were reported net of allowance for doubtful accounts of $356,000 and $528,000 as of December 31, 2013 and 2012 respectively.

 

Deferred Preservation Costs

 

By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory.  The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred.  Deferred preservation costs are stated at the lower of cost or market value on a first‑in, first‑out basis and are deferred until revenue is recognized.  At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status. 

 

Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services.  Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments for tissues not deemed to be recoverable, and includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

 

The calculation of deferred preservation costs involves judgment and complexity and uses the same principles as inventory costing.  Donated human tissue is procured from deceased human donors by organ and tissue procurement organizations (“OTPOs”), which consign the tissue to the Company for processing, preservation, and distribution.  Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight‑in charges), and indirect costs (including allocations of costs from support departments and facility allocations).  Fixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility’s normal capacity. 

 

These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed.  The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable.  Management estimates quarantine yields based on its experience and reevaluates these estimates periodically.  Actual yields could differ significantly from the Company’s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs.  These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods. 

 

The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value.  The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging.  Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation.  Impairment write-downs are recorded based on the book value of tissues deemed to be impaired.  Actual results may differ from these estimates.  Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

 

The Company recorded write-downs to its deferred preservation costs totaling $448,000, $195,000, and $270,000 for the years ended December 31, 2013,  2012, and 2011, respectively.

 

Inventories

 

Inventories are valued at the lower of cost or market on a first‑in, first‑out basis and the costs are recognized as cost of products upon shipment of the product.  Inventories are comprised of BioGlue; BioFoam; PerClot; revascularization technologies lasers, handpieces, and accessories; HeRO Grafts; other medical devices; supplies; and raw materials.  Cost of products also includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

 

Inventory costs for manufactured products consist primarily of direct labor and materials (including salary and fringe benefits, raw materials, and supplies) and indirect costs (including allocations of costs from departments that support manufacturing activities and facility allocations).  The allocation of fixed production overhead costs is based on actual production levels, to the extent that they are within the range of the facility’s normal capacity.  Inventory costs for products purchased for resale or contract manufactured consist primarily of the purchase cost, freight-in charges, and indirect costs as appropriate. 

 

The Company regularly evaluates its inventory to determine if the costs are appropriately recorded at the lower of cost or market value.  The Company also evaluates its inventory for costs not deemed to be recoverable, including inventory not expected to ship prior to its expiration.  Lower of cost or market value write-downs are recorded if the book value exceeds the estimated market value of the inventory, based on recent sales prices at the time of the evaluation.  Impairment write-downs are recorded based on the book value of inventory deemed to be impaired.  Actual results may differ from these estimates.  Write-downs of inventory are expensed as cost of products, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

 

The Company recorded write-downs to its inventory totaling $1.2 million, $77,000, and zero for the years ended December 31, 2013,  2012, and 2011, respectively.  The 2013 write-down includes $684,000 in additional contractual costs and inventory impairment costs, primarily related to a BioGlue accessory product, and $483,000 in additional costs for revascularization technologies handpieces that were made obsolete by the Company’s decision to exclusively distribute the new handpiece design, which was approved by the U.S. Food and Drug Administration (“FDA”) in June 2013.

 

Property and Equipment

 

Property and equipment is stated at cost.  Depreciation is provided over the estimated useful lives of the assets, generally three to ten years, on a straight‑line basis.  Leasehold improvements are amortized on a straight‑line basis over the remaining lease term at the time the assets are capitalized or the estimated useful lives of the assets, whichever is shorter.

 

Depreciation expense for the years ended December 31 is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Depreciation expense

$
3,837 

 

$
3,662 

 

$
3,590 

 

Goodwill and Other Intangible Assets

 

The Company’s intangible assets consist of goodwill, patents, trademarks, and other intangible assets, as discussed in Note 9.  These assets include intangible assets from the acquisition of Hemosphere, as discussed in Note 4, and assets acquired from Cardiogenesis, as discussed in Note 6.  

 

The Company amortizes its definite lived intangible assets over their expected useful lives using the straight-line method, which the Company believes approximates the period of economic benefits of the related assets.  The Company’s indefinite lived intangible assets do not amortize, but are instead subject to periodic impairment testing as discussed in “Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets” below. 

 

Impairments of Long‑Lived Assets and Non-Amortizing Intangible Assets

 

The Company assesses the potential impairment of its long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable.  Factors that could trigger an impairment review include, but are not limited to, the following:

 

·

Significant underperformance relative to expected historical or projected future operating results,

·

Significant negative industry or economic trends,

·

Significant decline in the Company’s stock price for a sustained period, or

·

Significant decline in the Company’s market capitalization relative to net book value. 

 

If CryoLife determines that an impairment review is necessary, the Company will evaluate its assets or asset groups by comparing their carrying values to the sum of the undiscounted future cash flows expected to result from their use and eventual disposition.  If the carrying values exceed the future cash flows, then the asset or asset group is considered impaired, and the Company will write down the value of the asset or asset group.  For the years ended December 31, 2013,  2012, and 2011 the Company did not experience any factors that indicated that an impairment review of its long-lived assets was warranted.

 

CryoLife evaluates its goodwill and other non-amortizing intangible assets for impairment on an annual basis as of October 31 and, if necessary, during interim periods if factors indicate that an impairment review is warranted.  As of October 31, 2013 the Company’s non-amortizing intangible assets consisted of goodwill, acquired procurement contracts and agreements, trademarks, and other acquired technology.  The Company performed an analysis of its non-amortizing intangible assets as of October 31, 2013 and 2012, and determined that the fair value of the assets and the fair value of the reporting unit exceeded their associated carrying values and were, therefore, not impaired.  Management will continue to evaluate the recoverability of these non-amortizing intangible assets.

 

Accrued Procurement Fees

 

Donated tissue is procured from deceased human donors by OTPOs, which consign the tissue to the Company for processing, preservation, and distribution.  The Company reimburses the OTPOs for their costs to recover the tissue and passes these costs on to the customer when the tissue is shipped and the performance of the service is complete.  The Company accrues estimated procurement fees due to the OTPOs at the time tissues are received based on contractual agreements between the Company and the OTPOs.

Leases

 

The Company has operating lease obligations resulting from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment as discussed in Note 12.  Certain of the Company’s leases contain escalation clauses, rent concessions, and renewal options for additional periods.  Rent expense is computed on the straight‑line method over the lease term and the related liability is recorded as deferred rent obligations on the Company’s Consolidated Balance Sheets.

 

Liability Claims

 

In the normal course of business, the Company is made aware of adverse events involving its products and tissues.  Any adverse event could ultimately give rise to a lawsuit against the Company.  In addition, product and tissue processing liability claims may be asserted against the Company in the future based on events it is not aware of at the present time.  The Company maintains claims‑made insurance policies to mitigate its financial exposure to product and tissue processing liability claims.  Claims‑made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect.  Thus, a claims‑made policy does not generally represent a transfer of risk for claims and incidents that have been incurred but not reported to the insurance carrier during the policy period.  Any punitive damage components of claims are uninsured.

 

The Company engages external advisors to assist it in estimating its liability and any related recoverable under the Company's insurance policies as of each balance sheet date.  The Company uses a frequency‑severity approach to estimate its unreported product and tissue processing liability claims, whereby, projected losses are calculated by multiplying the estimated number of claims by the estimated average cost per claim.  The estimated claims are determined based on the reported claim development method and the Bornhuetter‑Ferguson method using a blend of the Company's historical claim experience and industry data.  The estimated cost per claim is calculated using a lognormal claims model blending the Company's historical average cost per claim with industry claims data.  The Company uses a number of assumptions in order to estimate the unreported loss liability including: the future claim reporting time lag, the frequency of reported claims, the average cost per claim, and the maximum liability per claim.  The Company believes that the assumptions it uses provide a reasonable basis for its calculation.  However, the accuracy of the estimates is limited by the general uncertainty that exists for any estimate of future activity due to uncertainties surrounding the assumptions used and due to Company specific conditions and the scarcity of industry data directly relevant to the Company's business activities.  Due to these factors, actual results may differ significantly from the assumptions used and amounts accrued.

 

The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long‑term liabilities and records the related recoverable insurance amounts as a component of receivables and other long‑term assets.  The amounts recorded represent management's estimate of the probable losses and anticipated recoveries for unreported claims related to products sold and services performed prior to the balance sheet date.

 

Legal Contingencies

 

The Company accrues losses from a legal contingency when the loss is both probable and reasonably estimable.  The accuracy of the Company’s estimates of losses for legal contingencies is limited by uncertainties surrounding litigation.  Therefore, actual results may differ significantly from the amounts accrued, if any.  The Company accrues for legal contingencies as a component of accrued expenses and other long‑term liabilities.  Gains from legal contingencies are recorded when the contingency is resolved. 

 

Legal Fees

 

The Company expenses the costs of legal services, including legal services related to product and tissue processing liability claims and legal contingencies, as they are incurred.  Reimbursement of legal fees by an insurance company or other third-party is recorded as a reduction to legal expense.

 

Uncertain Tax Positions

 

The Company periodically assesses its uncertain tax positions and recognizes tax benefits if they are “more-likely-than-not” to be upheld upon review by the appropriate taxing authority.  The Company measures the tax benefit by determining the maximum amount that has a “greater than 50 percent likelihood” of ultimately being realized.  The Company reverses previously accrued liabilities for uncertain tax positions when audits are concluded, statutes expire, administrative practices dictate that a liability is no longer warranted, or in other circumstances as deemed necessary.  These assessments can be complex and the Company often obtains assistance from external advisors to make these assessments.  The Company recognizes interest and penalties related to uncertain tax positions in other (income) expense, net on its Consolidated Statements of Operations and Comprehensive Income.  See Note 10 for further discussion of the Company’s liabilities for uncertain tax positions. 

 

Deferred Income Taxes

 

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes.  The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets.  Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.

 

Assessing the recoverability of deferred tax assets involves judgment and complexity.  Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following:

 

·

Projected future operating results,

·

Anticipated future state tax apportionment,

·

Timing and amounts of anticipated future taxable income,

·

Timing of the anticipated reversal of book/tax temporary differences,

·

Evaluation of statutory limits regarding usage of certain tax assets, and

·

Evaluation of the statutory periods over which certain tax assets can be utilized. 

 

Significant changes in the factors above, or other factors, could materially, adversely affect the Company’s ability to use its deferred tax assets.  Such changes could have a material, adverse impact on the Company’s operations, financial condition, and cash flows.  The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets. 

 

The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended.  The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company’s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control.  The Company also believes that its acquisition of Cardiogenesis constituted a change in control.  The deferred tax assets recorded on the Company’s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control.  A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized.  Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.

 

Valuation of Acquired Assets or Businesses

 

 As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies.  The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group, or as a business combination, as appropriate.  The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.

 

For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values.  In-process research and development acquired as part of an asset group is expensed upon acquisition.  The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value.  Transaction costs related to a business combination are expensed as incurred.  In-process research and development acquired as part of a business combination is accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.

 

The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief from royalty methods.  The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates.  Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge.  Management believes that its estimates are reasonable, but actual results could differ significantly from the Company’s estimates.  A significant change in management’s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company’s financial position and profitability.  If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company’s financial position and profitability.

 

Derivative Instruments

 

The Company determines the fair value of its stand-alone and embedded derivative instruments at issuance and records any resulting asset or liability on the Company’s Consolidated Balance Sheets.  Changes in the fair value of the derivative instruments are recognized in the line item change in valuation of derivative on the Company’s Consolidated Statements of Operations and Comprehensive Income. 

 

New Accounting Pronouncements

In January 2013 the Company adopted Accounting Standards Update ("ASU"), 2012-02, Intangibles-Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test.  The adoption of ASU 2012-02 did not have a material effect on the Company's financial condition, profitability, or cash flows.

 

In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220):  Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements.  This update also requires companies to disclose the income statement line items affected by any significant reclassifications.  The adoption of ASU 2013-02 did not have a material effect on the Company's financial disclosures.

 

XML 55 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cardiogenesis Acquisition (Tables) (Cardiogenesis [Member])
 12 Months Ended
Dec. 31, 2013
Cardiogenesis [Member]
  
Business Acquisition [Line Items]  
Business Acquisition Purchase Price Allocation

 

 

 

 

Opening

 

Balance Sheet

Cash and cash equivalents

$
650 

Receivables

 
1,055 

Inventory

 
852 

Property and equipment

 
248 

Intangible assets

 
11,900 

Goodwill

 
4,220 

Net deferred tax assets

 
5,002 

Other assets

 
230 

Liabilities assumed

 
(2,445)

Total purchase price

$
21,712 

 

Summary Of Unaudited Pro Forma Results Of Operations

 

 

 

 

 

 

2011

Total revenues

$
123,951 

Net income

 
7,962 

 

XML 56 R83.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income (Loss) Per Common Share [Line Items]                              
Net income $ 9,026 [1] $ 3,169 $ 1,785 $ 2,192 $ 2,083 $ 1,538 $ 3,334 $ 991 $ 1,866 $ 2,019 $ 1,820 $ 1,666 $ 16,172 $ 7,946 $ 7,371
Net income allocated to common shareholders, basic                         15,805 7,766 7,222
Basic weighted-average common shares outstanding                         26,885,000 26,967,000 27,441,000
Basic income per common share                         $ 0.59 $ 0.29 $ 0.26
Net income allocated to common shareholders, diluted                         15,813 7,768 7,224
Effect of dilutive stock options and awards                         813,000 [2] 444,000 [2] 318,000 [2]
Diluted weighted-average common shares outstanding                         27,698,000 27,411,000 27,759,000
Diluted income per common share $ 0.31 [1] $ 0.11 $ 0.06 $ 0.08 $ 0.07 $ 0.06 $ 0.12 $ 0.04 $ 0.07 $ 0.07 $ 0.06 $ 0.06 $ 0.57 $ 0.28 $ 0.26
Antidilutive securities excluded from computation of earnings per share                         656,000 1,700,000 2,000,000
Basic [Member]
                              
Income (Loss) Per Common Share [Line Items]                              
Net income allocated to participating securities                         (367) (180) (149)
Diluted [Member]
                              
Income (Loss) Per Common Share [Line Items]                              
Net income allocated to participating securities                         $ (359) $ (178) $ (147)
[1] The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.
[2] The Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share. Accordingly, stock options to purchase 656,000, 1.7 million, and 2.0 million, shares for the years ended December 31, 2013, 2012, and 2011, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.
XML 57 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Information (Tables)
 12 Months Ended
Dec. 31, 2013
Selected Quarterly Financial Information [Abstract]  
Schedule Of Quarterly Financial Information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

First

 

Second

 

Third

 

Fourth

 

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

REVENUE:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
35,536 

 

$
33,520 

 

$
36,250 

 

$
35,457 

 

2012

 
32,301 

 

 
33,188 

 

 
33,429 

 

 
32,800 

 

2011

 
30,196 

 

 
29,379 

 

 
29,654 

 

 
30,397 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS MARGIN:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
23,276 

 

$
21,479 

 

$
23,349 

 

$
22,282 

 

2012

 
21,292 

 

 
21,371 

 

 
21,310 

 

 
21,045 

 

2011

 
18,504 

 

 
19,053 

 

 
18,912 

 

 
19,375 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
2,192 

 

$
1,785 

 

$
3,169 

 

$
9,026 

*

2012

 
991 

 

 
3,334 

 

 
1,538 

 

 
2,083 

 

2011

 
1,666 

 

 
1,820 

 

 
2,019 

 

 
1,866 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME PER COMMON SHARE—DILUTED:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
0.08 

 

$
0.06 

 

$
0.11 

 

$
0.31 

*

2012

 
0.04 

 

 
0.12 

 

 
0.06 

 

 
0.07 

 

2011

 
0.06 

 

 
0.06 

 

 
0.07 

 

 
0.07 

 

 

 

*The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.

XML 58 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cardiogenesis Acquisition (Business Acquisition Purchase Price Allocation) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cardiogenesis [Member]
May 17, 2011
Cardiogenesis [Member]
Business Acquisition [Line Items]        
Cash and cash equivalents     $ 650  
Receivables     1,055  
Inventories     852  
Property and equipment     248  
Intangible assets     11,900  
Goodwill 11,365 11,365 4,220  
Net deferred tax assets     5,002  
Other assets     230  
Liabilities assumed     (2,445)  
Total purchase price     $ 21,712 $ 21,700
XML 59 R72.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity (Details) (USD $)
 0 Months Ended 9 Months Ended 12 Months Ended
May 28, 2013
Feb. 01, 2013
Aug. 21, 2012
Aug. 07, 2012
Nov. 01, 2011
May 27, 2013
Dec. 31, 2013
Dec. 31, 2012
Common stock repurchase, authorized amount   $ 15,000,000     $ 15,000,000      
Stock repurchased during period, shares             253,000 639,000
Stock repurchased during period, aggregate purchase price             1,500,000 3,300,000
Common stock repurchase, remaining authorized amount             13,500,000  
Retired shares of treasury stock       2,700,000        
Retirement of treasury shares       15,100,000        
Increase in quarterly cash dividend, percentage 10.00%              
Quarterly cash dividend per share of common stock outstanding approved $ 0.0275   $ 0.025     $ 0.025 $ 0.108 $ 0.050
Initial quarterly cash dividend per share paid             $ 0.108 $ 0.050
Dividend payment from cash on hand             2,967,000 1,373,000
Price of Rights per unit             $ 33.33  
Rights conditions, minimum acquisition percentage of common stock             15.00%  
Series A Stock purchasable upon exercise of a Right, minimum preferential quarterly dividend payment             $ 1.00  
Number of times an aggregate dividend is bigger than common stock dividend             100  
Number of times liquidation payment of preferred stock per share is bigger over common stock per share             100  
During merger, Number of times amount received per share of preferred stock is bigger than amount received per share of common stock             100  
Minimum percentage of consolidated assets or earning power to be sold to qualify for preferred stock provision             50.00%  
Minimum percentage of common stock acquired to qualify for preferred stock provision             50.00%  
Treasury Stock [Member]
                
Retirement of treasury shares       15,100,000        
Common Stock [Member]
                
Retirement of treasury shares       27,000        
Additional Paid-In Capital [Member]
                
Retirement of treasury shares       $ 15,100,000        
XML 60 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 37,643,000 $ 13,009,000
Restricted cash and securities 5,350,000 323,000
Receivables:    
Trade accounts, net 17,838,000 15,941,000
Other 469,000 579,000
Total receivables 18,307,000 16,520,000
Deferred preservation costs 27,297,000 27,954,000
Inventories 9,771,000 10,557,000
Deferred income taxes 5,162,000 6,100,000
Prepaid expenses and other 2,797,000 3,040,000
Total current assets 106,327,000 77,503,000
Property and equipment:    
Equipment and software 26,976,000 24,007,000
Furniture and fixtures 4,390,000 4,339,000
Leasehold improvements 30,051,000 29,440,000
Total property and equipment 61,417,000 57,786,000
Less accumulated depreciation and amortization 49,246,000 46,119,000
Net property and equipment 12,171,000 11,667,000
Other assets:    
Investment in equity securities   5,908,000
Restricted cash   5,000,000
Goodwill 11,365,000 11,365,000
Patents, less accumulated amortization of $2,414 in 2013 and $2,530 in 2012 1,934,000 2,114,000
Trademarks and other intangibles, less accumulated amortization of $4,593 in 2013 and $2,886 in 2012 19,985,000 21,968,000
Notes receivable 2,000,000 2,000,000
Deferred income taxes 16,885,000 16,564,000
Other 4,016,000 3,067,000
Total assets 174,683,000 157,156,000
Current liabilities:    
Accounts payable 4,137,000 3,156,000
Taxes payable 1,377,000 619,000
Accrued compensation 4,886,000 5,055,000
Accrued procurement fees 5,427,000 4,762,000
Accrued expenses 2,411,000 4,205,000
Deferred income 316,000 1,401,000
Other 2,168,000 2,232,000
Total current liabilities 20,722,000 21,430,000
Contingent consideration liability 1,884,000 1,912,000
Deferred compensation liability 1,533,000 796,000
Deferred rent obligations 1,686,000 1,603,000
Other 4,111,000 3,303,000
Total liabilities 29,936,000 29,044,000
Shareholders' equity:    
Common stock $0.01 par value per share, 75,000 shares authorized, 28,244 shares issued in 2013 and 27,486 shares issued in 2012 282,000 275,000
Additional paid-in capital 128,585,000 122,414,000
Retained earnings 18,741,000 5,536,000
Accumulated other comprehensive income (loss) 7,000 (39,000)
Treasury stock at cost, 413 shares in 2013 and 14 shares in 2012 (2,868,000) (74,000)
Total shareholders' equity 144,747,000 128,112,000
Total liabilities and shareholders' equity 174,683,000 157,156,000
Series A Junior Participating Preferred Stock [Member]
    
Shareholders' equity:    
Preferred stock      
Convertible Preferred Stock [Member]
    
Shareholders' equity:    
Preferred stock      
XML 61 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Financial Instruments [Abstract]    
Contingent consideration, balance as of December 31, 2012 $ 1,912,000  
Gain on remeasurement of contingent consideration (28,000) 72,000
Contingent consideration, balance as of December 31, 2013 $ 1,884,000 $ 1,912,000
XML 62 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement Of Shareholders' Equity (USD $)
In Thousands, except Share data
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings (Deficit) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Total
Balance at Dec. 31, 2010 $ 300 $ 133,845 $ (8,408) $ (32) $ (11,763) $ 113,942
Balance, shares at Dec. 31, 2010 29,950,000       (2,049,000)  
Net income     7,371     7,371
Other comprehensive income (loss)       26   26
Comprehensive income           7,397
Equity compensation   965     2,049 3,014
Equity compensation, shares (25,000)       360,000  
Exercise of options 1 380     27 408
Exercise of options, shares 84,000       37,000 260,000
Employee stock purchase plan   286       286
Employee stock purchase plan, shares 64,000         64,000
Excess tax shortfall   (445)       (445)
Repurchase of common stock         (2,926) (2,926)
Repurchase of common stock, shares         (593,000)  
Redemption and repurchase of stock to cover tax withholdings   (28)     (110) (138)
Redemption and repurchase of stock to cover tax withholdings, shares (6,000)       (20,000)  
Balance at Dec. 31, 2011 301 135,003 (1,037) (6) (12,723) 121,538
Balance, shares at Dec. 31, 2011 30,067,000       (2,265,000)  
Net income     7,946     7,946
Other comprehensive income (loss)       (33)   (33)
Comprehensive income           7,913
Cash dividends paid     (1,373)     (1,373)
Equity compensation   2,410     966 3,376
Equity compensation, shares 37,000       229,000  
Exercise of options   37       37
Exercise of options, shares 8,000         48,000
Employee stock purchase plan 1 292       293
Employee stock purchase plan, shares 72,000         72,000
Excess tax shortfall   (143)       (143)
Repurchase of common stock         (3,310) (3,310)
Repurchase of common stock, shares         (639,000)  
Redemption and repurchase of stock to cover tax withholdings   (66)     (153) (219)
Redemption and repurchase of stock to cover tax withholdings, shares (11,000)       (26,000)  
Shares retired (27) (15,119)     15,146  
Shares retired, shares (2,687,000)       2,687,000  
Balance at Dec. 31, 2012 275 122,414 5,536 (39) (74) 128,112
Balance, shares at Dec. 31, 2012 27,486,000       (14,000)  
Net income     16,172     16,172
Other comprehensive income (loss)       46   46
Comprehensive income           16,218
Cash dividends paid     (2,967)     (2,967)
Equity compensation 3 3,465       3,468
Equity compensation, shares 352,000          
Exercise of options 4 2,728     (1,000) 1,732
Exercise of options, shares 365,000       (102,000) 365,000
Employee stock purchase plan 1 474       475
Employee stock purchase plan, shares 97,000         97,000
Excess tax shortfall   (87)       (87)
Repurchase of common stock         (1,523) (1,523)
Repurchase of common stock, shares         (253,000)  
Redemption and repurchase of stock to cover tax withholdings (1) (409)     (271) (681)
Redemption and repurchase of stock to cover tax withholdings, shares (56,000)       (44,000)  
Balance at Dec. 31, 2013 $ 282 $ 128,585 $ 18,741 $ 7 $ (2,868) $ 144,747
Balance, shares at Dec. 31, 2013 28,244,000       (413,000)  
XML 63 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Schedule Of Goodwill By Reportable Segment) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Medical Devices Segment [Member]
Dec. 31, 2012
Medical Devices Segment [Member]
Dec. 31, 2011
Medical Devices Segment [Member]
Dec. 31, 2012
Hemosphere [Member]
Dec. 31, 2012
Hemosphere [Member]
Medical Devices Segment [Member]
Goodwill [Line Items]              
Balance as of January 1, $ 11,365 $ 11,365 $ 11,365 $ 11,365 $ 4,220 $ 7,145  
Goodwill from Hemosphere acquisition             7,145
Balance as of December 31, $ 11,365 $ 11,365 $ 11,365 $ 11,365 $ 4,220 $ 7,145  
XML 64 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2013
Income Taxes [Abstract]  
Schedule Of Income Before Income Tax

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Domestic

$
23,004 

 

$
11,686 

 

$
11,238 

Foreign

 
288 

 

 
366 

 

 
228 

Income before income taxes

$
23,292 

 

$
12,052 

 

$
11,466 

 

Schedule Of Components Of Income Tax Expense

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Current:

 

 

 

 

 

 

 

 

Federal

$
6,304 

 

$
2,778 

 

$
2,634 

State

 
396 

 

 
180 

 

 
103 

Foreign

 
96 

 

 
98 

 

 
84 

 

 
6,796 

 

 
3,056 

 

 
2,821 

Deferred:

 

 

 

 

 

 

 

 

Federal

 
1,142 

 

 
1,274 

 

 
1,087 

State

 
(818)

 

 
(227)

 

 
183 

Foreign

 

 -

 

 
3 

 

 
4 

 

 
324 

 

 
1,050 

 

 
1,274 

Income tax expense

$
7,120 

 

$
4,106 

 

$
4,095 

 

Schedule Of Effective Income Tax Rate Reconciliation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Tax expense at statutory rate

$
8,152 

 

$
4,220 

 

$
4,013 

Increase (reduction) in income taxes resulting from:

 

 

 

 

 

 

 

 

Non-deductible transaction costs

 

--

 

 
151 

 

 
540 

State income taxes, net of federal benefit

 
183 

 

 
296 

 

 
150 

State valuation allowance adjustment

 
(760)

 

 
(427)

 

 
100 

Equity compensation

 
(29)

 

 
32 

 

 
149 

Non-deductible entertainment expenses

 
207 

 

 
188 

 

 
142 

Foreign income taxes

 
96 

 

 
(199)

 

 
3 

Domestic production activities deduction

 
(402)

 

 
(407)

 

 
(727)

Research and development credit

 
(392)

 

 

--

 

 
(314)

Other

 
65 

 

 
252 

 

 
39 

 

$
7,120 

 

$
4,106 

 

$
4,095 

 

Schedule Of Deferred Tax Assets And Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

Deferred tax assets:

 

 

 

 

 

Allowance for bad debts

$
131 

 

$
194 

Deferred preservation costs and inventory write-downs

 
1,077 

 

 
392 

Investment in equity securities

 
1,959 

 

 
925 

Property

 
2,737 

 

 
2,644 

Intangible assets

 
422 

 

 
502 

Accrued expenses

 
3,766 

 

 
3,782 

Loss carryforwards

 
15,689 

 

 
17,539 

Credit carryforwards

 
241 

 

 
2,166 

Stock compensation

 
2,409 

 

 
2,319 

Other

 
1,108 

 

 
969 

Less valuation allowance

 
(1,532)

 

 
(2,292)

Total deferred tax assets

 
28,007 

 

 
29,140 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Prepaid items

 
(451)

 

 
(314)

Intangible assets

 
(5,289)

 

 
(5,814)

Other

 
(220)

 

 
(348)

Total deferred tax liabilities

 
(5,960)

 

 
(6,476)

 

 

 

 

 

 

Total net deferred tax assets

$
22,047 

 

$
22,664 

 

Schedule Of Uncertain Tax Position Liability And Liability For Interest And Penalties On Uncertain Tax Positions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Beginning balance

$
2,004 

 

$
1,788 

 

$
1,822 

Increases related to current year tax positions

 
281 

 

 
231 

 

 
78 

Decreases related to prior year tax positions

 
(185)

 

 
(15)

 

 
(112)

Ending balance

$
2,100 

 

$
2,004 

 

$
1,788 

 

A reconciliation of the beginning and ending balances of the Company’s liability for interest and penalties on uncertain tax positions is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Beginning balance

$
489 

 

$
418 

 

$
391 

Accrual of interest and penalties

 
66 

 

 
79 

 

 
65 

Decreases related to prior year tax positions

 
(133)

 

 
(8)

 

 
(38)

Ending balance

$
422 

 

$
489 

 

$
418 

 

XML 65 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Schedule Of Components Of Income Tax Expense) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Taxes [Abstract]      
Current, Federal $ 6,304 $ 2,778 $ 2,634
Current, State 396 180 103
Current, Foreign 96 98 84
Income tax expense, Current 6,796 3,056 2,821
Deferred, Federal 1,142 1,274 1,087
Deferred, State (818) (227) 183
Deferred, Foreign   3 4
Income tax expense, Deferred 324 1,050 1,274
Income tax expense $ 7,120 $ 4,106 $ 4,095
XML 66 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation
 12 Months Ended
Dec. 31, 2013
Stock Compensation [Abstract]  
Stock Compensation

15.  Stock Compensation

 

Overview

 

Under the Company’s plans, the Company is currently authorized to grant the following number of shares and the Company has available for grant up to the following number of shares as of December 31, 2013 and 2012:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Authorized

 

Available for Grant

Plan

 

Shares

 

2013

 

2012

1996 Discounted Employee Stock Purchase Plan, as amended

 
1,900,000 

 
749,000 

 
847,000 

2004 Employee Stock Incentive Plan

 
2,100,000 

 
60,000 

 
41,000 

2008 Non-Employee Directors Stock Incentive Plan

 
300,000 

 

--

 
27,000 

2009 Employee Stock Incentive Plan

 
4,100,000 

 
2,221,000 

 
2,847,000 

Total

 
8,400,000 

 
3,030,000 

 
3,762,000 

 

During 2012 the Company amended the 2009 Employee Stock Incentive Plan to increase the authorized shares under the plan by 2.1 million shares.  Upon the exercise of stock options or grants of RSAs, RSUs, or PSUs, the Company may issue the required shares out of authorized but unissued common stock or out of treasury stock, at management’s discretion. 

 

Stock Awards

 

In 2013 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled 467,000 shares of common stock and had an aggregate market value of $3.1 million.  The PSUs granted in 2013 represent the right to receive from 50% to 150% of the target numbers of shares of common stock.  The performance component of PSU awards granted in 2013 is based on the attainment of specified levels of adjusted EBITDA, as defined in the grant, for the 2013 calendar year.  The PSUs granted in 2013 earned approximately 115% of the target number of shares.

 

In 2012 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, counting PSUs at target levels, together totaled 451,000 shares of common stock and had an aggregate market value of $2.4 million.  The PSUs granted in 2012 earned approximately 125% of the target number of shares.

 

In 2011 the Compensation Committee of the Company’s Board of Directors authorized awards from approved stock incentive plans of RSAs to non-employee Directors and certain Company officers and RSUs to certain employees,  which together totaled 421,000 shares of common stock and had an aggregate market value of $2.2 million. 

 

A summary of stock grant activity for the years ended December 31, 2013,  2012, and 2011 for RSAs, RSUs, and PSUs, based on shares granted at goal, is as follows: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

 

 

 

Grant Date

 

 

RSAs

 

Shares

 

Fair Value

 

 

Unvested at December 31, 2010

 
364,000 

 

$
7.07 

 

 

Granted

 
360,000 

 

 
5.18 

 

 

Vested

 
(128,000)

 

 
7.28 

 

 

Forfeited

 
(44,000)

 

 
5.48 

 

 

Unvested at December 31, 2011

 
552,000 

 

 
5.91 

 

 

Granted

 
229,000 

 

 
5.39 

 

 

Vested

 
(142,000)

 

 
7.00 

 

 

Unvested at December 31, 2012

 
639,000 

 

 
5.48 

 

 

Granted

 
232,000 

 

 
6.10 

 

 

Vested

 
(215,000)

 

 
5.80 

 

 

Forfeited

 
(34,000)

 

 
5.31 

 

 

Unvested at December 31, 2013

 
622,000 

 

 
5.62 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

Contractual

 

Intrinsic

RSUs

 

Shares

 

Term in years

 

Value

Outstanding at December 31, 2010

 
58,000 

 

 
1.85 

 

$
313,000 

Granted

 
61,000 

 

 

 

 

 

 

Vested

 
(19,000)

 

 

 

 

 

 

Forfeited

 
(3,000)

 

 

 

 

 

 

Outstanding at December 31, 2011

 
97,000 

 

 
1.66 

 

 
466,000 

Granted

 
64,000 

 

 

 

 

 

 

Vested

 
(37,000)

 

 

 

 

 

 

Forfeited

 
(4,000)

 

 

 

 

 

 

Outstanding at December 31, 2012

 
120,000 

 

 
1.54 

 

 
747,000 

Granted

 
73,000 

 

 

 

 

 

 

Vested

 
(54,000)

 

 

 

 

 

 

Forfeited

 
(10,000)

 

 

 

 

 

 

Outstanding at December 31, 2013

 
129,000 

 

 
1.56 

 

 
1,425,000 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
118,000 

 

 
1.55 

 

$
1,314,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

Contractual

 

Intrinsic

PSUs

 

Shares

 

Term in years

 

Value

Outstanding at December 31, 2011

 

--

 

 

--

 

$

--

Granted

 
159,000 

 

 

 

 

 

 

Vested

 

--

 

 

 

 

 

 

Forfeited

 

--

 

 

 

 

 

 

Outstanding at December 31, 2012

 
159,000 

 

 
0.93 

 

 
989,000 

Granted

 
182,000 

 

 

 

 

 

 

Vested

 
(99,000)

 

 

 

 

 

 

Forfeited

 
(6,000)

 

 

 

 

 

 

Outstanding at December 31, 2013

 
236,000 

 

 
0.81 

 

 
2,612,000 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
224,000 

 

 
0.78 

 

$
2,487,000 

 

Stock Options

 

The Compensation Committee of the Company’s Board of Directors authorized grants of stock options from approved stock incentive plans to certain Company officers and employees totaling 162,000,  159,000, and 599,000 shares in 2013,  2012, and 2011, respectively, with exercise prices equal to the stock prices on the respective grant dates. 

 

A summary of the Company’s stock option activity for the years ended December 31, 2013,  2012, and 2011 follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted

 

Remaining

 

Aggregate

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

Shares

 

Exercise Price

 

Term in years

 

Value

Outstanding at December 31, 2010

 
2,281,000 

 

$
6.74 

 

 
3.46 

 

$
603,000 

Granted

 
599,000 

 

 
5.13 

 

 

 

 

 

 

Exercised

 
(260,000)

 

 
4.53 

 

 

 

 

 

 

Forfeited

 
(100,000)

 

 
5.60 

 

 

 

 

 

 

Expired

 
(320,000)

 

 
5.30 

 

 

 

 

 

 

Outstanding at December 31, 2011

 
2,200,000 

 

 
6.83 

 

 
4.00 

 

 

--

Granted

 
159,000 

 

 
5.67 

 

 

 

 

 

 

Exercised

 
(48,000)

 

 
5.64 

 

 

 

 

 

 

Forfeited

 
(2,000)

 

 
7.01 

 

 

 

 

 

 

Expired

 
(249,000)

 

 
7.03 

 

 

 

 

 

 

Outstanding at December 31, 2012

 
2,060,000 

 

 
6.74 

 

 
3.66 

 

 
1,225,000 

Granted

 
162,000 

 

 
6.12 

 

 

 

 

 

 

Exercised

 
(365,000)

 

 
7.48 

 

 

 

 

 

 

Forfeited

 
(49,000)

 

 
5.56 

 

 

 

 

 

 

Expired

 
(14,000)

 

 
6.69 

 

 

 

 

 

 

Outstanding at December 31, 2013

 
1,794,000 

 

 
6.57 

 

 
3.31 

 

 
8,274,000 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest

 
1,781,000 

 

$
6.57 

 

 
3.29 

 

$
8,205,000 

Exercisable at December 31, 2013

 
1,372,000 

 

$
6.86 

 

 
2.75 

 

$
5,971,000 

 

Other information concerning stock options for the years ended December 31 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Weighted-average fair value of options granted

$
2.54 

 

$
2.67 

 

$
2.54 

Intrinsic value of options exercised

 
673,000 

 

 
10,000 

 

 
261,000 

 

Employees purchased common stock totaling 97,000,  72,000, and 64,000 shares in 2013,  2012, and 2011, respectively, through the Company’s ESPP.

 

Stock Compensation Expense

 

The following weighted‑average assumptions were used to determine the fair value of options:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

 

Stock

 

ESPP

 

Stock

 

ESPP

 

Stock

 

ESPP

 

Options

 

Options

 

Options

 

Options

 

Options

 

Options

Expected life of options

4.3 Years

 

.50 Years

 

4.3 Years

 

.50 Years

 

4.0 Years

 

.50 Years

Expected stock price volatility
0.60 

 
0.39 

 
0.60 

 
0.48 

 
0.65 

 
0.39 

Dividends
1.91% 

 
1.59% 

 

N/A

 

N/A

 

N/A

 

N/A

Risk-free interest rate
0.70% 

 
0.13% 

 
0.71% 

 
0.12% 

 
1.25% 

 
0.14% 

 

The following table summarizes stock compensation expenses (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

RSA, RSU, and PSU expense

$
2,616 

 

$
2,204 

 

$
1,408 

Stock option and ESPP option expense

 
852 

 

 
1,172 

 

 
1,606 

Total stock compensation expense

$
3,468 

 

$
3,376 

 

$
3,014 

 

Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the Company’s ESPP.  These amounts were recorded as stock compensation expense and were subject to the Company’s normal allocation of expenses to deferred preservation costs and inventory costs.  The Company capitalized $228,000, $214,000 and $224,000 in the years ended December 31, 2013,  2012,  and 2011, respectively, of the stock compensation expense into its deferred preservation costs and inventory costs.

 

As of December 31, 2013 the Company had total unrecognized compensation costs of $532,000 related to unvested stock options and $2.8 million related to RSAs, RSUs, and PSUs, before considering the effect of expected forfeitures.  As of December 31, 2013 this expense is expected to be recognized over a weighted-average period of 1.13 years for stock options, 0.92 years for RSAs, 2.27 years for RSUs, and 0.81 years for PSUs. 

 

XML 67 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingencies (Tables)
 12 Months Ended
Dec. 31, 2013
Commitments And Contingencies [Abstract]  
Schedule Of Future Minimum Operating Lease Payments

 

 

 

 

 

 

 

Operating

 

Leases

2014

$
2,799 

2015

 
3,031 

2016

 
2,943 

2017

 
2,980 

2018

 
3,010 

Thereafter

 
10,124 

Total minimum lease payments

$
24,887 

 

XML 68 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Transactions With Related Parties
 12 Months Ended
Dec. 31, 2013
Transactions With Related Parties [Abstract]  
Transactions With Related Parties

17.  Transactions with Related Parties

 

An investment banking services company employee became a member of the Company’s Board of Directors and a shareholder of the Company in 2012.  The Company made stock repurchases of $321,000, $794,000, and $2.9 million in 2013,  2012, and 2011, respectively, which includes the cost of stock and commissions of less than 1%, and expensed $818,000 in 2011 for investment banking services from that company.  The Company did not record expenses for investment banking services from that company in 2013 or 2012.

 

A member of the Company’s Board of Directors and a shareholder of the Company is a current employee of and the former Chief of Thoracic Surgery of a university hospital that generated preservation services and product revenues of $353,000, $267,000, and $198,000 for the Company in 2013,  2012, and 2011, respectively.  Additionally, the son of this member of the Company’s Board of Directors receives a retainer for performing heart and lung transplants from a medical center that generated preservation services and product revenues of $345,000, $312,000, and $219,000 for the Company in 2013,  2012, and 2011, respectively.

 

The Company expensed $47,000, $22,000, and $45,000 in 2013,  2012, and 2011, respectively, relating to supplies for clinical trials purchased from a company whose Chief Financial Officer is a member of the Company's Board of Directors and a shareholder of the Company. 

 

A relative of the Company’s CEO is employed as a vice president of the Company.  His compensation and benefits are set and subject to review by the Compensation Committee of the Board of Directors.

 

XML 69 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Schedule Of Uncertain Tax Position Liability And Liability For Interest And Penalties On Uncertain Tax Positions) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Taxes [Abstract]      
Beginning balance $ 2,004 $ 1,788 $ 1,822
Increases related to current year tax positions 281 231 78
Decreases related to prior year tax positions (185) (15) (112)
Ending balance 2,100 2,004 1,788
Beginning Balance 489 418 391
Accrual of interest and penalties 66 79 65
Decreases related to prior year tax positions (133) (8) (38)
Ending Balance $ 422 $ 489 $ 418
XML 70 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 71 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement Of Shareholders' Equity (Parenthetical) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Consolidated Statement Of Stockholders' Equity [Abstract]    
Cash dividends paid per share $ 0.108 $ 0.050
XML 72 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]    
Trademarks and other intangibles, accumulated amortization $ 4,593 $ 2,886
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 5,000,000 5,000,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 28,244,000 27,486,000
Treasury stock, shares 413,000 14,000
Series A Junior Participating Preferred Stock [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 0 0
Convertible Preferred Stock [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Preferred stock, shares authorized 460,000 460,000
Preferred stock, shares issued 0 0
Patents [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Accumulated amortization $ 2,414 $ 2,530
ZIP 73 0001193125-14-062525-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-14-062525-xbrl.zip M4$L#!!0````(`.UT540#_^6N3S\"`/Q$.0`0`!P`8W)Y+3(P,3,Q,C,Q+GAM M;%54"0`#;JL'4VZK!U-U>`L``00E#@``!#D!``#L76USHSBV_KQ3-?^!3=6= M3^..[;QUTNG9REMWYV[23B7IV=U/*05D6[YQQ)1]+1Z3_>1K;Q@ADGU/F\T_G0WC&P8U*+.(//.S\>6F1BRW@E[M"X M8)3S/F'8>)X8]^0%N\8#[;NO2%P)7V@ M&F>W0_D#90#S5WMLECI36Q#M!R1.3>H[+)M$3?FF. MS0\#^K(;WI3OVVNU.ZV]3O18[!'Y$O&;VJ3O2^07[W1GA2U,TNL7-U+J)ISN M=SM'>4($):8/V,3YF5-:WGX6RIT6]WAK@-`X>J*/^+-?.KR1\DFR0FM.B+#^ MP]W@9KPH60*`MX6O?]WS2W>.CX]W_;M144[2"HIJ.[O_OKUY,(=XA%K1"P0G M#.-45G#"_5OWN&_X%9X,&>Y_WA&@M:98?7CCUDYXUYV,A25P,AK;>&?7K^;7 M7T(J4L?%;X+LV'0%QWWBB9>8X65B?=ZY]!B2]YXZXE]9_=,C?>ITG_;"7^*M M3]?""D?X1MC0'687=#2BSL-0&,39&^%^@4MB>X+RMWCTC%D@B7B-,$/B3L)? MXC>QY)4^PRF\PQ]3TK8[HH[H:E00.]:L6*!;1=LMS)\N\7P[2J`+]BN%MAV$MAVP'8KP[=3#-^.`OB" M[:J-[<>G@\@O?WPZ"OX.QR5/#ZZH60IR]9Q(!>Q#4VD<\@MR`>X) MW,\LB\BZD'V'B'7M7*`Q<9'=*`[DRMAT/E2.H8(*.>-/O7X\LC!E^[7S@KDK MT7RDR((%_U+^(.B?,X9!C?BBJ'7`]36)0LZ.T4$*UL"PC"B&XB MJ#"]MCD#H>VN/W9;=\#=#E42#+FGXV^U=")&H.T".A'%.J7H)#WX M#T/5>H:J:DP/`/JU!2H4"#`#^O6@7T_X>3W/#X&J;?7Z@/RV>GQ`7A]OGQFS M*0;U/781<;!UA9A#G($FX_J">*<+ITV$9EDL86ZAL*)?CEQB(+?GGC?GE-Q.=G%MJ) MF86V6DMKVL5"[NU20^ZS0>.=C9SO:#1;0O?X2A^'U./(L;X+!WXU&MMT@K$_ M`R'@EY*]8/F4'JR/RQ+DRAO:ZKO=X8VM!>:]9> MK\F,HLM8H?G>L*M78&%K%A?.7A&SHNV+TZL)!?7&LB(]H$^(,XLG9LJSM4A+ ML\]T>8&&-)D+FH-KKX8T6'D3L<_:F`;8;Q+[>K:F MS4TCON/A[S%W&3'%\,97U`^'N/S^X8>6L,\6=>3(5"GBM/9PHD)4NC39HO3<`!8^H MZC+B)9%K$F*:(05#@,W96%6+@,'&%$-JO=D3`$Z_R/ER"$,WF)@'^3LMRQZCEF6Y/D)Z]$#/95IS9MK])_B&0 M5I-81)I(L00`J3(UR9>O@K@T\C\1-ST;L4?"N:=)UH=TK*5YITD#*$]$<1?9 MX5VM#=K??;$H#&`<88RYN.[7%!9H"MY9@@'VDZ=[_!)Z/O)?OZ9';`X=:M,! MT1__`L(!!R9R$NG"IHIWT-]'.R'&%N$:I;+ZBNF`H?&0F,B.P+T6%3('!:G* M](`X4Z``YQ2)M@CM3"O^AN][7QGJ:V_'_C,L!.@_'E3'-Z\Q#H0X^?'0)$P/GCJS M0^%3ENB<>YPXF/,S\R^/<#\';*P-'E$^'F*FB9/.D&7:#B>%J3K,?=#J%#CG M?B/+L"#,W=1E6$LA#F'N;4$9PMQ;@S&$N;<0>PAS`P<@S*TUKA#FWB:T(;O4\L+]6 M.VAU#A79CPC![J;N3UP*<0AV;PO*$.S>&HPAV+V%V$.P&S@`P6ZM<85@]S:A MG1/L'E&A.:Y]5WQ.$,`6@MW;@#$$NQN'-02[]<4T:YW^/;9%Y=:=^)3)(T,. M1Z:?,.A\$K\S2Z9$G5X_T$:O?TZ%Z^OUHW,\];#PXA*':93>%[E)>P#>F?`" MOJC.%[5R?`)?5.?+9MJCS!.5KIT7S%WY\0MY06^I@R>WB/W$[A?/L33!?U&@ M6%:\5(DT/%T)4-/G!)A<6Y-.]SN]1:['Q+=)P]87+^E-TV1IAGT!4DK:U`UQ M<*]_P;!%W"_()#:)=6>^7@4WHJ2*@3Q-27J<)7L`<(;P.B<^+L_R*QJ?;U?7 M&4;EP!*E6:+U6!Q8TJ@1^(PE,I7UK,T1?X9MCH7)TPT>(/O*__;YY.77CJDV M].+[3^:^/Y&M/!*@XI:ATVYUVP5:!E%L?32/8BW#<92F'*`LR7T?%4M`?KQ& M`O+,H44T5W5A(\Y[??]`A\1HX8**P15SR;.-[QCN8\:T.D,G4\!9=_X="=7M MX*^`:G"V`".8_Z_G$,ID"R5D&@M#=P8-PS^:2+\WR,[J2^F2\2ZS+[7I+'<*#(6SL-1H6VXJ+#]..ZB,B'`RF+>!%4QU?"5MP M)Q=T-*:.^,F3N\E-TQMY?N31WX$MBS$\E+I^P=>.24>*=R,6.H5IXL9VFA>5 M=XNF:8`IZC)%C?XI,$5]IM2\8/(2]T77RSH7W:L^<>]LY/!+PDV;K_$>NT@ZR2O$'.(,-/'[!;N(Z<(UIS_8?NI^3(*>L?3X.W7. MA$06MN9BGZLL6%:='%E+D.>54&8(M)+%SVOXF(Z_H.CCFFU,87X!N8!9-6R= M4)TLJF%75<\3L*L>NXK7-<",U49GK&J(+B]]$&OOF5,;NS@WT^`WY%AC@AN0 M4',E<1LX7[7R@;VFT`JG;!(6U)T/N6(U`/>&6#)P2%]^0%VQ=.Z*Y&<@U MFV><8Y>?3V[1_U'FKP),A!(>&;+P"+&?FKB")>6=XG3Q[O00F`:<>I,K6ZW'WRBZ`A$XL$$.*+JV$#C0 M^&.PLOQ`W@:8^6UA!8D3IA>0^90OL7\L37A;#^;D[FA9=J=T:(MOZLP$BV\`3B&SK%MFN>7<,-#L;;W8VD*4%F@^%F@]%\4X) M:3<2Z!5"]YHC7#R4V"C`RPL1-@!_Z.@IT-%3D!=949W&H;]J^$H9C"$TI$8? MO:H,6]!'5[./KA+>T$=O*L+01Z^OCZX*_M!'5ZN/K@HOH(^N"\:Q<1@B[$]D M>_A\$OWY36@6,7,XN<$OV$XT[%&9:V?LN=POL*<)RH4DG;7M.:+J.!8#G)7" MN:RLMP=/G?UHHE7\./1_5([1LE.%!ZW._OM3A;+88=6;JLY>$;,>)^/DFJA[ M+!MTT\76@TO-GWI0/2%*_!3(%%D:N,UI.82#@X\Q]G72&\N*M$8Y4YX&()W9 M70%H]>AX9"$FAPES[LDOP.^VU6ZO]F$8.E=7(?C&-'):AD7C[O3?U M&,III%@[U]XKI4?33ETOJ99.NO(DW,TM(3V*J63J29332"%/TBW7DW3CGD0] MC13Q)-UR/4DW[DG4TTBQA;+E>I*Y\R_4TDFGF"3=.*>1#V-%#M$I21/4O!`K:N_/"'!!1V-J8/G#]*Y MQRXB#K:N$'.(,]!D^)8K6SS0EB9<`^(O2Q^H!1S8(`=JWGKSB-XN&+:(>X$8 MF_0IDY&,*+KSB-\0CXKH`76F1$'D)DTD=2,QF;A=XF?W6E3)//E="0L]1QS? M"XK,;1V_$<3N]0.QOR"3V$*`".BO5\&-:(E;L_(D+&IK9O-)=96YL3Q+XP$1 M,U2NG@O^7M#GBD#TK]+>DF\.5T!XY5@?#E'WP8G(&..V8M?VX/X0Y[J MI`=C"QQ6E2U<`WOJJW,@>:978]!/$ZN!N*]VY#'8OLXCM/(X`+:O,^ZK'74- MME\-!^HYZGIU#H#MZXE[.[_#EW?&N=`-ZE-V[9AZP)U[.OF\,!5W[@I-7);6 MN4L'6:UI*35T4HCX?R+[!;^90SGDCPBSZ"O][3Z]?K!.+Q[,$<'< MG4U&Q:]B_!V-,%!<,&@-W8$=;#AND;JZ#\P`S*!F,]C,DL[,R2H@/A!_8\3? MP+YCX#/PN0X^5Y4OH=B*MT>&$??81">R%5ONEB*9-EYI613%Y1%UFH?A@ES: M(+CLRE.P0Q6]Z;(H@AVJAF#*_!+8X090[-2*(MBA:@BVP0YKL<-VK2B"'=:. M8"S_5OGWEQ,*GTK?,;D%K&?V/WB M.=;\J<(E9#CLZ.%.,U45V\&0JJLR(W]EI%GL:!9^6(:M%YA)S$UA(KS7O\1C MRJ>"`673*)NC,.!MW5ZV`?Q:S25JB6&.*34`R#4N MS]:MI98R&-:?RZBZ**A*HI476.H<+"9V+[3*_1L>43X>8H;U,+[GSPE2] M^.^@U3FH.%-]IG<%4)7WHH6PND#,(G2`Q7VB20.8"U>*/.I.D17=&0D`ZKX7 M,K!-T38>`;*;,DW9\!U5G;`&VL$&;/!9`V,P4AV17J6A!6O6I(F%X><&1BKA MJ%*](Q[U"Q`K')M5^(A'P%F=R,-JI]U)!QP[-NS,L1*'B=UY0D6(XSL;.4&) MJ[>Q4*\FKCKE6*W5A6U@%ZPX1^`0-F4.85.`-UF9`\&WJ.A;U,HN";Y%%]^B M5G9*\"TJ^A:ULE>";]'%M]3#F_7.ICJS+#_:@^P[1*QKYP*-B8ML/4A2<$]5 MKHQ;U),%1M3/"+7Z'\"(^AFQR4D,=8[>3L2"P],KUXD%=Y\Z^U*R?94DVV^U MA2'OKQW]/`XWD+:#1)'!!MMVH8DH07_1D7[$YM"A-AU,IOUJ/8PW=UHJ7[1* M;;8M,Q_*/;'Y-AL46WDW\<(LAX7)TPT>(/O*_U3M>^*.W-*#2'27BQ&Q?$3\[RY^7S9@R)GT^GUB M8J;Q:*Y"=6Q1GQYXUE2>J352`)XUE6=J1:V2/)M>382&@W#PW`[0E$-'T9L^ MAX[.$6IZ.5/NJ@__C.NN@:WI__X&M-QK(*G3N&X+QU99D4I`LBFQ0$!2FVC;09B'>)J:>2_I72\8 MMHC[!9G$CG?;SH1T%K;F.FTWQ,&]?L8C7Z^"&V<#AOV>B1Y<6)0FZ+LE-%!F MSRU+B<%K,[18=2MQ4#@-]%Y99U[ZON5H<4%2)4>EJ<["F@XY6]>1%>GP^\6J M[R:NXIN:,EJHQ*7`<"4U!X`J9QLDE\\%1Q:L$X@[C$X?]A>-8=>U?;)$K)E? M:S0KHK:1^`O%TL5)+#V:EZ?:'`?KKW=<,IL,+`-4-Z::/MJJW<74MD@Y1FU) MWC9BCX1S3_6I`4G97)&F';H4F=0E\XK( M^4FAD-DDX-)$T@:W+ECZQP5BM,?^R++DU517-AF09QM?"PKWV%=&O?$7 MRJ*,8F$&A\3I.X@/I=6](%N(.7]J.#.3B3.D]L\M!#@Q[:>LRLZK0\Z*$UM/4#ID(/376.UM!#VU!^$5@HI\M" M.;56X<.A)?JNSP]:+LC_5??"GRBM5Q6;*?=A,R5LIBRVMGJ_BBUXTYZ&6NO/ M"C>BHEAEC:A:*JEG3]AO29'ES#%XA'TVK9)9ZUB(O M0M*9%++<=V^$A2G11!LUK9APNM_M')W\>+A,OBV0,/UYO]I+[-`1<;(JEHT4 M.>%^DHFLFA>K.-V-29`M\-Z"UK)?EUU+-Z.6L?BS:!T+560J-%;'E!Z/WMC& M<_R8WKL*]@3,L\??(FB:S),+TZ@I*I>EOF#,C9"`][B?8DZ&A4TR0C;_O-/: MVS'DI_@%0R'VCPZ[PEH$BS/K7^?]>^^]_V"_>[3F^^^HZ`U-'L47G-O4_)GX MG'?;DM]L]Y-@WF\#]Y,1_FUP=V(+[S)";$"OQCT= M(2>XQ\E_\8G1$0]'E?NURYO3%UB$CVTT.3&((U\0//@:O.69VE98DRQ\(A.* M$S-6=R?Z\%"91DR;AE2G?-VN?"`NW>YX&5D=F6G&5DK:W]!H_,EYYN-/)P#F1Q7;2JDU%8D[- MEU0X=4$J-_<#B]3D+ZTU"#?&`3\MH\_H2'H3X5K%KZ$G%&U85'"-&\\3H_=X MU^._&Z]#8@ZE"^!"%L,=8L,-:G*I_RM,=FGT*?-K%B-]H8G?Q=^SQ;Z_&\BQ MQ+!-!G&?/7GEPXP^QMJ2/<8^@V$R>O88%^R17^<+X7^;^$68D(.[7'ZZ&`?2 M%\SB`LEO'",>/LIQ6)@Z4U%-C[M4M.!")SBA"J%4/B3CL="BK$3>&<_20QFT M[U^2ZB"F7]H47VMC%\?4,/LK+@[R?0HW,'>%SY=$&,>\2U\V%M8,BT!:Y(;? M-II^H+C&L!09DQ=1Q;./MY!+.G:&3-=#MH&FV^H$^-A]Q:&$T8>$8=9J8HB0:XUW\4 M5HQEGTR,^7O]((E7KR\$'M'_9^]/F]PVDGUQ^/V-.-\!T9Z)*T=0'`+965F9CLC;_=4#$Y5/;K.;$>W=%C>]SM2F;6SNV6`\Z5UC&*^JX&E618%- MP^`@!?0+4"#5(&0I3IG<.XY!H<]\SBP'<"LJUCHY8FE9*^MMVV,Z^DZQ.7;T M\U-S7H#&?Q?*CZ+.^036_L[R_."3"U#[8/.M4=\!KG]AJQ.6[,54&;G<3[*A M,5R1+/_R4[0$<`]2<>A/;H"N*[/Q5#'Z=8;Q76BT/FV^#[?7+I:>+/Z(^:Y6 MES$IO&5S/Q5OP(8O.?H5E,5G9M2P[STL]M%;7Z!]"SU]5O=E)LSQ)7I-E(E,+*YKL/_I&LOS#? MVN\I*Y64<^\SGGV^ M_O(J*P?51%-Q:/\=$`J.E\2T?HBSQ-ZR7E"\?-,T6!U!G$?!IC2 MA,?`\H3BBVOO.$;(6V9E;P2UOQ%"/33%]&(P/K\>KEPO9!.'LB?RYQD*4K.: M2"=2\D3ZK$B[LP)6KE0C8WPS'"33V_F,O-/(4Y7LD&&GWZ3`O^H59%?$.[2$ M4:]7/A,.IGT98^-F7/XTRI0%P^C?*+."\V1AV!M>%[($2L$[*RDMIJ>6)J@F M*%J'++Q&IMCI(]5S['(GH/VRU*9\PCUF:S9[[D2I=''NE9[F!"%=@/KL<[J6PR?RWO*DJCBU*X<)P9![N2^3"?)Z"5ZRUW)I%% MR6ZIT2P';'N1_Q:ED>XKP;RV##+/V.9M@5EHXAT^#*.%M M$JE=H5E]B2ZG,PFC->%D_$`^7V:[V>XS]S#3#K^`%)X+GP76@9X<_)!I4\P: MR3TML<0?KHW>S6O+Z10_J!L&F*!G^8*RN-"8NK#=!):M>1SX+I,.,8GQT8&A MBJ7\;:!Q9LY@&K;(7_1G'"@Y`7)W5I/)X`I(EQU.A%\@$B>G*^%Y8I;-P$L6 MJ9B8>8#&E(B&,Z00V2JB&B1Q/?"V95&0?1M\5\@]?^S-DZ-#!(K0%%TX- MT,/&7%:4;VL.RP3?#9^)DA+Z>TE$.P/M#&7L#+\O0#MB>8\3@5<)U+!+1(** MXCN-&K]TLG4\R<$%,1?0MT\7$3CX=U`,3/5E?@2+T_6O1AG)?N8.8 MSSQ!,C_P.-];3D\\.IY[[N?*S5A`&.SIU@11+N)DS((._"'`#'#-7[B`A8_B MO<"#;2OB.X*]9KV)&0)3<#RG6 M^(RNW:0M^1/NSN1^ONL]PH`KLV?MVH?XT/JO8&@!N/GBI!%2]NIWHZ??Y=\C MQ962/'-XDW\./U[@HM/JKWVNC9@`;)J@+H`?`'*QU;!U\<>DFD]!+Q_!-^4.GUH!C"!^ MRH1N^B%NZEQNUM%>YG>BGPE,+M:?BM;D_QCOT=%J)&E2\V>V[9J1`D1FAB]U M$J?L>KC[+Y@72--"S#?>DE,__;%0S'B7_XK>=WG!:Q*:$L7!8IFAP[VRZ:+9 MIV]Q11>X4D`A15.SP8JT@5V1`,-6@[(3S*3+O!3C/5O!S)+B[N$)2RQM,;E6 M6G;S<JM!Y@IUG`Q_!AJ9A-EDX%/ED=+)WD:B8*<(!W,5=:P>8N2'XZFA8I M!/I+(4)=?#W30`O"$RQ5'`D<[X?F0,.BMAIXL?XZ<>+F?LKZN%=0-P=/(MCO$@Z M,AQ#;^*7\C;M:B1)?/`5;3L[>"FO`,:/,=W0QDUU.L5*)2!`(F%*1(L$XJB[( MGM1L>0LZX^?)DV&6TS#`B++D+H7;E'-BU0JW%1-?6[_Z_X@G%@`+*^A!9-KG M"`.03CC8QW.$-4N:/BEC"R^?@B$NP1-#2-[DR".'P_L`!M".G^C4C8L7[`]M MK4SD="@,<<$,Y"_$U498%$;+8L-P8%/8*; M$0@8TQQ`._$`<=25[,_)22D\$QQ02294#9C$D^6&?N33Q$*T?]N/]E.*H9)G M$BET6K@C6=R_GV!R"H#97W)O;8/!=:?7Z^4>IU/`7/2;84%S0=C(/Q]C MW"MD/G%E(&W)&;AVW$&6%Y"Y8,I"M7V]HV%*5@%TVX$!9Q&OIQL%<;*(N>@% MS`44$0T<<-_!HSS=W5A_<"'5B8[-[#LB%U#LX6\`@?9F`6ZVGM]?8D74"#R4 MIY@\N+!)[BF+E%4ZYV98Q23WW#3(F"3`]'F3%-4YG0FE>KKGI7K&]%/*)J+B MBG6R^-[(@#!"T4:Q.\<-'5-XG^"UH-'WB\N\";I#;\2)%`:"9Y@)B1&"I\A- MM0`1K.3\G8F(:<`Q(&$R?Z9-(HG%#W/O>7_I=7O&,+\!A'%!4>M7.O)X5PA^ MCSCDKFX+9;O#CK!MSB!<0C26GPYZ[Z_YB9!$2:.3L%V,>^`@F5BF+?ZB#VX" MO!]]'U(6Q.!QI1Q..T2K#$T\`S"MA8SDLV5\HK*B64PN$13^B,70.MK_ MA@[O:%_X(A"6L;0>$SL9)B823M$*E[$-07>8Z$PDP<*_XB1#>F7B<0E/%E'9 M-LQ`@R_$1Z>BQ&?`@"H3&-M#IOEQ7"8S:G#G.C[LQ!,19OHEBN1_PZ6+3S&3FGN#!4WHHBOL'USA\,(K+()5&5:\J-F^>QD7GNTAGT-<,LL[V^@& M]$37AU=CWL9ULC?OYZ^^P=S.[ZR[ZC^ M#F9O"7G[S<6@)OX:OOU6GN^DZJ4>+OJZ)["4W7]BM:H<4RI_77MB4=EW>_7" MUR6M9$>4',!\:8L7RJV7QF`P3*_KO"F5O:J3>75SK?ZB]NP` MF:S2;_IE+.J]D^P56`$FV2^2XB<9X#B,*F(?4X9E8\8''[>:X0?\_B>9J7=2 M5/23/ORW?&IJB/2XC\Q.=A/3HHXW9X8I!2&U-4K2\3I=IBSK,F568Q3;%0U; M1-"(:;802#,1R.6J50M^$6_P/+C!#+..'H3=)U-5F>\Z\'(9I8[L2HO]FGL% M,`^\.^\Q,[G6<2"%!;X5+]'UMM:'6PRLR;;F5B!O@F#TU<.X%Q;PTL#Y\\!: M%/E@X(%;C[NSF[ZN:A&PG7E'.[)O6>0S2*;@)<@I4'996I.?F/F[2")B@7B; MS76B:[?1S)([+(+Q+M9?`/(6W(RT)[/Y+:S`6D<\H2 M$4[+M;@9[.,EOOUW_RN(5![<7E,[<1P:>N=ZO\>2"W;U)SC9L]=803=JE2>(>2*/3Q?LKM6V6*0/`U M_[/H((;[XV>.%XB!LG(P'/AMDD6,_7@5H@\VGKW&;MS]F`PGKN44*F#S&4Q> M_:P6#0ZZ:;WK8VF37N$IE/G(OJ/&WT5W!]4DSA[T.98^&^MYH]-4%_]BVIK@C;%27]-PGR[?%;75]4G5V.>^IR#T2?]IG_H M.2(F#]1*177\6QMOR6!TY]^<>9%J9#-N^,TP$L[!B_ZZ_;'#\KB=BZ3=#7OC M'&/E$`STTW;;":M-D6A#M81$^.]E(1H`K`WKY*1`[SY32\[CZ)U`CY9XXFQ+ M6N>NGG--6^W0>9^_W+TYI<]]YOAVMQW/J:8"1UA1IPQH>T^IE&CTQQ]7,<7[^.: MM65>I\NG'[_.%&W6K*B4^+V-C/CU/`\1AOP)^ZE1DE_(7K*!0B6>X[IQ5LF$$;DTB"6X9// MAX`!F(G];K\?3WI[[-635\XL<,L+HGI><=H`.I=5GT>F?OAL38*9.-Q*CG)D M;563VW9T9"18B*]]]'RCU]'O'S"4[;TT7=MF"Y^_BO]X+0?68.0NGIQM3G#] M>"SPDI?R-=8IQH,I?$`0N/.K]?D.Q]W!]5]?1P\/W,4K?1%HCNMP[8#C MSAOQ];[CQO4G85K@%'R45S-K`AY+ZBAC\]FGG*0>.$A=/W6(3B&"R6FL[($5 M9S2;E0>/CL_GY3IC$$8=0E>R-?>VNNF>9+#KC&\C"<9/2GAE$:NI'J\/%;MSF%FNS"P7=<"LOZRH?EH/`?_$B*\@X5LG`"\!?N3=?E:G!DJQ?9C#ZQMMTZ:^(2W^# MZ^Y@H/(V2Y?^3MBQKT?-9J4*"=)'\4+7NZ.&JU5M>-$;=H>D%XKP@C!*&5X0 M1JG#"\(HA7A!&*4,+Q"C5$[1;`@OBC@95]V3I$M_S8'`IF1&-\).:Q4S5#?4 MVL4,@BEUF$$PI1`S"*948@;!E#K,4-VC;`HSVN!2TJ6_>@-?TW.X5#?)FDY_ MU:VP!M"_NHM:BO!"]5M:OSL>A^G]ET]*V%](OTB_6JY?;Z/FQZ>I%UGG9)V3 M=4[6>9OI3]8#60]MMQ[^`1_`>L@T)^6J'R]45ZZ/S/N#!V27U_+BYA[F"KF; M<-.5M\Q>P4*YM[J5]X:;HM^CUM<[VMD%UZ@"D?H*?N?Z@?8+\RV?-E#:0$G% M2E"Q7YGE^-J+#Z[O<_]'4C-2,U*S$M3LG\P.3RNY1I:J*I;JIE'"_)G&5Q45 M7ETJS1 MXG^Q7E^UGMY'6.Y2FXM3)FT*ZRPC#$U)0K6H`EJ79*+CR%Q*$=!AIS^X*:8V M,=E>"MI>+:,_@5)E)D!?7)R,+8%MH*J4C]K+EW1,1HC70/K7!/%4OEU>%S., M'-`Z.*!WW`NLJ66R`![C3K4)7[B^=5K&(\%?#;:?NAAR%<+:F'S+1H@Z00U! M#?F,Y#/67Y,(R:I',O(%\QI-Y`DJ&CWYS/W`L\R`3S034TZ9,]%\;H:>%5C\ M,B66:MI3_94V1/M9G^A#^$/ZVF/^%/Y?A3!W^NAO0G)Z\6QWW@YI%; M5R.U:I1956G*0J]WL'T\V5`U$'8"&P(;.MTC;[#^FD1(5CV2U<$;5-UL(M>O M#JX?735L!Z+508LJ1+3^D-S`)H@Z00U!#;F!Y`;67Y,(R:I',G(#\QI-Y`0> MIPF]`YRD=E1J\T]U)&NZ_JA,?[*DR))J,_T)?PA_6DU_PI_*\:<.GEP-Z4_N M74'LR1T2+*ZKF4$>8(TTD"RP&M"?+#"RP-I,?\(?PI]6TY_PIW+\(0^0/$"5 MV5/&G;Y*N@6VC&]D5K66_F16D5G59OH3_A#^M)K^A#^5XP^Y=>36T>4]NKQ7 M+^>\Q2VY*LQ7USM]G7HY*+[S$"@1**G.)[H.V!1.$N+5B?XU0;PZ^*2JFV'D M@"JJ,ZGN$-04HL$;3D--M]K0GPPN,KC:3/^FXD\^7Y$`J;4*08!4/2#5P;.K M(?W)V:O#:2-UB:B96C7*SJHP8$5=(IHB[`0V!#9T'DC>8/TUB9"L>B2K@S>H MNME$KE\=7#]*-&T'HM5!BRI$M+[1)S>P`:).4$-00VX@N8'UUR1"LNJ1C-S` MO$;3AA,H7[('FV^.%7]Z2&0@A;Y0*S^R4DLU^LS39>AAP6 MGOG3E2XQ>3MI5_\_6^FMWSUQ9SQ26CS^RD>R^&_;U>U7CZXSN-7[LW? M.T_<#^;XUJTS^3)SO6#C[:](Y:_`\5]LU_SCY__Y/YKV]_7AW_`I]SP^^>1Q MGWM/HH3HG>MO_E0S81'PXC.?_G3U)I2E1K_I\(_1T_O?OKK?=.-;7[ZZ^CF2 MGF1M*4F2')7:@FR-7DOY7U/GC1]&"@E@D8B@D"'-Y+8=X<]/5[TK\=I?,#-^ M'?T^4C30(ILM?/XJ_N.U'!@VX5X7D6AS@NN2$$8I MPPO"J(OPHH@3)N6M-&I!!V0!HQX8:%P=@$`PXPO=CKH8\_-=VYIH/_3$_REP MM\`$[XY[ZC2A$(.A\U=*#%)M^Z+^,3!2KEHHUVFM6VAC+$CWBD^T]R86,[7` M\OV0EY1JL>T%9&L9L:W::A(9+H*"C*JRG(31,?J%E?4B2Z+BTTS")<*E9N"2 MWKD97B3_E8RP$K3FG\PW0YMYE[;"\K%-"4^I+MM-&0'84AA0)8H-.[WA-5E7 M#1!WPAO"&_7Q9M3I]09D-37AUM!7-V"V-HD2R+1%*H-,,S&%K`:1+2"B-G%# MS".K$\JUT8X;-2,RD)-F:\8+T@GA!O"",4ID7I!?$"^)%-D8I77*E&;PH MXF!*=4]R**K<7,*3C)Y4TLTC6Q:G<.,]MEI[6*&:09Q`QB!L&4XLP@ MS2!F$#/JZ%$VA1EM<"EUH_S32:I?L8.7I5RQ/XN=-;AB7T;]"L5WM2*4D^I7 MD'(57;^"E(N4BY3K:.723U*N5EB=_>ZP=-TK.MLYG=:I\>\+[OC\4K"IT@7_ M.O*N#IGJ93&JPCSU?N>Z7]`5&M6MB4MHA7(!0`6EG6")8.DP+(U&!L$2P5)# M&%`36-H^LU"0497"TO#FU+)5\B5=ZCOV4M]9-_.R+OG=!S/NO7>F2#UY-]`Q MN>>`CG\)X"?W"WR36O44<\-OW!TJ'$$859L;?JI[DI2.66_8JW]24;VA MKNGT5]T$:SK]"7\(?]I,?\(?PI\VTY_PIRSZDWO7"O>.[BS4XLY"&;?MR':@ M"T&D7"7=MB/E(N4BY:KFMIWZ5F?]>HO\2SR73UXR4&KVR+4ILSSD0\@U=ZJY M,K]2>_08B.'D4B<-*B4LG\G5JE6X_%SS;"==0=95F&MN=`_WCVF*X='TWE:$ M4X13S<6I44$7B`FG"*<(IPBGJK.G6N)KEA_G*5IGWCN!9SF^96[[E_P[]TS+ MOYR'V3)6TEGN0?I7B&JC<;\#Z-X6`ZS9XDYP0W"C-MSH/4*;ID@[H0VAC=IH M8XST8^!FPVN3+ZG@RG$%5\ZIDI)5;>7+C'G\%P9^V)T[Q\J;8C3QKG\;!C/7 M@XE/?G=`(E,#?[(9E6`IK,GZM(%Z84ZO""]4(<7I!?U*36ANL5,=Y'J;28W/(*E/-0UG/[*;_L- MIS_)/\E_F^E/\J_V57LR;\F\59Q_!&^7IW_5Z="';HBN3@M+T"DR&2YV";M/ ME["55;$G9MGB2'OJ>MJO>$/W)%U3TCPA]A_+?LRZ('NEAMAZ67N%%.I8A=)D MGA/9*^W0J3P7ZTBI*JYQEJE1:EV5))4BE2I+I4ZK;%:>H:^6QM6O^I)^W^1M=M M*!Y02V)`E??6.C>]`J^NJ6^5D\2KP(`*)7X\N"%Y)WEOC;Q?#\9GW!54(W)= M1P^R:'O6Z/4&FT;L>P>]*.M)6K&MM%Q;&`I0C_Y57H'NZ.TR7$G@%:!_A0(_ M(FDG:6^-M`_.*7!!1JM"1NNU]IOKO$P,US>6Q\W`]7PR80GC%*)_A1C7)P.6 MQ%UM^FO]KH&'R#WY[[8*5+K+:"]?4F81:5+K-@Z#(KHU-XYO**)+J):7_J5D M=E7I\U-(ER2^51)O=`SCJ$`723Q)?$,DGO(1VQ+=NGYDW>?MG:`7+]XX?>"&^Z8M>(%]G MS(FZ?OR3^P&?W#J3M]\7W(0_O[KXUGT8^`%S$"MN'Q\]_L@"GC1H_*?HSYCN MX7'K?[N?IIIV?`O]EX^,+;Z)27Q=+OCM=\M/WOT$.($"X9A3HO\,?^M7/QN!Z#+(;D5L]BC2679_A"9Z%3Q/RBNSP/W_Y M_2BFZ7U]0$P[-+G?0B3E*6UQ2M"P/JB8H0:S)#T:RIOSU0DXI.O7Q*&-N?Q+ MV!CP';`_V2/_S.?,PNY6=\`RCYE!R.ROW)M?0+U^_G3S4=??5,^>(TG25O[M M5\&?/^G_'GW4K]O%Q^\+2Y(4A-MR)P52.TX02%F[DM(K?N#LUG[SD7VWYN$\ MX>P-3D9E%UB\SR,LR. M.I0[5-Q([W=3@9[DKS0=Q;L_?`>ZW+S6)%&U8T)"Q0:P3E_Z<57'SYO\Q;F& M7WYE!&FI'%?$MG(Q-^ON2T=[QQ^\D'E+_%)_-QLR1&"#>VE&A0LM<&O%KGM84XI< M@^[V<8;B\$IH6@6:OG,](?U+SCQ-U!#,#XN;NKM=Z/5D%4@#?*RH$XTM`#F^ M@ST?<'N9?][&L"^.2'//UAEH%VB.RP,=3)Q M]U8L3D%!Z:Q)2B&;_%_`]2B.G/`=S8MC>D@NQ.6;R MX1+:NUU35DWM'?5OFJ&]_6X!@+FMO?DI_'7&8:41>9ZYAV)J8F;,I*.!I6VZ M?B"*T2Z8%R`I`H\S/P333!(/J(B"D'L:F?;='>@/YOPP+)?["[/Q@$;[,N,\ M\+=-H8)L$;*J%`LN?(T%3H07"ETK,:J1YN^]H]V&CZ$?:&.YV:WM51X/A#^: MW[+LCHNS(%;[TP;`/EO!;'U[>A()0$5%'O1RC7T2) MOLZ!0PQ>B2?.Y)PN32=@SLTLZF_:4@/5'KD=W,!@2P M)F(5;('XOTM^5N:)M+$UMM8+S?+]4!@&;"WZ$SJ6/,"2O^W2=E_%=G^\S56" MY7#'_)GVQGJR8!.:^'4BV^EK571US34M##W#MCC^F$+@]%,4I;8<@$06;X), M^S,$9XM[`.`FBO`D$N%B=DCLX5E`Z&/!/0FM.*LU?]I=Y3OMBN]_9-NA_2.) MEQ".Y;?@]-Y?B]B&3301N#`68#F[F/?`04A%@"CZH@]V$+P??1]7*4@R]=RY M.FP.W`*";3B7<:4R]S4=K$*S(V'+0N9X^)+N@F4PZHP5I6[](@^+<%8%Q#Z[ M@^*F-$U%*WV%#QL*(5TAD=,.V+$^)HA:3V"CTYF>TG95*A=)^XP_]K?K8"G* M)TIM4<)D_+IV=H4A#S\E4YZ4*?;H<1DA$4T(.?K%L/6"I:#?W`RE9R^[P>%[ M1J\WS-SF?E^=-6V,V]$X,V>KW3-E>/U??^=>NI:TH0,6B]E8B/.!%=AHJKD: MWII=Q>WO7@LUZ:S>>?,:7?,)GP*%K'KNQS/;G'WV M>:54R'@N?G3&]FCYDH(1A6&&R8&.V./3-B?.W44I#IT)_":820,\(=,7[EDP M\JWVOZ%CP4[W"6PUR[068*P#=3YY?,H]?)9,?7N1)D/RTU7<.B+'CQL,P'.6 M`@R-?K=?P#Z)-M8.JJ26B_3II'BHL6;`0F>"$JI*DL!E]8;8,.]H9T9R>!A)B MSL6<85@F!9J9?X:6;\7.80$!O=Q#_!6Y-' MWJM?:"\"]Y'C'1H9Y$:'+_F.CX>.OFO&?P/#`H\Y/@@@EV]H5[=(&D\HHGC( MU8^9'(NV[0?N``3!@"""FON,6(03!(=^8YA8])Y<\!,$8@CX%<(G1`AV-LDB MN38__L'F0-&\M]X&07_BFN/&`O<,PN^[_`G&#W<">"%V8FI/0W6UIDOY5O3B ME86;STMPC#`[83$CN[+YYLG;-;-@?=.*-TX1:P\7H!HQCLD-0>Z_SY:`ZP1^ M$1>YZ&`KY1_`;L)-&YX`'PEHGEL.W@;3%F)#P=\Q.Q4WV?3-B\J?*N+0916" M>`BWERZ6ESZK2X?N"@A7%;"`0`@^(DPRMY@[N^,KN^)X.`S@EF21;0'.3408 M,\O:W!"M3-)E2T9JX+1(J$;/>&IS-N$GDO*=%5E&U@9-T3J<<^^1>QVT%*)L M&$%AV%%=L7F*?9'),U3XO31*5N?):ULR3HA_!YUV'E$;^3[ES^*0!\87UH)6 MC?9LCDVUX^F=*LGRD#'><3V1GA>(&[QH(IBP.<(>X:&Q$%@3RPZE)'KN$QAF MP!0*X=!6>PR9UP`S2/R(V'R,]E;<;"/-3.VOW!&;,/X*;5>`@TCY9QD6K-]9 M\WI3N26[;E)LJ+[PUWW3LQ[PH.4!W)ILK\Z&#=MA,I#9P8W^P*KPX\@M3QD0 MZ"-Q.W+2(A7N;-L;R=C2JG!@7^`A?B!_@LM?7T9'NI6.K/@!7]P!BAO>.%CG MPMM,/3U)N0F>W13J))\GB:+)'`_OF#BW3N16I-TDZ1NA+QQ1,(/!ZQG1Z/^* M+\CH$(MVC-4.\1#Z().^<,\>+$?NI.EM`[Z9&XV'^0%]S;&4>;JI!%#P!WD@ M(@2<>>(@;>$^(_'@^_`MV,X`DA'X$V1.MC"Q)?NNE`>A6MM2*+Z+Y.*2)\)) M2SRQ;=%<$X#5.)U-Z=Q0K75A.U%$(RD1[O+S;".6A2+#G4?V*,4`/YH"+1]= M)%6:VR\P:R80*;T@B#_**;!@Y=SB/-"_3?](D$?0!.1+W(4N4"OBI*!$'_"8 M;D,CI#;XF1X[DAR>YGIQF"<=-8$M/$6[9+PB+,BB95[`>RKBM9[?A9]FG(BO MP6=LW&D80TL/%:$R6, M;Q-N??L`WJW]%OV"95+BX2.?,,";]XYY3%F&?E95C*-FMUH1ELJYG[ZQL/C/ M@S#*LY>0U%NX^6:,<1$]++@`+Z[EB[ALQ2_1-GF[`H]D=5\"!O/XRLV9X]KN MXS*>UJK&T#`J:;-G5JFI>[`C(8QBB0M11^B]`YKZ:(&9!,\WPWEHXZ9W"\@0 M1%>)]K)EC=K]C!(DU]>CA-CG/+V\N?PL^W`$@5(WHN3.#]XPV6"C_^9BY&_NI]PJ_DW6"'X"]>/ MPO*^6A4XH+_Y5D!?^,^.[!S1^;K)_@5 M]Y[$E.]ON"L.W0.$UQBM#Z/29E+:*$R423`P55W$JFHY2QL:YRP`; M^=4MYNN@U??.9H^GU?^:PNSXW_^V-6;S$:D?NM,WN"!TTG/ M>?E2-U[V=?FD74.N'OK&-47A2_D5J4+OX+W3Z/_SNW_+!^X<;M<3<5)G/`__ M-^N)R7#;SY.3.8NF^+]ILF8.N?U$K)9WVH/TWLO_M_X('&,ULG3/[CA6%K7? M@S_U_?_QY6F/0%0:7P_TFQOYH,PAMYXH@@?"=Y-.W?U:0&/3#3"^Z0-\W""M MF.]_>Y?E,(ZO;P9CO;W?`]T?7.Y$%X-%P^+$(@(IATD]?&W?SH9_"!]LRWV'[B`RRC[[U>UMX MF%7P?3CL]?7>L)]^;FKHS:=^%OEW'G."W]C\1(F^^_SO^P_OW[W5WO]VEW[< M^IB;3_RG:X?@`7J2&B>R\SDNUCYA%'))[PQ?@M\F+CO"WS45PU%D+U7T2 M1WBPQ=@`]UA*_<_06AP,2A\4JY&NWVS.O)!I77ZQAX'OQAALL:GGS&'=]ZXM(7_^#Z/@#(_12<\EP,?-G?R;YCGEW:Q`\R8VL+RC'M)(?^$[/` MY[R391-2%G`^B#$`[@;KTSWXQ")G>!A^C.OA]3#G#.-#QZ_NCM\F4:2WTRDW M@W>>.\\N&@Y<*C((]'(PV%Q;H7-5AA#)>1LZ2^)<3)Y9XI!@`H/UL=8Z8L?L M,@X96T74$X-S+_5!OQ6$N*AT-9:H)P9-7UZ/6T&'BPK796GZ!!:?Y8M>1'[P MR;4M-L%+.!AO#42R*WY=)GSBJ-&(_L$J*[+*G\P(Q:6)C'3/PFLM&#%= M+),;L#[#R]M8L_P0;6 M<>HG'D;#G\N$+.)V!\SI@6NA+VZF+1=`7;PKQ-S#Y6Z3'48D`]\ON!?5DT9*K/F-FH1]45LQ_S6Y MZ^M>(>4)BZB46&3)=T,[@NA#YY2N%M#%63$CP=K<`U%U2)IZBJ0/EK M9&Y4!MX\V&Y)K//N\YH,:2`5:G!AF MZ_?'*DZ[8L$VC)X2ZGX\54H4;'ULJ$"+$R-\_<%("6PZH>7L)01[I"NA[L=3 MI3S!OAX6(]?/R(AWKO?^":6AOIZ0I67J,NT)J3B5;IZ>Y]=&'3/'%OUF_&>A73/!%I08M&YT\S MJ5#RQ+]P,_1$DM+;[S+ZA`<"J(-A$`WV5EZD1P@46GHK@UCGRD;F+<_>IFM4 MQ!0OO>J3_$%,SAXW8=6GN)U]O(,U*GW-V^IV>B;F>"M#-4N3#C[IB/1*,)KZ M1SZIB.S)\7BXF2:8'OO,QQY>9V_4-\:G/?<=L[Q_8OV(-Y9OVJX?>L=OZ]G^ MXL#(F$'&8XJ836)@)3_\99G\^0^+>WA9?/D!#W+6#H23[[QW0.Y]\07]6(?X M@@L\?!EOL!E_*W,V%9#[W`5FU!``/#-!"]@COY_^T\53M/A.HOP6GLEMKW[X M31^MR]J^\@3_X'/77V#QFNWE&9NK,T":NNFUG3?IPPOWW'?H6&T"._@"EGE6 M!.I<$F3<)QI<_=SKZOI^(NQ;0(G+WQ6G*'KY?:."Y;]!BX"?=/E;-?Y'2RB5 M!!>3@!;<02GN`2DU`^?K4DP$_DL M2FJYMLX7/7\5_O)8#:S!R%Y-E M-B>XGA$3>,E+^7J");FL1P'.#_VCQA^*).S^5H^_^7!(PXV-F_H'%MYP)+MWU7FD_L#!P7\?Y0;!F6&1$ MOXT%'Y=BA*_W91BM/PD31*:V^_QJ9DTF/)U_M/GL4Y*GCCCA7QW=1D>YP>0T M5O:,KMYK-BL/9HN=S\MUQAS!"U@B:#$P`RS%O7S1;[J&07PIFR_RM7<(#8]F MV_6H.U):G8SN>%@R-":,T@I%PZ+@,.&E<4@%^]U!(;R\,*]2N:2F:`)TFM:= MQ#Y2-%*T@A7M.'9U@;B:2'+5?I`'`S55MYVIZD5U9\M,*B15+595RV?S9J*_ MR!7WL`)XR/VS]/,,OR!;X8AK1W=,+9Y1NM[MUX)1Q]%9WX!4\=#75_#(9X\M M?KJ2_TV"):E0RA2K"*W?GHF3D'6CW[D9ZJO]C("OMBJ$%RTM<4^EA<&02S"L M'/L_!Y:I1_\*H6S$$8I0XO M"*,4.D>MMY5&1SI)Z&MX(/2%9KS2Z0L-/>SY^LSM)ZY]=$71F;=8P:.,LQ_2 M8]+C\WA)Y[;'JG*Z;@[I,.GPV>D5V3JZE5*;E/K]\;FY3-EQN3:!IDUR&?*#M@IR*@J\YGZ_<[8.)@&T(R#@_J; M$@1,!$PM`29CT+D>CPM*M"0KK%')E:J?BN;WD:0.U6;G4?UHM'H\N^Z,A]=D M9C76S*H__0E]FHL^_8[1&Y(M1:<];04WPC*B/QE7-:`_X0_A3S/I3^:5HJ&J M3YZKB6MU4<`*>_.)WH:NH_E86%![J3U@?4DRMVK!SXM%[-7C4X4N)I9NI?B6 MVEL081)A4KLP22^J5`N992J:91-9\ID,LUIPE$"P(L/L(`B284:&63WH3YC4 M#$PZV3"3+ZGTU*5+3XG6&I\\R\SJAS3\IH^/;X>2U0OCB'8@@^%X[_)6,SRX M&#\FQ6\\>"^LR@^N?U+CR2(6FMDG[6:TWDOKZ-FKLNA]G5XRV_<:O:$Z*RZZ MMTUF.]KQ\+KL%7^6]UY4$&G=Z-\,]:,7',V\^J6>RE;=&%R/Q]6N\Q+BJ_?[ M8^-XD-J[SCMW_F`Y8@FIWW[F-G9GOG/]T[H!%R+!6SU3`:(V&\4>/_V#R[Z# MY8&5S)T`_O(ML.?D<)['X-TYO._?S?#/]X[L.GH_W?&3#Q9[L&PK6.KG]HO- M:/?\_6SD0WP-:#:9_SK?GH?!KCI^%$?R\=9J7T@LY1N M,#RL=#G6#TE>P:F5:U\Y\Y04ZCHIR M'+KN/NJFG-7DKS62:"FB'>//%NM]G[[DC16>YHRKQBW\\BLK8+9E9J[N_HE[ M3Q9_)L84Q1@1XK*<"8!66KT3==>BL&:D\(-D.9O!FIR#ID)M:Z&S4\E\[V@? MV5+3QQT-363MSENZ'ZPINA'SAYN,GZQ`Q=;WM:%7^$.RI(X@84>Y1Q`&C/%F$9;'%PG._PT88<'NIY9^C MH7<+F"+(N`VLRD;OF,.ACXU\F3_3@*E@2TZTP-6F(?X7^!J`C>0S4W`>9:\/JW6<'1O3#!]C++>8MN]L12L(@PJ`M,J]+%`J59G,F M$&6"C>]1]!!4P-![M$QF:Z!RD]`$6!(B;#F1P'(6H$V/7UV`W8?FO?9L!3/- MAU%`7<'4!\-1`X@*;30\M:GGSK6)-9W".`!XGNN`U&K,"SC\!V;.F<]3.I0? MP]97"B3^@\,<$6`]_L1\,[299_U7V*Q:P,V9X]KNH\7]#JB89_:C;,%-,>'-^UN=!7L&@?;:'D'6UJ@=7ZTET$EBD4?6%Q MD_N9Z/!UQH$6"8$1Y7*O^MV;V_R#"*!]`G;C9@("@6<4R$.V)A8FGX`WH/WA M`!8A-GU%%)LO71,)#U_YO$GFCI0A'%0($`ZY(3RRWT0D/,&,!2BBCAN@("W0 M<7GBB)Q`_"?X%8P)SP$&>6Q!"*BV>7QKFA@Z$5"``@!:]76U[66IAU)4.!&R M]9'J&T'1VD);[L[J9R#J=V#A,V<),&9BHL`$(`X->\#*V,Q'A5#`;B_4)B[` M_@\]<\;$+HG'W0#]:]NZ`(L?OH,W=?-:"W#;>(BV9`LY;4TML9]8SNHSW^>Q MC^4)/DPT.PJ"P>:/GX=S>/^!X5;E"G/'\M9\L@F8YMJ4P;M/&,'X:M-'DZ/D&,X,?[,!>NPP2\1=R3I7FRFHPTW7$'FK']U MWZ_A61\S8BO+:,E!!)^5-B^:B/8; M^I#"`:F/Z>K?,A2$^L8P>(/\\K47PL]R0Q_@R?_Q5<4B>:9$GF77UKX=W?6H MVUS2AJN5"KR0K_-=O5(>`>M;<.A0K.A8 M5\")%FPG.2H"S]R)I MR/66!&8$9HHPI$(PNQX>K`Y(4*8HE'WR,%$7TR+`(T5G=('9N(1KA&N*,*1" M7#,&![OZ$*XIBFOO-]/A"-((TA1A2)5^I]ZYZ5$7"1HG)QF4/+,4,1&"RZ5&._V\L]1ER51A2QVZBX:#D! M?Y0%C#53U+KW9.5X++:R63XE*H*WY,S3N(,E2+8*.NPL:!(7`IH`+&%=,T$Q MS0<66%/+9+"B]-1<+V-FN0FQL;2-(I.IA>9^$E`*2W#C.K`(=.$EVFJ+*QN: MIT[IMCB[3!,-([3/HGZC7P"KJ)I>,Z%_9SDN3S8;$05O\F\`PP++DLE:I`A] MDZ@Z5!KTL`QG4ELJ@OK,\E)WH@*H-1%8^B6`_V3F8)XZR^W0\\GKA!7=+Z(* M_[[8WW`!'I]Q64%3=C%*ZC`>N9'EWPY^SSV"P\*)A?1>)*UH98E9(6;N:M'' MK*TCXV)8DG+_/CAC$\TU(],F]QK`5\7)N6(.N4?K"($%YOIX$5I65\5ZX@PI M\21J42U<']3P@=ONLV*5I=1">2J+55Y9K/%U=Z3TZ1>5Q3HZ*&9T]5ZS6:E" M*::8%TF]C_Z!>A_Z3==0NE9/,_ARY/G`T6R['G5'2JM3?4ON%`6'1Y?+] M0"\^8UU+""/X+#CUKJ/C M^W>N&?H=S'#H:B]6^1IWKU,?K]Y^\_I';6K9F+`HFW`SRPGBI(_?NU^ZVAO+ M#SS+#+0[-_2")*T@>1N`[2/S?6;.0I\'@;_^T/6/Q!#K#V>/\$0_V,P]<'!" M3BBR%3"O05Q,%*?ZCK6GX1S>]GF4J8*I'#_9:I`_BG26J8==T$3KWH?EQF.Q M/]NSBRU914?6&;S>5C",EHQ$\:!S7_L\WS*_ M*(6X"BV^=[3_#<&NU@<=F3*Z+IHB2BH$&`5:0WVRI12S1X_+OT0'8>P3S$$O ML;4BR'!*(\3'*5G>J46IP;$-LC7AD=QS4&4@`9;=`_7"AM4""Z1VBIPRT#/- M!!"9^UN-)3>2;F,E`ZSY,\1&A5$BLGC0QC"B<2[WHGW1;00-N)D0[B@\,AZ_\&<+&)#UAL5VEE$09YQ9^A[@FXI3:2;ZRVXY'3'V=\C#23U>Z).WN,]?TL9*6?O'W MOX7^RT?&%J]^00ISWP>Y>;`<`1MODG.'K[`E_6*[YA\__\__T;2_G_8;<-8< MW-,^\^E/5V]""4G?=/@';ZI^^^I^TXUO_>A5-/2W>.C;U>6@V^^6_\WTEM_^ MP>>NOYAQCW\4VG3U%&K[TDB>]*(<$XE"XVR%3W%3VT%+G( M,%3LD.7^B7M/%G]NF@NNCU2WA-7='IKF<]P[VD>VU/11'%N.ZU6(,Q^.5C*: MS>DKGV!7YK8J@"&YQ_AK["2Y8>`'8&`(>Q_F&2SQDQ7(@E.!59">Y/&Z.+N1 M!T;+CK`Z<\_D+_JXX"(<:#=U-IRY(IRX_/9K,DMAIXHKM:+]*PJ(QR>=*"PO MHA]H(\*?OC6)_!H9'F/:E%D>)B^%7,,`_SP._S_PPLNCZ-WKXM:,!Q`K3>BL MN5OK!;=*2.O(3PO#*%!,"_"$1U^)A M*TB99.*$X7GFVL`T]]F!X?SP`6388MXRTYQ3=[>JL0W7?)OFU`%2(FKYLD8' M?^(VBK"091GTDL$@_/0?_/.]]JO'IH'<`%T`)AZ`$&N/^.;+!X:JXKMV*-0! ML8P[$S"+V2/7/(Y;#DQ+G.7.X-$@__92'G$&ECB@%6!N6W-1=8*9)L=@XV(5 MO\(+/!Z,\L0=-X2/'OS`"TUY3E=@Z8Q$]1^X;0%%HB/I=1)HV&1$FUKP!X<_ MQ&$Y&C9`E@G,25NX7C!U`=>0>G,^L4QC7^2>;#67>GK$(K96O,I=X#-"!\T3'#">]GKE%)_9.`1G<\0M&P;TD!TP)NR8 M0#\7;!QQ7HY4GEF+B`OK,T(&X/J`_+@ZKD4PR+\O\"_@MVW]-SF\VB!4*L6G M`6!WNM>G*!X6M+J[E65VE[;,2O)Q*2#12*_Q-LF)23N&>*C267F0JS.IW?Y` MG`:T+,2K5,M;R#\0GI<`X+_$+*2UC*FLPZQ?F,T

Y@;/@SYG$PEN$G_KK;K84+UXF$9(9; MHS@S@*^8W`N8Y<3W+2-#!*@&4W2=/4F<:[7(DN2V)!-->F-S!BY7."_J^*O8 M/*QI&(0>WR!R=)R"EH/GAH^SU:D3&`5#39('3V"`%V!-H-$FK010>!YDDZMF MVS3!>!4PCCIU`ABLP/H9?.05GCPLQ8V7..4%\"&"GFC5Y?W.!=10_GZ#2F%,KF5R!CSP,=OB893SA\8O3:;IB'_C] M<3Z7R(%/\2G!")BMY4[D7$4H$DMORB`%_'>#LZ!;(ET:56LN?@Z36>6`"9U: MJ6#=LJ')"*C*"-A.(]3P]E4Q-K1QW>D5<-RG9(+8'H/[U*$V4\WZ^2DF+\O% M2:#YW>NQ42PG]U0@-N(-*-D;8^_Q..S=N?$^1&[R:<9N$9&%FP+/(8MA:$DB MEQ\QBDFT+%"YU?"KC`HR:< MJX"#/.]<.5U^M.6E<]4RM_A?779!1ZV"`*M M+YI_-SF?^#OMOZMX3&3UWXYK.O M6&N.\[M;;%5$6W)BRAT[5BK%2AN\*Q11\+[W%- MO#A4$[*9"%C?HOO'Q&<++;J/6Z32#68:6H[_?L$=6,])S"7=)=TM57>IF\:Q MZKN6LTA*W(2*\G?B-J`3W<'"ZYC``TSWNI3?H6"SAEHQL)RN&AE.B8*,.H[. M^@:T%E**OM_1A\/5ED>H5RNE^S MT;!/8%93,'OO/('!YGH6@1F!F3(,J1#,AL,!@5EMP6PC"X4@C2!-$894"6F= M\4V/0*VFH!9GBQ&6$98IPI`*L6SHJ9:+ M1:A6"DY,O,5EJ<[CX4X4N&Q=W95/92\C*%V-(2@JG>D$' M_#&JU"-;2Q=2X.AFT+M8A:.^K":YT9!B>V$;W=$W.O$4W2[%Z`[RKSXN4]2R MBET%U"S2"IR>]G7&?1Y)T3,69(YJ.XJRFHDJB6*2^"G8/*#3`#RI8B?^WD:M M._JL-KANY):9D0_RJ6A&D:61/GFN]@XIJGT613=]]1=9#_XTS9[85;7DP+I)"+;<=.,=%NXE,+-V$1S MS=B`$H+TO\P)L;>6)*XN-&]5DEQTD$+QE-934@L,NT:YS[LDVH_KE/EBN%5M M_"=FV5&--2'1Z5ITV<*]WID#3#T4]FV/(BDOCL_#.F8.Q[9>TBP$L+9,.7\8 M[CENLI7]P&;03PUT3Y+SG>!E?M3T]G]L.Q'["E1U1'%XQ:BNK?LD!(SLO+B56K9*!>K MO-7""EOC?K>G='H`5=@ZX=Q@V'!6JE#5Z3A>W'1OE#Z+:Q,O^MWK`?%"#5X0 M1JG#"\*HNE0!5-Y*JV\EL:),LZ22V)"J`"I91NSK,[>?N/81/IKYVMO,R!OI M,>EQ97I,%0&/5>5TE)ITF'1XIPZ?5]4S3\TY4N)CE3CS=*DD9U_!*H*ENC7E M7@0@]:J'>FV?F-+>6,.\=7GK($X[N=2Y0=L@LVBNE7#;(#M@IR"CCJ-S*7<- M]'Z_,S:,0Y<-FG%P4']3@H")@*DEP&0,.M?C\27NM9,55H+:_,8#3))UY^7< M^%3[5+1MM]F5/QJM'L^N.^/A-9E9C36SZD]_0I_FHD^_8_0N4LVQ#;94S4][ M6@ENA&5$?S*N:D!_PA_"GV;2G\PK14-5GU(W$3%@)2X8PA]SUXGN&;[$:Z*6 M2>96+?AYL8B]>GRJT,7L=?MTC*CX%D281)C4+DS2+U(9F\RRBLRRB66'04D5 MLPD$"02;`8*'VP.084:&63WH3YC4#$PZV3"3+T\L<*V]['5O%DE-_/-%K;@B M2156>NHI5::*2FD>MGSCLFHJEE'JVZS,'=?D3DJ/JUR& MNR-*!F(QPI?88A'#P[XLW^R*]F1R$BM?P>--V_1!X+FM' MF\PV0TF3T,TRT<_3B8J5KY,F]LO[@K[G':%DMYW4RP4@_7>E22G8;%>F- M2TN_^/O?0O_E(V.+5[\@M[GO@P8]6(Y0CC>);'P%C/G%=LT_?OZ?_Z-I?]_S MF_M."*4)TX)!/O/I3U=O0OF%;SK\@_7SOWUUO^G&MW[T*AK^6SS\ M[4I_;[];_C?36WY;E<#\*.#@2IMP$\32]D6YOM"QY+-^AS_TJY]O!IC?OG>U M.V9^<,6I7EJWGH4J\\YSYW>P7OB3.R:^+RI&?N:F^^@`PR9KU+CUO]U/OPV_ MZ2-0W[Z.-]_*R:?1+E,VM):I"SI)DLZ\WCY8P M"@=M@%]6`YYZKTR%W[%2M6A;CK2.AOT&T37N&O^5?9??_LV5#6W`O*U";$%F MC=+(NV>QRE&X'.$=]L;22+PN,_SICSJ^N.WD&S[T:]-5O#MO\ MY:U947*7)--"I)M(ZB?XONLM*Y'@ZV%Y.)RLK&+BE22/PT&=*9?N3EZ)9S48 ME&>XIMZIG(+E2-_-N#R]O0CU/GG88B98?K(96,(RJK"85V6/&H/KTLBYH#(?C:4:,L.@X^*HF1$)-?1Q,6;1H<551<$+"*0^U@O1<%5)6&XLWC!Z M+9'`PA59"J*Q-7]<=M(9(=CCS^?\#]$.TM4LB0I+D3S!GX1D;G1D7\!P`8*/ M)=O(RNZ&:!QA6\.%YTY",]!PIK+!J6@*Z<"7#W4U39XG?\=,4S:&Q'0;%JO% M`CZ'-SOP`%.TX^Y@JD;@60^AS%M!TJXE?\11`E0E*XD9:$SJ%_,%-1:A9\Z8 M+U,Y'/DA_D#^@>E[BXY\K3'M(5)(7%J,>9UCTDMPL1,><&\>_4IVF>1RGIO3 MD(\5?\JY^C/1"F9A"TI"3/Z&0F-0JG*#I*#*_3+?#?N^1TC:`5WOG9>@[M@\%C,#.8.1!>Q,^!.W7>D8)[C%5JB\H:L`P/S[ M`K%LHH4+3&0[V+`U1:PT2&9INZ\])"2-6_XFG`"H,GG2)#<"1%B!G0J3K%80 M1*3*HE#V1#<9DV05PB-W@!/>)$K(`42SY#G%I%@.9#\;V]UF`"NJS=2"#8^_ MM$%")EN[")CB@65'G8+E`G=.)V[6^\@L!V?]B#F%&`P5>P?04FQ3OL@_%"E& M(:Z=D):0]HA:ZRE@")8+V-AM&ZPJYY$]<@09,#P@)# M$<9-3),8)U;J+91FI4@)>`G_)!-V.E&6[%/BW,S!S'$GKNT^(JSX(2J'_TH\ M"%M)P^]!8_#9OMP/A`9(7329/]/PGH^PP2(]L_A4FWKN7//<);.#9?2`W6;F MEN656I_E"-7W)@PL&^W9"F:;%)ASAAF?0HFG'IOS9]?[8[\M)<$TADL_M6=U M@&AX3P3MY+DE$1%(88FN[#"SE14]A2UP:=KXZV0@,?:29>[,A"% M1-=#IW=L@6'!#Z#M_/X!]G_YU;LC4I`.I/6G@L#['U+4A/IE3.*/9/-6)4CGMRA9Q8\3?V($[/>L/)I&@=3QOJ]WDWET^P?9/IX-.B7,\UW M8`>++Z^N/AUWP)7\\)>E.-"XLV'C$RH7?^.CZ_#E1^;]P8-WH3,Y-HNOKQ_# MD8QY*[G0PKV3Z#@'?<"8>N` MY7D_?<.%07##>B[Y/!T9]FNZW#TZOUK73]B<2?/\O)+ M-]:6?M`H>GD]&AQCN]5@Y9NY*`<3#X#.%U6CQSC\/5OW>_=#4P_)DGE`FE&Z\P.C[77JR> M5C`+4>;+2>>^\AM+>#FS,&SR.SH/2K8YBR? M649ZP"2Z6!E718WRIC()LEFAR8"O.:+/J$@9^(79XGE?9IP'8J^*#O?$D[U5 MD13FKP+NHC11G".13J^0YU@@P4#Y@UDDZ60#<1SUB^6^<]E<\L$$IN-9LA9@ ML#Z:&<`:'C\PVXY/-SP^CT[Z0L=?B-,'=#OB]!)@%9X'B",^6`L,\F<([`5R MP._1/"%84M^">F>[S]J7 M$X<[,8YCA3Q?ELA+XZ?V0D")&_J`1OZ/KRJ&CN+J41Z>>LIGDP5.4>P2SHB2 MG)K);3OBICB-P]?^@IGQZ^CW4>%2T[5MMO#YJ_B/UW)@$-)>%V5Z4U+6%WMJ M>?:1T1TI79`5UIRS;F[O0#W7]2O\&LC7O6:S\B"HG\_+ MPGN%#1JN5O7A!>D%\8)X01BE,B](+X@7Q(M,C#*(%V7S0K[.U^A+=4]RV#7* M[FZ__J22>MV3*UD(+X]5NW.8V2X[K5W,(,T@9A`S"*849P9I!C&#F%%#C[(I MS&B#2ZD;Y9].EN1%'DJZ.%;7@"S^@@$#C:L#>M?K]@K5NR[(KB82MK0?9*W* MJMB92LPP.>8K7KAMZW;ZT$9SOY[>;U^,H`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`AL2AWM1MAIK6*&ZH9: MNYA!,*4.,PBF%&(&P91*S""84H<9JGN436%&&UQ*W>B.R_8IZWX91&7@*X)_ M*B=#JFZ2-9W^JEMA#:!_=8T^%.&%ZET^?G<\#M/[+Y^4L+^0?I%^M5R_WOJ! M-6?!B>I%UCE9YV2=DW7>9OJ3]4#60]NMAW_`![`>,LU)N>K'"]652U[8)+N\ M"M4KD[E"[B;<=.4MVU>P4.ZM;AV_X2:?/W!/Z^L=[>SVW`WK8-M(!;]S_4#[ MA?E6&>6.:0-M[@9**G:LBOW*+,?77GQP?9_[/Y*:D9J1FI6@9O]D=LC)4JVE MI9K5C#U5$3HF!E#LN"WT)P0B!&HU`PB!"(%:S8#L1'YB M`"7OE\H>A?KM?83E+J-J@MH4UEE2U[W6;S-%,ZZ$-J-U228ZCLPE=>?K#PYV M&B7;JP9;/X$2@5*5)D!?7)R,+8%MH*J4C]K+EW1,1HC70/K7!/%4OEU>%S., M'-`Z.*!WW`NLJ66R`![C3K4)7[B^=5K&(\%?#;:?NAAR%<+:F'S+1H@Z00U! M#?F,Y#/67Y,(R:I',O(%\QI-Y`DJ&CU)-?.OAS-:0_.7FU..X#-X_)PF]`YPDMI1J?.GAR-:0_N7<%L2=W2+"XKF8&>8`U MTD"RP&I`?[+`R`)K,_T)?PA_6DU_PI_*\8<\0/(`569/&7?Z*ND6V#*^D5G5 M6OJ3645F59OI3_A#^--J^A/^5(X_Y-:16T>7]^CR7KV<\Q:WY*HP7UWO]'7J MY:#XSD.@1*"D.I_H.F!3.$F(5R?ZUP3QZN"3JFZ&D0.JJ,ZDND-04X@&;S@- M-=UJ0W\RN,C@:C/]FXH_^7Q%`J36*@0!4O6`5`?/KH;T)V>O#J>-U"6B9FK5 M*#NKPH`5=8EHBK`3V!#8T'D@>8/UUR1"LNJ1K`[>H.IF$[E^=7#]*-&T'8A6 M!RVJ$-'Z1I_0&UE^3",FJ1S)R`_,:31M.H'S)'FR^.5;\ MZ2&1<5QOSNSSX/4<;-W1/B%9S.*4R9^_,VQ.7;#2UR;W,<>CL_6IN$7`M< MC6DFS,=C9A`R&_Z>SZU@#HJ$G\U<>R+FD?H9#+VP^>01!@-TM^%Q'OS.X_`7 M:)BV\"R8&4`$_MYRX%-'E/B%[P3LN^8^@,J)-_SN2BSRRZFR:EBD[`^[!<@] MP+<-Y-\K8286ZGH&3J^+5$J.Q#<2"9I:#G-,2\C/$X>_`_CNGZ'E<2%)HKKS MGJ=Y?&(%&GOTN/S^LQ7,\O/R5^X(T7QK@UK!M+4[MK`">./.]191X6GMQ6HJ M=Z]_?1M_9_7NF]<_XM+A@6;H^[!RR\G/@]_<@&NZGGN@E`JM_KK-/6PYNI1_ M']%6B\R/W%4KD^V"/;('GE=*X[,Y3Q2K4-3\.K-66HWKL-G"QV>KW&@;P&6 M>?&F2DRU!6Y?MX&*`M!0E['0G3[W2/M,A4T#>\8FFN." MJQ<@E"RU"1@/V3:?DO)4J-\/!D41CG:!O,%_ MWZ[LWUMG\E'$)/&4Y$O"HJ_@(/QBN^8?/__/_]&TOR<#)(%&_.$=3`/\"NZ8 M\(LWEF^"F1UZ//FMB%'"B\]\^M/5FU"ZI=]T^`/"D@$)CLNO_7U]P%]^1ICHW"F3ZTP6TX MM`-MZKESL5='WYAJ-D(-_OL06C:NTX?/68`G2@O/@N\$:\\PHR`\UV:<3?X, MF1=P3^(5\#*! M^%IH3."]@X=GKB?#1)U->D4AUET<`7(D/(F.8X!X,&>3>P&S-D/4,&)J%5EF MKZH':@H%*01!/3X'\@IBIYARZ,@KS4U?G`[DGLU_N9<_[DGA>B6VG#J$ZS5Q M>!7!2K(-B!I&]*Z!^N+`(P#7;7N97%7V87_<%2F="YQNY<45Y$R[0 M(5H(T@<6VDNO7\,S03P1A*T&P'@2IUZDB.IH5K"3-,!/^%7\//F+$.Q]&YYD M&(5N4$4>#Z0,#O#A8=_7)GS*/0\HX2$%5EB*1,L?HM"[X^)BP*S9>^-?].Y( M;6(ILOU[V,`<#_-<9S>D@??MN[8U$1;K+PRP$2S(+S/.`[#Q5ME2*9OV2-7/ MQ)ZO+F:O%+`R!\T3_GW!'9@''F!N.`42E`N('19Y.&,5<#Y3G"+F)XY1)&H! M<1[<(A*K4'GRCP(44BD*7M(9,5G/9#UOD_E=&(0>!\UTK'DXWXJW+-A21F^E M%^FXSDL3MPT;(^LQ_,I]=>.K"([O2`*B72)@Y8-!`'.Y+0GZYZ5^(U1K?BU]'OH[LZ(E5[ MX?-7\1^OY<"@>+TNZNFF]*\O]M3R!]>#[E#I.TBPYD6^*V#X>I_LK#\IN0]V MQ'6PPH1K7;#.O2%?YRL`HSH"#L6] M\$L@8/2DDV[$$@1>F)?'JMTYS&P7!C:%&6T`P2)*`1Q"P9)P[Y@8R#&Z!F0! MKP$8:%P=`$'P$U0&P0*:'Y@<[ZM>N"3*H22O^S@XTO5WBY6%1(' M&]H//?%_I,#9"IR1X$?:>Z$R/+F9NWU*,+B4?Y&M7,2K\^\UE.1[*,BHX^A< M2FTEHS.^N4@K30*X<@!N.S>J\0&4QI>$4SQFH@!L]3N]ODZP55_8VDY9(]@B MV&HZ;!F=F\&IM2P)MA2"K>T$/X(M@JT6P-;U1?JP$&R5`UO7!%L$6ZV#+7`2 M=8*MNL*6*#'(I@'WZ@%>2IRNM1F]2F%`A?"E]SJZ,2#\.K^;3OQO]>WOQ$6_ MY`;)^KV1&IQ0`OVTB1OB188Z`5P;SRC+8U65#NB@O=)9%GO` MVD!+[*.J>7X MH2<*5K`Y[.9!`56J1(7_`KIW7"O5!FID%#4=I4O+(-CME,L0DKG(2U8(&*/9$>\.NE3Y_Y/L_P+4\=MB-6L0!.+3P+UIQ[P&Z1=:D*'.I= MZ`EF,(?92]\"478FEBF+_&`U-%'F)Q%2=17?=$-[HCWP1`U%D:('465B!I:: M5L@N7F2I&Q`QC/+"5TT[%+71&'9R\5U'Z)6T.T51(S]@@!P!L,76IG:(/?!D M_49XPPRE2CXP7Y9X$BWR/.QRYEMS_!`-AH";,\?Z$Z"JUC7&&U/;MZ#5O9TO M;%=$T[3;N-U5LU>LZ.J:YHEN%3YT-+Z2M8W6:FC\W,TL/M7>?N=FB":7=B]J M$'OKG0OOWMZO7F++PJC>IC/%&I$/W.%3'.MY9IDS>`DFA(@6"S@4S=YR8V\A M#3Y5@Z+X@[3<9%CM_>8SPIF%Q,A355*T,6%^Q8 MJ4`Q=?+RUVY+U\G;XQE(`0W6C/FD_./.2H\@HPMPF[AHQ+#2QS45S!3/+"GO M"--%ZC+\!BS+:%+V4N.`4!8,N3-.L/6$>$$KZ`E<]P^-3Z?@X^'2_I0RXU1J#F;H+^5K%4L5`H"N&B"D0(.@JCL ML1_CB0,[6D*Y.I?_VSJRL>%!2EL&!=D]G[AW9[N!]A4->5CYXY(81R;=*0AR M[VA?^"*0$!CUO5VO\9T;I,2]=M%\6O3;?G8]>_)L`6;!CP//>@B%Q;*"\!?B M0"%E(+Y)?V_=HUFUN<:J[;"QF:+F[W8GCCW#?XA^M&-D@9U?/KY'U/P"%N__ MNC[O:'=`>]C)'(N)#2U21'#>M85K+WW`WAFXVQ.L>CQWA:=NPAQ$0W'9B%OS M0^^1>[N#XMFK%LVD1#_7V+J+TR@6H0?/]'FZ>[G<_&6-\KCB??[-J]0"].]$ M[<^D!CV8#V+/W>`FK.KW[IIA1C$/O`!4!9\&(^T@(5%$W4^)"GQ]UV=P/ M7`>=`ZRX:X*;_L0GN^WNZ'`V][31)T$6P;3E`8(VE=6$4R2/#6W520\:'EBB MI0<3?8P`T<"G07I/@)BV*]H3)57H72\.["*#8JQ"1Q\/?U@4-8#=`\0;O22$ M;%-`AM@XP8%'SR@ZQ^CF!Z@CM?F0W;7^>*NP#HTG-5C<;L[H.E\"^."-]01; ML#/Q`2:_P'[,L>OC)V9-]K9D--9:,AI7P$_3`HO8_^GJ_6_OK@!2+/G#W^$/ M?7#U;.+Y!%3UGO794T97&J;H>!61>5X`D5-^1JFF,P9 M7IPP96-8V92-9,K#;\;X:,&H;,H7D.6BIPR$'25SAA?7)U!Y7!29/S'OWOLB MK*-_,COD\0_7IGSK?[N?GJIO>N8,=SVOT`D>1\2")B@^]6_#8.9ZL(=-\E"N M?_7S>"A3C3,GM_FL0B9UB%H%3^H]YJODI9(Q'ER/]D](/B?W9(Z@CG%M#`8% M3.8^#,!/D3W-]LRH]RT:X9L04S1TL!EUL+Q+DGQNOUM^\JW48'=JKM6LZBOF-83>\I1UO31Z@YL+KTLOG5O]7F\T5GQ5YW'+&`TO MO"ZC?-TZC%R5K^HL;ND'(+#P5?7+Y]5A8*]\56?Q:J#W\R]+F$='[^/;$T%= MV*G?8O#S']T_^.AKX[1'8R1&V.VWSD3F2''^BSS._F0SQ[_'.-G7&7,$`7_! MU+GTKY)XPTGNR\\8X4A'.U)WO#;/>:+77E+=^6HMV*+:Z>3&L<`@,WX8$UJ+ M**T)4M?AF/+0@A4]H2SH:'G0TU_\\:/@5AV850_>-.WT>+L3>N%ZA)%W]B,O,A9&?N+@Y8',\`6*! MN#*.2>@>X`I@?C`3QP0^]YXL^O!:03 M3C7.S!DPSPLLTX*)!__77YNL.'B61R.Y'S",BH[!;6A-WJ#8C(\4311O43&C,:=21'I*<7G:'>B^Y5% MH6M^_#KB[O%MDO-A+SL;>(?__B%RU$PT5.!+WJ8Z1<"'AHV\LR"2*6QP$>.+ M9AG[(6;EAIB/DS&?W]R]SQ/7C^-L7YQEE,>[6!E#45Y5P:F\)3LGIZ8U"7V58RB0HX95A&:4_0TR+M>#E;M%>O_R5?$](?3KQ=G=B M;/HG`F^?5]FP*\\1P#&9)D#Q!'\EKYPO@BC7RO52UZLL+_95<`\SF3_3'EPG MS,Y2W9Z']&NY+S=L]OWE)/[XT7.?@QD^)7G+3!$E<_Q/&_F<:_O)63O+,.)]N88>^]BA2B'&A6!>%^YW536'+>>*^R+W2IB%F#RZB M6\4SU^>.]K"4N]IJ[)QBN*S MW.ZW%XVS"QV?FR(9U7T`=69)H"%F7.;8"5=QHK`^!K_U9T+1//;P8&F!!Z". MEH"\3&4%,I=56"U;=HK@)`98TE-8Y<:N2=3I`BFFDA)$,9&').EY(NFZ-2\A M1VBQR!EB*J6D?IZ)?HWGL^XQ(0$D.Z1\RQS\6!CNGQUX0\S]?5*X8OV2ZOV' M]]LW#M(F8R)!,S``I`ZXL/%C$C,(B65'VL@D%.`+42,#TVX+,-=HYZ?@[.[@ M[+HN9&Y#ZQ5>/!XE:"/@;!5NV7.;5-9O>2DNFQQ\SF8YE=0N!%`C0!05=>V> M$-Y0W8WN8MOVQ<00,I[$(2-"+:@O7C9-%@7*ORHW\S)5(R8;C,4-:JR"(J]O MQ\.FL#YV[.1N9:[_8.^T-HF]B*Z\!+OXY\9===?O^.8V]'`B?OCP'[P[&\%\ MYO,E7L2>;F1!)5.!7R+$.LGU@T0,Q"UB[TG^Q'3]H-2R(Y=U6D_#M/+2YHLZ MX]X^//?X#+X%]MY[!TLP_,:#^^E7]GWO8;B^=ABN'SK1'_=OMK*@=CVWF`GN MR4+/G.#-=M9%N1/!`[;72\MJK%,;4<\$9$X:XXFN)U$16E6.G"ZIU/:1KD;ZS91T0]P*Q7Y>Q]Y,',G[Y,` M2=9E-(+*S..Y3&'[)[.?^/\O*D]4!X!L=TK8)R^VY$62I;92A#KPKAZLHN.' MS0'>.]K_AO92'CRL!=RBV@I%'#AW!_E/ZN.+X;Y(OQ;E0CCNL]JMMJDY1:3) MI,&S`[IH=M$*12@4!VN;/O^@7>+7^\%YA84AJX5E/6-=CSB>B M!NJ$8_:?%MLJXD0>ZV/YBQ`C%%-MZKES[<[&V_EHO]S!1"Q3G@V)"_NB@,R4 MX_F!-N,8A7G"AV+],YN947VQI-(2!GP#(.59L:O,#(8_"0GPF\SQA2R:AIF`FJO@F9SN1"1E%JN,R)4!34Y;/B0_4 M4E:>C-D4E.,1'Q:LSSLUP:3J'$;%G+3`%E#"YB;W$'_5N+`)A6'M^3-K@>9N M6DH+Y?2MKV4KM$@'$Z"2^QD6AO8PD"E39I#UDS@:BW#[`(9!]*Q8T$4$-PW* M$Y?+4?AW$*`-5V(*LB@J73QQ3UO'+U&_R=\=4- MU`3LF8NF&5'E5D+R6C^B]$M((\U5;%JW91SP/QZ".(XEP!FSPVQ M-#^6]W+M)Q$2`Y)8\"5FRHX#VT7\W&/3AX2&1M:/#_:19[DAD'$ZM4#11#X+ M[D4.?Y0OL*6%PS9J.*^"Y';&OR\L3]8JRTT^(2O]GDB_VFY??>IH M'2UT;.[[J^)X(K'&MKBW-\_%!M*MUU1#6HIL#\S+D<%"V/9$)DX!J[XN()>> M.4X(?,*R<=+(P$/.*!_G82D"H@$>-LM*7K"2.*0 MG5!8*TA#S05`B8M[1T8UEK.#0:>8P86U(Q]EVLRZOF/:VIKCEE^Y=7U<4.*\ MS$-"^C[PU.&T-"!A*(\ABK[$$?"<'VPR80?*5B)3'A->$"A6](-T99,GM(XF M&J+43I#9D%C`'#SM*Z\?5;&0&:UQ+7^!^2F;$^QM[J?:Z9QK7$:-7+*[S4F* MM=WZ5,*Z:4'4[XT,J`CI2_(*/;[@*+8`?"#R,M%X3<]%S&?M'0P`"1-CRD([ M2'=F$#B3VMTGH<@3QLJAKN>G-OO=?O<4+"VL7@D_+^"("&*TKH MBH_>\0=/9G8/A:H/RLS(J9VRJ^UJOD_%(`"?I><9]^MJ([L(FR^*S8A!?P)X M8%%;>2]Q54D^BX> MT9^)_FXNFD M8!'(C5L2KD=\'[@M:EC+*1T@K#`*Q")EDHKP]V:6-TGD&1:QNL\JEI/01/Q: MY@[+]?#YPO5V7<>^]44?8L$-V)^^R<*+^9]-G&DOB2\Z87`LSXWQ"0(8*6ON3-%N3T-Z@<*]M6W+X` M;;N5PB\.#.,[^U+\10\*E%.^(:<3:R*.1R)Y/5U<=V[; MV_Y^<.JNEPZ.[O&74F%31UZ]7UVV7+B^%0]U:`==J75E>V@!`;,5R;`35WJ' M3=R]:'.:NJCU&[M3OU,(GI]@".1^'F[@^2>=QQ;!GGT3;MJ"NJG3:5LFS,H] M8P[$7R5//(N;HA@GMPNT5/RCH5_>C$PV@!TQNJ:8*@5D(A70YC$*O19G,+TL MRF#ZNF4^[[TK=@(TRO8D0G)3-AZ*4&XR_)=[;@%'.=F2?V$R%4*0OQ0II3L( M0]%Z-0S#%D2$-I,S5SU=68";CM@FL"X%L]`S6K7:DM?RX1,_7&`Y#H&08.1Y M091-)2I4Q.=ZA!9IJ+Y6>3QR$[R0% M%6SK#SQI?>"IP>:J( M8&NT^+G1XC21)Z@]@C$*AA/GJU&C_+9E4K1,'DS&Y2#\$-M_6[)-[\;8&2VM MV@96:I\VW"\VVF^JA,@G\J<1VXKR\88[UUE!4-*!6AQ33;AO>M8#NA0/[E,: M*C?3WV3UH7U9<$F^F,P_249*?&@!LK@ZD5]C>3XF:TU#7P)MU&5O?CZ-,L:1AMDOF;BA8-^JTL^G#B#=7M"ZY;O\K5$F)XT]LL09#QB+RS M^#;AUK\MM'/F&@-N\=,Z.5QC"CC<1HJR]6&=--6H*8 M,]`UF]]/LSFV_2[GO[$Y3]8G\"&Z?I$L,XWHO']P@<.>O]$6`D5RN_?#F!O_1;\6Q(OY+]L"R8NW^<@6 MN(O&T8Q\H4M=]X&]\R9.I.ZMW)35+?;5O7%3BJR,-Z]$.>N6=_31X:LOM^GC MU_0)FL#(2%>B&Z`>9Q,+@W?)P>?V]E*Z?(6Z>I,)#J!2/I=Q(-9J0+K411-Q)+F M7%Q>$P^/YXXO+'$-;`%NDX@ZB:PY&5\[?,MKXSX_%Z4JW"?+EWUM,*JFH09/ M$-3!5L/*(-;3[FMY-K;,2%+U4D/)2YLB$":R#5>I%3OO1J6>A^>]H]V;@(H#&2)P(;I:CM"[06`9KU5%2[+AX.\4-?9$(Z,!N@\`#5F*2:#4C>ZX.'I$_BTZ0/D'W9O-?%!=S"CU6\C\#@,5<1@44U8^P>HI MJV_EI^QUD8(FVN%$^3\\LO1E-M2,V\+^1(?2?4[.B[%`NS^-*K&E[C'CD0"L M&75^=\K+A*7HP#HV:(<%)(ZGV@6M0DE1#R116"-6GXV&!JO[.L8@ M@NWXFY\`K)9:F&H(L7!]7]Q7=Z?3 MG:TRY.7S1"57K8!2W436]%(@W_.,RZL@8L[1!!^6:0:0V[&9(';(#5'++GZ3 MSEY)TLCDU74\Q@<'(T>=_!VTR78PU"(,.0R724>+8U5)&I5HIK9PGR#;C M<]'#:$\\#=!5CT4N+^>C`3)G"[\"Q;\(!V`-+THVLK2E/7V"U:3`,;)K"C72B6 MQ^SFA]$AYNH'G42/%LPJHE]XD?6S118G7JF%56ZJB6*^(&U".VX5]O<\L%=C$X?%A[_3SC!HM+)8<0:7J4/0E,7$&-W(4WQ M5!FHV);4BG.;!T5ZS4RN9!*:T255#?PSO&`!=O9D;CD(A2*L+X\60#?^X.L- MW5QY67#M"/G+J@$,+/E^=:(NJIFG^SQILM%3@M\<[UMOAQ[:=Z)M!__6^B/XGY[\MZ";<&F0BF*SFLTQ`U':DBE+,!4* M06U$VU/FLH!!!#O.G>WFBH&L7@YQ;P5'Z"5NLG&9A5?"3H,9;O%T)2D_?+]] MFY\D'>G=PX;ANUQ]*&:9#I M]_$P)&VHKT?FI+QVCX&(=9DH]$[#40G11^11W\M:NS9^F)%W/HZ;4]8N[3PS M0W]X3(9^FB3;%)QO?3V(>H9^C>M'O%^5F"BPNV9_L#WWDR93REK&J;7&\_R7_!A&'N^ZELEJ92)FG)ZZD7 M'0M;Z_WT5]>=^+?.!"0>>Z[Y7UQ[4F0C\$%_?+TM3=G/+6-^VTH?,^(+?Q14 M2G,!N\^]$Q&CQXXY;8W^095^4N,@3C_DD5,U_O7-5E>#AD;RGWS8HL\<5,<]OKC<87S*UO&AOJ@)LO+(V-& M/[>,%;T_[MM`\DWD1!3="S/Y9G*J`;I/&'?-)&9>D;S9M?'%SSI['J=&4W:` M8^YYG.J:[U"@'?.0%8/>\0D>EWUEW]_*$[%?N,.GUGXW^T1&&2/!J-2\]C^[ MN(F>R$EC/+ZN9J(GLGK4[Q5`4=?CUJ-3*NNOLZ>YX\G%3?-$QM]DL[WT:9[( M]IM1[FG*\^IRU?W:T+/FN>/1A4WS5-CN#3/)6?8T3U7U<3;73YFF,-O`A/K@ MFB5#O=[K9TUV_P2*GO.IIM6F857%G$_=Z[.%XI0YO^$/04;1,JI\E'6TKNO9 M356`AG7(3BF]WI$RB=Y9J_OUK78GVQI3O_"J'Z?'>%5+'DJ(H+/$K< M9\/)/[B>YSY'3V,F%OQ9M0_.6(W,Z\K?MT(?%MQF/?^4C%Z14WJQZG>3Y,3A M/49)3S]\B)L^_QBU3P^D3"+=15F.J%X5DCN6Y*AVAH[KW9#NP4[.I\OT6K*0 M#Y;$E142S)H2%4PV\D:Q>I0?IR]GB,OA6B?S MU;)3UR1<;$[N/D=9V,D=;Y'G#>8-Z`[>'8VN),)ZOEOS<([?***C2H&YZ0O@ M$':N[:1O%F[>;5U5B4D:1?D-Z7CVP,P_'D4IY9>F:[O>JR5'OM)F6JO-].N. MO0!^B.%3VP)@B5[/\OK!^C6GXF%SG+$_#, ML'BZS9^XQQX!#G$Y'?@B?!/[8XF[YP`T`*8(-&R"U5G@!Z#:CFABG5+O>##Y M)7F#09936BDZ7G&(MG)X1C0=48HJJL&`GFID9(A;$D#X$$LU6.*2&;87Q9(7 MJXDG+-A5@RDI?K7:W@^!]WK9+-QEC*GIL)P9$WYD5)/+2'`,.GP%I!99Y-7WD-/&ZRPKSU&^!H M8N*=1AX12PI#[E5M%>?*3Z="VMYAN"?_5,XL-=F)"GV[W9V6L219D7UYF1?L4=+&/5\.HU`@44E53R>%+M;Q\4(8VP+!H/QEQU9 M9E&J=U10;LU(ZA2L:(6:OSOMOBP"YGYJLHV8`+BPV7O+E"4ERW9@;XY5[\D) M?P"9P+/S['L.*U-YRKE4:''S,=7Q$!LDB1LI4)DNBIMNBI_M_DVVE&ER;AFO&0!">JI;"4FRJF`38;% MR]#[Q3IGMAT++;SY:,6%GA%XXY=8!EF(]MK](=&E#<8"7&:8\RS>?`#33Q.U M^6"/D5B==`Z&9Z>,"FRF8XEXS8?WO]Q_[L2-9F)C4@1PBH"%0=?([[K^M8,F MZ&KZZSLO`J"8<'FKZ!>R"M&>O`,>2BCK>+,%8)DIKLQ*^264(I0J"J64WM73 M)1P?(EMY]^:M4.7=3F3OPM0>1>_S&&P%U!0RSU%WF-_F_6L!*TW:I"7=N*-N M!,*6%(NM@X5?DB84X$Z2)I`FE*\)A5@2Z9U,OU8H2Z&.MD9!V0OB+F*]+$.5 MN=(T"_`KEN)=P7)4UZ@@L!KK!55(+>#4?GQ3T%P0Y@N8S\`H9#X8[BHB[IW? M9.]H.U2VLDA\I[!3`;V`N8!^+;!]S!.WEW%MJRC\.UDIH(M-EQ]DN56L;2]K M1P?LNQ87!/(+KV[5PF:\.[)7MU-)T;_QX\]8'&&M MZL%'&>[:ODWW_K=WFQG"QM7/8&<.C.$ZQ8XCQL6)F%S"9SY7D8[]8N@HBU7@ M40=LT>+$_(,5.1>BU(4XG_\M:>:>JS?TYJV!DY]>XN2/N&+8[Y>:TV?^Q)V0WQ5@#NB#GIXYF_5GY)W'8?G1LQEUS#36+K==`CVN ML\'NF'F4M((38>6E861;(14NX43`>7FM7Q>\!/C:KN\P/?9NTR?.Z+`AI8\.8-,I,RHHO**/AH=4;.UA14WL,"2- MKJ\/X.0I$XMZ7SB/6*#RCGG>? M\IJ5<_S\CRE\>^XL#JTENAZ<8Z,?':(S/B+O-(X(*O6R+<^3YO')B'L.QW,F8].@LWL1//CSM^+W(Y4T?C8#^1!YP3DWHZP>@^.AY7&(]1^A+ MK[+U?!9U43E6,KTU32^$28K_\DE14="M4MY%S>KR:ST<1QP?@=&5K153$S'% M]YWKO7'#AV`:VK?QW=]<9O/-@5T_]_2J7/YABZQ_&%*K7W[\5CY=OBE"E>.W M+K6LPQSLC0_8@46NZY_,#B5NQRS/&58[Q)3M!Q8ZPV/R)HJ;80H4]P1_BPV< M7^L[`>Z\Z5QP=8<#6<;N`$)YJ\OOC_<'._W@S><4,J%C@LA%3NB3Q_&&_=NX M(VPN6ATEP!M/+'B2AP][ACOWT1,FB=>-[V`6<:MQ]-S?SA>VN^0>9F9Z'-]E MWC+])7FK^MQ3V@POR^AM$3S'Q"ZVR#T'N1F+W.PU6)-%[CGJS5KD=C#C4HO\ MR`)S9CF/:Y_+-,YS1=7(SB0='KV^/7.ZR-KV2&CMU[9',.NPMONI^+!8T32. M5[W#4[OD2D\6U$%=5WJRV):ZTH4'3Y>50HMLZB(R*M;FO7K0F5,X-<5UM'7@ MG'L*IZ997F^=EQPS!?C;YE&@$K9!+[#^6SB#!MMYC8#B M4SZUH=GU(/^4/>M)5+!\QRP/'7]^/UV]>2ASYMN$6]\^\$=FOW6"](6;?=TP M,\RZM346-T,`F>#UVS<$I[9)1E%GVI1EW![5?C.KLE' MM5@?'>SR&_\<"0FTX'--]K_&]Y_BJ"R.F!KMZ%4D?1E%$9PHD0<+4"+1\.<> MGW''ESB`J=*Y"H>4=J5W%]QO;`O)M=_[:?IT]C.WD1C8],[_,@/JXW72R2=9 MPMVGO6-_@YMAINR+SNI:FLIUV#S:W>[F_@D;/O+G.G"J'HQI6LV8WY-2IIE; M"_P>F[UL5&"/$H:QG&D8S%Q/;&J!JSUZHBD'[HPN'BJ*4L>AJ*&&=><1B/VD MM%8\GJAV+HMKV5P4R);#R+8:AP93MNBA.D7,7Q5=8^1$*#@3"4H!`H6GGC(G MGJU),!.@E>AU(+3#Y+8=88'PL/&UCPV3HM?1[Q^PZ+^'Y=%LMO#YJ_B/UW)@ M@+A>%Q%Q$V?6%QMXR4OY>H+6*2`./B`(W/G5^GR'P^[UX*^OHX<'[@()H3EH MX/_PY@;_T>(/Q1-W?BI'W_UYY$%M?[Q9&4[[`?#)?1UO`K!F6&1$OXT%'R<^ M^'J?[*P_R87==PK(]6IF@6>3EJS-9Q;G.F+R\T/7NJ$>\4((7/:,[)+U0@Q>D%^KP@O1"'5Z07ER$%_*UUVR+V2C? M9$Z8HQ5J)1^*([7#3"Z`?P=U[20&M@SJ&DY_Y;?]AM.?Y)_DO\WT)_DOC?YD MWI)Y2^8MP5L9]$^=76-2.?<*.JL_5H4.Y83<)H?:)>@4F0QEZQ0LRU\P8$#_ MZ@`O>MU>H;SH#N$;(A5/^T',D75/2/"'V'\M^O&Y$ M]DH-L?6R]@HIU+$*I8DL9Y_LE7;H5+9.D%(5JU29B:`E:50>CI)*D4K51Z6V M$YJK,?35TKCQL&R-R\W;S6M"-S%/H6>.6,^U]#6 M[V"B/IMS9U)*3$5]N[]\]C8*4$MBP''JH6\`J7CHZRMXY+/'%C]=R?\FF?FI MO'V@/PO6[^/$=QOUSDVO)[H$)[1OME5.$J\"`RJ4^/'@AN2=Y+TU\GX]&!\C M[TI&KNOH019MSQJ]WF#3B'WOH!>%M1(H8MT>7%./_A7"FM'1VV6XDL`K0/\* M!7Y$TD[2WAII'^ADM-;;:+W6?G.=EXGA^L;RN!FXGD\F+&&<0O2O$./Z9,"2 MN*M-?ZW?-?`0N2?_W5:!2G<9[>5+RBPB36K=QF%01+?FQO$-170)U?+2OY3, MKBI]?@KIDL2W2N*-CF$<%>@BB2>);XC$4SY";J<\_G=4M27[U0V83<9J.X`L M1UJ5`9]/W!#OU38'RJX[`S)72>9;)?/]3J]/,D\RWRZ9'X^,,TQ6^1*+26R. M&']*O6U:V=OF3>AATQB\<[C6<2:ZB";>.QPCQBXTEF-Z'"^SX4]2/6^B+C1A MTD0'^^5H#\L".K]T]=QC:"`.-K:2D]/,[.KU^R+J+,>_<\^T?-')SA=DR M<5STVOG\Y=;OP/_^#O\+'WP2?Z2).V=+T:A/TLKC?X:6MZ*4&P8X2HJ$ M#_!.Z(A?8.F>^1SG*Y_OQ5\/D/BAMY0?=+`7(`@V>Q1][M8;%DV27O"Y^MH1 M8%RP2YG4NMMGYDVH(2FA^0XROW=$9RZ$E?S(F&YCB"_F5A#PI(MG9BNT7UR0 M3_S&*L,N!6-,2*\V]=RYQA8+#ZS-281C5K*=B&YJ,8KBO@(FVDN^E;DG\14_ M-[D7,,O1XN_`1]A73/P<__BT\;T8A-WIU(+WX.O/,\N<=31Q21LW0_$+P,\` M&,<#S>9/W$8$=^'5##1O^*LL--NW*Z8!0A+\VCJ_H*;UM2"CR7L M"$MP\I_0%^4C?GG_]Y3AR++]P*6KTH,'PSU0FSH`J=4K35N=`=E6./YH2)KKQ=QQY)V6H-VVI;L MM/I(]:TVMR`6M%?G=]1IKSYAK\Z_/-PT=NW?^&'^)^RT)G(/W=$*%!9AJJAM MB1C%6"(51_.,;GZ#_BC[@;;*"K9*Y8\P;C4_G,/SEJM#5F$O:LP$Y+6"91+D MPJ"2K\ECZMP2^X:;7-AV?;VC%1)`*A3]"G&SI7NHAADAN)@^*(\=ULXJ.AKA M8.PN@%_ZZ#*[@Q%4!ANT:]ONL_^JS"V@S1!U?*:3II\Y\;/FG4J4BC+'`$L3 MN!$Y3F#+V'8$43]=]:[$:W_!S/AU]/LH'F'"M"]:928M&KSMH."M5Z"-_;`*IH?0% MFQ;Q0OE+,VWBA5%P!S_BQ?D8U>\.":/4X$5OW.T3+Q3AQ8WBEV^:P0OY.M\] M9N6]%VI87F^7I?GWW-1V4QI.?^5=D_K3/VDN;ERZN;@BO%"]P^"_Q.>EM)E3 MW:BNAJ-5XIWJIG63.$(&-AG89&"3@=UF^I.!30:VXIM_Z0;V+;"?/6YGMY)] M72=KCNQKU3A"]C79UV1?DWW=9OJ3?4WVM>*;?^GVM?:KN!+PA@5D8]?;HB,; M6S6.*&EC=X<[B\&>S[/QL('0B'=J6FETG\5-!?2M&J.;%.I8A?HB;J&58&:H M;\?77:6JL^-)O8XVY=\QR]/^B??76VG*5\%4,N7;P9'R3/D[\\3]Z%+[9NF![0HB;3#?ZQXS/,-\SZE$36O'UQ\-BNOFH[YQW6B!S[YT M2KM&OEUCN[A323=2%614A<`T[O;&Q:"2^NY(LU%)?>>CKO17\M1`#?:HTR+W M5UE)B_R+&BE6=?Y%PW;Q_JC`9J'D7BCH7A#]J8Z-,G`S[.K7Y#0T0-;):2"G MHXA[_0C6OT&7XD5Z&V8DZN`KD*BL/,N&N0J]`$ M62=7@5R%-KL*[UQORBWR%NJE6I5Y"TU+8'HQ&)"W4&\Q)V^!O`7%46;8'9"W MT`19)V^!O`75V7/)>P_;307):U!7Q>C>0V$;^M"@Q*2&"#SY#^0_J`XWW1N= M_(<&R#KY#^0_M/FT@6XSU$^QZ#9#0;NX8=R0T]`0>2>G@9P&Q>%FV.W?D-/0 M`%DGIX&_L+0AY2?5&\Q)U>!7`7%86;8O297H0FR3JX"N0IM=A6HW&H= M58NN,Q3E+O2IW&K-Q9R\!?(6%$>98;=/Y9*:(.OD+9"WH#I[+GF;H4]>0XU4 MK)J\)`,^G[CA@\T;Y#>,#,I,:HK$DP-!#H3B<#/LC@QR(!H@Z^1`7,J!D"\9 MF!V;RA1_>F@=CNO-F7V>K7V.H;VQU-BJ3A:S*''R9\[]K*FG("_:`$!@$L@3 M+--,;MN1#/YTU;L2K_T%,^/7T>\C80=)MMG"YZ_B/U[+@8$IO2Y*HR225*EU M$3O+S32Z(Z5!-+\.']KOUI^4*/01^ER8UQWQ]?-9N5!.#Z?EX5[GB.E M]\86\:+7[XZ)%XKP8MP=]8@7Q`OB1;WB9FWB!?B-9$>IP0NRHR["BT(.+%7W M)`L(!QUR)4^*!A475FF'^UC?<%XSH*[A]%?>3:P__6%9_H(!`XRK`[SH-?,8 M,W669G(GX-Z%TV&>Y8,>7'N2N;_\2WQ>1@*]\@Y.-1RM.%6`]GO:[QM(?W)G MR)TA=X;@K&W!G%C=_2W1GM%OC/'CFY,^3.U)4C=:$_[??DSI`[0^Y, M_=2+X*T&]&^J.Z.TP44.CN(.SF<^9Y8#*]+(Q2&-(^Z4KW&WCX\>?V3!:3&% MEECPXR%9\'6VX'/S3V4+L@86?*/I7P,+ON[T;Y+UM#MXTV-F$#*[ ME18[:5C->:&ZAKT'_;(AD'H=JUY?N3>''VA+SKPRM$Q]/X"TC+2L;"W[ M)[-#5<+T"O;"KE7AYOLP\`/FX(2S:C?WR/JO(8B>8?WGU*.FM7P97A=7N9E, M\VJ/1S*K,;5MWR`&*(TW>O=Z2'7BFR#LF;MBY=20_N2^U^=Z4V[105R]5*LR:&M:7N6+/CEP M]99R2>O@NBO.-H`(H_HBEP39)T\.`5M&_7H7R'6#$8CNOC6D!,WNOC6*ARCBV]I M(!L-R$5KB+C7Q44@^A/]2Z$_N6WDMK68_G5QVVI(?_+C:N#'R8MOY,;52*\: MA6N59DV.*6VRWE).W@/1O]7T)^^-O+<6T[\N5DX-Z4_>6PV\-[KW5D?5HGMO M17EP`W+@ZBWEY$`0_5M-?W+@R(%K,?W)@2,'3G7V7/C>FT&^7(VTC.Z]%783 MQ>A15F5#!)[<"J*_ZG#3'0[HXEL39)U<.`6-&_7H7R'6C`='W>DGCZT&1VYT M\:U5.$87W]:`[*C.E>2BU4#0]$/U;37_RWLA[:S']ZV+EU)#^Y+W5P'NC MBV]U5"VZ^%98R^X>>7#U%G/R((C^K:8_>7#DP;68_N3!D0>G.GLN?/.M3\Y< MC;2LFJ1*`SZ?N.&#S1ODSNG&#>55-D3BR:\@^JL.-]TA]7QKA*R3#Z>@=:,> M_:O$FL[`&-+EM^+TX1`_3U*',WRX#14B;ZW1>+;'W2(.E+&CD_=&W@/1G^A/ MIW+MI#]Y=(I90$1_.I53BSWEW(33F#/1^/<%-_%%X&I/\#:Y>#52L$8!7)4A M*_V:3N,:(N[D3Q#]58>;[G!(IW%-D'7RW8HW3O]2@@E*)M#A4[N^/CCCU$Z^ M9`\VWQPQ_O20@#FN-V?V>2)6X'%6LIA%B9,_>>[/\C$/KCU)+^:LM:0$(5(+ M4.U$$`0/-9/;=H06/UWUKL1K?\',^'7T^TC<099MMO#YJ_B/UW)@X%*OB[@A MJ2:5:AU\&AD+*/^L=_U)R=97Z,$OG?L6PLJ#&^?YO&Q9@*!%O%`^>M`F7JCN MR1(OB!=5\$+UJ$.;>*%Z!*)%O"`[ZB*\H%-E2AM6WGUL>.!;>:AK./V5=Q/K M3W]8EK]@P`#CZ@`O>MU>$WF1.F$PN1-P[\+'0CM"W\GT_R4^+Z,>G/(.3C4< MI8/6)N,=[?>4)*LR>\B=J3?_"-Z(_N3.D#M34^.W='=&NP7^LT=.[@RY,W7E M2%WH3_L]N3/DSI`[4S_U(GBK`?V;ZLXH;7"1@Z.X@_.9SYGE8"%H.CQQ]9<%I,@2QXLN#)@B<+OLWT;ZH%KQ#]R7I0W'K0[N!-CYE!R&RR MV$G#ZL<+U37L/>B7Y?B667_[O#MQZO65>W/X@;;DS"M#R\@/("TC+?LGLT-5PO0Y>G76 M4OMR,_>TGKQOH]Y;!@..DO9S&"L,;ZBW5$'E7O@HQT9_H7R;]R9U4T)TD M^M8_+@:Z56;<4WY4!>=7C9.EW@NC?_'ST7O>F7PS6D`M'+IQZ M5PN5,W?4XTB%Z'-S?92Q0SY<#8[ZZ%I?0W<6NM9WA-=V;9#7UA!YKXO70/0G M^I="?_+DR)-K,?WKXK?5D/[DR-7`D:-K?;73JT;A6H5NW(L;$8_ZD;RWVDHY M>0]$_U;3G[PW\MY:3/^Z6#DUI#]Y;S7PWNC&71U5JUDW[JKTX$;DP-5;RLF! M(/JWFO[DP)$#UV+ZDP-'#ISJ[+GP7;@^^7(UTK)JDBH-^'SBA@\V;Y`W9_1' ME%;9$(DGOX+HKSC<]+K7.EV&:X*L-]2'H\MP#48?HS/2C[I%0F[<<0AUB)\G MJ<,97MV&"I'_UJ`=9AO/]CA@Q($R]GCRY\B?(/H3_>F#52L$8!7)4A*V-`YW,-$7?R M)XC^BL--#S9$.I]K@JR3[U:\ M$C#']>;,/D_$"CS.2A:S.&7RYVO'45-_ED]Y<.U)-!)^^945`.?-S-5]"5SS M#^U^$5BNXQ>P0.*.>(!0-\N![46>Q\H'2K3`UUH$L1$"#)+E;&)9SD%3:K^F MQJ>2^>N,:W?N?,$=GZ&HX(NY%02<:^Y4"Z)/F;,4_/CAN]'3;U[[VB\N\R;X MC3>6Q\W`]7P-<&SF>C#Z1'O$TJD^?NP+*72E%&I3SYUK;+'P8*N>1)]9#F9^ M6$]<@[G"=P)7,[D7,,N)GPSC3"UXSY=QBOG"=I>B;A'Y.8&RDGN8 MX4TQT]'\&?.`42#4NE7CM+Y@9OXY^'\5+3)!VMO#YJ_B/UW)@@/U>%W>)3>Q=7_W)A\F][K72 MA\GE)PNO/RF)G1::.7R)Q.'>L&LH?(E[T^EVC MX1!7'U[HI!>J\$(WNM=*'P&UB!>$40KQ8J3XT6B;>'&M>.I,FWC1[PY)+Q3A M!=E1RO`"?;T1\:)L7LC7.:].J![MHKOQ]0YQ-3R[4_FP5L/IK[R;V'3ZJVYV M-9S^RH>L&DY_PI^*Z:]Z:*KI]%<]'-5T^JL>@FHZ_WFA[(?>NM?0G\XK"2RVF/^%/Z?2'9?D+!@PPK@[PHM?M-5$7(!%NP7^LT=.`9;FN_--W>_KRQ$*L%"` MA0(L%&"IGWI1@*4&]"<'AQP%ZJKUV<^9Y:366V? M(@AU]%=)XQ37N-O'1X\_LN"TD%U+W.'QD-SA.KO#N?FGLCM6`W>XT?2O@;U> M=_HWR7HXBQ?*6P\E'O>1XP:5C->:&ZAKT'_;(< MWS+)^:6SX*8YOW4/UE_6^>T"OFF^:UL3[8>>^#^*&&:#YA?19+25)G_=5:HZ M@X34ZUCU>ALW@/V$;5Y)S4C-2,U*4+.OW)MCHVS1OK:5WC5I&6E9V5KV3V:' M=+)`HK>.OQ2_-V1?=E>0415"TZ@['A`J-0&5,CM3*"CLC65` M9FL*!1E0(=KTNX-146A#H1.R@<@&.N^ZOX*,JM(&ZO6/<M2*;%*N.GJ?<*:!L@Z M=355,71$]+_@+4V*)I&MTUKZ4TU(J@G9YJ!1G$Y-8:,ZJ58U=X":Y\:],$8] M#!O]2!Y<;<6<+"B*%BD.,X/ND*)%39!UBA91M*C5]*=H$=DZ+:8_18LH6M3F M:-$[UYMRBY*,ZJ5:%"TJ*%H$_*-H4;W%G"PHBA8I#C-#\'$I6M0`6:=H$46+ M6DU_BA:1K=-B^E.TB*)%;8X6O?V^L#R*%=5*L2J+%36M\-&+OD'!HIK+.1E0 M%"Q2'&:&W3X%BYH@ZQ0LHF!1J^E/P2*R=5I,?PH64;!(=?84'2`Z4#-;I\A1 MC;0L1^2(:F9OULR6B4;DV#5`Y,FPHB"2XH`SZE[3_;0FR#H%D2B(I#C6#+K% MV344,"*[IK7T;VC`2`,38KC*8MG>HC%MK+ER<%)2CT5(,\)2J(@ M,^[V=(H5-4#6*59$L:)6TY]B163KM)C^%"NB6%&;8T54-;M^BE59I*AII8]> M&(,;"A;56\[)@*)@D>(P,^[VJ.!1$V2=@D44+&HU_2E81+9.B^E/P2(*%JG. MGJ(#1`>J9AL4.:J1EN6('%'5[(VJV;T15`494583N&,3S&D:((40W2B:BX=8.1 MC(I;'X"RD4$1H8;(.UE.%!%2'&Y&7=T@K&F`K%-$B")"K:8_18G(UFDQ_>L2 M):HA_2EH5(.@$16WKJ-J578+K6%NW(O^:$B7T.HMYF1!4;1(<9@9=P?7%"UJ M@*Q3M(BB1:VF/T6+R-9I,?TI6D31HC9'BZBZ=1U5BZ)%1;5"HXI%-9=R,J`H M6*0XR@R[P\(N@!#64+"HO?2G8!$%B]I,?[)U*O>H*%A$P:*V!HNHO'7]%*NR M4%'3:A2]T`<4*ZJWF)/]1+$BQ5%FU!W=4*RH`;).L2**%;6:_A0K(ENGQ?2G M6!'%BE1G3]'QH0/5K?L4.*J1EN4('.4H9&3`YQ,W?+!Y@T)'>F=\,Z!B1@V1 M>;*L*(JD..",NL,Q84T#9)VB2!1%4AQK^MV^3N6MFR#K9-=4[DO5(6)4(=9< M=XSQ48X4A8B.TX=#_#Q)'IA!3C12LLGMK#0N9ZYWQM4ZY1PT1>+*H2M@R_E+\QE"7 MR!/E*#5$)RC*U%[ZUR3*5&F.DE'8K5J**)']0_9/0R)/U>8R]8:4RU1CO8DZ MK3',9Z'K;FW8?BC>=$2\J3\V*-[4$($G>ZLF]A;%FP['FZZI"G)&/A2<*Y,GR*.E2BO0I M//44#,6@W/MK(DP"0323VW8D@#]=]:[$:W_!S/AU]/L(;`%);;;P^:OXC]=R M8-"K7A?5<%.XUQ=[:I!\.%;$JRB[K>FL/+@/G<_+ M@FWHF^Y0:1NZ3;P8$"^4X05AE#J\((Q2AQ>$4>KP@C!*'5X01EV"%T6D6RGO M25+IJ'K#7M./752'NJ;37W43K.GT)_PA_&DS_0E_"'_:3'_"'Y4+MY![I[Q[ M!V3Q%PP8:%P=4+5>MU7.FG(T4!3%:Y6K<+EWSG(=M(59%VE%Z&&@V(N0JEO M>)0/?LI%!!44=L(IPJES<&I44#%"PBG"*<(IPJGJ[*F6^)KUN_?\W@D\R_$M M<]N_Y+*4V.4\S):QDLYR5;Z:/AKWBZL8IKX!UFQQ)[@AN%$;;O0>H4U3I)W0 MAM!&;;0Q1@VMND-%=JHHLO-VOK#=)0=B+$+/G#'P&373G<]=)RJQ$[@!/,9Y MU/:NX)A'W8R%X.8=IJ/MR>4[=;"HMG#^.6&#N-S#C`:%S$;S9\P#CEI._BEE M)M55RK+,3*2*&):9N''Z7(!9V%K0>N+VLJ,%,]B`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`TFE5.-(\;L4J51;5*H.*8H-4*GS M=BD*'ZH>/I3-HA>>97+MR;598-E6L*Q!;F))7#R.":5TB.]U1P?;P],>5<<] MBH3_".'OWY#PD_"W5/@)^4GX6RO\@VL2?A+^E@K_:$C"WT3AKTN!9L5M?HH@ M*1I!>F,]6:!1DXMEG*G'KPI51^_>Z'^EC:.)&P=)_Q'2/[PAZ2?I;PU#BMZ\ M?_O;+1V-DRZUDB&D2[5E'>F28@PA7:HMZR@TIAA#JM8EBK0I&FG[;/E_O)QZ MG,.7`NYQ/]`\%G"*NU42LA[W*/+0R%V)I/\(Z=?[)/TD_6V5_C&=N9#TMU;Z M=8.DGZ2_G=*O=XTA27\CI;\NT:AJL7]P4/HWXD?R)7NP^>9H\:>'`BV.Z\V9 M?5ZHY:@XRZ&":3MJ]2>K6YRRFO/#1IMK$=RU'-`2VV/WI_ M3:1'\M_DMAU)W$]7O2OQVE\P,WX=_3Y"5H!-FRU\_BK^X[4<&!0)3!O0NTUI M7E_LJ5'NX;@[5-I>*K]-ROJ3DMV[T)XI!X2KF,U?;SPK#VX\Y_.R<$-LJ+0A MUB9>#(@7RO"",$H=7A!&J<,+PBAU>$$8I0XO"*,NP8LB\J64]R0+Z&][R)6L M<\=-Y6&O^?V)U8:ZIM-?=1.LZ?0G_"'\:3/]"7\(?]I,?\*?LNC?$O>N])-" MQ=T[((N_8,!`X^J`JE$ST*H:%QH]O5^"[ZZ^[5`%-\O=S4C=:J%N!JE;C4P5 M4JY:*9=^DG*1'5IV?NV9AN?G+[<=[?.7WSL:%4/5P?@B6" MI7;`DMX9]`[V2R&G45&E^2(N,[H+<8T1_<:W7SY]BE]?V'_,QTK5HCTULY1+ M.+@MA2,5(MWUT"#SJY'"3W"D&D<(CHXPO/0Q`5)S_4$%I9WP1S6.5(H_H][! MN#DY?CNU0XO_'57M!'YU`V;OJ6M3@P-$`SZ?N"&6:JD8\R@&5AFK*@3#?F

2K',"*8(I@BFBH*IGGXPWV'#OY0OE2[R MVLB:KOHH6<^FMN08-5=1UX/%=/=-]!C.O7=,.YSPB29JOG(M..!%=S3F:VRQ ML"U3E!2%GW%FSK0%]RQWTM&>N<=7E60];K,`!@]<[?.76U]D]L+_?A+_BP>U M?NKDUM-_@YGK\]0/%O!X+YH%?LH" MF+X36$Z(:]*>L+_3)/1$+5Q89CQ=G,/:,E,SQN_=P6?,60KY_N&[T=-O7OOB M=+F;$OGDKZ\S#I-BD\+B)$#;!.>^FJIB'^+X?/OP'UKSW^5*[-6;; MKBF'<:N@`27OP=`[NN6=Z,NVR+EA5.B.4B2*6M7VUY?1EK;#47G80 M+U`\]@"2!?B@68`7)V/)EJ&IBC70'D-&^>+TMSZ*H(*(E-YTM1F;1/90Z.`^ M_NB('7!-7Z0BP&+R@_^P;Q0#_BD;)G30\N&;AE9!NU7W.O]D03'L#<,K;2I& MM\#@KP<^=<%``JO.M\`GC"TY/IVBO1190"8.`=^;LBV,D_OU[W M)O^&GYJ?%+L"M,(8%SNM6`\*H-AU?ELB-354S)2&;4]0F0VT^+U_G7PPTD]7 MNJ3/[E!;.I2CI5_\_6^A__*1L<6K-Y9OVJX/V'4_O4MM-)\E/-[A=O-EQCS^ M"_/YY!-;SF'[]K_"OOP+>(-__/P__T?3_KX:[`F@TIGX,-+<=42:]!WS9\(U MAI]\YM.?KMZ$GGC"-QW^02/ZVU?W&_QO7[ZZ`@O0M,#?]'^Z>MF_@AW%DK_[ M'?[0KWY^J??'?=BVTDO(?FKQ<_L6#?;M2P#$04J\_3.T@B42SG60,+??+3_Y MUF<>,&#^Y"WS'-@^_(\"OI5:8']M@?V#@ZN?>UUCM)I4YN/RSFB/(NZ8T4W),]HCG=DS&N:;T1O+ M#@-A<1_@6_]XMO7VL"UZ7D&3*DJ8\L]JD)K5Z%N_IP2IQJE)W9PPJ7&I_.N= MR<"2IY5"A/[Q@-`;7&I2)\'4]05DW4C+^A&3THT+R+J1EO5C^%J5)U]@98*JD&J5G%LGX,J2Z!Z_VTK!\Q*5V_A*SO9Z`U^>GJ M/=BR+WL]F%36+/MY9_G)M2USF?AK)TG;SU':0>(^IE(0-H.WT6LOJ29ZI9#C MO7VJC5]^)`[C:F"KU,@J%BU0-0629'Q#[T-J+YQDL&(BT8-9$)$[KT%[?/+]DS\R;R3U=`6#*$Y?B! M%XK`>)2MYKD+SP)BGIZ=4%*8_X!9N-^&).MQ;TZD/LH4Z1J;D`>S0&EKNL36 MA*`]=0&7GP7F":/*YX$X"PUF`L8D+B9)F1M(+%)5LXVF%\*H"39 M/UWUKL1K?\',^'7T^^B^!$S(9@N?OXK_>"T'!H7M=5&_-[5FG0AGW&V_&:A\ M@ZK\ABSGMT8]2>CV"=>Z8)U_`>M:Z3(%S6AS>Q0O=#R6(%XHP8M>GWBA#"\( MHY3A!6&4.KP@C%*(%X11RO"",.HBO)"OGN0]%L,^ ME_\A98T^E/^$/XTV+Z$_X0_K29_H0_I=&?O#NEO;M#N2#'JE?# MNEV?Q+LQ`MH.ZV$G*52OEVJXJ0LI%RD7*58AR;1>@(:OS`KI7)FN% MU$VPT*E(?'T5XA4.\4OQ&%E78D?BZZ7.(-1J=UMWK#W#"2<&4!2P+?0G!"($ M:C4#"($(@5K-`$(@.HFH@#WJ=./\+;DX3EEF:CKTY7>(JLMI['%D+J?]\*BX M_N=D=F4%!O30(E`J6JZ4^@U`Q0ZH_U$SMIDF^8X1OJ M1M4*M'(.U\N<[2IQ5@\74HD,@+IL3&4`7BD,J!#Q7O1'XQ_)^*JMC!/($,BH M#S+Z=8]`IKXR3B!#(%,#D!G<[``9\MAJ=9JW[K"E,SEGK@TDNIBOEN,L'?Q? M;>*&6%:S3AA7VS"6DJRJ\M!OV+GN#2F^WH#-G[")L*E1V#3NC$=T]$?01-!$ MT*0<-!G&P50I/4YO>`5XJ7J;B1.3;HP^UY:#*>\\VH!$'Z`9.J^A/&$08 MU'(.$`81!K6;`X1!=`^PW2>'LOC+5F_8G1UAU4_UK&D83"D45)4#%4:WC%'G M^IH.!9L@[X0X57.`$.T#5G7GJ>:-`J@.U!ZS#CD.H1*C4)E2B]H`$2@VB/X%2,T")V@,V MY&HAM0=4`Q@;%A]K7%.=_G!74QTROFH@XP0R!#+J@XP^OB:0J:^,$\@0R-0` M9`:[&AV3QU:KTSQJ#TAA+.ISD_/0;]BYUOL47V_`YD_81-C4*&S"]H#7!$T$ M301-!$VJ09-A#.@`L!BUZ1W@)=6%49V#*N\]=!^Z:@Z0]:6:]44:0!C4+@X0 M!A$&M9L#A$%T#[#=)X?-:P^H"(M5T$!*;:?6@"3MA#8*T9_0YABTH;:`S9!V M0AM"&]71AEH"-N;>WMOIE)N!YDZU"=;SM)ZXYBZPW*>O@?>FL6?F3;830$]X MRNHE$@I9^'*`%'-]2U05];C-\+%;9!#38_5P'BF[GK+K"X582B9MAJP3V!#8 M*`\V@\'!'"P"FQK(.H$-@8WR8-/7#^:BD^=8@U/`N/V#>N>`2B99MPORE&1! MM1&ST0W=P6F"P!/F5,X"PIQCH_3ZP2@]84X-!)XPIW(6$.8@8^>QM077F]7E585XV.L.6Y*5=0F]4,H"4U?>"9L( MFX[")J,E$2G")F7DG;")L.DX;#K8K&;#BY0O&=!A<[#XT_+DZT3AVAQH[T,% M:2T'($56>)&3E[*QH5%:?[3R(%^OB'IFYN:!_N_E#$VT.67H1/`7I0FZL4_0 M#S%`BS@00]$:[7,F$7>O>@ MO["BK[(Y[%E!_!68QX([OIRPZ?J!QH+`LQ["J)#Q-`Q"F(//O2<86`[EN(&V MY('F@7H].D"K24=[9K[VZ'$6P+2#&7/DHZ+%`O?_@.^OS4VNO*,]<).%,'%\ M3RS1CT@';\#;ZV1^=D-[`C^!:016DFH/T]P17NNFC,3DKUL34`$):2\[&^-C MJYW0,V<,GIQ;;$;#40<,B=SC=+0]-<%.'4SOCG./H0'(MS,@H8$;%,+6G MZP7,!5BYX"9J.2KK,_?X"H&+P]SN[HWM`K9!'B-X7\G`'5-?9P:,]-.5+G5H MMZ.6=@2T](N__RWT7SXRMGCUEGD.D-+_Q+TO2."OL)W_8@.X_OP__T?3_IY\ M3=R4`GZ^%XC]E7W_#'O&'3S43/?H<_=./JYUZW/TI-]>@Y7&+N MWZ+AO_T"6Y_#??_6_#.TI$%V^]WROYG>\ML=@QW+?>3PN>5_%"!4JS4;:VLV MCIC[0-6Y'\6O?_"YZR]F@%=',TN=!??7%MP_8NYZ67/_#":F8UJV)7YR&[SC MX,8Q^TO`@C!PO>7:EPM>U/#0HDZ:7-9J[Z=OOX.QZ3QR_,:]<\?\V:TSP?^\ M!9D"PQ_\I[.!\&5_+/8`L8EO0N]#SX/MKL[[UO]U/3R#TL#<'V3NY0_?"L[^L!?]]//B:\+!H[EPO?\P+]C M"RM@-KY[*[WJ,U6UM[U"PQAD+K#@&5=/ECT`D$46O25DV8,JF=)RK2A9?G.= M)^Z#2MZ*(@A?71@P_3D^Z#4P@]+7XGCH1%*?0P6%B1V_FTP*B7@O M@FC;5,P0UV'?:!0-I?HIZGTWGGS_I_]8_ZN,W%R!FYBH;0N$T M(HCX4$+?FX^&0=3-1]T-#%[)+H@NT;90VHJM[/.7WQ,:&__N?U0%'MXQR_LG M'F>]L7S3=OT0%"T)%)YD#OT M8;VS'(`JB]G:>P?8'\[1/2P@<.T@!MJJAJXOQJDSCJ\/'S5?\DQ\@\RW>%X, MSUOB^<@TD1UK)3O:G#-4QXG&`FT*:BJ/G37+UQB>IH&K\.QK+RP\V'5#GSD3 M_\=711^;')\OI>EG2AX\82MQ:\EQ=6<(9`ISXL2T*%5"9+%A&I5FPN`18X4I MC*_]!3/CU]'OHV0SF)#-%CY_%?_Q6@X,\MKKHGAO"LTZ$4Z]_S/0N\9(Y:33 M_/F.AV1J_4E)`FJAS;T.H%U1^:MCI:]R72!U]7Q>%G[-\4;I7.X6\:)G=,?$ M"T5X01BE#"\0HWK$"R5X01BE$"\(HY3A!6&4.KP@C%*(%X11RO"",.HBO)"O M\U6[43W:->P:97>O7W]22;WL"PIW`8G\!7-$?N9^..QU>RIO36?R-17\-[D3 M<.\LI3R'U>VR'`I0.Z6807I#>J,P>Y1E!ND-Z8W"[%&6&:0WRNM-&[RGB]3. MW9E!=*R'M"?=ZT#)DL.7S]56UBXP1XU&.#D5MDP9$(-]X$_38,:1QI'&G7S(8OFH_;R)1WN$^(UD/Z$>(1XA'B$>.VA/R%>:QQ/"KG5(>1VQ[W` MFEHF"["1X52;<-'"E^)N3=M^*)YV$-;&%$UKA*@3U%0/-76PH,AG)"136Y,( MR0C)",D(R>JO281DA&3U=_\HIJ5H''C5ND[SN1EZHE_SQ2XSMHQY%,6BK'VR MJQ2A/P%2Y8!4![N*`*GF#*D-_0F0")`(D`B0E*$_`1(!4DL`B>)3=UCJJ3X#&?)\'%XMPY2B79\#G$S=\ ML'FMX*TF5ZH+K4!?'JLJ!,)19S"XIGA8`[9]@J9:05.A15>5817YFX1[A'N$ M>X1[A'N$>X1[A'LUPSW575&*RBFJ-A]2+58'^A,H*0!*O49R@$!),8;4AOX$2@1*!$H$2DK1GT")0*E% MH$3QJL-99-5?CKR#]V#F''YENHYO`3%88+G.I1+(%$S.K%7PL2:M(%5@%)U4 M-@4_5=C>"/.:AGFUN#E`F$>81YBG/@,(\QJ1F?%"[UQ?#WXD."(X(C@B.%(: MCBC@=CC@INRUS53JV*5";TIF81(*UN;N)KFB9/O5T?9K@C(U$O=JT5&XGH'^+G^V).@[`R]VH"_ MEEWD/(^WIR%A#GZV[5;GF>S(YVDJPQ_53;=6*0MAEU+L4/]*`V$789P2R5F$':IQ`["KLKXTX;86A&AZ$/QM&9%T)K'/Y5/<\JX(JH" M_56\1]\(6ZWI"D&`5#T@4==SA1A"@$2`U&;Z$R`IQA`")`*D-M.?`*FRTF?R M)7NP^6826?SI(<%R7&_.[*,3"]-YA2>$;N"A6TQ:BDRQQD7Z5RJ*+ M!;#WUR2+3E!#,V'PB-\_7?6NQ&M_P1 MT9)X4GS7N=?(&"&LN>00X?J3$ETI-%Y(X<)"6'EL:/X,7K8L=-@B7BAO$[>) M%X11RO!">5NY1;P@C%*(%X11RO"",$H=7A!&*<0+PBAE>$$8=1%>M"$C;BB* MJ%PBVA4]J:3TN(+"74`B?\&`F<;5`3CL=7LJ;TUG\C45]3>Y$W#O+*4\A]7M MLAP*4#NEF$%Z0WJC,'N490;I#>F-PNQ1EAFD-\KK31N\IWJ4MMI3*5O(T82; MKNQ.]PH6RCWQ2_&8-]SD\P?N:7V]HQD]W:B94]7%`J%*=!7(J;!ERH`8[`-_ MXK:FEY`CHOC.6!%#F[H]DL:=IG'G(2II'&D<:=QY&MD_2- MO$95O,;-AN;,GVG\S]`"TH.H^:]*@-&B:UG7DG'*E9]H``-4O,S4:LNB-O0G M2*H>D@HMFD\,(`2J%?T)@0B!R"@B2%*(_@1)!$E-90`%H':R)^DQI!M51Z,^ MPG*7&DSM#QYH4UCGQ;I[UYZ+C>RK5@=SX#@RE])43>_T]9L5!I+MI>+.0Z#4 M,%!2^HH>-=TFQ"/$JPO]"?$(\0CQ"/':0W]"O-8XGA1R4U1G/G,_\"PSX!/- MYV;H68'%+Y?XU3+F*9?W57_ZTPFG8@RI#?T)D"H'I#I85@1(-6=(;>A/@$2` M1(!$@*0,_0F0")!:`D@4GZ*4L/)03XF+Q`IH6661JE(84&',O6_T*=6K`;). M8*,`V!1M8ZG``$II("PC+&L7`PC+",L(RPC+FL"`VF"9VDX@A;4.A[6,P<7# M6D?55-.8[_/@8A&N'%>+#?A\XH;8EKQ.\%:3]--"JW65QZI*,U!'`X/B80W8 M]@F::@5-A1:H4(95Y&\2[A'N$>X1[A'N$>X1[A'NU0SW5'=%*2JGJ-I\<)W' MEP'WYIIML0?+OMQER#W*T%SV*95DUA0.J)A=2[98'>A/H*0`*/4:R0$")<48 M4AOZ$R@1*!$H$2@I17\")0*E%H$2Q:L.9Y%5?SGR#MZ#F7/XE>DZO@7$8('E M.I=*(%,P.;-6P<>:E,U7@5%T4MD4_%1A>R/,:QKFU>+F`&$>81YAGOH,(,QK M1&;&"[USHQL_$AP1'!$<$1PI#4<4<#L<<%/VVF8J=>Q2H3X5P<6$.ZUP>\E2")((D@B2%((DC9"DBN'->;,_L\R3I'K#:T/Y:O9#&+4R9_OE)L3ETPT7(`N@+Q%/E` M*87X6HMT-Y:K4;*>32W),>I@79K6I.-D.N^;US$#?)UQ[D(%:'("-3[*W0TDWN!-;5,%L#(\+,)7[B^%70T MYJ0;AG9SKWZ'F)[E"*4I:Q^\B68MF9D_O,IT`96'UN.O\&6J0-\K-KZGK`$P_DR=/@ M!V8(-)#+6NE:_PCZ92[W3DBKT,8ILSRALAS'CL=-'2YH#.AG(^\GV@,'6U![ M`3\+9F[H@W+Z/V;<6\\'_K7>N4Z<_)ES/VOJ*2LE-MMZ?TWV%&%L``[;=K1W M_735NQ*O_04SX]?1[R-;#`PMFRU\_BK^X[4<&)C2Z^(6OKDOKB_VU*/&ZV%7 M5[I1%:PYIS?0.V"BKC\I\'> M,6&28W0-R`)>`S#0N#H`@N`G%'K(TAT6G<1Y+CM3`3\3_'/N*99%F+K'>W?V M/=XVZ',M3WE^839S3(Y1,G>Z'?N[E#F3XPR(V%C285VFJ:,@HRH\JA,G=9-SSOS0DR=7`(.[HN7U<.[J=X>H80Y=X^X&&=O@5E'65BU,>P:F86E=ZZO!R>:=O+E!;.Q+GDLO%A/48"!?KK290[" M;AE-TT!+O_C[WT+_Y2-CBU?OF.7]$_,*WEB^:;MHA_E?@9F_V*[YQ\__\W\T M[>];7WWO+,+`QQ^`"`6?6<"%S0:_^LRG/UV]":6]]FWX31]\0S_VVU<77XS$ MBRMMPDT+Z.R+P%/H6/)GO\,?\.G/O6[O.F-^VP_=,;L/JZ2(C]*PG-P[GS$Y MR0/<^87YEO^[XS[XW'M"61'CPL>N8\*OQ,23]6<(>O?:2*.)5FM>4`J#^626E`#2&E2H<.S?B^*LAO&B#6T4I`,V! MP*:<.C<"`YO"C#:`(*4`4`H`I0`T1Y]K&6*D%(!&L+$.D6)*`2#L4TII*`5` M$<8VS*&C%`""-J7-.DH!J`TCZV#840I`52D`QBDY``J>^A=X6+[C./[CRK+[ M!!)N+N7_5GW&?KG:-D?&?/#+KZP`%,C,Q"$DJ"8HJJ5(ZA\C1$VNY%!9#:)! MLIQ-1O$8C8,X`=>**O^L"!59Z0#'YEV*#9J MS63^3.-_AA9\A%_M)"/)NC0B)655`&CUL<=A>,O$JB1K'^_P[V0E(7@%#PJL M)YZ>WL%R-7.&__X!-I>C69['GUQ3S(O;W!355@)7B_Q,S1456XX@`[JG.%[R M^(/W-] M+@DC";?4_-"<)23+)OJ[%75V4!`HG!0/`BE@)OXM[&%1E@BGDB)QVOF?>FS. MGUWOC^TB4@1S!'/[88[9?J+B*[`#P_?E2DZ9[_-,)1??\V+31RKV+LSQ^<:W MDVIJ?@2;`#O1>_!I]$RA6J!YINL',$U`C$FZZEHG/VS8KO.8>Q"QTA^NC=X- MB."3J.>%TY?8C,MF<]<+K/_BRBPG8,ZCA3`;+1(K8EG`#LO#1150OXW98"9* M.DIF`5I%S[($-HMZ8EX\3PV]FL5K,5FV6-A+P0!39(WBGSB_A]"'Q_G(B?D# M2,9NJ-LHP^7P!M/.C#U8#B;6(JG2P][D3\?)Y9ID" M*Y?K@`H+>(:--`#@GKC/3C>_V.P[1";0)=#-!-V#6A`!(18`3'UW9H&MYYFS M)4@V@/`"Q!VMPO]B1M0?#ZP7/91+.Q2-X^ M!)=?D!449T`BP&$L=DHF]]_OKJ4'9Z,H"7 M_#79&.VRVV##WU8:NS_,2L!!P$'`43AP&$<`QS96H/[[%LR>>=G:CR]3ME8T M4`(QX`JCV^'$1AA&CJ(ZY.[FPSK@7&%0S_/:TJ+& M`XPH5K<*97A);SY-JPAS(9A_!@[H\> M%Z7^XP'%E+&MA\V_[^H7D#$^GHE%DQ-3!CW$49^89[FAGS]RB*'L3J3&'51J MRX%)\A0:R#BW:[N/62V03X\&+Q:V)6-`:_&A5/,3[@?67+0H$3%@WP_GB]T1 MWH_)#]^WUIO!CR2&B0V.*POJA1 MH\Q-14/=C[)=\WL6Q?4M%4T<6Y8$6[:?L6_+W=BE+;`0^`=,?WR?I#C>"K6Y M-XS_]P MGX\CU6#<;R2E!#;N^=&1@F0TCSKQ;^Y"/W#GW/L`,G4D.?I(C8:2XS<78_<+ M'O!;/'T0V'@<50SCIK%4^<2"$P@Q5%H^^A??AXS1>-Q(@A2_#XWU02,I5=`^ M--8;1YT<^]!P;#26'#GVH5'SP.:\?6AP03!)_>CM]P5W?/X;4.#K,[>?^$<@ MQ\S/%_V^&1SORAR>2YYU_9LS0+*GO-'\P?&\V3V'W.MP0R_G.H;'VSJ[YY!W M'5]GF"F3;R$W>00LF43NE3R[.16E-\R[CF?WZ%7\ZKG^7LVN(.HQZ!E'RZ28 MOPJK+=Z4[`^'1SMDRI"A(#OQ>%U68N6Y8A'C>@E[?@.O?WVT%Z#4BD\RW@:C MXPV$@E=Y^0!!E9"MDO=?(617[=H;O:-]62567D_(KLHGKPZR+^AO#_K'^ZBG MK?(W'N1R"FX&@Z.=`GC6L?/ZW>?3T/Y@37>T_HM2E8RU5*6+FL@_?]*'_SYF MV:NE*+CX(_0/%MIKSD+7U0[6-J[_VO;91\F`GV$,OD:*C^R[-0_G*U*,VDL* M>,0:*?1FD.(X`^H$&>D37;(%IOYTV6-VG@(B#<#3,RFQ*1(5Z\I&&G>[;*,B M%E\+VZC(A:IF&Q4EP0VPC:HDA6*V45&D:)IMI`Y=U+*-BD3(>MM&%5*B8-O( M];CUZ-R%GL<=<_G58XX?524`6T2\M.6]$6H&<=:]MQ0)\5IW1&\M(OAFH0U% MKXJP4FF5?"/HLB"/"8 M1V8YT1TWU\=YNEN36Z9'VVA;@(5$1,$=UXG*`^6^TB6;3KR0)7)^C`G8P=H- M^0OC1.5H,OF&;8.QNY0@_Y<`_B.OR,&B[A?1?4))*ORYQVR]FFDEF MN?UL72&$$=,U,4!Z75&"Z6C9D!Q?DXBT0"1/>(CZJ_DSSJ,RIZ+:SQ8+?;Y@ M8I0U7K)5TF/4"\1<6WE4QN@%BLZ/R37!&0P_`[CBGO]_Q8708!G?'=Q8^1[Z MQYWAON#,_=-O^)5U2>[\B>7B?5G? M.O:(TMC(LXAGDV>."9;$D_W"1;6RE;?RD6.5&OL-?\)J5=''%Y_QX0HN>G\T M+.IA1['P'WSN^@M`'G[T]9#B)U@J_XJDZ>'DUR(?IB9]XMC0&Q':_20:A9P5 M:S]%+"]#BIW"G;7F'=1QMISC-Y9OP@8.:$P.YH:GM6X\WF2:>(FJH&$E*RVL M**Q)$M?9#]-'JCMB15=_4"Z.\1[(.A7A)4W$ETH1,+5K7I!V5%?&4=E>C8BX MN4?!/3__5-"IW:CIL]?7M58J;0N5ME8JS:*@P5I')0R(:%A/TX=5^S^>W&#I MF.+_!PK]Q[^/>F:;,#&V\/FK^(_7<=7]7J^+^K@IY.M*MVI'?5P[\-%UU]AN M!Y[9[_NH;N`[/S^W%[AL-9"G:_NA@K#K3W*?N#<%T7@ULR8`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`F>-03?E;"TE!;[MV%1XZ*S%V+1AF,F7 MK;UY3]5N.A3&TU-Q;YN"O4'7,.I' MP;,WZ6T*@$FJ7S>8`H5#<7%5`X[,J\$OO[("X*"9B=5OXNH3'T23]O>K)NVW MHDG[Y1%V'RCSL+/.P'9[`+$E1J&7OG(\9/#,![.0`/%B#OJ^9S/.60`/$ ML9#['8V99C@/;1:`P+.YZP76?QF>?'5D(X_%PG._6W/X>.U3#8O:N!,_+FB1 M6;8B*>9B"W6R5NK$A#IIS.-K52LFN-%[OK91O6)KHZJ)$76Y^BLU7%*=[,5, M+V\XZO95OOA!Y3E.B:T,!LUFI0H&Y+'!D_XU\4(-7@RZ0](+17BA*QY_;Q,O M%+_SV2I>$$:IPXL1Z84RO!AV1TJ71F\&+S:"HHWT)*F$4'-^&64X;Z1H5PS2[6$JJ$- MU?-_8GXW;:&TA9)VE;R+DI*1DI&2E:!DG\0=([)1:VFC;OGU41/S@)LS!U;U MN+Q4\HV"-4MKQ;IR*F1D).8HR*CCZ%Q.?8Q!IW>XNBS9$VK8$V=DVR@H[H1+ M5/3Z$"X9G=%X3+#4!%C*S*Y14-HOFU]3-$[I^A90G3K$=NWDDRTKY>V\L M/_"LAU`D6V(]37A(.&5F$'I8@U.0PA5=Z`,M MN*?9X"%*#]#CMKA.X,^L!9T0ML(0(S?PD!O8'U,&;"-,,7(#%6,(N8&'T&-MI:S\S75@,?,%QYZ!CQ[G MV!28E.;0''-IKG4S*)IB4Y,XJQA!R9P\FO([HUF8CL*^3IM<':(D_O@+75H\.#1EA;Y.DIQA#R]`[?]J(H M4R.PIR:>7KW]#Q6J\YQ7AIVH(S0I6*UY MH;R"44?HJC6P3!Z?V!':J)FE2NTTJ2-T]0K.W#MJ`-U6QI(GJ/+V1/V>&R/LY`DJQA#R!`_&H<9] MPIXF8`_Y@0?]0.KW3'X@^8'4[[D=;"2O3^7-B-H[-T;8R>M3C"'D]1U$'SK] M:P;VU,3KJ[N26\(_]5:0N2NCDW0]3)>U6,(>2]'LQ> M-2A?HA'84Q/OM.7K4S;E!O"+'3ND=YX;*631"U,FQ4XPAY-@= MQ!Z#DE$;@3TU<>SJ[6ZH4$B'FC?75'AR^ZKR)7NP^2:*QY\>0C#']>;,/F_5 M)RYYBZ5+;@,T[FU4E2QR4>*BSES319=TOFP>M:+MNL?XY5=6`+IB9LKN6M.. MM]\7W/'YY5F71QY59I+`*9G#CJ8!TP MUZS%D^F<=Y-;DSCI]^\]N%-1]2,PYY/VI<`_H,Y!O"; MJ7:_X+*/B4RBQY][?`9#PK.T]X[ISKDV=3TQ]A+Q7>,.SC#5YD2SX+<^?`NQ MPM=>6#@3-_1A//_'5]O[08LUJH9(GO*RI"V%J)#H@-BL-1,&CW3MIZO>E7CM M+Y@9OXY^']E(,"&;+7S^*O[CM1P8F-7K(N1LZO$Z$4Z.98^[`Z7C<[#FG'Y; M[X"+O?ZDQ(DKM$?G`7TI+/ZDM!F?GY4']]SS>5EXZ&FDM#_>)EX,NL.&0UQ] M>$$8I0XO"*/4X05AE#J\((Q2AQ>$49?@12%948I[DL.ND?<$\$A/,GK22<>! MY$I>F)?'JMTYS&P7!K:+&8H;:NUB!L&40LP@F%*(&013"C$HA9A!,7809 M;7`IB\@J/>13EN1%'CK!/U;7J(^]^GWLC5Y&/9W&FQ@-2/DFY:J%Z)[9W=4Y][5A=&.EAFO/W5$S3=G?!+:?**Q MM*<-L[6<@#F/%MY-9+[/`S^YP^H`5;0I7FZ5MUGI[FI)DZ>[JP7<734&BM=A MI+NK)QB>`Z5KIS4CS_\X7HR[PX:K57UX,5"\?&:;>$$8I0XO"*/4X05AE#J\ M((Q2AQ>$4>KP@C!*'5X01JG#"\(H=7A!&*4.+PBCU.$%890ZO"",4H<7A%'J M\((PJBYUBE0_-:0Z10E.M"W"1U4YQ! MEU"W$:D;J1NIVZ74;4SJ1NI&ZG8I=;LF=2-U(W6[B+I]=0-FGZ1O%-4L*'"2 MF[=5M3K(.,E1L"9LK7A71O'>S%,>!1EU')W+JBD^N"ZJIG@C#0R%S`F")8*E MUL!2;TBP1+#4$`80+#4$EJYOR%HB6&H*`PB6F@)+PX,=6`B6")9JP@""I:;` MTF!`L$2PU!`&$"PU`I9N.H/!P=C2QAF??'G!?G7G-Z[:E]"?+&6]YU:\)OD0 M&.BG*UT,L]UP+?EEF@9:^L7?_Q;Z+Q\96[SZU74GSY9MWSJ3]TDKM%O1">V- M]?]G[VQ[W,:1!/S]@/L/1,\=D`"*3Y+?TY<%,LD,)H?,9+#)?@[8$MW6C"PJ MI-3=WE]_14IVR[;R?8,W>?/D<\4`\>/-/-GEW\S$5>O7ONP/_5?>[??_&OSON]V[V M[N8?N9DLI2Z8S/JE6?E[L=RA<7.(OJN[RF_/56WUY;=!`H[BE=)FT:*$1C[Y MDDR9(,\M2[*FW<=8JK7SPVM^SMOE\/[%;X#T0.(M;G8%\0(P?I]-@B@`DPR# M!VWAZVZN1FK*S0.ALY"\!+Z52C9)0_V(A#<@N`:!!!XJ';Q19OA MS;+`C[>J1?ECYV0S*3!E&UZ,B;K7(N>UB%MP*?\4'`SGQ9#:42%U-X^HG1OP M!@^L,93O;MYT;T@*EJ(?^Q>\<&[^X8SZ=@]&G07YGG_G!`&6,?U."8;]4>^\ M$GS/G__^-0$W4S;ZLW)P)N57=J]-]OU3(+][8O[]=P:V3\./["'PF/Q=WT6] MJP*]\;C7-Z4"?PH(=,2#+NTKO-B_&FZ_U^^:4(W%M]Z'H1X&+3XLKT;@O[OY M!*6]L6W'+5%.;U!1G7J%.@V^=^W]W&ML5]:HPX(`X[T%&(T=MRJMVDG93ONN+(V*`BP;(*=$@!DG=%9)3@SX_H#QZG*D4ZNP`F,&[FC MBAEW7#6.9YRS6:L!4*92QKE%QNWA7MVA4RWCW"+C]A%`_7ZEC#O0P5W'KCH& MZ!89U]TI0-<=5NR@ZW.S.R08V]W1>24X,^,&H,.A*14X@7%C=U!Q7W-<-8YG MG%TR2JB*,+U"E1:(V^U=3F]8%6.'!0'&>PO0[?:J$F"!N`/]VW6A]]Q/A.?) M@"_B(XS1N:3AEXF:$]!3`ME@]Y.>A0VB^_)1,*XB';6*5#(/<_@4RN$_F\W< M@'V,;P^?]<'975S4VCW%"[:B_I?-J7*U6A70L#A-">:NYE1#-?68387F\Y\) M)W>,3%GH:WM,U?3EXY1%3$T#P[^TKPCB3<$NU11R1+Q`>.E,@J%Z^@\JF$@8 M_#1-].][5(BY,N8'&J:,S.AJ:E<3\TNJTR$TGG<7ZF7<"&SHCR>@DP) M--P]2$*C8FT$A"Y@`?E:U?.!S_B]H/&T/HY8Z`6R;!SE>4OCU-DCFY_?WA"/A6%N MY.]N[.R]C*F7OU\6():O_+5R1D5/BTL^+$D5>Y:_D/NREF.4\/B&Y*^UIZT6 M39Q1=@DA66_+U59?2E2BRD.MX0#5WSX;'1ET>NI$A&YQB>@Y\Z=H%ML?*O[T MU_D,NJ\RVSRJ0H4ELL*JPD]//P\W#:_$\E:UMYH1]H)IJ,^>7QUH(RMF4328 MVJC^&"!\!6F#">`:'DNATQ(Q$Q-5'2!YMLX&/8/J$98+?]-``I'5:%%U`K'@ M?V5_GZ1)"KSE4`#5RU\P(DM#E?FP9?EG307_\\R#ES/3$$LF8VEX!)6&"*7Z M0ZE<\:`Z M)#:+[!51._QB2>[FQ%//B#R=.1!K4]=ZS139R&JDL7YY&A5D0C\HI M49M;Y?/$"3R938DLMTU`\:G:9A'YV;1Z2D/=]?%L)T7IA/BG2%Y^I'1!9PS(_VQ]QLAHW]'!RB8]")6_[_#&K M4K:DD.NBK'[EZPI<9[23.:,"6@_RD(1YTXB'_'Z^:\<1R1=1%#N4$F@X5PK(R;*S-NN*RIM'B:00 MG@FW#(G\YV7V"2BBI#_,:EK^!<%B)0G(H?*7\C`B"R0"W8MR+]#`7`\X5)&/ M>H.G:B4&U867BK^+^*&TD7Z'QKC/]*`-7"DCB-)LA6D1H&5RY7D!01@D\UQ: MR78VWEY<7G77RG8JG2&-:RU/+(+HE'WF4OX*$>2'K.V@J"_9FALXP<]:$=GW MOM$G)C_""^A9O"IW(#F.VUW-F#Q!L,O4\,#T9,<9K.7F&E_#0[,3N_;:/K9K MUA"B<8@2HBJ-U'5/-M%]T]5];$7,;,%#>>[:?1=;\*3^ M8GU/X)5;$`HL.70)T][+AIF.73Z5J!N2:-54,,(_^_3$KFK6:;[BB)T*2VV1 M7TJN`D*=X2ACKR]>5 MY,HW9CK3Y.,/31%]X^C,.5.F=::="#O27A;/Y\=]@D`AC25[NWAQN\A!45<7 M`D;6G7.U$5ZX'D\GN:P(VQ]VNCV33_O-LFY..6MVUSS[ZB\M3_[=X^#?RIQE MU:J./SBX7^F]EN:IKPN*S[$>=SI&WV(=IMTT>L,4!>&Z`(998XND%'F MZ`(998XND%'FZ`(9=0E=%/*K]QE&EJK*^)%D!=>6[!I*'G1M3'731/NZ&C2+ MC"DHT+W9X79VQZX4@7IG0OG5*!=69V'6TF-JK>?"]]+LFG0N3;H7.A+DI18H#+PPKU;Z.L?- MAJ6C;@,5M5\[G^5F0[=KV79E-ZYB_'#=&U>12\BE9G#)<:S!:(!<0BXU1`'( MI:9PR>V.#KP*&A`P[=&V#K"!F%C.FQ<%\=DQ[O"XL@M,KCV^&S[)LH:K..Y\+G/ M4[53KDYH:^/,U/E4==VU/'?L8M#5A#X?V81L:A*;'->R^\@F9!.R"=ED&IL< MJ[=[LFIM_)B]/?0"ARL=SE+=,2%X/E!9L0<,;6$PJ\]/CR3#&30-98L2.P:2N*105MTB0?$Z@`)%"]%(`$ M0@*U6@%(H+,I`,=T6]5CSO[27QG4GH8M3$&KXVC\8CLBS-/3%;=##*PNG@AK M>F^#4$(HM0E*KC4+-PUF`VN( MX[1FF#L"Y]H:0.#LL6)OV7T$3B/,'8%S;0T@:U,ZQ,,^[HCQO MR^GAK=*-,':$#<+&=-BX0SP8J1'&CK!!V)@.&WLTQ$6W!HS/\&P19%@[&?9J MY(Q>8YA47Q-'Q"!B#$>,ZPX1,34V<40,(L9LQ#@C/$ND">,P/$L$(58O!9!N MQ^T_N]`FV:[J3^19BV_.X%08F#4N,#/!I^JC@+I`[9I;X7`UK@F6CJA!U)B. M&CRR!(\LP0V]-469B1JX9MCD8AI3(XP=<7-M#2!N]DIEZN/)_XTP=P3.M36` MP*DH41O':Q5Y0]7K"I\BC\\82>@384\QB^3%DB=/<",7/O=Y>A>R6I&L:MU= M[!Y*(U5U1>0-+R,O$APA_O'.NB:V4&$2`L6Q3,?C"S1O6> MY#Z\L*_!LC[KWG)"J;U5JUJQDH/;^26Y]BG@VY21#WP6TVBN=?;3DVL[XUL) MSZP/B>%/Y.3?@]*[)Q=BD2WV=:1$;@42T"0[S[HZO=RMYLHF$^8EP0,K&JZ`RI%' M*@F-8\&?@AF\#^>G2]$]74G_;983='M&U*@2)^H.#*B+\SJ"R/ M9Q#.:.D]P?P@L033'4FJO'\U'NI M'RI&%WXJ($;*JA<(F9`?4'`";<(GR]()]?]*9:)$@X>Y&H^DNI!3*.]V92X77?2>)6$)X#+UIHJ0/N93$HT+,H04>J?"E1>ZH MA#8`J01["-1+)A/=%4DE7YH$8?#OK!*9N-`6)TN\(L(VNSU3NZP9OGRV_*E@ M3*NQS`],PV0!K`E7.%,U?`482*8\E>"U\G7)U1XM]K$#A3]2=OC1C?G-.5/Z MP2JM3: MH2X:NI[>)ET@H\S1!3+*'%T@H\S1!3+*'%T@HRZAB^Q]PW>)]'%7?ZVQ5X'^ MC$X[-1UU36]_TT.PIK<_\@?YT^;V1_X@?]K<_L@?O.#VNENB:CZ\@V:1,04% MNC<[7,WNV)6BKM,WY8230J*.QZ*$B0OO>7O,?NB.A_ZV'.'-#.KFQP[UWS** MSE4+Y]K<#(#.AYM9Z)=;A M-(5S*6J_=C[+60HCR^F[>,Q+/<(*Q!)BJ1U8ZEDN'HR'6&J,`A!+#<&2FN[$ M(XKKZ32?(D\P"H/$5_I4!;7#^K4Z@.%Y=RG\?+9W4^W65+M62_9H-GY=MND= MDNGKLDUO?PS(#`S(L/V1/RUI?^0/\J?-[8_\P;RTBZN'+/X97'L4^`>/WOC9 M^$^=9I((&DFJ!X/$XS*1..*KD<>UF7BDVW'[SYZU.=EU53XK>Z3NX;M@$4T?4(&K,1DV_MS-%`4>$-1@1?M6'1Q=7`:WL*.G)\BC: M.Q:Q29#@V!`QUSK,.:.=*0\84=7!U!$UB!JS4>..\"NY.ZAPO1`.VQ!PK0/M8YGK]PQ1DPUMG`D#!+&;,)T M\3BG1E@ZD@9)8S9IG-X8QV8-&)O]L;HC3A_6FM`@4DMGBX,U<5L<$JY]A'/M M(09333!U1`VBQFS4.*,1HJ8)IHZH0=08CIK>SBDB'+?58-SV*Q?PRZOG5^(P M#8'6.J#AKI%F6#J2!DEC-FE>.6-:QS'CW!?#SL$9G61J9U MQS@RJ[.)(V(0,7C72!6:1)(AR=K<_C4AV56#):>'`\#Z#@"_)%,FZC',DSP, M?/*3K?^#Z+H\NLZB@"NR:]#'G,DFF#JR!EEC.FOT''?G4;D89=6ADTY=BX0Q?1A&A"-!F')GN\\T>U7I,?N5 M.Q[Z>4GJRV^#!*S!*]^"QR9,".:3;QL'HQQ7PPNJS63U:!\,(NAYLBF"[`TQ*55YI1O,MH9XG4AI*,N%BL2=5?RL) MI$P9R4N`!B9A0.^"4-_6$=)@)F\SX4D`%0R$*D[]*?*5(*I"JD`&_^>#:#X4 ME7#"8]4&NC`.S\I.P927KXJM1KT?::#J*T&;P23P*&B@I`&M0@M&(-/J#Q&/ M"C&'&CY2H:29"#XC`32[+EX&JA%U\_[&9ES&4R:8;H,/\/6`*\W)0*I:)2": M9!Z'SWZD5"1,Z,=*_:5LF]V!T7<=0I7E*A*K2$R25QHX/)7PF'S]]LHV M>Z3)5AIJ%F+W;#"C3'>I71UZ$P\*SRWBW8U]H]_+F'J+]_GS^0@%!`II+-G; MQ8O;K&`P=+NC_&+=VE8;X=#5H<&H8QN].@1U/O/BT.HO+>E]5./SE.IVOT]%^+=&'W._T!ZL(,72"CC-$%,NHBNJ@BA\?X M*`US>.J-O8:O!AJ/NH:WO_$A6-/;'_F#_&EF^[^]>!(=186$3Q]]>6%4X$V$QM65>S:3O<,L;/IL4,%SGGEO@N= MJQ;.Y1[D7*WH&.N80OEQHR#[M?,Y_G MRN6N4\T&2(R^#(R^6M;^B*1&(&GAKP8*(L!^I MVA@OF9<*O;<3`RED6^O8YECC_LY35C&0JH&Q(VP0-H;#9NP>>D`7!E(F!E)_ M"G58#P1/&#(AQ5I',=<:=G'NJ0G&CK!!V!@/FT$/%_>:$#1]BA(:W0?JP*LL MIQV#)^19ZWC6-,'4 M$36(&M-18SF[I[HQ>JI!]/0UX=[?Q.,SM7"G#S/`V`F!UD*@]6R3TBJ&JO>$*JF:&`*V+ME6/UN^YKC)UJ:^6(&<2,^9AQ M+7>\#3,8-^V.FQSWVH'3-Y[0\/_9>]/FQHVD7?3SG8CY#PC-O.?8-RB:`+BJ MW1VA5G?;?<+M[B/)?N_[25$"BQ+&(,#!(K7FU]\L+"2X"5P`H@`\X_!8(`F@ M*I>G,K,RLY3Q^J%[I[*#%D]UD'<@3MD<`.+L M@CBCEMKM(`Z5CSIT,IBYES8<8%&M:)#\)I1L#&P_*.4GU(QZJ*."`&$",[Q.AJ%VE3U362 M<)P+4$P2^I>)8KV6-AS!5*JND`-D`#+R@\P0QE*5C:4*M3)`;BZ@#Q,*=7>H>FD0C($!L*0J0W\@$!"HK@R`B943>XH)3-G< M+[-#U.$\U.C[L1.(-*TJN8MY<_&?^7,J[[!\<9PJLZ^+UNITT4E*\L4'R`1D M:B`R]?O=/3M.19>,*+'ZN.3;+/FR'7?*K,,D+,>0T'PRLWT&?[ARK`X]Y*9I M$X)%4;/HA9$XBFLEUN%8P+KSZ:PJRY$/34G5DI3L2^9+3W$FRJNCVZW)@\&G M]]Q5=+6E:!U5/_J)BO_(E2MG.F/VBS)EINW3OV3#,L4/#5L:]3H"[?L2M=T[ M?J`D4-:F$Q+W?I!I;VJ#[RGL@:;N;;3C6XK++>:+SQQZ%_T56OS.C+OT&/M! ML1S/6SX%NZ4P6Y!QLV>0#UTUK=V1A[#M%);,_RI(\+5J"+[6SD%#(?B;!'\@ M#V%3@K\NZ4_FE%37>LE! M]?1V#M@;:YZ8`2'#.9],N"%`9C>$H3DR7[GG#\P6L,2_STR7"W0['E?R,*E: M.5"YK[;(C8:CR$LC_D3MYS9E"0^Q&2#P-GT-Y'WF5@D:&RNT%CK MD&<4/BL'N["OYS;-:":>,G&=::@$D2R1A-WR[RP]J4E@D2;$,[I_$3,:M(\> MPVM[ZY59`M;<\A+'%R99=J:QD7]_D"GD"AM0 MN26]^.9XIC"3O&KQ3V8^U\0OB#V(PCT[@T6N\'S?TDFRP:F1E9GSWN*HW9.Z"4"3>-%M]\$+27@!C)*'%\`H>7@!C)*' M%\`H>7@!C#H%+Z+KXY*UI?ZB'JS3LY<`_J=-198>ZNM-?=A.L[O0'_@!_ MFDQ_X`_PI\GT!_[(7(LKO7N'=B=$%F_&B(':68:J==J=7*&NW2NJ@]"^[$PE MRQA3.N@-8*F[UN"1FU&YV+Z:S0ZG0R&RO`E)## ME``L`9::`4MJ:S`<`I8`2S5A`&"I)K`TU+0]VU#!-Y3R#)O/MN%RYM$[4DU5 MC,!U137^"V?N4MUG,;/EPIPU5V&!U$'5`#:!&IJ=U*@.NP==2`I MS*G:F5,`&8!,SB`#C*FRB`-C@#'R8XRJ%7C@<4V]M7(=M(]+[58KD(B)4ZXJ MDUQ0SV.N6L1KA,'KL*0#F@!-]8(FY(D#F@!-@";IH&FG7/$5)S&ZK,C9H%4\ M"`8'C&0=,#(_2429..Z6(T04>M'F@T@\'"Z2W^$B..FB:)L*)UV4&8V7C)4R M=`6N1S)5DW@AN]O8)%X`H^3A!3!*'EX`H^3A!3!*'EX`HW#2A3S1^2Q74O)6 MJ-6&O;KOKL@.=76GO^PF6-WI#_P!_C29_L`?X$^3Z0_\P4D7<.]PTL51[*Q` MOW"<=%$E[(1R54JY<-(%E`O*A9,NZJ1[>>>;XZ2+BC*N"H4"13&JQ#*![G"$ M^J5J&!(`)8!20T!)Q2D7`*6Z,`"@5`M0TD>9O9CA%6Y5&8DZI%X:AALP2Y0A M;JXO1/Y9[1:BBNR_E@AO_3Y,KCI(.I`&2",WT@P0<:J%I`-I@#1R(TV_!X^M M#AX;SK0`U*$5].M8]X.JZ^@W7V$9!\@`9*0'F2$@IL(2#H@!Q$@/,?HVC(&O M)NF&-$ZTJ";?JI!(4,O>S%U-0PB\#NLY@`G`5"M@0C8X@`G`!&"2#IBR,\)7 MW,/H\IBS+$H[]D'M)_*V)FY'/#7/Z>[A@=N'/V8 M#]S@TWON*KK:4C9V>MCWB=L/`?$=GUDK1WS,#P9IT3,-*PA##MO.!YDHZTB] M[_"T=N_X*9(P6Z9CMY1GYH5GI1`.C\4))4Q`\/G1+S`"UR6A3!V;XM@%,N;* ML<.5*=R#?Q_%>Y2;1\[]HU^ZOF^_[Q/:*2-J_E=!TK_>B@'2OY?TNWP<&.&1 M0;ZCC/F$DQR/PZDRS^-^3K-0.WJ+#*#C9R(H'*GL!HW+A][=W.@MSD>JO`JO MZVR=SUHZG8&T8W\,\>,+DX#(-#;.[BL)F`NNX&"XS62^W;JX$<*+G#U/K*(= M@BER.Q\>0X-2>>`V=YEEO=#J,!4KGT.+FE@?^'9/W&WI22+KLO] MP*6'35QG&@\X2CBDIXN1BW4X?HW-?3%2E\9'8[$<3R0JB@5#S-6@9R1 M/7&%T3`Y+8?,Y41,`NMHAN*DNPU3#!?#P']T7%.LZVUYG:X]%6\O%5R60'KF MVS,U6NVVQV+2WKZ2OOCYI\`[?V!L=O'9-IPIOV7?/YB>03P+7'Y+LO_>-F>/?B=L&O91^?,TG;\\^!&[(M3N5_A%]A.YNG3M5N].C MJS,R;@R3(,Y[>W:NGY%99T;W_4%_J&?O]%Z_2Q;*AH'-7W?4<+2EX6A9PU&U MOE[DA9P^GU1P<.Y^-WTBR/OR=(F9BY==5. M_S0#VY.+`U7K'#&P;V2N&B]S[=QK9._B$.,<"5+AQM7E,+Z.%L.E<+0$:+J_ MA?8A<:HB0BJATL!B@\6V+<(1BXL9B8LOQ(7,H(E%-E-HCP@[1]@D?#(1'XE3 M?/ETYKC,?5'&)GU(?K$XWO>>^\^<1RZHP5SW)3P'>.H$=N36QPZ^L)`2)UJ$ M+805-"$3R#9,9M&+Z M&FAB="(D059?RI$7IMJ&:$1+!"UL3K/S:+8M,OSXDHM-YIMX2S1_XY'9#^$; MF(#1P!J3M>K3U]$`(NI%+Z)/YU9??"KRSF/:..\OS&8/?"H"%#/7>3+'@FYB M`RJ(7L+$NR,SU(LZN/SV<82L)U7B!%?'[41RO;#/KQ3.))M/%R^ZY M99(![=%@A:D]=F:/R+(QD!SKZ`:PL#G]0`#G%AVWP]L)^8S`BMQ3 M<5>$Q2$4AT_@XXUW1X%FWE+N`S]T684>6N;4C`KP6N&SHI/6Q09^LP)VNQR. MOO;]F[.L`]/G#W#G?XU7GC-,Z]ULPY>+N2UO(LY=Z7C7/'YZDIW@.[,S)?X[ MU+OE1ROJ,#JD3UFEY3+5YR,Z!J3>K)2AZLO)(:O@J=/40"\KV3<.CY=11;3 M+#;CA:T"G87.0F=ET%EZ81AO$0D+J9C+NB:3#H=:%,5[H,!08"BP1`H<>_AI MQ77%%K47=2Z]=YR_?A++\,88++09V@QMED&;/RXB:Z2UPGH.?(>4-8RCB?V5 M!^:&R9R!QQZX^$TZ[7.^^T"K.32ZFAJ]FR9#@XLD_/&:*];BA?9&6XID6=." M'&>!K:NM8C!;[%L%OAGO6[V6W'J4,EU)T_HR%I8E M7VQ/;TT?3_;/?$?L3NVU-WT3"#6)QQJ-(+'(-7$MGCN+%C MTXP6>0.&8X_#/I#1HFDP[U$11;C9:0+A5K/(+3+M@(OY1:D",B0*1)FGN:4+ M*#DH)1"E;HB2UH5Y.D2+%3%CQK\#4XC9>@ITE/DS<=QGLF_C/(Y[ M/M\^)JB*PU#)4CJ.E2[6BG#?FD;I.O/\$"^X]\RQR5R1+?0KGSK>C&`MVN6^ M$E:T(Q+(P\P44D*B:%3C?!:U4S8!QC7-4RC\E3,.S6]U M-.Q'B2]33KP89^+&,JWF9(FZT8HGIH9*,_)\DXP(40:U8:9ABI-XS#S7?#L0 M+U[22K_BD8U3(#..L9_3CP7?GFV"UT=SMHP]WF,(/O?1`,TQ=S>/+Y,6S/*< M;((L,2N+)EO?N2E]8UYC=E@%%$FA$V8YQ*D/\PAJ/).0L,;&M*307XIEF-Y, M2UAJ57YM*I>+;*@XXK.S4IE+_9"CG9FE[#V1&1)9IX>D:D73V#TK:S.?7$ZC MX*VE17!1"IB5FN8E.TY9Q&C7?DU;QO7\"R%6TJRW)&-?$^O(TK+,D&D?DBI. M[_\&)`83DX^_N4[\V27]_U.4VYEC^OU`&VS.)3]H9">;Y;ZY_)U*SG+/PH!N M1SOU+#\1&)'KM/B6P.5#'#CW8P72:7-:#B9[6G:)ZKHU$U)K:G-(ZV M5,\4,*TM!3"7_B<^%B60-TFD:>DU^58QJ3N)YV$C+8L(^Z*LMJTPJ=P6-69[BG+VFYF4_$SO7ED+G_//#X6/@]]$O[RRO%R%N&=5N+]!GCJ M.>\IS/K!6BO/E/>4ZG.M+#:'73XNQ_\*/#^J2,G3.MYI4JLCR'_8>\J?MMMJ M6?RX]Q2B_I:B]1R&+59^3M#YFV,P*U6AGRO4]7:RU+8-I;AY["L^NWD9IY_' MGN*D#G=R'XZ:!WUP%>['/7#ZD'M+#\M5N#H["=>KXREX1OLZZ=W=PF1E3FG? M57#0/R&7HK8]U]SCS!7;UCFN>^J6AB]9@RAB['OR0!_MM/CM//8_DB:'(GX7 M!:#1WB-Z4E9[CSGI1&,/Y=O&TR_KN`V"*+K=:K-V)K\3S:6CP76XOGMN,OOO_P1NQ: MBORXV2.WQO0?1[1=>S*)57$'-#:;N<[,->.2L["N)6Z(MKF0/CW'*6>BJYCX/+A?I.=$V::\CJ&A$K4!I MBN:CXXR79N=,E,"*"OLMD280E;B^OEN:VB(-$Z%$[@^1Q`D\P2C#<`.^WC5E M&\_"Y",6A/WG6)1]$&YKCUMQ*B/=S[_/3+$]R\:"')XO\/:)TUL9^9$B24FT MU0OI+VC"4FU/34^Q'<5R:)UUE6?FNHQP>QSFFXG6?6':@6&Z1C"EEX7Y3DPD M)O%IN+4=9TAMHX/'8[&,_:`HDS)NHQ"G22R(Y4Q\FJES+V@@7N.9T2NC[GVD M/U&J!QL_F9[(C".YF[*_>+S!G'K1JRF:QRA<2G6V=.U-[>1OX^>,AL%%0X(:4H!N,@/B]2)_8F/*QH\8.9JVYX/!FGUXP)`*G]:>SE1O/?XF MXZSV[:UX$EXE;<4*"@N=JX/^FJ.;/82\1[WW%KJV[IZ??M3[.N!]M8!!?W/Y MC)GCY,XX;DVR%H4BXTJ*_"0F>Q*[C*CP6>T+4>OA.!EGM6_CT/6&I@7,ZIJ, M4?-)(%RN@J9I^EJ\:ON;\QKDWDBDKS?\+7Z4^P:;^WJ6TKX^2&$!,XM,PZEC MAUMBWJ7ON^9]$%95W3J+;3):Z\2/+X4[\\"/WO0RQV_//I,%?D[#7YN8+H*! M:UOS1X[VI+//D+;T[+4-L^]VUT*A59I]AA2G9Z]NF/UP/0,KY]F/^82<>I__ M1OX=K$(%C]^C\^1^<5QQO/BIV2NE][=UTF*M7?Q4^\RGOK^Y8OH MS']ED5=]^=WT[@SWY>Z;ZQA!-#<1FA>Q!9%JD>ZK.V-UH=@6>FJN=(B MBNO%-FBQJ8I+KSI\'/LF$@Y6`R$YC6/O`P7V'X8X+B)/G@PWDT*\YL`![)M) MLEDFCAC`OIO!.[__B0#*<5\V'+6"W=Y-(>[AQBC\O$,_.;T>=Y^BLCF1RQ>% M\Q,ZF]4XYN$5(JR=1_S"17%@G;:+&W#P[%Q>9VEY-2)Y]0LXD?;X1PHU$MB; MPY/<:+M2G/@U3O:FYLW2Q0X>?>($'KW1^_%B[\VFLI6WR!2./0=_X-@/&OHN M3;,R&F0E]\='LA.^66SF\8ODCS=)MZI.IRW`:57CER>[..\\OLXX;;X_;&O] MM=/F-QXGO]-A\UN_/_2H^:A%5ZK51;I]UD[BD]5F8_E-HGF*Z`]S\6B."64W M=;:*WYVC<"T+UE)?KMU9V5';PTZ]69FY.A_.RV7&',L+56WK-5>KRO"BTVMW M-?!"#EX`HZ3A!3#J)+Q(]6VLKY6FM0>]@LVT.7.47"VS+)=E5U4CLI!13PS4 MSC(@D,SX7)>C-E%>"3,\E7^$=4N=LMB9BC2(/&CNYA1:R2N,)F("!=C=LML7 M.2AG)N_VTLZ]US$H5R642]M+N;`P%AV2/G`E#-LQ,D/Q3<\+5O8."O0"-FL9 MV+8KV_Z9/Z,VNP@2,FHW.JLK.!J^],T9O?+99;.W9]%_Y^';5'"7EC;F+V^? M))49JM;2]-%B38,E(;,E`5P"+C4$E]36J-?)PB4889)JS9_,$V=TNZ>VPHYC MFQ2>4E66FR("L(4PH$P4Z[4ZO2&LJQJ(._`&>",_WO1;G4X75M/!VI`<0J.H M6MDFU*WC,VMQ7L5ZUF$%(EM$1&7L!"*/K$HHUT0?LCA6E8B'VJ"EC0:POVJP M_`.;@$UUPZ91;U];+;K$V:EHA[A"YE2U5#'5*$<_,^_?Y#03F+ M].4L^57-HO6X2+X!1TO`"&(4R%XDBA"AS M028^REPD54Z4N4"Y4.8BJ>[EO6]SS9X5<1:+:S(K:ICE!;.9M=HM2\Z]-W"P M(CMO-]/9,CJP<#9QXN2?9W M9_E\R4WO.'873?P\GN80 MK4A<^-@TPKYI3Z8A1IED14?])]QTUG2*HL>__FJ5E_0"AVX0AZR'Y//$12!Z MN;6.?YMY]!/&9$9/F&%:IO^B\.BH\1;](1AL/G'%FSFFQ1["SWR7=,\-@2V2 M`Y<+R;!$KXQ0MML;3#.`/\!_*_B_Q)@X"1'>#D@2_2!J=<($AWHKE)APY7;^$*\FSZ3^&;7!HT6*" MADF7G'C4T8+WG4S>T1M/B=15,9AHF4)?'HM.N4+S)J&;R]DL<(W'D%3B8Y>3 M\'!A=PB3WR72+8OG1JD,%^GX,>$K6@E:DI8I]+'[D"R@*])%BP*;T5#H<223 MKTX:>`H\W;`;1*)W138?LU](=A^$04##^Z1QC/0COID70EWD/?FI''GBNH_/8:/91GU_3Y M^=AYMA=V?TC-F.KWCO-7_%-AM3\UICTRT1(N1'$)=,-G8ZM(Y^_.- MK[R,5B4"W,`B+DT9W6Q.)D33<$FEEW@+>G@;'_'?J:$NC4*,.S9I-_I9K<0S M\]8Y-2/U8+:@A#DG2KRJ&RZGL9`?:A/PA,\,W;R6\OQH&H^T^-E"&D.I]6@< M$1V$",[(W3*=P(L7WD0(8N587DGG4Q8+!ZV[;:P$6`GV7@EBG4T+=RR+Z=5` M1/((3=QT-H@K!63%H*7K693 M'H,]GI4Y,G(!1/.0V/&3_&=_V,U%S^D[10"SL(^$%QN[?D'X=V@>AZY;`IP+ MPR#ZNI5R!UUNL=@494D`=AXV?4DLD)Q$\I_=H5X,`1(W.2-.O(@/1Q82F<2< M3+DQ687WGF.1KZ'CYKGD?T.WB7F%NS=]$ M-WFT6"9&UW/B0C\)$S5ZU]'D^*-]TU8^.//C\0,0_/@_`3EI0H_WMP"+WD%?V1[=LHEZS9Z_S,-SQVP; M]X9Z?_,.;OH51XXBV3R*I5<<.XQ,:@SZ M6S;R=QJ&6`T^B,7@M8UU=6EC74V/J+,^H(UC2=YSU#BTI7%H&>,8;*-++F-9 M339(%"ZVR3EB*&;HA3L/GVW#F?+/ MHN<8?7*H8FW,VEDG^Z97YC"P5S1MT\#6X;B@<;VF=1O&=0B]?N/,XY?V^)I^ MQZR/4?#J8"YN@`)ML`(%&]]X[*!>XV!I@]H3-/7.@8-Z=*SQYVEHBX91PU]< MY\C%7AMUNQO&LO%%>0PH.W^PT^FIAP\(>74'Y=6%M%MQF"4-_NX_N7K$A]6^ M[`'BHYW2=(3YD=QN9\:%QMH/BB7DDUQ^&F2<'Q%MZXCODMVC? M^\"TQ&23[94X=RT=+_C?`J[.*C1>1W_#O@+FT?GIQ]DA&-C<`36U+DW1_-C=\=HD@.T='UZ,+>P8J% M!E]QUV>FG>PZ;@SZQ!03T"]^RCV#6?&IIA8CRHLDG2BT9H>Y:"1.2=*9S9^) M?::!BM\H4^X_ M.N,P.R>E!&(+_GBR)]FEB9!;)KN/$HI,+[5][RW.D`WIFE;3:/HR!8HWBLP5 MC574#873?$_B0I*AW#QRON$0W./EOZ3HVB8#:=6$>F"6R#/U8$<=:$<1`95/ MO"*V5"T-I4IMI,=+AI?*E!(&3"A&7A0.\M)Y2.,G`FW3\X(PKS]< MX,1]<^BF-="<>K%I\1!O1HD<5MLPXS3R>8IFDD^^9!Z_&DE"!ZW$0( M_[U(CJ7;/8(*`:5&/%U:4*,L>O_1=,?G(JEU;3%A=)7DD=*\HJ?&=&I8KDIA M"\$6F-^P&H18MD=`)@Q?1'$M2\8NY85(N0I;KXV7KHWRRDM[?.,3_T24 MA%R7C^04"$T_8NIJ;Z#VM@YDX_OR&UTFE=1!M[\2QSYX=%<"X>SCRDXUM;NR M:;;^@F,&D"TVG8&F'3J`3\QT_Q29EHNZY>-D9Z1N'>$/]`V(),]4LQ5D.-P*7$6.JPP6Y#'5 MET^.^P<9*F%PX99]_^9XH=>_-SILV'%3.YN1*NN=>X[T=R@JK M9\*2A*1,>>Z0;@Z=7HKJG?23Q$"LL2+"^].H5.A!U`M'D7N1]6BQ9X]L.H4] M$!1Y?GJ06VK8YV'X1APM/>\$XEKF*FENS\-+A#=^^/QL$HVCG;@4C:)=F:W(,A,&CH"/,9NRAR@2Y=CA:$1I73Q* M8@_]3KR-C]%J`''<_>.X]@-)EQ=6NKMBLY!6---SW!`+"2!$2;=8".RD_"Y9 M)A']OL6V]`:18*-2<&8^T"D6;6)[8Q%+&6<7?Q\Q= M;*DJ8?^.?P?<-HZOS4_!D$>+J!M21Z3@BXF)3/[8DP@)>/3;`GL.._NM2$>_ M6908<)??OX16R;^B$F-R4[VDUPZS1-:G'Q4>3(5!-+->$OQ;E/+:05AAM<"S MN$QA\0LF!.DAVF$0B!G]<&MUT.+&%$#."[M7*G7GU`M_*_KB<,N)ED M'_F]X]J/`??I.7G*R"?N/@0>C29^71!RBRFD./9X)5.`].;1%+6S80^?:,1B M;X$6%Z$M<0>%P/-%J3'S6:[)"RND7>)%F#2PX'9XV'1C,=HE-$]X?Q$B;G%'B)/9`XQH:FQ)'>QK[)YVO-R;+*&OYO38)H: MQR9MR!%>+>J;8KB-NQ?$=_R4:+/]N)H5:X2J7 ML%8TB(D8%K><(6T)0J-^\0BQ(-$*%39'340U/?$@K)TGOL1W)N02U8OFQ#1$ MA"ARVA9]SCRR`T7[EZ@:/Z6G<>.>J#Z./S'A53DKVI%XM:DV.1O)^"$:3U2] M+]*X'-&IC&UM)R"JQ<2`Z:7T_GDZVL:YLBF10SC%AN$&8F,5IJ8$IJ9J%\3S72+&ZS2<1+3`&-Y_$SPL?O@@A^)O1*&S-%8]QGB:Q<+]) M+6B]$];6_UYF9MS8\3Z<;F)4ABZ&3\["+$T1030!\2G^QWQ=SR_Q1(/M",OF M62BTA-+MTU!LXKXX80N7#2Z(+*EPK^Y-K.YCV/SKY,KEM!A]BGN3788,^1KX MGL^BU6VGC]6G-+2J.NB=>7_K

C8M3WV:"WV1)_,];2SV\0)-2")!9654J&+#^)@W1ES6@<>"0()O M[W-PSZH/OM5KVC#:;Y,)LOR%WPF_/H`S](`L`NZ`@]?K$M>O<- M"MKD=VP^@QQK^0]K55;C:$AF,^S/(F<$7%X?)O!#TEOL8MGP2R: ME[@OWQ$;G\P/GKGZF%BW`'7SX1Y1)B-QN>//&F3@1_WMA>EA"Z2^PDX`;E^8 M_COQO'2>-3E2HP"MU?,4^JZ/7Z_=ZQJ&Q*`[^GRS1B(HTHC*YU"`W^(FIXKG?2&C:K!$`O@`T M,;UGO@H4>(]T>AX M-!H-AJ.$Y`EVC&D:A$FMN'SX;X8PZ46W*,61QZ:'K+1##-:.\T\HF4EI-*J? MJ&`AU$;TZT'_P`@\$)',6?6FC!LQOX9#^@'\HOM7I"C&_96 M!1C9>2!GYT$S=H[G\Q\`1F#89))N6+(4462ZH9SIE+OHC#\''_XE7(I9,4MA M6KWMHPXM,M1QJ]L83)@1?F5+R^6]:&[:-/0^0#_1R*KJT"*KGFRH^=5C53[: MJYA6G*%]]I47,VMG19QJ[E!#37AL621P?6\)J]3<15FZ97!EI%IX1M'FX>I. MH7]I4OJ!W1>^RRJPO53>]I&@2J]>'6K$@M-6]_*9S63F.WKA.FG92%Z:LQL, MJ`HTLO]9JWN!Q)S^!W&M\@%^-6U;;2RY@B6/2:U3;]&R1JE=BS.EE3$`99SK M9.`*X-1FQPU9^CMQ7YX0G<7.R0_B([Z-1TPW[:F4VK]*49JSHC;(:A/TAKB2 M>[9#O"`F2JZYS95@J4W1CVM9(;LW?>939`V3_E%3,TB`4/.8&VI,\9DI0>.) M?];42E(PU#S;ANR4<=M7IG"EPZ)\`9K;>DV@$1O.6\T&ML1^B_PI2<[>1*L; M>6DUM[$\ILB&FSB4+M2!>P*ZE^/:11YD/N6O>FU-.Z9;( M81OH)\3T&[MEJMK+\$QI;0Q'@Y.^_E2I`%F+#1)^[)==P+N9S2EYY<QO#FK*&J`M=@)O0ZHB]DI<%#*-7YG_RLTNC!]1VVNAG?##3UW&64! MBUV-C*[TYUFP,&W'K*>.56T1O*DN>GEGA8'RB?5SY<9T?D==DBWI=@]/ST:@ MEL;QE4-)F;'?&\&4H6'*5M)SSC!3@K&M9\P3\=[?O?G!]OKD3KNE$W?(O`H`U9RZAIHO MO_$J9=JD!\94JZ=R[-UR\.J=HZAGALAT.70 M@-V$(!;,(MG,Y!IE'%UQPC2./N!H^N29LLT4P6EQ;R#"(]TVA>D[8-]J&+4X M.!R?JWM`K\@-2H;8_,0=,K`"0+7#$PU9-XX4=4EFS]B-+JE%(3-XR`%L1U$# M8Y6)UEHJE-1J7D@2HB[86NR41-W;`]LV*CM5DYNV"Q:7!Z:%JQWW:"S0"7*] M-%4O'=/S>$A;Z\(CHM M/'KI?97<%?[VFG2=/0E)J%HLE=W3J+OBH(KN?>:D;)^%)4V3M:DLNK;N6$2A MQLJ,N)JL0Q:4@B;3)AOQHFT;AZ+?K)9II2TNH:CP7G39YVJ]PXU(-?")W^B_$F$C]+1/INP0^:6 M!%>ZH'ZXT,"O1RLA63<1IU7I]96D!8117`?%45R7/]Q-C&65!M1II"HUHEJ; M\5Y7P9=T>=T#>+7:YS#>NCRCR?![T M)UE*.$K)7BC=H@1I.QV#G8ZU)6%S"M-BUVWQ/D'IF).3LGT\:=KF.6OYDFIK MZWH@O]QQ3XEX)$ND:!\A9-6?-5P9K+8:+#H](FK&\<_M,U69PO,6<0JPM-4^ MCZ:#O$CR1T1?L84*PB@)4K?/>H6VR-GZ4L"EYOVWP*PL[HVD3>.D:>"GH\&H MIZ]!"T%IL9O)U_V2D$H"G:TDU=Z:TJ"TV!)A<6ON)IR5_*73L+MY)(XML*DX M0_LLJSYL*J(K;;"'+;.QG&';:4U%VQ0:M\RBK7.-0MECT(4FC!-UUH*%`-MZ M^F`QVXK6_4K7$N)T[3-C]8FC'#BI7K411Q8Y4.;+;\@%&.Q1W[$]PR[V?`;J M%46@1*ZM5.866[O09CE>;W6\6LQJ'I"'0(\LGN,5.((.X;$_BCE0F*<[IE>' MJ<7,9[G"&79\\;*H<%@@.%^:3BS0:&@.RUV$V($Q1W$2JH]562H M4JZRTJEX*S92+-5>'Q) MZVEJND]H-B?4I!\WL[F):4%P5^5R]MR3X][Z2BT]7]F*SH[#^D%<':(6\+ M%ZGD3.]0X4PO*]L("V_-4Y+W"'3..@=V2!M=H?#?;^^6$]A\SF[!H/&"'@#& MM\D$6<*AO*[2&SH2S`2_I^05@Y$O/G[W$$B]6+D86SY^#0..Y/2^XC/$:Q2: M;D/GT(9.F^XIZN7/R@'ENE6EQ>K?FD?1V\"*#9@NEQ\E.E`S=YN>M]G`-C)9=Y0UE56C162@QZE)T04,Q:GP-J)=Q=S$.\H+ M!65H\:YH2Q;K=H8_]>A)[7YS/6]R_`&%H2ORYMY-XMA8]Q1YB+YR!3!@7O2R MN@LE9M\[J%;(CO&D1B6I+:HU=[,O-3>\<6/(B05+X4ZF1-X=X\_ZNBD-;MH* MKS=>9+9`DRK+^IGT.\H/-7V4O@^[)B=R!QPQA=7'GHT M]$I3%O,#LA!^94\NR`\_B3P[QIOJ.BE_QS9-D..V$`0:`_CH=MPVHNX36@3O M6L/'?Z69(U/8GE+K*BOFFFRTBX9\FRSBE9=]V#I4YCD"::[)%+;GVKK*BKG6 M[B.C`JV&:Q,U[VU*%IK6Y@BT.=JYOMRIB`%>$\I>@$/(YH=H^60D1Y4E M')(L9^JUER,_18X69HLI+_-J)J M='_>A5O]Y.3TM'=VG@^'Y\Y=/[ND6(]Z&H#1D/L2!SK MDZ=$<::EKBH&PMB_M;J4+_R= M?5O6F?+TN;[HO>)%X$3XBAEZO0JO)T)Z^#+?P]0L%D^HL2V0OZ#V/?\;TK%: M3+^&FD#)##-_2K)C)"I4@MH%D`YT=.412C94VTYS<)LZU2-@X,9<&[X>LVV' ME5>Z9_AV55L:!7'[NZ?4QN0%@1YP[ M6]:T%B?1]^[&GO;UN!OM#B#8^2V\/<\WK5HM;H7NM_#VK%;8PFOW"]T[M84W M'`W[_3W5-Z[@#;])U#[F:[*%M^?_UG2L172O#F[N["F^,9TJ;NYT@-.JD>[XUH6&W'IR'R5SJ3L6,4*E1"Z1-5V[ZL)/G>UJ,U17;`8H\F/JKMZ)UG M=_3BRHUD[0:OGE]@3-1E?(I%8-<=$S\TO)FWF**+=^#229IYY2>2X!J[V)N& MO!:_XI.7.,WF8V#S<<--.D_SZ0=VI'%HLA/]G;8L1"PCA@^8G3X$\`_)DN-BS'47%U?G.#8V+XCT)NIS>1 MXR')'L\(]?&?O#(V1*:371/Z`X;%:_R*_HE,JCANCGHGJ^-F+!/-2696HD%(I8 MIJ1=HJ<%F>J?WH@Z/G%9[>LSY&R;BEM2&W`MQOH*<*%Z88"<:J7M*&^$T+7P M,=0`LR[_Z0TYK^B6N/Y4Y(NL5^CN\4A*`UJ<15!O/]4-B+D%;?,-S>W"D/_/IGOZ<5%]O$"34@B@=)TJ=_++C.& M)1F\KM5U1/Y+6&$B7>.+BG%89!;)/B\@_HJ*D'>+76X[X`FBR//Y\FVRE#"6 M^RWRIT3BFC8X&PW/CX?'0-KCYMY"5\4,TV9H/FY]2HP*;%_GU30A M\A:6:M6N%O/""IBOX#^>CZWZ.!J7N"?I1DA:J-[61<+/'<99C'_B(OY6V")! MY*6HCN9#^=%\66UB;(=T1E1U*T;UI28ND(LF6+QKF)LZS;MSX%U#;YG$>[=J MJ$IRI3E_.AH.>JWH4N3,D&W^5>!J,1#%P/CC0>QT!%3E5*."3!'MXT45RXKY M45D'6I$EPA:VK0,7UG^]O4) M*J81+4)7!5[J++3B6IX`8_["BO`*J6(I.T(4)?A:N!4%+8)OT;P@^`CC31*X M>J\B+"JM.+#*8-A%WJCK8,,+$[D/O0F$_T&8FQ#`*/_LH$@K3]1T/=-:W)%; MH<2:I76%%9M0@Q:GWA1`/TY-BBY,#]ELTQ*^+"Y>JG4S:F5WA6&;5XH6$68$ M\/F%H+']?X',$:_2W#O"&2G86@1=46@4M\ATV$7O;^SP"TQ3W8+8$^L6NR,\ M6D\?I2%06DPP@3K'\=(T\_X"=A$TM62CQK9J=>P(]6I4CA;!2`1J6-TJ9R"O M\&2"V((H5IW'E96V(]RJI(:*P4Y:P:*KL!,GKO>_@>G@">;Q?*)O8[;V6Q2* M;+U"=X13ZV@C7I3LJ:Y*;GF?(A/6+QU)2'6+(A,)0+Q%L8BMP[8FHEO^+%Q` MHO:&=RNQ M'9%03@)0(I[(ZGV^U;_+V5^MW/;R2)H!8A+5JQ4M3LGD0R]ZN:,@1UH-YZ"& MTZZ20XQ7BPVL?%#W%,U-;$=.FEH?LI)WAZ@@@UR+$[/9&-+R7E0\8K?2Y/6X M&*58=6OY(9J_FTX0FL5QR)OI6J(U-8F<&E!`9#P)NTOBU<[##-$]L4@)X;>H M*WO@0541FW..+8O")-N+/\E21*G0;K-G?57HV;](X5ZTJ&M"KTCP[$\"!WXC M@7C_L?Z*]OQ35X^>CHV<+MB_,@]'U%7\GG^R2M'B.(^$!I)G24`+T;+X&CP3 M%+AKS%)1@Q9'=?(PAX>O+TU*/R:$OIE4&))=,G?G62*+68MS.AF`JJ_!R!?0 M;6*HP=;BB$T&H^2"KO"=WZ[9O'3YMMU'5[)XPGA0[@L+%55I2!"7T'$FJ.'6 MXDQ*!F3!5I8L/PJ*2"MJ!(H:=8@@JL#+CY:TDB+E,3V+LG2;`F5`8Y.K;O5N M[C`13(!F.)08>)N^1;4X7'0=^)#T%KMX%LR6_2`R/71O?O#,:@>,!MG8N0E! M^/&AE"CI$T>A.$8DC[$0R.`2&;%(#9\Z2NO)2^EPH;5`M(F3H[/NOW MST]'YV?]9KH)27F?P)M"YL07^IC*Y;2O0UG'=-D^IAZ%:''$1!+JC?OT1OC+ M0>MQ:%G.GD,R"M%B5TD>*GM^I1X6+4K:\TA.)5KL!4F#92]HU$*D14%['DEI M1(O-'7FL\:M]:],H+FA/(RF-:+&O(XDU"L>U'H6B0O;T*=5&Q?V?3=\-ND>4 M3:>)RX,1L#W.P`\OGT\N3`];,+^^PD[@H\03!.D\:M/YTUY?<%\(2C7"8@U> MKO$I(0V;RW-Y^(0_DBC.^8D)]4NF@(8G]7]PNR)[_`K<>4$_@MDSHG>32'8N MH7<7^)YONC8P2]`.E4MIZ+XB1:P1F$Z"&-[8]RE^!@L^.^B)+*-=1"UF3*GI MOJ"2>!!K%IQJB\/>:#@<--PS5>3%RN7%3:A%BYF_0'T9O?'>0JU1Y9?120:M MKP$MIO@_D+\-U16LE>5V. M4(M.[G=H?%[8F2/[FTE=:(K\'"W4B.PGV!95'.?FC9<,^Q8K']X+(? M7!0HTM;AY=_=?5[&'D M!':T0GXXLC&R0N2,OKOA? M?SH]H1\9+<-P_O4N^=F41.CKMQS_[X:?3[2_7 MR9<#_Y?1A_7#^2\GYZ/QEVW++Y25N2MK>K%MZKG^'\_T M>R,J#Y_\_8<,@:_/V/LIP`O:\^3L?=KPA[CE+Z_$S;7^?I:V/7W_7U\>'NTE M6EGO7)^$EF_O>K%A1/U.+R\OW_-?MTWIYYUPVS9+S?G[^$?:E+B_$/ZIA\"V M0@YF*0LC:0OV7^_29N_8G]Z=?GAW=OK3*W%^H.(:C?Z&`P_-T'S$:?TEW*S1 MWW\@[FKM,1[YWY88S?_^@XTW=(#3L],/PPI=$Q_K@.?!)[K,"2O+(^) MYW&)J"[\,&*#?YO=YWB@`]'6& M;86/[1\G\VN++.^\X'L]X8L';)OVQR65U3+P'+K,W/XKN3Y=G5W+NZ=[.>86$-E2)?KQ"[)8/V<< MWEDN_LWRHNKL-_KQ)O66+-FZ^&)Y[*-CWYDA2H)KTV64_4;_\(CL"%/E:T() M:GZN)[ZW.!5[?;'P'Y0Z.BEWS;N13E6B6EZGZ^N(YK`M\W$5$9TG-Z2E%!(T]+['3FV6TPG=;EL16T;[Y5N2X5!>G.+@+\,JBVAEY(9G,)VN$ M.4W5=;_!3S9/>1BI0QJM(H\%D<8K2JK[)]=_.M9XO<;!J[NB/V5_F2+L M!@[ATZ97=>R!F>8PN_FW"QU0.UN3:_EQ]\N0Z-V@M!*N5&ZX2-_`Z MX*$5Y#<3P#$:O,'X5"&"6ST$)1^J07K#P/Z#RFJ-?&(U8XAK#-DB_;LUALN/ MC%_H)]D:3@V^S]BJL874^%0W_+*?^'?'-I4VU1=*QXQ8U=?S6A_KD^>H2YXC M"#Q/N^1YVA7/VR`\^V6RYO9`0D:#S.I\I1-D?T?N8LGLGQ?JC2Z8`1.M.#GD M&T'.4T"I07A%W?MMC)UYKO6U?Z"6=;Y/3=NT00*:D\T379*(97-E M^]T-ES/$/8>IA6N=:6@.VZ!6QYXEE>%G%"RPM5ZZ]KT_9\$I1L0,O2"?.DN3^CBG(2R_$4R=(U9T"%MG4ET.Y._ MHC#EX&J3D-R6J/0^VIT,MDM\CIY=VX>ZT>G&"6A2-AYB1Y3_B.BD1MC;9(ZS MMP368-QD](0K"]NZC$E2Z-+,/)8[=\X97M(AL!T]HW>.2Z$@/.LE^5"6H>TH MKA^^ITW?)VW>"P=HD>#M5]XYPK=#J M&6%#0O-=6R32\CPSTGB'A*`DDDT%^D`_G1#`6C60SYGE$+V&R'>0L_VK&[)O MG)R-:UL-'[/@F] M]BQ"$G-[_.J2,IJ+[;?D[]1CC/.,4&5*QTWTJN*R&&`'X;__<)J.-L?!2B[8 MA(1`BXV(4*("[E7M\G*[!25+U$VRN@K1$#5L"8;B>J^)@4RQLG"(^#AL'/YY M<7;^X>?S3^GV'VH@ITV*P!`VBX/U+I#]_2?I<9`IF%+4'#S4W-5 M*Y`MW/D3VV!/WK&=_(L=^"&U/F\]WI3:VK%[O?N=.I_(^?L/(8YZ,MSBP_;K M"+-;1.-G$F++#B4X2=I"F#5ZH$D8`+>ZQ4G8^QG782[O0K;&Z?6%L$LI52^W MV.GQ!`W&0E8]2X0C<6I#PK4$1*V>$*:=-H1:',$#T$94V]A5J*\HU%LC2_IT M"MI9;="4O$"#*[GF179D[ZB6[6C*+A`622T=S.UQ2I:@8<;3#84\2A!3=8"P M(AKCI6((&EHF0$'`2+(`&F/4.CS"P(4T15X0I%"T[53B'RMN.24\0)L(Z96& M#54'B?[GFW0*PGG-?3]/.C39IVKR9+W&')4N1G2)S41,9)2?0@*+S>&VY M3I)HE=XMR/$J`4RK9Z?`?:H)G!9'T`#4@:I/4'ZN"0IP\4]QL$8XW$P]BV?D ML-C'FGG,=-*7>*%Z72'88GJ!.SU^6K;'MA]E!1*2.F0\3TY@CRG:0O`J350K M-<\4+$&;.7<1IH*-,%MH[]Q7]B\B0DJC/02?TA0M#;:@(?:`+,+O3-VOUCAX MX2N"$C)5!PCK6E7,5'Q!`TW*HPJXLDX0W-6JX)7Q!@W`S-7=&[3&R':3-->U MA]([O-F+NS+VY-'5AH:'X#Y758KFI`!-?502J6"8PO#%&Y_[((,H&??S:^#; M6D=;)7T@+-QZWD0)(]"P8C'0+RA]JO&`"".V(,I`F#T-!-2Z-(L-O]#,'I,$9F1W[+L9,I79=]'JX6 M!$NR/T+81;3%N$\\-.45%O.1&V?RYA#L;V/EEK,##:>'P%\\(;Q*^!B&_ MD/L06'X^D:-T,ZDV%`3#VQC?:JQ"PUYTI%>*+?^MER*HZ0-B'].!0<0$- MHG2#G%H;MB'JI<3N-X800BC7-5$F[#XGT.#A-22UL!&VA!`2,`-&R`8T5&Y7 M:R_8()14$BIR*,%(HQ^$4($98AI,M1Q`H),91[P`.#4X^/)\AY`H\T+6$$)@ M04_H*BZ@S9*$3NW9H6@/P10SWF!DS$##*?6MDII->OFR^XTA6&=F",DX@08/ M=ZFT)Y&T-02WWPP@*2O0$-(&IW=<)&Z^&2Z'`$GZ8LIUL'IV_>2Z2%(NG)>& MKYJ)?:@H9TNY=D:KEMR>=$,_GZO=NC48!P(TU^R@)?ZLZ=`M*K5(Z*C:@892OD*6JGB-L M"2'R7:YF>[<-BVQ`0R6I,U\&2;$9A("W&1Y%'J"!,78<-_[^U'*=>__:6KNA MY64(EYE@&ATAQ+O-`-/A"AJ$,U:T>Z?B*PLG\R7J5>T5FHT"(O!O.3U,6H2'] MA)%%(KPIW?Y$#2'$XC$0`]_V",;*[X@@G3 M`-9:!;T[:K]:*Z1\P/$)SGL6W2J! M4!0`]"*YT*9\26&O#80(:45USH5-\UP!P.*PGU62Q4YK[:O#DTMM[X7]/KDT MO.%3IDD5W_"!,#N&9WO@/]NC6)0+)\+ZQN`#A*=]3%C+[3D&.]:A/@2DX"P3 M;<]6JC)7`NE`$&9P5>6HPF_+EV6>L.6@E87_(&FEX1UEFFA6'P;"::\IEM6Y MA18RSV\KU"R88&[/.?S498KPX]+">NDO\LX03H.K3E=='F$#RXDDXRA<4B+_ MW,71E8`6.T$X^6T&R")OAP#@/2&1$7AI!PA'P$T"E_(%#;1,QH_A6JK5$\*Q M<548M1@$C*?F$JKL`>$!6*5*Z>T-82;(8WA!77-S"7[Q*3J)#>E M+4'<#ZD*DI`C$)D9VS].YJS\YIT7?-]QH,[).#LY4>5D['Z8S$=L[%$\>)_G M)<(0?9/B^"%@N?&--)_[)-&__3/![2PO%L_9#D^Q<,;80M`:1!" MF3*E%Q+>V`*D*]SXX\+#EN+//1^Q*)0A%6B>7LC2S!]@7UY^_'39_UF^H82% M/#0?D/L5K0*R7B*,I$=4Q29]GD+)5"$-EA6I;5YHUQ9VW&"!?$1<<3J"M%6? M\>0RT0D)!F"VR>_]R?9/$&J84UQ<&+2TVUJ\TWPBS4 MR9H70O5-70/ MP"QCT+`9._\3)0]2/`4S1-<-V^65IG=$/P7-3-1V/@5A*C>C*>W(!YK""=]" MF2'+8^&ZSU3FBD5"LR^$Q:/->57ZM$Q1)-"T0.?],(D2Z'6%L"QTI0-Z$H&F M`CRF>&61?(TGF:4N:0PA1:,KF&4R@`8L6Y)6^TL23T-Y6EK^$UJM`VSAS?UJ M;;E8\>ABA7$@I'-TN?(;BJ?E9*W?Z=CH)OCN3^9I^;8I1@3AEZ12'PE91A(C MUZL")I](:24 M=+4*:(H$FA;P=8H5H:,2B`F]?65;FNRD2]$>0N9)5V@KQ``-X:)B;GE-:A"5 MA`M,!H"0O=+?C)?+!;Y2[%XWTU_T^Z4FMQSE\==A[C(K%F0JO MAVBK@]Y@$-SZIM5!CW-HZJ!_TA'7Y8_HWY(?`U]Q]E=K4`CN?SWUJ"N!`U&3 M.%#5P.&^MPWTE=]"@9@][(>20.\K_H\5N%B M>"H-NMN$FZEG^2$U55BEQK7BZ,9D``C+=4N@*[B&"_E=Q!Z>]QM;OMV`_ZX<"()M4,M_5W('#>KL>L;N8;.BY-0_*7TN1Z,?8.]=0Y-EWKN$ M67"X)EO69'[C,M9]IVQ?S[4$[(J;8B=B#RI:U,"8H76$[:5%]*:A1D?`'G9% M+%7<@H,VLW9DZ.>VHX!]C>56:Q0(NVCSBZ\6Z]`T0%\,]8UO[4$!>^6&^E%7 M$M#4A<>&?8?]#PL8OE@>T_@IHF0Z^\>,MZ^V%SF4(?J/I>4OT(S:K;?S.9): MY(V-#MB[-U2@QD0"39-BNB;S+*T37\RN1%W,A@#LT1OJA!G?T(`7TSFF@L%X M0V6@?*96KR^$E-LVIW^!86BUK_AU,.$C8VLDT@A(65"I>/.&5)!R#N3*RKY*V9 M0CL(@A=IBZ0V+""ACQW'C;\_M5QJ828IO4H`2OI`"+"7@5'"`@!@9BBD["+G MUL(^-=75;_W)&D.(CY=!(:,=``8:3]BK)XI^?PA![=))H\\.`/!R99Z5,`E; M0H@BEP$B)!R`Z(?#9A$(0DMGT7C MRXU@01<(^[X>/&H^H`$%O=YGW9POR/4\928'HY;?/'FR7B60Z'6%L./K(:7' M#S0`!027X*;L`>&45GN-D[,!#:5M*EEF968'2!*(Y,TAG)CJX2/G`1HXG+3X M3:&;"+-GI/E1/C_',ZLZ66$@".>B!C:?(7<'`G5L)#6!M7HD"*]PU0);S=Z! MH!UK+/MMPLDCMZ\(VRZ1WDJN,`Z(M[P:F-=B[@X$Z$1;ZR.M'*A;J&M&6KM9>L$&QVDZ3?&]VF[K"Q%:,U2WB]0,UYAP>".BQXDKYD`=(*X[6 M+?"U0D"5>80&_:Y.YE,@.6#6YQG/O-+.W6)8*QZFR]+!X:@S$0KU@UO:C'5]9^?&)2QE)<)H]ZPP+Q5% MW&SH67E!Y_3DX\GIZ-UH-Q;]C]UPH^QX?2BGO41.Q`I87B4E#3,$D:M-YK^4 M=W6,A^EC)@IH4]SCD;8&=(.G(GK9*2AE$\#2*:(M+M6&E)=*-/H!N?53HI)E M0.TQ=H21B%C#;_4LAN#Y(^85]L`N'.B;:&I<]Y%-F` M.4\*EE+Y%,ETZ2^%6(>5G-%GO&L=:KIQRM]UL'IV_?A%UZT=^$1IO_+DM:!T M.T-(2S95`5W>^K/XKRWLN,$"42K=+%N:1O]%T>C/C3C8_8/=/]C]@]T/P.X7 M6H>YQ4IJ(`I;':2-*.0$6B1QL!D'FW&P&>':C,(H\5/N-52EV7AV\O'D3"]6 M//HQ'O[+QKQRBX=FX$`[`KYSBX"[`*^O>G[/_ MX1-&T_?0'@5"P8:J3H@VD_`BV$8.R471(9'&L0>?9/!)!I]D\$E`^B1#0'L( M:`^>RN"I#)[*X*D,G@HL3^4Q6JTLO)G,'UVJLW/79N^KVW80L?>=%E/:SZ8J M^M7"[)&G%W3#BN=Z>A[,QY/38B9.\CW^(L;NBZ/=)T?I-T<_;K_ZE]&/R8=[ M]F_$-WO'E$Q_P3WQ,P#V!E3P@C=%M*2"-*STC1'HA'I%))`20B3HX)EVQ:^\7) MA\OSCS_#R=^OC960N^:]V"LW^.Q%B.Y4=&">E7U$8$WMM>K`B9/6GVK0B]K@&@%5U)G>\^`ZKL?356JEC MLNU\"HC1(M3Y7(BA%>X'#:K[*=#F52]:U9%)EJW+.",6_;^(3.G_22V`L@X0 MC+(V)T-J)93)`9HYD*O*%].M?&%'T1Z"-=*5DHL]MI`,!8$"I05_![%$.1LO9;+.=\&PHY=)N<\Q0#D7+H[R3:GPL&F MJ0.E,7"/3^XU)A;QV7]MH^!0,TW&S@O"H4MUHAHA; M:,X59^NYG//G?63PLK$TL79Q;QQ3*HH=MC M?FQ46QH64,MJ_OI>_R);F^07.$J7Y-,2((OW#6 MK@,2DM_I1]%-\'W_L%>W$XA')QM?H'4XAS91[_T7RE>`-S)(50UAO"C9R@P4 ML0L-NRD.U@B'&W8>&8Y]Y_9?D;MF['TCB"X8#^Y/AR>U]$].,7:A=&['Y3>&>YF+\)8G9AY$/QPLCV.Z/, MAT8_9NZ1B%NDM(S&X8A1,^+D]'R39"N6Y#Y8[AY82O'$IWMKA-D;'+3!U\#' MZ7]2[7*)ZB9)@^/WL9)LR;_:;/_YJXLPG;/+S0-Z09XB74"W,YS;)HUK0W9M MT14'@`UD2U_",Y_`1:*5>7V&8P!)5C!3>"&\>OR^193SJ087E^<7)W#R)3I" M7B@#2,IP[Z^CD'"&3Y5)`$%(Q*NFW$%@1AT`Q.S/&[`Q26D?MOXY^`98.+Y(52-QJ4Q:%93GSL4HZ\_;8-J$GX)?+3Y8N$_4'@7 M^8[X$D]98U"&8$LS*9=X*I$#`#RO6>(;*^\2(C*9WZ!U0%SQ;7FM'J#,Q0Z0 M50H#`+Q-&&&%X'@+XZHCV$1-[6$5;P#PU:483N=S=<%FPLDC>RR&Q/'+$`-ZKYW]*W M(&3[=F>`-"L[:.J8D9K^<.L*4B:$/A]KR%DXE+/=#I@808^,3TY[ MQ4JH9Z(WB>SC$T0RW21N`#U,44,X!_P-;$\B!L$!=&V%:!&D%5J59R,Z'8%L3G(E ME`,D9NBX`0.].34%8O,;TW#:K`!*I:"MGQL+38:OP1DQ_(=&CN$SU2>$ M_7>49KH-)_;#,4C7I_3#,-*]A.'\^ MOO-GX70UBJ2RFM_\7I9@#E<=",+$K@Y_'XHIUJ(FE`@7`/::E"526C.?O*Z#'D*$AI3QA#YC.7);.7=(-CZVFB6LP,--^YL)%IU1YG. MZ*$BN"GM`2&M5!LM)2?0@$HUZ3I8/;N^%?MOV^(U8\Q?\V9<7--=@OX3^3;[ M^XH]B\>*&RU\ECI9LM36'1Q"XJGQTEN7Z0/0E!VY]PY=G]RYR^R,I*A2,@,^ M!X'SW?6\?)$EVB9:(>L5@L]76JUD<@/(!;1Y5J,0]-@_8>)V&A/[ZB6F%I!411 M#PCOW&ICJ^0$&E#5%/%ZR?YY[\?[Y&0NZ;(MJ7C:Z!I0X>L0GMMM>7&H()7# M5<8M%[45*S,2B,=\6]"2#(L'@#B+@RQP8EUY[$2,OR"M#[1T`!#/^=;!5\I9 MRR?$@O@5^_!DGIJXMU3OPLT378R(97.Y^DZ&6!&`#8[;+:Y5@X$-,@QM%L_0 M"_(C)$_O27_N%JFZ@;X=W=`$?CN?(YN=DM_[S!-XLEZ9=1DO_Q'=`2;K9.F7 M9IH;#-`M:'7C?2:<`6@1-L6NCL<=5BO[9-/VB"8B/`M)V M3*"Y0(WR&Y>/BEO249#+'PWJ1/VDGX:0$].K$DHE<\RJR"[&^Y1.@\!V$]^" MD-+3I[)E1''>A-1F?%I:?IJCT(G6E=(`(<.H7VTL%1$T+2U1 MH)ZPE63\F&(+5^Q-:MT-FB.ZY3I/UFO"H!3.,>MDS@CD MRV#7-GGR40@92&"L\40FQZQXF;]TH'&YKT'(5>I3U7+".!(=>]-YU[)4IXZ4 MK(G\ZT[/@;=UB+_Y5N2X(7*F.+@+\,J:(1)1)9W,=Z?8ID?!9[I'P9E"PULZ M1I20$:=DE)#"?MX1,QP(#P?"PX'P<"`\'`@/!\+#@?";/A#.\K"7FU^^<\L M%G!>K,K'!_NO>#`HKCR[\_(%A$:HW)$3GOQQOL6%=A7\`R[.,0&5(H*P3D'A`$_J>N]M3PO9QPIDOEO_I M\OSR#,YS`=U"+!1%\W&B[)Y*+7EIL$C2#D+$2$\/TW"1A!%HINQC:(4\\)&] M#:C:'.7M(;Z?8[CSR9D#`%66*.7:)VH(9?LJ4[=$28'79.<9)! MQ.E3OFNB[`%A:9.K5FYZJ-B``(QZVI<%QO6[]QK5D4H;V,(2,PK M7GJ%VN%A`^&S&.9C0(B%5\&X(KO0K!$APQ/L+EQ*$OM1MN.5]X,0$:\S>S58 M[+YD3;;D3[[[").ENQ;,1],!(`2WJTY&4UY;QNXAL/S,C:\9>@F\%]=? M7-.EP0T9%U^L5W<5K:ZMM647BX!5'`-"K+HJ@A78[1W$V]>U&^>-W13+0E8; M`L+EDO8@W.>V=P33DO6"LIY5!H!PRZ,]]/*\MHT=_2!E@7_\CDYX5OV/D9CL MP>Q+O);85Q1.YG=(:)%6&`/"+8G*")JS"\TB_1J$**>$O$;@U,(LX;GT-I=V M;P@7%.I8I]J,0L.7L;HJF-7IY=`GM%H'V,*;^]7:Y9]YE]<6]AQ@P6B_I.;=:`J/I5X44S*R'T!^FN)H"]> M"$VE1Q2&<:1PO,`H_D?Q2$G9$F(:A?D="B6++=NK@N\*3XU*VO9\<*2A3@I! MITP<@JAS!_$?3B\O3L[[STEH0OQ"QEI_@)DM\'>!'9$=7=*D`V7K/L_GM)1K M]S:R@HN6Y9T\X":5\-[O?1ZS&,ETCVYHYNOA7E@L/?L:+BP.%Q;;VQD2T[]D M1]AK!2%3P_C:HI"3`UC'"B[K<(WQ^*XQ\CP$7@)?'^5L'PCI&@WP!(9'#%!TE0_". M@46IM4V\Z791?---<4Z<4C$\ZS94\0-\`CT$Q8>@^!`4'X+B0U`<=E!\>.P- M2%A^>.QM>.SMT"+^PV-OPV-O?3^O]28>>YOB@'IOX6;J671FQ2O\6G$KI*-O M'^+)24>B.69M')X>;.UPJ&,10=-2F$\/-G1&!%?L36K=\/0@V(??AJ<'W]33 M@P#?@QN>'CS.IP=[?A9N>'OP+62WRNZ@'U!Z:]7Q!CC4/\!U94+UUENQ29\+@PSCO;6@E;?6 MD#U`^-T%&-D6$5OT98TA!--+%5$$TSXC$`")GHGKN.S(&(N>G2V+I1OT[_$M M0U,F31XI!_:<8?S@WO;]O6\^%4SN2;ZM(RH*6!ATAA`TKP2L*:/0K,=#>TE" M9C?6F9257Y+H%JH;A-T77@_HSG+Q;Y87T65D]T=Y_I9.1P@WP6J!J,,D-$2G M.+`1-CB$A"S)IAW)ITAW.2I/`--&&T9L/%ZC8-7=V6%**5A M,K]S,0D%1,;5VC20;&14"%=E*D/):P5XNF\EJMP;6:[]L3?*=1-A)X"EBQ%3;4%4` MBM/R2MKWGYRG+^ATXI6PU/+:*9\0LN2\TAX`4O2TU*H4@([2]1J'('^(>7%Y M<7[2_QEMT[`(F>SBS4K+?G()B5#)3:9"L[Y3*C75+'>)J`#/"7-\^O0T M,C4-DJ.9?,FPG8M!%TZ\H5XQ/Y4?S56JG+%E0:"4BR;47E-P!? MS/Y;5X"\+_6)^E)G_3N,_2J%4"0`]$1H?"BS@94](*0$UU#]+,A*/ELXP<>! M30TPY@.P%PFQ9?.H\S;_4>Z\:O>$D"E:$QPC?J&=`CYART$K"_^AGF#%9A#2 M1!N:547F``!CL"7(@AKUANHO);\.Z^+L?#TS^U`KX,"LDUUML=4&%V[][!(. M;U]M+V)9EB6PF0]S`$NR-KSFW!]"W"QM>;69H76`0[;N/,;KB6F,K/!*J'F, M;-OC:C/:T3-*"`)3<#,E4R_LM=<:2"6K8RF?*<1BJ)());@$O4KFKV@5D#5= MFI#4"_&]?'++(!8`)L[XZG["1+O2K,7M('8D6?TD6JA"<(2"5&@;)^ M0;X-D"5(2\?R";8Y-@Y1^/E`ZL^7%^<7<&++]0`1LM9*G2;7MKP;].+:**50 M5;))WAK"=B'4H$P))SGUT)S9="TMBS$)VO470)(2+8X.[>T70QBH@S"0%D1P M8SQ;ES]Y#N0FPJZ_F")*YOXM8KTN$&(W1IB(V3B((`P.",EG,(UM.UI%'MTH MG?$JP*'[)\_(8B&PC6OD`SLE+>HQB"G*W7 M+*/"%[Z0=>L-A((T_RIA`VHHJ*N*U3(F4.FOL]I9Z*+/U0T@;" M!E8#'PE7+5R=8Z4MW._DS=['D>8W_SP^^_QI\ETZ3*H-` MB(#4G$!5V(8VM:XC$@8KA!\H+^H))FP)H?!D`]-,R!L`=+X&[)VO-0I121*V M3@<()24;P$K%8O/K(X_"J:B6K8FZ'2'4DZRY#NJR"FWM4Y!<=OZEU[6_(S$3 MUL2G9.6>W*$>G"DXX^%T<\B3;L!M3B7PY=P=T.R5G.^8`RL="+CU6A5J*;^' M`_XW@N:1]^#.92<_>EV!&[85`/"BD9GIZA01;$5[..>4 MY:CD[@O*60*P$@JI*XT^E_8"$FTN5;]2H(`516@%KES6YL#$C4&=+F6]>UJD_KUR/G=+Y<.#^ M]^U\CFQFFVWMP!EU.%@=!=>/7'\QH?LY=SMD`)L,`,$G-X?=A$-HKIF8]AFB MBFF[GAMG6H9WR&$%UMEMA8@2LLDU-L+=<&0(GGM3"F'(.C1-2:LB4@)CKY:E MK\:L>%[PW?)MF29H]83@PILCK<4:>"0?7.N9ZF7H4A=?\;)=22\()U8-(+C/ M%GCTDNW%7SRDJ?,)WX3?+AO[S@.E1G;SI/IP$,["&L!;FU_PBB`4!IDA@JAL ME[KXEXT"X0&V!F`O8_-`T>:GN_6@3H:`\'!;:S@G/+9VOZR&@R!6V^E9)\'5$]*SS&;=X=Q--JYA--G\&# M0Y;E+-4#-SL"B%?66L`WRV.?#W`]FU7G.CT5/9WU'/9[\LB@F,QCB.XLFPM> M=?"H:-]+7FJ.$,6!HZ@AG)/&4A1R6:@"5@"L;GFRE.=4XJ9`SA+E*B4'`=#) M84T8\D=G'R\O/GV$641)!6_K!$$ZUX'`1G] M`.0NVM<4F[2\>0];M21QQFBKEC,$%)P'YBABY2Y1W@W(!EZF?&5`Y9EJ?E/X M?!M_;WM;7+HY2%M"V"1TU2C=+*3,0-LTA(R5I'B7].DOPUN+F;(9<>#YW2*6 MDF)M5P'&P7?77UQ;:_I+N#'`5SX$!`NB$>#E++8!MWQN\X5RDE*BI[T_YTO=(^KU[LK%3Q,G M6'J@4M8!PKF*MEJEP8,RIJ`9)H+%(K,4B)8257I7I;'@I).VMG)6E`Q0_5"G M+TG;`UE':VE\&:B0TLX:`BZ7G75^>GEQ>0XI\:QM,(7L-[][7M].V!)SNUI[ MP2:SQ,A+R)?V@+!_EFIANF^6( M/T'!REN^(,Q8NO?I/LYJ'\:'NJ(R1XV-#"&IH. M@>\(WX86=E9.<7ORMDG9FT_: MM3R6VYYHD6C::77K%KF.0TCZ8F@9PKLHY&E.R88=)M^5F[UE';J%K8=84YD` M^DM6>UQ:&"T#CXJ&L)LEX<8L->VLF)J6'?+?1_&@_6:A\2QZOCTITLGV&_5A M46YIB*5V':S6@<\3">49$"5]X.2(B5'(O?6K9@6`R;]'F/)T6](62$J"EJKE M'GP1LP,`E">,++KV;/A-*&6E#V%+"&?62KW*/;\EX@``!BP?.?#+$1"T@W#L MIRU_`?T`I)_UPUSGWD].&95(E/2!R;T1 MDB10R^XL*GM`6`GU`%.R`1HE7K\@I?6:NMM?$-4R+;BD72$D0%3`3DC)F6B[&B-V;329S]S%,F2Z\8W* M2;!%B9N!.)0OWX[$Q+9?OWVE6Y]+V'EQ'-8DR?L; MF8-_LML>)W,6(;7\V+01P-+&1T`#V@;K;2<9)]0YG-:G8+IU%9-G?SD9 M6Y-I:RY)4V?J#M@MU)4"*4VP"0+6KQ&3QF3^Y*X0&2\6&"THWRFM]^3*72P0 M?EI:OF#7KHQ]S:]VJR"5PB^=R:+UC5A*:UPNE%\G3`L$OR"<(3+;(#'OA'MX MPU_H5CLJA79:X;M33<@0<_M*M=I?H+PB\_C&#-G(?>'U1#F1DWE^E*QVRWID MOE2J/3U1U:W&58I*@9%5RUJ:&%9Y8\HG@<>F"W)X.BN9X%L+L^CW-/A.20^N MT&/@.4\!W:L]=\X>Y\XS.<7!BQMGG!44L.T/=JM;E6-K;8NA#[79:FUZ.-:@ MAE0;NUMEJ!2F:YCC'A.5DT6270KF.VW%6IKG@H1E-O0H.S:<`IJ/]A(YD4^K+R5(Z9H[M@N-/KC:[-FF&^7<+.\JLY^;&[R,*R)+PV>-HBOSH?!-` MZ=!-(YN-%.:9!A"N30E29DSO-P*2*BU2,I&P`:5$5Q!WKNC8QV]RU3'>J>Y]MM?2_8-1)JVG9CP"A%QUL6YM M[Q::L@3M8.D@'Z5O=3,9'K$?'K$?'K%O0\[Q(VUJ.>?;0,@>+Y-SGF(`+-EG'N`5JS6W^Z-\B6AD6!#7RKI8"AJ1%K0IGXMK3#@IRFFO:`_BGEI' M4U\A!@"@BK1R]OC-9#W?[P/B9EH_Z_J^*```G%UB^,TM);32UB`NJW4$JE0( M`.`LE8%,!(6CJA6LI0\>A.=4?0%K26H@ M5;**!./I>$](A)Q[7_BJ44O?.`BOKMN=4RRHEO?*RM1^L?`?*.2E=M)E/29= ML&6V\9&#\""-=\XV)-5V.7([C"RO79NKA6^`J+O2N/ZT(*BCV>SB8"GA_))T M@?V,Y>_+M/(E$)5E8&U\*G&!T[[XCAA;66\BS&[^<&KC>96+S6_M2%;E7J9A M54<#4=VF'2VJ*A)HFK*E%>$7-PG]%J7E<0KHO]CS;':P\%F$)&:9U=8B21W> MTMJIK7T-1AF>5E2M-9D=I"I^#?P71)@EP,^7GP+*5/9WQNS7(/QO%.[$4$<9 MJWT/1JVA_M2QFM3>C$+&\Y(_G\7_Q-J==JVE$B)@5'$Z+-65B!+0)=J]0STR M?K%T2^/^*>'F[?#S=OAYNUP M\[:KF[?"^.#$1]GKC+]&OH,1_V>X>71?V5+'K&;D2)T[-";C%5\NI0FE;7P$ M0J:Y.C&T#:[;?F1T=[GU+HAPO1N_>B-`2-+0OO&KQU)W(-VR2F^B6PC5$*LP M'(04"6WX*O#7'99'><5>DE1PY%?LA[S-+D/20]YF[73`KK(UAQS-6L(ZFG5N MC\7]H$S+ZE?\'`0K!K86%F4&,\JWS9D8V]1*H.2QZ"2QB&F<[\PXSL=_YY\> MI=_FL;[9XY@,H3[(H;[#*)_11[!O*)\QE,^`4S[C;18SZ*G*18D(```Y>-F# MEWT0^A8_\W[OTXD4<0%-PF5O<=&=]-J:?[]P2MO0(A'XZV7LI[/ M#>YU/>_<]#.)XY-.7=E^';4=Z[`,^1VZ?^"B@8 M;H\V(L:WH\5;T^EWQ$[HD3-^0=A:H#A#TPK1G>5B?GNR/]-8@[3CN_0*2[YO M9T+DK3%XL\*8ON.[SPM0R&]G?N0-/GCSPYB^X=YQ!T)^._,CL28CC`B\R6%& MW!'?I08BX4-*Y(B,$SD^-IC(\6U(Y!@2.89$CB&18TCD`*!!AU[-'%9B!\!J MYD."QY#@<1#Z-B1X#`D>A[Q>#@D>0X+'\2KOD.!Q\,H[)'@,"1X'KL*M)G@T M6SQ<Q,>+!48+*T1*Q01+Y1%6Q@' MXW5:F2&D:/^6Q:=_MZ]K%O$_;VB?\TO'EHK0J MKF/3OHJ95-U_?D@+J2_#-Z*\B:G"O/P^E%?P^>-+V.A>AL>FO/+LD]34GF+7 M[B`/0_WU(2NCM@@/3G.ED5-AP*`-[6V2@B-,Q.A%CD>GQBE_O6JR(1'=*G.W M1SL=B_+H]%D0+NE#HXW)Z%:G81T+-2[,H]-J01BFGW7:D(QNM1K6@5/CPCPX MK:X=L^G!)ZQ+5+<:?Q@WRQL2[1O1_TS8!X[^:Q/5K?X?U$E>7=&"U/_G.9%?//JB4OFM*NM7T[D\-NY;GL:EW8QCI5N%A'9VV)U5(I1>V=P/W+*8Q(=$JYO0;82(*TQH-/YL^YI+2]BXA;I2A;L3(&ST%HRV!HZ@H:X#J+H.PE)FN8]-(VPO*?&,QF0_ M%0)FTO$@+K?71,Y$'D?C"A5,[Z%.QU"GH\4#@JU3DO$,MHY9&P%_C0\>Q.+6 M;?Q>0VI'LP2J>/TM\.@P'F5S9H6-QWU,OCR4^*@EOC>AK3?NB^L@W^E:5_/? M/>*"(NT+[ZCU=.:2/^XP8G%6A!$)N])3\7>'VB0UA`P@@DL-*$(=&1V- MTS-$TX=H>A4SU..#(T7EQ:=/EY\^G76! M")I;D1=V`XF0Q991XKN/U!O+_=JGGZVO4*FH_W/LU##]`"--]\ MQV4AQF>V"*0JMG4#GX*IA4/7=M=4"?W%3DLE@%4>K<^4/M-;FIG/.EQ"`WOOUEM<.#T)&68O M::N@-ARCS_R0RD`;\@@-YGUS006GI&V?C[Y4ADW""S1X])>1Q$"OO>ANQ^GS MC90.EMTMG]`@I_1C;HY;7H9K,@YC$R+FIQBTSQS:2'2@B8'[?'NDLE(TP3@T M+9%L.XE6%W8?LPU:/DJ?#W@TO47+N80&]OYFI5[KI:U[?;NBL9T:[,)=,U`S M7@41#[V(,&UH[%X??*BL`0TQW]]I]!/=28AE\^SNW]UP.4,><_VYXV^:+/VI M>,:<'7[$QA\E'Q@E7X!R5ISA>Y,E^FJ3^T7K2-AHK#Z6@QFS'A1ISIG?(1X$ M5\`J.VVT@I.P* M-",KY3V*`85"U!#*.F:LLC+``%7I MJ0%,+L/CYX^7GRX_]I_$TA980F:;SQB(5^C)_"I@A0BI;X^137O*;YV4=0"Q M.4EU+$W+*..BY3R-1^9O&8M>JQ>$[.ER^6NQ`BU0(9GB!1]#YZ+$5>VAY"&99JF$I9@H>6D+WT7B[9X\%P M^BJ&Z3,7IX7YJN"TQWHXL6DW]IW/*%A@:[UT[7N?W[5GPR9J2JX#$D[FCPB_ MN#8B[#HW#IS(#MD_/^.`D"\67KC\4>;)&N$D^Y,/;7@D]'/Q2"@9B%\HW%$Y MRI`Y^C$E]*\C1BHOJY,0R[NEY/XU'H11/$I('E&:1UNBTX\!*KT3$T0W_`"' M_"&9+=M7F^1'S2([^B/UA*10*.*_)7T@GD49XYES\]3\ M`M@M$H+4%7+R;8!$=K7T+P=&G@T`PB^LO#^(:BB,**FD$09HE>[`*P(@;:C@M@1.A6'1?C2_9LJ8A5C2$$:30%K6(# MFOD_]KQ)N$18:TF1-880A]'`IHP-`'`HS(>RF+=>UQXK!!FP)JD!I&];'6KD M.TWXC7EDO*1**D%=U0'"DED5=15?T-;0U#M5Q[>`Q*NK`K+C`IKXX^C%YR!P M6+PBW7`?`T^6=:[J`"&*7!4B%5_00.-!FBD.YJXLCSS7`D(@N"HL.4:Z.8:; MS!\"?_'@OB!G3`@*R:_(<^[];X_R8S=%%PB16E/AZW$&;E;0N?O=9;:4>$IL M?^[SQF/M^;#E`FQ@?%LV_BL*TXWO:I.$F4TCWA^J1+PS%>0I#:.4B-'5)HUV M@PEA)_1DR-<+6$O[]3'S$F(F.-DV%5%I<5.(P>@29+*34LP4@"4Q_@._===8(EO1RA;0@B%EFK+MMJ:C(OV M#;1K+PCE(=#\[Q!<>&V9[M'>LB1_1:O@,;04I=D++2#XW]K2+%#?LCRIB6$1 M._(L[/X9[Q7(7OJ!%RQ<1JQ<$IUI;[EH4JY*!EV5Y;V'$M^\DE))*OQ<)6$+Q8;=D* M.6A9MK\E*U&)<,7-^BR`8RQ=,0O=+`L&)]2E/?JL.E-UN1A.JUOT4TYJ8'0` M!];%$$,A]B=VT*$=3VLP(CZ5E@99#O4,&N9QIMHY;>,4LZ_8\U:S1R0,5@BS17?O2$BW MD$^507O-MMYA9'DZF=;%]A`#VW70%29<%]D&L+--#&'R'_OH M)7_^9S$3(O,#A(.,4O7B/ER&Z#9>-N$+:SRBU",6MH)@&>I)4,8!-,_7<,M;ONU: M7L;E,O/J+D7W:>.OC+:?&6V_D_?M8'AJZ7V\L?VOR"5140![;I8HI6TO:@C-XY*I7BZ!7,`' M`!P>$781&4_ID`ACY'#ZE*%_90\(YKUU_^AFVQ"8052UMU,M?- M]]AH(S_">T&O]I)5QE:)5-(.@I-C+%<)+S!7E[(XA+I+?[$&'5;$\03=C6.( M(/0SN1J+$@SW)4LRG4V%W](]R;?QN+,DZ]D4`^!O.Q_BZV*27&E39`[F;3%V M"_T+"I>!<^^_(!+RC+49LCSW3^1\I@)2S"#-OA!RLDWQTV0-(IJK?;)Y,N(3 MM4"?T&H=8`MO[E=KR\6)J2)#UG`<"-GA55`V9+/2><3?WK-//UL$T?_X_U!+ M`P04````"`#M=%5$XN;M-&F?``"S=@D`%``<`&-R>2TR,#$S,3(S,5]L86(N M>&UL550)``-NJP=3;JL'4W5X"P`!!"4.```$.0$``.V]:Y/LMI$@^OU&W/^` MZ]T(2Q%U)$NR9VSOS&[T4^[=19T*Q,<$NHKHY8I%EDM7GM'_]Q8,@ MP2)>?"%1+7^8\5%79B(3S$PD$HG$O_RO+[L4O>"B3/+L7W_SW3>_^PW"V2:/ MD^SI7W]S*-]%Y29)?O.__N?_^__\R__W[MV_G]^]1W&^.>QP5J%-@:,*Q^AS M4CVCBR(ORVU28/3XBNZ2%URA^WQ;?8[(7VKZZ`_?_/&;[WY'!D'/5;7_\[?? M?O[\^9N"PI8UZ#>;?/?N73W:>502Z@2/#?O]-]\UOUS4(^?9G]'WWW[_W;?? M_^Z[WZ/O?O?G[__PY]_]`9U]:"`_$%&VB1TT3;)?'LEXB,Q'5O[K;R0&OSP6 MZ3=Y\40P?_?#MP+P-QSRSU_*I`/]^0^B=TE65E&V:;$H M&17>=W_ZTY^^9;\2T#+Y<\GPW^>;J&)?R,H7TD+0_WHGP-[1/[W[[OMW/WSW MS9WB#'PY^IUC__U-V6RVZ>4A M',I(_KA\R*LH'<6JC%GSF]+_>D_XZG",OU0XBW$L>*9$#)K'QF`:RXA2LOFF M0S"EZIL7W3G8%*]$Q.]^^.Y[KH+_C?SA/R]KWW*6Q5=9E52O-]DV+W9,^<\> MRZJ(-I4@PYAG=!S1OFWXHYAG19?)J-@(RN2?%IEKB&\W.3'J??4NY=/*T;=% MOAO"5\U%[H[SG^EC>BQ/1Y@"E_FAV.`AGU#X=3;2R$GFC!$?1Q#I"H*S=Y_N M?_,_!2J*LAAQ9"1A_\NW;)AYQ>E\DIG%.%.*@7X6^/_W6"(7@ZC%8:)LH_*1 MR4.6X*4^^'Z9,/D2/K=NIY=4H@%"/S.P$+X]<>GXAORSM`DF`0+K0(]EI1XT M4'"Z<,2"21\H*&*PDY6BQ)MOGO*7;V.<<'T@_SA6`_*GQKL]$+)'DO1_]OO) M=>S1#WW\F[?/JQY8[_DIC*]O>49&C.FHUVGTI.#[Z'?_7U/)H/B0D_(@OB:\P:.01')R]*AD^-MP.$(@%*SC0FS(')G%< MC"BX;QVX3LI-E/X'CHIK\I?CE=H(":<'&J:/->$(#$07E#SHM8&#(PJ/&`*, M/G"E=-.(#BRT3B@85VN%!`BH%STNK)I1NPNONG%Q*(J.*NN7##VH?\VPL2T4 M0P?G52_,3/34H@;O^`O?2PA//5PG*2XNR+!/>?&J$$P)Y5\9#,P*/5"`>%4! M[?B]KU\G?1@H$K!^/_L%T;XB2F^R&'_Y/UC_X7MP4)]>PW#WXQ\!`7Q^)0>[79[= M5_GFE_OGB$B^/E3TO)@RI/=71B0P9^\@RI'G-V!`+`-6=K1K`L-$#'6%.#*2 ML/WJU%]QFOZ?+/^.HS#,*A00:XGA^E>;V\)@FF^LTCXY/V34P4,JA8+2K$!(`@!+T1M=]>`Z(&*3G M-8?O8^_P/B\JNCA64:7,.9G!P=89(_M'*XP2%F)M,3"B757J?$.#A#B67VWY M*4\/6145?).L5Y,>')1^:!CN*L81$(!&*#G0J4(#S/,/DU5@AD*#]?8ZR:)L MDT3I;5XFAC*M8:C`Q0@.8BG+$PQX<`4+5J;Z.R=K_4Y0>=#5] MCK@PBC](,-D0G!"]&\8`KOK*1I!8'>R&_@.WZ(O8R5Y41)AL91%Q5@B3O^9; M](JCWC9V1MG(.E=4`-(]XJRWF0OY$]T\1<> M4#,W3I@P+F.`4++#<$#S[BZ<>>KI7XN)&E64D)OE%F:-G46NC9"+[$@/!0E/ M,>#&Y@YO,#'QQQ27'W'E%F%:<*"LQT&0KMT8$``LQLJ-0J<:G!4B6.'$HA.E M`0Q(SS:;_$"LN>6F%4`7>!M1@/9=#F)TME\&>/^[,"LS_UM4S+I3FK!'8A`!C"W819$O00WNW M`QLK/.D""PB&K+.!14!.4<^840\+I&.PA_.H\G2=?')'+.[ MYZAH,<8HM/K&.-YB,G)\2V3$Q0N[B'N1E]7Q&94%%N!NN(WQYD*X#A#F%KB9 M&T49?<:.$9X/NRA#54*K&E!2HGU!!B)T$)T1%!/-8-T^.%B<9WE1TDXB-<)C ME/U2LETBX98`U-BL/I_])?D[XX38P^?G9/.,R.27R1,9\!D+&E7._NLBW^VC M[!5M\X*1P6699$\K\N]6H!4;*J8U?LGC@?[E&W1.4'",:=5G&GU>=00JR2XV MR_(*/1)6\\/3,^4*E7D:K\C_9\/*Y,6X=!XB1,@QW M'OC0B2(D#Y171J^,=I1HDFV2/;$G%!%J9/>=$:MY)=*7]*CX&R1_)?;7DL], M65'<750DZ2O-7\4)L9#4`)\&GF'9V*2OV<0FK ME*:]-IZ@%*N&[A&B!%)ZY%!X%46BF/.$`57B7[\_C"`]:;`UZYN+6 MI\//][BH7F_I%I@VNOO;@6^5RYB=7V^'0_`Z;LRI7"-''6% M&#+OJBC0V2$'^)'W#-(QL;#`&W4(KLP8-ZP0MD2+XA]I]V)%(L$`ZS]C;&5< M9(RU@"`98PLWBM9<-.&)'O$V+]C![V%W2%F:,<;[`F\2GI=A^<(=O1/#4[\L M"TCH)(\I1D2!RCPC'GDOE.E`L\M53O\0'S88/>5Y7-9U1\5+LA$!QA9MHGU" MG#G+,_)\)\V\DCA^?R!JCYI6U5ZSB4,GL8%GO4J;3MP,Q7\Z<3SW[`/5&'#K MZ?6AR)+J4-``]CKY0O]5JER&`SS,RFD50%XNM<#>UT@+)SV]:>"9W@B,%83: MSR/"ML:`4_WW]%SN.4_CFQUQG2_LR,VH^R8$&.6WBR!KOQ[:N_K;6.DI3X.` M9`Q0_9\@0R)A!+B7,AF!#2FP_9/6&,P8X>R93`IEV2TM:!NVQ,(H<7BF8:_< M)($6"HLP_5**TLF_4\QNG&;QF12L:R77I6!F(P]6@#SK]!P5*\]"&Z*P>4;& M5470SN0QB(_H>HM5UUT`W65==J+>TWHCYWUV@"NQOC3"C!+8 M*JPIG3#!A[,"ZPL"U/D\P,+5$3+0E&IH2ZYTDO:1:)W3734+#N"-!)L@O4L) M.@28>PEF;C17$T3/A!8-/&\_7ACXY@EY67W`U7,N7T/5B*F!!6J.8&*\TPQ! M!>B_^8&>"T4GF;)"'%B^MPRCVT,8;R%0DC%O3QR__H:RKW**(2+<%J(*J:0M M*=&F[G?`R[$#ZE9PU)FA]3N:21A"()#>!581C2T,M-CPG0PLK#DU-&#_D(C( M"^*\AM9[771Q(6EW@T":,PR5XGV>/;TCP^Q0$6BWAA_S//Z5]*S^$F_P[I%$GS]\MX+L,32(Z?\= M90?:Q7$AEJV>`5(%'&(<1_90E#+70IP2\6%)@=-76M_Q`<<)?9CE$O.BCA(_ MC=VF*ZN';LF(&2L!5]0YR#_ZKP_JLR8*@MI?0"J`CH=71-N;]!#CDEWCJV\+ M\CM]&WY;\[5#=G.2=<2M*W\ZL-LD2RK\+DU>Z.7$>I=-5GT!292% MWUN4DIYRCM-O;8]U>FJ`E?^[29J"!K+GJ8\B1*<,`(9C\?\PJ79`/R M/H^R;N757I)_\% MZ+:JL1P3_GKJ"/8\[@B2Z)&V8$JPXZL=)@2@Z-XJ0B>&UT+[C]0MK/3/?5J$ M<%HH#Y9",)ZVB`'T4;Z-7FF$[]9!^1@8MG>RFG55U^0N)%B_9!4;^D[)>PX- MIR(/-+IUT@\E)(QR&)B6-4,!YETMM#STUTP*B6I0X';!0[D&5^.KW3[-7S&^ MXTV2^`Y68+UR(1FW4`S%G4>Z*[JJ<#\=BIZQ-5GC+,. MXY0U22SGJ?%[^#Q(/80SD*`1!?=_*#V*[>-O#[H?H!PYKXX&>+!=@5F`HXV! M&AAB;V#B1*LYJCTQX!LJHV00C?3@CY?N>$]OMU:LQ\"PQTEJUE7'2%U(L.,C M%1NVDQ;@,Q9GKZB%!CQGJFV'6&88YNYN?;GSZ?T[=(R*:,;'<>DZQ^8H$]N$%8I"_()_2Q M%/IG(>6K9A9&48*QB`E"RR8S@HQWFQK-8__V0TT)2:3(RM$00QUJJV:!>859 M5>837!)Q(^,U!MR3T'\L?B'E]1IY+M*H+)-M@F/GZJ\!=&`C^,$"JX)[9R)@ MJ#F+)O/'-'GBJ>=P-OYN%98:A#"V_PZUEDIH\"2` M8]5E)P\`K?[C9`@B&V#?&P:P_[=L_"%W_,8M]HHAO;>)>9V MQ7K>6.HT30@P.FL7059A/;1WC;:QTM.;^^>HP#7";^L618`ECDV[(2;(3_02 MMT92)238(V(ZIH\>#3L&@W@D3,V#K?$39$>VW2[/K/K0!X/JPZ9FM]N"K0L# MT'U-Q8`B]43!ZLY?7[$*%*(.U&.P%B3?_VGUS]_]L;XJ_#M6E4+^]/M__@/_ MT^_^]#5;MA5,`?,!@B MK.:=`A<2D,\1N/-G?'6@?HA7IH/2I5X;<:L<]"!A?5O_*RII+XST>)^JP%%Y M*%ZMVP\5(-!M*BW+G`-D\8_:W5.3RX%JP.C-?]S6%[+P:!*_64X`%U`'DK(J^W^KJ->QHX*=: M1G$T1UU*',CS+P-#]K,FWLO;E_<9'%*^WUZP[[7MZL?"X M9>0#O;RM\R$#"`"MSH-%[*S:SMC^5_.!K/7/ZFH"-.+E)-XQ&J@E(MJU_'SL6B_B^R3#-Q7>:=^]=D(%>@)[@%B=U[`=\/P_C.W,5/^!:8OZ47S$ M"(2I@U+Z07[T1@/+"PC M,J&%>"6L1,VOTS&VR`CB0X=2CW8;%>OBOJ+\L63N+2Y8_9Q3L94>.82J-9MH M^D(V'29P;9N9+4.Y&\->(8*/\@)Q"HB10(0&8D1@RM-G$K#D`C:53J%8%^.^ M/&NJJYQFH8\4@C7I1-%;T3$&L/6HV;%;#<=#+6((EC)8F-I">O5^85G*#2LF M'#`#`B$<"^F*8+,.#AV$9-#XD M$'-`@RPM'QBAU-78X<9?DT4+)_*21'$,NXP8X%;C$G`9P"&MQ#$ZZ5I'(''6 M:#'"B[!ZHAC#*RUT():@#ZPTH/`68(Q&E&H#'8ITJONX$!IAE9`!E(=VF=;6 MAW(PV`)1F0=+^:10$#C-X&70+#[8V=^IT4+#:(B%>5E+-*#>-<7(AZJC5IFG M2T'?%!#(_8^+Q6Q?JQEA;%ZH-!79E2L]N](-6% M`;@.I6)`<7>(@P%>DK^/4ES6?-"'[`TO3*M!@0J[#&QW2K@4JT$!VY%IV.XU(CN"@VE!IF1"TWRL MJ^%@BCV4;_BXTQ)"0<>9IO@2+*ZTQ),+75$T7GNRL7;UT]7'3UFO,IM-DH3`L$^=6/6>U_=`$!],V[PZN]P7K; M;(CA>MPY,!O8+ECO@@?[[`!C1^"?=KSQ,D4PC3";O@S/['(B]+LE1NM>W^.A`PAJU@4K9DZ6?OIML;NZ<+ M#`)Q$)CHVH''N_7]/?IP=O?CS4<8Y^$ZC[NH>$K`;GC:N>26_V3@U6-BFQ^9 M9T]7]EGC@5\\X0OY`DV3@G-IQ]Q1IA* MR7)W%N^2C+[`3EA\P;5(NG,@1V2@8\%!HG5."9TP_1\:#F"K[T\YU@I%':05 M"TSH75!,51+H/'&*8+3%)2KP)B]BWM#[R4E2[?O9OA:7:5\S(H(V0DT`LSL=BPX4"=>#H)TC\$,"`!G8U9N M%"<_'(^OX`23@PFH`^(5X=(W(U;ODHD%IY]VM<+X8/&6]PI""FT0NK`H2S. MS'[7]-2P`#9H8D2OX$NL'>Z][^?EVN\9Y0==Q*T%YAZ.4WD^E.V!#7.2( M"W=RZ2S8\2&F%1'D/-.1*^71YKL=0T82]@H)?,12'5^]5[T^XLN`I@C(V*<' M@1%O%_P!Q]$VI^W6!"6X&JRQ,MUD2970$YRA[P;I\74?%ZL]M'2;'3/[\^@@ZESD505SE"`7+*DKO,I86`^9:EH4=C9+5VUWT M%=\4?+U"V=R7M-SCL0ER"/Z%0$HY?+>GH,''-5&UBSPCTAR(0&W[@W-,8HWZ M-;^'Z`LN/R193MS9J]BFG65QEPI_6J47[6@WAQXY@&RCX762^ZTYO`P/U.[# MHVR*O0CK!?+(AA&/559T()A4_2G-B&\_1Z2M??0YSK"^!E4+#>D_M,SW;;T' M"F27&CYT&D-T!/K8($2NW2Q^/J[]6>5'7%D/F(]@8"Q0R:AL=QT`[]:F&+WW MW0G,LL<`QOOE3AQ>/:";CQ?K#T#WS"%GT=76I_'HS[*OHB(C04&B?(GK\A]AW&3TC-`<(V7N.AIB8!M6X9),U*+A5=OAPL?WJXN@S#QYAE6632Q_L9)V;#\S52 M+_/+Y"6)<1:W(N%-2O['H9&\`16\J[Q5+$V+>2T>9+]Y"U.6IQ<:[%7KO,A? M:Q+@[S`,%>[?#E%!Z*>O:!.5SRBNT9EU,;,Z+J;IU-M$^WV1O\`YD`F"-_`H MK@%;F>%Z",[LZ8NX)/6S.]%2",CV;L`[&IR,1BOF9^?.ZN[,>6LPJPDD8(:OU MZKP9PY/4O'`,5^OM0_1%,UN.N(`EB*Z"]2H1;8@P!8EN7&GJ^50/`]75S2O: M1Y[NF0@-J+5ONH";CH!UPN6K5'4=QFN:Y5@BBU49,<"2*C8ACG(I.G"(%(J9 M%U7FI/^`%K]5)=O)"IU559$\'JKH,<6HRNGKKXO=!["WF)PF)O0I?/.BV7I[ M$97/UVG^V=:4S8P"U$C+08Q.^RP#O/^F659F!KQ*1RD@1B*(Q^>(,5".;HN< M)M#B\]=/)8YOLJ8'Q-FF2EZ2*K&V`AQ#"*P2;*3(1^5B`ZE`U)2-8E%9CL02 MRENFMW0ZI5XW44,&,%5U%O_7H:YI?LCO,%6#),6=6JN'?!Y-7V8H&%M8-FGK\G/T7-\P`3?(2DSAJD[`;"^3?*:;_ MH$T*=WE1)7]G?]?,M!LJC,D,$4LV`1<\[RKMSE0_F2.ALO9]D80#&##7)4XX MIH$\B>)->J8#!@J2C:QWPF,EI/_`V,!&_P5*"OSND4(C&1RH7^P0UC_FV3OF M9C<&OEU4?%.\,KW][OM::\D?_O.O15+AR_QSMMY>UI?.Y9<^Z$WODMWG>B'+ M05XDO9:48XGXU?)IHE+M'T=A$:N(\\V!KLXJYS*%S7X@L,L/-`C(MZAZQFAS M*&@NA18W)'G<7*G>$&U^(G9%0@+WQS$0[4!"B>X/Q3XO66T(ZP!,(XA8M#_H MH%+BG&)2<_ZZ(CCE'M.``Z?DOP@+4>/D:0<*XC2WZ9]"P:$@[%@4\;"<6K0"J)BP] M8+#^*QI.-">`F0A@HVY>`;:II`]9(!>9)NUS$>V3*DHM><4A!$)9;FPBFM<< M'78`"X^9M?YYSS/Y+Q)2TS9_;1:N+'$=!J5)])BDT!FYOIAW>(.3%QJ'N\<_ M'9Q0%%$AB%GW)(0`U*W'C6M\(R&&$]78I3&P/3J/HH^NAJ=3)M#RGU69++A( MKHPF!))CFDCZJD+`_LY"C*:&M'(C];J;;1AJY.KW[3,'-_0-L6T'=: MQNY"EYB%R]/,R!!A]U$2"^[KG0"1F$7]9RR47HC8/+#&5SMG&D(?;X41!/J6$M-RSS8;E^V^C5QK0T=/CS:8XD.EJ M-SW.D^9&+!3+'2*ZV7)=*`5@N>YL]D^R:E2TY[@K%''41LM7DII+&^93*(Y4 M->F<7)6G)AIZT:1I*L854*HH!EQ,J6=765C)"H(%6?3XBKZBE$F8]C5J7V)K MJ:]02Q^U`X#ULEMF4J1JT[TT-:H*M^#<`V^O.T/MM)%04&[`060'TS=0"<7< MK2PZU4XG@DH8A9I$R`W&,>L3?1^E>+UE$:J]\;L+(HR>NHLDZZ4=R[L>NK*D MV$)P1*YQ]_7#0_P(3<*&J;X;+95X-HK$D"RO5;`\,ED;V*`N%!2FH1,X,XIZU MGH<]#L,<#2M9T,@&:)#$AY"@NGJ]I6&HI3JI#`;E1;,6Y/F3Q M^SQ[(A'2[GT>9>PB64JGXS8J#(G2012@S',H6+JE.0I?9!\\ M8:7S*Z9_V[O."WF_*^UT.UDURW0Y4X&UQH'"JLS2D028?0[B3UW2#6U["X@0 MXB'$]#-*9Z*A'TY,/*-TI!CPH<5\9Y0-\1,[HYP^*9HSRJ\.8FI4QSS!.8KK M)"/!^@RGE49"03D$!Y$=G("!2BB&;V71Z;1R*ZB$=UIY4Y8'NM5<;Z6W`QQ. M631X\&>51H%T1Y5*)-"32@-'ED,L@DTTO]6C?9WKI_5L$30'4C8+9>":=6V2@(#VSKU>-"G#6EW"0$+ MO5VRLWTA/SY#"SZ3`$Z\R"[O#N_KC(G3@N&`")Y>L(BDR2AHL""3"$:6M)DO M=K&)UB8?BMF[/F6CH6_F)N3U' MB@%O\>?+[:G,^11R>],G1 M7]NZ^K))#[3NE?R#]2FY(\',U7:+M2F^V:@#/L#?'P20$>0*(Y1&>\S0FVQ\J6?7J_A:0"1?\42"[8)K7@?2( MD,\$V;@:\%Z03.JWB!,+XN6@ADO.$VVCGF?4SLZ^)+H5P8(#K(8F093JIT*` M4SL]-WV?Q]6HA24:1:`!M>F(^R>(K6_`YP7'0^N.#)E M#R3\S(&`5'4ZGUX?8A4G5$;E5,"!/;JJ9OCHJ=4N$,0#JRH.5.^--E4NP&H[ M*\L^W_Z+V5W;*+V-DO@FJR__&;79@@/U&I^#(-UG]0P(`._C6;E1W!43.(@B MH9L,B;N;L+8P@S#O'(3Q9R5WN"(!$(ZOHB)+LJ?2:!XZ8!B[,+,N&X0:TKLE MF-A0%(!P8"2@@35_(O-?7>)MLDFJKP/0^;/-YK`[L"NK["A?\1JX>95PQP=: M,88*V%D]7)']KR3#.%/UFA3X=66*\O%ZX!7&CY!?T7=I0S#&A[I.S[[54$+" M&)B!:=F4%&#>C4;+0[_3O:B8#&'3,3O;(%MG]IYHN6Y[C-FW6`H4\`VU5@S- MWKH'#[G-UC!CW+ZN$,=:(0EO$4/@3W9>9<8JXA'2G$K)^GX]1%\T8KNA`CYSYRA6[\4["Q[,XW=.3&G>CC,$2$T3 M.D(#JIIALGR;CGSU2Y%?I50^.,MJ;@M)[H&69F@F00\.8T$V]F6KT<%ZMQ0S M(_TW8P3X"G47QXO9:WO<;]2,E*'I#>5D#_11[O9&G\>E3BF/HLX'=5+75,(0=6#C!6Y6R0RE`I`Y<@X M%GL:R_=CG!+BI.JZWQ5BU.HH^]TC)8ADBLVR>YT76ZQNU.C+3F>;C[KZ8"-! M!F?!/$"?PX3-E(*R81>A'8S81"84*[;S.,B,Q2[YA.UXQ(PH#!E^IVIT4_2W M->\N<56WG=`U5A]!)RACM@OLO!ZKB(1BR#8.1ZW&#*2FAQJ"@1GL8,FOI$8K M=8N5X,RT]D+3[=1(*"A#=1#9?=$-V52M+/9M5;.X:7F@)A>*W7+@<$V8(DG6\T33MH50#,^114]#( MQ[NZB3X^["6-X(R9NRJMB/HK6R.I!670KL([QR%Z4J$8M1N?HY(`)KL&ZOO91H&X0+#)9W3L'LPX!<$MA`?X55P'$*.S-NZ-;#DES,6`E MJA#(:'7?D_K%3E.B%+;3 M%#A64-8CLS3#UR$K,JA! M.8JF,"H+)I1A.;&E-2Z.C?("<7Q_2Y3;1GNL?!1OQY+>K-M=T;$YOOLDT?(F M)PLE"_\^)]4S[7U$+Q8&;'XNBYD=.U`#M"YK-M3P3-!I@;/98!#KW$@9I]AA M,,MAL\:?9?$=KNB[ZF/W9D8*842:#D*:0DX#.GCL:>7-(0BE:EP3"6^QG"(I MLS5BH0PK=)L;M*LSDPC9ZMQW>B;\0.UNX.[/8'@+5FS,9'EF63NF![_L2;=' MFALE1`S&)NN"'R6Z$C(W5/#;QU:Q-+>0M7B0MY$M3%EN)4LWL@@^-Z55_5:# MXD*0'Z.:(-U-EE1)E**_':*"C).^\IM9<7-IBPC)#$QYW\E7]G7*Y^O?VFJ% M`NV`DQ_HTQ=/MWF:;.RONYH0P'K<6$0X:FJC@8;H8F-DI;_B'':[J'AE;9^3 MIRS9)IN(%GHV=)`@%$8'Z);'OJ@/^$MU3@;7O:[GB@P4!PX2K1,!.F'ZC_T& ML-772YLR4@*(40!J(C--/&>S@[.UZR@IV#[Q,BDW:5[2^U463VY&@;$K%S%D M:S+!>[UD(M5@!>>)0L*@L)[5TUBZ>U(87T"IK)VYHQ`GFSS/:2RM$+9.B,):@( M3K*AG1+9[_1O]WAS*-@K?D'X8\K7L:19_"$J?L%5])CBEEV;EQY%"4Y%1PI] MK+<#R8`H\R@>E1J^4KRT1S.Q+;V.?H.O#/-*/]"^X8SZ_%`F&2YIXY]'LL[1 M`U?ZTE,2UT^0/A115FYQ4>#8LL2,H@1CU!.$EHUZ!!GO1CV:QYY:_P7O\G+_ MC$D<=[8AVEVRVNH@5J;[S3..#RE>;X6X$H?E^:OT7P_4EG5;],%D@%(_(\7M M)($&TO"?#AK%8#]S4I.A92."D*R_9%5Z?.TJ-",'J,T*>=^3/]Q4>*<[N#:C MP#I9DQ@J;ZJ"!W.;>F;Z?6(5VH5^IEB(H06@4=(BT.Y_;<&Z*W(P2[E!-,OJ MK<`,8<'6LJ7700D[K`3,)/$NHB).\B=,""0=.X,ZC9TDC3J@@O,2-]D+YE?G MRDO\6)$="F\NUFY3+#N`(01@O,5P$66/X8[MW6L,9:VGC#]%Z0O^]_IUZ1!B M^HN\;,7X@*MG^KA]*Z3S\C6"#E25T4B!NR5'`XD`U!^-XE!1C%16+*%4=T#D MI)!$R^O"YU2Z,X_DLJD&%5/:U@H<+_"R[2@3ZSP)CXQ/M#GCAJ)%2()M"=9"" M4"T%1VY*)C"!WW>?4Z:572@7(]H4K\PROON^M@ORA__L.'GE.W9:*+\Z;V&6 M:K@&9!%]CO,-J^Y0M9@W\F%99A=]ODYEA,$RJS6Q)3CVMPBI8_H['*7)WW'\ M(S%N^D#2FB:']GD9I99`>3PYF"5KJOCR2C:6EO<%;AJC/97^@.-HFQ?H0U11 M(PDB'*<[UOY&%9>;(F%7LUUR+X[X<#F700(>YUJ5$AH<]]FE&!TS.BD3?`A:)G-0S4H81WCCI!D M@,'`61Y_3M*4,'1#]H'94_*8XK.RQ'*"WN*9!]*`L:-1@LJ&-8B`=TL; MP5U/804-IIW\]=J6%N+$@G#M3L+:G/U0(@&KK7%!&$8A3,6UN=I&%%&7Z'@>3/3>$\$> MO9M0@E$B2_2NAP]!C>S1>],Y/RBG.TD4R/C\?9X]/>!BQXK8$&/&^XY$P#IO#>0.V4+OIH&V^MT MJ`3AB9VDM!\<#B,2L+Y:CA"'4`A38^V'B2:5E5:%=E&`ZQVYK+1P5EF_R%Q> MYT7;$Z)WBQO`E;H;,.V!3Q3]M^):Q+0E05E= M*(_#1]&Y<',%'Z=A[`TNHLZ[DLJ_4@92K5P#7?/!FC5%]-,ES= M-_';/RAILWG\B=K6"&K"=<$G(XT8;22(![`>+C,K?9<`>%,M*C+Z1J)X,\9F MX09XH+MF-@$ZE\ETP/YOBYDYZ<=-'+Y]6BD`ZQ@J0UTR0D403T?!/C54F_%M M5%2OK/$I69,=^I;8T6!,P54CG.[G@;)6OJ*.U@95$#-=4JM%`O:'QD_\;O8^+^AI MK,7?Z\&!^CU;V._T==;`^N_?;&2D'R-S<'9F_B/.GXIH_YQLT$VVS8M=.-OH M8ZG<';D39ACZY>BX'=#`M<[=?0D%;%##\L_3!=-;%J0YI9B^B?%OXLW5YJTE MB3VKMQY$`\K$1@C:-;8!!`#,;C!W"CWE-%!#!,DO;X6U#A@%M2T%KL@PJCI, M-%E'W3"]*^<0MGI::55&\)5ADGBN1@=G:1^CBJ5CU_OZQ1I=-U`5((P%Z5F6 MK:4/Y=TR="STU(0#TIQ^"QJ`Z@_E?]V^`0-9Y)*5>9K$C&'V;*^V?M(-!:H, MQ2Y&MZY$#P]0*&)CIJ="MT5"O.(^Q24U@PX!N.Y74Z186Z3P^-!O7N#D*;LX M%`7.-MTL;N9RP1Z0`\$3YV`SN/!8XGY?UAX&J?]AWHY/20(=M.M MM%I+ILF?3']%/]?_&T`[N[DG1,*@YGXT/Z`IV4_L6D-9)22^Q+J0[A@(QCK5 MK,HFUX7P;D>JX7NZ0(#HPM6`K0+4?V=!UI(@D*=[+S@[X#N\R9^RQ#V<<\"# M.LES%*A[?F=!`CBU<^)(<5;'\)"$&**5S"@>8.;W.=GOZ;%0%O^%K,R$_A.M MKG(S(%=DH%SO(-$Z25XG3/_9W0%L*:X_<606?PET5@48HFW-(^I91]3GJ'B" M7*;.8B)XE90=6:Z^T&)$'!_]J)F6821@S&Z,F++Q#<'W;H+#F>MIIP35,;\5 M$G30,8@WR[1F^A:0'[(>17F59KVOK^'<$%W/JN0%L[LR7%:MOQI!"6I9'"UT M=XT<3`9@P1S)H_KRL.+NV`IQ:G6'SYI>?94SQ&5UM@FAM?3OSGL3$DY%O5L( M:\4*H[K>(6BUH(!7VKO%;@*K+;@/,3P=)]N,=?C*AB"7R4L2XRRVI.?-H/Y; M@=C8%GU`='`@34#,S%@N9$6;37Y@_8C0GNLT??PDKDFB?7V?Z7\T_T+TXDF! M-WD1$W\;D?\F_Q4?6$H:53GYCRI*,O(3KA7S&Z\=109/1@T.']=.X1[PH"Y* MBI^B](#76ZG8I*P*IK+F2-41%^@`;HA@G<,V%T3_!VON7/4/T0@N8LC48\C% M0`U^B"OC))%50@9@91]P1#TW98?S[WC\[8X/;&VN`BHMSH8,9W5NG)DL3Z+@ MW=BLN9AEY(2LR(K*9]KQD?P/;<_U$J6MR["69KGA`M5H#1&L4ZSE@NB_:LN= M*\6+L>4S2Y:P?TCH(2YFDP4]4P@*9U\?HN(7LE%X3/$]WAR*A%X&-,:*)@08 M2[*+()N/'MJ[S=A8Z3^)V2"@%B-$(YE'LLZ+0JLKP8L\6(*YY`1RU^>%'?%($5 M`C*[.TO3_#/9>F%:FH@N\\-CM3VDS7S,EZ"LGYZ47YYD1X`."4MG5(`$YD"Q MFH2F(QY,@G,0L&U62;=)#3-.B1+G1)DHWA[0^9DMV M>[)=X1LQ:K&?R;*!W\7YYXP0RC>X+''Y/PS$*=$#@6&4RVA'_K5O:_`C.K9X MX+4&]YQ"G3C=AD==P5W7LO(%\)2SVQ95#P[\A+/#1E0'"_=TL^N16PT>8N0\ M4A;8!RR*?(^+ZI56"%2T52W9V.[;S)/-!MS1@9ZQ&"A>YR4+1US_CUD,8DQQ M5XVCKUA92\7;+0L2(=K53/*RT+C!#?)9:3>C&T(@N.>D'0S/'3ND9Z3=E-'\ MA'2(UC>?R&$^(MUL1-8%V>3L\S)*UUOZ5N?[Y`7'G+T;L9%1SX!CO+C$2$"A MYG*3UHE2YQ_&?X"[E`S]>+(9"=&L3ST6W:[3T=ZQX1H_TXQX&DX(8A;95?[> MU#$O]C'/WIWM:,>PORNG<+8,V]EF4QSH+CO?U.>YUQ@[I-<<\?SGU@8))!)K M3D@@6;4!G+FEU`K\%!5-RDPJ+.1EAG0PEB"K1T-;3$^1NHFV*MG)&%%:HL_/ MR>:951WRFG>61"LRK!?QFR:9,7XV+)&1$L#S\)AH MC5N4HP8%>A[>P';G>7@%G/_GX;5,]!2$@89WE#54`DB%3J+')$VJUSN6?L:B MZX'Q'-B&!*3D3J)TU-V(X5_Q'=CI*Y!`0C56T[@B0+N8)N!%&B6[^4+*]R3" M2#O/)]O#20<<_Z&DLR`BC+0B@(20CER-NH*24MHLTFN('P>+TJEL$S'2WRCZ M8UX]TVCSD546T(Q50?QVGI'_?$68:3']03&*WS!R[!0RO*.'TP/8],XL$F38 MR(2P%H0XP$,%D!8!NE&D!A@@E#1RHE6:,LSDSSAQ8'=,_&[H0_3E$U&R@M[F MLU;GFE&@:@KL8G3K"O3P`+4%-F9T5WH)#NH@A6@6(\1K()F$MWG)NE6%8":N M)3KHC$)",$9Q!#!:+WA=L&MF>;?YV2(KVJ&M=-'W= M(>WD$A<)K1!]L:4J7!"`7D:VBM!Y]%@+[?\]8PLK"A_;((08-$V0)XQ;[!_Q MY[,FUW-;Y!GYYP9+E_'=3&0X&:`W/T:*VWD19"`-_^^%C&*P_QH'_HQ:.JA+ M*+S@S8?4@+T(-\\X/J3TP?.H?+Y.\\_WA_T^96Q%:9N\+1]H#M5FKJ.I`?4D MG"9\IR_A.%+^>Q-.X;/?CJ^FQMY$H1?.*<$5DDE*[RC2-X-8)A[:!1*; M:D5?2S,T]6DMY8%9*],EWA=XDS#R]2.\#[DH+Y<+TXTV/1--_P=NLTV$.)"; M3!#DP&XFKOO7EZ/'0QK1OG'RP5XLC8$P[\S+#N?HX1T9*,GCDE^/S,CP?L_= MEIH)V>YERLW+UP\Y4M_J`'>$(--2-VP.(=AIFACQ%`*1410R)+BLVQ+%:S(9 MFT-1D'CM/"J3H2'0+&-`!T8S3I0Z7)IA`,`@:C;NC:%5VS)K)7)>M,I!&DJT MTF(EL\UHB`T'[FR\3MMAMXN*5_;>E:JO7SM19Y4TKP&T^W.8@4]9_LBNH9.) MN,GVAXJ^Y4)$3!.GAX>7&0JXB>`"TZ;L-SCC.'"M"6<7PM#=;^7JGU9('A.Q M05%WU&!9/)H!NG]\)K^3N;S)),_%;O_@%R+\#_*$+["MI-O7HYYT]-K1 M`RYV4N\LXLOOG_.B.OKS@*WFK.-`;C\7F+#^EG3&08"WJ;-+8MR9T)%6BG:0 M=$A$BFR9EG\(0]LSUPX%_ MQ_%-3-]KV2;B1JLXD._&\>0W8OGQP%WS3*-`[YMGG2SUSGF6(0#WSC/R;]P] MWQ+VGZ,2H]LBV6#6=7#C-:IT>2')RZPTQ4&,%*^JU$\/?,69Q.9MD5_3(Q/I MY,3F4P93@:U-&RBLJF#-D018%=L@_IRT=T43[(A1D@_5P(.*>2670H9/672( MDXI?NZX%O\/E(>5](-9[7$2CBZ6MYXJ:9HJ#SA$=:<">&PX25'5.Z$0`_%QP M`)>68QY#']!0]D=O2ESGDST/,H>P.6F:6EX<")>6TH;AZ-#;"3?QU/L$,R[@ M!L"%,6-D+[59K4F`F]_<4JY;*0-)`QQWK2+;$=$Z;[#1.5."M[^!0NM,T9$, MJ%4.XM%BH$<=Q]BY==-I,41CG4EXEMTKBE=ZRL7.:4INRC'>)AF)WQ%OUA90 MA\EV$AJ)G2U9@0%ML5HAU);9`P>T0`TO1DL+V*8&B[.6Q#FGG7/V>2$2XD^P M39&E$A9FQLR*CYW&T#HQ=TK01C58:$W-ERL9R,JN83R:Z[<8K7<:EX\>7]&' MZ+_R@K90*N%WD`O.!;7L(J>W4[MKXXI>C3GL#KQLMFY96C_!PEX*VN^+_`OK M1M7YE3YJSBJ+^09U]I75DA"36:F+6P>DPARP(9-@SL+UTU]65.#$ER-_1CWN MJ&%-))Q*C[668(V)ADSFE2!2MS MT`>+8N9C?D)XLT)\I%#]"<"D=4,8&;MC:7Y'_**MF04(VPC9.G;'`F:9&)63<3,U0[R M'&=D@S;T7&X$16BG,'H2-.T$AI*#;"DPCE=S6X&&IN06:%M`$4%\55/^.D`G M,/N$K#L3LE9-2`B.X&J[Q1O:C*@1^BZJ\-']EV&>8`Q):%F%LR?E8N\]'"$Y!5!`1%E77?@?Z@X'4H%W!*.'57F`0 M*4`',()/H^TW%6A4QS77X,,S^UEG8:V>A;/N+``:.\^J2L%.I\6_U;J=T8', M>:!X'?MUQ/5OL(,8TR;2N\'YT6,5H5CE1%$E,U2W*&^L\+5CDZ\LFW>3$0;) M]I_]=(NS*&4N:YUIB`61[^,)SP])ENP.._YR5O3*+CL2D2ZB?5)%*7\E:VC5 MPVC"T$OYU"G1U$2,I`I9(C&)9?.1`C\RJ&DC1@4)ZJRO6$V?_Q20BUE\=M:] MV:DO_61/1_.T0,7#_7-4X'/Z-B=-0^"L9+L+]M?R[%`]YP6]N?@IBW%Q7Q%A MUGMVY8E(,N22T(RC0%90S#Y9_4J+V88`KLB860ZC;V%4W_$'9N715OP7$DXW M`Z(#'1&Q(1$?$[%!PZGT\#9SZWKFT'EOYA03]PEXXASO1WF?/3))+U&2LCF@ M0>&/111&/2OC[O%X)NY(O%HDFPK'3'P2N1[]Y5.6T)OI5?)"PMR!(>`20T(' MA\M-HSILG'\\P(!R*6%&+@?M,+4CH]FFWA_9Z$@,#^[?0IA5ZNS8W##OULX- M=7AW]V=!;&S5GO^L*&B/-1JTG+^V('5$??8Y*I33]!/Y&VO,0<_@-JQ]+OW3 M&'_HF:4@_"7(9S#X4Z_\0/M;`&%'^6,D\46O3,AP-6^(,:=PW(S!%>(L,C#8I_!TLIY]^H>8V;6/9^@4 M??M4:9=V[A)_[W@JXM?EW9?[/B;W?ANT>Y=R,Y.2$:,(A^EHW:=DB+>T4PW. MY;FR/#9G+*4XV3W6L/,`,TY/>X.ND^851!8X?5I7S[B0^N9=4#,ILB1[DJ48 M<-`TCB#DF=*4*>@?'XVA!GQ2-)YEX\+'R'9:2+:$NS8>SM'/KV8J'`]SYIR/ MUKFY3T=8\9$<,\KR-T]IL\[!#BYSJ4'"B9NF3Y4MAAH_0A#QU%3V[>>B]5;N M:*]WM=NG^2O&M9VUK:H),?ZF0,<=M:_$2_R`.RFPB?TK3IZ>R5[PW=D++J(G MW)F53R5_H/`2$\9W248FZ!D?O2L3D%^30U;:=)3L2?NSV&Z>R[:-N2[P9:U+ MSU^I*HVXE.B-%V@O"3#Q^HN0GA@!OD+I54KKYG`_@8QYOLSOS5-SZ#<-!7$8N(RUO`XA!7F]8\6>!^1]'FJJ`;:+F6'P_DTI]@Y"FH(RCF7%3L4K"%"=`)SS,8=?L$9ZX;) M0BVZYN/B)=E@?L/SMLCCPX:%5[2)-NNC^2$JGI*,=XMJKX'4XP'&!=W;Y_15 M*R;:-3$?P=Q#?D'VEGF:Q.R]>8MGF$(0QCE,GP+9/XRGYMU%3&75]A(N\14U M241GO-%V>M@ODPW(3\P^)=*^X".NQ'R4M%UV[29""`D$6U3.JR]DXY5%Z<6A MK$@D4[![\'GVQ-KL\7OLYZ\_XORIB/;/R28B=HJCH8GI^0>$#BR6FD+=DY+S MC@;ZNN02HA@CF(Y7$F.B9E#>K((,6W?*%.TQ260CCXW8X`%F0WS/J,*WM13) M1$*_4MG.S+\=HH+,1_IZG601\?-1*C_N-\R%#:(%[9U&"*YV/`,(`?J4P5P: MW45##37D@GS#==)_5, M]-1+Y)=8G-IDGGZF&/!*0@-,P=-EOHN2XRI!!WA0==$+H-"9/C"4XN@XT6O/ M64=[.`Y0Y#):ALA%AM$%S>=)_F-ZP&<;0KW,B]=ZV`]X]XB+(U$3;T,\?S6P0\4@0$(8.Q>M?/MQAMJNO'DHA` MV_2^1.7FD$9%_6C'`]X\9WF:/R6X_`MQ%_L$$V:T)CR2CG_3GB2P,/E11$!< MP01.>VHI:*$>,2130RTY&-_QEF4V^II`!?<72_,=)AG%L-,Z@H&)F96,RG%R M!\![;*P8O:<@?(]-@<"W4..S$:V@64QK%C]&.VS,DRNYI[OVM?)'E MKHS(_QW*6_)_VNC8A@!PX=9)A.9"K1$:YL*L`TM]R^K>9:>MVE:LL<^*]7^` M"5>G2X(H&J)XB"("1J!S?Q7FO$Q?QF/%'_51AKA2^AVH'N^8P4YYG?C1?[5< M=^1^\1O]'3R$9%PH_;<2`O`+]SVTXF>8KVRT\OH[@[BFP5Q.B!CFT<>Z];U1 M(X]@8'12R:BLE1T`[WJI&+WWS<4S`["Z.0>G'O4S^F+7SRX,D'ZJ&.WHIPS@ M7S_[H_>_.H>!UL\9.`TH):3;:+Y/,GQ3X9TNS)N#<*#I'NRZCTH_ZEU M#0O]!%8+J'OYV(_C'\4Q!G^K6?DH0-_('WOM1^L>/+=%LN$M$G9U$\%;3*8V MJTQ>9:$!`1>,1:>PMY`L,AK,`K.@*/,O/"NI]10=N^Z-PN[?T^%95V+*`."Y M@<\)O;J_O5VA/8>AG:7(?,1)N4;OT>X7B;(7!%B+@AI!P+QF3XFB?^(/B?5 MWMM.7[GRC`K>E-[U)MO0N^#X)FLN M@%Y$Y?-E\I+$.(MOFZ!2,4<#_GC`CBW09RU],[@8^(UOVMN?*[ M(23(EH'3D+<2?CW3;,+=9-)]9DH"73;"M53\>Q7/7P\P*9NF^6?Z*,YU7ESF MA\=J>TC/-FQ'6M[A#4Y>##>R79&!DK>#1.LD=)TP_2=Y![#53Z,*9-:+5J`C M@8]:`D#YX/F$BX5P48T_VR)\B;>X*$@<0:8`%R]M;]J_%DF%+_//JI7`!LM0>8>JPH1OMN&:QB[IA;9P)X6C'3;!ZCLC. M8[\O\B_)CH:8A%Y2H`Q7A%24)G]GC4U>:)MYO\O]Z"D6B$C&K/M7,UQ$D?TO M[Z,%8K^_BPD`^W*&#PNWI-]D+T21\^)5YY1,@#!+M9YE>5GN0WE?@G4L*`+` M&A"U*@/51M&9Z995JMR)0`/M8D'\<<4:OU?TF<:_'9(]70P^E9@L\.^3K2XT M=<($ZVSA*M11CPL;&D2W"S>>5#TC&.:*W2*J^/.C`GN%.#ZB!,!Z8(R4[*JL MV.H=HP,7(DU>0-\:..SW*-"9]Q5%!`U2@$ZWE!/HS9)1%!,=E M=4M8TZZ[,@A49-5GLQM3M;\#1%/'@ROB*`Z"*`R,_@[@$E(=Z4,7#]$77%(^ M/V*=0U^-L(@F<*N:"M>**T=QG1%(>'T]Q*3 M+?0F425YU"`P.JMB4]96^7?O>MH?7)&0:4%@]'(@D_`EO_1M1_:T(^_/33MV M)]%CDB950IO=1.6AP/$ZN\,T@T@"%`+P,<\*\9_T3:+2U-9V1OHP-C'[!,D& M-1MQ[]8X,^<]*Y'>'*VIU:\(-A39IEJF"=^[MIF4\]?FGW])<$'4[?GU/7XA M6JN_"^^*#&P&3J(I==R(":?`#FP9M'.%&B3P^_B-'++%](4S]FH:2`-8&8<( MJM1)%P)PJNG.G:O_E-]REA07M,'1S.+:Q0*PR)ML?ZA*YE:^,][_-F(`6YM> M"*5M]<'A+$G'BTF1.`[B2,`7R8<+PD"0GF]8(_AAL!'\$)X1_##,"'X(R`A^ M&&,$/P1H!&9!N!'H^3ZM??9[2YN%F<_1&DGSKQ,RDV:4Z$T,S\`'\9R M!@LH6X4SLG>-'\B9^HB5:B;[AT1B)6^&6C(P:]LL4N(6$_*5Y[(JDDV%8UJ9 M559L.W=6-:)H)L".!O5BLYLXW7>9S3@`KR^[,*1X8UF@(0EOA:)*,AV@KH23 M)2KI*L56,\#[*6QU=5^##/!`MU!L`G0NGNB`_=\U,7/2+Z:O7^7UN&#D592: M#&"H"`^4((H85@#;("G7]]>D>OZ4Y8^LQ/PQK7=WW=?1R[NC"):'HJ^F%66A ML<))><\V<;;4^.2!@DBASR2%<;LD#<4;;=M")(Z3*),;%#8DF-7'311Y&3%C M>%\/7-CI9X];)"^A7]89/4M16'E M%[*1RX_=7#S3?]YD_'XK;4^G1&FMDE`==;=5,\\ MF`K0S<%QPG9N$`XCX?\FX1C^^EWB:BI49Z7DL/;0"+[(F!ZF$JLM<)Q4U]&& MV:BAK%@/#K65,+/?W42H80&V#R9&%&4G&?%W]>.1P$7!*M8Y?\8Z8#M:..JC M$L>F1C).$.K49TBQ'\TP6I/(C2$B@8EJ=8.MXITB4]Z3:643:G23JQ^O^%!G M3P5F`9'V`5(MI/]V5A:F10\K#1A(XRHC+_U@$ET)%6@08%X6#9UO8^>G@

64LBA1*!K2X:(JJXT<:$`6'?BSIZI9D,?EC,"@50:*FM3 M+G@'OB'E+`T*M';JQ;!6/=7P850\=9CII\:+**9GL/=-8=!*VA*N4(T-E>T9 M(=']! M\5DP-F*18K8*=&5VZVA](RM>;PEL>:4]H5D%EB*3,):0_]S8-)%%ZFP<%9#, MVA16K?>&6*Q3&.,?WBK^D1+UVZA]?L'E#`+![IT`TK^U)%EK=UZBZS^U-Z_P M6D'\>)ZFB_`']A*HJHI_)IJ!^R/31(QR32J"X7LI/=>S."S<-*VN7YY]\?_* MQ*+S,="/M4V\.?TE+_+IJEB7G!,W^2!*C]@SRN>O%VE4.I89*3"@2XJT0JC+ MAWK@@*5"&EZ,94$,ASZER;#@"X`8&[4HMG,P#2Q0@P(3XYUF!"I`_XT']%ST MO3!3C499PCB'$O6A9QOB8\ND?@RT?I1OO?TIIQ6:HKDWARJTV8^QQ&#+W\>) MKJIF'T8)K#A]#)OZ6G.)FOQB)55T3A$U))&@"5T-/Q%_[+1_R6A8Q`;C\L="?!=C1@-X-ZGS)ZK&=9CJ<2#^;ZY(2IL=R.'$$YA,N/H]EVO-LH]QNL M!^#&TQEB):XTMJ/`K)2+SA"[?KE,(W\IT$Q-.DVU"\R9UV\K:&?Z8 MY_'G)$V[;2P)S&&'#:\\+39:,,YFSLFS>)\YA@K!'F3`A[3\3B3O/K$G4CQ')4;[(MD`M4\+3^[0&V_W2=XTB#!N.89IFIZMPS=""$XXLGLS]O[@HU%HR8QVJI]N>?I M.1BO._^L?8B^)+L#V6LV+3^VA^I0X&[,B/8\PQ-`3TC>*XRV,&(Q<519.SNJ M,()X'T(EA.%]"!D<^GV(/B_V]R%62&`ABA;$\Q`.EE`M=H422'012Q#",!$+,-%E",6=VSO$\7,E9HF"/T!2YF'K MTG%[.X&E!PUF8[7`5,YPJN0X8@@;N-G%<:VY%$<&M_3(`)VES`1Y^I.W_D#B M;1J_S1>6.EB:-HG-'(1SSWS6>>"?G$,2*CAA;RQX<6_:H=^`D[-,ZV*N3C/N M:3L\HU#SNSUIB#?@Z(9-GD'VTW1PM+-51OA\]3#7TEBG[\)Z$[>4SVH&.FDG M=23%_%ZI&>#T?9)MKL3OH;TE,T'@BLB7-,#KZAD7#\]1)HI_O$RZE8>WX+0< M)WHY9V9AX,2=G)-TTYW?V2XOJN3O]1.'8M#:%[X%!SAN'J6I@'YV=<[IN,1; M3$^J'J(O'/ICSL^NM,UMO8U^^B[187*7[F$*' M0U\U+RE]?7IUWC/-:#-!]*`AJF/D;*&Y&/=REL?9($J`XOZ,O(WEH9/"8$NE M[[Q)/>CI+P;ZJ?22D60CGK3KUXDS0\C;O>-S^C[=>:K8;V_*8TE_\3#1G=%. MWTY(<:$7 MG/6:G`["#*:3EDXH2]NL8[00>F2I>7(UR")'#!G5V+!AP'"Q^+74@L,$L)JK M)"";);ZK-KQO,0`_/"-2"NAJ2AWDH`Q*P=E@LZ(;Y3JE`OD0QE0QJ1B\T#(H M$Q,B7$5%EF1/Y2TN[I^C`M.^X!OWJ;"0"<;@G,2U=7XTT0C!_!P8'&R%@A9M M`(D8M17K';\)QAK'2$WEVS+YZAKH/9&._&.79ZBDR.\>53(&:;&727K0OULS MAE#P5GLD\DB[K:F$;+D=%F>QW9IB\-9KEMQNO[%:3HBV[_2FUP=?RVXUN M_=]-J-"-X.UBJ3O"Z_$`6\/;F#+VB*?([W8,&TGH\,WB6_EH]7SU>BQA_Z\8 M?XQV^.Q+[UFH>4A"Z^SX:5#K\G!Z@#H^EMG^#3*&@C[(&H_)VD+1T,\4$5#G M=?)$@9/>UV:P M_\YA:2'XYAOT,T=81F=5UC>*YQJ6LKPLQ\:F"@M-=3!1__O$_&*/.SIT).4F MWH`=0(,;VB[@B+%Q.P%*9,*30.I'%Q7<)U)X%O=9US5WQ'PD165^UP7R5.212G]4>.`'?"`'EQQ M%:CS[(H-R?_C*VX<.=I6N4("EZUW,'NQL3(9S.=E[#NAKAT'Y1?)^%YR_3DC M@CXG>X7#&$H@B!Z"#B(:F@4:L$/I"FAET:F9&SVOD)Z8JY^5RP4E\"Y_$Z24 MV_E)#^FMMZA.[#24@NC9-US2JZ./);[E;)[C?1YE4O^'._R2IR])]G1!O%92 MT9U$W=S[(MI'&\*+0M(1-/S[C]&""A2R$4C\H:+G#*1=[7(&XW("[J>JR_[A/<7 MO.RWZ!]'(D3'HQ;3W>]T\0-U.RHFQ]MA2PU=+M4?<[S3.3U9)[J<`0([>!S< M"AR/;!4ZTN&(1YL5+X*,(1"BLU&)Z.YJ9.Q`'4V?Q?&:F-2TEFO".][)G):< M$QV,-V''.Q=">[WE'%^30(FV8:`LU6FBI@O[1URMM]=8>4`R@@:`BQDK:.-E MAA*`<33CN%3<&\SX2ZIBM"&$$* M45I((L:?4F`7;P@T)0C@=^:2V?HMX6*0.=`H?HF( MEHPJO5XJE+V".+94X'Y/_H%RD9(_TNRA6FQ\&K`0)97(R_]LI<&&C7@ MFN+?11?)Q;B>4U^5Q<<6V"!TME]J;`0,16^-%;EJ'5BRLGB`[@;&N3%66Y3] M\65Q41$G^351FK(=4%L4;80&*'6S,]\4M>E!8D![0KI,3YN%?3M02"Z=UH$='2 MCE&#'4*'12-KCJ^FRYH;YJOIPZ2TOR1=U%)6N5QN"F>4[_%3E"J.UA2_PYA4 MCT'98IH?O1O$T,NW:[HU-. M(P:,NCH((2NP`=R[2EMYT47B)6WU@[A&24@PBC]<"FE;O:^W%L0[2QOOH$*F MT>UZ;XN<1('5ZRT1OJK?:]WO],>8GL8.)E!;;F*7:KFM'3B$\'`IJ1PCRW9X M)(]__#0`B](4_;E9ES;&!OD7963%(!M>@HE/O4VS@&?S@'7S$$[K+,<&;F9D MZ"8.+J(-:7P%WL;-SI:Q?8.J]=#D5F[*?/@''$W,A+3Q=J:/"SJ+"Y-F;8%V-]J.LO\>:;I_SEVQ@GW.N3?QP[>_(GOI.] M(DM;]:JH*E)"^+4\`Y/4XA0_>W/`VK$U^0`.-E.+0-\J_^;UH_8'[E^#KK\E2/7)/#Q.7;U-S?;Z(&#KM;;%WO'OD"NTK=N;6"G@ M6NH-9Q1^&9YE5L=78MV=1T5LLI(>!$#%E9K)ILJJ^S-,996*AWXISS=WWR`* M"-EWTI%5=,>?58V[B\%@F<1(5K^M"U9/VO:W+I#L^4(9BJ("=)(4K MLO\\Q3#.^JF*!A\1GZWID[Q(JTG>D:YI4/BQB_X.DJ*GV@;OO6V_>-'K#M#=$&$6<'<19*7+CN6]S7+ ME:6>]K4P*T11$<-=T=O%,*=;HR5AH/1X0.R6X@9IQE[.].TB9M[KMKZ26_!] MGAZ_[N6&`M&IV4V,MC&S&1ZH#[,+4XINJ?SY*>9>%46R)4'UW6-YBB!\)900 MZ];)B*)"]$\>)EOD M&XSC\IJ8S7W4'ELJA!Z"#'!G9K!HS84:9TR8VS8#V>M7,]0$4-100/N:!*(3 MB,HHE5J_^O4+\XG74D""!*(T$"72]GP%N.@S541)LKTH0ZR>HXJXCD-*7`6N MVQK-V.?@;$]4Y$NRBRHLF%UOKY.BK!32<)X<7,@L5/W[EADG0SB=&4B">*/9 M^.XK>4NY=4^T/0XECO8J)U97L(+[,#^3TC@UV@^)38K2]=63$H3G\S,Q$>_Y MHO:(7#NL2@1X%4!:"USO`AA1@"X#.(C1N0U@@/=_'<#*C*I&5(J@_%P(>,'% M8VZY$C!5DO3HLLQL$<6/49*MLY:=RP-^R"^3VI*Z2&Z3V[+\^(#IM=7XH8H\?HU M542`HYHN]?&4L-^@8!'YUYE8CX[29)82:=+RB]VF7]@L\MF3MDYZI>B$;@L+3<4.ELU`__ M[1']B#"_AFL[)EHQ`M)R=?=$"WA8FFZLKS8J"D1#Q1,3PQC(^9-E6JO%:/.0 ME.4!E^8>BSTPH.:*&G8[716/8.#:*2H943?QBS:HA@7LGQ@@O_:&B?,R/=J8 M?HK*S2&-"ILU:>#\FY.186%/2B`0@S)PHBCYX;"P)A4NQT:C6H3M^2/,]YHJ M>5>D@.+,GBC64//]HD7PHZ/-]Y8*>&-T\UY?^`X3="XEC;^#,GJK(".T7^^B MSQ\B8O5)E.I.R#2P,$=C1L;E,S$EH/?#,`,7/:UI8%>(0*,&'*:J=@CGE-V= M@&&-7LK#?I\FD%WA&O[_FA>_W&3L8*ZTJO@1,+".*UE7*GD'$D[+%6R8U)R" MTR.'&@%8T5V8IS#ODNS=7LTQ@'I?)UE2/N/XQSR/K>I]!`RLWDK6E>K=@813 M;P4;)O46X(C!0U4Q#.*^8?E)Q3)$EZZ;+,9;PE6%W],2I!L2?&9/2=.KS*U; MEQL1Z*Y=0T15=^]RH0#8QCJ.>O'Z+_ MRHN+-"I59WZCJ4!Y]%'"=EW](!(`:\`(_A2+0Z.YJ49S'U\1(X48K9E:*BVF MQZW4'Z,=5I[M3:(4I#Z;A!Z@TRHRH>FUGD>#;B.=5Y85F](#.H1;4G:=7:_< MA?=GW.OJ&1<]L57G$TX8,,;J((1LE`9P[\9GY:5_ZY%BJ.(=D$,!?W+XLXF' M(HKQ+BI^,1M"'PQ&^W7LRBI_#.-=S]4,J%Y!J<&`]7D^?H,)U.0`57=`-HU4 MD*&:4>R1^X]EC]AFVH38CJ@<=B*AG%099;[ZLDD/M`D`S6I]3M*14Z<@$Z0^ M:\4=H,L]&J'IL8;!$3H,EW.=64#$!4Q:`2.E@!`96B&$6RKV"!HZYZID7IU< M[8`"9E$5?!C3I0(>/BEZ7T45NS(D'B2YQT_L-J4A!6K!`=(?%T$Z6F1"\*]+ M=F[TS^4(6/#49,V(,>EX!`.D+2I&.]HA`_C7AO[HBK?.GO@C#J`)NP&<+E`4 M_P''R29*+_%+LL'"9$Q]XO70("WC;-UH%"-Y,W\J+J?4PQ4HZ!&>X': MRY\"^[:N\PO+X&_9$.&0+0NB@(-9/K0,RTM(#\C[,J+AH'_WO@E'@\@O"';$ MHW>7AX)LS&YQD>3'S3G=4&"5Q"2&2E]4\&"JHV=&JT6K]DE&CH4X&DR`,D$0 MWC'F+WB7E_MG7.`PGOF^GES",H@"C.V,$%(VI0'HWBUK,&_*BD!#H55@Y2H& M>0>4J@RF$IS>NI:H#"01DOX.*,^X/JFRE#EEUMGMS.4HZK:G]2+X@#?/69[F M3Z_:S;(>%*!!J87MINNH!@ZFE:B1F7['1Q$SM?`PF^/0^39WY%R.>8\M,Z.* MILN,Q2Y',$!-,56,=KI@R@#^VU[V1^]WA^0PP-4MZ1XO:W/(>3`'FUO=( M-E4M"1M"B."@#BG$:;$?*#5$R,&L6F]68'/?(ABIWYFD]K=.7AS**M_AXCUA MWKQ:*B%AUDP#T_+*J0#SOGYJ>>@W[*DA$0,%7DQ'LTW5^PZGS*>6S\D^A!K2 MCT2C\MT>5^T3=&95-R'`:+Q=!%GQ]=#>]=_&2D^?6H3V,4-H:Q@CQ+N+8RGF MCSK9=0-37D47:;HB^H\NAXDD(DHW+)`H<@AKFOLDECP?2*QXXF(9(\(99(-? M]`S\_UCDVI8Q=K3@#@4ZXCB>`C"'M+WR597`NZ&&IK1],5R,YP6+R#C.69JL`%Q`HA2".ULS"K; MV2XOJN3OO!>?NDC$GQW)S-"^*%U_H!'>A@1C.VZBR%9CQO!N+R[L#+:4CK9= M?=GCK%S&9!Q6GE$"=@3`:@%"6'=*F=%ZHC_B+]7#9YR^X`]Y5CV/".&SY4AP(KS7:%_@-'!5IG8`:\B,0J`U\A8G^_/Q4S MIY_EX7,^RZ0UM$[!J(\$'V_+-:'`3;C#Y0C+);BG8;EF0;4&^X>3,E@R_/`M MHH7:R1BM+/Q$LZ6D3L%P6S['F"[%/B'C-0BK-=]_.B7SO283/=MT<6*G8KRR MZ--LEU(Z`=-MV1QAN13Y=`S7(*K6;O_YI.R6P,XW6XS8R=BM)/I$NR6PIV"W M#9MC[)8@GY#=ZD75VNT?@[3;C[@:/BL,*3@[E$1QM#>"$9)=->P,3OL2S&4. M1O(J2D>:CEZ:!TH5L-5F].6BP'%2L=/-;5Y\CHK8U$7*A`#4?M,J0J<1IQ;: M?TM."RM]78F^((Z!9!3XIE)*2=Y;FCO8D`+2IIXH5HUZ#]8#PH4==\UZ'T)_ MB*OM%F\JXE=O:&DC)LS>116^P_1S)FG"PHNSZAK'N(A2VECK0-]:Z0!K)FL6 MRC"*.N.DR-H\`UGO*C\;SSV[:"@C#HVHH5!XU*6^0E&%Z@%0,\(Q$E1,O]S\ M")'+1N2$BUP1D0N%R/ZO89&[C)7M/FSN^-))$RTCB M[CC&2_)37X@214]1DI45BL4'I%X"NHEN3\;W2?1(O&*58$-"P(H5B']0"V/T M#5T4>+^@XL?-)RR6";"52(Z3@?RB,`V87,8X"5@R`V5*.4(R\?6>1"U5DCV] MS\M2WO"4K"WO61:_)]PXSXTSN4"4MDW,J6`+%V9#2GO<(F)`3V[3IJ-2B!V M[2:LT9S-)."MV(4_-^/5I+S(+X):(!8[2F3Q,_,_,7[!:;YG]WKI>KSA8I^6 MS;*[BM/FK"81M+5VQ!QAJ@P_5#N5F)MJI(Q4T!9J$I9?O&UM<;9;]B),?[W. MBT]$)XN*;+D)?[#6X>M\EXH>/+:ZXKK?=T=QM@XRUNAF@C, M:CM1Q$\:.RSP)B]B$FY$)?EW?-BP9'65AY6YL@I/N_U,,TN90J"6V1=RD'&V MZ.'9YS%O8TVTI1.HE5H%M1HJLJUU,F3T'TX=30Y@#=4)_*J>&V4 M54]\16E^S9\C:"XTT/GL)LS"B+F`C'-) M+IJV8D'U&'82IMMOV(@"T'O8@1]%0U\>#(HZ1!H5UXCHJQKU:ZBNQ!,$6@F) MP`VDA]B'%@G4/"RB**Q# M@P%E'$9VM+8A77CQ9!JV0M91XMRTEUB:6^N:0Q#_=3)U9#C,6%R186MCW$13 M5<68,<'J85S8TE?"B%V-?ZMR+8&9)%\`FQS!2B>\'&=9;B1@[6N(F"HK<\$' MLS5WYO06=[P1"M?R9I`6?%_4>!$>?XYB.;!E6-'J MO5.X=C5)O@"V4H*5<<84J!6-,)_0[&:DP2@,I<:$O1Q;RR]#'%M30/1925$2LVO[WR\>N9`>-5D?FG@3[**@E;23)N M5#*"1TWJ?`36-?\;3"6HR,IS:OW;3J"1QT"1N5QM MOS-:I,(`U.9I2>RZ-HOX:B^+\.9;4#/?X=$&/I!>8Q9)NCJ M;P=Z9VTC09^$Q_B`H[0D[O&*WDFGE_!V^ANET\D&[R>,TS'212AIANP=#`S/ MX!@8=18\=.@'[Q*&S,K1)A[+*"(M&=Y._O@$E*97+Y/M%M/RMV3H_L!.+2AO MX"J\@Q.PD0K%]MWX'&+RBE-^UC-=IAJ4H8^<`B&GG`,(SIPO17.+\M\.49IL M$QS?%GG]MS/:%IXU=1TV8*&.MJWHD8-$HH%\>"\PH-H66?KA3H`/RA;UPOHF.#K(H=BP3K. M!J?R.)&EFIU.-DMG.;6-3LUC!V5T.N$<3.X8-12# M4_,UQ-QXKT^)1%"AKZ-\RG:K@#V"/^)JO>V_1G+V6%8%68`MU8ON9`+I%>PH MKK%?L(4&?,]@)P:=7_Z@Y["*1X'0SX)>[T$[/W8XM]A5TZ;PSP'9)_F'^%N= M.*,+=?&":>[L;+,I#C2-)F0E&^G+_/!8;0\I^2T_Z-?%)08*Q,9GFS);U_!I MH\#[B9E$<.]`WOS09*_%@"SJ%$.N)"]#FS6*89$8-Q"'L]3\=:5_C&@\_AC4 MNS].DHL_S3J=+=%3\C;'4S'=LX@_G8@7Z;*[@,<0?SXEU^`Z*?N"`49MU2H3 M/LE>R$:#%N%_+NA#[G'^N=_>'=!)W!#^S)MS,TH@!JX0PVB^$CR\',HE.ER0,.X+>BC7]7K+>&_HD?@A->]H5!D"(%` MC,8JHM&$M-CP!F5AS?DS0EW-]D M%6&65H_PGUQGP4@B$%MS$--H;09\>'NS,N=F<8(,,[664/U[("8W7%9)$N@7 M-D;NCNG_XEAZ%'?>S;>"?"!6.W%Z9LA-]6C#6_LDQI?(0_&AD#16(+YBWID2 M\K4HLH#7O5HF!,-:@N&8X+`I M&!CP:J@%8:A#6)T2U';N"=+`5I`.QZ0G3<5]E6]^">2.8#\<&/+,>E@/JKL_ MG1[((^F#GT,/Z=%SZ_/F`2GU1SRD(C`8A9;8ME7VP2MSP\34"CW8QI8.\O`' MON-^`5X0&B]E3=RK895(X%9@$$5C#PH,2,O0LF.V$0EMA7XLZ'X[H*K5$4)5 MTHN^!"V,0E5)CML"[Z-$1',.VQ<3;DAFHQ',;CU'B($8D9*K`;94XXNM!MA= MQ"G2"1F2"N^"6W$,1X'#C[+'T@W)`$=,B-TX!Q`-Q'`' MU'"LT5#!P[^E,;"6HK^O6E+]'P:_I6$71Y%ZD/95<-;Q*2OP)G_*DK\SD[:< M`VFA86S"PKQL#AI0[Y9@Y*.G-3(T,X1%#U3VN$CR^"HS^O]A`A!BM(;B,4H7 M2Q!RKN^KJ*CFX_LLN$#H&8$1#^5>'L7\4$8 M5C,,3#YTT2EJYZ'`*0TE4)6C33T'KS@JV,*_U\T`N%.YQ*I9N"72%U-=RD#2 M03F44=/BX$X&T0W%F8Q@>H@K:<@?NQ(V@@='XKX57G""VEF0',F>S<`)N)%F M7W2+LRAEYTTLAX;)AZCJTN_![MF!8E!.8\@DN(4>5G*AN`AW7@<&&:)35T-7 M7*]BE,7MB>`V1Q/FH]Y`G0>[@9H@6[O)TH@W^EV_,;R*V.WR4!"6N*<^FHIY M2?M_\6_N:1'/_\U%%^0MP'F9G]>AB7$0'ZB.?KP^%/B/Z3'O*SW,47V[CE;= M)4)T.@][01;4;TKA;LJSYRS4_0\2IAIVBXN/=AK>=>#D37&XCD.=C`\>),^\ M?D?>HS:[,[X_I<-[2'/-Z:U_G1-IW^;#S.>)[/S?)QE>;_FUM^N(-B6N7A^B MQQ1K=@\&>)A=NU4`>4^N!?:^X[9PTK_S2^!IX%!?4!0HZ&>&U*M)]J=`71'. MOB2Z?+(*$$9E]"S+NM*'\JXD.A9TUU9;K:"PP2C%9;Z+DN-PP0P:@F)TV=:K M!H<#5@Z9";MZ<&B@FPP+,#YZH_0QS\Y(0!OC^`/>/?9J*-4@_K.DCC82FX6`FX?1-N`-P^4# M@EI$,`P:36$.+GV6*S]6-UE9%4PU#'&Q"A"J-%G'/>4'?:=7&!3T(_Y&!ADD1&QS]#!(=*'GHYW]NSM=W_!%?D!#!D4L*Y8%+ M8YPPVX3"9F'IWV[H%>,!&40))YQL;$\06T:V00@B*WO$C7MFEOW`,`/3K`_1 MEV1WV)WG19%_3K*GBVA/?JE>!TR*GD0X>F<3TZ:&.OP@M-+,G*N2KE!-!S6$ MD*`$$^O,(.L=?LG3%RH*?X$6;1MIHZ>G@AT4HFA'']*:+1BZC5[I&D\XC\KG MR^0EB-;S`X-:S$4*]8@;/]!U`CA1(`U`!4D^!K,7[\;"*=`C6M# M:*!8$$$1IX+VF!_YKM".4_K&:^0VGXAKXC^HB`T15%.A!5O\H+\FY#_H`_F0 M<,OZ'2;;NV13X9C*>Y:Q_Z$OK;Q$*7WJZ(QWNR5.D/9WTQWF#Z8"L[B/%%9> MWP>2\+[$C^)/]11[384;*JW18?^0**W$73Z8]7TN0;5+?%$/0#L:TE?OQ#RP M?^!VH!GS(*H]`QF(_/?K'1VQP"Q-N263\V-"N;[:;O&F>LA9']H[O">S_!R5 MQU8Z-W&([,O<4],F;N:B#)3SF9=];;S?,X]4C$(,I1D&170<],0&0IB-1,O5 M2M8GN6@&\QNX^)FDM6)3U(R"I&$0&P?Q@1`?"3WDB#>3;@>#2'@M/%$&=VO2 M)[TBA7("(TH]:1KPOJ)5FB14W%##?=+%3$,(A'!*XR*B_MS&A`U\DF-GS7XR MTA0P4R(KQ,F@EDX(YSTCY&S$*FBJ@_;P9]F.$CVR%$K_9B5L/O*,<;<^5&45 ML6N2`W)#"MQP,I!:P6RIQQYB$#E'#5?NR49.`$D4%C&P%UP\YL/3C*[B&5;# MO$6&;SBDDE%V)F=U/Y2K3'>)?Q"%<,S.(J3-^#3H09B@D3=W0^RL>RAJ^OH0 M4B%9Y#!IG?+^B;PTAF6;=Y@6:!#^IQS,F8B$8Z%V46U&JJ<0A)W:V',WU8:2 MKR.ZD;8Z6&)C#D_('+U$2`(S!IC"DW!I7Y;]IP9O/\@#?/69[F3Z^W=8Y'6Q9H0_"?IW830>2>S=`@ M^607EA2OX%$DU&(A@0938GA20A@3LKXD`5T!)9^B\GNF"P^C:`6SPKD+;EG1 M[(1"6,%]JMT_S5RE4+;7AG!7#?SSG*(0(Z"S@(!&=$T_]^_)7:Z8NJ,43 M^E+"!'4CY4!7"$H28V3G\;,$GMY@N\@'_*4Z)YS]\MYR667>(8)942=/T^2< MAX9^".OV1.;GC2?94(B.A=A@@5S/N8CV"7VDB'8*6S^FR1-;#\JZ1%,SUS8D MH.8Y3J)TVN@8,?PWU'%@I^_:.1)B6$A"`ZZS'25,>]:0MRCHD,7$NC:UH"EK M:C=?]2PEIVW2W/D5H'ZUSUQ3@-K^!%-!>CQ^_T2):21O"NZY<-.1-Z@VOW;^ MUD7RE&1$VPF='3V68UJ/MCFQ@[S8YZRNZAE'\=\.44''`CQ)IIR1I?:.*DM: M/UVL.[=3PP*="YL8[QS_J@#]G_+JN>BK#[&ZB+UXPK!*>HI+(I(:">ABY0#^ M^2.'!8-$F(,RY<\;P69>!J[**MG1VD;:J)78%VWEFI>E>(_Q]2.NUMNZ#^L= MWN0OA`\2T-UDY:&@55:\=DO5G'HVROZ7GYDG12Q=,Y$%6?9FY;W_2(>@3F(> M01ZEA'[SQN-KTMOTYO2P#0G&[-Q$D>W-C.'= MT%S8Z6<"V,E$C84DM&73PPXUW*/$$8+4.0%^^I(S&<7KR&E+"^VC5V9CAWV> M(0*%+J[6ORW12YZ2M2TJZ)UA<5PS7[/J.&9OJD1IW=#E(;_`^75>-,EM?@C; M>[ET*#)`F^O!HC4]L)TQ81ID#V2OKY<-`:IS[/BORJFV,;_>7B?`-1F_\?"< MXHDN10]DGX[*V/]\*"II@/*_H^Q`ODGJNOCF5C" M09%`\FOE([E?;Y&,@QHDWX'!$E]@OE6]+'%UMOG;(>$OIMWF%2&?1"EM'U6[ M')5;AFZQ'FK5. MJ"-)7]DA1!'S`)T(@]F--NH)8F+F:;YGR%A=!N$QJR:J&'AU!I^D#T2*W6%7 MSU!Y><"6+-M`(D!9MU&B=K)P@RCXS\J-8,^A7J>VY9J0,.02$5(K])%6$3]\ MQND+@2#&\0R4'9]%=F(COP_>%&^RA\\Y;>&L.W$:02=H@^P+/,(F6R*AFN4Q MA^,M2SR..L45`*VSBZ+O\B%%!X.F`![Q.A` M+)`@TIG3`7%E>QU%BC`EP/""S?&SH(T_I1=,@HY$[]@%O`&!:(,0P,*J%,$2 MAM;0(42A'5:<@]`:"\9^!DM1_UK'F?2B2"7D8D83B#'4;+8+OG'-8N+3UFBNF.E!O-_<<+$KK@NH8(!N22A9Z3WL1DH_;Z'%=*H+-?;OT9%$675NF#C7'VA%Z-*>D.#7[$JZW,% MZ:)6V3[WO-Z2@',?9=QG*`1>8A"`YQL6FZKFQ8?91X!Y)&(A,?K['#H0->EZ M*+0NN*&LD!@.M>.MFL,[>4CI675*J1Z5K\]^GZ3XQZR-?O["U]357G@CS8XX M0NW<%FXGA[CNC;0;GZ_K8BU=S%AZR&^;W`'>XH+$;$R,?^-]H-/7R^0EB7$6 MZ^^D3R4(T)5QEBEHNC1.H@;3M7$&EA77+&NBW"?0CBZW;3*M)BRV+PUM)(@O M>I-/B0[7)Z)(Q$Q'3?E>?+TA(N'YRCC^52&)'X> M/>\31PW5S:!TZP(R*'*( M:B>T%DY((M7TAJ&C=7U/!XK\R(;TG.S]QW0-SS7[F+-C'YU*PHOF/.3'?3.U MW#'3;#8['9+<-VTZWW7?#=1"_EN2^.H+6=2R)]Q=Q]B9UQW>X.0%QV(FUMLN M%7EQTV%((UD_%1!7T.L$Z,=0KRT@+`6P'@'*;7?*'5\KV.O[:CXB$D.VGIB" M'!$]CKR-N/+X@(M@P-](_8G>T!<:L.Z&])DN>2WP#A>$E+PCK;=7?$X+,:?M M&JU8P(]V74;<18Y!Q'VWSC%.5N8IC3YPS+J+ENOB*BIHU>-M_IG,7GZ.[_,T M?LC_[1"ER?;U.B^Z\WQ;Y"])J7:12P_H?_WU,X5B:5UV-)!5TX=(/2MN[J%V MCAKE<1$?&.4%JH=&;&R:H#K'B`Y/_UDSP%KV'[O;A@FO*]P_YG.!]0AT4H_/ MPZ5)C9I)Q?6D[MFD\A:N)9U4\L^_U9-*WU[H;2)UDSKOHM(LJ^(:SHSKQSC: M@2P54R;&N"J,(1S.`C">>V??)(778I`3\NB_Q@D:[J(7F"5]=1(O8J*3L:3/ MG>>BQ"7>)ADM3<^:!SYNB;CU>S[%AZC:/)/EI/,[%WR]93]JZM]GH`MSQ6*V M"9'O7TPFZOURQDP<][?-G"Z2$1&EO!+O6Q5($.\`K81;HM;&(&`N=BPU,779 MY&]+M!/B=SU,_3P6+G_+>O8+XJ?H.F:?VM-S%O-ZB1-R#XOYA5-S!^Y^0#;W M(T]01FE4C'J$WHL/N$S*#7T%-,\(ES*0\0;F5*)!^@+'J1C@#RP40_,)3NR. M\@L=REU(R"N@B\Q'ZQY89[N.;YCO[/2IK1((.^$W11,^P*W=U_8K_7I%$S]@J181%#I_^X/8(3][D$ M$^AGSL;_]9HV@IA0@E]/*.I/**+C*N>33R=%9M-Y!.9W.HU)IE^CDOJ+*N\P M?6Z6OE+',G+*=<,""Q,#&AF70SLEH/>(S<"%HBN%@*U3O##&-POK9Y^C(B[1 M5]0FOIZD[^KHJWQDI)`W0^3M,C/+KGA9SK+'@W-R?L8`#, M#)F8Z9!`^!@GB(!8+8@A,.XB0`?(*F[LZPU?/^[0/?H45M`\19ROZ'9S6NP\ M4\MC6AA]3MLSTXTL6;M8Y'5&6]@\L29ZYZ\MB'@AG2ZAHG+\+.9-:**T;KK> MM'35S.*B(P*U35Y^$CN-E9<;SG_KY:5EZ2]6%.S=(^M(+H^)I$'1XRN2X<0% M2S:R?%NA';WN02OU=0;JXNQ]0F^R3<%>[DDRT.<<=RK6?J3-N&AIL3*\5^P79J4.<)%Q_LEI+B3.1QKF8N'<_/<; MZS*J1Y5';7OG3I7C$Q\`1:R?9K-IYC_2[IKE"G'O0U"J9XRBBB:,?A3_UZ&D-*_.;QXNSSPW05U\=KO=_NJY;F_RU0[XZ-(=JH=" M9]KD!,"]/)]S12_5\;G*FG7+KI..X\2B M4=-$S1)_J@8XG8A3S_T2,6;MS?AP-+3B`YY84#E@SJ0'4>IKO1GU8/1)9QH] MTHH=E.79.]P_$(^R&&V.SF/S^CQVRC->RNAS]%Q\B(I?<,4>41)^GD^,8H%8 M8A#_L>AR4R5"TOE'`(E,EQ)#[9CJL'(C.Z:HZYA*"4ZTSHGH@&C'1D0O=$@I MDDC8J'XC3L^S=FYVY^>U.Z_A.NX<\1'Y$V]2K,I']1]_>INYMK/@L=YPA5&[ M^ME\]=FF.D3ILOF"!<;P[ZD7FRCAJ&ZK>3 M6_`\,YE.XE/3YO/(BVB=5E-*_&N\0+C8:<"W9,I.GK$2;=RBX.K8EY#!4P?'A MD,YUK5`[)GN1KAFU]DOL#4OBKZ210:\Q^IU'66H>:76R/)B7IP;NQ3[FV0NF M&P]>J_M`;VK*O],9^9A7_X&K=JZFS/ZX\0+V9%,F<+`O&S-8F-YLO"13_%DS M:EU9OT)LX&[`QA[F)6.C5UQ)/B]@ES;C9'[*BM;+=_S9AOK&-^C-N.>_SHOZ M3Q3N.]]?0\/$&_-[QJGVX@R5'+P=#VD0#\IMKD2L2+O*26R],7&=CLE%L2/KQ)CLP"$C7YB1P[CYM)![A/P75=_.R35 MZTU65@6KJRC7)&QD+\?4!S%-6,MG:>ZY'S[^B7FWL1,\B[L;.OCI^+]QDBWA M$#DG2&(%,5[X4T?-Z6S#CW"ABSA)OA6\RN)%'.5,D_ZIF0G"*-VIGD'..#/W5514IS$WY_@IR3*'Z7D+JTSWN-_[MSD>_JVM,>KI];/$=,=^0RN, M2C#`!>:X_.?$@O!YICN88J#EYN$GMCZ`NFL?43K(?I]D; M_@WY38UL@*ZSX>@M>T_7:6_@WK(/;?(6?ZWK#LYXV0$+M2_)1[J.DH+=-X5+ MJ3BP]M:\[O#/XCFC;.7K#?GIH4*'D8<6S**:6YY"0)1?1!GFE^'?=)YZ[/?2 MI[#!)S6$%/?T:55DO\?-[%M8@KNIK_#6X<'\O;7%>.0'@DC`_YJ6Y5&2!Y3" M!UU-EBP2]/3EFM.`7^_2T4T$AK=T#.;OK2T=(S\0Q('$KVGI&"5Y0$<:H$L' MX"GQ/-_MITD[Y+>P;M2IS0/Y_.$M&L.8>VLKQIA/X_4HQHFS-[16#!<;_@"' M,OMK72-F^%[2R<]R:\2\S8T=E\ZS+!8W31]R^J?UH2JKB&4YE5<`0F'JA)HG MS_XI)C=;GHVCTVK./+/87MWZ@RK^IWW6FXOB5<[^O$(2NXO>/E`MO__X/N%\ MGV4Z3B_]D:2IP]+4O;"I>[MU%]+T'$4I=W@7)?1L["+/JB)B75X?<+&;O8GI M,CR^M?W8A`_E9ULV@L$WM#L;+3W@)JVS(/0V&`W?2&(<,<[?VE9MOH\W=DII M2O4_QG;("6X'YSB)@84'SES_NO:``S]F")M$1Y9_=;O(0?-R$MN8`2[V5[,7 M_<=7_M7L:*=]:N.6UU?P$L9;'=*'1?;C'Z2AW$C9[,S`^T3=9:Y.,DM62.=T;T%R^6O:\ME^5@A M;+$T+/[JME3&>3B)X-K9[[W9#=,_ON$;V0X-^Y#&[<^LT4!P>YQENFSJQSGY M/64:7A+_2O[A:-+-10RC72: MOMHP:7-Z:\4P)^>OM3(LZK&E44^XJ<_@*7P+S7MJH4G8G10,9VF_I!SI-/V2 M8=+F]$N*84[.+VEE6-0O2:.>OE]RGT(&^1:\TLC[)/Z'/TW_->:.B.^Q3\[3 MP=\G.)$;`X%,^-N\&V">FZLON-@D)7UZ",*!*H9_4PY4.[T>'&AO[+?B0#6" MP3E0B:$WZ4!=)[PS#Z?N,/7U=[68^+9(-AXJQ\RCGZ:['#BY"YW$F(8^.6>("6HQ*R[P9>QC. MLB#-R4&@B]+\DSQH89IO^/`6I[EE&[5`E:XKE$-O5`\N=WHXO_BLZYN>OAG/ M*@0!=:X#F3A1_SIJJF=UL8,X.#TO.T*\91UMP]#;][5SS+V`>=,.5U%5`>%R M![-QHDYWY'3/ZG8'\G!ZCG>4@,NZ7F4EUEMUOO/,OZD1YYMQOXKB$9B(=R`; M)^I^1T[WS%'O(!Y.S_V.$G#IR%=1\\\]\4JYVN\YUN-N7RJ7"U[< M+QLPKAM"1L!JPU!:B(;W#:;T,'\-H`WHA$F/J=PM]Y3D9/$VW/O\GFM/; MS\?=R2T":@KGK2TOZYUN^A`EE?1C'XIM:7"9_(P_HR@KNW MLKZ,%CW47-&O9'V9[[N-G_;]R9NTH:2!S_ZW#FHS_*N+DZ M'>=MO%#+?KPD\EY'2;&DRQ[,Q6DZZI&3/:=['LC"R3GE4?(MZHH=KN8S$$09 M0Y2S4_:_\\R_P'L7U3.TI=/R0C%0OD4Y'PL]\U=L'_(J2KU$R6Y# MGZ:?'3*M\W:SMH][QX2B_OWLST&>;7; MI_DKQO=5OOGEEDSC,Q'H-FU>N_J`%4U7AR#Z?S)QF$CB%4,W+)"'!8>PUM_Q MU,B(82.!CBB^,$?T,R?Q?[V^M7?B8AF?GYLFV_WMK56&$Z@V:,+"L[(\[)J; MF'P?OT3U@,.`)U8-X#R%LYSN6T<[G=-Z1U&6B'':/1^2!E^UF;L3/$0?.YV- MS&FRE2.9$]SCF:;@ISPE9-*D>KTCV^&Y0\HA(Y_8#F_XI,ZRP7,?]G3V=T-E M`G%]+2.([O)4]S,0\FBUCV]3X9>&LPWYA4ODY2AQXEY2_7!>8GD%C\J$J7QY//>X; M\'BF"5W,XZD&/6V/IY?(I\>C7"#*!A)\O!67-V!^*>B[+9V$1$Q"H9B$T8E\ MEFGD24-:+F/./U)7G958F]R?0LQ_PG^ZZ.(08#PED(.!J>SVG0#;EG!X=$:K MS>QI=E03ACE$^!5-@?'`P<,\M*<25GG]A7%G*2..8[5?KQG5K`6NR#`!U3#1 MY*C(#=-[:#.$K9X^-LA(&ZG4!&#BBDG"<6/;R,)@M3`>-TB;9QP?4KS>GF55 M$B?IH4I>\#W>'(JD2C#9[FW20XSC:Z*T5-(#7Z;6VZNHH!?=REMB>A!ZS"0/@]IQD!@(T0^(I*$HDAB, MUB-Q+X-^9@..6M^44?I-1HP%<$FXYS MZ*"T7&9IH))PU#`T/5`QC'LS?[*,MEP2KR8;;3JH\ZM_FU0P)PQ0^@G$VGKC M][XC@X#)C03!G-$RIG(X6M\O:6R(8ZW&'_WN7^>5#`JM[_P(HO<*#A2'?`P& M1O>#8="H_W-P.7NT]C[)\$V%=T,V)!)..#%;3Q!;V-8@!!6Y'7&EBQ2^HIA? M*V(%BH\8@3!"N`7E\9<=^Y3%25D5R2.U39$X:'*`#_EM5%3))MF3CYT]M0D( M37YD-#68?-=$X>7$UDA2WC-8D_CLJ7B'6IMW:G/<58XZ%*4L;Z M(,2F!/>\,_`15RCAAA[)4N\[4I=:J?U9.N&T]61G+U&2TI3@0UY[-)JY?\[3 MF"SS+%;5S-Y@*C"6/5)8V:('DO!NR:/X4^IO=Z%J2%$U%BN61&V%&+UE@DQZ MN=1DO/,)K3+:#9>VI.MS(^VC2MH0S;8.L"?/7$,G=-,]$GB<\=9$`C;?#H>S M&'!-,703M@ON;,2Q6F)_9DQ$+EA97I1*6XCRK.*1")^"?L&>]#2H9CKG(`QC MZ/--B6SYTZEZ=P5SL:S:@0K"G;TGB=`EVM1HE-6PT@`PM2B+3Y,T:8[15A,T9Y,$0M50BB0 MN\,IC:)H!N3U@3C1,MHP=WC^VOG%J0YN$"WH&\REL4:M MQF&)OE2$5K'"='$(`^^DUH+4=$2^\9K^<#\HJZW MJ"6$!"7RC_IJGT3,?RD0Z)<-;JVOKTN5=(LI1\9_3:IG&6688W:G&E1,,'0R M'.($5Y*AQ`[#^!T23PC*/-T@TT:?"?'N-BRH,&/BG-QD]`DCWM8ARG[AY1;% M2[(1ZP)*P/2]H0>--MLV+'=OG`YH(6'.`2SL],-F"0$)#!B#.P7>S:GZ907PVCQO M73WCPBF,TP&#-<(%9G:^V`YW\O[L,.LMHHB(82*.BB@N+?+YA.[!RGJ\?1V(4X[; M(H\/FTI:?=W.-+1XT"<8%H'4YQ4:),#3"2-'QK.(&K,;4,W<"O<\R7^DKVED M,?G7=1[M].T'=9``K0C-3#=M"=5@,"T*3;ST^^UQ:-;QOX8':EXXE&TD\XV6 M9]S:7/S'9_!XG&^@Q*H5?[(U2<=@M4_! M@\)7WZT1`X-:_-RX1'?("Y^6Y6^F*1UM'`^T_5J=]M"O=THH_T9B8%88B@($ MQ%BT?/2^+H,4F2>@]2E,;HVF,SO+HTWH(BKB)-H\)&5YT.^OE%#^3I#%7SU"_[3[O:7(TX@!4X/@((13K[X0H\JB].)05OF.V-=9%A^5];CV^!Q#%+HJ9LI4Z+I^#J<(VOYS M++N6/J"<++_0+@BCAC)KJDUIO^N4M8'?`AXX'39O/)X<:%N7T>(KNKX,I@75 M%&8DH[J.*X-5/XQ%@D2\K%O^11J5Y7K+.K0I'G)W@`=R[38!.EY;!^S?(9LY MZ2=M*!CKL,#:WHU_\WP>M9&Y5CZ,;@*$410]R[*&]*&\JX:.!8U.K!N=`'D; M?"37N8WKT1D3LIM+;XN+`L=L8&W^9""^_VS**`%%;F40 M,DBF902'BEMUE`;B1(X>H6S("`6$R,.\*2&-69H9)3V;)JO'U3'/7C!AD6QM M')R.,Q;0NNDF3&<1-:/X7U%=^.DO5"U6(/;D7YY)-WZN/PUF%+5>>AU=_*\MUE!0_1>D! MG[^R-`(+I@W;=0,\S&IB%4!>1[3`WE<0"R?]WB<4"/&M#O1>O>&=)YX^X*@\ M$,^_SN[H>V4%":'H<\GEIRQ_9&=B9'VXR?:'BOQ,OF>2)G4KR%9PXXY_N>&` M-7:AZ5,J_,QCP=G+(H+TS(T.A]AX(KLJ1D3K##5CLL?+2R2/BMBPJ#LN.G]% M'0L&S:S`S>6CVS3X_/2($1AT8,''B+M!3W'I,(=*^V3>C3YN5Z>XGW.0GHS0D$$P90\L`N1"=Q MH`?WGS2P\=+?8$L8-"U?XT`G"Q:7PY]-M,^]/)"A#/L>%2#40_3>R*]*L*!B0%JV>DW[PP M1P(646"8`\9@&3:F9)?@>OS["A(K]#FZ)'L@T)AL%JIGPW,++E@`KR^X"],\ MQF!'@7F;P96O_CZOHS`<%S%DQ+&!'F\X58',KSL`2#6+K9_CZC/&,K=G6;S. M\'_@J'`R>Q<"L![`7425,[!C@_L%5Q8MNE>3Z2H?;7!'2"%*"]YAO`U)G3T) MN+@3FE.559%L*AQ?1.6SUI&HP2#:3^G9;?M-]6&`&DSI&%%4ZPM01&&A6DB% MR:^E290STT9._66&KM+DB98[T4L6Z^+'(C_LK_.B.4];[ZDZ&;*(`_!A\D2# M!9331<[(WK-&`SGKJ9_`9[=K4%X@1@)MR;^DTTU.!CQ]>2260G:W<@LK.G#Y MA*-XRG(("RY<>8,38Z8C]EH)NQJ[%AH;2.'!5"E7M9@KI+%,^,H"NF)=_>V0 MO$2I]1$Q#2S0":N)\<[9J@K0_ZFJG@MU%"$!0Q^D+L'Z3-L)LG6YI]5`267N M=&O%@=YH&`11[SH4"`%L0;1<6>-[N@EM44/8GIR&+`.V+HL+Y/-U0'HSZFS` M+2,C!M1;@%8AND\`:L$!7OZS\**_RQ;6E2(/@@`T-;C?X"PJDMREH4$7%KB9 M@8IQ92,#&1"NB4&?B[ZZ"-@5$M#@6V_!R*>LW.--LDUP;-QK&^"A^AI9!.BV M+-(``W0C,G*B:#14*XR$`+PW'BO"RDD&_R9PG1=X$Y7F`F,=,*SRJUE7:7X7 M$DSM56SH=5Y`0P<(8YA?V;D?_Q18079D!>^ADV=5$6TJ>A9X]E1@K'\(?A`F MP/-APX1J'A9S0X-YAL']82`'JI[,3E,K]O!B>DZKV6D_]4I*)*^/4Q_^5`9-G>27X!K?\O0>53B M.]V-'QT0S"*C9E5>4[H0WI<0U?#]EZ[IXZ5W<#=E9F;6X^L&A#.Z"!EB["X( MT/L%"C8[#Q9(O_M_H:`W>'_[1?ZK7NR!(V3!K#$@/@:"_>CZ<+<+`?;AC;&? M].E!(]>9F!T?E'[.'Y[S0QEE\<[?9J_8LP.*&^(+F15\H+I^/IX=2@% M@%!VG)!-E#L,'28`'L-C/VC[G"-!!E$Z2!"JCZP;4HCI)$SH_/9$-0?=L\A+ M!OO32!$]+H.X8(\#$;[NGZ-"4Z%GA09:&,W,=U9(-:C_I=+$1W\9:J$1!P>. MZR>PS_3_4Y94)?KJ]OY3^?7\YV[K#,MV^Y=#%I.=,/UG]7J??+E,RDU^R"H< M=RSZELS2,]F*4(O$9^49E28F.$TY\W;M!GC#V]S]]V?_O1/ MKG/CI%)S[(JNR61.VQ6Y40#=%0T14K$K*E`Z@>^*WHJHKKNB M"?*2P7Z_X*[(YERNDJ?GZF.>"0XNDP)O")5RG*<900[4[8P67^&#!M."=D@C M&3:;+".*"-5WC5(W=,-T5LM.`PIB&EP=V5QS04;^XRQ*X/-YV30B,1]]L.KU MH8BR,MI0$RK/7^5?#.=A0PA`/2$[5,3NH[&NV`#/Q`YC37%[D(&QY\I>P<_B M9*:-YW$J0'C5TI_+]:%`5<5XY'6D$J!G=#,S/;[W'G/2Z^UY'A7Q>MOX=&UH M:$,`Z*WG)$+32\\(#=,[SX&E?DLU]B/M$,_06*OX9D&&:8QW6F*8N]YYDV7\ M4[MYMMX.-E\G+(!G==V%:1[3M:/`/*'KRE?_XA;96Q"="<^R3U@D\_.X('(! M7,7_$>=/1;1_3C91ZG(=OP\/?"5?)X#R6OXQ,-S5?#4G/6V2P<"W*O?XZ9AU M\[U\/3Q41Q.+`-U^)AI@@&XF1DX4+4`8/.HJ#^R]_($B.+$^5/-+O/GF*7_Y MEIWX%:]<\>O_.-;Y^L__29@Y6AVD'SQ'0SV66,#3_-6;7AX/V?MZG]#/][X7 M;2M/W]Q_,W^H?9,1CC(6\$6I-K160OD/I0W,BM!9`0(2*FOY4+S=(T'"!,%! M,FL,;^?DN/[W>S($^6_R7^0?CU&)R7_\_U!+`P04````"`#M=%5$RI7?L"MX M```N^P@`%``<`&-R>2TR,#$S,3(S,5]P&UL550)``-NJP=3;JL'4W5X M"P`!!"4.```$.0$``.V]6W/C.)8N^GXBSG_0KOVP:R*FNB3?U3%]=OB:Y;V= M:;?MK)IYZJ`I2.841:IY<5K]ZP\`DA(I`B!``@0(*2:F.]L"0*QO?5@`%A86 M_N-_?R[]T0>(8B\,_O;3Y"_CGT8@<,.9%RS^]E,:_^+$KN?]]+__O__W__F/ M__'++_]Y]?PPFH5NN@1!,G(CX"1@-OKA)>^CZRB,X[D7@=';>O3L?8!D]!+. MDQ\._$O>_NCT+Q=_F8SA1T;O2;+ZZZ^__OCQXR\1*AOG1?_BALM??LF_=N7$ ML'58#W_VZ"^3S2_7^9?#X*^CHU^/)K\>C2G?QV?CBZ_;DI^A:+, MO>:BOA?\^0:_-X)X!/'??BIU\/,M\O\21@M8''?P=+YQ0OBQ`G<;2W4#*G>9#J=_HI_A45C[Z\QKO\0NDZ"-=38 MKQ&U!/I?OQ3%?D%_^F5R],OQY"^?\>PGB,%H]!]1Z(-G,!_A#OPU6:_`WWZ* MO>7*1QW'?WN/P/QO/[G1&C8P.9X<9=7_YTW.B>*_+X/9;9!XR?H^F(?1$G?^ MIQ%J_OOS?44*V%3H>W.L^5]1@5_YVOJU8X]?$L@@U/QU&,2P!S-$J"O'1UIZ M>0>0DKS]Y6E)?6^?X.@)DG>0>*[CR^OZ3K-*Y-C\\7'^N`(15G`,M7X=+E<1 M>`=!#$W$/;1*2]!),*'OJ);TVHG?[_SP1S>:D1M4W?>7=\B*]]"?0;M^^\\4 M#DU90I!:[E\:>6-)Y#-=Y;SQ8MT@EVP>7ER_0:68;QZ!Q&X=.'W8T]H&F]J1EX_ M?W?\#_#IOCO!@GN&H-66R8IHYH4+$(#8BSL!2&])7F^_@ID#EU=?G22!!DJ\ MC[OUY?7L!LQ!%('94P1B$'W@:?LZC/%`N`\^X)`(HU;CBKMA>;)\"H>6/[@.X+5AX;SZXC&.!-:=(B_)ZGZV-7IW/-FA7*LMDQUO21O6HEL2Q M'BZ77K+,S3-<`:`)$6ZDV]E[5F,25PFM5W'L-N3U\!:6#M<`7$'+-_>2)[@O M:0$GN16).":A^R?:0\`-A-A&E]6$[%'[!"+$JS#`*FL[?'=;D=?+UPBJQ7'Q MGNP/+WE_!CY:0,,UO?<-FX/_@9E]MT':!GY M]Q3B`B)_75HJ=Y*`J]F^=SSXO]M8.:'6^Y;JU8&3O;+=7-&ZVCU=6QE8;6G: MW[45I=5'%._UVLK";$S]#JN]"MCM];ZG:2N(8//][6_:"L3;KI*]3MM.$YKH M9>QF@-J5U!=R,%N:W>UJ2ML>9KMN?U:7MI!!KO>U7WS8G0 M"=4'M.6)X_G*UG?U[_0M*3HBGZ4^@,72%6P>,8/ET,9"*C#=>J!I_];=\';\ MG":Y-RRNU_KJ1'_"WL&)<%N\'W3:=DKQOK@[1SB;52S'51I[<+-;WNL^I9'[ M[L3@"6H$7/I^'GDF5]`6WU6,Q(9HWP,GG7G(4QR%=VA>A^Q,_20NQPS)!:/= MI]66C-B(>D^/#&/-V[)Z:7H8CA(_K1Z/?@:EW*^KBLAH+1ZEF=Y]F>5M M`J5":QD5=$$C/J4_]H<(Z:/]^86W_8"C,5K#W27>'L2H7S,P]P(X_!Z@,9[M M5FP-D/H>Z4"O*'FU?@:K,,J7Q]AIUP-2/%_7@@JZFU)5XZ7KILL4AP1<+F%7 MO7_A(0+;NERMHO#36\*?RK\\@<@+9S$V'5KIJ$&8'G56S+GEWG9U8TGY:/^\ MK>@2F9UJ,;@2^08^DSNHN?\"3H<%@NK^*#F3Z[[P9S:FI,_ER1;]\0K`==FV M@`Q)>#^A6#YT'!<&R%%3=`06Z#J,VW])L;2W\SEPD\W=(?CK,[2W5>>G7*F% MOJA8^F*E"?^<&0)H1V0XE#M]3+',WP,7P.6-%\"_/X79=K'HQKK4I34TBM!. M`K@(1X>F3R!P?-3/QX#4@F2L5'=2;@QWAYW.FXK5)2,80H+32:3Q7F3:TN8N M39#7`"X+E^DR=W`$BP>`/$'.&E=6(7>[#JB,AF]_;$IO2FUL?.L>,QM3&/,C M(PYV^IA.F=,^94Y-D/FI3YF?^I)Y$^R"?GE<80]*W@V)PO)\I0\I\ZW^)G0) M3L9PL1?`F;;4,YE:;OGA7EC^!_`6[\A[]@%7&PODT$B763^^QW"S$<+>@&CI M!:`4N"(?(:G=Z6VDE'_)-]XJ:-/\+;7QONC3:9+[OJZI MB_KUY5N<1-`2%\W`32;P<3N3L_A_U^<34L]+.O_,JKV MUHGA4L1_/).A)S"A-$,1'_[:?+3 M*(UA%T.\#MSFDU*IATO8L1GJW)WO+`B*J/Q>Z?QD/+TX/QJ6)IJER55QI$$5 MA4#9R?XM7!G"Y1-C;%3*#5XU_%+E*CK6J*([.&8-1Z<'V<'Y8YJ@7/RHXW3;QJ@T>*VU%+%0I0Y'0];E M/X#O_]\@_!&\`"<.`S"[C^,41%0M4LI7I9M`Z4Z'J$`1Z0K=Z?!,9+U]2M]\ MS[WS0V?7L4@L8XF.FB0J]*+#'9&;@6SCD-W7P6?P3D+$*Q>EP M3V2=_3WT4PAJE&TIZ!K;*6>)JGBD*G1$\TG\QZ^[QS]=#X5X7H+A.A*:C-&1 MT*8Y^.]RBZ.\R5'>9FO&S9WX#>LLC7]9.,XJHQWPD[CXRR[_\C__H_2NQ>:< MK8@0IQP@B52%^CR9G$\N)L='9Y.CLZ/)\;3+R)(@)TX#UB01+F3,".L,^';@ M"4A*/8Y:15X8P:&+ST>TZO+:=^(XCRBZ_/1V;6=C>7,U3%<+0Y=H7E^@J6;[5-GW#]*B['TXN+B5[5_K-QNM\4-$[_W>9Y MMEP,=6N>X+.+OOGFO&%S02QKKA[9*JGKDE\\!79]2X03348^RPZYFPHRJ21# MH9EZGKK&$85?WP2;WUIB2=SQ=VESH8#E@CN2YT.,M&ELP:`L41A7C M&"*N9<*2151@2;,/W.^\A02J'.NA"K[U2L230A1Z!2MI(BCNWLPX(C.-E<00 MYD3G&29,'+^[V2#?NZ)E926X,ZEEJ\*?0.%/AK>0$)>0>B%`QI#7Y-HHDNZN M(;4I([UA1>RU_7:.D9-:RB@ZBKI"SN3@UP$/.XQFWB@O<6J]?V)"Q,M2T M='B*PA6(DC7*U8<#Z/Z9>BODJ8-VL\%-Q5.UBN/9]&(Z'NB926MIE>XQA2T% M<3^QD04]FA7.DQ\01ISYA;"?H)8U3M6M-5;=7H@)K/3`;*+'1MRE4>"A9*H0 M@3OO$_TK)M&CL;R-%&DGM(V.)YQ:%^6KO5^NHO`#6UDF3^@5;":*H-0V'GA0 MT62QA5W)9L:TD%R6EXNX5-5W3%8\3U-^(1C^VP=8L4'E:1$J:O0C-2G-5_5Q M#O5Q;`T3E6*DU%&G*6B$A7V+;97-W!*66Y;K3LY!C<3SW=QQ&08N5[@(LXYQ MC&F]`1<74^G229./#AUL?07)>U@.JJ+&I1/*&D<(<;W6N<$OJ8T!K;5XNYU@ MS2VLO`&*U`:L9$]'\;ONY:<9I0*0F$*HXBD_"EV*GZTD`U,XQHPB-\+C"4Z2 M`3Z\)+A@MS]:I0$.T90&;V@:;,3',NG;`UIQJZC02EBE^T=-R[V',%B\@FA9 MA+]^"Q.-E6I9VU9S":`H&*#V3 MS'>;C5[!'@X(RJATI:KY$MN3LT:K)[[K:]7"QO%!4*W$\S)>.?\6;TZEA1B--:K(CB%"&IZ7TD:3=J)S.%@%+8"1`\.P!(\9[D@O;H2U!&&Z^/Y>)SCV9J>7M8T4Y42>LZVFY. M\V6S_)U'OGMFU<+V$4-`3H:;4//`QWX*[F%/*5V1^0C^QUC30P;2="LBJ%*G MGJY#!UY&[`,9Q'A@U=VPJS3V`A#'U^'RS0OR>_4!R@L*LMSDW@P_!XWRFV<@ M[3[SU*&E*LK0EHY-2:HKZAR2);S2XR9-%"NF4?0J/0CB*@HX3ZDW]\",^P2* MNQU[Z"5'=!L/I_+%^S.*(6XB$+&L/23A%T_61&82$787='Q'E<0*]E!"4$;J M:WAV+'2;5[CV:+Y)*/IK>P.^68'SE*-KEY"`*+8W63<^,$.K8`\3!&6DO]VG M?2%9S4?/2N%,*%D5]@@*>Z%;H4)ZJ2N65TCJJ:.>NRV;MR29.;AWBMFG/2X) M)9TOTIS-NM;LLYF7"?+D>+/[X-I9>7`6*2%"6\`W5K2/)RUEYCADU!1<]`P2 M!TYALULG"KQ@$5?N&\\]UZ/?8&JJ:)_V6\HLZ033M)##K?!X8X.\(1%X!T'L M?8#[P`V7X"&,493NX_S5^:1[`41:L8]3,@!0?`JJB6"O$7#B-%HW+D_J!:LH MG4RG$\UI\CK3A%/&KA[KSJ.AYO?L*(OX/$O&EYQ/^5]R'OU<^<2_6?BRLR;+[[Z# M6>H#W#$O`0]P433;O9[*?.*9NX'JF#B%8^)J3[89<>-Z1L%%3$@SW<9P*,2:KL&]L84AM8Q*T4N2MX%3%4=-F[K05W\84 MO"4L.&<:!LR)B5)ZKTC2/"618LXT;X,J`;>9'#SAQUE) MF]7+*R[C^G)-M3T%!98BJAY7>080Y`(@Q-QS1@E"-;"B!+<_/,Y'VT^.X#=' ME8^.\J]J('KVY4U/&T(%*:4A`TXFYY.+R=$)Q.3H[&PRU3-L\^Q@<8,8N\6J M##Z'#-;\EH<(SO4QRB6>43=17QP?Q'FWT8-`C/=82$6-TQ^7!@BA$KRR*7U5 M3=.%G[+P+R#Z\%S`28-2:1N9T"2>4C>T)D..W?)E$!H>:-HI:@L-N&53ZCS6 M=.^KP*QA$K=%UTQY%+QLH>LUU<T.'^`#]M5!@XQ*5Y": MSIKN@P1`C35,$3NEC&-`M]4BCW0*HHOUJ/L#"HHPRB`K1*?JG5S<.@((B-DU M>IB86E"72^DK2-[#V5;^^!DX/@IC_.)X`6-:X*IK&4O:RZPD&Z4NRBQW(!'ZD4$?H78LI%)W^25%%5<]W=IB'+Z%05A=B+'7 M).Q*EA&FA;!=TU@:8W2VJ_([B&CV@%T*(=C&D5Z!>1CE`:OXD?2O7H"7U<5$ M#C?[U5:R])\U:\X,]NRE!Y;Q5C=RLMZ.TGS$LX$G'_!7(`#TXQY*:2NIQ2>E MM'>E-&_?OH&DT6-3*5-%8PK1T/S\=3>=-\O&>BAJ2".^>%JCN(/8<+!'*VZ9 M_H7$+*@@-Q+$!#)<.;'G#L2G_C^6E"O7E) M*6T[)5AB*KTGH"U,<'/;],;[\&8@F&VQ`*X/_XOC;BZUJFUT:2VSI.-`6GBA M)O;\`;S%.\KT!/OE+,"W%"4I?)QGUUH?TR1.G&`&X6Y8AH@V8QRKNBU/I(A? MS%AFA"/QBL1:D@BU81PEI"BU/5=:+6TTAR529,NGY)J(8K2AM5+!Z!C^Q_'1 M/A%'"!:.W.*:J-/-PV&"VE5Y.'9T-QEZ*`+ME!4&NCYH M.214_;Q8#-R_+,*/7V?`R]0'_[&K-?BG?SR`A>/?!@EZA;/^O`^A1%6:"93F MU!!]T<'>:HA7(-6[,%[U9-TD/L>S^[,QBN'%N*J51E&TO[!"S%__&UB&\0JN MU0#U/9W=(D8IJA'VK9:X93%34]=.-//"!0A`[)%?MJ.4&K*^>,6Q)*_&9BYX M:'B2IE[0&"VWFM<$Y3+W%3JXN4&KKJ_J; MO5X6;\A:1XR^ MAL_`#0/7\T$%B]=0CF%1\:G]H6=OZ)E[&-+O#2T3V-2;TDG^T[:`=363Q)L6 M6_*=Z2'?#8#==SVL??AO'V`:!#R/]/%4/5!/`EZJ4E-H2DM0Q'("G(D>!#&+ M9.3"!UJU0DAIUEQ-J0W,N*QZ?`01OMA;#LH!3U+V!5K0I3!!B6[#/V!CX";\ M$3S.;_)>/2%=1Q]8UPB)&%]F^X!BAN@9<8)74;R1`]ND(J?T<3AM25Y<]%@- M"FS&_WT?%`B5[EU2K!]7W0,'90"F)$V$]D5=<77=A6B+W.NOE3^0K"U(71-% MF$FL^D#;X'KMK+S$\9O?<.)LX$`]::B9^])=73`(+/`^T*$:_^Q8JF,<:SJJ MCH<+3>*;YBLCKN3I4[CX@KYU6_:R1SXL7?U@#:PR9MD.L8'[Y%D!53[G0X#P M>B![QY+;4O$T9B\)%>#2U8DV%!9>NFZ8PI7'D[-&AAXYJETW2F&7/>?-\_&B M@IN%/(WM(PM;XR+)5V9*NFK^\V52=JG.(3^D1NVGHP)\9/G53$JC38$I\W1+ M"$%C-&0A%RP?YW@AT9QVL+EB%8GCZ?1D8F0T MD*@RZRQIB86D"#;:P9$FNP/7!+GKY]+]9^I%X"J-X:B#*],87_E#*LA_H>5\ M$6EBCUC6%17%&U%-:[`:+!!Y.-LGZR??"5""3I22<\4X0N=O8(^Y)H:)XLVF MIF<.MZ#"TM6RMP-]",LY7]XUL78!0'7)CE M,2.`TMUCQMGH_M!2`4Z2GOD8@N?LS@N,X($F5;+\9/Q1*+WYJ=IJA5(EYPM^&-5>I MY!X1AE-X.T,N2JO*9[!*(_?=B?E,3F/%_:.0(!:*/5JZMH$E`UP"!N]3"%!S MS&@P1UR0`H^!M5^VTXP>\^R:0L]'](:4"G&P,G\"G:<$,_10ES/+25B9U24/(RK?6]"!N`2*B&*UA#OWQT_ MI5VJXZJ[/PQK#T?75W5S:JVP57U)G"BIT4M3/CT=]#+S%$`?O[;>_JXOUF8$ MNPWJ^^`-O?I/TXX3DKR'/I0PSE[Q_:FB9FJ^]A.!?.WEC_RO4?X9O9G;L<^C M(C=_"G=Z7D)Y.)45]J>KKG<#9AJVB->'_T(YN9$?<(0$1-;DXI4I3N;3D_'ABB06Q`&8%0_I,GE!+FPE(01$57!PI,50N&ZZ3'$0..V1.;;1 MX*UO)5^Z2:\@W9P."KVB4X$T6C([5,RR5I*` M7U)90;ZV/*MC$@%:^0G8Q2:?/JT?0D2I>5+Z^6J M]BBYM;2*$]1KBG!2^-SZD%DB*J32V$U-U-A<#BG-CBC<@<(+6O$J7N<0K^.! MDD)(0DF;?L/2$F&9T24S,+M)([@ZRF)'<;"+V-,^P@W9PR-)LBL.@=1D=2C@ M9,MR&11CM60]QX2%EQ0,.0R292,0_?:(Y8QO/T'D>C$UQ9IP.]833%!T2:&0 MPZ!7/OBZ\XO1D/4$$Y6]\.:-]X)B>/C=+E=^N`;9,'S*+^>BE',MK!BU+>N) MUD+\@FNJKZU`J!@7%='M&'WH+9O'[V&E.BMS4MK MV54RG#28N*S]!IH?;Y?R%7L8V@V,PV5JW!> M0#C/ADV=-O(6])$9MV>&`Y^%!X_1::J]1_1A"%SP1]6;K,(/(:J9L2Z#V3-( MT',);=KJ>3>/3C*B7`=/ MC6;9B@C&KGYQ>A8*&X-$@FAIB M*H2UP[0>8@`H>9]/E=6X\6+7#^,T`B_I M6\KERS03DS'\/V@:MHTCFY&UCPW#]@NC[2=&FV_HN2^\(VF#(:!7J/!K.IF> M3W2EO6$I\A7J[LJG)__FJVRE55`[[/#$<.N"".*65Y\$: M!OE1?9!O6AN5F]/`_3O'B[!O8=N]IA'-KJ)C`)-ZU#1NF76,&ZX\:BJ/3G'I M!CDH=Y,L(F='\?)DU`!]57UNPR<.#(;:G)RT\0BI&XE%+:.-U+45J="R+B#TOEV1/$@)F&J+&> M<300T1>?MIOEU9X'%<[S6/.3HUSO\`__V,[(Q&1CI"*#T&:S/K9ZY192NPJ5 MC?/-*1?_$"'SR1!O0YQ+MR.<4->7-75XU<9\@_T+/;:B69>N`#0 MW'FQN+OGC.3J+;5HH,>G:=BSJQQ\./IG=I8R=3AK-!VZ*W#63*#,I_NRCJ>* M/RR5*W#6&$`#$7UU=M8TZUVCLZ8RGU+]-812@]!ILU:J+AM>.17H4OO+4TI= M.`;P0[L+I\H=4N('0^Q_;_X<`U@AK#XY_IQ>[8C*'=Y7,'/F8?3525`G./=U MY_5]7=[.J&A(VS,9NUOT9^#XWK_`[`N<05"JX4>DW%48.W[#3J]]<[K?1#C&.:$`P!I"Q_ M>-]%W384'QB5OS#"G\!1?>6/:'(%H\^OMYWF\/U2:^@8_80.-0UX5A7CQCB' MBLK#6%BV00;B?0G#V0_/]^$0PKGU[V%[P<*#2]_+.`;%F*JZM@:H/8;!X!=$2GXZSAQFYJ)9'4F`/^(<6I;1QHXJE MBLJ+*`+R#'(DH5OO7K;_1G=S0GS]%03\5[\GA%NAI4;QTK;:K*:\"!0IN6<^ MP39TI7]H[&*SATJD$>-&=BM5[^:!Z"C_("U!/5\,IP$@7#0E98+1,>Z?G#56 MY%T8;7.)/IY MR)2SSU?E/C?NY;NU:IR9D4.7ZGNI\A$:I&G)O(Y/^-UIE$0/RTQ+HX40"W?YM$@$VQ+-3B.LS";F^:!CRUO'%#N4DMY4$J)M4@ MAQ].FP'%1P&:?WC)>VY_GIR(/U_4A!!L5FYWA!H>Y2V/BJ8UL+HDW+KD=U*3?5!WQ6"09J!%[!`"PRX MX?D"PD7DK-X]]SZ8A]%29+E/""S+&\:^_&W3HW+;.B[D9;UZ!JLP0C[:IDS. MU.):;A/N](9_='/4-&Y4-ZFJK4<3H]N[C0,_:9O6T:_GR5#;0`7355MQ0= MH!BFL>#*V([_F^_L[JA;WO;1S]FWM#SJH"R!^QFDFZ:+9=^L\*'$8"&^#J%?0[)U/7K*+V*%A8RL(#U_6A;=T3R^:MN<CG07 MNR"-BB0^FFCS%3CH"`5)G@G.Z8[CK6\Q?5J)7E"HJX=7M]TAOXO'>0;`4[>* MWMET>C$>.'':BUV09OA.6M(SB,PYBE[!/H((REJP8OB>W-?(F8$B4U4.8_P, M7``'"42#21"NNO9QI;W8!6VZNG4EYZJF)AKDV-YP5K6'!9VE+DC0U46K>QFR M2>;'M_*@%;>'&:TD+=C0U/+YTD M+_@S?#\J(S$@'X/X&["/0QUE+UBDT],J:59:KAPO0J/G,2HR2S_.4?JN!^\# MS#)([@/73V<0;3)6G!.:_"_9Q\N^0"J"][KZE*4?%4`$HQ2M%$,W=UC=`<"Q ML.:J9P]?NHE<:'_H0;T/P(DYSP])1:O8G$-LC@=*!V$I"P8,W;?[X#EOGN\E MZV>\LP1%/"'3#\.N9"$KQ.4M^-'5C2O9\_(`%HY?21G8/#,TUK%'X>W%+?0] M?`=M+G^C-ZZQO#VT:"=J08GAQ]1N67-QB3HC8BJ''OA*>T&/;"7H%^Q@A*&O!B:Z>5MV/Q9'S<)=]$]BV;\DV<'4VFI\>:\DULGWI&D71W?OCC M)5VM?,QNQ]]J*=-QX^V^=JT-U&1L%%@OQBP4;"&P`[XGKEM+>O M87$"7C[\9E)(2IM5_*80O^E`B:0.#DE),?J=ATA7"X1FG:/ZK%-.@[9I5.L$ MLPF&+QF(ABF&747OC++I6W;T"WE:N/GA.,CC_6>/D-!N&D5PB%PYL2;%2AH7T*DCR^.%#Y'H1O.!(4@G,?K-($I7N`YL+W MN'+TJ?C4X(G:&RB#G.-VKK+@9U`@EA[*F9C?=MG>9!":_([KDQ]J<%3Z&D[L MN_U>]COZV_:36J=&\G6?IG>$&BI)70:CK^Q\J7AB$H4/QYOWY%[>PRC9^;/` MTECB=ZICYWP\GF@.-N+38*_0TLPWCU#B)PZ4)<8IRI2,ANG-3M MQK;14:E5K::!X/1'F0*]69XT$N=PR[348"]:M:1WC5UTN:2,^&J]J_#&931? M,\;9BPZJ)R^@.^#`L!%>"&?0-4X+J//(L"3&Y:='2^I'*6V<[J4HC7Z$R",^ MA\I/S5$Y^F<$P$VX=+Q`0/F5>L;10$1??-INEE?[=IBX%-U.S5_!\@U$A%7D M;I%!:+-9']5E(9>0VE6H;)S#Y2*X3\!2P+YOJAC'A_Z,/!L#JD-![^HO3T'Z M+S"[GZ$<;7.ON("3CYI9U04(?TN78";H8Y7R%>.H)E3%-ZAESL$'D(1;,5&"LJ`0(&WE$`PM:[3:.:%"P"1\.+=.8'7VW%&\I*6 MVC79X='D"657V5L7Q@4<`)IC7GF4*<]7D0O,L7'5%(^DP%=A@)*E**VEKV*0 M*E?@JS"`!B+ZZNRK:-:[1E]%96*ENBL(I0:ATV:M5#T6O'(JT.5V]$^,&?WR M/!@&\*,_T\_&X.#!D+L]-X!:PASHV8,AUVK1/!@GQMBMOCT8=E!0!@1*/1A' M?7@PJ/DG MX"4`YV'I_I7J]DO;T"\["D MOQOX7W'BN7"$W,&_>XM`>+_4HE7C#(6H)MF;)UF(6+>10D]AAP&Z'UK`!*') MC>45",#<$W7=";=H-?7DH&'=3NUV/@392_C6'0E)>T3M5"MR26[0K;P!T,@M MSNHVDJF+Z)*V;3WGP@F72V^3M:,JK<@FCI#VK=0T/A2K-*XWQPU=:.Y]GF`; MFMW2V!OQU0N\9;K,'@9RUKCO<.-Q[:R\Q/'QGX6]U"T;-LYVM*($Q6DM$Y-! M)L1Y2:`X:-\!]QC;91ZO*3DEY"U[*+6JU']N^9=NKHE-YQE`<PP@%L'Z'^HNP;AXQ+]$KK"+! M6=*^8IPYD<.0^MF'6L2L\RUM(:XJH>"@:&^Y=O60M."/* M_Z3%Y-8&GW7N++)AN(PB!RYC$/Y7ZVV17"67/YR(".3O\&_X&@)R$[HX!S;Z M4YN1T&N7]F^DZ(?7.O=<:UR?0(1O401N]IL)0ZE]GPYC20.^MC@@F]:KVZ5I MIV56BX8/M&X+DC+WIJ0M:Q[5O[G(=AVB!RP#+UB4!1;8G;9IL(HWEX*6:CUC,U1X!R_D[]-=.J_$B!?(( M\KLPJH.W71G%ES[N%BQ-FW"PXJ[6R`O5(I*GI[[LU6C0C6L^:.0_!ZL^OA6N M^-%94>YT%3K8(.2]RP-=8:.CK-41;E;KZ<:M@^?Q&'8*=Z;AW()>7'.`UTZ_ MT&,W*-3RQO/31#BQB5!KQMF2)I52`K@ZRZPD(TD/YY=@@2U@,/L"PD7DK-X] MMYPB0V30$W)#Y,WCH(CM!T:E+V@=_WGWGL$*75X(%@WCGUY<\SI\IU\E>*_6 M^8\""VZ1UHP;_TTJI:R9.\NL?7^7T8!B1&$%R"R>5",ISG<8)7"9&.*(U#!;X MQED6XWJUWLX@CG\9`4?4E2#[@X/F9\^P*#L\4[LZ\O&IQM]3)X)?]M>E-X/; MK9$(Z52*CXPV7ZD\(VS*2HD#B<;EDT`;U;>LCZ>G1V/=]JJ9!?RF2*"MZG`Z MAL/I0K>5Z:I'EC7JBLPPPTB+:/P7;Q%XCTA='VT^.BF^.?MY\]=]&/^4T8;O4*5 ME"?3TXFFC)\"Y_(Q[6">[RF#CNT;9X0$E=LI)*(%-.:FQG^*PEGJ)H_1"X@^ M/!8K3P`Y:;2H%4[5M%#'@)*TX9K>D\CFR/A M5QAKA4H9X[C1]R*A&0T&3S1KNSU"6ZF#&0J/^.8LV<\MJ?B4<=QKY@)A<](7 M,&:N8\K!:L^Q`_\_C9_@_U-G,'8%XRC1FWJKLUP+E)2N@C1M?VZ7*S]<`U"" M@TBLQO('7K4%R9)+B<\(5\:B:/-[%803*,!DOQ9$;"08AX.:%T.XWTSK4"IA MG);9J%.TQ)!%^VI!CE+SA"5,M5;*F*E81M_JJFV6QQ;E.I_-RBV7L4&YC?+8 MZ)9H?97UH>$QT.X-&\>ION=[11!2;PUK<8O-/D"4>+$7+/(DLS3?6*V@>?Q0 MHR^"9XP/"Z7[SF.-]JJ6\*6.\=LNQD]IY+ZCY&J1YV97FI;YW>8G$+FP%,N. M*?G@_O*W9TR5SMLZQT$;7>'_0/DE4-0'@&+,)K)G<,(G]ISK*E%4$!3<@=UD M5W1;#.#LYD6X<(8`R6LMJ^W]HZAZ^!0DJ)%]_G\?N"CZ'MP'FZ#9:R=^O_$^ MO!D(9OF\XBQVUZ5"=?>36]W@49!`1OOC]*4%2X'"YKKL#7!]^%^[-DZD:A7' M4XC!B>4TZXR.@GPRVEF&TB_\0#G&[L+H)DS?DGGJYZ&^\3-P@??!B';FJ[R_ M3.N`CX+<+[)7:M0GX?^`7P$WX8_=*!2^2OM'EPZX*,AVHCU<8/-L/(U'](+[ MQQU!+'*^3*7>:MXR1M.C@T]1N`)1@E,$H=0:M_],O16"\GL,H,E]\.:T&8RC MYOYRJBTXA2]YK':AI/]^8.F0)UVM?`R^XV];B1_G:!-S!UG>BZ@%C2`8$;33>Z^6I71^49 M'%#G@[@\6"B&X!GM(+@E<1;W`>P!B),GQZ/M^\M%C.-`%Q62UCL-HMIXH%EZ M!AO)_0TTOA2]*6@]';@$[N=TSZ2%R0V`7W6SG$CY^;_H^J.>0*7E^J/ M&4N7&.?'TR-="53*,%.D*!0.;I,0";3I+>*BXT\1@\`S>-(I2U+)A] M"X.H^)\H%VO,2G(BK7WC3(^P>NO&1RTXYN:XV,A]M=[\\S,*HB\>\URS4AKDT$E#^(PI+? MDMO')3N-)_QKWXECOE5-M;RY).E_(<.!C+FI6W9P(R"%H?D>A&\XJ@,BA(=, M-5=Y&02^98[DSYG+1RY^-&["U`)ER33X-0S`^JL3_0F2NS28D7._L`N;RZ,^ M>%"GH0!*EI#H&MTU1.*4.3>I%-B]%SXG>B$"10''2?:NYO;4CT*[IFH'MK4%R<9+Y!GF_$:-6OY` M*V%T9%W;#A/'K_%)]R%UR2_YAY>\UQ;/<77U'#_O`)^I:LVR=$J^=>!QK\AV MO1X^S<9``!;H[3]3K&I)0_RFE5WIP,MV$'6]0UXEV"O1UI[K"A3;?1SS^AU= M%HKO@PTZC_/L&*>$G&BT6.VB"B5:K-H9?/LDZPXL5HH.0S_@/HV.1Z5>V14T M=IA\)4P1%W`$'QMBY!BTZ'GBS%&1M.-=X".+X.EV_0 MN&2WI'&L,,0//>[K06%K"18S\W(?7"Y18#'*!4:LL@&3EN6JIZ\/GMPZ<>JZ M]R:N$P\V6HXUTIS)R%0C+2\S6V:E;X,J<56N-G?\L'#QOG69Y:[:%X0&7KNU M?%#UN'X1`=]7+GUW!+\SVGXY^QW];?OQTLNJ(\V+2+(/NV$9V51)]^/R.UK? MZ2??JZEQXQ8]J:JAE'`B%U\6F[45[MT4'$!&!?;C,Q+A<1P&LC MZG-AE)*#T&VC^;>\X!66!I"GR3O] M#5B.6G9JNZW@"EY?D*S\*Y#\`*`L#ESJ/`;@OX`3PIAFK!KK[0>CVL&@]#4Q3<\<$)`H M\.:G4%%C;\G#!*"?A\2,B%#7@$5&W&.K^Z0UP0* M<"JK\R$OA]8U'@14Z4]U]Y.*&:Y1;L54G?KO=,`H*8?"E/&ZH;QY)N^JSSHQ,0EBQ0=H87>RXBE36.)9VT2IB+ MN(76S@B.+4C%5 ML\W_\AHY09QILN$\M55+>@]97Y+0_?-JC7/#\QVHUFI41\5D/#X]TFLX.BB4 M?*+*)[*YIZ<%(*7AQW"444H;IV91_=0U+"(IAW9/S-$N^F<$`-/3U5C/.(V+ MZ(M/V\WRFNFWV,ZI5#?%;I%!:+-9']4E'9>0VE4HR1F)S%MN[)J<#,2RQC&@ MNP7GEY.Z3#?$9#^!R$7P+R`:OXPUSX`C$0?XGH-P*:JEE%HE;"VOCR!O:%Y&/D#L);&E6L M0&)R#:LH(BJGI-`+FC'1O.$H[:]+Z=(O(XA(L$#P;!+JNNCO.,LNRENZ"-!M M&GX?2HO&K6*=0DB4WEHRAYY;%.YG4%'>W$-KS/QYB'P\?PG#V0_/]ZO/1<`R MZ1+,O@$!GY^,K]E.8&48]7.A2CNC.=*;/Z-_/O(3=A)EK(<'0KA*\I-MOPYSZ9*+*VF]+D$;)`O=!'E M*W$?A;F@H*JF$^'F!FSGE(C8A2=Y;,:L33Q')#C.D4"/\V(/=@O'4++&$1.. MB_46S$H@D%@CK5TKR*06C8)CAD0[R@JS_@!!"N@!U-G/5M"#2ZA"RVI.&32M M_V_G<^"B\+_[`.V/7YU/M/W))NT4SMN/JWS"IE[HXV[`*J9T%+O@DN*,9[W' MJY*.@-/(?7=B\!1Y+KCT,9?AGT4#6FM)A6@!K447*G\M.C'"O1AMNW&(>M47 M]4H@2WRU+OTOOE!8OF:,LS[2XV,[X+!70;,&Z%Z*TOAB*VGB#TOE"B)ICR$. M%V:8`!Y]\6F[65[M89AJ(FD-U6:S/JI[5"XAM:M0V3C?K,+YASAEX6X`'_HS M\FP,C(RY%0Q"(`8?Y+<%F_._J_VH<<039HBT6)$NB"F],6S.Z6I[&+/\Z5E) MV`KP\$/DO7">\ND#\R7BIC2&V0+^H\QM`>RGP-EK]V\=&-X%**7/.I@3+-`! MO<0)K6R_@.>1OC=W^*,'VDM!3&FXN`5L+_VE M!YJ7_G+@=S>HND:!3S-B!V"!0C=->69-T?4XG1<6]YK:K:"2%7A.3"/8RT-P MQ+"LS8-OWP,GG7EPU#U%X5T8+9UG$*=P<#S.MP%KHI%9Q[R16:47W3;]&,&. MC'!/1GE7T,_;SASBL_8R/NMD/#Z;F&&YM,9GY3@,*UBG8WR6`;J7HK26\5G\ M*M=\D4EQ?)8!-!#15^?XK&:]#SD^RU!M-NM#)#[+%!4.(#[+`#[T9^39&!@9 MGU6&8KM7P+>C^'6_6],X"@CKBDO=7&(K#7- M2,W"VY@!D8!(`L(B?0/3R#K6#'B)Q^5G%;&9/R"6.@SDI]YO-XTJM6V7X*V7ZB=\R+ M*Y3LW!04V5SOUE:D#(A=H>I_!>";LP0,KV>7)HTC3&N5L]@C"1<.5FE*ID(3 MA>DP95,TWT(M5;>H5T4ML+B&G?,2A-=7Y]-;ILMK9^6X]>3WK=JPF39R MP.CG#$PQ-N^+-L4CL81'BL0;J,)T!F$Z MWR/*-")AUJ5L,F&@'!`L+-,=M)CHW1`D>;Y7(B=!3>F)>"L[:MU)(!@Z0GIHQ*EH)`7=;V MFD6>H%>P7(61$ZWOERO'BY9T>@FW8SO1Y`"B]+4IC92KP2OB"]H'ZO`)+>L% MJ<97[U3&(UX[T9\BYB[]@"F7&+Q"W/"TC@4$-&Z7(1@>P?]8@01DGC]"4% M_^HV1D1T%;&!O)HCQGDPRQJC/5&8&Q7$D,^LV"[RR2Z>Y.Y"-XVWLE&C]QBE MJP"0U<0`?O1G^MD82(JO5*9T'">(7X/EU_JVCG%J%]8/EXH;!+8YAXE%:6#M MHF1GM/C4GY^KE`;VA'XBTMN8.R5/;T7C2_&SC6Q@RF96Y*:D M"^SS.7#1$5Z6A^K5^40!9=6PZ`$L')\0 M\EG[W48NL(6S\?V9_)`BO@LC+/SVP(-&`$:-*FH7$+7CP5-"5%REX99:(YM( ME[?R2Z+8HW'I8YZBNQ2"H4]'`J%/12\J?RWZ,<(=&6U[]@U2Y@H->`V@@HJ_.![W->A_^0:^A.FW6BN!! MKSI=VGW0:P`_^C/];`R,?+Y"RC.O3OR>Y\/]<'S&%E/M1XTCGC!#I)WE=4', MQN0_4F$L/VJ\O;O9"^`_N@48P'[N9K=1^JT#P[L`I?1, MW9PHC=;H/47A"D3)^LEW@B*S_XIQO;R7;Q\H+Q,XI:$&%@R!>\BE8.%M"F]R M`Q1A8;U8^X8^'(:$"@"5QDQH6O`TL):,QQ3B<39X0C%E4QK98,'B]B9'X=7Y MS$HW9C+JZ>LV,E4G=))B/FBI2LZ&/Q0JFV8\D_3MX<`?/1!?"F(V9@N3"6/I M+SW0O/27`[^[0=4U)]DT(W8`%NA>0HW:YX.BMLF7J_::VJV@DI5/+0D3QZ<; M;1TQAR_I# M5+F"X$,#:""BK\[!A\UZ'W[PH:$Z;=:*8/"A.EU:'7P(%_'C\^F^F'XV!D8& M'Y:AV*[_\85Q?MWOUC2.`L*ZXE(WE]A*+88YZX4-%G`GG=T;?PAC`?-!KK]O M1&H67FEHW%$?_HBO8.;,P^BKDZ!.B#D6SNNIW//F1GE[>OT"]!5=DX>]!5X62_@C`$`TWU M;H(&.Z!>W4*("*Q37QT3O.O4F2C,C0IBR&?63H^HW'SJXTCN3BEINF(9ZJFJ M5D0^LQ1;GGICX/YE$7[\.@->-NO"?^Q.MO!/62J5VP"NBM8$XTLH88R>I1I= M7D$5[+MY-97UC&AQ=W\V1D>\L%85T2B*F5[0W'#`35>3[=P4,4I1C;`3[21; M%K,,)-EY_7SE1#.6UG9*5`6=C,<71X-1&H\H-CYW\0(5@B?S%Q<$#NP-XQB2 M6-88I4N=]L1%9MP]TYU7,>_Z]R!>`=>;>V#&/'"DEC=/U=S:(3D"1*34/K'* MI<)=&`'7B3W/4-Y(K, MN:$3#-2+FC(<4NB5AKA(*CC['L!/O22A^V?QI\WFG^2AXJYLGGH[:63'D=4- M!K/6]W+LAMPGI"^@E!>G=A!&7&JE>PE-N7AO0.1]X*33=XX7_>[X*32TVS_2 MX_*;*U8Q/(887MC%G)80V)CQXBD*70!F\1T$_,5!DS6^[M5L<260V\[+>U6UH!B+!PO!7MI8D$F`PZUT* M(DLN5ZLH_/263@(*T1[G=UX4)P39LQ<7..@CH56K>:4*'Z5)`C1-<^41Q_L2 M"J.*M;QJ+7S7"_@-F50T;;;Z?G3+1BIU@$'6U7=IK"+.?FB-]QAL!\A-"EY# M%"`.=Q,+,'L&L]1%_;X/+ETW3.$(@M:8$(?D)M11^X+?R8*AQ>11)8#^YD-PG1]?'3A;>(Y/<[X3RU8'QRD<'"># MV+:*"V5)*/5&X#_"Z,_[`!\J4*,)R(6MT7FS5`J685J5?H>\_.]9UMM&I5<* M6Z/T9JDDA2A6YW:M:J<'LI:+6*-BFBRR@@9+69O5K])*":KSR,CJ4T+;Y=FU M$T5K+UC@6-P8+==F8`[9GH`'[Z/^!I'8$FY:/V8H>H;7:[AOH^TW1ME'JFNW MHH>CK(O94W-QMP@TA7ZZ_.?X?1M>_$I*.5EJT8QQ$)*B9-7-U!&2QQMK)]02%TK,J^.,&D.C$+>RZS0214$[7<@!\G!##V=J M%)5T'09XMD8NSOD3,#2R?ZDVT]=HOM M`4&$1%=PZ=/`E4QY[J:=@79IRCA6Z5X,LY$Q*K%^FV>/35"Q-&W4%;#; MF=M/UT_1Q=4&C8LVLT_,D(*-I!6(UA-Z?M]O4?)J_0Q6890@@_L"%C@R7]#/ M6SNJ%_?S;FI7YT,3X^/3T9GT^FXPO=3MZB_WS> MW$IIXPQ1=UVP/+G-LIL[5 M,]U:OX%E&*_@[`NH_JO=(E7ISL>3\=@\;3;KH^J6XA)2NPHE)SLN@,N74*PC M-F8=XQC1S9J+R\K8%NA.;)TOUYF9CLMES-.EL#8(&FV44/O0ICT9X+F.?P,^ M/!<4@K->#Z"5-D^KC1JIVF=1VPSGWS4XX'!>&H- M4!0?U+QN6+EC<'B"7>TR>E#J&(=';B% MM#$O<'L;H#EI@P(C,)%V?)M9@=M@5E/SJ6'.]"B,XVHT]:7KILO4A^O;V>4R MC!+O7YE:@UDIY5OYEVS$Q#C-B[P8[&,)OGDDW&XD]K^/2@*.RG+\.VZY)&3E MUU$N9IX\AAW'O6=N?]T^_KNN0=Q-#52-Q04T%L=F6#\)`=RM9#?77_P,)0`, MG]'F=^-TVE$E=1VS135H:_.9[.FRV5LT'2C/):$"3.F)LY[40(M&$<,Z5-T5S`X MSG@T3>(,R03N00FV8AQANNI7B#'A'R[6U$,E6M$A MZ9];6]4S)R'1;5Q>/#D)]683L8SEI."7>0B9]E!F=N\MS3V.7YT@G3MN@CWS MS][B'5_+^K]!^..W\`?5.H@W8CE%)(*B]%$[7:]0I7$2+D'T`"%BVQ5"215@_Q*=]UFW.].ETOT6MN\/*KRU_E$0\=.6H:.95U``5Z5P*^\%X>@KC[$ M+"./DJU4>TF1BUW).(O2.7BKA;Q*UC\&F(U\5S%C0W(71M^@P;B#EO>_@!,) M!Z.>=@M&K<:99KF`=PO#+HY0'T>HDR/ M9:W_ZM,3TMKK#^!_@*]AD+RWV+)Q-%H9U-,Q'-33`1DQHF;%UMTM(5)H]TSF M)+(?KS]"*53,VSHP4`@9)9N_@1`/?EY\"\AL[4`^06RL>=E#')2[,*4=S+5K M[$`^,6@DG0$/DGNPK#SNP;('[HE!(^DHV6CNT=\X8E?:=R[1()!UO-SK8TGW M*,("O#J?(/[F1!%LZT/,48HN/.^Z-;)&1[C5T<^;=K6_/IF+*O#Z)*.&ENSJ MSN@7C1C&'>BIIU,4DX[BFJ.D@C"@(X^(+M7Q5 M[LEX,CG2JU%!%7'JF"JJN3=1B7(T7EIIJ#4,=5.UQ:GM!GG-O(+R"CZ=>",. M-::/5&P86FW02C5BCUM,[FJ+7>RN%A>@FU/(^\;`[,(JC]C01]";O.Y0\'=N,7;F*OR45'(&?6N1G,(OH5 MBP7`^BZ,OL-U8Y0X7@#E?`JSEV%V?0U<=>RB0WN1<_U?F*%_.9:E$8GK-$+J MH%@5WNIV44B*]#F;IGO%)I2OH1NAMBWL*:<:`"CHR"G$[&TQ-M#T"C/J+] MY!T<4207_X[B07P#_Q$GGLN4NE6+U6%U#(?5A;%Q+T0-UHV*;#0L.8=M`0NT MRL!;T`(RVC=X(%T3&);D-6Z!RE.4,2)`J[KKUT:2&W):NI8KQDZT91NT*I92]1A"16D`M*(T5V M5QA<#*%4LI<@(@++BB2IK43UG*WF5YR:+J.>UE@.7[GG=?+[L=44]&%6[8*\' M=@KY>*[9$E2QI@R$=E?(I'YCN%8GUS+#ZBC#1[LOF!B52I'[6XAL2@I-PIL/ M((:+PY^LPKIUA=FS-(DZI0,(2IS`%%O(V$["/R;E;L8A:,A&PQ(E, M@0)%?.((@`6`?P1'PY*P,42'[<`0%^!XZ.776]1D!.*65_2@_R[-KO?5.2'Q!+_.`6; M7<',H&,3#$YU_FUK;'\ZU0L(2ESH%DIML#(9!_/?4\;VY!V9/49C_ M[1+YM'#.!3'&<3:Z/\3K`DA7?_TTXU\`%NC%/?,8N+E;UI1'@+M^%<93"..) MI;SBE+VKG]]T"N&+[9>S_TYYK@D:Q!5M)G!FHQ"5_2PDTX0:#_04Y?`J/A;;E'1VBSZ`,C"7+INE"(G M1P$1W)+>A.E;,D]]^%N8TEHP=1\39Q596_9U82!@N-N[4F=:B`\1>$*1,GZR7<"=)D= M75]?,8Y[^!O86UZ)(:(TAZ\I+&.\V<;+,T83>\LT44SV)6,OQU(7_3\M1V7BM1?I@.DIN7DI2F^ABNH91/5\/U@H"(E9V8%[S3LM8`<)M?>6 M8`)PV)AZF,/LEV/MH.G/#UTZS+N4!O>9@AT0LC&%<7T:$$FJ3T@>OT=LHDO? M4U9B:Y^ZVB,2<4+1^9"=&*YC'J<$GKRJ/?FT1ZRAR5[0I+,WOQ2+81))2MM? M_A-Y0B7CB"/U_)U78$LN0)(E?XK`RO&*=1['(II>USBVM-`U+V%X1.]ZJ-TP M%YV:1".&`UG<3]^NW7VB7U=8NIJT(5&3GJSG.`_ MOB%5L9LJW!)W/8"NYMJ\W%6* MD4>O>)6>?7@"4%QLA@/BVUZB\?1G_/'TF^_A@/KBBYMP^G4EN'X]@OT>%1W' M/VVZ/GH,*(U9')!_`8>!)H/T/8B`&RX"[U]XL#6<@5!*#]<`Y\I+L95- MG[>!@838`+I9YF;^MFSAGD4:"L^8C2WNCTEJC8:D\..N*S=B6M,VLA;KA9LT M@G8Y,\<[Q)+9M$4,4PZ+]FQ9TDA66@#XF8,-3_[_!9R(L=A2_+4#%3LAU36\ MV/0EF3$SL*U+N_9P2`H^)B__5+IN;\!;(N92G8PGNRY5U(A>O^9#&"Q>0;1$ M/6EP:)*+ZACF4&?HC5\.]8Y0ECK*XU!, M(H:+4O/=\:H$EY\>;?M<+VB>[H1T4M].!^$XH&W3)=,M5;*F*E81M_JJFV6QQ+EHNW8?0"W8RG*F\,PMO6" MQJFYJ]7E%)%QS*MYPJP*\,U9`N96A5;<.,5R*J9)HPT2:A_1Q/7N@_<61N@Q M">J*=Z=$5;8I;._,).TU**&Z[N41S:P]BYR!C)Y,HNJ<7,@6M0M(9TD$&&G: M8DS$M.+&$:#K="PD*"/81O-8)HGQ@+;S$7-R;JHV"'53U<6G[49YS9RRO]QF M8EPN(@"0\:-.W922@]!MHW*J4[F(J#9.Z40(X=_N$[`4,?6;.H,@25=[SY:6 M&N9FBH*_.I_(C7`51E'XPPL6U\X*_I*L!?1-:V(0ZF>KCX\"0@`HM1S"EW&) ML\.3LT;F#XKIQ.\WWHQ$`S)X`CFO*92;,&`*UK6*(#-FM/",!<(?E MN0F8(5`N`_Q?*`_VA^.C?.N769I$.&Y0]B!:&(E@*U8Q2R8&9B6RI_B32%!! M,>'_7C\#^(\(+\\NY[`77^`@"Q:W\SEPD]?P)0G=/Y_!*HW<=[@[)[JB9#5N M%<5Z@$9I77I,DSAQ@AD<=R*.M]VZ5A*IO>22;H=\@.@M-)M%Y>%U MF=]AO@UHP?<"+>P-HT3DEY0V?@"\>@;(P0;'5Q?,AS9F.&%APYSX2;$-3+C8X&(HW"-#;:*BK M.(7A4P@[!I)\JUDNL>U\S+IO)*7MZF";C"=?*WF(C^PH^DRO8LS\W MWB69VV+*)X;`P3[G*[E`4B,TM*25<%8>2LJ.LEL]OOG>`JLUSO/@TCQ0S$IV ML$=$HW42M4!H`'!QJZL/2K_M,`1XHE(8!:G+"Y)G(GM%-JS!PF0:$6':? M22,.C%EQ?I(.G]&P@1`C\1V??4)(+'N@D`@P2@/VY,PXMW'B+5&@&,J-N`HC ME`$SC#=/UJSQHZ1Y4LYGX(8?($+@W0=PV8=?)\4A0J2$J9):WF?&J8;1K.@_ M7GYVIB$W3+`W)Z?[SC91M!0DB]:^]$(C;GMDO"Y0>IQ#'<3HF4E4@#:/\M3= M9]YU!TI2I*!1E,-0YZO5T@-R;+\!N]*!9*T04APF*/Q.+#EEXFSF9?W*;]"] MAM<@O`NC34QDYB.NI0H7J[S/%)*`E*1H0Y6Y-U'^YL?YC8[;OT@1'*N?+NR27A[YO8U?8=ZZT0*=@B1J?^(8EF@+=MP\09]#DR3T? M5P"%I0>+[,`@0TGP,>&C\9%@,'SY=>&L.Z.\/Z--AT:X1Z.B2_L6-H\I>GYT M?GYR/IE<'$TOSC5%#E09$E?8L^%+"AKV74*-5(/T1HO0F-$>2<#L'GG&C8DF:27XPX%>!'+)M6CK030`7!:?+1A/N M+DPC*7S;-'2@&S\L"@ZBS6:;]R''NFT:.K"-'Q8%Q\H&L^T5;O&!@S(Z=2/; MMIT#U[A1T?XR<:]4ZT:P`ZT:L)!UC!RBP.0RF53ZQ%[>(<[OH0^['J-,ALE: MS+MU7$_U4&[R?XVR1O6ZIPK-X8.V(D?>XSSK6H-;BK.NCF&/4[3A4T1&.H9J MH2IQIY"XFG,F"JFF/%(YY#(W,<*F\YF84*9I,QQ$QS)G&9\QA+1K,N4RO@12[\UBHS M[0Y/54NY(B*M6;>EB5OU>Z&QUOEU*/'2T[WC;EG& M:3^$/"$EX!5Y"?_8:PB66[\W7 M=V%4!>\I"C_@DC[C1-4GBT2NA]Y4K\?630ZREL=X6:U)_!"[Q!DC$5O$Q3Y MYD32=_&V@-ER>GIV?G9\,3V?'IT@I['&9[_0U>$BR2;21:Z@Z*N3P!$7+"J_ M9V/E<8Y_I!T-=&W7.//25;N$PP4E&%ER:ZP].-(96849]O=<2 M9&`-J""T45I2*%JT+A=BAG5U:_3`Q38`*M*XYD>JVH]G16-'#_(4>%!,88[_$FQ.#XJPC;EB:=6U4 M2QS[)B$O[MD5ZEEEM*%3QP4>:_'5>ENFR&3\PXEFS+08LMHWSB;)H5`E`%XI M5API'#0%!"'#^\U9`D92CG(1XYB@5F]UGC2"P:%J32\;%EUGINFH%C).W8WP MTS7&D$C[CHK\S,B/\/4]3&,GF'V#ZZ7"I9(Y]0.T-(=S.9*.^LR[8`O&:INA MNJJS3X;`VLD@9[0_([/'L.J;WXW3>M\FG8T$8Z>K>>K&_6:FURB5,$[+;-0I M6K)_V.;'%4RU5LJ8J5A&W^JJ;9;'%N4ZG\W*+9>Q0;F-\BA-AJ3I3E,Q<(#IR^ M@-$^%Q$WB\^Q$[^&W\+"BPYNO`BXL&[\'*H(S2J!$Q:\HFS2J@D0N_YY? M57B/HV!NUJIO9WC%6FH!*4U;"9X`>%W63/)J'O5TBE3VP ML0U`9JWIR!:S*@P&)][Y([HYB*YRS<-HZ00NV/Z1;ADE-'O@G&(LE>;6U&3I M*L[.1RP1T]I1RQ_8UQ8D2]Z0(HVPYY?O(G-GMR'IGS3G1LVCYD]._`404B=4P?%O^+>WC8-?)[U=Y-8 M4S8QF[]H'F/5,$@B55N"JM2Q(NEB<>E^U*L3+4!2R)I)6+DU]05E0T&W]XC[ M+M(%87FM[Q]K^P#0Q@=)M@&@;,6\[2IFF^\"YY$J(DV8*G4, MZ4J7WE97F6FYC^,4S.[1=2"/FH]?ZC>JFCD93RXF^\1VI3":E9J=N!1I#<)7 M)_H3)/A]A&)>S!`AK$CD?V3_6-LCCDHSQ\LY3[ITD]3QU:ZCI7]C/TG;#XQ* M\]:;&NE$4T]V=A)C&.-BAOH2A;%TCQS]2_M']K[!5)J>7^=K0]G4=)-&*$L1 M!B&S$97SP/E)4%TO/NX!_-?C_!FX MX2)`OLH,27Q9-G^.M/$Y1T5?VU]Z]PFHC0\:<.'W+0P^0(R6;SB"Z#6$6)5_ M1QA^"Y/_`LD6W2X#H,WW#D.@'T@[O^&P5Z,@LS%W893_"96;]#TTB)VH*O<4 M*O?D,%[ZPEGMPQF;0=1K\IV=>(GX\L/Q?!3_``'!^Q_1I#Q'/$EYBJ^.'N>C M[+NCS8='\,LC_.E#QI[=1C$MSR?3T[.3LZ.3D_')5/CQG+U.XF.`P51``,+V M42E\',E>-!U^=\KK8P`YU.J-$$S9!(;YJFZ=U\<`=3?"3]<80R(SKVH^!J"< MI.:W-)C!GJ!_)NL7[Q.91;2%!S.J=PM'(QW!]9T! MYE$!`7H[TFE>#VCV\W?,*6H`/=1JKLZ49C3,U79[A`S,*6H`]YJYT&(1)@L8 M[4<&1B9;-(`UO3&@3CY^@"QAS\%%:.Y,>G`1,F2\_6<*5PKW`1RO*4;\,7D' MT>N[$^37IS;!F-GF7#9-1;]O'IN-]ZI(@5B2G5YE%Z`2)TH&[VYLQ+5Z\[#W MD5/]?%6KY^/)='P8..H1[L<]:'D:,+Y*X1-_LV>(S>W1P&3E\02TK1E.UN;H-] M&CA_`!0W"F:7'R!R%B"[;0B-QYWC13A#EKXQU=BUPW`S#GU)B:?VV,]@WH`4 M[-]A5)JI`DD)LFC1AM9-D=6]KGG#4K!_AV%II@IL3`RF?!N=0KJ:-R)%.G<8 MC@;B;V.6,A.V"L/:0UJ6_&QHFTB)B=+H#AU#;P:DPC<#3B3>#/A^N!G`#@P_ M/3[<#&ALOSJD+^"0/K;F9D!!@-YN!N3PF1LKWO%F@`'T4*LYH9L!QFO;JIL! M!G"OF0LZ;@8TTW!(L=V*GY0V@$6],:+QI@`'4):P:C`W!DS@9\\SK"((#S<& M],?4F,!F->PR)J9&KIW>XY-\HVX,'`9.3P@?;@Q8R/O66>)=P;DODC..3-?!K/;SQ5`'KS7$/WI,4WB MQ`EF7K`@#A$S.K5_$X[!N"M];=JZ+4\)TYWPF&>`/._P[]=A@,^>4\=_!9%\ M5[&*/N[?B!R.&LQZ&]NX>8X36\,F0LY>[]^X'+)B#K\80_/"L#L&W1M`#[6: M$PJZ-U[;5@7=&\"]9B[H"+IOIN&0PJ.?0#0/HZ43N`##$C/#[2FEC6-.;RRH M$U`$(DLX-)@0>Q.8V?-\J@C"0XB]_B`4$]BLAEW&Q*#(M=.'$'LS0NP/`Z8@]5,JGXQ`\C1QW(BD/LK1L\)N]N#@.G M-XB5!]@//Y)C*`'V>S%J#,;]$&!_"+"/]V]$#D<-AP#[0X#]_HS+(2OF$&`_ ME`#[O1A*>B`]!-CO28#]7HRA(2G"R@#[=+ETHG4>7Y_!5@2YBT;6GW%%UF7F@`3VG?,8Z<:MBCU3C*@ M/(3#T_"KQD1_B<)8N@VF?^E`>]5@6AG/CI94]W&<@ME-&L&!GX&`\8I+ZZWX M]A-$KA<#:HBM<$-[3%@Y6!T2LI-&<^EU:551X?0O[3&G>P)3<93W0%<>MY\K M+\)U5).>\*4#Z56#V35&VT[2F[3#M.LU`+U;S(FT2&J)EQ+,H'S+NPI]?_XP M(VA!V*SP9J-'3+ZS0CY?'2.F]OG#B-&"\"',F#E%[T1P%^Z(I\AS>P@Z9GW] M,%YT`"PI('F(KG_JN2'1B:QBX,CKP6'PZ`*YI[CB@8V=`C>MPT>H$U7E0M6. M3P\CJ"^W\.H\@,R(M1 MIB9*P]0WGCM[EHP890;:!D@[WL..EJL[VN8.'XO*QN>3Q_&1Z_(*LB?I&-U MLLDUN&,:+N,X7680?8_1L@ZN!4"TA,O+C:V`2YIV:Y8+KC5+WC.T:"GZ]DO> MN5&I=R/4O=%K.-IT$K(SVJ^._)/QT41S:@PY M%.HA^WJ.E;GYN#MF7S>`"VHU5V=*,QKFYMIOCY"!V=<-X%XS%V1>;!`$QI+] MBJ+LZP:PIS*!+9[24)M>= M&#J%FI+"WP3&]KPT4P2A>2G\VT0C;1P6):_!YKA*10A:XP?-XZL:_D@,*6N' MJ8+Y6_O&M;6N6!#^'OJP&1_*]>PDTKW8_%_>\Y&A`5PKWP%0@>6-]^'-0##K M>X"4OWL8'OU"V_51`NL'Q[,7_WD7`13<`R#[DKX&!^F[A\'1+[1='R\P.5BK M]@LR&4$,A,\ZIZW>EJ[\7'SZ<'IY.+WLX#PXA:/VY'!Z*8*5M:>7!G!!K>:$ M3B^-U[95IY<&<*^9"SI.+YMIJ/',Z1FN!",/;9KP"@7+%._\\7O@)?$3B'!L M>>""[1^I)U(RFC6.7KU1I7I>I0Q+,QE9.L%%]T_8AW7Y&IK*P_:-'=BG!,'# M":K&$U036-SS\E`1A$:=H%[ZN'$P(PN;#TK:;H*KLGD\4J-7POZB/3Y*3RE/ M^G"DW0?PCP"N*Z#(RS#`$"#ITZS9QSG$PW/AO'#C^2G$*"O_$,9QM8Z8=^UL M/-GUKF4-CV"KHZS9$6YW]'.I-\C-AOLS@AT:Y3TJ:OZ,.O5OM08T^]YN'7Q! M$Z&%N]/@5:,7U^LONPP2;X;P]C[`"W!3R%`/Q+>?KI]"_=[!@5LAS:X8?$XS M&1^I#M,S.$S/]9JQ)@*0?6+*H%`1Z$U*ZW@MH,%MMA1&%) MR]:LY)-,++I.+].,>0'.QU5_8N;4`+MS^>%X/K*YKV$..CI!>`]]*'F,ET\\ MEJFY%2NY)@,#62&O*(U*C6%G>ABVD]LD>T(]/UDHIUME\4NH#2O9U1T!21&C M\/MOH3G):G>7C"P6$5[+V[&237)0R)G6 M^=DBXMRF:?4$88GP0:;CE_"-+Y-LS9G!5#_B+!V?4XC7O>&J#L['1RA)^="9 MJ`B6G)IJ7O_1%+9*63#D([2V;A!;>-%:L9)T,C#(&=;Y&1NB\=/DMMA=9+"G M4DII*QDC(FO.C*[OJ-`68+JN2'1S_%XNPS2@!5A(:=M*WJE#IG"[=GWHI'&? MH#)0ZA4N`V+'Q1]+W6=>L*X7-(X`'97$UCI#9NVS!#%@+K-\C_.K$+T:,K_Q M(N#"FO0[S>P*1FN;H9QJN%L+&PP)%UP>P+"!>1LWKWW-*[YOFP MBU%2T$-^%T>,*1/DU'-RTX'G\ M1?T\/F\()QK9]K+R_/K/14?_?82ZBG,`YYW%U8KN_GO6".KQ*._R"/9YM.ET M\3'=>8+S;L`%6ABA?C4<[M.+:\[MN].ODLZNUOF/G%E\>5NJ#M0I'*AGFMT" M#:JD9.+M)*_!65@A]EG*J#2&)CN.BP''.`9BUC%/WY)T2&"',`XJ0<1E\4F%[:$$"V$5."DU+A*(ZU@FXYO>:I6H#L>0^BFUJ[= MV\)A5G:C_,Y<)@82OQ@+%!;0*YBG^[8:JBM;4&JS3F6EGF@T'&!8S0*FC))6 M#(;E:\C\Q%_"<(8\P\7"Z27T:;=)Z15L9H:@U)(6$X9=+<5>^*!]@=AG'((E_`_[L/OC^0@_3H5:Q4>>MY59Z MU*C)!XP,X`_/]VG#/__91AYPR2@ITX[6N]H-!\R;MV*_@:18+UVM\^-:T9/C MHS8GQZ5G8V$?1D4G1E?KXM3X=;ILI9^ZGKF%-?>VU/+&*9E; M.52]<@IIYBG>E1=^06_6!S/XK[O0(5_(9I0T5:&<6JFNR45D',*!'HBN_3"A MG^&5?[=*D>63E1M:H4*OG6CF.>ZK%\V.D+Q^`AB M=3I,7K004U8N8-U!BG4?[4-#;"*CAG&$D.R+YI;9J+C#5M%D!BA/%/2ZVIBB M2?)$T@Z(3TTX(-[0OW)"O"W[@%@'"XH>%A^W.BS.>T,Z+2[5*?IT.#F6DP8\ M`QE=R;^%"HT@Q:_3.`F7<.*!VMH)H^'-!R[>J''FI=V9LS31S3V0WMS-W`Y* MQ^>Y8;Q;WCR5RU#80T1-"PD*3:3[#+=(B! M^Y=%^/&KBW+>1>N,#?G_V"5"_N=_U.-/-S^8IUHAU90\`VR1M.N0Z.BY#[#A MROI"=>X02MFC-@'YK$D(*S1S->WFVS9G'H7ZF-NEHG5P$DC):"91(V9Y$'H* M,?>!FX#9WU,G@NCYZSLO<`+7<_S2WEW,/3`E92'+OC+:?&:T^4[52:!WR\^! M1:,?0*`-S*KB[:F+R71RKFNMOS&>13Z>2_>?J1=[J+?QU;KTO_@\!'S-5$?5 M,1Q5%[K7(5VUQ_(==`#%X&UBL9FZ]ITX?ISCW,@\WH+=\N:108;B&/X!+@#, M57RY^TS'0+V@>:H6TDE=IYPB:M]&RIHG(P_$ET]%I['8S/-C1@WCN,"I2Y); M2$Q(2]A`,(X,\T\I;1P+%!E_$?$YGAK3E'V`)`7Z9P0`5M+!29!#:;-9'U=W():29*OS=\3_`I_N.7N!DZ9%8 MSDIE\DMJB?>8`%J3AYA5Q3A2]#=MLS$P[/6P%KY=`Y0IC#JO_U:2E9YF8SH` MB2DIQ#JDA;)#WTWB*;V_JFDU_@TD<.X*E^`!RDY1>Z5,%9F3\=')9/"*;Q:P MZZU7\T;[K1,%7K"(GT#T\@Y!OO'\--D>R.Q0@%+:1C*(B-KU+JQYM$`)$K^" MY#VO\#L"UP8,^P$5UT;*=-><$GW<`U,1KKG-B`/_'_P]02P,$ M%`````@`[7151&,=?(UB&@``W#`!`!``'`!C'-D550) M``-NJP=3;JL'4W5X"P`!!"4.```$.0$``.U=67/C.))^WXC]#UR_;'5$NWQ5 M];0KJF;"9[5W[9+65G7W/$W`)"0AF@(T(&E;\^LW$[S`"SQ$-;6Q?*FRB$0B M@?R0N!*)SW][6[G6"Y4>$_S+P(?%LQ@[^]M=__[?/ M_W%X^/OEX[WE"#M84>Y;MJ3$IX[URORE=26%Y\V9I-;SQGID+]2WGL3)O?7S_\_N38RC$6OK^^M/1T>OKZWN)M%Y$^MX6J\/#J+1+X@%WR*>*/7U_ MDJ1<124+_LDZ/3H].3H]/OE@G1Q_.OWXZ?BC=?&04#Y`5>:LGM2SEW1%+&@- M[GTYT,1[/7LOY`)R'9\<_?YP_Z3H#D+"3V_/TF49!').?H=()^P)]),W)^?GYD4H]L'PB%]3_1E;46Q.;9LAMN1$NFZMFQ8J? MG9R>G8"&78H*O!5R=4WG)'#]+P?_#(BK6NK`(KXOV7/@TPQ!P#624#X>K,IK MX_CRR-^LZ1%04,GL)(/@#?((?IC+!_5H4J]4*8Z?T.M-_/$H3(Q)`>!89*KQ M.?&>%7&'2&;"P M\(_OCW?5%4""HR?@J;1R);@':0X"_)*X")^G)84N>+OL8*V8&>DH^3^61-I:J'=\&=*[&"-EE2[H&1NP.[ MNJ(&+;;A8M;QJ5G':<)D;J5%65"6E2G,"DL;4=`6!5?$6]ZZXM74:4O)S7H] M:Z%7Y&DIIJ/ZVJKO:0ESD:5P'9BXW/PS8/ZFF1Y+\ID5^J&%0G7F_VF%[$?5 MYE5[S3S;%5X@Z2WC,)(QXM[!+$RJ*:OW%*Q61&XF\[+$!THPGW/AWQ(F?R5N M0*^I3Y@;]>+=L#8!Y`-8\A,`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`9WYU$'AK#D4TN(T8`"=%14Y0J([)&[FE'-4"2&3`"(YI:X!Q%*W7$1K-UM5BMF+^*MM^N!/<9AQ6IG5FT MW`8^D#Z`C*M@%9W!\<4]Q;4PV:C,5:OKGMF;,71:LL9.!8B.##41LJ`*Q;`B M.:Q$$$M)8L6BC,!J872F5*(&!%<'0CCT!WZT:KDD'K-!)=?,#7SJA/3WPO.R M>8R&J#_V9F#]5#S9B(P3<+-"=N&9E_5.DP)1I>10T(LDB7.^0V%^*#`8X34$ MO"YUC\U=U:QW&=:C MI>_!ZZ6IAELPJ?.',6J\UA]F!$'SX3YQ&7AB"\[FT%Y@:6U;!&HV/X5\.)_/ M#^$-=MO-Y:N*\5*.OIEY(HVIZ\B#:RA>H M1IEG165V\.H95=W2)Z>1BTV-ZCX455?N,3-JIUH[OQ+WA;[92\(7-*^43)I9 M%Q^+NE"Y?P]SCQIH[WC4U(^H1C,EB_Y*MZ!13=5J>J`.@07R`_%]F&+GE9-+ M-:OD+T651/FMB,&HB*V=K#HZ4M6H[N>BZEHX2XUJ[>X(U=:5J4:1YT5%-G%& M&C78Z!38<*IKULO)<>4>M52887>OX@JCD<*LGI*-@_%.8CNMW*S6KMA0>@DKD3GSIR[AA?Y3 M2F/63,F^0,S%BMA8BL^H&T./\87]!QX"4^[IAY$&`K-62G8(%`M+YS%JI)U# M0A.7@AJ]-'<*&)53K9R9!'M";"S;^XWYRT?JXAG=E,BR#>P::K/"2G8/='X6 M,K0BCE;$16\96*A23K);.+3AB-RA66,#A=;*WJ&<1`ZNEU$>4V*AD5<\691&T6'98R*;NF%4:Y6`Z59 MB:=%)5;$A1GUU:]K1KDBN[`P:_BLJ.%.P5=&_7?SURC7LXG4K,\/17U613L9 M5=;9A:"J=QJIS8K[J:PC5D89&777UW%VN2K;939K]N>B9EO%`1EUO?49=[F2 M&^8R:_>\J-UFP3=&M;8Y^"[78)'`J*SZ<`>C4K8YHZT8%FLSF)56L@BIN1L\ M:K'],53%AD`%F5EC'TO6_H4CJ5%-'<^F3*:PE-*LK)*)9^7EU5%CVYYZ5'2S M1IG,>BR99M:?@(PJ[>LHI$JQS;.:U5LRSVQZ+#(JN;=M\V]$8FB1EZK@%AVY MF%3_8=LSDZ2T,4!%CTA(@^`\!>MU^-0-<5,N7OK>@M85MX+-=D768:P0@*<- MQO1H/+IP&DEV>\Q9-Y_:CID9-_W<4-?F5]:(D.X'H75(:);)K/'&%]O' M27,O.DWF%=\Y"1R&GKA2X'./!/I4X&+8XO1=N#9Z[\2X#AN-#\ZU*4M2O@4" M6$H"*Q(A^^K="*/641,J`%%&8E9M30R%43/;N$+4C^`-\YEUV";:PFB]^U)N M'P:\5]YU(&GC0S.:\9WA*1NUHP(8Y41F#=='^!@5M),'E2HS]/6\4FT!9F!L M%S^D(D9],>/8_WM]?`DWK*7<,+Y0&R_J&9-(;'H/P[>3S[CE\TN=RS.#KV/, MD]SK*I%DX1Y4],1*+)REI"NR^&&$8Z]PC"DO-X]T+63TGJDZ1=\:>@UXU\&L ML-'9'F9)CLN-E5FC`U\5Z+<4;6T&2 MGC*ED@G'4V/D#DWCGR]J'=P[>M9FX(Z5RMO6'RVM8IFW[WY4G+7*95_&BZH7 M31+,EGGL2;WTI'B5J.O!?)K9!\LZ9!:>Q&J(S'3)F<'5>'[9T2V\;O?)1&K4 M<5V\M'&/:0NMI6/.=VY3F($P#M^GPHLD"X]<-]IC9)M;@?V80HNAE^24K-"7B=2LL<9A"$>==;H)5NOC7IO!K+]&`0M'2[FU'C5W M<31HWL4+M"%N]L'$\*LDE3N:W1G5Z;WH8EZB]XPKN2K/2@I4V^*X$[C9SQA:;:YL:B&]LZ MJ/RE)53B$YWT3G5:?@9'HQ'9>H#YC;+%$D^<7Z@D"SRT"U9AVWX'T68"FI?* M%>-4NSK6%E5]%E:'M9_;#E*Q3(>14)8FE85B63-A)8)9LR7-75X;H=CC>*:G M1.>T[:U7+:'F@`@'-,IF5W>4=@E&E/<3F>:0OE`?4 M0T]?Z+)4OC";XA'15`HGL-5ID?(G>B!RP;@'ZX;H9@!,0D+6E9;ASRO9#*Y. M[R3@S>E0P!^5&[0R,)&0XD%L,KY\HWZL MHLM-I(UN4&S$L@YCQ8W>!AC31B\HVXH+1T?5J/@1-+V`)IG\9E2'I^G?P#:OO^;>7&%,@^@Y&W M9^F^%W)Q='I\?!:")-]`4;DQ"R+M`I?7,\7CY/S\_$A1`1,!,P6,S!HZC?\XER$W2'\`-46TK'I]` M+2HE*,V#?QRFF3LT@>/+(^PP1SQ84L\H>>(<+0M:-D5>:\8BZOA=_:8W# M#*)5M#^Y:=T3]'SQCRI):!B54LU+82CXQ[6P@V@E<\/!^FZT>>+%L^=+8H,R M4'"PRLUHF:O\E+X<^#(`HQ8.12@P^X1!Q/CBSJJ8SE+D\JE1=&;1CN/SEB1=A.Q8UBQ(`] MR\I:\GU809\`CO9R1NTE%ZY8;*8!_`3+FQ6[EFK@2B0[@"4W;%4H^AE]\R]= M8?^1U*A5%E/U_)ANES6<2I@.2/4-[_?@.(V&)^F@N2[1G'Q8Q:GP6&!44V1E MZV%('U;PC)7DS@/AP1P:.<`9UR,Z4V!S_S<7K[^(UVR5.N4MU->;*S5S2_I$MA;5R<.*?<\X!A52LMT26UV\O6?02^#WYI&J[J*6 M#7.?RJ_L!5!U,Y]3VY\)Y:'Q2->1[8YKVBO'_9R$WT`Q&%O#^@0"@`A@A8YR6SPO[8#3-;;M]:W1IE'^MN MGB7'U_H4L.-)#E[MBQS[7?H*_% M8O>0_$3(0#'X$H'9Q+VF)6)7I`TKL!X'N;"PJ4K5;,%XNH97%ON6 MI@O_+AGW?M1P_$_.0PX>M$^4R_C1XG`UZH1#35*"(95 M1;CI=0O+?"\5LFQ?K(ID6/%O`U_%18E"E?A3LE&MG)U3UE+MXQPRVN*KTDIU M\K`:^09V$SXXU,G*6_)]X#VC,BGW2T35\X@]8YX7T)).64@:>F+GH9^/+).W M(FU8@6?")V[]Y+^>;-AJ7#+QU0TH3%=F>2PW(QVZU1\G7R69^_E6SW_>"^L17B`I MM1BYI*%!4OG^7!XB]83[5!63]'LB,"[Y\25)REY0"NB$PL4-\'!C`#<)'L@; M6P6K*[(F-O,WR?JZ0\;]W#^HK0BLI5G(^IKXM'D#%/*9/`R`8E@]QW%-'UO5 M,9>K',R`9!#6!GEV>]1J0Z&.=C*L[W=5IN[E"87^NH:WS#W9>2_X`EU9T"G' M2X)N/BV%]'.?ZSP#^F4^N`_!`\%39G^#W>V2^J^4\ME24OH`Z^LE5F/"Z=\I MD;GU:MM<0R]C=8'S2]G2M(&/`321\*(UTYNW6A75I`.O:0(/[)ZGO[LV#8T; M64"7"F.;3EXYE=Z2K9.E3MM<0UI2W/A_H/Y2.&EWAU5FZ!Z8V7!VPG""R=J_ M0T;3SJFBZ[E<')U,YF":L(S`TR) M@KKF_0QKR8;>=6KQ=#5B\9)XZ>9]Y]S[N`?;JC*)Y\(#D7]07P6UZ=0J%8SV ML8&^`A8G/-V$O@[H3.#]5K`I"_3R>".D+V9[N9]0C)I?7(`9209?1ND3TQD:._];@"", M@U7#NC%TG4IBC5+G`CVJU/4M:"*5\)VS5./]LAQR;AQURW#M?,U>F$.YXUVX MKGBE#@BL5HKASE>N)S?,LI\.I@U>E:W;;&B>4'T52G,&J2/:4Y>0ZE>! M,XXA]61#KP6T8^:R^U+%M'TZ@\Y)7)4X\!T08X^M1Z M^XY0!4D M=+1TDA9HDV,_!_.I\#QU72FMBA0VI8YW*\7JB;C)CF0RA6F38R^GY=H#M+'H MD_DMDYY?4K=0L56-T0^KO6REJ\=+&#L+ON_%SP,/_JEUF00^[@TX&+93V9XG M6%>E^]&U=+O'E";2QO4I+8Y_45(*;M*\9CR1W.B!*-[H3S?EKIJLM*^AJDAF9/ER!54F=7 M(+54`^^($8_ES&3VT]#WM]W`SSL1YS\.+6*T%3(5+K.+VV2&]/W=(:BJ2W/Z MP>M6[BI34;&FQ(/7ZIXNB)MY.K:B1DT(!Z^-OJVVEM1FBCRZDCT3TS`F(CZV MC1/.M5JGU.[/=64T?&MH[]7@(WGX&!H^>E5Y@:Z<:N"[9UVG-JF?X525M_5< MJ83AP,&1*LUG$K^JUM#JE'NY]@IA.)E?"E`!AJF"WN@+6;@X74,U,(@%G\R; MU:09Z<">])(X=`5+!^4'&+Z7%0=[\6#H"U:!,I1ZB*7$U;Y;WKWT'5!NON&M M<.)FU5B>-/@%'EN=N*$WJXK1$T;F^86ZSAW__I0[EC31#;F*SCX27+#DT=/! M@;\4DOU+]\\(!SGU8G?=J-\GZ^'G`4FUFKUM5]7U!%GP=1T]'1!"^FX M\PUOK6F<;..X9I[J\OP3<@7$`__0W3^P-O=W0LXU6 M1YN@%U[I=>6=<-Z7NUU*5C53]G(?U9%6Z3E7U5VPK7CM32>Y%8'LT$D:9MN; M:MY@^,(RD]>BSEUX_%]=F*JSKCN8YD@5Z=M3X^ELF<0/^Q40#W,NCBM.]=;, M3.`G[:PF/%?>?D7;HR2#GA@-V0*YAUV3\^XX`&M`7+PBM@_*:B[JP!L;0S;2 MQ6(AU7,;L(23L!AA=N9FP'Z*MH]W#:8P:L-J(0QN"R,V#M+)$K,\S;2L5*VZ MPW7EE4L\;S+_C:`J_8E4LMV\P7J6>1B+*/1=\!Z@QZR"E>:D[>E^/]'$78U: MR7G[+C@/Z1X4R^ZHFLQ$,D'-7&I+SN*3<_CLU;&MN>P2+3VU0>P`-F,K6.O% MW3>NRIUWR1:+T`AH3AEQ]JL%DGN6B@Z(JAU92>;L.)'=FR)Y;93P-/S6?TC7@S\A8&.\FM MY\O3AHX%'(5G!Y5_QXUJW%\%(:YAK#A+J[5];%=EO$7L(P\0_"D`%B M[K_"5`;*\]('%`P$^[BLC\-3VC;U/"$W4=B\\AB6540#'_`\PRR*^M087/$7 MPITUHX7HHETS#QW"&U^I^Z^`0]>9PHJ:V6Q-T)`Q0````(`.UT5420#;W+ M"QH``*ZD`0`4`!@```````$```"D@9D_`@!C`Q0````(`.UT5433.&S[ M)DH``(MF!0`4`!@```````$```"D@?)9`@!C`Q0````(`.UT543BYNTT M:9\``+-V"0`4`!@```````$```"D@6:D`@!C`Q0````(`.UT543*E=^P M*W@``"[["``4`!@```````$```"D@1U$`P!C`Q0````(`.UT541C'7R- M8AH``-PP`0`0`!@```````$```"D@9:\`P!C'-D550% K``-NJP=3=7@+``$$)0X```0Y`0``4$L%!@`````&``8`%`(``$+7`P`````` ` end XML 74 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
 12 Months Ended
Dec. 31, 2013
Income Taxes [Abstract]  
Income Taxes

10.  Income Taxes

 

Income Tax Expense

 

Income before income taxes consists of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Domestic

$
23,004 

 

$
11,686 

 

$
11,238 

Foreign

 
288 

 

 
366 

 

 
228 

Income before income taxes

$
23,292 

 

$
12,052 

 

$
11,466 

 

Income tax expense consists of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Current:

 

 

 

 

 

 

 

 

Federal

$
6,304 

 

$
2,778 

 

$
2,634 

State

 
396 

 

 
180 

 

 
103 

Foreign

 
96 

 

 
98 

 

 
84 

 

 
6,796 

 

 
3,056 

 

 
2,821 

Deferred:

 

 

 

 

 

 

 

 

Federal

 
1,142 

 

 
1,274 

 

 
1,087 

State

 
(818)

 

 
(227)

 

 
183 

Foreign

 

 -

 

 
3 

 

 
4 

 

 
324 

 

 
1,050 

 

 
1,274 

Income tax expense

$
7,120 

 

$
4,106 

 

$
4,095 

 

The Company’s income tax expense in 2013,  2012, and 2011 included the Company’s federal, state, and foreign tax obligations.  The Company’s effective income tax rate was approximately 31%,  34%, and 36% for the years ended December 31, 2013,  2012, and 2011, respectively.  The Company’s income tax rate for the twelve months ended December 31, 2013 was favorably affected by the full year 2012 research and development tax credit, which was enacted in January 2013 and, therefore, reduced the Company’s tax expense during the first quarter of 2013 and adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards.  The Company’s income tax rates for the three and twelve months ended December 31, 2012 were favorably affected by adjustments to valuation allowances on certain of the Company’s state net operating loss carryforwards, based on revised estimates of utilization of these carryforwards, and unfavorably affected by the tax treatment of certain acquisition related expenses due to the acquisition of Hemosphere and by the research and development tax credit, which had not been enacted for the 2012 tax year. 

 

The income tax expense amounts differ from the amounts computed by applying the U.S. federal statutory income tax rate of 35% to pretax income as a result of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Tax expense at statutory rate

$
8,152 

 

$
4,220 

 

$
4,013 

Increase (reduction) in income taxes resulting from:

 

 

 

 

 

 

 

 

Non-deductible transaction costs

 

--

 

 
151 

 

 
540 

State income taxes, net of federal benefit

 
183 

 

 
296 

 

 
150 

State valuation allowance adjustment

 
(760)

 

 
(427)

 

 
100 

Equity compensation

 
(29)

 

 
32 

 

 
149 

Non-deductible entertainment expenses

 
207 

 

 
188 

 

 
142 

Foreign income taxes

 
96 

 

 
(199)

 

 
3 

Domestic production activities deduction

 
(402)

 

 
(407)

 

 
(727)

Research and development credit

 
(392)

 

 

--

 

 
(314)

Other

 
65 

 

 
252 

 

 
39 

 

$
7,120 

 

$
4,106 

 

$
4,095 

 

Deferred Taxes

 

The Company generates deferred tax assets primarily as a result of write-downs of deferred preservation costs, inventory, and in-process research and development; accruals for product and tissue processing liability claims; asset impairments; and, in prior periods, due to operating losses.  The Company acquired significant deferred tax assets, primarily net operating loss carryforwards, from its acquisitions of Hemosphere and Cardiogenesis in the second quarters of 2012 and 2011, respectively.  See Note 4 and Note 6 for a further discussion of the Company’s acquisitions of Hemosphere and Cardiogenesis, respectively.

 

The tax effects of temporary differences which give rise to deferred tax assets and liabilities at December 31 are as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

Deferred tax assets:

 

 

 

 

 

Allowance for bad debts

$
131 

 

$
194 

Deferred preservation costs and inventory write-downs

 
1,077 

 

 
392 

Investment in equity securities

 
1,959 

 

 
925 

Property

 
2,737 

 

 
2,644 

Intangible assets

 
422 

 

 
502 

Accrued expenses

 
3,766 

 

 
3,782 

Loss carryforwards

 
15,689 

 

 
17,539 

Credit carryforwards

 
241 

 

 
2,166 

Stock compensation

 
2,409 

 

 
2,319 

Other

 
1,108 

 

 
969 

Less valuation allowance

 
(1,532)

 

 
(2,292)

Total deferred tax assets

 
28,007 

 

 
29,140 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Prepaid items

 
(451)

 

 
(314)

Intangible assets

 
(5,289)

 

 
(5,814)

Other

 
(220)

 

 
(348)

Total deferred tax liabilities

 
(5,960)

 

 
(6,476)

 

 

 

 

 

 

Total net deferred tax assets

$
22,047 

 

$
22,664 

 

As of December 31, 2013 the Company maintained a total of $1.5 million in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $22.0 million.  As of December 31, 2012 the Company maintained a total of $2.3 million in valuation allowances against deferred tax assets, related to state net operating loss carryforwards, and a net deferred tax asset of $22.7 million. 

 

As of December 31, 2013 the Company had approximately $3.2 million of tax-effected state net operating loss carryforwards that began to expire in 2013, $61,000 in research and development tax credit carryforwards that will begin to expire in 2022, and $163,000 in credits from the state of Texas that will fully expire by 2027. 

 

Uncertain Tax Positions

 

A reconciliation of the beginning and ending balances of the Company’s uncertain tax position liability, excluding interest and penalties, is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Beginning balance

$
2,004 

 

$
1,788 

 

$
1,822 

Increases related to current year tax positions

 
281 

 

 
231 

 

 
78 

Decreases related to prior year tax positions

 
(185)

 

 
(15)

 

 
(112)

Ending balance

$
2,100 

 

$
2,004 

 

$
1,788 

 

A reconciliation of the beginning and ending balances of the Company’s liability for interest and penalties on uncertain tax positions is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Beginning balance

$
489 

 

$
418 

 

$
391 

Accrual of interest and penalties

 
66 

 

 
79 

 

 
65 

Decreases related to prior year tax positions

 
(133)

 

 
(8)

 

 
(38)

Ending balance

$
422 

 

$
489 

 

$
418 

As of December 31, 2013 the Company’s total uncertain tax liability, including interest and penalties of $2.5 million, was recorded as a non-current liability on the Company’s Consolidated Balance Sheets.  As of December 31, 2012 the Company’s total uncertain tax liability, including interest and penalties of $2.5 million, was recorded as a reduction to deferred tax assets of $103,000 and a non-current liability of $2.4 million on the Company’s Consolidated Balance Sheets. 

 

Other

 

The Company’s tax years 2010 through 2013 generally remain open to examination by the major taxing jurisdictions to which the Company is subject.  However, certain returns from years prior to 2010, in which net operating losses and tax credits have arisen, are still open for examination by the tax authorities.

  

XML 75 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information (USD $)
 12 Months Ended
Dec. 31, 2013
Feb. 14, 2014
Jun. 30, 2013
Document And Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2013    
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
Entity Filer Category Accelerated Filer    
Entity Central Index Key 0000784199    
Entity Registrant Name CRYOLIFE INC    
Trading Symbol cry    
Entity Common Stock, Shares Outstanding   27,894,710  
Entity Well-known Seasoned Issuer No    
Entity Public Float     $ 155,031,053
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
XML 76 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt
 12 Months Ended
Dec. 31, 2013
Debt [Abstract]  
Debt

11.  Debt

 

GE Credit Agreement

 

On October 28, 2011 CryoLife amended and restated its March 26, 2008 credit agreement with GE Capital (the “GE Credit Agreement”) which provides revolving credit for working capital, acquisitions, and other corporate purposes.  The amendment increased the borrowing capacity under the GE Credit Agreement from $15.0 million to $20.0 million (including a letter of credit subfacility) and extended the expiration from October 31, 2011 to October 28, 2014.  The initial commitment may continue to be reduced or increased from time to time pursuant to the terms of the GE Credit Agreement.  The Company amended the agreement to allow the payment of cash dividends up to a maximum of $3.5 million per year, subject to satisfaction of specified conditions. 

 

The GE Credit Agreement places limitations on the amount that the Company may borrow and includes various affirmative and negative covenants, including financial covenants such as a requirement that CryoLife (i) not exceed a defined leverage ratio, (ii) maintain a minimum adjusted earnings subject to defined adjustments as of specified dates, and (iii) not make or commit capital expenditures in excess of a defined limitation.  As required under the terms of the GE Credit Agreement, the Company is maintaining cash and cash equivalents of at least $5.0 million in accounts in which GE Capital has a first priority perfected lien.  These amounts are recorded as restricted cash as of December 31, 2013 and 2012 on the Company’s Consolidated Balance Sheets, as they are restricted for the term of the GE Credit Agreement.  Also, the GE Credit Agreement requires that after giving effect to a stock repurchase the Company maintain liquidity, as defined within the agreement, of at least $20.0 million.  The GE Credit Agreement includes customary conditions on incurring new indebtedness.  Commitment fees are paid based on the unused portion of the facility.  As of December 31, 2013 the Company was in compliance with the covenants of the GE Credit Agreement. 

 

Amounts borrowed under the GE Credit Agreement are secured by substantially all of the tangible and intangible assets of CryoLife and its subsidiaries and bear interest as determined by GE Capital at either LIBOR, with a minimum rate of 4.25%, or GE Capital’s base rate, with a minimum rate of 3.25% each, plus the applicable margin. 

 

As of December 31, 2013 the outstanding balance of the GE Credit Agreement was zero, the aggregate interest rate was 6.50%, and the remaining availability was $20.0 million.  As of December 31, 2012 the outstanding balance of the GE Credit Agreement was zero, the aggregate interest rate was 6.50%, and the remaining availability was $20.0 million. 

 

Other

 

Total interest expense was $71,000, $179,000, and $142,000 in 2013,  2012, and 2011, respectively, which included interest on debt and uncertain tax positions.

 

XML 77 R80.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Summary Of Other Information Concerning Stock Options) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Stock Compensation [Abstract]      
Weighted-average fair value of options granted $ 2.54 $ 2.67 $ 2.54
Intrinsic value of options exercised $ 673,000 $ 10,000 $ 261,000
XML 78 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement Of Operations And Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenues:      
Products $ 76,194 $ 67,496 $ 59,387
Preservation services 64,498 63,603 59,793
Other 71 619 446
Total revenues 140,763 131,718 119,626
Cost of products and preservation services:      
Products 15,147 11,380 9,442
Preservation services 35,230 35,320 34,340
Total cost of products and preservation services: 50,377 46,700 43,782
Gross margin 90,386 85,018 75,844
Operating expenses:      
General, administrative, and marketing 68,112 65,149 57,302
Research and development 8,454 7,257 6,899
Total operating expenses 76,566 72,406 64,201
Operating income 13,820 12,612 11,643
Interest expense 71 179 142
Interest income (4) (6) (14)
Gain on sale of Medafor investment (12,742)    
Other than temporary investment impairment 3,229 340  
Other (income) expense, net (26) 47 49
Income before income taxes 23,292 12,052 11,466
Income tax expense 7,120 4,106 4,095
Net income 16,172 7,946 7,371
Income per common share:      
Basic $ 0.59 $ 0.29 $ 0.26
Diluted $ 0.57 $ 0.28 $ 0.26
Dividends declared per share $ 0.108 $ 0.050  
Weighted-average common shares outstanding:      
Basic 26,885 26,967 27,441
Diluted 27,698 27,411 27,759
Net income 16,172 7,946 7,371
Other comprehensive income (loss) 46 (33) 26
Comprehensive income $ 16,218 $ 7,913 $ 7,397
XML 79 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
ValveXchange
 12 Months Ended
Dec. 31, 2013
ValveXchange [Abstract]  
ValveXchange

5.  ValveXchange

 

Preferred Stock Investment

 

In July 2011 the Company purchased 2.4 million shares of Series A Preferred Stock of ValveXchange, Inc. (“ValveXchange”) for approximately $3.5 million.  ValveXchange is a private medical device company that was spun off from Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets.  The Company’s carrying value of this investment included the purchase price and certain transaction costs, and CryoLife’s investment represented an approximate 19% equity ownership in ValveXchange.  As ValveXchange’s stock is not actively traded on any public stock exchange, as the Company does not exert significant influence over ValveXchange, and as the Company’s investment is in preferred stock, the Company accounted for this investment using the cost method.  The Company recorded its investment as a long-term asset, investment in equity securities, on the Company’s Consolidated Balance Sheets.

 

Loan Agreement

 

In July 2011 the Company entered into an agreement with ValveXchange, as amended, to make available up to $2.0 million to ValveXchange in debt financing through a revolving credit facility (the “Loan”).  The Loan includes various affirmative and negative covenants, including financial covenant requirements, and expires on July 30, 2018, unless terminated earlier.  Amounts loaned under the Loan will earn interest at an 8% annual rate and are secured by substantially all of the tangible and intangible assets of ValveXchange.  The Company incurred loan origination costs, net of fees charged to ValveXchange, of approximately $117,000, which are being expensed on a straight-line basis over the life of the loan facility.  The Company advanced $2.0 million to ValveXchange under the Loan in 2012.  The $2.0 million advance is recorded as long-term notes receivable on the Company’s Consolidated Balance Sheets as of December 31, 2013 and 2012.

 

During 2013 CryoLife repeatedly notified ValveXchange that ValveXchange was in default of certain loan covenants, due to factors including ValveXchange’s failure to obtain CryoLife’s consent for certain convertible note financings that ValveXchange obtained during the year.  These events of default were ongoing as of February 15, 2014. 

 

Investment and Loan Analysis

 

During the quarter ended September 30, 2012 the Company reviewed available information to determine if factors indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment.  The Company determined that available information indicated that the Company should evaluate its investment in ValveXchange preferred stock for impairment.  The Company used available information to analyze its investment for impairment, and the information indicated that the fair value of the investment was less than the carrying value.  Therefore, based on this analysis, the Company believed that its investment in ValveXchange was impaired in the third quarter of 2012, and the impairment was other than temporary.  As a result, the Company recorded an other non-operating expense of $340,000 to write down its investment in ValveXchange preferred stock.  During the quarters ended December 31, 2012, June 30, 2013, and September 30, 2013 the Company reevaluated its investment in ValveXchange preferred stock for impairment.  At the time of each of these analyses, the Company did not believe that its investment in ValveXchange was impaired further. 

 

During the quarter ended December 31, 2013 the Company determined that available information, including ValveXchange’s financial condition and cash position, indicated that the Company should reevaluate its investment in ValveXchange preferred stock for impairment.  The Company used available information, including new information obtained in the fourth quarter of 2013, to analyze its investment for impairment, and this information indicated that the fair value of the investment had declined significantly and any remaining value was nominal.  Therefore, based on this analysis, the Company believes that its investment in ValveXchange was fully impaired as of December 31, 2013, and the impairment was other than temporary.  As a result, the Company recorded an other non-operating expense of $3.2 million to write-down its investment in ValveXchange preferred stock.  The carrying value of the Company’s investment in ValveXchange preferred stock after this write down was zero as of December 31, 2013.  The carrying value of the Company’s investment in ValveXchange preferred stock was $3.2 million as of December 31, 2012.

 

ValveXchange is currently attempting to raise additional funds to support its short-term and long-term operations.  If ValveXchange is unable to secure material amounts of additional financing, it will likely be unable to meet its obligations, and, therefore, CryoLife may need to foreclose on the related collateral to secure repayment of the Loan.  Although CryoLife currently believes that the value of the collateral is adequate to repay the Loan, there is no guarantee that the security for the notes will be sufficient to repay the Loan.

 

Option Agreement

  

Concurrently with the Loan described above, CryoLife entered into an option agreement with ValveXchange through which CryoLife obtained the right of first refusal to acquire ValveXchange during a period that extends through the completion of initial commercialization milestones and the right to negotiate with ValveXchange for European distribution rights.  The Company’s rights may be modified or reduced in connection with a future round of financing.

 

XML 80 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hemosphere Acquisition (Hemosphere [Member])
 12 Months Ended
Dec. 31, 2013
Hemosphere [Member]
  
Business Acquisition [Line Items]  
Hemosphere Acquisition

4.  Hemosphere Acquisition

 

Overview  

On May 16, 2012 CryoLife completed its acquisition of 100% of the outstanding equity of Hemosphere, a privately held company, for $17.0 million in cash, an additional $3.2 million paid for cash acquired, and contingent consideration with a fair value estimated to be approximately $1.8 million at acquisition, for a total purchase price of approximately $22.0 million.  CryoLife used cash on hand to fund the transaction and operates Hemosphere as a wholly owned subsidiary.  

 

Hemosphere is the developer and marketer of the HeRO Graft, a proprietary graft-based solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction.  CryoLife believes that the HeRO Graft will fit well into its product portfolio of medical devices for cardiac and vascular surgery and believes there is a significant opportunity for CryoLife’s sales team to leverage their strong relationships with vascular surgeons to introduce and to expand utilization of the HeRO Graft in the U.S.  

 

Contingent Consideration  

 

As of the acquisition date, CryoLife recorded a contingent consideration liability of $1.8 million in long-term liabilities on its Consolidated Balance Sheet, representing the estimated fair value of the contingent consideration expected to be paid to the former shareholders of Hemosphere upon the achievement of certain revenue-based milestones.  The acquisition agreement provides for a maximum of $4.5 million in future consideration payments through December 2015 based on specified sales targets.  

 

The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach.  The Company applied a risk-based estimate of the probability of achieving each scenario and then applied a cost of debt based discount rate of 8%.  This fair value measurement is based on unobservable inputs, including management estimates and assumptions about future revenues, and is, therefore, classified as Level 3 within the fair value hierarchy presented in Note 2.  The Company will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in other (income) expense on the Company’s Consolidated Statements of Operations and Comprehensive Income.  Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount periods and rates, as well as changes in the timing and amount of Company revenue estimates.

 

The Company recorded a gain of $28,000 for the year ended December 31, 2013 and a loss of $72,000 for the year ended December 31, 2012 on the remeasurement of the contingent consideration liability.  The balance of the contingent consideration liability was $1.9 million as of December 31, 2013 and 2012.  

 

Accounting for the Transaction

 

The Company has recorded an allocation of the $22.0 million purchase price to Hemosphere’s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values as of May 16, 2012.  Goodwill has been recorded based on the amount by which the purchase price exceeds the fair value of the net assets acquired and is not deductible for tax purposes.  Goodwill from this transaction has been allocated to the Company’s medical devices segment. 

 

The purchase price allocation as of December 31, 2012 is as follows (in thousands):

 

 

 

 

 

Opening

 

Balance Sheet

Cash and cash equivalents

$
3,155 

Receivables

 
653 

Inventories

 
554 

Intangible assets

 
5,790 

Goodwill

 
7,145 

Deferred tax assets, net

 
5,379 

Other assets

 
331 

Liabilities assumed

 
(972)

Total purchase price

$
22,035 

 

CryoLife incurred integration costs of $940,000 for the year ended December 31, 2013 and transaction and integration costs related to the acquisition of approximately $2.4 million for the year ended December 31, 2012.   These costs were expensed as incurred and were primarily recorded as general, administrative, and marketing expenses on the Company’s Consolidated Statements of Operations and Comprehensive Income.

 

Pro Forma Results

 

Hemosphere’s revenues of $3.1 million from the date of acquisition through December 31, 2012 are included in the Consolidated Statements of Operations and Comprehensive Income.  The Company’s unaudited pro forma results of operations for the year ended December 31, 2012 and 2011 assuming the Hemosphere acquisition had occurred as of January 1, 2011 are presented for comparative purposes below.  These amounts are based on available information of the results of operations of Hemosphere prior to the acquisition date and are not necessarily indicative of what the results of operations would have been had the acquisition been completed on January 1, 2011.  This unaudited pro forma information does not project operating results post acquisition.  This pro forma information is as follows (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

Twelve Months Ended

 

December 31,

 

2012

 

2011

Total revenues

$
133,722 

 

$
124,877 

Net income

 
8,758 

 

 
3,205 

 

 

 

 

 

 

Pro forma income per common share - basic

$
0.32 

 

$
0.11 

Pro forma income per common share - diluted

$
0.31 

 

$
0.11 

  

 

Pro forma results for the year ended December 31, 2011 include the Company’s acquisition and integration related costs of approximately $2.4 million, on a pre-tax basis, and other costs as appropriate.  Pro forma disclosures were calculated using a tax rate of approximately 34%.

 

XML 81 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Per Common Share
 12 Months Ended
Dec. 31, 2013
Income Per Common Share [Abstract]  
Income Per Common Share

16.  Income Per Common Share

 

The following table sets forth the computation of basic and diluted income per common share (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Basic income per common share

 

 

 

 

 

 

 

 

Net income

$
16,172 

 

$
7,946 

 

$
7,371 

Net income allocated to participating securities

 
(367)

 

 
(180)

 

 
(149)

Net income allocated to common shareholders

$
15,805 

 

$
7,766 

 

$
7,222 

 

 

 

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 
26,885 

 

 
26,967 

 

 
27,441 

Basic income per common share

$
0.59 

 

$
0.29 

 

$
0.26 

 

 

 

 

 

 

 

 

 

Diluted income per common share

 

 

 

 

 

 

 

 

Net income

$
16,172 

 

$
7,946 

 

$
7,371 

Net income allocated to participating securities

 
(359)

 

 
(178)

 

 
(147)

Net income allocated to common shareholders

$
15,813 

 

$
7,768 

 

$
7,224 

 

 

 

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 
26,885 

 

 
26,967 

 

 
27,441 

Effect of dilutive options and awardsa

 
813 

 

 
444 

 

 
318 

Diluted weighted-average common shares outstanding

 
27,698 

 

 
27,411 

 

 
27,759 

Diluted income per common share

$
0.57 

 

$
0.28 

 

$
0.26 

aThe Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share.  Accordingly, stock options to purchase 656,000,  1.7 million, and 2.0 million, shares for the years ended December 31, 2013,  2012, and 2011, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.

 

XML 82 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingencies
 12 Months Ended
Dec. 31, 2013
Commitments And Contingencies [Abstract]  
Commitments And Contingencies

12.  Commitments and Contingencies

 

Leases

 

The Company's operating lease obligations result from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment.  In prior years, the Company's capital lease obligations resulted from the financing of certain of the Company's equipment.  As of December 31, 2013 and 2012 the remaining obligations under the Company’s capital leases was zero.

 

The term of the lease of the land and buildings that comprise the Company’s corporate headquarters was originally 15 years.  During the second quarter of 2010 the Company signed an amendment to the lease on its corporate headquarters extending the lease until 2022.    The Company has a deferred rent obligation of $1.7 million as of December 31, 2013 and $1.6 million as of December 31, 2012 recorded on the Company’s Consolidated Balance Sheets, primarily related to the lease on its corporate headquarters.  Total rental expense for operating leases was $3.0 million in 2013 and $2.7 million in both 2012 and 2011.

 

Future minimum operating lease payments under non-cancelable leases as of December 31, 2013 are as follows (in thousands):

 

 

 

 

 

 

 

 

 

Operating

 

Leases

2014

$
2,799 

2015

 
3,031 

2016

 
2,943 

2017

 
2,980 

2018

 
3,010 

Thereafter

 
10,124 

Total minimum lease payments

$
24,887 

 

Liability Claims

 

At December 31, 2013 and 2012 the Company’s unreported loss liability was $1.5 million and $1.7 million, respectively.  The related recoverable insurance amounts were $580,000 and $620,000 as of December 31, 2013 and 2012, respectively.  The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long‑term liabilities and records the related recoverable insurance amounts as a component of receivables and other long‑term assets, as appropriate.   Further analysis indicated that the liability as of December 31, 2013 could be estimated to be as high as $2.7 million, after including a reasonable margin for statistical fluctuations calculated based on actuarial simulation techniques. 

 

Employment Agreement 

 

The Company has an employment agreement with its Chief Executive Officer (“CEO”) that confers benefits which become payable upon the occurrence of certain events, including the voluntary retirement of the CEO or termination of the CEO’s employment in conjunction with certain change events.  As of both December 31, 2013 and 2012 the Company had $2.1 million in accrued expenses and other current liabilities on the Consolidated Balance Sheets representing benefits payable upon the CEO’s voluntary retirement, for which he is currently eligible.  The CEO’s current agreement took effect on January 1, 2013 and terminates on December 31, 2015.  A payment of $100,000 was made in January 2013 in accordance with the terms of the new agreement.

 

PerClot Technology

 

On September 28, 2010 the Company entered into a worldwide distribution agreement (the “Distribution Agreement”) and a license and manufacturing agreement (the “License Agreement”) with SMI of San Jose, California for PerClot, a polysaccharide hemostatic agent used in surgery.  The Distribution Agreement contains certain minimum purchase requirements and has a term of 15 years.  Following the start of manufacturing and U.S. regulatory approval, CryoLife may terminate the Distribution Agreement and the related minimum purchase requirements and sell PerClot pursuant to the License Agreement.    The Company will pay royalties to SMI at stated rates on net revenues of products manufactured under the License Agreement and will pay additional contingent amounts of up to $2.5 million to SMI if certain FDA regulatory and other commercial milestones are achieved.  The Company expects to record future contingent payment amounts of up to $2.5 million initially as research and development expense or, after FDA approval or issuance of a patent, as acquired intangible assets.    

XML 83 R84.htm IDEA: XBRL DOCUMENT v2.4.0.8
Transactions With Related Parties (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Related Party Transaction [Line Items]      
Investment banking services from related party $ 0 $ 0 $ 818,000
Member Of Board Of Directors [Member]
      
Related Party Transaction [Line Items]      
Repurchases of common stock 321,000 794,000 2,900,000
Revenue from related parties 353,000 267,000 198,000
Purchases from related party transactions 47,000 22,000 45,000
Son Of Member Of Board Of Directors [Member]
      
Related Party Transaction [Line Items]      
Revenue from related parties $ 345,000 $ 312,000 $ 219,000
Maximum [Member]
      
Related Party Transaction [Line Items]      
Percentage of commisions included in stock repurchases 1.00% 1.00% 1.00%
XML 84 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Preservation Costs And Inventories
 12 Months Ended
Dec. 31, 2013
Deferred Preservation Costs And Inventories [Abstract]  
Deferred Preservation Costs And Inventories

8.  Deferred Preservation Costs and Inventories

 

Deferred preservation costs at December 31, 2013 and 2012 are comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

2013

 

2012

Cardiac tissues

$
12,239 

 

$
11,950 

Vascular tissues

 
15,058 

 

 
16,004 

Total deferred preservation costs

$
27,297 

 

$
27,954 

 

Inventories at December 31, 2013 and 2012 are comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

2013

 

2012

Raw materials and supplies

$
5,706 

 

$
5,836 

Work-in-process

 
767 

 

 
830 

Finished goods

 
3,298 

 

 
3,891 

Total inventories

$
9,771 

 

$
10,557 

 

XML 85 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Schedule Of Gross Carrying Values, Accumulated Amortization, And Approximate Amortization Periods Of Definite Lived Intangible Assets) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Acquired Technology [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value $ 14,020 $ 14,020
Accumulated amortization 2,677 1,538
Patents [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value 4,348 4,644
Accumulated amortization 2,414 2,530
Amortization Period 17 years 17 years
Distribution And Manufacturing Rights And Know-How [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value 3,559 3,559
Accumulated amortization 714 473
Amortization Period 15 years 15 years
Customer Lists And Relationships [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value 3,370 3,370
Accumulated amortization 572 330
Non-Compete Agreement [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value 381 381
Accumulated amortization 267 229
Amortization Period 10 years 10 years
Other [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Value 202 198
Accumulated amortization $ 171 $ 123
Minimum [Member] | Acquired Technology [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 11 years 11 years
Minimum [Member] | Customer Lists And Relationships [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 13 years 13 years
Minimum [Member] | Other [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 1 year 1 year
Maximum [Member] | Acquired Technology [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 16 years 16 years
Maximum [Member] | Customer Lists And Relationships [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 17 years 17 years
Maximum [Member] | Other [Member]
    
Finite-Lived Intangible Assets [Line Items]    
Amortization Period 3 years 3 years
XML 86 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cardiogenesis Acquisition (Cardiogenesis [Member])
 12 Months Ended
Dec. 31, 2013
Cardiogenesis [Member]
  
Business Acquisition [Line Items]  
Cardiogenesis Acquisition

6.  Cardiogenesis Acquisition

 

Overview

 

On May 17, 2011 CryoLife completed its acquisition of all of the outstanding shares of Cardiogenesis for $0.457 per share or approximately $21.7 million.  CryoLife used cash on hand to fund the transaction and operates Cardiogenesis as a wholly owned subsidiary.

 

Cardiogenesis is a leading developer of surgical products used in the treatment of patients with severe angina resulting from diffuse coronary artery disease.  Cardiogenesis markets its revascularization technologies, which include the Holmium: YAG laser console and single use, fiber-optic handpieces.  These products are FDA approved for performing a surgical procedure known as Transmyocardial Revascularization, used for treating patients with stable angina that is not responsive to conventional therapy.

 

Accounting for the Transaction  

The Company recorded an allocation of the $21.7 million purchase price to Cardiogenesis’ tangible and identifiable intangible assets acquired and liabilities assumed based on their acquisition date fair values.  The allocation of the purchase price to intangible assets was based on valuations performed to determine the fair value of such assets as of the acquisition date.  Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired.  The liability amounts recorded included the Company’s estimate of contingent liabilities assumed. 

 

The purchase price allocation as of December 31, 2011 was as follows (in thousands):

 

 

 

 

 

Opening

 

Balance Sheet

Cash and cash equivalents

$
650 

Receivables

 
1,055 

Inventory

 
852 

Property and equipment

 
248 

Intangible assets

 
11,900 

Goodwill

 
4,220 

Net deferred tax assets

 
5,002 

Other assets

 
230 

Liabilities assumed

 
(2,445)

Total purchase price

$
21,712 

  

CryoLife incurred approximately $3.0 million in transaction and integration costs related to the acquisition in the year ended December 31, 2011.  The Company did not incur significant transaction or integration costs related to the Cardiogenesis acquisition in 2012 or 2013.

  

Pro Forma Results

 

Cardiogenesis’ revenues of $5.7 million from the date of acquisition are included in the Company’s Consolidated Statements of Operations and Comprehensive Income for the year ended December 31, 2011.  Unaudited pro forma results of operations for the year ended December 31, 2011, assuming the Cardiogenesis acquisition had occurred prior to 2011, are presented for comparative purposes below (in thousands):

 

 

 

 

 

 

 

 

2011

Total revenues

$
123,951 

Net income

 
7,962 

 

Pro forma disclosures were calculated using a tax rate of approximately 36%.

 

Legal Action

 

In 2008 CardioFocus, Inc. (“CardioFocus”) filed a complaint in the U.S. District Court for the District of Massachusetts (“Massachusetts Court”) against Cardiogenesis and a number of other companies.  The litigation related to an alleged infringement by Cardiogenesis of two patents held by CardioFocus that have now expired.

  

On June 14, 2012 Cardiogenesis entered into a settlement agreement with respect to its litigation with CardioFocus.  The settlement provides that each party release the other from all claims and liabilities related to the patents in question and that all claims and counterclaims in the litigation be withdrawn with prejudice.  Pursuant to the terms of the settlement agreement, Cardiogenesis paid $4.5 million in cash to CardioFocus.  Cardiogenesis and CardioFocus agreed and acknowledged that each party would bear its own costs and expenses, including attorneys’ fees, incurred in or as a result of the litigation.

  

On June 14, 2012 the parties filed a stipulation of dismissal with prejudice in the Massachusetts Court.

 

Accounting for the Settlement

 

As a result of the settlement described above, the Company recorded an additional loss of $3.6 million in general, administrative, and marketing expenses on its Consolidated Statements of Operations and Comprehensive Income in the second quarter of 2012 for a total of $4.1 million in legal settlement expenses for the year ended December 31, 2012.  The Company paid the $4.5 million settlement payment to CardioFocus in July 2012 using cash on hand. 

 

XML 87 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Medafor Matters
 12 Months Ended
Dec. 31, 2013
Medafor Matters [Abstract]  
Medafor Matters

7.  Medafor Matters

 

Investment in Medafor Common Stock

 

In 2009 and 2010 CryoLife purchased shares of common stock in Medafor, Inc. (“Medafor”).  As financial information for Medafor is not readily available and as the Company does not exert significant influence over the operations of Medafor, the Company accounted for its investment in Medafor common stock using the cost method.  The Company recorded the stock as a long-term asset, investment in equity securities, on the Company’s Consolidated Balance Sheets.  The carrying value of the Company’s 2.4 million shares of Medafor common stock was approximately $2.6 million as of December 31, 2012, prior to the sale of this investment in 2013 as described below.

 

In connection with its purchase of Medafor common stock, the Company entered into agreements with the sellers that could have required CryoLife to make additional payments to the sellers if CryoLife acquired or merged with Medafor within a specified time period.  The Company accounted for these provisions as an embedded derivative.  The last of these provisions expired in June 2013, and as of December 31, 2013 a derivative no longer exists.  As of December 31, 2012 the value of this derivative was zero.

 

C.R. Bard’s Acquisition of Medafor

 

On October 1, 2013 C.R. Bard, Inc. (“Bard”) completed its previously announced acquisition of the outstanding shares of Medafor common stock.  The Company received an initial payment of approximately $15.4 million for its 2.4 million shares of Medafor common stock and recorded an initial gain of $12.7 million on the sale in the fourth quarter of 2013.  The Company could receive additional payments totaling up to an additional $8.4 million upon the release of funds held in escrow and the satisfaction of certain contingent milestones, measurable through June 2015, based on information provided by Medafor as part of the September 24, 2013 Medafor Proxy Statement.  The first of these additional payments, which the Company believes could be up to approximately $525,000, if released, would be received in late 2014, although this amount is subject to possible offsets.  These payments will be recorded as an additional gain when and if received by the Company.

 

Distribution Agreement and Legal Action

 

CryoLife distributed a powdered hemostat for Medafor from 2008 to 2010.  CryoLife filed a lawsuit against Medafor in 2009 in the U.S. District Court for the Northern District of Georgia (“Georgia Court”).  In 2010 Medafor filed counterclaims against CryoLife in the same case.  The litigation related to an exclusive distribution agreement that the parties entered into in April 2008.

 

In June 2012 the parties entered into a settlement agreement.  Per the settlement, Medafor paid $3.5 million in cash to CryoLife in the third quarter of 2012.  On June 29, 2012 the parties jointly filed stipulated dismissals with prejudice with the Georgia Court.  As a result of the settlement, CryoLife recorded a gain of $4.7 million as a reduction in general, administrative, and marketing expenses on its Consolidated Statements of Operations and Comprehensive Income in the second quarter of 2012 and recorded a reduction in accounts payable of $1.2 million to write off a payable for previous inventory purchases, which was discharged pursuant to the settlement agreement.

 

CryoLife received a letter from Medafor in September 2012 stating that PerClot®, when introduced in the U.S., will, when used in accordance with the method published in CryoLife’s literature and with the instructions for use, infringe Medafor’s U.S. patent.  CryoLife does not believe that it will infringe Medafor’s patent.  There have been no further communications between CryoLife and Medafor or CryoLife and Bard related to the September letter.

XML 88 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets
 12 Months Ended
Dec. 31, 2013
Goodwill And Other Intangible Assets [Abstract]  
Goodwill And Other Intangible Assets

9.  Goodwill and Other Intangible Assets

Indefinite Lived Intangible Assets

 

As of December 31, 2013 and 2012 the carrying values of the Company’s indefinite lived intangible assets are as follows (in thousands):

 

 

 

 

 

 

 

2013

 

2012

Goodwill

$
11,365 

 

$
11,365 

Procurement contracts and agreements

 
2,013 

 

 
2,013 

Trademarks

 
841 

 

 
870 

Other

 

--

 

 
250 

 

Based on its prior experience with similar agreements, the Company believes that its acquired contracts and procurement agreements have an indefinite useful life, as the Company expects to continue to renew these contracts for the foreseeable future.  The Company believes that its trademarks have an indefinite useful life as the Company currently anticipates that these trademarks will contribute cash flows to the Company indefinitely. 

 

A roll-forward of the goodwill balances for the Company’s medical devices reportable segment is as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

Balance as of January 1,

$
11,365 

 

$
4,220 

Goodwill from Hemosphere acquisition

 

--

 

 
7,145 

Balance as of December 31,

$
11,365 

 

$
11,365 

 

 

 

 

 

Definite Lived Intangible Assets

 

As of December 31, 2013 and 2012 gross carrying values, accumulated amortization, and approximate amortization periods of the Company’s definite lived intangible assets are as follows (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Carrying

 

Accumulated

 

Amortization

December 31, 2013

Value

 

Amortization

 

Period

Acquired technology

$
14,020 

 

$
2,677 

 

11-16

Years

Patents

 
4,348 

 

 
2,414 

 
17 

Years

Distribution and manufacturing rights and know-how

 
3,559 

 

 
714 

 
15 

Years

Customer lists and relationships

 
3,370 

 

 
572 

 

13-17

Years

Non-compete agreement

 
381 

 

 
267 

 
10 

Years

Other

 
202 

 

 
171 

 

1-3

Years

 

 

 

 

 

 

 

 

 

 

Gross Carrying

 

Accumulated

 

Amortization

December 31, 2012

Value

 

Amortization

 

Period

Acquired technology

$
14,020 

 

$
1,538 

 

11-16

Years

Patents

 
4,644 

 

 
2,530 

 
17 

Years

Distribution and manufacturing rights and know-how

 
3,559 

 

 
473 

 
15 

Years

Customer lists and relationships

 
3,370 

 

 
330 

 

13-17

Years

Non-compete agreement

 
381 

 

 
229 

 
10 

Years

Other

 
198 

 

 
123 

 

1-3

Years

 

 

Amortization Expense

 

Amortization expense recorded in general, administrative, and marketing expenses on the Company’s Consolidated Statements of Operations and Comprehensive Income for the years ended December 31 is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Amortization expense

$
2,006 

 

$
1,971 

 

$
1,370 

 

As of December 31, 2013 scheduled amortization of intangible assets for the next five years is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2015

 

2016

 

2017

 

2018

 

Total

Amortization expense

$
1,948 

 

$
1,905 

 

$
1,898 

 

$
1,850 

 

$
1,844 

 

$
9,445 

 

XML 89 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Schedule Of Income Before Income Tax) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Taxes [Abstract]      
Domestic $ 23,004 $ 11,686 $ 11,238
Foreign 288 366 228
Income before income taxes $ 23,292 $ 12,052 $ 11,466
XML 90 R85.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment And Geographic Information (Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
segment
Dec. 31, 2012
Dec. 31, 2011
Segment Reporting Information [Line Items]                              
Number of reportable segments                         2    
Total revenues $ 35,457 $ 36,250 $ 33,520 $ 35,536 $ 32,800 $ 33,429 $ 33,188 $ 32,301 $ 30,397 $ 29,654 $ 29,379 $ 30,196 $ 140,763 $ 131,718 $ 119,626
Total cost of preservation services and products                         50,377 46,700 43,782
Total gross margin 22,282 23,349 21,479 23,276 21,045 21,310 21,371 21,292 19,375 18,912 19,053 18,504 90,386 85,018 75,844
Percent of long-lived assets held in U.S. 95.00%       95.00%               95.00% 95.00%  
Goodwill allocated entirely to Medical Devices segment 11,365       11,365               11,365 11,365  
Medical Devices [Member]
                              
Segment Reporting Information [Line Items]                              
Total revenues                         76,194 67,496 59,387
Total cost of preservation services and products                         15,147 11,380 9,442
Total gross margin                         61,047 56,116 49,945
Preservation Services [Member]
                              
Segment Reporting Information [Line Items]                              
Total revenues                         64,498 63,603 59,793
Total cost of preservation services and products                         35,230 35,320 34,340
Total gross margin                         29,268 28,283 25,453
Other [Member]
                              
Segment Reporting Information [Line Items]                              
Total revenues                         71 [1] 619 [1] 446 [1]
Total gross margin                         $ 71 [1] $ 619 [1] $ 446 [1]
[1] For the years ended December 31, 2013, 2012, and 2011 the “Other” designation includes grant revenue.
XML 91 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Taxes [Abstract]      
Tax expense at statutory rate $ 8,152 $ 4,220 $ 4,013
Non-deductible transaction costs   151 540
State income taxes, net of federal benefit 183 296 150
State valuation allowance adjustment (760) (427) 100
Equity compensation (29) 32 149
Non-deductible entertainment expenses 207 188 142
Foreign income taxes 96 (199) 3
Domestic production activities deduction (402) (407) (727)
Research and development credit (392)   (314)
Other 65 252 39
Income tax expense $ 7,120 $ 4,106 $ 4,095
XML 92 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Narrative) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Tax Credit Carryforward [Line Items]      
Effective income tax rate 31.00% 34.00% 36.00%
Federal statutory income tax rate 35.00%    
Valuation allowances against deferred tax assets $ 1,532,000 $ 2,292,000  
Net deferred tax asset 22,047,000 22,664,000  
State net operating loss carryforwards 3,200,000    
Research and development tax credit carryforwards 61,000    
Total uncertain tax liability including interest and penalties 2,500,000 2,500,000  
Uncertain tax liability recorded as reduction to deferred tax assets   103,000  
Uncertain tax liability recorded to non-current liability   2,400,000  
Texas Tax Credit [Member]
      
Tax Credit Carryforward [Line Items]      
Other tax credit $ 163,000    
XML 93 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2013
Goodwill And Other Intangible Assets [Abstract]  
Schedule Of Carrying Values Of Indefinite Lived Intangible Assets

 

 

 

 

 

 

 

2013

 

2012

Goodwill

$
11,365 

 

$
11,365 

Procurement contracts and agreements

 
2,013 

 

 
2,013 

Trademarks

 
841 

 

 
870 

Other

 

--

 

 
250 

 

Schedule Of Goodwill By Reportable Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

Balance as of January 1,

$
11,365 

 

$
4,220 

Goodwill from Hemosphere acquisition

 

--

 

 
7,145 

Balance as of December 31,

$
11,365 

 

$
11,365 

 

Schedule Of Gross Carrying Values, Accumulated Amortization, And Approximate Amortization Periods Of Definite Lived Intangible Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Carrying

 

Accumulated

 

Amortization

December 31, 2013

Value

 

Amortization

 

Period

Acquired technology

$
14,020 

 

$
2,677 

 

11-16

Years

Patents

 
4,348 

 

 
2,414 

 
17 

Years

Distribution and manufacturing rights and know-how

 
3,559 

 

 
714 

 
15 

Years

Customer lists and relationships

 
3,370 

 

 
572 

 

13-17

Years

Non-compete agreement

 
381 

 

 
267 

 
10 

Years

Other

 
202 

 

 
171 

 

1-3

Years

 

 

 

 

 

 

 

 

 

 

Gross Carrying

 

Accumulated

 

Amortization

December 31, 2012

Value

 

Amortization

 

Period

Acquired technology

$
14,020 

 

$
1,538 

 

11-16

Years

Patents

 
4,644 

 

 
2,530 

 
17 

Years

Distribution and manufacturing rights and know-how

 
3,559 

 

 
473 

 
15 

Years

Customer lists and relationships

 
3,370 

 

 
330 

 

13-17

Years

Non-compete agreement

 
381 

 

 
229 

 
10 

Years

Other

 
198 

 

 
123 

 

1-3

Years

 

Summary Of Amortization Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Amortization expense

$
2,006 

 

$
1,971 

 

$
1,370 

 

Scheduled Amortization Of Intangible Assets For Next Five Years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2015

 

2016

 

2017

 

2018

 

Total

Amortization expense

$
1,948 

 

$
1,905 

 

$
1,898 

 

$
1,850 

 

$
1,844 

 

$
9,445 

 

XML 94 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
ValveXchange (Details) (USD $)
Share data in Millions, unless otherwise specified
 12 Months Ended 1 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Jul. 31, 2011
ValveXchange, Inc. [Member]
Dec. 31, 2013
ValveXchange, Inc. [Member]
Dec. 31, 2012
ValveXchange, Inc. [Member]
Sep. 30, 2012
ValveXchange, Inc. [Member]
Series A Preferred Stock [Member]
Dec. 31, 2013
ValveXchange, Inc. [Member]
Series A Preferred Stock [Member]
Dec. 31, 2012
ValveXchange, Inc. [Member]
Series A Preferred Stock [Member]
Jul. 31, 2011
ValveXchange, Inc. [Member]
Series A Preferred Stock [Member]
Schedule of Cost-method Investments [Line Items]                  
Preferred stock purchased, shares                 2.4
Preferred stock purchased, value                 $ 3,500,000
Equity ownership percent       19.00%          
Loans receivable, revolving credit line, maximum capacity     2,000,000            
Loans receivable, revolving credit line, expiration date     Jul. 30, 2018            
Loans receivable, revolving credit line, interest rate     8.00%            
Loan origination costs net of fees     117,000            
Amount of loan advanced       2,000,000 2,000,000        
Preferred stock, written down investment 3,229,000 340,000       340,000 3,200,000    
Preferred stock carrying value   $ 5,908,000         $ 0 $ 3,200,000  
XML 95 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plans
 12 Months Ended
Dec. 31, 2013
Employee Benefit Plans [Abstract]  
Employee Benefit Plans

14.  Employee Benefit Plans

 

401(k) Plan

 

The Company has a 401(k) savings plan (the "Plan") providing retirement benefits to all employees who have completed at least three months of service.  The Company made matching contributions of 40% of each participant's contribution for up to 5% of each participant's salary in 2013 and 2012.  In 2011 the Company made matching contributions to the plan of 20% of each participant’s contribution for up to 5% of each participant’s salary.  Total Company contributions approximated $541,000, $500,000, and $204,000 for the years ended December 31, 2013, 2012, and 2011, respectively.  Additionally, the Company may make discretionary contributions to the Plan that are allocated to each participant's account.  No discretionary contributions were made in any of the past three years.

   

Deferred Compensation Plan

 

On January 1, 2011 CryoLife initiated a nonqualified Deferred Compensation Plan (“Deferred Plan”).  The Deferred Plan allows certain employees of CryoLife to defer receipt of a portion of their salary and cash bonus.  The Deferred Plan provides for tax-deferred growth of deferred compensation.  Pursuant to the terms of the Deferred Plan, CryoLife agrees to return the deferred amounts plus gains and losses, based on investment fund options chosen by each respective participant, to the plan participants upon distribution.  All deferred amounts and deemed earnings thereon are vested at all times.  The Company has no current plans to match any contributions.  Amounts owed to plan participants are unsecured obligations of CryoLife.  CryoLife has established a rabbi trust in which it will make contributions to fund its obligations under the Deferred Plan.  Pursuant to the terms of the trust, CryoLife will be required to make contributions each year to fully match its obligations under the Deferred Plan.  The trust’s funds are invested in Company Owned Life Insurance (“COLI”) and the Company plans to hold the policies until the death of the insured.

 

The Company’s deferred compensation liabilities are recorded as a component of other current liabilities or long-term deferred compensation liabilities, as appropriate, based on anticipated distribution dates.  The cash surrender value of COLI is recorded in other long-term assets.  Changes in the value of participant accounts and changes in the cash surrender value of COLI are recorded as part of the Company’s operating expenses and are subject to the Company’s normal allocation of expenses to inventory and deferred preservation costs. 

 

XML 96 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Information
 12 Months Ended
Dec. 31, 2013
Selected Quarterly Financial Information [Abstract]  
Selected Quarterly Financial Information

SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

First

 

Second

 

Third

 

Fourth

 

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

REVENUE:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
35,536 

 

$
33,520 

 

$
36,250 

 

$
35,457 

 

2012

 
32,301 

 

 
33,188 

 

 
33,429 

 

 
32,800 

 

2011

 
30,196 

 

 
29,379 

 

 
29,654 

 

 
30,397 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS MARGIN:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
23,276 

 

$
21,479 

 

$
23,349 

 

$
22,282 

 

2012

 
21,292 

 

 
21,371 

 

 
21,310 

 

 
21,045 

 

2011

 
18,504 

 

 
19,053 

 

 
18,912 

 

 
19,375 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
2,192 

 

$
1,785 

 

$
3,169 

 

$
9,026 

*

2012

 
991 

 

 
3,334 

 

 
1,538 

 

 
2,083 

 

2011

 
1,666 

 

 
1,820 

 

 
2,019 

 

 
1,866 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME PER COMMON SHARE—DILUTED:

 

 

 

 

 

 

 

 

 

 

 

 

2013

$
0.08 

 

$
0.06 

 

$
0.11 

 

$
0.31 

*

2012

 
0.04 

 

 
0.12 

 

 
0.06 

 

 
0.07 

 

2011

 
0.06 

 

 
0.06 

 

 
0.07 

 

 
0.07 

 

 

 

*The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.

 

XML 97 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hemosphere Acquisition (Business Acquisition Purchase Price Allocation) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2012
Hemosphere [Member]
May 16, 2012
Hemosphere [Member]
Business Acquisition [Line Items]        
Cash and cash equivalents     $ 3,155  
Receivables     653  
Inventories     554  
Intangible assets     5,790  
Goodwill 11,365 11,365 7,145  
Deferred tax assets, net     5,379  
Other assets     331  
Liabilities assumed     (972)  
Total purchase price     $ 22,035 $ 22,000
XML 98 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Narrative) (Details) (USD $)
 0 Months Ended 9 Months Ended 12 Months Ended
May 28, 2013
Aug. 21, 2012
May 27, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Advertising expense       $ 880,000 $ 1,500,000 $ 948,000
ESPP, percentage of discounted price from market price       85.00%    
Increase in quarterly cash dividend, percentage 10.00%          
Quarterly cash dividend per share of common stock outstanding approved $ 0.0275 $ 0.025 $ 0.025 $ 0.108 $ 0.050  
Allowance for doubtful accounts       356,000 528,000  
Write-downs to deferred preservation costs       448,000 195,000 270,000
Write-down to inventory       1,200,000 77,000 0
Minimum [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Estimated useful lives       3 years    
Maximum [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Estimated useful lives       10 years    
Stock Options, RSAs, RSUs, And PSUs [Member] | Minimum [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period       1 year    
Stock Options, RSAs, RSUs, And PSUs [Member] | Maximum [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period       3 years    
Stock Options [Member] | Maximum [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Period within grant date stock options granted typically expire       7 years    
BioGlue Accessory Product [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Write-down to inventory       684,000    
Obsolete Revascularization Technologies Handpieces [Member]
            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Write-down to inventory       $ 483,000    
XML 99 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement Of Cash Flows (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Net cash flows from operating activities:      
Net income $ 16,172,000 $ 7,946,000 $ 7,371,000
Adjustments to reconcile net income to net cash from operating activities:      
Gain on sale of Medafor investment (12,742,000)    
Depreciation and amortization 5,843,000 5,633,000 4,960,000
Non-cash compensation 3,240,000 3,162,000 2,790,000
Other than temporary investment impairment 3,229,000 340,000  
Write-down of deferred preservation costs and inventories 1,693,000 288,000 270,000
Deferred income taxes 617,000 1,227,000 1,767,000
Other non-cash adjustments to income 298,000 683,000 767,000
Changes in operating assets and liabilities:      
Receivables (1,637,000) 1,363,000 (2,230,000)
Deferred preservation costs and inventories 193,000 (1,598,000) 2,445,000
Prepaid expenses and other assets (706,000) (583,000) (617,000)
Accounts payable, accrued expenses, and other liabilities 572,000 529,000 (772,000)
Net cash flows provided by operating activities 16,772,000 18,990,000 16,751,000
Net cash flows from investing activities:      
Proceeds from sale of Medafor investment 15,421,000    
Capital expenditures (4,338,000) (3,070,000) (2,538,000)
Advances under notes receivable   (2,000,000)  
Purchases of restricted securities and investments     (3,569,000)
Other (206,000) (810,000) (547,000)
Net cash flows provided by (used in) investing activities 10,877,000 (22,920,000) (27,716,000)
Net cash flows from financing activities:      
Proceeds from exercise of stock options and issuance of common stock 2,207,000 330,000 694,000
Cash dividends paid (2,967,000) (1,373,000)  
Repurchases of common stock (1,523,000) (3,529,000) (3,064,000)
Other (768,000) (143,000) (476,000)
Net cash flows used in financing activities (3,051,000) (4,715,000) (2,846,000)
Increase (decrease) in cash and cash equivalents 24,598,000 (8,645,000) (13,811,000)
Effect of exchange rate changes on cash 36,000 (51,000) 19,000
Cash and cash equivalents, beginning of year 13,009,000 21,705,000 35,497,000
Cash and cash equivalents, end of year 37,643,000 13,009,000 21,705,000
Hemosphere [Member]
      
Net cash flows from investing activities:      
Acquisition, net of cash acquired   (17,040,000)  
Cardiogenesis [Member]
      
Net cash flows from investing activities:      
Acquisition, net of cash acquired     $ (21,062,000)
XML 100 R88.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Information (Details) (USD $)
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Business Acquisition [Line Items]                              
REVENUE $ 35,457,000 $ 36,250,000 $ 33,520,000 $ 35,536,000 $ 32,800,000 $ 33,429,000 $ 33,188,000 $ 32,301,000 $ 30,397,000 $ 29,654,000 $ 29,379,000 $ 30,196,000 $ 140,763,000 $ 131,718,000 $ 119,626,000
GROSS MARGIN 22,282,000 23,349,000 21,479,000 23,276,000 21,045,000 21,310,000 21,371,000 21,292,000 19,375,000 18,912,000 19,053,000 18,504,000 90,386,000 85,018,000 75,844,000
NET INCOME 9,026,000 [1] 3,169,000 1,785,000 2,192,000 2,083,000 1,538,000 3,334,000 991,000 1,866,000 2,019,000 1,820,000 1,666,000 16,172,000 7,946,000 7,371,000
INCOME (LOSS) PER COMMON SHARE - DILUTED $ 0.31 [1] $ 0.11 $ 0.06 $ 0.08 $ 0.07 $ 0.06 $ 0.12 $ 0.04 $ 0.07 $ 0.07 $ 0.06 $ 0.06 $ 0.57 $ 0.28 $ 0.26
Gain on sale of Medafor investment 12,700,000                       12,742,000    
Other than temporary investment impairment                         3,229,000 340,000  
Medafor Inc. [Member]
                              
Business Acquisition [Line Items]                              
Gain on sale of Medafor investment 12,700,000                            
Series A Preferred Stock [Member] | ValveXchange, Inc. [Member]
                              
Business Acquisition [Line Items]                              
Other than temporary investment impairment $ 3,200,000                            
[1] The fourth quarter 2013 net income and income per common share-diluted includes the favorable effect of a $12.7 million pre-tax gain on the sale of an investment in the common stock of Medafor, Inc. as a result of C.R. Bard, Inc. completing its acquisition of the outstanding common shares of Medafor, Inc. and the unfavorable effect of a $3.2 million other than temporary investment impairment as a result of the impairment and write-down of the Company’s investment in ValveXchange preferred stock.
XML 101 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash Equivalents And Restricted Cash And Securities
 12 Months Ended
Dec. 31, 2013
Cash Equivalents And Restricted Cash And Securities [Abstract]  
Cash Equivalents And Restricted Cash And Securities

3.  Cash Equivalents and Restricted Cash and Securities

 

The following is a summary of cash equivalents and marketable securities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

Estimated

 

 

 

 

Holding

 

Market

December 31, 2013

Cost Basis

 

Gains (Losses)

 

Value

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$
5,349 

 

$

--

 

$
5,349 

Certificates of deposit

 
749 

 

 

--

 

 
749 

Restricted cash and securities:

 

 

 

 

 

 

 

 

Cash

 
5,000 

 

 

--

 

 
5,000 

Money market funds

 
350 

 

 

--

 

 
350 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$
1,319 

 

$

--

 

$
1,319 

Restricted securities:

 

 

 

 

 

 

 

 

Cash

 
5,000 

 

 

--

 

 
5,000 

Money market funds

 
323 

 

 

--

 

 
323 

 

As of December 31, 2013 and 2012 $350,000 and $323,000, respectively, of the Company’s money market funds were designated as short-term restricted securities due to a contractual commitment to hold the securities as pledged collateral relating primarily to international tax obligations.  As of December 31, 2013 $5.0 million of the Company’s cash was designated as restricted cash due to a financial covenant requirement under the Company’s credit agreement with General Electric Capital Corporation (“GE Capital”) as discussed in Note 11.  As of December 31, 2012  $5.0 million of the Company’s cash was designated as long-term restricted securities under the same covenant.  This restriction lapses upon expiration of the credit agreement with GE Capital on October 28, 2014.

 

There were no gross realized gains or losses on cash equivalents or restricted securities for the years ended December 31, 2013,  2012, and 2011.  At December 31, 2013 and 2012 $5.0 million of the Company’s restricted cash had no maturity date.  At December 31, 2013 $328,000 of the Company’s restricted securities had a maturity date within three months and $22,000 of the Company’s restricted securities had a maturity date between three months and one year.  At December 31, 2012 $323,000 of the Company’s restricted securities had a maturity date within three months. 

 

XML 102 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Other Intangible Assets (Schedule Of Carrying Values Of Indefinite Lived Intangible Assets)(Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Indefinite-lived Intangible Assets [Line Items]    
Goodwill $ 11,365 $ 11,365
Other Intangible Assets [Member]
    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite lived intangible assets   250
Procurement Contracts And Agreements [Member]
    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite lived intangible assets 2,013 2,013
Trademarks [Member]
    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite lived intangible assets $ 841 $ 870
XML 103 R82.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Summary Of Stock Compensation Expenses) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock compensation expense $ 3,468 $ 3,376 $ 3,014
RSA, RSU, And PSU Expense [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock compensation expense 2,616 2,204 1,408
Stock Option And ESPP Option Expense [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock compensation expense $ 852 $ 1,172 $ 1,606
XML 104 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details) (USD $)
 12 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
GE Credit Agreement [Member]
Dec. 31, 2012
GE Credit Agreement [Member]
Dec. 31, 2013
Minimum [Member]
GE Credit Agreement [Member]
Dec. 31, 2013
Minimum [Member]
LIBOR Rate [Member]
GE Credit Agreement [Member]
Dec. 31, 2013
Minimum [Member]
Base Rate [Member]
GE Credit Agreement [Member]
Oct. 28, 2011
Non-Amended [Member]
GE Credit Agreement [Member]
May 23, 2013
Amended [Member]
GE Credit Agreement [Member]
Oct. 28, 2011
Amended [Member]
GE Credit Agreement [Member]
Line of Credit Facility [Line Items]                      
Revolving credit facility, aggregate amount                 $ 15,000,000   $ 20,000,000
Payment of cash dividends allowed per year, maximum                   3,500,000  
Revolving credit facility, restriction on cash and cash equivalents           5,000,000          
Revolving credit facility, liquidity requirement after effect to stock repurchase           20,000,000          
Interest rate on amounts borrowed             4.25% 3.25%      
Revolving credit facility, outstanding balance       0 0            
Revolving credit facility, aggregate interest rate       6.50% 6.50%            
Revolving credit facility, remaining availability       20,000,000 20,000,000            
Total interest expense $ 71,000 $ 179,000 $ 142,000                
XML 105 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Policy)
 12 Months Ended
Dec. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Nature Of Business

Nature of Business

 

CryoLife, Inc. (“CryoLife,” the “Company,” “we,” or “us”) develops, manufactures, and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation.  CryoLife’s surgical sealants and hemostats include BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (“SMI”).  CryoLife’s subsidiary, Cardiogenesis Corporation (“Cardiogenesis”), specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.  CryoLife and its subsidiary, Hemosphere, Inc. (“Hemosphere”), market the Hemodialysis Reliable Outflow Graft (“HeRO® Graft”), which is a solution for end-stage renal disease (“ESRD”) in certain hemodialysis patients.  The cardiac and vascular human tissues distributed by CryoLife include the CryoValve® SG pulmonary heart valve (“CryoValve SGPV”) and the CryoPatch® SG pulmonary cardiac patch tissue (“CryoPatch SG”), both of which are processed using CryoLife’s proprietary SynerGraft® technology. 

Principles Of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant inter-company accounts and transactions have been eliminated in consolidation.

Translation Of Foreign Currencies

Translation of Foreign Currencies

 

The Company’s revenues and expenses transacted in foreign currencies are translated as they occur at exchange rates in effect at the time of each transaction.  Realized gains and losses on foreign currency transactions are recorded as a component of other (income) expense, net on the Company’s Consolidated Statements of Operations and Comprehensive Income.  Assets and liabilities of the Company denominated in foreign currencies are translated at the exchange rate in effect as of the balance sheet date and are recorded as a separate component of accumulated other comprehensive income (loss) in the shareholders' equity section of the Company’s Consolidated Balance Sheets.

Use Of Estimates

Use of Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods.  Actual results could differ from those estimates.  Estimates and assumptions are used when accounting for investments, allowance for doubtful accounts, deferred preservation costs, acquired assets or businesses, long‑lived tangible and intangible assets, deferred income taxes, commitments and contingencies (including product and tissue processing liability claims, claims incurred but not reported, and amounts recoverable from insurance companies), stock based compensation, certain accrued liabilities (including accrued procurement fees, income taxes, and financial instruments), contingent consideration liability, and other items as appropriate.

Revenue Recognition

Revenue Recognition

 

Revenues for products, including: BioGlue, BioFoam, PerClot, HemoStase, revascularization technologies handpieces and accessories, HeRO Grafts, and other medical devices, are recognized at the time the product is shipped, at which time title passes to the customer, and there are no further performance obligations.  The Company recognizes revenues for preservation services when services are completed and tissue is shipped to the customer.  Revenues from research grants are recognized in the period the associated costs are incurred.  Revenues from upfront licensing agreements are recognized ratably over the period the Company expects to fulfill its obligations.

 

Revenues from the sale of laser consoles are considered multiple element arrangements, and such revenues are allocated to the elements of the sale.  The Company allocates revenues based primarily on the revenue these individual elements would generate if sold separately.  Revenues from domestic laser consoles sales are typically recognized when the laser is installed at a customer site and all materials for the laser console’s use are delivered.  Revenues from the sales of laser consoles to international distributors are evaluated individually based on the terms of the sale and collectability to determine when revenue has been earned and can be recognized.

Shipping And Handling Charges

Shipping and Handling Charges

 

Fees charged to customers for shipping and handling of products and tissues are included in product revenues and preservation services revenues, respectively.  The costs for shipping and handling of products and tissues are included as a component of cost of products and cost of preservation services, respectively.

Advertising Costs

Advertising Costs

 

The costs to develop, produce, and communicate the Company’s advertising are expensed as incurred and are classified as general, administrative, and marketing expenses.  The Company records the cost to print or copy certain sales materials as a prepaid expense and amortizes these costs as an advertising expense over the period they are expected to be used, typically six months to one year.  The total amount of advertising expense included in the Company’s Consolidated Statements of Operations and Comprehensive Income was $880,000, $1.5 million, and $948,000 for the years ended December 31, 2013,  2012, and 2011, respectively.

Stock-Based Compensation

Stock‑Based Compensation

 

The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (“RSA”s), restricted stock units (“RSU”s), performance stock units (“PSU”s), and options to purchase shares of CryoLife common stock at exercise prices generally equal to the fair values of such stock at the dates of grant.  The Company also maintains a shareholder approved Employee Stock Purchase Plan (the “ESPP”) for the benefit of its employees.  The ESPP allows eligible employees the right to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.  The stock options, RSAs, RSUs, and PSUs granted by the Company typically vest over a one to three-year period.  The stock options granted by the Company typically expire within seven years of the grant date.

 

The Company values its RSAs, RSUs, and PSUs based on the stock price on the date of grant.  The Company expenses the related compensation cost of RSAs and RSUs using the straight-line method over the vesting period.  The Company expenses the related compensation cost of PSUs based on the number of shares expected to be issued if achievement of the performance component is probable using a straight-line method over each vesting tranche of the award.  The amount of compensation costs expensed related to PSUs is adjusted as needed if the Company deems that achievement of the performance component is no longer probable, or if the Company’s expectation of the number of shares to be issued changes.  The Company uses a Black-Scholes model to value its stock option grants and expenses the related compensation cost using the straight-line method over the vesting period.  The fair value of the Company’s ESPP options is also determined using a Black-Scholes model and is expensed over the vesting period.  The period expense is then determined based on this valuation and, at that time, an estimated forfeiture rate is used to reduce the expense recorded.  The Company’s estimate of pre-vesting forfeitures is primarily based on the recent historical experience of the Company and is adjusted to reflect actual forfeitures at each vesting date. 

 

The fair value of stock options and ESPP options is determined on the grant date using assumptions for the expected term, volatility, dividend yield, and the risk-free interest rate.  The expected term is primarily based on the contractual term of the option and Company data related to historic exercise and post-vesting forfeiture patterns, which is adjusted based on management’s expectations of future results.  The Company’s anticipated volatility level is primarily based on the historic volatility of the Company’s common stock, adjusted to remove the effects of certain periods of unusual volatility not expected to recur, and adjusted based on management’s expectations of future volatility, for the life of the option or option group.  The Company’s model included a zero dividend yield assumption in the periods prior to the Company’s initiation of a quarterly dividend in the third quarter of 2012.  The risk-free interest rate is based on recent U.S. Treasury note auction results with a similar life to that of the option.  The Company’s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions.

Income Per Common Share

Income Per Common Share

 

Income per common share is computed using the two class method, which requires the Company to include unvested RSAs that contain non-forfeitable rights to dividends (whether paid or unpaid) as participating securities in the income per common share calculation. 

 

Under the two class method, net income is allocated to the weighted-average number of common shares outstanding during the period and the weighted-average participating securities outstanding during the period.  The portion of net income that is allocated to the participating securities is excluded from basic and dilutive net income per common share.  Diluted net income per share is computed using the weighted-average number of common shares outstanding plus the dilutive effects of outstanding stock options and awards and other dilutive instruments as appropriate.

Dividends

Dividends

 

During 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding.  In 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 to $0.0275 per share of common stock outstanding.  The Company currently anticipates paying the quarterly dividends in March, June, September, and December of each year from cash on hand and will record the dividend payment as a reduction to retained earnings on the Company’s Consolidated Balance Sheets.

Financial Instruments

Financial Instruments

 

The Company’s financial instruments include cash equivalents, marketable securities, restricted securities, accounts receivable, notes receivable, accounts payable, and contingent consideration.  The Company typically values financial assets and liabilities such as receivables, accounts payable, and debt obligations at their carrying values, which approximate fair value due to their generally short-term duration.  Other financial instruments are typically recorded as discussed in the sections below.

 

Fair Value Measurements

Fair Value Measurements

 

The Company records certain financial instruments at fair value, including: cash equivalents, certain marketable securities, certain restricted securities, contingent consideration, and derivative instruments.  The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2013 the Company has not chosen to make any such elections.  Fair value financial instruments are recorded in accordance with the fair value measurement framework.

 

The Company also measures certain non-financial assets at fair value on a non-recurring basis.  These non-recurring valuations include evaluating assets such as cost method investments, long‑lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations.  The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.  

 

The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.  These levels from highest to lowest priority are as follows:

 

·

Level 1:  Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;

·

Level 2:  Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and

·

Level 3:  Unobservable inputs or valuation techniques that are used when little or no market data is available.

 

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment.  Level 3 valuations often involve a higher degree of judgment and complexity.  Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions.  Management’s assumptions could vary depending on the asset or liability valued and the valuation method used.  Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.  The Company may also engage external advisors to assist in determining fair value, as appropriate.

 

Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.

Cash And Cash Equivalents

Cash and Cash Equivalents

 

Cash equivalents consist primarily of highly liquid investments with maturity dates of three months or less at the time of acquisition.  The carrying value of cash equivalents approximates fair value.

 

In 2012 the Company’s cash equivalents included advance funding received from the U.S. Department of Defense (“DOD”) for the development of protein hydrogel technology.  The advance funding was accounted for as deferred income on the Company’s December 31, 2012 Consolidated Balance Sheet and revenue was recognized as expenses were incurred related to these grants.  The Company discontinued its BioFoam U.S. clinical trial and returned all of the remaining unspent funds to the DOD in the second quarter of 2013.

 

Cash Flow Supplemental Disclosures

 

Supplemental disclosures of cash flow information for the years ended December 31 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Cash paid during the year for:

 

 

 

 

 

 

 

 

Interest

$
3 

 

$
22 

 

$
89 

Income taxes

 
5,693 

 

 
1,263 

 

 
3,564 

 

 

 

 

 

 

 

 

 

 

Marketable Securities And Other Investments

Marketable Securities and Other Investments

 

The Company typically invests its excess cash for short-term periods in large, well‑capitalized financial institutions, and the Company's policy excludes investment in any securities rated less than "investment‑grade" by national rating services, unless specifically approved by the Board of Directors.  The Company sometimes makes longer term strategic investments in medical device companies, and these investments must be approved by the Board of Directors.

 

The Company determines the classification of its investments as trading, available-for-sale, or held-to-maturity at the time of purchase and reevaluates such designations quarterly.  Trading securities are securities that are acquired principally for the purpose of generating a profit from short-term fluctuations in price.  Debt securities are classified as held‑to‑maturity when the Company has the intent and ability to hold the securities to maturity.  Any securities not designated as trading or held‑to‑maturity are considered available-for-sale.  The Company typically states its investments at their fair values; however, for held‑to‑maturity securities or when current fair value information is not readily available, investments are recorded using the cost method.  The cost of securities sold is based on the specific identification method.

 

Under the fair value method, the Company adjusts each investment to its market price and records the unrealized gains or losses in other (income) expense, net for trading securities, or accumulated other comprehensive income (loss), for available-for-sale securities.  Interest, dividends, realized gains and losses, and declines in value judged to be other than temporary are included in other (income) expense, net.  Under the cost method, each investment is recorded at cost.  Subsequent dividends received are recognized as income, and the investment is reviewed for impairment if factors indicate that a decrease in the value of the investment has occurred.

Accounts Receivable And Allowance For Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

 

The Company’s accounts receivable are primarily from hospitals and distributors that either use or distribute the Company’s products and tissues.  The Company assesses the likelihood of collection based on a number of factors, including past transaction history with the customer and the credit worthiness of the customer, as well as the increased risks related to international customers and large distributors.  The accounts receivable balances were reported net of allowance for doubtful accounts of $356,000 and $528,000 as of December 31, 2013 and 2012 respectively.

Deferred Preservation Costs

Deferred Preservation Costs

 

By federal law, human tissues cannot be bought or sold, therefore, the tissues the Company preserves are not held as inventory.  The costs the Company incurs to procure and process cardiac and vascular tissues are instead accumulated and deferred.  Deferred preservation costs are stated at the lower of cost or market value on a first‑in, first‑out basis and are deferred until revenue is recognized.  At each balance sheet date, deferred preservation costs includes costs of tissues available for shipment, tissues currently in active processing, and tissues held in quarantine pending release to implantable status. 

 

Upon shipment of the tissue to an implanting facility, revenue is recognized and the related deferred preservation costs are expensed as cost of preservation services.  Cost of preservation services also includes, as applicable, lower of cost or market write-downs and impairments for tissues not deemed to be recoverable, and includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

 

The calculation of deferred preservation costs involves judgment and complexity and uses the same principles as inventory costing.  Donated human tissue is procured from deceased human donors by organ and tissue procurement organizations (“OTPOs”), which consign the tissue to the Company for processing, preservation, and distribution.  Deferred preservation costs consist primarily of the procurement fees charged by the OTPOs, direct labor and materials (including salary and fringe benefits, laboratory supplies and expenses, and freight‑in charges), and indirect costs (including allocations of costs from support departments and facility allocations).  Fixed production overhead costs are allocated based on actual tissue processing levels, to the extent that they are within the range of the facility’s normal capacity. 

 

These costs are then allocated among the tissues processed during the period based on cost drivers, such as the number of donors or number of tissues processed.  The Company applies a yield estimate to all tissues in process and in quarantine to estimate the portion of tissues that will ultimately become implantable.  Management estimates quarantine yields based on its experience and reevaluates these estimates periodically.  Actual yields could differ significantly from the Company’s estimates, which could result in a change in tissues available for shipment, and could increase or decrease the balance of deferred preservation costs.  These changes could result in additional cost of preservation services expense or could increase per tissue preservation costs, which would impact gross margins on tissue preservation services in future periods. 

 

The Company regularly evaluates its deferred preservation costs to determine if the costs are appropriately recorded at the lower of cost or market value.  The Company also evaluates its deferred preservation costs for costs not deemed to be recoverable, including tissues not expected to ship prior to the expiration date of their packaging.  Lower of cost or market value write-downs are recorded if the tissue processing costs incurred exceed the estimated market value of the tissue services, based on recent average service fees at the time of the evaluation.  Impairment write-downs are recorded based on the book value of tissues deemed to be impaired.  Actual results may differ from these estimates.  Write-downs of deferred preservation costs are expensed as cost of preservation services, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

 

The Company recorded write-downs to its deferred preservation costs totaling $448,000, $195,000, and $270,000 for the years ended December 31, 2013,  2012, and 2011, respectively.

Inventories

Inventories

 

Inventories are valued at the lower of cost or market on a first‑in, first‑out basis and the costs are recognized as cost of products upon shipment of the product.  Inventories are comprised of BioGlue; BioFoam; PerClot; revascularization technologies lasers, handpieces, and accessories; HeRO Grafts; other medical devices; supplies; and raw materials.  Cost of products also includes, as incurred, idle facility expense, excessive spoilage, extra freight, and rehandling costs.

 

Inventory costs for manufactured products consist primarily of direct labor and materials (including salary and fringe benefits, raw materials, and supplies) and indirect costs (including allocations of costs from departments that support manufacturing activities and facility allocations).  The allocation of fixed production overhead costs is based on actual production levels, to the extent that they are within the range of the facility’s normal capacity.  Inventory costs for products purchased for resale or contract manufactured consist primarily of the purchase cost, freight-in charges, and indirect costs as appropriate. 

 

The Company regularly evaluates its inventory to determine if the costs are appropriately recorded at the lower of cost or market value.  The Company also evaluates its inventory for costs not deemed to be recoverable, including inventory not expected to ship prior to its expiration.  Lower of cost or market value write-downs are recorded if the book value exceeds the estimated market value of the inventory, based on recent sales prices at the time of the evaluation.  Impairment write-downs are recorded based on the book value of inventory deemed to be impaired.  Actual results may differ from these estimates.  Write-downs of inventory are expensed as cost of products, and these write-downs are permanent impairments that create a new cost basis, which cannot be restored to its previous levels if the Company’s estimates change.

 

The Company recorded write-downs to its inventory totaling $1.2 million, $77,000, and zero for the years ended December 31, 2013,  2012, and 2011, respectively.  The 2013 write-down includes $684,000 in additional contractual costs and inventory impairment costs, primarily related to a BioGlue accessory product, and $483,000 in additional costs for revascularization technologies handpieces that were made obsolete by the Company’s decision to exclusively distribute the new handpiece design, which was approved by the U.S. Food and Drug Administration (“FDA”) in June 2013.

Property And Equipment

Property and Equipment

 

Property and equipment is stated at cost.  Depreciation is provided over the estimated useful lives of the assets, generally three to ten years, on a straight‑line basis.  Leasehold improvements are amortized on a straight‑line basis over the remaining lease term at the time the assets are capitalized or the estimated useful lives of the assets, whichever is shorter.

 

Depreciation expense for the years ended December 31 is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Depreciation expense

$
3,837 

 

$
3,662 

 

$
3,590 

 

Goodwill And Other Intangible Assets

Goodwill and Other Intangible Assets

 

The Company’s intangible assets consist of goodwill, patents, trademarks, and other intangible assets, as discussed in Note 9.  These assets include intangible assets from the acquisition of Hemosphere, as discussed in Note 4, and assets acquired from Cardiogenesis, as discussed in Note 6.  

 

The Company amortizes its definite lived intangible assets over their expected useful lives using the straight-line method, which the Company believes approximates the period of economic benefits of the related assets.  The Company’s indefinite lived intangible assets do not amortize, but are instead subject to periodic impairment testing as discussed in “Impairments of Long-Lived Assets and Non-Amortizing Intangible Assets” below.    

Impairments Of Long-Lived Assets And Non-Amortizing Intangible Assets

Impairments of Long‑Lived Assets and Non-Amortizing Intangible Assets

 

The Company assesses the potential impairment of its long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable.  Factors that could trigger an impairment review include, but are not limited to, the following:

 

·

Significant underperformance relative to expected historical or projected future operating results,

·

Significant negative industry or economic trends,

·

Significant decline in the Company’s stock price for a sustained period, or

·

Significant decline in the Company’s market capitalization relative to net book value. 

 

If CryoLife determines that an impairment review is necessary, the Company will evaluate its assets or asset groups by comparing their carrying values to the sum of the undiscounted future cash flows expected to result from their use and eventual disposition.  If the carrying values exceed the future cash flows, then the asset or asset group is considered impaired, and the Company will write down the value of the asset or asset group.  For the years ended December 31, 2013,  2012, and 2011 the Company did not experience any factors that indicated that an impairment review of its long-lived assets was warranted.

 

CryoLife evaluates its goodwill and other non-amortizing intangible assets for impairment on an annual basis as of October 31 and, if necessary, during interim periods if factors indicate that an impairment review is warranted.  As of October 31, 2013 the Company’s non-amortizing intangible assets consisted of goodwill, acquired procurement contracts and agreements, trademarks, and other acquired technology.  The Company performed an analysis of its non-amortizing intangible assets as of October 31, 2013 and 2012, and determined that the fair value of the assets and the fair value of the reporting unit exceeded their associated carrying values and were, therefore, not impaired.  Management will continue to evaluate the recoverability of these non-amortizing intangible assets.

Accrued Procurement Fees

Accrued Procurement Fees

 

Donated tissue is procured from deceased human donors by OTPOs, which consign the tissue to the Company for processing, preservation, and distribution.  The Company reimburses the OTPOs for their costs to recover the tissue and passes these costs on to the customer when the tissue is shipped and the performance of the service is complete.  The Company accrues estimated procurement fees due to the OTPOs at the time tissues are received based on contractual agreements between the Company and the OTPOs.

Leases

Leases

 

The Company has operating lease obligations resulting from the lease of land and buildings that comprise the Company's corporate headquarters and manufacturing facilities, leases related to additional manufacturing, office, and warehouse space, leases on Company vehicles, and leases on a variety of office equipment as discussed in Note 12.  Certain of the Company’s leases contain escalation clauses, rent concessions, and renewal options for additional periods.  Rent expense is computed on the straight‑line method over the lease term and the related liability is recorded as deferred rent obligations on the Company’s Consolidated Balance Sheets.

Liability Claims

Liability Claims

 

In the normal course of business, the Company is made aware of adverse events involving its products and tissues.  Any adverse event could ultimately give rise to a lawsuit against the Company.  In addition, product and tissue processing liability claims may be asserted against the Company in the future based on events it is not aware of at the present time.  The Company maintains claims‑made insurance policies to mitigate its financial exposure to product and tissue processing liability claims.  Claims‑made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect.  Thus, a claims‑made policy does not generally represent a transfer of risk for claims and incidents that have been incurred but not reported to the insurance carrier during the policy period.  Any punitive damage components of claims are uninsured.

 

The Company engages external advisors to assist it in estimating its liability and any related recoverable under the Company's insurance policies as of each balance sheet date.  The Company uses a frequency‑severity approach to estimate its unreported product and tissue processing liability claims, whereby, projected losses are calculated by multiplying the estimated number of claims by the estimated average cost per claim.  The estimated claims are determined based on the reported claim development method and the Bornhuetter‑Ferguson method using a blend of the Company's historical claim experience and industry data.  The estimated cost per claim is calculated using a lognormal claims model blending the Company's historical average cost per claim with industry claims data.  The Company uses a number of assumptions in order to estimate the unreported loss liability including: the future claim reporting time lag, the frequency of reported claims, the average cost per claim, and the maximum liability per claim.  The Company believes that the assumptions it uses provide a reasonable basis for its calculation.  However, the accuracy of the estimates is limited by the general uncertainty that exists for any estimate of future activity due to uncertainties surrounding the assumptions used and due to Company specific conditions and the scarcity of industry data directly relevant to the Company's business activities.  Due to these factors, actual results may differ significantly from the assumptions used and amounts accrued.

 

The Company accrues its estimate of unreported product and tissue processing liability claims as components of accrued expenses and other long‑term liabilities and records the related recoverable insurance amounts as a component of receivables and other long‑term assets.  The amounts recorded represent management's estimate of the probable losses and anticipated recoveries for unreported claims related to products sold and services performed prior to the balance sheet date.

Legal Contingencies

Legal Contingencies

 

The Company accrues losses from a legal contingency when the loss is both probable and reasonably estimable.  The accuracy of the Company’s estimates of losses for legal contingencies is limited by uncertainties surrounding litigation.  Therefore, actual results may differ significantly from the amounts accrued, if any.  The Company accrues for legal contingencies as a component of accrued expenses and other long‑term liabilities.  Gains from legal contingencies are recorded when the contingency is resolved. 

Legal Fees

Legal Fees

 

The Company expenses the costs of legal services, including legal services related to product and tissue processing liability claims and legal contingencies, as they are incurred.  Reimbursement of legal fees by an insurance company or other third-party is recorded as a reduction to legal expense.

 

Uncertain Tax Positions

Uncertain Tax Positions

 

The Company periodically assesses its uncertain tax positions and recognizes tax benefits if they are “more-likely-than-not” to be upheld upon review by the appropriate taxing authority.  The Company measures the tax benefit by determining the maximum amount that has a “greater than 50 percent likelihood” of ultimately being realized.  The Company reverses previously accrued liabilities for uncertain tax positions when audits are concluded, statutes expire, administrative practices dictate that a liability is no longer warranted, or in other circumstances as deemed necessary.  These assessments can be complex and the Company often obtains assistance from external advisors to make these assessments.  The Company recognizes interest and penalties related to uncertain tax positions in other (income) expense, net on its Consolidated Statements of Operations and Comprehensive Income.  See Note 10 for further discussion of the Company’s liabilities for uncertain tax positions. 

Deferred Income Taxes

Deferred Income Taxes

 

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and tax return purposes.  The Company periodically assesses the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its determination of the recoverability of its deferred tax assets.  Management provides a valuation allowance against the deferred tax asset when, as a result of this analysis, management believes it is more likely than not that some portion or all of its deferred tax assets will not be realized.

 

Assessing the recoverability of deferred tax assets involves judgment and complexity.  Estimates and judgments used in the determination of the need for a valuation allowance and in calculating the amount of a needed valuation allowance include, but are not limited to, the following:

 

·

Projected future operating results,

·

Anticipated future state tax apportionment,

·

Timing and amounts of anticipated future taxable income,

·

Timing of the anticipated reversal of book/tax temporary differences,

·

Evaluation of statutory limits regarding usage of certain tax assets, and

·

Evaluation of the statutory periods over which certain tax assets can be utilized. 

 

Significant changes in the factors above, or other factors, could materially, adversely affect the Company’s ability to use its deferred tax assets.  Such changes could have a material, adverse impact on the Company’s operations, financial condition, and cash flows.  The Company will continue to assess the recoverability of its deferred tax assets, as necessary, when the Company experiences changes that could materially affect its prior determination of the recoverability of its deferred tax assets. 

 

The Company believes that the realizability of its acquired net operating loss carryforwards will be limited in future periods due to a change in control of its subsidiaries Hemosphere and Cardiogenesis, as mandated by Section 382 of the Internal Revenue Code of 1986, as amended.  The Company believes that its acquisition of Hemosphere constituted a change in control and that prior to the Company’s acquisition, Hemosphere had experienced other equity ownership changes that should be considered a change in control.  The Company also believes that its acquisition of Cardiogenesis constituted a change in control.  The deferred tax assets recorded on the Company’s Consolidated Balance Sheets do not include amounts that it expects will not be realizable due to these changes in control.  A portion of the acquired net operating loss carryforwards is related to state income taxes for which management believes it is more likely than not that these deferred tax assets will not be realized.  Therefore, the Company recorded a valuation allowance against these state net operating loss carryforwards.

 

Valuation Of Acquired Assets Or Businesses

Valuation of Acquired Assets or Businesses

 

 As part of its corporate strategy, the Company is seeking to identify and evaluate acquisition opportunities of complementary product lines and companies.  The Company evaluates and accounts for acquired patents, licenses, distribution rights, and other tangible or intangible assets as the purchase of an asset or asset group, or as a business combination, as appropriate.  The determination of whether the purchase of a group of assets should be accounted for as an asset group or as a business combination requires significant judgment based on the weight of available evidence.

 

For the purchase of an asset group, the Company allocates the cost of the asset group, including transaction costs, to the individual assets purchased based on their relative estimated fair values.  In-process research and development acquired as part of an asset group is expensed upon acquisition.  The Company accounts for business combinations by allocating the purchase price to the assets and liabilities acquired at their estimated fair value.  Transaction costs related to a business combination are expensed as incurred.  In-process research and development acquired as part of a business combination is accounted for as an indefinite-lived intangible asset until the related research and development project gains regulatory approval or is discontinued.

 

The Company typically engages external advisors to assist it in determining the fair value of acquired asset groups or business combinations, using valuation methodologies such as: the excess earnings, the discounted cash flow, or the relief from royalty methods.  The determination of fair value in accordance with the fair value measurement framework requires significant judgments and estimates, including, but not limited to: timing of product life cycles, estimates of future revenues, estimates of profitability for new or acquired products, cost estimates for new or changed manufacturing processes, estimates of the cost or timing of obtaining regulatory approvals, estimates of the success of competitive products, and discount rates.  Management, in consultation with its advisor(s), makes these estimates based on its prior experiences and industry knowledge.  Management believes that its estimates are reasonable, but actual results could differ significantly from the Company’s estimates.  A significant change in management’s estimates used to value acquired asset groups or business combinations could result in future write-downs of tangible or intangible assets acquired by the Company and, therefore, could materially impact the Company’s financial position and profitability.  If the value of the liabilities assumed by the Company, including contingent liabilities, is determined to be significantly different from the amounts previously recorded in purchase accounting, the Company may need to record additional expenses or write-downs in future periods, which could materially impact the Company’s financial position and profitability.

Derivative Instruments

Derivative Instruments

 

The Company determines the fair value of its stand-alone and embedded derivative instruments at issuance and records any resulting asset or liability on the Company’s Consolidated Balance Sheets.  Changes in the fair value of the derivative instruments are recognized in the line item change in valuation of derivative on the Company’s Consolidated Statements of Operations and Comprehensive Income. 

New Accounting Pronouncements

New Accounting Pronouncements

In January 2013 the Company adopted Accounting Standards Update ("ASU"), 2012-02, Intangibles-Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment, which gives entities testing indefinite-lived intangible assets for impairment the option of performing a qualitative assessment before performing the quantitative impairment test as well as the option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test.  The adoption of ASU 2012-02 did not have a material effect on the Company's financial condition, profitability, or cash flows.

 

In February 2013 the Company adopted ASU 2013-02, Comprehensive Income (Topic 220):  Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires separate presentation of the components that are reclassified out of accumulated other comprehensive income either on the face of the financial statements or in the notes to the financial statements.  This update also requires companies to disclose the income statement line items affected by any significant reclassifications.  The adoption of ASU 2013-02 did not have a material effect on the Company's financial disclosures.

XML 106 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 300 451 1 true 89 0 false 5 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.cryolife.com/role/DocumentDocumentAndEntityInformation Document And Entity Information true false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.cryolife.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.cryolife.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Consolidated Statement Of Operations And Comprehensive Income Sheet http://www.cryolife.com/role/StatementConsolidatedStatementOfOperationsAndComprehensiveIncome Consolidated Statement Of Operations And Comprehensive Income false false R5.htm 00300 - Statement - Consolidated Statement Of Cash Flows Sheet http://www.cryolife.com/role/StatementConsolidatedStatementOfCashFlows Consolidated Statement Of Cash Flows false false R6.htm 00400 - Statement - Consolidated Statement Of Shareholders' Equity Sheet http://www.cryolife.com/role/StatementConsolidatedStatementOfShareholdersEquity Consolidated Statement Of Shareholders' Equity false false R7.htm 00405 - Statement - Consolidated Statement Of Shareholders' Equity (Parenthetical) Sheet http://www.cryolife.com/role/StatementConsolidatedStatementOfShareholdersEquityParenthetical Consolidated Statement Of Shareholders' Equity (Parenthetical) false false R8.htm 10101 - Disclosure - Summary Of Significant Accounting Policies Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies false false R9.htm 10201 - Disclosure - Financial Instruments Sheet http://www.cryolife.com/role/DisclosureFinancialInstruments Financial Instruments false false R10.htm 10301 - Disclosure - Cash Equivalents And Restricted Cash And Securities Sheet http://www.cryolife.com/role/DisclosureCashEquivalentsAndRestrictedCashAndSecurities Cash Equivalents And Restricted Cash And Securities false false R11.htm 10401 - Disclosure - Hemosphere Acquisition Sheet http://www.cryolife.com/role/DisclosureHemosphereAcquisition Hemosphere Acquisition false false R12.htm 10501 - Disclosure - ValveXchange Sheet http://www.cryolife.com/role/DisclosureValvexchange ValveXchange false false R13.htm 10601 - Disclosure - Cardiogenesis Acquisition Sheet http://www.cryolife.com/role/DisclosureCardiogenesisAcquisition Cardiogenesis Acquisition false false R14.htm 10701 - Disclosure - Medafor Matters Sheet http://www.cryolife.com/role/DisclosureMedaforMatters Medafor Matters false false R15.htm 10801 - Disclosure - Deferred Preservation Costs And Inventories Sheet http://www.cryolife.com/role/DisclosureDeferredPreservationCostsAndInventories Deferred Preservation Costs And Inventories false false R16.htm 10901 - Disclosure - Goodwill And Other Intangible Assets Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssets Goodwill And Other Intangible Assets false false R17.htm 11001 - Disclosure - Income Taxes Sheet http://www.cryolife.com/role/DisclosureIncomeTaxes Income Taxes false false R18.htm 11101 - Disclosure - Debt Sheet http://www.cryolife.com/role/DisclosureDebt Debt false false R19.htm 11201 - Disclosure - Commitments And Contingencies Sheet http://www.cryolife.com/role/DisclosureCommitmentsAndContingencies Commitments And Contingencies false false R20.htm 11301 - Disclosure - Shareholders' Equity Sheet http://www.cryolife.com/role/DisclosureShareholdersEquity Shareholders' Equity false false R21.htm 11401 - Disclosure - Employee Benefit Plans Sheet http://www.cryolife.com/role/DisclosureEmployeeBenefitPlans Employee Benefit Plans false false R22.htm 11501 - Disclosure - Stock Compensation Sheet http://www.cryolife.com/role/DisclosureStockCompensation Stock Compensation false false R23.htm 11601 - Disclosure - Income Per Common Share Sheet http://www.cryolife.com/role/DisclosureIncomePerCommonShare Income Per Common Share false false R24.htm 11701 - Disclosure - Transactions With Related Parties Sheet http://www.cryolife.com/role/DisclosureTransactionsWithRelatedParties Transactions With Related Parties false false R25.htm 11801 - Disclosure - Segment And Geographic Information Sheet http://www.cryolife.com/role/DisclosureSegmentAndGeographicInformation Segment And Geographic Information false false R26.htm 11901 - Disclosure - Selected Quarterly Financial Information Sheet http://www.cryolife.com/role/DisclosureSelectedQuarterlyFinancialInformation Selected Quarterly Financial Information false false R27.htm 20101 - Disclosure - Summary Of Significant Accounting Policies (Policy) Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy Summary Of Significant Accounting Policies (Policy) false false R28.htm 30103 - Disclosure - Summary Of Significant Accounting Policies (Tables) Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary Of Significant Accounting Policies (Tables) false false R29.htm 30203 - Disclosure - Financial Instruments (Tables) Sheet http://www.cryolife.com/role/DisclosureFinancialInstrumentsTables Financial Instruments (Tables) false false R30.htm 30303 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Tables) Sheet http://www.cryolife.com/role/DisclosureCashEquivalentsAndRestrictedCashAndSecuritiesTables Cash Equivalents And Restricted Cash And Securities (Tables) false false R31.htm 30403 - Disclosure - Hemosphere Acquisition (Tables) Sheet http://www.cryolife.com/role/DisclosureHemosphereAcquisitionTables Hemosphere Acquisition (Tables) false false R32.htm 30603 - Disclosure - Cardiogenesis Acquisition (Tables) Sheet http://www.cryolife.com/role/DisclosureCardiogenesisAcquisitionTables Cardiogenesis Acquisition (Tables) false false R33.htm 30803 - Disclosure - Deferred Preservation Costs And Inventories (Tables) Sheet http://www.cryolife.com/role/DisclosureDeferredPreservationCostsAndInventoriesTables Deferred Preservation Costs And Inventories (Tables) false false R34.htm 30903 - Disclosure - Goodwill And Other Intangible Assets (Tables) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables Goodwill And Other Intangible Assets (Tables) false false R35.htm 31003 - Disclosure - Income Taxes (Tables) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R36.htm 31203 - Disclosure - Commitments And Contingencies (Tables) Sheet http://www.cryolife.com/role/DisclosureCommitmentsAndContingenciesTables Commitments And Contingencies (Tables) false false R37.htm 31503 - Disclosure - Stock Compensation (Tables) Sheet http://www.cryolife.com/role/DisclosureStockCompensationTables Stock Compensation (Tables) false false R38.htm 31603 - Disclosure - Income Per Common Share (Tables) Sheet http://www.cryolife.com/role/DisclosureIncomePerCommonShareTables Income Per Common Share (Tables) false false R39.htm 31803 - Disclosure - Segment And Geographic Information (Tables) Sheet http://www.cryolife.com/role/DisclosureSegmentAndGeographicInformationTables Segment And Geographic Information (Tables) false false R40.htm 31903 - Disclosure - Selected Quarterly Financial Information (Tables) Sheet http://www.cryolife.com/role/DisclosureSelectedQuarterlyFinancialInformationTables Selected Quarterly Financial Information (Tables) false false R41.htm 40101 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails Summary Of Significant Accounting Policies (Narrative) (Details) false false R42.htm 40102 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Supplemental Disclosures Of Cash Flow Information) (Details) Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfSupplementalDisclosuresOfCashFlowInformationDetails Summary Of Significant Accounting Policies (Schedule Of Supplemental Disclosures Of Cash Flow Information) (Details) false false R43.htm 40103 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Depreciation Expense) (Details) Sheet http://www.cryolife.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfDepreciationExpenseDetails Summary Of Significant Accounting Policies (Schedule Of Depreciation Expense) (Details) false false R44.htm 40201 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) Sheet http://www.cryolife.com/role/DisclosureFinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) false false R45.htm 40202 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) Sheet http://www.cryolife.com/role/DisclosureFinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) false false R46.htm 40301 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Narrative ) (Details) Sheet http://www.cryolife.com/role/DisclosureCashEquivalentsAndRestrictedCashAndSecuritiesNarrativeDetails Cash Equivalents And Restricted Cash And Securities (Narrative ) (Details) false false R47.htm 40302 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Summary Of Cash Equivalents And Marketable Securities) (Details) Sheet http://www.cryolife.com/role/DisclosureCashEquivalentsAndRestrictedCashAndSecuritiesSummaryOfCashEquivalentsAndMarketableSecuritiesDetails Cash Equivalents And Restricted Cash And Securities (Summary Of Cash Equivalents And Marketable Securities) (Details) false false R48.htm 40401 - Disclosure - Hemosphere Acquisition (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureHemosphereAcquisitionNarrativeDetails Hemosphere Acquisition (Narrative) (Details) false false R49.htm 40402 - Disclosure - Hemosphere Acquisition (Business Acquisition Purchase Price Allocation) (Details) Sheet http://www.cryolife.com/role/DisclosureHemosphereAcquisitionBusinessAcquisitionPurchasePriceAllocationDetails Hemosphere Acquisition (Business Acquisition Purchase Price Allocation) (Details) false false R50.htm 40403 - Disclosure - Hemosphere Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) Sheet http://www.cryolife.com/role/DisclosureHemosphereAcquisitionSummaryOfUnauditedProFormaResultsOfOperationsDetails Hemosphere Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) false false R51.htm 40501 - Disclosure - ValveXchange (Details) Sheet http://www.cryolife.com/role/DisclosureValvexchangeDetails ValveXchange (Details) false false R52.htm 40601 - Disclosure - Cardiogenesis Acquisition (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureCardiogenesisAcquisitionNarrativeDetails Cardiogenesis Acquisition (Narrative) (Details) false false R53.htm 40602 - Disclosure - Cardiogenesis Acquisition (Business Acquisition Purchase Price Allocation) (Details) Sheet http://www.cryolife.com/role/DisclosureCardiogenesisAcquisitionBusinessAcquisitionPurchasePriceAllocationDetails Cardiogenesis Acquisition (Business Acquisition Purchase Price Allocation) (Details) false false R54.htm 40603 - Disclosure - Cardiogenesis Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) Sheet http://www.cryolife.com/role/DisclosureCardiogenesisAcquisitionSummaryOfUnauditedProFormaResultsOfOperationsDetails Cardiogenesis Acquisition (Summary Of Unaudited Pro Forma Results Of Operations) (Details) false false R55.htm 40701 - Disclosure - Medafor Matters (Details) Sheet http://www.cryolife.com/role/DisclosureMedaforMattersDetails Medafor Matters (Details) false false R56.htm 40801 - Disclosure - Deferred Preservation Costs And Inventories (Schedule Of Deferred Preservation Costs) (Details) Sheet http://www.cryolife.com/role/DisclosureDeferredPreservationCostsAndInventoriesScheduleOfDeferredPreservationCostsDetails Deferred Preservation Costs And Inventories (Schedule Of Deferred Preservation Costs) (Details) false false R57.htm 40802 - Disclosure - Deferred Preservation Costs And Inventories (Schedule Of Inventories) (Details) Sheet http://www.cryolife.com/role/DisclosureDeferredPreservationCostsAndInventoriesScheduleOfInventoriesDetails Deferred Preservation Costs And Inventories (Schedule Of Inventories) (Details) false false R58.htm 40901 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Carrying Values Of Indefinite Lived Intangible Assets)(Details) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfCarryingValuesOfIndefiniteLivedIntangibleAssetsDetails Goodwill And Other Intangible Assets (Schedule Of Carrying Values Of Indefinite Lived Intangible Assets)(Details) false false R59.htm 40902 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Goodwill By Reportable Segment) (Details) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails Goodwill And Other Intangible Assets (Schedule Of Goodwill By Reportable Segment) (Details) false false R60.htm 40903 - Disclosure - Goodwill And Other Intangible Assets (Schedule Of Gross Carrying Values, Accumulated Amortization, And Approximate Amortization Periods Of Definite Lived Intangible Assets) (Details) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfGrossCarryingValuesAccumulatedAmortizationAndApproximateAmortizationPeriodsOfDefiniteLivedIntangibleAssetsDetails Goodwill And Other Intangible Assets (Schedule Of Gross Carrying Values, Accumulated Amortization, And Approximate Amortization Periods Of Definite Lived Intangible Assets) (Details) false false R61.htm 40904 - Disclosure - Goodwill And Other Intangible Assets (Summary Of Amortization Expense) (Details) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpenseDetails Goodwill And Other Intangible Assets (Summary Of Amortization Expense) (Details) false false R62.htm 40905 - Disclosure - Goodwill And Other Intangible Assets (Scheduled Amortization Of Intangible Assets For Next Five Years) (Details) Sheet http://www.cryolife.com/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduledAmortizationOfIntangibleAssetsForNextFiveYearsDetails Goodwill And Other Intangible Assets (Scheduled Amortization Of Intangible Assets For Next Five Years) (Details) false false R63.htm 41001 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) false false R64.htm 41002 - Disclosure - Income Taxes (Schedule Of Income Before Income Tax) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesScheduleOfIncomeBeforeIncomeTaxDetails Income Taxes (Schedule Of Income Before Income Tax) (Details) false false R65.htm 41003 - Disclosure - Income Taxes (Schedule Of Components Of Income Tax Expense) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails Income Taxes (Schedule Of Components Of Income Tax Expense) (Details) false false R66.htm 41004 - Disclosure - Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details) false false R67.htm 41005 - Disclosure - Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) false false R68.htm 41006 - Disclosure - Income Taxes (Schedule Of Uncertain Tax Position Liability And Liability For Interest And Penalties On Uncertain Tax Positions) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomeTaxesScheduleOfUncertainTaxPositionLiabilityAndLiabilityForInterestAndPenaltiesOnUncertainTaxPositionsDetails Income Taxes (Schedule Of Uncertain Tax Position Liability And Liability For Interest And Penalties On Uncertain Tax Positions) (Details) false false R69.htm 41101 - Disclosure - Debt (Details) Sheet http://www.cryolife.com/role/DisclosureDebtDetails Debt (Details) false false R70.htm 41201 - Disclosure - Commitments And Contingencies (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments And Contingencies (Narrative) (Details) false false R71.htm 41202 - Disclosure - Commitments And Contingencies (Schedule Of Future Minimum Operating Lease Payments) (Details) Sheet http://www.cryolife.com/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOperatingLeasePaymentsDetails Commitments And Contingencies (Schedule Of Future Minimum Operating Lease Payments) (Details) false false R72.htm 41301 - Disclosure - Shareholders' Equity (Details) Sheet http://www.cryolife.com/role/DisclosureShareholdersEquityDetails Shareholders' Equity (Details) false false R73.htm 41401 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.cryolife.com/role/DisclosureEmployeeBenefitPlansDetails Employee Benefit Plans (Details) false false R74.htm 41501 - Disclosure - Stock Compensation (Narrative) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationNarrativeDetails Stock Compensation (Narrative) (Details) false false R75.htm 41502 - Disclosure - Stock Compensation (Schedule Of Shares Available For Grant) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationScheduleOfSharesAvailableForGrantDetails Stock Compensation (Schedule Of Shares Available For Grant) (Details) false false R76.htm 41503 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For RSAs) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationScheduleOfStockGrantActivityForRsasDetails Stock Compensation (Schedule Of Stock Grant Activity For RSAs) (Details) false false R77.htm 41504 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For RSUs) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationScheduleOfStockGrantActivityForRsusDetails Stock Compensation (Schedule Of Stock Grant Activity For RSUs) (Details) false false R78.htm 41505 - Disclosure - Stock Compensation (Schedule Of Stock Grant Activity For PSUs) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationScheduleOfStockGrantActivityForPsusDetails Stock Compensation (Schedule Of Stock Grant Activity For PSUs) (Details) false false R79.htm 41506 - Disclosure - Stock Compensation (Summary Of Stock Option Activity) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationSummaryOfStockOptionActivityDetails Stock Compensation (Summary Of Stock Option Activity) (Details) false false R80.htm 41507 - Disclosure - Stock Compensation (Summary Of Other Information Concerning Stock Options) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationSummaryOfOtherInformationConcerningStockOptionsDetails Stock Compensation (Summary Of Other Information Concerning Stock Options) (Details) false false R81.htm 41508 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsDetails Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details) false false R82.htm 41509 - Disclosure - Stock Compensation (Summary Of Stock Compensation Expenses) (Details) Sheet http://www.cryolife.com/role/DisclosureStockCompensationSummaryOfStockCompensationExpensesDetails Stock Compensation (Summary Of Stock Compensation Expenses) (Details) false false R83.htm 41601 - Disclosure - Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details) Sheet http://www.cryolife.com/role/DisclosureIncomePerCommonShareComputationOfBasicAndDilutedIncomeLossPerCommonShareDetails Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details) false false R84.htm 41701 - Disclosure - Transactions With Related Parties (Details) Sheet http://www.cryolife.com/role/DisclosureTransactionsWithRelatedPartiesDetails Transactions With Related Parties (Details) false false R85.htm 41801 - Disclosure - Segment And Geographic Information (Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments) (Details) Sheet http://www.cryolife.com/role/DisclosureSegmentAndGeographicInformationRevenuesCostOfServicesAndProductsAndGrossMarginsForOperatingSegmentsDetails Segment And Geographic Information (Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments) (Details) false false R86.htm 41802 - Disclosure - Segment And Geographic Information (Summary Of Net Revenues By Product) (Details) Sheet http://www.cryolife.com/role/DisclosureSegmentAndGeographicInformationSummaryOfNetRevenuesByProductDetails Segment And Geographic Information (Summary Of Net Revenues By Product) (Details) false false R87.htm 41803 - Disclosure - Segment And Geographic Information (Schedule Of Net Revenues By Geographic Location) (Details) Sheet http://www.cryolife.com/role/DisclosureSegmentAndGeographicInformationScheduleOfNetRevenuesByGeographicLocationDetails Segment And Geographic Information (Schedule Of Net Revenues By Geographic Location) (Details) false false R88.htm 41901 - Disclosure - Selected Quarterly Financial Information (Details) Sheet http://www.cryolife.com/role/DisclosureSelectedQuarterlyFinancialInformationDetails Selected Quarterly Financial Information (Details) false false All Reports Book All Reports Element us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount had a mix of decimals attribute values: -5 0. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet had a mix of decimals attribute values: -5 -3. Element us-gaap_CostMethodInvestments had a mix of decimals attribute values: -5 -3 0. Element us-gaap_CostmethodInvestmentsOtherThanTemporaryImpairment had a mix of decimals attribute values: -3 0. Element us-gaap_CostMethodInvestmentsRealizedGainLoss had a mix of decimals attribute values: -5 -3. Element us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized had a mix of decimals attribute values: -5 0. Element us-gaap_ProceedsFromSaleOfOtherInvestments had a mix of decimals attribute values: -5 -3. Element us-gaap_RelatedPartyTransactionAmountsOfTransaction had a mix of decimals attribute values: -5 0. Element us-gaap_RestrictedCashAndCashEquivalentsNoncurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_SellingGeneralAndAdministrativeExpense had a mix of decimals attribute values: -5 -3. Element us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised had a mix of decimals attribute values: -3 0. Element us-gaap_TreasuryStockRetiredCostMethodAmount had a mix of decimals attribute values: -5 0. 'Monetary' elements on report '00100 - Statement - Consolidated Balance Sheets' had a mix of different decimal attribute values. 'Monetary' elements on report '00300 - Statement - Consolidated Statement Of Cash Flows' had a mix of different decimal attribute values. 'Shares' elements on report '00400 - Statement - Consolidated Statement Of Shareholders' Equity' had a mix of different decimal attribute values. 'Monetary' elements on report '40202 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40301 - Disclosure - Cash Equivalents And Restricted Cash And Securities (Narrative ) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40401 - Disclosure - Hemosphere Acquisition (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40501 - Disclosure - ValveXchange (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40601 - Disclosure - Cardiogenesis Acquisition (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41001 - Disclosure - Income Taxes (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41101 - Disclosure - Debt (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41301 - Disclosure - Shareholders' Equity (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '41601 - Disclosure - Income Per Common Share (Computation Of Basic And Diluted Income (Loss) Per Common Share) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41901 - Disclosure - Selected Quarterly Financial Information (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Consolidated Statement Of Operations And Comprehensive Income Process Flow-Through: Removing column '0 Months Ended May 28, 2013' Process Flow-Through: Removing column '0 Months Ended Aug. 21, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: Removing column '9 Months Ended May 27, 2013' Process Flow-Through: 00300 - Statement - Consolidated Statement Of Cash Flows Process Flow-Through: 00405 - Statement - Consolidated Statement Of Shareholders' Equity (Parenthetical) cry-20131231.xml cry-20131231.xsd cry-20131231_cal.xml cry-20131231_def.xml cry-20131231_lab.xml cry-20131231_pre.xml true true XML 107 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation (Narrative) (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
ESPP, percentage of discounted price from market price 85.00%    
Actual percentage of target number of shares of common stock granted as Performance Stock Units 115.00% 125.00%  
Granted, Shares 162,000 159,000 599,000
Employees purchased common stock, shares 97,000 72,000 64,000
Capitalized stock compensation expense $ 228,000 $ 214,000 $ 224,000
RSAs To Non-Employee Directors, RSUs To Certain Employees, And RSAs And PSUs To Certain Company Officers [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Authorized stock incentive plans to non-employee Directors and certain Company officers, shares 467,000 451,000 421,000
Aggregate market value of issued stock incentive plans 3,100,000 2,400,000 2,200,000
Restricted Stock Awards (RSAs) [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected weighted-average period for recognizing the unrecognized compensation costs, in years 11 months 1 day    
RSA, RSU, And PSU Expense [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation costs 2,800,000    
Stock Options [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted, Shares 162,000 159,000 599,000
Unrecognized compensation costs $ 532,000    
Expected weighted-average period for recognizing the unrecognized compensation costs, in years 1 year 1 month 17 days    
Restricted Stock Units (RSUs) [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected weighted-average period for recognizing the unrecognized compensation costs, in years 2 years 3 months 7 days    
Performance Stock Units (PSUs) [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected weighted-average period for recognizing the unrecognized compensation costs, in years 9 months 22 days    
Minimum [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of target number of shares of common stock granted as Performance Stock Units 50.00%    
Maximum [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of target number of shares of common stock granted as Performance Stock Units 150.00%    
2009 Employee Stock Incentive Plan [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Increase in shares authorized under plan   2,100,000  
XML 108 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Per Common Share (Tables)
 12 Months Ended
Dec. 31, 2013
Income Per Common Share [Abstract]  
Computation Of Basic And Diluted Income (Loss) Per Common Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Basic income per common share

 

 

 

 

 

 

 

 

Net income

$
16,172 

 

$
7,946 

 

$
7,371 

Net income allocated to participating securities

 
(367)

 

 
(180)

 

 
(149)

Net income allocated to common shareholders

$
15,805 

 

$
7,766 

 

$
7,222 

 

 

 

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 
26,885 

 

 
26,967 

 

 
27,441 

Basic income per common share

$
0.59 

 

$
0.29 

 

$
0.26 

 

 

 

 

 

 

 

 

 

Diluted income per common share

 

 

 

 

 

 

 

 

Net income

$
16,172 

 

$
7,946 

 

$
7,371 

Net income allocated to participating securities

 
(359)

 

 
(178)

 

 
(147)

Net income allocated to common shareholders

$
15,813 

 

$
7,768 

 

$
7,224 

 

 

 

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 
26,885 

 

 
26,967 

 

 
27,441 

Effect of dilutive options and awardsa

 
813 

 

 
444 

 

 
318 

Diluted weighted-average common shares outstanding

 
27,698 

 

 
27,411 

 

 
27,759 

Diluted income per common share

$
0.57 

 

$
0.28 

 

$
0.26 

aThe Company excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares, because the inclusion of these stock options would be antidilutive to income per common share.  Accordingly, stock options to purchase 656,000,  1.7 million, and 2.0 million, shares for the years ended December 31, 2013,  2012, and 2011, respectively, were excluded from the calculation of diluted weighted-average common shares outstanding.

XML 109 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity
 12 Months Ended
Dec. 31, 2013
Shareholders' Equity [Abstract]  
Shareholders' Equity

13.  Shareholders’ Equity

 

Common Stock Repurchase

 

On November 1, 2011 the Company announced that its Board of Directors had authorized the Company’s purchase of $15.0 million of its common stock through December 31, 2012.  This program expired on December 31, 2012.  In February 2013 the Company’s Board of Directors authorized the purchase of up to $15.0 million of its common stock through October 31, 2014.

 

For the year ended December 31, 2013 the Company purchased approximately 253,000 shares of its common stock for an aggregate purchase price of $1.5 million.  As of December 31, 2013, the Company had $13.5 million in remaining authorizations under the repurchase program.  For the year ended December 31, 2012 the Company purchased approximately 639,000 shares of its common stock for an aggregate purchase price of $3.3 million.  These shares were recorded, at cost, as part of treasury stock on the Company’s Consolidated Balance Sheets. 

 

Treasury Stock 

 

On August 7, 2012 the Company retired 2.7 million shares of treasury stock with an aggregate value of $15.1 million.  The retirement was recorded as a reduction of $15.1 million in treasury stock, $27,000 in common stock, and approximately $15.1 million in additional paid in capital.  These shares remain available for issuance as authorized unissued shares. 

 

 Cash Dividends 

 

On August 21, 2012 the Company announced that its Board of Directors had approved the initiation of a quarterly cash dividend of $0.025 per share of common stock outstanding.  In May 2013 the Company announced that its Board of Directors approved a 10% increase in the quarterly cash dividend beginning in the second quarter of 2013 from $0.025 to $0.0275 per share of common stock outstanding.  The Company paid dividend payments from cash on hand of $3.0 million and $1.4 million for the years ended December 31, 2013 and 2012, respectively.

 

Shareholder Rights Plan

 

The Company has a shareholder rights agreement entered into in 1995 and amended in 2005.  Under the rights agreement, each share of the Company's common stock outstanding on December 11, 1995 is entitled to one “Right,” as defined in, and subject to, the terms of the rights agreement.  A Right entitles the registered holder to purchase from the Company one one-hundredth of a share of Series A Junior Participating Preferred Stock (“Series A Stock”) of the Company at $33.33 per one one-hundredth of a Preferred Share, subject to adjustment.  Additionally, each common share that has or shall become outstanding after December 11, 1995 is also entitled to a Right, subject to the terms and conditions of the rights agreement.  The Rights, which expire on November 23, 2015, may be exercised only if certain conditions are met, such as the acquisition of 15% or more of the Company's common stock by a person or affiliated group (together with its affiliates, associates, and transferees, an "Acquiring Person").  Rights beneficially owned by an Acquiring Person become void from and after the time such persons become Acquiring Persons, and Acquiring Persons have no rights whatsoever under the rights agreement.

 

Each share of Series A Stock purchasable upon exercise of a Right will be entitled, when, as, and if declared, to a minimum preferential quarterly dividend payment of $1.00 per share but will be entitled to an aggregate dividend of 100 times the dividend declared per share of common stock.  In the event of liquidation, each share of the Series A Stock will be entitled to a minimum preferential liquidation payment of 100 times the payment made per share of common stock.  Finally, in the event of any merger, consolidation, or other transaction in which shares of common stock are exchanged, each share of Series A Stock will be entitled to receive 100 times the amount received per share of common stock.  These rights are protected by customary antidilution provisions.

 

In the event the Rights become exercisable, each Right will enable the owner, other than Acquiring Persons, to purchase shares of the Company’s Series A Stock as described above.  Alternatively, if the Rights become exercisable, the holder of a Right may elect to receive, upon exercise of the Right and in lieu of receiving Series A Stock, that number of shares of common stock of the Company having an exercise value of two times the exercise price of the Right.  In the event that, after a person or group has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction or 50% or more of its consolidated assets or earning power are sold, proper provision will be made so that each holder of a Right will thereafter have the right to receive, upon the exercise of a Right, and in lieu of Series A Stock of the Company, that number of shares of common stock of the person with whom the Company has engaged in the foregoing transaction (or its parent) that at the time of such transaction will have a market value of two times the exercise price of the Right.  In addition, after any person or group becomes an Acquiring Person and prior to the acquisition by the person or group of 50% or more of the outstanding common stock, the Board of Directors may elect to exchange all outstanding Rights at an exchange ratio of one share of common stock (or fractional share of Series A Stock or other preferred shares) per Right (subject to adjustment).

 

]W5&6HTQ7:GW\N8YY9!%S+;_/AY\ME^B4Q[]=S M(^]W[A^20[$Q&VMU]`>,H-@Y[)!15L`X;_,1$S;>@E;9(7=I\.VJU&/&>8]AMZK]TBNZWGH3L>5>B(L;8G>R"WE MF5M6GEZ[P6:A!HAS%A;9#2(SQ/0#?U%2N!R!C+>LPTY4HD&9.=>$L#^6"'XN M%,:-:N[$'/U'9BMGBU_G.9,'EXWYF8@$VRPN=(R+;A?U)X$=#B.)S(:L6.V) M]=YA;KC;\B&,Q#KN]G#&/-+K3+D?"OR4_24.A:`E1NPA"!:&C;#X@VFDB!0R M=/G\A;BRQ.1++5?3MTP#+VR9NLMX`67-@K+Y)FI<\66)W`"A4DG?_:2#:B*^HAR+-#2L(V=/S+3$NGI.>'.CP*CBR;97F`\QMWNXG+=N/A]6^/( M:"!ID!(;PZG+>;+3T0C%C'\'9G1>@\@?FH68DW0HI1G-G"A5,=JZ\J/=4M+P MB>E'6S"IY6!B!6+S9KY5&7:Q/GJ$F_>.^+V_2I^$R5%YF^!6KO'CXSN_+J5] MQ3+T_,CMI23'QZ@P4!$`9D<;`\DF@.\HHM8FVJ%+"8.C)(_;FIZ5^GG4FCT2 MQHA4L>`G,EX!JD4G)-D>X;L;IEVL*NQFO3IZ+!N-)<]?:H4_1Y00'4Q7F3#Z MO[#%NO>&&!CO'0L=RV$\E6!72OKRF'6H,XGSO:`NW2*V1R*(CU.!74ZB+:RH M1$):RSQ*]\6/YF8NUJ#D\=B8 MAFVS0R/;>6)B2MXC$5HN'F!C80%[47)BRN^)F\;'IU&$*_/:!J[8EXQ]K3#[ M7BAKO*,I$H_"H((X1HG3'3.-LJ^@187L@3CH< M'D\6/4_Y0;SHQP@6U^$\]=`ME0?19D9+&9LBN\<>A\UGEB835N*'LXE%5CC-HLG&<"S:F(*:UQJRE M2OVH-_7&Q]T$]UZ8J>4OYAUOIXL[UXXIC,:Y\)A77_ED\N?X_*14:VQSDF3G MB%P@@5\\-D`%#=VP$4YGM(,L-Y>.L;5J"4J?1Q0L28?.4 MNR+`2;/P5@]`C:I]1%,/9H0_3WH5BXB;92;G&8IOPIPE]RG>#%CTX">G.)B* M]2RJ$DQ6;5L0TO:WY[LFI%KNY>4%Q$DPYE=G`LQF<6ET1=A^A2M>6MJD?)(OE]^/#Z[3[E))GTY?N2A_;(D M5,EU^8UX*(@B0*N_<<-TH;G#G/ M42`CT9[D4(RT99_6XZ-'$*Z7R4;$T4^SCJ]%RB<>T*"V,O_-@C;D(S:2PC9=D4-0P$7F$&0KAR<7M,7I^HB'.YV-I/(&^)S1]OKC\LNP/B5.FX MT[)8^N?*EH!;[F61&QV(9:]@86>$>_AS_$OL^=`FH0__9-937:SZ7Y198$VC M5>^1T[HG(EFKQOU\TO3[;W\N,W*>@T*_^<9\X[&&A$ED9R;FEU0KK5$HG#W= MN++DW3NT2A\](&<2:V`N>]]QI=5\ZV>S^1:=IQXWM9//<\Z"F\^X@K`ZHW#SW//CI7%\]'><$\XSR=4\L MMX.!NI/@[CBXDTUT7\'5M)'6J>)$]Y149G]JV5OFP40WUW*>ROH>?B14>- M87=5&.B#-4W(?1#S.K0;D>TF8HU1O^^K>3N"I4;#UUPXM7S\D;FB4^FFII*HV`['=@S7 MG/3C54Q/JUCV^;)JOX@E+$.RS/';L\_$W/-.^.7::M+1#L._RR0C]=8A<9DZ M=OK@D_?,B[JHY6;0:=HK,I0]EN(FLN_*.7C-@BAS(OLB5&_8>46EBIO)!],* MHB:6>4K7*POP+J,I$!R=!&<>TR/]O*_V%V(/96 M!:BLE#(Y,X&P*4V[$1WHF*A7^F,F&ATJ/YQ=WOQQ]F-+W*V==S21AN6++##1 M3?+\%\<9/YN6E6J*\L.M,R/;0.]U?KPX9`(0UP\1=0:1M7!\8#,Q8"L<$#F8D!L,:!4W8_@ M171$=UC='C6?C#+X_AT0`?QPDSJ\V?/".^XY_82G?RJ>03\6@XE^G7X^C4Q4 M)8F>(?%QJ,G[1`G6RXQY7O*`36^+6WE$34CBQ'?'X'R\:%(L^FGN/ICM?4'' M"SJ0O"7"1N\9AU6FX5$;3%1ATUC$Z2OA22))!>BB+\FB@\F\YW(K+J:/:[S# MDKFHU8KE/.?3*@/EH?L.??5!K[XT"WYC]!5_*SHANM*)_LT/03_Q>S<#0B.A MU4.$O%JJO_P\)-SS%XS,FFN(DYT;->X9$=9OS]LNI$X=2@W>BP>]8]LK- M\+L8*2;,F%=/+K#"2^)584&NF9PEYL?9T%M^NP7,3$\)HJ63W!!G,>EY?Q_Q MS'%TC"./RSC#D+:I'W@53\.7L?S M8##,?OQN/9#-PTKR]&DRF*++;G'(GA%X/0H2'@GR= M1!`:%2X_1,AP8!ABK1MTC\::&N76%RX/;+XI_S'I0Y]CP*K?I5\M$6_M=<>, M9M^(D];M](L;S9XAHT&_US]L-,7D(JAJOZMO'L^V0/N^(]HW@4;KKYP=G?N( M]@WSZ:LI!KN/Z#=15>!]"L^$^4+>W#28?F,OH4:*XU2.ZD3;'0X'FX?U^EL/ M&FHNI[$/1J-#!KSQX.<=[Q4IGT_\?SAS]VBANVE_+(2T_<>>>O^AXW<"]_CQ M:Z/AH>-/WG_@^&\?79X#`[31-J#:?0"'SN#9R4.`]"V+XJZO/VCTMZ*/_*\(4?=1F=AI,ZF7Z7<^7GIN$'$2#CX_?Q MRYPZRNN=_F##<%9><>0H,I6CVUG)R=]U%$OQD84M\3OWOTYNV?<\#3UMPP@S M7E_L@/=,[TD%E[:-9+>,G_()L6\IA*Y+-N*R6"\@%(46A8RY&0[*&O-BMC9==?N11->IH)5%IVVN.'TRV\3T: MK22([C&8/8WK3,)HNK8^E)TLOSV-W6P6;>+0OB/)RQ`E]^[5P;QJ!^X]GFRU M4E7U\/&(+YGW&*E>')?,M8QUL,ELW_36/`:W+XKVAQM86=3@]BUTCN(X!P_. M68Y<%L';[FCC`#>_.;=1[E\87\8H]^3V)AMDGT$N]JO$XI`'_/<&&[B[\35Y M#&<'Z^&(X=PP2VSI/7$[X*M+])%*T-UDUJR\[\@1[2GP?74#I?(=T;Y;81L6 MJ%<'E$05/SGN;_R!63?<]RW^RG9JNM9L,'=>111L<>O\!,9%A"SLY??),0)O M\;/=HF/=WDIT[)4AES*W^#4KAY(FO9XOQ=DR44^;%6K$G0U/2(5O46J@]\EU MIK&UN];_($^-[:TL"'L.I;AY[*GG0W4K[_TN]O&ON7UN0YW3XG1>]JHS.'N772CZ;D,]^ODP_P,ACSS%_3!YO&E MWG?<@/;5I%%_,[1E#NC6N8Q.&TL6".[]XFY-KNC=J;TYO>BBOQPK?FV1631> MW?'$Z\%J>E;6D'>>8!AC$GU,+I.#UO;9TQAS\RY&-3E_; M=8YKHRYHOJL;`=OF^RI#-U9`=[H[,W3?R=)Z00Z3_R(V0OU+>RPBWK/IJNMQ M;+AXM47![L,H9/C[+@*=00;]3SO\?:/(>E'4O^:BNZK(F4X=SYRKM=#K;UY^ M7Q_"MF%_"L31X_:#..`Q/(+\UEG.5==H=-376G5Z9]S#UTP\S_(%W M&?B/CAN>+'4$%77RE-:8_NK;FZX2]+U?VC8Y"D( M41.'I$;Y_.E7KZ]+FV>[+N+2S#;YQ95#L$`3O;?X87,,@U4GGV*6)I0G:AMV MR6LL:KO,5EI1^RR:6LN(&QESC,9]JOGEQKZ3S:HD%91J?O)P+30U2E"R%7M3 M^>Z9%[9IO3WSW8"?_53XD'?F0)$#+4@5RAYR8;2=,7,<;XF2GY=*QY29#,X=H2+^+K`!F8;Q07+^Z.56'G6R_,HK:2:R;P+5:@.ZW"8B^3E(;DD<5>F_>^NIJ MZM;!;WY_3N,5VKP8,?T9CS\O]::IO:+?.TYML&.1&9X/%QY0 MHCCD=X8=B43RT#1\3N#Q26`I5MB2+V[L%#7;:REB]]YEEO5R_$%VOJA(S^$T M.">'H7#[^(&\B/+TEFCPQ.@^EPD!R.DHT*'6&85:HMPSS]S@5*SQ65.R""B$-#W\FK4X)5CA, M@\U"N`P'NH]0AJW0Q%G*H3(\.N($:#0A!*KN0N8E8.1Q]<(D%K]0I<4QN22` M'[@1&O&*KH9'Z8K.HY9H=ZG\$':W9_T;=AZ2S&X9<7L"SMWB6MOQHSD.K[_WG''W#TWB*9LYO&+Y(\WT8-)*CMM M(<2KHK$\6=^=7T;7XL!@(23B!;[O3,^6Q]OKM57MO][$+Q>'FA(A%-LA,/O' MAY'X1TF^#-^X]=OHZ=N_CWLCKW_-C+\>7">PQV+JCGNA_(,%OO,FT5N:\W(W MSM2$=Q.?K$Z@RV\2X"V:N%X\FF-2QY2$K+X[1^%:%JQ8T/SQ?JSL:&VU7V]6 M9J+XX;Q<9LRQO%#5M@Y>R,$+Z`5X`5X`HV3F!?0"O``O-F-4%[PHFA?1M;MT M73=/LM?6>J?Q).,WS3FEP)64CY>[JMTAS&R6G=8H9D`SP`PP`S`E.3.@&6`& MF%%%C[(NS&B"2ZEJQ>].%N1%9F59[*IK1!9OQHB!VED&"';:G5QYV2;953S' M,L?*/Z*2V;+8FGS)-=.;J>>;G,8I%GVKP801[*FZEW(UPNK4V[W"=>]HUNZ097HJV-RL:N#=KKS[9_Z,VAPL ME)!1N]%970'3\*5OSNB5SRZ;O3V+_CO/"TYE#=/ZQOSE!.[D0&J]-=0'BW6M MSM;$*;1"N@"@A-(.6`(L9<-2OZ\!E@!+-6%`16!I?<]"0D:5"DN]42<+EE;< MP^A2%&FM/BWY-N?2-&V?VK0#BB"3:42/I7>^/5.CVMSM0IF>MI*^V*%%PDKC M@QW;)?P15K+^9D[V.B5IWBKLFMD/?*EYV!?V79PW'?<8>?=-[?S/#H-?#*.T M<4?G9,_'K1\S[/\;,%'V:[W$[6J8]=F>"/$48Y.Q-T51P:<#(T]9W2IN/O[V M\>KVXP?E__YQ>7W[\?JW_U$^??[]\O>KSY>_*9]___3U^LOE[>>OORL__/'[ MY1\?/M-/?]Q%9^6GS#(=EHI]6PK_;G!:+DA6%2_L>CUF/BMFXE(7H%>^$KC; MHS5<9FL51.[\6+8[LF<;]0H7NCMKM0!AR;Q`A@E#R^` M4?+P`A@E#R^`4?+P`A@E#R^`4?+P`A@E#R^`4?+P`AA5ET3FB/LM1 M7-8L9DB](S6(&8$HB9@"F)&(&8$HB9@"F)&(&8$HB9@"F)&(&8$HB M9@"F)&(&8*HRW89D#T.J6GM0=!P2W8;DYJ7L#1L^F:ZW?JQ:[6$T#]5L;#L4 M27@ANVK=<,.QQ]`MZ%;U>"&[;MT^FBY4"ZI505[(KEJ?G,#U'Z%;%=(M.--P MIJO7`+&6Z!D7]0,^*P2?T"_H%_0+^@7]@GY!OZ!?T"_H%]SK"G1NO/[XY\?? M__AX48`V;4R0DJF!8W75Z8BD*#``B5!-H3\0"`C4;`8`@8!`C68`$`@(U&CZ M`X&`0,UF`!`(4;V3LT=)_A7G7Y0;XBOH*&3)ZQ\K&8TMX!P=V4LC$S[M1N9B MCM'IM7IZ/Y_CO;#82&CN-HS^0*5:H)+>ZFF9IWL!E8!*U:`_4*D6J-1O:3V@ M$E"I)O0'*M4"E7JM;B^G<^.!2@@7-CQDL=#H$V=9!VH`W01GJTZ6HCH$T=I!UH`[21'&VTUK"#30+)I1WA MN(J$XU2$XRJD5EA$5+Z"-EQDDL[PG&[L:>3H4R2=Z#'8H+%!/3'\B(G M_8$_P)\FTQ_X`_QI,OV!/\"?)M,?^`/\:3+]@3\([TG.GKP3['ZY_GISHWRY MO/[E\^\G.P:C83S#DM)<^F-)@4G;9/H#?X`_3:8_\`?XTV3Z`W^`/TVF/_`' M^%-/^B.DMY4]!RVB:R'M0!N@C>1H,VIU>CK0I@[2 M#K0!VDB.-L/62,568RVD'6@#M)$<;<317@C'22[M",?MQIY.AC+A^`NY^8?% M!/3'\B(I_8$_P)\FTQ_X`_QI,OV!/\"?)M,?^`/\:3+]@3\([TG.GKP3['[_ M>*M\_OWJZY>/./RB2@J%!:4*],>"`H.VR?0'_@!_FDQ_X`_PI\GT!_X`?YI, M?^`/\*>>]$=`;RM[Y"J?Q>$7U0C$HG5J*;T:6BJ:WLF^U@"4`$I-`B6U-1BB M8`6@5!/Z`Y3J`$IZ2^WCY(O7E")%<8/;/G*A!UQB$;]G!FL/IFKSP@][6LAZH`:0(W<4*.W=!W]06LA[``; M@(W<8*.V>OH08%,'80?8`&SD!ANMU1FB%['DPHY`7$4"<3@^HTIJA34D+X.U MW\LA;`#;``V<P`&X"-W&!#E@W< M*-F%':&XW=C3R=`E')TA-_^PEH#^6%XDI3_P!_C39/H#?X`_3:8_\`?XTV3Z M`W^`/TVF/_`'X3W)V9-W.U0G]\^?J[6H)C-6H98^W68X4ZXP>YS\.:.OZ8^I8RO> M(W/Y^=BT`I^'WUO!F-CJB^>Q)\<5ZJOPR80;ON),%*8F&DK="U&[C$:M!BM38]XXIX_)9[2G^&7R<1]Q_A+_.@+'[.) MX[:4S[;15IA'F9OA@( M_5H\W@E\SR=:BY^D:>RMO>MX&@B6BG<&=E&\TMOKF;,'L^KH)SDT69=F3'SU M^71&,W9?EC@\G3'3#?]/1KZ8W'T^(]/CL\?'/>W9-GY37>;:/?Y8S.?X9 M0A:O2$.8_;+HYCIZXZUHX9_,>N+_GT%L?.!"?R?<=0E\0HU_MV;E^1C!D1C_\@_Y0S]ZI_9[6H?\MQK7Q'4<.0\\< MQE#O#`X8AD.$L\R09%\GU_R)VP'_Y#K3&_X@)-F[=:XA<-]N[620_]7>P!S7F9\H96[8_X.K(^ELST7?2@L[/_IJ@'Z@"] M8>$6^1D'J$:*$)'C)@S0N;$4NA6*00^/C;*W9YVS\-J;,2.YCN^/'3(: MD,5F'K](_G@3/9B4GKQ+LFY7";Y,A'T3"GJC=G4WS9W. M7(\)S,#=O.)CO9JS,M.].YR7N26,0BG_ MZ(3_*XN=97=R>8Y>=.]8XVWU!T5T'I;=OJAC]S"H6R74K8BN.U`WJ%L%&70* M==NON@Z6:=&)3P>:HM]<9QP8OE?,Z:<;'/#-^E5?AI6;Z;O!ZP8#$`YL"OV! M0$"@9C,`"`0$:C0#@$!2=\*IJ5,G42><]Z;SBQ5$)1GT]R>'31N8M%9%W[R8 M0Q3DWH@MO_BS-VQU\NID75/K:XWD$BQ&@"G`5*-@2F]I>9U)55.8`BI5B/Y` MI3J@4G?4ZO9Z6:@$Q[$*CN,W[EY9C@]GL7;K#7`L"\?T5G<$'Q`^8(484AGZ M`WVRT:!MUL';O.9/S#,"B[GF?\*^HXK/C4>;YOI@<@\N*-"M<>@V;(WZF=D/ MC3:EX"5*QI#*T!_HDXT^G9$&]*F#L`-L`#9R@TVO->@@T;,6CMRO_/JK\HO+ M)LCU!)+M0/]"6F25"V4Z*FG@M56((96A/^!GAVQ/5470J!;2#K0!VB"5((.5 M<`JSG4*M6[93>.OXS%)F<7M0.(;-P$H)&V.5:)D-^BT598#P#*O$D,K0'_B3 MB3_]0:L[Z@-_ZB#N@!O`C>1PTQNU].$`>WKY:$,G@YF2'S(&-*L&W#>7>]Q]BBKMQ%^FP4]W;%_# MF`=L:R[]85O!MFHR_8$_P)\FTQ_X`_RI)_WAVV5G7I9?CG?%W+')#,4W/2]` M*\\J*5BM`*[$3`1MU.II.A*?7I%V)%Y*QI#*T!_PLP/\#'K(NZR%M`-M@#:2 MHTV_U5=Q`D,M?+<_XXZ8E7+>9"AQ;32@U:ZC0;A_`.`&@Q`>JO?03I`+<0=>`.\D1UO>J/68)2)-W#G=M.& M3@8ST0A%;OY5#\U`?Q2K-(3^P!_@3Y/I#_P!_C29_L`?%,M)SIZ\-^B^^H_< M77/E]GC*XE+,77#E7.PZSAS/%-M]%RZWF&\^\;5IAJ]GU?`BD>.`'(=\#T/` M$7FOB7K-=@`EE'V`3W/!IZ^.@#YUD'6`#?/MGP6P*N],A^)852+8J=U.:]!'VX_9\:G>9-4NDWD,7PD>,N>&X81'? M!0D.=\,?;A[QH;N)V]^S2O=7>91%I!0$*3K1/:F8W('^.1.JH$?/=6&6(?N+ M=C_#Y!4QW93S\*.#=4-[33<.V%1N#X_95C[-RU<)D)N0BH?E)Z3'DO>8=X,[/?#J>!)%R2CS)WXX_HG*F'NT[D65YZ9M6`%] MH#RXC!X3QS7;Q[]D(27;!&8+'B^_D9[Z]DR-'[G5[$P;-4KZXN>?`N_\@;'9 MQ34M$K9A6F8X[Z^3ZVBFGUQG>L,?I@0XWJUSY=BAS?$<2WS[C;G^RRW1S&.&>.#EE`Q'W_LZ27VFT!L%H%WSR=NS#T&T1-VI M](^0M;M;YT[5[O3X*G[^W9;G>^]?TM]].\-]N?L2JO?7R7N'N>.ODP^F MRPW?<;WH\S/BM6%.F>6]/3OOG2F!;4:C^8/^4,_>::/0-$Y3:>?9%4,6;8DL M6O%DZ:Q393#JRD44?8DH>BE$T36U4*)\_#[CML<]H9#IN?RWZ3^F;]E'J3*F M-%2'NTQIUY&=;IHK2I(QS2K.<$7BY9KAM\`U'EG\M$-ELQ0E[O9V$?BM\RN0 M.C+@OJ;)2AT9%H#NH'CJ>!],S[`<+W#YW/S:"R?>Q<&TN2&8"JRM^I+QM3NO M(3Y;LD-/%A/;:$X_1V^Y=ZSQ1OM:';139O7\KS0ME6<"-R6FM")(;:XD+.P< M$5F:N>VX)"3ES'TM1OO"+XQ/W?.$T*??, M_HO>,V]A1NHZG3'[1>'3F>6\<*[<>$J( M3.(7(_,Y8\D$6L/H,&(R(:V61]2OYNR,:=Y"DAQ^2S!*?&T]0V- M?6E"UG&+X#&'6,;Q8R'W):>Q"-(?/QZM/3H^G$`J:$7QBEPB/8B#%1L':Y&* M>3/28/.)6R\MY?G1-!X7P2:AOH;C^4+Y(HT40R?DF)J>%ZY=](7%/?%+E@/' MCY_0?T74Y9$?D8=:D/>9BYKFI1(Y!#\GCOOJTC`AFU!PU$\6B4S,'IMCQ79$ M7-)PW#GYO?W?)`]P*#1T.0!C/ MI!^).\4/22$_WH>#-3 M)&B'NO_`;>Z&WL_&;KOA:V:N,PZ,^N'E+("NO1%7(>F8_NQ;2.\Z;%I$-(9!)[<+1WP MNCUI`$]7-:D`3U-'`#P`GHR`!P<`#L`.-8\I1<\Q`M+-RR[-`:+E6C%R6DR! MRE5$97$E,DV%V>8QW[S M)]-FMD&_5[Y.)F0&NI'?O=%T_=\'.?+M=+)?=9<4;"Z6O]1<*DF:]:M.U=7' MKT**XY@12:>0:.'CA(Z/*4:^7487?_UJ1ON5M*)%GI*0]'MRHB8F.5HD[N0Z M15Z8%]S_B[1!:"0Y3B8QZOYE_OCY[5=B!\/W^7SPZ\J4N\U5<"+"41;7LA3D MF,N[<_;(:MJ)1WZU\7AICS^0^VLY,[%]$">''9I9>*ZO)\OTAZ/12KK,*V_. M:Y"OY`5N&N1`ZZWF])Q@D*^D]FT:Y+#;6\W&W6>0M%`:)"I7S!,WB/]\_'=@ M/C%+)'POC?/2N_LZV91D]1OIPM?)E%^Y/G=L9-=AUP]Z\=Y"QBN7Q)YJLI_GV\"W+S,^G^;OSA?F!R[- M_`.M%963N\*">/E-V`]+3YO_YK,]"WPO_($J.[GTXD5AJZ3+/[DKYM21ZN5@EMF(M&$ M;T25\W'U4.IJ#*/`64M1`-9?C8?(/^'CV:RKJW5O!ZG,D_X1S8 MO%;\N<^L1?N$!SO,A/KF6*;Q@OJ\E1HU\>,+D7MJ&ALCYS$AE10EJ[4]AFVP MTVV#72?)>6%:8)2QY[7B`AK1`.GXG>OWIO,+^1XMA?[XY+!I2_G&W2O+\5O* MKWSJW/C,XV(K^HEY!AEUKOF?:(_+Y\:C[5C.@T"^1V:/9R9/<@N907]YCDM? MB:=O-)EL(_ MDH1'TU.\1W,VX^.6^$U4DA3]RO0M^AWYDZ(VR8G*DP+/=Z;<;27)Z/02\2+; M42:!&\XD3M=DML$5YYZ8'A+(RRQJF8_56R1A1GS>E+/Y_,C3&9PN#WH,-HYG(6`B<<"-]U2B+D#>*D5-.R(D=TTG2LPG4CF&&6:: MBCJNZ`XS"A2.=WAA,*/_$)L)++GMB50'EH2CU]Y.*PJ[MUX4T4ET=1SIK"32 M$#'U26!-3,M2Q`[N$E>JFY@`Y"T#>:,2,JYXS`KW\RT"1%=8.YYCS371%LD& M)/,*.;Z^26JI<"L48_K>%7MBH4BWXAP"TK"YQHO[F4465*A%L<[&-WM)_H!X M=R:>)$])P.`P'C^WF+YIK%),3"::M_\R$VN`]9+6\Q#HQ"BCVPC0 M3-LC>\J*,)W-`4WQ3!I:N-Z0GD]I6%$VU"3NH+?TVN6\D<"+4'S,+5$SM!-6 M)7SP-@@!L MR'`H-OH?.X1,]%V3,W22A=506_220U^]>V*(2J_6BGKYW+DDX\T/%?H7[M"2 M/GL4VA;YDJ(]%_F3?]QDC734&PTV>HQY#O1;9)M]=6\B`V?N[\;6Z:4]CLW3 MW2+OW5&W5]Z@K\@M-YEQ&UIDNPU8Z_?7NI"=;L!S0W^WP:K]M:RF4XHN#?AS M&FQWI+#>[ZW&K8L;]?N`K%GR@9*>DJF(5>CV?(B\GMV&WAOIPXT1R9,(1^P. M[DCEGE:X&&<3^5O*@XJGLS.I!Z.-4<&3D/IZU,VQV_//I.6G]-8^QO6 M]^[I;*>-*'/X;$;%S*:;FDW_3N_L9(5J(WUP_$K>NU/[KU$R(>"E\>_`C)JH M+YM*CO`S/7/'9L5ALO*Q8QZDR#7:G5S]M23D`^2N'VG>GE)/U]2B>%N,IT3N:&[@ MO_>`Q69&N)>QXW*KJKFMM@?([H&>TF"D%B['Q7A*_4$WOY#.WL*QEZ>D=P:G M@[4"/*6^WN_D9JSO3>H4DXS_24RJ7^`=X2N4JYF&>TG"MU?5I M1GRX;['!6NYO3MX['$K9)K"N#H^':_*4>J]1\C5/2<1H MO9G(/]C-3=+5_-PD+>TF[4"KKI:#T'4.\A?T,/Z8D\3K:3X2>4JYD%N4C?'])"]1GRX8]'=0/C3K3\Y>TF# M0B;334TF<9*R#6"]I^7F<^AIGR/[U7UMK:#S<)]C3^-;[W77.NAL>OF-R!Z, MO_K%<<;>[]Q_59;VW"):WX[>],8CQ[2G/[8>^"E@3'OR:QUE]QM3L@CESK[5 M](?\P[Y;=6Z6?09>Z\=D<^X_+IXV+J@BN&-RRXFSXL.Q/7'LS9B37\?WWCCOF MKNAK:+&9QR^2/]Y$#U;HR6U1$[`ZP.7$?]^=7T;78^4IS+D7+_!]9WJV/-Z^ MUN[W_^M-_')QJ+HZ\Q7;L;GRCP\C\8^2?!F^<>NWT=.W?Q\1<,/7JRT=E7^P MP'?>)&40-.?9TJGRJ0GO5DDAKE\KI%A^DZAAF9#473R:XS%/EUFLOGN?&I$= M&H0O( M+-Z,$0.ULPR]Z[0[N>I=FV17M#XSQ\H_HA-3RF)GJK%==-1W3HW\=N7H>J?; M'6"ZM3;O<)U[VC6 MKG!2)',J,T8B/P[<\.#L1ZZ\<.:*GK`7IP+0S4I77RY*%PX$`Q!U:C3]H0!` MH,8P``@D(?VA`"7O-8`!V%\HU*U7DG]5K6RW+VS>P3T?$;)*>.G_+(!/DJ>% M)'S:C45?H!X40L:U M!O0'(#4)D#0-B`1$J@?]*X)(,J>D28!(PU$6(L$?K(8_:#CB.%_VG7OP"6NW MX,"TR@*R7JL_@K]7"V$'_0$V/#*7OV<>'W]C+^*QEZ[+[`<>'7-CT=/" M7W^=+'ZX^A3O_`&,DH<7P"AY>`&,DH<7P"AY>`&,JLJQ"])[DEI[4/2Y"Q7?#:\] M_R2/!LL-=76GO^PF6-WI#_P!_C29_L`?X$^3Z0_\D;E%4072GVJ;0:96M%5D8#'-H#8L3IW,:VI^ M55?X`4>R<01PM(/AI0X`2/7U!R64=N"/;!PI%7_ZG.OXS*(;HA8LBT8M%=I`U.C[L1.(5BTE8QYB8*6QJD0PU%O=?F84K-'&6'5M M`6`5L*I>6*4/D/!0B&4&F`),`:;R@JF.NN\1$-$E>H3NT2/T=.T]7^LP2K)) M#_\ZB8[TNV7?/T:NYWMN\XGIHT]H3GU"]:[,RS7ZA)89,I:,E3+T5"HM6`Q> M'.R1],$+27@!C)*'%\`H>7@!C)*'%\`H>7@!C*I0GU"Y/4GT":U9\?U![*Q` M\7TQC63DMB^JVX0+RE4IY2JF;0R4"\H%Y2JG;4SMK8K[/G&: M/;,:F()616_\9-GF\O&IQ%3S?DO/K[4>["WI[*V&T1^@5`=0TEJ#06XEQ0`E M@!)`":"40[-T?=^B//B%,OJ%-S[S*]+:4P*^56>M`89E%A:/R1-^P`:NH@ZH`:0(WD4-/1X9?5P"_[Y+CT9KL:GID4N=)-!K%"&%`B MBL$UJX>H`VN`-=)C#7;7:B'JP!I@C>Q8,\2F&=HRE),M#BPK.UV\;F#6;PW@ MI]5#W`$X97,`@+/#CGVKTP/@U$+<`3AE=TYYWBVU MJR$67@=A!]@`;&0'&VV`QDBU$':`#(L"P9F+8#T-U M^"/,I.J*."`&$",YQ&C:`!!381$'Q`!BY(88=8A>(G7PP]!+!"!6+08H>EOK M+51H'=E*U2=EP<7S`I0*AEGM##,9=*HZ#*@*J)59"H?=N#I(.J`&4",[U*!E M"5J6H*"WHE`F(P?*-)LTI#'50M@!-V5S`'"S4RI3#YW_:R'N`)RR.0#`R2E1 M&_Y:3MJ0][["9]MPIESQV7>%?Y]QVSM9\N01:J31]V,GN+=XI9`L;]Z=[!Q* M*5E5(N0-6JH&&ZL6*SR@"=!4)VCJMM0.^E4"F@!-@";IH*DSZNWI*$:7C`BQ M^K3DVRSYLAUWRJR=)4Q+2UB6>+VVQ34?_6QIM,DTHL?2.]^>J7&"UU:Q3$]; M25_\_%/@G3\P-KNX,1[Y.+#XU\F5,YV18-B^]W42.7>W[/O'R+5[SVT^,?U; M0<];XNY[RS'^>O?WORG*S^L/2EI9TNV7GL=][](>_V:R>],R?9-[RP]1#!HX M75SSR=NS#X'+?-.Q[U3Z1^NH^MVM]FGJ7)F;HQTD2!)G/!"^5&,;AEQ0#U]JQS%EY[,V8DU_']L7J1[EALYO&+ MY(\WT8,)>SIM`56K`UR6EGUC&OUANR-U3(/F7/`6]/*;Y@MNKOO1)]J.'DI= M7'$\*S/7ZL-YF:_MI*IM76K;M4&\Z/3:O3YX(0Y+'S)+V5 MADS!:L->S4-9TD-=S>DOO0E6=_H#?X`_]:1_(\RK7N/-*R*+-V/$0.TL`^HZ M[4ZN4-?NY9XS=R`[4_LA!K=][IYX'^LY>M&]8XTWLEC$U@NPG66W'7)0SI+7 M+BA7)91+VTNY&K$P5G'_/]G7#'->6;BS6VP96)XRKW;*R,^;WO87^G$G9R`7FR58G#EEE- MJ6<>_@[KJP*+/R`)D%072!J=I+P;YMBI`E\SEWO"(54#80?8 M`&PD!YN1MF]W"1A2,AI2WUQGQETRGF`R`<4:AV)::Z`C]E0'80?8`&RD!YM^ M%YM[=3":/ML^LQ],T?`JRFF'\00\:QR>=;7,6#I,IPJ(.J`&4",YU/0ZV+:K M@^%T:1ANP,?)Z1>PFP!FS0,SO37HY]0U'I83+*<&TQ]@LPO8#&$[U<%V^LWQ M/,5@KOLR<=QGYHYA/0'0F@=H:J_5'R+-J0[2#K0!VLB.-H-63\]$&]A/%;"? MKEP^-GU84,`T&>A?9AY"%UT/ZB#J@!I`C>Q0TU*S0]VPGBI@/=WXT<[%Q M%S8S@.T$0&L@H'4["#[50=@!-@`;Z<%&5Q%[JH/U]-5_Y"X,)F!8XS!,;:F= M(0RF&@@[P`9@(SG8C/HPE^I@+OW&/4^P((BZ9K*DM7DU+*A\CW@"JLG!@!)A M[0>UU=.U'V$[55;*`3.`&?EA1FMIHVTP`[LIVVY2M;(-IUO'9Y8R7C]T[U26 MTY$'+@'3CL8T&3E09@Q]V.ITT.*I#O(.Q"F;`T"<71!GU%*['<2A\E&'3@8S M]]*&`RRJ%0V2WX22C8&-PS,P`"959>@/!`("U94!,+%R8D_>4:H/Z?B49;)[ MTPI/;;FHQOY>Y?@G';Z!_C"P&D)_X`_PIY[TAWE5@4RJ;RZ?,?(E3)]/T>V@ M2NI5*W@K,ZNAVU.1.E5=$0?$`&)DAQA=[2)MJKI&$HYS`8I)0O\R4:S7TH8C MF$K5%7*`#$!&?I`9PEBJLK%4H58&R.U$A4S.%3):!P92=64<(`.0D1]D].X0 M!E*]BO!224ZG,IUDK,IH%JS)R(%R7;]1'^93A<4<0%,V!P`TNP!-O]4=]&%" MH>X.52\-@C$P`)949>@/!`("U94!,+%R8D\Q@2F;^V5VB#JB2$256 M'Y=\FR5?MN-.F;6SA&EI"BR]\^V9&CY&V2Z6Z6DK MZ8N??PJ\\P?&9AAR71ICW];;.S="EK>$FO?6X[Q MU[N__TU1?EY_R$?FVJ30WC?NWCPRE[]GGFG0@SZ85N"+9Z]NG3M5N].CJ[-WL<#,YY(2GHB#D8H(-L;7[CS4=Y8F M9>K&6`L)2>92%\J,8G#+BL'I[5GG++SV9LQ(KN/[8]TBQ;'8S.,7R1]OH@<3 M[G3:`J96![@L*?MZ#[U!>R2U]T!S+C@^N_RF^5J;:["VO%AMK5B9N4X?SLN< M@R:=M@I>R,&+C@Y>2,,+8)0TO`!&R<,+8)1$O`!&2<,+8-1)>)''/I3TGF1U M4WW@/=8_T"X]TM6<_M);8'6G/_`'^--@^@-_@#]-IC_P1^HL0WAWTA=R$%F\ M&2,&:F<94-=I=W)5M7:OJ-JH?=F9RA_P*:T.I&W/#B1(F+VBBW%VD ME88IE_0LPYER9<9=TM3IU+$53^1CGFH/`J5F)3OA8`"B@$VA/Q`("-1H!@"! M@$"-9@`0"#L1);!'GK;EOW,_=OF092:G0W^"8N**[,:66$JL]EOJ0,NGR0%L M+@EMKH;1'ZA4!U0:M$;=/D`)H%0/^@.4Z@%*^D#=L^D*?$,I3VQ8.(<*LRS' M8+YHC>HBOUV#Q!S8!FVJ%38/6H(^M/T`3H`G0 M)!TT:5IFJA39-Q*D.N!XP"JL.$`EH%*34`G'`P*4:D1_ M@%(]0`G'`]:DM!#'`\H!C#6+C]7N4!V]M^U0'1A?%9!Q@`Q`1GZ040=#@$QU M91P@`Y"I`,ATMQUT#(^M4KMY.!X082R<@S&L/ZJ'+Y@"L+]FL+V@` M,*A9'``&`8.:S0%@$.H`F[US6+_C`25AL0P:B-1V'`T(:0?:2$1_H,TN:(-C M`>LA[4`;H(WL:(,C`6M3M_=Q,N&&KS@392SZ>9I/7'%FHMVGIY#WIK!GYH[7 M$T#W>,OB4A!*L/"\*RCF>&;85=3E%A.O72-#.#Q6#><1V?7(KL\58I%,6@]9 M!]@`;*0'FVXW,P<+8%,!60?8`&RD!QM=S&!.Z2P`YNR(.8/>"/X= MW=!K=SJ5WAF4X'R_8S.K"]"QP]C:@/)F>7E5(AYVVKV&9&6=0B^DLL#DE7=@ M$[!I)VS2&A*1`C9)(^_`)F#3;MB4>5C-BA<973*BP^K#DF^+DZ\]A6OU0:^^ M-"2M:1.D1!U>HL%'LK&B48K>7WB0;Q9$/3!S,^/\]V(>#=KL\^BYX,\*$W3M M"$'?E/O;'AZ3_7N:EZ\20"HAC#;<+^X=:[QQU3J&9N$#;A^YM,%9]^9S#+"*Q04._X/Y8WC)OW/7,#VZS34-+KX1GZ83UW\PXY^R*2UT?O(3 M&L>,VUXT8,/Q?(7YOFO>!W'WXTG@!S0&C[M/].#H4;;C*R_<5US2R0>;:#5N M*<_,4QY3#KZ@#Y> M)O.S$UACNH6&X9OS_'P:YI:87#ME6<[_NC0(2@0AK9?6RO/%^3R!:SPR>O/1 M8M/O]5MD?1S]G);R2B.Q?1^FM@='/T,AM;>(7JU0&HY^G-8^GD:+(<4:-7'< M4*1>.',]A=M"98]^RP=N\.D]R9BNMA2MH^IR\99&I.4PHGR8VE'5',9"K)QQ M0VBY4-9G[O(%`N>'N>U=;(CE2=!`WYZID>QM]XK25K>2OOCYI\`[?V!L=G%C M//)Q8/&ODX_,M6DPWC?NWH@AAFTE+NUQO.]P*TSY6UI;WUL$6>_^_C=%^7G# M0\+R):+7YQ`1;]GW:\+D:T)JVS`M,R32\I.(++98LJ_YY.W9AR`RLNY4^D=( M^-VMC"9S9VV,&)6![ALQAVPX:9+ MO>%V?(`AR]U8?M,\XI-K-\VY%5=L,\V>U`&[$\2*#N=ESL&[4;LW!"_DX$6W MW07@"CY.$%,$H>7@"CY.$%,.H4O%C9=*NG)]G#60R5AKT<^"=U MOH?L4%=W^LMN@M6=_L`?X$^3Z0_\`?XTF?[`'\G/7Y#;O<-1>T06;\:(@=I9 MAJIUVIUCIU0J9=G@ML_=$^>:9Z7Q; M*V#B0R%5C)L]<`D9M1N=B^G@WE)[6C[UU3`K)(SW22CM@"7`4A8L=5N:U@$L M`99JP@#`4DU@J9-]X@W\1$F5YK-MN%P4$?_@\G%@B(JZ'^GW29FRS[[3ZUWN M!98O"KI%)>-%`_/2ZKX@R;XO6W?ZPR"3T"`#_8$_#:$_\`?XTV3Z`W^0EW9R M]LAS(MCOCGT^COP_T:6O]%&D@GKP:UV3$4_2VUEMHUGJPJU0U M4\[/D;I4.TT"D@')Y`[1J[V<#A,#U`!JFDQ_0$T6U/2ZF2D*\`@KX!'>^,SG M2[N`+<7F83/F"2?",$NYYS:?F#Y\0\!M/LZ;.(TG.FJ"6:1RS#:XPL;_"CQ_RFVX;0"X MY@'<#X-^YT?84-45<4`,($9RB.EJ`T!,A44<$`.(D1MBB'UPTVK@IGW\=V#Z M+TL'F\(K`YXU#L]^T$:PF"HLX4`8((S<"*.CG5,M)!U(`Z21&VG4[@B^60U\ ML]^7*^+"9JT^,VVQ=98TUD19'!"N>0BG=08PINH@ZH`:0(W<4*,.AX":.H@Z MH`90(SG4=#-#1/#;*N"W?7)<>O-R_TJX:0"TQ@$:JD;J(>E`&B"-W$CS@SK" M_GV511P0`XB1&V)POD`=?+,/Y)%YOFDH,]>)SQI01)?))],WZ<7CY``"!0X; M,*YQ&/=#MZ/!C*JPB`-B`#'20PQJTZHLXH`80(SD$#/86OX*'ZT"/MHU]SAS MC4>%V6/RR)ZXYP2F-1'3]!$\LRJ+."`&$(.S1O+@))`,2-9D M^E<$R4HUEM0N',#J.H!?_4?N5L/-\QS+'"O_Z(3_`W2='KH*84")V-7O(6>R M#J(.K`'6R(XU6@\]26HAZP`;@(WL8*.C*4E.FM#)8.1>BG"`>[:B/"?PT3;K MPDX,U.C[L1.(!BI5`K.\7>I_%L"JC:`G):M*A+U!2]4R6^7"RJK"(@]H`C35 M"9JZ+;6#"EU`$Z`)T"0=-'5&F8'P%7\QNF1$B-6G)=]FR9?MN%-F[2QA6EK" MLL3K-<]I/OK9TFB3:42/I7>^/5.CO(KM8IF>MI*^^/FGP#M_8&QV<6,\\G%@ M\:^3CY,)%[5O_'/8J>26?;]F/K_FAF,;IF6&IP'<"H+>$GO?6X[QU[N__TU1 M?EY_TB=FNG\R*^"7GL=][](>_V:R>WJ&J*K[PID7N'S\U:9'!ZY+ZO^>>::W M_&B%WBK$Z)I/WIY]"-SP[7L.:1KYP<5[>`5*3(D0$.`(TY_H5JH=B MT,-C''Y[UCD+K[T9,Y+K^/X816A`%IMY_"+YXTWT8(+83EL@\BK!EXFP;P2G MJ[:UOLRV!,VYX`#.\IOF=D6NT9P3!7,&4@?CCF=EIDER."_S-1'53GLD==I6 M@WC1(0,+O)"$%\`H:7@A,*H#7DC!"V"41+P`1DG#"V"4/+P`1DG$"V"4-+P` M1IV$%WGD*\D>[>J%]86GB';%;RHH>2FG1R)LQ8J9VE@&'G79'YJ7I0+ZF M]GF,\#RJ@Y3R$%8WRW+(0>VD8@;T!GHC,7ND90;T!GHC,7ND90;T1GJ]:8+W M5(VDM^?H1?>.-=Z8US7FAA.EXUS01+F[R&?ZP`T^O>>NHJLM123F5,RI:O=D MJ70[4F&+E('P8;^)-GR*6D".B.0K8TD,K>OR"(W;3^,T:!PT#AIW0HT[S(:! MQD'CH''[:MRMXS-K+WV#URB+U[C"RBOF/2K\WX%)I"=1\RX*@-&-*09'E$Y5 MDG$E1C$WYY#7@`''M^8'"(C.*.5&H[[0=%\4&MI?W%"+E5(>1VQ5W?G)@&\^DUSD09\YGCF3[B;G5;?A!/RX2U`:)IM1!U0$WY M4%,%"PH^(Y!,;DT"D@')@&1`LNIK$I`,2%9]]P\Q+4GCP-?<\UW3\/E8\<1I M5>$)5B M]T\6X3JB79Y&WX^=X-[BE8*WBI14Y]J!OCA6E0B$_5:W.T0\K`;+/J"I4M"4 M:]-5:5@%?Q.X!]P#[@'W@'O`/>`><*]BN">[*XJHG*1J\YMC/YS[W)TJELGN M3>MTQ9"O*$-]V2=5DEE=."!C=BULL2K0'Z`D`2AU:LD!@))D#*D,_0%*`"6` M$D!)*OH#E`!*#0(EQ*NRL\C*+XZ\HL]HY)SN,AS;,XD8S#<=^U0)9!(F9U8J M^%B1HR!E8!1V*NN"GS(L;\"\NF%>)2H'@'G`/&">_`P`YM4B,^,'M34<=G\$ M'`&.`$>`(ZGA"`&W[(";M&6;J=2Q4X7>I,S"!`I6IG83KBALORK:?G50IEKB M7D4*!8![P#W@7A58`-QK@M\+2`(D`9(`21)!4A-"<=UVKY-G)*Z3P<_EU^X% M90?HU0K\-:R0\S#>[H>$1_"S:56=![+C.$]3&O[(;KHU2EF`75*Q0_Z2!F`7 ML$L69@"[9&('L$MN_@"[9&(&L$LF=@"[2N-/$V)K>82BL^)I]8J@U8]_,N_F M%%$B*@/]9:RCKX6M5G>%`""5#T@X]5PBA@"0`$A-IC\`23*&`)``2$VF/P"I MM-9GT26[M_AJ$EGR;99@V8X[9=;.B87IO,(]0C?TTC4FO7"+R/-J1&<^Q5GZ M*I5%EPA@Y[_F670A-12#'A[S^^U9YRR\]F;,2*[C^V/!H@%9;.;QB^2/-]&# M%7IR6S`Z(EXDOLO)F\0+8)0TO)#>5FX0+X!1$O$"&"4-+X!1\O`"&"41+X!1TO`"&'427C0A M(ZX7-E$Y1;0K?E-!Z7$YA;N(1-Z,$3.ULPPX[+0[,B]-!_(U%?4WN.US]R"E M/(35S;(<2,P>:9D!O8'>2,P>:9D!O9%>;YK@/56CM=4KG;)# M.1ISPXE.I[N@B7(WO#-\S0=N\.D]=Q5=;2E:1]4JYE2U18-0*4X5.%)ABY2! M\&&_\2=N*6H!.2*2KXPE,;2NRR,T;C^-.PQ1H7'0.&C<81JG0^.@<="XTYW! MLY>^P6N4Q6M8\*_W=@$NE)U+R+`F`T[U[6E62<=.TG:L``&8N9&FU9 M5(;^@*3R(2G7IOE@`!"H4O0'`@&!8!0!DB2B/R`)D%17!B``M94]\S.&5*WL M:-07FNZ+0D/[B_O*A.9YLM.]*\_%6IZK5@5S8#::>[YK&CX? M*QXW`M?T37ZZQ*^&,4^ZO*_JTQ\[G)(QI#+T!R"5#DA5L*P`2!5G2&7H#T`" M(`&0`$C2T!^`!$!J""`A/H64L.)03XI"8@FTK+1(52$,*#'FKFLZ4KUJ(.L` M&PG`)F\;2P8&(*4!6`8L:Q8#@&7`,F`9L*P.#*@,ELGM!"*LE1W6TKHG#VOM MU%--89['_9-%N(XH+=;H^[$3B&/)JP1O%4D_S;5;5W&L*C4#M=_5$`^KP;(/ M:*H4-.7:H$(:5L'?!.X!]X![P#W@'G`/N`?Z*(BHGJ=K\YM@/YSYW MIXIELGO3.ETQY"O*4%_V295D5A<.R)A="UNL"O0'*$D`2IU:<@"@)!E#*D-_ M@!)`":`$4)**_@`E@%*#0`GQJNPLLO*+(Z_H,QHYI[L,Q_9,(@;S3<<^50*9 MA,F9E0H^5J1MO@R,PDYE7?!3AN4-F%JP`+@7A/\7D`2(`F0!$B2"))60G'1)2,"K#XE^39+ MKFS'G3)K9\G2TI*5)5;1U);5/1&H^>AG2Z--IA$]EM[Y]DR-S,GMXIB>MI*^ M^/FGP#M_8&QV<6,\\G%@\:^33\QT_V16P"_#=F:7]OBW18#L"V=>X/+Q5_M: M'#[IDK*^9Y[IW0H*WQ*?WUN.\=>[O_]-47Y>?;0S^63:IL]_,Y_X^+/M,_O! MI+NBUWP*?'KNY=1Q??,_81K_YG(9BI=B M<,N*\>OM6>"$'+X!1\O`"&"4/+X!1\O`"&"4/+X!1\O`"&"4/ M+X!1\O`"&"4/+X!1\O`"&"4/+X!1\O`"&"4/+X!1\O`"&'4*7JSL@]=RU[`7 MIG>>8M63S8-CPQ+W=5NT.8V2P,;!8S)#?4FL4,P)1$S`!,2<0,P)1$ MS`!,2<0,P)1$S`!,2<0,P)1$S`!,2<0,P)1$S`!,2<0,P)1$S`!,2<0,P)1$ MS`!,G8093=A'S*/\/&LCL:"MP_F]1^X=$EF\&2,&:F<9>M=I=W+MYM`6'7JD M:.N9JE,WN.US5[)VA5I'[1:P,2RYB5&#]AQ0KDHH5P_*=2)N0MTD9]`IU*T/ M=8.Z0=U.I6X#J!O4#>IV*G4;0MV@;E"WTYWCL)>^(:J94^#D:-ZNL#+=`5#A M40O``I!TXT[.$7TVP;N'0AJB;M[ED9!1N]&YD':H:FO4'2X6-A@8,H>"`4N` MI<;`4J<'6`(LU80!@*6:P-)P!&L)L%07!@"6Z@)+O0Y@";!4$P8`ENH"2]TN M8`FP5!,&`)9J`4NC5K>;&5M:V>.++G$2V*XG@>5Q7-?F@\"^OO9DG/>5QWE? MO;[D>],X[VN?A7O]^,Y:L5*&?IF[\6(DN1';)%YTVSWHA22\4-L]F2NC&\6+ M47M8\Z6_.KP`1LG#BS[T0AI>]-K]7'.EP8L=(B"U]"31`[X^KF1=>J;4PI=L M%C,D-]2:Q0S)OY([F+6156:X&.B M/V")9?"2\%+V&OA?7,?SE"OFNB\TK0)B!Y*;'C7(WX..2:YCEX813`.+^7P, M!8."58\7TBM8NOO'7BH&,U26#.E7>!R*WY@;3I3'>4$3Y>XB_?4#-_CTGKN* MKK84D=%9,4L5#9MVU?,_F144T=8'2VA]EU!HUR&K*)0,2@8E*T#)OG'7=/9S M`V&CRF*CKOGU_PY,EX\5GQN/-LWJX>54R3<2UO55BG5%%&!N3,R1D%%EUH5W M6QTMMWX5L">DR[:14-R!2YOR#21D5(FXI+7Z@P%@J0ZPM#&[1D)I/VU^3=XX MI:IK0+7O(\Z/?D(A1P%MS/^!_.0L/__#F>O!"ZZ#R?*-^=SV]V-F+^,5?I-?G MC\XS7,,F&&=P#5]?K_16KS>"<58'XPRNH60,@6N8A3X#.(;UP!XXAIF.84[' M!\(QA&-8,=Z6RLJKP"-:<%>QR$.,/$"76V$Y@?=HSK!#V`A##&Y@EANH#Y`! M6PM3#&Z@9`R!&YB%/KV!!NRI`_94Q`VLMG.RH95`"5FN@P(,9_BV\&TKQMM2 M6?F[8]-DIC/N0YKPP[GM73A@?.*P[S@T-;!J*R$ M0]LV]L!PEL$0.)&-<")QF*;D)Q3A1.C*&QG0 M,M@47R>,\3H;6*6:HX3A,G0I>OP'5=0J%=.!$: M2@8EDT3)<")TA6U4G`A=%];A1&B<"%T#M9`NOT9"<02,W#)QJ=73<9!? M+6`))T+C1.C<_BI)U:"#O*121C2$7* M14I$'XV\5@33:H$^%2D%*3-$@P.@X=[!O<,!T$UE+#Q!F9<_P`^$'XKSG9K`17I_,BQ&.=ZZ-L,/KDXPA M\/HRT0>[?_7`GHIX?=7V17"\,\0'KJPDO,7QS@WA'?Q7J2U(G.9<#U&']RH9 M0^"]9F:O:LB7J`7V5,1[+7//$J#PYHH*S]&^:G3)[BV^BN+)MUD(9CON ME%D[SUI+SSIKRM'2LOD$JOGH9TNC758!>N?;,S5\S"OG0J2GK:0O?OXI\,X? M&)M=W!B/?!Q8_.ODDVF;/O_-?.+CS[;/[`>3B'?I>=SW;@4=;TE`WEN.\=>[ MO_]-47[>\(#`#US^A1XS#::_<>;Q;^Q%[$!ZGQSWBLU,GUGAQRO/4PP:.UU< M\\G;LP]!=!;"G4K_:!U5O[MU[E3M3H^NSM[%R_5\2JFE.V)DI':"F_%UI$A+ M>K!R8Z390LCG:WXH.HK!+2M6I+=GG;/PVILQ([F.[X\UEM318C./7R1_O(D> M3"K1:0L-6AW@LL#L&UD9DADA]3)&&)?<6NBIXUJ[ M)_6B0PWF9KW5("^A(ZB!,/7B11VQ9=@3LM;6BC\ENHW5/Y%S7H?U^W8UTV^QX2,JK,%./68)299`R`DU1I".!ZS0N@ MU#VK0/:8B02PI;F9=%F!+7M@JXEPBP!9@2V[8TEJC;F;F'V!+7M@JHC<% M8`NP)3UL#3/K\P!;\L+6$+`%V&H<;)&3F%U6#-B2%+9N'[G+V<0OI#RU`/"2 M8G>MR>A5"`/*+!+KM%0M\^A,X-=6;5"2?T5)1(%,$H>7LC>3:<>O,@CC"*[E88BTOI`8%WJ%FMAIS6*&;(;:LUB!F!* M(F9(;JK5A1E-L-747O$A-53+;N%E`=6R![)3]FI9$:@OP/B6W,0HB9O%+FU0 MMTJHF[:7NC5BJ:QB*L%[9C';X`KS%&>B_!]F!\Q]4=36*UNY^?H($I9!5XJ! M1>2";`QS2,BH,I/BU);>[^5U5I#<5D;-*=+4JK''A"J$DO>59&"`HH?A MUR3_7;(3&93S]>,XZA\RJKDJ`?Z'-B/@[?V[.VD_1_!1]Z M@[8N]0&^*.S<8U66NR%6/0IU=EUV>U(WQVH2+[KM/G@A"2^`4?+P`A@E#R^` M4?+P`A@E#R^`454I/I?>D\3Q?[6JL*CI\7\%%33);E]4?\<$RE4)Y=JO?`G* M!>6"RK6GU5G!S8LJ;D(GVVRGVJ"0L(RC4OPJ)FE@@]H?8%76(#6 MQ!F7UM%K(.L`'8 MR`XVF@:?['!5F!_PVB_;/XNJY)3[L&2.?AA>^>P[+^)TU[SC4BC_K4QDJI;E MOYK>TD8:C*XZK/G`)F!3G;!)U5J='K`)V`1L`C;)ADUJJYL=K%KQ'Z-+M$W9 MO6W*0=U0MK=6\9G]8-)/+SV/^Q[=/V_+@G8J^[53V0@=_6%;D[HY&3JJ[+%@ M2WV>7DVJ3W?BA:JV]9JK565XT>FUNZB0EX07P"AI>`&,JDRW`NFM-'0K0,UG M)6H^BSE^56[[HAQNHL1:<@:=0MU.?_QJ$Y;*T@[\.E700L)BE$KQJXAC(S9Z M"Q(RJMP=AAP/C:BE42&1"0%<`BX!EV!]2:\UWUS'"%P^)1L_W.9TF>%["K/' M"GMP>?AY,7FS:#CC=L\SC5V6/UY8/=%I+1'A@?]50^@%'DC$$<)0/ M','LDM3LNG79F--@_H)Q!323A2$EHMFPJ\*TJJ/L`XPD8PC`*!N,!AT85A4U MK+[ZC]R%3048JR9#%+VMB1R03O3OD?S)6[F4\W.D.-5>M8!UDC&D*EA79C2L MMZ_)%EVB^'*?XLL=ZR6W%UP^<=MWW)>KP'7I+U19HLH259956GGK4353CT6W M0;R0WD5H$B^`4=+P`AB%*DN)@KVHLD39%ZHL)55.U%1"N5!3*:GNY;U1<\V> ME2DC"3.9%67S>\%L9ID%]JQC]!K#3HYG3D"FT+"74P)I1VP!%C* MAJ6AOF]W65ACLBC-?SON7^>F?3YS'8-[R/BOW5HC?1RV?`0;]`)?-6H,!FD_48;$'-`&::@5-:J?5ZV7&S5=,L^@2A8W[%#:^5I>XK9KQ_P;, M];EKO7PR;68;)K,^VQ-!.5&WB-+&/$H;N[UV3^;-AE[8K.$4I8WQFPK*H,\I M@3YK<>[+;!SEP,M=:U4.86;.EM*PW>N"&9(P0V]W90Z+-(L9@"F)F`&8DH@9 M@"F)F`&8DH@9@"F)F`&8DH@9@"F)F`&8DH@9@*F3,"./O`79PY#HW5%B>P%) M>"E[;X%/INOY!425)8?1&FRY0[4D5ZT;;CCV&+H%W:H>+V37K=M'TX5J0;4J MR`O95>N3$[C^(W2K0KH%9QK.-'KU28&>3UQS\__O['QXL"M&EC@I2$S4\KJ$Y')$6!`4B$:@K]@4!` MH&8S``@$!&HT`X!`0*!&TQ\(!`1J-@.`0(CJG9P]$G7.+.A@4ZU>]AE46&RJL-@#E8!*-4$EO=73,H][`2H!E:I!?Z!2+5"I MW])Z0"6@4DWH#U2J!2KU6MWL;N)`)80+)66/7.%"#>'""JD5%I&<%A&MI7=R M.BX'BPA,VR;3'VBS0WA/'>9T%"K0!FC39/H#;79`FZXV`MK40=J!-D`;R=%& M:PT[V"207-H1CJM(.$Y%.*Y":H5%)*=%I--21\C*JX6T`VV`-G*CC39JZ0,X MR+60=J`-T$9ZM.GWND";.D@[T`9H(S?:D">ECY`=)[FT(QRW&WLZ&0=Z M+"983$!_+"]RTA_X`_QI,OV!/\"?)M,?^`/\:3+]@3_`GR;3'_B#\)[D[,D[ MP>Z7ZZ\W-\J7R^M?/O]^LF,P&L8S+"G-I3^6%)BT3:8_\`?XTV3Z`W^`/TVF M/_`'^--D^@-_@#_UI#]">EO9(UH@[4`;H(WD:#-LC51L-=9"VH$V0!O)T48<[85PG.32CG#<;NSI M9"@3CK^0FW]83$!_+"^2TA_X`_QI,OV!/\"?)M,?^`/\:3+]@3_`GR;3'_B# M\)[D[,D[P>[WC[?*Y]^OOG[YB,,OJJ106%"J0'\L*#!HFTQ_X`_PI\GT!_X` M?YI,?^`/\*?)]`?^`'_J27\$]+:R1Z[R61Q^48U`+%JGEM*KH:6BZ9WL:PU` M":#4)%!26X,A"E8`2C6A/T"I#J"DM]0^3KYX32E2%#>X[7,7,`68`DR=%J9& MK8Z&PPP+A*F\U>3_W4M-$':L2-@1AVC4SYG!ZI.Y^HS0T[X6H@ZH`=3(#35Z M2]?1'[06P@ZP`=C(#39JJZA%++NP(Q%4D$(?C M,ZJD5EA#\C)8^WUL`]5"V`$V`!O9P6:HX73)6@@[P`9@(S?8D'>L(@^O%L(. ML`'8R`TV9-G`C9)=V!&*VXT]G0Q=PM$9*_3'EZ^_*S>_7EY_ M##G[C^]:1^V^^?#YMS]N/W[`T1I54C@L.%6@/Q8<&+Q-IC_P!_C39/H#?X`_ M3:8_\`?XTV3Z`W^`/_6D/P)^6]DC5VDMCM:H1J`6G5C+R!WOM#MH&2/Y4@-, M`B8U#)-0S@),J@G]@4GUP"0538-?TPF:P;`&KEE'6&XBH3A<*A&E=0*2PC,5<@ZL$8>^@-K@#5-D75@#;!&>JR! M:UP+60?6`&N`-5+1NH*ROA*&BR[9O<57F9E\NW\^H.VX4V8=%K8Z)&:UY>R) M^?1F6=.IS>`/#Q>N#CWDL&F3V$5GBT0OC+1-7"NQZ"<:I,[G>W)7>X$5SO>J?=U6WC-W'']--\\L[I,4**9/ M/S7^'9B>Z8N!T*_%XYW`]WRBM?A)FL;>VKN.IX%@J7AG8!?%*[V]GCE[,*N. M?I)#DW5IQL17GT]G-&/W98G#TQDSW?#/%3X>_6IZ\_&$2(_/'A__O&?7]$EY MG6?[^&61TLC>GNF1L/9OMF4-D:4],7//P7>^0-CLXL;XY&/`XM_G?S?"%"M MET^FS6S#9-9G>R*6&_1Z-_]_6^*\O/Z(ZZYX3S8-+;Q9[&\ MF!.3CR\]C_O>I4`0FOVE/?[-9/>F16#"/?HNF/+Q\L,)3FRQX%SSR=NS#X$; MOO].I7\$U-_=.G>J=J?'5_$8[MX''K'+B]X3(=7E=].[,]R7NRO"-=-YX/2] MZ7WATWONGKV+3?(Y95+F^>J"&%]'R^&2W;AR8V1Y"PMBOMJ%=J%B<,N*5]6W M9YVS\-J;,2.YCN^/+6HRERTV\_A%\L>;Z,%D;Y![0.;)Z@"7;9!]=X2'_;8N MM:=`AD.'7+;YI[#;F>\Y9AK>85X!@.Z\W*3/O\<%[F&^Q0U?:@YFHE M`R_RR(F1'@%QNB61A19,8J!VE@&!M$36,<9;=OWH<_2B>\<:;^3OUQFW:3Y[ M,1>Z"]TM5'?;1'G%O0"..*>8]A MZ,P0?W#RBXD')'O>J?R.S8H'!I;8R62S4R(AHTK<@NWW.ED[L,`\257FFAN< M8.[>XB=#N>IS;$V!)-ACKT>(I7PP4UN=7@]P5E$X^VP_D<'FN"\`,X"9)`PI M$*:ULT\"0&X)BFN M?;9]9C^8(LN#A9DN@#1`FB0,*=/O5%NC#N)H546U7QQG_&Q:%L`,8"8)0TH$ MLVY+TX!E5<6RW[FOC)/D:U%"`3L-T"850TJ$MEZKTT%0K:K0]C4L%`*>`<^D M8DB9H30=AEI5T2Q5&"8P352&50/49,LP!:H5PI$28>T'K=7M]GX$H%6W+>RM MXS-+F06N\<@\40]L&NNEUO)EXA+=E+$3B/V-D@$.N;BEL:I,@TYM#;)/7%F! MP.ARWY8\1_2PT?;I87-`TYID&M%C"RC^SZ5ROUIM`7[E4\>;D0/-T1.@@+4)HI3CSKT>@1PZL$+.$3Y0"#JBN7FI>Q%Q>@)`-V53G?1$P`]`6118O0$ M``/K%X>LX;:RWE)11EM9I4%7`.PGR\>0$N&LW],!9A4%LZ0G@`DP`YA)PY`R M4YA[78!99<$,U;.`-#D94FI5QF"$/.:J@AJ*9X%EDC&D1"P;M-0N0F=5Q;(/ MZX6S+7':&K`-V"8)0TJUT_3!"-A646Q#]2SP3$*&E+G-J:M`LXJB&:IG@6HR M>/[EU^X\T"B\F@:S+IT.?,.+Z-%1>QBO+U1 MNRNU.X^*V#W6^5[-62E#%>9NO!BV!^"%)+SHM@=2ETDVB1?`*'EX`8R2AQ?` M*'EX`8R2AQ?`J*IT%I'>DT1W`G0GD+\[@0A0%1`;D-V^*(>;Q6YP0MTJH6X: MU`WJ!G4[E;JI>ZD;+%-)=[__:-^T3[6'(6'3EDKQJH!,AV, M6KJ6F:C0:(M"(OL!P`1@:@HPZ:UA)[.]!(`)P%01!@"8:@%,HUYK-#A)535\ MPF+:WHA$3I%ZR8II$Y'[QJP449O*K#4%[,;6K2A'5UM=?0C3J@[B#KP!WLB. M-]J@-5+ARM5"W($WP!OI\49O]7LG::=04Q=-NOIC-R[%J\!N'BJ/*Q.=JF7E ML=KMM`;]S";SL+:JL-@#G`!.M0(G79PICM`3P`G@!'"2#9S44:NO]=&TI?"F M+?GV5=G6O^6&/TRY[5_SF>/ZI/Z?[8F@M-CZ>_\2?XGF+&C.@N8L*"I&43%X M45E'HTF\`$;)PPM@E#R\`$;)PPM@E#R\`$:A.8L\\=PL5Q+-6;;P$N7K:,XB M(3?1+4)R!IU"W="H&=4-SELII8ZG;W,DNX,6I-C(D+&.M;6I(5>J(:\N` MFMH/E:$_$`@(U&P&`(&`0(UF`!"H,`;`J=O*'HE*][[PL18V)/UXHLT*FT3`%5*H0 M_8%*=4"EWJBE#P?H]U('I_&;RSWN/H7E=XKX"ZYC+5,KB4A!"L.B\*RCB>*9P"R]<;I%_^,37IAF^GE7#6Y0BW;O)"%JWKL>#S([' MC3;6X"L"?``^A7F+Z@CH4P=9!]@`;&0'FVYWWR:=\!1EV2''>0X-A3`I65`B MB.&@@Q;@P]6SJ>">F/:* M1E26@]6"-'``K10:17]@4-D<``:5S0%@$#"HV1P`!J&AB_3LR7N[[LKQ?,69 M*#/7&0>&[RG,'M/%AAJ]D_7Q;!A'I8(\T!]&%[;U:L>0RM`?@`1`:C+]@3_` MGWK2'Q[@5O9(5-J'EI[5U;!:(5R9V0N]EMK-[#;5:'L*#IYD#*D,_0$_VN%@(/S"F=!<"<73!' M;PV&V*M#4Q44$U<0T<`!E+(TBO[`H+(Y``PJFP/`(&!0LSD`#$))G?3LR7LW M[Q?7\3PE'DTU,C`KQS.I0`WTAUG5(/H#?X`_3:8_\`?XTV3Z`W_@TIVED'YZW";5(D8"10K3ZHIHU:6A]'`\.%JQ!#*D-_ MP$\F_`Q;VE`'_-1!VH$V0!O)T:;7ZO8RT08N7!54CL`WJC3TH=(IVJ0>R>E!@"L`%;98#7LM3HJ\A9JX8P`FX!-=<*F0:\U M[';W=!ZC2T:46'U<\FV6@-F..V76SB*FI44L2[Y>:UMI"]^_BGPSA\8FUW<&(]\'%C\Z^2&/TRY[5_SF>/ZI)6?[8F@ M@-B\>_\2?WE+K'UO.<9?[_[^-T7Y><-#'IG+WS./CZ^LR^X&+ M)]"CYC_YQE[$1Y?/S!U_([P4K[.-Z+L_;-/W_N2>S\>7]OCC]QDWZ,];1WQT M*]@Z'XIBT-3IXII/WIY]"-SPC7 M@!?@Q6JX1`=&2<(+K=V!'24'+V!'G807>>RY2^]):L6[DE4^VT1Z]S$'_LD< ML9<>ZFI.?^G=Q.K3GZ;ES1@Q0#O+X$6GW:DC+U*;(@:W?>Z>>#/K.7K1O6.- M-ZXO_QU^S\<%;'+)[N"4P]$R\4YV-Z?Z>(?UOKK-7N'.P)V1G7^`-]`?[@S< MF8H:OX6[,\HE\9\]<+@S<&>JRI&JT!_K/=P9N#-P9ZJG7H"W"M"_KNZ,U`87 M'!S)'9QK/F6F33-ZI?P#+@XTKC'<*5SC+A\>7/[`_/UB"K#@8<'#@H<%WV3Z MU]6"EXC^L!XDMQZ4*_K0988?,`L6.S2L>KR07<,^DWZ9MF<:U;?/V[U9_@T@ M:\GT;S=_%'#0&`SVFAGL4*A=%2KLSE+$V7WP`>IKH4"]=E6O6^Y.Z0;EA3.W M""V#'P`M@Y;]R:Q`EC#]$=W\*JE]1S-W]6"JP/=\9HL!*\Q7/G"#3^^YJ^AJ M2]$ZJ@KKOX(@>H#U?Z0>R8";BM[6!(9WHG^/;'^=MZ(IY^=%Y!+`[B]W[V5C MJZ>F+4I@0//`#-Y5[51I8Z%']56I='^J^$[GA=AT$K"N7B@HY6:8)(Q._NV7 M[1#_XC*[D$8M\'MKZ/<6P8#=I+V0LR#4WJA%=,CGH!JXIA)Z1J`_Z-\0^L.= ME-"=!/TKF^4#^L.1JY`C%YUN!3^N0GK59%R3/M2%W;@7H7_]\]$Y[I.>#-7#AX,+) M5UHHG;DC'T=*1)_1<"=C!SY&U##5Y;3>2]*EX#Z`_Z M%T)_>'+PY!I,_ZKX;16D/QRY"CAR*.NKG%[5"M=*=.-^&(7QJ!_AO556RN$] M@/Z-IC^\-WAO#:9_5:R<"M(?WEL%O#=4W%51M>I5<5>F!]>'`U=M*8<#`?HW MFOYPX.#`-9C^<.#@P,G.GA/7PNGPY2JD9>4D56KT_=@)[BU>(V].T_M(JZR) MQ,.O`/TEAYM.>ZBB&*X.LEY3'P[%<#5&'ZW55W>J(H$;MQM"9?%S+W4XP*M; M42'X;S5:8=;Q[!4'#!PH8HV'/P=_`O0'_;%/UTSZU]3'JPK]J^+159#^+2N,49H\5_GW'A.\H3?0P7KT(*5BN`*S-DI76Q/U<3<8<_`?I+#C<= M6A"Q/U<'68?OEK]Q^L\"3%"80-F[=MWAX(!=N^B2W5M\]8G)MUD"9CONE%D[ MBYB6%K$L^7IM_VH^^MG2:)-I1(^E=[X]4\/'O')>57K:2OKBYY\"[_R!L=G% MC?'(QX'%OTYN'IG+WS./CZ^6\YQE_O_OXW1?DY MQZ%W3IWJG:G1U=G M[V+QG9,U)=<[" M:V_&C.0ZOC_6=%)CB\T\?I'\\29Z,&%@IRT@C>L<8;UY?_#K\OHC>>]`Y.XRH.I7=SJH]W6.^1'RPS>^#.5)M_ M@#?0'^X,W)F*&K^%NS/*)?&?/7"X,W!GJLJ1JM`?ZSW<&;@S<&>JIUZ`MPK0 MOZ[NC-0&%QP$'S&JDQ0X-JS@O M9->PSZ1?INV91O7M\S;QIYCS9^O&].N;/[Q&&NRU#OGF;K!#H795J+`Y2P$J M50$?H.HJ59Z%`O7:5;UNN3NE&Y07SMPBM$Q^/P!:!BTK6LO^9%8@2YC^B(-+ M*ZE]1S-WOP.`.[#^*PBBIST`>/OMU6VNV1NBO7A-Y'US-Z:FK1M@@-1XH[:' M/308KX.P;ZR6D%#8*V6EGJS#N(2,*A&5=%7'LY<3<1=^N:ZH#_H7R3]X>!)Z."!_I5-7@']X<=5R(^+3P*& M'UMP?2OBI530?K#?:N` M^_;)<2?NP?2'`P<'3G;V MG+A(3H4O5R$M0Y%<7L[<:("LRIK(.[P*T%]RM"%$[J-$K@ZR#@].0MM&/OJ7 MB#7=?A^%;S79<4/A6Z-P#(5O:2#K=^&BU43VLP_:MB MY520_O#>*N"]H>ZMBJJ%NK>\/+@N'+AJ2SD<"-"_T?2'`P<'KL'TAP,'!TYV M]IRX[DV#+UGFGYX;!789,5EW)X#Z!_H^D/[PW>6X/I M7Q4KIX+TA_=6`>\-A6]55"T4ON5V9'<''ERUQ1P>!.C?:/K#@X,'UV#ZPX.# M!R<[>TY<^:;#F:N0EI635*G1]V,GN+=XC=PY51LAK[(F$@^_`O27'6[:/9SY M5@M9AP\GH74C'_W+Q)I65^NA^"T_?ON%O@0!$K M.KPW>`^@/^B/7;EFTA\>G606$.B/73FYV%-,)9S"[+'"O\^X(2Y\1WFBC^'B M54C!:@5P98:LU"%VXVHB[O`G0'_9X:;=ZV$WK@ZR#M\M?^/TGP68H#"!LG?M M=+5[P*Y==,GN+;[ZQ.3;+`&S'7?*K)U%3$N+6)9\O;9_-1_];&FTR32BQ]([ MWYZIX6.4[7*9GK:2OOCYI\`[?V!L=G%C//)Q8/&ODYM'YO+WS./C*V6_3+=W__FZ+\O&4D]ZLC67D-/7O3BR\-WWPR_9?E M-RD&D8*?2/R+9\^[6N5.U.SVZ.GL72^><:BE)C60ETD8A M,/&U.]\0/4LS+75CK/`$6G,1#Z53,;AEQ3CX]JQS%EY[,V8DU_']L2*3EEIL MYO&+Y(\WT8,)XCIM@8BK`UR6R;VC'")!1V:`*GX7>_E-\T4]URWM4^QH:YUV MM^:LS#0)#N=E[J$/3>K@88-X(;VOTB1>D+T)7LC!"U5O]X!1\"HPGF1RQZM[-X+DG"K[;+4/(PLO9M2<_I+[YI4G_XT+6_&B`':608O M.I*[)@?R(A6O-[CM<_?$FRS/T8ON'6N\<7WY[_#[(KJK26]4E\/1,O%.=M.Z M3AR!@0T#&P8V#.PFTQ\&-@QLR1?_P@WL2V(_>^"PKRMMS<&^EHTCL*]A7\.^ MAGW=9/K#OH9]+?GB7[A]K?SB,GK$!^;#QJZV10<;6S:.2&ECMWNS_(]Y&?1J M"(W7-Y=>(XWN@[@I@;Z58W1#H795J+!PJ@"5JH`=7W65*L^.AWKM;,I_8J:K M_,FLH)FF?!E,A2G?#(X49\H?<<2'+,Y7J7T/_K"?XK9^.U!N5Y'<^JDI_*7<-Y&"/DOS;+WO]"'=-BRC[@7]10_^B9JNXWN_`O:B) MO$O?TZ;F])>^CTWY<--KJT,X#360=3@-H@ZW`5X"HTV57XY+@3;L);J)9JE>8M MU"V!Z8=N%]Y"M<4XA MMP6]IR$QJ28"#_\!_H/L<-,>J?`?:B#K\!_@/S1YMP'5#-53+%0SY+2*:]H( M3D--Y!U.`YP&R>&FU]9'H@ZW`:X#0TV6E`@E+E]*JT!*6:K>$_:&H/^4G5%G.X"G`5)(>97GL(5Z$. ML@Y7`:Y"DUT%M%NMHFJAG"$O=T%'N]6*BSF\!7@+DJ-,KZVC75(=9!W>`KP% MV=ESRFH&'5Y#A52LG+PDC;X?.\&]Q6OD-_0U9";51>+A0,"!D!QN>NV^!@>B M!K(.!^)4#D1TR=B..V76SK:VEK:ULPSM2,.7YY:8T?/1SY9& MFTPC>BR]\^V9&CY&V6Z$IZ>MI"]^_BGPSA\8FUW<&(]\'%C\Z^3FD;G\GGE\ M?.5,9]SVF&\Z]C49_ZYID`-PXSO&7Y?V>.63/VS3]RX-WWPR_9=;0?!;0K_W M%GWU[N]_4Y2?M[SI_>J;PJ=]G8D_MSQ/,6B2=''-)V_//@1N>-N=2O\(7^3N MUKE3M3L]NCI[%\/K?.XIJ(TX'JF88'M\'2G-D@RNW!BO6"3AHFL0+V%'2\$+X>E)O2]>#%[ED@<@>[@ZDY_ MV#^E^U]2AYJJ2W^$EQ!>0GBI?'C#\@+WKK'TAWF%\%*#Z0_\*9S^-"UOQH@! MVED&+SKU+'U,U=\9W/:Y>^(2^N?H1?>.-=YHW_YW^'T13;?J&CPYDJ-8[\$1 M!%@08)&%/0BP5)M_LL-;'1> M.`(L]7?GZ[K>5Y^3K:#_$KS1Z@7 MU$M67LBN7M=\RDR;9E2,?B&"`(VK%G<*U[C+AP>7/S!_OY!=0]SA00_N<)7= MX:/Y)[,[5@%WN-;TKX"]7G7ZU\EZ.(@7TEL/!6[W0;F@7(U6+N6*/G29X0?, M:J0[#`VK."]DU[#/I%^F[9D&G%_L!=?-^:UZL/ZTSF^;\&W+<:N(&"ZI57B* MF-=(D[_J*E6>00+UVE6]/G[GKF%Z7/GFFD8S/6NH&=2L:#6[Y>Z4;E!>.'.+ M6L]=15=; MBM91._"Q*XBA!_C8FW%O9P84`IN[Z8&Z@ICA2]^Q;]]RR1W]3Q MT\0`YE^(.69'?7--VI,A7C@%Y+QW_S']MV%SL M+B&C2H2F?GO0!2K5`94VGDPAH;#7E@$;CZ:0D`$EHHW>[O;S0AN$3F`#P08Z MK-Q?0D:5:0-U]%V<,T2=MJJ-DOS;+UN%?G&974SS7@2:ZA=HJAF0]48C1)EJ M(N]U[9Q4%?I7I5-BF7#35G5@30UD':>:RA@Z`OU/6*6):!)LG<;2'STAT1.R MR4&C))T:8:,JJ58Y-4#U<^-^T/H=$3;Z$1Y<9<4<%A2B19+#3+?=0[2H#K*. M:!&B18VF/Z)%L'4:3']$BQ`M:G*TZ)/C3KB))*-JJ1:B13E%BXA_B!956\QA M02%:)#G,],C'1;2H!K*.:!&B18VF/Z)%L'4:3']$BQ`M:G*TZ./WF>DB5E0I MQ2HM5E2WQD<_Z!J"1167_(.$&7TS%81.:J0EAT1.4+/[-6>V5&B$1R[&H@\#"L$D20'G'Y[ MB/JT.L@Z@D@((DF.-=UV?G8-`D:P:QI+_YH&C!0R(7J++)9U_"DU8J&]=G\`K*F!K"/4A%!3 MH^F/\!-LG0;3OZ;A)QGHCZ!1!8)&:)Q=1=4JK;RM9F[<#]TABMNJ+>4PH!`L MDAQE>NU^%\&B&L@Z@D4(%C6:_@@6P=9I,/T1+$*PJ,G!(O3-KJ)J(5B4UREK MB!556\AA/R%6)#G(#-H=%;&B&L@Z8D6(%36:_H@5P=9I,/T1*T*LJ,FQ(G3- MKIYBE18IJEOKHQ^T[@C!HFK+.0PH!(LDAYE!NX.&1W60=02+$"QJ-/T1+(*M MTV#Z(UB$8)'L[,D[0)31-5M#Y*A"6G9$Y`A=LU>Z9G?ZZ)I=%Y&'884@DN2` MTV\/4)U6!UE'$`E!),FQ1F_W^^B:70=9AUU3NBM5A8!1F1UA6YK6V\610H2H M`NE$:&Y=8R1#<^L,*.MKB`C51-YA.2$B)#G<]-NJ!JRI@:PC(H2(4*/ICR@1 M;)T&T[\J4:(*TA]!HPH$C=#(:%$-9!W1(D2+&DU_1(M@ZS28_H@6(5K4Y&@1NEM74;40+M4[I'A6`1@D5-#1:AO77U M%*NT4%'=>A3]H'81*ZJVF,-^0JQ(L"+$BV=F3=WPHH[NUCL!1A;3LB,#1$8V,-/I^[`3W%J]1Z$AM#49=-#.J MB`2=(7J=-#+E.%]28^:8V) M?!:4NS5A^4&\:8=XDS[0$&^JB<##WJJ(O85X4W:\:8@NW+7`),2;$&^2&VNT M]J"'>%,=9!WV3S7L'\2;LC"IUQH-=DH$6(DW19"K+?$ MZ/<6??GN[W]3E)]?>]XW]C+EMG_YS-QQ^GE_,BL(7W+I><$T^FSYV8I!TZ*+ M:SYY>_8A<,-?WZGTCXA4W=TZ=ZIVIT=79^]BJ9K/-B5A$8\C+1*,CJ_=>3GA M69K8J1L31>W\UUPT0ZE2#&Y9,7Z]/>NC!G)=7Q_K("D71:;>?PB^>-- M]&""IDY;(-GJ`)=E:=_`J39H=Z5>@(NO`5U^TWPQSK4@-+FUR'I06B,Z-6=E MYE)^."]SMJNT=D]J'Z)!O(!>R,,+Z(4\O(!>R,,+Z(4\O(!>R,,+Z(4\O(!> MR,,+Z(5$O!A)'D.O!R_R2!.4/MJ%EF?57H+JOETH^[)3<_I#_B'_3:8_Y!_R MWV3Z0_XA_TVF/^0?\M]H^LL>:JHN_1%>:D1XB6MPV^?NB=.EGZ,7W3O6>".+"ZHMQMI5]-H%Y:J$<,2T+`V77UK#"Z%1K80WX*=%B"(624:$^WGS[ MUDC;$NI410;(KDY8GZ!0E6*`[`J%]0GJ5"$&R*Y.6)_JJ5";=YEKP`#9%6KO M]:DAX<.F;UJ?-B<*X?Y=]37N3M1(D[+JVVG0*>@4=`HZ!9V"3D&GH%/0*>@4 M=`HZ!9TJ0*=RKUN!3A6I4P@KYJ1R1W-W[42V&3=\/E8L<\(59Z(X12%F%3;5 MCM77J.U\J0SMMG7E?SASL>:=B('2&990J9Q5BJ0>*@65@DIAE:HL`Z%2LG$$ MJU3%&0B5DHTC^:]24*FFJ%054A1KH%*'K5(('\H>/O1$YK8REYP33Z[%:0^)88_MZB'[[[^]\4Y>?YL_F# M>,XUGSFN3\K\P?0,R_$"=WM"XZ>*:3]Z>?0C<\/%W*OTCSEZ_NW7N5.U. MCZ[.WL4B,Y].2GPB)D8J(C@97T="OZ3#Q0;9=HJP9;7*4X=K/#WZF>V4N,W_ MBCFD,'NL_,*=!]+-1]-0/ML3(?R"%[N(9KZ*E#\Y]U.TDXE&").F34;=Z\LQV^).YEG M!!9SS?]$P_*Y\6C3JOY@"I+'B: MN2:]\4693/Q-`W+^$ M+U0XF=9X;KW1$SDY2ZD1;;!!H8/0P8TZ.'$L$IYPR8U6Y6`Z%0M6:OUH[:$7 MT:J6UCE:?DCIMFJM0YK.A#NRL`=^,&FE?'0"CQ[E_7@!83Y\\`>.G5ZZ%H=X MX4)0#IA2RBU,(HR=_YK+;"1U!CT\EO.W9YVS\-J;,2.YCN^/8RC`QJ],6VKZJ0\M$V#>/I3=J=Z6."15_$.+RF^;QN5Q/1VJ[ M5W-69BYWA_,RYU#KL#T`+R3A1;<]D'K3ITF\`$;)PPM@E#R\`$;)PPM@E#R\ M`$:=@A"#S1%K^,- MU`U;F,4XX'(==%(\P\I,%-_H=8,!"`57KH>7E)&,HS*2!B:L5=$O_V-!OJ:-N M/F7S-;6\JELV#Y@"3-4#IOJ#5G?4!TS);1X#E8!*34*EWJBE#P=[=EV!TRBE MT_AM4^$D7,?:K3Y`M4Q;JTNV5D[GO=;4UH)+*!E#*D-_P$\F_.BM?D<'_-1! MVH$V0!NYT89MN6Q[/&5Q*0@A6'0N.OO,',\4;N&% MRRWR#Y_XVC3#U[-J>(M2I'LW&4$+84"96X@JC#7XB@`?@$\9WJ(Z`OK40=8! M-@`;V<&FV\U,08"G*.D.^:WCISH+G\I5.R+MFMQI9>P$HA$G(*R">F/:*1E26@]6"-'``K10:17]@4-D<``:5S0%@$#"HV1P` M!J&AB_3LR7N[[FKGPPU/UL>S81R5"O)`?QA=V-:K'4,J0W\`$@"IR?0'_@!_ MZDE_>(!;V2-1:1]:>E97PVJ%<&5F+_1::C>SVU2C[2DX>)(QI#+T!_QD)T^U M]&$'\%,':0?:`&WD1IM1J]O5D*A9!]^MPITU44%<,JK5K8)8[[4T'484?#@` M$`"H)`#2-0!0+<0=>`.\D1YONBV]FXDW<.0D3<.,NJ88.R=CGLJMD[*RM5DX M)R4+2D2Z7J>E#[`]UR#73DH-``B5SH(R.]3U6X,.W+M:"#PPIW06`'-VP1R] M-1ABKPY-55!,7$%$`P=0RM(H^@.#RN8`,*AL#@"#@$'-Y@`P""5UTK,G[]V\ M7US'\Y1X--7(P*P45Z6]9FF8U6=(9>@/^,G,`N^W5#7SA*E&PT]E MI!UH`[21&VVZH]:HVT/J91VN0@RI#/T! M/YGP,VQI0QWP4P=I!]H`;21'FUZKV\M$&[AP57#AOOJ/W%USV?9XRN)2$$*P MZ+PK*.)XIG`++UQND7_XQ->F&;Z>5<-;1(^IDA&T;CVF!BJ,-?B*`!^`3RGY M!B.@3QUD'6`#L)$=;+K=S-0">(HYJ4+>SF'42O,A58)W*G=-RH9%E>+=/PM@ M%7I+[0!XHTY+'R*=JD'NG90:`+`"6&6#U;#7ZJC(6ZB%,P)L`C;5"9L&O=:P MV]W3>8PN&5%B]7')MUD"9CONE%F'B=B>\K7&@Q=N$7B\VM5R/LG9/I,Z7&M6 MIQ1RV;0)VZ+&G]$+(S$5UTJLW+'@=1,U>G6/\8"'IJ1M27KV5>_?N:^X_(G; M`='C_B4Y,$*9.*[B/W+EA3/74SB-;:P%8GG*#Z9-7'4"C\;H_;BA MH=!Q:M;9&3$5]4#C=D^6U+A4V-/@ML_=$V^./$L\;:PW7I0L_[V13G<+':W$>I6"75;C]A#W:!N4+>"U&U]4PJ6:06S.KY% MV[S>R&8WNJ.X`/"!ZP00RI#?Z!/-OIT!FA&5`MA!]@`;.0&&ZW5TS+!!AY;%3RV M7_G4N?&9Q^&S`<@J07]%;VN]A0X=Z57DK4_*^7D!FE13DPP.H60,J0S]`6V` M-IDY61U-`I(!R>3V-M56?Y1YZA*\S2IXF]?\B7E&8#'7_`\39UPJ/C<>;9KK M@\D]N*!`M\:AV[`UZF=F/S3:E(*7*!E#*D-_H$\V^G1&&M"G#L(.L`'8R`TV MO=:@@T3/6CARO_+KK\HO+IL@UQ-(M@/]ZW8T+T&9CDH:>&T58DAEZ`_XV2'; M4U41-*J%M`-M@#9()/-G0R MF"GY(6-`L\JA&>A_,OK#FH(UU63Z`W^`/TVF/_`'^%-/^L.]RXD]>6_(?7.Y MQ]VGJ-)._&4:_'3']C6,><"VYM(?MA5LJR;3'_@#_&DR_8$_P)]ZTA^^77;F M9?GE>%?,'9O,4'S3\P*T\JR2@M4*X$K,1-!&K9ZF(_'I%6E'XJ5D#*D,_0$_ M.\#/H(>\RUI(.]`&:",YVO1;?14G,-3"=_LS[HA9*>=-AA+71@-:[3H:=%NC M`5H:P'T#``&`2@$@O37L9E:R-!J`*B/NP!O@307P1LTV>.#"9;MP\C0^V9!M M>2IW3L*RU&:AFX0,*+,-0;?5'>$\X@:Y837YMF M^'I6#2\2.0[(<:J-=L!U!"V0?X-!=\^NH(Z%,'60?8`&QD!YMN M-[/V%\ZAI,YAE+WI\B=N!Y5(V-3H^[$3W%N\4A"6-]_^60"K\LYT*(Y5)8*= MVNVT!GTD5S7(MY-2!8!60*L=T$I76X/L9@F-1BN`$\`)X%0&.*FC5E_;UW>, M+AF18O5YR;?%2=BJ>(44,6W"@2AM,WIAQ%)QK<2*D#"I/\^Q?&T[;L^G=I=9 MLT3J/70A?,28&XX;%O%=D.!P-_SAYA$?NINX_3VK='^51UE$2D&0HA/=DXK) M'>B?,Z$*>O1<%V89LK]H]S-,7A'333D//SI8-[37=..`3>7V\)AMY=.\?)4` MN0FI>%A^0GHL>8]Y=_B`3XZK^(]<>>',]11.-!@K1S_T`S?X])Z["IFUBM91 M]:.?V%)>27??]V$T(BV'$3$[!U+16-2C'Q)R,"30/[[3`Z^.)U&4C#)_XH?C MGZB,N4?K7E1Y;MJ&%=`'RH/+Z#%Q7+-]_$L64K)-8/;'8[VWAL?A1VF%M!UW MRJQ\K)4CBC]VGIPS0-Q7*,2):9[[OF M?>`3.0O$$).@+\UP-]G[G*%><1- MRW*>/>4'4[#="3P:H_?CAM/,CE/82J/-GH,_<.STTC7/^H4+[APPI92?'`4. MENROT,E5#'IX#$1OSSIGX;4W8T9R'=\?1P-H0!:;>?PB^>--]&!B5J+%6K,RT1P[GI?Q9)^!%3;<] MFL0+8)0\O`!&R<,+8)0\O`!&R<,+8-0I>+&R0UM/3Q*=?8@LWHP1`[6S#+7K MM#NY+D?MGBQU"ZD`L,%MG[LGSEUYCEYT[UCC;6'']:!L_>V+QXHPU:(Q6N M7"W$'7@#O)$>;_16OY?9&1LNVE9M6'1ST,KVU]`[LII^=A6B4_5L>(3>D?59 M[`%.`*=:@1-:10*<`$X`)RG!J:16D95NB%):^R69VUR&]USZ,O9"RJWQT/%- MD!2Q>!T_EE'OZ$?\5]+9RG+LAZ.?%G6>&VJ=$6G*$Q\KS/.X[R7ON'*F,V:_ M1&V7'KDU5LRHS99(5VXISX]A.R;+6OG]HI_=Z(VGD&8%$V;X@4O"J]!?IF7Z MHG&78&_8H\MQ9Z+#IW@%&_\[8*[/7?K:C=MY\7$[A0/SOR"TNW0KW,B2]75[ MWV>K:KM[_``)A2W1K.WH)Y'\/3C.^)F>ISPS3\AD)#D*H:GIX_);6J??$D;_>_?UOBO+SX@9BO_WP M"[>YRZQ+>WPYGIJVZ?ENV(GUX_<9MSV!#[98Z*[YY.W9AR!J!7RGTC^B_.7N MUKE3M3L]NCI3QMPPR43QWIZ=ZV=*8)O1?7_0'^K9N]Y`[VAD`J8'OM1D3OK")X^X[V^Z@Y-G&*9=# M5/^R^,DW]A)JS3/A0_A_?W)/+!G?N&LZ8W6?R=S%`[@+GW/[ M,N-S7;SQ:]<>HW\#[QO]&ZGD_,9K,<+PIN23+^R[.0VFL>J^^Z;_ M3Q8M#IMGC2E(.I^FH"HW!3_^.S#]E\\VP50@/O3"OMRWC\R.)__)<2?<)(/R MLQV]>1]TVD+@.?5H1JYIT,-#CNH*&%S+R&)!=$]:YO_MB- M]#HH_\J:5R3E(?,'X'CR*3UP(L*WML'#T7F[T;P/FA].\X.@78>8YT?R_0!& MW<7NK0/I`]+__PXC57Q\^42NV@/_11P1\H'Y_!,SW3^9%>P5>3E6$;15;G3/ MWO7:W>$)F;$332K'IYP!:S.?=+6I?`K?[,GB%41!LU/P8GG>=:/V?JM&7P71 M#_$%#K1(U=X(],[!]]J-VIH&:I_>T^V?R@>0GN@G<7+5X2YQ>-`[)TC10>W3 M^[:#4\4M92!Z!7Q;]22^[9YDJ2*WQ#F-J:Y<>G=?9TLR-\I)@AQ*N-U9:;5)_!^*WIO"#H7&4WK]4YE MI]:.P/L)\F@`.MC]G/*\W!',:6@L./H)*D:=65*0='% MT^0YU94I!24U];5F,N5KX'L^LT6O@94Q7?,I,VWZ_(J8X8J:;F;=V5*"1X,OVA`\RI='^217$7?4+SWP MIDS>9.M/_XL*'N7,HWPRB=Y]&WW1-/"F3-[LHC_@T9^A62E+:KJJG6JW M=:/VG@&P4\6_I"?Z"5*EU>ZIPKKUIO:>Y=BGVCR6GN@G294>`5%.F"FM]D#M MDV=*]TZ5OR8#T:7/E!ZTM9-$Q_%\Y#^WP+7>*0!?;/F1%AG M27>5)=K9NTZ[H_;R*#;8=?;5(W;RZ1+!(R+O3N-<]L&/H/%]]NON]WF=""V] MWO9MM[5Z#TE^]ZW_986(A`Y&0+9@YQ/TK"J=3^_G-QRQ3^;KUTFPKTWO MKT\NYY^)KB[W?`D-D4Y'[19$[DVSKQZQS.KQ M6<51(&=2OTK@U4*WK,R583=O.L@T^^WR]-7F:7GZ-;#'+@__]%]NS._B)$(G MH`>/MT(H*=@EC6[,QWLDUC:0TBG-_2AV\7]W[(2F'TR7G"'']791XVT'ZS2; MI)^C/NN*1O/&JHH&9^8:8DCWC\Y;IA8\VHU>W9N]4X'%!X_ M2@EH(=/J,NSFE-1>9;(7N=1HH&_>ZTXWIU,P:D+2/-8@K3DXD.G:Z!V]F/58 M0EK(M!0-5@\>;R+9A]IB"9$3;\YCVF&3-IMF>9\CW!WH=B#8S(RH< M=.9`W/;A MEDN/?=6EWM384UERQH["R;%\>,POKN/MU:$OLX8]KSX-VXOC::*T*,PN:HV'7/M1I+5_4!K]_+(5"[U-+CB MSU/,IF(_CS[_=:/B*_A7@3%J\`F0N8Y'5^;-4@9:%%8 MHY>#O#(F*D#'UYVJLW=#;9!O!%EJ8A30[C3<+\W7GZHR"8_12[5;^35BA].> ML[,4ACEE*6P;7HFSSXQ)AZ<>UG7V.VS7Y)7V(^'LL^-[@U%A:U'!LU]QGY,T MA&\$A;N[M)M\_GY[D*//O^.(I2-39IBNWQ[F4:Y:<3)EQN$@33L%VOKM7H[A MRL/)=)_]TON]7[KMS!EMGP/ZSMY]T_^G]T5=.V3OM$.6FV:K6PTYM?6L*[E6 M]Q2$B&TZ(Q`TV[Z#(&BF;SC7JG2:'8&?46/P2WL\[^7HB(]B\!1YUY;3GS7T:)Y'9%(@7`)9#K9-OX.[@69R:F+E$/7*.]^TZZE/3 MJB+NVG$3.0E8[F^2[0N6PHI;?.IC8-UUY`WUQQUR>^ M)]]Z)#'B%OK/M_3W8D+,?ODZF1`EW!V/)>SF5?ZYB3YED7[W7I>EDKY70]+O MWI6Q5-+W<\IVR('TWK[EFSO;#$>F^7;;O7WV#W*=A[0TW#/)M]?N[[.YT`P: M[IGB.VAW]SG(4FX:KI62GDJ;>VU]'\#+>282TW%/C1ZT._FB8EWHN*=6]]O] M?4YKE)N.&ZI>3Z?7_3SU>L^92$S'_?5ZGT[JS:'CGGK=:_?VB=++3<=7ZX$* M5.F]^LSG-PDYJ;>_R;U/Y+/NU-M[6=[KT([34B]ZZ*4]7FITYGUS+--XV2^: M^[\L_\W8?/I?#_X;)?Y;\?P7B[\]FS+WP;3/+3[Q+SHS_TU\[8JQAQ^,GB1]? MF#XCFJ2>K?*),@\N*OXC\Y69ZXA3QL.['D*,4IR)XLX+->*7 M,`%EGO)#),K?"3JNWES?7"XN/[SQ?FRMWR=@=>VV/U9OFRU*:[;?]VW]/C&Y MB!XT&T>9Q3L@BA<&(\5$KMP7YS=S(E8&L1V2S,97>`RY1`#"7$]YX#9!L66] M*/S?`;/$XWRB_X29KO(D-H_#QWF!\;AXAOC!F/G15R'QVBG5F/^5YB,M-XXB M]JY$Q):X$PWUD;"$NPJ;"6X0[9)0KQ)"E)+L["@"Y)4?Q&O3A/EX\^U;FC(_ MALP4O[JG24U,7PQ/D',N%5N'*1Y%8[2<9_HU2;!Y;_&4,(EGAG*^1.TET@K1 M)#%X""SF*O?,,[V$4O10FB,-97_(75&,8>_H1_R7&(@8%>GS7]R/I"`9Z3TG M%1>[BXI0)2%C$X4SXKPSF=#R39_/PE5\*QG3FNJU%%*4\/__\"*1)4GV(GDA M7M^_A.],!,1_F9E&*(=/I$L*B0/)Q?$DO6*%T*QEFS$M#`G02P!_ES](F"-/Q*2N_M:20I)1G*R['"+^>'1+@O3 MF2Z\<'$3@PE'(<:C!)Z`Z&@(+A,4/1>S4Z;?SX-98L<8(L&WK#=D,IF4(@!((I[RUF_'5^8Y`A1]=39\Q#"S+4EU!= MEFSWV,X6`KNC4.4LT@NK-J'&1JJ%UF"R?@J."N-US'WN3NGEX[G8;9J]F)R9 M$I!]AQA]G=PO'D4WV^FWIQ2,OA6S88EGU(HL.?%_M!`(@%+$6ZYLH6SF%@D[4J4%K?T3N'XI)$@ M,B7F\UFW>F!5(#*QV298QI!E6UL(Y2IXI#0W%O.%-9L@R>*(TKD+NU@HZ>Z6 M\C0_)[VEC$T1N:!7O9C<&D=F2.2A>G^=3\C-H"E$!YR&BOZJG!]"@:6AO:+. MQB)'-?IIK,*I2,Y\160^2Z^E"00LPA7BUS-:$C9`"C'UY;G]*!A]8*!$YIP8D$B'QV(XIJ&5&B7+RVA!\%=N`)OJ3>:#O^DGE&:!RX MD70=34_W'56E"6E:O3+ MQ-P*B4*\$0-SMI/=M$W?G-M23/EWP%R2.^+F_"7Q,VEE=L?)]^+'8MMJZVRV MZ*T0F#F]XZ7QC_9-6[EU.?,"-^08*49@A$.*!3;TXX5);!)T,S>B-(Y/3@KYNJ2A25`T"@8Q;VG]%H'=\$&1W1G'6YJF;.9*-2QQ[^2 M8EEA)K_G1S^]I57JO276$VQD[;:1%5,SQ*B$GLH5,8EAQRIV,7U0VBCOUV^6)7$*AS] MB!#NB=M!O%5%SI+'W:=H=1%_A9LSR4_"#2:QL!*V6"];@3N*31PY0B;\^D7< M(8Q_1.&=I7L7'VX8^.IXI8'O7=!W!;%)ELP).:.V?VF$"QW=%=YA<@^(O0)? MRUJD;I34FV!*PPTMW!1QE05UE82\!T)<"@2$V6I.7J*/XHN+T,HZ)X/-(4]L M]@C'O;#5ZG<66O_$Z??"T^5>+5F*55S253Q)@F@I9)FWE[,JYM^E,PB4U12# MV%M9_E'Z!\\K#Z"U-_UUX"TG*(Q%),"9T0))C`DF(CCB\G@G27CU(MA!$_^/ M""?S<1@"I5M"6T`LZP8Y228SPI\_,<\(DPW8;$9RQA81J'A)CBT+(A0Y4O>! M2-=X#.BU\V4_=,1=\E1$_DSDLV\$[(14RPXA>:`/X0`]SJQY7/^13VE%9;XW M]Q#?F\XO5G#4UO?BLB>DPYE=G`LQ(6?3%(.^"`-'9&JLJ44J"^W[Y7XM2!BN#'#[CW'C;8Q9\[SF+M\H3U)('-ITS"EQT>/(%PO[5#EF77TTZR7 MX^5*@-'13[GQF4MD^Q)!YR;8O_GR>4DZ\\DV'9?6LJ5`'!'Y-R) M!+$KQYTYD:^PLCBE?[:B3<*O2M:()-SHAPQI777%)@&9%JP0GD8;COXR.W\5^CI[I%=ODK7%MRLLC'/O M0F/CB/&%9M)8[-.&(G01D)'EAC\,1_[K\>EF4XV!-S6(V=[ M@^]*A'"3`['L%2SLC#!G=(Y_B3T?VB3TX9_,>JJ+5?^+,@NL:;3J/7):]\0& M_ZIQ/Y\T_?[;G\N,3+;@Q6^^,=]XK"%A$MF9B?G%XK).H7#V=./*DG?OT"I] M]("<2:R!(F)]]--FKD,FA3=/Z-ILOM&O9J[)?4&"FQ>;NTS/>QB1,X8,].J*2Q'D666YS!\G M2)Z9O"M<4T5XDD59(.0&/HD:)6Z+$JTIC=F/-E2-M`Z@0$1J]+H5#+7F252? M')<>82M7@4N&\Q%[?MCP`6'F(2F1I MI);CB7$Z:X-[649&YBX2]CIFL3C1I+[.N)O:]!*WN_R1QB5V93Z'(]V\^A!)X]5%1(U$4JK)UU8V MDEXGM<3L(!M^G+:=DHBT0,S?<"]VRT2]]R/G<19XF&*[QD*/SUCXE"5>TO(8 M3(/HG1%;C*691SQ2?A"B\V,2($X56WO_6Q1ZBWQ?CQOINJ!L^K^/1WXC1GY` M4F;9L%T-3,YIQ?G#"Y'G8UR0@W45Z^IQZRIA3(A'*&.8_^X*`!-578LB!+$O-&5_\7D!6@3PZ<*:J-PR M0N.HV&SFN"%R3^>^#=NX-K2B&E[3,PA4XWPFD>]'HQ:O3J\BJ>88"9$VD2)5 ML[-A%)N-E7'@)K60T4V+8L(M;E94>9/4!1"A+9$-(EHY*!/7F=*C'"]%L8T/ M^;B5GF+!"NL'GT5]8HJ1(AYNVJ((()FKZ*L1KASBJ[$3W/N3P)H[>BU:;&E, M8O][*9DTS&:ENXV0V^.$.?2(^SB93+!&5,3FM$T0-BJR3-&(Q!<[B6)'*?1P M[<5E.(;4B./EUF??Q6!$"H\933M.Z8FE)+08?HA) M1+THAL7,J7AP^%_QMB!\[7W@A]43B?C$93JQ#`D[0C38$B,..4WV9.#."XJ9 M3:,1.\EA[5I48I(NO6W--R6(1:ZHSDB+>&H6R==BZ*07H2).N"#$,EG$V!9J M0(/QW2`DTH^MM"()!#''L56W($+<[B:T=4Q?5$X+\V@6Q671$D)V0^0Z0C/E MFH3RP381IX2AL9W,U\G2%Q:3Q?4&+64..1?'^[)QCMX\+:^EQ*EE43H'.9G" MLZ4U.-X>-?\3X=%\KT2`8"HC)01>0T"WXX;&@MC-CW;YO31TK>1SMHYWG!.7 MD;3J/PL/-(PYA(6-\1IC>O]_>]_:Y#9NM/L]5?D//+-Y3^PJS5B7N=K9K1I[ M=A._M1O[V-Z\YWQR020D,:9(+4B.K/SZT]T`2)"B[I2&TB#)9F=&%`B@&T]? MT2VO@W!9'D!EEM%3?H+99XR<#.KFH[[IDJDHF%8#_X21,T@%K<0L4!'U@>A, MW=);43,BFZOACY%TKKK[0FI%]AM.`654P$E9RL5FOKKR"A8X6?2+42[BBREC M3%>F*.YHX8:HU'B!RJZOBE7$279UAJ3R&B],)_`OTAE=M-=1A@X%5_IQZ>T@ M!T&"S_(*$L8\S-HL>",G0>H$`S\(R!]?H(J5CA9Y-T%>:1IP)V8!&3&%=#U] M$J6F!EPZ!N,"K3:'!U(!9$9M6`DBZCZO-FH04,`BYH-;<.FN MN&D>H$Z,^8JE'Y[@$6A2B07!E-`99QT2908I3>D7NEJ8E7R&4XD(E02067A5C-*-]>BW^- MM@[L%>ZF$/34!)J]POVD5[B?^EP>QZ&K"5+N/1#JP`J$G',L--K0/;+JB/L3_PY<%E>OO5-CHLVQ;C'JG&#!I&69`[']WQD"E M$9$#X)KJ'B]<<1(!!AB52:NF8LJI/>55.%/8B;_L[,"ZO6VWVNWVSN.T:IA+ MYV+WVNH.($U`\1/AC&_H4^,TV]+%: MQ6E[)FQ#']O0QS;TL0U];$.?!C?TL>+Y@/$D%>7_"*S^3B(3-3ZR=+)J5/4V M*X:9R&H4),I&E)%(HFU"M21SRR^91C(C2%E]NP>T=_=.2CTCNUE><*Q&&3BF M=*V9>])/0PB,.A&*8@Q-*0V&/!FTR3+)2LF2V'DQ'7%Y@PKSC0!=TQ!_>HE0 M.@'1(E4-W*881;6\;ZLDD+]@B\&HPFMJ)?RW]H\]N.ML\^]8Y+CR4%)Q'\UU MY#(I7=F18H5[YPROF@]-/Y3)H*`TIDF<@-))9GI>Q$#Y1;2M,S?\(LP M7NE[RS!TJ]V?!&FL:EFHF1HVA?G@O!&LU+G\.FLVA'&=WU[,/R8M[T'+I5-< M7$-)=VKRXT'B+UK#)6=N"":DBWA*"`O8\#8"!$&@R?-V1LS+4T6DDK/(('=9 M/,JM\CIR+_[2OFAW:TCZS9':P%Z)GSFB5L+^^Y"R7;?8N&S3:DBHZ+3_:_=- M`*DEJ."]TE87$2Y/2-&5Z3@HT&7/2J^6!`TB\,V34M@,L,G2@0D6MW(XIX5L6.CZ8$8^12_/B`<^4];$\.LH]M\8VT`V'T/C\O#\[SW^3 M=Q[>."Q(1E$Z'*D2YCLCOVFBBR,JH@HWY-!+?K#BR,+*M.-)[G.2SF^*I>W4`-ZYT.^GSK/ MNIZSOERHZCY(!U6IZK,L;`WD\`4N:G?=5$>=,C4?T4J]RR=L+M:^ECE4;V0\ M9C()9JH&LUEX6Y?&1C]5WP_7K,R9ZL3M5="5YX++NAB&"21+4>N"&>9UPU)> M%OR:=;>>%0$5%C`%09I@?G0T#2NNIM=H2EC0M:"[,B.X^A0H($2'J?'LR`== M3[BCF;Z0[$>H%6(5F:A/%;9T1?DT-/[@AY,TR5/WM1XW?X+@][Z(F"?33Y%G<]F]%NI'R3,X5S?7$#_]^#?[(% MT>OFJ+SP.^:+/\_&_2A8R&DY4R@IJWR4;V_FV:*"+XI[6]C!]A+"X6?Y3QM2 ML$`TDYQ/19AM3M^OE!/?>5V%2O\GC1)9EQP6.[AK`,8\55"A578RH//UT`R77M=1`&<1DUS&4$H:>HS_D.Z/RRUK4 M=0BS4$)LSW:]"K1YO<* MLRP2QHULZ@'C_Y&:$)+W0`/$P7XJ\(TP,G&!$HP?&8!4/ZA*BMT)()XXVG<< M3HH54Y_CO64O7>6;4*A+C-N[+O/MS@XM]$_H&\A9IJ3AA-#Y]-34)]9E*)BI M.A>3-N"-KM2H5<$@>8%5NS*R*S'_3KTA/E;I=E"GRG061P-TX_GA8Q0\XK5" M\D,(F#LVO,$YZ0%US>%)P+_[275I](KQ,2:F)D=33F7#TT5R87?+RDW[;<&57O-VNNP* M"9N&14PF7*;_JRP_Z70V]"F5`Y-?VBCO!8%AY5P^RP!!^<7*D?;:6!D5FI`5 MZ'7:82OO!9G=0];ESO0]#2.A"(X#I/_:4)PL4,7;H:4IZPD:T;&\CT+(&I%)^5OV,0P!_,7E.9E'/?X]%0 ML,G(GHTYOY>\*]9=?/MFCOGRNCG>HVR^GDKM7N:EZ^O+."`5H7G`5H>)-A@? M^("JQA4*5S]\>,A_-:GM^K+K2.4\P^Z2"THJ@46V%9S*W/VLK6Z2JHS MLASBRFP;*K"#*3M4*1-O^,E.Q)(.+A"=HEF)H*0NFAF`&'4X#`)=\@=,>29M MA#2,)Y2>D.*-,75_'4BU_(K=LP2AYFM'OP31U/F<3B:R,2DPP`-P2Q!1WI\E MV3,7!54[7&`6+V>63",9($OY(96@)7]'51,?`RV=%P0<41H#]L0O7Q^>Z[:D MW-[R@%8$T_3W^V@2BW/L7\LF,7^M?WBC(UOM]@5R<)E!BHN5CO\\\&2$SOI1 MDD3C4L#LNGMQ??U?;]3+DVB"&X')K-SYX>$._^OH#^F-"S^5HR_^7!4*G_^8 MN=\P,S7T<.F1>.W\P-(D>J,/K0SG&:?`#*VMQ3ZK3F#Q35B@%WG^]1'#G@Q+#$L,"U,-)X8]&988EAA':%&>"C&>@TG9Z>X_.KDG M*W)5BL6Z9PVV)9XP(&#W;,6YPWK:==*2;O511I;S0YO^\U3D-)(3L2L;%S6E MG:Q+T?EDH2*)*\ODG;Q4J^-PKJ3=?@69/5Q'<;BZ]G#9PV4/UWX.5V>CP_4L MM,[>Q=7>S][.I*U*3Z;&A4;3-=EO!!9X*`"M/G2G2\7&N0,M`:S7Z5GOOST` M%H&>#0$L`C5P_^T!>.)8@R6`C2_LU:S75P2=3O>IS;[WZ%3@<6(]9$=AI?]E M#W1J>%J(IM-ZV]PI>NA@(`L*387T,48>SGJ MV0/11%EC]]\"TG,"I&[7(I)%I-/8_R-!I":GI#4`D6[O5B&2M0>/PQZDREL) M^UY1\]@"WK$+'*M:K0*RJ];UG;7W3H+9[?Y;L&DVV'1:W6L+-B?![';_GQQL MK(FVW(O=NKJ^M%::O15DL:SY6';JYZ?1^V_YW^[_<]Y_BS^6_^W^V_VWMMRI M[7_)O)._-KC_[.9M-GZC'I%4U_\S=[$YE*_Z:7Y(L$'I^[R%5,%RRK;#]MMX MUOTVS$X^R6R"K7J"F6H\%E,['_[=Q9YBLOD&-J@?12(YQZ:>SH0+/_*HDWT` MT^8M9\J#8.=*AH)Y_,SISQS9Z!B6`6_& MFZ?8&E=VB$U#FD8\X:X_4*2@KFO8WPJ^B:M\&S'A44\K7W!J#+NR0U,,$US_TW4*S.1_;R'K4M\GC.#GJ:,Q"G^?['?/"5\9I M3-TNUYGO=F?9<0##Y2Q\ZSE8JFIXB05[HC%7+4TX[(!,\P@ MQM[0@#K`IZJWM^I5%BQH%R1,P(]4#>]RY@A MRKJ`5N[5?5&Z80]BS8QRJQ3C:QX_@ETCJZ8O;X^(S`(S&VF(\G/#B/@@! M3_?NU*J;XZ-_P[_!F*8$-[I8,TRH("^:AJ@L6&0,-P[!I M0"0@'(W)%2#EL-)*D->E@$E#V70>6'7(P'ZB7M%1')-UY$3D*W@A^]"^U!UB M6]2LGM2#.1V%="3FNNDXE6UCY1!H)@@.)S;&1O:JK^T+?-%+"8+SX&T,6GG\ M])7-EN/YCWBL/'AY:3&X6KD::9YX'/O.RK7)_?QWZ@UE1CSJ6H][`,[^4)^-`"F(ZL,OH`&7\*5NHE["+M,5AX-F#4& M+XV.*DSDRB;"%XY%N(8Y".]EU^G8^42\0YY"Y)'[((BFLDF^`X76:@]6>ZC8X5T'>`MJ!`;M*L>8;]`GB_U#15'`VF="G+5@GX"/TJ-&W^6D53A^?$#M)AYB&[& MV#"T:]WY^T0Z!Y26Y<0C#COIP7:W\LE44$4Y*6+U*ZJ.FGFTDF$Y!-)J!]R4C&(NB="C_A MYUXT57[0W+L7[XY1Y/Q5B"!#B7R4&'\&_`N0&HJ.U)#:!I6Y=L-1M M-BR1)L<"U,9TULAR(?P8!:@O8F!AK&/W&/X(^'<*6H<88U1JYLZSB]F8ZZ2- M@,<%Q91F!#M39^Y%#7IE)#,.3"4=L5=IQ)[T"'K@,[,]V?W\D MABPT-!K]8BDT\$/_/RIY9>=WO=AH!$,513?FN]UY]\.7CQ_FR]=L,(>'W>?P MLN5,1SZHLY2I,0Q+4MDTCU"HF&JG>;Q:1=<@'?@(CT%<9G<1_._$$Q04(!0'_62$MG2N MP:G9(]DS#S\FL@4F4$C6=`+0&0,@EV)@D%`4;Q]):UC&C-'-KT*D8"@-LQ"I MWJYBP$(J#B!I)O`Q?+@WS+9ZC36WE%X3:$S MDLSTST\,V2">`-T;@V&4\JHB57FL3`ES`-'\;W,O61VLT_CIS'QT27#0=<:4 MIA#A,K(1*0-5.M@D\)F>"W@V_QXN!_!-*7FY-Q`.]=2'$=-`/@F"H\\I@<7P MF(MR'`DD+&P)N8Q0NB#$^>%*GY-4 MAU-R(JE$$HP2ZJ02G(1V?"U7M1=Q"'(US2:>GR><*!T/76IQ*X&,,RO-=<)% M+@_*4]+[,Y7?@:T$"3L444Q)6$-*KPHKOYZ]&68Y2!-T#:M+-!;(K8%:4L]K M3->`PS'$.`-@0(XS"$/+;%Q`S>QF!6:*)2-3D-!%']"Q)5*:.6TK`P6K01\] M8>M/=$#G%W]:[J/*M5_3IX4@X*ID"L0O-!S0[:5UOHDOY,O0-:^T.Q\L&.9^ M8\``P\K5_+HT4%+PV9E9R7[!FVEHHIGKGUQBY/KBTG.I4=LKQ6(*(^5WS#(A MA'D>Z+;`W1EF3TC#J'37A5XCJ;'(('N?YQ0N7%PA4[H?1=^,J2IZ%&@G/9D+ M=`0E\R3H(^[.M,C30LZ4H95#_(\QT17NGHU&G)>4# M)0\P&'-"@!QZ`06H,F&5E/UE6KAKET[JYJFDL]&6G=FW8]&6GZ M&B`VP06<")'D-607U)V?UG(6'/^M-J^J6?IVE*QC+O.]I3>?2R%GSEH234N: M>Z^B-CZW27)6\B[E#](724->:54=;>)5T:0LWFC*=6R5XY]6)7ZH3Q=<'2MN M)MU.\\D(&3AO_>COL+=O\(=?(C9^XWSDXET0@2@$?5KEY:D8H9-P=Q1&033$ MH0*P8]#MB6D%$Y]G&C]ST5JCU]40#/D'__3!^;M@@Z2.T>1MMF)1#QA7AZ=D MVK=@TSS856MDYUV9EO.Y+GFZQ^Y1H)U'J#?AQ(IA"_6+H7YF>+%@6BG>,4I% M'L=<$-'>/4Q=..Z2=34>O-PZ>FQ&C\HZ\BO<;#1QSBK8OI,C[3-6WD-6&P)/!Z-OE60P`Y-RFRY^(\"UT: M!U_1TMAXGBE6>*-9#&3,/=,!^ M'`5@6>@[!)6:C<==/Z9!(UF4.J9C4:YP@\I5]B95M3-+-=3FL5%:>>?M^/WB M\X7S"Y:^03(]B'3HW'M@(OE4%1HG_,*\I_++P[UY9>3E[A-`>OQW"B89GF.K M[S4M6/D1K&(NU&6VG_](9>3%DLFJYD4J$Z'Q:1Z*F<-2@4*L;PB+QOC98S_Z%IK^YU< MSE&"CQE(.KKD11<2L*:YZ3_*&4O&CHU.%-$F3$GR&ZM`TV'`^NE<6%%G,;3* M2#5@4%]-J3*'#6L6F8JA#HO%^"A$!T]':0PP'+]\?7@VVY)46S&9T0=8=M)" MKLI((8O2N#P(%-E^/&N?T>\Q!N;4[^K[JD,6EG]DDYB_UC^\D0,#Z[0OD&7+ M'%%<[*:=@Z^N+CJ-[ORU_\;!Q3=E7Q.W[D6GT4TD#]##;7M: MKMW0;2U:=#H7/4N+9M#"G@M+"TL+BU%-IH4]%Y86EA;5&'5I:;%O6LC?1>'W M4[,DKRZZ5X>Q)-6;-NHG;4W)`]-RW6.W#3&?EY[VK(AA3X8EAB6&A:F&$\.> M#$L,2XQCM"A/A1C/P:3L=/KEL,U?Q'LV6N=O8NKO9^]G4F[1F+IH6"S^JA9 MVJU]]ZU^0E4["QM(J/7VN5,"4WKIFS-XY52PR8]G\M]97K"1-0SRC26O<8EY M`C=\C#_W6K>]FURNG;(V<8A3T3@'8`.YW<*2A:75L'1]W;6P9&'I1`AP)+`T M'[-H(*&>%):N[MJK8*ED'LI?\9)6>33]J;T!>^KF[[#SZ.X@EL!-_7NB]W'D:5/U>7Y7'^68/G=TQX?H2%&:A> MX'Y6<+T[Y195\[(@9T&N!')9Q8JL,9T?^L"%6/W!JSC9NN2$+_)ZK86"$6FL MVZSJXA?G5+%BS)-1Y.D*4&8'[3X/?(Y?I9)0WU793*-1*P`'!["-QKZ;%?S6 MA2ETZ2XYO54%;,N0OG*Y7D2E:?4FM9Q^FE`%#3^,$ZS*':?]?V/9YR3*.IN: MI<823MWLYZ'"J$3UWBA0"JOZ-0J'Y[_2?.X5"`$>_3,*S^_E+'"\>67&J&6% M.QI-:RV3:V&D80IN!=-L3N3-7VO4H=F<12T/65&T5!0!F^#_5%=K5*1]%IAP MBN6A@=L"A$@)V0JG9:7J$?;41E9,$6:G(Y`5**[XHSPF(NNQC-7[?>&FXSC! MILTD"GQ7-M1699-<)L0,^5B6Q\;"UEE9Z*R8>:6\^86Y"?8*E\6FJ:MR(OSA MD&-G"W,U6$X:Z*#4Z%RVX'L"?^S+DI0MV9V!:N(@(;;D1,-+\N\4A-)@)O^D M?GGM8]#^W/=X-!1L,CJ>8[=.X9RYS]^NR2:G#GJ9_)0%8=V.KGLSSW@5G%>D7M$A MOH0U\+/\IPUYI,`6)L,<#>FW`83/,%M_``@-7TM!5@G0M0>X'`!O:0)@'RLJ M2*MLDI&/M?NI/YAL"O-O^7?5IQ[K.S+2S%7G@HI&794D>)7CP7)_KX6E)L/2 MS1:H=&-!Z?A!J9KPNV)2R(<2@D"/A!F+&8).YK-(!`\]BS`682S"6(39$F$\ M[I(;577NJ_1G@L;C?I/=HZC2*G-B6!R#KWG*.=D"7+(H](Q0Z*KLL%D#A-V2>*I8RZ[MX\K M''+/]QS=[%;X'/V7^.>!&3/2P2AO"8PLC(1A;ZTI'#N&!WW;UAQ62%HAF>]P M)N"*G9^'9HZM3&\,H_"PU:XA-;U4J.'A#(V5;4O]>/4Y*L9S%PEBXYQ4M38NS42"Y6+%=^7B5<(H M]XHIHUF.X41$+LA$U:-0MC.4J15L*+CL,K0HL30;)&OUM[A1I<8B%41![$`B ML&!&384DLJQ<39E0:GMP2@CADUA]B$*IY.T\DA_'`$ZRUR!RKTI7]T!B,LR$&J6P7+!%0A2-8#U^^/+Q M0][O'J72,%2]XF@D93UJ.3&0$704O[`=V#@7,$X\DF-'P;SN_5JT!W=7P(L- MTOUQ/Q4Z08P6H3N*H0E,_6_)?'6SQGAJ03C'"=.Y90#0\F'9Q)8,55!LHS%\ M::IMT"3;U'CD3R;LRVR'GVH/3Y\F4\X+W+EL7O:(.R=0D M0*"QJ6%CJ7>UQ?*FD^Z8L+Q6H!NA:ITE*,F.GE$?K'%"W%CYY_"S[)Z5>FC@ M!&0NP#_]U`]PQ5D>ZG@B_)B;)_^OB%8"-&M49T><>7^D#!MZ2K49=C5%Q:G!#7>P\@N%9>\<%!G.US*FT0=6. M(?KCHSQV62`#,&[`8.=A8X4R+TF<`SO)K8:_\BDFRTTDCU'\.*>J,K$KA=HG M'%!W^%02,$VD&#+O`>U^R$I-<.65HKP+;M[[=O=MUT)1,WG@:R//CTG#$![Y MW/#&%!>H5=?C6JUDF7LWG$2_?V-B=_QLJ M!%H+:$O3./5!@1@RO-!I3K(ZK!EF0K&EYV5,R["2 M#8'ATD&C&T1]Z0`4=&-U_ITZKT+%1C-C3F]+0M%CO(^:;9S\/EGD>-T4^&AO M]C>VF$>M(E8KJE.>$SO`T*D@\3,!@>3Z,HX]ANT>ZHCXP`_A`;P5!@I'%.,N MX$.Q#*['A^5Z1'X9RA#: M&RXU;Z1^_A)T?_ODQ?`#KJ[1P6OIQ*$Z.!AP-UG@F4A1$]P7:=4TO(A+!LXW M07#-O`Q#&V$\P#T9X"']1EKHXKT8,3C,?71GP`A,=+UN81334SEX9`- M*3$&S!8TM$!^^3%E`D0(!UA?!F$_U&Y"+11S4),&_RRS5(SKJ?*N5,GDKX`D M&&Y)8I!C/[LY9QL2V(R+W-**#^32-"-4+JV:XL[4 M3T;Y"M68\!JB6CI67";U9@B#*.)TR6S%C#V1LT_U"M^41G@MI MA#3+/$V`(B0!&ZK+\QIB2+$H\)VR3*J7WI-)1LD^3\L2A9\Q_1%.%2[80+JA1S=3)# M1I88.4U7)5!`H;0XH)8K?9/)3$Z6?_=CE>U#4DZ3%L94!&,NZ%*XCRK&E0^! M`@DD%)6(U*QJ+IQJ.U#047Y3;U<\X2[FJ:-O4YIH>49)#%J?JS(T"N?4\7R0 MEPGIH0%_Q!SW8O`33H>V8?6<_07FYT,6K8NY3D3"[!Z*P:EKQF0%>OX`E=PX M3ZR']^7U6L3QEQ;)6]-'A:000\_QNK?:@EEFTF10S MZ]A!;*2S!5O5,UHLZU$%R6;DJU=)-WY<\/.;VG.N*6?'#T59M@@I33#RCH_O M??HK2ISI.6;!B=RR'F?Y;'\M$E/ZCJ(^+5=KD&1/)&`93,P=P4U#/#?HK^AJ MQ`$S5UTI2;*1PQ M5=S2Q@K%%=Y^#4[RL,?2#)+XH!7E5N[A*GU2H6BO;7I1,MT<#%$)*OE:U^&4PU&:1DG^^<,; M524XG5"=X'1"94GH+JCR9U.P<")\BD*P[Q1*29-1A)'$E8&.,5@9J5#@;LP7 M!]K-NXB]M9U:(G^*(J\PNK0.9=G M.O6YK&Z))5@68'KQ<@WE36$\`;8D2N-@ENG4IM],NH"J:49Z+`/1E:@X9"0K M&X.]$"52$A!UR2Y!=WBWFW843*/":XZ)N[ M6-&*PD@D:(I%G2D[EZ/+*;L[O**I21S+:S)@_R"GR+L\W[,P@MZL:)#`2J.^ MS(:287J2?*3O5\;RQ^P;5Z$!XT5[O"N5'1VZ)0WVIKP$Q6%B1$A#F5A$SVQ; M7X!J$(WY2RV86U3"!XX/4KJ0/_P9:9=5I?\@+S'H\XR3$QR8)$:2OZ4'J:"=4-<,5#N;Q6GXZYT8:]@U6-=YT(G]DE%1X[%^3ZOI M+.,4"9-XQ@E@!P%UAL&\:(!+//DR`9.@@X_QXI70GC=.$LN\GIF5,M#.-YD[ MH0LEE"$FSXS-LR`FJ0"L4C4JLU/!F M4O'#=%;:CQAYBTB+2Q8XH25KE)4KLI856@VT^&7Q:Z[V!1UL;9O,GZ(J[MKY MI?*.!VS#OU-O*&]QAI[6N!?96S]G81-\6']3Y6W+6M-KEO;53YLO MJRCJFT_(@#,C)_542_362XAM3ME'VZ;$GE5[5H_BK-X;*7+JM,:)V#-KSZP]LTTXL_!"J"OW;$WT4)WJ]DVQ/\#XW?O>3*XO\Z=.KJ_%3<1M5 M8GCNV.H,FS3QR_E)AV@"=32N=!O/VF*'S8YE.J*L*VNI_A"L#^S9RC.4L^O: MY:!S2U<4R^//"[-^=,@,4ZIBOE'P^7.*QT3-5KS+&(,4*7<4%J4JDH73)T* M"E7#+$64)8#$:3_V/9_1->U_\'$43_"ZGTR[1"TZPEH=E'K"\,)?Z.GR0)^Y MO'S1N^WJ<_,^5`FLG[#P8(I+]TC][MS=7LO,EC'U(EN)&\6]RK9%IC_BB,94 ML0]!XB=4.;AJI3()ER7%^^/50)R_I&6^8L0\`V3T_4"L(XUTFX8`KR-_4L2> M>$3@T^=F][F*^:VN]Q_$T>H-*1!KU9XL?&=5QD9VZV:9X%A2#-CQ(MDY1V8[ M9!Y4M1+50;`J[XCL)<^LCF)(Y65+N<_3G93'9^U#Y1A\D@4CO= M)A=++F/]M*OE]W&34N:VO!RU*O MZ`S&.)^S^LZ2F3I8^L[':VE&:8<\Y[)0D5'B&$WAD?D!B6V.B=`@>*P,L4`T MO\.Z/W'E@5+GJ-!J"O08E\Z\O@%?;(FLOI+?@*>*T$Q:*'1AOI57=/9\X$WJ M;R4/C)Y$L\WD1S;S%9#50O0_/U7UZS+SC#$96_2SS*J492K$<@TLG MTX_UE3EUW]3`UG4:A.606'6VYMN#>2+Z"1&U5U0Y5 M3[1,F$([H&HHPM3H;#M8O+S@P-84J'ZW'U?"*!Z=@0_BC:LNRF69X<`W_*!4 M(F[!=%0Q7H=4=`Q?82XYNL1)4CQB<%K@1*@1N_2EV1L9%E=7^)N2V41=P%J_ M6'CYOGFQHZYQ;#*H(K.C$F1:JJAP;HW*>LG88UB6H,*C$,MRO-B9%[X/YP/? MK8KK$K_+DY?YG$F_4J?*YP-Y1^+9<3Y+0F17M,B14*VLYD%_X>(WEAU6>2JXA#T#@S61O MLT+U+^7K$]+75OX4OC\`0U+Y%A&X0NS^;NK(JN9B2\K3_-O&P]+?4N[IIO!U M[IVY;!;&2N1U=YF+/H=L54,`8Q`S**N!)[ZZZJ_GJSJ'$F\X:*VLNIC74@XC M3(67M)=UJ9$^\BB\B%^VZ*Z];O29SRI3"O*H@1EP*)3P_A9&TX![PVK9]UN% MPRCSY^4OE#6^=$UF=3NH6'E-!C:6UUY;7C]N@=\LG@N!X=;EGJX%H\F+5(`F M\J1L!A1J->K.8^[%G@H4KUXT#25K++?0]"M520ZC26FAA_=<2$A%Q1;N6!X& MT]?O94$$\WQ5*R*2FPO]R`M*%-9KGINPJ<1F-9<2\XLM4@6,_NA4G*3(!#IM M+9DOQ6?4ZD<-NLW%)/+N MP7NA@U6*FN6P?`#R/DHCZGT($)F25+1DLLWC:M9V,T",*Q17BG2"Q/#.61"% M,KK)QWWN(?AY.8OZ.8NB:8OU\;)KOKKHMXRUZ$:ZF0LPKS>T99BLNKM8.0O% M7)6\M%P]>54FE$KY9#><<2-A+_C8$.V%A"QCM+57L4OE'ILTT32\QC??9QJ` M\U%$881%B.J"[<8M^,36=$S.BIT'>!\Z_PV&*0:4`)EZ1;W?BR8(3P8S?T8) M0$'^WR>(7Y=_)6\B_F\=+`7C?3WL%1?D%FVZU9JM1S[ MG()=%R;21DG4A%:Z.U73H&Q"1`O9$YR\$;*)@^PQ]0=8LGXBQ4Q>TPZ,&+30 MS$=Q#'@8)Z-$G#$^5::+G2E'"L7F^]`@FDV82C-<\#9T]V2%BK0EX:)]DW7V MP7*YZT]F<7\-+]\'X#?-;/`>C_P_I7S-K-9300#_-:[.QRR8/^0;,[,SK72U M+N(*T/R%]\4*U)1\VB-0K%+B-!1VNP"%RW+P=P?%3UE9,CQ`RHOQB;L!>JX' M/LSV0YK(?!@W':M^=A*OJV9>&U3FCE\^890ZH=KF%'*)C8_)1JOL0 M9)-7-4D+DU5TI+R M$+-%9_D:."8Z8P-L1"P#K#33;.3<[(A5_K5T>E'O-_O4KC\R%CD]?& MW8E/@3'_QX M=A]__3#XVNE^[76^`HG;9V"?NCZ(H_C'L_/>&?9+E@_^#C]TSG[J='IWE]UV MNVW,:NX-.\W@J_K>U\SHE5]ZEQWR^^]^G#UE`!+A40&.)!K]AFX(L6IEY[U& M+2MS^WYDOO<^?,7C5H-?#G<132.]9;0:_=;M#T/W&,KG'O M9Q4Y79.A;B_;MPU:Q1=!L=79!F0X[W1NKGM[7$-G)2MW.U>]?>YBY\GPYKI) MJ]H-;@!K]LHE^X>;3H.FOR7<=-J]FP:M8BNXZ=YT]\E(W=5P<]OI[%,/Z#Z= M>G/7I&7MA#?=[F7GLD&KV1AONC?[U,XVG?YV>'-UU=NG!-MT$=O`SDN;VZW>=1W70UFR/-[3ZEV:;3WPYI.K8_-`[T'R@C]2%&4SR,F>/SS>!)$,\[IH8\JJ^QCP"C/ M+U\G?)&\?%\[7Y4*]R5:8'NURW/NG?UT70&/F\_HX,O:[Y$ZHGWI%O:ENXK< M-Q5(<03+VCNYCV5?>H5]Z:TB]UV%E#Z"9>V=W`??%_K_MY@`CVL`;8NIBUO- M0;SS;H42M-EZFKPA&PMTV!(R?IJ\)8>&R2KGT^GLQS8LTNU6N%R:M"6'AM;> MU0:B=/<-P0\_4!`[_OD[%ZZ/]V=JU(^[&T%`U6P.N9J]4_=V`[7XV'9C*PFQ M"2`>?#\V-`XN*ZS7QBYF_ZS>Y,W8T`[H76^BVSWU:O8OHTYY.[:!L?-.>Q.I MO?6.8-DMOM"@VE9N5_M$*P(7FT[HP&LZI-?[*/9GB?RJ7--=15RYX6LZ*,WO MUCKDQ[P_&\=.*F(.3=N1);*^:D6757'GAJ_ID*?@LBHB?%K[T^Q3L+OK;XU4 MK_5IO(,/HJ;E')+[[]93?8]S9[8(VG;;EVLY\)YJ0S94@7J]F_7UNJ=?SD&U M'\HO.-6MV8+U[ZX;S2H;JCV]RZKDB\8NYY"<#UO3:-`_L+*SOI&X\U[4&9VH MU&6K+I]L,ID#KN6@''^[`=0?U[[L4;<_LIW81MM;*USS-)NQJ:9W/$LYZ,EO M\+9LJ-%T;JINJS9T,0?5Y&^Z#19[!]9F-G!T'-=.;'6WK%UUIWC'_?C$/0[3 M]3Z(=RP(J@)BS1'WF+D\OP&K5]"T96^5BE5!^J=8^:$3%3H5&M[QK7LKBC>$ MUP^=OW!U$NO>AN*7%>*N]I63=*C33#_O5)4W6#F%?4_[D#K;>97*=FP[L%UU MC0W%TGX6OJ%U>=[M5(1%GGS:!^78*O?XL>W`5AQ[5>$A/?S"-[26SZ]O-]2# M#C+M@W+L9;L1A_;`%O#Y"=!]J^O&-[4M/.O<=A]ZGWB"_3\:;O2<=Z]O*UQ] M:RZED9NPG05TX%UHMLCN7'6J]99U5M7$[=@<#*M"',>[_BUP$7C@LE)SVWT/ M&N\"NZK*@%ZZ@%H7?'C\NZZJ>'6X!1_>`=*M5LYK67#]?H_N7;6+;O'K]SC; M0ZAD3[K>36W\7J_:-_$DLST`=9YVO9O:LYVKJC*)3S3;@[@=:EWO1Q$-!1O? MI\DH$MB\25:\7[#H]M=>.X<,C1^%.5]5J1J5\<:5DZAQXFK>1*[NUPK6.O"T M/_&Q;%*:?SE_9OE*5IZ2JJ7TKM9:RAK3*JTN'8^9F'T8R)IX7]CW=Y%J(EDH MQ+[18G["DN]F^7?XN5@!/^]>H7X75`<_*U&_;N'\5;TSS+KY6Y;-WTNGD0W; MI!QRZ@:MIKZ7C*@Y0=9*),$6LX[+@T"U':&+V/A[/&&N_EU]OX_=0L6Y&P4! MF\3\M?[AC1S8@9$OL/-!F2>*BTU$]JO\W<,F=/XPQ!%WT_.DKRZN+G:LRF9$<>IU7I#?1; M>=8V(N`S@[I3W_^FJV"GOO\6?RS^/.?]M_AC\><'V0:R5.1$],NSFGMKUT>)EQL=O[, M/(*VF4BP+D6G\D7]*/`J28PI'WNPW9NN.]1P.)]8=MG#=12'JVL/ESU<]G#M MYW!U-CI<5NNLZ>SM3-H2)=]RF`;FO3I]%K#0Y8<*)E2?,TNX=0GWEST0JM+J M;B"AUMOG3@E)Z:5OSN"54\$F/Y[)?V<)ND;Z+@@WEKS&)6:?OE)9V=U6NWV9 M"S6K2C19E;"P9&'I>VMAR<+2B1#`PM*)P-)MM[L*EJQMN/#0./J? M3O>I3]#[T,4[N_`.P0.6<,])(L=-A>`PSHPSX23LNS.)8JK.$C_#G+13%TQ- MC\D^/=QU;SM6!SL%5K=08Z&FX5#3LU!S$JQNH<9"3;.AYF:E8\E:<,=@P3WP M"@MN(OQ('*W]UHA@_7.&NKT0X`FQ[D7G]NJE5:>.E\\([D:AZP<^=;QPHH&3C+C3S^X;LM!S>,'BC?5#V#2&A3,BU0_? MN^W.W9O8@8'Z,%HR M^56F9,-+H1XW[)UZ=*7I4'?J^]]T%>S4]]_BC\6?Y[S_%G\L_CSG_;?X8SM= M6//.=KK8B9Q'4"_<=KHX)NRTA^NH#I?M=&$/ESU+(R7< M,5P4V!>AGO":P.7MG;V_=!R*A`4E"TK/!)0ZMLN%!:53(8`%I9,`I=[=REK, MUBI<>&0:5"'UWG5%R@*\AEA]O]#FGYV<(#J2^.L3PMOUM56Y3H'3+=)8I&DV MTMQ8C]-)<+I%&HLTS4::ZRMKL9V"Q69[6EBHLZ6@EV/=BTZO9^O-'S&/6Y"Q M(--XD+FU$'/$'&XAQD),XR&FMPACK*W6T("T[6AQG'0[AD2"DZS-?-GM6A?X M*^>-9AX:9[W*0?=-AVXTYE_8 M]W`P)Q>^!T]_ MXH,?S^[CKQ\&7SO=K[W.5[RY?.9XW/5A.^,?S\Y[9TX:^O+!W^&'SME/UYT[ M8-1\5A7C[S2!WJH)='HW-QO.0#"/WX?>AV3$Q;WKPO%)XD_!VH$\`*PE@S1P]./KG)MZ3_GFF[%+ M"P[;F:9JV'6V^`Z<$>.@,1C9U1%$^07V-B0WAC(OP^ MR$01.\F()0[W\=@[:JZTV<'G`^;B=%NP2VZ0 MDH=NPN+$200+8R:_.()Y1V+F3&$U]`HWA3^,80":)/Y!<,]/G&DDDA'L=9QU M[]%/MK#?SI0'`?X;/X#74;*&YP@__E9(V:!T^Y`PD`79"')'`N`-7MCHA9M3 M1<*LN="4`S$%G\"$X:4A3W#"K``CGH:1;"!X9%ZUVY3E>E?7+1`A.X]#V['[ M=*ZZMS5-A_9GYW$>@%C$F[U.RZDL%;351NT\"JHGNX\B>#S!T_C(@]G%O$+V M-+K=6BK*O%8#4/&9NZGP\3+,)PYH_!_N_9WYX:\1G/]E&DVGH-%T3*6K/:]S MM8LS7?K:.F?9+[ M*$Y^X\DH\N['B%O59^7VZU5VHF^_WLS;FE<5IMY5A]PBYD17OW^?,\Y(\SF! MS4?*_/Q'"J1`+3`*X=>8J*2?N@>E6>I0'YGOO0_?,5)5YVETDJN'/X^CD%Z] MWCF[.>;5%E[^1!3^/`(#*5[;O_/^G[^4)]6#65TNGI)\P4XSZ*V>P66G+$XV MG\*]"\02):3=0+^HGMEU[V[5S/2+ZYGA$MVB>H;=JY5[M_8,%0/6!>@]=<17 M3$^]=E^7OIN_7-,S!85M&KP*F7F\9 MF19,H.8I+^'\:BS=>]?N/7"@AB9R?*7AO6>R[%2*DRAM^602D+=?0T(UX\`.T\T;L^DL.QU49LQ!.]J[U`IN!N-`S1 M>_.%?7_+0S[PDZ6*<'OU.2YY'A:\9.>9=-8X1N5SM)^9K%3<8$,N#S*3U4I< MV7;;92;9O=E//$X#9+1?1#3^B!=G@>7]")_]J._-;NO8K:1L9RT6VVA^!U[Q M,MVV:L57Q[[@99IQ)8P\T8JS/)6/NE[7?>B]5X6\J+;7QLO.6C#;F`6M/&R7MV59V^P%K3Q,E^N)Y#H75'$J59K3?D7#G.I< MQP0/ON@-I4.WMRZD-'K5&XJ([NT!5AWS#X.?XP2FD6QF`SSG=+O?,6UIX&3[ M=@QY=)NOTJ;:'2S5;B+XA,GCIA/$,+F*DM@P\PS.):6T4R;8P`]9Z/HL@+>H M&%@,+\"'!L!%?J(2TE1Z%F6N"1^^,0E@QX<`&X(%P0P_YQ,<$+Z+;_S]XO.% M(SBY8V,':,*&-#BFGHW9-^[P#"2-2CG#XV&'`WH:&R!#(VSC+$ M,!=/I>\%/NO[`1GL+7H>]LD-HC@57*;FJ0SJQ'S287)LW`2]255;T)1,YD8Q?5M'NQ1Q8(A^&E.B(I(FB,+ASJE=,HWSMMN^`T!XQ$Q&%@Y]G:'L MA_FO-`=CQC[I:UB>"B<#/P-O2V[';V9<@GGVS@LC35-FBAJ)HO@G%]:$GVJ. MFCENP/PQ#DS_QK>E]-I^BA<\DHQ])$-I'D(9_`@G"&=,E/9#X%NB@#RP,)N7 M+=B@R/VF,DOQ[\!GM//P.BX2YA-52?$U6=Q8A?X8IP[G@@[B@'.9D&IL"\XM M/P8PF42DM$DO6^9!0@3Q/:XP)ML$^?V(DG%].$`QIBNR";P4(`-8LS&Y>$5% MI:C$_`^)&.[=(UV&_)^4P_MAH/R/,G[Y(4T`(N1-^]K4<8J=WI0\EQO.9G]+ MV4C)IJ5<=CK-7,I&FC,MY?KN=N]+F?L6N?YK9J_+R[5H4CV7?2UC8]:ZOBN% M.AJQC(W9ZOJVY+;;?!E__M.?__2W_W5^_DL4)2!EN/-9WD(X/Y>K!#GZ[?5` M??@K_.)\IS^)"`7N*$DFKU^]FDZG%]_[(KB(Q/!5M]WNO<*/7^ ^KY9#:! MYV'E'+1:[XP&U\,'D:N>&@ES_-V MKSA1&+0TR87+[RY8?K=QR^\N7GYWZ^5W%BR_T[CE=_:Q_/:"Y;<;M_SV'I:? M'YOB\MN]IBV_-*/"\CM;+W_!V6\W[NRWEYS][9>_X.RW&W?VVTO._M;+[RQ@ M_D[CF+^SA/FW%GSMZP74OV[:\DLSJ@GZ[A8L_ZYQR[_;Q_*O%BS_JG'+O]K' M\F\7+/^V<N8 MF>5IRI>"P1NEPL6_C@-X0S@$\S,\__WSV4\8XAC`A\G(^2-E(N&";C#3]7+E MS92^8/IQ`A^[E$_HQ&A'GWO22:-NXJO;_`/V&$DO+)=Q!PPQ.'_!8CO.V`\" M='-.X,O8W&"(_M9(1CEB%E#X@(6&(UV'0/1KR7D+#_W&/3:(1,MY'[H7Y!I5 M+G_\\-W%IPOG+1.>^AC=O`$G-SVFL9%O709==;@B*KB[\A7&%>]2,8PT7+#0 MWD4W6Z?TWR8C6!/PR@0>%[/"ZL83Y@OZL;0&JCA@?`IOG0H?.,*+IMFT=3V& MK!9#<>/^Q8)'_G]=>/N0(EG*>T^;>/&W5P7^VX@INWMERE\B0:O#%ABQ0UX2 M9^Z2/?U_5WK)T6%'WY`;\>X-W0N7OSR\<8`Q_:&LSI!SZE"P,-%!IYTVH[/W M$ZJ+9O#O-'E/'P,5DU)A+3@D+'#3(`M6ZM,Y5:ZP'1+HA:\>E;&:K-2&$7ZA MP)?#$IU9C+'-09I@X![ZK@G$8_YGQQ,DS+EK.E"$].4NRLX:O4HL=,_$- MGB_,3:Z\Y?2YR[#2B2KO$:1QC@GPY^(V3RF4V$=$3'S:6_^1R^H?E>AXX5`Y M'X';%LQ:I=&PT0N0?,3@/=>RP$;+Z>00J3C[HIW_0=%KL,WQ:#EF(8>6K":2 M\5-]'%1YDDI_^Q5^^8F\K:_PA,"/_Q]02P,$%`````@`[7151)`-O`L` M`00E#@``!#D!``#M75ESXSB2?M^(_0]N9I@B8A"UL4H0%)'_WK-P&2$BD2)$!1(D'IJ)^_6@_[EW8"#7(C9V7[X>!-ZAZ5D8'_SU?_[S/W[]K\/#?UP\?#=L8@4S MY/J&19'I(]MXP_[4N*3$\R:8(N/YPWC`K\@W'LG$?S/A2U2^GM[^TQ96B]*^MDBL\/#J+8+TX/2(1^O=O"YO_CE,JJ9N%^,P=&@ M?S3H]8^-?N_+X.1+[\08WRY2W@*4"2Y/ZF#WYS/49X`^7._K04+`]V?J?";T M!7+VAD=QPH,PY9=W#Z=2OPWCM/VC?]Q^?[2F:&8>8M?S3==:YF+%Y.7KCT:C M(_XK)/7P%X_G_TXLT^<6*I7+$*9@?QW&R0[9I\/^X'#8__SNV0>@`\/XE1(' M/:")P07XXG_,T=<##\_F#A.C!27Q/6( M@VUFG@O389@?IP@,?&"PPG]_N$EA@((@]83;_8@E.)(IZ6@3TBX^WDWNYHAR M?7MCU[XDLSE%4^1Z0-0;:!LSM!86I7HVC?32]*;7#GE;SSSY!6Y:]L=`%TAW\2.M-4V5'E].F&T89I^-1U6*32'!P0B8`L, MPWZ##X_("BCV,5K*F\UU:]*?(-VS@Y;)*^MJ*T+5I\._H1GQYE-$T=B"^CW, M>I:+P,,N\KS$I_N`6E,8`NX!"1H[3C2V5%937?76R29J8_*"0`#L;5<9-59= MGSZNT`11:,/W%'F(OO)J+HG'R7GCO@)-"644!E_##AQT-TE\K*R)6BJM3P>_ M$6*_8<>!VN]\(.N-"P[9"X9&.?8\\"IB.>SQC%`?_\GE94*EDUT3^@.]^]